Citrus Sinensis ID: 002355
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 931 | 2.2.26 [Sep-21-2011] | |||||||
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.332 | 0.377 | 0.645 | 1e-115 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.281 | 0.280 | 0.636 | 3e-99 | |
| Q54H46 | 642 | Probable serine/threonine | yes | no | 0.282 | 0.409 | 0.434 | 5e-61 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.279 | 0.283 | 0.428 | 6e-60 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.282 | 0.381 | 0.434 | 1e-59 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.276 | 0.343 | 0.433 | 2e-57 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.303 | 0.219 | 0.413 | 3e-57 | |
| Q54U31 | 744 | Dual specificity protein | no | no | 0.282 | 0.353 | 0.421 | 3e-53 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.279 | 0.156 | 0.360 | 3e-53 | |
| Q54Y55 | 506 | Dual specificity protein | no | no | 0.286 | 0.527 | 0.411 | 2e-51 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 417 bits (1071), Expect = e-115, Method: Compositional matrix adjust.
Identities = 202/313 (64%), Positives = 248/313 (79%), Gaps = 3/313 (0%)
Query: 612 PNATLPSQLDKEDESKLEK--QGKFPVG-PGPRYLNIEPSLAMDWLEISWDELHVKERVG 668
P+A +P Q +++E P+ P P N E L D ++I W +L++KE++G
Sbjct: 499 PSANMPPQNMMRASNQIEAAPMNAPPISQPVPNRANRELGLDGDDMDIPWCDLNIKEKIG 558
Query: 669 AGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728
AGSFGTVHRAEWHGSDVAVK+L QDF +++ EFLREVAIMKR+RHPN+VLFMGAVT+
Sbjct: 559 AGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 618
Query: 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLK 788
P+LSIVTEYL RGSLYRL+H+ A E +D+RRRL MA DVAKG+NYLHN NPPI+H DLK
Sbjct: 619 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLK 678
Query: 789 SPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFG 848
SPNLLVDK +TVKVCDFGLSR KA+TF+SSKS AGTPEWMAPE LR EPSNEKSDVYSFG
Sbjct: 679 SPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFG 738
Query: 849 VILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSF 908
VILWEL T+QQPW L PAQVV AV F+ +RL IP+N +P +A+++E CW ++P +RPSF
Sbjct: 739 VILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSF 798
Query: 909 ANIVESLKKLLKS 921
A I++ L+ L+KS
Sbjct: 799 ATIMDLLRPLIKS 811
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 363 bits (933), Expect = 3e-99, Method: Compositional matrix adjust.
Identities = 168/264 (63%), Positives = 202/264 (76%), Gaps = 2/264 (0%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
EI W++L + ER+G GS+G V+ A+WHG++VAVK QDF L EF EV IM+R+R
Sbjct: 663 EIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEVRIMRRLR 722
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
HPNVV F+GAVT+ P+LSIVTE+LPRGSLYR++HRP + +D+RRR++MALDVA G+N
Sbjct: 723 HPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKS--HIDERRRIKMALDVAMGMNC 780
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLR 834
LH P I+H DLK+PNLLVD NW VKV DFGLSR K NTF+SSKS AGTPEWMAPE LR
Sbjct: 781 LHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 840
Query: 835 GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894
EPSNEK DVYSFGVILWEL T++ PW G+ P QVVGAV FQNRRL IP+ PV+ ++
Sbjct: 841 NEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPVVGRII 900
Query: 895 ESCWADDPAQRPSFANIVESLKKL 918
CW DP RPSFA + E LK L
Sbjct: 901 LECWQTDPNLRPSFAQLTEVLKPL 924
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 236 bits (603), Expect = 5e-61, Method: Compositional matrix adjust.
Identities = 116/267 (43%), Positives = 164/267 (61%), Gaps = 4/267 (1%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
D +I ++ + R+G G++G V+ W GS VAVK L + ++ LKEF RE+ +MK
Sbjct: 365 DGKDIDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMK 424
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
+RHPNV+ F+G+ P + I TEY+PRGSLY ++H A + ++M +D AKG
Sbjct: 425 NLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQAL--QLQWSLLIKMMIDAAKG 482
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPE 831
+ YLHN P ILH DLKS NLLVD+NW VKV DFGLS + ++ + GTP W +PE
Sbjct: 483 VIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSPE 540
Query: 832 FLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891
LR + EK+DVYSFG+ILWE T Q P+ G+ P QV+ AV + R +PQN P
Sbjct: 541 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKYI 600
Query: 892 SLMESCWADDPAQRPSFANIVESLKKL 918
L+ C ++P+ RP+ +E L+ +
Sbjct: 601 QLLIDCLNENPSHRPTMEQCLERLESI 627
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 233 bits (594), Expect = 6e-60, Method: Compositional matrix adjust.
Identities = 114/266 (42%), Positives = 176/266 (66%), Gaps = 6/266 (2%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQ-LKEFLREVAIMKR 712
+EIS+ EL + ++G G+FG V++ W GS VA+K + + + +++Q L+EF +E+ I+ R
Sbjct: 655 IEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSR 714
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
+RHPN+VL M A T P+L +TEYLP GSLY +H M+ + ++A+ +A+G+
Sbjct: 715 LRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKKIK--MNMQLYKKLAIQIAQGM 772
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEF 832
NYLH ++H D+KS NLL+D++ VK+CDFGLS+ K+ + +KS+ G+P WM+PE
Sbjct: 773 NYLHL--SGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSI-GSPIWMSPEL 829
Query: 833 LRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892
L GE EK DVY+FG+ILWEL T + P++GL Q+ AV ++ R IP L+
Sbjct: 830 LMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSH 889
Query: 893 LMESCWADDPAQRPSFANIVESLKKL 918
L+++CW DP +RPSF I+ L ++
Sbjct: 890 LIQACWHQDPLKRPSFTEILNLLNEI 915
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 232 bits (592), Expect = 1e-59, Method: Compositional matrix adjust.
Identities = 116/267 (43%), Positives = 161/267 (60%), Gaps = 4/267 (1%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
D +I ++ + R+G G+FG V+ W GS VAVK L + ++ LKEF RE+ +MK
Sbjct: 382 DGKDIDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREINLMK 441
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
+RHPNV+ F+G+ P + I TEY+PRGSLY ++H + RM +D AKG
Sbjct: 442 NLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKI--KISWSLVKRMMIDAAKG 499
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPE 831
I YLH P ILH DLKS NLLVD+NW VKV DFGLS + ++ + GTP W +PE
Sbjct: 500 IIYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQG--ATMTACGTPCWTSPE 557
Query: 832 FLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891
LR + EK+DVYSFG+ILWE T Q P+ G+ P QV+ AV + R P+ P
Sbjct: 558 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYI 617
Query: 892 SLMESCWADDPAQRPSFANIVESLKKL 918
L++ C ++P+QRP+ +E L+ +
Sbjct: 618 QLLKDCLNENPSQRPTMEQCLEILESI 644
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 225 bits (573), Expect = 2e-57, Method: Compositional matrix adjust.
Identities = 117/270 (43%), Positives = 164/270 (60%), Gaps = 13/270 (4%)
Query: 656 ISWDELHVKERVGAGSFGTVHRAEWHGSDVAVK---VLTVQDFLDDQLKEFLREVAIMKR 712
I E+ V+ R+G GS V W G VA+K +L D +D L E +E IM +
Sbjct: 486 IDISEIVVQNRIGRGSCAEVFTGTWRGIIVAIKKAKLLNEDD--EDFLNELAQEATIMSQ 543
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
+RHPN+ F+G P + IV EY+P GSLYR++H P+ +D R MALD+AKG+
Sbjct: 544 LRHPNICQFLGTCNNPPEILIVMEYMPLGSLYRILHDPSIS--LDWPRMKSMALDIAKGM 601
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSV---AGTPEWM 828
NYLH +P ++H DLKS NLLVD+++ VK+ DFGLS RFK + + K+ GTP W
Sbjct: 602 NYLHCCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKH--LDKKTAMTPVGTPCWT 659
Query: 829 APEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888
APE LR +P EK+DV+SF ++LWE+VT + P+ G+ Q+V +V R +P S
Sbjct: 660 APEVLRNDPYTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQHKLRPIVPPQVSA 719
Query: 889 VLASLMESCWADDPAQRPSFANIVESLKKL 918
L+ CW++DP QRPSF IV+ L+ +
Sbjct: 720 PFTRLITECWSEDPQQRPSFQEIVKRLEAM 749
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 224 bits (570), Expect = 3e-57, Method: Compositional matrix adjust.
Identities = 120/290 (41%), Positives = 175/290 (60%), Gaps = 7/290 (2%)
Query: 630 KQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKV 689
K +FPV P + IE +W E+ E+ + R+G G +G V R W G++VAVK+
Sbjct: 822 KDHQFPVPTIPAKI-IEVEKPFEW-EVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKM 879
Query: 690 LTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR 749
L + + + +EV ++ ++RHPN+VLFMGA T+ IVTEYL RGSL ++
Sbjct: 880 LFNDNVNLKLISDLRKEVDLLCKLRHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILLD 939
Query: 750 PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
+ MD RL++ D A+G+ YLH+ NP I+H DLK+ NLLVD +W VKV DFGL+
Sbjct: 940 ESIE--MDWGLRLQLGFDCARGMTYLHSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLAT 997
Query: 810 FKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQV 869
K++TF +K++ GT W+APE L E EK+DVYS+ ++LWEL+T P+ G QV
Sbjct: 998 VKSHTF--AKTMCGTTGWVAPEVLAEEGYTEKADVYSYAIVLWELLTRLIPYAGKNTMQV 1055
Query: 870 VGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLL 919
V ++ + RL +P P A+LM CW DP RPSF I+ ++ ++
Sbjct: 1056 VRSID-RGERLPMPAWCPPKYAALMNRCWETDPTHRPSFPEILPIMEGMI 1104
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54U31|SHKD_DICDI Dual specificity protein kinase shkD OS=Dictyostelium discoideum GN=shkD PE=3 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (536), Expect = 3e-53, Method: Compositional matrix adjust.
Identities = 112/266 (42%), Positives = 161/266 (60%), Gaps = 3/266 (1%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
EI +E+ + +G GSFG+V++ + G +VAVK+ Q +L F EV IM ++
Sbjct: 271 EILPEEIDRTDFLGQGSFGSVYKGKCRGQEVAVKIPRKQKLSLYELTSFRHEVKIMSKIF 330
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
HPNVVLF+GA T+ + IVTE L + L +L+H + RR++MA D A G+N+
Sbjct: 331 HPNVVLFLGACTQSGKMQIVTE-LCQTDLEKLLHNDRTKKEFSLFRRMQMAKDAALGMNW 389
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLR 834
LH + I+H DLK+ NLLVD N VKV DFG S+ K K+ GTP WMAPE +
Sbjct: 390 LHGITR-IVHNDLKTANLLVDINLRVKVTDFGFSQIKEGEEFQDKAAKGTPLWMAPEVMM 448
Query: 835 GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQV-VGAVAFQNRRLAIPQNTSPVLASL 893
G P NEK+DVYSFG+ILWE++T + P++ + A+ + R IP +T P L L
Sbjct: 449 GNPYNEKADVYSFGIILWEILTKEAPYSHHKDYDIFFNAICNEKERPPIPADTLPSLRHL 508
Query: 894 MESCWADDPAQRPSFANIVESLKKLL 919
+++CW +P RPSF+ I+ L ++L
Sbjct: 509 IQTCWDHNPQNRPSFSEILFRLNEIL 534
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 211 bits (536), Expect = 3e-53, Method: Compositional matrix adjust.
Identities = 96/266 (36%), Positives = 168/266 (63%), Gaps = 6/266 (2%)
Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
W+ I++DE+ + E++G GS+G V+R +W DVA+K Q ++ L E+A +K+
Sbjct: 1392 WV-INYDEIKMGEQIGLGSYGVVYRGKWKNVDVAIKKFIKQKIDENHLLGIREEIAFLKK 1450
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
+ HPN++ +GA K+P++ IVTEY+ +G+L R R + ++ +++++ +++AKGI
Sbjct: 1451 LHHPNIITMVGASLKKPNICIVTEYMAKGNL-RDAMRTCTPK-LEWHQKIKILVNIAKGI 1508
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEF 832
+YLH+ +PPI+H D+K N+L+D+NW VK+ DFG +R K I ++ GTP W APE
Sbjct: 1509 SYLHSFDPPIIHRDIKPSNILIDENWNVKIADFGFARIKEENAIMTR--CGTPCWTAPEI 1566
Query: 833 LRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892
+R + +EK DV+SFG+++WE++T ++P+ G ++ + ++ R IPQ+ A
Sbjct: 1567 IRNDIYDEKVDVFSFGIVMWEVLTCKEPFIGANFMKITMDI-LEDVRPKIPQDCPEEFAK 1625
Query: 893 LMESCWADDPAQRPSFANIVESLKKL 918
LM CW +RP+ +++ L K
Sbjct: 1626 LMRKCWHAKSTKRPTMDDVIIVLAKF 1651
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54Y55|SHKC_DICDI Dual specificity protein kinase shkC OS=Dictyostelium discoideum GN=shkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 204 bits (520), Expect = 2e-51, Method: Compositional matrix adjust.
Identities = 112/272 (41%), Positives = 158/272 (58%), Gaps = 5/272 (1%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
EI +E++ +E +G GSFG V++ VAVK+L Q+F L F +EV +M ++
Sbjct: 18 EIRPEEINFEELIGTGSFGKVYKGRCRQKAVAVKLLHKQNFDAATLSAFRKEVHLMSKIY 77
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
HPN+ LFMGA T IVTE +P+G+L L+H + R+RMA D A GIN+
Sbjct: 78 HPNICLFMGACTIPGRCVIVTELVPKGNLETLLHDQKI--QLPLYLRMRMARDAALGINW 135
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA--NTFISSKSVAGTPEWMAPEF 832
LH NP +H D+KS NLLVD+N VK+CDFGLS K S GTP +MAPE
Sbjct: 136 LHESNPVFVHRDIKSSNLLVDENMRVKICDFGLSALKQKHKMLKDQSSAKGTPLYMAPEV 195
Query: 833 LRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVV-GAVAFQNRRLAIPQNTSPVLA 891
+ + NE SDVYSFG++LWE++T ++P++ + AV ++ R IP + L
Sbjct: 196 MMFKEFNESSDVYSFGIVLWEILTRKEPFSHHRELEKFREAVCVKHERPPIPNDCLDSLR 255
Query: 892 SLMESCWADDPAQRPSFANIVESLKKLLKSPA 923
L+E CW +P RPSF I+ +L ++ A
Sbjct: 256 RLIEKCWDKEPISRPSFKEIISALDHVIIDAA 287
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 931 | ||||||
| 359492500 | 905 | PREDICTED: serine/threonine-protein kina | 0.936 | 0.963 | 0.672 | 0.0 | |
| 449437280 | 925 | PREDICTED: serine/threonine-protein kina | 0.962 | 0.968 | 0.670 | 0.0 | |
| 255545998 | 949 | map3k delta-1 protein kinase, putative [ | 0.976 | 0.957 | 0.671 | 0.0 | |
| 356510128 | 932 | PREDICTED: serine/threonine-protein kina | 0.949 | 0.948 | 0.630 | 0.0 | |
| 356551777 | 952 | PREDICTED: serine/threonine-protein kina | 0.968 | 0.947 | 0.627 | 0.0 | |
| 357465219 | 926 | Serine/threonine protein kinase [Medicag | 0.955 | 0.961 | 0.610 | 0.0 | |
| 147781068 | 1169 | hypothetical protein VITISV_043709 [Viti | 0.921 | 0.733 | 0.635 | 0.0 | |
| 334186877 | 956 | protein kinase family protein [Arabidops | 0.961 | 0.936 | 0.583 | 0.0 | |
| 297803662 | 961 | hypothetical protein ARALYDRAFT_492397 [ | 0.963 | 0.933 | 0.585 | 0.0 | |
| 5051790 | 963 | putative protein kinase [Arabidopsis tha | 0.961 | 0.929 | 0.579 | 0.0 |
| >gi|359492500|ref|XP_003634421.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Vitis vinifera] gi|302142079|emb|CBI19282.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1228 bits (3177), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 647/962 (67%), Positives = 736/962 (76%), Gaps = 90/962 (9%)
Query: 1 MPHRTTYFFPRQFPDHRGFDASASPSPAAANKQLLENHEKNTEKGTFGINENDRKSAAAT 60
MPHRTTYFFPRQFPD R FDAS+ K+LL HEK E++RK T
Sbjct: 1 MPHRTTYFFPRQFPDRR-FDASS--------KELLA-HEKKIG------GESNRKGTRTT 44
Query: 61 TSTTTTTTKNLKNSAAPLSVSDLFTSGDEKFKVKKQQFAAFCDWLTEKKEDRSASRHVKS 120
T T N SDLFT G +KF+ KKQ AAFCDWL EKK DRS HV
Sbjct: 45 KDVTADRTYN---------ASDLFT-GSDKFRSKKQ-LAAFCDWLVEKKGDRSG--HV-- 89
Query: 121 FQSRLSSGADE-DREPLLPPPEPEPVPVPVPDTVTNIDNDRNFDRQVSLPRLSSTGSSYA 179
RL S DE DR+ P P P D+ FDRQVSLPR+SS GSSYA
Sbjct: 90 ---RLRSRNDEGDRDV-------LLPPPPAPVPEVVAGKDQQFDRQVSLPRVSS-GSSYA 138
Query: 180 ASSLFSGTTLDGNFSSDVKDTSTRV---STSRQEVEEEESKDTAAQRTKESYMLQLTLAR 236
S LFSGTT++GN SS +KD+ T ++R+EV+EE K++AAQ+++ESY LQLTLA+
Sbjct: 139 GS-LFSGTTVEGNVSSGLKDSHTNSHSQESTRREVDEE--KESAAQKSRESYYLQLTLAK 195
Query: 237 RLTLQACIFSGPLL-LQESALEVS----DTETVSYRLWVSGCLSYNDKISDGFYNILGMN 291
RL QA + P+L LQES E + D + VSYRLWVSGCLSY DKISDGFYNILGMN
Sbjct: 196 RLASQASLACEPVLFLQESGAEGNAVSFDPDVVSYRLWVSGCLSYTDKISDGFYNILGMN 255
Query: 292 PYLWVMCNDLEEGKRLPSLMSLKDIDSTETSMEVVLIDRHGDSRLKELEDKAQELYCASE 351
PY+WVMCN+LEEG+RLP LM+LK ++ +TSMEVVL+DR GDSRLKELEDKA +LYCASE
Sbjct: 256 PYVWVMCNELEEGRRLPPLMALKAVEPNDTSMEVVLVDRRGDSRLKELEDKAHQLYCASE 315
Query: 352 NTLVLVEELGKLVAICMGGTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRH 411
NTLVLVE+LGKLVAI MGG+FP+EQGDLHK+WK+ SKRLR F+KCIVLPIGSLSMGLCRH
Sbjct: 316 NTLVLVEQLGKLVAIYMGGSFPVEQGDLHKQWKLVSKRLRDFQKCIVLPIGSLSMGLCRH 375
Query: 412 RAILFKKLADYIGLPCRIARGCRYCEADHRSSCLVKIEDDRRSSREYVVDLVGEPGNIHG 471
RAILFKKLADYIGLPCRIARGC+YC ADHRSSCLVKI DD++SSREYVVDLVGEPGN+HG
Sbjct: 376 RAILFKKLADYIGLPCRIARGCKYCVADHRSSCLVKI-DDKQSSREYVVDLVGEPGNVHG 434
Query: 472 PNFSINGGFLSSMPSPFQLSDLKEFQKPYMDNTSYCQLPDSRSNSAFPESPPYSGIIRKG 531
P+ SI GG LSSMPSP Q+S LKE+Q+PYMDN S CQ+ +S++ +PE P Y
Sbjct: 435 PDSSITGGLLSSMPSPLQISHLKEYQQPYMDNESCCQIQNSKNTCIYPEDPLY------- 487
Query: 532 QKLKDIGLPKSSKDALVNQPRAEKESSLVPLKLQGNPKNS------------------DA 573
+G K++ +Q ESS++PL+ GN DA
Sbjct: 488 -----LGNEKNTLYTPTDQICERMESSVLPLEFNGNTDRCIIQSAMLQSVQSNVSEAVDA 542
Query: 574 AA-GAPIQEYSRLVEENVAIEAAYKEEIVVSESSVI---IKQPNATLPSQLD-KEDESKL 628
+A G I E R+ E + I+ A+K+EI +S S + +KQP +L S+ + KE E +L
Sbjct: 543 SASGVSIHECFRIAGEKIVIQQAHKKEIALSGSPITSKALKQPKVSLSSKSNIKEVEGRL 602
Query: 629 EKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVK 688
E +G+F PRYLN+EPSLAMDWLEISWDELH+KERVGAGSFGTVHRAEWHGSDVAVK
Sbjct: 603 ENRGRFHTVTIPRYLNLEPSLAMDWLEISWDELHIKERVGAGSFGTVHRAEWHGSDVAVK 662
Query: 689 VLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH 748
VLTVQ+F DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH
Sbjct: 663 VLTVQNFQDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH 722
Query: 749 RPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
RP + E++DQRRRLRMALDVAKGINYLH L PPI+HWDLKSPNLLVDKNWTVKVCDFGLS
Sbjct: 723 RPTSAEILDQRRRLRMALDVAKGINYLHCLKPPIVHWDLKSPNLLVDKNWTVKVCDFGLS 782
Query: 809 RFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQ 868
RFKANTF+SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGL PAQ
Sbjct: 783 RFKANTFLSSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLSPAQ 842
Query: 869 VVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQM 928
VVGAVAFQNRRL+IPQNTSPVLASLMESCWADDPAQRPSF++IVE+LKKLLKSP QLIQM
Sbjct: 843 VVGAVAFQNRRLSIPQNTSPVLASLMESCWADDPAQRPSFSSIVETLKKLLKSPLQLIQM 902
Query: 929 GG 930
GG
Sbjct: 903 GG 904
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449437280|ref|XP_004136420.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1212 bits (3136), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 642/958 (67%), Positives = 731/958 (76%), Gaps = 62/958 (6%)
Query: 1 MPHRTTYFFPRQFPDHRGFDASASPSPAAANKQLLENHEKNTEKGTFGINENDRKSAAAT 60
MPHRTTYFFPRQFPD RGFD+ A+ +K +L +HEK K TF E+D K
Sbjct: 1 MPHRTTYFFPRQFPD-RGFDS------ASTSKHIL-DHEKKINKDTFS-TESDAKPTPRP 51
Query: 61 TSTTTTTTKNLKNSAAPLSVSDLFTSGDEKFKVKKQQFAAFCDWLTEKKEDRSASRHVKS 120
+ T K+SA VSDLFT GD+ KK AF DWL +KK RSA+ HVK+
Sbjct: 52 ARDFSVT----KSSA----VSDLFT-GDKAQTNKK--LPAFYDWLVDKKATRSATAHVKT 100
Query: 121 FQSRLSSGADEDREPLLPPPEPEPVPVPVPDTVTNIDN--DRNFDRQVSLPRLSSTGSSY 178
+ S DEDRE LLPPP EP DT + D DRNFDRQVSLPRLSS GSSY
Sbjct: 101 WLSN----CDEDRELLLPPPTSEPEH----DTTSVKDRSVDRNFDRQVSLPRLSS-GSSY 151
Query: 179 AASSLFSGT---TLDGNFSSDVKDTS-TRVSTSR----QEVEEEESKDTAAQRTKESYML 230
A S LFSGT T+DGNFSSDVKD+S +++ +S +E+E + K+ AQ+ ESY L
Sbjct: 152 AGS-LFSGTGTGTVDGNFSSDVKDSSASKILSSHTARPEEIEVGDDKENIAQKATESYYL 210
Query: 231 QLTLARRLTLQACIFSGPLLLQESALEVSDTETVSYRLWVSGCLSYNDKISDGFYNILGM 290
QL LA L A + P+L++E +E++D ETVSYRLWVSGCLSY+DKISDGFYNILGM
Sbjct: 211 QLALAATLRSHANLAGDPVLMEEGRVEITDAETVSYRLWVSGCLSYSDKISDGFYNILGM 270
Query: 291 NPYLWVMCNDLEEGKRLPSLMSLKDIDSTETSMEVVLIDRHGDSRLKELEDKAQELYCAS 350
NPYLWVMCND EEG+RLPSLMSL+ I+ +ETSMEV+L+DR GDSRLKELEDKAQELYCAS
Sbjct: 271 NPYLWVMCNDFEEGRRLPSLMSLRTIEPSETSMEVILVDRRGDSRLKELEDKAQELYCAS 330
Query: 351 ENTLVLVEELGKLVAICMGGTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCR 410
E+TLVLVE+LGKLVAI MGGTFP+EQG LH WK+ SKRLR+F+KCIVLPIGSLSMGLCR
Sbjct: 331 ESTLVLVEKLGKLVAIYMGGTFPVEQGGLHLHWKVVSKRLREFQKCIVLPIGSLSMGLCR 390
Query: 411 HRAILFKKLADYIGLPCRIARGCRYCEADHRSSCLVKIEDDRRSSREYVVDLVGEPGNIH 470
HRAILFKKLADYIGLPCRIARGC+YC ADHRSSCLVKIEDD++S REYVVDLVGEPGNIH
Sbjct: 391 HRAILFKKLADYIGLPCRIARGCKYCVADHRSSCLVKIEDDKKSLREYVVDLVGEPGNIH 450
Query: 471 GPNFSINGGFLSSMPSPFQLSDLKEFQKPYMDNTSYCQLPDSRSNSAFPESPPYSGI--- 527
GP+ SINGGF SSMPSP Q+S LKEFQ+PY+++ Q S+ FPE P SG
Sbjct: 451 GPDSSINGGFQSSMPSPLQISHLKEFQEPYVESYFNHQTVGSKQICGFPEYPLRSGFGQY 510
Query: 528 -IRKGQKLKDIGLPKSSKDALVNQPRAEKESSLVPLK--------LQGNPKNSDAAAGAP 578
++ G L+ + D LV+Q S+ + L+ LQ + S A +
Sbjct: 511 QMKGGSTLRMSS--GAETDKLVDQACMGIGSTQLCLETKVSKECVLQNHIMPSTGADASE 568
Query: 579 IQEY---SRLVEENVAIEAAYKEEIVVSESSVI---IKQPNATLPSQLDKEDESKLEKQG 632
+ + L E V IE Y+EE VV+ + I TL +Q D ++ + +
Sbjct: 569 VLSSVGGASLCENKVVIEEIYQEEAVVAAGISVNETINPSKLTLSTQTDSKE--IVGRSQ 626
Query: 633 KFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTV 692
P+YL +EPSLAMDWLEISWDELH+KERVGAGSFGTVHRAEWHGSDVAVKVLTV
Sbjct: 627 NCSASTYPKYLTLEPSLAMDWLEISWDELHIKERVGAGSFGTVHRAEWHGSDVAVKVLTV 686
Query: 693 QDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAA 752
QDF DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRP+
Sbjct: 687 QDFHDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPSY 746
Query: 753 GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812
GE+MDQR+RLRMALDVAKGINYLH LNPPI+HWDLKSPNLLVDKNWTVKVCDFGLSRFKA
Sbjct: 747 GELMDQRKRLRMALDVAKGINYLHCLNPPIVHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 806
Query: 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGA 872
NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPW+GLGPAQVVGA
Sbjct: 807 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWSGLGPAQVVGA 866
Query: 873 VAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQMGG 930
VAFQNR+L+IP +TSP+LASL+ESCWADDP QRPSFA+IVESLKKLLKSP QLI MGG
Sbjct: 867 VAFQNRKLSIPSSTSPLLASLIESCWADDPVQRPSFASIVESLKKLLKSPQQLIAMGG 924
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545998|ref|XP_002514059.1| map3k delta-1 protein kinase, putative [Ricinus communis] gi|223547145|gb|EEF48642.1| map3k delta-1 protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1210 bits (3131), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 652/971 (67%), Positives = 740/971 (76%), Gaps = 62/971 (6%)
Query: 1 MPHRTTYFFPRQFPDHR-GFDASASPSPAAANKQLLENHEKNTEKGTFGI-NENDRK--- 55
MPHRTTYFFPRQFPD GFDAS++ KQLL++ +K K TF I N+ RK
Sbjct: 1 MPHRTTYFFPRQFPDRSSGFDASST-------KQLLDHEKKKLIKDTFNIDNDLPRKDFS 53
Query: 56 ---------SAAATTSTTTTTTKNLKNSAAPLSVSDLFTSGD-EKFKVK-KQQFA----- 99
TS TT+ + A DLFTS D EK+ K K+QF
Sbjct: 54 RSSSSNSTAGNGNITSQIQTTSSPTTTATAQTPAFDLFTSSDDEKYHQKEKKQFGEDDKL 113
Query: 100 --------AFCDWLTEKK-EDRSASRHVKSFQSRLSSGADEDREPLLPPPEP-------- 142
AF DWL EKK E RS HVK Q S DEDR LL P P
Sbjct: 114 QKKKKQLAAFYDWLAEKKAEKRSVISHVK-LQRLSSYDDDEDRHLLLTPEPPPAPEPEII 172
Query: 143 -EPVPVPVPDTVTNIDNDRNFDRQVSLPRLSSTGSSYAASSLFSGTTLDGNFSSDVKDTS 201
E VP VP+ D DR FDRQVSLPRLSS GSSYA S LFSGTTLDGNF S++K++
Sbjct: 173 GEIVPEIVPEVR---DVDRKFDRQVSLPRLSS-GSSYAGS-LFSGTTLDGNFLSEIKESV 227
Query: 202 TRVSTSRQEVEEEESKDTAAQRTKESYMLQLTLARRLTLQACIFSGPLLLQESALEVSDT 261
+ +E ++++ AQRT+E+Y LQL LARRL+ Q+ + S +LLQE E D
Sbjct: 228 RQDEEVEEEKKKDDE--KVAQRTRETYYLQLALARRLSFQSGLASEIVLLQEGP-EFPDA 284
Query: 262 ETVSYRLWVSGCLSYNDKISDGFYNILGMNPYLWVMCNDLEEGKRLPSLMSLKDIDSTET 321
ETVSYRLWV+GCLSY+D+ISDGFYNILGMNPYLW+MCND EEG+RLP LMSLK+I+ ++T
Sbjct: 285 ETVSYRLWVTGCLSYSDRISDGFYNILGMNPYLWLMCNDEEEGRRLPPLMSLKEIEPSDT 344
Query: 322 SMEVVLIDRHGDSRLKELEDKAQELYCASENTLVLVEELGKLVAICMGGTFPIEQGDLHK 381
SMEVVL+D GDSRLKELEDKA ELYCASENTLVLVE+LGKLVA+CMGGTFP+EQGDLHK
Sbjct: 345 SMEVVLVDGLGDSRLKELEDKAHELYCASENTLVLVEKLGKLVAVCMGGTFPVEQGDLHK 404
Query: 382 RWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLADYIGLPCRIARGCRYCEADHR 441
RWK+ SKRLR+F KCIVLPIGSLSMGLCRHRAILFKKLADYIGLPCRIARGCRYC ADHR
Sbjct: 405 RWKIVSKRLREFHKCIVLPIGSLSMGLCRHRAILFKKLADYIGLPCRIARGCRYCVADHR 464
Query: 442 SSCLVKIEDDRRSSREYVVDLVGEPGNIHGPNFSINGGFLSSMPSPFQLSDLKEFQKPYM 501
SSCLVKIEDD++ SREYVVDLVG+PGNIHGP+ +INGGF+ S+PSPF++S LK+FQ P M
Sbjct: 465 SSCLVKIEDDKQLSREYVVDLVGQPGNIHGPDSTINGGFIPSIPSPFKISHLKDFQHPCM 524
Query: 502 DNTSYCQLPDSRSNSAFPESPPYSGIIRKGQKLKDIGLPKSSKDALVNQPRAEKESSLVP 561
D+T Q+ S+ A P +P YSG + + + +G K S +Q +SS+VP
Sbjct: 525 DDTPR-QISVSKQLCAVPVNP-YSG---REEGRQSMGNLKLSTYVSADQATLGNDSSVVP 579
Query: 562 LKLQGNPKNSDAAAGAPIQEYSRLVEENVAIEAAYKEEIVVSESSVIIKQPNATLPSQLD 621
L L + ++ D + G I E S L E V I+ Y++EIV+S + ++K+ L Q +
Sbjct: 580 LDLTRSAESLDVS-GPSIHERSDLEVEQVVIQQTYRKEIVMSGNPSVLKRTEVNLSCQSN 638
Query: 622 K-EDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEW 680
K E +SKL+ Q K P PRYLN+EPSLAMDWLEISWDELH+KERVGAGSFGTVHRAEW
Sbjct: 639 KREVDSKLDGQSKLPALSIPRYLNLEPSLAMDWLEISWDELHIKERVGAGSFGTVHRAEW 698
Query: 681 HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPR 740
HGSDVAVKVL+VQDF DDQL+EFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPR
Sbjct: 699 HGSDVAVKVLSVQDFHDDQLREFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPR 758
Query: 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV 800
GSLYRLIHRP AGEM+DQRRRLRMALDVAKGINYLH L+PPI+HWDLKSPNLLVDKNWTV
Sbjct: 759 GSLYRLIHRPTAGEMLDQRRRLRMALDVAKGINYLHCLSPPIVHWDLKSPNLLVDKNWTV 818
Query: 801 KVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQP 860
KVCDFGLSRFKANTF+SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQP
Sbjct: 819 KVCDFGLSRFKANTFLSSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQP 878
Query: 861 WNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920
WNGL PAQVVGAVAFQNRRL IPQNTSP L SLMESCWADDPAQRPSF IVESLKKLLK
Sbjct: 879 WNGLSPAQVVGAVAFQNRRLTIPQNTSPALVSLMESCWADDPAQRPSFGKIVESLKKLLK 938
Query: 921 SPAQLIQMGGE 931
SP QL+QMGG+
Sbjct: 939 SPLQLLQMGGK 949
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356510128|ref|XP_003523792.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1156 bits (2990), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 615/975 (63%), Positives = 724/975 (74%), Gaps = 91/975 (9%)
Query: 1 MPHRTTYFFPRQFPDHRGFDASASPSPAAANKQLLENHEK----NTEKGTFGINENDRKS 56
MPHRTTY FPRQFP+ G D S+ KQLL++ +K + + TF + K
Sbjct: 1 MPHRTTYIFPRQFPERGGLDESS--------KQLLDHEKKKIVNSIKHDTFTAESDPPKK 52
Query: 57 AAATTSTTTTTTKNLKNSAAPLSVSDLFTSGDEKFKVKKQQFAAFCDWLTEKKEDRSAS- 115
+ T + K+SA VS LF +GD KF+ K +Q AAF DWLT+KK S
Sbjct: 53 SPPTKDNDVVVLSSAKHSA----VSYLFAAGD-KFRTKHKQIAAFSDWLTDKKASSQCSP 107
Query: 116 RHVKSFQSRLSSGADEDREPLLPPPEPEPVPVPVPDTVTNIDNDRNFDRQVSLPRLSSTG 175
RH DR+ LLPP TV + D+ FDRQVSLPRLSS G
Sbjct: 108 RH-------------HDRDLLLPPET----------TVKDAAVDQRFDRQVSLPRLSS-G 143
Query: 176 SSYAASSLFSGTTLDGNFSSDVKD--TSTRVSTS-------RQEVEEEESKDTAAQRTKE 226
SSYA S LFSGTTLD NFSSD+K+ +S+R T+ +E EEE+S A+++KE
Sbjct: 144 SSYAGS-LFSGTTLDCNFSSDIKEETSSSRTLTTIPAPRHKNEEEEEEQSTKKLAKKSKE 202
Query: 227 SYMLQLTLARRLTLQACIFSGPLLLQESALEVSDTETVSYRLWVSGCLSYNDKISDGFYN 286
SY+LQLTLA+RLT A + + P+L E D E+VSYRLWVSGCLSY DKISDGFYN
Sbjct: 203 SYILQLTLAKRLTCLATLVTEPVL--TPGTETWDAESVSYRLWVSGCLSYTDKISDGFYN 260
Query: 287 ILGMNPYLWVMCNDLEEGKRLPSLMSLKDIDSTETSMEVVLIDRHGDSRLKELEDKAQEL 346
ILGMNPYLWVMCND+EEG+R+P+LM+LK ++ ++T MEVVL+DR DSRLK L+DKAQEL
Sbjct: 261 ILGMNPYLWVMCNDVEEGRRIPTLMALKAVEPSDTCMEVVLVDRREDSRLKLLQDKAQEL 320
Query: 347 YCASENTLVLVEELGKLVAICMGGTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGSLSM 406
YCASENTL+LVE+LGKLVAI MGG FP+EQGDLHKRWK+ SK+LR F KC+VLPIGSLS
Sbjct: 321 YCASENTLLLVEQLGKLVAIYMGGMFPVEQGDLHKRWKLVSKKLRNFHKCVVLPIGSLSS 380
Query: 407 GLCRHRAILFKKLADYIGLPCRIARGCRYCEADHRSSCLVKIEDDRRSSREYVVDLVGEP 466
GLCRHRA+LFK+LADYIGLPCRIARGC+YC ADHRSSCLVKI+DD++ SREYVVDLVGEP
Sbjct: 381 GLCRHRAVLFKRLADYIGLPCRIARGCKYCVADHRSSCLVKIKDDKQLSREYVVDLVGEP 440
Query: 467 GNIHGPNFSINGGFLSSMPSPFQLSDLKEFQKPYMDNTSYCQLPDSRSNSAFPESPPYSG 526
GN+HGP+ SING ++SSMPSPFQ+S LKE Q PYMD+T+ + R + PES PYSG
Sbjct: 441 GNVHGPDSSINGAYVSSMPSPFQISHLKESQSPYMDDTASSISSNHRPVN--PESLPYSG 498
Query: 527 IIRKGQKLKDIGLPKSSKDAL---VNQPRAEKESSLVPLKLQGN---------------- 567
+ Q+L + L KS K ++ V+Q E SL+P L+GN
Sbjct: 499 SEQNDQQLNETDLLKSHKGSIYASVDQICEGTEPSLIPFGLEGNDEECAVLSSVLPTIHE 558
Query: 568 --PKNSDAAAGAPIQEYSRLVEENVAIEAAYKEEIVVSESSVI---IKQP--NATLPSQL 620
K+ A A + EY RL E+ ++ EI+V+ SSV+ +Q ++ S+L
Sbjct: 559 DVSKSLHPAIEASLHEYPRLSED--VVQETSHNEIIVNGSSVVKSTFQQSMLGSSCQSEL 616
Query: 621 DKEDESKLEKQGKFP-VGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAE 679
K+ ++E QG P G PRY+N+EPSLAMDWLEISWD+L +KERVGAGSFGTV+RAE
Sbjct: 617 -KQVGIRIENQGCLPAAGNIPRYVNLEPSLAMDWLEISWDDLRIKERVGAGSFGTVYRAE 675
Query: 680 WHGSDVAVKVLTVQDFLDDQLKEFLR-----EVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734
WHGSDVAVKVLTVQDF DDQLKEFLR EVAIMKRVRHPNVVLFMG+VTKRPHLSIV
Sbjct: 676 WHGSDVAVKVLTVQDFHDDQLKEFLREVCIHEVAIMKRVRHPNVVLFMGSVTKRPHLSIV 735
Query: 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV 794
TEYLPRGSLYRLIHRPA+GE++D+RRRLRMALDVAKGINYLH L PPI+HWDLKSPNLLV
Sbjct: 736 TEYLPRGSLYRLIHRPASGEILDKRRRLRMALDVAKGINYLHCLKPPIVHWDLKSPNLLV 795
Query: 795 DKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWEL 854
DKNWT KVCDFGLSRFKANTFI SKSVAGTPEWMAPEFLRGEPSNEKSDV+SFGVILWEL
Sbjct: 796 DKNWTAKVCDFGLSRFKANTFIPSKSVAGTPEWMAPEFLRGEPSNEKSDVFSFGVILWEL 855
Query: 855 VTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914
VTMQQPWNGL PAQVVGAVAFQNRRLAIP N SP LASLMESCWADDP++RPSF +IV+S
Sbjct: 856 VTMQQPWNGLSPAQVVGAVAFQNRRLAIPPNISPALASLMESCWADDPSERPSFGSIVDS 915
Query: 915 LKKLLKSPAQLIQMG 929
LKKL+KSPA++I+M
Sbjct: 916 LKKLVKSPAEVIKMA 930
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356551777|ref|XP_003544250.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1146 bits (2965), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 613/977 (62%), Positives = 721/977 (73%), Gaps = 75/977 (7%)
Query: 1 MPHRTTYFFPRQFPDHRGFDASASPSPAAANKQLLENHEKNTEKGTFGINENDRKSAAAT 60
MPHR TYFFPRQFP+ RG D S S K+ + N K+ + + K T
Sbjct: 1 MPHRATYFFPRQFPE-RGLDES-SKQRLDQEKRKIVNSIKSPDTNFAAFESDAPKKQTTT 58
Query: 61 TSTTTTTTKN--LKNSAAPLSVSDLFTSGDEKFKVKKQQFAAFCDWLTEKKEDRS-ASRH 117
+ T KN + +S +VSD+FT GD KF+ K++Q AAFCDWL +KK+DR+ S H
Sbjct: 59 PQSPTPDVKNDVVFSSTKQNAVSDIFTGGD-KFRTKQKQIAAFCDWLIDKKKDRNRPSHH 117
Query: 118 VKSFQSRLSSGADEDREPLLPPPEPEPVPVPVPDTVTNIDNDRNFDRQVSLPRLSSTGSS 177
K + + +++RE LL PP P+ V D V DR+FDRQVSLPRLSS GSS
Sbjct: 118 FKPYPNEEEEEEEDERELLLRPPPPDAAAQVVKDAV-----DRSFDRQVSLPRLSS-GSS 171
Query: 178 YAASSLFSGTTLDGN--FSSDVKDTSTRVSTSRQEVEEEESKD-----------TAAQRT 224
YA S LF TLDG FSSDV T S+ RQ EE++ AQ+
Sbjct: 172 YAGS-LF---TLDGTATFSSDV--TKEETSSFRQVFTEEDATQKQQEEEEKEKRNTAQKY 225
Query: 225 KESYMLQLTLARRLTLQACIFSGPLLLQESALEVSDTETVSYRLWVSGCLSYNDKISDGF 284
+ESY LQL +RL+ A + S P+L ++ E D E+VSYRLWVSGCLSY DKISDGF
Sbjct: 226 RESYYLQLAFTKRLSCLASLGSEPVLTLDAGTETWDAESVSYRLWVSGCLSYTDKISDGF 285
Query: 285 YNILGMNPYLWVMCNDLEE-GKRLPSLMSLKDIDSTETSMEVVLIDRHGDSRLKELEDKA 343
YNILGMNPYLWVMCND+EE GKRLP+LM+LK + ++TS+EVVL DRH DSRLKEL+DKA
Sbjct: 286 YNILGMNPYLWVMCNDVEEEGKRLPTLMALKAAEPSDTSIEVVLFDRHEDSRLKELQDKA 345
Query: 344 QELYCASENTLVLVEELGKLVAICMGGTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGS 403
QELY ASEN LVLVE+LGKLVAICMGG+FP+EQGDLHKRWK+ SKRLR F +C+VLP+GS
Sbjct: 346 QELYSASENALVLVEKLGKLVAICMGGSFPVEQGDLHKRWKLVSKRLRNFHQCVVLPVGS 405
Query: 404 LSMGLCRHRAILFKKLADYIGLPCRIARGCRYCEADHRSSCLVKIEDDRRSSREYVVDLV 463
LS GLCRHRAILFK+LADYIGLPCRIARGCRYC +DHRSSCLVKI+DDR+ SREYVVDLV
Sbjct: 406 LSSGLCRHRAILFKRLADYIGLPCRIARGCRYCVSDHRSSCLVKIKDDRQLSREYVVDLV 465
Query: 464 GEPGNIHGPNFSINGGFLSSMPSPFQLSDLKEFQKPYMDNTSYCQLPDSRSNSAFPESPP 523
GEPGNIHGP+ SING ++SS+PSPFQ+S LKE Q PY+D + Q S N++
Sbjct: 466 GEPGNIHGPDSSINGAYVSSIPSPFQISHLKESQSPYVDVAACSQ---SLGNTSL----- 517
Query: 524 YSGIIRKGQKLKDIGLPKSSKDAL---VNQPRAEKESSLVPLKLQGNPKNS--------- 571
G +++ Q+ ++ L K++ ++ ++Q R E L+P L+GN K
Sbjct: 518 --GCVQEDQQAEETDLQKNNNGSIYPAIDQTRGGAEPPLIPFGLKGNHKECAILGLLNFP 575
Query: 572 ----------DAAAGAPIQEYSRLVEENVAI-EAAYKE-EIVVSESSVI---IKQPNATL 616
A A + EY RL +++V + EA+ KE EI+V SS + KQ +L
Sbjct: 576 PVYEGVSEDLHPATEASLHEYPRLSKDSVVVLEASNKEIEIIVKGSSGVKSNYKQSTVSL 635
Query: 617 PSQLDKEDE---SKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFG 673
S+ +E E +K+E QG G PRYLN+EPSLAMDWLEI WD+L +KERVGAGSFG
Sbjct: 636 SSESKQEQEHVKNKVENQG---AGNIPRYLNLEPSLAMDWLEIPWDDLRIKERVGAGSFG 692
Query: 674 TVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733
TV+RAEWHGSDVAVKVLTVQDF DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI
Sbjct: 693 TVYRAEWHGSDVAVKVLTVQDFQDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 752
Query: 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLL 793
VTEYLPRGSL+RLIH+PA+GE++D RRRLRMALDVAKGINYLH L PPI+HWDLK+PNLL
Sbjct: 753 VTEYLPRGSLFRLIHKPASGEILDPRRRLRMALDVAKGINYLHCLKPPIVHWDLKTPNLL 812
Query: 794 VDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWE 853
VD+NWTVKVCDFGLSRFKANTF+SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWE
Sbjct: 813 VDRNWTVKVCDFGLSRFKANTFLSSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWE 872
Query: 854 LVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVE 913
LVT+QQPWNGL AQVVGAVAFQNRRLAIP N SP LASLMESCWAD+PA RPSF +IVE
Sbjct: 873 LVTLQQPWNGLSHAQVVGAVAFQNRRLAIPPNISPALASLMESCWADNPADRPSFGSIVE 932
Query: 914 SLKKLLKSPAQLIQMGG 930
SLKKLLKSPA I+MGG
Sbjct: 933 SLKKLLKSPADAIKMGG 949
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357465219|ref|XP_003602891.1| Serine/threonine protein kinase [Medicago truncatula] gi|355491939|gb|AES73142.1| Serine/threonine protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1113 bits (2880), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 586/960 (61%), Positives = 704/960 (73%), Gaps = 70/960 (7%)
Query: 1 MPHRTTYFFPRQFPDHRGFDASASPSPAAANKQLLENHEKNTEKGTFGINENDRKSAAAT 60
MPHR TYFFPRQFP+ RG D S+ K+LL+ + END
Sbjct: 1 MPHRATYFFPRQFPE-RGLDESS--------KKLLDQDKDKIVNSIKSPIEND------- 44
Query: 61 TSTTTTTTKNLKNSAAPLSVSD-LFTSGD-----EKFKVKKQQFAAFCDWLTEKKEDRSA 114
T TTK+L +S P +D +F+SG +K + +++Q +AFCDW +KK R +
Sbjct: 45 ----TPTTKSLSSSTPPTPKNDAVFSSGKHSVAGDKLRFRQKQISAFCDWFIDKK--RHS 98
Query: 115 SRHVKSFQSRLSSGADEDREPLLPPPEPEPVPVPVPDTVTNIDNDRNFDRQVSLPRLSST 174
F RLS+ +D+D + PE V DT DRNFDRQVSLPRLSS
Sbjct: 99 GHLTHHFHRRLST-SDDDHDFFHSQPE-----TAVNDTAI----DRNFDRQVSLPRLSS- 147
Query: 175 GSSYAASSLFSGTTLDGNFSSDVKDTSTRVSTSRQEVEEEESKDTAAQRTKESYMLQLTL 234
SSYA S LFS + SS V ++ +T+R++ E++E+KD ++ +ESY+LQLTL
Sbjct: 148 DSSYAGS-LFSSDIKEETQSSQV--STIPATTARRQKEDDENKDGLVKKCEESYILQLTL 204
Query: 235 ARRLTLQACIFSGPLLLQESALEVSDTETVSYRLWVSGCLSYNDKISDGFYNILGMNPYL 294
A+RL A + S P+L E D E+VSYRLWVSGCLSY DKISDGFYNILGMNPYL
Sbjct: 205 AKRLASLASLVSEPVL--TPGTENWDAESVSYRLWVSGCLSYTDKISDGFYNILGMNPYL 262
Query: 295 WVMCNDLEEGKRLPSLMSLKDIDSTETSMEVVLIDRHGDSRLKELEDKAQELYCASENTL 354
WVMCND EEGK++P+LM+LK ++ +E SMEVVL+DR DSRLK L DKAQELY +SENTL
Sbjct: 263 WVMCNDEEEGKKIPTLMALKAVEPSEASMEVVLVDRQEDSRLKLLHDKAQELYRSSENTL 322
Query: 355 VLVEELGKLVAICMGGTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAI 414
V VE+LGKLVAI MGG FP+E+GDLHK+WK+ SKRLR F KC+VLPIG LS GLCRHRAI
Sbjct: 323 VFVEQLGKLVAINMGGIFPVERGDLHKQWKLVSKRLRNFHKCVVLPIGGLSSGLCRHRAI 382
Query: 415 LFKKLADYIGLPCRIARGCRYCEADHRSSCLVKIEDDRRSSREYVVDLVGEPGNIHGPNF 474
LFK+LAD+IGLPCRIARGC+YC ADHRSSCLVKI+DD++ SREYVVDLVGEPG +HGP+
Sbjct: 383 LFKRLADFIGLPCRIARGCKYCVADHRSSCLVKIKDDKQISREYVVDLVGEPGIVHGPDS 442
Query: 475 SINGGFLSSMPSPFQLSDLKEFQKPYMDNTSYCQLPDSRSNSAF-PESPPYSGIIRKGQK 533
SING ++SS+PSPFQ+S KE Q PYMD+ + Q P S+F PE+ PY G + Q+
Sbjct: 443 SINGAYVSSIPSPFQISHFKELQSPYMDDEASSQPPICFDQSSFDPETHPYLGCGQIDQQ 502
Query: 534 LKDIGLPK--SSKDALVNQPRAEKESSLVPLKLQGNPK------------NSDAAAGAPI 579
+K+ L K S A ++ + L PL L+ N + + D + P+
Sbjct: 503 VKETDLLKVQGSFCASIDHTCEGTKPLLTPLGLKENDEECAVLGSILPTIHEDVSKVFPV 562
Query: 580 -----QEYSRLVEENVAIEAAYKEEIVVSESSVI---IKQP--NATLPSQLDKEDESKLE 629
EY RL E+ V ++ EI+V+E SV+ KQ +++ S+L K+ ++++E
Sbjct: 563 SEESLHEYPRLSEDAVVLQETSSNEIIVTEGSVVKSTFKQCILSSSCQSEL-KQVDNRIE 621
Query: 630 KQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKV 689
Q P G PRY+N+EPSL+MDWLEISW++L +KERVGAGSFGTVH AEWHGSDVAVKV
Sbjct: 622 NQDYLPAGNIPRYVNLEPSLSMDWLEISWNDLRIKERVGAGSFGTVHHAEWHGSDVAVKV 681
Query: 690 LTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR 749
LTVQDF DDQLKEFLREVAIMKRVRHPNVVLFMGAVT P+LSIVTEYLPRGSLY LIHR
Sbjct: 682 LTVQDFHDDQLKEFLREVAIMKRVRHPNVVLFMGAVTTCPNLSIVTEYLPRGSLYHLIHR 741
Query: 750 PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
PA+GE++D RRRLRMALDVAKGINYLH L PPI+HWDLKSPNLLVDKNWTVKVCDFGLSR
Sbjct: 742 PASGEILDSRRRLRMALDVAKGINYLHCLKPPIVHWDLKSPNLLVDKNWTVKVCDFGLSR 801
Query: 810 FKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQV 869
FKANTFI SKSVAGTPEWMAPEFLRGEPSNEK+DVYSFGVILWELVTMQQPW+GL P QV
Sbjct: 802 FKANTFIPSKSVAGTPEWMAPEFLRGEPSNEKADVYSFGVILWELVTMQQPWSGLNPPQV 861
Query: 870 VGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQMG 929
VGAVAFQNR+LAIP N SPVL+SLMESCWADDPAQRPSF I+ESL+KLLKSP ++I+MG
Sbjct: 862 VGAVAFQNRKLAIPSNISPVLSSLMESCWADDPAQRPSFGGIIESLRKLLKSPTEMIKMG 921
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147781068|emb|CAN68131.1| hypothetical protein VITISV_043709 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1113 bits (2879), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 606/953 (63%), Positives = 699/953 (73%), Gaps = 95/953 (9%)
Query: 11 RQFPDHRGFDASASPSPAAANKQLLENHEKNTEKGTFGINENDRKSAAATTSTTTTTTKN 70
RQFPD R FDAS+ K+LL HEK E++RK T T T N
Sbjct: 38 RQFPDRR-FDASS--------KELLA-HEKKIG------GESNRKGTRTTKDVTADRTSN 81
Query: 71 LKNSAAPLSVSDLFTSGDEKFKVKKQQFAAFCDWLTEKKEDRSASRHVKSFQSRLSSGAD 130
SDLFT G +KF+ KKQ AAFCDWL EKK DRS HV RL S D
Sbjct: 82 ---------ASDLFT-GSDKFRSKKQ-LAAFCDWLVEKKGDRSG--HV-----RLRSRND 123
Query: 131 E-DREPLLPPPEPEPVPVPVPDTVTNIDNDRNFDRQVSLPRLSSTGSSYAASSLFSGTTL 189
E DR+ P P P D+ FDRQVSLPR+SS GSSYA S LFSGTT+
Sbjct: 124 EGDRDV-------LLPPPPAPVPEVVAGKDQQFDRQVSLPRVSS-GSSYAGS-LFSGTTV 174
Query: 190 DGNFSSDVKDTSTRV---STSRQEVEEEESKDTAAQRTKESYMLQLTLARRLTLQACIFS 246
+GN SS +KD+ T ++R+EV+EE K++AAQ+++ESY LQLTLA+RL QA +
Sbjct: 175 EGNVSSGLKDSHTNSHSQESTRREVDEE--KESAAQKSRESYYLQLTLAKRLASQASLAC 232
Query: 247 GPLL-LQESALEVS----DTETVSYRLWVSGCLSYNDKISDGFYNILGMNPYLWVMCNDL 301
P+L LQES E + D + VSYRLWVSGCLSY DKISDGFYNILGMNPY+WVMCN+L
Sbjct: 233 EPVLFLQESGAEGNAVSFDPDVVSYRLWVSGCLSYTDKISDGFYNILGMNPYVWVMCNEL 292
Query: 302 EEGKRLPSLMSLKDIDSTETSMEVVLIDRHGDSRLKELEDKAQELYCASENTLVLVEELG 361
EEG+RLP LM+LK ++ +TSMEVVL+DR GDSRLKELEDKA +LYCASENTLVLVE+LG
Sbjct: 293 EEGRRLPPLMALKAVEPNDTSMEVVLVDRRGDSRLKELEDKAHQLYCASENTLVLVEQLG 352
Query: 362 KLVAICMGGTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLAD 421
KLVAI MGG+FP+EQGDLHK+WK+ SKRLR F+KCIVLPIGSLSMGLC R +KLAD
Sbjct: 353 KLVAIYMGGSFPVEQGDLHKQWKLVSKRLRDFQKCIVLPIGSLSMGLCT-RFSHMQKLAD 411
Query: 422 YIGLPCRIARGCRYCEADHRSSCLVKIEDDRRSSREYVVDLVGEPGNIHGPNFSINGGFL 481
YIGLPCRIARGC+YC ADHRSSCLVKI DD++SSREYVVDLVGEPGN+HGP+ SI GG L
Sbjct: 412 YIGLPCRIARGCKYCVADHRSSCLVKI-DDKQSSREYVVDLVGEPGNVHGPDSSITGGLL 470
Query: 482 SSMPSPFQLSDLKEFQKPYMDNTSYCQLPDSRSNSAFPESPPYSGIIRKGQKLKDIGLPK 541
SSMPSP Q+S LKE+Q+PYMDN S CQ+ +S++ +PE P Y +G K
Sbjct: 471 SSMPSPLQISHLKEYQQPYMDNESCCQIQNSKNTCIYPEDPLY------------LGNEK 518
Query: 542 SSKDALVNQPRAEKESSLVPLKLQGNPKNS------------------DAAA-GAPIQEY 582
++ +Q ESS++PL+ GN DA+A G I E
Sbjct: 519 NTLYTPTDQICERMESSVLPLEFNGNTDRCIIQSAMLQSVQSNVSEAVDASASGVSIHEC 578
Query: 583 SRLVEENVAIEAAYKEEIVVSESSVI---IKQPNATLPSQLD-KEDESKLEKQGKFPVGP 638
R+ E + I+ A+K+EI +S S + +KQP +L S+ + KE E +LE +G+F
Sbjct: 579 FRIAGEKIVIQQAHKKEIALSGSPITSKALKQPKVSLSSKSNIKEVEGRLENRGRFHTVT 638
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD 698
PRYLN+EPSLAMDWLEISWDELH+KERVGAGSFGTVHRAEWHGSDVAVKVLTVQ+F DD
Sbjct: 639 IPRYLNLEPSLAMDWLEISWDELHIKERVGAGSFGTVHRAEWHGSDVAVKVLTVQNFQDD 698
Query: 699 QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQ 758
QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRP + E++DQ
Sbjct: 699 QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPTSAEILDQ 758
Query: 759 RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS 818
RRRLRMALDVAKGINYLH L PPI+HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF+SS
Sbjct: 759 RRRLRMALDVAKGINYLHCLKPPIVHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFLSS 818
Query: 819 KSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVA-FQN 877
KSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGL PAQ+ + A F +
Sbjct: 819 KSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLSPAQIPRSEADFMD 878
Query: 878 RRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQMGG 930
L P VL + S DPAQRPSF++IVE+LKKLLKSP QLIQMGG
Sbjct: 879 FALTFPL---LVLMRVEMSGIISDPAQRPSFSSIVETLKKLLKSPLQLIQMGG 928
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334186877|ref|NP_194179.2| protein kinase family protein [Arabidopsis thaliana] gi|332659512|gb|AEE84912.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1097 bits (2836), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 572/980 (58%), Positives = 710/980 (72%), Gaps = 85/980 (8%)
Query: 1 MPHRTTYFFPRQFPDHRGFDASASPSPAAANKQLLENHEKNTEKG----TFGINENDRKS 56
MPHRTTYFFPRQFPD RGFD+ + L +H+K +FG +++ +
Sbjct: 1 MPHRTTYFFPRQFPD-RGFDSFS----------LKNDHDKKKSSSNVGESFGFQRDNKSN 49
Query: 57 AAA------TTSTTTTTTKNLKNSAAPLSVSDLFTSGDEKFKVKKQQFAAFCDWLTEKKE 110
ST ++ L S+A VSDLF+ + K +QQ AAF +WL EKK
Sbjct: 50 GVGEDSNKEKESTVFSSNPLLSKSSA---VSDLFSDDRKSEKKHQQQLAAFYEWLAEKKA 106
Query: 111 D--------RSASRHVKSFQSRLSSGADEDREPLLPPPEPEPVPVPV---PDTV------ 153
+ + R VK + +SS ADE+RE LL P +P P+P PD++
Sbjct: 107 NLSRSSSTTTTHGRGVKPTRFSMSSDADEERELLLSSP-ADPAPLPATSSPDSIIDSART 165
Query: 154 TNIDN---DRNFDRQVSLPRLSSTGSSYAASSLFSGTTLDGNFS-----SDVKDTSTRVS 205
NI DR+FDR+VSLPR+SS S A S FSGTT+DGNFS +D ++TST
Sbjct: 166 VNIHERNIDRSFDREVSLPRMSSESS--FAGSFFSGTTVDGNFSNFSSHTDARETSTTTL 223
Query: 206 TSRQEVEE------EESKDTAAQRTKESYMLQLTLARRLTLQACIFSGPLLLQESALEVS 259
S + EE + + + AQ+++E Y LQ+TLA+ L+ QA L ++ +
Sbjct: 224 VSVNKEEEEVEVREQGKEQSLAQKSREGYYLQVTLAKWLSSQAN-------LACESVHIQ 276
Query: 260 DTETVSYRLWVSGCLSYNDKISDGFYNILGMNPYLWVMCNDLEEGKRLPSLMSLKDIDST 319
TE++SYR WVSGCLSY+DKISDGFY+ILGM+PYLW+MCN+ E+GKR+PSL+ LK+ +
Sbjct: 277 STESISYRFWVSGCLSYSDKISDGFYSILGMDPYLWLMCNNSEDGKRIPSLLLLKETEPN 336
Query: 320 ETSMEVVLIDRHGDSRLKELEDKAQELYCASENTLVLVEELGKLVAICMGGTFPIEQGDL 379
+TSMEVVLIDR DSRLKELEDKA ELYC+S+N LVLVE+LG+LVA+ MGG F +EQGDL
Sbjct: 337 DTSMEVVLIDRREDSRLKELEDKAHELYCSSDNMLVLVEKLGRLVAVYMGGNFQVEQGDL 396
Query: 380 HKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLADYIGLPCRIARGCRYCEAD 439
KRWK+ S RL++FRKCI+LPIGSL+MGLCRHRAILFKKLADYIGLPCRIARGCRYC+
Sbjct: 397 QKRWKLVSNRLKEFRKCIILPIGSLTMGLCRHRAILFKKLADYIGLPCRIARGCRYCKES 456
Query: 440 HRSSCLVKIEDDRRSSREYVVDLVGEPGNIHGPNFSINGGFLSSMPSPFQLSDLKEFQKP 499
H+SSCLVKI+DDR+ SREYVVDL+GEPGN+H P+ SING +PSP Q+S L +F +P
Sbjct: 457 HQSSCLVKIDDDRKLSREYVVDLIGEPGNVHDPDSSINGETQCQIPSPLQMSHLTDFSRP 516
Query: 500 YMDNTSYCQLPDSRSNSAFPESPPYSGIIRKGQKLKDIGLPKSSKD---ALVNQPRAEKE 556
+ +TS CQ +S+++ E+ SG +GQ K+ LP ++ A ++Q K
Sbjct: 517 CVHSTSPCQTVESKTSRTLSENIQRSG--SQGQVHKEFELPDNAGTVCCAHIDQTCCAKV 574
Query: 557 SSLVPLKLQGNPKNSDAAAGAPIQEYSRLVEENVAIEAAYKEEIVVSESSVIIKQPNATL 616
SS+V +++ A + L EE +A + KEE V+ E +KQPN ++
Sbjct: 575 SSMVL---------TESVLRALPLDIPNLSEEKIAPQETCKEETVLLEDPTAMKQPNLSV 625
Query: 617 PSQLDKEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVH 676
++ + D K +K+G+ PV YL IEPSLA DWLE+SW+ELH+KERVGAGSFGTVH
Sbjct: 626 EPEIVEADTRK-DKKGRLPVDAISPYLTIEPSLASDWLEVSWNELHIKERVGAGSFGTVH 684
Query: 677 RAEWHGSDVAVKVLTVQDFLDDQLKEFLREV-----AIMKRVRHPNVVLFMGAVTKRPHL 731
RAEWHGSDVAVK+L++QDF DDQ +EFLREV AIMKRVRHPNVVLFMGAVT+RP L
Sbjct: 685 RAEWHGSDVAVKILSIQDFHDDQFREFLREVCKQAVAIMKRVRHPNVVLFMGAVTERPRL 744
Query: 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPN 791
SI+TEYLPRGSL+RLIHRPA+GE++DQRRRLRMALDVAKG+NYLH LNPP++HWDLKSPN
Sbjct: 745 SIITEYLPRGSLFRLIHRPASGELLDQRRRLRMALDVAKGLNYLHCLNPPVVHWDLKSPN 804
Query: 792 LLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVIL 851
LLVDKNWTVKVCDFGLSRFKANTFI SKSVAGTPEWMAPEFLRGEP+NEKSDVYSFGV+L
Sbjct: 805 LLVDKNWTVKVCDFGLSRFKANTFIPSKSVAGTPEWMAPEFLRGEPTNEKSDVYSFGVVL 864
Query: 852 WELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANI 911
WEL+T+QQPWNGL PAQVVGAVAFQNRRL IP NTSPVL SLME+CWAD+P+QRP+F +I
Sbjct: 865 WELITLQQPWNGLSPAQVVGAVAFQNRRLIIPPNTSPVLVSLMEACWADEPSQRPAFGSI 924
Query: 912 VESLKKLLKSPAQLIQMGGE 931
V++LKKLLKSP QLIQMGG+
Sbjct: 925 VDTLKKLLKSPVQLIQMGGD 944
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297803662|ref|XP_002869715.1| hypothetical protein ARALYDRAFT_492397 [Arabidopsis lyrata subsp. lyrata] gi|297315551|gb|EFH45974.1| hypothetical protein ARALYDRAFT_492397 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1093 bits (2828), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 578/988 (58%), Positives = 704/988 (71%), Gaps = 91/988 (9%)
Query: 1 MPHRTTYFFPRQFPDHRGFDASASPSPAAANKQLLENHEKNTEKGT---FGINENDRKSA 57
MPHRTTYFFPRQFPD RGFD+ + L +HEK + FG ++ +
Sbjct: 1 MPHRTTYFFPRQFPD-RGFDSLS----------LKNDHEKISSSNVSENFGFQRENKSNG 49
Query: 58 AATTSTT---TTTTKNLKNSAAPLSVSDLFTSGDEKFKVKK---QQFAAFCDWLTEKKED 111
+ S TT + + +VSDLF+ G + K +K QQ AAF DWL EKK +
Sbjct: 50 VSEDSNKDKETTVFSSNSLLSKSSAVSDLFSGGVDDRKSEKKHQQQLAAFYDWLAEKKAN 109
Query: 112 RSAS-------RHVKSFQSRLSSGADEDREPLL-PPPEPEPVP-VPVPDTV--------- 153
S S R VK + +SS ADE+RE LL P +P P+P PD+V
Sbjct: 110 LSRSSSTTAHGRAVKPTRFSMSSDADEEREHLLLSPADPAPLPATSSPDSVIAASSSSAR 169
Query: 154 -TNIDN---DRNFDRQVSLPRLSSTGSSYAASSLFSGTTLDGNFSSDVKDTSTRVSTSRQ 209
NI+ DR FDR+VSLPR+SS S A S FSGTT+DGNFS+ T R +++
Sbjct: 170 TVNINERNIDRGFDREVSLPRMSSESS--FAGSFFSGTTVDGNFSNFSSHTDARETSTTT 227
Query: 210 EVEEEES-----------KDTAAQRTKESYMLQLTLARRLTLQACIFSGPLLLQESALEV 258
V + + + AQ++KE Y LQ+TL +RL+ QA L ++ +
Sbjct: 228 RVSVTKDEEEVEVREEGKEQSLAQKSKEGYYLQVTLVKRLSSQAN-------LACESVHI 280
Query: 259 SDTETVSYRLWVSGCLSYNDKISDGFYNILGMNPYLWVMCNDLEEGKRLPSLMSLKDIDS 318
TETVSYR WVSGCLSYNDKISDGFY+ILGM+PYLW+MCN+ EEGKR+PSL+ LK+ +
Sbjct: 281 QSTETVSYRFWVSGCLSYNDKISDGFYSILGMDPYLWLMCNNSEEGKRIPSLLLLKETEP 340
Query: 319 TETSMEVVLIDRHGDSRLKELEDKAQELYCASENTLVLVEELGKLVAICMGGTFPIEQGD 378
+TS+EVVLIDR DSRLKELEDKA ELYC+S+N LVLVE+LG+LVA+ MGG F +EQGD
Sbjct: 341 NDTSLEVVLIDRREDSRLKELEDKAHELYCSSDNMLVLVEKLGRLVAVYMGGNFQVEQGD 400
Query: 379 LHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLADYIGLPCRIARGCRYCEA 438
L KRWK+ S RL++FRKCI+LPIGSL+MGLCRHRAILFKKLADYIGLPCRIARGCRYC
Sbjct: 401 LQKRWKLVSNRLKEFRKCIILPIGSLTMGLCRHRAILFKKLADYIGLPCRIARGCRYCRE 460
Query: 439 DHRSSCLVKIEDDRRSSREYVVDLVGEPGNIHGPNFSINGGFLSSMPSPFQLSDLKEFQK 498
H+SSCLVKI+DDR+ SREYVVDL+GEPGN+H P+ SING +PSP Q+S L +F +
Sbjct: 461 SHQSSCLVKIDDDRKLSREYVVDLIGEPGNVHDPDSSINGETQCQIPSPLQMSHLTDFSR 520
Query: 499 PYMDNTSYCQLPDSRSNSAFPESPPYSGIIRKGQKLKDIGLPKSSKD---ALVNQPRAEK 555
P + +TS C +S+++ A E+ SG +G K+ LP ++ A V+Q K
Sbjct: 521 PCVHSTSPCHTVESKASRALSENIQRSG--SQGHVHKEFELPDNAATICCAHVDQTCCAK 578
Query: 556 ESSLVPLK--LQGNPKNSDAAAGAPIQEYSRLVEENVAIEAAYKEEIVVSES---SVIIK 610
SS+V + L+ P N L E+ + + KEE V+ E + IK
Sbjct: 579 ASSMVLPESVLRALPLN-----------IPNLSEDKIQPQETSKEETVLLEDPIEKIAIK 627
Query: 611 QPNATLPSQLDKEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAG 670
QPN ++ ++ + D K +K+G+ PV YL IEPSLA DWLE+SW+ELH+KERVGAG
Sbjct: 628 QPNLSVEPEIVEADTRK-DKKGRLPVDAVSPYLTIEPSLASDWLEVSWNELHIKERVGAG 686
Query: 671 SFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH 730
SFGTVHRAEWHGSDVAVK+L++QDF DDQ +EFLREVAIMKRVRHPNVVLFMGAVT+RP
Sbjct: 687 SFGTVHRAEWHGSDVAVKILSIQDFHDDQFREFLREVAIMKRVRHPNVVLFMGAVTERPR 746
Query: 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDV-------AKGINYLHNLNPPIL 783
LSI+TEYLPRGSL+RLIHRPA+GE++DQRRRLRMALDV AKG+NYLH LNPP++
Sbjct: 747 LSIITEYLPRGSLFRLIHRPASGELLDQRRRLRMALDVVCGLSHYAKGLNYLHCLNPPVV 806
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSD 843
HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI SKSVAGTPEWMAPEFLRGEP+NEKSD
Sbjct: 807 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIPSKSVAGTPEWMAPEFLRGEPTNEKSD 866
Query: 844 VYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPA 903
VYSFGV+LWEL+T+QQPW+GL PAQVVGAVAFQNRRL IP NTSPVL SLME+CWAD+PA
Sbjct: 867 VYSFGVVLWELITLQQPWDGLSPAQVVGAVAFQNRRLIIPPNTSPVLVSLMEACWADEPA 926
Query: 904 QRPSFANIVESLKKLLKSPAQLIQMGGE 931
QRP+F+ IV +LKKLLKSP QLIQMGG+
Sbjct: 927 QRPAFSGIVNTLKKLLKSPVQLIQMGGD 954
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|5051790|emb|CAB45083.1| putative protein kinase [Arabidopsis thaliana] gi|7269298|emb|CAB79358.1| putative protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1089 bits (2816), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 572/987 (57%), Positives = 710/987 (71%), Gaps = 92/987 (9%)
Query: 1 MPHRTTYFFPRQFPDHRGFDASASPSPAAANKQLLENHEKNTEKG----TFGINENDRKS 56
MPHRTTYFFPRQFPD RGFD+ + L +H+K +FG +++ +
Sbjct: 1 MPHRTTYFFPRQFPD-RGFDSFS----------LKNDHDKKKSSSNVGESFGFQRDNKSN 49
Query: 57 AAA------TTSTTTTTTKNLKNSAAPLSVSDLFTSGDEKFKVKKQQFAAFCDWLTEKKE 110
ST ++ L S+A VSDLF+ + K +QQ AAF +WL EKK
Sbjct: 50 GVGEDSNKEKESTVFSSNPLLSKSSA---VSDLFSDDRKSEKKHQQQLAAFYEWLAEKKA 106
Query: 111 D--------RSASRHVKSFQSRLSSGADEDREPLLPPPEPEPVPVPV---PDTV------ 153
+ + R VK + +SS ADE+RE LL P +P P+P PD++
Sbjct: 107 NLSRSSSTTTTHGRGVKPTRFSMSSDADEERELLLSSPA-DPAPLPATSSPDSIIDSART 165
Query: 154 TNIDN---DRNFDRQVSLPRLSSTGSSYAASSLFSGTTLDGNFS-----SDVKDTSTRVS 205
NI DR+FDR+VSLPR+SS S A S FSGTT+DGNFS +D ++TST
Sbjct: 166 VNIHERNIDRSFDREVSLPRMSSESS--FAGSFFSGTTVDGNFSNFSSHTDARETSTTTL 223
Query: 206 TSRQEVEE------EESKDTAAQRTKESYMLQLTLARRLTLQACIFSGPLLLQESALEVS 259
S + EE + + + AQ+++E Y LQ+TLA+ L+ QA L ++ +
Sbjct: 224 VSVNKEEEEVEVREQGKEQSLAQKSREGYYLQVTLAKWLSSQAN-------LACESVHIQ 276
Query: 260 DTETVSYRLWVSGCLSYNDKISDGFYNILGMNPYLWVMCNDLEEGKRLPSLMSLKDIDST 319
TE++SYR WVSGCLSY+DKISDGFY+ILGM+PYLW+MCN+ E+GKR+PSL+ LK+ +
Sbjct: 277 STESISYRFWVSGCLSYSDKISDGFYSILGMDPYLWLMCNNSEDGKRIPSLLLLKETEPN 336
Query: 320 ETSMEVVLIDRHGDSRLKELEDKAQELYCASENTLVLVEELGKLVAICMGGTFPIEQGDL 379
+TSMEVVLIDR DSRLKELEDKA ELYC+S+N LVLVE+LG+LVA+ MGG F +EQGDL
Sbjct: 337 DTSMEVVLIDRREDSRLKELEDKAHELYCSSDNMLVLVEKLGRLVAVYMGGNFQVEQGDL 396
Query: 380 HKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLADYIGLPCRIARGCRYCEAD 439
KRWK+ S RL++FRKCI+LPIGSL+MGLCRHRAILFKKLADYIGLPCRIARGCRYC+
Sbjct: 397 QKRWKLVSNRLKEFRKCIILPIGSLTMGLCRHRAILFKKLADYIGLPCRIARGCRYCKES 456
Query: 440 HRSSCLVKIEDDRRSSREYVVDLVGEPGNIHGPNFSINGGFLSSMPSPFQLSDLKEFQKP 499
H+SSCLVKI+DDR+ SREYVVDL+GEPGN+H P+ SING +PSP Q+S L +F +P
Sbjct: 457 HQSSCLVKIDDDRKLSREYVVDLIGEPGNVHDPDSSINGETQCQIPSPLQMSHLTDFSRP 516
Query: 500 YMDNTSYCQLPDSRSNSAFPESPPYSGIIRKGQKLKDIGLPKSSKD---ALVNQPRAEKE 556
+ +TS CQ +S+++ E+ SG +GQ K+ LP ++ A ++Q K
Sbjct: 517 CVHSTSPCQTVESKTSRTLSENIQRSG--SQGQVHKEFELPDNAGTVCCAHIDQTCCAKV 574
Query: 557 SSLVPLKLQGNPKNSDAAAGAPIQEYSRLVEENVAIEAAYKEEIVVSESSVIIKQPNATL 616
SS+V +++ A + L EE +A + KEE V+ E +KQPN ++
Sbjct: 575 SSMVL---------TESVLRALPLDIPNLSEEKIAPQETCKEETVLLEDPTAMKQPNLSV 625
Query: 617 PSQLDKEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVH 676
++ + D K +K+G+ PV YL IEPSLA DWLE+SW+ELH+KERVGAGSFGTVH
Sbjct: 626 EPEIVEADTRK-DKKGRLPVDAISPYLTIEPSLASDWLEVSWNELHIKERVGAGSFGTVH 684
Query: 677 RAEWHGSDVAVKVLTVQDFLDDQLKEFLRE-----VAIMKRVRHPNVVLFMGAVTKRPHL 731
RAEWHGSDVAVK+L++QDF DDQ +EFLRE VAIMKRVRHPNVVLFMGAVT+RP L
Sbjct: 685 RAEWHGSDVAVKILSIQDFHDDQFREFLREVCKQAVAIMKRVRHPNVVLFMGAVTERPRL 744
Query: 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDV-------AKGINYLHNLNPPILH 784
SI+TEYLPRGSL+RLIHRPA+GE++DQRRRLRMALDV AKG+NYLH LNPP++H
Sbjct: 745 SIITEYLPRGSLFRLIHRPASGELLDQRRRLRMALDVVCAIPHYAKGLNYLHCLNPPVVH 804
Query: 785 WDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDV 844
WDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI SKSVAGTPEWMAPEFLRGEP+NEKSDV
Sbjct: 805 WDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIPSKSVAGTPEWMAPEFLRGEPTNEKSDV 864
Query: 845 YSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQ 904
YSFGV+LWEL+T+QQPWNGL PAQVVGAVAFQNRRL IP NTSPVL SLME+CWAD+P+Q
Sbjct: 865 YSFGVVLWELITLQQPWNGLSPAQVVGAVAFQNRRLIIPPNTSPVLVSLMEACWADEPSQ 924
Query: 905 RPSFANIVESLKKLLKSPAQLIQMGGE 931
RP+F +IV++LKKLLKSP QLIQMGG+
Sbjct: 925 RPAFGSIVDTLKKLLKSPVQLIQMGGD 951
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 931 | ||||||
| TAIR|locus:2144613 | 821 | CTR1 "CONSTITUTIVE TRIPLE RESP | 0.332 | 0.377 | 0.645 | 5.6e-167 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.283 | 0.256 | 0.650 | 6.3e-127 | |
| TAIR|locus:2143009 | 880 | AT5G11850 [Arabidopsis thalian | 0.291 | 0.307 | 0.626 | 3.1e-126 | |
| TAIR|locus:2194055 | 992 | AT1G18160 [Arabidopsis thalian | 0.286 | 0.269 | 0.637 | 9.1e-126 | |
| TAIR|locus:2025515 | 933 | EDR1 "ENHANCED DISEASE RESISTA | 0.281 | 0.280 | 0.636 | 1.6e-117 | |
| TAIR|locus:2127228 | 736 | AT4G23050 [Arabidopsis thalian | 0.285 | 0.361 | 0.559 | 6.5e-83 | |
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.281 | 0.338 | 0.568 | 2.8e-82 | |
| TAIR|locus:2084304 | 671 | AT3G06630 [Arabidopsis thalian | 0.259 | 0.360 | 0.590 | 2.8e-80 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.283 | 0.345 | 0.548 | 5.4e-79 | |
| TAIR|locus:2052786 | 775 | AT2G31010 [Arabidopsis thalian | 0.285 | 0.343 | 0.481 | 7.5e-78 |
| TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1058 (377.5 bits), Expect = 5.6e-167, Sum P(2) = 5.6e-167
Identities = 202/313 (64%), Positives = 248/313 (79%)
Query: 612 PNATLPSQLDKEDESKLEK--QGKFPVG-PGPRYLNIEPSLAMDWLEISWDELHVKERVG 668
P+A +P Q +++E P+ P P N E L D ++I W +L++KE++G
Sbjct: 499 PSANMPPQNMMRASNQIEAAPMNAPPISQPVPNRANRELGLDGDDMDIPWCDLNIKEKIG 558
Query: 669 AGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728
AGSFGTVHRAEWHGSDVAVK+L QDF +++ EFLREVAIMKR+RHPN+VLFMGAVT+
Sbjct: 559 AGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 618
Query: 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLK 788
P+LSIVTEYL RGSLYRL+H+ A E +D+RRRL MA DVAKG+NYLHN NPPI+H DLK
Sbjct: 619 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLK 678
Query: 789 SPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFG 848
SPNLLVDK +TVKVCDFGLSR KA+TF+SSKS AGTPEWMAPE LR EPSNEKSDVYSFG
Sbjct: 679 SPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFG 738
Query: 849 VILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSF 908
VILWEL T+QQPW L PAQVV AV F+ +RL IP+N +P +A+++E CW ++P +RPSF
Sbjct: 739 VILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSF 798
Query: 909 ANIVESLKKLLKS 921
A I++ L+ L+KS
Sbjct: 799 ATIMDLLRPLIKS 811
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 927 (331.4 bits), Expect = 6.3e-127, Sum P(2) = 6.3e-127
Identities = 173/266 (65%), Positives = 208/266 (78%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
EI W+E+ V ER+G GS+G V+R +WHG++VAVK QD + L+EF EV IMK++R
Sbjct: 742 EILWEEITVGERIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALEEFRSEVRIMKKLR 801
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
HPN+VLFMGAVT+ P+LSIVTE+LPRGSLYRLIHRP +D+RRRLRMALD A+G+NY
Sbjct: 802 HPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRP--NNQLDERRRLRMALDAARGMNY 859
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLR 834
LH+ NP I+H DLKSPNLLVDKNW VKVCDFGLSR K +T++SSKS AGT EWMAPE LR
Sbjct: 860 LHSCNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKSTAGTAEWMAPEVLR 919
Query: 835 GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894
EP++EK DVYS+GVILWEL T+QQPW + P QVVGAV FQ+RRL IP P +A L+
Sbjct: 920 NEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPDFVDPAIADLI 979
Query: 895 ESCWADDPAQRPSFANIVESLKKLLK 920
CW D RPSFA I+ SLK+L K
Sbjct: 980 SKCWQTDSKLRPSFAEIMASLKRLQK 1005
|
|
| TAIR|locus:2143009 AT5G11850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 926 (331.0 bits), Expect = 3.1e-126, Sum P(3) = 3.1e-126
Identities = 173/276 (62%), Positives = 212/276 (76%)
Query: 645 IEPSL--AMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKE 702
I P L A W EI W++L + ER+G GS+G V+RAEW+G++VAVK QDF D L +
Sbjct: 592 INPLLGEAAKW-EIMWEDLQIGERIGIGSYGEVYRAEWNGTEVAVKKFLDQDFSGDALTQ 650
Query: 703 FLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL 762
F E+ IM R+RHPNVVLFMGAVT+ P+ SI+TE+LPRGSLYRL+HRP +D++RR+
Sbjct: 651 FKSEIEIMLRLRHPNVVLFMGAVTRPPNFSILTEFLPRGSLYRLLHRP--NHQLDEKRRM 708
Query: 763 RMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
RMALDVAKG+NYLH +P ++H DLKSPNLLVDKNW VKVCDFGLSR K +T++SSKS A
Sbjct: 709 RMALDVAKGMNYLHTSHPTVVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHHTYLSSKSTA 768
Query: 823 GTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAI 882
GTPEWMAPE LR EP+NEK DVYSFGVILWEL T + PW GL P QVVGAV FQNRRL I
Sbjct: 769 GTPEWMAPEVLRNEPANEKCDVYSFGVILWELATSRVPWKGLNPMQVVGAVGFQNRRLEI 828
Query: 883 PQNTSPVLASLMESCWADDPAQRPSFANIVESLKKL 918
P + +A ++ CW +P RPSF +++SLK+L
Sbjct: 829 PDDIDLTVAQIIRECWQTEPHLRPSFTQLMQSLKRL 864
|
|
| TAIR|locus:2194055 AT1G18160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 925 (330.7 bits), Expect = 9.1e-126, Sum P(2) = 9.1e-126
Identities = 172/270 (63%), Positives = 211/270 (78%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
EI W+E+ V ER+G GS+G V+R +WHG+ VAVK QD + L+EF EV +M+R+R
Sbjct: 709 EILWEEITVAERIGLGSYGEVYRGDWHGTAVAVKKFIDQDITGEALEEFRSEVRMMRRLR 768
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
HPN+VLFMGAVT+ P+LSIVTE+LPRGSLYRLIHRP +D+R+RLRMALD A+G+NY
Sbjct: 769 HPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRP--NNQLDERKRLRMALDAARGMNY 826
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLR 834
LH+ NP I+H DLKSPNLLVDKNW VKVCDFGLSR K +T++SSKS AGT EWMAPE LR
Sbjct: 827 LHSCNPVIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKVSTYLSSKSTAGTAEWMAPEVLR 886
Query: 835 GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894
EP++EK DVYS+GVILWEL T+QQPW + P QVVGAV FQ+RRL IP+ P +A ++
Sbjct: 887 NEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQVVGAVGFQHRRLDIPEFVDPGIADII 946
Query: 895 ESCWADDPAQRPSFANIVESLKKLLKSPAQ 924
CW DP RPSF I++SLK+L K P Q
Sbjct: 947 RKCWQTDPRLRPSFGEIMDSLKQLQK-PIQ 975
|
|
| TAIR|locus:2025515 EDR1 "ENHANCED DISEASE RESISTANCE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 895 (320.1 bits), Expect = 1.6e-117, Sum P(2) = 1.6e-117
Identities = 168/264 (63%), Positives = 202/264 (76%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
EI W++L + ER+G GS+G V+ A+WHG++VAVK QDF L EF EV IM+R+R
Sbjct: 663 EIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEVRIMRRLR 722
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
HPNVV F+GAVT+ P+LSIVTE+LPRGSLYR++HRP + +D+RRR++MALDVA G+N
Sbjct: 723 HPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSH--IDERRRIKMALDVAMGMNC 780
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLR 834
LH P I+H DLK+PNLLVD NW VKV DFGLSR K NTF+SSKS AGTPEWMAPE LR
Sbjct: 781 LHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLR 840
Query: 835 GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894
EPSNEK DVYSFGVILWEL T++ PW G+ P QVVGAV FQNRRL IP+ PV+ ++
Sbjct: 841 NEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRRLEIPKELDPVVGRII 900
Query: 895 ESCWADDPAQRPSFANIVESLKKL 918
CW DP RPSFA + E LK L
Sbjct: 901 LECWQTDPNLRPSFAQLTEVLKPL 924
|
|
| TAIR|locus:2127228 AT4G23050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 813 (291.2 bits), Expect = 6.5e-83, Sum P(2) = 6.5e-83
Identities = 150/268 (55%), Positives = 196/268 (73%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
EI W++L + E VG GSF VHR W+GSDVA+KV D+ L E +E+ IMK++R
Sbjct: 462 EIRWEDLQLGEEVGRGSFAAVHRGVWNGSDVAIKVYFDGDYNAMTLTECKKEINIMKKLR 521
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
HPNV+LFMGAV +I+ EY+PRGSL++++H + +D++RRLRMALDVA+G+NY
Sbjct: 522 HPNVLLFMGAVCTEEKSAIIMEYMPRGSLFKILHN--TNQPLDKKRRLRMALDVARGMNY 579
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLR 834
LH NPPI+H DLKS NLLVDKNW VKV DFGLS++K TF+S+KS GTP+WMAPE LR
Sbjct: 580 LHRRNPPIVHRDLKSSNLLVDKNWNVKVGDFGLSKWKNATFLSTKSGKGTPQWMAPEVLR 639
Query: 835 GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894
EPSNEK DV+SFGVILWEL+T PW+ L QVVG V F +RRL +P+ +P +AS++
Sbjct: 640 SEPSNEKCDVFSFGVILWELMTTLVPWDRLNSIQVVGVVGFMDRRLDLPEGLNPRIASII 699
Query: 895 ESCWADDPAQRPSFANIVESLKKLLKSP 922
+ CW DPA+RPSF ++ + L + P
Sbjct: 700 QDCWQTDPAKRPSFEELISQMMSLFRKP 727
|
|
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 804 (288.1 bits), Expect = 2.8e-82, Sum P(2) = 2.8e-82
Identities = 150/264 (56%), Positives = 197/264 (74%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
EI WD+L + E+VG GS GTV+ W GSDVAVKV + Q++ + ++ F +EV +MKR+R
Sbjct: 488 EILWDDLTIGEQVGQGSCGTVYHGLWFGSDVAVKVFSKQEYSAEVIESFKQEVLLMKRLR 547
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
HPNV+LFMGAVT L IV+E+LPRGSL+RL+ + + +D RRR+ MALD+A+G+NY
Sbjct: 548 HPNVLLFMGAVTSPQRLCIVSEFLPRGSLFRLLQKSTS--KLDWRRRIHMALDIARGMNY 605
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLR 834
LH+ +PPI+H DLKS NLLVDKNWTVKV DFGLSR K T+++SKS GTP+WMAPE LR
Sbjct: 606 LHHCSPPIIHRDLKSSNLLVDKNWTVKVADFGLSRIKHETYLTSKSGKGTPQWMAPEVLR 665
Query: 835 GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894
E ++EKSD+YSFGV+LWEL T + PW L QV+GAV F ++RL IP++ P SLM
Sbjct: 666 NESADEKSDIYSFGVVLWELATEKIPWETLNSMQVIGAVGFMDQRLEIPKDIDPRWISLM 725
Query: 895 ESCWADDPAQRPSFANIVESLKKL 918
ESCW D RP+F +++ L+ L
Sbjct: 726 ESCWHSDTKLRPTFQELMDKLRDL 749
|
|
| TAIR|locus:2084304 AT3G06630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 780 (279.6 bits), Expect = 2.8e-80, Sum P(2) = 2.8e-80
Identities = 144/244 (59%), Positives = 187/244 (76%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
EI WD+L + E++G GS GTV+ W GSDVAVKV + Q++ + +K F +EV++MKR+R
Sbjct: 428 EILWDDLTIGEQIGRGSCGTVYHGIWFGSDVAVKVFSKQEYSESVIKSFEKEVSLMKRLR 487
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
HPNV+LFMGAVT L IV+E++PRGSL+RL+ R + +D RRR+ MALD+A+G+NY
Sbjct: 488 HPNVLLFMGAVTSPQRLCIVSEFVPRGSLFRLLQRSMS--KLDWRRRINMALDIARGMNY 545
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLR 834
LH +PPI+H DLKS NLLVD+NWTVKV DFGLSR K T+++SKS GTP+WMAPE LR
Sbjct: 546 LHCCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHQTYLTSKSGKGTPQWMAPEVLR 605
Query: 835 GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894
E ++EKSD+YSFGV+LWEL T + PW L QV+GAV F N+RL IP++T P SL+
Sbjct: 606 NESADEKSDIYSFGVVLWELATEKIPWENLNSMQVIGAVGFMNQRLEIPKDTDPDWISLI 665
Query: 895 ESCW 898
ESCW
Sbjct: 666 ESCW 669
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 794 (284.6 bits), Expect = 5.4e-79, P = 5.4e-79
Identities = 147/268 (54%), Positives = 200/268 (74%)
Query: 651 MDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIM 710
+D+ EI W++L + E++G GS GTV+ W GSDVAVKV + Q++ ++ + F +EV++M
Sbjct: 478 LDY-EILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEIITSFKQEVSLM 536
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
KR+RHPNV+LFMGAV L IVTE+LPRGSL+RL+ R + +D RRR+ MA D+A+
Sbjct: 537 KRLRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKS--KLDLRRRIHMASDIAR 594
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAP 830
G+NYLH+ +PPI+H DLKS NLLVD+NWTVKV DFGLSR K T++++ GTP+WMAP
Sbjct: 595 GMNYLHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETYLTTNG-RGTPQWMAP 653
Query: 831 EFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890
E LR E ++EKSDVYSFGV+LWELVT + PW L QV+GAV F N+RL +P++ P
Sbjct: 654 EVLRNEAADEKSDVYSFGVVLWELVTEKIPWENLNAMQVIGAVGFMNQRLEVPKDVDPQW 713
Query: 891 ASLMESCWADDPAQRPSFANIVESLKKL 918
+LMESCW +P RPSF +++ L++L
Sbjct: 714 IALMESCWHSEPQCRPSFQELMDKLREL 741
|
|
| TAIR|locus:2052786 AT2G31010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 668 (240.2 bits), Expect = 7.5e-78, Sum P(2) = 7.5e-78
Identities = 132/274 (48%), Positives = 179/274 (65%)
Query: 643 LNIEPSLA-MDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK 701
L +P L +W +I + EL V RVG G FG V R W+G+DVA+K+ QD + ++
Sbjct: 501 LQNQPLLPYQEW-DIDFSELTVGTRVGIGFFGEVFRGVWNGTDVAIKLFLEQDLTAENME 559
Query: 702 EFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRR 761
+F E++I+ RVRHPNVVLF+GA TK P LS++TEY+ GSLY LIH + + RR
Sbjct: 560 DFCNEISILSRVRHPNVVLFLGACTKPPRLSMITEYMELGSLYYLIHMSGQKKKLSWHRR 619
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSV 821
LRM D+ +G+ +H + I+H DLKS N LVDK+WTVK+CDFGLSR + + S
Sbjct: 620 LRMLRDICRGLMCIHRMK--IVHRDLKSANCLVDKHWTVKICDFGLSRIMTDENMKDTSS 677
Query: 822 AGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLA 881
AGTPEWMAPE +R P EK D++S GVI+WEL T+++PW G+ P +VV AVA + RL
Sbjct: 678 AGTPEWMAPELIRNRPFTEKCDIFSLGVIMWELSTLRKPWEGVPPEKVVFAVAHEGSRLE 737
Query: 882 IPQNTSPVLASLMESCWADDPAQRPSFANIVESL 915
IP P L+ L+ CWA+ P +RP+ I+ L
Sbjct: 738 IPDG--P-LSKLIADCWAE-PEERPNCEEILRGL 767
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh2_kg.7__1830__AT4G24480.1 | annotation not avaliable (961 aa) | |||||||||
(Arabidopsis lyrata) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 931 | |||
| pfam14381 | 203 | pfam14381, EDR1, Ethylene-responsive protein kinas | 2e-92 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-75 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-71 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-71 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-70 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-63 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-62 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-60 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-54 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-49 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-48 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-48 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-46 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-46 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-46 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-45 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-45 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-44 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-43 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-43 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-42 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-41 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-41 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-41 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-40 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-40 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-40 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-39 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-39 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-38 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-38 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-38 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-38 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-38 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-37 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-37 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-37 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-36 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-36 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-36 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-35 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-35 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-35 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-35 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-35 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-35 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-35 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-35 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-34 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-34 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-34 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-34 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-34 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-34 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-34 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-34 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-33 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-33 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-33 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-33 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-33 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-33 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-33 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-33 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-32 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-32 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-32 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-32 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-32 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-32 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-32 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-32 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-32 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-32 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-32 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-32 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-32 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-31 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-31 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-31 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-31 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-31 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-31 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-31 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-31 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-30 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-30 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-30 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-30 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-29 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-29 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-28 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-28 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-28 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-28 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-27 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-27 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-27 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-27 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-27 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-27 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-27 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-27 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-27 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-26 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-26 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-26 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-26 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-26 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-26 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-26 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-26 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-26 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-25 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-25 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-25 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-25 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-25 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-25 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-24 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-24 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-24 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-24 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-23 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-23 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-23 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-23 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-22 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-22 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-22 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-22 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-21 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-21 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-21 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-21 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-21 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-21 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-21 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-20 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-20 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-20 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-20 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-20 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-20 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-20 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-19 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-19 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-19 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-19 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-19 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-19 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-18 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-18 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-18 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-18 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-18 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-18 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-17 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-17 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-17 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-17 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-16 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-16 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-14 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-14 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-14 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-12 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-11 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-04 | |
| pfam03109 | 117 | pfam03109, ABC1, ABC1 family | 8e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.001 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.002 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.003 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|222722 pfam14381, EDR1, Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Score = 290 bits (744), Expect = 2e-92
Identities = 104/213 (48%), Positives = 137/213 (64%), Gaps = 13/213 (6%)
Query: 259 SDTETVSYRLWVSGCLSYNDKISDGFYNILGMNPYLWVMCNDLEEGKRLPSLMSLKDIDS 318
S E +S+R WV GCLSY+DKI DGFY+I GM+ C+DL+E R+PSL L+ +
Sbjct: 2 SSAEALSHRYWVYGCLSYDDKIPDGFYDIYGMD-----PCSDLKEFGRIPSLEDLQAVPP 56
Query: 319 TETSMEVVLIDRHGDSRLKELEDKAQELYCASE-NTLVLVEELGKLVAICMGGTFPIEQG 377
++S EVVL+DR D +LKELE A+ L NT LV++L LV+ MGG +
Sbjct: 57 GDSSFEVVLVDRRTDPKLKELEQLARCLVSGCGTNTAALVQKLAGLVSDHMGGPVKDAES 116
Query: 378 DLHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLADYIGLPCRIARGCRYCE 437
L RWK S L+ V+P+GSL +GLCRHRA+LFK LAD IGLPCR+ +GC+YC
Sbjct: 117 MLA-RWKECSNELK--ENSGVVPLGSLKIGLCRHRALLFKVLADSIGLPCRLVKGCKYCG 173
Query: 438 ADHRSSCLVKIEDDRRSSREYVVDLVGEPGNIH 470
+D +S LVK +D REY+VDL+G PG +
Sbjct: 174 SDDDASNLVKFDDG----REYLVDLMGAPGTLI 202
|
EDR1 regulates disease resistance and ethylene-induced senescence, and is also involved in stress response signalling and cell death regulation. Length = 203 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 246 bits (631), Expect = 3e-75
Identities = 104/264 (39%), Positives = 151/264 (57%), Gaps = 15/264 (5%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGS------DVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
L + +++G G+FG V++ G VAVK L + +++ +EFL E +IMK++
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLK-EGASEEEREEFLEEASIMKKLS 59
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
HPN+V +G T+ L IVTEY+P G L + + GE + + L+MAL +AKG+ Y
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH--GEKLTLKDLLQMALQIAKGMEY 117
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAG-TP-EWMAPEF 832
L + N +H DL + N LV +N VK+ DFGLSR K G P +WMAPE
Sbjct: 118 LESKN--FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPES 175
Query: 833 LRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891
L+ KSDV+SFGV+LWE+ T+ +QP+ G+ +V+ + RL P+N L
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLE-DGYRLPRPENCPDELY 234
Query: 892 SLMESCWADDPAQRPSFANIVESL 915
LM CWA DP RP+F+ +VE L
Sbjct: 235 ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 236 bits (605), Expect = 2e-71
Identities = 96/266 (36%), Positives = 144/266 (54%), Gaps = 18/266 (6%)
Query: 665 ERVGAGSFGTVHRAEWHGS-----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
+++G G+FG V++ + G +VAVK L +D +++ K+FL+E +MK++ HPNVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQR----RRLRMALDVAKGIN 773
+G T+ L +V EY+ G L Y RP L A+ +AKG+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT-FISSKSVAGTP-EWMAPE 831
YL + +H DL + N LV ++ VK+ DFGLSR + + K+ P WMAPE
Sbjct: 120 YLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 832 FLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890
L+ KSDV+SFGV+LWE+ T+ P+ GL +V+ + + RL P+ L
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYRLPKPEYCPDEL 236
Query: 891 ASLMESCWADDPAQRPSFANIVESLK 916
LM SCW DP RP+F+ +VE L+
Sbjct: 237 YELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 236 bits (604), Expect = 2e-71
Identities = 104/267 (38%), Positives = 151/267 (56%), Gaps = 21/267 (7%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGS------DVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
L + +++G G+FG V++ G +VAVK L +D + Q++EFLRE IM+++
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLD 59
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
HPN+V +G T+ L IV EY+P G L Y +RP + L AL +A+G+
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE---LSLSDLLSFALQIARGM 116
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPE---WMA 829
YL + N +H DL + N LV +N VK+ DFGLSR + V G WMA
Sbjct: 117 EYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--DYYKVKGGKLPIRWMA 172
Query: 830 PEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888
PE L+ KSDV+SFGV+LWE+ T+ ++P+ G+ A+V+ + + RL P N P
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK-KGYRLPKPPNCPP 231
Query: 889 VLASLMESCWADDPAQRPSFANIVESL 915
L LM CWA+DP RP+F+ +VE L
Sbjct: 232 ELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 233 bits (598), Expect = 1e-70
Identities = 102/267 (38%), Positives = 146/267 (54%), Gaps = 22/267 (8%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGS------DVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
L + +++G G+FG V++ + G +VAVK L + Q++EFLRE IM+++
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS-EQQIEEFLREARIMRKLD 59
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
HPNVV +G T+ L IV EY+ G L Y +RP + L AL +A+G+
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK----LSLSDLLSFALQIARGM 115
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPE---WMA 829
YL + N +H DL + N LV +N VK+ DFGLSR + G WMA
Sbjct: 116 EYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--DYYRKRGGKLPIRWMA 171
Query: 830 PEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888
PE L+ KSDV+SFGV+LWE+ T+ +QP+ G+ +V+ + RL P N P
Sbjct: 172 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK-NGYRLPQPPNCPP 230
Query: 889 VLASLMESCWADDPAQRPSFANIVESL 915
L LM CWA+DP RP+F+ +VE L
Sbjct: 231 ELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 212 bits (543), Expect = 8e-63
Identities = 77/260 (29%), Positives = 127/260 (48%), Gaps = 19/260 (7%)
Query: 662 HVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
+ E++G GSFG V+ A + VA+KV+ + + + LRE+ I+K+++HPN+V
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVI-KKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
L +V EY G L+ L+ + G + + R + + YLH+
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK--RGRLSEDEAR-FYLRQILSALEYLHSKG 117
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSN 839
I+H DLK N+L+D++ VK+ DFGL+R + GTPE+MAPE L G+
Sbjct: 118 --IVHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFVGTPEYMAPEVLLGKGYG 174
Query: 840 EKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQ------NTSPVLASL 893
+ D++S GVIL+EL+T + P+ G + F+ P + SP L
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLEL----FKKIGKPKPPFPPPEWDISPEAKDL 230
Query: 894 MESCWADDPAQRPSFANIVE 913
+ DP +R + ++
Sbjct: 231 IRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 211 bits (540), Expect = 2e-62
Identities = 85/265 (32%), Positives = 143/265 (53%), Gaps = 19/265 (7%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
+ ++G+GSFGTV++A+ G+ VAVK+L + + + RE+ I++R+ HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEM-MDQRRRLRMALDVAKGINYLHN 777
V + A + HL +V EY G L+ + R G + D+ + ++AL + +G+ YLH+
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR--GGPLSEDEAK--KIALQILRGLEYLHS 116
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLR-GE 836
I+H DLK N+L+D+N VK+ DFGL++ + S + GTP +MAPE L G
Sbjct: 117 NG--IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGN 174
Query: 837 PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQ-------NTSPV 889
K DV+S GVIL+EL+T + P++G + + + + S
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFSGENILDQL--QLIRRILGPPLEFDEPKWSSGSEE 232
Query: 890 LASLMESCWADDPAQRPSFANIVES 914
L++ C DP++RP+ I++
Sbjct: 233 AKDLIKKCLNKDPSKRPTAEEILQH 257
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 205 bits (523), Expect = 1e-60
Identities = 87/253 (34%), Positives = 126/253 (49%), Gaps = 42/253 (16%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
+G G FGTV+ A + VA+K++ +D L+E LRE+ I+K++ HPN+V G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS-SSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
HL +V EY GSL L+ + + LR+ L + +G+ YLH+ I+H
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHSNG--IIH 115
Query: 785 WDLKSPNLLVDK-NWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPS-NEKS 842
DLK N+L+D N VK+ DFGLS+ + K++ GTP +MAPE L G+ +EKS
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 843 DVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDP 902
D++S GVIL+EL P L L+ DP
Sbjct: 176 DIWSLGVILYEL---------------------------------PELKDLIRKMLQKDP 202
Query: 903 AQRPSFANIVESL 915
+RPS I+E L
Sbjct: 203 EKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 1e-54
Identities = 85/265 (32%), Positives = 137/265 (51%), Gaps = 19/265 (7%)
Query: 665 ERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
E +G GSFG+V+ A G +AVK + + +++L+ RE+ I+ ++HPN+V +
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 723 GAVTKRP--HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
G+ L+I EY+ GSL L+ + R+ R L +G+ YLH+
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL---EGLAYLHSNG- 121
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN--TFISSKSVAGTPEWMAPEFLRGEPS 838
I+H D+K N+LVD + VK+ DFG ++ + T + SV GTP WMAPE +RGE
Sbjct: 122 -IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180
Query: 839 NEKSDVYSFGVILWELVTMQQPWNGLG-PAQVVGAVAFQNRRLAIPQNTSPVLASLMESC 897
+D++S G + E+ T + PW+ LG P + + IP++ S + C
Sbjct: 181 GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKC 240
Query: 898 WADDPAQRPSFANIVESLKKLLKSP 922
DP +RP+ A+ +LL+ P
Sbjct: 241 LRRDPKKRPT-AD------ELLQHP 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 1e-49
Identities = 92/260 (35%), Positives = 137/260 (52%), Gaps = 14/260 (5%)
Query: 665 ERVGAGSFGTVHRAEWHGS-----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
+++G GSFG V R EW S VAVK L D L D + +FL+E AIM + H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLK-SDKLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
G V P L +VTE P GSL + + A G + A+ +A G+ YL +
Sbjct: 60 RLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFL-ISTLCDYAVQIANGMRYLESKR 117
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSR---FKANTFISSKSVAGTPEWMAPEFLRGE 836
+H DL + N+L+ + VK+ DFGL R + ++ + + W APE LR
Sbjct: 118 --FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 837 PSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895
+ SDV+ FGV LWE+ T ++PW GL +Q++ + + RL P+ + ++M
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVML 235
Query: 896 SCWADDPAQRPSFANIVESL 915
CWA +PA RP+FA + E L
Sbjct: 236 QCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 3e-48
Identities = 78/264 (29%), Positives = 141/264 (53%), Gaps = 15/264 (5%)
Query: 663 VKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
+ +++G GSFG V+ SD +K + + + + + ++ L EV I+K++ HPN++
Sbjct: 4 IIKQIGKGSFGKVYLVR-RKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII 62
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIH-RPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
+ + ++ L IV EY G L + I + G+ + + L + + + YLH+
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPS 838
ILH D+K N+ + N VK+ DFG+S+ ++T +K+V GTP +++PE + +P
Sbjct: 123 K--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPY 180
Query: 839 NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCW 898
N KSD++S G +L+EL T++ P+ G ++ + IP S L +L+ S
Sbjct: 181 NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP-PIPSQYSSELRNLVSSLL 239
Query: 899 ADDPAQRPSFANIVESLKKLLKSP 922
DP +RP S+ ++L+SP
Sbjct: 240 QKDPEERP-------SIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 7e-48
Identities = 91/269 (33%), Positives = 150/269 (55%), Gaps = 11/269 (4%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
E+ ++ +K ++G G +G V+ W + VAVK L +D + +++EFL+E A+MK
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTM--EVEEFLKEAAVMKE 58
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
++HPN+V +G T+ P I+TE++ G+L + R + ++ L MA ++ +
Sbjct: 59 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAM 117
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP-EWMAPE 831
YL N +H DL + N LV +N VKV DFGLSR ++ + A P +W APE
Sbjct: 118 EYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175
Query: 832 FLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890
L + KSDV++FGV+LWE+ T P+ G+ +QV + + R+ P+ P +
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKV 234
Query: 891 ASLMESCWADDPAQRPSFANIVESLKKLL 919
LM +CW +P+ RPSFA I ++ + +
Sbjct: 235 YELMRACWQWNPSDRPSFAEIHQAFETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 3e-46
Identities = 90/271 (33%), Positives = 142/271 (52%), Gaps = 21/271 (7%)
Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVL-----TVQDFLDDQLKEFLRE 706
W EI + L ++ ++GAG FG V W+G+ VAVK L + + FL +E
Sbjct: 1 W-EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFL--------QE 51
Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
IMK++RH +V ++ + IVTEY+ +GSL + G+ + + + MA
Sbjct: 52 AQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAA 110
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP- 825
+A+G+ YL + N +H DL + N+LV +N K+ DFGL+R + +++ A P
Sbjct: 111 QIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPI 168
Query: 826 EWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQ-PWNGLGPAQVVGAVAFQNRRLAIPQ 884
+W APE KSDV+SFG++L E+VT + P+ G+ +V+ V + R+ P
Sbjct: 169 KWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPP 227
Query: 885 NTSPVLASLMESCWADDPAQRPSFANIVESL 915
N L LM CW DP +RP+F + L
Sbjct: 228 NCPEELYDLMLQCWDKDPEERPTFEYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 7e-46
Identities = 93/270 (34%), Positives = 137/270 (50%), Gaps = 15/270 (5%)
Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMK 711
W EI + + ++GAG FG V W+ + VAVK L K+FL E IMK
Sbjct: 1 W-EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---DPKDFLAEAQIMK 56
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
++RHP ++ T + IVTE + GSL + AG + + + MA VA G
Sbjct: 57 KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASG 115
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMAP 830
+ YL N +H DL + N+LV +N KV DFGL+R K + + + + +W AP
Sbjct: 116 MAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAP 173
Query: 831 EFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPV 889
E + KSDV+SFG++L E+VT + P+ G+ A+V+ V Q R+ P
Sbjct: 174 EAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKE 232
Query: 890 LASLMESCWADDPAQRPSFANIVESLKKLL 919
L +M CW +DP RP+F E+L+ L
Sbjct: 233 LYDIMLDCWKEDPDDRPTF----ETLQWKL 258
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 9e-46
Identities = 93/281 (33%), Positives = 143/281 (50%), Gaps = 22/281 (7%)
Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLR 705
W E+ +++ + +G GSFG V+ G + VA+K + + +++ EFL
Sbjct: 1 W-ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLN 58
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA-----GEMMDQ 758
E ++MK +VV +G V+ +V E + +G L Y RP A
Sbjct: 59 EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL 118
Query: 759 RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS 818
++ ++MA ++A G+ YL +H DL + N +V ++ TVK+ DFG++R T
Sbjct: 119 QKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR 176
Query: 819 KSVAGT-P-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAF 875
K G P WMAPE L+ KSDV+SFGV+LWE+ T+ +QP+ GL +V+ V
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI- 235
Query: 876 QNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916
L +P+N L LM CW +P RP+F IV SLK
Sbjct: 236 DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-45
Identities = 95/266 (35%), Positives = 144/266 (54%), Gaps = 17/266 (6%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQ--LKEFLREVAIMK 711
I+ EL + +G G FG V ++ G VAVK L DD + FL E ++M
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLK-----DDSTAAQAFLAEASVMT 55
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
+RHPN+V +G V + L IVTEY+ +GSL + R ++ ++L ALDV +G
Sbjct: 56 TLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEG 114
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP-EWMAP 830
+ YL N +H DL + N+LV ++ KV DFGL++ + S K P +W AP
Sbjct: 115 MEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK----LPVKWTAP 168
Query: 831 EFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPV 889
E LR + + KSDV+SFG++LWE+ + + P+ + VV V + R+ P+ P
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPE 227
Query: 890 LASLMESCWADDPAQRPSFANIVESL 915
+ +M+ CW DPA+RP+F + E L
Sbjct: 228 VYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 1e-45
Identities = 86/257 (33%), Positives = 136/257 (52%), Gaps = 10/257 (3%)
Query: 665 ERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMG 723
E++G G+FG V++ G+ +VAVK D + K FL+E I+K+ HPN+V +G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIG 59
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
++ + IV E +P GSL + + + ++ L+M+LD A G+ YL + N +
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYLESKN--CI 115
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANT-FISSKSVAGTP-EWMAPEFLRGEPSNEK 841
H DL + N LV +N +K+ DFG+SR + + S + P +W APE L +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 842 SDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD 900
SDV+S+G++LWE ++ P+ G+ Q + R+ PQ + LM CWA
Sbjct: 176 SDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWAY 234
Query: 901 DPAQRPSFANIVESLKK 917
DP RPSF+ I L+
Sbjct: 235 DPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 5e-45
Identities = 79/271 (29%), Positives = 138/271 (50%), Gaps = 27/271 (9%)
Query: 660 ELHVKERVGAGSFGTVHRAE-WHGSD-VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
+ + +G G+FG V++ D VA+K ++++ ++ LK ++E+ ++K ++HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAA-GEM-----MDQRRRLRMALDVAKG 771
+V ++G++ L I+ EY GSL ++I + E + Q V +G
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ---------VLQG 111
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPE 831
+ YLH ++H D+K+ N+L K+ VK+ DFG++ + SV GTP WMAPE
Sbjct: 112 LAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPE 169
Query: 832 FLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891
+ ++ SD++S G + EL+T P+ L P + + Q+ +P+ SP L
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELK 228
Query: 892 SLMESCWADDPAQRPSFANIVESLKKLLKSP 922
+ C+ DP RP + K+LLK P
Sbjct: 229 DFLMQCFQKDPNLRP-------TAKQLLKHP 252
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 3e-44
Identities = 80/269 (29%), Positives = 146/269 (54%), Gaps = 29/269 (10%)
Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
+ E++G G FG V++A H G +VA+KV+ ++ ++ ++ + E+ I+K+ +HPN+V
Sbjct: 4 ILEKIGKGGFGEVYKA-RHKRTGKEVAIKVIKLES--KEKKEKIINEIQILKKCKHPNIV 60
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
+ G+ K+ L IV E+ GSL L+ + + + + + + ++ KG+ YLH+
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLK--STNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSN 839
I+H D+K+ N+L+ + VK+ DFGLS ++T + ++ GTP WMAPE + G+P +
Sbjct: 119 --IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK-ARNTMVGTPYWMAPEVINGKPYD 175
Query: 840 EKSDVYSFGVILWELVTMQQPWNGLGP------AQVVGAVAFQNRRLAIPQNTSPVLASL 893
K+D++S G+ EL + P++ L P G +N P+ S
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRN-----PEKWSDEFKDF 230
Query: 894 MESCWADDPAQRPSFANIVESLKKLLKSP 922
++ C +P +RP + ++LLK P
Sbjct: 231 LKKCLQKNPEKRP-------TAEQLLKHP 252
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 6e-43
Identities = 85/260 (32%), Positives = 136/260 (52%), Gaps = 13/260 (5%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
EL + +G+G FG VH +W G DVA+K++ +D +F+ E +M ++ HPN+
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNL 61
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
V G TK+ + IVTEY+ G L + + L M DV + + YL +
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESN 119
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP-EWMAPE-FLRGE 836
+H DL + N LV ++ VKV DFGL+R+ + +S P +W PE F
Sbjct: 120 G--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSR 177
Query: 837 PSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895
S+ KSDV+SFGV++WE+ + + P+ ++VV +V+ RL P+ + ++M
Sbjct: 178 FSS-KSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIMY 235
Query: 896 SCWADDPAQRPSFANIVESL 915
SCW + P RP+F ++ L
Sbjct: 236 SCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 7e-43
Identities = 86/280 (30%), Positives = 130/280 (46%), Gaps = 34/280 (12%)
Query: 667 VGAGSFGTVHRAEW------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
+G G FG V + G VAVK L + +F RE+ I++ + H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH-SGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 721 FMGAVTK--RPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
+ G K L ++ EYLP GSL Y HR ++ +R L + + KG++YL
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ----INLKRLLLFSSQICKGMDYLG 126
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF--KANTFISSKSVAGTP-EWMAPEFL 833
+ +H DL + N+LV+ VK+ DFGL++ + + K +P W APE L
Sbjct: 127 SQR--YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184
Query: 834 RGEPSNEKSDVYSFGVILWELVT--------MQQPWNGLGPAQVVGAVA-FQNR-----R 879
R + SDV+SFGV L+EL T + +G AQ V R
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGER 244
Query: 880 LAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLL 919
L P + + LM+ CW +P RPSFA+++ + +L
Sbjct: 245 LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 2e-42
Identities = 89/265 (33%), Positives = 138/265 (52%), Gaps = 14/265 (5%)
Query: 663 VKERVGAGSFGTVHRAEWHGS-----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
+++ +G G FG V R DVA+K L D Q +FL E +IM + HPN
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-SSDKQRLDFLTEASIMGQFDHPN 66
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
++ G VTK + I+TEY+ GSL + + R G+ + + M +A G+ YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFL-RENDGKFTVG-QLVGMLRGIASGMKYLSE 124
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAG-TP-EWMAPEFLRG 835
+N +H DL + N+LV+ N KV DFGLSR ++ + + G P W APE +
Sbjct: 125 MN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182
Query: 836 EPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894
SDV+SFG+++WE+++ ++P+ + V+ AV RL P + L LM
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMDCPSALYQLM 241
Query: 895 ESCWADDPAQRPSFANIVESLKKLL 919
CW D +RP+F+ IV +L K++
Sbjct: 242 LDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 84/259 (32%), Positives = 131/259 (50%), Gaps = 11/259 (4%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
+L + +G G FG V +W G DVA+K++ +D EF+ E +M ++ H +
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKL 61
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
V G TK+ + IVTEY+ G L + Q L M DV +G+ YL +
Sbjct: 62 VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQ--LLEMCKDVCEGMAYLESK 119
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA-NTFISSKSVAGTPEWMAPEFLRGEP 837
+H DL + N LVD VKV DFGLSR+ + + SS W PE L
Sbjct: 120 Q--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177
Query: 838 SNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMES 896
+ KSDV++FGV++WE+ ++ + P+ ++ V V+ Q RL P S + ++M S
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMYS 236
Query: 897 CWADDPAQRPSFANIVESL 915
CW + +RP+F ++ S+
Sbjct: 237 CWHEKAEERPTFQQLLSSI 255
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 7e-41
Identities = 95/291 (32%), Positives = 153/291 (52%), Gaps = 29/291 (9%)
Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQLKEFLR 705
W E+ D L + + +G G+FG V +AE G D VAVK+L D + L + +
Sbjct: 7 W-ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK-DDATEKDLSDLVS 64
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRP-----------A 751
E+ +MK + +H N++ +G T+ L +V EY G+L + RP
Sbjct: 65 EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 752 AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811
E + Q+ + A VA+G+ +L + +H DL + N+LV ++ +K+ DFGL+R
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARNVLVTEDHVMKIADFGLARDI 182
Query: 812 ANTFISSKSVAGT-P-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQ-QPWNGLGPAQ 868
+ K+ G P +WMAPE L +SDV+SFGV+LWE+ T+ P+ G+ P +
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVE 241
Query: 869 VVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLL 919
+ + + R+ PQN + L LM CW + P+QRP+F +VE L ++L
Sbjct: 242 ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 9e-41
Identities = 83/271 (30%), Positives = 137/271 (50%), Gaps = 12/271 (4%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKE-FLREVAIM 710
EI +++ + +G G FG V++ + +AV V T ++ ++E FL+E IM
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
++ HP++V +G +T+ P + IV E P G L + +D + + ++
Sbjct: 62 RQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLST 118
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP-EWMA 829
+ YL + +H D+ + N+LV VK+ DFGLSR+ + S P +WMA
Sbjct: 119 ALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMA 176
Query: 830 PEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888
PE + SDV+ FGV +WE++ + +P+ G+ V+G + RL +P N P
Sbjct: 177 PESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPP 235
Query: 889 VLASLMESCWADDPAQRPSFANIVESLKKLL 919
L SLM CWA DP++RP F + L +L
Sbjct: 236 TLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 81/258 (31%), Positives = 131/258 (50%), Gaps = 8/258 (3%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
E ++ ++G+G FG V W VA+K+L D L + ++F +EV +KR+RH ++
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL--KQQDFQKEVQALKRLRHKHL 64
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
+ + + I+TE + +GSL + R G+++ + MA VA+G+ YL
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPS 838
N +H DL + N+LV ++ KV DFGL+R S +W APE
Sbjct: 124 N--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTF 181
Query: 839 NEKSDVYSFGVILWELVTMQQ-PWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESC 897
+ KSDV+SFG++L+E+ T Q P+ G+ +V + R+ P + +M C
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKIMLEC 240
Query: 898 WADDPAQRPSFANIVESL 915
WA +P RPSF + E L
Sbjct: 241 WAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 2e-40
Identities = 99/296 (33%), Positives = 141/296 (47%), Gaps = 47/296 (15%)
Query: 661 LHVKERVGAGSFGTVHRAEWHGSD------------------VAVKVLTVQDFLDDQLKE 702
L+ E++G G FG VH E G VAVKVL D D+ ++
Sbjct: 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRP-DASDNARED 65
Query: 703 FLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR--------PAAGE 754
FL+EV I+ R+ PN+ +G T P L ++ EY+ G L + + + +
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 755 MMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814
+ L MA +A G+ YL +LN +H DL + N LV KN+T+K+ DFG+SR N
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNYTIKIADFGMSR---NL 180
Query: 815 FISSKS-VAGTP----EWMAPE-FLRGEPSNEKSDVYSFGVILWELVTM--QQPWNGLGP 866
+ S V G WMA E L G+ + KSDV++FGV LWE++T+ +QP+ L
Sbjct: 181 YSSDYYRVQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYEHLTD 239
Query: 867 AQVV-GAVAFQNRR-----LAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916
QV+ A F L P N + LM CW D RP+F I L+
Sbjct: 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 2e-40
Identities = 88/266 (33%), Positives = 145/266 (54%), Gaps = 14/266 (5%)
Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
WL ++ +L + E +G G FG V + E+ G VAVK + D + FL E A+M +
Sbjct: 1 WL-LNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKC----DVTAQAFLEETAVMTK 55
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
+ H N+V +G + L IV E + +G+L + R ++ + L+ +LDVA+G+
Sbjct: 56 LHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGM 113
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEF 832
YL + ++H DL + N+LV ++ KV DFGL+R + +SK +W APE
Sbjct: 114 EYLES--KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV---KWTAPEA 168
Query: 833 LRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891
L+ + + KSDV+S+GV+LWE+ + + P+ + +V V + R+ P+ +
Sbjct: 169 LKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVY 227
Query: 892 SLMESCWADDPAQRPSFANIVESLKK 917
LM SCW +P +RPSF + E L+K
Sbjct: 228 VLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 85/270 (31%), Positives = 135/270 (50%), Gaps = 20/270 (7%)
Query: 667 VGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF 721
+G G FG+V + D VAVK + + +++EFL E A MK HPNV+
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 722 MG------AVTKRPHLSIVTEYLPRGSL--YRLIHRPAAG-EMMDQRRRLRMALDVAKGI 772
+G ++ K P ++ ++ G L + L R E + + L+ +D+A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAGTP-EWMAP 830
YL N N +H DL + N ++ ++ TV V DFGLS+ + + +A P +W+A
Sbjct: 127 EYLSNRN--FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 184
Query: 831 EFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPV 889
E L KSDV++FGV +WE+ T Q P+ G+ ++ + RL P++
Sbjct: 185 ESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL-RHGNRLKQPEDCLDE 243
Query: 890 LASLMESCWADDPAQRPSFANIVESLKKLL 919
L LM SCW DP RP+F + E L+ +L
Sbjct: 244 LYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 79/272 (29%), Positives = 134/272 (49%), Gaps = 39/272 (14%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
E++G G+ G V++A G +VA+K + ++ + + E+ IMK +HPN+V +
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRK---QNKELIINEILIMKDCKHPNIVDYY 81
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA---LDVAKGINYLHNLN 779
+ L +V EY+ GSL +I M + + +A +V +G+ YLH+ N
Sbjct: 82 DSYLVGDELWVVMEYMDGGSLTDII-TQNFVRMNEPQ----IAYVCREVLQGLEYLHSQN 136
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFG----LSRFKANTFISSKSVAGTPEWMAPEFLRG 835
++H D+KS N+L+ K+ +VK+ DFG L++ K+ SV GTP WMAPE ++
Sbjct: 137 --VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK----RNSVVGTPYWMAPEVIKR 190
Query: 836 EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQ-----NTSPVL 890
+ K D++S G++ E+ + P+ P + + F IP SP
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL----FLITTKGIPPLKNPEKWSPEF 246
Query: 891 ASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
+ C DP +RPS ++LL+ P
Sbjct: 247 KDFLNKCLVKDPEKRPSA-------EELLQHP 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 88/261 (33%), Positives = 143/261 (54%), Gaps = 13/261 (4%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
EL + + +G G FG V ++ G+ VAVK + D + FL E ++M ++RH N+V
Sbjct: 7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNLV 62
Query: 720 LFMGA-VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
+G V ++ L IVTEY+ +GSL + R ++ L+ +LDV + + YL
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPS 838
N +H DL + N+LV ++ KV DFGL++ ++T + K +W APE LR +
Sbjct: 122 N--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKF 176
Query: 839 NEKSDVYSFGVILWELVTMQQ-PWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESC 897
+ KSDV+SFG++LWE+ + + P+ + VV V + ++ P PV+ +M+ C
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVVYDVMKQC 235
Query: 898 WADDPAQRPSFANIVESLKKL 918
W D A RPSF + E L+ +
Sbjct: 236 WHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 5e-38
Identities = 88/268 (32%), Positives = 138/268 (51%), Gaps = 17/268 (6%)
Query: 663 VKERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
++E +GAG FG V R VA+K L + + Q ++FL E +IM + HPN
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKS-GYTEKQRRDFLSEASIMGQFDHPN 66
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
++ G VTK + I+TE++ G+L + R G+ + + M +A G+ YL
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFL-RQNDGQFT-VIQLVGMLRGIAAGMKYLSE 124
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN-----TFISSKSVAGTPEWMAPEF 832
+N +H DL + N+LV+ N KV DFGLSRF + T+ SS W APE
Sbjct: 125 MN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 833 LRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891
+ SDV+S+G+++WE+++ ++P+ + V+ A+ Q+ RL P + L
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCPTALH 241
Query: 892 SLMESCWADDPAQRPSFANIVESLKKLL 919
LM CW D RP F IV +L K++
Sbjct: 242 QLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 90/257 (35%), Positives = 136/257 (52%), Gaps = 11/257 (4%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
EI + L + +++G G FG V W+G + VAVK L + FL E IMK++
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKL 58
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
RH +V V++ P + IVTEY+ +GSL + + G + + MA VA G+
Sbjct: 59 RHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP-EWMAPEF 832
Y+ +N +H DL+S N+LV K+ DFGL+R + +++ A P +W APE
Sbjct: 117 YIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 833 LRGEPSNEKSDVYSFGVILWELVTMQQ-PWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891
KSDV+SFG++L ELVT + P+ G+ +V+ V + R+ PQ+ L
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCPISLH 233
Query: 892 SLMESCWADDPAQRPSF 908
LM CW DP +RP+F
Sbjct: 234 ELMLQCWKKDPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 6e-38
Identities = 82/275 (29%), Positives = 136/275 (49%), Gaps = 27/275 (9%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
++ + +R+G+G++G V++A + VA+KV+ ++ D + +E++++K RHP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHP 60
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSL---YRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
N+V + G+ +R L IV EY GSL Y++ P + + R + KG+
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-----ETLKGLA 115
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFL 833
YLH +H D+K N+L+ ++ VK+ DFG+S T KS GTP WMAPE
Sbjct: 116 YLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA 173
Query: 834 ---RGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVV---GAVAFQNRRLAIPQNTS 887
R + K D+++ G+ EL +Q P L P + + F +L + S
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWS 233
Query: 888 PVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
PV ++ C DP +RP + KLL+ P
Sbjct: 234 PVFHDFIKKCLTKDPKKRP-------TATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 9e-38
Identities = 82/269 (30%), Positives = 137/269 (50%), Gaps = 33/269 (12%)
Query: 665 ERVGAGSFGTVHRAEW---HGS--DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
+ +G G+FG+V + + G +VAVK L Q+ + KEFLRE ++M ++ HP +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLK-QEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRR-------LRMALDVAKGI 772
+G V K L +V E P G L + + ++RR +A VA G+
Sbjct: 60 RLIG-VCKGEPLMLVMELAPLGPLLKYL----------KKRREIPVSDLKELAHQVAMGM 108
Query: 773 NYLHNLNPPILHWDLKSPN-LLVDKNWTVKVCDFGLSRF--KANTFISSKSVAGTP-EWM 828
YL + + +H DL + N LLV+++ K+ DFG+SR + + + + P +W
Sbjct: 109 AYLESKH--FVHRDLAARNVLLVNRHQ-AKISDFGMSRALGAGSDYYRATTAGRWPLKWY 165
Query: 829 APEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTS 887
APE + + KSDV+S+GV LWE + +P+ + A+V+ + RL P+
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECP 224
Query: 888 PVLASLMESCWADDPAQRPSFANIVESLK 916
+ S+M SCW P RP+F+ + + +
Sbjct: 225 QEIYSIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 4e-37
Identities = 89/284 (31%), Positives = 136/284 (47%), Gaps = 25/284 (8%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAE-WHGSD------VAVKVLTVQDFLDDQLKEFLREV 707
+ D + +K +G G+FG V E +H VAVK L + +D K+F RE
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREA 59
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRR---- 761
++ +H N+V F G T+ +V EY+ G L + + H P A +
Sbjct: 60 ELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 762 -----LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTF 815
L++A+ +A G+ YL + + +H DL + N LV + VK+ DFG+SR +
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY 177
Query: 816 ISSKSVAGTP-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAV 873
P WM PE + +SDV+SFGV+LWE+ T +QPW GL +V+ +
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237
Query: 874 AFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKK 917
Q R L P+ + +M CW DP QR + +I E L+K
Sbjct: 238 T-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 76/265 (28%), Positives = 138/265 (52%), Gaps = 22/265 (8%)
Query: 663 VKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
+ E++G GS+G+V++A G VA+KV+ V ++ L+E ++E++I+K+ P +V
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV----EEDLQEIIKEISILKQCDSPYIVK 62
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
+ G+ K L IV EY GS+ ++ + + + + KG+ YLH+
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMK--ITNKTLTEEEIAAILYQTLKGLEYLHSNK- 119
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNE 840
+H D+K+ N+L+++ K+ DFG+S +T +V GTP WMAPE ++ N
Sbjct: 120 -KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178
Query: 841 KSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR---RLAIPQNTSPVLASLMESC 897
K+D++S G+ E+ + P++ + P + + N+ L+ P+ SP ++ C
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHPMRAI--FMIPNKPPPTLSDPEKWSPEFNDFVKKC 236
Query: 898 WADDPAQRPSFANIVESLKKLLKSP 922
DP +RP S +LL+ P
Sbjct: 237 LVKDPEERP-------SAIQLLQHP 254
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 6e-37
Identities = 79/277 (28%), Positives = 135/277 (48%), Gaps = 16/277 (5%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGS------DVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
EL + +G+G+FGTV++ W VA+KVL ++ KE L E +M V
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASV 66
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
HP+VV +G + + ++T+ +P G L + + + L + +AKG++
Sbjct: 67 DHPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMS 123
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAG-TP-EWMAPE 831
YL ++H DL + N+LV VK+ DFGL++ + G P +WMA E
Sbjct: 124 YLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181
Query: 832 FLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890
+ KSDV+S+GV +WEL+T +P+ G+ PA + + + RL P + +
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGERLPQPPICTIDV 240
Query: 891 ASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQ 927
++ CW D RP+F ++ K+ + P + +
Sbjct: 241 YMVLVKCWMIDAESRPTFKELINEFSKMARDPQRYLV 277
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 83/259 (32%), Positives = 136/259 (52%), Gaps = 11/259 (4%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
EL + +G+G FG VH +W VA+K + ++ +F+ E +M ++ HP +
Sbjct: 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKL 61
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
V G T++ L IVTE++ G L + R G++ + L M DV +G+ YL
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYL-RQRQGKL-SKDMLLSMCQDVCEGMEYLERN 119
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP-EWMAPEFLRGEP 837
+ +H DL + N LV VKV DFG++R+ + +S S A P +W PE
Sbjct: 120 S--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK 177
Query: 838 SNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMES 896
+ KSDV+SFGV++WE+ T + P+ +VV ++ + RL P+ S + +M S
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFRLYRPKLASMTVYEVMYS 236
Query: 897 CWADDPAQRPSFANIVESL 915
CW + P RP+FA ++ ++
Sbjct: 237 CWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 89/290 (30%), Positives = 149/290 (51%), Gaps = 24/290 (8%)
Query: 658 WDELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV- 713
W+++ ++ +G G+FG V RA + G + + +++F ++ ++F E+ ++ ++
Sbjct: 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG 60
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR-------PA------AGEMMDQRR 760
HPN++ +GA R +L I EY P G+L + + PA + ++
Sbjct: 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 761 RLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820
L+ A DVA G+ YL +H DL + N+LV +N K+ DFGLSR K+
Sbjct: 121 LLQFASDVATGMQYLSE--KQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKT 176
Query: 821 VAGTP-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQ-QPWNGLGPAQVVGAVAFQNR 878
+ P WMA E L KSDV+SFGV+LWE+V++ P+ G+ A++ + Q
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGY 235
Query: 879 RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQM 928
R+ P+N + LM CW D P +RP FA I L ++L++ + M
Sbjct: 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVNM 285
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 9e-36
Identities = 82/258 (31%), Positives = 134/258 (51%), Gaps = 18/258 (6%)
Query: 665 ERVGAGSFGTVHRAEWHGSD---VAVK-VLTVQDFLDDQ--LKEFLREVAIMKRVRHPNV 718
E +G+GSFG+V+ + D AVK V D Q +K+ +E+A++ +++HPN+
Sbjct: 6 ELLGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL--RMALDVAKGINYLH 776
V ++G + +L I E +P GSL +L+ + G + RL R L G+ YLH
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILL---GLEYLH 119
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGE 836
+ N +H D+K N+LVD N VK+ DFG+++ + F +KS G+P WMAPE + +
Sbjct: 120 DRN--TVHRDIKGANILVDTNGVVKLADFGMAK-QVVEFSFAKSFKGSPYWMAPEVIAQQ 176
Query: 837 -PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895
+D++S G + E+ T + PW+ L V + IP + S +
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFIL 236
Query: 896 SCWADDPAQRPSFANIVE 913
C DP+ RP+ A ++E
Sbjct: 237 KCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 89/273 (32%), Positives = 143/273 (52%), Gaps = 13/273 (4%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQ-DFLDDQLKEFLREVAIM 710
EI + ++ +GAG FG V R +VAV + T++ + + Q ++FL E +IM
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
+ H N++ G VTK I+TEY+ G+L + + R GE + + M +A
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYL-RDHDGE-FSSYQLVGMLRGIAA 118
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP---EW 827
G+ YL ++N +H DL + N+LV+ N KV DFGLSR + + + +G W
Sbjct: 119 GMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176
Query: 828 MAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNT 886
APE + SDV+SFG+++WE+++ ++P+ + +V+ A+ RL P +
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRLPAPMDC 235
Query: 887 SPVLASLMESCWADDPAQRPSFANIVESLKKLL 919
+ LM CW D A+RP F +IV L KLL
Sbjct: 236 PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 85/269 (31%), Positives = 145/269 (53%), Gaps = 15/269 (5%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
E+ + L + +++GAG FG V ++G + VA+K L + FL E +MK++
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQL 58
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
+HP +V VT+ P + I+TEY+ GSL + P G + + + MA +A+G+
Sbjct: 59 QHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMA 116
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP-EWMAPEF 832
++ N +H DL++ N+LV + K+ DFGL+R + +++ A P +W APE
Sbjct: 117 FIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 174
Query: 833 LRGEPSNEKSDVYSFGVILWELVTMQQ-PWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891
+ KSDV+SFG++L E+VT + P+ G+ +V+ + + R+ P N L
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELY 233
Query: 892 SLMESCWADDPAQRPSFANIVESLKKLLK 920
LM CW + P +RP+F E L+ +L+
Sbjct: 234 ELMRLCWKEKPEERPTF----EYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 82/255 (32%), Positives = 133/255 (52%), Gaps = 9/255 (3%)
Query: 665 ERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRVRHPNVVLFMG 723
ER+G G+FG V + V V + ++ L LK +FL+E I+K+ HPN+V +G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
T++ + IV E + G + G + + ++M + A G+ YL + + +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLR--TEGPRLKVKELIQMVENAAAGMEYLESKH--CI 116
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKAN-TFISSKSVAGTP-EWMAPEFLRGEPSNEK 841
H DL + N LV + +K+ DFG+SR + + + S+ + P +W APE L + +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 842 SDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD 900
SDV+SFG++LWE ++ P+ L Q A+ Q RL P+ + LME CW
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWEY 235
Query: 901 DPAQRPSFANIVESL 915
DP QRPSF+ + + L
Sbjct: 236 DPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 89/273 (32%), Positives = 138/273 (50%), Gaps = 31/273 (11%)
Query: 667 VGAGSFGTVHRAEWHGSD-----VAVKVLT-VQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
+G G FG V+ SD AVK L + D +++++FL+E IMK HPNV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL--EEVEQFLKEGIIMKDFSHPNVLS 60
Query: 721 FMGAVTKR---PHLSIVTEYLPRGSLYRLI----HRPAAGEMMDQRRRLRMALDVAKGIN 773
+G P +V Y+ G L I H P +++ L VAKG+
Sbjct: 61 LLGICLPSEGSPL--VVLPYMKHGDLRNFIRSETHNPTVKDLIG------FGLQVAKGME 112
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR---FKANTFISSKSVAGTP-EWMA 829
YL + +H DL + N ++D+++TVKV DFGL+R K + + + A P +WMA
Sbjct: 113 YL--ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 830 PEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888
E L+ + KSDV+SFGV+LWEL+T P+ + + + Q RRL P+
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-LQGRRLLQPEYCPD 229
Query: 889 VLASLMESCWADDPAQRPSFANIVESLKKLLKS 921
L +M SCW P RP+F+ +V ++++ +
Sbjct: 230 PLYEVMLSCWHPKPEMRPTFSELVSRIEQIFST 262
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 89/285 (31%), Positives = 147/285 (51%), Gaps = 26/285 (9%)
Query: 656 ISWDELHVKERVGAGSFGTVHRAEWHGS----DVAVKVLTVQDFLDDQLKEFLREVAIMK 711
+ W+++ ++ +G G+FG V +A D A+K + DD ++F E+ ++
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLC 62
Query: 712 RV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR-------PA------AGEMMD 757
++ HPN++ +GA R +L + EY P G+L + + PA +
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 758 QRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817
++ L A DVA+G++YL +H DL + N+LV +N+ K+ DFGLSR
Sbjct: 123 SQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYV 178
Query: 818 SKSVAGTP-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQ-QPWNGLGPAQVVGAVAF 875
K++ P WMA E L SDV+S+GV+LWE+V++ P+ G+ A++ +
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 237
Query: 876 QNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920
Q RL P N + LM CW + P +RPSFA I+ SL ++L+
Sbjct: 238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 78/260 (30%), Positives = 134/260 (51%), Gaps = 11/260 (4%)
Query: 663 VKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDF--LDDQLKEFL-REVAIMKRVRHPNVV 719
V E +G GSFGTV + SD + V D+ + ++ K+ L EV I++ ++HPN+V
Sbjct: 4 VLETIGKGSFGTVRKVR-RKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 720 LFMGAVTKRPH--LSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLRMALDVAKGINYLH 776
+ + R + L IV EY G L +LI + + +++ R+ + + H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 777 NLNPP---ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFL 833
N + P +LH DLK N+ +D N VK+ DFGL++ + +K+ GTP +M+PE L
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL 182
Query: 834 RGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893
+EKSD++S G +++EL + P+ Q+ + + + IP S L +
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIPYRYSSELNEV 241
Query: 894 MESCWADDPAQRPSFANIVE 913
++S DP +RPS +++
Sbjct: 242 IKSMLNVDPDKRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 8e-35
Identities = 88/260 (33%), Positives = 141/260 (54%), Gaps = 11/260 (4%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
EI + L + ++G G FG V W+G+ VA+K L + + FL+E IMK++
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKKL 58
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
RH +V V++ P + IVTE++ +GSL + + G+ + + + MA +A G+
Sbjct: 59 RHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMA 116
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP-EWMAPEF 832
Y+ +N +H DL++ N+LV N K+ DFGL+R + +++ A P +W APE
Sbjct: 117 YIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 833 LRGEPSNEKSDVYSFGVILWELVTMQQ-PWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891
KSDV+SFG++L ELVT + P+ G+ +V+ V + R+ PQ L
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLH 233
Query: 892 SLMESCWADDPAQRPSFANI 911
LM+ CW DP +RP+F I
Sbjct: 234 ELMKLCWKKDPDERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 8e-35
Identities = 69/249 (27%), Positives = 131/249 (52%), Gaps = 6/249 (2%)
Query: 667 VGAGSFG--TVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
+G G+FG T++R S V K + + + + ++ L E+ I+ ++HPN++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
L I EY G+LY I R G++ ++ L + ++Y+H ILH
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILH 124
Query: 785 WDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDV 844
D+K+ N+ + K +K+ DFG+S+ + + +++V GTP +M+PE +G N KSD+
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDI 184
Query: 845 YSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQ 904
++ G +L+EL+T+++ ++ P +V + Q + S L SL+ S DP +
Sbjct: 185 WALGCVLYELLTLKRTFDATNPLNLVVKI-VQGNYTPVVSVYSSELISLVHSLLQQDPEK 243
Query: 905 RPSFANIVE 913
RP+ +++
Sbjct: 244 RPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 82/270 (30%), Positives = 136/270 (50%), Gaps = 20/270 (7%)
Query: 667 VGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF 721
+G G FG+V A+ D VAVK+L F ++EFLRE A MK HPNV+
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 722 MGAVTKR------PHLSIVTEYLPRGSLYRLIHRPAAGE---MMDQRRRLRMALDVAKGI 772
+G + P ++ ++ G L+ + GE + + +R +D+A G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAGTP-EWMAP 830
YL + N +H DL + N ++++N TV V DFGLS+ + + + P +W+A
Sbjct: 127 EYLSSKN--FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLAL 184
Query: 831 EFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPV 889
E L SDV++FGV +WE++T Q P+ G+ +++ + N RL P +
Sbjct: 185 ESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RLKQPPDCLED 243
Query: 890 LASLMESCWADDPAQRPSFANIVESLKKLL 919
+ LM CW+ +P RPSF ++ + L+ +
Sbjct: 244 VYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 84/263 (31%), Positives = 138/263 (52%), Gaps = 11/263 (4%)
Query: 656 ISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
I EL + + +G+G FG V W VA+K + + + ++ +F+ E +M ++
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEE--DFIEEAQVMMKLS 57
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
HP +V G T+R + +V E++ G L + R G Q L M LDV +G+ Y
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL-RAQRG-KFSQETLLGMCLDVCEGMAY 115
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP-EWMAPEFL 833
L + N ++H DL + N LV +N VKV DFG++RF + +S + P +W +PE
Sbjct: 116 LESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVF 173
Query: 834 RGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892
+ KSDV+SFGV++WE+ + + P+ ++VV + RL P+ S +
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-AGFRLYKPRLASQSVYE 232
Query: 893 LMESCWADDPAQRPSFANIVESL 915
LM+ CW + P RPSF+ ++ L
Sbjct: 233 LMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 78/257 (30%), Positives = 141/257 (54%), Gaps = 10/257 (3%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
EI + + + +++GAG FG V ++ S VAVK L ++ FL E +MK +
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTL 58
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
+H +V VTK + I+TEY+ +GSL + G+++ + + + +A+G+
Sbjct: 59 QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMA 117
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP-EWMAPEF 832
Y+ N +H DL++ N+LV ++ K+ DFGL+R + +++ A P +W APE
Sbjct: 118 YIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 175
Query: 833 LRGEPSNEKSDVYSFGVILWELVTMQQ-PWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891
+ KSDV+SFG++L+E+VT + P+ G+ + V+ A+ + R+ +N L
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRMPRMENCPDELY 234
Query: 892 SLMESCWADDPAQRPSF 908
+M++CW + +RP+F
Sbjct: 235 DIMKTCWKEKAEERPTF 251
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 88/265 (33%), Positives = 136/265 (51%), Gaps = 16/265 (6%)
Query: 665 ERV-GAGSFGTV--HRAEWHGSD---VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
E+V GAG FG V R + G VA+K L + + Q ++FL E +IM + HPN+
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
+ G VTK + IVTEY+ GSL + + + Q + M +A G+ YL ++
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQ--LVGMLRGIASGMKYLSDM 125
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP---EWMAPEFLRG 835
+H DL + N+LV+ N KV DFGLSR + ++ + G W APE +
Sbjct: 126 G--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183
Query: 836 EPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894
SDV+S+G+++WE+++ ++P+ + V+ A+ + RL P + L LM
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLPAPMDCPAALHQLM 242
Query: 895 ESCWADDPAQRPSFANIVESLKKLL 919
CW D +RP F IV L KL+
Sbjct: 243 LDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 90/290 (31%), Positives = 149/290 (51%), Gaps = 33/290 (11%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAE-------WHGSDVAVKVLTVQDFLDDQLKEFLREV 707
EI + E +G G+FG V++ E + VA+K L ++ +EF +E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEA 59
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRP-----------AAGE 754
+M ++HPN+V +G TK ++ EYL G L + + + P
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 755 MMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR--FKA 812
+D L +A+ +A G+ YL + + +H DL + N LV + TVK+ DFGLSR + A
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177
Query: 813 NTF-ISSKSVAGTPEWMAPE-FLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQV 869
+ + + SKS+ WM PE L G+ + E SD++SFGV+LWE+ + QP+ G +V
Sbjct: 178 DYYRVQSKSLLPV-RWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235
Query: 870 VGAVAFQNRR-LAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKL 918
+ + ++R+ L P++ + +LM CW + PA+RP F +I L+
Sbjct: 236 IEMI--RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 78/269 (28%), Positives = 133/269 (49%), Gaps = 34/269 (12%)
Query: 665 ERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
E +G GSFG V++A ++ VA+KV+ +++ +D++++ +E+ + + R P + +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
G+ K L I+ EY GS L+ +P +D+ + +V G+ YLH
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLL-KPGK---LDETYIAFILREVLLGLEYLHEEGK-- 119
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKS 842
+H D+K+ N+L+ + VK+ DFG+S +T + GTP WMAPE ++ +EK+
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKA 179
Query: 843 DVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA---------SL 893
D++S G+ EL + P + L P +V+ IP+N P L
Sbjct: 180 DIWSLGITAIELAKGEPPLSDLHPMRVL---------FLIPKNNPPSLEGNKFSKPFKDF 230
Query: 894 MESCWADDPAQRPSFANIVESLKKLLKSP 922
+ C DP +RP S K+LLK
Sbjct: 231 VSLCLNKDPKERP-------SAKELLKHK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 91/269 (33%), Positives = 134/269 (49%), Gaps = 24/269 (8%)
Query: 667 VGAGSFGTVHRAE-----WHGSD---VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
+G+G+FG V+ GS VAVK L + D + KEFL+E +M HPN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR-KGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAA----GEMMDQRRRLRMALDVAKGINY 774
V +G I+ E + G L + ++ + L + LDVAKG Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 775 LHNLNPPILHWDLKSPNLLV-----DKNWTVKVCDFGLSR-FKANTFISSKSVAGTP-EW 827
L ++ +H DL + N LV D + VK+ DFGL+R + + + P W
Sbjct: 122 LEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 828 MAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNT 886
MAPE L +SDV+SFGV++WE++T+ QQP+ L +V+ V RL P+N
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQKPENC 238
Query: 887 SPVLASLMESCWADDPAQRPSFANIVESL 915
+ LM +CWA DP++RP+F I E L
Sbjct: 239 PDKIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 83/255 (32%), Positives = 137/255 (53%), Gaps = 11/255 (4%)
Query: 665 ERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRVRHPNVVLFM 722
E +G G+FG V + + VAVK T ++ L +LK +FL E I+K+ HPN+V +
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVK--TCKEDLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
G T+R + IV E +P G + + + + ++ ++ ALD A G+ YL + N
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN--C 114
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP-EWMAPEFLRGEPSNEK 841
+H DL + N LV +N +K+ DFG+SR + + SS + P +W APE L + +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 842 SDVYSFGVILWELVTMQQ-PWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD 900
SDV+S+G++LWE ++ P+ G+ Q V + R++ PQ + +M+ CW
Sbjct: 175 SDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDY 233
Query: 901 DPAQRPSFANIVESL 915
P RP F+ + + L
Sbjct: 234 KPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 79/270 (29%), Positives = 132/270 (48%), Gaps = 27/270 (10%)
Query: 663 VKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
V +++G GS+G+V++ + SD A+K + + + ++ + E+ I+ V HPN++
Sbjct: 4 VLKKLGKGSYGSVYKVK-RLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII 62
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL------RMALDVAKGIN 773
+ A L IV EY P G L + I + +R+ + R+ + + +G+
Sbjct: 63 SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKK-----KRKLIPEQEIWRIFIQLLRGLQ 117
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFL 833
LH ILH DLKS N+L+ N VK+ D G+S+ +K+ GTP +MAPE
Sbjct: 118 ALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM--AKTQIGTPHYMAPEVW 173
Query: 834 RGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893
+G P + KSD++S G +L+E+ T P+ + V + + IP S L +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPIYSQDLQNF 232
Query: 894 MESCWADDPAQRPSFANIVESLKKLLKSPA 923
+ S P RP + K+L SPA
Sbjct: 233 IRSMLQVKPKLRP-------NCDKILASPA 255
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 1e-33
Identities = 88/280 (31%), Positives = 137/280 (48%), Gaps = 33/280 (11%)
Query: 667 VGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
+G G+FG V +A G + VAVK+L ++ D +F RE A+M HPN+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK-EEASADMQADFQREAALMAEFDHPNIV 71
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSL------------YRLIHRPAAGEMMDQRR------- 760
+G + ++ EY+ G L L H ++
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 761 RLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR--FKANTFISS 818
+L +A VA G+ YL +H DL + N LV +N VK+ DFGLSR + A+ + +S
Sbjct: 132 QLCIAKQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 819 KSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQN 877
++ A WM PE + +SDV+++GV+LWE+ + QP+ G+ +V+ V N
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN 249
Query: 878 RRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKK 917
L+ P N L +LM CW+ P+ RPSFA+I L++
Sbjct: 250 V-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 1e-33
Identities = 85/257 (33%), Positives = 138/257 (53%), Gaps = 11/257 (4%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
EI + L ++ ++G G FG V W+G+ VA+K L + FL+E +MK++
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKL 58
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
RH +V V++ P + IVTEY+ +GSL + + G+ + + + MA +A G+
Sbjct: 59 RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP-EWMAPEF 832
Y+ +N +H DL++ N+LV +N KV DFGL+R + +++ A P +W APE
Sbjct: 117 YVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 833 LRGEPSNEKSDVYSFGVILWELVTMQQ-PWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891
KSDV+SFG++L EL T + P+ G+ +V+ V + R+ P L
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLH 233
Query: 892 SLMESCWADDPAQRPSF 908
LM CW +P +RP+F
Sbjct: 234 DLMCQCWRKEPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 77/253 (30%), Positives = 132/253 (52%), Gaps = 18/253 (7%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
+G G+FG V+ A G +AVK + +QD +KE E+ +++ ++HPN+V + G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
R + I EY G+L L+ G ++D+ L + +G+ YLH+ I+H
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG--IVH 122
Query: 785 WDLKSPNLLVDKNWTVKVCDFGLS-RFKANT---FISSKSVAGTPEWMAPEFLRGEPSNE 840
D+K N+ +D N +K+ DFG + + K NT +S+AGTP +MAPE + G
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 841 K---SDVYSFGVILWELVTMQQPWNGLGPA-QVVGAVAFQNRRLAIPQNT--SPVLASLM 894
+D++S G ++ E+ T ++PW+ L Q++ V ++ IP + SP +
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP-PIPDSLQLSPEGKDFL 241
Query: 895 ESCWADDPAQRPS 907
+ C DP +RP+
Sbjct: 242 DRCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 88/274 (32%), Positives = 141/274 (51%), Gaps = 26/274 (9%)
Query: 667 VGAGSFGTVHRA----EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLF 721
+G G+FG V +A + D A+K + DD ++F E+ ++ ++ HPN++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNIINL 61
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHR-------PA------AGEMMDQRRRLRMALDV 768
+GA R +L + EY P G+L + + PA + ++ L A DV
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP-EW 827
A+G++YL +H DL + N+LV +N+ K+ DFGLSR K++ P W
Sbjct: 122 ARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRW 177
Query: 828 MAPEFLRGEPSNEKSDVYSFGVILWELVTMQ-QPWNGLGPAQVVGAVAFQNRRLAIPQNT 886
MA E L SDV+S+GV+LWE+V++ P+ G+ A++ + Q RL P N
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNC 236
Query: 887 SPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920
+ LM CW + P +RPSFA I+ SL ++L+
Sbjct: 237 DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 3e-33
Identities = 85/284 (29%), Positives = 149/284 (52%), Gaps = 35/284 (12%)
Query: 667 VGAGSFGTVHRA---EWHG----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
+G G FG V +A G + VAVK+L ++ +L++ L E ++K+V HP+V+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLI---------------HRPAAGEMMDQRRRLRM 764
GA ++ L ++ EY GSL + +R ++ R L M
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 765 ------ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR--FKANTFI 816
A +++G+ YL + ++H DL + N+LV + +K+ DFGLSR ++ ++++
Sbjct: 127 GDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAF 875
+WMA E L +SDV+SFGV+LWE+VT+ P+ G+ P ++ +
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLK- 243
Query: 876 QNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLL 919
R+ P+N S + +LM +CW +P +RP+FA+I + L+K++
Sbjct: 244 TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 70/269 (26%), Positives = 134/269 (49%), Gaps = 19/269 (7%)
Query: 660 ELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
+ + ++G GSFG V + + A+K + + + +E + E ++ ++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
++ + + + L+IV EY G L++L+ G + + + R + + G+ +LH+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKM-QRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEP 837
ILH D+KS NL +D VK+ D G+++ ++ + ++ GTP +++PE +P
Sbjct: 120 --KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP 177
Query: 838 SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVA---FQNRRLAIPQNTSPVLASLM 894
NEKSDV++ GV+L+E T + P++ A GA+ + + Q S LA L+
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFD----ANNQGALILKIIRGVFPPVSQMYSQQLAQLI 233
Query: 895 ESCWADDPAQRPSFANIVESLKKLLKSPA 923
+ C D QRP +LL++P+
Sbjct: 234 DQCLTKDYRQRPDTF-------QLLRNPS 255
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 93/294 (31%), Positives = 144/294 (48%), Gaps = 41/294 (13%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD------------------VAVKVLTVQDFL 696
E L KE++G G FG VH E G + VAVK+L +D
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLR-EDAN 59
Query: 697 DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR---PAAG 753
+ +FL+E+ IM R++ PN++ + L ++TEY+ G L + + R A
Sbjct: 60 KNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA 119
Query: 754 EMMDQR-----RRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
E D + MA +A G+ YL +LN +H DL + N LV KN+T+K+ DFG+S
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 809 R--FKANTF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM--QQPWNG 863
R + + + I ++V WM+ E + SDV++FGV LWE++T+ +QP++
Sbjct: 178 RNLYSGDYYRIQGRAVLPI-RWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236
Query: 864 LGPAQVVGAVAF----QNRRLAIPQNT--SPVLASLMESCWADDPAQRPSFANI 911
L QV+ Q R++ +P+ L LM SCW + +RPSF I
Sbjct: 237 LSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 92/302 (30%), Positives = 149/302 (49%), Gaps = 33/302 (10%)
Query: 639 GPRYLNIEPS-LAMD--WLEISWDELHVKERVGAGSFGTVHRAEWHG---SD----VAVK 688
G Y+ I+P+ L D W E + L + +GAG+FG V A +G SD VAVK
Sbjct: 13 GNEYVYIDPTQLPYDLKW-EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVK 71
Query: 689 VLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI 747
+L ++ + + E+ IM + H N+V +GA T + ++TEY G L +
Sbjct: 72 MLKPTAHSSER-EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL 130
Query: 748 HRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807
R + L + VAKG+ +L + N +H DL + N+L+ VK+CDFGL
Sbjct: 131 RRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFGL 187
Query: 808 SR---------FKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM- 857
+R K N + K WMAPE + +SDV+S+G++LWE+ ++
Sbjct: 188 ARDIMNDSNYVVKGNARLPVK-------WMAPESIFNCVYTFESDVWSYGILLWEIFSLG 240
Query: 858 QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKK 917
P+ G+ + + R+A P++ + +M++CW DP +RP+F IV+ + K
Sbjct: 241 SNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300
Query: 918 LL 919
L
Sbjct: 301 QL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 92/291 (31%), Positives = 148/291 (50%), Gaps = 30/291 (10%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
E+ D L + + +G G FG V AE G D VAVK+L D + L + +
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLK-SDATEKDLSDLIS 72
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
E+ +MK + +H N++ +GA T+ L ++ EY +G+L Y RP
Sbjct: 73 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132
Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811
E + + + A VA+G+ YL + +H DL + N+LV ++ +K+ DFGL+R
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 812 ANTFISSKSVAG--TPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQ 868
+ K+ G +WMAPE L +SDV+SFGV+LWE+ T+ P+ G+ P +
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVE 249
Query: 869 VVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLL 919
+ + + R+ P N + L +M CW P+QRP+F +VE L ++L
Sbjct: 250 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 93/291 (31%), Positives = 147/291 (50%), Gaps = 30/291 (10%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
E S D+L + + +G G FG V AE G D VAVK+L D + L + +
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVS 69
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRP-----------A 751
E+ +MK + +H N++ +GA T+ L ++ EY +G+L Y RP
Sbjct: 70 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129
Query: 752 AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811
E M + + VA+G+ YL + +H DL + N+LV +N +K+ DFGL+R
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 812 ANTFISSKSVAG--TPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQ 868
N K+ G +WMAPE L +SDV+SFGV++WE+ T+ P+ G+ P +
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVE 246
Query: 869 VVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLL 919
+ + + R+ P N + L +M CW P+ RP+F +VE L ++L
Sbjct: 247 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 78/267 (29%), Positives = 129/267 (48%), Gaps = 20/267 (7%)
Query: 667 VGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
+G G FG V A+ G + V VK L ++ EF RE+ + +++ H NVV
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVV 71
Query: 720 LFMGAV-TKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQ----RRRLRMALDVAKGI 772
+G PH ++ EY G L + + ++ ++++ + +A G+
Sbjct: 72 RLLGLCREAEPHY-MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP-EWMAPE 831
++L N +H DL + N LV VKV LS+ N+ A P W+APE
Sbjct: 131 DHLSNAR--FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 832 FLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890
++ + + KSDV+SFGV++WE+ T + P+ GL +V+ + L +P+ L
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRL 248
Query: 891 ASLMESCWADDPAQRPSFANIVESLKK 917
LM CWA +P RPSF+ +V +L +
Sbjct: 249 YKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 77/251 (30%), Positives = 124/251 (49%), Gaps = 17/251 (6%)
Query: 667 VGAGSFGTV---HRAEWHGSDVAVK-VLTVQD--FLDDQLKEFLREVAIMKRVRHPNVVL 720
+G G+FG V + + G ++AVK V D ++ E+ ++K ++H +V
Sbjct: 10 LGQGAFGRVYLCYDVD-TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
+ G + LSI EY+P GS+ + A R+ R L+ G+ YLH+
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE---GVEYLHSNM- 124
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS----KSVAGTPEWMAPEFLRGE 836
I+H D+K N+L D VK+ DFG S+ + T SS KSV GTP WM+PE + GE
Sbjct: 125 -IVHRDIKGANILRDSAGNVKLGDFGASK-RLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 837 PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMES 896
K+DV+S G + E++T + PW + +A Q +P + SP + +
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRR 242
Query: 897 CWADDPAQRPS 907
+ ++ +RPS
Sbjct: 243 TFVENAKKRPS 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 58/205 (28%), Positives = 116/205 (56%), Gaps = 6/205 (2%)
Query: 663 VKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKE-FLREVAIMKRVRHPNVV 719
+++++G G F V++A G VA+K + + + +D + ++ L+E+ ++K++ HPNV+
Sbjct: 6 IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVI 65
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
++ + + L+IV E G L R+I H ++ +R + + + + ++H+
Sbjct: 66 KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK 125
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPS 838
I+H D+K N+ + VK+ D GL RF ++ ++ S+ GTP +M+PE +
Sbjct: 126 R--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 839 NEKSDVYSFGVILWELVTMQQPWNG 863
N KSD++S G +L+E+ +Q P+ G
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 81/279 (29%), Positives = 138/279 (49%), Gaps = 23/279 (8%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDD-QLKEFLREVA 708
+ IS D + + + + G+FG + G + V V TV+D + Q+ L+E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 709 IMKRVRHPNVVLFMGAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEM-----MDQRRRL 762
++ + H N++ + + V Y+ G+L + + GE + ++ +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 763 RMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
MA+ +A G++YLH ++H D+ + N ++D+ VK+ D LSR + F
Sbjct: 121 HMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSR---DLFPMDYHCL 175
Query: 823 GTPE-----WMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQ 876
G E WMA E L + + SDV+SFGV+LWEL+T+ Q P+ + P ++ +
Sbjct: 176 GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-D 234
Query: 877 NRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESL 915
RLA P N L ++M CWA DP +RPSF+ +V+ L
Sbjct: 235 GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 74/263 (28%), Positives = 127/263 (48%), Gaps = 26/263 (9%)
Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDF-LDDQLKEFLREVAIMKRVRHPNVVLFMG 723
+ G++G V A+ G A+KV+ D +Q+ + L E I+ + + P VV
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
+ + +L +V EYLP G L L+ G + + R+ +A ++ + YLH+ I+
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLEN--VGSLDEDVARIYIA-EIVLALEYLHSNG--II 115
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--------KANTFISSKSVAGTPEWMAPEFLRG 835
H DLK N+L+D N +K+ DFGLS+ + K + GTP+++APE + G
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 836 EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN---RRLAIPQ--NTSPVL 890
+ ++ D +S G IL+E + P++G P ++ FQN ++ P+ S
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-----FQNILNGKIEWPEDVEVSDEA 230
Query: 891 ASLMESCWADDPAQRPSFANIVE 913
L+ DP +R +I E
Sbjct: 231 IDLISKLLVPDPEKRLGAKSIEE 253
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 79/254 (31%), Positives = 133/254 (52%), Gaps = 18/254 (7%)
Query: 667 VGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
VG G+FG VH R + V +K + V+ D+ E ++K + HPN++ +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
+ L IV EY P G+L I + ++D+ L + + ++++H ILH
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLDEDTILHFFVQILLALHHVHTKL--ILH 124
Query: 785 WDLKSPNLLVDKNWTV-KVCDFGLSRFKANTFISSKS----VAGTPEWMAPEFLRGEPSN 839
DLK+ N+L+DK+ V K+ DFG+S+ +SSKS V GTP +++PE G+P N
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKI-----LSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 840 EKSDVYSFGVILWELVTMQQPWNGLG-PAQVVGAVAFQNRRLAIPQNTSPVLASLMESCW 898
+KSD+++ G +L+EL ++++ + PA V+ + I SP L L+ S
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEAANLPALVLKIM--SGTFAPISDRYSPDLRQLILSML 237
Query: 899 ADDPAQRPSFANIV 912
DP++RP + I+
Sbjct: 238 NLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 93/296 (31%), Positives = 142/296 (47%), Gaps = 38/296 (12%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD----------------VAVKVLTVQDFLDD 698
E +L +KE++G G FG VH E G VAVK+L D
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLR-ADVTKT 59
Query: 699 QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYR-LIHRPAAGEM-- 755
+FL+E+ IM R+++PN++ +G L ++TEY+ G L + L R
Sbjct: 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119
Query: 756 ------MDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
+ L MA+ +A G+ YL +LN +H DL + N LV ++T+K+ DFG+SR
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 810 -FKANTFISSKSVAGTP-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM--QQPWNGLG 865
+ + + A P WMA E + SDV++FGV LWE+ T+ +QP++ L
Sbjct: 178 NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237
Query: 866 PAQVVGAVA--FQNRRLAIPQNTSPVLAS----LMESCWADDPAQRPSFANIVESL 915
QV+ F+N+ I + +P+ S LM CW+ D RP+F I L
Sbjct: 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 5e-32
Identities = 93/291 (31%), Positives = 147/291 (50%), Gaps = 38/291 (13%)
Query: 658 WDELHVK--ERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVAI 709
++E H+K +++G G+FG+V + G VAVK L Q + L++F RE+ I
Sbjct: 1 FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKL--QHSTAEHLRDFEREIEI 58
Query: 710 MKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRMA 765
+K ++H N+V + G R +L +V EYLP GSL Y HR E +D R+ L A
Sbjct: 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYA 114
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF--KANTFISSKSVAG 823
+ KG+ YL + +H DL + N+LV+ VK+ DFGL++ + + +
Sbjct: 115 SQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGE 172
Query: 824 TPE-WMAPEFLRGEPSNEKSDVYSFGVILWELVT------------MQQPWNGLGPAQVV 870
+P W APE L + SDV+SFGV+L+EL T M+ N +V
Sbjct: 173 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIV 232
Query: 871 GAVA---FQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKL 918
+ N RL P + ++M+ CW +DP+QRPSF+ + ++ +
Sbjct: 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 89/280 (31%), Positives = 146/280 (52%), Gaps = 21/280 (7%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREV 707
E++ +++ + +G GSFG V+ G + VA+K + + +++ EFL E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEA 60
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH--RPAAGEMMDQ-----RR 760
++MK +VV +G V++ ++ E + RG L + RP Q ++
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 761 RLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820
++MA ++A G+ YL N N +H DL + N +V +++TVK+ DFG++R T K
Sbjct: 121 MIQMAGEIADGMAYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 821 VAG--TPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQN 877
G WM+PE L+ SDV+SFGV+LWE+ T+ +QP+ G+ QV+ V +
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV-MEG 237
Query: 878 RRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKK 917
L P N +L LM CW +P RPSF I+ S+K+
Sbjct: 238 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 86/271 (31%), Positives = 142/271 (52%), Gaps = 28/271 (10%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVL---TVQDFLDDQLKEFL----REVAIMKRVRHPN 717
+G+GSFG+V+ G +AVK + +V D+ + L RE+A++K ++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
+V ++G+ HL+I EY+P GS+ L++ A E R +R L KG+NYLHN
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL---KGLNYLHN 124
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSK-----SVAGTPEWMAPE 831
I+H D+K N+LVD +K+ DFG+S + +AN+ + S+ G+ WMAPE
Sbjct: 125 RG--IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 832 FLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891
++ K+D++S G ++ E++T + P+ Q + + +N IP N S
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNISSEAI 241
Query: 892 SLMESCWADDPAQRPSFANIVESLKKLLKSP 922
+E + D +RP+ A +LLK P
Sbjct: 242 DFLEKTFEIDHNKRPTAA-------ELLKHP 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 92/289 (31%), Positives = 141/289 (48%), Gaps = 25/289 (8%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
E+S +++ + +G GSFG V+ E + D VAVK + L +++ EFL
Sbjct: 2 EVSREKITLLRELGQGSFGMVY--EGNARDIIKGEAETRVAVKTVNESASLRERI-EFLN 58
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH--RPAAGEMMDQ----- 758
E ++MK +VV +G V+K +V E + G L + RP A +
Sbjct: 59 EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 118
Query: 759 RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS 818
+ ++MA ++A G+ YL+ +H DL + N +V ++TVK+ DFG++R T
Sbjct: 119 QEMIQMAAEIADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR 176
Query: 819 KSVAG--TPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAF 875
K G WMAPE L+ SD++SFGV+LWE+ ++ +QP+ GL QV+ V
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV-M 235
Query: 876 QNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQ 924
L P N + LM CW +P RP+F IV LK L
Sbjct: 236 DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 92/296 (31%), Positives = 150/296 (50%), Gaps = 31/296 (10%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKE 702
W E D L + + +G G FG V RAE +G D VAVK+L + D L +
Sbjct: 6 KW-EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK-DNATDKDLAD 63
Query: 703 FLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRP--------- 750
+ E+ +MK + +H N++ +G T+ L ++ EY +G+L + RP
Sbjct: 64 LISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDI 123
Query: 751 --AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
E + + + A VA+G+ YL + +H DL + N+LV ++ +K+ DFGL+
Sbjct: 124 TKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 809 RFKANTFISSKSVAG--TPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLG 865
R + K+ G +WMAPE L +SDV+SFG+++WE+ T+ P+ G+
Sbjct: 182 RGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI- 240
Query: 866 PAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921
P + + + + R+ P N + L LM CW P QRP+F +VE+L K+L +
Sbjct: 241 PVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 72/256 (28%), Positives = 132/256 (51%), Gaps = 27/256 (10%)
Query: 665 ERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH---PNV 718
E +G G++G V+R H G VA+K++ + D DD + + REVA++ ++R PN+
Sbjct: 7 ELIGRGAYGAVYRG-KHVPTGRVVALKIINL-DTPDDDVSDIQREVALLSQLRQSQPPNI 64
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRL-----IHRPAAGEMMDQRRRLRMALDVAKGIN 773
+ G+ K P L I+ EY GS+ L I ++ R + +AL
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVII---REVLVAL------K 115
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFL 833
Y+H + ++H D+K+ N+LV VK+CDFG++ + GTP WMAPE +
Sbjct: 116 YIHKV--GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVI 173
Query: 834 R-GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNT-SPVLA 891
G+ + K+D++S G+ ++E+ T P++ + + + + +++ + N S +L
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP-KSKPPRLEDNGYSKLLR 232
Query: 892 SLMESCWADDPAQRPS 907
+ +C ++P +R S
Sbjct: 233 EFVAACLDEEPKERLS 248
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 4e-31
Identities = 83/277 (29%), Positives = 135/277 (48%), Gaps = 30/277 (10%)
Query: 662 HVKER-------VGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKEFLREVAI 709
H+K R +G G+FG V AE H + V V +++ + ++F RE +
Sbjct: 1 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 60
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAA-----GEM-----MD 757
+ ++H ++V F G T+ L +V EY+ G L R + H P A GE +
Sbjct: 61 LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLT 120
Query: 758 QRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR--FKANTF 815
+ L +A +A G+ YL +L+ +H DL + N LV + VK+ DFG+SR + + +
Sbjct: 121 LGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 178
Query: 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVA 874
WM PE + +SD++SFGV+LWE+ T +QPW L + + +
Sbjct: 179 RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238
Query: 875 FQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANI 911
Q R L P+ P + ++M+ CW +P QR +I
Sbjct: 239 -QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 72/267 (26%), Positives = 127/267 (47%), Gaps = 23/267 (8%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLR--------EVAIMKRVR 714
E +G G++G V+ A G +AVK + + + + + E+ +K +
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
H N+V ++G T +LSI EY+P GS+ + E R L +G+ Y
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL---EGLAY 123
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK--SVAGTPEWMAPEF 832
LH+ ILH DLK+ NLLVD + K+ DFG+S+ + + + + S+ G+ WMAPE
Sbjct: 124 LHSKG--ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 833 --LRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQ----NT 886
+ + K D++S G ++ E+ ++PW+ + + + IP N
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241
Query: 887 SPVLASLMESCWADDPAQRPSFANIVE 913
SPV + +C+ +P RP+ +++
Sbjct: 242 SPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 6e-31
Identities = 94/291 (32%), Positives = 148/291 (50%), Gaps = 30/291 (10%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
E+S L + + +G G FG V AE G D VAVK+L D D L + +
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLK-DDATDKDLSDLVS 66
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAA---------- 752
E+ +MK + +H N++ +GA T+ L ++ EY +G+L Y RP
Sbjct: 67 EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811
E + + + A VA+G+ YL + +H DL + N+LV ++ +K+ DFGL+R
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184
Query: 812 ANTFISSKSVAG--TPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQ 868
N K+ G +WMAPE L +SDV+SFGV+LWE+ T+ P+ G+ P +
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVE 243
Query: 869 VVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLL 919
+ + + R+ P N + L +M CW P+QRP+F +VE L ++L
Sbjct: 244 ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 92/299 (30%), Positives = 135/299 (45%), Gaps = 55/299 (18%)
Query: 661 LHVKERVGAGSFGTVHRAE------------------WHGSDVAVKVLTVQDFLDDQLKE 702
L KE++G G FG VH E VAVK+L D + +
Sbjct: 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILR-PDANKNARND 65
Query: 703 FLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL------YRLIHRPAAGEMM 756
FL+EV I+ R++ PN++ +G L ++TEY+ G L + L + G
Sbjct: 66 FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125
Query: 757 DQRRR----------LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806
L +AL +A G+ YL +LN +H DL + N LV +N T+K+ DFG
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENLTIKIADFG 183
Query: 807 LSR-FKANTFISSKSVAGTP-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM--QQPWN 862
+SR A + + A P WMA E + SDV++FGV LWE++ + +QP+
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243
Query: 863 GLGPAQVV----------GAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANI 911
L QV+ G + R PQ L LM CW+ D +RPSF++I
Sbjct: 244 ELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQG----LYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 8e-31
Identities = 84/287 (29%), Positives = 146/287 (50%), Gaps = 31/287 (10%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEW------HGSDVAVKVLTVQDFLDDQ-LKEFLREV 707
E+ + E +G +FG +++ H VA+K T++D + Q EF +E
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIK--TLKDINNPQQWGEFQQEA 58
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYR-LIHRPAAGEM----------- 755
++M + HPN+V +G VT+ + ++ EYL +G L+ LI R ++
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 756 --MDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR--FK 811
+D L +A+ +A G+ YL + +H DL + N+L+ + VK+ D GLSR +
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLS--SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176
Query: 812 ANTF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQ-QPWNGLGPAQV 869
A+ + + KS+ WM PE + + SD++SFGV+LWE+ + QP+ G +V
Sbjct: 177 ADYYRVQPKSLLPI-RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235
Query: 870 VGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916
+ V + + L ++ P + SLM CW + P++RP F +I L+
Sbjct: 236 IEMVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 9e-31
Identities = 88/282 (31%), Positives = 137/282 (48%), Gaps = 22/282 (7%)
Query: 663 VKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
+K +G G+FG V AE + + V V T++D D+ K+F RE ++ ++H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEM--------MDQRRRLRMALD 767
+V F G + L +V EY+ G L + + H P A M + Q + L +A
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR--FKANTFISSKSVAGTP 825
+A G+ YL + + +H DL + N LV +N VK+ DFG+SR + + +
Sbjct: 129 IAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 826 EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQ 884
WM PE + +SDV+S GV+LWE+ T +QPW L +V+ + Q R L P+
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-QGRVLQRPR 245
Query: 885 NTSPVLASLMESCWADDPAQRPSFANIVESLKKLLK-SPAQL 925
+ LM CW +P R + I L+ L K SP L
Sbjct: 246 TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPVYL 287
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 73/255 (28%), Positives = 136/255 (53%), Gaps = 7/255 (2%)
Query: 662 HVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
+ +++G GSFG ++ +A+ +K + + + + +EV ++ +++HPN+V
Sbjct: 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIV 62
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
F + + L IV EY G L + I+R G + + + L + ++ G+ ++H+
Sbjct: 63 TFFASFQENGRLFIVMEYCDGGDLMKRINR-QRGVLFSEDQILSWFVQISLGLKHIHDRK 121
Query: 780 PPILHWDLKSPNLLVDKNWTV-KVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPS 838
ILH D+KS N+ + KN V K+ DFG++R ++ + + GTP +++PE + P
Sbjct: 122 --ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPY 179
Query: 839 NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCW 898
N K+D++S G +L+EL T++ P+ G Q+V + Q I N S L SL+ +
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC-QGYFAPISPNFSRDLRSLISQLF 238
Query: 899 ADDPAQRPSFANIVE 913
P RPS +I++
Sbjct: 239 KVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 75/257 (29%), Positives = 123/257 (47%), Gaps = 25/257 (9%)
Query: 665 ERV---GAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
ERV G GS G V++ + G A+K + V ++ K+ LRE+ ++ P VV
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG-DEEFRKQLLRELKTLRSCESPYVV 62
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
GA K +SIV EY+ GSL L+ + + +A + KG++YLH
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLL---KKVGKIPEPVLAYIARQILKGLDYLHTKR 119
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSR------FKANTFISSKSVAGTPEWMAPEFL 833
I+H D+K NLL++ VK+ DFG+S+ + NTF+ GT +M+PE +
Sbjct: 120 -HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV------GTVTYMSPERI 172
Query: 834 RGEPSNEKSDVYSFGVILWELVTMQQPW---NGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890
+GE + +D++S G+ L E + P+ +++ A+ + SP
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232
Query: 891 ASLMESCWADDPAQRPS 907
+ +C DP +RPS
Sbjct: 233 RDFISACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (310), Expect = 2e-30
Identities = 77/271 (28%), Positives = 124/271 (45%), Gaps = 26/271 (9%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKE-FLREVAIMKRVRHP-N 717
+ ++G GSFG V+ A VA+KVL + + E FLRE+ I+ + HP N
Sbjct: 1 SYRILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
+V L +V EY+ GSL L+ + + + L + + + YLH+
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 778 LNPPILHWDLKSPNLLVDKN-WTVKVCDFGLSRFKANTFISS------KSVAGTPEWMAP 830
I+H D+K N+L+D++ VK+ DFGL++ + +S + GTP +MAP
Sbjct: 120 KG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 831 EFLRG---EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTS 887
E L G ++ SD++S G+ L+EL+T P+ G + L P S
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 888 PV-----------LASLMESCWADDPAQRPS 907
P+ + L++ A DP R S
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLS 268
|
Length = 384 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 77/270 (28%), Positives = 129/270 (47%), Gaps = 23/270 (8%)
Query: 665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
E +G G+ V+ A + VA+K + + + + E +EV M + HPNVV +
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDL-EKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
+ L +V YL GSL ++ +D+ + +V KG+ YLH+ N I
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS-NGQI 124
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKA----NTFISSKSVAGTPEWMAPEFL-RGEP 837
H D+K+ N+L+ ++ +VK+ DFG+S A T K+ GTP WMAPE + +
Sbjct: 125 -HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 838 SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNT-----SPVLAS 892
+ K+D++SFG+ EL T P++ P +V+ + QN ++ S
Sbjct: 184 YDFKADIWSFGITAIELATGAAPYSKYPPMKVL-MLTLQNDPPSLETGADYKKYSKSFRK 242
Query: 893 LMESCWADDPAQRPSFANIVESLKKLLKSP 922
++ C DP++RP+ +LLK
Sbjct: 243 MISLCLQKDPSKRPTAE-------ELLKHK 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 77/269 (28%), Positives = 135/269 (50%), Gaps = 44/269 (16%)
Query: 668 GAGSFGTVHRAEWHGSDV--AVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAV 725
G G+FG V++A+ + + A K++ ++ +++L++F+ E+ I+ +HPN+V A
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 726 TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHW 785
L I+ E+ G+L ++ G Q R + + + +N+LH+ ++H
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYV--CRQMLEALNFLHSHK--VIHR 127
Query: 786 DLKSPNLLVDKNWTVKVCDFGLS------RFKANTFISSKSVAGTPEWMAPEFLRGE--- 836
DLK+ N+L+ + VK+ DFG+S K +TFI GTP WMAPE + E
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI------GTPYWMAPEVVACETFK 181
Query: 837 --PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS-- 892
P + K+D++S G+ L EL M+ P + L P +V+ L I ++ P L
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL---------LKILKSEPPTLDQPS 232
Query: 893 --------LMESCWADDPAQRPSFANIVE 913
++SC DP RP+ A +++
Sbjct: 233 KWSSSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 5e-30
Identities = 81/269 (30%), Positives = 133/269 (49%), Gaps = 19/269 (7%)
Query: 667 VGAGSFGTVHRAEWHGSD----VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
+G G FG+V + + D VAVK + + ++++FL E MK HPNV+ +
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 723 GAVTKR------PHLSIVTEYLPRGSLYRLIHRPAAGE---MMDQRRRLRMALDVAKGIN 773
G + P ++ ++ G L+ + G+ + + ++ D+A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN-TFISSKSVAGTP-EWMAPE 831
YL + + +H DL + N ++++N V V DFGLS+ N + +A P +W+A E
Sbjct: 127 YLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184
Query: 832 FLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890
L KSDV+SFGV +WE+ T Q P+ G+ +++ + Q RL P + L
Sbjct: 185 SLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-QGNRLKQPPDCLDGL 243
Query: 891 ASLMESCWADDPAQRPSFANIVESLKKLL 919
SLM SCW +P RPSF + L+K L
Sbjct: 244 YSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 73/245 (29%), Positives = 123/245 (50%), Gaps = 16/245 (6%)
Query: 667 VGAGSFGTV----HRAEWHGSDVAVKVLTVQDFLDDQLKEF-LREVAIMKRVRHPNVV-L 720
+G GSFG V + G A+KVL + + + E L E I+ R+ HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDT--GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
T+ L +V EY P G L+ + + G ++R R A ++ + YLH+L
Sbjct: 59 HYAFQTEE-KLYLVLEYAPGGELFSHLSK--EGRFSEERARFYAA-EIVLALEYLHSLG- 113
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNE 840
I++ DLK N+L+D + +K+ DFGL++ ++ + + GTPE++APE L G+ +
Sbjct: 114 -IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGK 172
Query: 841 KSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD 900
D +S GV+L+E++T + P+ ++ + L P+ SP L+
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI--LKDPLRFPEFLSPEARDLISGLLQK 230
Query: 901 DPAQR 905
DP +R
Sbjct: 231 DPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 85/280 (30%), Positives = 133/280 (47%), Gaps = 24/280 (8%)
Query: 663 VKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
+K +G G+FG V AE + + V V ++D K+F RE ++ ++H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRR-----------LRM 764
+V F G L +V EY+ G L + + H P A ++D + R L +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR--FKANTFISSKSVA 822
A +A G+ YL + + +H DL + N LV N VK+ DFG+SR + + +
Sbjct: 129 ASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 823 GTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLA 881
WM PE + +SDV+SFGVILWE+ T +QPW L +V+ + Q R L
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT-QGRVLE 245
Query: 882 IPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921
P+ + +M CW +P QR + I + L L K+
Sbjct: 246 RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 69/255 (27%), Positives = 123/255 (48%), Gaps = 17/255 (6%)
Query: 665 ERVGAGSFGTVHRA-EWHGSDVAVKVLTV----QDFLDDQLKEFLREVAIMKRVRHPNVV 719
E +G G++GTV+ G +AVK + + + + ++ EV ++K ++H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
++G +SI E++P GS+ +++R + + LD G+ YLHN
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD---GVAYLHNNC 122
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS------KSVAGTPEWMAPEFL 833
++H D+K N+++ N +K+ DFG +R A + KS+ GTP WMAPE +
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 834 RGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAV-AFQNRRLAIPQNTSPVLAS 892
KSD++S G ++E+ T + P + + + A + +P + S
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAID 240
Query: 893 LMESCWADDPAQRPS 907
+ SC D +RPS
Sbjct: 241 FVTSCLTRDQHERPS 255
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 8e-29
Identities = 79/257 (30%), Positives = 141/257 (54%), Gaps = 11/257 (4%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
EI + L +++++GAG FG V A ++ + VAVK + ++ FL E +MK +
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---SVEAFLAEANVMKTL 58
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
+H +V VTK P + I+TE++ +GSL + + G + + + +A+G+
Sbjct: 59 QHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMA 116
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP-EWMAPEF 832
++ N +H DL++ N+LV + K+ DFGL+R + +++ A P +W APE
Sbjct: 117 FIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 174
Query: 833 LRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891
+ KSDV+SFG++L E+VT + P+ G+ +V+ A+ + R+ P+N L
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELY 233
Query: 892 SLMESCWADDPAQRPSF 908
++M CW + P +RP+F
Sbjct: 234 NIMMRCWKNRPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 70/274 (25%), Positives = 132/274 (48%), Gaps = 28/274 (10%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQ----DFLDDQLKEFLREVAIMKRVRHPNV 718
+++G G+F + ++A G+ +AVK +T ++ ++ +E+ +M R+ HP++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
+ +GA + H ++ E++ GS+ L+ + A + + + +G++YLH
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQLLRGLSYLHEN 122
Query: 779 NPPILHWDLKSPNLLVDKN-WTVKVCDFGLSRFKANTFISSK-----SVAGTPEWMAPEF 832
I+H D+K NLL+D +++ DFG + + + + GT +MAPE
Sbjct: 123 Q--IIHRDVKGANLLIDSTGQRLRIADFG-AAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 833 LRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPA---QVVGAVAFQNRRLAIPQNTSPV 889
LRGE DV+S G ++ E+ T + PWN + ++ +A +IP++ SP
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239
Query: 890 LASLMESCWADDPAQRPSFANIVESLKKLLKSPA 923
L + C P RP ++LLK P
Sbjct: 240 LRDVTLRCLELQPEDRP-------PSRELLKHPV 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 83/274 (30%), Positives = 137/274 (50%), Gaps = 26/274 (9%)
Query: 659 DELHVKERVGAGSFGTV----HRAEWHGSDVAVKVLTVQDFLDDQL-KEFLREVAIMKRV 713
D+L +GAG+ G V HR G +AVK + ++ +++ + K+ LRE+ I+ +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHR--PTGKIMAVKTIRLE--INEAIQKQILRELDILHKC 56
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
P +V F GA +SI EY+ GSL ++ + +R ++A+ V KG+
Sbjct: 57 NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKI--LKEVQGRIPERILGKIAVAVLKGLT 114
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFL 833
YLH I+H D+K N+LV+ +K+CDFG+S N+ +K+ GT +MAPE +
Sbjct: 115 YLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--AKTFVGTSSYMAPERI 171
Query: 834 RGEPSNEKSDVYSFGVILWELVTMQQPWNG-----LGPAQVVGAVAFQNRRLAIPQNTSP 888
+G + KSD++S G+ L EL T + P+ G +++ + + SP
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSP 231
Query: 889 VLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
+ C DP +RP S K+LL+ P
Sbjct: 232 DFQDFVNLCLIKDPRERP-------SYKELLEHP 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-28
Identities = 74/267 (27%), Positives = 128/267 (47%), Gaps = 22/267 (8%)
Query: 665 ER-VGAGSFGTVHRAEW----HGSDVAVKVLTVQDFLDD-QLKEFLREVAIMKRVRHPNV 718
ER +G G FG + R ++ V + T++ D Q + FL E + + H N+
Sbjct: 10 ERILGTGRFGELCRG-CLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNI 68
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRP----AAGEMMDQRRRLRMALDVAKGINY 774
V G +T+ + IVTEY+ G+L + + AG++M M +A G+ Y
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG------MLPGLASGMKY 122
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG-LSRFKANTFISSKSVAGTPEWMAPEFL 833
L + +H L + +LV+ + K+ F L K+ ++ S W APE +
Sbjct: 123 LSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAI 180
Query: 834 RGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892
+ + SDV+SFG+++WE+++ ++P+ + V+ AV RL P+N +L
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFRLPAPRNCPNLLHQ 239
Query: 893 LMESCWADDPAQRPSFANIVESLKKLL 919
LM CW + +RP F+ I L K++
Sbjct: 240 LMLDCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-28
Identities = 65/251 (25%), Positives = 134/251 (53%), Gaps = 6/251 (2%)
Query: 665 ERVGAGSFGT--VHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
+++G GSFG + +++ G +K + + + +E +EVA++ ++HPN+V +
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
+ + +L IV +Y G LY+ I+ G + + + L + + + ++H+ I
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINA-QRGVLFPEDQILDWFVQICLALKHVHDRK--I 122
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKS 842
LH D+KS N+ + K+ T+K+ DFG++R +T +++ GTP +++PE P N KS
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKS 182
Query: 843 DVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDP 902
D+++ G +L+E+ T++ + +V + + + + S L +L+ + +P
Sbjct: 183 DIWALGCVLYEMCTLKHAFEAGNMKNLVLKI-IRGSYPPVSSHYSYDLRNLVSQLFKRNP 241
Query: 903 AQRPSFANIVE 913
RPS +I+E
Sbjct: 242 RDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 77/260 (29%), Positives = 137/260 (52%), Gaps = 27/260 (10%)
Query: 659 DELHVK-ERVGAGSFGTVHRA-EWHGSDV-AVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
+EL K ER+G GSFG V++ + +V A+K++ +++ +D++++ +E+ ++ +
Sbjct: 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDS 61
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
P + + G+ K L I+ EYL GS L+ +P E LR ++ KG++YL
Sbjct: 62 PYITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILR---EILKGLDYL 117
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRG 835
H+ +H D+K+ N+L+ + VK+ DFG++ +T I + GTP WMAPE ++
Sbjct: 118 HSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 836 EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL----- 890
+ K+D++S G+ EL + P + L P +V+ IP+N+ P L
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---------FLIPKNSPPTLEGQYS 226
Query: 891 ---ASLMESCWADDPAQRPS 907
+E+C DP RP+
Sbjct: 227 KPFKEFVEACLNKDPRFRPT 246
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 86/283 (30%), Positives = 135/283 (47%), Gaps = 29/283 (10%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQLKEFLREV 707
E+ D + + +G G+FG V+ + G D VAVK L D+ +FL E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDES-DFLMEA 60
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH-------RPAAGEMMDQRR 760
IM + H N+V +G +R I+ E + G L + RP++ M D
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL-- 118
Query: 761 RLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD---KNWTVKVCDFGLSR--FKANTF 815
L A DVAKG YL + +H D+ + N L+ K+ DFG++R ++A+ +
Sbjct: 119 -LFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY 175
Query: 816 ISSKSVAGTPEWMAPE-FLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAV 873
+WM PE FL G ++ K+DV+SFGV+LWE+ ++ P+ G +V+ V
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTS-KTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234
Query: 874 AFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916
RL P+ + +M CW P RP+FA I+E ++
Sbjct: 235 T-GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 83/275 (30%), Positives = 130/275 (47%), Gaps = 28/275 (10%)
Query: 665 ERVGAGSFGTVHRAEWHG----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
+ +G G FG V E H + V VK L D+QL FL+EV + + HPNV+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQL-LFLQEVQPYRELNHPNVLQ 59
Query: 721 FMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
+G + +V E+ P G L Y +R +M + RMA +VA G+ +LH
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGL--SRFKANTFISSKSVAGTPEWMAPEFLRGE 836
+ +H DL N + + +VK+ D+GL ++ + +I+ A W+APE +
Sbjct: 120 D--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 837 PSN-------EKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAF-QNRRLAIPQNTS 887
+ +KS+++S GV +WEL T QP+ L QV+ V Q+ +L PQ
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL 237
Query: 888 PVLA---SLMESCWADDPAQRPSFANIVESLKKLL 919
+M+ CW DP RP+ E + +LL
Sbjct: 238 KYSDRWYEVMQFCWL-DPETRPT----AEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 76/260 (29%), Positives = 135/260 (51%), Gaps = 27/260 (10%)
Query: 659 DELHVK-ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
+EL K ER+G GSFG V + VA+K++ +++ +D++++ +E+ ++ +
Sbjct: 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDS 61
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
P V + G+ K L I+ EYL GS L+ AG D+ + M ++ KG++YL
Sbjct: 62 PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR---AGPF-DEFQIATMLKEILKGLDYL 117
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRG 835
H+ +H D+K+ N+L+ + VK+ DFG++ +T I + GTP WMAPE ++
Sbjct: 118 HSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ 175
Query: 836 EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA---- 891
+ K+D++S G+ EL + P + + P +V+ IP+N P L
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL---------FLIPKNNPPTLTGEFS 226
Query: 892 ----SLMESCWADDPAQRPS 907
+++C DP+ RP+
Sbjct: 227 KPFKEFIDACLNKDPSFRPT 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 73/264 (27%), Positives = 125/264 (47%), Gaps = 41/264 (15%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
D+ + +G GSFG V GS A+K+L+ + Q++ L E I++ +RH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK----- 770
P +V G+ +L +V EY+P G L+ + R+ R VA+
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-----------RKSGRFPEPVARFYAAQ 109
Query: 771 ---GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSVAGTPE 826
+ YLH+L+ I++ DLK NLL+D + +K+ DFG + R K T+ ++ GTPE
Sbjct: 110 VVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY----TLCGTPE 163
Query: 827 WMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQ-----VVGAVAFQNRRLA 881
++APE + + + D ++ G++++E++ P+ P Q + G V F
Sbjct: 164 YLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF------ 217
Query: 882 IPQNTSPVLASLMESCWADDPAQR 905
P SP L+ + D +R
Sbjct: 218 -PSFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 78/280 (27%), Positives = 136/280 (48%), Gaps = 14/280 (5%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK-----EFLREVAIMKRVR 714
EL + +G+G+FGTV++ W VK+ L++ EF+ E IM +
Sbjct: 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
HP++V +G V P + +VT+ +P G L +H + + + L + +AKG+ Y
Sbjct: 68 HPHLVRLLG-VCLSPTIQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMY 124
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP--EWMAPEF 832
L ++H DL + N+LV VK+ DFGL+R + G +WMA E
Sbjct: 125 LEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 833 LRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891
+ +SDV+S+GV +WEL+T +P++G+ P + + + + RL P + +
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTIDVY 241
Query: 892 SLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQMGGE 931
+M CW D RP F + ++ + P + + + G+
Sbjct: 242 MVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGD 281
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 72/257 (28%), Positives = 132/257 (51%), Gaps = 10/257 (3%)
Query: 663 VKERVGAGSFGTVH-----RAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
+++R+G GSFGTV+ +A +K + V + ++ + +E ++ ++ HP
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSL-YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
+V F + +R I+TEY L +L G+ + + + + + G++Y+H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGE 836
ILH DLK+ N+ + N +K+ DFG+SR + + + GTP +M+PE L+ +
Sbjct: 124 QRR--ILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQ 180
Query: 837 PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMES 896
+ KSD++S G IL+E+ + + G VV + + ++P+ S L S+M+S
Sbjct: 181 GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNSIMQS 239
Query: 897 CWADDPAQRPSFANIVE 913
DP+ RPS A I+
Sbjct: 240 MLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-27
Identities = 73/252 (28%), Positives = 139/252 (55%), Gaps = 11/252 (4%)
Query: 659 DELHVK-ERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
+EL K E++G GSFG V + + + VA+K++ +++ +D++++ +E+ ++ +
Sbjct: 3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDS 61
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
P V + G+ K L I+ EYL GS L+ P +D+ + + ++ KG++YL
Sbjct: 62 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGP---LDETQIATILREILKGLDYL 117
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRG 835
H+ +H D+K+ N+L+ ++ VK+ DFG++ +T I + GTP WMAPE ++
Sbjct: 118 HSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 836 EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895
+ K+D++S G+ EL + P + L P +V+ + +N + N S L +E
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVE 234
Query: 896 SCWADDPAQRPS 907
+C +P+ RP+
Sbjct: 235 ACLNKEPSFRPT 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 7e-27
Identities = 74/244 (30%), Positives = 120/244 (49%), Gaps = 13/244 (5%)
Query: 666 RVGAGSFGTVHRA-EWH-GSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNVVLFM 722
++G GS G V A + G VAVK + D Q +E L EV IM+ +HPN+V
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKM---DLRKQQRRELLFNEVVIMRDYQHPNIVEMY 82
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
+ L +V E+L G+L ++ M++ + + L V K +++LH +
Sbjct: 83 SSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLAVLKALSFLHAQG--V 136
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKS 842
+H D+KS ++L+ + VK+ DFG + KS+ GTP WMAPE + P +
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEV 196
Query: 843 DVYSFGVILWELVTMQQPWNGLGPAQVVGAVA-FQNRRLAIPQNTSPVLASLMESCWADD 901
D++S G+++ E+V + P+ P Q + + +L SP L S ++ D
Sbjct: 197 DIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRD 256
Query: 902 PAQR 905
PAQR
Sbjct: 257 PAQR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 79/285 (27%), Positives = 143/285 (50%), Gaps = 27/285 (9%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGS-----DVAVKVLTVQDFLDDQLKEFLREVAI 709
EI+ + E +G FG V++ G+ AV + T++D + L+E + A+
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 710 MK-RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYR-LIHRPAAGEM--MDQRRRLRMA 765
M+ R++HPN+V +G VTK LS++ Y L+ L+ R ++ D + ++
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 766 LD----------VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR--FKAN 813
L+ +A G+ +L + + ++H DL + N+LV VK+ D GL R + A+
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNVKISDLGLFREVYAAD 178
Query: 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQ-QPWNGLGPAQVVGA 872
+ + WM+PE + + SD++S+GV+LWE+ + QP+ G V+
Sbjct: 179 YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238
Query: 873 VAFQNRR-LAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916
+ +NR+ L P + + +LM CW + P++RP F +I L+
Sbjct: 239 I--RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 77/277 (27%), Positives = 135/277 (48%), Gaps = 15/277 (5%)
Query: 664 KERV-GAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL-----KEFLREVAIMKRVRHPN 717
K +V G+G+FGTV++ W VK+ L + KE L E +M V +P+
Sbjct: 11 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 70
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
V +G + + ++T+ +P G L + + + + L + +AKG+NYL
Sbjct: 71 VCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEE 127
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAG-TP-EWMAPEFLRG 835
++H DL + N+LV VK+ DFGL++ + G P +WMA E +
Sbjct: 128 RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH 185
Query: 836 EPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894
+SDV+S+GV +WEL+T +P++G+ PA + ++ + RL P + + +M
Sbjct: 186 RIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIM 244
Query: 895 ESCWADDPAQRPSFANIVESLKKLLKSPAQLIQMGGE 931
CW D RP F ++ K+ + P + + + G+
Sbjct: 245 VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGD 281
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 79/270 (29%), Positives = 135/270 (50%), Gaps = 36/270 (13%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
++L +GAG+ G+V + + H G+ +A KV+ + K+ LRE+ IM R
Sbjct: 5 EDLETISDLGAGNGGSVSKVK-HIPTGTVMAKKVVHI-GAKSSVRKQILRELQIMHECRS 62
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR--PAAGEMMDQRRRLRMALDVAKGIN 773
P +V F GA ++ + E++ GSL R+ + P E++ ++A+ V +G+
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLT 117
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS----RFKANTFISSKSVAGTPEWMA 829
YL+N++ I+H D+K N+LV+ +K+CDFG+S A+TF+ GT +M+
Sbjct: 118 YLYNVHR-IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV------GTSTYMS 170
Query: 830 PEFLRGEPSNEKSDVYSFGVILWELVTMQQPW---NGLGPAQVVGAVAFQNRRLAIPQNT 886
PE ++G KSDV+S G+ + EL + P+ N Q + + I Q
Sbjct: 171 PERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ-DDPMGILDLLQQIVQEP 229
Query: 887 SPVLAS---------LMESCWADDPAQRPS 907
P L S +++C DP +RP+
Sbjct: 230 PPRLPSSDFPEDLRDFVDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 67/264 (25%), Positives = 137/264 (51%), Gaps = 12/264 (4%)
Query: 663 VKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRVRHPNVV 719
+++++G G F V+RA G VA+K + + D +D + + + ++E+ ++K++ HPNV+
Sbjct: 6 IEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI 65
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
+ + + L+IV E G L R+I H ++ ++ + + + + ++H+
Sbjct: 66 KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR 125
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPS 838
++H D+K N+ + VK+ D GL RF ++ ++ S+ GTP +M+PE +
Sbjct: 126 R--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 839 NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP----QNTSPVLASLM 894
N KSD++S G +L+E+ +Q P+ G + ++ + + P + S L L+
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPF--YGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 241
Query: 895 ESCWADDPAQRPSFANIVESLKKL 918
C DP +RP + + K++
Sbjct: 242 NMCINPDPEKRPDITYVYDVAKRM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 78/259 (30%), Positives = 123/259 (47%), Gaps = 26/259 (10%)
Query: 670 GSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH-PNVVLFMGAV 725
G+FG+V+ A+ G A+KVL D + +Q+ E AIM P V +
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 726 TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHW 785
+ +L +V EYL G LI G + + + +A +V G+ LH I+H
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKT--LGGLPEDWAKQYIA-EVVLGVEDLHQRG--IIHR 121
Query: 786 DLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVY 845
D+K NLL+D+ +K+ DFGLSR + +K GTP+++APE + G ++ SD +
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSR----NGLENKKFVGTPDYLAPETILGVGDDKMSDWW 177
Query: 846 SFGVILWELVTMQQPWNGLGPAQVVGAVAFQN---RRLAIPQNT----SPVLASLMESCW 898
S G +++E + P++ P V F N RR+ P+ SP L+
Sbjct: 178 SLGCVIFEFLFGYPPFHAETPDAV-----FDNILSRRINWPEEVKEFCSPEAVDLINRLL 232
Query: 899 ADDPAQRPSFANIVESLKK 917
DPA+R AN + +K
Sbjct: 233 CMDPAKRLG-ANGYQEIKS 250
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 81/266 (30%), Positives = 134/266 (50%), Gaps = 27/266 (10%)
Query: 660 ELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
++ +E +G G+ GTV++A +H +AVKV+ + ++ Q K+ + E+ I+ + P
Sbjct: 2 DIQYQEILGHGNGGTVYKA-YHLLTRRILAVKVIPLDITVELQ-KQIMSELEILYKCDSP 59
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
++ F GA +SI TE++ GSL YR I G R+A+ V KG+ Y
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG---------RIAVAVVKGLTY 110
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLR 834
L +L ILH D+K N+LV+ VK+CDFG+S N+ +K+ GT +MAPE +
Sbjct: 111 LWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYVGTNAYMAPERIS 166
Query: 835 GEPSNEKSDVYSFGVILWELVTMQQPW-------NGLGPAQVVGAVAFQNRRLAIPQNTS 887
GE SDV+S G+ EL + P+ L P Q++ + ++ + S
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFS 226
Query: 888 PVLASLMESCWADDPAQRPSFANIVE 913
+ C P +RP+ N+++
Sbjct: 227 EKFVHFITQCMRKQPKERPAPENLMD 252
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 68/251 (27%), Positives = 131/251 (52%), Gaps = 11/251 (4%)
Query: 667 VGAGSFGTV----HRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
VG GS+G V HR + G +K L +++ + K +E ++ +++HPN+V +
Sbjct: 8 VGKGSYGEVSLVRHRTD--GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 723 GAVTKRP-HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
+ L IV + G LY + + G+++ + + + + +A + YLH +
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQIAMALQYLHEKH-- 122
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEK 841
ILH DLK+ N+ + + +KV D G++R N + ++ GTP +M+PE +P N K
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYK 182
Query: 842 SDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADD 901
SDV++ G ++E+ T++ +N +V + + + +P++ SP L L+ + +
Sbjct: 183 SDVWALGCCVYEMATLKHAFNAKDMNSLVYRI-IEGKLPPMPKDYSPELGELIATMLSKR 241
Query: 902 PAQRPSFANIV 912
P +RPS +I+
Sbjct: 242 PEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 72/284 (25%), Positives = 125/284 (44%), Gaps = 33/284 (11%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKE--FLREVAIMKRV- 713
D+ + +G GSF TV A+ ++ A+K+L + L + K E ++ R+
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR-QLIKEKKVKYVKIEKEVLTRLN 59
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
HP ++ +L V EY P G L + I + G + ++ R A ++ +
Sbjct: 60 GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK--YGSLDEKCTRFYAA-EILLALE 116
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-----------KANTFISS---- 818
YLH+ I+H DLK N+L+DK+ +K+ DFG ++ T I S
Sbjct: 117 YLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 819 -----KSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAV 873
S GT E+++PE L +P+ + SD+++ G I+++++T + P+ G +
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234
Query: 874 AFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKK 917
+ P N P L+E DP R + LK
Sbjct: 235 --LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 80/278 (28%), Positives = 134/278 (48%), Gaps = 30/278 (10%)
Query: 667 VGAGSFGTVH------RAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
+G G FG V + G VAVK L + + + + +E+ I++ + H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVK 70
Query: 721 FMGAVTKRPHLSI--VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
+ G T+ I + E+LP GSL + P ++ +++L+ A+ + KG++YL +
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANT-FISSKSVAGTPE-WMAPEFLRG 835
+H DL + N+LV+ VK+ DFGL++ + + + + K +P W APE L
Sbjct: 129 Q--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 836 EPSNEKSDVYSFGVILWELVT--------MQQPWNGLGPAQVVGAVAF------QNRRLA 881
SDV+SFGV L+EL+T M +GP V + +RL
Sbjct: 187 SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLP 246
Query: 882 IPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLL 919
P N + LM CW P++R +F N++E + +L
Sbjct: 247 RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 81/276 (29%), Positives = 140/276 (50%), Gaps = 16/276 (5%)
Query: 660 ELHVKERVGAGSFGTVHRAEW--HGSD----VAVKVLTVQDFLDDQLKEFLREVAIMKRV 713
EL + +G+G+FGTV++ W G + VA+KVL ++ KE L E +M V
Sbjct: 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLR-ENTSPKANKEILDEAYVMAGV 66
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
P V +G + + +VT+ +P G L L + + + + L + +AKG++
Sbjct: 67 GSPYVCRLLG-ICLTSTVQLVTQLMPYGCL--LDYVRENKDRIGSQDLLNWCVQIAKGMS 123
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAG-TP-EWMAPE 831
YL + ++H DL + N+LV VK+ DFGL+R + G P +WMA E
Sbjct: 124 YLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181
Query: 832 FLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890
+ +SDV+S+GV +WEL+T +P++G+ PA+ + + + RL P + +
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTIDV 240
Query: 891 ASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLI 926
+M CW D RP F +V+ ++ + P++ +
Sbjct: 241 YMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRFV 276
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 81/287 (28%), Positives = 131/287 (45%), Gaps = 63/287 (21%)
Query: 664 KERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVV 719
E +G G++G V++A H G VA+K+ D ++D+ +E E I+++ HPN+
Sbjct: 11 VEVIGEGTYGKVYKAR-HKKTGQLVAIKI---MDIIEDEEEEIKEEYNILRKYSNHPNIA 66
Query: 720 LFMGAVTKRPH------LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL------D 767
F GA K+ L +V E GS+ L+ + + +RL+ +
Sbjct: 67 TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKG-----LRKKGKRLKEEWIAYILRE 121
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR------FKANTFISSKSV 821
+G+ YLH ++H D+K N+L+ KN VK+ DFG+S + NTFI
Sbjct: 122 TLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI----- 174
Query: 822 AGTPEWMAPEFLRGEPSNE-----KSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ 876
GTP WMAPE + + + +SDV+S G+ EL + P + P + + F+
Sbjct: 175 -GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL----FK 229
Query: 877 NRRLAIPQNTSPVLAS----------LMESCWADDPAQRPSFANIVE 913
IP+N P L S + C + QRP ++E
Sbjct: 230 -----IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 65/249 (26%), Positives = 108/249 (43%), Gaps = 21/249 (8%)
Query: 667 VGAGSFGTVH--RAEWHGSDVAVKVLT-VQDFLDDQLKEFLREVAIMKRVRHPNVVLFMG 723
+G G FG V + + A+K + Q + E I++ HP +V
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
+ ++ ++ EY G L+ ++ G + R +A V YLHN I+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARFYIAC-VVLAFEYLHNRG--II 115
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGL-----SRFKANTFISSKSVAGTPEWMAPEFLRGEPS 838
+ DLK NLL+D N VK+ DFG S K TF GTPE++APE + +
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC------GTPEYVAPEIILNKGY 169
Query: 839 NEKSDVYSFGVILWELVTMQQPWNG--LGPAQVVGAVAFQNRRLAIPQNTSPVLASLMES 896
+ D +S G++L+EL+T + P+ P ++ + N +L P L++
Sbjct: 170 DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQ 229
Query: 897 CWADDPAQR 905
+P +R
Sbjct: 230 LLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 79/283 (27%), Positives = 133/283 (46%), Gaps = 35/283 (12%)
Query: 665 ERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
R+G G+ G+V + G A+K +T D D K+ LRE+ I K + P +V +
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITT-DPNPDLQKQILRELEINKSCKSPYIVKYY 65
Query: 723 GAVT--KRPHLSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
GA + I EY GSL + + G + ++ ++A V KG++YLH+
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSN 839
I+H D+K N+L+ + VK+CDFG+S N+ + + GT +MAPE ++G+P +
Sbjct: 126 --IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGTFTGTSFYMAPERIQGKPYS 181
Query: 840 EKSDVYSFGVILWELVTMQQPW-----NGLGPAQVVGAVAFQNRRLAIPQ---------N 885
SDV+S G+ L E+ + P+ LGP +++ + + P+
Sbjct: 182 ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV----NMPNPELKDEPGNGIK 237
Query: 886 TSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQM 928
S ++ C DP +RP + +L+ P QM
Sbjct: 238 WSEEFKDFIKQCLEKDPTRRP-------TPWDMLEHPWIKAQM 273
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 71/258 (27%), Positives = 130/258 (50%), Gaps = 15/258 (5%)
Query: 667 VGAGSFGTV----HRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
+G+G+FG V ++ DVA+KVL ++ + E +RE IM ++ +P +V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVR-DEMMREAEIMHQLDNPYIVRMI 61
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
G V + L +V E G L + + + + + + V+ G+ YL N
Sbjct: 62 G-VCEAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--F 116
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKA--NTFISSKSVAGTP-EWMAPEFLRGEPSN 839
+H DL + N+L+ K+ DFGLS+ +++ ++S P +W APE + +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 840 EKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCW 898
+SDV+S+G+ +WE + Q+P+ + +V+ + Q +RL P P + +LM+ CW
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCW 235
Query: 899 ADDPAQRPSFANIVESLK 916
RP+FA + E ++
Sbjct: 236 IYKWEDRPNFAKVEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 79/275 (28%), Positives = 135/275 (49%), Gaps = 22/275 (8%)
Query: 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVL--TVQDFLDDQ-LKEFLREVAIMKRVR 714
EL + +G+G FGTVH+ W G + + V T+QD Q +E + M +
Sbjct: 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD 67
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
H +V +G + L +VT+ P GSL L H + +D +R L + +AKG+ Y
Sbjct: 68 HAYIVRLLG-ICPGASLQLVTQLSPLGSL--LDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-----KANTFISSKSVAGTP-EWM 828
L ++H +L + N+L+ + V++ DFG++ K + K TP +WM
Sbjct: 125 LEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHK----TPIKWM 178
Query: 829 APEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTS 887
A E + +SDV+S+GV +WE+++ +P+ G+ P +V + + RLA PQ +
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-KGERLAQPQICT 237
Query: 888 PVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
+ +M CW D RP+F + ++ + P
Sbjct: 238 IDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-25
Identities = 75/261 (28%), Positives = 123/261 (47%), Gaps = 33/261 (12%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQ---LKEFL------------REVAIMK 711
VG GSFG + L VQ DQ +KE +E ++
Sbjct: 8 VGEGSFG--------------RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLA 53
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
+++HPN+V F + HL IV EY G L + I + G++ + L+ + + G
Sbjct: 54 KMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKI-KLQRGKLFPEDTILQWFVQMCLG 112
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPE 831
+ ++H +LH D+KS N+ + +N VK+ DFG +R + + + GTP ++ PE
Sbjct: 113 VQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE 170
Query: 832 FLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891
P N KSD++S G IL+EL T++ P+ ++ V Q +P + S L
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELR 229
Query: 892 SLMESCWADDPAQRPSFANIV 912
SL++ + +P RPS I+
Sbjct: 230 SLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 70/267 (26%), Positives = 132/267 (49%), Gaps = 10/267 (3%)
Query: 654 LEISWDELHVKERV--GAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
LE ++ ERV G G++G V+ A + V + + + + ++ E+A+
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRM-ALDVAK 770
++H N+V ++G+ ++ I E +P GSL L+ R G + D + + + +
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIIFYTKQILE 119
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGLSRFKANTFISSKSVAGTPEWMA 829
G+ YLH+ I+H D+K N+LV+ + VK+ DFG S+ A +++ GT ++MA
Sbjct: 120 GLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMA 177
Query: 830 PEFLRGEPS--NEKSDVYSFGVILWELVTMQQPWNGLGPAQ-VVGAVAFQNRRLAIPQNT 886
PE + P +D++S G + E+ T + P+ LG Q + V IP++
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESL 237
Query: 887 SPVLASLMESCWADDPAQRPSFANIVE 913
S + + C+ DP +R S ++++
Sbjct: 238 SAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 74/256 (28%), Positives = 132/256 (51%), Gaps = 16/256 (6%)
Query: 667 VGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
+G G+FG V++A+ G+ A KV+ + +++L++++ E+ I+ HP +V +GA
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL-RMALDVAKGINYLHNLNPPIL 783
L I+ E+ P G++ ++ G Q + + R L+ + YLH++ I+
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE---ALQYLHSMK--II 132
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGE-----PS 838
H DLK+ N+L+ + +K+ DFG+S T S GTP WMAPE + E P
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPY 192
Query: 839 NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN-RRLAIPQNTSPVLASLMESC 897
+ K+D++S G+ L E+ ++ P + L P +V+ +A L+ P S +++
Sbjct: 193 DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTA 252
Query: 898 WADDPAQRPSFANIVE 913
P RPS A ++E
Sbjct: 253 LDKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 75/252 (29%), Positives = 126/252 (50%), Gaps = 17/252 (6%)
Query: 667 VGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRVRHPNVVLF 721
+G+G+FGTV + + VAVK+L D D LK E LRE +M+++ +P +V
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILK-NDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
+G + + +V E G L + + + + + ++ + V+ G+ YL N
Sbjct: 62 IG-ICEAESWMLVMELAELGPLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRF--KANTFISSKSVAGTP-EWMAPEFLRGEPS 838
+H DL + N+L+ K+ DFGLS+ + +K+ P +W APE +
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 839 NEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESC 897
+ KSDV+SFGV++WE + Q+P+ G+ +V + R+ PQ P + LM+ C
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLC 234
Query: 898 WADDPAQRPSFA 909
W +RP FA
Sbjct: 235 WTYGVDERPGFA 246
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 66/266 (24%), Positives = 137/266 (51%), Gaps = 16/266 (6%)
Query: 663 VKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKE-FLREVAIMKRVRHPNVV 719
+++++G G F V+RA VA+K + + + +D + ++ ++E+ ++K++ HPNV+
Sbjct: 6 IEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVI 65
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
++ + + L+IV E G L ++I + ++ +R + + + + ++H+
Sbjct: 66 KYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR 125
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPS 838
++H D+K N+ + VK+ D GL RF ++ ++ S+ GTP +M+PE +
Sbjct: 126 R--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 839 NEKSDVYSFGVILWELVTMQQPWNG-----LGPAQVVGAVAFQNRRLAIP-QNTSPVLAS 892
N KSD++S G +L+E+ +Q P+ G Q + + +P ++ S L
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYP----PLPTEHYSEKLRE 239
Query: 893 LMESCWADDPAQRPSFANIVESLKKL 918
L+ C DP QRP + + K++
Sbjct: 240 LVSMCIYPDPDQRPDIGYVHQIAKQM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 1e-24
Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 28/208 (13%)
Query: 664 KERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKE-----FLREVAIMKRVRHP 716
E++G G++G V++A + G VA+K + + D +E LRE++++K ++HP
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRL-----DNEEEGIPSTALREISLLKELKHP 58
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
N+V + + L +V EY L + + + + + + +G+ Y H
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGP--LSPNLIKSIMYQLLRGLAYCH 115
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPE----WM-APE 831
+ ILH DLK N+L++++ +K+ DFGL+R T E W APE
Sbjct: 116 SHR--ILHRDLKPQNILINRDGVLKLADFGLAR-----AFGIPLRTYTHEVVTLWYRAPE 168
Query: 832 FLRGEPSNEKS-DVYSFGVILWELVTMQ 858
L G + D++S G I E++T +
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 74/272 (27%), Positives = 132/272 (48%), Gaps = 22/272 (8%)
Query: 659 DELHVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
++ + +R+G+G++G V++A G A+KV+ ++ D + + +E+ +MK +H
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ--QEIIMMKDCKHS 66
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
N+V + G+ +R L I E+ GSL + H + + + ++ + +G+ YLH
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYYLH 123
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGE 836
+ +H D+K N+L+ N VK+ DFG+S T KS GTP WMAPE E
Sbjct: 124 SKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 837 PS---NEKSDVYSFGVILWELVTMQQPWNGLGPAQ---VVGAVAFQNRRLAIPQNTSPVL 890
N+ D+++ G+ EL +Q P L P + ++ FQ +L S
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF 241
Query: 891 ASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
++ +P +RP + +KLL+ P
Sbjct: 242 HHFVKMALTKNPKKRP-------TAEKLLQHP 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-24
Identities = 73/272 (26%), Positives = 132/272 (48%), Gaps = 28/272 (10%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREVAIMKRVRHPN 717
DE+ V + +G G++G+V++ + V + + ++ LD+ + + + E+ I+ + P
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY 60
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL-- 775
+V F GA + + EY+ GSL +L A E + + R+ V KG+ +L
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 776 -HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS-SKSVAGTPEWMAPEFL 833
HN I+H D+K N+LV+ N VK+CDFG+S N S +K+ G +MAPE +
Sbjct: 121 EHN----IIHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNIGCQSYMAPERI 173
Query: 834 RGEPSNE------KSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL------A 881
+ N+ +SDV+S G+ + E+ + P+ P + + Q +
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY----PPETYANIFAQLSAIVDGDPPT 229
Query: 882 IPQNTSPVLASLMESCWADDPAQRPSFANIVE 913
+P S + C P +RP++A ++E
Sbjct: 230 LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 80/263 (30%), Positives = 129/263 (49%), Gaps = 24/263 (9%)
Query: 665 ERVGAGSFGTVHRAE----WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
+ +G G FG V E + + V VK L V + +Q+K FL E + ++H N++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK-FLEEAQPYRSLQHSNLLQ 59
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMM--DQRRRLRMALDVAKGINYLHNL 778
+G T+ +V E+ P G L + E+M D RMA ++A G+ +LH
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLS--RFKANTFISSKSVAGTPEWMAPEFLRGE 836
N +H DL N L+ + TVK+ D+GLS ++K + +++ + W+APE +
Sbjct: 120 N--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 837 PSN-------EKSDVYSFGVILWELVTM-QQPWNGLGPAQVVG-AVAFQNRRLAIPQNTS 887
N ++S+V+S GV +WEL + QP+ L QV+ V Q +L P+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237
Query: 888 PV---LASLMESCWADDPAQRPS 907
P+ +M+ CW P QRPS
Sbjct: 238 PLSDRWYEVMQFCWL-QPEQRPS 259
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 9e-24
Identities = 89/337 (26%), Positives = 142/337 (42%), Gaps = 74/337 (21%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQLKEFLREV 707
E D L + + +G G+FG V A G D VAVK+L + K + E+
Sbjct: 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEH-KALMSEL 61
Query: 708 AIMKRV-RHPNVVLFMGAV------------------------TKRPHLSIVTEYLPRG- 741
I+ + H NVV +GA KR S E P+
Sbjct: 62 KILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQR 121
Query: 742 -------SLYRLIHRPAAGEMMDQRRRLRM----------------------------AL 766
R+ R AG+ R + +
Sbjct: 122 GRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSF 181
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR--FKANTFISSKSVAGT 824
VA+G+ +L + +H DL + N+L+ +N VK+CDFGL+R +K ++ S
Sbjct: 182 QVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 825 PEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIP 883
+WMAPE + + +SDV+SFGV+LWE+ ++ P+ G+ + R+ P
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAP 299
Query: 884 QNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920
+N +P + +M +CW DP +RP+F+ +VE L LL+
Sbjct: 300 ENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 80/284 (28%), Positives = 135/284 (47%), Gaps = 34/284 (11%)
Query: 661 LHVKERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKE-FLREVAIMKRV 713
L +G G FG V + G VAVK L + Q + +E+ I+K +
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTL 63
Query: 714 RHPNVVLFMGAVTKR--PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
H N+V + G +++ L ++ EY+P GSL + + + L A + +G
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLN----LAQLLLFAQQICEG 119
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF--KANTFISSKSVAGTPE-WM 828
+ YLH+ + +H DL + N+L+D + VK+ DFGL++ + + + + +P W
Sbjct: 120 MAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 177
Query: 829 APEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNG--------LGPAQ----VVGAVAFQ 876
A E L+ + SDV+SFGV L+EL+T +GP Q VV +
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237
Query: 877 NR--RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKL 918
R RL P+N + LM++CW + RP+F +++ LK++
Sbjct: 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-23
Identities = 52/160 (32%), Positives = 91/160 (56%), Gaps = 5/160 (3%)
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR--FKANTFISSKSVA 822
+ VA+G+ +L + +H DL + N+L+ +N VK+CDFGL+R +K ++
Sbjct: 179 SFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 823 GTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLA 881
+WMAPE + + +SDV+SFGV+LWE+ ++ P+ G+ + + R+
Sbjct: 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR 296
Query: 882 IPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921
P+ +P + S+M CW ++P RP+F+ +VE L LL+
Sbjct: 297 APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 70/251 (27%), Positives = 121/251 (48%), Gaps = 15/251 (5%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
+RVG+G++G V++A G AVK++ ++ D +E+ ++K +H N+V +
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
G+ R L I EY GSL + H + + + + + +G+ YLH+
Sbjct: 73 GSYLSREKLWICMEYCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLAYLHSKGK-- 127
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPS---N 839
+H D+K N+L+ N VK+ DFG++ T KS GTP WMAPE E + N
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 840 EKSDVYSFGVILWELVTMQQPWNGLGPAQ---VVGAVAFQNRRLAIPQNTSPVLASLMES 896
+ D+++ G+ EL +Q P L P + ++ FQ +L S + ++
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKI 247
Query: 897 CWADDPAQRPS 907
+P +RP+
Sbjct: 248 SLTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 76/292 (26%), Positives = 124/292 (42%), Gaps = 68/292 (23%)
Query: 663 VKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDF--LDDQLKEFLREV-AIMKRVRHPN 717
V +++G G+FG+V+ A G VA+K + + F ++ + LREV ++ K HPN
Sbjct: 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMN--LREVKSLRKLNEHPN 59
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL-------RMALDVAK 770
+V + L V EY+ G+LY+L M D++ + + + +
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQL--------MKDRKGKPFSESVIRSIIYQILQ 110
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN-----TFISSKSVAGTP 825
G+ ++H H DLK NLLV VK+ DFGL+R + ++S++
Sbjct: 111 GLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR------ 162
Query: 826 EWM-APE-FLRGEPSNEKSDVYSFGVILWELVTMQQPWNG-------------LG-PAQV 869
W APE LR + D+++ G I+ EL T++ + G LG P +
Sbjct: 163 -WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQ 221
Query: 870 V---GAVAFQNRRLAIPQ-----------NTSPVLASLMESCWADDPAQRPS 907
G PQ N SP L++ DP +RP+
Sbjct: 222 DWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT 273
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 71/280 (25%), Positives = 118/280 (42%), Gaps = 48/280 (17%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQL-KEFLREVAIMKRVRHPNVVLF 721
++G G++G V++A G VA+K + F + + K LRE+ ++K + HPN++
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIK-LRFESEGIPKTALREIKLLKELNHPNIIKL 63
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
+ + L +V E++ LY+LI G + + + +G+ + H+
Sbjct: 64 LDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRG--LPESLIKSYLYQLLQGLAFCHSHG-- 118
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPE----WM-APEFLRGE 836
ILH DLK NLL++ +K+ DFGL+R S T W APE L G+
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLAR-----SFGSPVRPYTHYVVTRWYRAPELLLGD 173
Query: 837 PS-NEKSDVYSFGVILWELVTMQQPWNG-------------LG-PAQVVGAVAFQNRR-- 879
+ D++S G I EL++ + + G LG P V R
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233
Query: 880 -LAIPQ-----------NTSPVLASLMESCWADDPAQRPS 907
+ P+ N SP L+ DP +R +
Sbjct: 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT 273
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 75/279 (26%), Positives = 121/279 (43%), Gaps = 43/279 (15%)
Query: 665 ERVGAGSFGTV----HRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
VG G++G V ++A G VA+K + +D K LREV +++++RH N+V
Sbjct: 7 GVVGEGAYGVVLKCRNKAT--GEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVN 64
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
A ++ L +V EY+ R +L L+ G D R L + I Y H+ N
Sbjct: 65 LKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQL--LQAIAYCHSHN- 120
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTPEWMAPEFLRGEPSN 839
I+H D+K N+LV ++ +K+CDFG +R +A T + APE L G+ +
Sbjct: 121 -IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179
Query: 840 EKS-DVYSFGVILWELVTMQQPWNG-------------LGP-AQVVGAVAFQNRRLA--- 881
K DV++ G I+ EL+ + + G LGP + N R A
Sbjct: 180 GKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239
Query: 882 -IPQNT------------SPVLASLMESCWADDPAQRPS 907
+ S +++C DP +R +
Sbjct: 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 1e-22
Identities = 54/160 (33%), Positives = 90/160 (56%), Gaps = 5/160 (3%)
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR--FKANTFISSKSVA 822
+ VAKG+ +L + +H DL + N+L+ +N VK+CDFGL+R +K ++
Sbjct: 185 SFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 823 GTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLA 881
+WMAPE + +SDV+SFGV+LWE+ ++ P+ G+ + + R+
Sbjct: 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 302
Query: 882 IPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921
P T+P + M CW +P+QRP+F+ +VE L LL++
Sbjct: 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 1e-22
Identities = 75/274 (27%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
E++G G+ GTV A G +VA+K + +Q +L + E+ +MK +++PN+V F+
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKELKNPNIVNFL 82
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
+ L +V EYL GSL ++ MD+ + + + + + +LH +
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVVTETC----MDEAQIAAVCRECLQALEFLHA--NQV 136
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKS 842
+H D+KS N+L+ + +VK+ DFG ++ GTP WMAPE + + K
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 843 DVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-RLAIPQNTSPVLASLMESCWADD 901
D++S G++ E+V + P+ P + + +A L P+ SP+ + C D
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMD 256
Query: 902 PAQRPSFANIVE----SLKKLLKSPAQLIQMGGE 931
+R S +++ L K L S LI E
Sbjct: 257 VEKRGSAKELLQHPFLKLAKPLSSLTPLILAAKE 290
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 54/195 (27%), Positives = 88/195 (45%), Gaps = 11/195 (5%)
Query: 665 ERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
R+G G+ G V +A+ + VA+K + ++ + LRE+ ++ +HP VV +
Sbjct: 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
+V EY+P L ++ + +RM L KG+ Y+H
Sbjct: 66 DVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLL---KGVAYMHANG-- 119
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMAPEFLRGEPS-N 839
I+H DLK NLL+ + +K+ DFGL+R F T + APE L G +
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 840 EKSDVYSFGVILWEL 854
D+++ G I EL
Sbjct: 180 PGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 3e-22
Identities = 74/254 (29%), Positives = 120/254 (47%), Gaps = 22/254 (8%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVA-------IMKRVRHPNVV 719
+G G+FG V+ + D ++ Q D + E +EV+ ++K ++H +V
Sbjct: 10 LGQGAFGRVYLC--YDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 720 LFMGAVTKRPH--LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH- 776
+ G + R L+I EY+P GS+ + A R+ R L+ G++YLH
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE---GMSYLHS 124
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS---KSVAGTPEWMAPEFL 833
N+ I+H D+K N+L D VK+ DFG S+ +S +SV GTP WM+PE +
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 834 RGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893
GE K+DV+S G + E++T + PW + +A Q +P + S
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241
Query: 894 MESCWADDPAQRPS 907
+ C + RPS
Sbjct: 242 L-GCIFVEARHRPS 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 73/255 (28%), Positives = 124/255 (48%), Gaps = 22/255 (8%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREV-------AIMKRVRHPNVV 719
+G G+FG V+ + +D ++ Q D +E +EV ++K +RH +V
Sbjct: 10 LGRGAFGEVYLC--YDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 720 LFMGAVT--KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH- 776
+ G + + LSI EY+P GS+ + A G + + R R + +G++YLH
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLK--AYGALTENVTR-RYTRQILQGVSYLHS 124
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS---KSVAGTPEWMAPEFL 833
N+ I+H D+K N+L D VK+ DFG S+ +S KSV GTP WM+PE +
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 834 RGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893
GE K+DV+S + E++T + PW + +A Q + +P S
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF 241
Query: 894 MESCWADDPAQRPSF 908
++ + ++ +RP+
Sbjct: 242 LKQIFVEE-KRRPTA 255
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 4e-22
Identities = 68/240 (28%), Positives = 118/240 (49%), Gaps = 16/240 (6%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT 726
+G G+FG V++A+ + V + +++L++++ E+ I+ HPN+V + A
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 727 KRPHLSIVTEYLPRGSLYRL---IHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
+L I+ E+ G++ + + RP + R + L+ +NYLH I+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQI--RVVCKQTLE---ALNYLHE--NKII 125
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGE-----PS 838
H DLK+ N+L + +K+ DFG+S T S GTP WMAPE + E P
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 839 NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN-RRLAIPQNTSPVLASLMESC 897
+ K+DV+S G+ L E+ ++ P + L P +V+ +A LA P S ++ C
Sbjct: 186 DYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKC 245
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 9e-22
Identities = 75/268 (27%), Positives = 130/268 (48%), Gaps = 14/268 (5%)
Query: 666 RVGAGSFGTVHRA-EWH-GSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNVVLFM 722
++G GS G V A E H G VAVK + D Q +E L EV IM+ H NVV
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKM---DLRKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
+ L +V E+L G+L ++ M++ + + L V + ++YLHN +
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG--V 139
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKS 842
+H D+KS ++L+ + +K+ DFG + KS+ GTP WMAPE + P +
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 843 DVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ-NRRLAIPQNTSPVLASLMESCWADD 901
D++S G+++ E++ + P+ P Q + + R+ S VL ++ +
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259
Query: 902 PAQRPSFANIVES-LKKLLKSPAQLIQM 928
P+QR + +++ KL P+ ++ +
Sbjct: 260 PSQRATAQELLQHPFLKLAGPPSCIVPL 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 1e-21
Identities = 70/261 (26%), Positives = 127/261 (48%), Gaps = 18/261 (6%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
E++G G+ GTV+ A G +VA+K + +Q +L + E+ +M+ +HPN+V ++
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKHPNIVNYL 82
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
+ L +V EYL GSL ++ MD+ + + + + + +LH+ +
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQ--V 136
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKS 842
+H D+KS N+L+ + +VK+ DFG ++ GTP WMAPE + + K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 843 DVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-RLAIPQNTSPVLASLMESCWADD 901
D++S G++ E+V + P+ P + + +A L P+ S + + C D
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD 256
Query: 902 PAQRPSFANIVESLKKLLKSP 922
+R S K+LL+ P
Sbjct: 257 VEKR-------GSAKELLQHP 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 1e-21
Identities = 71/257 (27%), Positives = 124/257 (48%), Gaps = 23/257 (8%)
Query: 666 RVGAGSFGTV--HRAEWHGSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNVVLFM 722
++G GS G V R + G VAVK++ D Q +E L EV IM+ +H NVV
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
+ L ++ E+L G+L ++ + +++ + + V + + YLH+ +
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQG--V 138
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKS 842
+H D+KS ++L+ + VK+ DFG + KS+ GTP WMAPE + P +
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 843 DVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP------QNTSPVLASLMES 896
D++S G+++ E+V + P+ P Q A + R + P SPVL +E
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDSPVQ-----AMKRLRDSPPPKLKNAHKISPVLRDFLER 253
Query: 897 CWADDPAQRPSFANIVE 913
+P +R + +++
Sbjct: 254 MLTREPQERATAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-21
Identities = 73/270 (27%), Positives = 121/270 (44%), Gaps = 27/270 (10%)
Query: 657 SWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
S EL R+G+G+ GTV++ + A+KV+ + D ++ RE+ I++ V
Sbjct: 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI-YGNHEDTVRRQICREIEILRDVN 130
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
HPNVV + ++ E++ GSL + ++ Q + GI
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ---------ILSGI 181
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEF 832
YLH + I+H D+K NLL++ VK+ DFG+SR A T S GT +M+PE
Sbjct: 182 AYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPER 239
Query: 833 L-----RGEPSNEKSDVYSFGVILWELVTMQQPWNGLGP----AQVVGAVAFQNRRLAIP 883
+ G D++S GV + E + P+ G+G A ++ A+ A P
Sbjct: 240 INTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF-GVGRQGDWASLMCAICMSQPPEA-P 297
Query: 884 QNTSPVLASLMESCWADDPAQRPSFANIVE 913
S + C +PA+R S +++
Sbjct: 298 ATASREFRHFISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 2e-21
Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 31/204 (15%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDF--LDDQL-KEFLREVAIMKRVRHPNVVLF 721
+G G++ V++A + VA+K + + + D + LRE+ +++ ++HPN++
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHR------PAAGEMMDQRRRLRMALDVAKGINYL 775
+ + ++++V E++ L ++I PA D + + M L +G+ YL
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPA-----DIKSYMLMTL---RGLEYL 118
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA--NTFISSKSVAGTPEWMAPEFL 833
H+ ILH DLK NLL+ + +K+ DFGL+R N ++ + V T + APE L
Sbjct: 119 HSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYRAPELL 174
Query: 834 RGEPSNEKS---DVYSFGVILWEL 854
G + D++S G I EL
Sbjct: 175 FG--ARHYGVGVDMWSVGCIFAEL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 71/247 (28%), Positives = 119/247 (48%), Gaps = 19/247 (7%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRV-----RHPNV 718
+G GSFG V AE G+D AVKVL L DD ++ + E KRV +HP +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTE----KRVLALAGKHPFL 58
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
+ L V EY+ G L I R D+ R A ++ G+ +LH
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR---FDEPRARFYAAEIVLGLQFLHER 115
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPS 838
I++ DLK N+L+D +K+ DFG+ + +++ + GTP+++APE L +P
Sbjct: 116 G--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY 173
Query: 839 NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCW 898
D ++ GV+L+E++ Q P+ G ++ ++ + P+ S S+++S
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI--LEDEVRYPRWLSKEAKSILKSFL 231
Query: 899 ADDPAQR 905
+P +R
Sbjct: 232 TKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 72/269 (26%), Positives = 130/269 (48%), Gaps = 28/269 (10%)
Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFL--------DDQLKEFLREVAIMK 711
V E +G+G+FG V++ + +A+K + V + D + + + EV I+K
Sbjct: 4 VLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIK 63
Query: 712 -RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLRMALDVA 769
++RHPN+V + + L IV + + L + + + R + + +
Sbjct: 64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMA 829
+ YLH I+H DL N+++ ++ V + DFGL++ K SV GT +
Sbjct: 124 LALRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK-QPESKLTSVVGTILYSC 181
Query: 830 PEFLRGEPSNEKSDVYSFGVILWELVTMQQPW---NGLGPA-QVVGAVAFQNRRLAIPQN 885
PE ++ EP EK+DV++FG IL+++ T+Q P+ N L A ++V AV +P+
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV-----YEPLPEG 236
Query: 886 T-SPVLASLMESCWADDPAQRPSFANIVE 913
S + ++ SC D RP +I++
Sbjct: 237 MYSEDVTDVITSCLTPDAEARP---DIIQ 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 77/261 (29%), Positives = 124/261 (47%), Gaps = 20/261 (7%)
Query: 666 RVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNVVLFM 722
++G GS G V A + G VAVK + D Q +E L EV IM+ +H NVV
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKM---DLRKQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
+ L +V E+L G+L ++ M++ + + L V K ++ LH +
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG--V 137
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKS 842
+H D+KS ++L+ + VK+ DFG + KS+ GTP WMAPE + P +
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 843 DVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ-NRRLAIPQNTSPVLASLMESCWADD 901
D++S G+++ E+V + P+ P + + + +L SP L ++ D
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257
Query: 902 PAQRPSFANIVESLKKLLKSP 922
PAQR + A +LLK P
Sbjct: 258 PAQRATAA-------ELLKHP 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 29/210 (13%)
Query: 662 HVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKE-----FLREVAIMKRVR 714
++G G++G V++A G VA+K + + + KE +RE+ +++++R
Sbjct: 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRM-----ENEKEGFPITAIREIKLLQKLR 56
Query: 715 HPNVVLFMGAVTKRPHLSI--VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
HPN+V VT + SI V EY+ L L+ P Q + + +G+
Sbjct: 57 HPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCY--MKQLLEGL 113
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPE----WM 828
YLH+ ILH D+K N+L++ + +K+ DFGL+R + S T W
Sbjct: 114 QYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARP----YTKRNSADYTNRVITLWY 167
Query: 829 -APEFLRGEPS-NEKSDVYSFGVILWELVT 856
PE L G + D++S G IL EL
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 3e-21
Identities = 72/269 (26%), Positives = 131/269 (48%), Gaps = 15/269 (5%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
E++G G+ GTV+ A G +VA+K + +Q +L + E+ +M+ ++PN+V ++
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKNPNIVNYL 82
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
+ L +V EYL GSL ++ MD+ + + + + +++LH+ +
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALDFLHS--NQV 136
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKS 842
+H D+KS N+L+ + +VK+ DFG ++ GTP WMAPE + + K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 843 DVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-RLAIPQNTSPVLASLMESCWADD 901
D++S G++ E+V + P+ P + + +A L P+ S V + C D
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMD 256
Query: 902 PAQRPSFANIVE----SLKKLLKSPAQLI 926
+R S +++ L K L S LI
Sbjct: 257 VDRRGSAKELLQHPFLKLAKPLSSLTPLI 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 4e-21
Identities = 75/246 (30%), Positives = 123/246 (50%), Gaps = 17/246 (6%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRV-----RHPNVV 719
+G GSFG V AE G++ A+K L L+D E + +RV HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVEC---TMVERRVLALAWEHPFLT 59
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
+ HL V EYL G L + H ++G + R R A ++ G+ +LH
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARF-YAAEIICGLQFLHKKG 116
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSN 839
I++ DLK N+L+DK+ +K+ DFG+ + N + + GTP+++APE L+G+ N
Sbjct: 117 --IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYN 174
Query: 840 EKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWA 899
E D +SFGV+L+E++ Q P++G ++ ++ N R P+ S + +
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI--LNDRPHFPRWISKEAKDCLSKLFE 232
Query: 900 DDPAQR 905
DP +R
Sbjct: 233 RDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 71/276 (25%), Positives = 130/276 (47%), Gaps = 34/276 (12%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREV-AIMKRVR 714
++L +G G+FGTV++ H G+ +AVK + +Q K L ++ +M+
Sbjct: 4 EDLKDLGEIGRGAFGTVNKM-LHKPSGTIMAVKRIRSTVDEKEQ-KRLLMDLDVVMRSSD 61
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRG--SLYRLIHRPAAGEMMDQRRRL------RMAL 766
P +V F GA+ + I E + Y+ ++ + + ++A+
Sbjct: 62 CPYIVKFYGALFREGDCWICMELMDISLDKFYKYVY-------EVLKSVIPEEILGKIAV 114
Query: 767 DVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP 825
K +NYL L I+H D+K N+L+D+N +K+CDFG+S ++ ++ AG
Sbjct: 115 ATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD-AGCR 171
Query: 826 EWMAPEFL---RGEPSNEKSDVYSFGVILWELVTMQQP---WNGL--GPAQVVGAVAFQN 877
+MAPE + + + +SDV+S G+ L+E+ T + P WN + QVV
Sbjct: 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPIL 231
Query: 878 RRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVE 913
+ + SP + + C D ++RP + ++E
Sbjct: 232 SN-SEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 7e-21
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 668 GAGSFGTVHRAEWHGSD--VAVKVLTVQDFLD-DQLKEFLREVAIMK---RVRHPNVVLF 721
G G FG V AE+ + A+K L D + D+++ + E I + RHP +V
Sbjct: 8 GRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNL 67
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
H+ V EY G L IH ++ + R + A V G+ YLH
Sbjct: 68 FACFQTEDHVCFVMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK-- 121
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEK 841
I++ DLK NLL+D VK+ DFGL + + + GTPE++APE L
Sbjct: 122 IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRA 181
Query: 842 SDVYSFGVILWELVTMQQPWNG 863
D + GV+++E++ + P+ G
Sbjct: 182 VDWWGLGVLIYEMLVGESPFPG 203
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 7e-21
Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 47/217 (21%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPNVV--- 719
+G+G++G V A + G VA+K + + DD + K LRE+ +++ +RH N++
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKK--ISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 720 -LFMGAVTKRP-------HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
+ RP + IVTE + L+++I P + D + + + +G
Sbjct: 66 DIL------RPPSPEDFNDVYIVTELME-TDLHKVIKSP--QPLTDDHIQYFL-YQILRG 115
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWM--- 828
+ YLH+ N ++H DLK N+LV+ N +K+CDFGL+R ++
Sbjct: 116 LKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE-------DEKGFLTEY 166
Query: 829 -------APEFLRGEPSNEKS-DVYSFGVILWELVTM 857
APE L K+ D++S G I EL+T
Sbjct: 167 VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (230), Expect = 9e-21
Identities = 73/279 (26%), Positives = 131/279 (46%), Gaps = 41/279 (14%)
Query: 665 ERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMG 723
E VG G++G V++ H + + V D D+ +E +E+ ++K+ H N+ + G
Sbjct: 12 ELVGNGTYGQVYKGR-HVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 724 AVTKR------PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
A K+ L +V E+ GS+ LI + G + + + ++ +G+++LH
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREILRGLSHLHQ 129
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEP 837
++H D+K N+L+ +N VK+ DFG+S T + GTP WMAPE + +
Sbjct: 130 HK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 838 SNE-----KSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA- 891
+ + KSD++S G+ E+ P + P + + IP+N +P L
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---------FLIPRNPAPRLKS 238
Query: 892 --------SLMESCWADDPAQRPSFANIVESLKKLLKSP 922
S +ESC + +QRP + ++L+K P
Sbjct: 239 KKWSKKFQSFIESCLVKNHSQRP-------TTEQLMKHP 270
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-20
Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 31/219 (14%)
Query: 657 SW--DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLD-DQLKEFLREVAIMK 711
SW + + E +G GSFG V A+ G+ A+K L ++ L Q++ +E +I+
Sbjct: 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILM 73
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK- 770
+ HP +V M + + + E++ G L+ H AG R DVAK
Sbjct: 74 ELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFT--HLRKAG---------RFPNDVAKF 122
Query: 771 -------GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSVA 822
YLH+ + I++ DLK NLL+D VKV DFG + + TF ++
Sbjct: 123 YHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF----TLC 176
Query: 823 GTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPW 861
GTPE++APE ++ + + D ++ GV+L+E + P+
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 71/253 (28%), Positives = 118/253 (46%), Gaps = 20/253 (7%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVA-------IMKRVRHPNVV 719
+G G+FG V+ + +D ++ Q D + E +EV ++K + H +V
Sbjct: 10 LGQGAFGRVYLC--YDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 720 LFMGAVTKRPH--LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
+ G + LSI E++P GS+ + A R+ R L+ G++YLH+
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILE---GVSYLHS 124
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS---KSVAGTPEWMAPEFLR 834
I+H D+K N+L D VK+ DFG S+ +S KSV GTP WM+PE +
Sbjct: 125 --NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 835 GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894
GE K+D++S G + E++T + PW + +A Q +P + S +
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFL 242
Query: 895 ESCWADDPAQRPS 907
+ + + RPS
Sbjct: 243 KRIFV-EAKLRPS 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 55/249 (22%), Positives = 117/249 (46%), Gaps = 16/249 (6%)
Query: 675 VHRAEWHGSDVAVKVLT-VQDFLDDQLKEFLREVAIMKRVRHPNVV----LFMGAVTKRP 729
+++ ++ +V ++ + E+ ++R+ N++ + V P
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLK 788
LS++ EY RG L ++ + + + + +L MA+D KG+ L+ N P + +L
Sbjct: 96 RLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 789 SPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRG--EPSNEKSDVYS 846
S + LV +N+ +K+ GL + ++ K+V + + + L K D+YS
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSP--PFKNV-NFMVYFSYKMLNDIFSEYTIKDDIYS 207
Query: 847 FGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRP 906
GV+LWE+ T + P+ L ++ + +N L +P + + ++E+C + D +RP
Sbjct: 208 LGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRP 267
Query: 907 SFANIVESL 915
+ I+ +L
Sbjct: 268 NIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 3e-20
Identities = 69/282 (24%), Positives = 126/282 (44%), Gaps = 32/282 (11%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAI-MK 711
++L +G+G+ G V++ + G +AVK + ++ K L ++ + +K
Sbjct: 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG-NKEENKRILMDLDVVLK 69
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPR--GSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
P +V G + I E + L + I P + + +M + +
Sbjct: 70 SHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGP-----IPEDILGKMTVAIV 124
Query: 770 KGINYL---HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPE 826
K ++YL H ++H D+K N+L+D + VK+CDFG+S ++ ++S AG
Sbjct: 125 KALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-AGCAA 179
Query: 827 WMAPEFLRGEPSNEK----SDVYSFGVILWELVTMQQPWNGL-GPAQVVGAVAFQNR-RL 880
+MAPE + N K +DV+S G+ L EL T Q P+ +V+ + + L
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL 239
Query: 881 AIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
+ SP S ++ C D +RP + ++LL+ P
Sbjct: 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKY-------RELLQHP 274
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 3e-20
Identities = 69/274 (25%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
E++G G+ GTV+ A G +VA++ + +Q +L + E+ +M+ ++PN+V ++
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYL 83
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
+ L +V EYL GSL ++ MD+ + + + + + +LH+ +
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHS--NQV 137
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKS 842
+H D+KS N+L+ + +VK+ DFG ++ GTP WMAPE + + K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 843 DVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-RLAIPQNTSPVLASLMESCWADD 901
D++S G++ E++ + P+ P + + +A L P+ S + + C D
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257
Query: 902 PAQRPSFANIVE----SLKKLLKSPAQLIQMGGE 931
+R S +++ + K L S LI E
Sbjct: 258 VEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKE 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 5e-20
Identities = 81/289 (28%), Positives = 126/289 (43%), Gaps = 38/289 (13%)
Query: 649 LAMDWLEISWDELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLRE 706
L ++ L D + E +G G++G V++ + GS AVK+L D + D +E E
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL---DPISDVDEEIEAE 68
Query: 707 VAIMKRV-RHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIH-RPAAGEMMDQR 759
I++ + HPNVV F G K L +V E GS+ L+ G+ +D+
Sbjct: 69 YNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEA 128
Query: 760 RRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK 819
+ G+ +LHN I+H D+K N+L+ VK+ DFG+S +T +
Sbjct: 129 MISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186
Query: 820 SVAGTPEWMAPEFLRGEPSNEKS-----DVYSFGVILWELVTMQQPWNGLGPAQVVGAVA 874
+ GTP WMAPE + E + S DV+S G+ EL P + P + +
Sbjct: 187 TSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL---- 242
Query: 875 FQNRRLAIPQNTSPVL----------ASLMESCWADDPAQRPSFANIVE 913
IP+N P L + C D RPS +++E
Sbjct: 243 -----FKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 5e-20
Identities = 68/261 (26%), Positives = 119/261 (45%), Gaps = 17/261 (6%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQD-FLDDQLKEFLREVAIMKRVRHP 716
+ + +VG G +G V A+ + VA+K + F ++++ L E I+ +
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
+V + A +L + EY+P G L++ G + + R MA ++ + ++ LH
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMA-EMFEAVDALH 118
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGE 836
L +H DLK N L+D + +K+ DFGLS + SV G+P++MAPE LRG+
Sbjct: 119 ELG--YIHRDLKPENFLIDASGHIKLTDFGLS---KGIVTYANSVVGSPDYMAPEVLRGK 173
Query: 837 PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP------QNTSPVL 890
+ D +S G +L+E + P++G P + + + L P N S
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEA 233
Query: 891 ASLMESCWADDPAQRPSFANI 911
L+ D + S +I
Sbjct: 234 WDLITKLINDPSRRFGSLEDI 254
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 7e-20
Identities = 72/286 (25%), Positives = 127/286 (44%), Gaps = 49/286 (17%)
Query: 667 VGAGSFGTVH--RAEWHGSDVAVKV-LTVQDFLDDQLKEF-LREVAIMKRVRHPNVVLFM 722
VG GS+G V + + G VA+K L +D D +K+ +RE+ ++K++RH N+V +
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
++ L +V E++ L L P +D+ R + + +GI + H+ N I
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHSHN--I 121
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKS 842
+H D+K N+LV ++ VK+CDFG +R A T + APE L G+ ++
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRA 181
Query: 843 -DVYSFGVILWELVTMQQPWNGLGPA-----------QVVGAVA------------FQNR 878
D+++ G ++ E++T L P + +G + F
Sbjct: 182 VDIWAVGCLVTEMLTG----EPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 879 RLAIPQNT----------SPVLASLMESCWADDPAQRPSFANIVES 914
RL + S ++ L + C DP RPS + ++
Sbjct: 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 8e-20
Identities = 52/167 (31%), Positives = 92/167 (55%), Gaps = 5/167 (2%)
Query: 756 MDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANT 814
+D L + VAKG+++L + N +H DL + N+L+ K+CDFGL+R + ++
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268
Query: 815 FISSKSVAGTP-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGA 872
K A P +WMAPE + +SDV+S+G++LWE+ ++ P+ G+
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK 328
Query: 873 VAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLL 919
+ + R+ P+ + +M+SCW DP +RP+F IV+ +++ L
Sbjct: 329 MIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 61/261 (23%), Positives = 114/261 (43%), Gaps = 22/261 (8%)
Query: 667 VGAGSFGTV----HRAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLF 721
+G G+FG V R A+K + Q ++ ++ L E I++ + HP +V
Sbjct: 8 IGKGAFGKVCIVQKRDT--KKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 722 MGAVTKRPHLSIVTEYLPRGSL-YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
+ ++ +V + L G L Y L + + +++ + + ++ + YLH+
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWIC-EIVLALEYLHSKG- 120
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMAPEFLRGEPSN 839
I+H D+K N+L+D+ V + DF ++ +T +S S GTP +MAPE L + +
Sbjct: 121 -IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--GTPGYMAPEVLCRQGYS 177
Query: 840 EKSDVYSFGVILWELVTMQQPWNG--LGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESC 897
D +S GV +E + ++P+ G + A L P S +
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVL-YPATWSTEAIDAINKL 236
Query: 898 WADDPAQRPSFANIVESLKKL 918
DP +R + ++ LK
Sbjct: 237 LERDPQKR--LGDNLKDLKNH 255
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-19
Identities = 66/222 (29%), Positives = 112/222 (50%), Gaps = 16/222 (7%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQD--FLDDQLKEFLREVAIMKRV-RHPNVVLF 721
+G GSFG V AE G++ A+K L +D +DD ++ + E ++ HP +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALK-KDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
+ +L V EYL G L I + D R A ++ G+ +LH+
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSKG-- 116
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEK 841
I++ DLK N+L+D + +K+ DFG+ + + + GTP+++APE L G+ N
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS 176
Query: 842 SDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP 883
D +SFGV+L+E++ Q P++G ++ FQ+ R+ P
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGHDEEEL-----FQSIRMDNP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-19
Identities = 70/256 (27%), Positives = 123/256 (48%), Gaps = 15/256 (5%)
Query: 667 VGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKEFL---REVAIMKRVRHPNVVL 720
+G GSFG V A H ++ AVKVL + L + ++ + R V ++K V+HP +V
Sbjct: 3 IGKGSFGKVLLAR-HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVG 60
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
+ L V +Y+ G L+ + R ++ R R A ++A + YLH+LN
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARF-YAAEIASALGYLHSLN- 116
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNE 840
I++ DLK N+L+D + + DFGL + ++ + GTPE++APE L +P +
Sbjct: 117 -IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 841 KSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD 900
D + G +L+E++ P+ A++ + N+ L + N + L+E
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL--NKPLQLKPNITNSARHLLEGLLQK 233
Query: 901 DPAQRPSFANIVESLK 916
D +R + +K
Sbjct: 234 DRTKRLGAKDDFMEIK 249
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 4e-19
Identities = 72/245 (29%), Positives = 118/245 (48%), Gaps = 15/245 (6%)
Query: 667 VGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKEFL---REVAIMKRVRHPNVVL 720
+G GSFG V A+ SD AVKVL + L + + + R V ++K ++HP +V
Sbjct: 3 IGKGSFGKVLLAK-RKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVG 60
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
+ L V +Y+ G L+ + R ++ R R A +VA I YLH+LN
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERC--FLEPRARF-YAAEVASAIGYLHSLN- 116
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNE 840
I++ DLK N+L+D V + DFGL + ++ + GTPE++APE LR EP +
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 841 KSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD 900
D + G +L+E++ P+ +Q+ + + L +P + L+
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK--PLQLPGGKTVAACDLLVGLLHK 233
Query: 901 DPAQR 905
D +R
Sbjct: 234 DQRRR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 5e-19
Identities = 64/242 (26%), Positives = 116/242 (47%), Gaps = 10/242 (4%)
Query: 667 VGAGSFGTV--HRAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
+G G+FG V R + G A+K+L + + D++ + E +++ RHP +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
A L V EY G L+ + R ++R R A ++ + YLH+ + ++
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGA-EIVSALEYLHSRD--VV 117
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSD 843
+ D+K NL++DK+ +K+ DFGL + + + K+ GTPE++APE L D
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 844 VYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPA 903
+ GV+++E++ + P+ ++ + + R P+ SP SL+ DP
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--PRTLSPEAKSLLAGLLKKDPK 235
Query: 904 QR 905
QR
Sbjct: 236 QR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 8e-19
Identities = 49/148 (33%), Positives = 86/148 (58%), Gaps = 20/148 (13%)
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS--KSVAGTPEWMAPEFLRGEPSN 839
++H D+KS N+L+ N VK+ DFG S+ A T ++ GTP ++APE R +P +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 840 EKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLA-----IPQNTSPVLASLM 894
+K+D++S GV+L+EL+T+++P++G +V+ ++ LA +P + SP + ++
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFDGENMEEVM------HKTLAGRYDPLPPSISPEMQEIV 277
Query: 895 ESCWADDPAQRPSFANIVESLKKLLKSP 922
+ + DP +RPS KLL P
Sbjct: 278 TALLSSDPKRRPSS-------SKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-18
Identities = 62/242 (25%), Positives = 115/242 (47%), Gaps = 10/242 (4%)
Query: 667 VGAGSFGTV--HRAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
+G G+FG V R + G A+K+L + + D++ L E ++K RHP +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
+ + L V EY+ G L+ + R + + R ++ ++YLH+ I+
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHS--GKIV 117
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSD 843
+ DLK NL++DK+ +K+ DFGL + + K+ GTPE++APE L D
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 844 VYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPA 903
+ GV+++E++ + P+ ++ + ++ + P+ S SL+ DP
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED--IKFPRTLSADAKSLLSGLLIKDPN 235
Query: 904 QR 905
+R
Sbjct: 236 KR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 73/272 (26%), Positives = 133/272 (48%), Gaps = 29/272 (10%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH- 715
D+L V E +G G++G V R G+ +AVK + +Q K L ++ I R
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDC 59
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRG--SLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
P V F GA+ + + I E + Y+ ++ G + + ++A+ + K +
Sbjct: 60 PYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDK--GLTIPEDILGKIAVSIVKALE 117
Query: 774 YLH-NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSV-AGTPEWMAPE 831
YLH L+ ++H D+K N+L+++N VK+CDFG+S + ++ +K++ AG +MAPE
Sbjct: 118 YLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--AKTIDAGCKPYMAPE 173
Query: 832 FLRGEPS----NEKSDVYSFGVILWELVTMQQPWNGLGP-----AQVVGAVAFQNRRLAI 882
+ E + + KSDV+S G+ + EL T + P++ QVV + +
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-----EEPSPQL 228
Query: 883 PQNT-SPVLASLMESCWADDPAQRPSFANIVE 913
P SP + C + +RP++ +++
Sbjct: 229 PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-18
Identities = 52/167 (31%), Positives = 90/167 (53%), Gaps = 13/167 (7%)
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR--FKANTFISSK 819
L VA+G+ +L + N +H DL + N+L+ + VK+CDFGL+R + ++S
Sbjct: 240 LSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG 297
Query: 820 SVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR- 878
S +WMAPE + SDV+S+G++LWE+ ++ P +V + F N+
Sbjct: 298 STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLG---GTPYPGMIVDS-TFYNKI 353
Query: 879 ----RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921
R+A P + + + +M CW +P +RPSF ++ + ++ LL S
Sbjct: 354 KSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLPS 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-18
Identities = 73/268 (27%), Positives = 122/268 (45%), Gaps = 57/268 (21%)
Query: 667 VGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKE----FLREVAIMKRVRHPNVVL 720
+G GSFG V+ R VA+K ++ + Q E ++EV ++++RHPN +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMS---YSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA-------KGIN 773
+ G + +V EY GS A ++++ ++ +++A +G+
Sbjct: 80 YKGCYLREHTAWLVMEYC-LGS---------ASDILEVHKKPLQEVEIAAICHGALQGLA 129
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK--ANTFISSKSVAGTPEWMAPE 831
YLH+ +H D+K+ N+L+ + TVK+ DFG + AN+F+ GTP WMAPE
Sbjct: 130 YLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPE 181
Query: 832 FLRGEPSNE---KSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888
+ + K DV+S G+ EL + P + + +A QN SP
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---------QNDSP 232
Query: 889 VLAS---------LMESCWADDPAQRPS 907
L+S ++SC P RPS
Sbjct: 233 TLSSNDWSDYFRNFVDSCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-18
Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 729 PHLSIVTEYLP----RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
+ S +YLP R LI+ A MD + + VA G+ +L + N +H
Sbjct: 208 NYESPYDQYLPSAPERTRRDTLINESPALSYMDL---VGFSYQVANGMEFLASKN--CVH 262
Query: 785 WDLKSPNLLVDKNWTVKVCDFGLSR--FKANTFISSKSVAGTPEWMAPEFLRGEPSNEKS 842
DL + N+L+ + VK+CDFGL+R + + +IS S +WMAPE + S
Sbjct: 263 RDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLS 322
Query: 843 DVYSFGVILWELVTMQ-QPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADD 901
DV+SFG++LWE+ T+ P+ L + + R+A P + S + +M+ CW +
Sbjct: 323 DVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEK 382
Query: 902 PAQRPSFANIVESLKKLL 919
RP F+ +V + LL
Sbjct: 383 FEIRPDFSQLVHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 4e-18
Identities = 71/279 (25%), Positives = 126/279 (45%), Gaps = 41/279 (14%)
Query: 665 ERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMG 723
E VG G++G V++ H + + V D +D+ +E E+ ++K+ H N+ + G
Sbjct: 22 EVVGNGTYGQVYKGR-HVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 724 AVTKRP------HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
A K+ L +V E+ GS+ L+ + G + + + ++ +G+ +LH
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLV-KNTKGNALKEDWIAYICREILRGLAHLHA 139
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEP 837
++H D+K N+L+ +N VK+ DFG+S T + GTP WMAPE + +
Sbjct: 140 HK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 197
Query: 838 SNE-----KSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892
+ + +SD++S G+ E+ P + P + + IP+N P L S
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL---------FLIPRNPPPKLKS 248
Query: 893 ---------LMESCWADDPAQRPSFANIVESLKKLLKSP 922
+E C + RP S ++LLK P
Sbjct: 249 KKWSKKFIDFIEGCLVKNYLSRP-------STEQLLKHP 280
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 5e-18
Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 11/211 (5%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
D+L + VG G+FG VH R A+KV+ + + + Q + E ++K V H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
P ++ + L ++ EY+P G L+ + +G + A ++ + YL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLR--NSGRFSNSTGLF-YASEIVCALEYL 117
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRG 835
H+ I++ DLK N+L+DK +K+ DFG F + ++ GTPE++APE ++
Sbjct: 118 HSKE--IVYRDLKPENILLDKEGHIKLTDFG---FAKKLRDRTWTLCGTPEYLAPEVIQS 172
Query: 836 EPSNEKSDVYSFGVILWELVTMQQPWNGLGP 866
+ N+ D ++ G++++E++ P+ P
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPPFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 6e-18
Identities = 73/244 (29%), Positives = 120/244 (49%), Gaps = 13/244 (5%)
Query: 667 VGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLD-DQLKEFLREVAIM-KRVRHPNVVLF 721
+G GSFG V A+ H +D AVKVL + L + K + E ++ K V+HP +V
Sbjct: 3 IGKGSFGKVLLAK-HKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
+ L V +Y+ G L+ + R + + R R A ++A + YLH+LN
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERS--FPEPRARF-YAAEIASALGYLHSLN-- 116
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEK 841
I++ DLK N+L+D V + DFGL + ++ + GTPE++APE LR +P +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT 176
Query: 842 SDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADD 901
D + G +L+E++ P+ A++ + N+ L + N S L+E D
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL--NKPLRLKPNISVSARHLLEGLLQKD 234
Query: 902 PAQR 905
+R
Sbjct: 235 RTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 64/271 (23%), Positives = 115/271 (42%), Gaps = 33/271 (12%)
Query: 665 ERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK----------EFLREVAIMKRVR 714
E +G G+F +++ V Q+ + LK F ++M ++
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQE-VSVVLKVLGSDHRDSLAFFETASLMSQLS 59
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
H ++V G V R +V EY+ G L +HR + + L +A +A ++Y
Sbjct: 60 HKHLVKLYG-VCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHY 116
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWT-------VKVCDFGLSRFKANTFISSKSVAGTPEW 827
L + ++H ++ N+LV + +K+ D G+ + V P W
Sbjct: 117 LEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI---TVLSREERVERIP-W 170
Query: 828 MAPEFLRGEPSNEKS--DVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQ 884
+APE +R ++ D +SFG L E+ + ++P + L ++ F + +P
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFYQDQHRLPM 227
Query: 885 NTSPVLASLMESCWADDPAQRPSFANIVESL 915
LA+L+ CW DP +RPSF I+ L
Sbjct: 228 PDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 7e-18
Identities = 76/264 (28%), Positives = 133/264 (50%), Gaps = 27/264 (10%)
Query: 667 VGAGSFGTVH-----RAEWHGSDVAVKVL-----TVQDFLDDQLKEFLREVAIMKRVRHP 716
+G GSFG V G A+KVL V+D + ++ E I+ V HP
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-----ERDILAEVNHP 58
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMAL-DVAKGINY 774
+V A L ++ ++L G L+ RL + E+M ++ L ++A +++
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLAELALALDH 113
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLR 834
LH+L I++ DLK N+L+D+ +K+ DFGLS+ + + S GT E+MAPE +
Sbjct: 114 LHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171
Query: 835 GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894
+ +D +SFGV+++E++T P+ G + + + +L +PQ SP SL+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQSLL 229
Query: 895 ESCWADDPAQR-PSFANIVESLKK 917
+ + +PA R + + VE +K+
Sbjct: 230 RALFKRNPANRLGAGPDGVEEIKR 253
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 7e-18
Identities = 49/163 (30%), Positives = 92/163 (56%), Gaps = 9/163 (5%)
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSV 821
LR + VA+G+++L + N +H D+ + N+L+ K+CDFGL+R N S+ V
Sbjct: 215 LRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMND--SNYVV 270
Query: 822 AGTP----EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQ 876
G +WMAPE + +SDV+S+G++LWE+ ++ + P+ G+ + +
Sbjct: 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR 330
Query: 877 NRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLL 919
+++ P P + S+M+ CW +P +RP+F+ I + +++ L
Sbjct: 331 GYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-17
Identities = 64/242 (26%), Positives = 114/242 (47%), Gaps = 9/242 (3%)
Query: 667 VGAGSFGTV--HRAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
+G G+FG V + + G A+K+L + + D++ L E +++ RHP +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
+ L V EY G L+ + R + R R A ++ ++YLH+ ++
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGA-EIVSALDYLHS-EKNVV 118
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSD 843
+ DLK NL++DK+ +K+ DFGL + + K+ GTPE++APE L D
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 178
Query: 844 VYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPA 903
+ GV+++E++ + P+ ++ + + R P+ SP SL+ DP
Sbjct: 179 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF--PRTLSPEAKSLLSGLLKKDPK 236
Query: 904 QR 905
QR
Sbjct: 237 QR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 79/279 (28%), Positives = 125/279 (44%), Gaps = 38/279 (13%)
Query: 659 DELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-H 715
D + E +G G++G V + + +GS AVK+L D + D +E E I+K + H
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL---DPIHDIDEEIEAEYNILKALSDH 74
Query: 716 PNVVLFMGAVTKRP-----HLSIVTEYLPRGSLYRLIH-RPAAGEMMDQRRRLRMALDVA 769
PNVV F G K+ L +V E GS+ L+ GE M++ + +
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMA 829
G+ +LH N I H D+K N+L+ VK+ DFG+S +T + + GTP WMA
Sbjct: 135 MGLQHLHV-NKTI-HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192
Query: 830 PEFLRGEPS-----NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQ 884
PE + E + + DV+S G+ EL P L P + + IP+
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL---------FKIPR 243
Query: 885 NTSPVLAS----------LMESCWADDPAQRPSFANIVE 913
N P L + C D +RP+ +++++
Sbjct: 244 NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 68/257 (26%), Positives = 117/257 (45%), Gaps = 35/257 (13%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQ-DFLDDQLKEFLREVAIMKRVRHPNVVLFMG 723
+G GSFG V+ A + VA+K ++ +++ ++ ++EV ++++RHPN + + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 724 AVTKRPHLSIVTEY-LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
+ +V EY L S +H+ E+ + +G+ YLH+ N +
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV----EIAAVTHGALQGLAYLHSHN--M 136
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNE-- 840
+H D+K+ N+L+ + VK+ DFG A+ + GTP WMAPE + +
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 841 -KSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS------- 892
K DV+S G+ EL + P + + +A QN SP L S
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---------QNESPALQSGHWSEYF 243
Query: 893 --LMESCWADDPAQRPS 907
++SC P RP+
Sbjct: 244 RNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 3e-17
Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 14/213 (6%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRH 715
+ VK VG G FG V R + G A+KV+ L + + F E I+
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
P + A + +L +V EY P G L L++R + + + +A ++ I+ +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNR-YEDQFDEDMAQFYLA-ELVLAIHSV 118
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSVAGTPEWMAPEFLR 834
H + +H D+K N+L+D+ +K+ DFG + R AN ++SK GTP+++APE L
Sbjct: 119 HQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 835 GEPSNEKS------DVYSFGVILWELVTMQQPW 861
+ K D +S GVI +E++ + P+
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 81/279 (29%), Positives = 130/279 (46%), Gaps = 37/279 (13%)
Query: 665 ERVGAGSFGTVHRAE-WHGSDVA---VKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
+ +G G FG V +E + + VA VK L +Q EFL++ + ++HPN++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ-NEFLQQGDPYRILQHPNILQ 59
Query: 721 FMG-AVTKRPHLSIVTEYLPRGSLYRLI-----HRPAAGEMMDQRRRLRMALDVAKGINY 774
+G V P+L +V EY G L + HR + ++ QR MA ++A G+ +
Sbjct: 60 CLGQCVEAIPYL-LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR----MACEIAAGVTH 114
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL--SRFKANTFISSKSVAGTPEWMAPEF 832
+H N LH DL N + + TVKV D+G+ SR+K + + W+APE
Sbjct: 115 MHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPEL 172
Query: 833 -------LRGEPSNEKSDVYSFGVILWELV-TMQQPWNGLGPAQVVGAVAF-QNRRLAIP 883
L + S+V++ GV LWEL QP++ L +V+ V Q +L P
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKP 232
Query: 884 QNTSPV---LASLMESCWADDPAQRPSFANIVESLKKLL 919
Q P +++ CW P +R + E + +LL
Sbjct: 233 QLELPYSERWYEVLQFCWL-SPEKRAT----AEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 21/206 (10%)
Query: 662 HVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQ--LKEFLREVAIMKRVR--- 714
+G G++GTV++A G VA+K + V L ++ LRE+A++K++
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVP--LSEEGIPLSTLREIALLKQLESFE 59
Query: 715 HPNVV----LFMGAVTKRP-HLSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLRMALDV 768
HPN+V + G T R L++V E++ + L + + P G + + +
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG--LPPETIKDLMRQL 116
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWM 828
+G+++LH+ I+H DLK N+LV + VK+ DFGL+R + ++ SV T +
Sbjct: 117 LRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIYSFE-MALTSVVVTLWYR 173
Query: 829 APEFLRGEPSNEKSDVYSFGVILWEL 854
APE L D++S G I EL
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 5e-17
Identities = 67/250 (26%), Positives = 123/250 (49%), Gaps = 25/250 (10%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVL----TVQDFLDDQLKEFLREVAIMKRV-----RH 715
+G GSFG V AE G+D A+K+L +QD DD + + KRV +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQD--DD-----VECTMVEKRVLALPGKP 60
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
P + L V EY+ G L + H G+ + A ++A G+ +L
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEPHAVF-YAAEIAIGLFFL 117
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRG 835
H+ I++ DLK N+++D +K+ DFG+ + ++++ GTP+++APE +
Sbjct: 118 HSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY 175
Query: 836 EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895
+P + D ++FGV+L+E++ Q P++G ++ ++ N ++ P++ S S+ +
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSLSKEAVSICK 233
Query: 896 SCWADDPAQR 905
PA+R
Sbjct: 234 GLLTKHPAKR 243
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-16
Identities = 63/245 (25%), Positives = 119/245 (48%), Gaps = 15/245 (6%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVL----TVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
+G GSFG V AE G+D A+K+L +QD DD + + + + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD--DDVECTMVEKRVLALSGKPPFLTQ 65
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
L V EY+ G L I + + + A ++A G+ +LH+
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR---FKEPHAVFYAAEIAIGLFFLHSKG- 121
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNE 840
I++ DLK N+++D +K+ DFG+ + +++K+ GTP+++APE + +P +
Sbjct: 122 -IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK 180
Query: 841 KSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD 900
D ++FGV+L+E++ Q P+ G ++ ++ N +A P++ S ++ +
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--VAYPKSMSKEAVAICKGLMTK 238
Query: 901 DPAQR 905
P +R
Sbjct: 239 HPGKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-16
Identities = 74/252 (29%), Positives = 122/252 (48%), Gaps = 29/252 (11%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRV-----RHPNV 718
+G GSFG V AE G AVK L L DD ++ + E KRV +P +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVE----KRVLALAWENPFL 58
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
+ HL V E+L G L + H G D R A ++ G+ +LH+
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRF-DLYRATFYAAEIVCGLQFLHSK 115
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK--SVAGTPEWMAPEFLRGE 836
I++ DLK N+++D++ +K+ DFG+ K N F ++ + GTP+++APE L+G
Sbjct: 116 G--IIYRDLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGL 171
Query: 837 PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS---L 893
D +SFGV+L+E++ Q P++G ++ F++ R+ P + +
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL-----FESIRVDTPHYPRWITKESKDI 226
Query: 894 MESCWADDPAQR 905
+E + DP +R
Sbjct: 227 LEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 70/268 (26%), Positives = 127/268 (47%), Gaps = 47/268 (17%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQ-DFLDDQLKEFLREVAIMKRVRHPNVVLFMG 723
+G GSFG V+ A ++ VAVK ++ +++ ++ ++EV +++++HPN + + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA-------KGINYLH 776
K +V EY GS A ++++ ++ +++A +G+ YLH
Sbjct: 89 CYLKEHTAWLVMEYC-LGS---------ASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 138
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGE 836
+ N ++H D+K+ N+L+ + VK+ DFG A+ + S GTP WMAPE +
Sbjct: 139 SHN--MIHRDIKAGNILLTEPGQVKLADFG----SASKSSPANSFVGTPYWMAPEVILAM 192
Query: 837 PSNE---KSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS- 892
+ K DV+S G+ EL + P + + +A QN SP L S
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---------QNDSPTLQSN 243
Query: 893 --------LMESCWADDPAQRPSFANIV 912
++ C P +RP+ A ++
Sbjct: 244 EWTDSFRGFVDYCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 66/247 (26%), Positives = 114/247 (46%), Gaps = 20/247 (8%)
Query: 667 VGAGSFGTV--HRAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
+G G+FG V R + G A+K+L + + D++ L E +++ RHP +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
+ L V EY G L+ H + R R A ++ + YLH+ + ++
Sbjct: 63 SFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALGYLHSCD--VV 117
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSD 843
+ DLK NL++DK+ +K+ DFGL + + + K+ GTPE++APE L D
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 177
Query: 844 VYSFGVILWELVTMQQPW-----NGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCW 898
+ GV+++E++ + P+ L ++ + F P+ SP SL+
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF-------PRTLSPEAKSLLAGLL 230
Query: 899 ADDPAQR 905
DP QR
Sbjct: 231 KKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 8/196 (4%)
Query: 665 ERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
E++G G++G V++ G VA+K + ++ + +RE++++K ++HPN+V
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
+ + L ++ E+L L + + G+ MD + +GI + H+ +
Sbjct: 66 DVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--V 122
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMAPEFLRGEPS-NE 840
LH DLK NLL+D +K+ DFGL+R F + + V T + APE L G P +
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLGSPRYST 181
Query: 841 KSDVYSFGVILWELVT 856
D++S G I E+ T
Sbjct: 182 PVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 65/250 (26%), Positives = 125/250 (50%), Gaps = 16/250 (6%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLR-EVAIMKRV-RHPNVVLFM 722
+G GS+ V ++ A+KV+ + DD+ ++++ E + ++ HP +V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
L V EY+ G L + H ++ ++ R A +++ +NYLH I
Sbjct: 63 SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYLHERG--I 117
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKS 842
++ DLK N+L+D +K+ D+G+ + ++ + GTP ++APE LRGE
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 843 DVYSFGVILWELVTMQQPWNGLG----PAQVVGAVAFQ---NRRLAIPQNTSPVLASLME 895
D ++ GV+++E++ + P++ +G P Q FQ +++ IP++ S AS+++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237
Query: 896 SCWADDPAQR 905
S DP +R
Sbjct: 238 SFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 59/216 (27%), Positives = 107/216 (49%), Gaps = 33/216 (15%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSDV--AVKV--LTVQDFLDDQLKEFLREVAIMKRVR 714
D+ +GAG+ G V + S + A K+ L ++ + +Q+ +RE+ ++
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQI---IRELKVLHECN 57
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL------RMALDV 768
P +V F GA +SI E++ GSL +++ + R+ ++++ V
Sbjct: 58 SPYIVGFYGAFYSDGEISICMEHMDGGSL---------DQVLKKAGRIPENILGKISIAV 108
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS----RFKANTFISSKSVAGT 824
+G+ YL I+H D+K N+LV+ +K+CDFG+S AN+F+ GT
Sbjct: 109 LRGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GT 161
Query: 825 PEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQP 860
+M+PE L+G +SD++S G+ L E+ + P
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-16
Identities = 71/282 (25%), Positives = 133/282 (47%), Gaps = 47/282 (16%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQ-DFLDDQLKEFLREVAIMKRVRHPNVVLFMG 723
+G GSFG V+ A ++ VA+K ++ +++ ++ ++EV ++R++HPN + + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA-------KGINYLH 776
+ +V EY GS A ++++ ++ +++A +G+ YLH
Sbjct: 93 CYLREHTAWLVMEYC-LGS---------ASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGE 836
+ N ++H D+K+ N+L+ + VK+ DFG A+ + S GTP WMAPE +
Sbjct: 143 SHN--MIHRDIKAGNILLTEPGQVKLADFG----SASIASPANSFVGTPYWMAPEVILAM 196
Query: 837 PSNE---KSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS- 892
+ K DV+S G+ EL + P + + +A QN SP L S
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---------QNESPTLQSN 247
Query: 893 --------LMESCWADDPAQRPSFANIVESLKKLLKSPAQLI 926
++SC P RP+ +++ + L + P ++
Sbjct: 248 EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVL 289
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 70/277 (25%), Positives = 119/277 (42%), Gaps = 41/277 (14%)
Query: 665 ERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPNVVL 720
++G GS+G V R G VA+K + DD + K LRE+ ++K+++HPN+V
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESE--DDPVIKKIALREIRMLKQLKHPNLVN 64
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
+ ++ L +V EY L L P + + ++ + +N+ H N
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCHKHN- 120
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPS-N 839
+H D+K N+L+ K +K+CDFG +R T + APE L G+
Sbjct: 121 -CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYG 179
Query: 840 EKSDVYSFGVILWELVTMQQPWNGLGPA-------QVVGAVAFQNRR----------LAI 882
DV++ G + EL+T Q W G + +G + ++++ L+I
Sbjct: 180 PPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239
Query: 883 PQ------------NTSPVLASLMESCWADDPAQRPS 907
P+ N S S ++ C DP +R S
Sbjct: 240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 51/159 (32%), Positives = 86/159 (54%), Gaps = 17/159 (10%)
Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
+ ++G G+FG V++A G VA+K + + + D LRE+ I+K+++HPNVV
Sbjct: 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVV 70
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRL---IHRPAAGEMMDQRRRLRMA------LDVAK 770
+ +RP S RGS+Y + + +G + + +L + L + +
Sbjct: 71 PLIDMAVERPDKSKRK----RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLE 126
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
GINYLH + ILH D+K+ N+L+D +K+ DFGL+R
Sbjct: 127 GINYLHENH--ILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 4e-16
Identities = 60/245 (24%), Positives = 122/245 (49%), Gaps = 15/245 (6%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVL----TVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
+G GSFG V AE G+D A+K+L +QD DD + + + + + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD--DDVECTMVEKRVLALQDKPPFLTQ 65
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
L V EY+ G L I + + + + A +++ G+ +LH
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGLFFLHRRG- 121
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNE 840
I++ DLK N+++D +K+ DFG+ + +++++ GTP+++APE + +P +
Sbjct: 122 -IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGK 180
Query: 841 KSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD 900
D +++GV+L+E++ Q P++G ++ ++ N ++ P++ S S+ +
Sbjct: 181 SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--VSYPKSLSKEAVSICKGLMTK 238
Query: 901 DPAQR 905
P++R
Sbjct: 239 HPSKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 11/200 (5%)
Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFL---REVAIMKRVRHPNVVLF 721
+G GSFG V A+ G AVKVL + L+ + ++ + R V ++K V+HP +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVGL 61
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
+ L V +++ G L+ H + R R A ++A + YLH++N
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELF--FHLQRERSFPEPRARFYAA-EIASALGYLHSIN-- 116
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEK 841
I++ DLK N+L+D V + DFGL + ++ + GTPE++APE +R +P +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176
Query: 842 SDVYSFGVILWELVTMQQPW 861
D + G +L+E++ P+
Sbjct: 177 VDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 59/198 (29%), Positives = 99/198 (50%), Gaps = 19/198 (9%)
Query: 667 VGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMG 723
+G+G+ G V A G +VA+K L+ + F + K RE+ +MK V H N++ +
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLS-RPFQNVTHAKRAYRELVLMKLVNHKNIIGLLN 82
Query: 724 AVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
T + L +V E L +L ++I +D R + + GI +LH+
Sbjct: 83 VFTPQKSLEEFQDVYLVME-LMDANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHS 136
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEP 837
I+H DLK N++V + T+K+ DFGL+R +F+ + V T + APE + G
Sbjct: 137 AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMG 193
Query: 838 SNEKSDVYSFGVILWELV 855
E D++S G I+ E++
Sbjct: 194 YKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 9/199 (4%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRVR-HPNVVLFM 722
+G GSFG V AE G+D A+KVL L DD + + E I+ HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
+ L V EY+ G L I R D+ R A +V + +LH +
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG--V 117
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKS 842
++ DLK N+L+D K+ DFG+ + +++ + GTP+++APE L+
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV 177
Query: 843 DVYSFGVILWELVTMQQPW 861
D ++ GV+++E++ Q P+
Sbjct: 178 DWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-15
Identities = 55/213 (25%), Positives = 108/213 (50%), Gaps = 19/213 (8%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRV 713
E+ D+ +GAG+ G V + + S + + + + ++ + +RE+ ++
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL------RMALD 767
P +V F GA +SI E++ GSL +++ + +R+ ++++
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSL---------DQVLKEAKRIPEEILGKVSIA 111
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEW 827
V +G+ YL + I+H D+K N+LV+ +K+CDFG+S ++ + S GT +
Sbjct: 112 VLRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSY 168
Query: 828 MAPEFLRGEPSNEKSDVYSFGVILWELVTMQQP 860
M+PE L+G + +SD++S G+ L EL + P
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-14
Identities = 71/240 (29%), Positives = 107/240 (44%), Gaps = 25/240 (10%)
Query: 682 GSDVAVKVLTVQDFLDD-QLKEFLREVAIMKRVRHPNVV-LFMGAVTKRPHLSIVTEYLP 739
G +VA+K+L ++ Q F RE A+ R+ HPN+V L L V EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 740 RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DK 796
+L ++ AA + R+ L V + HN I+H DLK N++V
Sbjct: 63 GRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG--IVHRDLKPQNIMVSQTGV 117
Query: 797 NWTVKVCDFGLSRF-------KANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGV 849
KV DFG+ T + V GTP + APE LRGEP SD+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 850 ILWELVTMQQPWNGLGPAQVVGAVAFQN---RRLAIPQN-TSPVLASLMESCWADDPAQR 905
I E +T Q+ G A+++ +Q +++P L ++ DP QR
Sbjct: 178 IFLECLTGQRVVQGASVAEIL----YQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 16/225 (7%)
Query: 704 LREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL-YRLIHRPAAGEMMDQRRRL 762
L E I+++V +V A + L +V + G L Y + + G + R +
Sbjct: 41 LNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG--FPEARAI 98
Query: 763 RMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSV 821
A + G+ +LH I++ DLK N+L+D + V++ D GL+ K I K
Sbjct: 99 FYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI--KGR 154
Query: 822 AGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLA 881
AGTP +MAPE L+GE + D ++ G L+E++ + P+ + V + R L
Sbjct: 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK--EKVEKEELKRRTLE 212
Query: 882 I----PQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
+ P SP L E+ DP +R S ++ + P
Sbjct: 213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRG--GSADEVREHP 255
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-14
Identities = 57/207 (27%), Positives = 109/207 (52%), Gaps = 7/207 (3%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK-EFLREVAIMKRV 713
E+ D+ +GAG+ G V + S + + + + ++ + +RE+ ++
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
P +V F GA +SI E++ GSL +++ + AG + +Q ++++ V KG+
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILG-KVSIAVIKGLT 117
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFL 833
YL + I+H D+K N+LV+ +K+CDFG+S ++ + S GT +M+PE L
Sbjct: 118 YLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERL 174
Query: 834 RGEPSNEKSDVYSFGVILWELVTMQQP 860
+G + +SD++S G+ L E+ + P
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
E++G G++G V++A G VA+K + ++ + +RE++++K + HPN+V +
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL 64
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL-DVAKGINYLHNLNPP 781
V L +V E+L L + ++ ++ L + +GI Y H+
Sbjct: 65 DVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR-- 119
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMAPEFLRGEPSNE 840
+LH DLK NLL+D+ +K+ DFGL+R F + V T + APE L G
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQYS 178
Query: 841 KS-DVYSFGVILWELVT 856
D++S G I E+V
Sbjct: 179 TPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 69/258 (26%), Positives = 113/258 (43%), Gaps = 32/258 (12%)
Query: 668 GAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLDDQ--LKEFLREVAIMKRVRH-PNVV 719
G G++G V G A+KVL + + E +++ VR P +V
Sbjct: 9 GTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLV 68
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
A L ++ +Y+ G L+ L R + R+ +A ++ +++LH L
Sbjct: 69 TLHYAFQTDTKLHLILDYVNGGELFTHLYQR---EHFTESEVRVYIA-EIVLALDHLHQL 124
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMAPEFLRGEP 837
I++ D+K N+L+D V + DFGLS+ F A + S GT E+MAPE +RG
Sbjct: 125 G--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGS 182
Query: 838 S--NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ---NRRL-----AIPQNTS 887
++ D +S GV+ +EL+T G P V G Q +RR+ P+ S
Sbjct: 183 GGHDKAVDWWSLGVLTFELLT------GASPFTVDGEQNSQSEISRRILKSKPPFPKTMS 236
Query: 888 PVLASLMESCWADDPAQR 905
++ DP +R
Sbjct: 237 AEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 4e-14
Identities = 64/229 (27%), Positives = 100/229 (43%), Gaps = 41/229 (17%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRH 715
D+ V + +G G+FG V R + G A+KVL D + +Q+ E I+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 716 PNVV-LFMGAVTKRPHLSIVTEYLPRGSLYR-LIHRPAAGEMMDQRRRLRMALDVAKGIN 773
P +V L+ + HL +V EY+P G L LI + E + + L ++
Sbjct: 61 PWIVKLYYSFQDEE-HLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVL----ALD 115
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS------------------------- 808
+H L +H D+K N+L+D + +K+ DFGL
Sbjct: 116 SVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 809 ----RFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWE 853
R + + S GTP+++APE LRG P + D +S GVIL+E
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 10/196 (5%)
Query: 666 RVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMG 723
R+G G++G V+RA S VA+K + + + D LRE+ ++ +RHPN+V
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 724 AVTKRPHLSI--VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
V + SI V EY + L L+ Q + L L + +G+ YLH
Sbjct: 74 VVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCL--MLQLLRGLQYLHE--NF 128
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEK 841
I+H DLK NLL+ +K+ DFGL+R T + APE L G +
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTT 188
Query: 842 S-DVYSFGVILWELVT 856
+ D+++ G IL EL+
Sbjct: 189 AIDMWAVGCILAELLA 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 4e-14
Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 30/220 (13%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFL-DDQLKEFLREVAIM 710
++ +++ + +G GSFG V A + D VA+K + Q+ E I+
Sbjct: 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKIL 85
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDV-- 768
+ HP V G+ +L +V E++ G + + RR R DV
Sbjct: 86 NYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-----------RRNKRFPNDVGC 134
Query: 769 --AKGI----NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSV 821
A I YL +LN I++ DLK NLL+DK+ +K+ DFG ++ T+ ++
Sbjct: 135 FYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY----TL 188
Query: 822 AGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPW 861
GTPE++APE L + +D ++ G+ ++E++ P+
Sbjct: 189 CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 26/208 (12%)
Query: 665 ERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQ--LKEFLREVAIMKRVRHPNVVL 720
E++G G++GTV +A+ VA+K + + D DD+ LRE+ ++K ++H N+V
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVR 63
Query: 721 FMGAVTKRPHLSIVTEYLPRG------SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
+ L++V EY + S I M Q + KG+ +
Sbjct: 64 LYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQ---------LLKGLAF 114
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMAPEFL 833
H+ N +LH DLK NLL++KN +K+ DFGL+R F S V T + P+ L
Sbjct: 115 CHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVL 171
Query: 834 RGEPSNEKS-DVYSFGVILWELVTMQQP 860
G S D++S G I EL +P
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 5e-14
Identities = 63/225 (28%), Positives = 103/225 (45%), Gaps = 23/225 (10%)
Query: 667 VGAGSFGTVH--RAEWHGSDVAVKVLTVQDF-LDDQLKEFLREVAIMKRVRHPNVVLFMG 723
+ G++G V+ R + A+K + Q+ L +Q+++ E I+ +P VV
Sbjct: 9 ISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFC 68
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
+ + HL +V EY+ G L+ G + R+ A V + YLHN I+
Sbjct: 69 SFETKRHLCMVMEYVEGGDCATLLKN--IGALPVDMARMYFAETVL-ALEYLHNYG--IV 123
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF---------------KANTFISSKSVAGTPEWM 828
H DLK NLL+ +K+ DFGLS+ K K V GTPE++
Sbjct: 124 HRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYI 183
Query: 829 APEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAV 873
APE + + + D ++ G+IL+E + P+ G P ++ G V
Sbjct: 184 APEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-14
Identities = 43/148 (29%), Positives = 82/148 (55%), Gaps = 5/148 (3%)
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT--FISSKSVAGTPEWMAPEFLRGEPSN 839
++H DLKS N+ + +K+ DFG S+ +++ + S GTP ++APE + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 840 EKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWA 899
+K+D++S GVIL+EL+T+ +P+ G +++ V + P S + +L++ +
Sbjct: 250 KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-PFPCPVSSGMKALLDPLLS 308
Query: 900 DDPAQRPSFANIVESLKKLLKSPAQLIQ 927
+PA RP+ ++ + + LK A L Q
Sbjct: 309 KNPALRPTTQQLLHT--EFLKYVANLFQ 334
|
Length = 478 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 56/191 (29%), Positives = 95/191 (49%), Gaps = 8/191 (4%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFL-DDQLKEF-LREVAIMKRVRHPNVVLFMGA 724
VG G++G V + + V + +D ++++KE LRE+ +++ ++ N+V A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784
+R L +V EY+ + L L P G ++ R L K I++ H + I+H
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPN-GVPPEKVRSYIYQL--IKAIHWCHKND--IVH 123
Query: 785 WDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSD 843
D+K NLL+ N +K+CDFG +R + + T + +PE L G P + D
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVD 183
Query: 844 VYSFGVILWEL 854
++S G IL EL
Sbjct: 184 MWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 9e-14
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 33/208 (15%)
Query: 665 ERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
E++G G++ TV+ R G VA+K + + D + +RE+++MK ++H N+V
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHL-DAEEGTPSTAIREISLMKELKHENIVRLH 64
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA----------KGI 772
+ L +V EY+ L + MD R ALD KGI
Sbjct: 65 DVIHTENKLMLVFEYM-DKDLKK---------YMDTHGV-RGALDPNTVKSFTYQLLKGI 113
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR---FKANTFISSKSVAGTPEWMA 829
+ H +LH DLK NLL++K +K+ DFGL+R NTF S++ V T + A
Sbjct: 114 AFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF-SNEVV--TLWYRA 168
Query: 830 PEFLRGEPSNEKS-DVYSFGVILWELVT 856
P+ L G + S D++S G I+ E++T
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 74/280 (26%), Positives = 129/280 (46%), Gaps = 51/280 (18%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL-KEFLREVAIMKRVRHPNVV---- 719
VG G+FG V A + G +VA+K + ++ F L K RE+ ++K +RH N++
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKI-MKPFSTPVLAKRTYRELKLLKHLRHENIISLSD 76
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
+F ++ + VTE L L+RL+ + + Q + + +G+ Y+H+
Sbjct: 77 IF---ISPLEDIYFVTELLGT-DLHRLL---TSRPLEKQFIQY-FLYQILRGLKYVHSAG 128
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPE-FLRGEPS 838
++H DLK N+L+++N +K+CDFGL+R + S T + APE L +
Sbjct: 129 --VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS---TRYYRAPEIMLTWQKY 183
Query: 839 NEKSDVYSFGVILWELVTMQQPWNG-------------LG--PAQVVGAVAFQN------ 877
+ + D++S G I E++ + + G LG P V+ + +N
Sbjct: 184 DVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243
Query: 878 ---RRLAIP-----QNTSPVLASLMESCWADDPAQRPSFA 909
+R +P +N P L+E DP +R S A
Sbjct: 244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAA 283
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 66/259 (25%), Positives = 121/259 (46%), Gaps = 34/259 (13%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRV-----RHPNVV 719
+G GS+ V E + A+KV+ + DD E + V K V HP +V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD---EDIDWVQTEKHVFETASNHPFLV 59
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLR------MALDVAKGIN 773
L V E++ G L + H M ++R+L + +++ +N
Sbjct: 60 GLHSCFQTESRLFFVIEFVSGGDL--MFH-------MQRQRKLPEEHARFYSAEISLALN 110
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFL 833
+LH I++ DLK N+L+D +K+ D+G+ + ++ + GTP ++APE L
Sbjct: 111 FLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 834 RGEPSNEKSDVYSFGVILWELVTMQQPWNGLG----PAQVVGAVAFQ---NRRLAIPQNT 886
RGE D ++ GV+++E++ + P++ +G P Q FQ +++ IP++
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL 228
Query: 887 SPVLASLMESCWADDPAQR 905
S +S+++ DP +R
Sbjct: 229 SVKASSVLKGFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 9/210 (4%)
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL-YRLIHRPAAGEMMDQRRRLRM 764
E I+ +V +V A + L +V + G L Y + + + R
Sbjct: 43 EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY 102
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
+ G+ +LH I++ DLK N+L+D + V++ D GL+ + +K AGT
Sbjct: 103 TAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160
Query: 825 PEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL---- 880
P +MAPE L+GE + D ++ GV L+E++ + P+ G + V + R L
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG--EKVENKELKQRILNDSV 218
Query: 881 AIPQNTSPVLASLMESCWADDPAQRPSFAN 910
P SP S E+ A DP +R F +
Sbjct: 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRD 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-13
Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 17/197 (8%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
+G+G+ G V A G +VAVK L+ K RE+ ++K V H N++ +
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
T + L +V E L +L ++IH +D R + + GI +LH+
Sbjct: 89 FTPQKSLEEFQDVYLVME-LMDANLCQVIHME-----LDHERMSYLLYQMLCGIKHLHSA 142
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPS 838
I+H DLK N++V + T+K+ DFGL+R F+ + V T + APE + G
Sbjct: 143 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV-TRYYRAPEVILGMGY 199
Query: 839 NEKSDVYSFGVILWELV 855
E D++S G I+ ELV
Sbjct: 200 KENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 5e-13
Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 8/198 (4%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMG 723
+G GSFG V + + A+K + + ++ L E ++ +V P +V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
+ L +V ++ G L+ + R G R R A ++ + LH N ++
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQR--EGRFDLSRARFYTA-ELLCALENLHKFN--VI 115
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSD 843
+ DLK N+L+D + +CDFGL + + + GTPE++APE L G + D
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVD 175
Query: 844 VYSFGVILWELVTMQQPW 861
++ GV+L+E++T P+
Sbjct: 176 WWTLGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEF------------LREVAIMKR 712
+G G++G V +A G VA+K + + + +D K+ LRE+ IM
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 713 VRHPNVVLFMGAV---TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
++H N+ MG V + +++V + + L +++ R + + + + + L +
Sbjct: 77 IKHENI---MGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKI--RLTESQVKCIL-LQIL 129
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAG------ 823
G+N LH +H DL N+ ++ K+ DFGL+R S
Sbjct: 130 NGLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 824 ---TPE-----WMAPEFLRG-EPSNEKSDVYSFGVILWELVT 856
T + + APE L G E + D++S G I EL+T
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 7e-13
Identities = 63/229 (27%), Positives = 109/229 (47%), Gaps = 18/229 (7%)
Query: 667 VGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEF---LREVAIMKRV---RHPNV 718
+G G+FG V+ R + A+KVL+ ++ + KE + E I+ R P +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV--AKKEVAHTIGERNILVRTLLDESPFI 58
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
V + L +VT+Y+ G L+ H G + R + +A ++ + +LH
Sbjct: 59 VGLKFSFQTDSDLYLVTDYMSGGELF--WHLQKEGRFSEDRAKFYIA-ELVLALEHLHKY 115
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPS 838
+ I++ DLK N+L+D + +CDFGLS+ ++ + GT E++APE L E
Sbjct: 116 D--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173
Query: 839 NEKS-DVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNT 886
K D +S GV+++E+ P+ Q+ +AF R P+N
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF--PKNV 220
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 8e-13
Identities = 60/216 (27%), Positives = 107/216 (49%), Gaps = 36/216 (16%)
Query: 666 RVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEF----LREVAIMKRVRHPNVV 719
R+ G++G V+RA + VA+K L ++ + + F LRE+ I+ +++HPN+V
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLK----MEKEKEGFPITSLREINILLKLQHPNIV 67
Query: 720 ----LFMGAVTKRPHLSIVTEYLP---RGSLYRLIHRPAAGE---MMDQRRRLRMALDVA 769
+ +G + + +V EY+ + + + E +M Q +
Sbjct: 68 TVKEVVVG--SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQ---------LL 116
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWM 828
G+ +LH+ ILH DLK+ NLL++ +K+CDFGL+R + + ++ V T +
Sbjct: 117 SGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYR 173
Query: 829 APEFLRGEPS-NEKSDVYSFGVILWELVTMQQPWNG 863
APE L G + D++S G I EL+T + + G
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 9e-13
Identities = 54/216 (25%), Positives = 106/216 (49%), Gaps = 14/216 (6%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFL-REVAIM 710
L++ ++ V + +G G+FG V S A+K+L+ + + F E IM
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
P VV A +L +V EY+P G L L+ + ++ ++ + A +V
Sbjct: 98 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYTA-EVVL 153
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSVAGTPEWMA 829
++ +H++ ++H D+K N+L+DK+ +K+ DFG + + + GTP++++
Sbjct: 154 ALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYIS 211
Query: 830 PEFLRGEPSN----EKSDVYSFGVILWELVTMQQPW 861
PE L+ + + + D +S GV L+E++ P+
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 9e-13
Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 33/210 (15%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVK-------VLTVQDFLDDQLKEFLREVAIMKRVRH 715
E +G+G++G V A G VA+K V T+ K LRE+ I++ +H
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLA-------KRTLRELKILRHFKH 63
Query: 716 PNVV----LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
N++ + + +V + L L+ +IH + + ++ R + + +G
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIH--SDQPLTEEHIRYFL-YQLLRG 119
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS-----VAGTPE 826
+ Y+H+ N ++H DLK NLLV+++ +++ DFG++R +++ K VA T
Sbjct: 120 LKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA-TRW 176
Query: 827 WMAPEFLRGEPS-NEKSDVYSFGVILWELV 855
+ APE L P D++S G I E++
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 25/203 (12%)
Query: 667 VGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR---HPNVVLF 721
+G G++GTV++A G VA+K + VQ D +REVA++KR+ HPN+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 722 MGAVT-----KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
M + +++V E++ + L P G + + L +G+++LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQF--LRGLDFLH 125
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPE-----WMAPE 831
N I+H DLK N+LV VK+ DFGL+R I S +A TP + APE
Sbjct: 126 -ANC-IVHRDLKPENILVTSGGQVKLADFGLAR------IYSCQMALTPVVVTLWYRAPE 177
Query: 832 FLRGEPSNEKSDVYSFGVILWEL 854
L D++S G I E+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-12
Identities = 80/301 (26%), Positives = 130/301 (43%), Gaps = 61/301 (20%)
Query: 667 VGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPNVVL 720
+G G G V+ A + VA+K + +D ++ L K FLRE I + HP +V
Sbjct: 10 IGKGGMGEVYLA--YDPVCSRRVALKKIR-EDLSENPLLKKRFLREAKIAADLIHPGIV- 65
Query: 721 FMGAVTKRPHLSIVTE---------YLPRGSLYRLIHRPAAGEMMDQRRR--------LR 763
P SI ++ Y+ +L L+ E + + L
Sbjct: 66 --------PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 764 MALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK------------ 811
+ + I Y+H+ +LH DLK N+L+ V + D+G + FK
Sbjct: 118 IFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 812 -------ANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPW-NG 863
++ I K V GTP++MAPE L G P++E +D+Y+ GVIL++++T+ P+
Sbjct: 176 DERNICYSSMTIPGKIV-GTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234
Query: 864 LGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPA 923
G V +A + P L+ + A DPA+R S V+ LK+ L+
Sbjct: 235 KGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYS---SVQELKQDLEPHL 291
Query: 924 Q 924
Q
Sbjct: 292 Q 292
|
Length = 932 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-12
Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 37/209 (17%)
Query: 667 VGAGSFGTVHRAEW------HGSDVAVKVL--TVQDFLDDQLKEFLREVAIMKRVRHPNV 718
+G G+FG V W G VA+K + Q+ + K RE+ ++ +H NV
Sbjct: 8 IGYGAFGVV----WSVTDPRDGKRVALKKMPNVFQNLV--SCKRVFRELKMLCFFKHDNV 61
Query: 719 VLFMGA--VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
+ A + + PH+ +VTE L + L+++I P + ++ + +
Sbjct: 62 ---LSALDILQPPHIDPFEEIYVVTE-LMQSDLHKIIVSPQP--LSSDHVKV-FLYQILR 114
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR---FKANTFISSKSVAGTPEW 827
G+ YLH+ ILH D+K NLLV+ N +K+CDFGL+R + ++ + V T +
Sbjct: 115 GLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV--TQYY 170
Query: 828 MAPEFLRGEPS-NEKSDVYSFGVILWELV 855
APE L G D++S G I EL+
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 2e-12
Identities = 59/211 (27%), Positives = 109/211 (51%), Gaps = 17/211 (8%)
Query: 665 ERVGAGSFGTVHR--AEWHGSDVAVKVLTVQDFLDDQLKEF--LREVAIMKRVRHPNVVL 720
E++G GS+ TV++ ++ +G VA+KV+ +Q+ ++ F +RE +++K ++H N+VL
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQE---EEGTPFTAIREASLLKGLKHANIVL 67
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
+ + L++V EY+ L + + + G + + L +G++Y+H
Sbjct: 68 LHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQL--LRGLSYIHQRY- 123
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNE 840
ILH DLK NLL+ +K+ DFGL+R K+ + + T + P+ L G S E
Sbjct: 124 -ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG--STE 180
Query: 841 KS---DVYSFGVILWELVTMQQPWNGLGPAQ 868
S D++ G I E++ + G+ Q
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 55/196 (28%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
E++G G++G V++A G VA+K + + + +RE++++K + HPN+V +
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
+ L +V E+L + + P +G + + L +G+ + H+ +
Sbjct: 66 DVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFCHSHR--V 121
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMAPEFLRG-EPSNE 840
LH DLK NLL++ +K+ DFGL+R F + V T + APE L G + +
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYST 180
Query: 841 KSDVYSFGVILWELVT 856
D++S G I E+VT
Sbjct: 181 AVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 13/208 (6%)
Query: 665 ERVGAGSFGTVHR--AEWHGSDVAVKVLTVQDFLDDQLKEF--LREVAIMKRVRHPNVVL 720
E++G GS+ TV++ + +G VA+KV++++ ++ F +RE +++K ++H N+VL
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKT---EEGVPFTAIREASLLKGLKHANIVL 67
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
+ + L+ V EY+ +I P G + RL M + +G+ Y+H +
Sbjct: 68 LHDIIHTKETLTFVFEYMHTDLAQYMIQHP--GGLHPYNVRLFM-FQLLRGLAYIHGQH- 123
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNE 840
ILH DLK NLL+ +K+ DFGL+R K+ + S T + P+ L G
Sbjct: 124 -ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYS 182
Query: 841 KS-DVYSFGVILWELVTMQQPWNGLGPA 867
+ D++ G I E++ Q + G+
Sbjct: 183 SALDIWGAGCIFIEMLQGQPAFPGVSDV 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 14/205 (6%)
Query: 667 VGAGSFGTVHRAE-WHGSD----VAVKVLTVQDFLDDQLKEFLREVA---IMKRVRHPNV 718
+G G +G V + G+D A+KVL + +Q K+ A I++ V+HP +
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQ-KDTAHTKAERNILEAVKHPFI 62
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
V + A L ++ EYL G L+ +H G M+ ++ +++ + +LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELF--MHLEREGIFMEDTACFYLS-EISLALEHLHQQ 119
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPS 838
I++ DLK N+L+D VK+ DFGL + + + + GT E+MAPE L
Sbjct: 120 G--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH 177
Query: 839 NEKSDVYSFGVILWELVTMQQPWNG 863
+ D +S G ++++++T P+
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 67/255 (26%), Positives = 121/255 (47%), Gaps = 24/255 (9%)
Query: 667 VGAGSFGTV---HRAEWH--GSDVAVKVLTVQDFLDD-QLKEFLR-EVAIMKRVRH-PNV 718
+G G++G V + H G A+KVL + + E R E +++ +R P +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
V A L ++ +Y+ G L+ H +Q ++ ++ + +LH L
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELF--THLSQRERFKEQEVQIYSG-EIVLALEHLHKL 124
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMAPEFLR-GE 836
I++ D+K N+L+D N V + DFGLS+ F + + S GT E+MAP+ +R G+
Sbjct: 125 G--IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGD 182
Query: 837 PSNEKS-DVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL-----AIPQNTSPVL 890
++K+ D +S GV+++EL+T P+ G ++ RR+ PQ S +
Sbjct: 183 GGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS---RRILKSEPPYPQEMSALA 239
Query: 891 ASLMESCWADDPAQR 905
+++ DP +R
Sbjct: 240 KDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 59/248 (23%), Positives = 120/248 (48%), Gaps = 14/248 (5%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLR-EVAIMKRVR-HPNVVLFM 722
+G GS+ V +D A+KV+ + DD+ ++++ E + ++ +P +V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
L +V EY+ G L + H ++ ++ R A ++ +N+LH I
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARF-YAAEICIALNFLHERG--I 117
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKS 842
++ DLK N+L+D + +K+ D+G+ + ++ + GTP ++APE LRGE
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV 177
Query: 843 DVYSFGVILWELVTMQQPWNGL--GPAQVVGAVAFQ---NRRLAIPQNTSPVLASLMESC 897
D ++ GV+++E++ + P++ + P FQ + + IP+ S + +++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237
Query: 898 WADDPAQR 905
DP +R
Sbjct: 238 LNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-12
Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 22/220 (10%)
Query: 654 LEISWDELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKE-----FLRE 706
L + ++ V + +G G+FG V R + A+K+L+ + +K F E
Sbjct: 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK----FEMIKRSDSAFFWEE 93
Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
IM +V A +L +V EY+P G L L+ + ++ ++ R A
Sbjct: 94 RDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIPEKWARFYTA- 149
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSVAGTP 825
+V ++ +H++ +H D+K N+L+DK+ +K+ DFG + AN + + GTP
Sbjct: 150 EVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTP 207
Query: 826 EWMAPEFLRGEPSN----EKSDVYSFGVILWELVTMQQPW 861
++++PE L+ + + + D +S GV L+E++ P+
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 47/215 (21%)
Query: 667 VGAGSFGTV----HRAEWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPNVVL 720
+G G++G V H+ G VA+K + F + Q + LRE+ I++R +H N++
Sbjct: 13 IGEGAYGMVCSATHKP--TGVKVAIK--KISPF-EHQTFCQRTLREIKILRRFKHENIIG 67
Query: 721 FMGAVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD------- 767
+ + + P IV E + LY+LI + ++ D
Sbjct: 68 IL-DIIRPPSFESFNDVYIVQELMET-DLYKLI------------KTQHLSNDHIQYFLY 113
Query: 768 -VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS----KSVA 822
+ +G+ Y+H+ N +LH DLK NLL++ N +K+CDFGL+R + + VA
Sbjct: 114 QILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 823 GTPEWMAPEFLRGEPSNEKS-DVYSFGVILWELVT 856
T + APE + K+ D++S G IL E+++
Sbjct: 172 -TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
E++G G++G V++A +A+K + ++ + +RE++++K ++H N+V
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL-DVAKGINYLHNLNPP 781
V L +V EYL L H ++ + R ++ L + +GI Y H+
Sbjct: 68 DVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR-- 122
Query: 782 ILHWDLKSPNLLVDK-NWTVKVCDFGLSR---FKANTFISSKSVAGTPEWMAPEFLRGEP 837
+LH DLK NLL+D+ +K+ DFGL+R TF + V T + APE L G
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF--THEVV-TLWYRAPEILLGSR 179
Query: 838 S-NEKSDVYSFGVILWELVTMQQP 860
+ D++S G I E+V Q+P
Sbjct: 180 HYSTPVDIWSVGCIFAEMVN-QKP 202
|
Length = 294 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 9e-12
Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 33/225 (14%)
Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEF----LREVA 708
W + D+ + ++G G++G V++A + V + V+ LD++ + F +RE+
Sbjct: 1 WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVR--LDNEKEGFPITAIREIK 58
Query: 709 IMKRVRHPNVVLFMGAVT----------KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQ 758
I++++ H N+V VT + +V EY+ L L+ D
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDH 117
Query: 759 RRRL-RMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817
+ + L+ G+NY H N LH D+K N+L++ +K+ DFGL+R + S
Sbjct: 118 IKSFMKQLLE---GLNYCHKKN--FLHRDIKCSNILLNNKGQIKLADFGLARL----YNS 168
Query: 818 SKSVAGTPE-----WMAPEFLRGEPSNEKS-DVYSFGVILWELVT 856
+S T + + PE L GE + DV+S G IL EL T
Sbjct: 169 EESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-11
Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 23/200 (11%)
Query: 667 VGAGSFGTVHRA-----EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF 721
+G+G+ G V A E + VA+K L+ K RE+ +MK V H N++
Sbjct: 32 IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 722 MGAVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
+ T + L IV E L +L ++I +D R + + GI +L
Sbjct: 89 LNVFTPQKSLEEFQDVYIVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHL 142
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRG 835
H+ I+H DLK N++V + T+K+ DFGL+R +F+ + V T + APE + G
Sbjct: 143 HSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILG 199
Query: 836 EPSNEKSDVYSFGVILWELV 855
E D++S G I+ E++
Sbjct: 200 MGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 660 ELHVK-ERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
E +VK +++G G++ TV R++ + VA+K + ++ + +REV+++K ++H
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHA 63
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
N+V + L++V EYL L + G +M + +G++Y H
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCH 120
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGE 836
ILH DLK NLL+++ +K+ DFGL+R K+ + + T + P+ L G
Sbjct: 121 KRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG- 177
Query: 837 PSNEKS---DVYSFGVILWELVT 856
S E S D++ G IL+E+ T
Sbjct: 178 -STEYSTPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 9/199 (4%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRVR-HPNVVLFM 722
+G GSFG V A S AVKVL L DD ++ + E I+ R HP +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
L V E++ G L I + D+ R A ++ + +LH+ I
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG--I 117
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKS 842
++ DLK N+L+D K+ DFG+ + ++ + GTP+++APE L+
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSV 177
Query: 843 DVYSFGVILWELVTMQQPW 861
D ++ GV+L+E++ P+
Sbjct: 178 DWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 2e-11
Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
+G+G+ G V A +VA+K L+ K RE+ +MK V H N++ +
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
T + L +V E L +L ++I +D R + + GI +LH+
Sbjct: 85 FTPQKSLEEFQDVYLVME-LMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 138
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPS 838
I+H DLK N++V + T+K+ DFGL+R +F+ + V T + APE + G
Sbjct: 139 G--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGY 195
Query: 839 NEKSDVYSFGVILWELV 855
E D++S G I+ E+V
Sbjct: 196 KENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 55/216 (25%), Positives = 105/216 (48%), Gaps = 14/216 (6%)
Query: 654 LEISWDELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFL-REVAIM 710
L + ++ V + +G G+FG V R + A+K+L+ + + F E IM
Sbjct: 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
P VV A +L +V EY+P G L L+ + ++ ++ R A +V
Sbjct: 98 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTA-EVVL 153
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSVAGTPEWMA 829
++ +H++ +H D+K N+L+DK+ +K+ DFG + + + GTP++++
Sbjct: 154 ALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 211
Query: 830 PEFLRGEPSN----EKSDVYSFGVILWELVTMQQPW 861
PE L+ + + + D +S GV L+E++ P+
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 63/271 (23%), Positives = 119/271 (43%), Gaps = 34/271 (12%)
Query: 665 ERVGAGSFGTVHRA---------EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
E +G G+F + + E H ++V +KVL + + F ++M ++ H
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSH 58
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
++VL G +V EY+ GSL + + +++ +L +A +A +++L
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK--NKNLINISWKLEVAKQLAWALHFL 116
Query: 776 HNLNPPILHWDLKSPNLLV-----DKNWT---VKVCDFGLSRFKANTFISSKSVAGTPEW 827
+ + H ++ + N+L+ K +K+ D G+S T + + + W
Sbjct: 117 EDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI----TVLPKEILLERIPW 170
Query: 828 MAPEFLRGEPSNEK--SDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQ 884
+ PE + P N +D +SFG LWE+ + +P + L + + F R +P
Sbjct: 171 VPPECIE-NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQFYEDRHQLPA 226
Query: 885 NTSPVLASLMESCWADDPAQRPSFANIVESL 915
LA+L+ C +P RPSF I+ L
Sbjct: 227 PKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 46/227 (20%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEF--------------LREVAIMKR 712
+G G++G V++A+ + +K+F RE+A+++
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEY---------AIKKFKGDKEQYTGISQSACREIALLRE 58
Query: 713 VRHPNVV----LFMGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRMAL 766
++H NVV +F+ K + ++ +Y L+++I HR A + ++ L
Sbjct: 59 LKHENVVSLVEVFLEHADKS--VYLLFDYAEH-DLWQIIKFHRQAKRVSI-PPSMVKSLL 114
Query: 767 -DVAKGINYLH-NLNPPILHWDLKSPNLLV----DKNWTVKVCDFGLSRFKAN---TFIS 817
+ G++YLH N +LH DLK N+LV + VK+ D GL+R
Sbjct: 115 WQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171
Query: 818 SKSVAGTPEWMAPEFLRGEPSNEKS-DVYSFGVILWELVTMQQPWNG 863
V T + APE L G K+ D+++ G I EL+T++ + G
Sbjct: 172 LDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 41/158 (25%), Positives = 74/158 (46%), Gaps = 18/158 (11%)
Query: 704 LREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLP--RGSLYRLIHRPAAGEMMDQRRR 761
L E +++ V HP+V+ + +V LP LY + +
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYL------TKRSRPLP 155
Query: 762 LRMAL----DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817
+ AL + +G+ YLH I+H D+K+ N+ ++ V + D G ++F +
Sbjct: 156 IDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PA 212
Query: 818 SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELV 855
+AGT E APE L + N K+D++S G++L+E++
Sbjct: 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 55/282 (19%), Positives = 102/282 (36%), Gaps = 50/282 (17%)
Query: 670 GSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729
+ + + + VAVK + + + LK +E+ ++++HPN++ ++ +
Sbjct: 13 LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS 72
Query: 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL---DVAKGINYLHNLNPPILHWD 786
L +V+ + GS L+ + L +A DV ++Y+H+ +H
Sbjct: 73 ELYVVSPLMAYGSCEDLLKT----HFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRS 126
Query: 787 LKSPNLLVDKNWTVKVCDFGLSR-------FKANTFISSKSVAGTPEWMAPEFLRGEPS- 838
+K+ ++L+ + V + S + KS W++PE L+
Sbjct: 127 VKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQG 186
Query: 839 -NEKSDVYSFGVILWELVTMQQPW-------------NGLGPA--------QVVGAVAFQ 876
NEKSD+YS G+ EL P+ G P +++
Sbjct: 187 YNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQS 246
Query: 877 NRRLAIPQNT-----------SPVLASLMESCWADDPAQRPS 907
P N S +E C DP RPS
Sbjct: 247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS 288
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 55/229 (24%), Positives = 98/229 (42%), Gaps = 35/229 (15%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSDV--AVKVLTVQDFL-DDQLKEFLREVAIMKRVRH 715
+ +G G G V G+ A+KVL ++ + +++K L E I+ + H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
P + + +L +V +Y P G L+RL+ R + ++ R A +V + YL
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEYL 119
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS--------------------------- 808
H L I++ DLK N+L+ ++ + + DF LS
Sbjct: 120 HLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 809 --RFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELV 855
F S S GT E++APE + G+ D ++ G++L+E++
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 72/312 (23%), Positives = 129/312 (41%), Gaps = 65/312 (20%)
Query: 660 ELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
EL V+ G + +V+ A H G+ V V++ +++ ++ LK EV + RHP
Sbjct: 1 ELQVEIGRGFCNLTSVYLAR-HTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHP 59
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
N++ T L +++ ++ GS L+ + E M + + +G+NYLH
Sbjct: 60 NIMTSWTVFTTGSWLWVISPFMAYGSANSLL-KTYFPEGMSEALIGNILFGALRGLNYLH 118
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA--NTFISSKSVAGTPE-------W 827
+H ++K+ ++L+ + V + GLS + +K V P+ W
Sbjct: 119 QNG--YIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPW 174
Query: 828 MAPEFLRGEPS--NEKSDVYSFGVILWELVTMQQPW------------------------ 861
++PE LR + N KSD+YS G+ EL T + P+
Sbjct: 175 LSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT 234
Query: 862 -----------------NGLGPAQVV--GAVAFQNRRLAIP--QNTSPVLASLMESCWAD 900
+G+G + V + RL P + SP +L+E C
Sbjct: 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQ 294
Query: 901 DPAQRPSFANIV 912
DP +RPS ++++
Sbjct: 295 DPEKRPSASSLL 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 46/163 (28%), Positives = 84/163 (51%), Gaps = 8/163 (4%)
Query: 701 KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL-YRLIHRPAAGEMMDQR 759
K L E I+++V P +V A + HL +V + G L Y + + G ++
Sbjct: 38 KMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG--LEME 95
Query: 760 RRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISS 818
R + + + GI +LH+++ I++ D+K N+L+D ++ D GL+ K I+
Sbjct: 96 RVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQ 153
Query: 819 KSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPW 861
+ AGT +MAPE L+ EP + D ++ G ++E+V + P+
Sbjct: 154 R--AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 66/266 (24%), Positives = 116/266 (43%), Gaps = 20/266 (7%)
Query: 667 VGAGSFGTVHRA---EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR---HPNVVL 720
+G G++G V +A + G VA+K + VQ + +REVA+++ + HPNVV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 721 FMGAVT-----KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
T + L++V E++ + L P G + + M + +G+++L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD--MMFQLLRGLDFL 126
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRG 835
H+ ++H DLK N+LV + +K+ DFGL+R + + SV T + APE L
Sbjct: 127 HSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT-SVVVTLWYRAPEVLLQ 183
Query: 836 EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895
D++S G I E+ + + G +G + L ++ P +L
Sbjct: 184 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI-LDVIGLPGEEDW-PRDVALPR 241
Query: 896 SCWADDPAQRPSFANIVESLKKLLKS 921
+ AQ V + +L K
Sbjct: 242 QAFHSKSAQ--PIEKFVTDIDELGKD 265
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 52/201 (25%), Positives = 101/201 (50%), Gaps = 10/201 (4%)
Query: 660 ELHVK-ERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
E ++K +++G G++ TV++ +D VA+K + ++ + +REV+++K ++H
Sbjct: 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHA 64
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
N+V + L++V EYL + L G ++ + +G+NY H
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYLDKDLKQYL---DDCGNSINMHNVKLFLFQLLRGLNYCH 121
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGE 836
+LH DLK NLL+++ +K+ DFGL+R K+ + + T + P+ L G
Sbjct: 122 RRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGS 179
Query: 837 PS-NEKSDVYSFGVILWELVT 856
+ + D++ G I +E+ T
Sbjct: 180 TDYSTQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 75/289 (25%), Positives = 129/289 (44%), Gaps = 53/289 (18%)
Query: 663 VKERVGAGSFGTVHRA-EWH-GSDVAVK-VLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
++E +G GS+G V A + H G VA+K + V + + D + LRE+ +++ +RHP++V
Sbjct: 4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR-ILREIKLLRLLRHPDIV 62
Query: 720 ---LFMGAVTKRPHLSI-VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
M ++R I V L L+++I A ++ + + + + + + Y+
Sbjct: 63 EIKHIMLPPSRREFKDIYVVFELMESDLHQVIK--ANDDLTPEHHQFFL-YQLLRALKYI 119
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN---TFISSKSVAGTPEWMAPE- 831
H N + H DLK N+L + + +K+CDFGL+R N T I T + APE
Sbjct: 120 HTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 832 ----FLRGEPSNEKSDVYSFGVILWELVTMQQPWNG-------------LG--PAQVVGA 872
F + P+ D++S G I E++T + + G LG + +
Sbjct: 178 CGSFFSKYTPA---IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234
Query: 873 VAFQNRR---------LAIP-----QNTSPVLASLMESCWADDPAQRPS 907
V + R +P N P+ L+E A DP RP+
Sbjct: 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT 283
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 662 HVKERVGAGSFGTVHRAEWHGSD----VAVKVLTVQDFLDDQL--KEFLREVAIMKRVR- 714
+ + +G G++G V A + VA+K +T + ++ K LRE+ +++ R
Sbjct: 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKIT--NVFSKKILAKRALRELKLLRHFRG 60
Query: 715 HPNVV-LF-MGAVTKRPHLSI-VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
H N+ L+ M V + + E L L+++I +G+ + + G
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIR---SGQPLTDAHFQSFIYQILCG 117
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAG--TPEWM 828
+ Y+H+ N +LH DLK NLLV+ + +K+CDFGL+R F N ++ + W
Sbjct: 118 LKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWY 175
Query: 829 -APEFLRGEPSNEKS-DVYSFGVILWEL 854
APE + S K+ DV+S G IL EL
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAEL 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 50/225 (22%)
Query: 666 RVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKE-F----LREVAIMKRVRHPNV 718
++G G+FG V +A VA+K + L + KE F LRE+ I++ ++H NV
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKV-----LMENEKEGFPITALREIKILQLLKHENV 73
Query: 719 V-LFMGAVTK-------RPHLSIVTEYLPRGSLYRLIHRPAA----GEMMDQRRRLRMAL 766
V L TK + +V E+ L L+ E+ ++ ++M L
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEI---KKVMKMLL 129
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAG--- 823
+ G+ Y+H ILH D+K+ N+L+ K+ +K+ DFGL+R F SK+
Sbjct: 130 N---GLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLAR----AFSLSKNSKPNRY 180
Query: 824 -----TPEWMAPEFLRGEPS-NEKSDVYSFGVILWELVT----MQ 858
T + PE L GE D++ G I+ E+ T MQ
Sbjct: 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ 225
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 57/202 (28%), Positives = 101/202 (50%), Gaps = 23/202 (11%)
Query: 665 ERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEF--LREVAIMKRVRHPNVVL 720
+++G GS+ TV++ + VA+K + ++ ++ F +RE +++K ++H N+V
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEH---EEGAPFTAIREASLLKDLKHANIVT 67
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
+ + L++V EYL + M + R L L +G+ Y H
Sbjct: 68 LHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL---RGLAYCHQRR- 123
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA---NTFISSKSVAGTPEWMAPEFLRGEP 837
+LH DLK NLL+ + +K+ DFGL+R K+ T+ S++ V T + P+ L G
Sbjct: 124 -VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY-SNEVV--TLWYRPPDVLLG-- 177
Query: 838 SNEKS---DVYSFGVILWELVT 856
S E S D++ G I +E+ T
Sbjct: 178 STEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 706 EVAIMKRVRH-PNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLR 763
E +++ VR P +V A L ++ +Y+ G ++ L R E D+ R
Sbjct: 54 ERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE--DEVRF-- 109
Query: 764 MALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVA 822
+ ++ + +LH L I++ D+K N+L+D V + DFGLS+ F + + S
Sbjct: 110 YSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC 167
Query: 823 GTPEWMAPEFLRGEPSNEKS-DVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL- 880
GT E+MAPE +RG+ + K+ D +S G++++EL+T P+ G V+ RR+
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS---RRIL 224
Query: 881 ----AIPQNTSPVLASLMESCWADDPAQR 905
P P L+ DP +R
Sbjct: 225 KCDPPFPSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 6e-10
Identities = 41/161 (25%), Positives = 79/161 (49%), Gaps = 28/161 (17%)
Query: 709 IMKRVRHPNVV-LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLR---- 763
+MK +PN + L+ T + H+ ++ +Y+ G L+ L+ + +L
Sbjct: 64 LMKD--NPNFIKLYYSVTTLKGHV-LIMDYIKDGDLFDLLKK---------EGKLSEAEV 111
Query: 764 --MALDVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSRFKANTFISSKS 820
+ + + +N LH N I+H D+K N+L D + +CD+GL + I + S
Sbjct: 112 KKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKI-----IGTPS 164
Query: 821 VA-GTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQP 860
GT ++ +PE ++G + D ++ GV+ +EL+T + P
Sbjct: 165 CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 6e-10
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 40/217 (18%)
Query: 662 HVKERVGAGSFGTVHRAEWHGSD------VAVKVL--TVQDFLDDQLKEFLREVAIMKRV 713
+ +++G G++G V W D VA+K + ++ D Q + F RE+ ++ +
Sbjct: 10 EILQKLGKGAYGIV----WKAIDRRTKEVVALKKIFDAFRNATDAQ-RTF-REIMFLQEL 63
Query: 714 R-HPNVV-LF--MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
HPN+V L + A + + +V EY+ L+ +I A + D +R M +
Sbjct: 64 GDHPNIVKLLNVIKAENDK-DIYLVFEYM-ETDLHAVIR---ANILEDVHKRYIM-YQLL 117
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP---- 825
K + Y+H+ N ++H DLK N+L++ + VK+ DFGL+R + + P
Sbjct: 118 KALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLAR----SLSELEENPENPVLTD 171
Query: 826 ----EWM-APEFLRGEPSNEKS-DVYSFGVILWELVT 856
W APE L G K D++S G IL E++
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQ--LKEFLREVAIMKRVRHPNVVL 720
E++G G++G V++A G VA+K ++ +D++ LRE+++++ + ++
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLE--MDEEGIPPTALREISLLQMLSESIYIV 64
Query: 721 FMGAV------TKRPHLSIVTEYLPRG-SLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
+ V +P L +V EYL + + G + + + KG+
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTV-KVCDFGLSRFKANTFISSKSVAG---TPEWMA 829
+ H ++H DLK NLLVDK + K+ D GL R I KS T + A
Sbjct: 125 HCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGR---AFSIPVKSYTHEIVTLWYRA 179
Query: 830 PEFLRGEPSNEKS-DVYSFGVILWELVTMQ 858
PE L G D++S G I E+ Q
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 55/203 (27%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 660 ELHVK-ERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
E ++K E++G G++ TV + ++ VA+K + ++ + +REV+++K ++H
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHA 64
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
N+V V L++V EYL + L + + G +M + +G+ Y H
Sbjct: 65 NIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCH 121
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGE 836
+LH DLK NLL+++ +K+ DFGL+R K+ + + T + P+ L G
Sbjct: 122 RRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG- 178
Query: 837 PSNEKS---DVYSFGVILWELVT 856
S+E S D++ G I +E+ +
Sbjct: 179 -SSEYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-10
Identities = 62/255 (24%), Positives = 107/255 (41%), Gaps = 43/255 (16%)
Query: 667 VGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMG 723
+G G+FG V + G A+K+L D L+ +Q+ E I+ VV
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
+ + +L ++ E+LP G + L+ + + ++ + +A + I+ +H L +
Sbjct: 69 SFQDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIA-ETVLAIDSIHQLG--FI 123
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGL------------------------------SRFKAN 813
H D+K NLL+D VK+ DFGL S+ KA
Sbjct: 124 HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAE 183
Query: 814 TFISSK-----SVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQ 868
T+ ++ S GTP+++APE N+ D +S GVI++E++ P+ P +
Sbjct: 184 TWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243
Query: 869 VVGAVAFQNRRLAIP 883
V L P
Sbjct: 244 TYKKVMNWKETLIFP 258
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 63/263 (23%), Positives = 110/263 (41%), Gaps = 43/263 (16%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
D+ + +G G+FG V + G A+K+L D L+ +Q+ E I+
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
VV + + +L ++ E+LP G + L+ + + ++ + +A + I+ +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIA-ETVLAIDAI 117
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL---------------------------- 807
H L +H D+K NLL+D VK+ DFGL
Sbjct: 118 HQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 808 --SRFKANTFISSK-----SVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQP 860
S+ KA T+ ++ S GTP+++APE N+ D +S GVI++E++ P
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 861 WNGLGPAQVVGAVAFQNRRLAIP 883
+ P + V L P
Sbjct: 236 FCSETPQETYRKVMNWKETLVFP 258
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 21/200 (10%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
VG+G++G V A + VA+K L+ K RE+ ++K + H NV+ +
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 725 VTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
T L +VT + L ++ + D + + + +G+ Y+H+
Sbjct: 83 FTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQK---LSDDHIQF-LVYQILRGLKYIHSA 137
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPE--FLRGE 836
I+H DLK N+ V+++ +K+ DFGL+R + + VA T + APE
Sbjct: 138 G--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM--TGYVA-TRWYRAPEIMLNWMH 192
Query: 837 PSNEKSDVYSFGVILWELVT 856
N+ D++S G I+ EL+T
Sbjct: 193 -YNQTVDIWSVGCIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 57/248 (22%), Positives = 100/248 (40%), Gaps = 51/248 (20%)
Query: 667 VGAGSFGTVHRAEWHGSDV--AVKVLTVQD-FLDDQLKEFLREVAIMKRVRHPNVVLFMG 723
+G G+FG V ++ A+K L D + +Q E I+ + VV
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
+ + +L V +Y+P G + L+ R G + R +A ++ I +H + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIR--LGIFEEDLARFYIA-ELTCAIESVHKMG--FI 123
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLS----------------------------------- 808
H D+K N+L+D++ +K+ DFGL
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC 183
Query: 809 --------RFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQP 860
R + + + S+ GTP ++APE L + D +S GVIL+E++ Q P
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 243
Query: 861 WNGLGPAQ 868
+ PA+
Sbjct: 244 FLADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 24/203 (11%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPNVVLFM 722
+G G++G V A VA+K + + D+++ K LRE+ +++ + H NV+ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIK--KIANAFDNRIDAKRTLREIKLLRHLDHENVIA-I 69
Query: 723 GAVTKRPH------LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
+ PH + IV E L L+++I R + D + L +G+ Y+H
Sbjct: 70 KDIMPPPHREAFNDVYIVYE-LMDTDLHQII-RSSQTLSDDHCQYFLYQL--LRGLKYIH 125
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT--FISSKSVAGTPEWMAPEFLR 834
+ N +LH DLK NLL++ N +K+CDFGL+R + F++ V T + APE L
Sbjct: 126 SAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV--TRWYRAPELLL 181
Query: 835 GEPSNEKS-DVYSFGVILWELVT 856
+ DV+S G I EL+
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 51/222 (22%), Positives = 101/222 (45%), Gaps = 20/222 (9%)
Query: 703 FLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL 762
F ++M +V H ++ G + +V E++ G L + + + + +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--I 120
Query: 763 RMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT-------VKVCDFGLSRFKANTF 815
+A +A ++YL + N ++H ++ + N+L+ + +K+ D G+S T
Sbjct: 121 TVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSF----TA 174
Query: 816 ISSKSVAGTPEWMAPEFLRGEPS-NEKSDVYSFGVILWELV-TMQQPWNGLGPAQVVGAV 873
+S + W+APE + G S + +D +SFG L E+ + P P++
Sbjct: 175 LSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE---KE 231
Query: 874 AFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESL 915
F ++ +P+ + LA+L+ C +P QRPSF I+ L
Sbjct: 232 RFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 52/212 (24%), Positives = 98/212 (46%), Gaps = 40/212 (18%)
Query: 666 RVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVR-HPNVVLF 721
++G G+F V +A+ G A+K + + F +Q+ LRE+ ++R+ HPN++
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNN-LREIQALRRLSPHPNILRL 63
Query: 722 MGAVTKRPH--LSIVTEYLPRGSLYRLI---HRPAAGEMMDQRRRLRMALDVAKGINYLH 776
+ + R L++V E L +LY LI RP + ++R + K ++++H
Sbjct: 64 IEVLFDRKTGRLALVFE-LMDMNLYELIKGRKRP-----LPEKRVKSYMYQLLKSLDHMH 117
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP--------EWM 828
I H D+K N+L+ + +K+ DFG S + + P W
Sbjct: 118 RNG--IFHRDIKPENILIKDD-ILKLADFG----------SCRGIYSKPPYTEYISTRWY 164
Query: 829 -APE-FLRGEPSNEKSDVYSFGVILWELVTMQ 858
APE L K D+++ G + +E++++
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILSLF 196
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 67/249 (26%), Positives = 116/249 (46%), Gaps = 55/249 (22%)
Query: 639 GPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL 696
G RY+++ P +G GS G V A D VAVK + + D
Sbjct: 4 GSRYMDLRP-------------------LGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-- 42
Query: 697 DDQLKEFLREVAIMKRVRHPNVV-----LF---------MGAVTKRPHLSIVTEYLPRGS 742
+K LRE+ I++R+ H N+V L +G++T+ + IV EY+
Sbjct: 43 PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETD 101
Query: 743 LYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV-K 801
L ++ + G + ++ RL M + +G+ Y+H+ N +LH DLK N+ ++ V K
Sbjct: 102 LANVLEQ---GPLSEEHARLFM-YQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLK 155
Query: 802 VCDFGLSR-----FKANTFISSKSVAGTPEWMAPEFLRGEPSN--EKSDVYSFGVILWEL 854
+ DFGL+R + ++S V T + +P L P+N + D+++ G I E+
Sbjct: 156 IGDFGLARIVDPHYSHKGYLSEGLV--TKWYRSPRLLL-SPNNYTKAIDMWAAGCIFAEM 212
Query: 855 VTMQQPWNG 863
+T + + G
Sbjct: 213 LTGKPLFAG 221
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 8e-09
Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL-KEFLREVAIMKRVRHPNVVLFMG 723
VG+G++GTV A G+ VA+K L + F + K RE+ ++K ++H NV+ +
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKHMKHENVIGLLD 81
Query: 724 AVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
T L + YL + + + E + + R + + KG+ Y+H I
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG--I 139
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPE-FLRGEPSNEK 841
+H DLK NL V+++ +K+ DFGL+R + ++ ++ V T + APE L +
Sbjct: 140 IHRDLKPGNLAVNEDCELKILDFGLAR-QTDSEMTGYVV--TRWYRAPEVILNWMHYTQT 196
Query: 842 SDVYSFGVILWELVT 856
D++S G I+ E++T
Sbjct: 197 VDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 9e-09
Identities = 61/245 (24%), Positives = 109/245 (44%), Gaps = 46/245 (18%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKR 712
E +E V +++G G FG V + + K ++ + + + + + EV +M+
Sbjct: 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE 68
Query: 713 VRHPNVVLFMGAVTKRPH--LSIVTEYLPRGSL-------YRLIHRPAAGEMMDQRRRLR 763
++H N+V ++ + + L I+ E+ G L Y++ + ++D R+L
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 764 MALDVAKGINYLHNLN-----PPILHWDLKSPNLLVDKNW-----------------TVK 801
AL Y HNL +LH DLK N+ + K
Sbjct: 129 HAL------AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 802 VCDFGLSRFKANTFISS--KSVAGTPEWMAPEFLRGEPS--NEKSDVYSFGVILWELVTM 857
+ DFGLS+ N I S S GTP + +PE L E ++KSD+++ G I++EL +
Sbjct: 183 IGDFGLSK---NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
Query: 858 QQPWN 862
+ P++
Sbjct: 240 KTPFH 244
|
Length = 1021 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 25/163 (15%)
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRR---- 761
E I++ + HP+++ G T ++ LPR ++ + +R
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPR-------YKTDLYCYLAAKRNIAIC 182
Query: 762 --LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF----KANTF 815
L + V + I YLH I+H D+K+ N+ ++ V + DFG + F AN +
Sbjct: 183 DILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240
Query: 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQ 858
AGT APE L +P D++S G++L+E+ T
Sbjct: 241 YGW---AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 55/241 (22%), Positives = 110/241 (45%), Gaps = 15/241 (6%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDD-QLKEFLREVAIMKRVRH 715
++ + + +G G+FG V + +D A+K+L + L + F E ++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
+ A +L +V +Y G L L+ + + + R +A ++ I+ +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSK-FEDRLPEDMARFYLA-EMVIAIDSV 118
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFG--LSRFKANTFISSKSVAGTPEWMAPEFL 833
H L+ +H D+K N+L+D N +++ DFG L + T SS +V GTP++++PE L
Sbjct: 119 HQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEIL 175
Query: 834 RGEPSNE-----KSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888
+ + + D +S GV ++E++ + P+ + G + R P +
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD 235
Query: 889 V 889
V
Sbjct: 236 V 236
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 21/201 (10%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF----- 721
+G GSFG V+ A D + KV + D Q K RE+ IMK + H N++
Sbjct: 74 IGNGSFGVVYEAIC--IDTSEKVAIKKVLQDPQYKN--RELLIMKNLNHINIIFLKDYYY 129
Query: 722 ---MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
K L++V E++P+ + H + + + + + Y+H+
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS- 188
Query: 779 NPPILHWDLKSPNLLVDKN-WTVKVCDFGLSRFKANTFISSKSVA--GTPEWMAPEFLRG 835
I H DLK NLL+D N T+K+CDFG ++ N +SV+ + + APE + G
Sbjct: 189 -KFICHRDLKPQNLLIDPNTHTLKLCDFGSAK---NLLAGQRSVSYICSRFYRAPELMLG 244
Query: 836 EPS-NEKSDVYSFGVILWELV 855
+ D++S G I+ E++
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 57/238 (23%), Positives = 100/238 (42%), Gaps = 46/238 (19%)
Query: 659 DELHVKERVGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
D+ + +G G+FG V + + G A+K L + L+ +Q+ E I+ +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
P VV + +L ++ EYLP G + L+ + ++ R +A + I+ +
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT--FTEEETRFYIA-ETILAIDSI 117
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-------------------------- 809
H L +H D+K NLL+D +K+ DFGL
Sbjct: 118 HKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 810 ------------FKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELV 855
+K N + S GTP+++APE N++ D +S GVI++E++
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 27/203 (13%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
VG+G++G+V A G VAVK L+ Q + K RE+ ++K ++H NV+ +
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHENVIGLL 82
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAG--------EMMDQRRRLRMALDVAKGINY 774
T L + +Y + H A ++ D + + + +G+ Y
Sbjct: 83 DVFTPARSLEEFND------VYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKY 135
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPE-FL 833
+H+ + I+H DLK NL V+++ +K+ DFGL+R + T + APE L
Sbjct: 136 IHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIML 190
Query: 834 RGEPSNEKSDVYSFGVILWELVT 856
N+ D++S G I+ EL+T
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-08
Identities = 57/241 (23%), Positives = 104/241 (43%), Gaps = 44/241 (18%)
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA 765
E+A M +++HPN+V +G ++ EY+ +L ++ + RR ++A
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIA 786
Query: 766 LDVAKGINYLH-NLNPPILHWDLKSPNLLVDKNWTVKVCDF--GLSRFKANTFISSKSVA 822
+ +AK + +LH +P ++ +L +++D + GL FISS
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA--- 843
Query: 823 GTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAV--------- 873
++APE + EKSD+Y FG+IL EL+T G PA V
Sbjct: 844 ----YVAPETRETKDITEKSDIYGFGLILIELLT------GKSPADAEFGVHGSIVEWAR 893
Query: 874 -AFQN------------RRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920
+ + +++ QN + +L C A DP RP +++++L+ +
Sbjct: 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953
Query: 921 S 921
S
Sbjct: 954 S 954
|
Length = 968 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 36/219 (16%)
Query: 704 LREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL-YRLIHRPAAGEMMDQRRRL 762
L E I+++V VV A + L +V + G L + + H AG ++ R +
Sbjct: 48 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG--FEEGRAV 105
Query: 763 RMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
A ++ G+ LH I++ DLK N+L+D + +++ D GL+ + K
Sbjct: 106 FYAAEICCGLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRV 162
Query: 823 GTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAI 882
GT +MAPE ++ E D ++ G +L+E++ Q P FQ R+ I
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP--------------FQQRKKKI 208
Query: 883 PQNT----------------SPVLASLMESCWADDPAQR 905
+ SP SL + DP +R
Sbjct: 209 KREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 52/224 (23%), Positives = 103/224 (45%), Gaps = 24/224 (10%)
Query: 703 FLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL 762
F ++M++V H ++VL G + +V E++ G L +HR + +++ +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKF 108
Query: 763 RMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT-------VKVCDFGLSRFKANTF 815
++A +A ++YL + + ++H ++ + N+L+ + +K+ D G+ T
Sbjct: 109 KVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI----TV 162
Query: 816 ISSKSVAGTPEWMAPEFLRGEPS-NEKSDVYSFGVILWELVTMQQPWNGLGPAQ---VVG 871
+S + W+APE + + + +D +SFG LWE+ +NG P + +
Sbjct: 163 LSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEIC-----YNGEIPLKDKTLAE 217
Query: 872 AVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESL 915
F + + + LA LM C DP QRP F I+ +
Sbjct: 218 KERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 52/194 (26%), Positives = 97/194 (50%), Gaps = 10/194 (5%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL-KEFLREVAIMKRVRHPNVVLFMG 723
VG+G++G+V A + G VA+K L+ + F + K RE+ ++K ++H NV+ +
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLS-RPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
T ++ + + G + + + + + G+ Y+H+ I+
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG--II 139
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPE-FLRGEPSNEKS 842
H DLK NL V+++ +K+ DFGL+R A+ ++ V T + APE L N+
Sbjct: 140 HRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVV--TRWYRAPEVILNWMHYNQTV 196
Query: 843 DVYSFGVILWELVT 856
D++S G I+ E++T
Sbjct: 197 DIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 40/162 (24%), Positives = 74/162 (45%), Gaps = 8/162 (4%)
Query: 704 LREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL-YRLIHRPAAGEMMDQRRRL 762
L E I+++V VV A + L +V + G L + + + G D+ R +
Sbjct: 48 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG--FDEERAV 105
Query: 763 RMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSV 821
A ++ G+ LH I++ DLK N+L+D +++ D GL+ I +
Sbjct: 106 FYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI--RGR 161
Query: 822 AGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNG 863
GT +MAPE ++ E D + G +++E++ + P+
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 43/160 (26%), Positives = 73/160 (45%), Gaps = 4/160 (2%)
Query: 704 LREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLR 763
L E I+++V VV A + L +V + G L I+ ++ R L
Sbjct: 48 LNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFEEERALF 106
Query: 764 MALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAG 823
A ++ G+ LH N ++ DLK N+L+D +++ D GL+ K S + G
Sbjct: 107 YAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRVG 163
Query: 824 TPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNG 863
T +MAPE L + D + G +++E++ Q P+ G
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 59/250 (23%), Positives = 111/250 (44%), Gaps = 33/250 (13%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
D+ + + +G G+FG V + ++ A+K+L + L E A + R+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRA------ETACFREERN- 53
Query: 717 NVVLFMG----------AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
VL G A +L +V +Y G L L+ + + + R +A
Sbjct: 54 --VLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSK-FEDRLPEDMARFYIA- 109
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG--LSRFKANTFISSKSVAGT 824
++ I+ +H L+ +H D+K N+L+D N +++ DFG L + T SS +V GT
Sbjct: 110 EMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GT 166
Query: 825 PEWMAPEFLRGEPS-----NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR 879
P++++PE L+ + D +S GV ++E++ + P+ + G + R
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER 226
Query: 880 LAIPQNTSPV 889
P + + V
Sbjct: 227 FQFPSHITDV 236
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 67/289 (23%), Positives = 113/289 (39%), Gaps = 59/289 (20%)
Query: 667 VGAGSFGTV--HRAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMG 723
+G G+FG V + A+K L +D L+ +Q+ E I+ + VV
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
+ + +L V +Y+P G + L+ R + R +A ++ I +H + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIR--MEVFPEVLARFYIA-ELTLAIESVHKMG--FI 123
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLS---RFKANTFISSK--------------------- 819
H D+K N+L+D + +K+ DFGL R+ N+ K
Sbjct: 124 HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNC 183
Query: 820 -----------------------SVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT 856
S+ GTP ++APE L + + D +S GVIL+E++
Sbjct: 184 RCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLV 243
Query: 857 MQQPWNGLGPAQVVGAVAFQNRRLAIPQNT--SPVLASLMES--CWADD 901
Q P+ P + V L IP SP L+ C A++
Sbjct: 244 GQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEE 292
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-07
Identities = 62/267 (23%), Positives = 106/267 (39%), Gaps = 55/267 (20%)
Query: 667 VGAGSFGTV--HRAEWHGSDVAVKVLTVQD-FLDDQLKEFLREVAIMKRVRHPNVVLFMG 723
+G G+FG V R + A+K L +D L +Q+ E I+ + VV
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
+ + +L V +Y+P G + L+ R G + R +A ++ + +H + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIR--MGIFPEDLARFYIA-ELTCAVESVHKMG--FI 123
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGL------------------------------------ 807
H D+K N+L+D++ +K+ DFGL
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC 183
Query: 808 ---SRFKANTFISSK--------SVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT 856
R K +++ S+ GTP ++APE L + D +S GVIL+E++
Sbjct: 184 RCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 243
Query: 857 MQQPWNGLGPAQVVGAVAFQNRRLAIP 883
Q P+ P + V L IP
Sbjct: 244 GQPPFLAQTPLETQMKVINWQTSLHIP 270
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 41/170 (24%), Positives = 77/170 (45%), Gaps = 18/170 (10%)
Query: 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA----LDVAKGINYLHNLNPPILHW 785
+L +V +Y G L L+ + + R MA ++ I+ +H L +H
Sbjct: 75 NLYLVMDYYVGGDLLTLLSK------FEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHR 126
Query: 786 DLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKS-- 842
D+K N+L+DKN +++ DFG R A+ + S GTP++++PE L+ +
Sbjct: 127 DIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYG 186
Query: 843 ---DVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPV 889
D +S GV ++E++ + P+ + G + P + + V
Sbjct: 187 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 64/250 (25%), Positives = 111/250 (44%), Gaps = 21/250 (8%)
Query: 667 VGAGSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEF-LREVAIMKRVRH---PNVVL 720
+G G FG V+ R G A+K L + Q + L E ++ V P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
A L + + + G L+ H G ++ R A ++ G+ ++HN
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLH--YHLSQHGVFSEKEMRF-YATEIILGLEHMHNRF- 117
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA--GTPEWMAPEFL-RGEP 837
+++ DLK N+L+D++ V++ D GL A F K A GT +MAPE L +G
Sbjct: 118 -VVYRDLKPANILLDEHGHVRISDLGL----ACDFSKKKPHASVGTHGYMAPEVLQKGTA 172
Query: 838 SNEKSDVYSFGVILWELVTMQQPW--NGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895
+ +D +S G +L++L+ P+ + + + + +P + SP L SL+E
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TVNVELPDSFSPELKSLLE 231
Query: 896 SCWADDPAQR 905
D ++R
Sbjct: 232 GLLQRDVSKR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 32/103 (31%), Positives = 56/103 (54%), Gaps = 9/103 (8%)
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA-- 822
A ++ G+ ++HN +++ DLK N+L+D++ V++ D GL A F K A
Sbjct: 103 AAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGL----ACDFSKKKPHASV 156
Query: 823 GTPEWMAPEFL-RGEPSNEKSDVYSFGVILWELVTMQQPWNGL 864
GT +MAPE L +G + +D +S G +L++L+ P+
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 5e-06
Identities = 59/246 (23%), Positives = 96/246 (39%), Gaps = 57/246 (23%)
Query: 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQD-FLDDQLKEFLREVAIMKRVRH 715
++ H + +G G+FG V + G A+K L + F DQL E ++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYR-LIHRPAAGEMMDQRRRLRMALDVAKGINY 774
P VV + +L ++ E+LP G L LI E + R MA + I
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVT---RFYMA-ECVLAIEA 116
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR------------------------- 809
+H L +H D+K N+L+D+ +K+ DFGLS
Sbjct: 117 VHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 810 ----------------------FKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSF 847
+K N + + S GTP+++APE + ++ D +S
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234
Query: 848 GVILWE 853
G I++E
Sbjct: 235 GAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 667 VGAGSFGTVHRA--EWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
VG+G++G+V A VAVK L+ Q + + RE+ ++K ++H NV+ +
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLI--HARRTYRELRLLKHMKHENVIGLL 80
Query: 723 GAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
T + E YL + ++ + + + + +G+ Y+H+
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG-- 138
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPE-FLRGEPSNE 840
I+H DLK N+ V+++ +++ DFGL+R T + APE L N+
Sbjct: 139 IIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTGYVATRWYRAPEIMLNWMHYNQ 195
Query: 841 KSDVYSFGVILWELV 855
D++S G I+ EL+
Sbjct: 196 TVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 40/122 (32%), Positives = 60/122 (49%), Gaps = 13/122 (10%)
Query: 639 GPRYLNIEP-SLAMD--WLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVK 688
G Y+ ++P L D W E+ D L + +G+G+FG V A HG VAVK
Sbjct: 15 GHEYIYVDPMQLPYDSAW-EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVK 73
Query: 689 VLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI 747
+L ++ + + E+ IM + H N+V +GA TK + I+TEY G L +
Sbjct: 74 MLKSTARSSEK-QALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYL 132
Query: 748 HR 749
HR
Sbjct: 133 HR 134
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 24/203 (11%)
Query: 682 GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRG 741
G V V+ + ++ ++ + E+ + K HPN+V + L +VT ++ G
Sbjct: 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84
Query: 742 SLYRLIHRPAAGEMMDQRRRLRMA---LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW 798
S LI MD L +A V K ++Y+H++ +H +K+ ++L+ +
Sbjct: 85 SAKDLI----CTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDG 138
Query: 799 TVKVCDFGL----------SRFKANTFISSKSVAGTPEWMAPEFLRG--EPSNEKSDVYS 846
KV GL R + SV P W++PE L+ + + KSD+YS
Sbjct: 139 --KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYS 195
Query: 847 FGVILWELVTMQQPWNGLGPAQV 869
G+ EL P+ + Q+
Sbjct: 196 VGITACELANGHVPFKDMPATQM 218
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 666 RVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV----L 720
+VG G++G V++A+ G D L + + RE+A+++ ++HPNV+ +
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA-CREIALLRELKHPNVIALQKV 66
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLI--HRP--AAGEMMDQRRRLRMAL--DVAKGINY 774
F+ ++ + ++ +Y L+ +I HR A + M R + +L + GI+Y
Sbjct: 67 FLSHSDRK--VWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 775 LHNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGLSRF---KANTFISSKSVAGTPEW 827
LH +LH DLK N+LV + VK+ D G +R V T +
Sbjct: 124 LH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 828 MAPEFLRGEPSNEKS-DVYSFGVILWELVTMQ 858
APE L G K+ D+++ G I EL+T +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 41/220 (18%)
Query: 666 RVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEF---------LREVAIMKRVRHP 716
+VG G++G V++A+ +D D LK+ RE+A+++ ++HP
Sbjct: 8 KVGRGTYGHVYKAKRKDG---------KDDRDYALKQIEGTGISMSACREIALLRELKHP 58
Query: 717 NVV----LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL------RMAL 766
NV+ +F+ ++ + ++ +Y L+ +I A + + +L +
Sbjct: 59 NVISLQKVFLSHADRK--VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLY 115
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGLSRF---KANTFISSK 819
+ GI+YLH +LH DLK N+LV + VK+ D G +R
Sbjct: 116 QILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 820 SVAGTPEWMAPEFLRGEPSNEKS-DVYSFGVILWELVTMQ 858
V T + APE L G K+ D+++ G I EL+T +
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 39/159 (24%), Positives = 72/159 (45%), Gaps = 6/159 (3%)
Query: 704 LREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLR 763
L E I+++V VV A + L +V + G L I+ D++R +
Sbjct: 48 LNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIF 106
Query: 764 MALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSVA 822
A ++ G+ L I++ DLK N+L+D +++ D GL+ + + +
Sbjct: 107 YAAELCCGLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR--V 162
Query: 823 GTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPW 861
GT +MAPE + E D + G +++E++ Q P+
Sbjct: 163 GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 43/164 (26%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 670 GSFGTVH--RAEWHGSDVAVKVLTVQDFLDDQLKEFLR-EVAIMKRVRHPNVVLFMGAVT 726
G+FG V+ R + + AVKV+ D ++ + ++ E + + P +V ++
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 727 KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWD 786
++ +V EYL G + L+H D+ ++ +VA ++YLH I+H D
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG--IIHRD 129
Query: 787 LKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAP 830
LK N+L+ +K+ DFGLS+ N ++ + TP P
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 4e-04
Identities = 39/152 (25%), Positives = 73/152 (48%), Gaps = 11/152 (7%)
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLP--RGSLYRLIHRPAAGEMMDQRRRLR 763
E +++R+ HP V+ + R + LP R LY + + +
Sbjct: 210 EARLLRRLSHPAVLALLDV---RVVGGLTCLVLPKYRSDLYTYLGARL--RPLGLAQVTA 264
Query: 764 MALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS--KSV 821
+A + I+Y+H I+H D+K+ N+LV+ + + DFG + F ++ + +
Sbjct: 265 VARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322
Query: 822 AGTPEWMAPEFLRGEPSNEKSDVYSFGVILWE 853
AGT + APE L G+P D++S G++++E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 7e-04
Identities = 23/62 (37%), Positives = 35/62 (56%), Gaps = 5/62 (8%)
Query: 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAF 875
+ + + GTP+++APE L G+P D ++ GV L+E +T P+N P QV F
Sbjct: 535 VEGERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQV-----F 589
Query: 876 QN 877
QN
Sbjct: 590 QN 591
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|111949 pfam03109, ABC1, ABC1 family | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 8e-04
Identities = 15/35 (42%), Positives = 18/35 (51%), Gaps = 5/35 (14%)
Query: 657 SWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVL 690
+DE E + A S VHRA G +VAVKV
Sbjct: 13 EFDE----EPIAAASIAQVHRAVLKDGEEVAVKVQ 43
|
This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 0.001
Identities = 48/194 (24%), Positives = 86/194 (44%), Gaps = 21/194 (10%)
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAA---GEMMDQRRR 761
RE+ I+K + H ++ + A + + +V + L+ + R + + +RR
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKY-KCDLFTYVDRSGPLPLEQAITIQRR 193
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSV 821
L AL YLH I+H D+K+ N+ +D+ + DFG + K + +
Sbjct: 194 LLEAL------AYLHGRG--IIHRDVKTENIFLDEPENAVLGDFG-AACKLDAHPDTPQC 244
Query: 822 ---AGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGL----GPAQVVGAV- 873
+GT E +PE L +P K+D++S G++L+E+ G +Q+ +
Sbjct: 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304
Query: 874 AFQNRRLAIPQNTS 887
Q L PQN S
Sbjct: 305 CMQVHPLEFPQNGS 318
|
Length = 392 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.002
Identities = 31/160 (19%), Positives = 62/160 (38%), Gaps = 39/160 (24%)
Query: 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLR------EVAIMKRVRH----- 715
+ G+ ++ ++ G +K + + +L E +R E ++ R R
Sbjct: 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNT 61
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQ---RRRLRMALDVAKGI 772
P VV + K +IV EY+ G+ + + ++ + +
Sbjct: 62 P-VVYDVDPDNK----TIVMEYIE-------------GKPLKDVIEEGNDELLREIGRLV 103
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVC--DFGLSRF 810
LH I+H DL + N++V + K+ DFGL ++
Sbjct: 104 GKLHKAG--IVHGDLTTSNIIVRDD---KLYLIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.003
Identities = 33/156 (21%), Positives = 60/156 (38%), Gaps = 32/156 (20%)
Query: 670 GSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLR------EVAIMKRVRHPNVVLFMG 723
G+ ++ ++ G +K + + +L E +R E IM R R G
Sbjct: 7 GAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARK------AG 60
Query: 724 AVTKRPHL------SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
+ IV EY+ L LI+ L ++ ++ + + LH+
Sbjct: 61 VNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG-------MEELELSREIGRLVGKLHS 113
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVC--DFGLSRFK 811
I+H DL + N+++ K+ DFGL+ F
Sbjct: 114 AG--IIHGDLTTSNMILSGG---KIYLIDFGLAEFS 144
|
Length = 211 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 9/105 (8%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREV 707
E D L + +GAG+FG V A G VAVK+L D++ + + E+
Sbjct: 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDER-EALMSEL 92
Query: 708 AIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPA 751
I+ + +H N+V +GA T + ++TEY G L + + A
Sbjct: 93 KILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKA 137
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 931 | |||
| PF14381 | 204 | EDR1: Ethylene-responsive protein kinase Le-CTR1 | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.26 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.23 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.23 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.22 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.96 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.89 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.69 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.69 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.55 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.43 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.42 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.37 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.32 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.25 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.24 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.17 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.1 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.05 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.98 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.98 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.7 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.61 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.61 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.5 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.49 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.38 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.38 | |
| smart00460 | 68 | TGc Transglutaminase/protease-like homologues. Tra | 97.37 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.3 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.29 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.29 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.27 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.21 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.18 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.16 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.16 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.0 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.84 | |
| COG5279 | 521 | CYK3 Uncharacterized protein involved in cytokines | 96.84 | |
| PF01841 | 113 | Transglut_core: Transglutaminase-like superfamily; | 96.75 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.47 | |
| PLN02236 | 344 | choline kinase | 96.46 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.26 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.21 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.07 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.87 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.8 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.7 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.63 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.63 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.54 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.87 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.13 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.96 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 93.85 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.85 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.72 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 92.46 |
| >PF14381 EDR1: Ethylene-responsive protein kinase Le-CTR1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-66 Score=533.09 Aligned_cols=200 Identities=53% Similarity=0.917 Sum_probs=188.8
Q ss_pred CCccceEEEEeeecccccCcCCCCceeeecccCcchhhhcc-cc-cccCCCCCcccccccCCCCceeeEEEEeccCChhH
Q 002355 259 SDTETVSYRLWVSGCLSYNDKISDGFYNILGMNPYLWVMCN-DL-EEGKRLPSLMSLKDIDSTETSMEVVLIDRHGDSRL 336 (931)
Q Consensus 259 ~~~~~~s~~~w~~~~l~~~d~i~dGFY~i~~~~~~~~~~~~-d~-~~~~~~P~l~~L~~~~~~~~~~EvilVdr~~D~~L 336 (931)
+++|++|||||++|||+|+||||||||+|+||+ |+ +. .+++|||+|++|+++++..+++|||||||++|++|
T Consensus 1 ~~~e~lS~r~W~~~~L~y~dki~DGFYdi~g~~------~~~~l~~~~~~~Psl~~L~~~~~~~~~~EvIlVDr~~D~~L 74 (204)
T PF14381_consen 1 SSAESLSHRYWVNGCLSYDDKIPDGFYDIYGMD------CTNSLKEEFGRMPSLEDLQAVPPDDSSREVILVDRRRDPSL 74 (204)
T ss_pred CcHHHHHHHHHHcCCCCCCCcCCCCCcccccCC------CccccccccCCCCCHHHHhcCCCCCCCeeEEEEccccCHHH
Confidence 478999999999999999999999999999997 63 54 68999999999999998899999999999999999
Q ss_pred HHHHHHHHHHHhhcc-ChHHHHHHHHHHHHHhhCCCcCCCcchhhhhHHHHHHHHHhhhcCceEEeecccccchhhhHHH
Q 002355 337 KELEDKAQELYCASE-NTLVLVEELGKLVAICMGGTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAIL 415 (931)
Q Consensus 337 ~~l~~~a~~~~~~~~-~~~~~~~~la~~V~~~mgg~~~~~~~~~~~~~~~~~~~l~~~~~~~v~plG~l~~G~~rhRAlL 415 (931)
++|+|+|+++++++. ++++++++||++||++|||++..++.. ..+|++++.+|+. +++|+|||+|++|+|||||||
T Consensus 75 ~~L~~~a~~~~~~~~~~~~~~v~~LA~lVa~~MGG~~~~~~~~-~~~w~~~s~~lk~--~s~~vplG~l~~G~~rhRALL 151 (204)
T PF14381_consen 75 KELEQRAHELSKGLSTNTKELVQKLAKLVADRMGGPVSDAEDM-LFRWELRSEKLKE--NSGVVPLGSLRIGLCRHRALL 151 (204)
T ss_pred HHHHHHHHHHHhccccCHHHHHHHHHHHHHHHhCCCCCcchhh-hHHHHHHHHHHHh--CCCeEEEeeecccchHHHHHH
Confidence 999999999999986 799999999999999999999886644 4489998888888 899999999999999999999
Q ss_pred HHHHhhhcCCCceeeecccccCC-CCceeEEEEecCcccccceeEeeccCCCCcccC
Q 002355 416 FKKLADYIGLPCRIARGCRYCEA-DHRSSCLVKIEDDRRSSREYVVDLVGEPGNIHG 471 (931)
Q Consensus 416 FKvLaD~i~l~c~lv~G~~y~~~-~~~~~~~v~~~~~~~~~~~~ivDlm~~pG~l~~ 471 (931)
||||||+||||||||||||||+. ++++||+|++.+. +|||||||++||+|+|
T Consensus 152 FKvLAD~iglpCrLvrG~~y~g~~~~~a~~~V~~~~~----~eyiVDLm~~PG~L~P 204 (204)
T PF14381_consen 152 FKVLADRIGLPCRLVRGCYYCGWDDDDASNLVKFDDG----REYIVDLMGAPGQLIP 204 (204)
T ss_pred HHHHHHhcCCCceEEeeccCCccCCCCceEEEEcCCC----cEEEEEcCCCCCCcCC
Confidence 99999999999999999999999 9999999999998 9999999999999998
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=409.24 Aligned_cols=252 Identities=26% Similarity=0.441 Sum_probs=227.1
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchH-HHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD-QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~-~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
..++|++++.||+|+||+||+++. +++.+|+|++++...... ..++..+|..||..++||+||+++..|++..++||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 458999999999999999999975 677899999998876653 67889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
|+||+.||.|+.+|.+ .+.+++..++.++.+|+.||.|||++| ||||||||+|||||.+|+|+|+|||+|+....
T Consensus 103 Vld~~~GGeLf~hL~~---eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQR---EGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEeccCCccHHHHHHh---cCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999986 346999999999999999999999999 99999999999999999999999999997666
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
....+.++|||+.|||||++.+.+++.++||||||+++|||++|.+||.+.+..+++..+.. ......|..++.+.++|
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~-~k~~~~p~~ls~~ardl 256 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK-GKLPLPPGYLSEEARDL 256 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc-CcCCCCCccCCHHHHHH
Confidence 55567789999999999999999999999999999999999999999999998888888763 33355666799999999
Q ss_pred HHHhcccCCCCCC----CHHHHHHH
Q 002355 894 MESCWADDPAQRP----SFANIVES 914 (931)
Q Consensus 894 I~rcL~~DPeeRP----Sa~ELLq~ 914 (931)
|+++|+.+|++|. ++.+|.+|
T Consensus 257 l~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 257 LKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred HHHHhccCHHHhcCCCCChHHhhcC
Confidence 9999999999995 45554443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=413.88 Aligned_cols=270 Identities=50% Similarity=0.833 Sum_probs=246.4
Q ss_pred cccccccCceEEEEEecccCceEEEEEEEcCCc-eEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC-
Q 002355 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP- 729 (931)
Q Consensus 652 ~~lei~~drY~Ii~kLG~G~fGtVylAr~~g~~-VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~- 729 (931)
..+++.++.+.+.+.||.|+||+||+|.|.|+. ||+|++............|.+|+.+|.+++|||||+|++++....
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 356677788888899999999999999999998 999999987766665788999999999999999999999999887
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC-cEEEEecCcc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-TVKVCDFGLS 808 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg-~IKL~DFGlA 808 (931)
.++|||||+++|+|.+++.+. ....++...+..|+.||++||+|||+.++ ||||||||+||||+.++ ++||+|||++
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccc
Confidence 799999999999999999764 35679999999999999999999999886 99999999999999998 9999999999
Q ss_pred ccccccccccCCCCCCCcccCccccc--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCC
Q 002355 809 RFKANTFISSKSVAGTPEWMAPEFLR--GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNT 886 (931)
Q Consensus 809 r~~~~~~~~~~~~~GT~~Y~APEvL~--~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~ 886 (931)
+.............||..|||||++. ...++.++||||||+++|||+||..||.+....+....+.....++.+|..+
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~ 271 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC 271 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence 98766533334478999999999999 5689999999999999999999999999999988888888899999999999
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCch
Q 002355 887 SPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPA 923 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~ 923 (931)
++.+..||.+||..||..||++.+++..|..+.....
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 9999999999999999999999999999999887544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=423.53 Aligned_cols=249 Identities=27% Similarity=0.462 Sum_probs=231.1
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.+|...+.||+|||++||.+++ +|+.||+|++.+..... .+...+.+||+|.++|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6899999999999999999986 78899999998865543 45678899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
|+|..++|..++++ .+.++|.+++++++||+.||.|||+++ |||||||..||||+.+.+|||+|||+|.......
T Consensus 98 ELC~~~sL~el~Kr---rk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR---RKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHh---cCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 99999999999985 457999999999999999999999999 9999999999999999999999999999887666
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~ 895 (931)
....+.||||.|.|||++....++..+||||+||+||.|++|++||...+-.+++..+. .....+|..++.++++||+
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik--~~~Y~~P~~ls~~A~dLI~ 250 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK--LNEYSMPSHLSAEAKDLIR 250 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH--hcCcccccccCHHHHHHHH
Confidence 67789999999999999999999999999999999999999999999988888888875 4455678899999999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 002355 896 SCWADDPAQRPSFANIVES 914 (931)
Q Consensus 896 rcL~~DPeeRPSa~ELLq~ 914 (931)
++|+.+|.+|||+++++.|
T Consensus 251 ~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 251 KLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HHhcCCcccCCCHHHHhcC
Confidence 9999999999999999987
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=401.24 Aligned_cols=250 Identities=32% Similarity=0.529 Sum_probs=223.0
Q ss_pred cccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC-eEE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP-HLS 732 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~-~l~ 732 (931)
+..++++.++.||+|..|+||+++++ ++.+|+|++... ......+++.+|+++++..+|||||.+|++|.... .++
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is 154 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS 154 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence 34568888999999999999999884 778999999443 34455678999999999999999999999999988 499
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs-~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
|+||||.||+|.+++... +++++...-.++.+|++||.|||. ++ ||||||||+|||++..|.|||||||.+...
T Consensus 155 I~mEYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEVKICDFGVSGIL 229 (364)
T ss_pred eehhhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCEEeccccccHHh
Confidence 999999999999999762 569999999999999999999995 88 999999999999999999999999999987
Q ss_pred cccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHhcccccCCCCC-
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGL-----GPAQVVGAVAFQNRRLAIPQN- 885 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~-----~~~eii~~i~~~~~r~~lP~~- 885 (931)
.++ ...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||... +..+.+..+. ...++.+|..
T Consensus 230 vnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~~~ 306 (364)
T KOG0581|consen 230 VNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPEGE 306 (364)
T ss_pred hhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCccc
Confidence 776 457789999999999999999999999999999999999999999774 4566666665 3455667775
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 886 TSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+++++++||..||++||.+|||++|+++|
T Consensus 307 fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 307 FSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 99999999999999999999999999988
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=400.07 Aligned_cols=254 Identities=23% Similarity=0.371 Sum_probs=217.7
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchH-----HHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD-----QLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~-----~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
..+.|.+.+.||.|+||.|-+|.. +++.||||++.+...... ....+.+|++||++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 347899999999999999999965 788999999988765441 1234579999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC---CcEEEEecC
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN---WTVKVCDFG 806 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d---g~IKL~DFG 806 (931)
..||||||+.||+|++.+-. .+.+.+...+.+++||+.||.|||+.| |+||||||+|||+..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999999975 346888888999999999999999999 9999999999999876 679999999
Q ss_pred ccccccccccccCCCCCCCcccCcccccCCCC---CchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhccccc--
Q 002355 807 LSRFKANTFISSKSVAGTPEWMAPEFLRGEPS---NEKSDVYSFGVILWELVTMQQPWNGLGPAQ-VVGAVAFQNRRL-- 880 (931)
Q Consensus 807 lAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~---t~ksDIWSLG~ILyELLTG~~PF~~~~~~e-ii~~i~~~~~r~-- 880 (931)
+|+..+.. ....+.|||+.|.|||++.+... ..++|||||||++|-+++|.+||.+..... ...++.......
T Consensus 325 lAK~~g~~-sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p 403 (475)
T KOG0615|consen 325 LAKVSGEG-SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP 403 (475)
T ss_pred hhhccccc-eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC
Confidence 99988744 34578899999999999987654 347899999999999999999998876555 555654333332
Q ss_pred CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 881 AIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 881 ~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
.....++++..+||.+||..||++|||+.|+|+|=|
T Consensus 404 ~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 404 LQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 234678999999999999999999999999998844
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=391.41 Aligned_cols=251 Identities=26% Similarity=0.504 Sum_probs=222.3
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
..+|.+.++||+|+||+||+|++ ++..||||.+.+.....+..+-+..|++||+.++|||||++++++..++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 47899999999999999999987 5678999999998877777788899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC------CcEEEEecCccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN------WTVKVCDFGLSR 809 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d------g~IKL~DFGlAr 809 (931)
|||.||+|.+|+++. +.+++..++.++.||+.||++||+++ ||||||||+||||+.. -.+||+|||+|+
T Consensus 89 EyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999999873 36999999999999999999999999 9999999999999764 468999999999
Q ss_pred cccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc-cCCCCCChH
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR-LAIPQNTSP 888 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r-~~lP~~~s~ 888 (931)
..... ....+.||++.|||||++....|+.|+|+||+|+++|+|++|+.||...+..+....+...... ..++...+.
T Consensus 164 ~L~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~ 242 (429)
T KOG0595|consen 164 FLQPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSN 242 (429)
T ss_pred hCCch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccC
Confidence 87654 3557889999999999999999999999999999999999999999999988888766544433 334556677
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 889 VLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
...+|+...++.++..|-+..+.+.+
T Consensus 243 ~~~~Ll~~ll~~~~~~~~~~~~~~~~ 268 (429)
T KOG0595|consen 243 PLRELLISLLQRNPKDRISFEDFFDH 268 (429)
T ss_pred chhhhhhHHHhcCccccCchHHhhhh
Confidence 78899999999999999887766544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=379.72 Aligned_cols=239 Identities=28% Similarity=0.508 Sum_probs=222.9
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
..++|++++.||.|+||.|.+++. ++..+|+|++.+....+ ++.++..+|..+|+.+.||+++++++.|.+...+||
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 347999999999999999999976 67889999999887655 678889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
||||++||.|+.++++ .+++++..++.++.||+.||+|||+++ |++|||||+|||||.+|++||+|||+|+....
T Consensus 122 vmeyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EEeccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 9999999999999987 457999999999999999999999999 99999999999999999999999999987655
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
. +.+.||||.|+|||++...+++.++|+|+||+++|||+.|.+||...++.+++.++. .....+|...+.++++|
T Consensus 197 r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~--~~~v~fP~~fs~~~kdL 271 (355)
T KOG0616|consen 197 R---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL--EGKVKFPSYFSSDAKDL 271 (355)
T ss_pred c---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH--hCcccCCcccCHHHHHH
Confidence 4 478899999999999999999999999999999999999999999999999999886 55667899999999999
Q ss_pred HHHhcccCCCCC
Q 002355 894 MESCWADDPAQR 905 (931)
Q Consensus 894 I~rcL~~DPeeR 905 (931)
|+++|+.|-.+|
T Consensus 272 l~~LL~vD~t~R 283 (355)
T KOG0616|consen 272 LKKLLQVDLTKR 283 (355)
T ss_pred HHHHHhhhhHhh
Confidence 999999999999
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=389.29 Aligned_cols=259 Identities=27% Similarity=0.494 Sum_probs=226.9
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEe-eeeeCC-eEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMG-AVTKRP-HLSI 733 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid-~f~~~~-~l~L 733 (931)
..+|+|+++||+|.||+||++.+ ++..+|+|.+.-.....+..+.+..|+.+|++|+|||||++++ .|..++ .++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 46899999999999999999975 7889999999877666677788899999999999999999998 555544 4999
Q ss_pred EEeecCCCCHHHHhhcC-CCCCCCcHHHHHHHHHHHHHHHHHHHhCCC--CEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 734 VTEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNP--PILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~-~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~--~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
|||+|.+|+|..++++. ..+..++++.+|+++.|++.||.++|+.-+ .|+||||||.||+|+.+|.+||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999999753 345679999999999999999999999433 499999999999999999999999999998
Q ss_pred ccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC-CCChHH
Q 002355 811 KANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP-QNTSPV 889 (931)
Q Consensus 811 ~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP-~~~s~e 889 (931)
.........+.+|||.||+||++.+.+++.++|||||||++|||+.-++||.+.+-.+...++. +..-+++| ...+..
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~-qgd~~~~p~~~YS~~ 256 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIE-QGDYPPLPDEHYSTD 256 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHH-cCCCCCCcHHHhhhH
Confidence 8777666778899999999999999999999999999999999999999999987777666664 34444566 778999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002355 890 LASLMESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 890 L~dLI~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
+..||..|+..||+.||+.-.++..+..
T Consensus 257 l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 257 LRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 9999999999999999997666665554
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=398.17 Aligned_cols=253 Identities=27% Similarity=0.446 Sum_probs=224.0
Q ss_pred cccCceEEEEEecccCceEEEEEE--EcCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr--~~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
+..++|+++..||+|+||.||+|+ ++|..+|+|++++..... .++..++.|..||....+|+||+|+..|++..++|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 356899999999999999999995 478999999999987654 67889999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
|||||++||++..+|.+ .+.|++..++.++.+++.||+-||.+| +|||||||+|+|||..|||||+|||++.-..
T Consensus 218 LiMEylPGGD~mTLL~~---~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMR---KDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEEecCCccHHHHHHh---cCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999986 456999999999999999999999999 9999999999999999999999999984211
Q ss_pred c-----------------------ccc------------------------ccCCCCCCCcccCcccccCCCCCchhHHH
Q 002355 813 N-----------------------TFI------------------------SSKSVAGTPEWMAPEFLRGEPSNEKSDVY 845 (931)
Q Consensus 813 ~-----------------------~~~------------------------~~~~~~GT~~Y~APEvL~~~~~t~ksDIW 845 (931)
. ... .....+|||.|||||++.+.+++..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 0 000 01245799999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC--CCChHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 002355 846 SFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP--QNTSPVLASLMESCWADDPAQRP---SFANIVES 914 (931)
Q Consensus 846 SLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP--~~~s~eL~dLI~rcL~~DPeeRP---Sa~ELLq~ 914 (931)
||||||||||.|.+||.+.++.+++..+.........| ..+++++.+||.+||. ||++|. .++||.+|
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 99999999999999999999999999887666556565 4567999999999999 999996 57777765
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=374.87 Aligned_cols=265 Identities=31% Similarity=0.556 Sum_probs=218.9
Q ss_pred cccccCceEEEEEecccCceEEEEEEE-------cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeee
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEW-------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAV 725 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~-------~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f 725 (931)
|.+..++|++.++||.|+||.||+|.+ .++.||||+++... .......+.+|+.++..+ +||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 567789999999999999999999974 23579999987543 233446788999999999 899999999988
Q ss_pred ee-CCeEEEEEeecCCCCHHHHhhcCCC----------------------------------------------------
Q 002355 726 TK-RPHLSIVTEYLPRGSLYRLIHRPAA---------------------------------------------------- 752 (931)
Q Consensus 726 ~~-~~~l~LVmEy~~GgSL~d~L~r~~~---------------------------------------------------- 752 (931)
.. +..+++||||+++|+|.+++.....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 65 4568999999999999999864211
Q ss_pred -------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc--ccccCCCCC
Q 002355 753 -------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT--FISSKSVAG 823 (931)
Q Consensus 753 -------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~--~~~~~~~~G 823 (931)
...+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++..... ........+
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 124778888999999999999999999 999999999999999999999999999754321 112223456
Q ss_pred CCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCC
Q 002355 824 TPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDP 902 (931)
Q Consensus 824 T~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DP 902 (931)
+..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+............+..+++.+.+||.+||..||
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp 318 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDP 318 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 778999999999889999999999999999997 9999987654444433333444455677889999999999999999
Q ss_pred CCCCCHHHHHHHHHHHhhC
Q 002355 903 AQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 903 eeRPSa~ELLq~L~~Llks 921 (931)
.+|||+.++++.|+.+++.
T Consensus 319 ~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 319 KERPTFSALVEILGDLLQE 337 (338)
T ss_pred hhCcCHHHHHHHHHHHHhc
Confidence 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=396.10 Aligned_cols=250 Identities=26% Similarity=0.455 Sum_probs=225.6
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchH-HHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD-QLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~-~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~L 733 (931)
..+|.+++.||.|+|++|++|+. +++.|||||+.+..+... .++-+.+|..+|.+| .||.|++|+..|++...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 37899999999999999999976 688899999988766553 345678899999999 79999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
|+||+++|+|.++|++. +.+++..++.++.||+.||+|||++| ||||||||+|||||.++++||+|||-|+....
T Consensus 152 vLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999999874 46999999999999999999999999 99999999999999999999999999986432
Q ss_pred ccc-----------c--cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc
Q 002355 814 TFI-----------S--SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL 880 (931)
Q Consensus 814 ~~~-----------~--~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~ 880 (931)
... . ..+++||..|.+||++.+...++.+|||+||||+|.|+.|.+||.+.++-.+++.+. ....
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~--~l~y 304 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ--ALDY 304 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH--Hhcc
Confidence 211 1 156899999999999999999999999999999999999999999999888888775 5566
Q ss_pred CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 ~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+|.+.++.+++||.++|..||..|+|+++|.+|
T Consensus 305 ~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 305 EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 7899999999999999999999999999999887
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=383.13 Aligned_cols=253 Identities=29% Similarity=0.491 Sum_probs=223.3
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc---hHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCe
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL---DDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPH 730 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~---~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~ 730 (931)
..++|.+.+.||+|+||+|++|++ +++.||+|++...... ....+.+.+|+.+++.++ ||||+++++++....+
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 457999999999999999999976 6789999988775222 123456678999999999 9999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC-CcEEEEecCccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN-WTVKVCDFGLSR 809 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d-g~IKL~DFGlAr 809 (931)
+|+||||+.||+|++++.. .+++.+..++.+++||+.|++|||++| |+||||||+|||++.+ +++||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 9999999999999999976 456899999999999999999999999 9999999999999999 999999999998
Q ss_pred cccccccccCCCCCCCcccCcccccCCC-C-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCC-
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLRGEP-S-NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNT- 886 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~~~~-~-t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~- 886 (931)
..........+.+||+.|+|||++.+.. | +.++||||+|++||.|++|..||...+...++..+ ......+|..+
T Consensus 170 ~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki--~~~~~~~p~~~~ 247 (370)
T KOG0583|consen 170 ISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI--RKGEFKIPSYLL 247 (370)
T ss_pred ccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH--hcCCccCCCCcC
Confidence 7632333557889999999999999977 6 58899999999999999999999998777777664 35666788888
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 887 SPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
++++++||++||..+|.+|+|+.+++.+=+
T Consensus 248 S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w 277 (370)
T KOG0583|consen 248 SPEARSLIEKMLVPDPSTRITLLEILEHPW 277 (370)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHhhChh
Confidence 999999999999999999999999996643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=372.47 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=209.9
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|+.+.++|+|+||+||+|++ +|+.||||++..+.......+-.++||++|++|+|+|+|.|+++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 5788999999999999999976 68889999998765444444567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
||.. ++.+-+.+.. ..++...+..++.|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+....+..
T Consensus 82 ~~dh-TvL~eLe~~p--~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 82 YCDH-TVLHELERYP--NGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred ecch-HHHHHHHhcc--CCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence 9955 5555555532 34889999999999999999999999 99999999999999999999999999998775555
Q ss_pred ccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-cc-----------------
Q 002355 817 SSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAF-QN----------------- 877 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~-~~----------------- 877 (931)
..+..+.|.+|+|||.+.+ .+|+.++|||++||++.||++|.+.|.+..+.+.+..+.. .+
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 5567788999999999987 7899999999999999999999999998775443322211 00
Q ss_pred -cccCCC----------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 878 -RRLAIP----------QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 878 -~r~~lP----------~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+.+-| +.++..+.+|+..||..||.+|++.++++.|
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111111 3456678999999999999999999999976
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=376.27 Aligned_cols=255 Identities=31% Similarity=0.526 Sum_probs=216.9
Q ss_pred CceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC--eEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP--HLSIV 734 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~--~l~LV 734 (931)
.++...+.||+|+||+||++.+. ++..|||.+....... .+.+.+|+.+|++++|||||++++...... .++|+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 45778889999999999999874 6899999998763222 567889999999999999999999854444 69999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC-CCcEEEEecCccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~-dg~IKL~DFGlAr~~~~ 813 (931)
|||+++|+|.+++.+.+. .+++..++.+++||++||+|||++| |||+||||+|||++. ++.+||+|||++.....
T Consensus 95 mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999999987432 6999999999999999999999999 999999999999999 79999999999986552
Q ss_pred ---cccccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcccccCCCCCChH
Q 002355 814 ---TFISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNG-LGPAQVVGAVAFQNRRLAIPQNTSP 888 (931)
Q Consensus 814 ---~~~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~-~~~~eii~~i~~~~~r~~lP~~~s~ 888 (931)
.........||+.|||||++... ....++|||||||++.||+||..||.. ......+..+......+.+|..++.
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~ 250 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSD 250 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCH
Confidence 11224567899999999999953 334599999999999999999999988 4555555555555555688999999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 002355 889 VLASLMESCWADDPAQRPSFANIVESLKKLL 919 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Ll 919 (931)
++++||.+|+.++|++|||+.++|+|.....
T Consensus 251 ~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 251 EAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 9999999999999999999999999865443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=387.53 Aligned_cols=266 Identities=38% Similarity=0.667 Sum_probs=239.3
Q ss_pred cccccccccCceEEEEEecccCceEEEEEEEcCC-ceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC
Q 002355 650 AMDWLEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728 (931)
Q Consensus 650 ~~~~lei~~drY~Ii~kLG~G~fGtVylAr~~g~-~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~ 728 (931)
+.+.|++..+.++++++||+|-||.||+|++++. .||+|.++...... +.|.+|+++|++|+|+|||++++++..+
T Consensus 197 ~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~ 273 (468)
T KOG0197|consen 197 ARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQ 273 (468)
T ss_pred ccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence 3567889999999999999999999999999887 89999998764433 4678999999999999999999999998
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
+.+|||||||+.|+|.++++. ..+..+...+.+.|+.||+.|++||++++ +|||||-..||||+.+..+||+|||+|
T Consensus 274 ~piyIVtE~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 274 EPIYIVTEYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred CceEEEEEecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccc
Confidence 899999999999999999986 44667899999999999999999999999 999999999999999999999999999
Q ss_pred cccccccc-ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCC
Q 002355 809 RFKANTFI-SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNT 886 (931)
Q Consensus 809 r~~~~~~~-~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~ 886 (931)
+...+... ......-+..|.|||.+....++.++||||||++||||+| |+.||.++...+.+..+. .+.+++.|..+
T Consensus 351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-~GyRlp~P~~C 429 (468)
T KOG0197|consen 351 RLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-RGYRLPRPEGC 429 (468)
T ss_pred cccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-ccCcCCCCCCC
Confidence 96554432 2223334678999999999999999999999999999998 799999999999988874 78899999999
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 887 SPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
|+++.++|..||..+|++|||++.+...|.++....
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 999999999999999999999999999999887653
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=361.54 Aligned_cols=248 Identities=24% Similarity=0.443 Sum_probs=217.2
Q ss_pred CceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|+++++||+|+||+||+|++. ++.||+|++....... .....+.+|+.+++.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47899999999999999999874 7889999997654322 34567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+++++|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 99999999999975 235889999999999999999999999 999999999999999999999999998765432
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~ 895 (931)
.....|++.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+.. ....++...++.+++||.
T Consensus 155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~ 230 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA--GKLEFPRHLDLYAKDLIK 230 (291)
T ss_pred --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCcCCCccCCHHHHHHHH
Confidence 2345789999999999998899999999999999999999999998887776666543 345567788999999999
Q ss_pred HhcccCCCCCCC-----HHHHHHHHH
Q 002355 896 SCWADDPAQRPS-----FANIVESLK 916 (931)
Q Consensus 896 rcL~~DPeeRPS-----a~ELLq~L~ 916 (931)
+||..||.+||+ +.++++|-+
T Consensus 231 ~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 231 KLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred HHcCCCHHHccCCccCCHHHHhcCcc
Confidence 999999999995 999988743
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=391.34 Aligned_cols=250 Identities=29% Similarity=0.492 Sum_probs=228.2
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeec-ccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQ-DFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~-~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
+-|++++.||.|+-|.|-+|++ +|+.+|||++.+. .....+...+.+||.||+-+.||||+++|++|.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4578999999999999999987 7999999999876 555566678899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||++||.|++++.+ .+.+++.++.+++.||+.|+.|||..+ |+||||||+|+||+..++|||+|||+|.......
T Consensus 92 Eyv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred EecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 99999999999987 446999999999999999999999999 9999999999999999999999999998755442
Q ss_pred cccCCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPS-NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~-t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI 894 (931)
...+.||.++|.+||++.|.+| +.++||||.|+|||.|+||+.||.+.+...++.++. .....+|.++++++.+||
T Consensus 167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~--~G~f~MPs~Is~eaQdLL 243 (786)
T KOG0588|consen 167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQ--RGVFEMPSNISSEAQDLL 243 (786)
T ss_pred -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHH--cCcccCCCcCCHHHHHHH
Confidence 3467799999999999999887 789999999999999999999999988888888774 567788999999999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHH
Q 002355 895 ESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 895 ~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
++||..||++|.|++||++|..
T Consensus 244 r~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 244 RRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred HHHhccCccccccHHHHhhCch
Confidence 9999999999999999999854
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=386.91 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=213.2
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCC-eEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRP-HLS 732 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~-~l~ 732 (931)
.-++|.++++||.|+||.||+|+. .+..||||.++.....-++ ..-+||++.|++|+ ||||++|.+++.+.+ ++|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 347999999999999999999975 6888999999887654332 34478999999998 999999999998877 999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||| ..+|+++++.. +..+++..++.|+.||++||+|+|.+| ++||||||+|||+.....|||+|||+||...
T Consensus 87 fVfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEecccccccccc
Confidence 999999 78999999873 678999999999999999999999999 9999999999999999999999999999765
Q ss_pred ccccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-------------
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR------------- 878 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~------------- 878 (931)
... ..+..+.|.+|+|||++.. ..|+.++|||++|||++|+++-++.|.+.++.+.+.++...-.
T Consensus 162 Skp-PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 162 SKP-PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred cCC-CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 543 3456788999999999865 5578999999999999999999999999876554433321111
Q ss_pred ------ccC---------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 ------RLA---------IPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 ------r~~---------lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+.+ +-.+.+.++.++|.+||+|||.+|||+.|++++
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 000 113478899999999999999999999999987
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=366.92 Aligned_cols=248 Identities=25% Similarity=0.443 Sum_probs=218.0
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
..++|++.+.||+|+||.||+|++ +++.||+|++....... .....+.+|+.++++++||||+++++++..++.+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 448999999999999999999987 46789999998654322 345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
||||+.|++|.+++.+ ...+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 96 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 96 LLEFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEcCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999999975 345889999999999999999999999 99999999999999999999999999986543
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+. .....+|..++..+++|
T Consensus 171 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~l 245 (329)
T PTZ00263 171 R---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL--AGRLKFPNWFDGRARDL 245 (329)
T ss_pred C---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCcCCCCCCCHHHHHH
Confidence 3 234579999999999999989999999999999999999999998887776666654 33456777889999999
Q ss_pred HHHhcccCCCCCCC-----HHHHHHH
Q 002355 894 MESCWADDPAQRPS-----FANIVES 914 (931)
Q Consensus 894 I~rcL~~DPeeRPS-----a~ELLq~ 914 (931)
|.+||+.||.+|++ +.+++.|
T Consensus 246 i~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 246 VKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 99999999999986 7888877
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=388.09 Aligned_cols=248 Identities=31% Similarity=0.559 Sum_probs=228.1
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|.+.+.||+|+||+||+|+. +.+.||+|.+.+..-.++.++.+.+|++|++.|+|||||.++++|+...++|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5789999999999999999975 56789999999988888888999999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+.| +|+.++.. .+.++++.++.++.+++.||.|||+++ |+|||+||.|||+++.|++|+||||+|+.......
T Consensus 82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~ 155 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS 155 (808)
T ss_pred hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhcccCce
Confidence 9966 99999976 456999999999999999999999999 99999999999999999999999999998776666
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMES 896 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~r 896 (931)
......|||.|||||++.+.+|+..+|+|||||++|||++|++||.....-+.+..+. ..+...|...+..+.+|+..
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~--~d~v~~p~~~S~~f~nfl~g 233 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL--KDPVKPPSTASSSFVNFLQG 233 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh--cCCCCCcccccHHHHHHHHH
Confidence 6677899999999999999999999999999999999999999999887777777765 44455677999999999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 002355 897 CWADDPAQRPSFANIVES 914 (931)
Q Consensus 897 cL~~DPeeRPSa~ELLq~ 914 (931)
+|.+||.+|.+..+++.|
T Consensus 234 LL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 234 LLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HhhcChhhcccHHHHhcC
Confidence 999999999999999976
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=389.50 Aligned_cols=245 Identities=29% Similarity=0.488 Sum_probs=222.0
Q ss_pred cccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCeE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~l 731 (931)
+..++|++++.||+|.||+|++|.. +++.+|||++++..+.. +.+.....|.+|+.... ||++++++..|+..+|+
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 4568999999999999999999976 56789999999987654 56788889999988885 99999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
|+||||+.||++..+.+ ...+++..++.++.+|+.||.|||++| |||||||.+|||||.+|++||+|||+++..
T Consensus 445 ~fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEeccccccccc
Confidence 99999999999554443 346999999999999999999999999 999999999999999999999999999976
Q ss_pred cccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHH
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~ 891 (931)
......+.++|||+.|||||++.+..|+.++|||||||+||||+.|..||.+.+.+++...+. ......|..++.++.
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~--~d~~~yP~~ls~ea~ 596 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV--NDEVRYPRFLSKEAI 596 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCCCCCCcccHHHH
Confidence 655557789999999999999999999999999999999999999999999999999999886 444557888999999
Q ss_pred HHHHHhcccCCCCCCCH
Q 002355 892 SLMESCWADDPAQRPSF 908 (931)
Q Consensus 892 dLI~rcL~~DPeeRPSa 908 (931)
+||+++|+++|++|..+
T Consensus 597 ~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 597 AIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHhccCcccccCC
Confidence 99999999999999755
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=365.23 Aligned_cols=243 Identities=26% Similarity=0.459 Sum_probs=211.5
Q ss_pred EEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCC
Q 002355 665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRG 741 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~Gg 741 (931)
+.||+|+||.||+|++ +++.||||+++..... ......+.+|+.+++.++||||++++++|..++.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999976 5778999999865432 234567789999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCCC
Q 002355 742 SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSV 821 (931)
Q Consensus 742 SL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~~ 821 (931)
+|.+++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++............
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 155 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence 99999875 346899999999999999999999999 9999999999999999999999999987543332233456
Q ss_pred CCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccC
Q 002355 822 AGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADD 901 (931)
Q Consensus 822 ~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~D 901 (931)
+||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+. .....+|..+++++.+||.+||..|
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~d 233 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCC
Confidence 79999999999999999999999999999999999999998877666665554 2345677889999999999999999
Q ss_pred CCCCC-----CHHHHHHH
Q 002355 902 PAQRP-----SFANIVES 914 (931)
Q Consensus 902 PeeRP-----Sa~ELLq~ 914 (931)
|++|| ++.++++|
T Consensus 234 P~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 234 PKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHcCCCCCCCHHHHHcC
Confidence 99999 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=354.79 Aligned_cols=247 Identities=21% Similarity=0.375 Sum_probs=216.1
Q ss_pred EEecccCceEEEEEEEcCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeee----CCeEEEEEeecC
Q 002355 665 ERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTK----RPHLSIVTEYLP 739 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~----~~~l~LVmEy~~ 739 (931)
..||+|++|.||+|+++++.||||+++...... ...+.+.+|+.+|++++||||+++++++.+ ...+++||||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 579999999999999999999999997654333 234678899999999999999999999876 457899999999
Q ss_pred CCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhC-CCCEEEeccCCCCeEECCCCcEEEEecCcccccccccccc
Q 002355 740 RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL-NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS 818 (931)
Q Consensus 740 GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~-G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~ 818 (931)
+|+|.+++... ..+++.....++.|++.||.|||+. + ++||||||+|||++.++.+||+|||+++......
T Consensus 106 ~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 106 RGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 99999999752 3588899999999999999999984 7 8899999999999999999999999987644321
Q ss_pred CCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHH
Q 002355 819 KSVAGTPEWMAPEFLRG--EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMES 896 (931)
Q Consensus 819 ~~~~GT~~Y~APEvL~~--~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~r 896 (931)
....|+..|+|||++.+ ..++.++|||||||++|||++|..||.+.+..++...+.....+...+..+++++.+||.+
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 33468899999999976 5789999999999999999999999999888887777765666667777889999999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHHh
Q 002355 897 CWADDPAQRPSFANIVESLKKLL 919 (931)
Q Consensus 897 cL~~DPeeRPSa~ELLq~L~~Ll 919 (931)
||+.||++|||+.++++.|+++.
T Consensus 258 cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 258 CTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HhcCCcccCcCHHHHHHHHHHHH
Confidence 99999999999999999998865
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=385.53 Aligned_cols=249 Identities=27% Similarity=0.493 Sum_probs=223.6
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
...|....+||+|+.|.||.|+. +++.||||.+........ .-+.+|+.+|+.++|+|||++++.|..++.+++||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k--eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK--ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch--hhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 46788889999999999999976 567799999988776554 35789999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
|||+||+|.+++.. ..+++.++..|++++++||+|||.+| |||||||.+|||++.+|.+||+|||+|.......
T Consensus 350 Eym~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred eecCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 99999999999975 34999999999999999999999999 9999999999999999999999999998777666
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-cccCCCCCChHHHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN-RRLAIPQNTSPVLASLM 894 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~-~r~~lP~~~s~eL~dLI 894 (931)
....+.+||++|||||++....|++++||||||++++||+-|.+||-..++-+.+..+...+ .....+..+++++++|+
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL 503 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFL 503 (550)
T ss_pred CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHH
Confidence 57778899999999999999999999999999999999999999998777666555554333 34456788999999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 002355 895 ESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 895 ~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+||..|+++|+++.|||+|
T Consensus 504 ~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 504 DRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHhhcchhcCCCHHHHhcC
Confidence 99999999999999999987
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=362.22 Aligned_cols=248 Identities=26% Similarity=0.430 Sum_probs=215.0
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|+++++||+|+||.||+|++ +++.||||++....... .....+.+|+.++..++||||+++++++..+++.|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 4799999999999999999987 47789999998654322 34567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||++|++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 99999999999975 335889999999999999999999999 99999999999999999999999999976543
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC------CCChHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP------QNTSPV 889 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP------~~~s~e 889 (931)
......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+.........+ ..++++
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~ 232 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDE 232 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHH
Confidence 2245679999999999999999999999999999999999999999888777666554333222222 245899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 890 LASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 890 L~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+.+||.+||..+|.+||++.+++++
T Consensus 233 ~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 233 AWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHHHhhChhhhcCCHHHHHhC
Confidence 9999999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=369.57 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=226.9
Q ss_pred ccccCceEEEEEecccCceEEEEEEEcC--CceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEWHG--SDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~~g--~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
.+..+.|+++++||+|.-|+||+|+..+ ..+|+||+.+.... .+.+.++..|..||+.+.||.++.||..|+.+...
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 3455789999999999999999998865 67999999887765 35567888999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
|+|||||+||+|..++++ +.++.+++..++.++.+++.||+|||..| ||+|||||+||||..+|+|.|+||.++...
T Consensus 153 cl~meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EEEEecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 999999999999999877 56778999999999999999999999999 999999999999999999999999987421
Q ss_pred cc-----------------------------------c---------------------ccccCCCCCCCcccCcccccC
Q 002355 812 AN-----------------------------------T---------------------FISSKSVAGTPEWMAPEFLRG 835 (931)
Q Consensus 812 ~~-----------------------------------~---------------------~~~~~~~~GT~~Y~APEvL~~ 835 (931)
.- . ......++||-+|+|||+|.|
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 00 0 011235679999999999999
Q ss_pred CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCC----HHHH
Q 002355 836 EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPS----FANI 911 (931)
Q Consensus 836 ~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPS----a~EL 911 (931)
..++.++|||+||+++|||+.|..||.+.++.+++..+..+....+-....+..++|||+++|.+||.+|.. +.||
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI 389 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHh
Confidence 999999999999999999999999999999999999887666555555577899999999999999999988 8888
Q ss_pred HHH
Q 002355 912 VES 914 (931)
Q Consensus 912 Lq~ 914 (931)
.+|
T Consensus 390 K~H 392 (459)
T KOG0610|consen 390 KRH 392 (459)
T ss_pred hcC
Confidence 766
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=364.21 Aligned_cols=250 Identities=28% Similarity=0.482 Sum_probs=216.6
Q ss_pred CceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|+++++||+|+||+||+|++. ++.||||++....... .....+.+|+.++..++|+||+++++++.+++++|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999875 8889999998754333 44567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+.+++|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999763 46899999999999999999999999 9999999999999999999999999987644332
Q ss_pred -----------------------------cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 002355 816 -----------------------------ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGP 866 (931)
Q Consensus 816 -----------------------------~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~ 866 (931)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 122345789999999999999999999999999999999999999998887
Q ss_pred HHHHHHHHhcccccCCC--CCChHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 002355 867 AQVVGAVAFQNRRLAIP--QNTSPVLASLMESCWADDPAQRPS-FANIVES 914 (931)
Q Consensus 867 ~eii~~i~~~~~r~~lP--~~~s~eL~dLI~rcL~~DPeeRPS-a~ELLq~ 914 (931)
......+........+| ..+++.+.+||.+||. +|.+||+ +.++++|
T Consensus 236 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 76666665422333333 3459999999999998 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=352.19 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=215.6
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|..+++||+|.||+||+|++ +|+.||||.++.....+......++||+.|+.++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 5788899999999999999987 68889999999887666555678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|| ..+|..+++. ....+....+..++.++++||+|||+++ |+||||||.|+|++.+|.+||+|||+|+..+....
T Consensus 82 fm-~tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FM-PTDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred ec-cccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 99 5699999975 3457899999999999999999999999 99999999999999999999999999998887665
Q ss_pred ccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-cccc--------------
Q 002355 817 SSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ-NRRL-------------- 880 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~-~~r~-------------- 880 (931)
.....+.|.+|+|||++.|. .|+..+||||.||++.||+-|.+-|.+.++-+-+..+-.. +.+.
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 55555789999999999885 5789999999999999999999999887765444333111 1000
Q ss_pred -----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 -----------AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 -----------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+-...+.++.+|+.+||.+||.+|+++.|++++
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0113456778999999999999999999999987
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=347.95 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=206.2
Q ss_pred CceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|++.+.||+|+||+||+|++. ++.||+|++............+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999874 6779999998765444445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc-
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF- 815 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~- 815 (931)
|+.++.+..+... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9988776655432 235889999999999999999999999 9999999999999999999999999998653321
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-----------------
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR----------------- 878 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~----------------- 878 (931)
.......|++.|+|||++.+..++.++|||||||++|+|++|++||.+.+.......+.....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 122345689999999999988899999999999999999999999987664433222211000
Q ss_pred ccC-------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 RLA-------------IPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 r~~-------------lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
... ....++.++.+||.+||+.||++|||+.++++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000 112367889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=364.15 Aligned_cols=250 Identities=25% Similarity=0.412 Sum_probs=212.9
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|+++++||+|+||+||+|++ +++.||||++...... ......+.+|+.+++.++||||++++++|..+.++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4799999999999999999987 5778999999865432 234566789999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||++|++|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.++|+|||++.......
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 99999999999875 235899999999999999999999999 9999999999999999999999999986432110
Q ss_pred c--------------------------------------ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhC
Q 002355 816 I--------------------------------------SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM 857 (931)
Q Consensus 816 ~--------------------------------------~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG 857 (931)
. .....+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 0 01134699999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcccccCCCC--CChHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 002355 858 QQPWNGLGPAQVVGAVAFQNRRLAIPQ--NTSPVLASLMESCWADDPAQRPS---FANIVES 914 (931)
Q Consensus 858 ~~PF~~~~~~eii~~i~~~~~r~~lP~--~~s~eL~dLI~rcL~~DPeeRPS---a~ELLq~ 914 (931)
..||......+....+.........+. .+++++.+||.+||. +|.+|++ +.++++|
T Consensus 236 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999998887776666543333333443 468999999999997 8999997 9999886
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=348.77 Aligned_cols=251 Identities=22% Similarity=0.287 Sum_probs=210.1
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
.|++.++||+|+||+||+|++ +++.||+|++....... .....+.+|+.+++.++|+||+.+++++..++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 378899999999999999976 57889999987654332 233467899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+++++|..++.... ...+++..++.++.||+.||+|||+.| |+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 999999988875422 335899999999999999999999999 9999999999999999999999999997643321
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--hcccccCCCCCChHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVA--FQNRRLAIPQNTSPVLASLM 894 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~--~~~~r~~lP~~~s~eL~dLI 894 (931)
......||..|+|||++.+..++.++|||||||++|+|++|+.||...........+. ........+...+..+.+||
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 2234578999999999999999999999999999999999999998765432222211 12333456677899999999
Q ss_pred HHhcccCCCCCCC-----HHHHHHH
Q 002355 895 ESCWADDPAQRPS-----FANIVES 914 (931)
Q Consensus 895 ~rcL~~DPeeRPS-----a~ELLq~ 914 (931)
++||+.||.+||+ +.++++|
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 9999999999997 8888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=362.44 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=211.0
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|+++++||+|+||+||+|++ +++.||||++...... ......+.+|+.++..++|+||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4799999999999999999977 4678999999765432 234467788999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||++|++|.+++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++.++++||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 99999999999975 346899999999999999999999999 9999999999999999999999999987432110
Q ss_pred -----------------------------------cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCC
Q 002355 816 -----------------------------------ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQP 860 (931)
Q Consensus 816 -----------------------------------~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~P 860 (931)
......+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 001245799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcccccCCCC--CChHHHHHHHHHhcccCCC---CCCCHHHHHHH
Q 002355 861 WNGLGPAQVVGAVAFQNRRLAIPQ--NTSPVLASLMESCWADDPA---QRPSFANIVES 914 (931)
Q Consensus 861 F~~~~~~eii~~i~~~~~r~~lP~--~~s~eL~dLI~rcL~~DPe---eRPSa~ELLq~ 914 (931)
|.+....+....+........+|. .+++++++||.+|+. +|. .||++.|+++|
T Consensus 236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 236 FCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence 998887777776654333333443 468899999999765 344 56899999988
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.76 Aligned_cols=257 Identities=27% Similarity=0.498 Sum_probs=218.0
Q ss_pred cccCceEEEEEecccCceEEEEEEEc-----CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH 730 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~-----g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~ 730 (931)
+..++|++.+.||+|+||.||+|.+. +..||+|+++... .......+.+|+.+++.++||||+++++++..+++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 45578999999999999999999753 4579999987653 23344678899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
.++||||+++++|.+++.+. ...+++..++.++.||+.||+|||++| ++||||||+|||++.++.++++|||.+..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCccccc
Confidence 99999999999999998753 246899999999999999999999999 99999999999999999999999998765
Q ss_pred cccccc-ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChH
Q 002355 811 KANTFI-SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888 (931)
Q Consensus 811 ~~~~~~-~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~ 888 (931)
...... ......++..|+|||.+.+..++.++|||||||++||+++ |..||......+....+. .....+.+..++.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 235 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFRLPAPRNCPN 235 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCH
Confidence 332211 1122335678999999999889999999999999999775 999999888776666553 3344556788899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 002355 889 VLASLMESCWADDPAQRPSFANIVESLKKL 918 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRPSa~ELLq~L~~L 918 (931)
.+.+++.+||+.+|.+||++.+|++.|..+
T Consensus 236 ~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 236 LLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=348.73 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=205.9
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|+++++||.|+||+||+|++ +++.||+|+++..... .....+.+|+.+++.++||||+++++++......++||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 36899999999999999999976 5678999998764322 22345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+. ++|.+++... ...+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 83 EYLD-SDLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred eCCC-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 9996 5899888652 335788999999999999999999999 9999999999999999999999999997654332
Q ss_pred cccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc----------------
Q 002355 816 ISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR---------------- 878 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~---------------- 878 (931)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 23344567999999999875 5578999999999999999999999988765554433321100
Q ss_pred -ccC-----------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 -RLA-----------IPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 -r~~-----------lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
... .....+.++.+||.+||++||.+|||+.|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 113467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=348.35 Aligned_cols=258 Identities=33% Similarity=0.520 Sum_probs=210.7
Q ss_pred cccCceEEEEEecccCceEEEEEEEc------------------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCC
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH------------------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~------------------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpN 717 (931)
+..++|++.++||+|+||.||+|.+. +..||+|++.... .......+.+|++++..++|||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCC
Confidence 35589999999999999999999752 2359999987643 2334567899999999999999
Q ss_pred eeeEEeeeeeCCeEEEEEeecCCCCHHHHhhcCC----------------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCC
Q 002355 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPA----------------AGEMMDQRRRLRMALDVAKGINYLHNLNPP 781 (931)
Q Consensus 718 IV~Lid~f~~~~~l~LVmEy~~GgSL~d~L~r~~----------------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~ 781 (931)
|+++++++...+..++||||+.+++|.+++.... ....+++..++.++.||+.||.|||++|
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-- 158 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-- 158 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence 9999999999999999999999999999986421 1124677889999999999999999999
Q ss_pred EEEeccCCCCeEECCCCcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh--C
Q 002355 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT--M 857 (931)
Q Consensus 782 IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT--G 857 (931)
|+||||||+|||++.++.+||+|||+++...... .......++..|+|||++.+..++.++|||||||++|+|++ +
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 9999999999999999999999999987543221 11223445788999999998889999999999999999986 5
Q ss_pred CCCCCCCChHHHHHHHHhc---c---cccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 858 QQPWNGLGPAQVVGAVAFQ---N---RRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 858 ~~PF~~~~~~eii~~i~~~---~---~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
..||......+....+... . .....+..++..+.+||.+||..+|.+|||+.+|.+.|+
T Consensus 239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7889887766555433211 1 112235677899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=375.32 Aligned_cols=258 Identities=25% Similarity=0.373 Sum_probs=218.6
Q ss_pred cccccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC-
Q 002355 652 DWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR- 728 (931)
Q Consensus 652 ~~lei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~- 728 (931)
.|.....+.|+.+++||+|+||.||+|++ +|+.||+|.++.............+||.||++|.||||++|.+.....
T Consensus 110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~ 189 (560)
T KOG0600|consen 110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL 189 (560)
T ss_pred cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence 56677789999999999999999999987 677899999998876666667788999999999999999999999866
Q ss_pred -CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCc
Q 002355 729 -PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807 (931)
Q Consensus 729 -~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGl 807 (931)
..+|||+||| ..+|.-++.. .+-.+++.++..++.||+.||+|||++| |+|||||.+|||||.+|.+||+|||+
T Consensus 190 ~~siYlVFeYM-dhDL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGL 264 (560)
T KOG0600|consen 190 SGSIYLVFEYM-DHDLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGL 264 (560)
T ss_pred CceEEEEEecc-cchhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEeccccc
Confidence 7899999999 5588888875 3456999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccc-cccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc--------
Q 002355 808 SRFKANTF-ISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN-------- 877 (931)
Q Consensus 808 Ar~~~~~~-~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~-------- 877 (931)
|+...... ...+..+.|.+|+|||++.|. .|+.++|+||+||||.||++|++.|.+.+..+-+..|...-
T Consensus 265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence 99654332 234556679999999999985 57999999999999999999999999988765554442111
Q ss_pred cccCC-------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 878 RRLAI-------------------PQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 878 ~r~~l-------------------P~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
....+ ...+++...+|+..||..||.+|.|+.++|++
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 00111 13467789999999999999999999999875
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=362.85 Aligned_cols=249 Identities=24% Similarity=0.432 Sum_probs=217.0
Q ss_pred cccCceEEEEEecccCceEEEEEEEcC---CceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWHG---SDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~g---~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
+..++|+++++||.|+||.||+|++.+ ..||+|++...... ......+.+|+.+++.++||||+++++++..++.+
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 355899999999999999999997643 46999998765432 23456788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
|+||||+.+++|.+++.+. ..+++..+..++.||+.||+|||+.| |+||||||+|||++.++++||+|||++...
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999999763 35899999999999999999999999 999999999999999999999999999765
Q ss_pred cccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHH
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~ 891 (931)
... .....||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+.. ....+|...++.+.
T Consensus 182 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~ 256 (340)
T PTZ00426 182 DTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE--GIIYFPKFLDNNCK 256 (340)
T ss_pred CCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHH
Confidence 432 2456799999999999998899999999999999999999999998877666666543 33456778899999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHHHH
Q 002355 892 SLMESCWADDPAQRP-----SFANIVES 914 (931)
Q Consensus 892 dLI~rcL~~DPeeRP-----Sa~ELLq~ 914 (931)
++|++||+.+|++|+ +++++++|
T Consensus 257 ~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 257 HLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 999999999999995 89999887
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=357.68 Aligned_cols=243 Identities=25% Similarity=0.459 Sum_probs=210.4
Q ss_pred EEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCC
Q 002355 665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRG 741 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~Gg 741 (931)
+.||+|+||.||++++ +++.||+|++...... ......+.+|+++++.++||||++++++|...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999986 5788999999875432 234567788999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCCC
Q 002355 742 SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSV 821 (931)
Q Consensus 742 SL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~~ 821 (931)
+|..++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.............
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 155 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence 99988865 235899999999999999999999999 9999999999999999999999999987533322233456
Q ss_pred CCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccC
Q 002355 822 AGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADD 901 (931)
Q Consensus 822 ~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~D 901 (931)
.||+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.. ....+|..+++++.+||.+||..|
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~d 233 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHccCC
Confidence 799999999999998899999999999999999999999988877666655542 334567889999999999999999
Q ss_pred CCCCC-----CHHHHHHH
Q 002355 902 PAQRP-----SFANIVES 914 (931)
Q Consensus 902 PeeRP-----Sa~ELLq~ 914 (931)
|.+|+ ++.++++|
T Consensus 234 P~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 234 PKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHhCCCCCCCHHHHHcC
Confidence 99998 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=376.53 Aligned_cols=267 Identities=38% Similarity=0.647 Sum_probs=234.1
Q ss_pred ccccccccccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC
Q 002355 649 LAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728 (931)
Q Consensus 649 l~~~~lei~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~ 728 (931)
.....|+|..+.+.+...||+|.||+||+|+|.| .||||++.......++++.|.+|+.+|++-+|.||+-+++++...
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 3446789999999999999999999999999998 699999999988889999999999999999999999999999998
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
+. .||+-+|+|.+|+.+++-. ...+.....+.|++||++|+.|||.++ |||||||..|||+.++++|||+|||++
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred ce-eeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEecccce
Confidence 88 9999999999999999863 356888999999999999999999999 999999999999999999999999998
Q ss_pred ccccc--cccccCCCCCCCcccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---cccc
Q 002355 809 RFKAN--TFISSKSVAGTPEWMAPEFLRG---EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ---NRRL 880 (931)
Q Consensus 809 r~~~~--~~~~~~~~~GT~~Y~APEvL~~---~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~---~~r~ 880 (931)
..... .........|...|||||++.. .++++.+|||||||++|||+||..||...+.++++..+... ....
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s 615 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLS 615 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccch
Confidence 64322 1112345567789999999975 46789999999999999999999999977777777665443 2333
Q ss_pred CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 881 AIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 881 ~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
....+++.++++|+..||++++++||.+.+|+..|..++.+
T Consensus 616 ~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 616 KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 45577889999999999999999999999999999888873
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=351.94 Aligned_cols=253 Identities=24% Similarity=0.411 Sum_probs=211.0
Q ss_pred cccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
+..++|+++++||+|+||.||++++. +..||+|++.... .......+.+|+++|+.++||||+++++++..++.+++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 45589999999999999999999874 6779999987643 23344678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhC-CCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL-NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~-G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
||||+++++|.+++.+ ...+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 81 CMEHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred EeecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 9999999999999975 23588999999999999999999984 6 9999999999999999999999999987554
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-----------------
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAF----------------- 875 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~----------------- 875 (931)
.. ......|+..|+|||++.+..++.++|||||||++|||++|+.||......+....+..
T Consensus 156 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 156 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred cc--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence 33 22345789999999999998899999999999999999999999976554333221110
Q ss_pred ----------------------------cccccCC-CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 876 ----------------------------QNRRLAI-PQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 876 ----------------------------~~~r~~l-P~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
...+... ....++++.+||.+||.+||++|||+.++++|..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 0001111 1246789999999999999999999999998854
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=355.00 Aligned_cols=241 Identities=24% Similarity=0.412 Sum_probs=209.1
Q ss_pred ecccCceEEEEEEE--cCCceEEEEEeeccc-chHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCCCH
Q 002355 667 VGAGSFGTVHRAEW--HGSDVAVKVLTVQDF-LDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL 743 (931)
Q Consensus 667 LG~G~fGtVylAr~--~g~~VAVKVlk~~~~-~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~GgSL 743 (931)
||+|+||+||+|++ +++.||+|++..... .......+.+|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999987 467899999976432 234456788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCCCCC
Q 002355 744 YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAG 823 (931)
Q Consensus 744 ~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~~~G 823 (931)
.+++.+ ...+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++............+|
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 155 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG 155 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence 999975 235899999999999999999999999 999999999999999999999999999754333223345679
Q ss_pred CCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCC
Q 002355 824 TPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPA 903 (931)
Q Consensus 824 T~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPe 903 (931)
|+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+. .....++..+++.+.+||.+||..||.
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dp~ 233 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL--QEPLRFPDGFDRDAKDLLIGLLSRDPT 233 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHcCCCHH
Confidence 999999999999999999999999999999999999999887776666554 345567788999999999999999999
Q ss_pred CCC---CHHHHHHH
Q 002355 904 QRP---SFANIVES 914 (931)
Q Consensus 904 eRP---Sa~ELLq~ 914 (931)
+|| ++.+++.|
T Consensus 234 ~R~~~~~~~e~l~h 247 (312)
T cd05585 234 RRLGYNGAQEIKNH 247 (312)
T ss_pred HcCCCCCHHHHHcC
Confidence 997 56777766
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=358.32 Aligned_cols=243 Identities=26% Similarity=0.451 Sum_probs=210.9
Q ss_pred EEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCC
Q 002355 665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRG 741 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~Gg 741 (931)
+.||+|+||.||+|++ +++.||+|++...... ......+.+|+++++.++||||+++++++..++.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999986 5778999999865432 234567889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCCC
Q 002355 742 SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSV 821 (931)
Q Consensus 742 SL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~~ 821 (931)
+|..++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++............
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 155 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF 155 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence 99988865 235899999999999999999999999 9999999999999999999999999987543322233456
Q ss_pred CCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccC
Q 002355 822 AGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADD 901 (931)
Q Consensus 822 ~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~D 901 (931)
+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+. .....+|..+++++.+||.+||..|
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~d 233 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEDIKFPRTLSADAKSLLSGLLIKD 233 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc--cCCccCCCCCCHHHHHHHHHHcCCC
Confidence 79999999999999889999999999999999999999998877766655543 2344577889999999999999999
Q ss_pred CCCCC-----CHHHHHHH
Q 002355 902 PAQRP-----SFANIVES 914 (931)
Q Consensus 902 PeeRP-----Sa~ELLq~ 914 (931)
|.+|+ ++.++++|
T Consensus 234 P~~R~~~~~~~~~~il~h 251 (328)
T cd05593 234 PNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHcCCCCCCCHHHHhcC
Confidence 99997 89999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=367.00 Aligned_cols=251 Identities=26% Similarity=0.474 Sum_probs=226.5
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
..+|++.++||+|.||.|-+|.. .|+.||||.+++..+.+ ..+-++.+||+||..|+||||+.+|++|.+.+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 36899999999999999999965 68999999999887655 4567899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||..+|.|++|+.+ .+.+++++++.+++||+.|+.|+|.++ ++|||||.+|||+|.++++||+|||++.++...
T Consensus 132 MEYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 132 MEYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999986 457999999999999999999999999 999999999999999999999999999876654
Q ss_pred ccccCCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 815 FISSKSVAGTPEWMAPEFLRGEPS-NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~~~~~-t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
. ...++||.+.|.+||++++.+| ++.+|.||||++||.|+.|.+||.+.+-..++.++....++. +..+..+.-|
T Consensus 207 k-fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE---P~~PSdA~gL 282 (668)
T KOG0611|consen 207 K-FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE---PETPSDASGL 282 (668)
T ss_pred c-HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC---CCCCchHHHH
Confidence 3 3467899999999999999988 678999999999999999999999999888888886555443 2345568899
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHH
Q 002355 894 MESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 894 I~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
|++||..+|++|.|+.+|..|+|-
T Consensus 283 IRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 283 IRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred HHHHHhcCcccchhHHHHhhhhee
Confidence 999999999999999999999874
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=364.48 Aligned_cols=251 Identities=23% Similarity=0.371 Sum_probs=211.1
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|+++++||+|+||+||+|++ +++.||||++...... ......+.+|+++++.++||||++++++|.++.++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4799999999999999999976 5778999998765432 344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||++|++|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 99999999999875 345889999999999999999999999 9999999999999999999999999986321100
Q ss_pred -----------------------------------------------cccCCCCCCCcccCcccccCCCCCchhHHHHHH
Q 002355 816 -----------------------------------------------ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFG 848 (931)
Q Consensus 816 -----------------------------------------------~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG 848 (931)
......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 000124699999999999998899999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCC--CChHHHHHHHHHhcccCCCCC---CCHHHHHHHH
Q 002355 849 VILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQ--NTSPVLASLMESCWADDPAQR---PSFANIVESL 915 (931)
Q Consensus 849 ~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~--~~s~eL~dLI~rcL~~DPeeR---PSa~ELLq~L 915 (931)
|++|||++|..||......+.+..+........+|. .++.++.+||.+||. +|.+| +++.+++.|-
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp 306 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHP 306 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCC
Confidence 999999999999988777666665543333444444 578999999999998 67765 5999999873
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=363.38 Aligned_cols=250 Identities=26% Similarity=0.368 Sum_probs=209.5
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
.|+++++||+|+||+||+|++ +++.||||++...... ......+.+|+.+++.++|+||+++++++.+.+++|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 689999999999999999987 5678999999875433 3456778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc-
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF- 815 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~- 815 (931)
|++|++|.+++.+ ...+++..++.++.||+.||+|||+.| |+||||||+|||++.++++||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 9999999999875 235889999999999999999999999 9999999999999999999999999975321000
Q ss_pred ----------------------------------------------cccCCCCCCCcccCcccccCCCCCchhHHHHHHH
Q 002355 816 ----------------------------------------------ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGV 849 (931)
Q Consensus 816 ----------------------------------------------~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ 849 (931)
......+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0012357999999999999988999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC--CCChHHHHHHHHHhc--ccCCCCCCCHHHHHHH
Q 002355 850 ILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP--QNTSPVLASLMESCW--ADDPAQRPSFANIVES 914 (931)
Q Consensus 850 ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP--~~~s~eL~dLI~rcL--~~DPeeRPSa~ELLq~ 914 (931)
++|||++|..||......+....+.........+ ..+++++.+||.+|+ ..++..|+++.++++|
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999999998877665555544333333343 357899999999965 4455569999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=348.60 Aligned_cols=251 Identities=23% Similarity=0.348 Sum_probs=201.8
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|+++++||.|+||+||+|++ +++.||||++....... ....+.+|+.+++.++||||+++++++..+...++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 37899999999999999999987 57789999987653222 2245678999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+ +++|.+++.+. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 83 e~~-~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 83 EYV-HTDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred ECC-CcCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 999 56888877652 345888999999999999999999999 9999999999999999999999999987544332
Q ss_pred cccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhc-ccc-------------
Q 002355 816 ISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPA-QVVGAVAFQ-NRR------------- 879 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~-eii~~i~~~-~~r------------- 879 (931)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+..+. ..+..+... ...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 23344578999999999876 45788999999999999999999999876432 222111100 000
Q ss_pred -----c--CCC---------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 -----L--AIP---------QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 -----~--~lP---------~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
. ..+ ...+..+.+||.+||+.||.+|||+.++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0 000 1234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=354.24 Aligned_cols=246 Identities=28% Similarity=0.458 Sum_probs=209.9
Q ss_pred eEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHH---hcCCCCeeeEEeeeeeCCeEEEE
Q 002355 661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMK---RVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk---~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
|+++++||+|+||.||+|++ +++.||||+++..... ....+.+.+|++++. .++||||+++++++..++++|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 68899999999999999987 5778999999865432 233456777776654 56799999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||++|++|..++.+ ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988854 35899999999999999999999999 999999999999999999999999998754333
Q ss_pred ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHH
Q 002355 815 FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI 894 (931)
.......+|++.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+.. .....|..+++.+.+||
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li 232 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN--DEVRYPRFLSREAISIM 232 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHH
Confidence 2233456799999999999998899999999999999999999999998877776665543 33446778899999999
Q ss_pred HHhcccCCCCCC-----CHHHHHHH
Q 002355 895 ESCWADDPAQRP-----SFANIVES 914 (931)
Q Consensus 895 ~rcL~~DPeeRP-----Sa~ELLq~ 914 (931)
.+||..||.+|| ++.+++++
T Consensus 233 ~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 233 RRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 999999999999 67787776
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=353.64 Aligned_cols=248 Identities=25% Similarity=0.426 Sum_probs=212.1
Q ss_pred ceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCC-CeeeEEeeeeeCCeEEEEE
Q 002355 660 ELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHP-NVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~Hp-NIV~Lid~f~~~~~l~LVm 735 (931)
+|++++.||+|+||.||+|++. ++.||||++...... ......+..|++++..+.|+ +|+.++++|...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5899999999999999999874 567999999865432 23456778899999999765 6888999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||++|++|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 99999999999865 235889999999999999999999999 9999999999999999999999999987533222
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~ 895 (931)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+. .....+|..+++++.+||.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~ 233 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICK 233 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHH
Confidence 23345679999999999999989999999999999999999999999888777766654 3345567789999999999
Q ss_pred HhcccCCCCCCCH-----HHHHHH
Q 002355 896 SCWADDPAQRPSF-----ANIVES 914 (931)
Q Consensus 896 rcL~~DPeeRPSa-----~ELLq~ 914 (931)
+||..+|.+|++. .++++|
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 234 GLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcC
Confidence 9999999999976 677665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.01 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=204.4
Q ss_pred CceEEEEEecccCceEEEEEEE---cCCceEEEEEeecccchHHHHHHHHHHHHHHhc---CCCCeeeEEeeee-----e
Q 002355 659 DELHVKERVGAGSFGTVHRAEW---HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV---RHPNVVLFMGAVT-----K 727 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~---~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L---~HpNIV~Lid~f~-----~ 727 (931)
++|+++++||+|+||+||+|++ .++.||+|+++...........+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4799999999999999999986 356799999876554433334566777777766 6999999999885 3
Q ss_pred CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCc
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGl 807 (931)
...+++||||+. ++|.+++.... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456999999995 68999886532 345899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc-------
Q 002355 808 SRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL------- 880 (931)
Q Consensus 808 Ar~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~------- 880 (931)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|.+||.+....+.+..+.......
T Consensus 157 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 157 ARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred eEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 9765433 22345578999999999998889999999999999999999999999877666555443211100
Q ss_pred ------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 ------------------AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 ------------------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+...+++.+.+||.+||+.+|++|||+.++++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0113467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=355.82 Aligned_cols=243 Identities=24% Similarity=0.408 Sum_probs=209.8
Q ss_pred EEecccCceEEEEEEE-----cCCceEEEEEeecccch--HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 665 ERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLD--DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~-----~g~~VAVKVlk~~~~~~--~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
++||+|+||.||+|+. .++.||||++....... .....+.+|+.+|+.++||||++++++|..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 46779999998654322 2345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccc
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~ 817 (931)
+.+++|.+++.+ ...+.+..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc
Confidence 999999999875 335788899999999999999999999 999999999999999999999999998754333223
Q ss_pred cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHh
Q 002355 818 SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESC 897 (931)
Q Consensus 818 ~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rc 897 (931)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+. .....+|..+++.+.+||.+|
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~ 234 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL--KGKLNLPPYLTPEARDLLKKL 234 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHH
Confidence 345679999999999999889999999999999999999999999887766665554 234567788899999999999
Q ss_pred cccCCCCCC-----CHHHHHHH
Q 002355 898 WADDPAQRP-----SFANIVES 914 (931)
Q Consensus 898 L~~DPeeRP-----Sa~ELLq~ 914 (931)
|..+|++|| ++.+++++
T Consensus 235 l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 235 LKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred cccCHhHcCCCCCCCHHHHhcC
Confidence 999999999 89998886
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=341.52 Aligned_cols=257 Identities=32% Similarity=0.565 Sum_probs=218.1
Q ss_pred ccCceEEEEEecccCceEEEEEEEcC-------CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~g-------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
..++|++.+.||+|+||.||+|.+.+ ..||+|.+.... .......+.+|+.++..++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 45789999999999999999997643 359999887543 2334467889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhhcCCC-------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAA-------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK 796 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~-------------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~ 796 (931)
..|++|||+++++|.+++.+... ...+++..++.++.||+.||+|||+.| ++|+||||+||+++.
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~ 159 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGE 159 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcC
Confidence 99999999999999999975321 145788999999999999999999999 999999999999999
Q ss_pred CCcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 002355 797 NWTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAV 873 (931)
Q Consensus 797 dg~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i 873 (931)
++.++|+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999987543221 12233456788999999988889999999999999999998 99999988877776655
Q ss_pred HhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002355 874 AFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 874 ~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
. .......+..+++++.+|+.+||+.+|.+||++.+++++|+.
T Consensus 240 ~-~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 R-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H-cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 4 334445677899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=363.20 Aligned_cols=263 Identities=29% Similarity=0.506 Sum_probs=217.8
Q ss_pred ccccccCceEEEEEecccCceEEEEEEE-------cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEee
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEW-------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGA 724 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~-------~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~ 724 (931)
.+.+..++|++.++||+|+||+||+|++ .+..||||+++..... .....+.+|+.+|..+ +||||++++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc-HHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 3567778999999999999999999964 2457999998754322 3346788999999999 89999999999
Q ss_pred eeeCCeEEEEEeecCCCCHHHHhhcCCC----------------------------------------------------
Q 002355 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAA---------------------------------------------------- 752 (931)
Q Consensus 725 f~~~~~l~LVmEy~~GgSL~d~L~r~~~---------------------------------------------------- 752 (931)
+..++..++||||+++|+|.+++.+...
T Consensus 108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 9999999999999999999999864211
Q ss_pred --------------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 753 --------------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 753 --------------------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceecc
Confidence 124778889999999999999999999 9999999999999999999999999997543
Q ss_pred cccc--ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHH
Q 002355 813 NTFI--SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPV 889 (931)
Q Consensus 813 ~~~~--~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~e 889 (931)
.... ......++..|+|||++.+..++.++|||||||++|||++ |..||.................+...+...+.+
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSE 345 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHH
Confidence 3211 1122334668999999999999999999999999999998 899998766544444444444445556677899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 002355 890 LASLMESCWADDPAQRPSFANIVESLKKL 918 (931)
Q Consensus 890 L~dLI~rcL~~DPeeRPSa~ELLq~L~~L 918 (931)
+.+||.+||..||++|||+.++++.|++.
T Consensus 346 l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 346 MYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=363.08 Aligned_cols=264 Identities=29% Similarity=0.519 Sum_probs=219.5
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEc-------CCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEee
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGA 724 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~-------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~ 724 (931)
.|.+..++|++.+.||+|+||.||+|++. +..||||+++..... .....+.+|+.+++.+ +|+||++++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 45677789999999999999999999752 246999999765432 3356788999999999 89999999999
Q ss_pred eeeCCeEEEEEeecCCCCHHHHhhcCC-----------------------------------------------------
Q 002355 725 VTKRPHLSIVTEYLPRGSLYRLIHRPA----------------------------------------------------- 751 (931)
Q Consensus 725 f~~~~~l~LVmEy~~GgSL~d~L~r~~----------------------------------------------------- 751 (931)
+..++..++||||+.+|+|.+++.+..
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 999999999999999999999985421
Q ss_pred --------------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc-
Q 002355 752 --------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI- 816 (931)
Q Consensus 752 --------------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~- 816 (931)
....+++..++.++.||+.||+|||++| |+||||||+|||++.++++||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 1124788889999999999999999999 99999999999999999999999999875433211
Q ss_pred -ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHH
Q 002355 817 -SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894 (931)
Q Consensus 817 -~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI 894 (931)
......++..|+|||++.+..++.++|||||||++|+|++ |..||.....................+...++++.++|
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 348 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIM 348 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHH
Confidence 1122335668999999998889999999999999999997 99999887655444444434445556667789999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHh
Q 002355 895 ESCWADDPAQRPSFANIVESLKKLL 919 (931)
Q Consensus 895 ~rcL~~DPeeRPSa~ELLq~L~~Ll 919 (931)
.+||+.+|.+|||+.++++.|++++
T Consensus 349 ~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=362.67 Aligned_cols=249 Identities=26% Similarity=0.372 Sum_probs=209.9
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
+|+++++||+|+||+||+|++ +++.||+|++...... ......+.+|+.++++++|+||+++++.|..++++|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 689999999999999999987 5678999999765432 3445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc--
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT-- 814 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~-- 814 (931)
|+++|+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++++||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999998752 35889999999999999999999999 999999999999999999999999997521100
Q ss_pred ---------------------------------------------ccccCCCCCCCcccCcccccCCCCCchhHHHHHHH
Q 002355 815 ---------------------------------------------FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGV 849 (931)
Q Consensus 815 ---------------------------------------------~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ 849 (931)
.......+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012357899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC--CCChHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 002355 850 ILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP--QNTSPVLASLMESCWADDPAQRPS---FANIVES 914 (931)
Q Consensus 850 ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP--~~~s~eL~dLI~rcL~~DPeeRPS---a~ELLq~ 914 (931)
++|||++|+.||...++.+....+.........| ..+++++.+||.+|+ .+|++|++ +.++++|
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 9999999999999887766665554333333333 467899999999987 49999987 8988876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=363.21 Aligned_cols=250 Identities=25% Similarity=0.349 Sum_probs=209.9
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|+++++||+|+||+||+|++ +++.||||++...... ......+.+|+.+|+.++|+||+++++.|..++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 4799999999999999999986 4678999998764332 233466789999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc-
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT- 814 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~- 814 (931)
||++|++|.+++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|......
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 99999999999976 235889999999999999999999999 999999999999999999999999997421100
Q ss_pred ------------------------------------------ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHH
Q 002355 815 ------------------------------------------FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILW 852 (931)
Q Consensus 815 ------------------------------------------~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILy 852 (931)
.......+||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00012357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHhcccccCCC--CCChHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 002355 853 ELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP--QNTSPVLASLMESCWADDPAQRP---SFANIVES 914 (931)
Q Consensus 853 ELLTG~~PF~~~~~~eii~~i~~~~~r~~lP--~~~s~eL~dLI~rcL~~DPeeRP---Sa~ELLq~ 914 (931)
+|++|+.||.+....+....+........++ ..+++++.+||.+|+. +|.+|+ ++.++++|
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~-~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhCC
Confidence 9999999999887766655544332333333 4678999999999874 999999 99999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=335.50 Aligned_cols=257 Identities=30% Similarity=0.560 Sum_probs=218.2
Q ss_pred cccccCceEEEEEecccCceEEEEEEEc-CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~-g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
|++..++|+++++||+|+||.||+|.+. +..||+|.+..... ..+.+.+|+.+++.++|+||+++++.+..++..+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 4677899999999999999999999864 56699998765432 2467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
++|||+++++|.+++.+. ....+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 78 IITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIE 154 (261)
T ss_pred EEEecCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceecC
Confidence 999999999999998753 2446888899999999999999999999 9999999999999999999999999998654
Q ss_pred cccc-ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHH
Q 002355 813 NTFI-SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 813 ~~~~-~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL 890 (931)
.... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.. ..+.+.+..++.++
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (261)
T cd05072 155 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR-GYRMPRMENCPDEL 233 (261)
T ss_pred CCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHH
Confidence 3221 1122345678999999988888999999999999999998 9999988777666655542 33444556788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
.+||.+||..+|++||+++++++.|++
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 234 YDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=366.61 Aligned_cols=255 Identities=26% Similarity=0.408 Sum_probs=214.1
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHH------------HHHHHHHHHHHHhcCCCCeeeEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQ------------LKEFLREVAIMKRVRHPNVVLFM 722 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~------------~~~~l~EIkILk~L~HpNIV~Li 722 (931)
..++|++++.||+|.||.|-+|++ .++.||||++.+....... ++...+||.||+++.|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 458999999999999999999987 5788999999775543221 35788999999999999999999
Q ss_pred eeeee--CCeEEEEEeecCCCCHHHHhhcCCCCCC-CcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc
Q 002355 723 GAVTK--RPHLSIVTEYLPRGSLYRLIHRPAAGEM-MDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT 799 (931)
Q Consensus 723 d~f~~--~~~l~LVmEy~~GgSL~d~L~r~~~~~~-L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~ 799 (931)
++..+ .+++|||+|||..|.+...- ...+ +.+.++++++++++.||+|||.+| ||||||||+|+||+.+|+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCCCc
Confidence 99875 46899999999988775332 3344 999999999999999999999999 999999999999999999
Q ss_pred EEEEecCccccccc-----cccccCCCCCCCcccCcccccCCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 002355 800 VKVCDFGLSRFKAN-----TFISSKSVAGTPEWMAPEFLRGEP----SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVV 870 (931)
Q Consensus 800 IKL~DFGlAr~~~~-----~~~~~~~~~GT~~Y~APEvL~~~~----~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii 870 (931)
+||+|||.+..... ........+|||.|+|||.+.+.. .+.+.||||||++||.|+.|+.||.+....+++
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 99999999875521 112223468999999999988733 367889999999999999999999998888888
Q ss_pred HHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002355 871 GAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 871 ~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
.++.......+..+.+.+.+++||.+||.+||++|.++.+|..|.+-
T Consensus 329 ~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 329 DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 88864433333334578999999999999999999999999888653
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=356.18 Aligned_cols=243 Identities=26% Similarity=0.456 Sum_probs=209.7
Q ss_pred EEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCC
Q 002355 665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRG 741 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~Gg 741 (931)
+.||+|+||.||+|++ +++.||+|++....... .....+.+|+++++.++||||++++++|..++.+|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999986 57789999998654322 34566788999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCC
Q 002355 742 SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820 (931)
Q Consensus 742 SL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs-~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~ 820 (931)
+|..++.+ ...+++..++.++.||+.||+|||+ .| |+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence 99998865 2358999999999999999999997 78 999999999999999999999999998753322223345
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhccc
Q 002355 821 VAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD 900 (931)
Q Consensus 821 ~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~ 900 (931)
..||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+. .....+|..+++++.+||.+||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~L~~ 233 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLSGLLKK 233 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHhhc
Confidence 579999999999999889999999999999999999999998877766665543 334556788999999999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 002355 901 DPAQRP-----SFANIVES 914 (931)
Q Consensus 901 DPeeRP-----Sa~ELLq~ 914 (931)
||.+|+ ++.++++|
T Consensus 234 dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 234 DPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CHHHhCCCCCCCHHHHhcC
Confidence 999996 89999877
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=349.22 Aligned_cols=249 Identities=24% Similarity=0.400 Sum_probs=200.3
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC-----CeEE
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR-----PHLS 732 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~-----~~l~ 732 (931)
+|++.++||+|+||.||+|++ ++..||||++............+.+|+++++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 589999999999999999986 577899999875433334446788999999999999999999988533 3589
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+ +++|.+++.+ ...+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELM-ESDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecC-CCCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 999999 5789988865 235899999999999999999999999 9999999999999999999999999997543
Q ss_pred ccc---cccCCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh------------
Q 002355 813 NTF---ISSKSVAGTPEWMAPEFLRG--EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAF------------ 875 (931)
Q Consensus 813 ~~~---~~~~~~~GT~~Y~APEvL~~--~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~------------ 875 (931)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 11234578999999999876 5678999999999999999999999977654322211100
Q ss_pred --------------cccccC---CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 876 --------------QNRRLA---IPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 876 --------------~~~r~~---lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
...... .....++.+.+||.+||..+|++|||+.+++++
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000 112467889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=356.19 Aligned_cols=243 Identities=28% Similarity=0.434 Sum_probs=210.1
Q ss_pred EEecccCceEEEEEEE-----cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecC
Q 002355 665 ERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLP 739 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~-----~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~ 739 (931)
+.||+|+||.||+++. .++.||+|++............+.+|+++|++++||||++++++|..++.+|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999965 46789999998765443444567889999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccC
Q 002355 740 RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK 819 (931)
Q Consensus 740 GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~ 819 (931)
+++|.+++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++...........
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 156 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY 156 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCcee
Confidence 9999999865 235899999999999999999999999 99999999999999999999999999876544433334
Q ss_pred CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcc
Q 002355 820 SVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWA 899 (931)
Q Consensus 820 ~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~ 899 (931)
...|++.|+|||++.+..++.++|||||||++|+|++|+.||......+....+. .....+|..+++.+.+||++||+
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~l~ 234 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQSLLRALFK 234 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhh
Confidence 5678999999999999888999999999999999999999999887776666553 33445777889999999999999
Q ss_pred cCCCCCCC-----HHHHHHH
Q 002355 900 DDPAQRPS-----FANIVES 914 (931)
Q Consensus 900 ~DPeeRPS-----a~ELLq~ 914 (931)
.||++||+ +.+++.+
T Consensus 235 ~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 235 RNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred cCHhHcCCCCCCCHHHHhCC
Confidence 99999999 5556554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=351.29 Aligned_cols=248 Identities=25% Similarity=0.430 Sum_probs=211.9
Q ss_pred ceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccc-hHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEEEEE
Q 002355 660 ELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~LVm 735 (931)
+|++++.||+|+||.||+|++. ++.||||++...... ......+..|..++..+ .|++|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999874 568999999865432 23345667788888877 5889999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+++++|..++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999999988652 35889999999999999999999999 9999999999999999999999999987543322
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~ 895 (931)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.. ....+|...+.++.+||.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~ 233 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEAVAICK 233 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCcCCHHHHHHHH
Confidence 233456799999999999999999999999999999999999999998887777766643 344567789999999999
Q ss_pred HhcccCCCCCCCH-----HHHHHH
Q 002355 896 SCWADDPAQRPSF-----ANIVES 914 (931)
Q Consensus 896 rcL~~DPeeRPSa-----~ELLq~ 914 (931)
+||+.+|.+|+++ .+++++
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 234 GLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred HHcccCHHhcCCCCCCCHHHHhcC
Confidence 9999999999984 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.40 Aligned_cols=259 Identities=34% Similarity=0.622 Sum_probs=220.0
Q ss_pred cccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
|++...+|++.++||.|+||.||+|.+ .++.||+|++.... .....+.+|+++++.++|+||+++++++..++.+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 456778899999999999999999976 47789999987542 2345788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.| ++||||||+||+++.++.+||+|||++...
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~ 154 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLM 154 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCcccccc
Confidence 99999999999999986532 345889999999999999999999999 999999999999999999999999998765
Q ss_pred cccccc-cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHH
Q 002355 812 ANTFIS-SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPV 889 (931)
Q Consensus 812 ~~~~~~-~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~e 889 (931)
...... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+. ...+...+...+.+
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 233 (263)
T cd05052 155 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPK 233 (263)
T ss_pred ccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHH
Confidence 433211 112234568999999998889999999999999999998 999998877666555443 33455677888999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 002355 890 LASLMESCWADDPAQRPSFANIVESLKKLL 919 (931)
Q Consensus 890 L~dLI~rcL~~DPeeRPSa~ELLq~L~~Ll 919 (931)
+.++|.+||..+|++||++.++++.|+.++
T Consensus 234 ~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 234 VYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred HHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=358.79 Aligned_cols=256 Identities=27% Similarity=0.459 Sum_probs=220.1
Q ss_pred cccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
+.+..+.|++...||.|..++||+|++ .++.||||++........ ++.+.+|+..|+.++||||+.++..|..+..+
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 344668999999999999999999987 678899999998876555 78999999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
|+||.||.+|++.++++..... .+++..+..|++++++||.|||.+| .||||||+.||||+.+|.|||+|||.+...
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeeeee
Confidence 9999999999999999875443 4999999999999999999999999 999999999999999999999999986543
Q ss_pred ccccc---cc-CCCCCCCcccCccccc--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc-----
Q 002355 812 ANTFI---SS-KSVAGTPEWMAPEFLR--GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL----- 880 (931)
Q Consensus 812 ~~~~~---~~-~~~~GT~~Y~APEvL~--~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~----- 880 (931)
..... .. .+++||++|||||++. ..+|+.|+||||||++..||.+|+.||....+.+++.... ++.++
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-qn~pp~~~t~ 255 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-QNDPPTLLTS 255 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCCCCcccc
Confidence 22211 11 5678999999999954 3568999999999999999999999999999888775543 22222
Q ss_pred CC----CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 AI----PQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 ~l----P~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+ ....+..++.+|..||.+||.+|||+.+++++
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11 13456789999999999999999999999976
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=360.22 Aligned_cols=254 Identities=22% Similarity=0.371 Sum_probs=215.6
Q ss_pred ccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
.+..++|+++++||+|+||+||+|++ +++.||+|++....... .....+.+|+.+++.++||||+++++++..+..+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 34568999999999999999999987 47789999997643322 2345577899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 119 ~lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999999864 24788999999999999999999999 999999999999999999999999998764
Q ss_pred cccc-cccCCCCCCCcccCcccccCC----CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCC--
Q 002355 812 ANTF-ISSKSVAGTPEWMAPEFLRGE----PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQ-- 884 (931)
Q Consensus 812 ~~~~-~~~~~~~GT~~Y~APEvL~~~----~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~-- 884 (931)
.... ......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+......+..+........+|.
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI 272 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcC
Confidence 4321 122356799999999998754 367899999999999999999999998887777766654444444454
Q ss_pred CChHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 002355 885 NTSPVLASLMESCWADDPAQ--RPSFANIVES 914 (931)
Q Consensus 885 ~~s~eL~dLI~rcL~~DPee--RPSa~ELLq~ 914 (931)
.++.++.+||.+||..+|.+ |+++.++++|
T Consensus 273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 57899999999999999987 9999999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=336.89 Aligned_cols=259 Identities=31% Similarity=0.530 Sum_probs=215.2
Q ss_pred cccccCceEEEEEecccCceEEEEEEEc-------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT 726 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~-------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~ 726 (931)
|++..++|++.++||+|+||.||+|++. +..||+|++.... .......+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 3456789999999999999999999764 3469999886433 2233456889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhhcCCC-------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc
Q 002355 727 KRPHLSIVTEYLPRGSLYRLIHRPAA-------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT 799 (931)
Q Consensus 727 ~~~~l~LVmEy~~GgSL~d~L~r~~~-------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~ 799 (931)
.+...++||||+++++|.+++..... ...+++..+..++.|++.||+|||+.| ++|+||||+||+++.++.
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCC
Confidence 99999999999999999999865221 123577888999999999999999999 999999999999999999
Q ss_pred EEEEecCcccccccccc--ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 002355 800 VKVCDFGLSRFKANTFI--SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQ 876 (931)
Q Consensus 800 IKL~DFGlAr~~~~~~~--~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~ 876 (931)
++|+|||++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. .
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-~ 236 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-E 236 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-c
Confidence 99999999875433211 1122345778999999998889999999999999999999 789998877766655443 3
Q ss_pred ccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 877 NRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 877 ~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
......+..++..+.+||.+||+.+|++|||+.++++.|+
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 237 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 3344567788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=335.47 Aligned_cols=256 Identities=31% Similarity=0.591 Sum_probs=220.2
Q ss_pred cccCceEEEEEecccCceEEEEEEEc-CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~-g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
....+|+++++||.|+||.||+|++. ++.+|+|++..... .....+.+|+.+++.++|+||+++++++......++|
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 34578999999999999999999874 57799999876542 2235688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||+++++|.+++.... +..+++..++.++.||+.||.|||+.| |+|+||||+||+++.++.+||+|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 81 TELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999999999997632 456899999999999999999999999 999999999999999999999999999765433
Q ss_pred ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 815 FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
........++..|++||.+.+..++.++|||||||++|+|++ |+.||......+.+..+. ...+...+..+++.+.++
T Consensus 158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05148 158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKI 236 (261)
T ss_pred cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHHHH
Confidence 222233345678999999998889999999999999999998 899998887766666654 344556677889999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHH
Q 002355 894 MESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 894 I~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
|.+||+.+|.+|||+.++++.|+.
T Consensus 237 i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 237 MLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHHHcCCCchhCcCHHHHHHHHhc
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.31 Aligned_cols=258 Identities=24% Similarity=0.459 Sum_probs=214.8
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeeccc-chHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDF-LDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~-~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|++.++||+|+||.||+|++ +++.||||.+..... .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 6899999999999999999976 678899998876433 2344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCC-CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 736 EYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~-~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
||+++++|.+++.... ....+++..++.++.||+.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999998885322 2345789999999999999999999999 999999999999999999999999998765443
Q ss_pred ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhcccccCCCCCChHHHHH
Q 002355 815 FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGP--AQVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~--~eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
........++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ......+.....+...+...+..+.+
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 2222345688899999999988889999999999999999999999965432 33333332222222233467788999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHH
Q 002355 893 LMESCWADDPAQRPSFANIVESLKKL 918 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~L~~L 918 (931)
||.+||..+|++||++.++++.++++
T Consensus 240 li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 240 LVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 99999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=371.28 Aligned_cols=252 Identities=28% Similarity=0.498 Sum_probs=232.3
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe-EEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH-LSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~-l~LVm 735 (931)
++|.+++.+|+|+||.++++++ .+..+++|.+..............+|+.++++++|||||.+.+.|..++. +||||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 6899999999999999999977 45679999999988777766788999999999999999999999998887 99999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
+||+||+|.+.+.+.. +..++++.++.|+.||+.|+.|||+.. |+|||||+.|||+++++.|||+|||+|+......
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998744 667999999999999999999999988 9999999999999999999999999999887776
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~ 895 (931)
....+.+||+.||+||++.+.+|+.++|||||||++|||++-+++|...+....+..+... .-.++|...+.+++.+|+
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~-~~~Plp~~ys~el~~lv~ 239 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG-LYSPLPSMYSSELRSLVK 239 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc-cCCCCCccccHHHHHHHH
Confidence 5677889999999999999999999999999999999999999999999988888777533 356788999999999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 002355 896 SCWADDPAQRPSFANIVES 914 (931)
Q Consensus 896 rcL~~DPeeRPSa~ELLq~ 914 (931)
.||..+|+.||++.++|.+
T Consensus 240 ~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 240 SMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHhhcCCccCCCHHHHhhC
Confidence 9999999999999999987
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=352.03 Aligned_cols=250 Identities=27% Similarity=0.355 Sum_probs=202.9
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC------C
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------P 729 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~------~ 729 (931)
.++|++.+.||+|+||.||+|++ .++.||||++............+.+|+.+++.++||||++++++|... .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 37999999999999999999976 577899999976654445556788999999999999999999998644 3
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
.+|+||||+. ++|...+.. .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 100 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 100 DVYLVMELMD-ANLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred eeEEEEeCCC-cCHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 5799999995 567666643 3788889999999999999999999 9999999999999999999999999997
Q ss_pred cccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-------------
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ------------- 876 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~------------- 876 (931)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 172 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 172 TACTNF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred ccccCc-cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 543322 223457899999999999999999999999999999999999999876543322111100
Q ss_pred -------cccc--------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 877 -------NRRL--------------------AIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 877 -------~~r~--------------------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
.... ......++.+++||.+||..||++|||+.|+++|-+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 0000 011224578999999999999999999999998743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=351.79 Aligned_cols=243 Identities=26% Similarity=0.407 Sum_probs=207.8
Q ss_pred EEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEEEEEeecCC
Q 002355 665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPR 740 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~LVmEy~~G 740 (931)
+.||+|+||+||+|++ +++.||||++...... ......+..|+.++..+ +||||++++++|...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 4678999999765322 23446677888898877 699999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCC
Q 002355 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820 (931)
Q Consensus 741 gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~ 820 (931)
++|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++............
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST 155 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence 9999988752 35899999999999999999999999 999999999999999999999999998754322223345
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhccc
Q 002355 821 VAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD 900 (931)
Q Consensus 821 ~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~ 900 (931)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+. ......+..++.++.+||.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~L~~ 233 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTWLSQDAVDILKAFMTK 233 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccc
Confidence 679999999999999889999999999999999999999999888777776654 334456777899999999999999
Q ss_pred CCCCCCCH------HHHHHH
Q 002355 901 DPAQRPSF------ANIVES 914 (931)
Q Consensus 901 DPeeRPSa------~ELLq~ 914 (931)
||.+||++ ++++.|
T Consensus 234 dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 234 NPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CHHHCCCCCCCCCHHHHHcC
Confidence 99999998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=332.61 Aligned_cols=257 Identities=33% Similarity=0.591 Sum_probs=218.2
Q ss_pred ccCceEEEEEecccCceEEEEEEEc-----CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~-----g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
..++|++.+.||+|+||+||+|++. ...||+|++.... .......+.+|+.+++.++|+||+++++++..++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 3478999999999999999999873 2468999886543 334456788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+++ |+|+||||+||+++.++.++|+|||++...
T Consensus 81 ~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 81 MIITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999999763 236899999999999999999999999 999999999999999999999999999866
Q ss_pred cccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChH
Q 002355 812 ANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888 (931)
Q Consensus 812 ~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~ 888 (931)
.... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+. .....+.+..++.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 235 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMDCPS 235 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 4211 11122344678999999998889999999999999999998 999998877766665553 3334455677899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 002355 889 VLASLMESCWADDPAQRPSFANIVESLKKLL 919 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Ll 919 (931)
.+.+|+.+||+.+|++||++.+++++|..++
T Consensus 236 ~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 236 ALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 9999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=353.42 Aligned_cols=265 Identities=31% Similarity=0.543 Sum_probs=219.0
Q ss_pred cccccCceEEEEEecccCceEEEEEEEc-------CCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeee
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAV 725 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~-------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f 725 (931)
|+++.++|++.+.||.|+||.||+|++. ++.||+|++.... .......+.+|+.++.++ +|+||+++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 5677899999999999999999999642 3579999987543 233456778899999999 799999999987
Q ss_pred e-eCCeEEEEEeecCCCCHHHHhhcCCC----------------------------------------------------
Q 002355 726 T-KRPHLSIVTEYLPRGSLYRLIHRPAA---------------------------------------------------- 752 (931)
Q Consensus 726 ~-~~~~l~LVmEy~~GgSL~d~L~r~~~---------------------------------------------------- 752 (931)
. .+..++++|||+++++|.+++.....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 5 45678999999999999999854211
Q ss_pred ------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc--cccCCCCCC
Q 002355 753 ------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGT 824 (931)
Q Consensus 753 ------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~--~~~~~~~GT 824 (931)
...+++..+..++.||+.||+|||+.| |+||||||+|||++.++.++|+|||++....... .......++
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 125788999999999999999999999 9999999999999999999999999997543221 112234556
Q ss_pred CcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCC
Q 002355 825 PEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPA 903 (931)
Q Consensus 825 ~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPe 903 (931)
..|+|||++.+..++.++|||||||++|||++ |..||.+....+..........+...+...++++.+++.+||+.+|+
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChh
Confidence 78999999999999999999999999999998 99999876554444333333444556677889999999999999999
Q ss_pred CCCCHHHHHHHHHHHhhC
Q 002355 904 QRPSFANIVESLKKLLKS 921 (931)
Q Consensus 904 eRPSa~ELLq~L~~Llks 921 (931)
+||++.+++++|..+++.
T Consensus 319 ~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 319 DRPTFSELVEILGDLLQE 336 (337)
T ss_pred hCcCHHHHHHHHHHHHhc
Confidence 999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.20 Aligned_cols=251 Identities=25% Similarity=0.475 Sum_probs=217.9
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
+|.+.+.||+|++|.||+|.+ +++.|++|.+............+.+|+++++.++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 478999999999999999977 578899999987655556667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccc
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~ 817 (931)
++|++|.+++... ....+++..++.++.||+.||.|||+.| ++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999763 2456889999999999999999999999 999999999999999999999999998865544333
Q ss_pred cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHh
Q 002355 818 SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESC 897 (931)
Q Consensus 818 ~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rc 897 (931)
.....|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+. ......++..++..+.++|.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII-RGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCccccCHHHHHHHHHH
Confidence 344568899999999999889999999999999999999999998877655555443 2333445567889999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 002355 898 WADDPAQRPSFANIVES 914 (931)
Q Consensus 898 L~~DPeeRPSa~ELLq~ 914 (931)
|+.+|++||++.+++++
T Consensus 237 l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 237 LTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccCCcccCcCHHHHhhC
Confidence 99999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=350.77 Aligned_cols=243 Identities=26% Similarity=0.410 Sum_probs=208.6
Q ss_pred EEecccCceEEEEEEEc--CCceEEEEEeecccc-hHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEEEEEeecCC
Q 002355 665 ERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPR 740 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~LVmEy~~G 740 (931)
++||+|+||.||+|++. ++.||||++...... ......+..|++++..+ +||||++++++|..++.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999874 568999999865432 23445677899998876 799999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCC
Q 002355 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820 (931)
Q Consensus 741 gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~ 820 (931)
++|..++.+ ...+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++............
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT 155 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence 999988865 235889999999999999999999999 999999999999999999999999998754333333345
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhccc
Q 002355 821 VAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD 900 (931)
Q Consensus 821 ~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~ 900 (931)
..||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.. .....|..++.++.+||.+||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH--DDVLYPVWLSKEAVSILKAFMTK 233 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHhcc
Confidence 6789999999999998899999999999999999999999998887777766543 33445667899999999999999
Q ss_pred CCCCCC-------CHHHHHHH
Q 002355 901 DPAQRP-------SFANIVES 914 (931)
Q Consensus 901 DPeeRP-------Sa~ELLq~ 914 (931)
+|++|| ++.++++|
T Consensus 234 dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhcC
Confidence 999999 78888876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=349.90 Aligned_cols=243 Identities=30% Similarity=0.491 Sum_probs=206.2
Q ss_pred EEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEEEEEeecCC
Q 002355 665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPR 740 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~LVmEy~~G 740 (931)
+.||+|+||+||+|++ +++.||||+++..... ......+..|..++..+ +||||+++++++..++++|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 4567999999875432 23345566777777655 799999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCC
Q 002355 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820 (931)
Q Consensus 741 gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~ 820 (931)
++|..++.. ...+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...........
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 155 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence 999999865 235899999999999999999999999 999999999999999999999999999754333333345
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhccc
Q 002355 821 VAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD 900 (931)
Q Consensus 821 ~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~ 900 (931)
.+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+. .....+|..++.++.+||.+||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL--NDRPHFPRWISKEAKDCLSKLFER 233 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccC
Confidence 679999999999999889999999999999999999999999888777766654 334556778899999999999999
Q ss_pred CCCCCCCHH-HHHHH
Q 002355 901 DPAQRPSFA-NIVES 914 (931)
Q Consensus 901 DPeeRPSa~-ELLq~ 914 (931)
+|.+||++. +++++
T Consensus 234 ~P~~R~~~~~~l~~h 248 (316)
T cd05592 234 DPTKRLGVDGDIRQH 248 (316)
T ss_pred CHHHcCCChHHHHcC
Confidence 999999875 56554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=352.73 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=213.0
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|++.++||+|+||+||+|++ +++.||+|+++..... ......+.+|+.+++.++|+||+++++++...+++|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4799999999999999999986 5778999999876432 234466788999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+++++|.+++.+. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 999999999999763 246899999999999999999999999 9999999999999999999999999997654321
Q ss_pred -cccCCCCCCCcccCccccc------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC--CCC
Q 002355 816 -ISSKSVAGTPEWMAPEFLR------GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP--QNT 886 (931)
Q Consensus 816 -~~~~~~~GT~~Y~APEvL~------~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP--~~~ 886 (931)
.......||+.|+|||++. +..++.++|||||||++|+|++|..||........+..+.........| ..+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence 1223457899999999987 4556789999999999999999999998877766666654433333333 357
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 887 SPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+..+.+||.+||+ +|.+|||+.++++|
T Consensus 237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 237 SSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 8999999999998 99999999999876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=349.83 Aligned_cols=248 Identities=24% Similarity=0.394 Sum_probs=206.5
Q ss_pred ceEEEEEecccCceEEEEEEE-----cCCceEEEEEeecccch--HHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeE
Q 002355 660 ELHVKERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLD--DQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~-----~g~~VAVKVlk~~~~~~--~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l 731 (931)
+|+++++||+|+||+||+++. +++.||+|++....... .....+.+|+.+++.+ +|+||++++++|..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 589999999999999999975 46789999997653322 2345678899999999 499999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
++||||+.+++|.+++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 999999999999999865 235899999999999999999999999 999999999999999999999999998754
Q ss_pred ccc-ccccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcccccCCCCC
Q 002355 812 ANT-FISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGP----AQVVGAVAFQNRRLAIPQN 885 (931)
Q Consensus 812 ~~~-~~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~----~eii~~i~~~~~r~~lP~~ 885 (931)
... ........||+.|+|||++.+. .++.++|||||||++|||++|..||..... ......+ ......++..
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~ 233 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--LKCDPPFPSF 233 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH--hcCCCCCCCC
Confidence 322 1122345799999999999875 478899999999999999999999965332 2222222 2334456778
Q ss_pred ChHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 002355 886 TSPVLASLMESCWADDPAQRP-----SFANIVES 914 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRP-----Sa~ELLq~ 914 (931)
+++.+.+||.+||..||++|| +++++++|
T Consensus 234 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 234 IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 899999999999999999999 78888876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=330.22 Aligned_cols=257 Identities=35% Similarity=0.570 Sum_probs=218.3
Q ss_pred cccccCceEEEEEecccCceEEEEEEE-cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
|++..++|++.++||+|+||.||+|.+ .++.||+|.++..... ...+.+|+.++++++|+||+++++++...+..+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 356778999999999999999999986 4457999998764432 346788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+.+++|.+++.... +..+++..+..++.|++.||.|||+.| |+||||||+||+++.++.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred eeeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 9999999999999997533 446899999999999999999999999 9999999999999999999999999998654
Q ss_pred ccccc-cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHH
Q 002355 813 NTFIS-SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 813 ~~~~~-~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL 890 (931)
..... ......+..|+|||++.+..++.++|+|||||++|+|++ |+.||.+.........+. .......+...+..+
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 233 (261)
T cd05068 155 EDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKEL 233 (261)
T ss_pred CCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHH
Confidence 32111 111223457999999999889999999999999999999 999998887766665553 233445667788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
.++|.+||+.+|.+||++.++++.|++
T Consensus 234 ~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 234 YDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=356.18 Aligned_cols=250 Identities=25% Similarity=0.400 Sum_probs=211.3
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|++++.||+|+||+||+|++ +++.||||++...... ......+.+|+.++..++|+||+++++.|..++++|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4789999999999999999987 5778999999764332 234567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||++|++|.+++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++.+++++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 99999999999875 345899999999999999999999999 9999999999999999999999999986432110
Q ss_pred -----------------------------------cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCC
Q 002355 816 -----------------------------------ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQP 860 (931)
Q Consensus 816 -----------------------------------~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~P 860 (931)
......+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 001235799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcccccCCCC--CChHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 002355 861 WNGLGPAQVVGAVAFQNRRLAIPQ--NTSPVLASLMESCWADDPAQRPS---FANIVES 914 (931)
Q Consensus 861 F~~~~~~eii~~i~~~~~r~~lP~--~~s~eL~dLI~rcL~~DPeeRPS---a~ELLq~ 914 (931)
|...........+........+|. .+++++++||.+|+. +|.+|++ +.++++|
T Consensus 236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 236 FCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 998887777666654333333443 468899999999875 9999984 7788877
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.63 Aligned_cols=259 Identities=33% Similarity=0.537 Sum_probs=219.3
Q ss_pred cccccCceEEEEEecccCceEEEEEEEcC-------CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT 726 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~g-------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~ 726 (931)
|++..++|++.+.||.|+||.||+|.+.+ ..||+|++.... .......+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 35677899999999999999999997642 569999986543 2234467889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhhcCCC-------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc
Q 002355 727 KRPHLSIVTEYLPRGSLYRLIHRPAA-------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT 799 (931)
Q Consensus 727 ~~~~l~LVmEy~~GgSL~d~L~r~~~-------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~ 799 (931)
.+...++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~ 157 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLT 157 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCC
Confidence 99999999999999999999864221 224678899999999999999999999 999999999999999999
Q ss_pred EEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 002355 800 VKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQ 876 (931)
Q Consensus 800 IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~ 876 (931)
+||+|||+++...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+. .
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~ 236 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-D 236 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-c
Confidence 9999999987543321 11233456789999999988889999999999999999998 999998887777666554 4
Q ss_pred ccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 877 NRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 877 ~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
......|..++..+.+||.+||+.+|.+|||+.++++.|+
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 237 GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 4455677888999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=328.62 Aligned_cols=252 Identities=27% Similarity=0.486 Sum_probs=216.3
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc---hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL---DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~---~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
++|++.+.||.|++|.||+|.. +++.||+|++...... ......+.+|++++++++||||+++++++..+...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5789999999999999999976 5788999998765332 2234678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
||||+++++|.+++... ..+++..+..++.||+.||.|||+.| |+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 99999999999998752 35888999999999999999999999 99999999999999999999999999875432
Q ss_pred ccccc---CCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHH
Q 002355 814 TFISS---KSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 814 ~~~~~---~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL 890 (931)
..... ....++..|+|||++.+..++.++|||||||++|+|++|+.||....................++...+..+
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDA 236 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHH
Confidence 21111 234578899999999998899999999999999999999999988766655555555555666778899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
.+||.+||..+|.+|||+.+++++.
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 237 RNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred HHHHHHHhhcCcccCCCHHHHhhCC
Confidence 9999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=374.86 Aligned_cols=250 Identities=34% Similarity=0.653 Sum_probs=227.4
Q ss_pred cccccccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 652 ~~lei~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
+.|+|.++.+.-++-||.|+.|.||+|+..++.||||+++.-. ..+|+-|++|+|+||+.|.++|+...-+
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCcee
Confidence 4589999999999999999999999999999999999875322 2578899999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
|||||||..|.|+.+++. +..+.......|..+|+.|+.|||.+. |||||||.-||||..+..|||+|||-++..
T Consensus 188 CIiMEfCa~GqL~~VLka---~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKA---GRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred EEeeeccccccHHHHHhc---cCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhh
Confidence 999999999999999975 456888889999999999999999999 999999999999999999999999998865
Q ss_pred cccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHH
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~ 891 (931)
... .....++||+.|||||+|.+++.+.|+||||||++||||+||..||.+.+...++.-+......+++|..+++-|+
T Consensus 263 ~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gfk 341 (904)
T KOG4721|consen 263 SDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFK 341 (904)
T ss_pred hhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHH
Confidence 443 2346789999999999999999999999999999999999999999998877776666666667789999999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 892 SLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 892 dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
-||++||+-.|.+||++.+++.||+
T Consensus 342 lL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 342 LLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred HHHHHHHhcCCCCCccHHHHHHHHh
Confidence 9999999999999999999999986
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=335.59 Aligned_cols=256 Identities=33% Similarity=0.541 Sum_probs=216.5
Q ss_pred ccCceEEEEEecccCceEEEEEEEc-------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~-------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
..++|.+.+.||+|+||.||+|++. ++.||+|++..... ......+.+|+++++.++|+||+++++++..+.
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4578999999999999999999753 35799999876533 334568899999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhhcCC-----------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPA-----------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW 798 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~-----------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg 798 (931)
..++||||+++++|.+++.... ....+++..+..++.||+.||.|||++| ++||||||+||+++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~ 159 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDL 159 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCCC
Confidence 9999999999999999997532 1245788899999999999999999999 99999999999999999
Q ss_pred cEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 002355 799 TVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAF 875 (931)
Q Consensus 799 ~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~ 875 (931)
.++|+|||++....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~- 238 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT- 238 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-
Confidence 99999999987532211 11223345788999999999999999999999999999998 999998877776666554
Q ss_pred cccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 876 QNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 876 ~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
.......+...+..+.+||.+||..+|.+||++.|+++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 33344456678999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=353.87 Aligned_cols=249 Identities=28% Similarity=0.416 Sum_probs=205.0
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
..++|+++++||+|+||+||+|++ +++.||||++.... .......+.+|+++++.++|+||+++++++..++.+++|
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 347889999999999999999987 47889999986543 233446788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||+.+++|.... ...+..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.....
T Consensus 151 ~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 151 LEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred EecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 9999999986432 3567788889999999999999999 999999999999999999999999999865443
Q ss_pred ccccCCCCCCCcccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHhcccccCCCCCCh
Q 002355 815 FISSKSVAGTPEWMAPEFLRG-----EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGA--VAFQNRRLAIPQNTS 887 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~~-----~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~--i~~~~~r~~lP~~~s 887 (931)
........||..|+|||++.. ...+.++|||||||++|||++|+.||........... ..........+..++
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS 301 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccC
Confidence 323345678999999998743 2345689999999999999999999974332222111 112233445667889
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002355 888 PVLASLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 888 ~eL~dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
.++.+||.+||..||++|||+.|+++|-
T Consensus 302 ~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 302 REFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 9999999999999999999999999883
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=347.26 Aligned_cols=251 Identities=24% Similarity=0.422 Sum_probs=207.6
Q ss_pred cccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
+..++|++.++||.|+||.||+|++. +..+|+|++.... .......+.+|+++++.++|+||++++++|..++++++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 45689999999999999999999874 6779999887643 23344678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs-~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
||||+.+++|.+++.+ ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 81 CMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 9999999999999975 2358899999999999999999997 47 9999999999999999999999999987543
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH------------------
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVA------------------ 874 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~------------------ 874 (931)
.. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||......+....+.
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 156 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred hh--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence 32 1234568999999999998889999999999999999999999997654332211110
Q ss_pred -------------------------hcccccCCC-CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 875 -------------------------FQNRRLAIP-QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 875 -------------------------~~~~r~~lP-~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
........+ ...+.++.+||.+||.+||++|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 001111111 2357889999999999999999999999977
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=339.72 Aligned_cols=265 Identities=32% Similarity=0.567 Sum_probs=221.7
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEcC---------CceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEE
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWHG---------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFM 722 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~g---------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Li 722 (931)
.+++..++|.+.++||+|+||.||+|++.+ ..+|+|++.... .......+.+|+.+++.+ +|+||++++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 346677999999999999999999997632 359999987643 233456788899999999 799999999
Q ss_pred eeeeeCCeEEEEEeecCCCCHHHHhhcCCC-------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCC
Q 002355 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAA-------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS 789 (931)
Q Consensus 723 d~f~~~~~l~LVmEy~~GgSL~d~L~r~~~-------------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKP 789 (931)
+++...+..|+||||+.+++|.+++..... ...+++..++.++.||+.||+|||++| ++||||||
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp 168 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAA 168 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccH
Confidence 999999999999999999999999975321 235888999999999999999999999 99999999
Q ss_pred CCeEECCCCcEEEEecCcccccccccc--ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 002355 790 PNLLVDKNWTVKVCDFGLSRFKANTFI--SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGP 866 (931)
Q Consensus 790 eNILLd~dg~IKL~DFGlAr~~~~~~~--~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~ 866 (931)
+||+++.++.+||+|||++........ ......++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 999999999999999999875433211 1112234568999999998889999999999999999998 8899988776
Q ss_pred HHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 867 AQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 867 ~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
.+....+. .......+...+.++.+||.+||..+|.+|||+.++++.|+.++..
T Consensus 249 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 249 EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 55555443 3444566778899999999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=336.65 Aligned_cols=263 Identities=33% Similarity=0.595 Sum_probs=221.8
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEcC-------CceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEee
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGA 724 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~g-------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~ 724 (931)
.+++..++|++.+.||+|+||.||++.+.+ ..+|+|++.... .......+.+|+.+++.+ +|+||++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 456777999999999999999999997632 468999887543 234456788999999999 79999999999
Q ss_pred eeeCCeEEEEEeecCCCCHHHHhhcC-------------CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCC
Q 002355 725 VTKRPHLSIVTEYLPRGSLYRLIHRP-------------AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPN 791 (931)
Q Consensus 725 f~~~~~l~LVmEy~~GgSL~d~L~r~-------------~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeN 791 (931)
+..++.+++||||+++++|..++.+. .....+++..++.++.||+.||+|||+.+ |+||||||+|
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~N 162 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARN 162 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceee
Confidence 99999999999999999999998642 22456889999999999999999999999 9999999999
Q ss_pred eEECCCCcEEEEecCcccccccccc--ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHH
Q 002355 792 LLVDKNWTVKVCDFGLSRFKANTFI--SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQ 868 (931)
Q Consensus 792 ILLd~dg~IKL~DFGlAr~~~~~~~--~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~e 868 (931)
||++.++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 9999999999999999986543211 1122234568999999998889999999999999999997 999998887766
Q ss_pred HHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 002355 869 VVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLL 919 (931)
Q Consensus 869 ii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Ll 919 (931)
....+. .......+...+..+.+|+.+||..+|.+|||+.++++.|..++
T Consensus 243 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKLLK-EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 665543 33444566778899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=330.54 Aligned_cols=256 Identities=31% Similarity=0.581 Sum_probs=217.0
Q ss_pred cccccCceEEEEEecccCceEEEEEEE-cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
|++..++|+++++||+|+||.||+|.. .++.||+|.+...... ...+.+|+.+++.++|+||+++++++. .+..+
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 467789999999999999999999976 5678999998765432 246789999999999999999998874 45789
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
++|||+.+++|.+++.... +..+++..+..++.|++.||+|||+.| ++|+||||+||+++.++.++|+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 77 IITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred EEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 9999999999999986532 346889999999999999999999999 9999999999999999999999999987654
Q ss_pred ccc-cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHH
Q 002355 813 NTF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 813 ~~~-~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL 890 (931)
... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+. ...+.+.+...+.++
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEEL 232 (260)
T ss_pred CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCCCCCCCCCHHH
Confidence 221 11123345678999999998888999999999999999999 999998887766655543 334456677788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
.+||.+||..+|++||++++++..|++
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 233 YELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=330.11 Aligned_cols=256 Identities=31% Similarity=0.538 Sum_probs=215.0
Q ss_pred eEEEEEecccCceEEEEEEEc-----CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe-----
Q 002355 661 LHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH----- 730 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~~-----g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~----- 730 (931)
|++.+.||+|+||.||+|.+. +..||+|+++...........+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567899999999999999763 2569999998765555666788999999999999999999998765443
Q ss_pred -EEEEEeecCCCCHHHHhhcCC---CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecC
Q 002355 731 -LSIVTEYLPRGSLYRLIHRPA---AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806 (931)
Q Consensus 731 -l~LVmEy~~GgSL~d~L~r~~---~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFG 806 (931)
.++||||+++++|..++.... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEECCcc
Confidence 799999999999998885421 2236899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccc--ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCC
Q 002355 807 LSRFKANTFI--SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIP 883 (931)
Q Consensus 807 lAr~~~~~~~--~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP 883 (931)
+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+. .......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 237 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR-HGNRLKQP 237 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 9875433211 1122234678999999988889999999999999999999 899998887777665554 33455567
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 002355 884 QNTSPVLASLMESCWADDPAQRPSFANIVESLKKLL 919 (931)
Q Consensus 884 ~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Ll 919 (931)
..++..+.++|.+||+.||.+|||+.++++.|++++
T Consensus 238 ~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~ 273 (273)
T cd05035 238 EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273 (273)
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 888999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=333.78 Aligned_cols=258 Identities=29% Similarity=0.548 Sum_probs=215.9
Q ss_pred cccCceEEEEEecccCceEEEEEEE------cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~------~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
+.+++|++.++||+|+||+||+|++ .+..||+|.+.... .......+.+|+.+++.++||||+++++++..+.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 3457899999999999999999974 34679999987543 2344567889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhhcCCC--------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAA--------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD 795 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~--------------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd 795 (931)
..|+||||+.+++|.+++..... ...+++..+..++.||+.||+|||++| |+||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~ 158 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIG 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEc
Confidence 99999999999999999853211 234788899999999999999999999 99999999999999
Q ss_pred CCCcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 002355 796 KNWTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGA 872 (931)
Q Consensus 796 ~dg~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~ 872 (931)
.++.+||+|||++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.....+...
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999997543221 11233345678999999988889999999999999999998 9999988776655554
Q ss_pred HHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002355 873 VAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 873 i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
+. .......+..+++.+.++|.+||+.+|.+||++.+++++|..
T Consensus 239 ~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 43 344455677889999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=327.87 Aligned_cols=253 Identities=36% Similarity=0.633 Sum_probs=219.5
Q ss_pred ccccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
.+..++|++.+.||.|+||.||+|...++.||+|.+..... ..+++.+|+.+++.++|+||+++++++......++|
T Consensus 2 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 2 AINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred ccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 34568999999999999999999999999999999976542 456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||+++++|.+++.... ...+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||.++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 79 TEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 99999999999997532 235899999999999999999999999 999999999999999999999999999866432
Q ss_pred ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 815 FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
. .....+..|+|||.+.+..++.++|+|||||++|+|++ |..||......+....+. ...+...+...++.+.+|
T Consensus 156 ~---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 231 (256)
T cd05039 156 Q---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYKV 231 (256)
T ss_pred c---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCCCccCCCHHHHHH
Confidence 2 12334668999999988888999999999999999997 999998877666555443 233445667789999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHH
Q 002355 894 MESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 894 I~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
|.+||..+|++||++.++++.|+.
T Consensus 232 i~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 232 MKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHhccChhhCcCHHHHHHHHhc
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=329.09 Aligned_cols=253 Identities=33% Similarity=0.620 Sum_probs=216.2
Q ss_pred ccccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeee-eeCCeEEE
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAV-TKRPHLSI 733 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f-~~~~~l~L 733 (931)
.+...+|++.+.||+|+||.||++...+..||+|.++... ..+.+.+|+.+++.++|+||+++++++ ..+...++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 3556899999999999999999999999999999986542 235688999999999999999999876 45667999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
||||+++++|.+++.... ...+++..++.++.||+.||+|||++| ++||||||+||+++.++.+||+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred EEECCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceeccc
Confidence 999999999999987532 335889999999999999999999999 99999999999999999999999999875433
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
.. ....++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+. .......+..+++.+.+
T Consensus 155 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 230 (256)
T cd05082 155 TQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVVYD 230 (256)
T ss_pred cC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHH
Confidence 21 23345678999999998889999999999999999997 999998877666655543 23344566788999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHH
Q 002355 893 LMESCWADDPAQRPSFANIVESLKKL 918 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~L~~L 918 (931)
||.+||..+|++|||+.++++.|+.+
T Consensus 231 li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 231 VMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 99999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=357.61 Aligned_cols=253 Identities=23% Similarity=0.391 Sum_probs=213.4
Q ss_pred cccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
+..++|++.++||+|+||.||+|++ +++.||+|++.+..... .....+.+|+.+++.++||||++++++|..+..+|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 4458999999999999999999987 46789999997643322 33456788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||++|++|.+++.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++....
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999999964 24789999999999999999999999 9999999999999999999999999998654
Q ss_pred ccc-cccCCCCCCCcccCcccccCCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCC--C
Q 002355 813 NTF-ISSKSVAGTPEWMAPEFLRGEP----SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQ--N 885 (931)
Q Consensus 813 ~~~-~~~~~~~GT~~Y~APEvL~~~~----~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~--~ 885 (931)
... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+........+|. .
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 273 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE 273 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCccc
Confidence 321 1224567999999999987643 67899999999999999999999998887777766654444444554 5
Q ss_pred ChHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 002355 886 TSPVLASLMESCWADDPAQ--RPSFANIVES 914 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPee--RPSa~ELLq~ 914 (931)
++..++++|.+||..++.+ |+++.++++|
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 6899999999999855543 8999999988
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=328.48 Aligned_cols=250 Identities=32% Similarity=0.576 Sum_probs=212.7
Q ss_pred cCceEEEEEecccCceEEEEEEEcC-CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 658 WDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~~g-~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
.++|++.+.||+|+||.||++++.. ..+|+|.+...... ...+.+|+.+++.++||||+++++++..+...++|||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 4689999999999999999998754 47999987654332 2467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+++++|.+++.... ..+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||.++.......
T Consensus 80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 80 FMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred cCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999999987522 35889999999999999999999999 99999999999999999999999999875433221
Q ss_pred -ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHH
Q 002355 817 -SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894 (931)
Q Consensus 817 -~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI 894 (931)
......++..|+|||.+.+..++.++|+|||||++|+|++ |+.||...+..+....+... .+...+...+..+.+||
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~li 234 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG-FRLYRPKLASMTVYEVM 234 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCCHHHHHHH
Confidence 1122335668999999998889999999999999999999 89999888877777666433 33445667788999999
Q ss_pred HHhcccCCCCCCCHHHHHHHH
Q 002355 895 ESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 895 ~rcL~~DPeeRPSa~ELLq~L 915 (931)
.+||+.+|.+||++.++++.|
T Consensus 235 ~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 235 YSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHccCCcccCcCHHHHHHhh
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=348.96 Aligned_cols=243 Identities=29% Similarity=0.462 Sum_probs=205.2
Q ss_pred EEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHH-HHHhcCCCCeeeEEeeeeeCCeEEEEEeecCC
Q 002355 665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVA-IMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPR 740 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIk-ILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~G 740 (931)
+.||+|+||+||+|++ +++.||||++....... .....+..|.. +++.++||||+++++.+...+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999987 57889999997654322 23345556655 46789999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCC
Q 002355 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820 (931)
Q Consensus 741 gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~ 820 (931)
++|..++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++............
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST 155 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence 999999875 335889999999999999999999999 999999999999999999999999998754333333345
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhccc
Q 002355 821 VAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD 900 (931)
Q Consensus 821 ~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~ 900 (931)
.+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.. ....++...+..+.+||.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~ 233 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN--KPLRLKPNISVSARHLLEGLLQK 233 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHhhc
Confidence 6799999999999999999999999999999999999999998877776666542 34456677899999999999999
Q ss_pred CCCCCCCHH----HHHHH
Q 002355 901 DPAQRPSFA----NIVES 914 (931)
Q Consensus 901 DPeeRPSa~----ELLq~ 914 (931)
||.+||++. +++++
T Consensus 234 ~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 234 DRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred CHHhCCCCCCCHHHHHcC
Confidence 999999884 55544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=347.80 Aligned_cols=243 Identities=28% Similarity=0.441 Sum_probs=205.6
Q ss_pred EEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEEEEEeecCC
Q 002355 665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPR 740 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~LVmEy~~G 740 (931)
+.||+|+||.||+|++ +++.||+|+++..... ......+..|..++..+ +||||++++++|..++++|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 3699999999999987 5678999999865322 23345667788888765 899999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCC
Q 002355 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820 (931)
Q Consensus 741 gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~ 820 (931)
++|..++.. ...+++..+..++.||+.||+|||++| |+||||||+|||++.++.++|+|||+++...........
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST 155 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence 999998865 245889999999999999999999999 999999999999999999999999998743222223345
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhccc
Q 002355 821 VAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD 900 (931)
Q Consensus 821 ~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~ 900 (931)
.+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+. .....++..++.++.+||.+||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR--VDTPHYPRWITKESKDILEKLFER 233 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHHccC
Confidence 679999999999999999999999999999999999999998887776666553 233456677899999999999999
Q ss_pred CCCCCCCHH-HHHHH
Q 002355 901 DPAQRPSFA-NIVES 914 (931)
Q Consensus 901 DPeeRPSa~-ELLq~ 914 (931)
||++||++. ++++|
T Consensus 234 dP~~R~~~~~~~~~h 248 (316)
T cd05620 234 DPTRRLGVVGNIRGH 248 (316)
T ss_pred CHHHcCCChHHHHcC
Confidence 999999984 66644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=347.26 Aligned_cols=243 Identities=28% Similarity=0.457 Sum_probs=208.6
Q ss_pred EEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEEEEEeecCC
Q 002355 665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPR 740 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~LVmEy~~G 740 (931)
+.||+|+||+||+|++ +++.||||+++..... ......+.+|+.++..+ +||||+++++++...+++|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 4678999999865432 23445677899999888 699999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCC
Q 002355 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820 (931)
Q Consensus 741 gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~ 820 (931)
++|..++.+. ..+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST 155 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence 9999988752 35899999999999999999999999 999999999999999999999999998753332223345
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhccc
Q 002355 821 VAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD 900 (931)
Q Consensus 821 ~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~ 900 (931)
.+|++.|+|||++.+..++.++|||||||++|+|++|..||......+....+. ......+..++..+.+||.+||..
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~ 233 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL--EDEVRYPRWLSKEAKSILKSFLTK 233 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHccC
Confidence 578999999999999999999999999999999999999998887766665554 234456778899999999999999
Q ss_pred CCCCCCCH-----HHHHHH
Q 002355 901 DPAQRPSF-----ANIVES 914 (931)
Q Consensus 901 DPeeRPSa-----~ELLq~ 914 (931)
||.+||++ .+++++
T Consensus 234 dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CHHHcCCCCCCCHHHHhcC
Confidence 99999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=336.84 Aligned_cols=265 Identities=32% Similarity=0.605 Sum_probs=219.1
Q ss_pred cCceEEEEEecccCceEEEEEEEc--CC--ceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEWH--GS--DVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~~--g~--~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~ 732 (931)
+++|++.+.||.|+||.||+|... +. .+++|.++... .......+.+|+.++.++ +||||+++++++...+.++
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 478999999999999999999763 32 36888776322 233346788999999999 7999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCC-------------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc
Q 002355 733 IVTEYLPRGSLYRLIHRPA-------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT 799 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~-------------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~ 799 (931)
+||||+++++|.+++.... ....+++..++.++.||+.||+|||++| |+||||||+|||++.++.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCCe
Confidence 9999999999999996522 1235889999999999999999999999 999999999999999999
Q ss_pred EEEEecCccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccc
Q 002355 800 VKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNR 878 (931)
Q Consensus 800 IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~ 878 (931)
+||+|||++....... .......+..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+. ...
T Consensus 158 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~-~~~ 235 (297)
T cd05089 158 SKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGY 235 (297)
T ss_pred EEECCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCC
Confidence 9999999986432211 1122233557999999998889999999999999999997 999998887776665553 233
Q ss_pred ccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhhhc
Q 002355 879 RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQ 927 (931)
Q Consensus 879 r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l~~ 927 (931)
....+..++..+.+||.+||..+|.+||++.++++.|..++......+.
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~~ 284 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVN 284 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccccc
Confidence 4456677899999999999999999999999999999999887655443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=340.29 Aligned_cols=262 Identities=28% Similarity=0.517 Sum_probs=217.8
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCC----ceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGS----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH 730 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~----~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~ 730 (931)
...+|++.+.||+|+||+||+|++ ++. .||+|++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 447899999999999999999976 333 38999986532 233456788999999999999999999998764 5
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
.++|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred ceeeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEcccccccc
Confidence 77999999999999999763 235888999999999999999999999 99999999999999999999999999986
Q ss_pred ccccccc--cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCCh
Q 002355 811 KANTFIS--SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTS 887 (931)
Q Consensus 811 ~~~~~~~--~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s 887 (931)
....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+... +.........+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 237 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQPPICT 237 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhCCCCCCCCCCCC
Confidence 5432211 122234668999999999999999999999999999997 999998876655443 333444555667788
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhh
Q 002355 888 PVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQL 925 (931)
Q Consensus 888 ~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l 925 (931)
..+.++|.+||..+|.+||++.+++..|.++.+.+...
T Consensus 238 ~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~~ 275 (316)
T cd05108 238 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 275 (316)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCchh
Confidence 99999999999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=357.70 Aligned_cols=265 Identities=31% Similarity=0.518 Sum_probs=221.0
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEcC-------CceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEee
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGA 724 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~g-------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~ 724 (931)
.+++..++|+++++||.|+||.||+|.+.+ ..||||++.... .....+.+.+|+++|+++. ||||++++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~ 109 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGA 109 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence 567778999999999999999999997632 359999986543 2334467899999999996 9999999999
Q ss_pred eeeCCeEEEEEeecCCCCHHHHhhcCCC----------------------------------------------------
Q 002355 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAA---------------------------------------------------- 752 (931)
Q Consensus 725 f~~~~~l~LVmEy~~GgSL~d~L~r~~~---------------------------------------------------- 752 (931)
+.....+||||||+++|+|.+++.+...
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 9999999999999999999998864210
Q ss_pred -----------------------------------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCC
Q 002355 753 -----------------------------------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPN 791 (931)
Q Consensus 753 -----------------------------------------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeN 791 (931)
...+++..+..++.||+.||+|||+.+ |+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~N 267 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARN 267 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHh
Confidence 124778888999999999999999999 9999999999
Q ss_pred eEECCCCcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHH
Q 002355 792 LLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQ 868 (931)
Q Consensus 792 ILLd~dg~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~e 868 (931)
||++.++.+||+|||+++...... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 999999999999999987543221 11223456788999999999889999999999999999997 999998765544
Q ss_pred HHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 002355 869 VVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920 (931)
Q Consensus 869 ii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llk 920 (931)
..........+...+..++..+.+||.+||..+|++||++.++.+.|..+++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 4433333444556677889999999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.44 Aligned_cols=249 Identities=32% Similarity=0.564 Sum_probs=207.7
Q ss_pred eEEEEEecccCceEEEEEEEcC--CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeec
Q 002355 661 LHVKERVGAGSFGTVHRAEWHG--SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYL 738 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~~g--~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~ 738 (931)
|+++++||+|+||+||++++.+ +.||+|++..............+|+.++++++||||+++++++......++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 7899999999999999999854 46999999988755554445567999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccccc
Q 002355 739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS 818 (931)
Q Consensus 739 ~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~ 818 (931)
.+++|.+++.. ...+++..++.++.||+.||++||+.| |+|+||||+||+++.++.++|+|||.+..........
T Consensus 81 ~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENF 155 (260)
T ss_dssp TTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEB
T ss_pred ccccccccccc---ccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccc
Confidence 99899999973 345899999999999999999999999 9999999999999999999999999987532223344
Q ss_pred CCCCCCCcccCccccc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhcccccC--CCCCChHHHHH
Q 002355 819 KSVAGTPEWMAPEFLR-GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQ---VVGAVAFQNRRLA--IPQNTSPVLAS 892 (931)
Q Consensus 819 ~~~~GT~~Y~APEvL~-~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~e---ii~~i~~~~~r~~--lP~~~s~eL~d 892 (931)
....++..|+|||++. +...+.++||||||+++|+|++|..||....... ............. .....+..+.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence 5667899999999998 7888999999999999999999999999873222 2222211111111 11233589999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 002355 893 LMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+|.+||..||++||++.+++++
T Consensus 236 li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999865
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=365.97 Aligned_cols=255 Identities=26% Similarity=0.441 Sum_probs=219.4
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC-----
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP----- 729 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~----- 729 (931)
..++|++.++||+|+||+||+|++ +++.||||++............+.+|+.++..++|+||+++++.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 457999999999999999999976 6789999999887666666678889999999999999999998775332
Q ss_pred ---eEEEEEeecCCCCHHHHhhcC-CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEec
Q 002355 730 ---HLSIVTEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDF 805 (931)
Q Consensus 730 ---~l~LVmEy~~GgSL~d~L~r~-~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DF 805 (931)
.+++||||+++|+|.+++... .....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCCCEEEEec
Confidence 378999999999999988642 23456899999999999999999999999 999999999999999999999999
Q ss_pred Ccccccccc--ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC
Q 002355 806 GLSRFKANT--FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP 883 (931)
Q Consensus 806 GlAr~~~~~--~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP 883 (931)
|+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+.. .....++
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-~~~~~~~ 266 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-GRYDPLP 266 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCC
Confidence 999764432 1123456799999999999999899999999999999999999999998877666655543 3334577
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 884 QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 884 ~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
..+++++.+||.+||..+|.+||++.+++++
T Consensus 267 ~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 267 PSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 8899999999999999999999999999876
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=345.95 Aligned_cols=248 Identities=23% Similarity=0.420 Sum_probs=210.9
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCeEEEEE
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~l~LVm 735 (931)
+|++.+.||+|+||+||+|++ +++.||||++...... ......+..|+.++..+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 478899999999999999987 5778999999865332 234456778999998886 577888999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||++|++|.+++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 99999999999875 235899999999999999999999999 9999999999999999999999999987543332
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~ 895 (931)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.. .....|..++.++.+|+.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~ 233 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME--HNVSYPKSLSKEAVSICK 233 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHHH
Confidence 233456799999999999998899999999999999999999999998887777666543 344567788999999999
Q ss_pred HhcccCCCCCCCH-----HHHHHH
Q 002355 896 SCWADDPAQRPSF-----ANIVES 914 (931)
Q Consensus 896 rcL~~DPeeRPSa-----~ELLq~ 914 (931)
+||..+|.+|++. .++++|
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 234 GLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred HHcccCHhhCCCCCCCCHHHHhcC
Confidence 9999999999974 455544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=348.94 Aligned_cols=243 Identities=23% Similarity=0.424 Sum_probs=204.0
Q ss_pred EEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEEEEEeecCC
Q 002355 665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPR 740 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~LVmEy~~G 740 (931)
+.||+|+||.||+|++ +++.||||+++...... .....+.+|+.+++.+ +||||++++++|...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999987 56789999998754333 3456678899999998 699999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCC
Q 002355 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820 (931)
Q Consensus 741 gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~ 820 (931)
++|..++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...........
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST 155 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence 999988865 246899999999999999999999999 999999999999999999999999998753222223345
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------hHH-HHHHHHhcccccCCCCCChHHHH
Q 002355 821 VAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLG--------PAQ-VVGAVAFQNRRLAIPQNTSPVLA 891 (931)
Q Consensus 821 ~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~--------~~e-ii~~i~~~~~r~~lP~~~s~eL~ 891 (931)
.+||+.|+|||++.+..++.++|||||||++|+|++|..||.... ... ....+ ......+|..++..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~ 233 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKAS 233 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--HcCCCCCCCCCCHHHH
Confidence 679999999999999989999999999999999999999996321 111 22222 2344567788999999
Q ss_pred HHHHHhcccCCCCCCC------HHHHHHH
Q 002355 892 SLMESCWADDPAQRPS------FANIVES 914 (931)
Q Consensus 892 dLI~rcL~~DPeeRPS------a~ELLq~ 914 (931)
+||.+||+.||.+|++ +.++++|
T Consensus 234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 9999999999999997 6777765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=329.09 Aligned_cols=255 Identities=30% Similarity=0.536 Sum_probs=211.0
Q ss_pred EEEEEecccCceEEEEEEEcCC----ceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee------CCeE
Q 002355 662 HVKERVGAGSFGTVHRAEWHGS----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK------RPHL 731 (931)
Q Consensus 662 ~Ii~kLG~G~fGtVylAr~~g~----~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~------~~~l 731 (931)
.+.++||+|+||.||+|++... .||+|.++...........+.+|+.+++.++|+||+++++++.. ....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4678899999999999987432 58999987765555666788999999999999999999987642 2357
Q ss_pred EEEEeecCCCCHHHHhhcC---CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 732 SIVTEYLPRGSLYRLIHRP---AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~---~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
++||||+.+++|.+++... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEECCCCcc
Confidence 8999999999999887421 12235889999999999999999999999 999999999999999999999999999
Q ss_pred cccccccc--ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCC
Q 002355 809 RFKANTFI--SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQN 885 (931)
Q Consensus 809 r~~~~~~~--~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~ 885 (931)
+....... ......+++.|++||.+.+..++.++|||||||++|+|++ |..||......+....+. .......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-QGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCC
Confidence 86543211 1123346778999999999889999999999999999999 899998877766665554 3334455677
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 002355 886 TSPVLASLMESCWADDPAQRPSFANIVESLKKLL 919 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Ll 919 (931)
++..+.++|.+||+.+|++|||+.++++.|+.++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 272 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 8899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=326.77 Aligned_cols=250 Identities=28% Similarity=0.486 Sum_probs=215.4
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
+|++.++||.|+||.||++++ +++.||+|.++.... ....+.+.+|+.+++.++|+||+++++.+..++++|+||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 588999999999999999976 577899999875442 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccc
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~ 817 (931)
+++++|.+++... ....+++..++.++.||+.||.|||++| |+|+||||+||+++.++.++|+|||.+.........
T Consensus 80 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 80 CDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 9999999988652 2345789999999999999999999999 999999999999999999999999998765443333
Q ss_pred cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHh
Q 002355 818 SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESC 897 (931)
Q Consensus 818 ~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rc 897 (931)
.....|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.......+. ......++..++..+.+||.+|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHH
Confidence 344568899999999998889999999999999999999999998877666555543 3334456677889999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 002355 898 WADDPAQRPSFANIVES 914 (931)
Q Consensus 898 L~~DPeeRPSa~ELLq~ 914 (931)
|..+|++||++.+++..
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=329.63 Aligned_cols=258 Identities=32% Similarity=0.594 Sum_probs=215.6
Q ss_pred cccccCceEEEEEecccCceEEEEEEEcC-CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~g-~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
|++..++|++.++||+|+||+||+|++.+ ..||+|++....... ..+.+|+++++.++|+||+++++.+. ....+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCH---HHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 35667899999999999999999998744 469999987644322 46788999999999999999998875 45689
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+.+++|.+++.+. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+....
T Consensus 77 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~ 153 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE 153 (262)
T ss_pred EEEEcCCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeecc
Confidence 999999999999999753 2345789999999999999999999999 9999999999999999999999999997544
Q ss_pred cccc-ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHH
Q 002355 813 NTFI-SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 813 ~~~~-~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL 890 (931)
.... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+. .......+..++..+
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 232 (262)
T cd05071 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESL 232 (262)
T ss_pred ccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-cCCCCCCccccCHHH
Confidence 3221 1123345678999999988889999999999999999999 889998877666655543 233344566788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 002355 891 ASLMESCWADDPAQRPSFANIVESLKKLL 919 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~L~~Ll 919 (931)
.+||.+||+.+|++||++.++++.|++.+
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 233 HDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 99999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=337.53 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=210.5
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchH-HHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD-QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~-~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
+|++.++||+|+||+||++++ +++.||||++........ ....+.+|+.+++.++|+||+++++.+..++++|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 488999999999999999987 577899999976543322 23456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+.+++|.+++.+. ....+++..+..++.||+.||.|||+.| |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 99999999888652 2345899999999999999999999999 9999999999999999999999999987643322
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--hcccccCCCCCChHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVA--FQNRRLAIPQNTSPVLASLM 894 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~--~~~~r~~lP~~~s~eL~dLI 894 (931)
......|+..|+|||++.+..++.++||||+||++|+|++|..||.+.........+. ........+...+..+.+||
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 1234578999999999998889999999999999999999999998765433322221 12233445667899999999
Q ss_pred HHhcccCCCCCC-----CHHHHHHH
Q 002355 895 ESCWADDPAQRP-----SFANIVES 914 (931)
Q Consensus 895 ~rcL~~DPeeRP-----Sa~ELLq~ 914 (931)
.+||..||.+|| ++++++++
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcC
Confidence 999999999999 89999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=323.88 Aligned_cols=251 Identities=26% Similarity=0.499 Sum_probs=214.2
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee-CCeEEEEEe
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK-RPHLSIVTE 736 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~-~~~l~LVmE 736 (931)
+|++++.||.|++|.||++++ .++.||+|.+..........+.+.+|++++++++|+||+++++.+.. +..+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 489999999999999999976 46789999998765555556778899999999999999999998864 456899999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+++++|.+++... ....+++.+++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999998752 2345899999999999999999999999 99999999999999999999999999876544333
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMES 896 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~r 896 (931)
......+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+. .......+...++++.+||.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHHH
Confidence 3345568899999999999889999999999999999999999998776655544433 223334567789999999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 002355 897 CWADDPAQRPSFANIVES 914 (931)
Q Consensus 897 cL~~DPeeRPSa~ELLq~ 914 (931)
||+.+|++||++.+++++
T Consensus 237 ~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HhccCcccCCCHHHHhcC
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=349.55 Aligned_cols=253 Identities=26% Similarity=0.337 Sum_probs=212.2
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee--CCeEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--RPHLS 732 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~--~~~l~ 732 (931)
+.++|+.+++|++|+||.||+|++ +++.||+|.++........--..++||.+|.+++|||||.+-++... -+.+|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 447999999999999999999987 56779999998876444333456899999999999999999998864 35799
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
|||||| ..+|..++..- ..++...+++.+..|+++||+|||.++ |+||||||+|+|++..|.+||+|||+|+..+
T Consensus 154 ~VMe~~-EhDLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 154 IVMEYV-EHDLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eeHHHH-HhhHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhhhc
Confidence 999999 56999999752 357889999999999999999999999 9999999999999999999999999999998
Q ss_pred ccccccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-ccccc----------
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAF-QNRRL---------- 880 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~-~~~r~---------- 880 (931)
......+..+.|.+|+|||++.+. .|++++|+||+|||+.||+++++.|.+....+.+..+.. .+.+.
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 886666777889999999999885 589999999999999999999999998775443333311 11110
Q ss_pred ------------------CCCC-CChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 ------------------AIPQ-NTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 ------------------~lP~-~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.++. .++..-.+|++.+|.+||.+|.|+.+.|+|
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0111 155788999999999999999999999987
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=351.73 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=207.2
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee-----CCeE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK-----RPHL 731 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~-----~~~l 731 (931)
..|..++.||.|+||.|+.|.+ +|+.||||.+.......-..++.++|+++|+.++|+||+.+.+++.. -+.+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 4666689999999999999976 67889999987555445566889999999999999999999999965 3569
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
|+|+|+| +.+|..+++. +..+++..+..++.||++||.|+|+.+ |+||||||.|+|++.+..+||||||+|+..
T Consensus 102 YiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred EEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEeccccceeec
Confidence 9999999 8899999976 334999999999999999999999999 999999999999999999999999999977
Q ss_pred ccc--ccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc------------
Q 002355 812 ANT--FISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ------------ 876 (931)
Q Consensus 812 ~~~--~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~------------ 876 (931)
... ....+..+.|.+|+|||++.. ..|+.++||||+|||+.||++|++.|.+.+..+-+..+...
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 531 112245677999999998765 56899999999999999999999999886533222211110
Q ss_pred ------------ccccC-----CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 877 ------------NRRLA-----IPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 877 ------------~~r~~-----lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
..... +-++.++.+.+|+.+||..||.+|+|++|.|+|
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00001 124778999999999999999999999999987
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=347.87 Aligned_cols=248 Identities=26% Similarity=0.349 Sum_probs=202.6
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC------C
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------P 729 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~------~ 729 (931)
.++|++++.||+|+||.||+|.+ .++.||||++............+.+|+.+++.++||||++++++|... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 47999999999999999999976 577899999976554445556788999999999999999999988643 3
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
..|+||||+. ++|.+.+.. .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 96 DVYLVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred eeEEEhhhhc-ccHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEEeeCcccc
Confidence 5799999995 567776643 3788899999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-----------
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR----------- 878 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~----------- 878 (931)
...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 168 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 168 TAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred cCCCcc-ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 654432 22345789999999999998899999999999999999999999987654333221111000
Q ss_pred ---------c--------------------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 ---------R--------------------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 ---------r--------------------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
. ...+...+..+++||.+||..||++|||+.|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 00112235678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=345.39 Aligned_cols=243 Identities=27% Similarity=0.447 Sum_probs=205.7
Q ss_pred EEecccCceEEEEEEEc--CCceEEEEEeecccc-hHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEEEEEeecCC
Q 002355 665 ERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPR 740 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~LVmEy~~G 740 (931)
+.||+|+||+||+|++. ++.||||+++..... ......+..|..++..+ +||||+++++++...+.+++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999874 567999999875422 23345567788888765 899999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCC
Q 002355 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820 (931)
Q Consensus 741 gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~ 820 (931)
++|.+++.. ...+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||++............
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT 155 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence 999999875 235889999999999999999999999 999999999999999999999999998754322223345
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhccc
Q 002355 821 VAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD 900 (931)
Q Consensus 821 ~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~ 900 (931)
..||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+... ....+..++..+.+||.+||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPCYPRWLTREAKDILVKLFVR 233 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHHhcc
Confidence 67899999999999988999999999999999999999999988877766665432 2345667899999999999999
Q ss_pred CCCCCCCHH-HHHHH
Q 002355 901 DPAQRPSFA-NIVES 914 (931)
Q Consensus 901 DPeeRPSa~-ELLq~ 914 (931)
+|.+||++. +++++
T Consensus 234 ~P~~R~~~~~~l~~h 248 (316)
T cd05619 234 EPERRLGVKGDIRQH 248 (316)
T ss_pred CHhhcCCChHHHHcC
Confidence 999999996 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=353.62 Aligned_cols=255 Identities=23% Similarity=0.386 Sum_probs=213.5
Q ss_pred ccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
.+..++|++.+.||+|+||.||+|++ +++.||+|++...... ......+.+|+.+++.++||||+++++++..+..+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 44568999999999999999999987 4678999998764332 23345678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
|+||||++|++|.+++.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++++||+|||++...
T Consensus 119 ~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 999999999999999864 24788999999999999999999999 999999999999999999999999999765
Q ss_pred cccc-cccCCCCCCCcccCcccccCCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC--C
Q 002355 812 ANTF-ISSKSVAGTPEWMAPEFLRGEP----SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP--Q 884 (931)
Q Consensus 812 ~~~~-~~~~~~~GT~~Y~APEvL~~~~----~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP--~ 884 (931)
.... ......+||+.|+|||++.+.. ++.++|||||||++|||++|..||...+.......+........+| .
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (371)
T cd05622 193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 272 (371)
T ss_pred CcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcC
Confidence 4321 1223567999999999987643 6789999999999999999999999888777776665444334444 4
Q ss_pred CChHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 002355 885 NTSPVLASLMESCWADDPAQ--RPSFANIVESL 915 (931)
Q Consensus 885 ~~s~eL~dLI~rcL~~DPee--RPSa~ELLq~L 915 (931)
.++..+++||.+||..++.+ |+++.++++|.
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 273 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 68999999999999844433 78999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=324.34 Aligned_cols=258 Identities=26% Similarity=0.507 Sum_probs=216.3
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|++.++||.|+||.||+|.+ +++.||+|.++...... .....+.+|++++++++|+||+++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 6899999999999999999987 58889999987644333 34577899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCC-CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 736 EYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~-~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
||+++++|..++.... ....+++..++.++.||+.||.|||+.| |+|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999999986422 2345889999999999999999999999 999999999999999999999999998765443
Q ss_pred ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcccccCCCC-CChHHHH
Q 002355 815 FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLG--PAQVVGAVAFQNRRLAIPQ-NTSPVLA 891 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~--~~eii~~i~~~~~r~~lP~-~~s~eL~ 891 (931)
........++..|+|||.+.+..++.++|+|||||++|+|++|..||.... ..+....+.. ......+. ..+..+.
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-CDYPPLPADHYSEELR 238 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc-CCCCCCChhhcCHHHH
Confidence 323344568889999999998889999999999999999999999996543 2223333222 22233443 6788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 002355 892 SLMESCWADDPAQRPSFANIVESLKKLL 919 (931)
Q Consensus 892 dLI~rcL~~DPeeRPSa~ELLq~L~~Ll 919 (931)
++|.+||..+|++|||+.++++.|+++.
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 9999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=338.73 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=205.4
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|+++++||+|+||+||+|++ +++.||+|+++..... .....+.+|+.+++.++||||+++++++..+++.++||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 37899999999999999999976 5677999998765422 22245678999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+. ++|.+++... +..+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++.......
T Consensus 84 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 84 EYLD-KDLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred eCCC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 9995 5888887652 345788999999999999999999999 9999999999999999999999999997654333
Q ss_pred cccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc----------------
Q 002355 816 ISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR---------------- 878 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~---------------- 878 (931)
.......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 22334567899999998865 4578999999999999999999999988765444332211100
Q ss_pred -----cc-------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002355 879 -----RL-------AIPQNTSPVLASLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 879 -----r~-------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
+. .....+++++.+||.+||..||.+|||+.|++++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 00 01134678899999999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=325.08 Aligned_cols=257 Identities=33% Similarity=0.590 Sum_probs=217.9
Q ss_pred cccccCceEEEEEecccCceEEEEEEEc-CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~-g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
|++..++|++.++||.|+||+||+|.+. +..||||.+...... ...+.+|+.+++.++|+||+++++++......+
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 4567799999999999999999999864 456999998765432 246889999999999999999999999989999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+++++|.+++... ....+++..+..++.||+.||.|||+.| ++|+||||+||+++.++.++|+|||++....
T Consensus 78 ~v~e~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred EEEeccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceecc
Confidence 999999999999999763 2346899999999999999999999999 9999999999999999999999999987654
Q ss_pred ccc-cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHH
Q 002355 813 NTF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 813 ~~~-~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL 890 (931)
... .......++..|+|||.+.+...+.++|+|||||++|+|++ |+.||.+.........+. .......+...+..+
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 233 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPEEL 233 (261)
T ss_pred chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHH
Confidence 321 11122234568999999998889999999999999999998 999998877666665553 333445566778999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
.+++.+||+.+|++||+++++++.|+.
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 234 YDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=336.00 Aligned_cols=246 Identities=26% Similarity=0.391 Sum_probs=204.0
Q ss_pred ecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCCCH
Q 002355 667 VGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL 743 (931)
Q Consensus 667 LG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~GgSL 743 (931)
||+|+||+||+|.+ +++.||+|++....... .....+..|+++++.++|+||++++++|..+.++|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999976 57789999987654332 2345678899999999999999999999999999999999999999
Q ss_pred HHHhhcC-CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCCCC
Q 002355 744 YRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822 (931)
Q Consensus 744 ~d~L~r~-~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~~~ 822 (931)
..++... .....+++..++.++.||+.||+|||++| |+||||||+||+++.++.++|+|||++..............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 8887432 22346899999999999999999999999 99999999999999999999999999876544332334567
Q ss_pred CCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--hcccccCCCCCChHHHHHHHHHhccc
Q 002355 823 GTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVA--FQNRRLAIPQNTSPVLASLMESCWAD 900 (931)
Q Consensus 823 GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~--~~~~r~~lP~~~s~eL~dLI~rcL~~ 900 (931)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+. ........+..+++.+.+|+.+||+.
T Consensus 159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 238 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAK 238 (280)
T ss_pred CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcC
Confidence 8999999999999999999999999999999999999997654321111111 11223445677899999999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 002355 901 DPAQRP-----SFANIVES 914 (931)
Q Consensus 901 DPeeRP-----Sa~ELLq~ 914 (931)
||++|| +++++++|
T Consensus 239 ~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 239 DPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CHHHhcCCCCCCHHHHhcC
Confidence 999999 78888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.42 Aligned_cols=262 Identities=32% Similarity=0.519 Sum_probs=220.3
Q ss_pred cccCceEEEEEecccCceEEEEEEE-------cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW-------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~-------~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~ 728 (931)
|.+++|.+.+.||+|+||.||+++. .+..+|+|.+.... ......+.+|+.++++++|+||+++++++..+
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4678999999999999999999974 22348888876542 33456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhhcCC----------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPA----------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW 798 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~----------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg 798 (931)
+.+++||||+++++|.+++.... ....+++..++.++.||+.||+|||++| ++||||||+||+++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENL 157 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCC
Confidence 99999999999999999986422 1234899999999999999999999999 99999999999999999
Q ss_pred cEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 002355 799 TVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAF 875 (931)
Q Consensus 799 ~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~ 875 (931)
.++|+|||++....... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+..
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999999987543221 11123345778999999998889999999999999999998 8999988877666665542
Q ss_pred cccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 876 QNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 876 ~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
......+...+.++.+|+.+||+.+|.+|||+.++++.|+++.+..
T Consensus 238 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 238 -GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred -CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 3334456678899999999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=346.99 Aligned_cols=239 Identities=28% Similarity=0.445 Sum_probs=201.3
Q ss_pred EEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHH-HHHhcCCCCeeeEEeeeeeCCeEEEEEeecCC
Q 002355 665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVA-IMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPR 740 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIk-ILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~G 740 (931)
+.||+|+||+||+|++ +++.||+|++....... .....+..|.. +++.++|+||+++++++...+.+|+||||+.|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999987 45679999998654322 22334445544 56788999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCC
Q 002355 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820 (931)
Q Consensus 741 gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~ 820 (931)
++|.+++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence 999999875 235788889999999999999999999 999999999999999999999999998754333333445
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhccc
Q 002355 821 VAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD 900 (931)
Q Consensus 821 ~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~ 900 (931)
.+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.+..+.. .....+..++..+.++|.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~ 233 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--KPLQLKPNITNSARHLLEGLLQK 233 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh--CCcCCCCCCCHHHHHHHHHHccc
Confidence 6799999999999999999999999999999999999999998887776665542 34455678899999999999999
Q ss_pred CCCCCCCHHH
Q 002355 901 DPAQRPSFAN 910 (931)
Q Consensus 901 DPeeRPSa~E 910 (931)
+|.+|+++.+
T Consensus 234 ~p~~R~~~~~ 243 (325)
T cd05602 234 DRTKRLGAKD 243 (325)
T ss_pred CHHHCCCCCC
Confidence 9999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=360.37 Aligned_cols=251 Identities=22% Similarity=0.369 Sum_probs=213.9
Q ss_pred CceEEEEEecccCceEEEEEEEc---CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~---g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
..|.+.+.||+|+||.||+|... ++.||+|.+.... ......+.+|+.+|+.++||||++++++|..++++||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 56999999999999999999752 5668888765432 333456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcC-CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 736 EYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~-~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
||++|++|.+++... .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 999999999887532 22345889999999999999999999999 999999999999999999999999999865432
Q ss_pred c--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHH
Q 002355 815 F--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 815 ~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
. ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||......++...+... .....+..++..+.+
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG-KYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCccCCHHHHH
Confidence 2 1234557999999999999988999999999999999999999999988777766665433 333456778999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 002355 893 LMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~ 914 (931)
||.+||..+|++||++.+++.+
T Consensus 302 li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 302 LLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHHHhccChhhCcCHHHHHhC
Confidence 9999999999999999999864
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=328.79 Aligned_cols=258 Identities=25% Similarity=0.488 Sum_probs=215.1
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|++.+.||.|+||.||+|++ +++.+|||.+...... ......+.+|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 5789999999999999999985 6788999988764432 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcC-CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 736 EYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~-~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
||+++++|.+++... .....+++..++.++.||+.||.|||++| ++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999999999988642 22346899999999999999999999999 999999999999999999999999998765443
Q ss_pred ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhcccccCCCCCChHHHHH
Q 002355 815 FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPA--QVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~--eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
........++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.... .....+.....+...+...++.+.+
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence 32233456889999999999888999999999999999999999999765432 2222222222222233567889999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHH
Q 002355 893 LMESCWADDPAQRPSFANIVESLKKL 918 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~L~~L 918 (931)
||.+||..+|++|||+.++++.++++
T Consensus 240 li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 240 LVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 99999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=337.52 Aligned_cols=267 Identities=31% Similarity=0.609 Sum_probs=219.3
Q ss_pred cccCceEEEEEecccCceEEEEEEEc--CCc--eEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCe
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH--GSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH 730 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~--g~~--VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~ 730 (931)
+.+++|++.+.||+|+||.||+|++. +.. +|+|.+... ........+.+|+.++.++ +|+||+++++++..++.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 35689999999999999999999863 443 466655432 2234456788999999999 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhcCC-------------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC
Q 002355 731 LSIVTEYLPRGSLYRLIHRPA-------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN 797 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~-------------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d 797 (931)
+++||||+++++|.+++.+.. ....+++..++.++.||+.||+|||++| |+||||||+|||++.+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~ 160 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN 160 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCC
Confidence 999999999999999997532 1235789999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 002355 798 WTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQ 876 (931)
Q Consensus 798 g~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~ 876 (931)
+.+||+|||++....... ......++..|+|||.+.+..++.++|||||||++|+|+| |..||......+....+. .
T Consensus 161 ~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~ 238 (303)
T cd05088 161 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-Q 238 (303)
T ss_pred CcEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh-c
Confidence 999999999986432211 1122234667999999988888999999999999999998 999998877666555442 2
Q ss_pred ccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhhhc
Q 002355 877 NRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQ 927 (931)
Q Consensus 877 ~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l~~ 927 (931)
......+...++.+.+||.+||+.+|++||++.++++.|..++.....++.
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~ 289 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN 289 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhh
Confidence 334445667889999999999999999999999999999999888766544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=336.57 Aligned_cols=262 Identities=31% Similarity=0.535 Sum_probs=219.0
Q ss_pred cccccCceEEEEEecccCceEEEEEEEc-------CCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeee
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAV 725 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~-------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f 725 (931)
+.+.+++|++.++||+|+||.||+|.+. +..||+|+++.... ......+.+|+++++++ +|+||+++++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 4467789999999999999999999752 33689998875432 33446788999999999 799999999999
Q ss_pred eeCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEec
Q 002355 726 TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDF 805 (931)
Q Consensus 726 ~~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DF 805 (931)
...+..++||||+.+++|.+++.+.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+||
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCC
Confidence 99999999999999999999997532 234899999999999999999999999 999999999999999999999999
Q ss_pred Cccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCC
Q 002355 806 GLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAI 882 (931)
Q Consensus 806 GlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~l 882 (931)
|++....... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.................+...
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 265 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCC
Confidence 9987543321 11122345778999999998889999999999999999998 99999887765554444434444455
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 002355 883 PQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLL 919 (931)
Q Consensus 883 P~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Ll 919 (931)
+...++.+.+||.+||..+|++|||+.++++.|.+++
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~ 302 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence 6677899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=326.85 Aligned_cols=256 Identities=34% Similarity=0.600 Sum_probs=215.0
Q ss_pred cccccCceEEEEEecccCceEEEEEEEc-CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~-g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
|++..++|+++++||+|+||.||+|.+. +..||+|.+....... ..+.+|+.++++++|+||+++++++. ....+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 4566789999999999999999999864 4679999987654332 46889999999999999999999875 45689
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
++|||+.+++|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIE 153 (260)
T ss_pred EEEEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeecc
Confidence 999999999999998753 2345899999999999999999999999 9999999999999999999999999997643
Q ss_pred cccc-ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHH
Q 002355 813 NTFI-SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 813 ~~~~-~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL 890 (931)
.... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+. ...+...+...+..+
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCPISL 232 (260)
T ss_pred CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHH
Confidence 3211 1122334568999999988889999999999999999999 899998877666665553 334455677889999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
.+||.+||..+|.+|||+.++.+.|++
T Consensus 233 ~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 233 HELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=345.06 Aligned_cols=238 Identities=29% Similarity=0.467 Sum_probs=201.4
Q ss_pred EEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHH-HHHhcCCCCeeeEEeeeeeCCeEEEEEeecCC
Q 002355 665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVA-IMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPR 740 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIk-ILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~G 740 (931)
+.||+|+||+||+|++ +++.||+|++....... .....+..|+. +++.++||||++++++|...+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999987 56789999997654322 23345555654 67889999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCC
Q 002355 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820 (931)
Q Consensus 741 gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~ 820 (931)
++|..++.+ ...+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST 155 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence 999988865 235888999999999999999999999 999999999999999999999999998754333223345
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhccc
Q 002355 821 VAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD 900 (931)
Q Consensus 821 ~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~ 900 (931)
.+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+. ..+..++...+..+.++|.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~ 233 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL--HKPLQLPGGKTVAACDLLVGLLHK 233 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccC
Confidence 678999999999999889999999999999999999999999887766665554 334567778899999999999999
Q ss_pred CCCCCCCHH
Q 002355 901 DPAQRPSFA 909 (931)
Q Consensus 901 DPeeRPSa~ 909 (931)
+|.+||++.
T Consensus 234 ~p~~R~~~~ 242 (321)
T cd05603 234 DQRRRLGAK 242 (321)
T ss_pred CHhhcCCCC
Confidence 999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=329.57 Aligned_cols=252 Identities=25% Similarity=0.355 Sum_probs=204.8
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
+|+++++||.|+||.||+|++ ++..||||++............+.+|+.+++.++||||+++++++..++.+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 588999999999999999987 577899999876543333345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccc
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~ 817 (931)
+. ++|.+++.....+..+++..++.++.||+.||+|||++| |+|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 96 688888865444457899999999999999999999999 999999999999999999999999998754433222
Q ss_pred cCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-------------------
Q 002355 818 SKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN------------------- 877 (931)
Q Consensus 818 ~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~------------------- 877 (931)
.....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+..............
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 2334568899999988754 46889999999999999999999998755432221110000
Q ss_pred --------cccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 878 --------RRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 878 --------~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
........+++++.+||.+||..||.+|||+.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0001123578899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=331.99 Aligned_cols=263 Identities=32% Similarity=0.512 Sum_probs=216.9
Q ss_pred cccccCceEEEEEecccCceEEEEEEEc-------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT 726 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~-------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~ 726 (931)
|++..++|++.++||+|+||.||+|.++ +..||+|.+..... ......+.+|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4667799999999999999999999653 33699998765432 233356788999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhhcCCC-------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc
Q 002355 727 KRPHLSIVTEYLPRGSLYRLIHRPAA-------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT 799 (931)
Q Consensus 727 ~~~~l~LVmEy~~GgSL~d~L~r~~~-------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~ 799 (931)
.+...|+||||+.+++|.+++.+... ...+....+..++.||+.||.|||+++ |+||||||+||+++.++.
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~ 157 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCc
Confidence 99999999999999999999965221 133567788899999999999999999 999999999999999999
Q ss_pred EEEEecCcccccccccc--ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 002355 800 VKVCDFGLSRFKANTFI--SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQ 876 (931)
Q Consensus 800 IKL~DFGlAr~~~~~~~--~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~ 876 (931)
++|+|||+++....... ......++..|+|||.+.+..++.++|+|||||++|||++ |..||.+....+....+. .
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~ 236 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM-D 236 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-c
Confidence 99999999875432211 1122345678999999998889999999999999999998 789998877766555443 2
Q ss_pred ccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 002355 877 NRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920 (931)
Q Consensus 877 ~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llk 920 (931)
......+...++.+.+||.+||+.+|.+|||+.++++.|++.+.
T Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 33344566778999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=332.12 Aligned_cols=249 Identities=37% Similarity=0.689 Sum_probs=208.9
Q ss_pred EEEEEecccCceEEEEEEEc------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 662 HVKERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 662 ~Ii~kLG~G~fGtVylAr~~------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.+.+.||.|.||.||+|.+. +..|+||+++.. ......+.+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccc
Confidence 57889999999999999887 566999999553 33344678999999999999999999999999888899999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc-
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT- 814 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~- 814 (931)
||+++++|.+++... ....+++..+..|+.||+.||.|||+++ ++|+||+++|||++.++.+||+|||++......
T Consensus 81 e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp E--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccc
Confidence 999999999999874 2356899999999999999999999999 999999999999999999999999999865221
Q ss_pred -ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHH
Q 002355 815 -FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 815 -~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
............|+|||.+.+..++.++||||||+++|||++ |..||......+....+ ....+...+..++..+.+
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYS 236 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHH
Confidence 112233446778999999988889999999999999999999 78999998887777776 456667778889999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHH
Q 002355 893 LMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~L 915 (931)
+|.+||..+|++|||+.++++.|
T Consensus 237 li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 237 LIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHhcC
Confidence 99999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=337.51 Aligned_cols=254 Identities=25% Similarity=0.450 Sum_probs=228.5
Q ss_pred cccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHH-HHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQ-LKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~-~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
...++|++++.||+|-||.||+|+.+ +..||+||+.++.....+ ..++.+|++|-..|+||||+++|++|.+...+|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 35589999999999999999999874 456999999887654433 356789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
|++||..+|+|+..+.. +....+++..+..++.|++.||.|+|..+ ||||||||+|+|++..|.+||+|||-+....
T Consensus 99 LilEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999999974 23557999999999999999999999988 9999999999999999999999999987765
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHH
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
. ....+.|||..|.+||...+..++..+|+|++|++.||++.|.+||......+.+..+. .....+|..++..+++
T Consensus 176 ~--~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~--k~~~~~p~~is~~a~d 251 (281)
T KOG0580|consen 176 S--NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR--KVDLKFPSTISGGAAD 251 (281)
T ss_pred C--CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH--HccccCCcccChhHHH
Confidence 3 35678899999999999999999999999999999999999999999988888888775 4556678999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHH
Q 002355 893 LMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
+|.+||.++|.+|....|++.|-+
T Consensus 252 lI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 252 LISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred HHHHHhccCccccccHHHHhhhHH
Confidence 999999999999999999999865
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=326.98 Aligned_cols=250 Identities=33% Similarity=0.593 Sum_probs=212.6
Q ss_pred cCceEEEEEecccCceEEEEEEEcCC-ceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 658 WDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~~g~-~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
.++|++++.||+|+||+||+|++.+. .+|+|.+...... ...+.+|+.+++.++||||+++++++......++|||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 46899999999999999999987654 5999988754432 2467899999999999999999999998889999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+.+++|.+++.... ..+++..++.++.||+.||+|||+.| ++|+||||.||+++.++.+||+|||.++.......
T Consensus 80 ~~~~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 80 YMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred cCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999999987532 35899999999999999999999999 99999999999999999999999999875433211
Q ss_pred -ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHH
Q 002355 817 -SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894 (931)
Q Consensus 817 -~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI 894 (931)
......++..|++||.+.+..++.++|||||||++|+|++ |..||...........+. ...+...+...+..+.++|
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 234 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIM 234 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHH
Confidence 1122335678999999988888999999999999999998 999998877766655553 3344455667789999999
Q ss_pred HHhcccCCCCCCCHHHHHHHH
Q 002355 895 ESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 895 ~rcL~~DPeeRPSa~ELLq~L 915 (931)
.+||..+|.+||++.++++.|
T Consensus 235 ~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 235 YSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred HHHcCCCcccCCCHHHHHHhh
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=346.25 Aligned_cols=244 Identities=25% Similarity=0.426 Sum_probs=203.0
Q ss_pred EEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEEEEEeecCC
Q 002355 665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPR 740 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~LVmEy~~G 740 (931)
+.||+|+||+||+|++ +++.||+|+++...... .....+.+|+.++.++ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999987 46789999998764332 3445678899998877 799999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCC
Q 002355 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820 (931)
Q Consensus 741 gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~ 820 (931)
++|..++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 155 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence 999988865 235899999999999999999999999 999999999999999999999999998754332223345
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcccccCCCCCChHHHHH
Q 002355 821 VAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLG--------PAQVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 821 ~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~--------~~eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
..||+.|+|||++.+..++.++|||||||++|+|++|..||.... ........ .......+|...+..+.+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-i~~~~~~~p~~~~~~~~~ 234 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV-ILEKQIRIPRSLSVKAAS 234 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH-HhcCCCCCCCCCCHHHHH
Confidence 679999999999999999999999999999999999999995321 11112121 123445678889999999
Q ss_pred HHHHhcccCCCCCCC------HHHHHHH
Q 002355 893 LMESCWADDPAQRPS------FANIVES 914 (931)
Q Consensus 893 LI~rcL~~DPeeRPS------a~ELLq~ 914 (931)
||.+||..||.+||+ +.++++|
T Consensus 235 ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 235 VLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 999999999999998 4677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=333.97 Aligned_cols=265 Identities=32% Similarity=0.563 Sum_probs=222.0
Q ss_pred cccccCceEEEEEecccCceEEEEEEEc---------CCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEe
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWH---------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMG 723 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~---------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid 723 (931)
+++..++|++.+.||+|+||.||+|++. +..||+|++.... .......+.+|+.+++.+ +||||+++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 4567799999999999999999999752 2358999886542 234456788999999999 8999999999
Q ss_pred eeeeCCeEEEEEeecCCCCHHHHhhcCCC-------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCC
Q 002355 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAA-------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSP 790 (931)
Q Consensus 724 ~f~~~~~l~LVmEy~~GgSL~d~L~r~~~-------------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPe 790 (931)
++......++||||+.+++|.+++.+... ...+++..+..++.||+.||.|||++| |+||||||+
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~ 166 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAAR 166 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccc
Confidence 99999999999999999999999975321 235788889999999999999999999 999999999
Q ss_pred CeEECCCCcEEEEecCcccccccccc--ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 002355 791 NLLVDKNWTVKVCDFGLSRFKANTFI--SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPA 867 (931)
Q Consensus 791 NILLd~dg~IKL~DFGlAr~~~~~~~--~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~ 867 (931)
||+++.++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 99999999999999999976543211 1222345678999999998889999999999999999998 78999888777
Q ss_pred HHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 868 QVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 868 eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
++...+. ...+...+..++..+.+||.+||..+|.+|||+.++++.|..++...
T Consensus 247 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 247 ELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred HHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 7666553 33344566788999999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=321.67 Aligned_cols=248 Identities=36% Similarity=0.616 Sum_probs=214.8
Q ss_pred EEecccCceEEEEEEEc-----CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecC
Q 002355 665 ERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLP 739 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~~-----g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~ 739 (931)
++||+|+||.||+|.+. +..|++|++....... ....+.+|+++++.++|+||+++++++..+..+++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 36999999999999875 6679999987765433 45788999999999999999999999999999999999999
Q ss_pred CCCHHHHhhcCCC------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 740 RGSLYRLIHRPAA------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 740 GgSL~d~L~r~~~------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
+++|.+++..... ...+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.++|+|||.+.....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999976311 356899999999999999999999999 99999999999999999999999999986544
Q ss_pred cc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHH
Q 002355 814 TF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 814 ~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL 890 (931)
.. .......++..|+|||.+....++.++|||||||++|+|++ |..||......+....+.. ......+..++.++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDEL 236 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCChHH
Confidence 31 22334567889999999988888999999999999999999 5999998877776666543 44556777889999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
.++|.+||..+|.+|||+.+++++|+
T Consensus 237 ~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 237 YELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHccCCcccCcCHHHHHHhhC
Confidence 99999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=343.55 Aligned_cols=252 Identities=21% Similarity=0.355 Sum_probs=208.7
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|++++.||+|+||+||++++ .++.||+|++.+.... ......+.+|+.++..++|+||++++++|..++++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4799999999999999999987 4678999999764322 234456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+.|++|.+++.+. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999752 346899999999999999999999999 9999999999999999999999999987543322
Q ss_pred c-ccCCCCCCCcccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC---CCC
Q 002355 816 I-SSKSVAGTPEWMAPEFLRG-----EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP---QNT 886 (931)
Q Consensus 816 ~-~~~~~~GT~~Y~APEvL~~-----~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP---~~~ 886 (931)
. ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||......+....+........++ ..+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence 1 2223468999999999873 346789999999999999999999998877766666654433333333 347
Q ss_pred hHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q 002355 887 SPVLASLMESCWADDPA--QRPSFANIVES 914 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPe--eRPSa~ELLq~ 914 (931)
++.+++||++||..++. .|+++.++++|
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 89999999999865443 37899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=333.60 Aligned_cols=257 Identities=27% Similarity=0.473 Sum_probs=215.0
Q ss_pred cccCceEEEEEecccCceEEEEEEEc-------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~-------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~ 728 (931)
+...+|++.++||.|+||.||+|++. +..||||++.... .......+.+|+.++..++||||+++++++...
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 34567899999999999999999763 3569999987543 223346688999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhhcC-------------CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRP-------------AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD 795 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~-------------~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd 795 (931)
...++++||+.+++|.+++... .....+++..++.++.|++.||.|||++| |+||||||+||+++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~ 158 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF 158 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec
Confidence 9999999999999999998521 11234788889999999999999999999 99999999999999
Q ss_pred CCCcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 002355 796 KNWTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGA 872 (931)
Q Consensus 796 ~dg~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~ 872 (931)
.++.+||+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+....
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999987543221 11123345779999999988889999999999999999998 8899988877766666
Q ss_pred HHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 873 VAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 873 i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
+.. ......+..++..+.+|+.+||+.+|.+||+++++++.|+
T Consensus 239 i~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 239 IRN-RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHc-CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 543 3344567789999999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=331.94 Aligned_cols=250 Identities=26% Similarity=0.337 Sum_probs=200.2
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhc---CCCCeeeEEeeeee-----CC
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV---RHPNVVLFMGAVTK-----RP 729 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L---~HpNIV~Lid~f~~-----~~ 729 (931)
+|++.+.||+|+||+||+|++ +++.||+|+++...........+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 589999999999999999987 577899999876543322223455677777665 69999999998853 35
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
.+++|||++. ++|.+++.+.. ...+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccCccc
Confidence 6899999996 58888886532 345899999999999999999999999 9999999999999999999999999997
Q ss_pred cccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc----------
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR---------- 879 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r---------- 879 (931)
...... ......||..|+|||++.+..++.++|||||||++|+|++|.+||.+.........+......
T Consensus 157 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 157 IYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred cccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 654332 223456799999999999888999999999999999999999999877655444333211000
Q ss_pred ---------------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 ---------------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 ---------------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
......++..+.+||.+||.+||++|||+.+++.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00123567789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=329.42 Aligned_cols=257 Identities=29% Similarity=0.494 Sum_probs=213.1
Q ss_pred cccCceEEEEEecccCceEEEEEEEcC-------CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~g-------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~ 728 (931)
+.+++|++.+.||+|+||.||+|.+.+ ..||+|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 456899999999999999999998743 458888775433 223345688999999999999999999999988
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCC----CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC---cEE
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAA----GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW---TVK 801 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~----~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg---~IK 801 (931)
...++||||+.|++|.+++.+... ...+++..++.++.||+.||+|||+++ ++||||||+||+++.++ .+|
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceE
Confidence 899999999999999999875321 135889999999999999999999999 99999999999998654 589
Q ss_pred EEecCcccccccccc--ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccc
Q 002355 802 VCDFGLSRFKANTFI--SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNR 878 (931)
Q Consensus 802 L~DFGlAr~~~~~~~--~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~ 878 (931)
|+|||+++....... .......+..|+|||++.+..++.++|||||||++|+|++ |..||......+....+. ...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~ 238 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-GGG 238 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCC
Confidence 999999976432211 1112233568999999998889999999999999999997 999998877666655443 334
Q ss_pred ccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 879 RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 879 r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
+...+..++..+.+||.+||+.+|++||++.+++++|+
T Consensus 239 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 239 RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 45567788999999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.98 Aligned_cols=258 Identities=31% Similarity=0.583 Sum_probs=216.0
Q ss_pred ceEEEEEecccCceEEEEEEEcC-------CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 660 ELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~~g-------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
+|++.+.||+|+||.||+|.... ..+|+|++..... ......+.+|+.+++.++||||+++++.+..++..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 47889999999999999997632 4588888765432 334567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCC---------------------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCC
Q 002355 733 IVTEYLPRGSLYRLIHRPA---------------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPN 791 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~---------------------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeN 791 (931)
+||||+.+++|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~n 157 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARN 157 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhhe
Confidence 9999999999999986421 1234788999999999999999999999 9999999999
Q ss_pred eEECCCCcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHH
Q 002355 792 LLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQ 868 (931)
Q Consensus 792 ILLd~dg~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~e 868 (931)
||++.++.+||+|||+++...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+..+.+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999987543221 11223345678999999988889999999999999999998 999998877766
Q ss_pred HHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 869 VVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 869 ii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
+...+. .......+..++..+.+||.+||+.+|.+||++.++++.|++++..
T Consensus 238 ~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 238 LFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHHHh-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 555443 3334456778899999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=332.28 Aligned_cols=257 Identities=35% Similarity=0.568 Sum_probs=213.1
Q ss_pred ccCceEEEEEecccCceEEEEEEEcC------------------CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCe
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWHG------------------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~g------------------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNI 718 (931)
...+|+++++||+|+||.||+|++.. ..||+|++..... ......+.+|++++++++||||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCE
Confidence 45789999999999999999997632 3489999876532 3445778999999999999999
Q ss_pred eeEEeeeeeCCeEEEEEeecCCCCHHHHhhcCC--------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCC
Q 002355 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPA--------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSP 790 (931)
Q Consensus 719 V~Lid~f~~~~~l~LVmEy~~GgSL~d~L~r~~--------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPe 790 (931)
+++++++..++..++|||++.+++|.+++.+.. ....+++..++.++.|++.||+|||++| |+|+||||+
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~ 159 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATR 159 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchh
Confidence 999999999999999999999999999987532 1225899999999999999999999999 999999999
Q ss_pred CeEECCCCcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCh
Q 002355 791 NLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT--MQQPWNGLGP 866 (931)
Q Consensus 791 NILLd~dg~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT--G~~PF~~~~~ 866 (931)
||+++.++.++|+|||+++...... .......++..|+|||.+.+..++.++|||||||++|||++ +..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999987543221 12234456788999999988889999999999999999998 7889987776
Q ss_pred HHHHHHHHhc------ccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 867 AQVVGAVAFQ------NRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 867 ~eii~~i~~~------~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
.+.+...... ......+...+.++.+||.+||+.+|.+|||+.+|++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 6655544322 1112234567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=344.45 Aligned_cols=265 Identities=31% Similarity=0.538 Sum_probs=216.8
Q ss_pred cccccCceEEEEEecccCceEEEEEEE-------cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeee
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEW-------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAV 725 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~-------~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f 725 (931)
|+++.++|+++++||.|+||+||+|++ .++.||||+++.... ......+.+|+.++.++ +|+||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 466778999999999999999999974 356799999976432 33456788999999999 689999999987
Q ss_pred ee-CCeEEEEEeecCCCCHHHHhhcCCC----------------------------------------------------
Q 002355 726 TK-RPHLSIVTEYLPRGSLYRLIHRPAA---------------------------------------------------- 752 (931)
Q Consensus 726 ~~-~~~l~LVmEy~~GgSL~d~L~r~~~---------------------------------------------------- 752 (931)
.. +...++||||+.+++|.+++.....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 54 4568999999999999999864210
Q ss_pred ------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc--ccc
Q 002355 753 ------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF--ISS 818 (931)
Q Consensus 753 ------------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~--~~~ 818 (931)
...+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++....... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 123677888999999999999999999 9999999999999999999999999987542211 111
Q ss_pred CCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHh
Q 002355 819 KSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESC 897 (931)
Q Consensus 819 ~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rc 897 (931)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||.....................+...++.+.+++.+|
T Consensus 239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c 318 (343)
T cd05103 239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence 22345678999999998889999999999999999997 89999876544333333334445556667788999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHHhhC
Q 002355 898 WADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 898 L~~DPeeRPSa~ELLq~L~~Llks 921 (931)
|+.+|.+|||+.+++++|+.+++.
T Consensus 319 l~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 319 WHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred ccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=329.68 Aligned_cols=251 Identities=27% Similarity=0.447 Sum_probs=206.4
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|+++++||+|+||.||+|++ +++.||+|++..... .....+.+|+.++++++||||+++++++..++.+++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 46899999999999999999986 567899999875432 22356788999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+++++|.+++.+ ...+++..+..++.|++.||.|||+.| |+||||||+||+++.++.++|+|||++.......
T Consensus 86 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 86 EYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 99999999999865 235889999999999999999999999 9999999999999999999999999998654332
Q ss_pred cccCCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc---CCCCCChHH
Q 002355 816 ISSKSVAGTPEWMAPEFLR---GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL---AIPQNTSPV 889 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~---~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~---~lP~~~s~e 889 (931)
.......++..|+|||.+. ...++.++|+|||||++|+|++|..||....+.+....+....... .....++..
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST 240 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence 2234456889999999885 3446789999999999999999999997655433322221111111 112356789
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHH
Q 002355 890 LASLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 890 L~dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
+.+||++||..+|++|||+++++++|
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 99999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=335.84 Aligned_cols=264 Identities=32% Similarity=0.566 Sum_probs=220.6
Q ss_pred cccccCceEEEEEecccCceEEEEEEEc---------CCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEe
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWH---------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMG 723 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~---------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid 723 (931)
+.+..++|.++++||+|+||.||+|++. ...||+|+++... .......+.+|+++++.+ .||||+++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 4567799999999999999999999752 3358999887543 334456788999999999 6999999999
Q ss_pred eeeeCCeEEEEEeecCCCCHHHHhhcCC-------------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCC
Q 002355 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPA-------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSP 790 (931)
Q Consensus 724 ~f~~~~~l~LVmEy~~GgSL~d~L~r~~-------------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPe 790 (931)
++.....+++||||+.+++|.+++.... ....+++..+..++.||+.||.|||++| |+||||||+
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~ 163 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAAR 163 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccce
Confidence 9999999999999999999999996532 1235888999999999999999999999 999999999
Q ss_pred CeEECCCCcEEEEecCccccccccccc--cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 002355 791 NLLVDKNWTVKVCDFGLSRFKANTFIS--SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPA 867 (931)
Q Consensus 791 NILLd~dg~IKL~DFGlAr~~~~~~~~--~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~ 867 (931)
|||++.++.+||+|||+++........ .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999754432111 112233467999999998889999999999999999999 89999887776
Q ss_pred HHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 868 QVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 868 eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
+....+. .......+..++..+.+||.+||..+|.+|||+.++++.|+.+...
T Consensus 244 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 244 ELFKLLR-EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 6665554 3334456778889999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.89 Aligned_cols=246 Identities=28% Similarity=0.521 Sum_probs=208.5
Q ss_pred EecccCceEEEEEEE----cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCC
Q 002355 666 RVGAGSFGTVHRAEW----HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRG 741 (931)
Q Consensus 666 kLG~G~fGtVylAr~----~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~Gg 741 (931)
+||+|+||.||+|.+ ++..+|+|+++.........+.+.+|+.+++.+.|+||+++++++. +...++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999965 4567999998766544455678899999999999999999999875 45779999999999
Q ss_pred CHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc---cc
Q 002355 742 SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI---SS 818 (931)
Q Consensus 742 SL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~---~~ 818 (931)
+|.+++.+. ..+++..+..++.||+.||+|||++| |+||||||.||+++.++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999999652 35889999999999999999999999 99999999999999999999999999976543221 11
Q ss_pred CCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHh
Q 002355 819 KSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESC 897 (931)
Q Consensus 819 ~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rc 897 (931)
....++..|+|||.+....++.++|||||||++|||++ |..||......+....+. .......|..+++++.+||.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~ 234 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLC 234 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHH
Confidence 22234578999999988888999999999999999998 999998887766666554 3345567788999999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHH
Q 002355 898 WADDPAQRPSFANIVESLKKL 918 (931)
Q Consensus 898 L~~DPeeRPSa~ELLq~L~~L 918 (931)
|+.+|++||++.+|.+.|...
T Consensus 235 ~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 235 WTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred hccCchhCcCHHHHHHHHhcc
Confidence 999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=345.54 Aligned_cols=248 Identities=25% Similarity=0.327 Sum_probs=204.1
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC------C
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------P 729 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~------~ 729 (931)
.++|++.+.||+|+||.||+|++ .++.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 47999999999999999999976 577899999976554445556788999999999999999999987543 4
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
.+|+||||+. ++|..++.. .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 103 DVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred eEEEEEeCCC-CCHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 6899999995 577777753 3788889999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc----------
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR---------- 879 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r---------- 879 (931)
...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 175 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 175 TAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred ccCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 654432 223457899999999999999999999999999999999999999887655444333211000
Q ss_pred ----------c--------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 ----------L--------------------AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 ----------~--------------------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
. ......+..+++||.+||..||.+|||+.++++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0011234678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=321.38 Aligned_cols=252 Identities=26% Similarity=0.489 Sum_probs=218.5
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
+|++++.||.|+||.||.++. +++.+++|.+............+.+|+.++++++|+||+++++++...+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 589999999999999998876 577899999887765556667888999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccc
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~ 817 (931)
+++++|.+++.+.. ...+++..+..++.|++.||.|||+.| ++|+||+|+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence 99999999997632 346899999999999999999999999 999999999999999999999999998765443323
Q ss_pred cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHh
Q 002355 818 SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESC 897 (931)
Q Consensus 818 ~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rc 897 (931)
.....+++.|+|||.+.+..++.++|+|||||++|+|++|..||......+....+.. ......+...+.++.++|.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ-GNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-CCCCCCccccCHHHHHHHHHH
Confidence 3445689999999999988889999999999999999999999988776666655543 223334567789999999999
Q ss_pred cccCCCCCCCHHHHHHHH
Q 002355 898 WADDPAQRPSFANIVESL 915 (931)
Q Consensus 898 L~~DPeeRPSa~ELLq~L 915 (931)
|..+|.+||++.++++++
T Consensus 237 l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 237 LQQDPEKRPTADEVLDQP 254 (256)
T ss_pred cccCcccCCCHHHHhhCc
Confidence 999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=363.56 Aligned_cols=249 Identities=29% Similarity=0.516 Sum_probs=221.3
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
..|+.++.||+|.||.||+|.+ +++.||+|++..... ...+..+.+|+.+|.+++++||.++|+.|..+..++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 4677789999999999999987 577899999988753 3446778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
||.||++.+.++. +..+.+..+..++++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+....+...
T Consensus 92 y~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 92 YCGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HhcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999999975 344588888889999999999999999 99999999999999999999999999988877766
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMES 896 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~r 896 (931)
...+++||+.|||||++....|+.++||||||++.+||.+|.+||....+...+..+ ....++.+...+++.+++||..
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-pk~~PP~L~~~~S~~~kEFV~~ 245 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-PKSAPPRLDGDFSPPFKEFVEA 245 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-cCCCCCccccccCHHHHHHHHH
Confidence 678899999999999999989999999999999999999999999998875443333 2344444556889999999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 002355 897 CWADDPAQRPSFANIVES 914 (931)
Q Consensus 897 cL~~DPeeRPSa~ELLq~ 914 (931)
||.+||+.||+|.++++|
T Consensus 246 CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 246 CLDKNPEFRPSAKELLKH 263 (467)
T ss_pred HhhcCcccCcCHHHHhhh
Confidence 999999999999999987
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=326.82 Aligned_cols=261 Identities=29% Similarity=0.534 Sum_probs=216.9
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCC----ceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGS----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH 730 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~----~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~ 730 (931)
..++|+++++||.|+||+||+|++ +++ .||+|++.... .......+.+|+.+++.+.|+||+++++++.. ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~ 82 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST 82 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence 457899999999999999999976 343 38999987543 23344678899999999999999999998875 45
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
.+++|||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceee
Confidence 78999999999999998752 246899999999999999999999999 99999999999999999999999999986
Q ss_pred ccccccc--cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCCh
Q 002355 811 KANTFIS--SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTS 887 (931)
Q Consensus 811 ~~~~~~~--~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s 887 (931)
....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...........+. .......+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGERLPQPPICT 237 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCccCC
Confidence 5432111 112234678999999998889999999999999999998 899998776655554433 344445567789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchh
Q 002355 888 PVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQ 924 (931)
Q Consensus 888 ~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~ 924 (931)
..+.++|.+||..||++||++.++++.|..+...+..
T Consensus 238 ~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~ 274 (279)
T cd05109 238 IDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSR 274 (279)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcC
Confidence 9999999999999999999999999999998877643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=323.16 Aligned_cols=255 Identities=34% Similarity=0.614 Sum_probs=213.1
Q ss_pred ccccCceEEEEEecccCceEEEEEEEcC-CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~~g-~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
++..++|++.++||.|+||.||+|.+.+ ..+|+|++...... ...+.+|+++++.++|+||+++++++. .+..++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 4566889999999999999999998754 46999987654322 246788999999999999999998875 456899
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
||||+.+++|.+++... ....+++..+..++.||+.||+|||+.| ++|+||||+||+++.++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 78 VTEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred EEEcCCCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 99999999999999753 2345789999999999999999999999 99999999999999999999999999976433
Q ss_pred ccc-ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHH
Q 002355 814 TFI-SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891 (931)
Q Consensus 814 ~~~-~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~ 891 (931)
... ......++..|+|||.+.+...+.++|||||||++|+|++ |..||.+....+....+. .......+...+..+.
T Consensus 155 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05069 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLH 233 (260)
T ss_pred CcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHH
Confidence 211 1122345678999999998889999999999999999999 899998877766655543 2334455677899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHH
Q 002355 892 SLMESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 892 dLI~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
+||.+||..+|.+||+++++++.|++
T Consensus 234 ~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 234 ELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHHHccCCcccCcCHHHHHHHHhc
Confidence 99999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.19 Aligned_cols=255 Identities=33% Similarity=0.576 Sum_probs=214.6
Q ss_pred cCceEEEEEecccCceEEEEEEEc--C---CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEWH--G---SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~~--g---~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
.++|++.+.||.|+||.||+|++. + ..+|+|.++... .......+.+|+.++++++||||+++++++..++..|
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 478999999999999999999762 2 258999886543 2344567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+++++|.+++.+. ...+++..++.++.|++.||.|||+++ ++||||||+|||++.++.++|+|||++....
T Consensus 82 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 82 IVTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 999999999999999763 245889999999999999999999999 9999999999999999999999999987654
Q ss_pred ccccc---cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChH
Q 002355 813 NTFIS---SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888 (931)
Q Consensus 813 ~~~~~---~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~ 888 (931)
..... .....++..|+|||.+.+..++.++|+|||||++|++++ |..||......+....+.. ..+.+.+...++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 236 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE-GYRLPAPMDCPA 236 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC-CCcCCCCCCCCH
Confidence 32111 111223568999999998889999999999999999886 9999988776666555542 334455667889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 002355 889 VLASLMESCWADDPAQRPSFANIVESLKKL 918 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRPSa~ELLq~L~~L 918 (931)
.+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 237 ALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=325.24 Aligned_cols=250 Identities=32% Similarity=0.619 Sum_probs=211.8
Q ss_pred cCceEEEEEecccCceEEEEEEEcC-CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 658 WDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~~g-~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
..+|++.+.||+|+||.||+|++.+ ..+|+|++....... ..+.+|+.+++.++|+||+++++++...+..|+|||
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 4678999999999999999998754 479999986544322 357789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|++|++|.+++.... ..+++..++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||+++...+...
T Consensus 80 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 80 YMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred cCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999999987532 36899999999999999999999999 99999999999999999999999999876543221
Q ss_pred c-cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHH
Q 002355 817 S-SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894 (931)
Q Consensus 817 ~-~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI 894 (931)
. .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+. ...+...+...+.++.+|+
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 234 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIM 234 (256)
T ss_pred cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHH
Confidence 1 111223457999999998889999999999999999999 899998877766665554 3344556677899999999
Q ss_pred HHhcccCCCCCCCHHHHHHHH
Q 002355 895 ESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 895 ~rcL~~DPeeRPSa~ELLq~L 915 (931)
.+||..+|++|||+.++++.|
T Consensus 235 ~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 235 YSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHhcCChhhCcCHHHHHHHh
Confidence 999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=326.46 Aligned_cols=263 Identities=28% Similarity=0.472 Sum_probs=218.8
Q ss_pred ccccCceEEEEEecccCceEEEEEEEc------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee-
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK- 727 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~~------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~- 727 (931)
.+..++|++.+.||+|+||.||+|.+. +..|++|++... ........+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 356789999999999999999999874 367899987643 334556778899999999999999999998765
Q ss_pred CCeEEEEEeecCCCCHHHHhhcCCCC-----CCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEE
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRPAAG-----EMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKV 802 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~~~~-----~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL 802 (931)
+...+++++|+.+++|.+++...... ..+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEE
Confidence 57789999999999999998653222 46889999999999999999999999 999999999999999999999
Q ss_pred EecCcccccccccc--ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccc
Q 002355 803 CDFGLSRFKANTFI--SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRR 879 (931)
Q Consensus 803 ~DFGlAr~~~~~~~--~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r 879 (931)
+|||+++....... ......++..|+|||.+.+..++.++|||||||++|++++ |+.||...+..++...+. ...+
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~ 237 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-DGYR 237 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-cCCC
Confidence 99999975422110 1122345678999999998889999999999999999999 999998877666554443 2333
Q ss_pred cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 880 LAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 880 ~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
...+..+++++.++|.+||..+|++|||+.++++.|.++.+.
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 238 LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 445566789999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=365.28 Aligned_cols=247 Identities=28% Similarity=0.380 Sum_probs=207.6
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CC-----CeeeEEeeeeeCC
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HP-----NVVLFMGAVTKRP 729 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-Hp-----NIV~Lid~f~~~~ 729 (931)
.-+|.|++.||+|+||.|.+|.+ +++.||||+++... ....+...|++||+.|+ |. |||+++++|...+
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 34999999999999999999976 67889999998764 33455678999999997 43 9999999999999
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC--CcEEEEecCc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN--WTVKVCDFGL 807 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d--g~IKL~DFGl 807 (931)
|+|||+|.+ +-+|+++++.+. ...++...++.|+.||+.||.+||+.+ |||+||||+||||..- ..|||+|||.
T Consensus 262 HlciVfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 262 HLCIVFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred ceeeeehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEeccc
Confidence 999999999 789999998754 445999999999999999999999999 9999999999999653 3699999999
Q ss_pred cccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc--------
Q 002355 808 SRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR-------- 879 (931)
Q Consensus 808 Ar~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r-------- 879 (931)
|+...... .+.+.+..|+|||+|.|.+++.+.||||||||++||++|.+.|.+.+..+.+..+......
T Consensus 338 Sc~~~q~v---ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 338 SCFESQRV---YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred ccccCCcc---eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 99877654 3678899999999999999999999999999999999999999987765443222110000
Q ss_pred ------------------------------------------cCCC-----------CCChHHHHHHHHHhcccCCCCCC
Q 002355 880 ------------------------------------------LAIP-----------QNTSPVLASLMESCWADDPAQRP 906 (931)
Q Consensus 880 ------------------------------------------~~lP-----------~~~s~eL~dLI~rcL~~DPeeRP 906 (931)
...| ......+.+||.+||.+||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 0011 12335689999999999999999
Q ss_pred CHHHHHHH
Q 002355 907 SFANIVES 914 (931)
Q Consensus 907 Sa~ELLq~ 914 (931)
|..+.++|
T Consensus 495 tp~qal~H 502 (586)
T KOG0667|consen 495 TPAQALNH 502 (586)
T ss_pred CHHHHhcC
Confidence 99999987
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=321.97 Aligned_cols=251 Identities=29% Similarity=0.511 Sum_probs=211.7
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|++.++||.|+||.||+|++ +++.+++|++...... ..+.+.+|+.+++.++||||+++++++..+..+|++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 37899999999999999999987 4677999999865432 4567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+.+++|.+++... ...+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 80 EYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred eCCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 999999999998753 246899999999999999999999999 9999999999999999999999999987654432
Q ss_pred cccCCCCCCCcccCcccccCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc---CCCCCChHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGE---PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL---AIPQNTSPV 889 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~---~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~---~lP~~~s~e 889 (931)
.......++..|+|||.+.+. .++.++|+|||||++|+|++|..||......+............ ..+...+.+
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 233445688899999998776 78889999999999999999999998877655544433221111 123345788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 890 LASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 890 L~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+.+||.+||..+|..|||+.+++.+
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcC
Confidence 9999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=329.10 Aligned_cols=263 Identities=32% Similarity=0.505 Sum_probs=220.2
Q ss_pred cccCceEEEEEecccCceEEEEEEEc-------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~-------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~ 728 (931)
+...+|.+.+.||+|+||.||+|++. +..+++|.+.... ....+.+.+|+.+++.++|+||+++++++..+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 35578999999999999999999752 2348888875433 23345788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhhcCC-------------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPA-------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD 795 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~-------------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd 795 (931)
...++||||+++++|.+++.... ....+++..++.++.||+.||+|||++| |+||||||+||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~ 157 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVG 157 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc
Confidence 99999999999999999996532 1234789999999999999999999999 99999999999999
Q ss_pred CCCcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 002355 796 KNWTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGA 872 (931)
Q Consensus 796 ~dg~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~ 872 (931)
.++.++|+|||++....... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999987543221 11233456788999999999889999999999999999999 9999988777666554
Q ss_pred HHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCch
Q 002355 873 VAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPA 923 (931)
Q Consensus 873 i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~ 923 (931)
+. .......+..++..+.+||.+||..+|.+||++.++++.|.++.+...
T Consensus 238 ~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 238 IT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred Hh-CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 43 333444566788999999999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=347.96 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=204.2
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC-----eEE
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP-----HLS 732 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~-----~l~ 732 (931)
+|+++++||+|+||+||+|++ +++.||||++...........++.+|+.+++.++|+||+++++++.... +.|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999986 5788999998654333344567889999999999999999999998766 899
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+. ++|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999994 688887754 346899999999999999999999999 9999999999999999999999999997643
Q ss_pred ccc-cccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--------------
Q 002355 813 NTF-ISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ-------------- 876 (931)
Q Consensus 813 ~~~-~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~-------------- 876 (931)
... .......+++.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 221 112334678999999998874 4688999999999999999999999887655443332110
Q ss_pred ---------ccc-------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002355 877 ---------NRR-------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 877 ---------~~r-------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
... ..+....++++.+||.+||..||.+|||+.+++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 000 012345678999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=345.01 Aligned_cols=238 Identities=28% Similarity=0.445 Sum_probs=201.6
Q ss_pred EEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHH-HHHhcCCCCeeeEEeeeeeCCeEEEEEeecCC
Q 002355 665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVA-IMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPR 740 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIk-ILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~G 740 (931)
+.||+|+||+||+|++ +++.||+|++....... .....+..|.. +++.++||||+++++++..++.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999987 57889999997653322 23345566665 46778999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCC
Q 002355 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820 (931)
Q Consensus 741 gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~ 820 (931)
++|..++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT 155 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence 999988865 345899999999999999999999999 999999999999999999999999998754333223345
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhccc
Q 002355 821 VAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD 900 (931)
Q Consensus 821 ~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~ 900 (931)
.+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.. ....++...+..+.++|.+||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ll~~ll~~ 233 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH--KPLVLRPGASLTAWSILEELLEK 233 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--CCccCCCCCCHHHHHHHHHHhcc
Confidence 6799999999999999899999999999999999999999998877776665543 23445567899999999999999
Q ss_pred CCCCCCCHH
Q 002355 901 DPAQRPSFA 909 (931)
Q Consensus 901 DPeeRPSa~ 909 (931)
+|.+||++.
T Consensus 234 ~p~~R~~~~ 242 (325)
T cd05604 234 DRQRRLGAK 242 (325)
T ss_pred CHHhcCCCC
Confidence 999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=357.92 Aligned_cols=248 Identities=22% Similarity=0.325 Sum_probs=198.6
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC------
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------ 728 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~------ 728 (931)
...+|+++++||+|+||+||+|.+ +++.||||++.... ....+|+.+|+.++|+||++++++|...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 346899999999999999999986 57789999886532 2234799999999999999999887432
Q ss_pred --CeEEEEEeecCCCCHHHHhhcC-CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC-cEEEEe
Q 002355 729 --PHLSIVTEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-TVKVCD 804 (931)
Q Consensus 729 --~~l~LVmEy~~GgSL~d~L~r~-~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg-~IKL~D 804 (931)
..+++||||++ ++|.+++... .....+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|
T Consensus 138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeec
Confidence 25779999995 5777766431 23456899999999999999999999999 99999999999998665 799999
Q ss_pred cCccccccccccccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-----
Q 002355 805 FGLSRFKANTFISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR----- 878 (931)
Q Consensus 805 FGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~----- 878 (931)
||+|+...... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+....+.+..+.....
T Consensus 215 FGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 215 FGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99998654322 22345789999999998764 689999999999999999999999988765444333321100
Q ss_pred ----------------------ccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 ----------------------RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 ----------------------r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
...+|...++++.+||.+||.+||.+|||+.|+++|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 011345678899999999999999999999999977
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=321.58 Aligned_cols=251 Identities=26% Similarity=0.489 Sum_probs=217.5
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
+|++.++||+|+||.||+++. .++.||+|.+............+.+|+.+++.++|+||+++++++...++.++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 589999999999999999976 577899999987654455557889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccc
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~ 817 (931)
+.+++|.+++.... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 99999999986522 335789999999999999999999999 999999999999999999999999999765443322
Q ss_pred cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHh
Q 002355 818 SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESC 897 (931)
Q Consensus 818 ~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rc 897 (931)
.....|+..|+|||++.+...+.++|+|||||++|+|++|..||......+....+.. ......+...+..+.++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR-GSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc-CCCCCCcccCCHHHHHHHHHH
Confidence 3345688899999999988889999999999999999999999988777666655543 334456678899999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 002355 898 WADDPAQRPSFANIVES 914 (931)
Q Consensus 898 L~~DPeeRPSa~ELLq~ 914 (931)
|..+|.+||++.+++++
T Consensus 237 l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 237 FKRNPRDRPSVNSILEK 253 (256)
T ss_pred hhCChhhCcCHHHHhhC
Confidence 99999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=342.48 Aligned_cols=244 Identities=23% Similarity=0.386 Sum_probs=203.9
Q ss_pred EEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEEEEEeecCC
Q 002355 665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPR 740 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~LVmEy~~G 740 (931)
+.||+|+||+||+|++ +++.||+|++....... .....+.+|+.++.++ +||||+.+++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999986 46789999998764332 3456788999999888 699999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCC
Q 002355 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820 (931)
Q Consensus 741 gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~ 820 (931)
++|..++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++............
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST 155 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence 9999888652 35899999999999999999999999 999999999999999999999999998753332223345
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhcccccCCCCCChHHHHHHH
Q 002355 821 VAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLG------PAQVVGAVAFQNRRLAIPQNTSPVLASLM 894 (931)
Q Consensus 821 ~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~------~~eii~~i~~~~~r~~lP~~~s~eL~dLI 894 (931)
.+||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+...... ...+..+|..++..+.++|
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~p~~~~~~~~~li 234 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI-LEKPIRIPRFLSVKASHVL 234 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH-HhCCCCCCCCCCHHHHHHH
Confidence 679999999999999999999999999999999999999996422 222222222 2344567888999999999
Q ss_pred HHhcccCCCCCCCH------HHHHHH
Q 002355 895 ESCWADDPAQRPSF------ANIVES 914 (931)
Q Consensus 895 ~rcL~~DPeeRPSa------~ELLq~ 914 (931)
.+||..||.+|+++ .++++|
T Consensus 235 ~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 235 KGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 99999999999985 566655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=343.25 Aligned_cols=252 Identities=20% Similarity=0.340 Sum_probs=209.7
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|+++++||+|+||+||++++ +++.||+|++...... ......+.+|+.++..++|+||+++++++...++.|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5799999999999999999987 4677999998764322 233456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||++|++|.+++.+. ...+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999999752 246889999999999999999999999 9999999999999999999999999987544322
Q ss_pred c-ccCCCCCCCcccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCC---CC
Q 002355 816 I-SSKSVAGTPEWMAPEFLRG-----EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQ---NT 886 (931)
Q Consensus 816 ~-~~~~~~GT~~Y~APEvL~~-----~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~---~~ 886 (931)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.....+..+|. .+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence 1 1233578999999999875 4567899999999999999999999998877777666654444444443 46
Q ss_pred hHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 002355 887 SPVLASLMESCWADDPAQ--RPSFANIVES 914 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPee--RPSa~ELLq~ 914 (931)
+.++++||.+||...+.+ |++++++++|
T Consensus 237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 237 SEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 899999999999865544 4689988877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=341.43 Aligned_cols=252 Identities=19% Similarity=0.354 Sum_probs=209.9
Q ss_pred CceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|+++++||+|+||+||++++. ++.||+|++.+.... ......+.+|+.++..++|+||+++++++...+++|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999874 567999998754322 233455788999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc-
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT- 814 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~- 814 (931)
||+.+|+|.+++.+. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999999999752 235899999999999999999999999 999999999999999999999999998754322
Q ss_pred ccccCCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC---CCC
Q 002355 815 FISSKSVAGTPEWMAPEFLR-----GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP---QNT 886 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~-----~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP---~~~ 886 (931)
.......+||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+.....+..+| ..+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence 11223457999999999986 3457889999999999999999999999888777777765544444444 357
Q ss_pred hHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 002355 887 SPVLASLMESCWADDPAQ--RPSFANIVES 914 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPee--RPSa~ELLq~ 914 (931)
++++++||++||..++.+ |+++.++++|
T Consensus 237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 899999999999765444 6899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.97 Aligned_cols=258 Identities=32% Similarity=0.533 Sum_probs=210.7
Q ss_pred cccCceEEEEEecccCceEEEEEEEcC----------------CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCee
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWHG----------------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~g----------------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV 719 (931)
+..++|++.++||+|+||.||+|++.+ ..||+|++.... .......+.+|++++++++|+||+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 456899999999999999999997532 248999987543 334456788999999999999999
Q ss_pred eEEeeeeeCCeEEEEEeecCCCCHHHHhhcCC---------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCC
Q 002355 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPA---------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSP 790 (931)
Q Consensus 720 ~Lid~f~~~~~l~LVmEy~~GgSL~d~L~r~~---------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPe 790 (931)
++++++...+..++||||+.+++|.+++.... ....+++..++.++.||+.||+|||++| ++|+||||+
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~ 158 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATR 158 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChh
Confidence 99999999999999999999999999986421 1123678889999999999999999999 999999999
Q ss_pred CeEECCCCcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCCh
Q 002355 791 NLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT--MQQPWNGLGP 866 (931)
Q Consensus 791 NILLd~dg~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT--G~~PF~~~~~ 866 (931)
||+++.++.+||+|||++....... .......++..|+|||++.+..++.++|||||||++|+|++ +..||.....
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 9999999999999999987543221 11122345678999999998889999999999999999988 6789988776
Q ss_pred HHHHHHHHh------cccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 867 AQVVGAVAF------QNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 867 ~eii~~i~~------~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
.+.+..+.. .......+...++.+.+||.+||..+|.+|||+.++++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 665544321 11112345567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=330.82 Aligned_cols=258 Identities=33% Similarity=0.533 Sum_probs=210.6
Q ss_pred cccCceEEEEEecccCceEEEEEEEc------------------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCC
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH------------------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~------------------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpN 717 (931)
+..++|++.++||+|+||.||++++. +..||+|++.... .......+.+|+++++.++|+|
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCC
Confidence 35578999999999999999998643 2358999987543 2334467889999999999999
Q ss_pred eeeEEeeeeeCCeEEEEEeecCCCCHHHHhhcCCC--------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCC
Q 002355 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAA--------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS 789 (931)
Q Consensus 718 IV~Lid~f~~~~~l~LVmEy~~GgSL~d~L~r~~~--------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKP 789 (931)
|+++++++..++..++||||+.+++|.+++..... ...+++..++.++.||+.||+|||++| ++|+||||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp 158 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLAT 158 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCh
Confidence 99999999999999999999999999999875321 134678889999999999999999999 99999999
Q ss_pred CCeEECCCCcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCC
Q 002355 790 PNLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT--MQQPWNGLG 865 (931)
Q Consensus 790 eNILLd~dg~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT--G~~PF~~~~ 865 (931)
+|||++.++.++|+|||++....... .......++..|++||.+.+..++.++|||||||++|||++ |..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS 238 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence 99999999999999999987543221 11122334678999999888889999999999999999998 789998877
Q ss_pred hHHHHHHHHh------cccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 866 PAQVVGAVAF------QNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 866 ~~eii~~i~~------~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
..+.+..... .....+.+..+++.+.+||.+||..+|.+||++.++++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 239 DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 6665543311 11122345667899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=321.20 Aligned_cols=246 Identities=33% Similarity=0.568 Sum_probs=206.2
Q ss_pred EEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCCC
Q 002355 665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGS 742 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~GgS 742 (931)
++||+|+||+||+|++ +++.||+|++.... .......+.+|+++++.++||||+++++++......++||||+.+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 3699999999999976 67889999876432 33445678899999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccccc--CC
Q 002355 743 LYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS--KS 820 (931)
Q Consensus 743 L~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~--~~ 820 (931)
|.+++.+. ...+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++.......... ..
T Consensus 80 L~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 80 FLTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 99998652 345889999999999999999999999 9999999999999999999999999987543221110 11
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcc
Q 002355 821 VAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWA 899 (931)
Q Consensus 821 ~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~ 899 (931)
..++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+. ...+...+...+..+.+||.+||.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 234 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWE 234 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCcccCCHHHHHHHHHHcC
Confidence 123457999999998889999999999999999997 899998777655544443 334456677889999999999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 002355 900 DDPAQRPSFANIVESLK 916 (931)
Q Consensus 900 ~DPeeRPSa~ELLq~L~ 916 (931)
.+|++|||+.++++.|+
T Consensus 235 ~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 235 YDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CChhhCcCHHHHHHHHh
Confidence 99999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=350.44 Aligned_cols=245 Identities=22% Similarity=0.295 Sum_probs=198.5
Q ss_pred cccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
+..++|+++++||+|+||.||+|++ +++.||+|+... ..+.+|+++|++|+||||++++++|..+...++
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 4557899999999999999999987 577899997532 346789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
|||++ +++|..++.. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+....
T Consensus 161 v~e~~-~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 161 ILPRY-KTDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred EEecC-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 99999 5788888865 235889999999999999999999999 99999999999999999999999999975332
Q ss_pred c-ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHhc---------
Q 002355 814 T-FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLG-------PAQVVGAVAFQ--------- 876 (931)
Q Consensus 814 ~-~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~-------~~eii~~i~~~--------- 876 (931)
. ........||+.|+|||++.+..++.++|||||||++|||++|..||.... ....+..+...
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 1 112235679999999999999899999999999999999999998774321 01111111000
Q ss_pred ---------------c--cc--cCCC-----CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 877 ---------------N--RR--LAIP-----QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 877 ---------------~--~r--~~lP-----~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
. .. ...+ ...+.++.+||.+||++||.+|||+.|++++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 00 0000 1346689999999999999999999999986
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=351.70 Aligned_cols=264 Identities=32% Similarity=0.518 Sum_probs=220.9
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEcC-------CceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEee
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGA 724 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~g-------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~ 724 (931)
.|++..++|.+.++||+|+||.||+|++.+ +.||||++..... ......+.+|+++|..+. ||||++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 367788999999999999999999998643 4699999976432 233457889999999997 9999999999
Q ss_pred eeeCCeEEEEEeecCCCCHHHHhhcCCC----------------------------------------------------
Q 002355 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAA---------------------------------------------------- 752 (931)
Q Consensus 725 f~~~~~l~LVmEy~~GgSL~d~L~r~~~---------------------------------------------------- 752 (931)
+...++.++||||+.+|+|.+++++...
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 9999999999999999999999965321
Q ss_pred -------------------------------------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCC
Q 002355 753 -------------------------------------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS 789 (931)
Q Consensus 753 -------------------------------------------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKP 789 (931)
...+++..++.++.||+.||+|||+.+ |+||||||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp 267 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAA 267 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCc
Confidence 123567778899999999999999998 99999999
Q ss_pred CCeEECCCCcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 002355 790 PNLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGP 866 (931)
Q Consensus 790 eNILLd~dg~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~ 866 (931)
+|||++.++.+||+|||+++...... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 99999999999999999997543211 11223456789999999998889999999999999999998 8999987665
Q ss_pred HHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 002355 867 AQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLL 919 (931)
Q Consensus 867 ~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Ll 919 (931)
.+..........+...|..++.++.+||.+||..+|.+||++.+|++.|+.++
T Consensus 348 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 55544443344455567788999999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=352.30 Aligned_cols=252 Identities=27% Similarity=0.442 Sum_probs=224.1
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchH-HHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCeEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD-QLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~-~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~l~L 733 (931)
.+.|++.+.||+|.||+||+|+. +|+.+|+|++.+...... ....+.+|++||+++. |||||.++++|.....+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 36899999999999999999976 578899999988765432 3467889999999998 9999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC----CCcEEEEecCccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK----NWTVKVCDFGLSR 809 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~----dg~IKL~DFGlAr 809 (931)
|||++.||.|++.+.+. .+++..+..++.||+.++.|||+.| |+||||||+|+|+.. ++.+|++|||++.
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999764 2999999999999999999999999 999999999999954 3579999999999
Q ss_pred cccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc--CCCCCCh
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL--AIPQNTS 887 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~--~lP~~~s 887 (931)
.... .......+||+.|+|||++....++..+||||+|+++|.|++|.+||.+.........+....... +....++
T Consensus 188 ~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is 266 (382)
T KOG0032|consen 188 FIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDIS 266 (382)
T ss_pred EccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccC
Confidence 8766 345577899999999999999999999999999999999999999999999888887776554433 3446779
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 888 PVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 888 ~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
..+++||++||..||..|+|+.++|+|-|
T Consensus 267 ~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 267 ESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred HHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 99999999999999999999999999844
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=318.57 Aligned_cols=252 Identities=28% Similarity=0.496 Sum_probs=215.9
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeee--eCCeEEEEE
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT--KRPHLSIVT 735 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~--~~~~l~LVm 735 (931)
+|++++.||.|+||.||+|.+ +++.||+|++..........+.+.+|+++++.++|+||+++++++. .+...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588999999999999999976 5678999999876666666678899999999999999999999875 456789999
Q ss_pred eecCCCCHHHHhhcC-CCCCCCcHHHHHHHHHHHHHHHHHHH-----hCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 736 EYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLH-----NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~-~~~~~L~e~~~~~Ia~QIa~AL~yLH-----s~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
||+++++|.+++.+. .....+++..++.++.||+.||+||| +.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEecccccc
Confidence 999999999998652 22456899999999999999999999 777 9999999999999999999999999998
Q ss_pred cccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHH
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPV 889 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~e 889 (931)
.............++..|+|||.+.+..++.++|+||||+++|+|++|..||......+....+. ......++...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 237 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIPYRYSSE 237 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh-cCCCCCCccccCHH
Confidence 76544322344578999999999998888999999999999999999999998877555554443 33344567788999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 890 LASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 890 L~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+.+++.+||..+|.+||++.+++++
T Consensus 238 ~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 238 LNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHHccCCcccCCCHHHHhhC
Confidence 9999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.61 Aligned_cols=257 Identities=32% Similarity=0.520 Sum_probs=214.6
Q ss_pred cccCceEEEEEecccCceEEEEEEEc-------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~-------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~ 728 (931)
+..++|+++++||+|+||.||+|++. +..||+|++.... .......+.+|+.+++.+.||||+++++++..+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 35689999999999999999999863 4679999987543 233446788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhhcCC-------------------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCC
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPA-------------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS 789 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~-------------------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKP 789 (931)
.+.++||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ++||||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p 158 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLAT 158 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccH
Confidence 99999999999999999986421 1234778889999999999999999999 99999999
Q ss_pred CCeEECCCCcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 002355 790 PNLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGP 866 (931)
Q Consensus 790 eNILLd~dg~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~ 866 (931)
+||+++.++.++|+|||++....... ........+..|+|||.+.+..++.++|||||||++|+|++ |..||.+...
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999987533221 11122334667999999998889999999999999999997 8889988877
Q ss_pred HHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 867 AQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 867 ~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
.+....+.. ......+...+.++.+||.+||+.+|.+|||+.|+++.|+
T Consensus 239 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 239 EEVIYYVRD-GNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 776655542 3333456778899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=348.52 Aligned_cols=252 Identities=25% Similarity=0.450 Sum_probs=226.9
Q ss_pred cccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
+..++|..++.||+|.||.|-+++. +++.+|+|++++..+.. +.+.+-+.|-++|+..+||.+..|-..|+..+++|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 4568899999999999999999976 68899999999887654 56677889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||..||.|+-++.+ ...+++..++.+..+|+.||.|||+++ ||+||||.+|+|+|++|+|||+|||+++...
T Consensus 245 FVMeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999999998876 346889999999999999999999999 9999999999999999999999999998766
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHH
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
.......++||||.|+|||++....|+.++|||.+|++||||++|+.||...+...++..+. .....+|..++++++.
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl--~ed~kFPr~ls~eAkt 397 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL--MEDLKFPRTLSPEAKT 397 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH--hhhccCCccCCHHHHH
Confidence 55556789999999999999999999999999999999999999999999988877777665 4455689999999999
Q ss_pred HHHHhcccCCCCCC-----CHHHHHHH
Q 002355 893 LMESCWADDPAQRP-----SFANIVES 914 (931)
Q Consensus 893 LI~rcL~~DPeeRP-----Sa~ELLq~ 914 (931)
|+..+|.+||.+|. .+.|+.++
T Consensus 398 LLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 398 LLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred HHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 99999999999994 46666655
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=322.47 Aligned_cols=260 Identities=30% Similarity=0.550 Sum_probs=216.9
Q ss_pred ccccCceEEEEEecccCceEEEEEEEcC-----CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~~g-----~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
++..++|.+.++||+|+||.||+|.+.+ ..||||...... .....+.+.+|+.+++.+.|+||+++++++.. .
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 3566889999999999999999997632 358888876543 23445678899999999999999999998875 4
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
..++||||+++++|.+++.+. ...+++..++.++.||+.||+|||++| ++|+||||+||+++.++.++|+|||+++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~ 155 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSR 155 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceee
Confidence 578999999999999999753 235899999999999999999999999 9999999999999999999999999987
Q ss_pred ccccccc-ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCCh
Q 002355 810 FKANTFI-SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTS 887 (931)
Q Consensus 810 ~~~~~~~-~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s 887 (931)
....... ......++..|+|||.+....++.++|||||||++|+|++ |..||......+....+. ...+...+..++
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (270)
T cd05056 156 YLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP 234 (270)
T ss_pred ecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCC
Confidence 5433211 1122334568999999988889999999999999999986 999998887666655543 334456678889
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 888 PVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 888 ~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
..+.+||.+||..+|.+|||+.++++.|..+...
T Consensus 235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 235 PTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=321.42 Aligned_cols=258 Identities=33% Similarity=0.556 Sum_probs=216.1
Q ss_pred cccCceEEEEEecccCceEEEEEEEc--CC---ceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH--GS---DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH 730 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~--g~---~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~ 730 (931)
|..++|+..+.||+|+||.||+|+.. +. .+|+|.+.... .......+.+|+++++.++|+||+++++++...+.
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 45578999999999999999999763 33 58899886543 23345678899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+.| ++|+||||+||+++.++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 81 AMIITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCcccee
Confidence 99999999999999998652 246889999999999999999999999 99999999999999999999999999875
Q ss_pred cccccccc---CCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCC
Q 002355 811 KANTFISS---KSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNT 886 (931)
Q Consensus 811 ~~~~~~~~---~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~ 886 (931)
........ .....+..|+|||++.+..++.++|||||||++|||++ |..||......+....+.. ..+.+.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~ 235 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-GFRLPAPMDC 235 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-CCCCCCCCCC
Confidence 43321111 11223457999999988888999999999999999997 9999988777666666543 3344455677
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 002355 887 SPVLASLMESCWADDPAQRPSFANIVESLKKLL 919 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Ll 919 (931)
+..+.+|+.+||+.+|.+||++.++++.|.+++
T Consensus 236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 236 PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=327.33 Aligned_cols=256 Identities=32% Similarity=0.547 Sum_probs=214.5
Q ss_pred cccCceEEEEEecccCceEEEEEEE-------cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW-------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~-------~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~ 728 (931)
+.+.+|++.++||+|+||.||+++. .+..+|+|.+.... ......+.+|+++++.++|+||+++++++..+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 3568899999999999999999964 24468888876443 34456789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCC------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAA------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK 796 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~------------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~ 796 (931)
...++||||+++++|.+++..... ...+++..++.++.||+.||+|||++| ++||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~ 157 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQ 157 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcC
Confidence 999999999999999999875321 134788999999999999999999999 999999999999999
Q ss_pred CCcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 002355 797 NWTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAV 873 (931)
Q Consensus 797 dg~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i 873 (931)
++.+||+|||++....... .......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+....+
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 9999999999987443211 11123345678999999999889999999999999999998 89999887766665555
Q ss_pred HhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 874 AFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 874 ~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
. .......+..+++.+.+||.+||+.+|.+||++.++++.|+
T Consensus 238 ~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 T-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H-cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 3 33445566788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=328.62 Aligned_cols=252 Identities=27% Similarity=0.511 Sum_probs=210.4
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
..+.|+++++||.|+||.||+|++ .+..|++|++.... ......+.+|+.+++.++|+||+++++.+..++.+|+|
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 347899999999999999999987 46789999987543 34456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||+++++|..++.+. ...+++..++.++.||+.+|.|||++| ++||||||+||+++.++.++|+|||++......
T Consensus 88 ~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 88 IEFCPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred EecCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 9999999998887642 235899999999999999999999999 999999999999999999999999998754433
Q ss_pred ccccCCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-ccCCCCCChH
Q 002355 815 FISSKSVAGTPEWMAPEFLR-----GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-RLAIPQNTSP 888 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~-----~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~-r~~lP~~~s~ 888 (931)
........++..|+|||++. ...++.++|||||||++|+|++|..||...+.......+..... ....+..++.
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSM 243 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCH
Confidence 22334456889999999985 34467899999999999999999999988766554444422211 2233566788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 889 VLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+.+||.+||..+|++||++.+++++
T Consensus 244 ~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 244 EFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 99999999999999999999999876
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.49 Aligned_cols=251 Identities=27% Similarity=0.451 Sum_probs=207.8
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeee------C
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTK------R 728 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~------~ 728 (931)
.+.|++.++||.|+||.||+|++ .++.||+|++..... ....+.+|+.+++.+ +|+||++++++|.. .
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 36789999999999999999977 567899999875432 234678899999998 69999999999864 3
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
.++|+||||+.+++|.+++... ....+++..+..++.||+.||+|||+++ |+|+||||+||+++.++.++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4689999999999999998753 2346889999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC
Q 002355 809 RFKANTFISSKSVAGTPEWMAPEFLR-----GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP 883 (931)
Q Consensus 809 r~~~~~~~~~~~~~GT~~Y~APEvL~-----~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP 883 (931)
..............|+..|+|||++. +..++.++|||||||++|+|++|..||.................+...+
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 238 (272)
T ss_pred eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCC
Confidence 76543333334567899999999986 3357789999999999999999999998766554444433333333344
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 884 QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 884 ~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
..++..+.+||.+||..+|.+|||+.+++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 5678899999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=326.11 Aligned_cols=262 Identities=27% Similarity=0.507 Sum_probs=215.2
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCC----ceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGS----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH 730 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~----~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~ 730 (931)
..++|++++.||.|+||+||+|++ +++ .+++|.+.... .......+..|+.+++++.||||+++++++. +..
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~ 82 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS 82 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence 347899999999999999999987 444 36677764322 2233466788888999999999999999875 456
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
.++++||+++++|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCcccee
Confidence 78999999999999999752 345899999999999999999999999 99999999999999999999999999975
Q ss_pred ccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCCh
Q 002355 811 KANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTS 887 (931)
Q Consensus 811 ~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s 887 (931)
..... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+ ........+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLAQPQICT 237 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCCCCCCCC
Confidence 43221 11223456778999999998889999999999999999998 99999887665544333 3444555666778
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhh
Q 002355 888 PVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQL 925 (931)
Q Consensus 888 ~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l 925 (931)
..+.+++.+||..+|.+|||+.|+++.|..+..++..+
T Consensus 238 ~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~~ 275 (279)
T cd05111 238 IDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRY 275 (279)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcce
Confidence 89999999999999999999999999999988877543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=324.63 Aligned_cols=251 Identities=26% Similarity=0.404 Sum_probs=205.3
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|++.++||+|+||.||+|++ +++.||+|++............+.+|+.+++.++|+||+++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4799999999999999999987 47889999987654332333567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|++++.|..++.. ...+++..++.++.||+.||+|||++| ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 9999888877654 235899999999999999999999999 99999999999999999999999999986544332
Q ss_pred ccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-----------------
Q 002355 817 SSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR----------------- 878 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~----------------- 878 (931)
......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+....+....+.....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 2334567889999999876 4578899999999999999999999987765443322211000
Q ss_pred ccCC------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 RLAI------------PQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 r~~l------------P~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.... ....+..+.+||.+||..+|++||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000 12457889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=344.96 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=210.4
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCC-eeeEEeeeeeCC------
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN-VVLFMGAVTKRP------ 729 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpN-IV~Lid~f~~~~------ 729 (931)
..|+.+++||+|+||+||+|+. +|+.||+|+++.....+..-....+|+.+|+.|+|+| |+.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 5678888999999999999976 6888999999887543333345689999999999999 999999998776
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCC-CCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAG-EMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~-~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
.+++||||+ .-+|..++...... ..++...++.+++||+.||+|||+++ |+||||||+||||+.+|.+||+|||+|
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeeeccchH
Confidence 899999999 67999999764321 35777899999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc-------
Q 002355 809 RFKANTFISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL------- 880 (931)
Q Consensus 809 r~~~~~~~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~------- 880 (931)
+...-+.......++|.+|+|||++.+. .|++.+||||+||+++||+++++.|.+..+.+.+..+-..-..+
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 9766444445667889999999999987 67899999999999999999999999987755544442211111
Q ss_pred ---------CC-----C-------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 ---------AI-----P-------QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 ---------~l-----P-------~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+ + +..++...+++.+||+++|.+|.|++.++.|
T Consensus 248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00 1 1223578999999999999999999999987
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=360.08 Aligned_cols=271 Identities=32% Similarity=0.567 Sum_probs=240.0
Q ss_pred ccccccccccCceEEEEEecccCceEEEEEEEcC-----Cc-eEEEEEeec-ccchHHHHHHHHHHHHHHhcCCCCeeeE
Q 002355 649 LAMDWLEISWDELHVKERVGAGSFGTVHRAEWHG-----SD-VAVKVLTVQ-DFLDDQLKEFLREVAIMKRVRHPNVVLF 721 (931)
Q Consensus 649 l~~~~lei~~drY~Ii~kLG~G~fGtVylAr~~g-----~~-VAVKVlk~~-~~~~~~~~~~l~EIkILk~L~HpNIV~L 721 (931)
+....|++..++..+.++||+|+||.||+|+..- .. ||+|..+.. .....++.++.+|.++|++++|||||++
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 3445688999999999999999999999997621 23 899998863 3566788999999999999999999999
Q ss_pred EeeeeeCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEE
Q 002355 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVK 801 (931)
Q Consensus 722 id~f~~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IK 801 (931)
|++......++||||+|.||+|.+++++.. ..++..+...++.+.+.||+|||+.+ +|||||-.+|+|++.++.+|
T Consensus 227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEEEcCCCccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEE
Confidence 999999999999999999999999998743 26899999999999999999999999 99999999999999999999
Q ss_pred EEecCccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccc
Q 002355 802 VCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRL 880 (931)
Q Consensus 802 L~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~ 880 (931)
|+|||+++.............-+..|+|||.+....+++++|||||||++||+++ |..||.+....++...+.....+.
T Consensus 303 ISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~ 382 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM 382 (474)
T ss_pred eCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC
Confidence 9999999865422211112235789999999999999999999999999999998 788999999999999988888999
Q ss_pred CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCch
Q 002355 881 AIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPA 923 (931)
Q Consensus 881 ~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~ 923 (931)
..|...+.++..++.+||..+|+.||++.++.+.|+.+.+...
T Consensus 383 ~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 383 PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 9999999999999999999999999999999999999887654
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=335.46 Aligned_cols=266 Identities=32% Similarity=0.550 Sum_probs=221.7
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEc---------CCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEE
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWH---------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFM 722 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~---------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Li 722 (931)
.|++...+|+++++||+|+||.||+|++. ...||+|++.... .......+.+|+++++++ +|+||++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 45677789999999999999999999752 1258999877542 334457789999999999 799999999
Q ss_pred eeeeeCCeEEEEEeecCCCCHHHHhhcCC-------------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCC
Q 002355 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPA-------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS 789 (931)
Q Consensus 723 d~f~~~~~l~LVmEy~~GgSL~d~L~r~~-------------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKP 789 (931)
+++..++.++++|||+++++|.+++.+.. ....+++..+..++.||+.||+|||++| |+||||||
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp 162 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAA 162 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eecccccc
Confidence 99999999999999999999999987532 1234778889999999999999999999 99999999
Q ss_pred CCeEECCCCcEEEEecCcccccccccc--ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 002355 790 PNLLVDKNWTVKVCDFGLSRFKANTFI--SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGP 866 (931)
Q Consensus 790 eNILLd~dg~IKL~DFGlAr~~~~~~~--~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~ 866 (931)
+|||++.++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999875443211 1122234567999999999889999999999999999998 8999988877
Q ss_pred HHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 867 AQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 867 ~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
.+....+. .......+...+.++.+||.+||..+|.+|||+.++++.|..++...
T Consensus 243 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 243 EELFKLLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 66665553 33444566778899999999999999999999999999999988543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=355.31 Aligned_cols=248 Identities=20% Similarity=0.298 Sum_probs=196.5
Q ss_pred ccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCC------CCeeeEEeeee
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH------PNVVLFMGAVT 726 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~H------pNIV~Lid~f~ 726 (931)
++..++|+++++||+|+||+||+|.+ .++.||||+++... .....+..|+.+++.++| .+|++++++|.
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34568999999999999999999976 56789999996532 222345667777777754 45889999887
Q ss_pred eC-CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCCEEEeccCCCCeEECCCC------
Q 002355 727 KR-PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNW------ 798 (931)
Q Consensus 727 ~~-~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs-~G~~IIHrDLKPeNILLd~dg------ 798 (931)
.. .++|+|||++ |++|.+++.+. ..+++..+..++.||+.||+|||+ .| ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccc
Confidence 54 6899999998 88899888652 358999999999999999999997 58 99999999999998765
Q ss_pred ----------cEEEEecCccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH
Q 002355 799 ----------TVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQ 868 (931)
Q Consensus 799 ----------~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~e 868 (931)
.+||+|||.+...... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~~---~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERHS---RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred cccccCCCCceEEECCCCccccCccc---cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 4999999988643322 245689999999999999999999999999999999999999998876544
Q ss_pred HHHHHHhccccc-------------------------C-C--------------CCCChHHHHHHHHHhcccCCCCCCCH
Q 002355 869 VVGAVAFQNRRL-------------------------A-I--------------PQNTSPVLASLMESCWADDPAQRPSF 908 (931)
Q Consensus 869 ii~~i~~~~~r~-------------------------~-l--------------P~~~s~eL~dLI~rcL~~DPeeRPSa 908 (931)
.+..+....... . . ....++.+.+||.+||.+||.+|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 433221110000 0 0 00124567899999999999999999
Q ss_pred HHHHHH
Q 002355 909 ANIVES 914 (931)
Q Consensus 909 ~ELLq~ 914 (931)
.|+++|
T Consensus 433 ~e~L~H 438 (467)
T PTZ00284 433 RQMTTH 438 (467)
T ss_pred HHHhcC
Confidence 999987
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.75 Aligned_cols=248 Identities=29% Similarity=0.506 Sum_probs=213.7
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|++.+.||.|+||.||+|++ +++.||+|++.... .......+.+|+++++.++|+||+++++++..+..+++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 4788999999999999999987 56789999987653 23345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+.+++|.+++... .+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 80 YCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 99999999998752 6899999999999999999999999 99999999999999999999999999987654433
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCC-ChHHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQN-TSPVLASLME 895 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~-~s~eL~dLI~ 895 (931)
......++..|+|||.+.+..++.++|||||||++|+|++|..||...........+.. ......+.. ++..+.++|.
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~ 232 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK-NNPPSLEGNKFSKPFKDFVS 232 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh-cCCCCCcccccCHHHHHHHH
Confidence 33455788899999999988899999999999999999999999987766555544432 223333434 7889999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 002355 896 SCWADDPAQRPSFANIVES 914 (931)
Q Consensus 896 rcL~~DPeeRPSa~ELLq~ 914 (931)
+||..+|++|||+.+++++
T Consensus 233 ~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 233 LCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHhhCChhhCcCHHHHhhC
Confidence 9999999999999999886
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=324.11 Aligned_cols=257 Identities=29% Similarity=0.512 Sum_probs=216.1
Q ss_pred ccCceEEEEEecccCceEEEEEEEc-------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~-------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
..++|++++.||+|+||+||+|+.. .+.|++|++..... ......+.+|++++++++|+||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4578999999999999999999863 34689998765432 234567899999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCC------CCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEE
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGE------MMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVC 803 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~------~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~ 803 (931)
..++||||+++++|.+++....... .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEEc
Confidence 9999999999999999997543221 5899999999999999999999999 9999999999999999999999
Q ss_pred ecCcccccccc-ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccC
Q 002355 804 DFGLSRFKANT-FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLA 881 (931)
Q Consensus 804 DFGlAr~~~~~-~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~ 881 (931)
|||++...... ........++..|+|||.+.+...+.++|||||||++|+|++ |..||....................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence 99998643221 112233355778999999988888999999999999999998 7899988777666666554444445
Q ss_pred CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 882 IPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 882 lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
.+..++..+.++|.+||..+|++|||+.++++.|+
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 56778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=329.06 Aligned_cols=241 Identities=24% Similarity=0.329 Sum_probs=196.6
Q ss_pred ecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCCCH
Q 002355 667 VGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL 743 (931)
Q Consensus 667 LG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~GgSL 743 (931)
||+|+||+||+++. +++.||+|++....... .....+..|++++++++||||+++++++..+.++|+||||+.|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999976 57889999987543322 2234456799999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCCCCC
Q 002355 744 YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAG 823 (931)
Q Consensus 744 ~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~~~G 823 (931)
.+++.... ...+++..+..++.||+.||+|||+.| |+||||||+||+++.++.++|+|||++....... ......|
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~ 156 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAG 156 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCC
Confidence 98886422 335888999999999999999999999 9999999999999999999999999987654332 2234568
Q ss_pred CCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHhcccccCCCCCChHHHHHHHHHhcc
Q 002355 824 TPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPA----QVVGAVAFQNRRLAIPQNTSPVLASLMESCWA 899 (931)
Q Consensus 824 T~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~----eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~ 899 (931)
+..|+|||++.+..++.++|||||||++|+|++|..||...... ++..... ..........+++++++||.+||+
T Consensus 157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~ 235 (277)
T cd05607 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL-EDEVKFEHQNFTEESKDICRLFLA 235 (277)
T ss_pred CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh-ccccccccccCCHHHHHHHHHHhc
Confidence 99999999999888999999999999999999999999765432 2222211 111111224678999999999999
Q ss_pred cCCCCCCCHHHHH
Q 002355 900 DDPAQRPSFANIV 912 (931)
Q Consensus 900 ~DPeeRPSa~ELL 912 (931)
.||++||++.|++
T Consensus 236 ~~P~~R~~~~~~~ 248 (277)
T cd05607 236 KKPEDRLGSREKN 248 (277)
T ss_pred cCHhhCCCCccch
Confidence 9999999996655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=320.50 Aligned_cols=256 Identities=30% Similarity=0.573 Sum_probs=215.2
Q ss_pred cccccCceEEEEEecccCceEEEEEEEc-CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~-g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
|++..++|++.++||+|+||.||++.+. +..+|+|++.... .....+.+|+++++.++|+||+++++.+.. ...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 4677899999999999999999999864 4569999876532 234578899999999999999999999887 7789
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
++|||+++++|.+++.+.. ...+++..++.++.||+.||.|||+.| ++|+||||+||+++.++.+||+|||.+....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EEEEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 9999999999999997632 445788899999999999999999999 9999999999999999999999999987543
Q ss_pred ccc-cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHH
Q 002355 813 NTF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 813 ~~~-~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL 890 (931)
... .......++..|+|||++....++.++|+|||||++|+|++ |+.||...........+. .......+...+.++
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEEL 232 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCcccCCHHH
Confidence 321 11122345677999999998888999999999999999998 999998877665555443 333445567788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
.+++.+||..+|++||++.++++.|+.
T Consensus 233 ~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 233 YNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=329.93 Aligned_cols=252 Identities=21% Similarity=0.323 Sum_probs=205.1
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
..++|+++++||.|+||.||+|++ +++.||+|.+....... ....+.+|+.+++.++|+||+++++++...+..++|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC-chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 347899999999999999999977 46789999987553222 224567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||+. ++|.+++.+. ...+++..++.++.||+.||+|||+.| |+|+||||+||+++.++.++|+|||++......
T Consensus 83 ~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 83 FEYLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred Eeccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 99995 6898888652 335889999999999999999999999 999999999999999999999999998764433
Q ss_pred ccccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc----------------
Q 002355 815 FISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN---------------- 877 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~---------------- 877 (931)
........+++.|+|||++.+. .++.++|||||||++|+|++|++||...+..+....+....
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 2222344578899999998764 47889999999999999999999998776544332221100
Q ss_pred -cccC-----------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 878 -RRLA-----------IPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 878 -~r~~-----------lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.... ....+++.+++||.+||+.||.+|||+.|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 113568889999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=325.79 Aligned_cols=246 Identities=30% Similarity=0.465 Sum_probs=204.1
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|+++++||+|+||.||+|++ +++.||+|++.... .......+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 3688999999999999999986 57789999987643 23344678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+++++|..+. .+++..+..++.||+.||.|||+.| |+|+||||+|||++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 80 FMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred cCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 99999996542 3678889999999999999999999 999999999999999999999999998765433
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHhcccccCCCCCChHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPA-------QVVGAVAFQNRRLAIPQNTSPV 889 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~-------eii~~i~~~~~r~~lP~~~s~e 889 (931)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||...... .....+.............+++
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEK 228 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHH
Confidence 223457899999999999988999999999999999999999999653321 1222221111122223457889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 890 LASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 890 L~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
+.+||.+||..+|++||++.+++++-.
T Consensus 229 ~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 229 FVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred HHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 999999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=343.08 Aligned_cols=241 Identities=24% Similarity=0.411 Sum_probs=201.3
Q ss_pred ecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhc---CCCCeeeEEeeeeeCCeEEEEEeecCC
Q 002355 667 VGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRV---RHPNVVLFMGAVTKRPHLSIVTEYLPR 740 (931)
Q Consensus 667 LG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L---~HpNIV~Lid~f~~~~~l~LVmEy~~G 740 (931)
||+|+||+||+|++ +++.||||++....... ........|..++..+ .||||+.+++.|....++|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999987 47889999997654322 2344556677777766 699999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCC
Q 002355 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820 (931)
Q Consensus 741 gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~ 820 (931)
++|..++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.++|+|||++............
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~ 155 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT 155 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence 999998875 345899999999999999999999999 999999999999999999999999998754333223345
Q ss_pred CCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC-CCChHHHHHHHHHhc
Q 002355 821 VAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP-QNTSPVLASLMESCW 898 (931)
Q Consensus 821 ~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP-~~~s~eL~dLI~rcL 898 (931)
.+||..|+|||++.+. .++.++|||||||++|+|++|..||......+....+..... .++ ..+++++.+||.+||
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~~L 233 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV--RFPKNVLSDEGRQFVKGLL 233 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHc
Confidence 6799999999998764 478999999999999999999999998877777666543332 233 357899999999999
Q ss_pred ccCCCCCC----CHHHHHHH
Q 002355 899 ADDPAQRP----SFANIVES 914 (931)
Q Consensus 899 ~~DPeeRP----Sa~ELLq~ 914 (931)
..+|.+|| ++.++++|
T Consensus 234 ~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 234 NRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CCCHHHCCCCCCCHHHHhcC
Confidence 99999998 67888775
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=321.09 Aligned_cols=255 Identities=33% Similarity=0.605 Sum_probs=214.2
Q ss_pred cCceEEEEEecccCceEEEEEEEc--C---CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEWH--G---SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~~--g---~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
..+|++.+.||+|+||.||+|++. + ..||||++.... .......+..|+.+++.++||||+++++++..+...+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 367999999999999999999763 2 259999986542 3445578899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+.+++|.+++... ...+++..++.++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++....
T Consensus 82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 82 IITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCccccccc
Confidence 999999999999998753 345889999999999999999999999 9999999999999999999999999987543
Q ss_pred ccccc---cCCCC--CCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCC
Q 002355 813 NTFIS---SKSVA--GTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNT 886 (931)
Q Consensus 813 ~~~~~---~~~~~--GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~ 886 (931)
..... ..... .+..|+|||.+.+..++.++|||||||++|||++ |..||...........+. ...+.+.+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~ 236 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDC 236 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccC
Confidence 32111 01111 2357999999998889999999999999999886 999998877766665553 33444556678
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 002355 887 SPVLASLMESCWADDPAQRPSFANIVESLKKL 918 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~L 918 (931)
+..+.+++.+||..+|.+||++.+++..|+.+
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 237 PTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 89999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=340.96 Aligned_cols=246 Identities=22% Similarity=0.333 Sum_probs=201.9
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC------Ce
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------PH 730 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~------~~ 730 (931)
++|++++.||.|+||+||+|.+ +++.||||++............+.+|+++|+.++|+||++++++|... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 7899999999999999999976 567899999876543334456678999999999999999999988533 45
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
.|++++++ +++|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 95 ~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 95 VYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred EEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEEEcCCcccee
Confidence 79999998 8899888753 35899999999999999999999999 99999999999999999999999999986
Q ss_pred ccccccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-----------
Q 002355 811 KANTFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR----------- 878 (931)
Q Consensus 811 ~~~~~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~----------- 878 (931)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 168 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 168 ADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred cCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 5443 234578999999999877 5678999999999999999999999987654433322211000
Q ss_pred ----------ccC--------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 ----------RLA--------IPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 ----------r~~--------lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
... .....++.+.+||.+||..||.+|||+.|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 112456778999999999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=329.94 Aligned_cols=253 Identities=25% Similarity=0.439 Sum_probs=214.2
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|++.++||+|+||+||+|.+ .++.||+|.+....... .....+.+|+++++.++|+||+++++.+..+...|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 4799999999999999999987 46889999998765443 35567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+.|++|.+++.+. ....+++..++.++.||+.||+|||+.| ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998752 3456899999999999999999999999 9999999999999999999999999986432211
Q ss_pred -----------------------------cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 002355 816 -----------------------------ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGP 866 (931)
Q Consensus 816 -----------------------------~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~ 866 (931)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 011234678899999999998899999999999999999999999988877
Q ss_pred HHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 002355 867 AQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPS----FANIVES 914 (931)
Q Consensus 867 ~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPS----a~ELLq~ 914 (931)
......+.............+..+.+||.+||..+|++||+ +++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 66665554333333233347899999999999999999999 8888876
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=327.16 Aligned_cols=251 Identities=23% Similarity=0.289 Sum_probs=209.8
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchH-HHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD-QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~-~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
.|++.++||.|+||+||+|++ +++.||+|++........ ....+.+|+++++.++|+||+.+++.+..++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 377889999999999999987 477899999876543332 23457889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+.+++|.+++.... ...+++..+..++.|++.||.|||+.| |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 81 IMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred eccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 999999998886522 335899999999999999999999999 9999999999999999999999999987543221
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--cccccCCCCCChHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAF--QNRRLAIPQNTSPVLASLM 894 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~--~~~r~~lP~~~s~eL~dLI 894 (931)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+.. .......+...+..+.+||
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 12345789999999999988899999999999999999999999988765443333221 1223345667889999999
Q ss_pred HHhcccCCCCCCC-----HHHHHHH
Q 002355 895 ESCWADDPAQRPS-----FANIVES 914 (931)
Q Consensus 895 ~rcL~~DPeeRPS-----a~ELLq~ 914 (931)
.+||..+|++||+ +.+++.+
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcC
Confidence 9999999999999 7788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.57 Aligned_cols=250 Identities=26% Similarity=0.463 Sum_probs=207.1
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|++.++||.|+||.||+|++ +++.||+|+++.... .....+.+|+.+++.++||||+++++.+..++.+++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 36889999999999999999987 577899999876532 23356788999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+++++|.+++.. ...+++..++.++.||+.||.|||++| ++|+||||+||+++.++.++|+|||++.......
T Consensus 86 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 86 EFCGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred eccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 99999999999865 235899999999999999999999999 9999999999999999999999999987654433
Q ss_pred cccCCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccC-C--CCCChHH
Q 002355 816 ISSKSVAGTPEWMAPEFLR---GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLA-I--PQNTSPV 889 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~---~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~-l--P~~~s~e 889 (931)
.......|+..|+|||++. ...++.++|+|||||++|+|++|..||....+............... . ...++..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence 3334557899999999874 44578899999999999999999999976654443332221111111 1 1246788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 890 LASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 890 L~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+.+||.+||..+|++||++++++++
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcC
Confidence 9999999999999999999998875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=317.48 Aligned_cols=250 Identities=32% Similarity=0.601 Sum_probs=211.9
Q ss_pred cCceEEEEEecccCceEEEEEEEc-CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 658 WDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~~-g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
..+|++.++||.|+||.||+|.+. +..+|+|++....... ..+.+|++++++++||||+++++++......++|||
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 468999999999999999999874 7789999887554332 357889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+.+++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 80 FMEHGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred cCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 99999999998652 235789999999999999999999999 99999999999999999999999999875433211
Q ss_pred c-cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHH
Q 002355 817 S-SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894 (931)
Q Consensus 817 ~-~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI 894 (931)
. .....++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.. ......+...+..+.+|+
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~ 234 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA-GFRLYKPRLASQSVYELM 234 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-CCCCCCCCCCCHHHHHHH
Confidence 1 122334678999999998889999999999999999998 9999988776666665532 233345666789999999
Q ss_pred HHhcccCCCCCCCHHHHHHHH
Q 002355 895 ESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 895 ~rcL~~DPeeRPSa~ELLq~L 915 (931)
.+||+.+|++||++.++++.|
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 235 QHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHcccChhhCCCHHHHHHhh
Confidence 999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=324.28 Aligned_cols=262 Identities=27% Similarity=0.416 Sum_probs=211.5
Q ss_pred ccccccccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeee
Q 002355 649 LAMDWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAV 725 (931)
Q Consensus 649 l~~~~lei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f 725 (931)
...+++....++|++++.||+|+||.||+|++ .++.+|+|++..... ....+.+|+.+++.+ +|+||+++++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 34456666789999999999999999999976 567899998765322 124577899999999 699999999987
Q ss_pred e-----eCCeEEEEEeecCCCCHHHHhhcC-CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc
Q 002355 726 T-----KRPHLSIVTEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT 799 (931)
Q Consensus 726 ~-----~~~~l~LVmEy~~GgSL~d~L~r~-~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~ 799 (931)
. .++..++||||++|++|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGG 162 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCC
Confidence 3 456799999999999999987532 22346889999999999999999999999 999999999999999999
Q ss_pred EEEEecCccccccccccccCCCCCCCcccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 002355 800 VKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRG-----EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVA 874 (931)
Q Consensus 800 IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~-----~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~ 874 (931)
++|+|||++..............|+..|+|||++.. ..++.++|||||||++|+|++|..||.............
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 242 (286)
T cd06638 163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP 242 (286)
T ss_pred EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc
Confidence 999999998765433323345578999999998753 346889999999999999999999998776544433322
Q ss_pred hcc-cccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002355 875 FQN-RRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 875 ~~~-~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
... .....+...+..+.+||.+||..+|++|||+.++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 243 RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 111 12223455678899999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=326.89 Aligned_cols=246 Identities=26% Similarity=0.490 Sum_probs=215.0
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|++.+.||.|+||.||++++ .++.||+|++....... .....+.+|+++++++.||||+++++++..++.+++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4799999999999999999987 56889999987654332 34567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+++++|.+++.+. ..+++..+..++.||+.||.|||+.| |+|+||+|.||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999999763 46899999999999999999999999 999999999999999999999999998865443
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~ 895 (931)
.....+++.|+|||.+.+...+.++||||||+++|+|++|..||...........+. .....++...+..+.++|.
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~ 230 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIR 230 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHH
Confidence 244568999999999988888999999999999999999999998877655555443 3345677788999999999
Q ss_pred HhcccCCCCCC-----CHHHHHHH
Q 002355 896 SCWADDPAQRP-----SFANIVES 914 (931)
Q Consensus 896 rcL~~DPeeRP-----Sa~ELLq~ 914 (931)
+||..+|.+|+ ++++++++
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 231 NLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HHccCCHHHccCcccCCHHHHHcC
Confidence 99999999998 88888866
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=319.73 Aligned_cols=248 Identities=33% Similarity=0.614 Sum_probs=211.7
Q ss_pred ccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
..++|++.+.||+|+||.||+++..++.||+|++.... ....+.+|+.+++.++||||+++++++..+ ..++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 44789999999999999999999999999999986542 235678999999999999999999998754 4799999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+.+++|.+++.... ...+++..++.++.|++.||.|||+.| ++||||||+||+++.++.++|+|||++.......
T Consensus 79 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 79 LMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 999999999997532 345889999999999999999999999 9999999999999999999999999987543321
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~ 895 (931)
.....+..|+|||.+.+..++.++|+|||||++|+|++ |+.||......+....+. ...+...+..++..+.+||.
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 231 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVLMT 231 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-CCCCCCCCCcCCHHHHHHHH
Confidence 22334678999999988889999999999999999997 999998887666555443 33444556778899999999
Q ss_pred HhcccCCCCCCCHHHHHHHHH
Q 002355 896 SCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 896 rcL~~DPeeRPSa~ELLq~L~ 916 (931)
+||+.+|.+||+++++++.|+
T Consensus 232 ~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 232 SCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HHcCCChhhCcCHHHHHHHHc
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=316.28 Aligned_cols=250 Identities=29% Similarity=0.510 Sum_probs=215.0
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
+|++.+.||+|+||.||+|.. +++.+|+|.+............+.+|+++++.++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 589999999999999999976 577899999987665556667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC-CcEEEEecCcccccccccc
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN-WTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d-g~IKL~DFGlAr~~~~~~~ 816 (931)
+++++|.+++.... +..+++..+..++.|++.+|+|||++| ++|+||||+||+++.+ +.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 99999999997532 345899999999999999999999999 9999999999999865 468999999998655432
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMES 896 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~r 896 (931)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+.. .....++...+..+.++|.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-GTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh-cCCCCCCCCcCHHHHHHHHH
Confidence 22335678899999999988889999999999999999999999988776655544432 33345667789999999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 002355 897 CWADDPAQRPSFANIVES 914 (931)
Q Consensus 897 cL~~DPeeRPSa~ELLq~ 914 (931)
||..+|.+|||+.+++++
T Consensus 236 ~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HccCChhhCCCHHHHhhC
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=330.30 Aligned_cols=250 Identities=25% Similarity=0.450 Sum_probs=211.3
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
.+|+++++||+|+||.||+|++ .++.||+|.+....... ...+.+|+.+++.+.|+||+++++.|..+.+.|+|||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch--HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 6899999999999999999976 57789999987655332 3568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+++++|.+++.. ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.++|+|||++........
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred ccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 9999999999864 24788899999999999999999999 99999999999999999999999999875433222
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-cccCCCCCChHHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN-RRLAIPQNTSPVLASLME 895 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~-~r~~lP~~~s~eL~dLI~ 895 (931)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||................ .....+..++..+.+||.
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence 2234568899999999998888999999999999999999999998766544333322111 122345667889999999
Q ss_pred HhcccCCCCCCCHHHHHHHHH
Q 002355 896 SCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 896 rcL~~DPeeRPSa~ELLq~L~ 916 (931)
+||..+|++||++.+++++-.
T Consensus 252 ~~l~~~p~~Rpt~~eil~~~~ 272 (296)
T cd06654 252 RCLDMDVEKRGSAKELLQHQF 272 (296)
T ss_pred HHCcCCcccCcCHHHHhhChh
Confidence 999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=319.24 Aligned_cols=246 Identities=30% Similarity=0.537 Sum_probs=207.3
Q ss_pred EEecccCceEEEEEEEc-----CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecC
Q 002355 665 ERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLP 739 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~~-----g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~ 739 (931)
++||+|+||.||+|++. +..+|+|.+...... .....+.+|+++++.+.|+||+++++++. ++..++||||+.
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 46999999999999763 256999998766543 34567889999999999999999999775 556899999999
Q ss_pred CCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccc--
Q 002355 740 RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS-- 817 (931)
Q Consensus 740 GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~-- 817 (931)
+++|.+++.+. ..+++..+..++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||+++........
T Consensus 79 ~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 79 LGPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999999763 26899999999999999999999999 999999999999999999999999998755332211
Q ss_pred -cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHH
Q 002355 818 -SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895 (931)
Q Consensus 818 -~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~ 895 (931)
.....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+. .......+..++..+.+||.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~ 232 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSIML 232 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHH
Confidence 111223467999999998889999999999999999998 999998887766655553 34455677788999999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHH
Q 002355 896 SCWADDPAQRPSFANIVESLKKL 918 (931)
Q Consensus 896 rcL~~DPeeRPSa~ELLq~L~~L 918 (931)
+||..+|.+||++.++++.|..+
T Consensus 233 ~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 233 SCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHhcCChhhCcCHHHHHHHHHhc
Confidence 99999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=326.98 Aligned_cols=253 Identities=27% Similarity=0.463 Sum_probs=211.5
Q ss_pred CceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|++++.||.|+||.||+|++. ++.||+|.+.... .......+.+|+.++++++|+||+++++.+...+.+++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 47899999999999999999874 7889999887542 33445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs-~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
|+++++|..++........+++..+..++.||+.||.|||+ .+ |+|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999998764334468999999999999999999996 58 999999999999999999999999998755333
Q ss_pred cccCCCCCCCcccCcccccCCC------CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--hcccccCCCCCCh
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEP------SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVA--FQNRRLAIPQNTS 887 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~------~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~--~~~~r~~lP~~~s 887 (931)
......++..|+|||.+.+.. ++.++|+|||||++|+|++|..||...........+. .......++..++
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS 235 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccC
Confidence 223456788999999985543 4789999999999999999999997765444333221 1233445667789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 888 PVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 888 ~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
.++.+||.+||..+|.+||++.+++.+-+
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 236 DDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 99999999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=318.16 Aligned_cols=252 Identities=28% Similarity=0.464 Sum_probs=212.0
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|++.+.||.|+||+||+|.+ ++..+|+|++....... ....+.+|+++++.++|+||+++++.+..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4799999999999999999976 56789999987655443 55778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
++++++|.+++........+++..+..++.||+.||+|||+.| ++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999976433356899999999999999999999999 99999999999999999999999999875443221
Q ss_pred ----ccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC-----CCC
Q 002355 817 ----SSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP-----QNT 886 (931)
Q Consensus 817 ----~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP-----~~~ 886 (931)
......|+..|+|||++... .++.++|+|||||++|+|++|+.||......+......... ....+ ..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 236 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-PPSLETGADYKKY 236 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC-CCCcCCccccccc
Confidence 12334688999999998876 78899999999999999999999998877655554443221 11111 256
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 887 SPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
++.+.+||.+||..+|++||++.++++|
T Consensus 237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 237 SKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 7899999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=328.50 Aligned_cols=250 Identities=24% Similarity=0.325 Sum_probs=208.0
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
.|++.+.||+|+||+||+|.+ +++.||+|.+....... .....+.+|+.+++.++|+||+.+++.+..++++|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 378889999999999999977 56789999987654333 223567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|++|++|.+++.... ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 999999999886422 235889999999999999999999999 9999999999999999999999999987543321
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcccccCCCCCChHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPA---QVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~---eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
......|+..|+|||++.+..++.++|||||||++|+|++|..||...... ....... .......+...++.+.+|
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 235 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDARSL 235 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHHHH
Confidence 123347899999999999988999999999999999999999999865432 1121111 122334567789999999
Q ss_pred HHHhcccCCCCCCC-----HHHHHHH
Q 002355 894 MESCWADDPAQRPS-----FANIVES 914 (931)
Q Consensus 894 I~rcL~~DPeeRPS-----a~ELLq~ 914 (931)
|.+||+.||++||| +.|+++|
T Consensus 236 i~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 236 CKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HHHHhhcCHHHccCCCCCchHHHHcC
Confidence 99999999999999 8899986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=323.61 Aligned_cols=254 Identities=28% Similarity=0.461 Sum_probs=205.3
Q ss_pred Cce-EEEEEecccCceEEEEEEE------cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee--CC
Q 002355 659 DEL-HVKERVGAGSFGTVHRAEW------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--RP 729 (931)
Q Consensus 659 drY-~Ii~kLG~G~fGtVylAr~------~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~--~~ 729 (931)
++| ++++.||+|+||+||++.+ .+..||+|++..... ......+.+|+++|+.++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 345 9999999999999998753 456799999876532 2334677899999999999999999998764 34
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
.+++||||+.+++|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++.
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred eEEEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeeccccc
Confidence 68999999999999999865 24899999999999999999999999 9999999999999999999999999987
Q ss_pred ccccccc---ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--------------HHHH
Q 002355 810 FKANTFI---SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQ--------------VVGA 872 (931)
Q Consensus 810 ~~~~~~~---~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~e--------------ii~~ 872 (931)
....... ......++..|+|||.+.+..++.++|||||||++|+|++|..||....... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 6543211 1122345667999999988888999999999999999999999986532110 0111
Q ss_pred HHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 002355 873 VAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLL 919 (931)
Q Consensus 873 i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Ll 919 (931)
..........+..++.++.+|+.+||..+|++|||++++++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11112233456778899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=327.30 Aligned_cols=251 Identities=28% Similarity=0.524 Sum_probs=213.1
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|+++++||.|+||+||+|++ ++..||+|++.... ......+.+|+++++.++|+||+++++++..+...|+||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 37899999999999999999987 46789999987543 344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+++++|.+++.+. ...+++..++.++.|++.||.|||+.| |+|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 82 EFCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 999999999998752 345899999999999999999999999 9999999999999999999999999987654433
Q ss_pred cccCCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-ccCCCCCChHH
Q 002355 816 ISSKSVAGTPEWMAPEFLR-----GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-RLAIPQNTSPV 889 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~-----~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~-r~~lP~~~s~e 889 (931)
.......++..|++||.+. ...++.++|+|||||++|+|++|..||......+....+..... ....+..++.+
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSS 237 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHH
Confidence 3334556899999999975 34467789999999999999999999988776665554432221 22345678899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 890 LASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 890 L~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+.+||.+||..+|.+||++.+++++
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 238 FNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHHHhccChhhCcCHHHHhcC
Confidence 9999999999999999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=368.45 Aligned_cols=269 Identities=26% Similarity=0.446 Sum_probs=221.4
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEc-C-CceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEee-ee--
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWH-G-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGA-VT-- 726 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~-g-~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~-f~-- 726 (931)
.+++-..+++|.+.|.+|||+.||+|++. + ..||+|.+-.. ....+..+.+||.+|+.|+ |+|||.+++. ..
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence 34566689999999999999999999874 3 78999998765 4556788899999999997 9999999993 32
Q ss_pred --e--CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEE
Q 002355 727 --K--RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKV 802 (931)
Q Consensus 727 --~--~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL 802 (931)
+ .-.+.|+||||.||.|-+++..... ..|++.++++|+.|+++|+++||.+.++|||||||-+||||+.+|+.||
T Consensus 109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred cCCCceeEEEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEe
Confidence 1 1357899999999999999975333 3499999999999999999999999999999999999999999999999
Q ss_pred EecCcccccccccccc---------CCCCCCCcccCcccc---cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 002355 803 CDFGLSRFKANTFISS---------KSVAGTPEWMAPEFL---RGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVV 870 (931)
Q Consensus 803 ~DFGlAr~~~~~~~~~---------~~~~GT~~Y~APEvL---~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii 870 (931)
||||.|.......... -....|+.|+|||.| .+.+++.|+|||+|||+||-|+....||+....-.
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-- 265 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-- 265 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee--
Confidence 9999986432221000 012358999999986 47788999999999999999999999998865432
Q ss_pred HHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhhhcC
Q 002355 871 GAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQM 928 (931)
Q Consensus 871 ~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l~~~ 928 (931)
|...+...+..+.++..+++||+.||+.+|.+||++-+++..+-.+...+-.+-.+
T Consensus 266 --Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~ 321 (738)
T KOG1989|consen 266 --ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDI 321 (738)
T ss_pred --EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcccc
Confidence 22334444444688999999999999999999999999999999998876655443
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=320.18 Aligned_cols=247 Identities=28% Similarity=0.527 Sum_probs=206.0
Q ss_pred EecccCceEEEEEEEc----CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCC
Q 002355 666 RVGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRG 741 (931)
Q Consensus 666 kLG~G~fGtVylAr~~----g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~Gg 741 (931)
.||.|+||.||+|.+. +..||+|++.... .......+.+|+.++++++|+||+++++++. ....++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 3899999999999763 3459999987553 2334467889999999999999999999875 45789999999999
Q ss_pred CHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc---cc
Q 002355 742 SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI---SS 818 (931)
Q Consensus 742 SL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~---~~ 818 (931)
+|.+++... ...+++..++.++.||+.||+|||++| ++||||||+||+++.++.+||+|||++........ ..
T Consensus 80 ~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 80 PLNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999998642 346899999999999999999999999 99999999999999999999999999875433211 11
Q ss_pred CCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHh
Q 002355 819 KSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESC 897 (931)
Q Consensus 819 ~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rc 897 (931)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+. ...+...+...++++.++|.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDC 234 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHH
Confidence 11223578999999988889999999999999999996 999999887766655443 4455667788899999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHHh
Q 002355 898 WADDPAQRPSFANIVESLKKLL 919 (931)
Q Consensus 898 L~~DPeeRPSa~ELLq~L~~Ll 919 (931)
|..+|++||++.++++.|..++
T Consensus 235 ~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 235 WIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred cCCChhhCcCHHHHHHHHhhhc
Confidence 9999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=326.36 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=200.7
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
+|++.++||.|+||.||+|++ +++.||+|++............+.+|+.+++.++|+||+++++++.+...+++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 589999999999999999987 578899999976543333345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccc
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~ 817 (931)
+. ++|.+++... ...+++..++.++.||+.||.|||+.| |+||||||+||+++.++.++|+|||+++........
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 95 5788877642 345899999999999999999999999 999999999999999999999999998765433222
Q ss_pred cCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcc---------------cc-
Q 002355 818 SKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGL-GPAQVVGAVAFQN---------------RR- 879 (931)
Q Consensus 818 ~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~-~~~eii~~i~~~~---------------~r- 879 (931)
.....++..|+|||++.+. .++.++|||||||++|+|++|..||... +..+....+.... ..
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence 2344678899999998764 4688999999999999999998886433 3222222111000 00
Q ss_pred -----------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 -----------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 -----------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
......+++++++||.+||..||.+|||+.+++.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 01123467899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=319.60 Aligned_cols=249 Identities=29% Similarity=0.498 Sum_probs=210.2
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-------HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-------DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH 730 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-------~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~ 730 (931)
+|.+...||.|+||.||+|.+ .++.||+|++....... .....+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 467788999999999999976 56789999887653321 234568899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
.++||||+++++|.+++.+. ..+++..+..++.|++.||+|||+.| ++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999999752 35888999999999999999999999 99999999999999999999999999875
Q ss_pred ccccc------cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCC
Q 002355 811 KANTF------ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQ 884 (931)
Q Consensus 811 ~~~~~------~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~ 884 (931)
..... .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||........+..+.. .....++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~ 234 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPEIPS 234 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCCcCCc
Confidence 54211 111234578899999999988889999999999999999999999988765554444322 33445677
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 885 NTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 885 ~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
..+..+.++|.+||+.+|.+||++.+++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 235 NISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 889999999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=318.47 Aligned_cols=247 Identities=35% Similarity=0.615 Sum_probs=211.3
Q ss_pred EEecccCceEEEEEEEcC---C--ceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecC
Q 002355 665 ERVGAGSFGTVHRAEWHG---S--DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLP 739 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~~g---~--~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~ 739 (931)
++||+|+||+||+|.+.. + .||||++...... ...+.+.+|++++++++|+||+++++++.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 368999999999998632 2 5899998776543 556788999999999999999999999988 88999999999
Q ss_pred CCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc---c
Q 002355 740 RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF---I 816 (931)
Q Consensus 740 GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~---~ 816 (931)
+++|.+++..... ..+++..++.++.|++.||+|||+.| ++|+||||+||+++.++.+||+|||++....... .
T Consensus 79 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 79 LGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 9999999976332 46899999999999999999999999 9999999999999999999999999987654321 1
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~ 895 (931)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+.........+...+..+.+++.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVML 235 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHH
Confidence 1123456788999999998889999999999999999998 999998887777766665444555566778899999999
Q ss_pred HhcccCCCCCCCHHHHHHHHH
Q 002355 896 SCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 896 rcL~~DPeeRPSa~ELLq~L~ 916 (931)
+||..+|++||++.++++.|.
T Consensus 236 ~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 236 QCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHCCCCcccCCCHHHHHHHhc
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=319.43 Aligned_cols=250 Identities=27% Similarity=0.448 Sum_probs=210.1
Q ss_pred ceEEEEEecccCceEEEEEEE-cCCceEEEEEeecccc----hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 660 ELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFL----DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~----~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
+|++.+.||.|+||.||+|.. +++.+|+|++...... ......+.+|+.+++.++|+||+++++++...+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999976 6778999998765322 23346688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||+++++|.+++.+. ..+++..+..++.||+.||+|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999999752 35789999999999999999999999 999999999999999999999999998753211
Q ss_pred ------ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-ccccCCCCCCh
Q 002355 815 ------FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ-NRRLAIPQNTS 887 (931)
Q Consensus 815 ------~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~-~~r~~lP~~~s 887 (931)
........++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+... .....++...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFS 235 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCC
Confidence 11123456889999999999988899999999999999999999999876654433333222 22345677789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 888 PVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 888 ~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.++.+||.+||..+|.+||++.+++++
T Consensus 236 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 236 AAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 999999999999999999999998864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=323.74 Aligned_cols=252 Identities=27% Similarity=0.472 Sum_probs=210.0
Q ss_pred CceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
+-|+++++||.|+||.||+|++. +..+++|.+.... ......+.+|+++++.++|+||+++++++..++..++|||
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 34688899999999999999874 5567888875442 3445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+.+++|..++.+. ...+++..+..++.||+.||.|||+.| ++||||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 83 FCAGGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred ecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 99999999887642 346899999999999999999999999 99999999999999999999999999876544332
Q ss_pred ccCCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-cccCCCCCChHHH
Q 002355 817 SSKSVAGTPEWMAPEFLR-----GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN-RRLAIPQNTSPVL 890 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~-----~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~-~r~~lP~~~s~eL 890 (931)
......++..|+|||++. +..++.++|||||||++|+|++|..||...+..+....+.... .....+..++..+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEF 238 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHH
Confidence 334456899999999984 3456789999999999999999999998877665554443221 2233456788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
.+||.+||..+|.+||++.+++++-.
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 239 KDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCCC
Confidence 99999999999999999999988744
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.30 Aligned_cols=263 Identities=29% Similarity=0.538 Sum_probs=220.6
Q ss_pred cccCceEEEEEecccCceEEEEEEEc--CC----ceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH--GS----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~--g~----~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
+...+|++++.||+|+||+||+|.+. +. .||+|++..... ......+.+|+.+++.++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 34578999999999999999999763 33 488998765543 3445678899999999999999999999877 7
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
..++||||+++++|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCcccc
Confidence 899999999999999999763 335899999999999999999999999 9999999999999999999999999997
Q ss_pred cccccccc--cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCC
Q 002355 810 FKANTFIS--SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNT 886 (931)
Q Consensus 810 ~~~~~~~~--~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~ 886 (931)
........ .....++..|+|||.+....++.++|+|||||++||+++ |..||......++...+. .......+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPIC 236 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCC
Confidence 65432111 111223568999999988888999999999999999998 999998887766655554 34455566778
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhh
Q 002355 887 SPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQL 925 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l 925 (931)
+..+.+++.+||..+|..||++.++++.|.++++.+..+
T Consensus 237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~ 275 (279)
T cd05057 237 TIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQRY 275 (279)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCcce
Confidence 899999999999999999999999999999998877544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=324.52 Aligned_cols=252 Identities=25% Similarity=0.442 Sum_probs=206.9
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeee------e
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVT------K 727 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~------~ 727 (931)
..+.|++.++||.|+||.||+|++ .++.+|+|++.... .....+..|+.+++++ +|+||++++++|. .
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 447899999999999999999987 56789999986542 2335678899999998 6999999999985 3
Q ss_pred CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCc
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGl 807 (931)
+..+|++|||+.+++|.+++.... ...+++..++.++.||+.||.|||++| |+|+||||+||+++.++.++|+|||+
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~~l~dfg~ 167 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGV 167 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCcc
Confidence 567999999999999999987532 345888899999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccCCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCC
Q 002355 808 SRFKANTFISSKSVAGTPEWMAPEFLR-----GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAI 882 (931)
Q Consensus 808 Ar~~~~~~~~~~~~~GT~~Y~APEvL~-----~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~l 882 (931)
+..............|+..|+|||.+. +..++.++|+|||||++|+|++|..||....+......+.........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 247 (282)
T cd06636 168 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK 247 (282)
T ss_pred hhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCc
Confidence 875543322334567899999999886 345678999999999999999999999876654444433322222233
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 883 PQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 883 P~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
...++..+.+||++||..||.+|||+.|++++
T Consensus 248 ~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 248 SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 45678999999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=338.43 Aligned_cols=252 Identities=24% Similarity=0.406 Sum_probs=223.1
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
+.|++.+.||+|.|+.|+++.+ +|+.+|+|++....+.....+.+.+|++|.+.|+||||++|++.+......|||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 7889999999999999999954 78899999998877776667889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC---CCCcEEEEecCccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD---KNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd---~dg~IKL~DFGlAr~~~~ 813 (931)
+|.|++|..-+-.. ..+++..+-..++||+.+|.|+|.+| |||||+||+|+|+- ...-+||+|||+|....
T Consensus 91 ~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred cccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 99999997655331 35788888999999999999999999 99999999999994 34569999999998776
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCC--CCCChHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAI--PQNTSPVLA 891 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~l--P~~~s~eL~ 891 (931)
........+|||.|||||++...+++..+|||+-|++||-|+.|.+||++.+...+++.+......... ..+++++.+
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak 244 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAK 244 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHH
Confidence 334556788999999999999999999999999999999999999999999988899888755554433 368899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 892 SLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 892 dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
+||++||..||.+|.|+.|.|+|=+
T Consensus 245 ~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 245 SLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred HHHHHHhccChhhhccHHHHhCCch
Confidence 9999999999999999999998755
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=328.81 Aligned_cols=250 Identities=24% Similarity=0.413 Sum_probs=206.6
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|++.++||+|+||.||++++ ++..+|+|.+.... .......+.+|++++++++||||++++++|..++++|+|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 4799999999999999999987 46678999886542 23344678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs-~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
|+++++|.+++.+. ..+++..+..++.||+.||.|||+ .+ ++|+||||+|||++.++.++|+|||++......
T Consensus 80 y~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 80 HMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred ccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 99999999999763 458899999999999999999997 57 999999999999999999999999998754332
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc------------------
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN------------------ 877 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~------------------ 877 (931)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||...+............
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence 2244578999999999988888999999999999999999999997654333222111100
Q ss_pred -----------------cccCCC-CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 878 -----------------RRLAIP-QNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 878 -----------------~r~~lP-~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
.....| ...+.++++||.+||..+|++||++.+++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 011111 236778999999999999999999999998854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=348.43 Aligned_cols=267 Identities=34% Similarity=0.551 Sum_probs=211.3
Q ss_pred ccccccccCceEEEEEecccCceEEEEEEEcC-CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 651 MDWLEISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 651 ~~~lei~~drY~Ii~kLG~G~fGtVylAr~~g-~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
.+.+.-..++|.-.+.||+|+||+||+|...+ +.||||.+....... ..+|.+|+.++.+++|||+|+|++||.+++
T Consensus 67 ~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~ 144 (361)
T KOG1187|consen 67 YDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGG 144 (361)
T ss_pred HHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCC
Confidence 33444455888888999999999999998765 889999776654332 355999999999999999999999999888
Q ss_pred -eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhC-CCCEEEeccCCCCeEECCCCcEEEEecCc
Q 002355 730 -HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL-NPPILHWDLKSPNLLVDKNWTVKVCDFGL 807 (931)
Q Consensus 730 -~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~-G~~IIHrDLKPeNILLd~dg~IKL~DFGl 807 (931)
+.+||+|||++|+|.+++...... .++|..+.+|+.++++||+|||.. .++||||||||+|||||.+++.||+|||+
T Consensus 145 ~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGL 223 (361)
T KOG1187|consen 145 EHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGL 223 (361)
T ss_pred ceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccC
Confidence 599999999999999999864332 789999999999999999999984 44799999999999999999999999999
Q ss_pred cccccc-cccccCCC-CCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhcccc
Q 002355 808 SRFKAN-TFISSKSV-AGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLG------PAQVVGAVAFQNRR 879 (931)
Q Consensus 808 Ar~~~~-~~~~~~~~-~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~------~~eii~~i~~~~~r 879 (931)
|+.... .. ..... .||.+|+|||++.....+.++||||||++|.||+||+.+..... ..++..........
T Consensus 224 a~~~~~~~~-~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~ 302 (361)
T KOG1187|consen 224 AKLGPEGDT-SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKL 302 (361)
T ss_pred cccCCcccc-ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcch
Confidence 976543 21 11112 79999999999998889999999999999999999998876432 11221111111111
Q ss_pred -----cCCC-CCCh-----HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 880 -----LAIP-QNTS-----PVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 880 -----~~lP-~~~s-----~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
..+. ...+ ..+..+..+|++.+|..||++.|+++.|+.+...
T Consensus 303 ~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 303 REIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred hheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 1111 2222 2356778899999999999999999998665543
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.34 Aligned_cols=246 Identities=34% Similarity=0.593 Sum_probs=207.9
Q ss_pred EEecccCceEEEEEEEc-CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCCCH
Q 002355 665 ERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL 743 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~~-g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~GgSL 743 (931)
++||+|+||.||+|.+. ++.||+|++...... .....+.+|+++++.+.|+||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 36999999999999875 788999998765543 3456788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc--ccCCC
Q 002355 744 YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI--SSKSV 821 (931)
Q Consensus 744 ~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~--~~~~~ 821 (931)
.+++.+. ...+++..+..++.+++.||+|||+++ ++||||||+||+++.++.++|+|||++........ .....
T Consensus 80 ~~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 80 LTFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 9998652 235788999999999999999999999 99999999999999999999999999875442111 11122
Q ss_pred CCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhccc
Q 002355 822 AGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD 900 (931)
Q Consensus 822 ~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~ 900 (931)
.++..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+. .......+...+.++.+||.+||..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~ 234 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWAY 234 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHhcc
Confidence 33567999999988889999999999999999999 899998877655554443 2334456678889999999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 002355 901 DPAQRPSFANIVESLK 916 (931)
Q Consensus 901 DPeeRPSa~ELLq~L~ 916 (931)
+|.+||++.|+++.|+
T Consensus 235 ~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 235 DPENRPSFSEIYNELQ 250 (251)
T ss_pred ChhhCcCHHHHHHHhh
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.43 Aligned_cols=250 Identities=26% Similarity=0.454 Sum_probs=209.1
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeeccc---chHHHHHHHHHHHHHHhcCCCCeeeEEeeeee--CCeE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDF---LDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--RPHL 731 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~---~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~--~~~l 731 (931)
.+|++.++||+|+||.||+|++ +++.||||++..... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5799999999999999999986 567899999865432 22445678899999999999999999999875 3568
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
++||||+++++|.+++.+. ..+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 8999999999999998752 34788899999999999999999999 999999999999999999999999998754
Q ss_pred cccc---cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChH
Q 002355 812 ANTF---ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888 (931)
Q Consensus 812 ~~~~---~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~ 888 (931)
.... .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||.....................|...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSD 236 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCH
Confidence 3211 1123346888999999998888899999999999999999999999877655555444434444556777888
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 889 VLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+.++|.+||. +|.+||++++++++
T Consensus 237 ~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 237 HCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 99999999995 89999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=368.33 Aligned_cols=269 Identities=32% Similarity=0.557 Sum_probs=233.0
Q ss_pred cccccccCceEEEEEecccCceEEEEEEEc-------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 002355 652 DWLEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724 (931)
Q Consensus 652 ~~lei~~drY~Ii~kLG~G~fGtVylAr~~-------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~ 724 (931)
.-.+++..+.+..++||+|+||.||+|+.. ...||||.++.... .+..++|.+|+.+|..++|||||+|++.
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-~~~~~dF~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-NQARQDFRREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 345778899999999999999999999753 24599999987653 3345789999999999999999999999
Q ss_pred eeeCCeEEEEEeecCCCCHHHHhhcCC-------C----CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeE
Q 002355 725 VTKRPHLSIVTEYLPRGSLYRLIHRPA-------A----GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLL 793 (931)
Q Consensus 725 f~~~~~l~LVmEy~~GgSL~d~L~r~~-------~----~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNIL 793 (931)
+..++.+|||+|||..|+|.++|+-.. . ...++..+.+.|+.||+.|++||-++. +|||||-..|+|
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCL 635 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCL 635 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhce
Confidence 999999999999999999999996321 1 223888999999999999999999999 999999999999
Q ss_pred ECCCCcEEEEecCcccccccc--ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 002355 794 VDKNWTVKVCDFGLSRFKANT--FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVV 870 (931)
Q Consensus 794 Ld~dg~IKL~DFGlAr~~~~~--~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii 870 (931)
|+.+-.|||+|||+++-.-.. +.......-+.+|||||.|....+++++||||+||+|||+++ |..||.+..+.+++
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 999999999999999843222 111112334789999999999999999999999999999997 79999999999999
Q ss_pred HHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchh
Q 002355 871 GAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQ 924 (931)
Q Consensus 871 ~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~ 924 (931)
..+.. ...++.|.++|.++.+||..||+.+|.+||++.||-..|+...+....
T Consensus 716 e~i~~-g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 716 ECIRA-GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred HHHHc-CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 88864 444889999999999999999999999999999999999988776543
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.79 Aligned_cols=250 Identities=33% Similarity=0.606 Sum_probs=206.1
Q ss_pred EecccCceEEEEEEEcC--C--ceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEEEEEeecCC
Q 002355 666 RVGAGSFGTVHRAEWHG--S--DVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPR 740 (931)
Q Consensus 666 kLG~G~fGtVylAr~~g--~--~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~LVmEy~~G 740 (931)
.||+|+||.||+|++.+ . .+++|.++... .......+.+|+.++.++ +||||+++++++...+.+++||||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 58999999999998743 3 36777776432 233446788999999999 799999999999999999999999999
Q ss_pred CCHHHHhhcCC-------------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCc
Q 002355 741 GSLYRLIHRPA-------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807 (931)
Q Consensus 741 gSL~d~L~r~~-------------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGl 807 (931)
++|.+++.... ....+++..++.++.|++.||+|||++| ++||||||+||+++.++.+||+|||+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEECCCCC
Confidence 99999986532 1234789999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCC
Q 002355 808 SRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNT 886 (931)
Q Consensus 808 Ar~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~ 886 (931)
+....... .......+..|+|||++....++.++|||||||++|||++ |..||.+.........+. .......+...
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (270)
T cd05047 159 SRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNC 236 (270)
T ss_pred ccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh-CCCCCCCCCcC
Confidence 86332211 1122234567999999988889999999999999999997 999998877666555543 23344566678
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 002355 887 SPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llk 920 (931)
+.++.+|+.+||..+|.+|||+.++++.|..++.
T Consensus 237 ~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~ 270 (270)
T cd05047 237 DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270 (270)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence 8999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.22 Aligned_cols=249 Identities=30% Similarity=0.510 Sum_probs=213.1
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc---hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL---DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~---~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
+|+..+.||+|+||.||+|.. +++.|++|++...... ......+.+|+.+++.++|+||+++++++..+..+++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 467788999999999999976 5788999998765422 33557788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||+++++|.+++.+. ..+++..++.++.||+.||+|||+.| |+|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999999753 35889999999999999999999999 999999999999999999999999998765433
Q ss_pred ccccCCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 815 FISSKSVAGTPEWMAPEFLRGEP-SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~~~~-~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
. ......++..|++||.+.... ++.++|+|||||++|+|++|..||...........+........++..+++.+.+|
T Consensus 156 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (258)
T cd06632 156 S-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDF 234 (258)
T ss_pred c-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHH
Confidence 2 224456889999999987766 88999999999999999999999987765555544443344555677889999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 002355 894 MESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 894 I~rcL~~DPeeRPSa~ELLq~ 914 (931)
|.+||..+|.+||++.+++.+
T Consensus 235 i~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 235 ILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHHhhcCcccCcCHHHHhcC
Confidence 999999999999999999865
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=316.64 Aligned_cols=248 Identities=29% Similarity=0.556 Sum_probs=211.2
Q ss_pred CceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|++.++||.|+||.||+|++. ++.+++|.+..... ...+.+|+++++.++|+||+++++.+..+.+.|+++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 78999999999999999999874 57899999875432 5678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+.+++|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||+|.||+++.++.++|+|||++........
T Consensus 79 ~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 79 YCGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred cCCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 9999999999864 2346899999999999999999999999 99999999999999999999999999886554432
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-ccccCCCCCChHHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ-NRRLAIPQNTSPVLASLME 895 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~-~~r~~lP~~~s~eL~dLI~ 895 (931)
......++..|+|||++.+..++.++|||||||++|+|++|+.||...........+... ......+..++..+.+||.
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence 334456788999999999888999999999999999999999999876654443332211 1122234567789999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 002355 896 SCWADDPAQRPSFANIVES 914 (931)
Q Consensus 896 rcL~~DPeeRPSa~ELLq~ 914 (931)
+||+.+|.+|||+.+++++
T Consensus 235 ~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 235 KCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred HHHhcChhhCcCHHHHhcC
Confidence 9999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=324.93 Aligned_cols=249 Identities=27% Similarity=0.477 Sum_probs=212.4
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
+.+|++.++||.|+||+||+|.+ .++.||+|.+...... ....+.+|+.+++.++|+||+++++++..+..+++|+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 46899999999999999999975 6788999998765432 2356789999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+.+++|..++.. ..+++..+..++.|++.||+|||++| ++|+||||+||+++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 96 EYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 99999999998864 24889999999999999999999999 9999999999999999999999999987543332
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-cccCCCCCChHHHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN-RRLAIPQNTSPVLASLM 894 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~-~r~~lP~~~s~eL~dLI 894 (931)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+.... .....+..+++.+.+||
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFL 249 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHH
Confidence 22234568889999999998888999999999999999999999998876654443332221 22335567889999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 002355 895 ESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 895 ~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+||..+|.+||++.+++.+
T Consensus 250 ~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 250 NRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHhhcChhhCCCHHHHhhC
Confidence 99999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=317.50 Aligned_cols=253 Identities=28% Similarity=0.485 Sum_probs=207.4
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeC-----
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKR----- 728 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~----- 728 (931)
..++|++.+.||.|+||.||+|++ .++.+++|++..... ....+.+|+.+++++ .|+||+++++++...
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 458999999999999999999987 457799999876542 235688999999999 699999999999654
Q ss_pred -CeEEEEEeecCCCCHHHHhhcCC-CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecC
Q 002355 729 -PHLSIVTEYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806 (931)
Q Consensus 729 -~~l~LVmEy~~GgSL~d~L~r~~-~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFG 806 (931)
..+++||||+.+++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEECCCc
Confidence 45899999999999999886522 2356899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccCCCCCCCcccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-cc
Q 002355 807 LSRFKANTFISSKSVAGTPEWMAPEFLRG-----EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-RL 880 (931)
Q Consensus 807 lAr~~~~~~~~~~~~~GT~~Y~APEvL~~-----~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~-r~ 880 (931)
++..............|+..|+|||++.. ..++.++|||||||++|+|++|+.||...........+..... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 98765443333345668899999998754 2357789999999999999999999987665544444332211 12
Q ss_pred CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 ~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
..+...+..+.+||.+||..||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 2233467899999999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.66 Aligned_cols=250 Identities=26% Similarity=0.459 Sum_probs=209.1
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc---hHHHHHHHHHHHHHHhcCCCCeeeEEeeeee--CCeE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL---DDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--RPHL 731 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~---~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~--~~~l 731 (931)
.+|++.+.||+|+||.||+|.+ ++..||+|++...... ......+.+|+.+++.++||||+++++++.. +..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688999999999999999976 5778999998765322 2345678899999999999999999998865 4678
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
+++|||+++++|.+++... ..+++...+.++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 9999999999999998752 34888999999999999999999999 999999999999999999999999998754
Q ss_pred cccc---cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChH
Q 002355 812 ANTF---ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888 (931)
Q Consensus 812 ~~~~---~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~ 888 (931)
.... .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||......+.............++...++
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISE 236 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCH
Confidence 3211 1112345788999999999988999999999999999999999999887665555554444445556777889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 889 VLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+.+|| +||..+|++||+++++++|
T Consensus 237 ~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 237 HARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 999999 6777899999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.04 Aligned_cols=250 Identities=24% Similarity=0.372 Sum_probs=207.8
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
+|++.+.||.|+||.||+|++ .++.||+|++............+.+|+.+++.++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 589999999999999999986 578899999987665455557789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc-
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI- 816 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~- 816 (931)
+ +++|.+++.... ..+++..++.++.||+.||+|||++| ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999999986532 46899999999999999999999999 99999999999999999999999999876543321
Q ss_pred ccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc----------------
Q 002355 817 SSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR---------------- 879 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r---------------- 879 (931)
......++..|+|||.+.+. .++.++|||||||++|+|++|.+||.+......+..+......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 12345688999999998764 4588999999999999999999888776654433322211000
Q ss_pred ------------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 ------------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 ------------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.......+..+.+||.+||..+|.+||++.+++.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00113457889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=314.24 Aligned_cols=250 Identities=29% Similarity=0.545 Sum_probs=210.0
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
+|++.++||+|+||.||+|.. +++.||+|++............+.+|+.+++.++|+||+++++.+...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588999999999999999976 577899999987765545678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccc
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~ 817 (931)
+++++|.+++.. ...+++..+..++.|++.||.|||+.| |+|+||+|+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 999999999975 235788999999999999999999999 999999999999999999999999998765432211
Q ss_pred ----cCCCCCCCcccCcccccCCC---CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCC--hH
Q 002355 818 ----SKSVAGTPEWMAPEFLRGEP---SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNT--SP 888 (931)
Q Consensus 818 ----~~~~~GT~~Y~APEvL~~~~---~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~--s~ 888 (931)
.....++..|+|||.+.+.. .+.++|||||||++|+|++|..||....................+|... ++
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSP 235 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCH
Confidence 11346788999999998766 7889999999999999999999997764333222222223334445444 88
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 889 VLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+.+||.+||+.+|.+||++.+++.+
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 236 EGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhcC
Confidence 99999999999999999999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=344.05 Aligned_cols=260 Identities=22% Similarity=0.294 Sum_probs=209.0
Q ss_pred ccCceEEEEEecccCceEEEEEEEc----CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~----g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
...+|+++++||.|+||.||+|... +..||+|.+.... ...+|+++|+.++||||++++++|......|
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 3468999999999999999999753 3568888876432 3457999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+|||++ +++|.+++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||+++...
T Consensus 163 lv~e~~-~~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 163 MVMPKY-KCDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred EEehhc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 999999 5788888854 346899999999999999999999999 9999999999999999999999999997544
Q ss_pred cccc--ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhc--c--------
Q 002355 813 NTFI--SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPA---QVVGAVAFQ--N-------- 877 (931)
Q Consensus 813 ~~~~--~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~---eii~~i~~~--~-------- 877 (931)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... ..+..+... .
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 3221 223467999999999999998999999999999999999999999765321 111111000 0
Q ss_pred ---------------cc--cCCC-----CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhhhcCCC
Q 002355 878 ---------------RR--LAIP-----QNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQMGG 930 (931)
Q Consensus 878 ---------------~r--~~lP-----~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l~~~~~ 930 (931)
.+ ...+ ...+.++.+||.+||..||++|||+.+++.+ .-+.+.+++.+.+..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~-p~f~~~~~~~~~~~~ 390 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL-PLFTKEPINLLNITP 390 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC-chhhccchhhhcCcc
Confidence 00 0011 2346788999999999999999999999999 444567777777654
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=318.37 Aligned_cols=254 Identities=33% Similarity=0.559 Sum_probs=204.3
Q ss_pred CceEEEEEecccCceEEEEEEE------cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeee--eCCe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT--KRPH 730 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~------~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~--~~~~ 730 (931)
.+|++++.||+|+||+||+|+. .+..||+|++.... ......+.+|+++++.++||||+++++++. ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 5899999999999999999974 36679999986543 344567889999999999999999999874 3456
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
+++||||+++++|.+++.+. ...+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++..
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred eEEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 89999999999999999652 235889999999999999999999999 99999999999999999999999999986
Q ss_pred cccccc---ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---------------HHHH
Q 002355 811 KANTFI---SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQ---------------VVGA 872 (931)
Q Consensus 811 ~~~~~~---~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~e---------------ii~~ 872 (931)
...... ......++..|+|||.+.+..++.++|||||||++|||++|..++....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 433211 1111223456999999998889999999999999999999877664322110 0111
Q ss_pred HHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 002355 873 VAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKL 918 (931)
Q Consensus 873 i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~L 918 (931)
..........+..++..+.+||.+||..+|++|||+.++++.|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1122233345567889999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=331.49 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=199.7
Q ss_pred EEEEeccc--CceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeec
Q 002355 663 VKERVGAG--SFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYL 738 (931)
Q Consensus 663 Ii~kLG~G--~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~ 738 (931)
++++||+| +|++||++++ +++.||+|++............+.+|+.+++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 7899999976 5788999999876555555567788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc---
Q 002355 739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF--- 815 (931)
Q Consensus 739 ~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~--- 815 (931)
++++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.++++||+.+.......
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 9999999986532 234889999999999999999999999 9999999999999999999999998654321110
Q ss_pred ----cccCCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc----------
Q 002355 816 ----ISSKSVAGTPEWMAPEFLRG--EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR---------- 879 (931)
Q Consensus 816 ----~~~~~~~GT~~Y~APEvL~~--~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r---------- 879 (931)
.......++..|+|||++.+ ..++.++|||||||++|||++|..||......+..........+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 01122346778999999876 45789999999999999999999999876544433222111000
Q ss_pred ----------------------------------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 ----------------------------------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 ----------------------------------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.......++.+.+||.+||+.||++|||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00112346789999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=311.46 Aligned_cols=245 Identities=31% Similarity=0.564 Sum_probs=206.3
Q ss_pred EecccCceEEEEEEE-cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCCCHH
Q 002355 666 RVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY 744 (931)
Q Consensus 666 kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~GgSL~ 744 (931)
+||+|+||.||+|.. .+..||+|++.... .......+.+|+.+++.++||||+++++++......++||||+++++|.
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 689999999999976 45679999886543 2333456889999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccc-cCCCCC
Q 002355 745 RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS-SKSVAG 823 (931)
Q Consensus 745 d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~-~~~~~G 823 (931)
+++... ...+.+..+..++.|++.+|.|||++| ++|+||||+||+++.++.+||+|||++......... .....+
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 998652 235789999999999999999999999 999999999999999999999999998754332111 112234
Q ss_pred CCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCC
Q 002355 824 TPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDP 902 (931)
Q Consensus 824 T~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DP 902 (931)
+..|+|||++.+..++.++||||||+++|+|++ |..||...........+. ...+...+..++..+.+|+.+||..+|
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 567999999998888999999999999999998 999998887666555543 344455667789999999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 002355 903 AQRPSFANIVESLK 916 (931)
Q Consensus 903 eeRPSa~ELLq~L~ 916 (931)
++||++.++++.|.
T Consensus 236 ~~Rp~~~~l~~~l~ 249 (250)
T cd05085 236 ENRPKFSELQKELA 249 (250)
T ss_pred ccCCCHHHHHHHhc
Confidence 99999999998864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.96 Aligned_cols=251 Identities=29% Similarity=0.523 Sum_probs=213.9
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
+|++.+.||.|+||.||+|.+ .+..||+|.+............+.+|+.+++.++|+||+++++.+..+...++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 588999999999999999987 467899999877654444556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc-EEEEecCcccccccccc
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT-VKVCDFGLSRFKANTFI 816 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~-IKL~DFGlAr~~~~~~~ 816 (931)
+++++|.+++.+.. ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++. ++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999987532 335789999999999999999999999 999999999999998864 69999999876554332
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMES 896 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~r 896 (931)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+. .......+...+..+.++|.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC-QGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-cccCCCCCCCCCHHHHHHHHH
Confidence 3334568899999999988888999999999999999999999998777666555443 233344556778899999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 002355 897 CWADDPAQRPSFANIVES 914 (931)
Q Consensus 897 cL~~DPeeRPSa~ELLq~ 914 (931)
||..+|++|||+.+++++
T Consensus 237 ~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 237 LFKVSPRDRPSITSILKR 254 (257)
T ss_pred HhccChhhCcCHHHHhhC
Confidence 999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=311.60 Aligned_cols=250 Identities=38% Similarity=0.680 Sum_probs=211.0
Q ss_pred eEEEEEecccCceEEEEEEEcC------CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 661 LHVKERVGAGSFGTVHRAEWHG------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~~g------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
+++.+.||.|+||.||+|++.. ..||+|++..... ......+.+|+.+++.++|+||+++++++...+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3577899999999999998754 6799999865532 22457888999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||+++++|.+++..... ..+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999999975221 12899999999999999999999999 999999999999999999999999999765443
Q ss_pred ccccC-CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHH
Q 002355 815 FISSK-SVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 815 ~~~~~-~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
..... ...++..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+. .......+...+..+.+
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK-KGYRLPKPENCPPEIYK 235 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHH
Confidence 11111 2236789999999988888999999999999999998 789998877666666554 33445566778999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHH
Q 002355 893 LMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~L 915 (931)
++.+||..+|++|||+.++++.|
T Consensus 236 ~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 236 LMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHCcCChhhCcCHHHHHhhC
Confidence 99999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=324.21 Aligned_cols=251 Identities=28% Similarity=0.480 Sum_probs=209.4
Q ss_pred ccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
..++|+++++||+|+||+||++++. ++.||+|++..... ......+.+|+++++.++||||+++++++...+.+++|
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 4578999999999999999999874 78899999876432 33356788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs-~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
|||+++++|.+++.+ ...+++..+..++.|++.||.|||+ ++ ++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 82 MEFMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EecCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 999999999999875 2358999999999999999999997 57 99999999999999999999999999865433
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHHHHhcccccCC
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPA-----------QVVGAVAFQNRRLAI 882 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~-----------eii~~i~~~~~r~~l 882 (931)
. ......|+..|+|||++.+..++.++|||||||++|+|++|..||...... .....+.. .....+
T Consensus 157 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 233 (284)
T cd06620 157 S--IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EPPPRL 233 (284)
T ss_pred h--ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-ccCCCC
Confidence 2 123457899999999998888899999999999999999999999865432 12222221 112222
Q ss_pred CC-CChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 883 PQ-NTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 883 P~-~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
+. ..+..+.+||.+||..||.+|||+.|++++..
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 234 PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 32 37788999999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=314.04 Aligned_cols=250 Identities=32% Similarity=0.533 Sum_probs=203.2
Q ss_pred EEecccCceEEEEEEEc-----CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeee-eCCeEEEEEeec
Q 002355 665 ERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT-KRPHLSIVTEYL 738 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~~-----g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~-~~~~l~LVmEy~ 738 (931)
+.||+|+||.||+|.+. ...||+|.+.... .......+.+|+.+++.++||||+++++++. .++..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 35899999999999752 2358999875432 2334567889999999999999999999765 556689999999
Q ss_pred CCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc---
Q 002355 739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF--- 815 (931)
Q Consensus 739 ~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~--- 815 (931)
.+++|.+++.+.. ..+.+..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++......
T Consensus 80 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 80 KHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999997532 34677778889999999999999999 9999999999999999999999999987432211
Q ss_pred -cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 816 -ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 816 -~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
.......++..|+|||.+.+..++.++|||||||++|||++ |.+||......+....+. .......+...+..+.++
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 234 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGRRLLQPEYCPDPLYEV 234 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHHH
Confidence 11123345778999999988889999999999999999999 467787776665555443 333444566778999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHhh
Q 002355 894 MESCWADDPAQRPSFANIVESLKKLLK 920 (931)
Q Consensus 894 I~rcL~~DPeeRPSa~ELLq~L~~Llk 920 (931)
|.+||..+|++||++.++++.|+.++.
T Consensus 235 i~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 235 MLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=320.99 Aligned_cols=256 Identities=29% Similarity=0.520 Sum_probs=207.0
Q ss_pred CceEEEEEecccCceEEEEEEE------cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC--Ce
Q 002355 659 DELHVKERVGAGSFGTVHRAEW------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--PH 730 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~------~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~--~~ 730 (931)
.-|+++++||+|+||.||+|++ .+..||+|.+.... .......+.+|+.+++.+.||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 4578999999999999999974 35679999986543 234456789999999999999999999998764 67
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
.++||||++|++|.+++.+. ...+++..++.++.||+.||+|||++| |+||||||+||+++.++.++|+|||++..
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCccccc
Confidence 89999999999999998652 235889999999999999999999999 99999999999999999999999999875
Q ss_pred cccccc---ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------------hHHHHHHH
Q 002355 811 KANTFI---SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLG--------------PAQVVGAV 873 (931)
Q Consensus 811 ~~~~~~---~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~--------------~~eii~~i 873 (931)
...... ......++..|+|||.+.+..++.++|||||||++|+|+++..|+.... ........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 433211 1123456778999999988888999999999999999999876643210 00111111
Q ss_pred HhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 002355 874 AFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLL 919 (931)
Q Consensus 874 ~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Ll 919 (931)
.........+..++..+.+||.+||+.+|.+||+++++++.|+.++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 2223344556778999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=333.57 Aligned_cols=248 Identities=25% Similarity=0.350 Sum_probs=202.4
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC------C
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------P 729 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~------~ 729 (931)
.++|++++.||+|+||.||+|++ +++.||||++............+.+|+.+++.++|+||++++++|... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 37899999999999999999986 578899999876543444456778899999999999999999988643 3
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
+.|+||||+ +++|.+.+.. .+++..+..++.||+.||+|||+.| |+||||||+||+++.++.+||+|||+++
T Consensus 95 ~~~lv~e~~-~~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 95 DVYLVMELM-DANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred cEEEEEecc-CCCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCccce
Confidence 679999999 5688888754 2788899999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-----------
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR----------- 878 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~----------- 878 (931)
...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 167 TAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred eCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 654432 22344678999999999999999999999999999999999999987654332222211000
Q ss_pred ---------cc---------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 ---------RL---------------------AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 ---------r~---------------------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+. ..+...+..+.+||.+||..||.+|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0012346678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.66 Aligned_cols=251 Identities=23% Similarity=0.331 Sum_probs=204.3
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
+|++++.||.|++|.||+|++ +++.||||++............+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 488999999999999999987 577899999876544433445788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccc
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~ 817 (931)
+. ++|..++.... ...+++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 95 68988886532 346899999999999999999999999 999999999999999999999999998765433222
Q ss_pred cCCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc-----------------
Q 002355 818 SKSVAGTPEWMAPEFLRGEP-SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR----------------- 879 (931)
Q Consensus 818 ~~~~~GT~~Y~APEvL~~~~-~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r----------------- 879 (931)
.....++..|+|||++.+.. ++.++|||||||++|+|+||+.||...........+......
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 23345688999999887644 588999999999999999999999876543332222110000
Q ss_pred ----------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 ----------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 ----------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
......+++++++||.+||..||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 01123567889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=326.48 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=187.6
Q ss_pred EEEecccCceEEEEEEEc----CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeee--eCCeEEEEEee
Q 002355 664 KERVGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT--KRPHLSIVTEY 737 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~~----g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~--~~~~l~LVmEy 737 (931)
.++||+|+||+||+|++. ++.||+|++...... ..+.+|+++|++++||||++++++|. .+.++|+||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999853 467999998654322 34678999999999999999999985 35678999999
Q ss_pred cCCCCHHHHhhcCC------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEE----CCCCcEEEEecCc
Q 002355 738 LPRGSLYRLIHRPA------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGL 807 (931)
Q Consensus 738 ~~GgSL~d~L~r~~------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILL----d~dg~IKL~DFGl 807 (931)
+ +++|.+++.... ....+++..++.++.||+.||+|||+.| |+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 82 A-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred c-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 9 568888875321 1235889999999999999999999999 9999999999999 4567899999999
Q ss_pred cccccccc---cccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChH---------HHHHHHH
Q 002355 808 SRFKANTF---ISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPA---------QVVGAVA 874 (931)
Q Consensus 808 Ar~~~~~~---~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~---------eii~~i~ 874 (931)
++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...... ..+..+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 98654321 122345789999999998874 5788999999999999999999999643211 0010000
Q ss_pred h-ccc-----------------------cc------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 875 F-QNR-----------------------RL------------AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 875 ~-~~~-----------------------r~------------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
. ... .. ......+..+.+||.+||++||.+|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 000 00 0011235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.80 Aligned_cols=248 Identities=26% Similarity=0.462 Sum_probs=209.9
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
.+|+++++||.|+||.||+|+. .++.||+|.+....... ...+.+|+.+++.++|+||++++++|..+.+.|+|||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 7899999999999999999986 57889999987654332 3567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+++++|.+++.+ ..+++..+..++.|++.||.|||+.| ++||||||+||+++.++.++|+|||++........
T Consensus 97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 9999999999864 24788899999999999999999999 99999999999999999999999999875433322
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-cccCCCCCChHHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN-RRLAIPQNTSPVLASLME 895 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~-~r~~lP~~~s~eL~dLI~ 895 (931)
......+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+.... .....+...+..+.+||.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN 250 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence 2334568899999999999888999999999999999999999997765433322222111 122345667889999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 002355 896 SCWADDPAQRPSFANIVES 914 (931)
Q Consensus 896 rcL~~DPeeRPSa~ELLq~ 914 (931)
+||..+|++||++.+++++
T Consensus 251 ~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 251 RCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred HHccCChhhCcCHHHHhcC
Confidence 9999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=308.57 Aligned_cols=252 Identities=31% Similarity=0.556 Sum_probs=219.8
Q ss_pred ceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 660 ELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
+|++.+.||.|+||.||++.+. +..|++|++............+.+|+++++.++|+|++++++.+..+...++|+|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5899999999999999999885 78899999987665555667788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCC-CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 738 LPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 738 ~~GgSL~d~L~r~~-~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
+++++|.+++.+.. .+..+++..+..++.||+.||.|||+.| ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 99999999987532 2356899999999999999999999999 99999999999999999999999999976554432
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMES 896 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~r 896 (931)
......|++.|+|||.+.+...+.++|+||||+++|+|++|..||......+...... ......++...+..+.++|.+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~ 237 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-KGQYPPIPSQYSSELRNLVSS 237 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHH
Confidence 3344568889999999988888999999999999999999999998877666665553 333455677889999999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 002355 897 CWADDPAQRPSFANIVES 914 (931)
Q Consensus 897 cL~~DPeeRPSa~ELLq~ 914 (931)
||..+|++|||+.+++++
T Consensus 238 ~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 238 LLQKDPEERPSIAQILQS 255 (258)
T ss_pred HcCCChhhCcCHHHHhcC
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.83 Aligned_cols=256 Identities=31% Similarity=0.539 Sum_probs=210.3
Q ss_pred cCceEEEEEecccCceEEEEEEEc------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee--CC
Q 002355 658 WDELHVKERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--RP 729 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~~------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~--~~ 729 (931)
.+.|++.++||+|+||.||+|++. +..||||++...... .....+.+|+++++.+.|+||+++++++.. +.
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 367889999999999999999863 567999999766543 345778999999999999999999999876 66
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.| ++|+||||.||+++.++.++|+|||++.
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 8999999999999999997532 35899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccc---ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--------------HHHH
Q 002355 810 FKANTFI---SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQ--------------VVGA 872 (931)
Q Consensus 810 ~~~~~~~---~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~e--------------ii~~ 872 (931)
....... ......++..|++||.+.+..++.++|||||||++|+|++|..||....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 6542211 1112234567999999988889999999999999999999999986532211 1112
Q ss_pred HHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 002355 873 VAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKL 918 (931)
Q Consensus 873 i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~L 918 (931)
......+...+..++.++.+|+.+||..+|.+|||+.++++.|..+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 2222334445567788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=311.66 Aligned_cols=249 Identities=30% Similarity=0.499 Sum_probs=213.9
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|++.+.||.|++|.||+|++ +++.|++|++...... .....+.+|+.++..++|+||+++++++..+..+++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 4689999999999999999987 4788999998776432 445678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs-~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
|+++++|.+++... ..+++..++.++.||+.||+|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 80 YMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred ecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999999753 468999999999999999999999 99 9999999999999999999999999988655443
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcccccCCCCC-ChHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLG---PAQVVGAVAFQNRRLAIPQN-TSPVLA 891 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~---~~eii~~i~~~~~r~~lP~~-~s~eL~ 891 (931)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+....+. .......+.. ++..+.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~ 233 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFR 233 (264)
T ss_pred CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHH
Confidence 33234567889999999999888999999999999999999999998774 333333333 2333445555 889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 002355 892 SLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 892 dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
++|.+||..+|.+||++.+++++
T Consensus 234 ~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 234 DFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHccCChhhCCCHHHHHhC
Confidence 99999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=319.26 Aligned_cols=248 Identities=27% Similarity=0.517 Sum_probs=213.0
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
..|+.+++||.|+||.||+|.+ .+..||+|++..... ......+.+|+.+++.+.|+||+++++++..+...++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 4678889999999999999986 467899999876532 3445778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+.|++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 83 YLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 9999999999864 24788899999999999999999999 99999999999999999999999999976544332
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMES 896 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~r 896 (931)
......++..|+|||++.+...+.++|+|||||++|+|++|..||....+......+ .......++..++..+.+||.+
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~ 235 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-PKNNPPTLTGEFSKPFKEFIDA 235 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-hcCCCCCCchhhhHHHHHHHHH
Confidence 333456788999999999888899999999999999999999999887765554433 2233444556778899999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 002355 897 CWADDPAQRPSFANIVES 914 (931)
Q Consensus 897 cL~~DPeeRPSa~ELLq~ 914 (931)
||..+|++||++.+++++
T Consensus 236 ~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 236 CLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HcccCcccCcCHHHHHhC
Confidence 999999999999999988
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.70 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=205.6
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|++.++||+|+||.||+|.+ +++.||+|++............+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 4799999999999999999987 46789999987654444445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+.++.+..+..+ ...+++..++.++.||+.||.|||..+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9988777665544 234889999999999999999999999 99999999999999999999999999876544322
Q ss_pred -ccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-----------------
Q 002355 817 -SSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN----------------- 877 (931)
Q Consensus 817 -~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~----------------- 877 (931)
......++..|+|||++.+. .++.++|+||||+++|+|++|..||.+......+.......
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 22345678899999999888 78899999999999999999999998765433322211000
Q ss_pred cc-------------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 878 RR-------------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 878 ~r-------------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.. ...+..++.++.+||.+||..+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 01233458889999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.16 Aligned_cols=251 Identities=25% Similarity=0.383 Sum_probs=204.6
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|++.++||.|+||.||+|.+ .++.||+|++..........+.+.+|+++++.++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4799999999999999999987 46789999986654333344567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+.+++|..+.... ..+++..++.++.||+.||+|||+.| ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 99999888877542 34899999999999999999999999 99999999999999999999999999876544322
Q ss_pred ccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-----------------
Q 002355 817 SSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR----------------- 878 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~----------------- 878 (931)
......++..|+|||++.+ ..++.++|||||||++|+|++|.+||......+....+.....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2334567889999999875 3467899999999999999999999976554332222110000
Q ss_pred ---cc---------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 ---RL---------AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 ---r~---------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.. .....++..+.+||.+||..+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 0123567889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=316.77 Aligned_cols=250 Identities=28% Similarity=0.516 Sum_probs=200.5
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHH-HHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAI-MKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkI-Lk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|++++.||+|+||.||+|++ +++.||+|++......... ..+..|+.+ ++.+.||||+++++++..++..|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 4789999999999999999987 4788999998776443333 345556665 66678999999999999999999999
Q ss_pred eecCCCCHHHHhhcC-CCCCCCcHHHHHHHHHHHHHHHHHHHhC-CCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 736 EYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNL-NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~-~~~~~L~e~~~~~Ia~QIa~AL~yLHs~-G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
||++ ++|.+++... .....+++..++.++.||+.||+|||++ + ++||||||+||+++.++.+||+|||++.....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9995 6888877542 2335689999999999999999999986 8 99999999999999999999999999876543
Q ss_pred cccccCCCCCCCcccCcccccC----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcccccCCC-CCCh
Q 002355 814 TFISSKSVAGTPEWMAPEFLRG----EPSNEKSDVYSFGVILWELVTMQQPWNGLGP-AQVVGAVAFQNRRLAIP-QNTS 887 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~----~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~-~eii~~i~~~~~r~~lP-~~~s 887 (931)
.. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||..... .+.+.... ......++ ..++
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (283)
T cd06617 157 SV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAEKFS 234 (283)
T ss_pred cc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCCCCCccccC
Confidence 32 1223467889999998865 4467899999999999999999999975432 22233322 22222233 4578
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 888 PVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 888 ~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.++.+||.+||..+|.+||++.+++++
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=322.20 Aligned_cols=265 Identities=28% Similarity=0.534 Sum_probs=217.0
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCC----ceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGS----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH 730 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~----~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~ 730 (931)
..++|++.+.||+|+||.||+|.+ .+. .||+|++..... ......+.+|+.+++.++||||+++++++... .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 457899999999999999999976 344 468888765432 23335688999999999999999999988654 4
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
.++++||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+|+||||+||+++.++.+||+|||+++.
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred ceeeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEcccccccc
Confidence 67999999999999998752 335888999999999999999999999 99999999999999999999999999986
Q ss_pred cccccc--ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCCh
Q 002355 811 KANTFI--SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTS 887 (931)
Q Consensus 811 ~~~~~~--~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s 887 (931)
...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+ ........+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGERLPQPPICT 237 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCCCCCCCCC
Confidence 432211 1223345678999999998889999999999999999997 89999887655444333 3344445566778
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhhhcC
Q 002355 888 PVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQM 928 (931)
Q Consensus 888 ~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l~~~ 928 (931)
..+.++|.+||..+|++||++.++++.|..+...+..++..
T Consensus 238 ~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~ 278 (303)
T cd05110 238 IDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVI 278 (303)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhhheee
Confidence 89999999999999999999999999999998877665544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=368.98 Aligned_cols=258 Identities=23% Similarity=0.366 Sum_probs=209.3
Q ss_pred ccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee--CCe
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--RPH 730 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~--~~~ 730 (931)
+...++|+++++||+|+||+||+|++ .+..||+|++............+..|+.+|+.|+|||||+++++|.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 34558999999999999999999987 45679999998776666666788999999999999999999999854 457
Q ss_pred EEEEEeecCCCCHHHHhhcC-CCCCCCcHHHHHHHHHHHHHHHHHHHhCC-----CCEEEeccCCCCeEECC--------
Q 002355 731 LSIVTEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLN-----PPILHWDLKSPNLLVDK-------- 796 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~-~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G-----~~IIHrDLKPeNILLd~-------- 796 (931)
+||||||+.+++|.+++... .....+++..++.|+.||+.||+|||+.+ .+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 99999999999999998652 12346899999999999999999999854 34999999999999964
Q ss_pred ---------CCcEEEEecCccccccccccccCCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002355 797 ---------NWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRG--EPSNEKSDVYSFGVILWELVTMQQPWNGLG 865 (931)
Q Consensus 797 ---------dg~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~--~~~t~ksDIWSLG~ILyELLTG~~PF~~~~ 865 (931)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||+|++|..||....
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 3458999999997654322 2234578999999999864 447889999999999999999999997765
Q ss_pred hHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 866 PAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 866 ~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
....+....... +.......+.++.+||..||..+|.+||++.++|.+
T Consensus 248 ~~~qli~~lk~~-p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 248 NFSQLISELKRG-PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred cHHHHHHHHhcC-CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 433332222111 222224568999999999999999999999999965
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=314.44 Aligned_cols=255 Identities=30% Similarity=0.529 Sum_probs=210.2
Q ss_pred eEEEEEecccCceEEEEEEE-----cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC------
Q 002355 661 LHVKERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP------ 729 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~-----~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~------ 729 (931)
|++.+.||+|+||.||+|.+ ++..||||++..........+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 56788999999999999975 3567999999876655566678899999999999999999999886432
Q ss_pred eEEEEEeecCCCCHHHHhhcCC---CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecC
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPA---AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~---~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFG 806 (931)
..+++++|+.+++|..++.... ....++...++.++.||+.||+|||+.| |+||||||+||+++.++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEECccc
Confidence 3478999999999988874311 1124788999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCC
Q 002355 807 LSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIP 883 (931)
Q Consensus 807 lAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP 883 (931)
+++...... .......++..|++||.+.+..++.++|||||||++|+|++ |..||...+..+....+. .......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 237 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-KGNRLKQP 237 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-cCCcCCCC
Confidence 988543221 11223345678999999998888999999999999999999 899998877666555443 23334455
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 002355 884 QNTSPVLASLMESCWADDPAQRPSFANIVESLKKL 918 (931)
Q Consensus 884 ~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~L 918 (931)
...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 238 ~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 67789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=321.41 Aligned_cols=251 Identities=24% Similarity=0.401 Sum_probs=208.2
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|++++.||.|+||.||++++ .++.||+|.+...... ......+.+|+++++.++||||+++++.+..++++++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 4789999999999999999987 4577999998765432 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||++|++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999999999652 35899999999999999999999999 9999999999999999999999999986321100
Q ss_pred ---------------cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc
Q 002355 816 ---------------ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL 880 (931)
Q Consensus 816 ---------------~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~ 880 (931)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||.+....+............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 235 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Confidence 01112457889999999988889999999999999999999999998877776666554332222
Q ss_pred -CCCCCChHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 002355 881 -AIPQNTSPVLASLMESCWADDPAQRPSF---ANIVES 914 (931)
Q Consensus 881 -~lP~~~s~eL~dLI~rcL~~DPeeRPSa---~ELLq~ 914 (931)
......++.+.+||.+||..+|++||++ .+++++
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 236 PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 2223678999999999999999999984 555554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=314.84 Aligned_cols=246 Identities=30% Similarity=0.507 Sum_probs=195.1
Q ss_pred EecccCceEEEEEEEc----CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCC
Q 002355 666 RVGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRG 741 (931)
Q Consensus 666 kLG~G~fGtVylAr~~----g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~Gg 741 (931)
+||+|+||.||+|... ...+|+|.+.... .......+.+|+.+++.++|+||+++++.+......++||||++++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 5899999999999652 2357777765432 2333467889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCC--CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc--ccc
Q 002355 742 SLYRLIHRPAA--GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT--FIS 817 (931)
Q Consensus 742 SL~d~L~r~~~--~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~--~~~ 817 (931)
+|.+++..... ....++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999975322 233567888899999999999999999 999999999999999999999999998643221 111
Q ss_pred cCCCCCCCcccCcccccC-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccc----ccCCCCC
Q 002355 818 SKSVAGTPEWMAPEFLRG-------EPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNR----RLAIPQN 885 (931)
Q Consensus 818 ~~~~~GT~~Y~APEvL~~-------~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~----r~~lP~~ 885 (931)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||....+.+.......... ....+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 223345678999998743 346789999999999999999 7889988776665554433222 1223456
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002355 886 TSPVLASLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
.+..+.+++..|| .||++|||++++++.|
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 7889999999999 5999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=319.71 Aligned_cols=250 Identities=24% Similarity=0.331 Sum_probs=205.5
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc---hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL---DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~---~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
+|+++++||.|+||.||+|.+ .++.||||++...... ......+.+|+.+++.++|+||+++++++...+.+++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 588999999999999999986 4778999999876544 23345677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||+ +++|.+++.... ..+++..++.++.||+.||.|||++| |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 999999997532 36899999999999999999999999 999999999999999999999999999866544
Q ss_pred ccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc--------------
Q 002355 815 FISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR-------------- 879 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r-------------- 879 (931)
........++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+....+....+......
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 323334456788999998865 45688999999999999999998888776654433322111000
Q ss_pred ------------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 ------------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 ------------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.......+..+.+||.+||..+|.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00123457889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.69 Aligned_cols=246 Identities=22% Similarity=0.357 Sum_probs=210.9
Q ss_pred ceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 660 ELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
+|++.++||.|+||.||+|++. ++.||+|++....... ...+.+.+|++++++++||||+++++.+..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999874 7889999998654433 456788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+.|++|.+++... ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999763 46889999999999999999999999 9999999999999999999999999987654332
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGP---AQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~---~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||..... ........ ......+...+..+.++
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 232 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE--TADVLYPATWSTEAIDA 232 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc--cccccCcccCcHHHHHH
Confidence 22345678899999999988889999999999999999999999987763 33322221 14455677889999999
Q ss_pred HHHhcccCCCCCCCH--HHHHH
Q 002355 894 MESCWADDPAQRPSF--ANIVE 913 (931)
Q Consensus 894 I~rcL~~DPeeRPSa--~ELLq 913 (931)
|.+||..+|.+||++ +++++
T Consensus 233 i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHHHccCChhHcCCccHHHHhc
Confidence 999999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=316.72 Aligned_cols=258 Identities=29% Similarity=0.423 Sum_probs=208.5
Q ss_pred cccccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeC
Q 002355 652 DWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKR 728 (931)
Q Consensus 652 ~~lei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~ 728 (931)
..+.-..++|++.+.||.|+||.||+|.. .++.+|+|++..... ....+.+|+.++.++ +||||+++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 33444568999999999999999999987 577899999865432 224567899999999 799999999998643
Q ss_pred -----CeEEEEEeecCCCCHHHHhhcC-CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEE
Q 002355 729 -----PHLSIVTEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKV 802 (931)
Q Consensus 729 -----~~l~LVmEy~~GgSL~d~L~r~-~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL 802 (931)
...++||||+++++|.++++.. .....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEE
Confidence 4689999999999999988632 12346899999999999999999999999 999999999999999999999
Q ss_pred EecCccccccccccccCCCCCCCcccCcccccCCC-----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc
Q 002355 803 CDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEP-----SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN 877 (931)
Q Consensus 803 ~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~-----~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~ 877 (931)
+|||++..............|+..|+|||.+.... ++.++|||||||++|+|++|+.||........+..+....
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 249 (291)
T cd06639 170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249 (291)
T ss_pred eecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC
Confidence 99999876543322233456889999999986432 5789999999999999999999998877655444432211
Q ss_pred -cccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 878 -RRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 878 -~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.....+...+..+.+||.+||..+|++||++.+++++
T Consensus 250 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 250 PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1122345567889999999999999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=313.18 Aligned_cols=242 Identities=25% Similarity=0.441 Sum_probs=209.7
Q ss_pred ecccCceEEEEEEEc--CCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCCCH
Q 002355 667 VGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL 743 (931)
Q Consensus 667 LG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~GgSL 743 (931)
||.|+||.||+|++. ++.||+|++....... ...+.+.+|+++++.++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999886 7889999997654432 3456789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCCCCC
Q 002355 744 YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAG 823 (931)
Q Consensus 744 ~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~~~G 823 (931)
.+++.+. ..+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......+
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~ 154 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCG 154 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccC
Confidence 9999763 34889999999999999999999999 9999999999999999999999999988655432 2234568
Q ss_pred CCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccC
Q 002355 824 TPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLG--PAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADD 901 (931)
Q Consensus 824 T~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~--~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~D 901 (931)
+..|++||.+.+..++.++|+|||||++|+|++|..||.... ..+....+.........|...++++.+||.+||..+
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC
Confidence 899999999988888999999999999999999999998776 555555555445566677777999999999999999
Q ss_pred CCCCCC-----HHHHHHH
Q 002355 902 PAQRPS-----FANIVES 914 (931)
Q Consensus 902 PeeRPS-----a~ELLq~ 914 (931)
|.+||+ ++|++++
T Consensus 235 p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 235 PEERLGNLKGGIKDIKKH 252 (262)
T ss_pred hhhCcCCcccCHHHHhcC
Confidence 999999 7888775
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=313.93 Aligned_cols=250 Identities=27% Similarity=0.494 Sum_probs=207.7
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc----hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL----DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~----~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
+|+..+.||+|+||.||+|+. +++.||+|++...... ......+.+|++++++++|+||+++++++..+++.++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999976 6788999998754321 1235678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC-cEEEEecCcccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-TVKVCDFGLSRFKA 812 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg-~IKL~DFGlAr~~~ 812 (931)
||||+.+++|.+++.+. ..+++..++.++.||+.||.|||++| ++|+||+|+||+++.++ .++|+|||.+....
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999999752 35889999999999999999999999 99999999999998776 59999999987654
Q ss_pred cccc----ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcccccCCCCC
Q 002355 813 NTFI----SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPA---QVVGAVAFQNRRLAIPQN 885 (931)
Q Consensus 813 ~~~~----~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~---eii~~i~~~~~r~~lP~~ 885 (931)
.... ......++..|+|||.+.+..++.++|+|||||++|+|++|..||...... ...............+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH 235 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchh
Confidence 3211 112346788999999998888899999999999999999999999654422 222222222334556677
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 886 TSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.++.+.++|.+||..+|.+||++.+++++
T Consensus 236 ~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 236 LSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred hCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 88999999999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=315.52 Aligned_cols=248 Identities=31% Similarity=0.545 Sum_probs=208.5
Q ss_pred CceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|++.++||.|+||.||+|.+. ++.||+|++..... ......+.+|+++++.++||||+++++.+..+..+++|+|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 36788899999999999999874 77899999876543 2445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs-~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
|+.+++|.+++.... ..+++..+..++.||+.||+|||+ .| ++|+||||+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 80 YMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred ecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 999999999997532 568899999999999999999999 88 9999999999999999999999999987554332
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhcccccCCCCC-ChHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLG-----PAQVVGAVAFQNRRLAIPQN-TSPV 889 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~-----~~eii~~i~~~~~r~~lP~~-~s~e 889 (931)
. ....++..|+|||.+.+..++.++|||||||++|+|++|..||.... ..+....+. .......+.. ++.+
T Consensus 156 ~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (265)
T cd06605 156 A--KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPPRLPSGKFSPD 232 (265)
T ss_pred h--hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCCCCCChhhcCHH
Confidence 1 22668889999999999889999999999999999999999997652 222222222 2233334444 7889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 890 LASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 890 L~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+.+||.+||..+|++|||+.+++.+
T Consensus 233 ~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 233 FQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHHHHcCCCchhCcCHHHHhhC
Confidence 9999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=322.45 Aligned_cols=255 Identities=27% Similarity=0.359 Sum_probs=206.3
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC--CeEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--PHLS 732 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~--~~l~ 732 (931)
..++|++.++||.|+||.||+|++ +++.||+|+++...........+.+|+.++++++|+||+++++++... +.++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 347899999999999999999987 578899999976543333234566899999999999999999998754 5689
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+. ++|.+++... ...+++..++.++.||+.||+|||+.| ++||||||+||+++.++.+||+|||++....
T Consensus 85 lv~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 85 LVMEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEEecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999995 5888888652 246899999999999999999999999 9999999999999999999999999998654
Q ss_pred ccccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-------------
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR------------- 878 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~------------- 878 (931)
..........++..|+|||++.+ ..++.++|||||||++|+|++|..||...+..+.+..+.....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 43222223345788999999875 4578999999999999999999999988777665554432110
Q ss_pred ----ccCCC-----------CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 879 ----RLAIP-----------QNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 879 ----r~~lP-----------~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
....+ ...++.+.+||.+||.+||++|||+.+++.|-+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~ 292 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 00011 124788999999999999999999999998733
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=304.09 Aligned_cols=250 Identities=31% Similarity=0.554 Sum_probs=215.5
Q ss_pred ceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC--CeEEEEE
Q 002355 660 ELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--PHLSIVT 735 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~--~~l~LVm 735 (931)
+|++.+.||+|++|.||+|.+. ++.|++|++............+.+|+.++++++|+||+++++.+... ..+++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788999999999999999875 78899999987665455667889999999999999999999999888 8999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
|++.+++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999997632 6899999999999999999999999 9999999999999999999999999988665443
Q ss_pred c--ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcccccCCCCCChHHHHH
Q 002355 816 I--SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLG-PAQVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 816 ~--~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~-~~eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
. ......++..|++||.+.+...+.++|+||||+++|+|++|..||.... .......+........++...+..+.+
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKD 235 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHH
Confidence 2 1244568899999999988888999999999999999999999998766 222333333223455677788999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 002355 893 LMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~ 914 (931)
||.+||..+|.+||++.+++.+
T Consensus 236 ~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 236 FLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHHHhCcCChhhCCCHHHHhhC
Confidence 9999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=343.56 Aligned_cols=250 Identities=27% Similarity=0.446 Sum_probs=224.4
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
.=|.+.+.||+|.|++|-+|++ +|..||||++.+.........++..|++.|+-++|||||+||++......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4578889999999999999986 89999999999988777666788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEE-CCCCcEEEEecCccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV-DKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILL-d~dg~IKL~DFGlAr~~~~~~ 815 (931)
+-.+|+|++||.+.. ..+.+..+.+++.||+.|+.|+|... +|||||||+|+.+ .+-|-|||+|||++......
T Consensus 98 LGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG- 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG- 172 (864)
T ss_pred ecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCc-
Confidence 999999999998743 45999999999999999999999999 9999999999976 56799999999998755433
Q ss_pred cccCCCCCCCcccCcccccCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSN-EKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t-~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI 894 (931)
....+.||...|-|||++.+..|+ +++||||||+|||.|++|++||..-++-+.+..+. .-...+|..++.++++||
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm--DCKYtvPshvS~eCrdLI 250 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM--DCKYTVPSHVSKECRDLI 250 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh--cccccCchhhhHHHHHHH
Confidence 345678999999999999998775 67899999999999999999999988888877664 556778999999999999
Q ss_pred HHhcccCCCCCCCHHHHHHHH
Q 002355 895 ESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 895 ~rcL~~DPeeRPSa~ELLq~L 915 (931)
..||..||.+|.+.++|..+-
T Consensus 251 ~sMLvRdPkkRAslEeI~s~~ 271 (864)
T KOG4717|consen 251 QSMLVRDPKKRASLEEIVSTS 271 (864)
T ss_pred HHHHhcCchhhccHHHHhccc
Confidence 999999999999999998663
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=312.94 Aligned_cols=254 Identities=26% Similarity=0.439 Sum_probs=210.5
Q ss_pred ceEEEEEecccCceEEEEEEEc---CCceEEEEEeecc--------cchHHHHHHHHHHHHHHh-cCCCCeeeEEeeeee
Q 002355 660 ELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQD--------FLDDQLKEFLREVAIMKR-VRHPNVVLFMGAVTK 727 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~~---g~~VAVKVlk~~~--------~~~~~~~~~l~EIkILk~-L~HpNIV~Lid~f~~ 727 (931)
.|++.+.||+|+||.||+|++. ++.+|+|.+.... ........+.+|+.++.. ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4788899999999999999874 4679999886532 122345667789988875 699999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhhcC-CCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCCEEEeccCCCCeEECCCCcEEEEec
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDF 805 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~-~~~~~L~e~~~~~Ia~QIa~AL~yLHs-~G~~IIHrDLKPeNILLd~dg~IKL~DF 805 (931)
+++.++||||++|++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||+|.||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999887531 223468999999999999999999996 67 999999999999999999999999
Q ss_pred CccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCC
Q 002355 806 GLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQN 885 (931)
Q Consensus 806 GlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~ 885 (931)
|++....... ......|+..|++||.+.+..++.++|+||||+++|+|++|..||...........+............
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCccc
Confidence 9997654432 234556889999999999888899999999999999999999999877665555554433333222336
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 886 TSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
.++.+.+||.+||..||++||++.|+.+.+.
T Consensus 238 ~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 238 YSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 7899999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.84 Aligned_cols=255 Identities=26% Similarity=0.446 Sum_probs=205.8
Q ss_pred cccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
+..+.+.....||+|+||.||+|++ ++..||+|.+.... ......+.+|+.+++.++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445566667899999999999986 45679999876543 2344678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC-CCcEEEEecCcccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGLSRFKA 812 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~-dg~IKL~DFGlAr~~~ 812 (931)
||||+++++|.+++.........++..+..++.||+.||+|||+.| |+||||||+||+++. ++.++|+|||++....
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 9999999999999875321112278888899999999999999999 999999999999976 6799999999987544
Q ss_pred ccccccCCCCCCCcccCcccccCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcccccCCCCCChHH
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEP--SNEKSDVYSFGVILWELVTMQQPWNGLGPAQ-VVGAVAFQNRRLAIPQNTSPV 889 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~--~t~ksDIWSLG~ILyELLTG~~PF~~~~~~e-ii~~i~~~~~r~~lP~~~s~e 889 (931)
..........++..|+|||++.+.. ++.++|+||||+++|+|++|..||....... .............++...+++
T Consensus 161 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd06624 161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAE 240 (268)
T ss_pred cCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHH
Confidence 3222233446789999999986643 6889999999999999999999997654322 222222223344567788999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 890 LASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 890 L~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+.+||.+||..+|.+|||+.+++.+
T Consensus 241 ~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 241 AKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HHHHHHHHcCCCchhCCCHHHHHhC
Confidence 9999999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=305.24 Aligned_cols=249 Identities=29% Similarity=0.568 Sum_probs=216.6
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
+|++.++||.|++|.||++++ .++.|++|.+............+.+|++++++++|+||+++++++..++..++|||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 588999999999999999976 467899999988765556667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccc
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~ 817 (931)
+.+++|.+++... ..+++..++.++.|++.||.|||+.| |+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999998753 46899999999999999999999999 999999999999999999999999999866554332
Q ss_pred cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHh
Q 002355 818 SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESC 897 (931)
Q Consensus 818 ~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rc 897 (931)
.....++..|+|||.+.+...+.++|||+||+++|+|++|..||............. ......++...+..+.++|.+|
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~ 234 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQC 234 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHH
Confidence 344568899999999988878899999999999999999999998776544444433 2344456778899999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 002355 898 WADDPAQRPSFANIVES 914 (931)
Q Consensus 898 L~~DPeeRPSa~ELLq~ 914 (931)
|..+|++|||+.+++.+
T Consensus 235 l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 235 FQKDPNLRPTAKQLLKH 251 (254)
T ss_pred HhCChhhCcCHHHHhcC
Confidence 99999999999998864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=355.47 Aligned_cols=245 Identities=31% Similarity=0.537 Sum_probs=215.4
Q ss_pred EEEEecccCceEEEEEEE--cCCceEEEEEeecccch--HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC--eEEEEEe
Q 002355 663 VKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD--DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP--HLSIVTE 736 (931)
Q Consensus 663 Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~--~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~--~l~LVmE 736 (931)
...+||+|+|-+||+|-+ +|..||.-.++...... ..++++..|+.+|+.|+||||+++|++|.+.. .+.+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 346899999999999976 56778877666655443 45689999999999999999999999997554 4889999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC-CCcEEEEecCccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~-dg~IKL~DFGlAr~~~~~~ 815 (931)
++..|+|..|+++. +.++.+.++.|++||++||.|||++.+||||||||..||+|+. .|.|||+|+|+|.......
T Consensus 124 L~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred cccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 99999999999873 4688999999999999999999999999999999999999975 5899999999998876654
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcccccCCCCCChHHHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGL-GPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~-~~~eii~~i~~~~~r~~lP~~~s~eL~dLI 894 (931)
. ...+|||.|||||++. +.|+..+||||||++|.||+|+..||... ++.++++++.....+-.+..--++++++||
T Consensus 201 a--ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fI 277 (632)
T KOG0584|consen 201 A--KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFI 277 (632)
T ss_pred c--ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHH
Confidence 3 5589999999999887 66899999999999999999999999764 678999999877777777777899999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 002355 895 ESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 895 ~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+||.. ...|||+.|||++
T Consensus 278 ekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 278 EKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHhcC-chhccCHHHHhhC
Confidence 999999 9999999999975
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=319.29 Aligned_cols=251 Identities=28% Similarity=0.375 Sum_probs=205.7
Q ss_pred CceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC--CeEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--PHLSIV 734 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~--~~l~LV 734 (931)
++|++.+.||.|+||.||+|++. ++.+|+|.++...........+.+|+.++++++||||+++++++... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 68999999999999999999874 67899999986654444345677899999999999999999998877 899999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||+. ++|.+++.... ..+++..++.++.||+.||+|||+.| ++|+||||+||+++.++.++|+|||++......
T Consensus 85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99995 59998886522 35899999999999999999999999 999999999999999999999999998865544
Q ss_pred ccccCCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc----------------
Q 002355 815 FISSKSVAGTPEWMAPEFLRGEP-SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN---------------- 877 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~~~~-~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~---------------- 877 (931)
........++..|+|||.+.+.. .+.++|||||||++|+|++|..||...........+....
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 22233456788999999987654 5889999999999999999999998766544433221100
Q ss_pred -------------cccCCCCC-ChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 878 -------------RRLAIPQN-TSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 878 -------------~r~~lP~~-~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
....++.. +++.+.+||.+||+.+|++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00112233 58889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=339.11 Aligned_cols=273 Identities=25% Similarity=0.363 Sum_probs=220.0
Q ss_pred cchhhhhhhhhcCCCcCCCCCCCCCCCccccccccccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch
Q 002355 620 LDKEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD 697 (931)
Q Consensus 620 ~~~E~es~~~~~g~~Pv~~G~ry~~~epsl~~~~lei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~ 697 (931)
.++|+...|.++|||||..|+.|.+ .+|.+.+|||||-|+|||+|.+ ..+.||+||.+...
T Consensus 53 ~eqE~~~dY~kGGYHpV~IGD~F~~--------------gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--- 115 (590)
T KOG1290|consen 53 EEQEDPEDYRKGGYHPVRIGDVFNG--------------GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--- 115 (590)
T ss_pred ccccChhhhhcCCCceeeccccccC--------------ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---
Confidence 3466777899999999999999864 7999999999999999999987 46789999998643
Q ss_pred HHHHHHHHHHHHHHhcC-----C---CCeeeEEeeee----eCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHH
Q 002355 698 DQLKEFLREVAIMKRVR-----H---PNVVLFMGAVT----KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA 765 (931)
Q Consensus 698 ~~~~~~l~EIkILk~L~-----H---pNIV~Lid~f~----~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia 765 (931)
...+..+.||++|++++ | .+||+|+++|. ++.|+|||+|++ |.+|..+|.+... +.++...++.|+
T Consensus 116 hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~ 193 (590)
T KOG1290|consen 116 HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEIC 193 (590)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHH
Confidence 23356788999999994 2 38999999995 677999999999 9999999987654 459999999999
Q ss_pred HHHHHHHHHHHh-CCCCEEEeccCCCCeEEC-------------------------------------------------
Q 002355 766 LDVAKGINYLHN-LNPPILHWDLKSPNLLVD------------------------------------------------- 795 (931)
Q Consensus 766 ~QIa~AL~yLHs-~G~~IIHrDLKPeNILLd------------------------------------------------- 795 (931)
+||+.||.|||. +| |||.||||+|||+-
T Consensus 194 ~qvL~GLdYLH~ecg--IIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k 271 (590)
T KOG1290|consen 194 RQVLTGLDYLHRECG--IIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFK 271 (590)
T ss_pred HHHHHHHHHHHHhcC--ccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHH
Confidence 999999999997 56 99999999999990
Q ss_pred -----------------------------------------------------------------CC-------------
Q 002355 796 -----------------------------------------------------------------KN------------- 797 (931)
Q Consensus 796 -----------------------------------------------------------------~d------------- 797 (931)
++
T Consensus 272 ~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~ 351 (590)
T KOG1290|consen 272 KMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPE 351 (590)
T ss_pred HHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccc
Confidence 00
Q ss_pred ---------------------------------------CcEEEEecCccccccccccccCCCCCCCcccCcccccCCCC
Q 002355 798 ---------------------------------------WTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPS 838 (931)
Q Consensus 798 ---------------------------------------g~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~ 838 (931)
-.|||+|||-|++....+ +..+.|..|+|||++.+..|
T Consensus 352 ~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khF---T~DIQTRQYRapEVllGsgY 428 (590)
T KOG1290|consen 352 SQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHF---TEDIQTRQYRAPEVLLGSGY 428 (590)
T ss_pred hhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhhhh---chhhhhhhccCcceeecCCC
Confidence 037899999999877665 45578999999999999999
Q ss_pred CchhHHHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHhc------------------cccc-------------
Q 002355 839 NEKSDVYSFGVILWELVTMQQPWNGL-------GPAQVVGAVAFQ------------------NRRL------------- 880 (931)
Q Consensus 839 t~ksDIWSLG~ILyELLTG~~PF~~~-------~~~eii~~i~~~------------------~~r~------------- 880 (931)
++.+||||++|++|||+||...|... +.+.+...+... +++.
T Consensus 429 ~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL 508 (590)
T KOG1290|consen 429 STSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPL 508 (590)
T ss_pred CCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcH
Confidence 99999999999999999999999542 222222111000 0000
Q ss_pred --------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 881 --------AIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 881 --------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
..+.....++.+|+.-||.++|++||||.++|+|-+
T Consensus 509 ~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPw 552 (590)
T KOG1290|consen 509 YEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPW 552 (590)
T ss_pred HHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCcc
Confidence 112223356899999999999999999999998743
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=316.00 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=199.7
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|++.++||.|+||+||+|++ +++.||||.+....... ....+.+|+.+++.++|+||+++++++..+.+.++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 37899999999999999999976 57789999987643221 2234678999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+. ++|.+++.+. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 83 e~~~-~~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 83 EYLD-TDLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred ecCC-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 9996 5899988753 236889999999999999999999999 9999999999999999999999999987543322
Q ss_pred cccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhccc---------------
Q 002355 816 ISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLG-PAQVVGAVAFQNR--------------- 878 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~-~~eii~~i~~~~~--------------- 878 (931)
.......++..|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+....+.....
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 22233356889999999875 457889999999999999999999997654 2222211110000
Q ss_pred ----cc---------CCCCCCh--HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 ----RL---------AIPQNTS--PVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 ----r~---------~lP~~~s--~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.. .....++ ..+.++|.+||..+|++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00 0001233 788999999999999999999998865
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=312.76 Aligned_cols=250 Identities=29% Similarity=0.499 Sum_probs=206.3
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc--------hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL--------DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~--------~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
+|.+.+.||.|+||.||+|.. +++.||+|.++..... ....+.+.+|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 578899999999999999975 5788999988653221 112356788999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
..++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999999763 46889999999999999999999999 9999999999999999999999999987
Q ss_pred cccccc--cccCCCCCCCcccCcccccCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC--
Q 002355 810 FKANTF--ISSKSVAGTPEWMAPEFLRGEP--SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP-- 883 (931)
Q Consensus 810 ~~~~~~--~~~~~~~GT~~Y~APEvL~~~~--~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP-- 883 (931)
...... .......++..|+|||.+.... ++.++|+||||+++|+|++|..||......+....+........++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD 236 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcc
Confidence 543321 1123346788999999987654 7889999999999999999999997665544443333222232233
Q ss_pred --CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 884 --QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 884 --~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
..++..+.+||.+||..+|..|||+.++++|
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 237 VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 3568899999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=302.07 Aligned_cols=247 Identities=30% Similarity=0.589 Sum_probs=210.4
Q ss_pred ceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 660 ELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
+|++.+.||.|++|.||++.+. ++.+++|++..... .....+.+|+.+++.++|+||+++++++..+...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4788999999999999999874 77899999976543 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccc
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~ 817 (931)
+++++|.+++.... ..+++..+..++.|++.||.|||.+| ++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 ~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 79 CSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999999987632 46899999999999999999999999 99999999999999999999999999876554321
Q ss_pred cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCC--CChHHHHHHHH
Q 002355 818 SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQ--NTSPVLASLME 895 (931)
Q Consensus 818 ~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~--~~s~eL~dLI~ 895 (931)
.....++..|++||.+.+...+.++|+||||+++|+|++|..||.............. ......+. .++..+.++|.
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~ 232 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLK 232 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHH
Confidence 2455688999999999988889999999999999999999999988765544443332 22222332 33889999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 002355 896 SCWADDPAQRPSFANIVES 914 (931)
Q Consensus 896 rcL~~DPeeRPSa~ELLq~ 914 (931)
+||+.+|.+|||+.+++++
T Consensus 233 ~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHccCChhhCCCHHHHhcC
Confidence 9999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=308.64 Aligned_cols=250 Identities=29% Similarity=0.510 Sum_probs=215.9
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
+|++.++||.|+||.||++++ +++.+|+|++............+.+|+++++.++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 589999999999999999976 567899999987665555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCC-CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 738 LPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 738 ~~GgSL~d~L~r~~-~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
+++++|.+++.+.. ....+++..++.++.|++.||+|||+.| ++|+||+|.||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 99999999886522 2346889999999999999999999999 999999999999999999999999999866544
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMES 896 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~r 896 (931)
......++..|++||.+.+..++.++|+||||+++|+|++|+.||...+.......+. .......+...+.++.++|.+
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPIYSQDLQNFIRS 235 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCchhhCHHHHHHHHH
Confidence 2234567889999999998888999999999999999999999998887665554443 233344556788999999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 002355 897 CWADDPAQRPSFANIVES 914 (931)
Q Consensus 897 cL~~DPeeRPSa~ELLq~ 914 (931)
||..+|.+||++.+++++
T Consensus 236 ~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 236 MLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HcCCCcccCCCHHHHhcC
Confidence 999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.93 Aligned_cols=249 Identities=27% Similarity=0.503 Sum_probs=210.4
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
+.|++.+.||.|+||.||+|.+ .+..||+|++..... ......+.+|+++++.++|+||+++++.+..+...++|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 4567778899999999999976 467899999875432 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+.+++|.+++.. ..+++..++.++.||+.||.|||+.| ++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 83 YLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred ccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 9999999998854 35889999999999999999999999 99999999999999999999999999876544322
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMES 896 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~r 896 (931)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+. .......+...+..+.+||.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 235 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYSKPFKEFVEA 235 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-cCCCCCCCcccCHHHHHHHHH
Confidence 2334567889999999999888999999999999999999999998766554443322 233334556678899999999
Q ss_pred hcccCCCCCCCHHHHHHHH
Q 002355 897 CWADDPAQRPSFANIVESL 915 (931)
Q Consensus 897 cL~~DPeeRPSa~ELLq~L 915 (931)
||..+|.+||++.+++++-
T Consensus 236 ~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 236 CLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred HccCCcccCcCHHHHHHhH
Confidence 9999999999999999863
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=315.16 Aligned_cols=251 Identities=23% Similarity=0.355 Sum_probs=204.4
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
+|++.++||.|++|.||+|++ +++.||||++...... .....+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 589999999999999999987 5778999999765432 2235667899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccc
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~ 817 (931)
+.+ +|.+++........+++..+..++.||+.||.|||+.| ++||||||+||+++.++.++|+|||++.........
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 964 88888865443456899999999999999999999999 999999999999999999999999998754433222
Q ss_pred cCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc----------------cc
Q 002355 818 SKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR----------------RL 880 (931)
Q Consensus 818 ~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~----------------r~ 880 (931)
.....++..|++||.+.+. .++.++|||||||++|+|++|..||.+.+..+....+..... ..
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 2334568899999988664 468899999999999999999999987765544433321100 00
Q ss_pred -----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 -----------AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 -----------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+....+..+.++|.+||+.+|.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0112457789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.74 Aligned_cols=248 Identities=28% Similarity=0.533 Sum_probs=212.3
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
+-|+++++||.|+||.||+|.+ .+..||||+...... ......+.+|+.++++++||||+++++++..+...++|||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 4578889999999999999976 567899998865432 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+.+++|.+++.. ..+++..+..++.|++.||.|||+.| ++|+||||.||+++.++.++|+|||++........
T Consensus 83 ~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 83 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 9999999999864 35889999999999999999999999 99999999999999999999999999875544322
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMES 896 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~r 896 (931)
......++..|+|||.+.+...+.++|+|||||++|+|++|..||...........+. ......++..++..+.++|.+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~ 235 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEA 235 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-cCCCCCCCcccCHHHHHHHHH
Confidence 2234567889999999988888999999999999999999999998777655554442 233444566788999999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 002355 897 CWADDPAQRPSFANIVES 914 (931)
Q Consensus 897 cL~~DPeeRPSa~ELLq~ 914 (931)
||..+|.+||++.+++++
T Consensus 236 ~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 236 CLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HccCChhhCcCHHHHHhC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=316.52 Aligned_cols=252 Identities=24% Similarity=0.345 Sum_probs=203.5
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|++.++||.|++|+||+|++ +++.||+|++............+.+|+++++.++|+||+++++++..+.++|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 6899999999999999999986 46789999987654433444667889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC-CCcEEEEecCccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~-dg~IKL~DFGlAr~~~~~~ 815 (931)
|+. ++|.+++.... ...+++..++.++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 58888775422 234678889999999999999999999 999999999999985 5679999999997654332
Q ss_pred cccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-c--------------
Q 002355 816 ISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-R-------------- 879 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~-r-------------- 879 (931)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|..||......+.+..+..... .
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 22234467889999998876 4578899999999999999999999987665444433211000 0
Q ss_pred ------------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 ------------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 ------------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.......++++.++|.+||+.+|++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00123567889999999999999999999999975
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=316.39 Aligned_cols=253 Identities=25% Similarity=0.301 Sum_probs=201.8
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCe-----
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPH----- 730 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~----- 730 (931)
++|++.+.||.|+||.||+|++ +++.||||++............+.+|+.+++.+. |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4799999999999999999987 5778999998765433333456788999999995 6999999999876655
Q ss_pred EEEEEeecCCCCHHHHhhcCCC--CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC-CCcEEEEecCc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAA--GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGL 807 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~--~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~-dg~IKL~DFGl 807 (931)
.|+||||+.+ +|.+++..... ...+++..++.++.||+.||.|||++| |+||||||+||+++. ++.+||+|||+
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeeccc
Confidence 8999999975 88888764322 346899999999999999999999999 999999999999998 88999999999
Q ss_pred cccccccccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc-------
Q 002355 808 SRFKANTFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR------- 879 (931)
Q Consensus 808 Ar~~~~~~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r------- 879 (931)
+..............+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 8754433222233456889999998865 45688999999999999999999999876654443322111000
Q ss_pred -------------------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 -------------------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 -------------------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
......++.++.+||.+||..+|.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00113578889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=312.59 Aligned_cols=247 Identities=29% Similarity=0.433 Sum_probs=195.8
Q ss_pred EecccCceEEEEEEEcC----CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCC
Q 002355 666 RVGAGSFGTVHRAEWHG----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRG 741 (931)
Q Consensus 666 kLG~G~fGtVylAr~~g----~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~Gg 741 (931)
.||+|+||.||+|++.+ ..+|+|.++..... .....+.+|+.++++++||||+++++++......++||||++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 58999999999997643 45899988765432 23356888999999999999999999999989999999999999
Q ss_pred CHHHHhhcCCC--CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc--c
Q 002355 742 SLYRLIHRPAA--GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI--S 817 (931)
Q Consensus 742 SL~d~L~r~~~--~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~--~ 817 (931)
+|.+++..... ....++..+..++.|++.||+|||+.+ ++|+||||+||+++.+++++|+|||++........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 99999864221 224567788889999999999999999 99999999999999999999999999875433211 1
Q ss_pred cCCCCCCCcccCcccccCC-------CCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcc-cc---cCCCCC
Q 002355 818 SKSVAGTPEWMAPEFLRGE-------PSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQN-RR---LAIPQN 885 (931)
Q Consensus 818 ~~~~~GT~~Y~APEvL~~~-------~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~-~r---~~lP~~ 885 (931)
.....++..|+|||++.+. .++.++|||||||++|||++ |..||......+......... .+ ..+...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 2234567889999998643 34779999999999999996 999998877655543322211 11 122235
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 886 TSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
.++.+.++|.+|+ .+|++|||+++|+..|.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 6788999999999 58999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=332.50 Aligned_cols=243 Identities=23% Similarity=0.312 Sum_probs=193.3
Q ss_pred cCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
..+|++++.||+|+||.||+|++. ++.||+|+.... ....|+.++++++|+||+++++++..+...++||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 467999999999999999999874 567999975432 2356899999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
|++ .++|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 137 e~~-~~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 137 PHY-SSDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred Ecc-CCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 999 5688888864 2346899999999999999999999999 9999999999999999999999999997533221
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCC-CCCChH----------HHHHHHHhcc-cccCCC
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPW-NGLGPA----------QVVGAVAFQN-RRLAIP 883 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF-~~~~~~----------eii~~i~~~~-~r~~lP 883 (931)
......||..|+|||++.+..++.++|||||||++|||+++..++ ...... .+...+.... .+..++
T Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 223457899999999999999999999999999999999865544 332110 1111110000 000011
Q ss_pred ------------------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 884 ------------------------------QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 884 ------------------------------~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
..++..+.+||.+||+.||.+|||+.|+++|
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 2346677889999999999999999999987
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=309.41 Aligned_cols=250 Identities=27% Similarity=0.470 Sum_probs=211.4
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecc---cchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC--CeE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQD---FLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--PHL 731 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~---~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~--~~l 731 (931)
.+|++.+.||+|+||.||+|++ +++.||+|++.... ........+.+|+.++++++|+||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5799999999999999999976 57789999875432 1224456788999999999999999999998654 568
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+.| ++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 9999999999999998652 34788999999999999999999999 999999999999999999999999998754
Q ss_pred cccc---cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChH
Q 002355 812 ANTF---ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888 (931)
Q Consensus 812 ~~~~---~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~ 888 (931)
.... .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||..........++.....+..+|...++
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 236 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD 236 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCH
Confidence 3211 1112356889999999999888899999999999999999999999887666655555545556667889999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 889 VLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+.++|.+||. +|..||++.+++.|
T Consensus 237 ~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 237 ACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHHHHHHhc-CcccCccHHHHhcC
Confidence 99999999999 47999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=312.80 Aligned_cols=247 Identities=35% Similarity=0.575 Sum_probs=205.3
Q ss_pred EecccCceEEEEEEEcC--------CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 666 RVGAGSFGTVHRAEWHG--------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 666 kLG~G~fGtVylAr~~g--------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
.||.|+||.||+|++.. ..+|+|.+.... .......+.+|+.+++.++||||+++++++......++||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 58999999999997642 468999876542 223346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCC----CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC-----cEEEEecCcc
Q 002355 738 LPRGSLYRLIHRPA----AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-----TVKVCDFGLS 808 (931)
Q Consensus 738 ~~GgSL~d~L~r~~----~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg-----~IKL~DFGlA 808 (931)
+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++ .++|+|||++
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999986421 2234788999999999999999999999 99999999999999877 8999999998
Q ss_pred ccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCC
Q 002355 809 RFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQN 885 (931)
Q Consensus 809 r~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~ 885 (931)
....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+. .......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-cCCccCCccc
Confidence 7543221 11122345678999999998889999999999999999998 999998877666555443 3344556678
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 886 TSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
.+..+.+||.+||..+|.+||++.++++.|+
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 8999999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=309.44 Aligned_cols=236 Identities=25% Similarity=0.451 Sum_probs=193.3
Q ss_pred EEecccCceEEEEEEEcCC------------ceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 665 ERVGAGSFGTVHRAEWHGS------------DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~~g~------------~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
++||+|+||.||+|.+.+. .+++|++...... ...+.+|+.+++.++|+||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 3699999999999987433 3777776544321 4678899999999999999999999887 7789
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC-------cEEEEec
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-------TVKVCDF 805 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg-------~IKL~DF 805 (931)
+||||+.+++|.+++.+.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++ .+||+||
T Consensus 77 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEEEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999999997632 25889999999999999999999999 99999999999999887 8999999
Q ss_pred CccccccccccccCCCCCCCcccCcccccCC--CCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCC
Q 002355 806 GLSRFKANTFISSKSVAGTPEWMAPEFLRGE--PSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAI 882 (931)
Q Consensus 806 GlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~--~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~l 882 (931)
|++...... ....++..|+|||++.+. .++.++|||||||++|+|++ |..||............. .....
T Consensus 153 g~a~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~~~~~ 225 (259)
T cd05037 153 GIPITVLSR----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---DQHRL 225 (259)
T ss_pred Ccccccccc----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---cCCCC
Confidence 998765432 334567789999999876 78899999999999999999 588887765433332221 12223
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002355 883 PQNTSPVLASLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 883 P~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
+......+.+||.+||..+|.+|||+.++++.|
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 226 PMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 333348899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.21 Aligned_cols=250 Identities=25% Similarity=0.415 Sum_probs=208.0
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeeccc-chHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDF-LDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~-~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.+|++.++||+|+||+||+|+. .++.||+|++..... .......+.+|+.+++.++||||+++++++..++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 5789999999999999999986 578899999865433 2344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+. ++|.+++... ...+++..+..++.||+.||.|||+.| |+|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 9995 5777776542 235899999999999999999999999 999999999999999999999999998754332
Q ss_pred cccCCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLR---GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~---~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
....++..|+|||++. ...++.++||||||+++|+|++|..||...+.......+.........+..++..+.+
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRN 245 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 3456788999999874 3457889999999999999999999998877655544443222222233457889999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHH
Q 002355 893 LMESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
||.+||..+|.+||++.+++.+..-
T Consensus 246 li~~~l~~~p~~Rp~~~~il~~~~~ 270 (307)
T cd06607 246 FVDSCLQKIPQDRPSSEELLKHRFV 270 (307)
T ss_pred HHHHHhcCChhhCcCHHHHhcChhh
Confidence 9999999999999999999987553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=313.19 Aligned_cols=247 Identities=27% Similarity=0.541 Sum_probs=207.0
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC---CCCeeeEEeeeeeCCeEEEE
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR---HPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~---HpNIV~Lid~f~~~~~l~LV 734 (931)
.|++.++||.|+||.||+|.+ .++.||+|++.... .......+.+|+.+++.++ ||||+++++++..+...|+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 477889999999999999987 57789999987543 2334567889999999996 99999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||+.+++|.+++.. ..+++..++.++.||+.||.|||+.| |+|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 81 MEYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999999864 25889999999999999999999999 999999999999999999999999998765544
Q ss_pred ccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCC-CChHHHHH
Q 002355 815 FISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQ-NTSPVLAS 892 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~-~~s~eL~d 892 (931)
........|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+.. .....++. ..+.++.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 155 SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK-SKPPRLEDNGYSKLLRE 233 (277)
T ss_pred ccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc-CCCCCCCcccCCHHHHH
Confidence 333344578899999998865 4568899999999999999999999987765544433221 12222333 37889999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 002355 893 LMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~ 914 (931)
||.+||..+|.+||++.+++.+
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhC
Confidence 9999999999999999999876
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=333.81 Aligned_cols=245 Identities=26% Similarity=0.395 Sum_probs=197.5
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC--C---eEE
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--P---HLS 732 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~--~---~l~ 732 (931)
.|.-.+.+|.|+||.||+|+. +++.||||..-...-.. .+|+++|+.+.|||||+|+.+|... . ...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 678899999999999999976 56789999886543211 3799999999999999999888532 2 456
Q ss_pred EEEeecCCCCHHHHhhcC-CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC-CcEEEEecCcccc
Q 002355 733 IVTEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN-WTVKVCDFGLSRF 810 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~-~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d-g~IKL~DFGlAr~ 810 (931)
+|||||+ .+|+++++.. ..+..++...++-+..||++||+|||++| |+||||||.|||+|.+ |.+||||||.|+.
T Consensus 99 lVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 99 LVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 8999995 5999998742 12346788888889999999999999999 9999999999999976 8999999999997
Q ss_pred ccccccccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc---------
Q 002355 811 KANTFISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL--------- 880 (931)
Q Consensus 811 ~~~~~~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~--------- 880 (931)
..... ...+...|..|+|||.+.+. .|+.+.||||.||+|.||+-|++.|.+.+....+..+...-..+
T Consensus 176 L~~~e-pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 176 LVKGE-PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred eccCC-CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 65443 22456679999999999885 57999999999999999999999999876543332221110000
Q ss_pred ------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 ------------------AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 ------------------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+....+++..+|+.++|.++|.+|.++.|++.|
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0235678999999999999999999999999976
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=314.98 Aligned_cols=238 Identities=23% Similarity=0.429 Sum_probs=196.0
Q ss_pred EecccCceEEEEEEEc---------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 666 RVGAGSFGTVHRAEWH---------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 666 kLG~G~fGtVylAr~~---------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
.||.|+||.||+|.+. ...||+|++.... ....+.+.+|+.+++.+.||||+++++++..+...++|||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 5899999999999763 2348888875432 2334677889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc--------EEEEecCcc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT--------VKVCDFGLS 808 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~--------IKL~DFGlA 808 (931)
|+.+++|..++.... ..+++..+..++.||+.||+|||++| |+||||||+||+++.++. ++++|||++
T Consensus 80 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 80 YVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred cCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999997532 35889999999999999999999999 999999999999987764 699999998
Q ss_pred ccccccccccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcccccCCCCCC
Q 002355 809 RFKANTFISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNT 886 (931)
Q Consensus 809 r~~~~~~~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG-~~PF~~~~~~eii~~i~~~~~r~~lP~~~ 886 (931)
...... ....++..|+|||++.+. .++.++|||||||++|+|++| ..||........... ......+|...
T Consensus 156 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 228 (258)
T cd05078 156 ITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF---YEDRHQLPAPK 228 (258)
T ss_pred cccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH---HHccccCCCCC
Confidence 654332 345678899999999874 478899999999999999999 567766554433222 22345567777
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 887 SPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
+.++.+||.+||+.+|++|||++++++.|+
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=319.75 Aligned_cols=244 Identities=23% Similarity=0.355 Sum_probs=186.7
Q ss_pred EEEecccCceEEEEEEEc----CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeee--eCCeEEEEEee
Q 002355 664 KERVGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT--KRPHLSIVTEY 737 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~~----g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~--~~~~l~LVmEy 737 (931)
..+||+|+||+||+|+.. +..||+|.+...... ..+.+|+++++.++||||+++++++. .+..+++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 468999999999999863 357999988654322 34678999999999999999999885 45678999999
Q ss_pred cCCCCHHHHhhcC------CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEE----CCCCcEEEEecCc
Q 002355 738 LPRGSLYRLIHRP------AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGL 807 (931)
Q Consensus 738 ~~GgSL~d~L~r~------~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILL----d~dg~IKL~DFGl 807 (931)
+ +++|.+++... .....+++..++.++.||+.||.|||+.| |+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 82 A-EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred e-CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 9 46888777421 11235889999999999999999999999 9999999999999 5667999999999
Q ss_pred ccccccccc---ccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChH----------HHHHHH
Q 002355 808 SRFKANTFI---SSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPA----------QVVGAV 873 (931)
Q Consensus 808 Ar~~~~~~~---~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~----------eii~~i 873 (931)
++....... ......||+.|+|||++.+. .++.++|||||||++|||+||.+||...... +.....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 986543321 12345679999999998774 4789999999999999999999999653211 000000
Q ss_pred Hhcc-----------------------cc------------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 874 AFQN-----------------------RR------------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 874 ~~~~-----------------------~r------------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.... .. .......+..+.+||.+||..||.+|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000 00 00112335678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=313.37 Aligned_cols=250 Identities=25% Similarity=0.345 Sum_probs=203.5
Q ss_pred eEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeec
Q 002355 661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYL 738 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~ 738 (931)
|++.++||.|++|.||+|.+ ++..||+|++............+.+|+.+++.++|+||+++++++..++..|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67889999999999999976 5788999998766444333456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccccc
Q 002355 739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS 818 (931)
Q Consensus 739 ~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~ 818 (931)
+++|.+++.... ...+++..++.++.||+.||+|||+++ ++||||+|+||+++.++.++|+|||++..........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 81 -DLDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred -CcCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 568999886532 235899999999999999999999999 9999999999999999999999999987544332222
Q ss_pred CCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc--------------------
Q 002355 819 KSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN-------------------- 877 (931)
Q Consensus 819 ~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~-------------------- 877 (931)
....++..|+|||++.+. .++.++|||||||++|+|++|..||...........+....
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 334568899999988664 46889999999999999999999998766543322221100
Q ss_pred -------cccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 878 -------RRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 878 -------~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
........++..+.++|.+||+.+|.+|||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0001234567889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=313.18 Aligned_cols=250 Identities=24% Similarity=0.325 Sum_probs=197.9
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|++++.||+|+||.||+|.+ +++.||+|++...... .....+.+|+.+++.++|+||+++++++..+...|+|||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 6899999999999999999976 5788999998765322 222356789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+. ++|.+++... ...+++..+..++.||+.||.|||+.| |+|+||||+||+++.++.++|+|||+++.......
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 84 YMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred ccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 994 6777766542 234778888899999999999999999 99999999999999999999999999876443322
Q ss_pred ccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhccc----------------
Q 002355 817 SSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPA-QVVGAVAFQNR---------------- 878 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~-eii~~i~~~~~---------------- 878 (931)
......++..|+|||.+.+. .++.++|||||||++|+|++|..||...... +.+..+.....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 23344578899999998764 4788999999999999999999999765532 21111110000
Q ss_pred -----ccCCC---------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 -----RLAIP---------QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 -----r~~lP---------~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
....+ ...+..+.+||.+||..||.+|||+.+++.|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000 1235688999999999999999999998865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.18 Aligned_cols=239 Identities=23% Similarity=0.423 Sum_probs=192.5
Q ss_pred EEecccCceEEEEEEEcC--------------CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe
Q 002355 665 ERVGAGSFGTVHRAEWHG--------------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH 730 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~~g--------------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~ 730 (931)
+.||+|+||.||+|+... ..|++|++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 368999999999997421 247888765432 2334577889999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc-------EEEE
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT-------VKVC 803 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~-------IKL~ 803 (931)
.++||||+.+++|..++.+. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. ++++
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred CEEEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999999888652 245899999999999999999999999 999999999999987664 8999
Q ss_pred ecCccccccccccccCCCCCCCcccCccccc-CCCCCchhHHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhcccccC
Q 002355 804 DFGLSRFKANTFISSKSVAGTPEWMAPEFLR-GEPSNEKSDVYSFGVILWELV-TMQQPWNGLGPAQVVGAVAFQNRRLA 881 (931)
Q Consensus 804 DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~-~~~~t~ksDIWSLG~ILyELL-TG~~PF~~~~~~eii~~i~~~~~r~~ 881 (931)
|||++...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......+... .. .....
T Consensus 155 d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~--~~~~~ 227 (262)
T cd05077 155 DPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FY--EGQCM 227 (262)
T ss_pred CCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HH--hcCcc
Confidence 99998654322 2345788999999887 466888999999999999997 5888887655433321 11 12222
Q ss_pred CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 882 IPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 882 lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
.....++++.+||.+||+.||.+||++.+|++.|+
T Consensus 228 ~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 228 LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 33445688999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=359.48 Aligned_cols=260 Identities=26% Similarity=0.364 Sum_probs=211.1
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|+++++||+|+||.||+|++ +++.||||++...... .....++.+|+++++.++||||+++++++..++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 6899999999999999999987 4788999999764332 233467899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCC--------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCc
Q 002355 736 EYLPRGSLYRLIHRPAA--------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~--------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGl 807 (931)
||++|++|.+++..... ...++...++.++.||+.||+|||++| |+||||||+|||++.++.++|+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEecCc
Confidence 99999999998864211 123556778899999999999999999 99999999999999999999999999
Q ss_pred ccccccc------------------ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH
Q 002355 808 SRFKANT------------------FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQV 869 (931)
Q Consensus 808 Ar~~~~~------------------~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~ei 869 (931)
++..... .......+||+.|+|||++.+..++.++|||||||++|||+||..||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 9754110 0011235699999999999999999999999999999999999999987554333
Q ss_pred HHHHHhccccc--CCCCCChHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHhhC
Q 002355 870 VGAVAFQNRRL--AIPQNTSPVLASLMESCWADDPAQRP-SFANIVESLKKLLKS 921 (931)
Q Consensus 870 i~~i~~~~~r~--~lP~~~s~eL~dLI~rcL~~DPeeRP-Sa~ELLq~L~~Llks 921 (931)
..... ...+. .....+++.+.+++.+||..||.+|+ +++++++.|...++.
T Consensus 240 ~~~~~-i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 240 SYRDV-ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhhhh-ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 22211 11111 11246788999999999999999995 677888888887765
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=310.53 Aligned_cols=249 Identities=26% Similarity=0.484 Sum_probs=213.7
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCeEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~l~LV 734 (931)
++|++.+.||+|+||.||+|+. ++..||+|++...... ......+.+|+.+++++. |+||+++++.+..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4799999999999999999987 6788999998765432 233467789999999998 99999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
||++.+++|.+++.+. ..+++..++.++.||+.||.|||++| ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999999999763 36999999999999999999999999 999999999999999999999999998754432
Q ss_pred c--------------------cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 002355 815 F--------------------ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVA 874 (931)
Q Consensus 815 ~--------------------~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~ 874 (931)
. .......++..|+|||++.+...+.++|+|||||++|++++|..||........+..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 2 12233457889999999988888999999999999999999999999877655554443
Q ss_pred hcccccCCCCCChHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 002355 875 FQNRRLAIPQNTSPVLASLMESCWADDPAQRPSF----ANIVES 914 (931)
Q Consensus 875 ~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa----~ELLq~ 914 (931)
.....++..+++.+.+||.+||..+|.+||++ .++++|
T Consensus 236 --~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 236 --KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred --hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 34455677889999999999999999999999 777764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.93 Aligned_cols=250 Identities=29% Similarity=0.509 Sum_probs=212.3
Q ss_pred cCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.+.|++.+.||.|+||.||+|++. +..|++|++..... ....+.+|+.+++.++|+||+++++.+......++|+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 467889999999999999999885 78899999976543 3467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+.+++|.+++.... ..+++..++.++.||+.||.|||+.| |+|+||+|+||+++.++.++|+|||++.......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999999997632 36899999999999999999999999 9999999999999999999999999886544332
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc-cCCCCCChHHHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR-LAIPQNTSPVLASLM 894 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r-~~lP~~~s~eL~dLI 894 (931)
.......++..|++||++.+..++.++|+|||||++|+|++|..||...........+...... ...+..++..+.+||
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 250 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFL 250 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHH
Confidence 2223445788999999999888899999999999999999999999887765554444322221 122334788999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 002355 895 ESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 895 ~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+||+.+|.+||++.+++++
T Consensus 251 ~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 251 NKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHhccChhhCcCHHHHhhC
Confidence 99999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=313.13 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=198.4
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC------
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP------ 729 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~------ 729 (931)
.++|++.++||+|+||.||+|++ +++.||||++............+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 36899999999999999999987 5788999998765433333345678999999999999999999876543
Q ss_pred --eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCc
Q 002355 730 --HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807 (931)
Q Consensus 730 --~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGl 807 (931)
..++||||+. ++|.+++... ...+++..++.++.||+.||+|||++| ++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEEECcCCC
Confidence 4699999994 5888887642 235899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccc----ccCCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc---
Q 002355 808 SRFKANTFI----SSKSVAGTPEWMAPEFLRGEP-SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR--- 879 (931)
Q Consensus 808 Ar~~~~~~~----~~~~~~GT~~Y~APEvL~~~~-~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r--- 879 (931)
+........ ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||.+.........+......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 875433211 112345678899999887643 688999999999999999999999876654433222111000
Q ss_pred --------------cCCC-------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 --------------LAIP-------------QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 --------------~~lP-------------~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
...+ ...+..+.+||.+||..||.+|||++++++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0011 1235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.11 Aligned_cols=264 Identities=24% Similarity=0.400 Sum_probs=213.0
Q ss_pred cccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC---
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--- 728 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~--- 728 (931)
+.|+.++|++.+.||+|||+.||+++. +++.||+|.+.... .+.....++|+...++++||||++++++...+
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 456779999999999999999999985 77889999998876 44567889999999999999999999887433
Q ss_pred --CeEEEEEeecCCCCHHHHhhcCC-CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEec
Q 002355 729 --PHLSIVTEYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDF 805 (931)
Q Consensus 729 --~~l~LVmEy~~GgSL~d~L~r~~-~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DF 805 (931)
...||+++|...|+|.+.+.+.. .+..+++.+++.|+.+|.+||++||+..++++||||||.|||+..++.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 34899999999999999987543 344899999999999999999999999999999999999999999999999999
Q ss_pred Ccccccccccc---------ccCCCCCCCcccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 002355 806 GLSRFKANTFI---------SSKSVAGTPEWMAPEFLRG---EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAV 873 (931)
Q Consensus 806 GlAr~~~~~~~---------~~~~~~GT~~Y~APEvL~~---~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i 873 (931)
|.+....-... .......|..|+|||.+.- ...+.++|||||||++|+|+.|.-||...-...--.+.
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL 253 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL 253 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence 99875322110 0112235889999998864 44588999999999999999999999653211100011
Q ss_pred HhcccccCCC--CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 002355 874 AFQNRRLAIP--QNTSPVLASLMESCWADDPAQRPSFANIVESLKKLL 919 (931)
Q Consensus 874 ~~~~~r~~lP--~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Ll 919 (931)
..++....+| ...+..+.+||+.||+.||.+||++.+++.+++++.
T Consensus 254 Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 254 AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1112222233 347899999999999999999999999999998875
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=316.85 Aligned_cols=249 Identities=26% Similarity=0.464 Sum_probs=208.8
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|++.++||+|+||.||++.. ++..||+|++..... ...+.+.+|+.+++.++||||+++++.+..++..|+|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 47999999999999999999975 567899999865432 23467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+++++|.+++.+ ..+++..+..++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 96 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred ecCCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 99999999999865 24788899999999999999999999 9999999999999999999999999887544332
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-cccCCCCCChHHHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN-RRLAIPQNTSPVLASLM 894 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~-~r~~lP~~~s~eL~dLI 894 (931)
.......+++.|++||.+.+..++.++|+|||||++|+|++|..||...+.......+.... .....+..++..+.+||
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 249 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 249 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHH
Confidence 22334568889999999988888999999999999999999999998766544332222111 11223445678899999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 002355 895 ESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 895 ~rcL~~DPeeRPSa~ELLq~ 914 (931)
++||..+|++||++.+++.+
T Consensus 250 ~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 250 NRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHccCChhhCcCHHHHhcC
Confidence 99999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=361.66 Aligned_cols=264 Identities=33% Similarity=0.571 Sum_probs=228.8
Q ss_pred ccccCceEEEEEecccCceEEEEEEEc---CC----ceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEWH---GS----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK 727 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~~---g~----~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~ 727 (931)
+++..+.++.+.||+|+||.||.|... +. .||||.++... .......|++|..+|+.++|||||++++++..
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 467889999999999999999999762 32 27777776543 34556889999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhhcCCC----CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEE
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRPAA----GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVC 803 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~~~----~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~ 803 (931)
....+|++|||+||+|..+|++... ...+..+..+.++.||++|+.||++++ +|||||-..|+||+....+||+
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEc
Confidence 9999999999999999999987421 345888999999999999999999998 9999999999999999999999
Q ss_pred ecCcccc-ccccccccCC-CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccccc
Q 002355 804 DFGLSRF-KANTFISSKS-VAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRL 880 (931)
Q Consensus 804 DFGlAr~-~~~~~~~~~~-~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~ 880 (931)
|||+|+- .......... ..-+..|||||.+....++.++||||||++|||++| |..||.+.++.+++..+.... ++
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL 923 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RL 923 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-cc
Confidence 9999993 2222211111 234579999999999999999999999999999998 799999999999888776555 99
Q ss_pred CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 881 AIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 881 ~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
..|..++..+.++|..||+.+|+.||++..|++.+.++.+..
T Consensus 924 ~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 924 DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 999999999999999999999999999999999998887764
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=319.92 Aligned_cols=248 Identities=27% Similarity=0.470 Sum_probs=207.5
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
+.|....+||.|+||.||+++. ++..||||.+.... ......+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 4555567899999999999976 57789999986543 2334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+++++|.+++.. ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.++|+|||++........
T Consensus 100 ~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 100 FLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred CCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 9999999998854 24888999999999999999999999 99999999999999999999999999875443332
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-cccCCCCCChHHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN-RRLAIPQNTSPVLASLME 895 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~-~r~~lP~~~s~eL~dLI~ 895 (931)
......|+..|+|||.+.+..++.++|+||||+++|||++|..||...........+.... .........+..+.+||.
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 253 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLD 253 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHH
Confidence 3344568899999999988889999999999999999999999998776655444432211 111223356889999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 002355 896 SCWADDPAQRPSFANIVES 914 (931)
Q Consensus 896 rcL~~DPeeRPSa~ELLq~ 914 (931)
+||..+|.+|||+.+++++
T Consensus 254 ~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 254 LMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHccCChhHCcCHHHHhhC
Confidence 9999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.03 Aligned_cols=246 Identities=27% Similarity=0.468 Sum_probs=206.8
Q ss_pred eEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeec
Q 002355 661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYL 738 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~ 738 (931)
|....+||.|+||.||+|++ .++.||+|++...... ....+.+|+.+++.+.||||+++++++..++..++||||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 44455799999999999976 5788999998764332 2356789999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccccc
Q 002355 739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS 818 (931)
Q Consensus 739 ~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~ 818 (931)
++++|..++.. ..+++..++.++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++..........
T Consensus 101 ~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 174 (297)
T cd06659 101 QGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 174 (297)
T ss_pred CCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence 99999998754 34889999999999999999999999 9999999999999999999999999987544333233
Q ss_pred CCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-cccCCCCCChHHHHHHHHHh
Q 002355 819 KSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN-RRLAIPQNTSPVLASLMESC 897 (931)
Q Consensus 819 ~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~-~r~~lP~~~s~eL~dLI~rc 897 (931)
....|+..|+|||++.+..++.++|+|||||++|+|++|+.||......+....+.... .....+...+..+.++|.+|
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence 45678999999999998889999999999999999999999998766555544432211 11223456788999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 002355 898 WADDPAQRPSFANIVES 914 (931)
Q Consensus 898 L~~DPeeRPSa~ELLq~ 914 (931)
|+.+|.+||++.+++++
T Consensus 255 l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 255 LTREPQERATAQELLDH 271 (297)
T ss_pred hcCCcccCcCHHHHhhC
Confidence 99999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=315.37 Aligned_cols=252 Identities=22% Similarity=0.356 Sum_probs=197.8
Q ss_pred ceEEEEEecccCceEEEEEEE----cCCceEEEEEeeccc-chHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC--CeEE
Q 002355 660 ELHVKERVGAGSFGTVHRAEW----HGSDVAVKVLTVQDF-LDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--PHLS 732 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~----~g~~VAVKVlk~~~~-~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~--~~l~ 732 (931)
+|++.++||+|+||.||+|.+ .++.||||++..... .......+.+|+.+++.++||||+++++++... ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 588999999999999999987 467899999987431 122235567899999999999999999999877 8899
Q ss_pred EEEeecCCCCHHHHhhcCC--CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC----CCcEEEEecC
Q 002355 733 IVTEYLPRGSLYRLIHRPA--AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK----NWTVKVCDFG 806 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~--~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~----dg~IKL~DFG 806 (931)
+||||+. ++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999995 57777664322 2236899999999999999999999999 999999999999999 9999999999
Q ss_pred cccccccccc---ccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---------HHHHH
Q 002355 807 LSRFKANTFI---SSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQ---------VVGAV 873 (931)
Q Consensus 807 lAr~~~~~~~---~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~e---------ii~~i 873 (931)
++........ ......++..|+|||++.+. .++.++|||||||++|+|++|++||....... .+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9886543221 22344678899999988764 57889999999999999999999997654321 00000
Q ss_pred Hh------------------------cccccCCC-----------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 874 AF------------------------QNRRLAIP-----------QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 874 ~~------------------------~~~r~~lP-----------~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.. .......+ ...+..+.++|.+||..||++|||+.|++++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 00001111 1566789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=307.70 Aligned_cols=246 Identities=22% Similarity=0.331 Sum_probs=197.1
Q ss_pred eEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeC--CeEEEEE
Q 002355 661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKR--PHLSIVT 735 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~--~~l~LVm 735 (931)
|+++++||.|+||.||+|++ +++.||+|+++........ ....+|+.++.++. |+||+++++++..+ +.+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 67899999999999999976 5778999998765322222 23457899999885 99999999999877 8899999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+. ++|.+.+... ...+++..++.++.||+.||+|||+.| ++||||||+||+++. +.+||+|||++.......
T Consensus 80 e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 80 ELMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred ecCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9996 5888777642 246899999999999999999999999 999999999999999 999999999997654332
Q ss_pred cccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc----------------c
Q 002355 816 ISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN----------------R 878 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~----------------~ 878 (931)
. .....++..|+|||.+.. ..++.++|||||||++|||++|..||.+.+..+.+..+.... .
T Consensus 154 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 154 P-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred C-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 1 123457889999997654 456889999999999999999999998776544433221100 0
Q ss_pred ccCC-----------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 RLAI-----------PQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 r~~l-----------P~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.... ....+..+.+||.+||..+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0011 13567899999999999999999999999876
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=321.63 Aligned_cols=259 Identities=23% Similarity=0.411 Sum_probs=218.6
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc------hHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCC
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL------DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRP 729 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~------~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~ 729 (931)
+.|.-.+.||+|..++|-++.+ ++..+|+|++...... ......-..|+.||+++ .||||+++.++|..+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4667778899999999999854 6788999998654321 12234557899999999 5999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
..++|+|.|+.|.|++++.. .-.++++..+.|++||+.|++|||.++ ||||||||+|||++++-+|||+|||+|+
T Consensus 97 F~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred hhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEeccceee
Confidence 99999999999999999975 346999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccCCCCCCCcccCccccc------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLR------GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP 883 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~------~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP 883 (931)
...... .....||||+|+|||.+. ..+|+..+|+|++|++||.|+.|.+||++....-++..+...+.....|
T Consensus 172 ~l~~Ge-kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 172 QLEPGE-KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred ccCCch-hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 765543 456789999999999874 2457888999999999999999999999977666677766555544333
Q ss_pred --CCChHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHhhCch
Q 002355 884 --QNTSPVLASLMESCWADDPAQRPSFANIVES--LKKLLKSPA 923 (931)
Q Consensus 884 --~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~--L~~Llks~~ 923 (931)
.+++...++||.+||+.||++|.|++|+|+| ..++....+
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~ 294 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQA 294 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcc
Confidence 5788999999999999999999999999987 344444433
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=316.03 Aligned_cols=255 Identities=25% Similarity=0.433 Sum_probs=212.6
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeeccc-chHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDF-LDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~-~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
..|...+.||+|+||.||+|++ .+..||+|++..... .......+.+|+++++.++|+|++++++++..+...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 4578899999999999999986 567899999876533 2344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+. ++|.+++... ...+++..+..++.||+.||.|||++| |+||||+|+||+++.++.++|+|||++......
T Consensus 105 e~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 105 EYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred eCCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 9996 5777777542 345899999999999999999999999 999999999999999999999999998654332
Q ss_pred cccCCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLR---GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~---~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
....++..|+|||.+. +..++.++|||||||++|+|++|..||...........+.............++.+.+
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 255 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN 255 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHH
Confidence 3456888999999974 3457889999999999999999999998877665555554433333444567889999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 893 LMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
||.+||+.+|.+||++.++++++..+...+
T Consensus 256 li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 256 FVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred HHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 999999999999999999999876655444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=308.08 Aligned_cols=247 Identities=26% Similarity=0.426 Sum_probs=194.7
Q ss_pred EecccCceEEEEEEE-cCC---ceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCC
Q 002355 666 RVGAGSFGTVHRAEW-HGS---DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRG 741 (931)
Q Consensus 666 kLG~G~fGtVylAr~-~g~---~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~Gg 741 (931)
+||+|+||.||+|+. .+. .+++|.+..... ......+.+|+.+++.++||||+++++.+......|+||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 599999999999975 333 345555544322 233567899999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCC-CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc--cccc
Q 002355 742 SLYRLIHRPAA-GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT--FISS 818 (931)
Q Consensus 742 SL~d~L~r~~~-~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~--~~~~ 818 (931)
+|.+++.+... ....++..++.++.||+.||+|||+.+ ++||||||+|||++.++.++|+|||++...... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999975321 234677788899999999999999999 999999999999999999999999998642211 1122
Q ss_pred CCCCCCCcccCcccccC-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccc----ccCCCCCC
Q 002355 819 KSVAGTPEWMAPEFLRG-------EPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNR----RLAIPQNT 886 (931)
Q Consensus 819 ~~~~GT~~Y~APEvL~~-------~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~----r~~lP~~~ 886 (931)
....++..|+|||++.. ..++.++|||||||++|||++ |..||......+.+..+..... +..++...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 34567889999998753 234678999999999999997 5778987776666555432221 23344567
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 887 SPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
++.+.++|..|| .+|.+||+++++++.|.
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 889999999999 67999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=312.33 Aligned_cols=247 Identities=29% Similarity=0.477 Sum_probs=207.5
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
+|...++||.|++|.||++.+ .++.+++|++..... ...+.+.+|+.+++.++|+||+++++++..++..++|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 455667999999999999976 567799998865432 2335678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccc
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~ 817 (931)
+.|++|.+++.. ..+++..+..++.||+.||+|||++| |+||||+|+||+++.++.++|+|||++.........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~ 171 (285)
T cd06648 98 LEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR 171 (285)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence 999999999865 34888999999999999999999999 999999999999999999999999988754433223
Q ss_pred cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-ccCCCCCChHHHHHHHHH
Q 002355 818 SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-RLAIPQNTSPVLASLMES 896 (931)
Q Consensus 818 ~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~-r~~lP~~~s~eL~dLI~r 896 (931)
.....|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+..... ....+..++..+.+||.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDR 251 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHH
Confidence 3445689999999999888889999999999999999999999987766555554433211 111233478899999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 002355 897 CWADDPAQRPSFANIVES 914 (931)
Q Consensus 897 cL~~DPeeRPSa~ELLq~ 914 (931)
||..+|++||++.+++++
T Consensus 252 ~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 252 MLVRDPAQRATAAELLNH 269 (285)
T ss_pred HcccChhhCcCHHHHccC
Confidence 999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=309.50 Aligned_cols=251 Identities=29% Similarity=0.499 Sum_probs=204.6
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee--CCeEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--RPHLSIV 734 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~--~~~l~LV 734 (931)
++|++.++||.|++|.||+|++ +++.+|+|++...... .....+.+|+++++.++||||++++++|.. .+.+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 4789999999999999999987 5678999998765332 345678899999999999999999998864 4578999
Q ss_pred EeecCCCCHHHHhhcC-CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 735 TEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~-~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
|||+++++|.+++.+. .....+++..+..++.||+.||+|||+.| ++|+||+|.||+++.++.++|+|||++.....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999999887532 12345889999999999999999999999 99999999999999999999999999875443
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHhcccccCCC-----
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLG-----PAQVVGAVAFQNRRLAIP----- 883 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~-----~~eii~~i~~~~~r~~lP----- 883 (931)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|..||.... ..+....+.. .....++
T Consensus 158 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (287)
T cd06621 158 SL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPELKDEPGN 234 (287)
T ss_pred cc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhhccCCCC
Confidence 22 123457889999999998889999999999999999999999997652 2233332221 1111111
Q ss_pred -CCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002355 884 -QNTSPVLASLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 884 -~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
...++.+.+||.+||..+|.+|||+.|++++-
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred CCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 23467899999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=345.48 Aligned_cols=254 Identities=22% Similarity=0.399 Sum_probs=234.0
Q ss_pred ccCceEEEEEecccCceEEEEEEEcCCc--eEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~g~~--VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
...+++++..||-||||.|-+++.+++. +|+|++++..+.+ ++..++..|.+||...+.|+||++|-.|.+...+||
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 4578889999999999999999887665 8999998877655 567889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
+||-|-||.|+.+++. .+.+.+.+++.++..++.|++|||++| ||+|||||+|++++.+|.+||.|||+|+..+.
T Consensus 498 LmEaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 498 LMEACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hHHhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999999976 456999999999999999999999999 99999999999999999999999999998776
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
.. .+-++|||+.|.|||++.+..++.++|.|+||+++|||++|.+||++.++..++..+........+|..++....+|
T Consensus 573 g~-KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~L 651 (732)
T KOG0614|consen 573 GR-KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDL 651 (732)
T ss_pred CC-ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHH
Confidence 53 56788999999999999999999999999999999999999999999999999999988888899999999999999
Q ss_pred HHHhcccCCCCCCC-----HHHHHHHHH
Q 002355 894 MESCWADDPAQRPS-----FANIVESLK 916 (931)
Q Consensus 894 I~rcL~~DPeeRPS-----a~ELLq~L~ 916 (931)
|++++..+|.+|.. +.+|.+|.+
T Consensus 652 ik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 652 IKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred HHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 99999999999965 677777755
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=311.62 Aligned_cols=237 Identities=23% Similarity=0.411 Sum_probs=192.4
Q ss_pred EecccCceEEEEEEEc--------------------------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCee
Q 002355 666 RVGAGSFGTVHRAEWH--------------------------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719 (931)
Q Consensus 666 kLG~G~fGtVylAr~~--------------------------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV 719 (931)
+||+|+||.||+|... ...||+|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 5999999999998631 1237888875432 23345678899999999999999
Q ss_pred eEEeeeeeCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC-
Q 002355 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW- 798 (931)
Q Consensus 720 ~Lid~f~~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg- 798 (931)
++++++..+...++||||+++++|..++.+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGL 155 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999999988652 346889999999999999999999999 99999999999997643
Q ss_pred ------cEEEEecCccccccccccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHH-hCCCCCCCCChHHHH
Q 002355 799 ------TVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELV-TMQQPWNGLGPAQVV 870 (931)
Q Consensus 799 ------~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELL-TG~~PF~~~~~~eii 870 (931)
.+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||......+..
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 231 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231 (274)
T ss_pred ccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 4899999987643222 23357788999998875 55789999999999999984 789999877655433
Q ss_pred HHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002355 871 GAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 871 ~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
... ......+...++.+.+||.+||+.+|++|||+.++++.|
T Consensus 232 ~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 232 RFY---EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHH---HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 222 122334555677899999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=310.70 Aligned_cols=244 Identities=26% Similarity=0.351 Sum_probs=201.7
Q ss_pred ecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCCCH
Q 002355 667 VGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL 743 (931)
Q Consensus 667 LG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~GgSL 743 (931)
||.|+||+||+|.+ +++.||+|++....... .....+.+|+++++.++||||+++++.|...++.|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999976 57889999987644322 2345567899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCCCCC
Q 002355 744 YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAG 823 (931)
Q Consensus 744 ~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~~~G 823 (931)
.+++.+.. ...+++..++.++.|++.||.|||+.| ++||||+|+||+++.++.++|+|||++....... ......+
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 156 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-KIKGRAG 156 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccCC-ccccccC
Confidence 99987533 235899999999999999999999999 9999999999999999999999999987544321 2234467
Q ss_pred CCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--hcccccCCCCCChHHHHHHHHHhcccC
Q 002355 824 TPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVA--FQNRRLAIPQNTSPVLASLMESCWADD 901 (931)
Q Consensus 824 T~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~--~~~~r~~lP~~~s~eL~dLI~rcL~~D 901 (931)
+..|+|||.+.+..++.++|||||||++|+|++|+.||...........+. ........+...++.+.++|.+||..+
T Consensus 157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 889999999988888999999999999999999999997654311111111 122344566778999999999999999
Q ss_pred CCCCC-----CHHHHHHH
Q 002355 902 PAQRP-----SFANIVES 914 (931)
Q Consensus 902 PeeRP-----Sa~ELLq~ 914 (931)
|.+|| ++.+++.+
T Consensus 237 p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 237 PEKRLGCRGGSADEVREH 254 (277)
T ss_pred hhHccCCCcccHHHHHhC
Confidence 99999 78888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=337.75 Aligned_cols=244 Identities=22% Similarity=0.309 Sum_probs=195.9
Q ss_pred cCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
...|.+.++||+|+||.||+|++. ++.||||.... ..+.+|+++|++|+|+||+++++++..++..++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 468999999999999999999874 57799996432 23568999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
|++ .++|..++... ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++......
T Consensus 240 e~~-~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 240 PKY-RSDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred Ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 999 57888888642 236899999999999999999999999 9999999999999999999999999997643221
Q ss_pred c--ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcccc-cCCC-
Q 002355 816 I--SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLG--------PAQVVGAVAFQNRR-LAIP- 883 (931)
Q Consensus 816 ~--~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~--------~~eii~~i~~~~~r-~~lP- 883 (931)
. ......||..|+|||++.+..++.++|||||||++|||++|..|+.... ..++...+...... ..++
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 1 1224579999999999999999999999999999999999876543221 12222222111100 0000
Q ss_pred ------------------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 884 ------------------------------QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 884 ------------------------------~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
...+..+.+||.+||++||.+|||+.|+|+|
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1345678999999999999999999999987
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=311.99 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=203.9
Q ss_pred cccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC--
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP-- 729 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~-- 729 (931)
.+...++|++.++||+|+||.||+|.+ +++.||+|+++...........+.+|+++++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 345568999999999999999999987 4678999999765433333356778999999999999999999886544
Q ss_pred --------eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEE
Q 002355 730 --------HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVK 801 (931)
Q Consensus 730 --------~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IK 801 (931)
++++|+||+.+ +|..++... ...+++..++.++.||+.||+|||+.| |+|+||||+||+++.++.+|
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCcEE
Confidence 89999999965 777777542 335899999999999999999999999 99999999999999999999
Q ss_pred EEecCcccccccccc-ccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc
Q 002355 802 VCDFGLSRFKANTFI-SSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR 879 (931)
Q Consensus 802 L~DFGlAr~~~~~~~-~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r 879 (931)
|+|||++........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|++||......+....+......
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 999999876543221 1122345778999998865 34688999999999999999999999876654443333221100
Q ss_pred c----------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 L----------------------------AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 ~----------------------------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
. .....++..+.+||.+||..+|.+||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0122468899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=303.99 Aligned_cols=240 Identities=28% Similarity=0.502 Sum_probs=203.2
Q ss_pred ecccCceEEEEEEEc--CCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCCCH
Q 002355 667 VGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL 743 (931)
Q Consensus 667 LG~G~fGtVylAr~~--g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~GgSL 743 (931)
||.|+||.||+|++. ++.+++|++...... ......+.+|+++++.++|+||+++++.+..+...|+||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999874 788999998765432 24456788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc-------
Q 002355 744 YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI------- 816 (931)
Q Consensus 744 ~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~------- 816 (931)
.+++.+. ..+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 9999763 26899999999999999999999999 99999999999999999999999999875433211
Q ss_pred -ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCC--hHHHHHH
Q 002355 817 -SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNT--SPVLASL 893 (931)
Q Consensus 817 -~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~--s~eL~dL 893 (931)
......++..|++||.+.+...+.++|+||||+++|+|++|..||......+....+... ....+... +..+.+|
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 233 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--KIEWPEDVEVSDEAIDL 233 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CcCCCccccCCHHHHHH
Confidence 223446788999999998888899999999999999999999999888777766655432 23344444 8999999
Q ss_pred HHHhcccCCCCCCCH---HHHHH
Q 002355 894 MESCWADDPAQRPSF---ANIVE 913 (931)
Q Consensus 894 I~rcL~~DPeeRPSa---~ELLq 913 (931)
|.+||+.+|.+|||+ .++++
T Consensus 234 i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHHHhcCCHhhcCCCccHHHHhc
Confidence 999999999999999 55554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=366.52 Aligned_cols=268 Identities=22% Similarity=0.374 Sum_probs=232.5
Q ss_pred cccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH 730 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~ 730 (931)
+-...++|+|++.||+|+||.|.++++ +++.||+|++.+-... ......|..|..||..-+.+-|++++.+|++..+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 345679999999999999999999987 5677999999874433 2344678899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
+|+|||||+||+|..++.+.. .+++..++.++.+|+.||+-||+.| +|||||||.|||||..|||||+|||.+-.
T Consensus 150 LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccchhHHh
Confidence 999999999999999998732 7999999999999999999999999 99999999999999999999999998765
Q ss_pred cc-ccccccCCCCCCCcccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC-
Q 002355 811 KA-NTFISSKSVAGTPEWMAPEFLRG-----EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP- 883 (931)
Q Consensus 811 ~~-~~~~~~~~~~GT~~Y~APEvL~~-----~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP- 883 (931)
.. +........+|||.|++||++.. +.|+.-+||||||+++|||+.|..||....-.+.+..|......+.+|
T Consensus 225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~ 304 (1317)
T KOG0612|consen 225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPD 304 (1317)
T ss_pred cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCc
Confidence 44 45555677899999999999853 457889999999999999999999999999999999998888888888
Q ss_pred -CCChHHHHHHHHHhcccCCCCCCC---HHHHHHH-------HHHHhhCchhhhc
Q 002355 884 -QNTSPVLASLMESCWADDPAQRPS---FANIVES-------LKKLLKSPAQLIQ 927 (931)
Q Consensus 884 -~~~s~eL~dLI~rcL~~DPeeRPS---a~ELLq~-------L~~Llks~~~l~~ 927 (931)
..+|+++++||+++++ +|+.|.. ++++..| +..|....++++|
T Consensus 305 ~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vP 358 (1317)
T KOG0612|consen 305 ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVP 358 (1317)
T ss_pred ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCC
Confidence 5689999999999998 5898987 9888877 3445555555443
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=321.15 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=204.6
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC-----CeE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR-----PHL 731 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~-----~~l 731 (931)
++|++.+.||+|+||+||+|++ +++.||||.+............+.+|+.+++.++|+||+++++++... .++
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 6899999999999999999986 577899999876543333445678899999999999999999988643 358
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 85 ~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 85 YIVYELM-DTDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEeCC-CCCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 9999999 5789888865 345899999999999999999999999 999999999999999999999999999865
Q ss_pred cccccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-------------
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN------------- 877 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~------------- 877 (931)
...........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 443222234567889999998865 457889999999999999999999997654322221111000
Q ss_pred -----------c--c---cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHH
Q 002355 878 -----------R--R---LAIPQNTSPVLASLMESCWADDPAQRPSFANIVES--LKKL 918 (931)
Q Consensus 878 -----------~--r---~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~--L~~L 918 (931)
. . ......+++.+.+||.+||+.+|++|||+.+++++ +..+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0 0 01224678899999999999999999999999988 5443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=311.62 Aligned_cols=250 Identities=26% Similarity=0.452 Sum_probs=199.2
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|+..++||+|+||.||++++ +++.||+|++...... .....+.+|+.++.++. |+||+++++++...+..+++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 5677888999999999999987 5678999998765433 34467889999999996 999999999999999999999
Q ss_pred eecCCCCHHHHhhc--CCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 736 EYLPRGSLYRLIHR--PAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 736 Ey~~GgSL~d~L~r--~~~~~~L~e~~~~~Ia~QIa~AL~yLHs-~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
||+ +++|.++... ......+++..+..++.|++.||+|||+ .+ ++||||||+||+++.++.++|+|||++....
T Consensus 83 e~~-~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 83 ELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ecc-cCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 998 4566554321 0123468999999999999999999997 48 9999999999999999999999999987544
Q ss_pred ccccccCCCCCCCcccCcccccCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcccccC----CCC
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGE---PSNEKSDVYSFGVILWELVTMQQPWNGLGPA-QVVGAVAFQNRRLA----IPQ 884 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~---~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~-eii~~i~~~~~r~~----lP~ 884 (931)
... ......|+..|+|||++.+. .++.++|||||||++|+|++|+.||...... +....+.. ..... .+.
T Consensus 160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (288)
T cd06616 160 DSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK-GDPPILSNSEER 237 (288)
T ss_pred cCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcC-CCCCcCCCcCCC
Confidence 332 12334678899999998876 6788999999999999999999999765421 11122111 11111 223
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 885 NTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 885 ~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.++.++.+||.+||..+|++|||+++++++
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 478899999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=306.64 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=204.9
Q ss_pred eEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeec
Q 002355 661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYL 738 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~ 738 (931)
|++.+.||.|++|.||+|++ +++.+++|++............+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56788999999999999986 5778999998776544344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccccc
Q 002355 739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS 818 (931)
Q Consensus 739 ~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~ 818 (931)
.+ +|.+++... ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||.+..........
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~ 155 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY 155 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccc
Confidence 64 888887652 246899999999999999999999999 9999999999999999999999999987655432222
Q ss_pred CCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc------------------
Q 002355 819 KSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR------------------ 879 (931)
Q Consensus 819 ~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r------------------ 879 (931)
....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+..+.+..+......
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence 334578899999998876 6889999999999999999999999876654443332211000
Q ss_pred ----------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 ----------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 ----------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.......+.++.+||.+||..||.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00123467889999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=317.07 Aligned_cols=249 Identities=25% Similarity=0.372 Sum_probs=207.2
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC-----eEE
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP-----HLS 732 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~-----~l~ 732 (931)
+|++.++||.|+||.||+|++ .++.||||++..........+.+.+|+.+++.++|+||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 589999999999999999987 4688999998765433444567889999999999999999999987765 899
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+. ++|.+++.+. ..+++..++.++.||+.||+|||+.| |+|+||||.|||++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999995 5898888652 36899999999999999999999999 9999999999999999999999999998655
Q ss_pred ccc---cccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc--------
Q 002355 813 NTF---ISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL-------- 880 (931)
Q Consensus 813 ~~~---~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~-------- 880 (931)
... .......++..|+|||++.+. .++.++|+|||||++|+|++|..||...+..+....+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 432 122344678899999999887 78999999999999999999999998877655444332211100
Q ss_pred ---------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 ---------------------AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 ---------------------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
......+..+.+||.+||.++|.+||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0123467889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.30 Aligned_cols=255 Identities=16% Similarity=0.263 Sum_probs=190.4
Q ss_pred ccccCceEEEEEecccCceEEEEEEEcC-----CceEEEEEeecccchH-HH--------HHHHHHHHHHHhcCCCCeee
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDD-QL--------KEFLREVAIMKRVRHPNVVL 720 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~~g-----~~VAVKVlk~~~~~~~-~~--------~~~l~EIkILk~L~HpNIV~ 720 (931)
++..++|++.++||+|+||+||+|++.+ ..+|+|+......... .. .....+...+..+.|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 4556899999999999999999998743 3567776543322110 00 11123334455668999999
Q ss_pred EEeeeeeCC----eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC
Q 002355 721 FMGAVTKRP----HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK 796 (931)
Q Consensus 721 Lid~f~~~~----~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~ 796 (931)
+++.+.... ..+++++++ ..++.+.+... ...++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~ 161 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDG 161 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcC
Confidence 998765432 457888887 55777776542 23578888999999999999999999 999999999999999
Q ss_pred CCcEEEEecCccccccccc-------cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HH
Q 002355 797 NWTVKVCDFGLSRFKANTF-------ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGP-AQ 868 (931)
Q Consensus 797 dg~IKL~DFGlAr~~~~~~-------~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~-~e 868 (931)
++.++|+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+... ..
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 9999999999997543211 112234699999999999999999999999999999999999999987732 22
Q ss_pred HHHHHH----hc-ccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002355 869 VVGAVA----FQ-NRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 869 ii~~i~----~~-~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
...... .. ..........++++.+++..|+..+|++||+++++++.|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 211110 00 111112345689999999999999999999999999876
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.01 Aligned_cols=249 Identities=24% Similarity=0.362 Sum_probs=202.5
Q ss_pred eEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC--CeEEEEEe
Q 002355 661 LHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--PHLSIVTE 736 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~--~~l~LVmE 736 (931)
|++.++||.|+||.||+|++. ++.+|+|++............+.+|+.+++.++|+||+++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678999999999999999874 57899999987653334445678999999999999999999999887 89999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+. ++|.+++.+. ...+++..++.++.||+.||+|||+.| ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~-~~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMD-HDLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-ccHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 996 5898888653 246899999999999999999999999 99999999999999999999999999886544321
Q ss_pred -ccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc--------------
Q 002355 817 -SSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL-------------- 880 (931)
Q Consensus 817 -~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~-------------- 880 (931)
......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+.......
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 1123456788999998765 457889999999999999999999998776554443332110000
Q ss_pred ---------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 ---------------AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 ---------------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+...+++.+.++|++||..+|.+||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0111237889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=317.72 Aligned_cols=248 Identities=24% Similarity=0.384 Sum_probs=197.9
Q ss_pred EEeccc--CceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCC
Q 002355 665 ERVGAG--SFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPR 740 (931)
Q Consensus 665 ~kLG~G--~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~G 740 (931)
.+||.| +||+||+|++ .++.||+|++..........+.+.+|+.+++.++||||++++++|..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 9999999987 688999999987665556667889999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc----
Q 002355 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI---- 816 (931)
Q Consensus 741 gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~---- 816 (931)
++|.+++.+.. ...+++..+..++.||+.||+|||+.| |+||||||+||+++.++.++++||+.+........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999987633 235889999999999999999999999 99999999999999999999999986532211100
Q ss_pred ---ccCCCCCCCcccCcccccCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-------------
Q 002355 817 ---SSKSVAGTPEWMAPEFLRGE--PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR------------- 878 (931)
Q Consensus 817 ---~~~~~~GT~~Y~APEvL~~~--~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~------------- 878 (931)
......++..|+|||++.+. .++.++|||||||++|+|++|..||.................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 01112345679999998764 468899999999999999999999987664443322211000
Q ss_pred --------------------------------ccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002355 879 --------------------------------RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 879 --------------------------------r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
....+..+++.+.+||++||..||++|||+.+++++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 0011234567899999999999999999999999773
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=340.68 Aligned_cols=254 Identities=17% Similarity=0.225 Sum_probs=189.4
Q ss_pred cCceEEEEEecccCceEEEEEEEcC---CceEEEEE--------------ee-cccchHHHHHHHHHHHHHHhcCCCCee
Q 002355 658 WDELHVKERVGAGSFGTVHRAEWHG---SDVAVKVL--------------TV-QDFLDDQLKEFLREVAIMKRVRHPNVV 719 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~~g---~~VAVKVl--------------k~-~~~~~~~~~~~l~EIkILk~L~HpNIV 719 (931)
.++|+++++||+|+||+||+|.... ..+++|.+ .+ ..........+.+|+.+|+.++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3789999999999999999986532 22222211 00 011122345678999999999999999
Q ss_pred eEEeeeeeCCeEEEEEeecCCCCHHHHhhcCCC--CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC
Q 002355 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAA--GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN 797 (931)
Q Consensus 720 ~Lid~f~~~~~l~LVmEy~~GgSL~d~L~r~~~--~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d 797 (931)
++++++...+..|+|++++ +++|..++..... ........++.++.||+.||+|||++| ||||||||+|||++.+
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~~ 303 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNCD 303 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC
Confidence 9999999999999999999 5678777653211 122346677889999999999999999 9999999999999999
Q ss_pred CcEEEEecCccccccccc-cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCC-CCCCC--h-HHHHHH
Q 002355 798 WTVKVCDFGLSRFKANTF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQP-WNGLG--P-AQVVGA 872 (931)
Q Consensus 798 g~IKL~DFGlAr~~~~~~-~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~P-F~~~~--~-~eii~~ 872 (931)
+.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|||++|..+ |.... . .+....
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 999999999998654322 122346799999999999999999999999999999999998754 43322 1 111111
Q ss_pred HHhcc------------------------cccCC-----CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 873 VAFQN------------------------RRLAI-----PQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 873 i~~~~------------------------~r~~l-----P~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+.... ....+ ...++..+.++|.+||++||.+|||+.|++++
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11000 00000 11345678889999999999999999999986
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=309.04 Aligned_cols=252 Identities=26% Similarity=0.399 Sum_probs=198.5
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC-------
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------- 728 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~------- 728 (931)
.++|++.++||.|+||.||+|++ +++.||||++............+.+|+++++.++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47999999999999999999987 467899999876543333334567899999999999999999887533
Q ss_pred -CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCc
Q 002355 729 -PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807 (931)
Q Consensus 729 -~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGl 807 (931)
..+++||||+. ++|...+.. ....+++..+..++.||+.||+|||++| |+|+||||+||+++.++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcCcc
Confidence 35799999995 577777654 2346899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccc-----------ccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Q 002355 808 SRFKANTFI-----------SSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAF 875 (931)
Q Consensus 808 Ar~~~~~~~-----------~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~ 875 (931)
++....... ......+++.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+.......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 875432211 11223567889999987654 578899999999999999999999987765544333221
Q ss_pred ccccc---------------------CCC-------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 876 QNRRL---------------------AIP-------QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 876 ~~~r~---------------------~lP-------~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
..... ..+ ...++.+.+||.+||..+|++|||+.+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 11000 000 2344678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=337.23 Aligned_cols=256 Identities=22% Similarity=0.336 Sum_probs=209.9
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEc-CCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCe
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPH 730 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~-g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~ 730 (931)
.+.+....|+++++||+||.+.||+++.. .+.||+|.+.........+.-+.+|+.+|.+|+ |.+|++||+|-..++.
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 45678899999999999999999999874 456888887776666777889999999999995 8999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
+||||||- ..+|..++++.. ..++...++.+..||+.++.++|.+| |||.||||.|+|+- .|.+||+|||+|..
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~--~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKK--SIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLKLIDFGIANA 508 (677)
T ss_pred EEEEeecc-cccHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEEeeeechhcc
Confidence 99999987 789999998633 34554578889999999999999999 99999999999985 47999999999975
Q ss_pred ccc--cccccCCCCCCCcccCcccccCCC-----------CCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhc
Q 002355 811 KAN--TFISSKSVAGTPEWMAPEFLRGEP-----------SNEKSDVYSFGVILWELVTMQQPWNGLGP-AQVVGAVAFQ 876 (931)
Q Consensus 811 ~~~--~~~~~~~~~GT~~Y~APEvL~~~~-----------~t~ksDIWSLG~ILyELLTG~~PF~~~~~-~eii~~i~~~ 876 (931)
... ..+....-+||+.||+||.+.... .+.++||||||||||+|+.|++||....+ ...+..+..-
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P 588 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDP 588 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCC
Confidence 433 334456778999999999885332 35789999999999999999999977543 2233344333
Q ss_pred ccccCCCCCChHH-HHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 877 NRRLAIPQNTSPV-LASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 877 ~~r~~lP~~~s~e-L~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+-..++|..-+.. +.++++.||++||.+||++.+||+|
T Consensus 589 ~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 589 NHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred CccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 3344555444333 9999999999999999999999987
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.49 Aligned_cols=242 Identities=23% Similarity=0.354 Sum_probs=195.0
Q ss_pred EecccCceEEEEEEE--cCCceEEEEEeecccchH-HHHHHHHHHHHHH---hcCCCCeeeEEeeeeeCCeEEEEEeecC
Q 002355 666 RVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD-QLKEFLREVAIMK---RVRHPNVVLFMGAVTKRPHLSIVTEYLP 739 (931)
Q Consensus 666 kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~-~~~~~l~EIkILk---~L~HpNIV~Lid~f~~~~~l~LVmEy~~ 739 (931)
.||+|+||.||++++ +++.+|+|++........ ....+.+|..+++ ...|+||+.+++++..++..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 389999999999987 467899999876543322 1223344544433 3479999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccC
Q 002355 740 RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK 819 (931)
Q Consensus 740 GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~ 819 (931)
+++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++...... ...
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~ 153 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPH 153 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceecccc--Ccc
Confidence 99999988752 35899999999999999999999999 999999999999999999999999998754432 223
Q ss_pred CCCCCCcccCccccc-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhcccccCCCCCChHHHHHHHHH
Q 002355 820 SVAGTPEWMAPEFLR-GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPA--QVVGAVAFQNRRLAIPQNTSPVLASLMES 896 (931)
Q Consensus 820 ~~~GT~~Y~APEvL~-~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~--eii~~i~~~~~r~~lP~~~s~eL~dLI~r 896 (931)
...|+..|+|||.+. +..++.++||||+||++|+|++|..||...... ...... .......++...+..+.++|.+
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~ 232 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTVNVELPDSFSPELKSLLEG 232 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hhcCCcCCccccCHHHHHHHHH
Confidence 456899999999986 456789999999999999999999999764322 112111 1223445677889999999999
Q ss_pred hcccCCCCCC-----CHHHHHHHH
Q 002355 897 CWADDPAQRP-----SFANIVESL 915 (931)
Q Consensus 897 cL~~DPeeRP-----Sa~ELLq~L 915 (931)
||..||.+|| +++++++|.
T Consensus 233 ~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 233 LLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred HhcCCHHHhcCCCCCCHHHHHhCc
Confidence 9999999999 699999873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.73 Aligned_cols=249 Identities=24% Similarity=0.319 Sum_probs=201.4
Q ss_pred eEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhc---CCCCeeeEEeeeeeCCe-----
Q 002355 661 LHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV---RHPNVVLFMGAVTKRPH----- 730 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L---~HpNIV~Lid~f~~~~~----- 730 (931)
|++.++||.|+||.||+|++. ++.||+|++............+.+|+.+++++ .|+||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 688999999999999999874 68899999976544333334566788877776 59999999999987766
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
++++|||+. ++|.+++.+.. ...+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEeccCccee
Confidence 999999995 58988886532 235899999999999999999999999 99999999999999999999999999876
Q ss_pred ccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc-----------
Q 002355 811 KANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR----------- 879 (931)
Q Consensus 811 ~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r----------- 879 (931)
..... ......++..|+|||++.+..++.++|+|||||++|+|++|.+||......+....+......
T Consensus 157 ~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 157 YSFEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred ccCCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 54332 112335788999999999988999999999999999999999999887765554443221100
Q ss_pred --------------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 --------------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 --------------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.......++.+.+||.+||+.||.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00012345778999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=300.85 Aligned_cols=241 Identities=29% Similarity=0.430 Sum_probs=197.7
Q ss_pred EEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHH-HhcCCCCeeeEEeeeeeCCeEEEEEeecCC
Q 002355 665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIM-KRVRHPNVVLFMGAVTKRPHLSIVTEYLPR 740 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkIL-k~L~HpNIV~Lid~f~~~~~l~LVmEy~~G 740 (931)
+.||.|+||.||+|++ .++.||+|++....... .....+..|..++ ..++|+||+++++++..++.+|+||||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4699999999999987 57789999987654322 2233445555544 445899999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCC
Q 002355 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820 (931)
Q Consensus 741 gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~ 820 (931)
++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~ 152 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKK 152 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc----ccc
Confidence 9999999752 35889999999999999999999999 99999999999999999999999999875433 234
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc--ccCCCCCChHHHHHHHHHhc
Q 002355 821 VAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR--RLAIPQNTSPVLASLMESCW 898 (931)
Q Consensus 821 ~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~--r~~lP~~~s~eL~dLI~rcL 898 (931)
..++..|++||.+.+..++.++||||||+++|+|++|..||...+..+....+..... .......+++.+.++|.+||
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 232 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHc
Confidence 5688899999999888889999999999999999999999988777666554432221 22234467899999999999
Q ss_pred ccCCCCCCCH---HHHHHH
Q 002355 899 ADDPAQRPSF---ANIVES 914 (931)
Q Consensus 899 ~~DPeeRPSa---~ELLq~ 914 (931)
+.+|++||++ .|++.|
T Consensus 233 ~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 233 CMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cCCHHHccCCCcHHHHHcC
Confidence 9999999966 455544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=303.04 Aligned_cols=251 Identities=28% Similarity=0.471 Sum_probs=207.1
Q ss_pred ceEEEEEecccCceEEEEEEEc--CCceEEEEEeeccc---chHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 660 ELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDF---LDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~---~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
+|.+.++||+|+||+||++++. +..+++|+++.... .......+.+|+.+++.++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5889999999999999999874 34566777654322 222334567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcC-CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 735 TEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~-~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
|||+++++|.+++... .....+++..++.++.|++.||.|||+.| ++|+||+|+||+++. +.++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 9999999999888642 22356899999999999999999999999 999999999999975 5699999999876544
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
.........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...........+. .......+..++.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHHH
Confidence 3333344567889999999988888899999999999999999999998766555444433 233444567788999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 002355 894 MESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 894 I~rcL~~DPeeRPSa~ELLq~ 914 (931)
|.+||..+|++||++.+++++
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhC
Confidence 999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=298.03 Aligned_cols=240 Identities=29% Similarity=0.486 Sum_probs=207.4
Q ss_pred ecccCceEEEEEEEc--CCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCCCH
Q 002355 667 VGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL 743 (931)
Q Consensus 667 LG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~GgSL 743 (931)
||.|+||.||++.+. ++.+|+|++....... .....+.+|+.+++.++|+||+++++.+..+..+|+|||++.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999874 7889999988765433 3556788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCCCCC
Q 002355 744 YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAG 823 (931)
Q Consensus 744 ~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~~~G 823 (931)
.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..............+
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG 155 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence 9999763 35899999999999999999999999 999999999999999999999999998765443223345568
Q ss_pred CCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCC
Q 002355 824 TPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPA 903 (931)
Q Consensus 824 T~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPe 903 (931)
+..|++||.+.+...+.++|+||||+++|+|++|..||......+....+.. ....++...+..+.+||.+||..+|+
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~ 233 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPT 233 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHh
Confidence 8899999999988889999999999999999999999987776555555442 45667788899999999999999999
Q ss_pred CCCCH---HHHHH
Q 002355 904 QRPSF---ANIVE 913 (931)
Q Consensus 904 eRPSa---~ELLq 913 (931)
+||++ .++++
T Consensus 234 ~R~~~~~~~~l~~ 246 (250)
T cd05123 234 KRLGSGGAEEIKA 246 (250)
T ss_pred hCCCcccHHHHHh
Confidence 99999 55544
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.81 Aligned_cols=254 Identities=24% Similarity=0.406 Sum_probs=200.5
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC-----CeE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR-----PHL 731 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~-----~~l 731 (931)
++|++.++||+|+||.||+|++ +++.||||++.... .......+.+|+.+++.++|+||+++++++... .+.
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 7899999999999999999976 57889999986432 123345678899999999999999999887543 468
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
|+|+||+. ++|.+++.. ..+++..++.++.||+.||+|||+.| |+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999995 588887753 35899999999999999999999999 999999999999999999999999998754
Q ss_pred ccccc---ccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc----------
Q 002355 812 ANTFI---SSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN---------- 877 (931)
Q Consensus 812 ~~~~~---~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~---------- 877 (931)
..... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 33211 1123467899999998755 467899999999999999999999997654332221111000
Q ss_pred --------------cccC-----CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHhh
Q 002355 878 --------------RRLA-----IPQNTSPVLASLMESCWADDPAQRPSFANIVES--LKKLLK 920 (931)
Q Consensus 878 --------------~r~~-----lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~--L~~Llk 920 (931)
.... .....++++.+||.+||..+|++|||+.+++++ +++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0000 113457789999999999999999999999988 554443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=312.15 Aligned_cols=251 Identities=20% Similarity=0.303 Sum_probs=200.9
Q ss_pred eEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCC
Q 002355 661 LHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPR 740 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~G 740 (931)
+.+.+.+|.|+++.||+++.+++.||||++............+.+|+.+++.++|+||++++++|......+++|||+++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 34556667777777777777889999999987655556677899999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc-----
Q 002355 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF----- 815 (931)
Q Consensus 741 gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~----- 815 (931)
++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||.+.......
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 84 GSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 99999997532 335889999999999999999999999 9999999999999999999999999886432211
Q ss_pred --cccCCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-------------
Q 002355 816 --ISSKSVAGTPEWMAPEFLRG--EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR------------- 878 (931)
Q Consensus 816 --~~~~~~~GT~~Y~APEvL~~--~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~------------- 878 (931)
.......++..|+|||++.. ..++.++|+|||||++|+|++|..||.................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 11123456778999999876 3578899999999999999999999987654433221111000
Q ss_pred -------------------ccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 -------------------RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 -------------------r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
........+.++.+||.+||.++|++|||+++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000112335678999999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=309.35 Aligned_cols=247 Identities=25% Similarity=0.428 Sum_probs=205.4
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
+.|...++||+|+||+||+|++ .++.|++|++...... ......+.+|+.+++.++|+||+++++++..+...|+||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 3467778899999999999986 5778999998765432 234467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+. ++|.+++... ...+++..+..++.||+.||.|||+.| ++|+||+|+||+++.++.++|+|||++.....
T Consensus 101 e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 101 EYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred ecCC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 9995 5787777542 345889999999999999999999999 99999999999999999999999999864322
Q ss_pred cccCCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLR---GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~---~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
.....|+..|+|||++. +..++.++|||||||++|+|++|..||...........+............++..+.+
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRG 251 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 23456889999999984 3557889999999999999999999998877655555443333333334456788999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 002355 893 LMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~ 914 (931)
||.+||+.+|.+||++.+++.+
T Consensus 252 li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 252 FVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=317.82 Aligned_cols=252 Identities=23% Similarity=0.359 Sum_probs=203.0
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeee----eCCeEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT----KRPHLS 732 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~----~~~~l~ 732 (931)
++|++.+.||.|+||.||+|+. +++.||+|++............+.+|+.+|+.++||||++++++|. ....++
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 7899999999999999999976 5788999998765433334567788999999999999999999875 345789
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++....
T Consensus 85 lv~e~~-~~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 85 VVMDLM-ESDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEehh-hhhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 999999 5689888865 234899999999999999999999999 9999999999999999999999999987543
Q ss_pred cccc----ccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-----------
Q 002355 813 NTFI----SSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ----------- 876 (931)
Q Consensus 813 ~~~~----~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~----------- 876 (931)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 3211 1123468899999999866 45788999999999999999999999776533222211110
Q ss_pred -------------ccccC-----CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 877 -------------NRRLA-----IPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 877 -------------~~r~~-----lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
..... +....+..+.+||.+||+.+|++||++.+++.+-+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 296 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence 00111 11456889999999999999999999999998744
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=369.19 Aligned_cols=250 Identities=29% Similarity=0.467 Sum_probs=217.6
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
+++-..+||.|.||.||-|.. +|...|+|-++.+.........+.+|+++|..|+|||+|+++++-.+++..+|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 446678899999999999965 788899999888766555556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc--
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF-- 815 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~-- 815 (931)
|.||+|.+++.. ++..++.....+..|++.|++|||++| ||||||||+||+|+.+|.||++|||.|....+..
T Consensus 1316 C~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1316 CEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred hccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 999999999976 455788888889999999999999999 9999999999999999999999999998655442
Q ss_pred --cccCCCCCCCcccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHH
Q 002355 816 --ISSKSVAGTPEWMAPEFLRG---EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 816 --~~~~~~~GT~~Y~APEvL~~---~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL 890 (931)
.......||+.|||||++.+ .++.-+.|||||||++.||+||+.||...+..-.+-.....+..+.+|..++.+-
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g 1470 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEG 1470 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhH
Confidence 12245689999999999976 4567899999999999999999999988875444333344567778999999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
++||.+||..||.+|.++.||+++
T Consensus 1471 ~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1471 RDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHHHHHHhcCchhhhHHHHHHHh
Confidence 999999999999999999999876
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=345.16 Aligned_cols=271 Identities=33% Similarity=0.582 Sum_probs=241.0
Q ss_pred cccccCceEEEEEecccCceEEEEEEEc--C---CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWH--G---SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~--g---~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~ 728 (931)
.||......|.+.||.|.||.||+|+.+ + ..||||.++.. +.+++...|+.|..||.+..||||++|.++.+..
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 3788889999999999999999999863 3 45999999765 4567778899999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
..+.||.|||++|+|..+|+.+. +.+..-+...|++.|+.|+.||-+.+ +|||||-..||||+.+-.+|++|||++
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccce
Confidence 99999999999999999998743 45888899999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccCCCC---CCCcccCcccccCCCCCchhHHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHhcccccCCCC
Q 002355 809 RFKANTFISSKSVA---GTPEWMAPEFLRGEPSNEKSDVYSFGVILWELV-TMQQPWNGLGPAQVVGAVAFQNRRLAIPQ 884 (931)
Q Consensus 809 r~~~~~~~~~~~~~---GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELL-TG~~PF~~~~~~eii~~i~~~~~r~~lP~ 884 (931)
+...+......+.. -+.+|.|||.|....++.++||||+|++|||.+ .|..||+++.+.++++.+ .+..+++.|.
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI-e~gyRLPpPm 857 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-EQGYRLPPPM 857 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH-HhccCCCCCC
Confidence 97654432222222 246899999999999999999999999999966 589999999999999887 4788999999
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhhhcCCC
Q 002355 885 NTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQMGG 930 (931)
Q Consensus 885 ~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l~~~~~ 930 (931)
++|..+..||..||++|..+||.+.+|+..|++++.+|.-|-...+
T Consensus 858 DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~ 903 (996)
T KOG0196|consen 858 DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAP 903 (996)
T ss_pred CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCC
Confidence 9999999999999999999999999999999999999987765443
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=305.36 Aligned_cols=248 Identities=24% Similarity=0.405 Sum_probs=203.4
Q ss_pred ceEEEEEecccCceEEEEEEE-----cCCceEEEEEeecccch--HHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeE
Q 002355 660 ELHVKERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLD--DQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~-----~g~~VAVKVlk~~~~~~--~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l 731 (931)
+|++.++||.|+||.||+|+. +++.||+|++....... .....+.+|+++++.+ +|+||+.+++.|..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 488999999999999999976 57789999987643322 2345678899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.| ++||||+|+|||++.++.+||+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999998752 35888999999999999999999999 999999999999999999999999998764
Q ss_pred cccc-cccCCCCCCCcccCcccccCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcccccCCCC
Q 002355 812 ANTF-ISSKSVAGTPEWMAPEFLRGE--PSNEKSDVYSFGVILWELVTMQQPWNGLGP----AQVVGAVAFQNRRLAIPQ 884 (931)
Q Consensus 812 ~~~~-~~~~~~~GT~~Y~APEvL~~~--~~t~ksDIWSLG~ILyELLTG~~PF~~~~~----~eii~~i~~~~~r~~lP~ 884 (931)
.... .......|+..|+|||.+.+. .++.++|||||||++|+|++|..||..... ..+...+ .......+.
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~ 233 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPYPQ 233 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh--hccCCCCCc
Confidence 3321 112345688999999998753 467889999999999999999999964322 2222222 122344567
Q ss_pred CChHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 002355 885 NTSPVLASLMESCWADDPAQRP-----SFANIVES 914 (931)
Q Consensus 885 ~~s~eL~dLI~rcL~~DPeeRP-----Sa~ELLq~ 914 (931)
.+++.+.+||.+||..+|++|| ++.+++.+
T Consensus 234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 7899999999999999999997 78888776
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=306.49 Aligned_cols=254 Identities=24% Similarity=0.424 Sum_probs=204.1
Q ss_pred ccccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCeE
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~l 731 (931)
.+..++|++.++||.|+||.||+|++. ++.||||+++...... ....+.+|+.++..+. |+||+++++++..+...
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV 89 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence 456689999999999999999999885 7889999997654322 3456677887776665 99999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs-~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
|+||||+ +++|.+++... ...+++..+..++.||+.||+|||+ .| |+||||+|+||+++.++.+||+|||++..
T Consensus 90 ~~v~e~~-~~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 90 FICMELM-STCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred EEEeecc-CcCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCCCCEEECccccchh
Confidence 9999999 55777777542 2368999999999999999999997 58 99999999999999999999999999876
Q ss_pred ccccccccCCCCCCCcccCcccccCCC----CCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcccccCCC--
Q 002355 811 KANTFISSKSVAGTPEWMAPEFLRGEP----SNEKSDVYSFGVILWELVTMQQPWNGLGP-AQVVGAVAFQNRRLAIP-- 883 (931)
Q Consensus 811 ~~~~~~~~~~~~GT~~Y~APEvL~~~~----~t~ksDIWSLG~ILyELLTG~~PF~~~~~-~eii~~i~~~~~r~~lP-- 883 (931)
....... ....++..|+|||.+.+.. ++.++|||||||++|+|++|+.||..... .+.+..+.... ....+
T Consensus 165 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~ 242 (296)
T cd06618 165 LVDSKAK-TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE-PPSLPPN 242 (296)
T ss_pred ccCCCcc-cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-CCCCCCC
Confidence 5433211 2335778999999987654 68899999999999999999999976433 23333332222 22222
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 884 QNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 884 ~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
..++.++.+||.+||..+|.+||++.+++++-.
T Consensus 243 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 346889999999999999999999999998744
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=311.67 Aligned_cols=255 Identities=25% Similarity=0.416 Sum_probs=209.6
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeeccc-chHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDF-LDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~-~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
..|...++||.|+||.||+|++ ++..+|+|.+..... .......+.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 5678889999999999999987 567799999875432 2344567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+. ++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 9995 6787776532 345889999999999999999999999 999999999999999999999999998754332
Q ss_pred cccCCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLR---GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~---~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
....++..|+|||.+. ...++.++|||||||++|+|++|..||...........+.........+...+..+.+
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence 3456788999999975 3456889999999999999999999998776555444443333333334578889999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 893 LMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
||.+||..+|.+||++.+++++-......+
T Consensus 246 li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~ 275 (308)
T cd06634 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (308)
T ss_pred HHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence 999999999999999999999866554443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=304.60 Aligned_cols=240 Identities=23% Similarity=0.333 Sum_probs=195.1
Q ss_pred EecccCceEEEEEEE--cCCceEEEEEeecccchH-HHHHHHHHH---HHHHhcCCCCeeeEEeeeeeCCeEEEEEeecC
Q 002355 666 RVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD-QLKEFLREV---AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLP 739 (931)
Q Consensus 666 kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~-~~~~~l~EI---kILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~ 739 (931)
.||+|+||.||+|++ +++.||+|++........ ....+..|. ++++...||||+.++++|...+..|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 389999999999976 567899999876543321 112233343 34455579999999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccC
Q 002355 740 RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK 819 (931)
Q Consensus 740 GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~ 819 (931)
|++|..++.+ ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++...... ...
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~ 153 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPH 153 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCc
Confidence 9999998865 246899999999999999999999999 999999999999999999999999998754332 223
Q ss_pred CCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcccccCCCCCChHHHHHHHH
Q 002355 820 SVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGP---AQVVGAVAFQNRRLAIPQNTSPVLASLME 895 (931)
Q Consensus 820 ~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~---~eii~~i~~~~~r~~lP~~~s~eL~dLI~ 895 (931)
...|+..|+|||++.+. .++.++||||+||++|+|++|..||..... ...... .......++...+..+.++|.
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~~li~ 231 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--TLTMAVELPDSFSPELRSLLE 231 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH--hhccCCCCCCcCCHHHHHHHH
Confidence 45789999999998754 578899999999999999999999977532 222111 123345567778999999999
Q ss_pred HhcccCCCCCC-----CHHHHHHH
Q 002355 896 SCWADDPAQRP-----SFANIVES 914 (931)
Q Consensus 896 rcL~~DPeeRP-----Sa~ELLq~ 914 (931)
+||..+|.+|| ++.+++++
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 232 GLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHhhcCHHhccCCCCCCHHHHHhC
Confidence 99999999999 99999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=312.67 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=201.2
Q ss_pred CceEE-EEEecccCceEEEEEEE--cCCceEEEEEeecccchHH------------HHHHHHHHHHHHhcCCCCeeeEEe
Q 002355 659 DELHV-KERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQ------------LKEFLREVAIMKRVRHPNVVLFMG 723 (931)
Q Consensus 659 drY~I-i~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~------------~~~~l~EIkILk~L~HpNIV~Lid 723 (931)
++|.. .+.||.|+||+||+|++ .++.||||+++........ ...+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 56654 56799999999999976 5778999998765432210 124678999999999999999999
Q ss_pred eeeeCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEE
Q 002355 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVC 803 (931)
Q Consensus 724 ~f~~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~ 803 (931)
++..++..++||||+. ++|.+++.. ...+++.....++.||+.||+|||+.| |+|+||+|+||+++.++.++|+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCCCCEEEC
Confidence 9999999999999995 689988864 335899999999999999999999999 9999999999999999999999
Q ss_pred ecCcccccccc--------------ccccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHH
Q 002355 804 DFGLSRFKANT--------------FISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQ 868 (931)
Q Consensus 804 DFGlAr~~~~~--------------~~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~e 868 (931)
|||++...... ........++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+..+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99998765411 1111233467889999998764 46889999999999999999999998877655
Q ss_pred HHHHHHhccccc--------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002355 869 VVGAVAFQNRRL--------------------------AIPQNTSPVLASLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 869 ii~~i~~~~~r~--------------------------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
....+....... ......+..+.+||.+||..+|++||++.+++.+-
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 443332110000 01234578899999999999999999999999863
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=313.75 Aligned_cols=247 Identities=25% Similarity=0.359 Sum_probs=201.9
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC------
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP------ 729 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~------ 729 (931)
.++|++++.||.|+||.||+|.+ ++..||||++............+.+|+.+++.++|+||++++++|..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 47899999999999999999976 5778999998654433344456889999999999999999999987543
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
.+++||||+ +++|.+++.. ..+++..++.++.||+.||+|||+.| |+||||||+||+++.++.++|+|||++.
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 468999999 8899888853 35899999999999999999999999 9999999999999999999999999987
Q ss_pred cccccccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc---------
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR--------- 879 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r--------- 879 (931)
..... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+......
T Consensus 167 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 167 QTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred ccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 65432 233467889999999876 45788999999999999999999999876543332222110000
Q ss_pred --------------------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 --------------------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 --------------------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.......++.+.++|.+||..||.+|||+.+++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 01224577889999999999999999999999965
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=328.97 Aligned_cols=250 Identities=24% Similarity=0.320 Sum_probs=212.3
Q ss_pred ccccCceEEEEEecccCceEEEEEE--EcCCceEEEEEeecccchHH-HHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQ-LKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr--~~g~~VAVKVlk~~~~~~~~-~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
.+..+.|+.-+.||+||||.||-++ .+|+-+|+|.+.+..+-... ....++|..||+.++.++||.+-.+|...+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 3456788999999999999999884 58999999998776554332 34568999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
|+|+..|+||+|.-+|...+ ...+++..++.++.+|+-||++||+.+ ||+|||||+|||+|+.|+|+|+|+|+|...
T Consensus 261 ClVLtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999999998886544 356999999999999999999999999 999999999999999999999999999865
Q ss_pred cccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--hcccccCCCCCChHH
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVA--FQNRRLAIPQNTSPV 889 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~--~~~~r~~lP~~~s~e 889 (931)
.... .....+||.+|||||++.++.|+...|+|||||+||||+.|+.||...........+. ......+++...+++
T Consensus 338 ~~g~-~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~e 416 (591)
T KOG0986|consen 338 PEGK-PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEE 416 (591)
T ss_pred CCCC-ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHH
Confidence 5442 2234489999999999999999999999999999999999999998765432222221 223455677899999
Q ss_pred HHHHHHHhcccCCCCCCCH
Q 002355 890 LASLMESCWADDPAQRPSF 908 (931)
Q Consensus 890 L~dLI~rcL~~DPeeRPSa 908 (931)
+++|.+.+|++||.+|...
T Consensus 417 akslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 417 AKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHHHHHHHccCHHHhccC
Confidence 9999999999999999644
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=335.44 Aligned_cols=253 Identities=27% Similarity=0.477 Sum_probs=224.3
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
....|.+..+||.|.|+.|.+|++ ++..||||++.+..........+.+|+++|+.|+|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 347899999999999999999987 688999999988877666667789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||+.+|.+++++.+. +++.+..++.++.|+++|++|||+++ |||||||.+||||+.+-++||+|||++......
T Consensus 134 ~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccceeeccc
Confidence 9999999999999873 35667999999999999999999999 999999999999999999999999999876533
Q ss_pred ccccCCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 815 FISSKSVAGTPEWMAPEFLRGEPS-NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~~~~~-t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
....+++|++.|.|||++.+..+ ++.+|+||||+++|-|+.|..||.+.+-.+....+.... ..+|.-++.++.++
T Consensus 209 -~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk--~rIp~~ms~dce~l 285 (596)
T KOG0586|consen 209 -LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK--YRIPFYMSCDCEDL 285 (596)
T ss_pred -ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee--ecccceeechhHHH
Confidence 35678899999999999999876 688999999999999999999999887666555554333 34566778899999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHH
Q 002355 894 MESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 894 I~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
|+++|-.+|.+|++++++.++-+-
T Consensus 286 Lrk~lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred HHHhhccCccccCCHHHhhhhccc
Confidence 999999999999999999987554
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=302.80 Aligned_cols=240 Identities=20% Similarity=0.390 Sum_probs=195.0
Q ss_pred CceEEEEEe--cccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEEE
Q 002355 659 DELHVKERV--GAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 659 drY~Ii~kL--G~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~L 733 (931)
++|++.+++ |.|+||.||+++. ++..+|+|++....... .|+.+...+ +|+||+++++.|..++..|+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 456666665 9999999999976 56789999987653221 122222222 69999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC-cEEEEecCcccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-TVKVCDFGLSRFKA 812 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg-~IKL~DFGlAr~~~ 812 (931)
||||+++++|.+++... ..+++..++.++.||++||.|||+.| ++||||||+||+++.++ .++|+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 99999999999999763 26899999999999999999999999 99999999999999988 99999999987654
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHH-HhcccccCCCCCChHHH
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVV-GAV-AFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii-~~i-~~~~~r~~lP~~~s~eL 890 (931)
.. ....++..|+|||++.+..++.++|||||||++|+|++|..||......... ... .........+...++.+
T Consensus 162 ~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T PHA03390 162 TP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNA 237 (267)
T ss_pred CC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHH
Confidence 33 3346889999999999988999999999999999999999999865433221 111 11133344556789999
Q ss_pred HHHHHHhcccCCCCCCC-HHHHHHH
Q 002355 891 ASLMESCWADDPAQRPS-FANIVES 914 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPS-a~ELLq~ 914 (931)
.+||.+||+.+|.+||+ ++++++|
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHhcC
Confidence 99999999999999996 6888865
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=338.90 Aligned_cols=243 Identities=28% Similarity=0.490 Sum_probs=208.2
Q ss_pred EecccCceEEEEEEEcCC--ceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCCCH
Q 002355 666 RVGAGSFGTVHRAEWHGS--DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL 743 (931)
Q Consensus 666 kLG~G~fGtVylAr~~g~--~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~GgSL 743 (931)
.||+|.||+||-|++... .+|||-+.... ....+-+..||.+-++|+|.|||++++.+..++++-|.||-++||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 699999999999988554 46777665433 33445678899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCC--cHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC-CCCcEEEEecCccccccccccccCC
Q 002355 744 YRLIHRPAAGEMM--DQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSRFKANTFISSKS 820 (931)
Q Consensus 744 ~d~L~r~~~~~~L--~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd-~dg~IKL~DFGlAr~~~~~~~~~~~ 820 (931)
.++++.. -+++ ++.++-.+.+||++||.|||++. |||||||-.|+||+ ..|.+||+|||-++....-...+.+
T Consensus 660 SsLLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 660 SSLLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred HHHHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 9999753 3455 88899999999999999999999 99999999999996 5899999999999876665556778
Q ss_pred CCCCCcccCcccccCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhcccccCCCCCChHHHHHHHHHh
Q 002355 821 VAGTPEWMAPEFLRGE--PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQV-VGAVAFQNRRLAIPQNTSPVLASLMESC 897 (931)
Q Consensus 821 ~~GT~~Y~APEvL~~~--~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~ei-i~~i~~~~~r~~lP~~~s~eL~dLI~rc 897 (931)
+.||..|||||+|..+ +|+.++|||||||++.||.||++||-.+...+. ..++..-+..+++|..++.+++.||.+|
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc 815 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC 815 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence 8999999999999864 478899999999999999999999987764433 3334334456778999999999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 002355 898 WADDPAQRPSFANIVES 914 (931)
Q Consensus 898 L~~DPeeRPSa~ELLq~ 914 (931)
+..+|..||+++++|+.
T Consensus 816 Fepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 816 FEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred cCCCcccCccHHHhccC
Confidence 99999999999999864
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=339.72 Aligned_cols=250 Identities=28% Similarity=0.518 Sum_probs=218.1
Q ss_pred CceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
+-++|+..||-|+||.||+|..+ +-..|-|++... ....+..++-||.||..+.||+||+|+++|...+.++|+.|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 44567888999999999999664 334577777554 34567889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
||.||-...++-. -+..+.+.++..+++|++.||.|||+.+ |||||||..|||++.+|.|+|+|||.+........
T Consensus 110 FC~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred ecCCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 9999999888765 3557999999999999999999999999 99999999999999999999999999876666555
Q ss_pred ccCCCCCCCcccCcccc-----cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-cccCCCCCChHHH
Q 002355 817 SSKSVAGTPEWMAPEFL-----RGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN-RRLAIPQNTSPVL 890 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL-----~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~-~r~~lP~~~s~eL 890 (931)
...+++|||+|||||+. ...+|+.++||||||++|.||..+.+|-...++..++..+.... ..+.-|..++..|
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence 66789999999999986 45788999999999999999999999999999988877764332 2334578899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+|+.+||.+||..||++.+|++|
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhhC
Confidence 999999999999999999999987
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=338.49 Aligned_cols=254 Identities=26% Similarity=0.425 Sum_probs=214.8
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeeccc-chHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDF-LDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~-~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
.|.-++.||.|+||.||.|++ +.+.||||.+....- .......++.|++.|.+++|||++.+-++|-.....|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 345567799999999999987 567799999876542 23445789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|| -|+-.+++.- ...++.+.++..|+.+.+.||+|||+++ .||||||..|||++..|.|||+|||.|......
T Consensus 107 YC-lGSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-- 179 (948)
T KOG0577|consen 107 YC-LGSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-- 179 (948)
T ss_pred HH-hccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhcCch--
Confidence 99 5677777753 2346889999999999999999999999 999999999999999999999999998765433
Q ss_pred ccCCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLR---GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~---~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
.+++|||+|||||+|. .+.|+-++||||||++..||...++|+..++-...+..|.....+..-.+.++..|++|
T Consensus 180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~F 257 (948)
T KOG0577|consen 180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 257 (948)
T ss_pred --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHH
Confidence 6789999999999985 45688899999999999999999999999887766666654334433446789999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 894 MESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 894 I~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
+..||++-|.+|||..+++.|-=-+...|
T Consensus 258 vd~CLqKipqeRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 258 VDSCLQKIPQERPTSEELLKHRFVLRERP 286 (948)
T ss_pred HHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence 99999999999999999999854444333
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=327.50 Aligned_cols=248 Identities=27% Similarity=0.523 Sum_probs=219.9
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
+-|.++.+||+|+||.||+|.+ .|..+|||.+... ..++++..||.|+++.+.|++|++|+.|.....++||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 4578899999999999999955 6888999988654 356789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
||.-|++.++++- .+..+.+.++..+++..++||+|||... -||||||..|||++.+|+.||+|||.|....++..
T Consensus 109 YCGAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 109 YCGAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred hcCCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 9999999999974 3457999999999999999999999987 89999999999999999999999999998888877
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-ccCCCCCChHHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-RLAIPQNTSPVLASLME 895 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~-r~~lP~~~s~eL~dLI~ 895 (931)
...+++||+.|||||++..-.|+.++||||||++..||..|++||.+..+...+..+..... ....|..++.++.+||+
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~ 264 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIR 264 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHH
Confidence 78899999999999999999999999999999999999999999998877654443322211 22345678899999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 002355 896 SCWADDPAQRPSFANIVES 914 (931)
Q Consensus 896 rcL~~DPeeRPSa~ELLq~ 914 (931)
+||-+.|++|.|+.++++|
T Consensus 265 ~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 265 SCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HHhcCCHHHHHHHHHHhhh
Confidence 9999999999999999987
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=303.37 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=202.9
Q ss_pred ceEEEEEecccCceEEEEEEE-----cCCceEEEEEeecccch--HHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeE
Q 002355 660 ELHVKERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLD--DQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~-----~g~~VAVKVlk~~~~~~--~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l 731 (931)
+|++.+.||.|+||.||++++ +++.||||+++...... .....+.+|++++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 488999999999999999975 45679999987643322 2345678999999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
|+||||+.+++|.+++.+ ...+++..++.++.|++.||.|||+.+ ++||||||.||+++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 999999999999999865 235889999999999999999999999 999999999999999999999999998754
Q ss_pred ccccc-ccCCCCCCCcccCcccccCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcccccCCCC
Q 002355 812 ANTFI-SSKSVAGTPEWMAPEFLRGEP--SNEKSDVYSFGVILWELVTMQQPWNGLGP----AQVVGAVAFQNRRLAIPQ 884 (931)
Q Consensus 812 ~~~~~-~~~~~~GT~~Y~APEvL~~~~--~t~ksDIWSLG~ILyELLTG~~PF~~~~~----~eii~~i~~~~~r~~lP~ 884 (931)
..... ......|+..|++||.+.+.. .+.++|+||||+++|+|++|..||..... .+....+. ......+.
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~ 233 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL--KSKPPFPK 233 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH--ccCCCCCc
Confidence 33211 122346789999999987654 68899999999999999999999964322 22222221 23345667
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 885 NTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 885 ~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
.++..+.++|.+||+.+|++|||+.++.+.|+
T Consensus 234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred ccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 78899999999999999999999766654433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=314.40 Aligned_cols=249 Identities=23% Similarity=0.359 Sum_probs=200.1
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC------Ce
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------PH 730 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~------~~ 730 (931)
++|.+.+.||.|+||.||+|++ +++.||||++............+.+|+.+++.++|+||++++++|... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 6899999999999999999976 578899999876543333345678999999999999999999998644 35
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
+++|+||+. .+|..++. ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.++|+|||+++.
T Consensus 95 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 95 FYLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 799999994 57776653 24889999999999999999999999 99999999999999999999999999875
Q ss_pred ccccccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-----------
Q 002355 811 KANTFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR----------- 878 (931)
Q Consensus 811 ~~~~~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~----------- 878 (931)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+....+..+.....
T Consensus 167 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 167 ADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 4332 233467889999999876 4578899999999999999999999987664443332221100
Q ss_pred ----------ccC--------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHH
Q 002355 879 ----------RLA--------IPQNTSPVLASLMESCWADDPAQRPSFANIVES--LKKL 918 (931)
Q Consensus 879 ----------r~~--------lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~--L~~L 918 (931)
... .....++.+.+||.+||+.||.+||++.+++.| ++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000 012467789999999999999999999999976 5443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=312.10 Aligned_cols=247 Identities=24% Similarity=0.348 Sum_probs=200.9
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC------C
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------P 729 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~------~ 729 (931)
.++|++.+.||+|+||.||+|.+ +++.||+|++............+.+|+.++++++|+||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 48899999999999999999975 577899999876543333456778899999999999999999988543 3
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
..|++++++ +++|.+++.. ..+++..++.++.||+.||+|||+.| |+||||||+||+++.++.+||+|||++.
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred cEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCCCCEEEecccccc
Confidence 578899987 8899888754 24889999999999999999999999 9999999999999999999999999987
Q ss_pred cccccccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc----------
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR---------- 878 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~---------- 878 (931)
..... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus 169 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 169 HTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred ccccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 65432 234567899999999876 4678899999999999999999999977654433322211000
Q ss_pred -----------ccC--------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 -----------RLA--------IPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 -----------r~~--------lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
... .....++++.+||.+||..+|.+||++.+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 112457889999999999999999999999987
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=331.84 Aligned_cols=260 Identities=31% Similarity=0.577 Sum_probs=228.2
Q ss_pred cccccCceEEEEEecccCceEEEEEEEc----CC--ceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWH----GS--DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK 727 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~----g~--~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~ 727 (931)
+++..+...+.++||.|-||.||.|.++ |+ .||||+.+.....++ .+.|+.|..+|+.++||||++|++++.+
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-TEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-HHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 4556678888899999999999999763 32 389999888765555 5789999999999999999999999876
Q ss_pred CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCc
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGl 807 (931)
...+||||+++-|.|..|++.+ ...++......++.||..||+|||+.. .|||||-..|||+.....|||+|||+
T Consensus 463 -~P~WivmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred -cceeEEEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccch
Confidence 4589999999999999999873 457999999999999999999999998 99999999999999999999999999
Q ss_pred ccccccccc-ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCC
Q 002355 808 SRFKANTFI-SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQN 885 (931)
Q Consensus 808 Ar~~~~~~~-~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~ 885 (931)
+++..+... ......-+..|||||.++-..++.++|||-||++|||++. |..||.+..+.+++..+ .++.++++|++
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-EnGeRlP~P~n 616 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-ENGERLPCPPN 616 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-cCCCCCCCCCC
Confidence 998665432 2233344678999999999999999999999999999875 89999998887777665 46788999999
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 002355 886 TSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llk 920 (931)
+|+.+..|+.+||+++|.+||.+.+|...|.++++
T Consensus 617 CPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 617 CPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999887
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=305.84 Aligned_cols=243 Identities=28% Similarity=0.470 Sum_probs=203.6
Q ss_pred EEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCC
Q 002355 664 KERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRG 741 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~Gg 741 (931)
..+||+|+||.||++.. +++.||||++.... ......+.+|+.+++.++|+||+++++.|..+++.++||||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 35799999999999976 57789999875432 223456889999999999999999999999999999999999999
Q ss_pred CHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCCC
Q 002355 742 SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSV 821 (931)
Q Consensus 742 SL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~~ 821 (931)
+|.+++.. ..+++..++.++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||++.............
T Consensus 103 ~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~ 176 (292)
T cd06657 103 ALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 176 (292)
T ss_pred cHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence 99998754 24788999999999999999999999 9999999999999999999999999987544332223345
Q ss_pred CCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-ccccCCCCCChHHHHHHHHHhccc
Q 002355 822 AGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ-NRRLAIPQNTSPVLASLMESCWAD 900 (931)
Q Consensus 822 ~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~-~~r~~lP~~~s~eL~dLI~rcL~~ 900 (931)
.++..|++||.+.+..++.++|+||+|+++|+|++|..||.+....+....+... .........+++.+.++|.+||..
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 256 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVR 256 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhC
Confidence 6889999999998888899999999999999999999999877655544433221 112223356788999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 002355 901 DPAQRPSFANIVES 914 (931)
Q Consensus 901 DPeeRPSa~ELLq~ 914 (931)
+|.+||++.+++++
T Consensus 257 ~P~~R~~~~~ll~~ 270 (292)
T cd06657 257 DPAQRATAAELLKH 270 (292)
T ss_pred CcccCcCHHHHhcC
Confidence 99999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=314.93 Aligned_cols=247 Identities=24% Similarity=0.365 Sum_probs=204.1
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe-----
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH----- 730 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~----- 730 (931)
.++|++.+.||.|+||.||+|++ .++.||+|++............+.+|+.+++.++|+||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 47899999999999999999987 46789999987654334445677889999999999999999988865554
Q ss_pred -EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 731 -LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 731 -l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
.++|+||+ +++|.+++.. ..+++..++.++.||+.||+|||+.| |+||||||+||+++.++.++|+|||++.
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999999 7899998864 35899999999999999999999999 9999999999999999999999999987
Q ss_pred cccccccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc--------
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL-------- 880 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~-------- 880 (931)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+....+.+..+.......
T Consensus 167 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 167 HTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred ccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 65432 234567889999999865 357889999999999999999999998776554444332211000
Q ss_pred ---------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 ---------------------AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 ---------------------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
......++.+.+||.+||..+|.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0112458899999999999999999999999876
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.81 Aligned_cols=248 Identities=25% Similarity=0.382 Sum_probs=201.1
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee-CCeEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK-RPHLSI 733 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~-~~~l~L 733 (931)
..++|++++.||.|+||.||+|++ +++.||+|++............+.+|+.+++.++||||++++++|.. +...++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 347899999999999999999976 56789999887644333445677899999999999999999999865 568999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||+|.||+++.++.++|+|||++.....
T Consensus 88 v~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 88 VTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred Eeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 99999 6789888864 24788888999999999999999999 99999999999999999999999999875432
Q ss_pred cccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-----------------
Q 002355 814 TFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAF----------------- 875 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~----------------- 875 (931)
. .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+..
T Consensus 161 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 161 Q---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred C---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 2 133467889999998866 5678999999999999999999999987654322211110
Q ss_pred -------cccccC-----CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 876 -------QNRRLA-----IPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 876 -------~~~r~~-----lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
...... ....+++.+.++|.+||+.+|++||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000001 113567899999999999999999999999877
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=309.57 Aligned_cols=265 Identities=26% Similarity=0.467 Sum_probs=217.4
Q ss_pred hcCCCcCCCCCCCCCCCccccccccccccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHH
Q 002355 630 KQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREV 707 (931)
Q Consensus 630 ~~g~~Pv~~G~ry~~~epsl~~~~lei~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EI 707 (931)
+.|+...+.|.+|.. ..++++++..||.|+.|+||+++.. |...|||.+.... .....+++++.+
T Consensus 75 ~tg~lti~~g~r~~~------------dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDl 141 (391)
T KOG0983|consen 75 QTGYLTIGGGQRYQA------------DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDL 141 (391)
T ss_pred CceeEEecCCccccc------------ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhh
Confidence 456666666777753 3477888999999999999999874 5789999998764 334567888888
Q ss_pred HHHHhc-CCCCeeeEEeeeeeCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCCEEEe
Q 002355 708 AIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHW 785 (931)
Q Consensus 708 kILk~L-~HpNIV~Lid~f~~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs-~G~~IIHr 785 (931)
.++..- .+|+||+.+++|..+..+++.||.| ..-+..++++ ...++++..+-++..-+++||.||.+ +| ||||
T Consensus 142 dvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH~--viHR 216 (391)
T KOG0983|consen 142 DVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKHG--VIHR 216 (391)
T ss_pred hHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeec
Confidence 876655 4999999999999999999999998 5566677765 34569999999999999999999975 67 9999
Q ss_pred ccCCCCeEECCCCcEEEEecCccccccccccccCCCCCCCcccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002355 786 DLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRG---EPSNEKSDVYSFGVILWELVTMQQPWN 862 (931)
Q Consensus 786 DLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~---~~~t~ksDIWSLG~ILyELLTG~~PF~ 862 (931)
|+||+|||+|..|+|||||||++....++...+ ...|-+.|||||.+.- ..|+.++||||||++++||.||+.||.
T Consensus 217 DvKPSNILlDe~GniKlCDFGIsGrlvdSkAht-rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~ 295 (391)
T KOG0983|consen 217 DVKPSNILLDERGNIKLCDFGISGRLVDSKAHT-RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYK 295 (391)
T ss_pred ccCccceEEccCCCEEeecccccceeecccccc-cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCC
Confidence 999999999999999999999998766654333 3468899999999864 357889999999999999999999999
Q ss_pred CCC-hHHHHHHHHhcccccCCC--CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 863 GLG-PAQVVGAVAFQNRRLAIP--QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 863 ~~~-~~eii~~i~~~~~r~~lP--~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+.+ +.+++..+.. ..++.++ ...++.+.+|+..||++|+.+||.+.++|+|
T Consensus 296 ~c~tdFe~ltkvln-~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 296 GCKTDFEVLTKVLN-EEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCccHHHHHHHHh-cCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 865 4455555543 4444444 3479999999999999999999999999986
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=299.85 Aligned_cols=249 Identities=24% Similarity=0.362 Sum_probs=203.5
Q ss_pred eEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeec
Q 002355 661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYL 738 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~ 738 (931)
|++.++||.|+||.||+|+. +++.||+|++............+.+|+.+++.++|+||+++++++......++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 57788999999999999987 4788999999876533344466788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccccc
Q 002355 739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS 818 (931)
Q Consensus 739 ~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~ 818 (931)
. ++|.+++.+.. ..+++..++.++.|++.||+|||+.| |+||||+|+||+++.++.++|+|||++..........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence 6 58999997632 35899999999999999999999999 9999999999999999999999999987654432222
Q ss_pred CCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc----------------cc-
Q 002355 819 KSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR----------------RL- 880 (931)
Q Consensus 819 ~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~----------------r~- 880 (931)
....++..|+|||.+.+. .++.++|+|||||++|+|++|..||........+..+..... ..
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 334567789999998776 778899999999999999999999987664443332211000 00
Q ss_pred ----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 ----------AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 ----------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
......+..+.++|++||..+|++||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0112347789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=311.53 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=200.6
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeee--CCeEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTK--RPHLS 732 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~--~~~l~ 732 (931)
.++|++.+.||+|+||.||+|.+ .++.+|+|++............+.+|+.+++++ +|+||++++++|.. +...|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 37899999999999999999987 467899998865433334445677899999999 99999999998864 44789
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+. ++|..++... .+++..++.++.||+.||+|||+.| |+||||||+||+++.++.+||+|||++....
T Consensus 86 lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 9999995 5999888652 5788899999999999999999999 9999999999999999999999999987543
Q ss_pred ccc-----cccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc--------
Q 002355 813 NTF-----ISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-------- 878 (931)
Q Consensus 813 ~~~-----~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~-------- 878 (931)
... .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 321 12233468889999998765 4578899999999999999999999977654333222111100
Q ss_pred ---------------------ccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 ---------------------RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 ---------------------r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.......++.++.+||.+||+.+|.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 001123468899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=325.80 Aligned_cols=263 Identities=32% Similarity=0.543 Sum_probs=223.0
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEcC-CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~g-~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
-.++..+.+.+.++||+|-||.|.+|...+ ..||+|+++...... ....|..|+++|.+|+||||++++++|..++.+
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~-~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKN-ARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchh-HHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 357888999999999999999999998876 889999998765332 247899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
|+|+|||+.|+|.+++.++.... +.-.....|+.||+.|++||.+.+ +|||||.+.|+|++.++++||+|||+++-.
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCccccccc
Confidence 99999999999999998753222 344556679999999999999999 999999999999999999999999999832
Q ss_pred --cccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHhcc------cccC
Q 002355 812 --ANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT--MQQPWNGLGPAQVVGAVAFQN------RRLA 881 (931)
Q Consensus 812 --~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT--G~~PF~~~~~~eii~~i~~~~------~r~~ 881 (931)
++........+-+.+|||+|.|....+++++|+|+||+++||+++ ...||....+++++....... ..+.
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~ 767 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS 767 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc
Confidence 222222223345789999999999999999999999999999864 689999999888876553221 1234
Q ss_pred CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 002355 882 IPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLL 919 (931)
Q Consensus 882 lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Ll 919 (931)
.|..++..+.++|.+||..+-++||+++++..+|++..
T Consensus 768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 67889999999999999999999999999999988754
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.53 Aligned_cols=248 Identities=26% Similarity=0.393 Sum_probs=199.1
Q ss_pred eEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCeEEEEEee
Q 002355 661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
|++.++||+|+||+||+|+. .++.|+||.+........ .....+|+..+++++ |+||+++++++..+++.++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 67889999999999999987 467899999866533222 234457999999999 99999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccc
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~ 817 (931)
+ +++|.+++.... +..+++..+..++.||+.+|.|||++| ++|+||+|.||+++.++.++|+|||++....... .
T Consensus 80 ~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~ 154 (283)
T cd07830 80 M-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-P 154 (283)
T ss_pred C-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccCCC-C
Confidence 9 889999887632 346899999999999999999999999 9999999999999999999999999987654322 1
Q ss_pred cCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc-----------------
Q 002355 818 SKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR----------------- 879 (931)
Q Consensus 818 ~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r----------------- 879 (931)
.....++..|+|||++.+ ..++.++|+||||+++|+|++|++||...........+......
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 223467889999998754 45788999999999999999999999776544333222110000
Q ss_pred -----------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 -----------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 -----------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.......+..+.+||++||+.+|++|||+.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00112336789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=306.54 Aligned_cols=249 Identities=26% Similarity=0.364 Sum_probs=196.7
Q ss_pred ceEEEEEecccCceEEEEEEEc----CCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeee----CCe
Q 002355 660 ELHVKERVGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTK----RPH 730 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~~----g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~----~~~ 730 (931)
+|++.+.||.|+||.||++++. +..||+|++..........+.+.+|+.+++++ .|+||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5889999999999999999874 55799999875433333345678899999999 59999999987532 246
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
++++++++ +++|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+||+++.++.++|+|||++..
T Consensus 81 ~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELM-EADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEecc-cCCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 88999999 5789888864 345899999999999999999999999 99999999999999999999999999975
Q ss_pred cccccc----ccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc---------
Q 002355 811 KANTFI----SSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ--------- 876 (931)
Q Consensus 811 ~~~~~~----~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~--------- 876 (931)
...... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|.+||...+.......+...
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 432211 1223468999999998765 56789999999999999999999999876533322211100
Q ss_pred -----------------cccc---CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 877 -----------------NRRL---AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 877 -----------------~~r~---~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.... ......+..+.+||.+||+.+|.+|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 1123457889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=336.64 Aligned_cols=147 Identities=27% Similarity=0.444 Sum_probs=132.9
Q ss_pred cCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
.++|+++++||+|+||+||+|++. ++.||||+++..... ......+..|+.+++.++|+||+++++++....++|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 378999999999999999999885 788999999765433 33446788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
|||+.|++|.+++... ..+++..++.++.||+.||+|||.++ ||||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999752 35889999999999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.88 Aligned_cols=247 Identities=22% Similarity=0.340 Sum_probs=197.2
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC--------
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR-------- 728 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~-------- 728 (931)
.+|++.+.||.|+||.||+|.+ +++.||+|++..... .....+.+|+++++.++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 7899999999999999999977 577899999876543 3346688999999999999999999876543
Q ss_pred ------CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC-CCcEE
Q 002355 729 ------PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-NWTVK 801 (931)
Q Consensus 729 ------~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~-dg~IK 801 (931)
...|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.| |+||||||+||+++. ++.++
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEE
Confidence 36899999995 689888854 25889999999999999999999999 999999999999974 56789
Q ss_pred EEecCcccccccccc---ccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc
Q 002355 802 VCDFGLSRFKANTFI---SSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN 877 (931)
Q Consensus 802 L~DFGlAr~~~~~~~---~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~ 877 (931)
|+|||++........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+............
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 999999875432211 1122357889999998754 557889999999999999999999998766544333221100
Q ss_pred -----------------------ccc-----CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 878 -----------------------RRL-----AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 878 -----------------------~r~-----~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
... ......+.++.+||.+||+.||.+|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000 1123577889999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=321.67 Aligned_cols=263 Identities=34% Similarity=0.612 Sum_probs=232.2
Q ss_pred cccccccCceEEEEEecccCceEEEEEEEcC--CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG--SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 652 ~~lei~~drY~Ii~kLG~G~fGtVylAr~~g--~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
+.|++...++...++||-|.||.||.|.|+. -.||||.++.... .+.+|+.|..+|+.++|||+|+|+++|+...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 6788888999999999999999999998864 4599999876542 3578999999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
..|||+|||..|+|.+|+++.. ...++....++|+.||..|++||..++ +|||||-..|+|+..+..||++|||+++
T Consensus 337 PFYIiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchhh
Confidence 9999999999999999998744 345788889999999999999999999 9999999999999999999999999999
Q ss_pred ccccccc-ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCCh
Q 002355 810 FKANTFI-SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTS 887 (931)
Q Consensus 810 ~~~~~~~-~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s 887 (931)
+...... ......-+..|.|||-+....++.++|||+||++||||.| |-.||.+.+.-+++..+ ....+..-|..++
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL-EkgyRM~~PeGCP 492 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL-EKGYRMDGPEGCP 492 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH-hccccccCCCCCC
Confidence 7543321 1112234668999999999999999999999999999998 67899999988877655 5788899999999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 888 PVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 888 ~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
+.+.+||+.||++.|..||++.|+-+.++.++++
T Consensus 493 pkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 493 PKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred HHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 9999999999999999999999999999988765
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=315.13 Aligned_cols=246 Identities=25% Similarity=0.429 Sum_probs=216.1
Q ss_pred cccCceEEEEEecccCceEEEEEEEcC--CceEEEEEeecccch-HHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWHG--SDVAVKVLTVQDFLD-DQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~g--~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l 731 (931)
+...+|..+..||+|+||.|-+|..+| +.+|||++++..+.. +.++--..|-++|.-. +-|.+++++..|+.-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 455789999999999999999997654 569999999887654 3344456677777765 467999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
|+||||+.||+|--.+++ -+.+.+..+..++.+|+.||-|||++| ||+||||..||+++.+|+|||+|||+++..
T Consensus 426 yFVMEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeEEEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999999888876 345888899999999999999999999 999999999999999999999999999865
Q ss_pred cccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHH
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~ 891 (931)
.-....+.+++|||.|+|||++...+|+..+||||+|++||||+.|++||.+.+.+++...+... ....|..++.++.
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh--nvsyPKslSkEAv 578 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH--NVSYPKSLSKEAV 578 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc--cCcCcccccHHHH
Confidence 55555678899999999999999999999999999999999999999999999999999888644 4457889999999
Q ss_pred HHHHHhcccCCCCCCCH
Q 002355 892 SLMESCWADDPAQRPSF 908 (931)
Q Consensus 892 dLI~rcL~~DPeeRPSa 908 (931)
+++...|.+.|.+|..+
T Consensus 579 ~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 579 AICKGLLTKHPGKRLGC 595 (683)
T ss_pred HHHHHHhhcCCccccCC
Confidence 99999999999999543
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=325.17 Aligned_cols=256 Identities=34% Similarity=0.602 Sum_probs=224.7
Q ss_pred cccCceEEEEEecccCceEEEEEEEc---CC--ceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH---GS--DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH 730 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~---g~--~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~ 730 (931)
|..++..+.++||+|.||+||+|.|+ |+ .||||+++...... .+..|++|+.+|.+|+|+|+++||++..+ ..
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 45577788899999999999999985 33 49999998776443 56889999999999999999999999887 77
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
+.||||+++.|+|.+.+++ .....|.......++.||+.|+.||.+++ +|||||-..||||-....|||+|||+.+.
T Consensus 185 ~mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred hhHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccceec
Confidence 8999999999999999987 55667888899999999999999999999 99999999999999999999999999986
Q ss_pred cccccc---ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCC
Q 002355 811 KANTFI---SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNT 886 (931)
Q Consensus 811 ~~~~~~---~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~ 886 (931)
.+.... ......-...|+|||.+....++.++|+|++|++||||++ |..||.+....++++.+. ...+++.|+.+
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~c 340 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYC 340 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCC
Confidence 654322 2222233568999999999999999999999999999998 589999999999998887 78889999999
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002355 887 SPVLASLMESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
++.+.+++..||+.+|+.|||+..|.+.+-.
T Consensus 341 sedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 341 SEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred hHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 9999999999999999999999999865433
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=319.42 Aligned_cols=266 Identities=24% Similarity=0.361 Sum_probs=218.1
Q ss_pred cccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
+...-|..++.||-|+||.|++++. +...||+|.+++.... ..++.....|..||....++-||+||..|++.+.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 3457899999999999999999964 5567999999887654 467788999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc---
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR--- 809 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr--- 809 (931)
+||+|++||++-.+|-+ .+.+++..++.++.++..|+++.|..| +|||||||.|||||.+|+|||+|||++.
T Consensus 706 FVMdYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EEEeccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccce
Confidence 99999999999999876 346999999999999999999999999 9999999999999999999999999984
Q ss_pred ccccc---------------------------------------ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHH
Q 002355 810 FKANT---------------------------------------FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVI 850 (931)
Q Consensus 810 ~~~~~---------------------------------------~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~I 850 (931)
+..+. .+.....+||+.|+|||++....++.-+||||.|+|
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 11110 001225579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHhccccc--CCCCCChHHHHHHHHHhcccCCCCCC---CHHHHHHH-------HHHH
Q 002355 851 LWELVTMQQPWNGLGPAQVVGAVAFQNRRL--AIPQNTSPVLASLMESCWADDPAQRP---SFANIVES-------LKKL 918 (931)
Q Consensus 851 LyELLTG~~PF~~~~~~eii~~i~~~~~r~--~lP~~~s~eL~dLI~rcL~~DPeeRP---Sa~ELLq~-------L~~L 918 (931)
||||+.|++||-...+.+.-..+......+ ....++++++.++|.+++. +++.|. .++++..| +..|
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfssl 939 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSSL 939 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHhh
Confidence 999999999998776655444333222223 3346889999999998776 477774 34555554 3457
Q ss_pred hhCchhhhc
Q 002355 919 LKSPAQLIQ 927 (931)
Q Consensus 919 lks~~~l~~ 927 (931)
.+..+.+++
T Consensus 940 Rkq~ApYIP 948 (1034)
T KOG0608|consen 940 RKQRAPYIP 948 (1034)
T ss_pred hhccCCcCc
Confidence 777777665
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=311.00 Aligned_cols=248 Identities=24% Similarity=0.344 Sum_probs=201.2
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCC--C----CeeeEEeeeeeC
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH--P----NVVLFMGAVTKR 728 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~H--p----NIV~Lid~f~~~ 728 (931)
..++|.++.+||+|.||.|..+.+ .+..|||||++.-. ......+-|+++|+++.+ | -+|++.++|.-.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 358999999999999999999965 46789999987542 333456779999999942 2 478889999999
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC-------------
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD------------- 795 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd------------- 795 (931)
+|.|||+|.+ |.++++++..+. ..+++..+++.|+.||+++++|||+.+ ++|.||||+|||+.
T Consensus 164 ghiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999 889999998744 456899999999999999999999999 99999999999993
Q ss_pred -------CCCcEEEEecCccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH
Q 002355 796 -------KNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQ 868 (931)
Q Consensus 796 -------~dg~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~e 868 (931)
++-.|+|+|||.|....... ...+.|..|+|||++.+-+|+.++||||+||||+|++||...|.+..+.+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 13468999999998765543 56788999999999999999999999999999999999999998876544
Q ss_pred HHHHHHh--cc-----------------cccCCC-------------------------CCChHHHHHHHHHhcccCCCC
Q 002355 869 VVGAVAF--QN-----------------RRLAIP-------------------------QNTSPVLASLMESCWADDPAQ 904 (931)
Q Consensus 869 ii~~i~~--~~-----------------~r~~lP-------------------------~~~s~eL~dLI~rcL~~DPee 904 (931)
-+..+.. +. .++.-+ .....++.+||++||.+||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 2211100 00 000000 112235889999999999999
Q ss_pred CCCHHHHHHH
Q 002355 905 RPSFANIVES 914 (931)
Q Consensus 905 RPSa~ELLq~ 914 (931)
|+|+.|++.|
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999999976
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=285.09 Aligned_cols=219 Identities=21% Similarity=0.217 Sum_probs=182.3
Q ss_pred cCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCCCHHHHh
Q 002355 670 GSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI 747 (931)
Q Consensus 670 G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~GgSL~d~L 747 (931)
|.||.||++++ +++.||+|++.... ...+|...+....||||+++++++......++||||++|++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 89999999987 67789999987653 2234555555667999999999999999999999999999999998
Q ss_pred hcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCCCCCCCcc
Q 002355 748 HRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEW 827 (931)
Q Consensus 748 ~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y 827 (931)
.+. ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.++|+|||.+....... ....++..|
T Consensus 77 ~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~y 148 (237)
T cd05576 77 SKF---LNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVENMY 148 (237)
T ss_pred HHh---cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCccc
Confidence 753 34899999999999999999999999 9999999999999999999999999876544321 234557789
Q ss_pred cCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCC
Q 002355 828 MAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPS 907 (931)
Q Consensus 828 ~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPS 907 (931)
+|||.+.+..++.++|+||+||++|+|++|..||...... . .......+|..+++.+++||.+||+.||.+||+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~ 222 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-I-----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLG 222 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c-----ccccccCCcccCCHHHHHHHHHHccCCHHHhcC
Confidence 9999998888899999999999999999999887643211 0 112233466778999999999999999999999
Q ss_pred HH
Q 002355 908 FA 909 (931)
Q Consensus 908 a~ 909 (931)
+.
T Consensus 223 ~~ 224 (237)
T cd05576 223 AG 224 (237)
T ss_pred CC
Confidence 73
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=317.37 Aligned_cols=246 Identities=28% Similarity=0.408 Sum_probs=211.4
Q ss_pred EEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCC
Q 002355 664 KERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRG 741 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~Gg 741 (931)
.+.||.|.||+||-|++ +|+.||||++.+-.+..++...+.+|+.||+.+.||.||.|...|+..+.+++|||.+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 57899999999999965 79999999999988888877889999999999999999999999999999999999995 5
Q ss_pred CHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC---CcEEEEecCcccccccccccc
Q 002355 742 SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN---WTVKVCDFGLSRFKANTFISS 818 (931)
Q Consensus 742 SL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d---g~IKL~DFGlAr~~~~~~~~~ 818 (931)
++.++|-. ...++++++....++.||+-||.|||-++ |+|.||||+|||+... -.+||||||+|+..+... ..
T Consensus 648 DMLEMILS-sEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-FR 723 (888)
T KOG4236|consen 648 DMLEMILS-SEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-FR 723 (888)
T ss_pred hHHHHHHH-hhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhh-hh
Confidence 55555543 34668999999999999999999999999 9999999999999654 369999999999877643 34
Q ss_pred CCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--hcccccCCCCCChHHHHHHHHH
Q 002355 819 KSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVA--FQNRRLAIPQNTSPVLASLMES 896 (931)
Q Consensus 819 ~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~--~~~~r~~lP~~~s~eL~dLI~r 896 (931)
++.+||+.|+|||++.++.++..-|+||+|+|+|--+.|..||.... ++-.++. .-..+......+++++.+||..
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLINN 801 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence 67899999999999999999999999999999999999999996532 2323332 1233444556789999999999
Q ss_pred hcccCCCCCCCHHHHHHHHH
Q 002355 897 CWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 897 cL~~DPeeRPSa~ELLq~L~ 916 (931)
+|+..-.+|-|++..+.|.+
T Consensus 802 LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 802 LLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred HHHHHHHHhcchHhhccchh
Confidence 99999999999999888765
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=302.29 Aligned_cols=245 Identities=24% Similarity=0.377 Sum_probs=201.4
Q ss_pred CceEE-EEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeee----eCCe
Q 002355 659 DELHV-KERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVT----KRPH 730 (931)
Q Consensus 659 drY~I-i~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~----~~~~ 730 (931)
++|.+ -++||-|-.|.|-.|.+ +++.+|+|++... ....+|+++--.. .|||||.++++|. ...-
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 55655 36899999999999854 7889999998654 3567888875544 6999999999885 3456
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC---CCcEEEEecCc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---NWTVKVCDFGL 807 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~---dg~IKL~DFGl 807 (931)
+.+|||+|+||.|+..+...+ ...++++++-.|+.||..|+.|||+.+ |.||||||+|+|... +..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEeccccc
Confidence 789999999999999998643 456999999999999999999999999 999999999999964 55799999999
Q ss_pred cccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcccccCCC
Q 002355 808 SRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGP----AQVVGAVAFQNRRLAIP 883 (931)
Q Consensus 808 Ar~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~----~eii~~i~~~~~r~~lP 883 (931)
|+..... ....+++-|+.|.|||++..+.++..+|+||+|++||-|++|.+||....- ..+...+.. ....+|
T Consensus 211 AK~t~~~-~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~--gqy~FP 287 (400)
T KOG0604|consen 211 AKETQEP-GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT--GQYEFP 287 (400)
T ss_pred ccccCCC-ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc--cCccCC
Confidence 9876543 244678899999999999999999999999999999999999999976432 222333332 233344
Q ss_pred ----CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 884 ----QNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 884 ----~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
..+|+..+++|+.+|+.+|++|.|+.+++++=+
T Consensus 288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw 324 (400)
T KOG0604|consen 288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW 324 (400)
T ss_pred ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence 466889999999999999999999999998744
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=300.23 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=200.3
Q ss_pred CceEEEEEecccCceEEEEEEEc------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee-CCeE
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK-RPHL 731 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~-~~~l 731 (931)
..|+++.+||+|+||.||+|..+ ...+|||.++.+.-.........+|+.+++.|+||||+.|..+|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 57899999999999999999431 2369999998764333333567899999999999999999999976 8899
Q ss_pred EEEEeecCCCCHHHHhhc--CCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC----CcEEEEec
Q 002355 732 SIVTEYLPRGSLYRLIHR--PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN----WTVKVCDF 805 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r--~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d----g~IKL~DF 805 (931)
+|++||. ..+|+.+|+. ......++...++.|+.||+.|+.|||++. |+||||||.||||..+ |.|||+||
T Consensus 104 ~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 104 WLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecc
Confidence 9999999 5589888863 233467999999999999999999999999 9999999999999887 89999999
Q ss_pred Ccccccccccc---ccCCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCh-------HHH--HHH
Q 002355 806 GLSRFKANTFI---SSKSVAGTPEWMAPEFLRGEP-SNEKSDVYSFGVILWELVTMQQPWNGLGP-------AQV--VGA 872 (931)
Q Consensus 806 GlAr~~~~~~~---~~~~~~GT~~Y~APEvL~~~~-~t~ksDIWSLG~ILyELLTG~~PF~~~~~-------~ei--i~~ 872 (931)
|+++...+... ....++.|.+|+|||.+.|.. |+.+.|||++|||+.||+|-.+.|.+... .+. +..
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 99998766532 223456789999999999865 58889999999999999999988865321 000 000
Q ss_pred HHh-ccccc--------CC--------------------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 873 VAF-QNRRL--------AI--------------------------PQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 873 i~~-~~~r~--------~l--------------------------P~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
+.. .+.+. .+ -..-++...+|+.+||++||.+|.|+.+.+++.-
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 000 00000 00 1123445889999999999999999999998843
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=332.94 Aligned_cols=248 Identities=29% Similarity=0.473 Sum_probs=194.6
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee---------
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--------- 727 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~--------- 727 (931)
.+|+.++.||+||||.||++|. +|+.||||.+.... .+.....+.+|+++|.+|+|||||+++.+|..
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 5788889999999999999976 79999999998876 56666789999999999999999998843210
Q ss_pred ---------------------------------------------------------------------C----------
Q 002355 728 ---------------------------------------------------------------------R---------- 728 (931)
Q Consensus 728 ---------------------------------------------------------------------~---------- 728 (931)
+
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred -------------------------------CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHh
Q 002355 729 -------------------------------PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777 (931)
Q Consensus 729 -------------------------------~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs 777 (931)
-.+||-||||+..+|.++++++.... ....+|++++||+.||.|+|+
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHh
Confidence 13678899999988888887743211 467899999999999999999
Q ss_pred CCCCEEEeccCCCCeEECCCCcEEEEecCcccccc------------------ccccccCCCCCCCcccCcccccCCC--
Q 002355 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA------------------NTFISSKSVAGTPEWMAPEFLRGEP-- 837 (931)
Q Consensus 778 ~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~------------------~~~~~~~~~~GT~~Y~APEvL~~~~-- 837 (931)
.| ||||||||.||+++.++.|||+|||+|.... ......+..+||.-|+|||++.+..
T Consensus 716 ~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 716 QG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred Cc--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99 9999999999999999999999999997511 0111234568999999999998755
Q ss_pred -CCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhcccccC--CCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002355 838 -SNEKSDVYSFGVILWELVTMQQPWNGL-GPAQVVGAVAFQNRRLA--IPQNTSPVLASLMESCWADDPAQRPSFANIVE 913 (931)
Q Consensus 838 -~t~ksDIWSLG~ILyELLTG~~PF~~~-~~~eii~~i~~~~~r~~--lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq 913 (931)
++.|+|+||||++++||+. ||... .+..++..+.....+.+ +....-+.-..+|++|++.||.+||||.|+|.
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 8999999999999999985 57543 33344433331111111 11223345678999999999999999999987
Q ss_pred H
Q 002355 914 S 914 (931)
Q Consensus 914 ~ 914 (931)
+
T Consensus 871 s 871 (1351)
T KOG1035|consen 871 S 871 (1351)
T ss_pred c
Confidence 5
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-32 Score=319.56 Aligned_cols=264 Identities=33% Similarity=0.589 Sum_probs=226.3
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEc---------CCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEE
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWH---------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFM 722 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~---------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Li 722 (931)
.|++..+++.+.+.||.|.||.||+|... ...||||.++..... .+.+.+..|+++|+.+ +|+||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 57888899999999999999999999642 235999998876655 5668899999999999 599999999
Q ss_pred eeeeeCCeEEEEEeecCCCCHHHHhhcCC-----------CC--CCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCC
Q 002355 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPA-----------AG--EMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS 789 (931)
Q Consensus 723 d~f~~~~~l~LVmEy~~GgSL~d~L~r~~-----------~~--~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKP 789 (931)
+++..++.+++|+||+..|+|..++++.. .. ..+.....+.++.||+.|++||++.. +|||||-.
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAa 446 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAA 446 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhh
Confidence 99999999999999999999999998643 00 23888999999999999999999988 99999999
Q ss_pred CCeEECCCCcEEEEecCccccccccc-cccCCCC--CCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCC
Q 002355 790 PNLLVDKNWTVKVCDFGLSRFKANTF-ISSKSVA--GTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLG 865 (931)
Q Consensus 790 eNILLd~dg~IKL~DFGlAr~~~~~~-~~~~~~~--GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~ 865 (931)
.|||+..+..+||+|||+|+...... ....... -+..|||||.+....++.++||||+|++||||++ |..||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999998533321 1112112 2457999999999999999999999999999998 689999876
Q ss_pred -hHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 002355 866 -PAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920 (931)
Q Consensus 866 -~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llk 920 (931)
..+. ......+.+...|..+++++.+||+.||..+|+.||++.++.+.+...+.
T Consensus 527 ~~~~l-~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 PTEEL-LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred cHHHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 4444 44566788999999999999999999999999999999999999999765
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-33 Score=321.17 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=208.1
Q ss_pred eEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC------CeEE
Q 002355 661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------PHLS 732 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~------~~l~ 732 (931)
+...+.||+||||.||++++ +|+.||||.++..... ...+..-+|+++|++|+|+|||+++++-... ....
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~-r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL-RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhccc-chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 45567899999999999986 6899999999876532 3346778999999999999999999876543 4678
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC--CCCc--EEEEecCcc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD--KNWT--VKVCDFGLS 808 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd--~dg~--IKL~DFGlA 808 (931)
+|||||.||+|..++.++.....+++.+.+.++..+..||.|||++| ||||||||.||++- .+|. -||+|||.|
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999999888888999999999999999999999999 99999999999984 3343 599999999
Q ss_pred ccccccccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcc------
Q 002355 809 RFKANTFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGP----AQVVGAVAFQN------ 877 (931)
Q Consensus 809 r~~~~~~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~----~eii~~i~~~~------ 877 (931)
+...+.. ...+.+||..|++||++.+ ..++..+|.|||||++|+++||..||..... .++...+...+
T Consensus 172 rel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 172 RELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred ccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence 9776654 4567899999999999985 7788899999999999999999999965432 22332222111
Q ss_pred -------------cccCCCCCChHH----HHHHHHHhcccCCCCCC--CHHHHHHHHHHHhhC
Q 002355 878 -------------RRLAIPQNTSPV----LASLMESCWADDPAQRP--SFANIVESLKKLLKS 921 (931)
Q Consensus 878 -------------~r~~lP~~~s~e----L~dLI~rcL~~DPeeRP--Sa~ELLq~L~~Llks 921 (931)
...+.|..+++. +...+..+|..+|.+|. ...+....+.+|+..
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 111233344433 45667789999999999 889999999988875
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=300.42 Aligned_cols=258 Identities=36% Similarity=0.624 Sum_probs=209.3
Q ss_pred CceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhc--CCCCeeeEEeeeeeCC----eEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV--RHPNVVLFMGAVTKRP----HLS 732 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L--~HpNIV~Lid~f~~~~----~l~ 732 (931)
.+.++.+.||+|.||.||+|+|.|+.||||++.... ...+.+|.+|++.. +|+||+.++++-..++ .++
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 678999999999999999999999999999997543 25677888888775 8999999998865433 589
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHh-----CC-CCEEEeccCCCCeEECCCCcEEEEecC
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-----LN-PPILHWDLKSPNLLVDKNWTVKVCDFG 806 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs-----~G-~~IIHrDLKPeNILLd~dg~IKL~DFG 806 (931)
||.+|-+.|+|++|+.+ ..++.+..++++.-++.||++||. +| +.|.|||||..||||.++|.+.|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 99999999999999987 348899999999999999999994 23 359999999999999999999999999
Q ss_pred cccccccc----ccccCCCCCCCcccCcccccCCCC------CchhHHHHHHHHHHHHHh----------CCCCCCCCC-
Q 002355 807 LSRFKANT----FISSKSVAGTPEWMAPEFLRGEPS------NEKSDVYSFGVILWELVT----------MQQPWNGLG- 865 (931)
Q Consensus 807 lAr~~~~~----~~~~~~~~GT~~Y~APEvL~~~~~------t~ksDIWSLG~ILyELLT----------G~~PF~~~~- 865 (931)
+|...... .+.....+||.+|||||++...-. ...+||||||.++||+.. -++||.+..
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 99754332 234456789999999999875421 346899999999999974 268887653
Q ss_pred ----hHHHHHHHHhcccccCCCCCCh-----HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhh
Q 002355 866 ----PAQVVGAVAFQNRRLAIPQNTS-----PVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQL 925 (931)
Q Consensus 866 ----~~eii~~i~~~~~r~~lP~~~s-----~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l 925 (931)
.+++..-+-.+..++.+|+.+. ..+..||+.||..+|.-|.|+--+.+.|.++.+++.+.
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ek~ 510 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDEKI 510 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChhhh
Confidence 2444444445555666665432 34678899999999999999999999999998766543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=314.89 Aligned_cols=241 Identities=24% Similarity=0.315 Sum_probs=203.8
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~LV 734 (931)
.+.|.+...+|.|+|+.|-.+.+ +++..++|++..... ...+|+.++... .||||+++++.+.++.+.|+|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 57889999999999999999966 677899999987631 223577665555 699999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEE-CCCCcEEEEecCccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV-DKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILL-d~dg~IKL~DFGlAr~~~~ 813 (931)
||.+.|+.|.+.+.... .....+..|+.||+.|+.|||++| ||||||||+|||+ +..|+++|+|||.++....
T Consensus 395 ~e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred ehhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 99999999988876522 222778889999999999999999 9999999999999 6899999999999987655
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcccccCCCCCChHHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPA-QVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~-eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
. ..+.+-|..|.|||++...+++.++||||||++||+|++|+.||...... ++...+ ....+...+|.++++
T Consensus 469 ~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s~~vS~~AKd 541 (612)
T KOG0603|consen 469 S---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFSECVSDEAKD 541 (612)
T ss_pred h---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccccccCHHHHH
Confidence 4 24567789999999999999999999999999999999999999776554 333332 233344889999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHH
Q 002355 893 LMESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
||++||+.||.+|+++++++.|=+.
T Consensus 542 Ll~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 542 LLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHhccCChhhCcChhhhccCcch
Confidence 9999999999999999999988554
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=294.92 Aligned_cols=246 Identities=22% Similarity=0.391 Sum_probs=212.5
Q ss_pred cccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l 731 (931)
+..++|.+++.||+|+|+.|.++++ +.+.+|+|++++.-+.+ ..++-...|-.+..+. +||.+|-++.+|+....+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 4558999999999999999999976 56779999998876654 3456677788888777 699999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
++|.||++||+|--.+++ .+.++++.++.+..+|..||.|||++| ||+||||..|+|++..|+|||+|+|+++..
T Consensus 327 ffvieyv~ggdlmfhmqr---qrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEEecCcceeeehhh---hhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999999877765 346999999999999999999999999 999999999999999999999999999876
Q ss_pred cccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHhcccccCCCC
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGL-------GPAQVVGAVAFQNRRLAIPQ 884 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~-------~~~eii~~i~~~~~r~~lP~ 884 (931)
......+.+++|||.|.|||++.+..|++.+|||+||++|+||+.|+.||.-. +.++.+-++ ...+...+|.
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv-ilekqiripr 480 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV-ILEKQIRIPR 480 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH-Hhhhcccccc
Confidence 55555678899999999999999999999999999999999999999999532 222222233 2345566888
Q ss_pred CChHHHHHHHHHhcccCCCCCCC
Q 002355 885 NTSPVLASLMESCWADDPAQRPS 907 (931)
Q Consensus 885 ~~s~eL~dLI~rcL~~DPeeRPS 907 (931)
.++.....+++..|++||.+|..
T Consensus 481 slsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 481 SLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred eeehhhHHHHHHhhcCCcHHhcC
Confidence 89999999999999999999953
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=277.17 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=205.7
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
+|...++||+|.||+||+|+. +++.||+|.++...-.+......++||-+|+.|+|.|||++++....++.+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 566678999999999999975 567799999998765555556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccc
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~ 817 (931)
| .-+|..+... .++.++...++.++.|+++||.|+|+++ +.||||||.|+||+.+|.+||+|||+++..+-+...
T Consensus 83 c-dqdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 83 C-DQDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred h-hHHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 9 6688888865 3456899999999999999999999999 999999999999999999999999999987765433
Q ss_pred cCCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhccc-cc--------CCC---
Q 002355 818 SKSVAGTPEWMAPEFLRGEP-SNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNR-RL--------AIP--- 883 (931)
Q Consensus 818 ~~~~~GT~~Y~APEvL~~~~-~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~-r~--------~lP--- 883 (931)
....+.|.+|++|.++.+.. +++..|+||-||++.|+.. |++.|.+.+-.+.+..+-..-. +. .+|
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 34456799999999999865 6888999999999999986 6677888765544444322111 10 011
Q ss_pred ---------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 884 ---------------QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 884 ---------------~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+.+...-++|+.++|.-+|.+|.++++.+++
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1223346899999999999999999998876
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=317.41 Aligned_cols=253 Identities=26% Similarity=0.452 Sum_probs=219.4
Q ss_pred cccCceEEEEEecccCceEEEEEE--EcCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeee-----e
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVT-----K 727 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr--~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~-----~ 727 (931)
-..+.|+|++.||.|.+|.||+++ ++++.+|+||+......+ .++..|.+||+.+ .|||++.++++|. .
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 345789999999999999999996 478899999987765333 4567889999988 5999999999985 4
Q ss_pred CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCc
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGl 807 (931)
++.+|||||||.||+.-++++... +.++.|..+.+|++.++.||.+||... +||||||-.|||++.++.|||+|||+
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEeeeee
Confidence 578999999999999999998755 778999999999999999999999988 99999999999999999999999999
Q ss_pred cccccccccccCCCCCCCcccCcccccCC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc-cC
Q 002355 808 SRFKANTFISSKSVAGTPEWMAPEFLRGE-----PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR-LA 881 (931)
Q Consensus 808 Ar~~~~~~~~~~~~~GT~~Y~APEvL~~~-----~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r-~~ 881 (931)
+.....+.....+.+||+.|||||++.-. .++..+|+||||++..||--|.+|+.++-+...+-.+.....+ +.
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLk 249 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLK 249 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcccc
Confidence 99888877778889999999999998643 3567899999999999999999999999887666555332222 22
Q ss_pred CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 882 IPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 882 lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
-|..++.+|.+||..||.+|.++||++.++++|
T Consensus 250 rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 250 RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 367889999999999999999999999999876
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-31 Score=266.93 Aligned_cols=236 Identities=31% Similarity=0.513 Sum_probs=196.9
Q ss_pred CceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCCCHHHHhh
Q 002355 671 SFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH 748 (931)
Q Consensus 671 ~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~GgSL~d~L~ 748 (931)
+||.||+|++. ++.+|+|++........ ...+.+|++.++.++|+||+++++++......+++||++.+++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 68999999874 58899999976654332 4678899999999999999999999999999999999999889999987
Q ss_pred cCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCCCCCCCccc
Q 002355 749 RPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWM 828 (931)
Q Consensus 749 r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~ 828 (931)
... .++...++.++.+++.+|.|||..+ ++|+||+|.||+++.++.++|+|||.+....... ......++..|+
T Consensus 80 ~~~---~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~ 153 (244)
T smart00220 80 KRG---RLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYM 153 (244)
T ss_pred hcc---CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCC
Confidence 522 2889999999999999999999999 9999999999999999999999999998665432 224456788999
Q ss_pred CcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcccccCCCCC--ChHHHHHHHHHhcccCCCCC
Q 002355 829 APEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLG-PAQVVGAVAFQNRRLAIPQN--TSPVLASLMESCWADDPAQR 905 (931)
Q Consensus 829 APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~-~~eii~~i~~~~~r~~lP~~--~s~eL~dLI~rcL~~DPeeR 905 (931)
+||.+.+...+.++|||+||+++|+|++|..||.... ......... .......... ++..+.+++.+||..+|.+|
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG-KPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh-ccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence 9999988888999999999999999999999998743 333333322 2222222211 78899999999999999999
Q ss_pred CCHHHHHHH
Q 002355 906 PSFANIVES 914 (931)
Q Consensus 906 PSa~ELLq~ 914 (931)
|++.+++++
T Consensus 233 p~~~~~~~~ 241 (244)
T smart00220 233 LTAEEALQH 241 (244)
T ss_pred cCHHHHhhC
Confidence 999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=333.46 Aligned_cols=249 Identities=22% Similarity=0.382 Sum_probs=194.6
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
..|...+.||+|+||.||+|++ .+..||||.+...... ...|++++++++|||||++++++......|+|||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 3566778899999999999986 5778999988653321 1246889999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhC-CCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL-NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~-G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
|+++++|.++++. +++..+..++.||+.||+|||.. .++|+||||||+||+++.++..++. ||.+......
T Consensus 764 y~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~- 835 (968)
T PLN00113 764 YIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD- 835 (968)
T ss_pred CCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence 9999999999963 78899999999999999999943 2239999999999999998887775 6655432221
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHH--hcc------ccc-----
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGP--AQVVGAVA--FQN------RRL----- 880 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~--~eii~~i~--~~~------~r~----- 880 (931)
....+|..|+|||++.+..++.++|||||||++|||+||+.||..... ..+..... ... ...
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 233678999999999999999999999999999999999999854211 11111110 000 000
Q ss_pred -CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchh
Q 002355 881 -AIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQ 924 (931)
Q Consensus 881 -~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~ 924 (931)
..+.....++.+++.+||+.+|++|||+.|+++.|+.+.+....
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~ 957 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS 957 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccc
Confidence 01112234577899999999999999999999999999886543
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=295.67 Aligned_cols=242 Identities=25% Similarity=0.430 Sum_probs=200.1
Q ss_pred EEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCeEEEEEeecCC
Q 002355 664 KERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIVTEYLPR 740 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~l~LVmEy~~G 740 (931)
.+.||+|+|+.|--|.. ++..||||++.++.. ....++.+|++++.+.+ |+||++|+++|.++...|||||.|.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g--HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG--HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCc--hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 35799999999998854 889999999988743 33468899999999985 99999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC---cEEEEecCcccccc-----
Q 002355 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW---TVKVCDFGLSRFKA----- 812 (931)
Q Consensus 741 gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg---~IKL~DFGlAr~~~----- 812 (931)
|+|...|.+ ...+++.++.+++++|+.||.|||.+| |.||||||+|||-.... -||||||.+..-..
T Consensus 161 GplLshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 161 GPLLSHIQK---RKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred chHHHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 999999976 346999999999999999999999999 99999999999986654 37999998864211
Q ss_pred --ccccccCCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---------------HHHH
Q 002355 813 --NTFISSKSVAGTPEWMAPEFLR-----GEPSNEKSDVYSFGVILWELVTMQQPWNGLGP---------------AQVV 870 (931)
Q Consensus 813 --~~~~~~~~~~GT~~Y~APEvL~-----~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~---------------~eii 870 (931)
.......+++|...|||||+.. ...|+.++|.||||+|+|-|+.|.+||.+.-. ..++
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 1112234678899999999863 23468899999999999999999999976421 2223
Q ss_pred HHHHhcccccCCCC----CChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 871 GAVAFQNRRLAIPQ----NTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 871 ~~i~~~~~r~~lP~----~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
..+ +....++|. .++.+.+++|..+|..++.+|.++.+++.+
T Consensus 316 esI--QEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 316 ESI--QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred HHH--hccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 333 455666764 578899999999999999999999998875
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-33 Score=305.64 Aligned_cols=254 Identities=23% Similarity=0.365 Sum_probs=206.3
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchH-----HHHHHHHHHHHHHhcCCCCeeeEEeeee-eCC
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD-----QLKEFLREVAIMKRVRHPNVVLFMGAVT-KRP 729 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~-----~~~~~l~EIkILk~L~HpNIV~Lid~f~-~~~ 729 (931)
.++|-+++.||+|||+.||+|-+ ..++||+|+-.......+ ..+...+|.+|-+.|.||.||++|++|. +..
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 47899999999999999999965 678999999766544332 2356788999999999999999999997 556
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC---CCCcEEEEecC
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD---KNWTVKVCDFG 806 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd---~dg~IKL~DFG 806 (931)
..|-|+|||+|.+|.-|++. ...+++++++.|+.||+.||.||.+..+||||-||||.||||- ..|.|||+|||
T Consensus 542 sFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 78999999999999999976 3468999999999999999999999999999999999999984 45789999999
Q ss_pred cccccccc-------ccccCCCCCCCcccCcccccCC----CCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Q 002355 807 LSRFKANT-------FISSKSVAGTPEWMAPEFLRGE----PSNEKSDVYSFGVILWELVTMQQPWNGLGPA-QVVGAVA 874 (931)
Q Consensus 807 lAr~~~~~-------~~~~~~~~GT~~Y~APEvL~~~----~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~-eii~~i~ 874 (931)
++++.... ...+....||.+|++||.+--. ..+.++||||+|+|+|.++.|+.||...-.. +++....
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 99875432 1234567899999999986532 3578999999999999999999999775433 3332221
Q ss_pred h-ccc--ccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 875 F-QNR--RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 875 ~-~~~--r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
. ... ..+..+..+.++++||++||++.-+.|.+..+|..+
T Consensus 699 IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 699 ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 1 111 223335788999999999999999999998887643
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-33 Score=310.20 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=209.5
Q ss_pred cccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCC------CCeeeEEeeeee
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH------PNVVLFMGAVTK 727 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~H------pNIV~Lid~f~~ 727 (931)
+.-.+|.|....|+|-||+|.+|++ .+..|||||++....- .+.=+.|++||++|+. -|+++|+.+|..
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M---~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM---HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH---hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 3448999999999999999999987 4678999999876432 2345789999999952 389999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC-cEEEEecC
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-TVKVCDFG 806 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg-~IKL~DFG 806 (931)
.+|+|||+|.+ ..+|.+++++.+.+..|....++.++.|++.||..|..+| |+|.||||.||||+... .+||||||
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccCc
Confidence 99999999999 7899999998877778999999999999999999999999 99999999999998764 57999999
Q ss_pred ccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccC-----
Q 002355 807 LSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLA----- 881 (931)
Q Consensus 807 lAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~----- 881 (931)
.|-..+...+. .......|+|||+|.|.+|+...|+||+||+||||+||+..|.+..+.+++........+.+
T Consensus 583 SA~~~~eneit--PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR 660 (752)
T KOG0670|consen 583 SASFASENEIT--PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR 660 (752)
T ss_pred ccccccccccc--HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence 99876665432 23346789999999999999999999999999999999999999888777654433222211
Q ss_pred --------------------------------------------------CCCC---ChHHHHHHHHHhcccCCCCCCCH
Q 002355 882 --------------------------------------------------IPQN---TSPVLASLMESCWADDPAQRPSF 908 (931)
Q Consensus 882 --------------------------------------------------lP~~---~s~eL~dLI~rcL~~DPeeRPSa 908 (931)
+|.. .-..+++|+.+||..||++|.|.
T Consensus 661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~ 740 (752)
T KOG0670|consen 661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV 740 (752)
T ss_pred hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence 0000 11258899999999999999999
Q ss_pred HHHHHH
Q 002355 909 ANIVES 914 (931)
Q Consensus 909 ~ELLq~ 914 (931)
.+.|+|
T Consensus 741 nqAL~H 746 (752)
T KOG0670|consen 741 NQALKH 746 (752)
T ss_pred HHHhcC
Confidence 998876
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=296.65 Aligned_cols=256 Identities=32% Similarity=0.514 Sum_probs=209.8
Q ss_pred CceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhc--CCCCeeeEEeeeeeCC----eEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV--RHPNVVLFMGAVTKRP----HLS 732 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L--~HpNIV~Lid~f~~~~----~l~ 732 (931)
...++++.||+|.||.||+|+.+++.||||++... +.+.+.+|.+|++.. +|+||++++++-..+. .++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~-----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ-----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhccCceeEEEecCHH-----HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 56678889999999999999999999999998653 457788999988775 7999999999876555 799
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhC-------CCCEEEeccCCCCeEECCCCcEEEEec
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL-------NPPILHWDLKSPNLLVDKNWTVKVCDF 805 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~-------G~~IIHrDLKPeNILLd~dg~IKL~DF 805 (931)
||++|-+.|+|.+|+..+ .++|....+|+.-+++||+|||+- .++|+|||||..||||.++++..|+||
T Consensus 285 LVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 999999999999999763 489999999999999999999952 357999999999999999999999999
Q ss_pred Cccccccccc--cccCCCCCCCcccCcccccCCCC------CchhHHHHHHHHHHHHHhC------------CCCCC---
Q 002355 806 GLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPS------NEKSDVYSFGVILWELVTM------------QQPWN--- 862 (931)
Q Consensus 806 GlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~------t~ksDIWSLG~ILyELLTG------------~~PF~--- 862 (931)
|+|....... .....-+||.+|||||++.+.-. -.++||||+|.+||||++. ++||.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9998654321 22234689999999999976432 2468999999999999874 23343
Q ss_pred --CCChHHHHHHHHhcccccCCCCCC-----hHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCch
Q 002355 863 --GLGPAQVVGAVAFQNRRLAIPQNT-----SPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPA 923 (931)
Q Consensus 863 --~~~~~eii~~i~~~~~r~~lP~~~-----s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~ 923 (931)
+..-+++...+.....++.+|..+ ...+++.|..||..|++.|.|+.=+.+++.++.....
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 123345555666677777777433 4568999999999999999999999999998877653
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=290.42 Aligned_cols=256 Identities=25% Similarity=0.436 Sum_probs=205.3
Q ss_pred cccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHH-HhcCCCCeeeEEeeeeeCCe
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIM-KRVRHPNVVLFMGAVTKRPH 730 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkIL-k~L~HpNIV~Lid~f~~~~~ 730 (931)
+++..++++-+..||.|+||+|++..+ .|+..|||.++.... ....++++.|.... +.-++||||++|++....+.
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 345567788888999999999999876 578899999988765 44457888888764 44579999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhc--CCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCCEEEeccCCCCeEECCCCcEEEEecCc
Q 002355 731 LSIVTEYLPRGSLYRLIHR--PAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r--~~~~~~L~e~~~~~Ia~QIa~AL~yLHs-~G~~IIHrDLKPeNILLd~dg~IKL~DFGl 807 (931)
.||.||+| ..+|..+.++ ......++++..-.|....+.||+||.. +. ||||||||+|||++..|.|||||||+
T Consensus 138 cWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGI 214 (361)
T KOG1006|consen 138 CWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGI 214 (361)
T ss_pred eeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccc
Confidence 99999999 6777665542 1123468999999999999999999975 56 99999999999999999999999999
Q ss_pred cccccccccccCCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhccccc-CCC
Q 002355 808 SRFKANTFISSKSVAGTPEWMAPEFLRG--EPSNEKSDVYSFGVILWELVTMQQPWNGLGP-AQVVGAVAFQNRRL-AIP 883 (931)
Q Consensus 808 Ar~~~~~~~~~~~~~GT~~Y~APEvL~~--~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~-~eii~~i~~~~~r~-~lP 883 (931)
+....++... +..+|-..|||||.+.. ..++.++|+||||++|||+.||..||.+.+. .+.+.++.....+. ..+
T Consensus 215 cGqLv~SiAk-T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~ 293 (361)
T KOG1006|consen 215 CGQLVDSIAK-TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFD 293 (361)
T ss_pred hHhHHHHHHh-hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCc
Confidence 9876655433 34578889999999864 4578999999999999999999999988764 22223333222222 222
Q ss_pred C---CChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 884 Q---NTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 884 ~---~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
. ..+..+..||.-||.+|-..||.+.+++++
T Consensus 294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2 368899999999999999999999998865
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=285.77 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=199.7
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeee--------e
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT--------K 727 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~--------~ 727 (931)
.+.|+-..+||+|.||.||+|+. +++.||+|++-........-...++|+++|..|+|+|++.+++.+. .
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 36788889999999999999976 5677999876543322222345689999999999999999998773 2
Q ss_pred CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCc
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGl 807 (931)
...+|+||.+| ..+|.-++.. ...+++..++.+++.+++.||.|+|+.. |+|||+|++|+||+.+|.+||+|||+
T Consensus 96 r~t~ylVf~~c-ehDLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 96 RATFYLVFDFC-EHDLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred cceeeeeHHHh-hhhHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEeecccc
Confidence 34689999999 5588888864 3356899999999999999999999988 99999999999999999999999999
Q ss_pred ccccccccc----ccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc--c-
Q 002355 808 SRFKANTFI----SSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR--R- 879 (931)
Q Consensus 808 Ar~~~~~~~----~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~--r- 879 (931)
++....... .....+.|.+|++||.+.+ ..++++.|||.-||+|.||+|+.+.|.+..+.+.+..+...-. .
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 975433211 1223455899999999887 4689999999999999999999999988776655443321100 0
Q ss_pred -----------------cCC-------------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002355 880 -----------------LAI-------------PQNTSPVLASLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 880 -----------------~~l-------------P~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
.++ |-.-+++..+|+.++|.+||.+|+++++++.|.
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 001 112345789999999999999999999999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=301.43 Aligned_cols=249 Identities=17% Similarity=0.180 Sum_probs=168.4
Q ss_pred ccCceEEEEEecccCceEEEEEEEc------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEee------
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA------ 724 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~------ 724 (931)
..++|++.++||+|+||.||+|++. +..||+|++...... .....| .+....+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 5589999999999999999999873 568999987643211 111111 1122222233322222
Q ss_pred eeeCCeEEEEEeecCCCCHHHHhhcCCCC-----------------CCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEecc
Q 002355 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAG-----------------EMMDQRRRLRMALDVAKGINYLHNLNPPILHWDL 787 (931)
Q Consensus 725 f~~~~~l~LVmEy~~GgSL~d~L~r~~~~-----------------~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDL 787 (931)
...+..+++||||+.+++|.+++...... .......+..++.||+.||+|||+++ |+||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDL 281 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDV 281 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcC
Confidence 24566899999999999999998642210 01123456679999999999999999 999999
Q ss_pred CCCCeEECC-CCcEEEEecCcccccccc-ccccCCCCCCCcccCcccccCCC----------------------CCchhH
Q 002355 788 KSPNLLVDK-NWTVKVCDFGLSRFKANT-FISSKSVAGTPEWMAPEFLRGEP----------------------SNEKSD 843 (931)
Q Consensus 788 KPeNILLd~-dg~IKL~DFGlAr~~~~~-~~~~~~~~GT~~Y~APEvL~~~~----------------------~t~ksD 843 (931)
||+|||++. ++.+||+|||+|+..... ........+++.|+|||.+.... ++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999985 689999999999753221 12234567899999999664322 234569
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc---------c----------cCCCCCChHHHHHHHHHhcccCCCC
Q 002355 844 VYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR---------R----------LAIPQNTSPVLASLMESCWADDPAQ 904 (931)
Q Consensus 844 IWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~---------r----------~~lP~~~s~eL~dLI~rcL~~DPee 904 (931)
||||||++|||+++..++.... ......+..... . ..+.........+||.+||++||.+
T Consensus 362 VwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 9999999999999776653311 111111100000 0 0011122334568999999999999
Q ss_pred CCCHHHHHHH
Q 002355 905 RPSFANIVES 914 (931)
Q Consensus 905 RPSa~ELLq~ 914 (931)
|||+.++++|
T Consensus 441 R~ta~e~L~H 450 (566)
T PLN03225 441 RISAKAALAH 450 (566)
T ss_pred CCCHHHHhCC
Confidence 9999999987
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=298.87 Aligned_cols=261 Identities=30% Similarity=0.526 Sum_probs=223.7
Q ss_pred CceEEEEEecccCceEEEEEEE--c----CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--H----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~----g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
...+..++||.|+||+||+|.| + +.+||+|++....... ...+++.|+-+|..|.|||+++|++++.... +-
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~-~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK-ASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch-hhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 3556678999999999999977 3 3469999987665433 3478899999999999999999999998766 88
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
||++||++|.|.++++. .+..+-.+..+.|..||++|+.|||.++ ++||||-..|+||..-.++||.|||+++...
T Consensus 774 lvtq~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 99999999999999986 3456888999999999999999999998 9999999999999999999999999999765
Q ss_pred ccccc--cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHH
Q 002355 813 NTFIS--SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPV 889 (931)
Q Consensus 813 ~~~~~--~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~e 889 (931)
..... .......+.|||-|.+....++.++||||+|+++||++| |..|+.+..-+++-.. .....++.-|+.++.+
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl-le~geRLsqPpiCtiD 928 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL-LEKGERLSQPPICTID 928 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-HhccccCCCCCCccHH
Confidence 43222 222334668999999999999999999999999999997 8999999886665544 4566778899999999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhhh
Q 002355 890 LASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLI 926 (931)
Q Consensus 890 L~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l~ 926 (931)
+..++.+||..|+..||+++++...+....+.|.-+.
T Consensus 929 Vy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl 965 (1177)
T KOG1025|consen 929 VYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRYL 965 (1177)
T ss_pred HHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceEe
Confidence 9999999999999999999999999999988876543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=289.14 Aligned_cols=258 Identities=18% Similarity=0.207 Sum_probs=185.1
Q ss_pred cccCceEEEEEecccCceEEEEEEE------------------cCCceEEEEEeecccchH------------HHHHHHH
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW------------------HGSDVAVKVLTVQDFLDD------------QLKEFLR 705 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~------------------~g~~VAVKVlk~~~~~~~------------~~~~~l~ 705 (931)
+..++|++.++||+|+||+||+|.+ .++.||||.+........ .......
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 4678999999999999999999853 245699999865432110 0122345
Q ss_pred HHHHHHhcCCCCe-----eeEEeeeee--------CCeEEEEEeecCCCCHHHHhhcCCC--------------------
Q 002355 706 EVAIMKRVRHPNV-----VLFMGAVTK--------RPHLSIVTEYLPRGSLYRLIHRPAA-------------------- 752 (931)
Q Consensus 706 EIkILk~L~HpNI-----V~Lid~f~~--------~~~l~LVmEy~~GgSL~d~L~r~~~-------------------- 752 (931)
|+.++.+++|.++ ++++++|.. .+..+|||||+.+++|.++++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777777876554 567777642 3568999999999999998864210
Q ss_pred -CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc-ccCCCCCCCcccCc
Q 002355 753 -GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI-SSKSVAGTPEWMAP 830 (931)
Q Consensus 753 -~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~-~~~~~~GT~~Y~AP 830 (931)
...+++..++.++.||+.+|.|||+.+ |+||||||+|||++.++.+||+|||++........ ......+|+.|+||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 112456778899999999999999999 99999999999999999999999999865432211 11122347899999
Q ss_pred ccccCCCC----------------------CchhHHHHHHHHHHHHHhCCC-CCCCCChHHH-----------HHHHHhc
Q 002355 831 EFLRGEPS----------------------NEKSDVYSFGVILWELVTMQQ-PWNGLGPAQV-----------VGAVAFQ 876 (931)
Q Consensus 831 EvL~~~~~----------------------t~ksDIWSLG~ILyELLTG~~-PF~~~~~~ei-----------i~~i~~~ 876 (931)
|.+..... ..+.||||+||++|+|++|.. ||........ .......
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 98764321 124699999999999999975 7754321110 0111111
Q ss_pred ccccCCCCCChHHHHHHHHHhcccCC---CCCCCHHHHHHHH
Q 002355 877 NRRLAIPQNTSPVLASLMESCWADDP---AQRPSFANIVESL 915 (931)
Q Consensus 877 ~~r~~lP~~~s~eL~dLI~rcL~~DP---eeRPSa~ELLq~L 915 (931)
..........++...+||.+||..+| .+|+|+.|+|+|-
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 22233345678999999999999866 6899999999873
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=239.57 Aligned_cols=211 Identities=42% Similarity=0.693 Sum_probs=184.8
Q ss_pred ecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCCCHH
Q 002355 667 VGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY 744 (931)
Q Consensus 667 LG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~GgSL~ 744 (931)
||.|++|.||+++.. ++.+++|++....... ....+.+|+++++.++|++|+++++++......+++||++.|++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999986 7889999998765322 3467889999999999999999999999999999999999989999
Q ss_pred HHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC-CCcEEEEecCccccccccccccCCCCC
Q 002355 745 RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGLSRFKANTFISSKSVAG 823 (931)
Q Consensus 745 d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~-dg~IKL~DFGlAr~~~~~~~~~~~~~G 823 (931)
+++.... ..++...++.++.+++.+|.+||+.| ++|+||+|.||+++. ++.++|+|||.+..............+
T Consensus 80 ~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (215)
T cd00180 80 DLLKENE--GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG 155 (215)
T ss_pred HHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccC
Confidence 9997532 35889999999999999999999999 999999999999999 899999999998765543212234567
Q ss_pred CCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCC
Q 002355 824 TPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDP 902 (931)
Q Consensus 824 T~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DP 902 (931)
...|++||.+... ..+.+.|+|+||+++++| ..+.+++.+|+..+|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p 202 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDP 202 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCc
Confidence 8899999998876 778899999999999999 689999999999999
Q ss_pred CCCCCHHHHHHHH
Q 002355 903 AQRPSFANIVESL 915 (931)
Q Consensus 903 eeRPSa~ELLq~L 915 (931)
.+||++.++++++
T Consensus 203 ~~R~~~~~l~~~~ 215 (215)
T cd00180 203 EKRPSAKEILEHL 215 (215)
T ss_pred ccCcCHHHHhhCC
Confidence 9999999998763
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=271.35 Aligned_cols=246 Identities=25% Similarity=0.336 Sum_probs=201.7
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC------e
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP------H 730 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~------~ 730 (931)
.+|.-+..+|.|.- .|..|-+ .++.||+|.+..........++..+|..++..+.|+||+.++.+|+... .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 57888889999999 7777755 6889999998776444445577889999999999999999999997554 5
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
.|+|||+| ..+|...+.- .++.+.+.+++.|++.|+.|||+.| |+||||||+||++..++.+||.|||+|+.
T Consensus 96 ~y~v~e~m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeeccchhhcc
Confidence 79999999 7799988863 4778899999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc----------
Q 002355 811 KANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL---------- 880 (931)
Q Consensus 811 ~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~---------- 880 (931)
....+ ..+..+.|..|+|||++.+..+...+||||+||++.||++|...|.+.+.-.-..++...-..+
T Consensus 168 e~~~~-~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 168 EDTDF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred cCccc-ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 76553 3455678999999999999999999999999999999999999998765322222111110000
Q ss_pred -------------------CCC-----------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 -------------------AIP-----------QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 -------------------~lP-----------~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+| ......+++++.+||..+|++|.+++++|+|
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 011 1223468999999999999999999999987
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=261.81 Aligned_cols=258 Identities=20% Similarity=0.363 Sum_probs=201.5
Q ss_pred CCCCCCCccccccccccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CC
Q 002355 640 PRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HP 716 (931)
Q Consensus 640 ~ry~~~epsl~~~~lei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-Hp 716 (931)
.+|++.+. +..+|- ..++|++++++|+|-|+.||.|.. +++.++||+++... .+.+.+|++||..|. ||
T Consensus 22 ~eYWdYE~-~~i~wg--~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~ 93 (338)
T KOG0668|consen 22 REYWDYES-LVIDWG--NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGP 93 (338)
T ss_pred hhhcchhh-eeeecc--ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCC
Confidence 34555553 445565 458999999999999999999974 67889999998643 367899999999997 99
Q ss_pred CeeeEEeeeeeC--CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEE
Q 002355 717 NVVLFMGAVTKR--PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV 794 (931)
Q Consensus 717 NIV~Lid~f~~~--~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILL 794 (931)
||+.|+++..+. ....||+||+.+.+...+.. .++.-.++.++.||++||.|+|+.| |+|||+||.|++|
T Consensus 94 NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmI 165 (338)
T KOG0668|consen 94 NIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMI 165 (338)
T ss_pred CeeehhhhhcCccccCchhHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeee
Confidence 999999998654 56889999998877766654 3777888999999999999999999 9999999999999
Q ss_pred CCC-CcEEEEecCccccccccccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCC--ChHHHH
Q 002355 795 DKN-WTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGL--GPAQVV 870 (931)
Q Consensus 795 d~d-g~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~--~~~eii 870 (931)
|.. ..++|+|+|+|........ ....+.+..|..||.+-. ..++..-|+|||||++..|+..+.||... +.++.+
T Consensus 166 dh~~rkLrlIDWGLAEFYHp~~e-YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLV 244 (338)
T KOG0668|consen 166 DHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 244 (338)
T ss_pred chhhceeeeeecchHhhcCCCce-eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHH
Confidence 864 5699999999987654322 233355778899998865 45788899999999999999999998543 233332
Q ss_pred HHHHhc----------ccccC------------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 871 GAVAFQ----------NRRLA------------------------IPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 871 ~~i~~~----------~~r~~------------------------lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
...... ..... ...-.++++.+|+.++|.+|-.+|+|++|.+.|
T Consensus 245 kIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 245 KIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 211000 00000 012246899999999999999999999999987
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=257.05 Aligned_cols=218 Identities=27% Similarity=0.476 Sum_probs=181.1
Q ss_pred cccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCe
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH 730 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~ 730 (931)
+++..+.+..+..||+|+||.|-+.++ +|...|+|.++... ..+..++.++|+.+..+. .+|++|++|+.......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 566678888899999999999977766 78889999987654 345557888999875544 79999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhc-CCCCCCCcHHHHHHHHHHHHHHHHHHHhC-CCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 731 LSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLRMALDVAKGINYLHNL-NPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r-~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~-G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
++|.||.| ..+|..+.++ ...+..+++..+-+|+..+++||.|||++ . +||||+||+|||++.+|++||||||++
T Consensus 120 vwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 120 VWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred EEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccc
Confidence 99999999 6788776643 23456799999999999999999999985 5 999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCcccCcccccC----CCCCchhHHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHhc
Q 002355 809 RFKANTFISSKSVAGTPEWMAPEFLRG----EPSNEKSDVYSFGVILWELVTMQQPWNGL-GPAQVVGAVAFQ 876 (931)
Q Consensus 809 r~~~~~~~~~~~~~GT~~Y~APEvL~~----~~~t~ksDIWSLG~ILyELLTG~~PF~~~-~~~eii~~i~~~ 876 (931)
-...++... +...|-..|||||.+.. ..|+.++||||||++++||.+++.||... .+.+.+.++...
T Consensus 197 G~L~dSiAk-t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 197 GYLVDSIAK-TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred eeehhhhHH-HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 877665322 23467889999999853 36788999999999999999999999765 466777776543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=273.75 Aligned_cols=248 Identities=26% Similarity=0.396 Sum_probs=196.1
Q ss_pred EEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC-----eEEEEE
Q 002355 663 VKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP-----HLSIVT 735 (931)
Q Consensus 663 Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~-----~l~LVm 735 (931)
-.+.||+|+||+||.+.+ +|+.||+|++......-..-+++.+|+++|.-.+|.|++..+++..... .+|+|+
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 345699999999999976 6889999988654433334578899999999999999999988775442 478899
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
|+| ..+|..++-.+ ..++...+.-+++||++||.|||+.+ |.||||||.|+|++.+..+||||||+++......
T Consensus 137 ELm-QSDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 137 ELM-QSDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHH-HhhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccccccchhh
Confidence 999 67888888653 35888889999999999999999999 9999999999999999999999999999654332
Q ss_pred -cccCCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc-------------
Q 002355 816 -ISSKSVAGTPEWMAPEFLRGEP-SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL------------- 880 (931)
Q Consensus 816 -~~~~~~~GT~~Y~APEvL~~~~-~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~------------- 880 (931)
...+..+.|.+|+|||++.|.. |+.++||||+||++.|++..+..|...++.+.+..+...-..+
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 1123345688999999999865 6889999999999999999999998877665544332211100
Q ss_pred -------C------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 881 -------A------------IPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 881 -------~------------lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
. .+..-..+...++..+|..||.+|.+..+.+.++.
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 0 11233456788899999999999999999887753
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-29 Score=293.85 Aligned_cols=241 Identities=30% Similarity=0.455 Sum_probs=190.3
Q ss_pred EEEecccCceE-EEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEEEEEeecCCC
Q 002355 664 KERVGAGSFGT-VHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRG 741 (931)
Q Consensus 664 i~kLG~G~fGt-VylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~LVmEy~~Gg 741 (931)
.+.+|.|+.|+ ||+|...++.||||.+-... .+.+.+|+..|+.- .|||||++++.-.++...||..|.| ..
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~ 587 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-AC 587 (903)
T ss_pred HHHcccCCCCcEEEEEeeCCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hh
Confidence 34689999998 79999999999999876543 24567999999888 5999999999999999999999999 78
Q ss_pred CHHHHhhcCC-CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC---C--CcEEEEecCcccccccc-
Q 002355 742 SLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---N--WTVKVCDFGLSRFKANT- 814 (931)
Q Consensus 742 SL~d~L~r~~-~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~---d--g~IKL~DFGlAr~~~~~- 814 (931)
+|.+++.... ..........+.+..|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++.....
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 9999997631 1111122345778899999999999999 999999999999976 3 46899999999865432
Q ss_pred --ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhccccc-CCCCCChHHH
Q 002355 815 --FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRL-AIPQNTSPVL 890 (931)
Q Consensus 815 --~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG-~~PF~~~~~~eii~~i~~~~~r~-~lP~~~s~eL 890 (931)
........||-+|+|||++.....+.++|||||||++|..++| .+||...-..+. .+...+... .+......++
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d~eA 743 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPDCEA 743 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCchHHH
Confidence 2234566799999999999998888899999999999999987 899977543322 122222211 1222222389
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+||.+|+..+|..||++.++|.|
T Consensus 744 ~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 744 KDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred HHHHHHhcCCCcccCCCHHHHhCC
Confidence 999999999999999999999876
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-29 Score=280.45 Aligned_cols=200 Identities=25% Similarity=0.435 Sum_probs=174.4
Q ss_pred ccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccch------HHHHHHHHHHHHHHhcC---CCCeeeEEeee
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD------DQLKEFLREVAIMKRVR---HPNVVLFMGAV 725 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~------~~~~~~l~EIkILk~L~---HpNIV~Lid~f 725 (931)
.+.+|..++.||.|+||.||+|.++ ...|+||.+.+..... ..+-.+..||+||..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3467999999999999999999774 4569999988776432 22344678999999997 99999999999
Q ss_pred eeCCeEEEEEee-cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEe
Q 002355 726 TKRPHLSIVTEY-LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCD 804 (931)
Q Consensus 726 ~~~~~l~LVmEy-~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~D 804 (931)
++++.+||+||. -+|.+|+++|.. ...+.+.++..|++|++.|+++||++| |||||||-+|+.++.+|.+||+|
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~---kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEF---KPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhc---cCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEEee
Confidence 999999999996 456799999976 446999999999999999999999999 99999999999999999999999
Q ss_pred cCccccccccccccCCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCC
Q 002355 805 FGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPS-NEKSDVYSFGVILWELVTMQQPWNG 863 (931)
Q Consensus 805 FGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~-t~ksDIWSLG~ILyELLTG~~PF~~ 863 (931)
||.|....+. ....++||..|.|||++.|..| +..-|||+||++||.++...-||..
T Consensus 714 fgsaa~~ksg--pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 714 FGSAAYTKSG--PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccchhhhcCC--CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9998766554 3467899999999999999877 6778999999999999999888864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=232.79 Aligned_cols=206 Identities=35% Similarity=0.589 Sum_probs=174.2
Q ss_pred eEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeec
Q 002355 661 LHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYL 738 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~ 738 (931)
|.+.+.||.|++|.||++... ++.+|+|.+...... .....+.+|++.++.++|+|++++++++......++++|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 567899999999999999874 578999999876433 24567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc-cc
Q 002355 739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF-IS 817 (931)
Q Consensus 739 ~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~-~~ 817 (931)
.+++|.+++..... .+++..++.++.+++.+|.+||.++ ++|+||+|.||+++.++.++|+|||.+....... ..
T Consensus 80 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 80 EGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 99999999975321 1788999999999999999999998 9999999999999999999999999987654431 01
Q ss_pred cCCCCCCCcccCcccc-cCCCCCchhHHHHHHHHHHHHHhCCCCCCC-CChHHHHH
Q 002355 818 SKSVAGTPEWMAPEFL-RGEPSNEKSDVYSFGVILWELVTMQQPWNG-LGPAQVVG 871 (931)
Q Consensus 818 ~~~~~GT~~Y~APEvL-~~~~~t~ksDIWSLG~ILyELLTG~~PF~~-~~~~eii~ 871 (931)
.....++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .++...+.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~ 211 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLS 211 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHH
Confidence 2334677889999998 666678899999999999999999999977 44443333
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-29 Score=284.73 Aligned_cols=251 Identities=28% Similarity=0.470 Sum_probs=217.8
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
..++|+++.++|.|+||.||+||+ +++..|+|+++..... ...-+..|+-+++..+||||+.+++.+..+..++++
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--cccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 347999999999999999999987 6788999999987533 335567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
||||.||+|.+..+- .+.+++.++.+++++.++||+|||+.| =+|||||-.|||++..|.+|+.|||.+...+..
T Consensus 91 MEycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EEecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhhh
Confidence 999999999998864 457999999999999999999999999 899999999999999999999999999887777
Q ss_pred ccccCCCCCCCcccCcccc---cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc---ccCCCCCChH
Q 002355 815 FISSKSVAGTPEWMAPEFL---RGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR---RLAIPQNTSP 888 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL---~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~---r~~lP~~~s~ 888 (931)
..+...++||++|||||+- ....+...+|||++|+...|+-.-++|..+.-+.+.......... ...-+..+++
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~ 245 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSE 245 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchH
Confidence 7778899999999999985 345688999999999999999988988877776666554433222 2233457789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 889 VLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.|.+|++.+|.++|.+||+++.+|.|
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheec
Confidence 99999999999999999999988764
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=254.28 Aligned_cols=265 Identities=26% Similarity=0.431 Sum_probs=220.9
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEcC-------CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAV 725 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~g-------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f 725 (931)
.+.+...+++....+-+|.||.||+|.|.. +.|-+|.++... +.-++..++.|--++..+.|||++.+.++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 345667889999999999999999996632 346677765443 344567888999999999999999999887
Q ss_pred e-eCCeEEEEEeecCCCCHHHHhh-----cCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc
Q 002355 726 T-KRPHLSIVTEYLPRGSLYRLIH-----RPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT 799 (931)
Q Consensus 726 ~-~~~~l~LVmEy~~GgSL~d~L~-----r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~ 799 (931)
. +....+.++.++.-|+|..++. +......+...+...++.|++.|++|||++| |||.||-..|.+|++.-.
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhhee
Confidence 5 5567889999999999999998 4444455777788889999999999999999 999999999999999999
Q ss_pred EEEEecCcccccccc--ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 002355 800 VKVCDFGLSRFKANT--FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQ 876 (931)
Q Consensus 800 IKL~DFGlAr~~~~~--~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~ 876 (931)
+||+|=.+++-.-.. .........+..||+||.+.+..++.++|+||||++||||+| |+.|+...++.++...+. .
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk-d 513 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK-D 513 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh-c
Confidence 999999998843211 111122234678999999999999999999999999999998 799999999998877664 6
Q ss_pred ccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 877 NRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 877 ~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
+.+..-|.++|+++..+|.-||+..|++||+++|+...|.+.-.+
T Consensus 514 GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 514 GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 788889999999999999999999999999999999998876443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-25 Score=241.37 Aligned_cols=257 Identities=21% Similarity=0.288 Sum_probs=206.4
Q ss_pred ceEEEEEecccCceEEEEEEEcCC---ceEEEEEeecccchHHHHHHHHHHHHHHhcCC----CCeeeEEeee-eeCCeE
Q 002355 660 ELHVKERVGAGSFGTVHRAEWHGS---DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH----PNVVLFMGAV-TKRPHL 731 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~~g~---~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~H----pNIV~Lid~f-~~~~~l 731 (931)
+|.+.++||+|+||.||+|.+... .+|+|+......... ..+..|+.++..+.. +++..+++.+ ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 899999999999999999987543 589998876532221 146678888888862 6999999999 588899
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC-----CcEEEEecC
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN-----WTVKVCDFG 806 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d-----g~IKL~DFG 806 (931)
+|||+.+ |.+|.++..... ...++..++..++.|++.+|++||+.| ++||||||.|+++... ..+.|.|||
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 9999999 999999886544 567999999999999999999999999 9999999999999865 369999999
Q ss_pred ccc--cccccc----c---c-cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 002355 807 LSR--FKANTF----I---S-SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ 876 (931)
Q Consensus 807 lAr--~~~~~~----~---~-~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~ 876 (931)
+++ ...... . . .....||..|+++....+...+.+.|+||++.++.+++.|..||...........+...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 321111 1 1 22456999999999999999999999999999999999999999876643222222211
Q ss_pred ccccC---CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 877 NRRLA---IPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 877 ~~r~~---lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
..... .....+.++..+...+-..+...+|.+..+...|++++...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11111 34556788899988888899999999999999998887653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-24 Score=217.24 Aligned_cols=251 Identities=30% Similarity=0.482 Sum_probs=204.9
Q ss_pred eEEEEEecccCceEEEEEEEcCCceEEEEEeecccchH-HHHHHHHHHHHHHhcCCC-CeeeEEeeeeeCCeEEEEEeec
Q 002355 661 LHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKEFLREVAIMKRVRHP-NVVLFMGAVTKRPHLSIVTEYL 738 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~-~~~~~l~EIkILk~L~Hp-NIV~Lid~f~~~~~l~LVmEy~ 738 (931)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+++++.+......+++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 788999999999999999888 7899999987765543 567889999999999988 7999999998888899999999
Q ss_pred CCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC-cEEEEecCcccccccccc-
Q 002355 739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-TVKVCDFGLSRFKANTFI- 816 (931)
Q Consensus 739 ~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg-~IKL~DFGlAr~~~~~~~- 816 (931)
.++++.+++........+.......++.|++.++.|+|+.+ ++||||||+||+++..+ .++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 99999977764221125889999999999999999999999 99999999999999988 799999999875443321
Q ss_pred -----ccCCCCCCCcccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcccc-cCCC
Q 002355 817 -----SSKSVAGTPEWMAPEFLRG---EPSNEKSDVYSFGVILWELVTMQQPWNGLGP----AQVVGAVAFQNRR-LAIP 883 (931)
Q Consensus 817 -----~~~~~~GT~~Y~APEvL~~---~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~----~eii~~i~~~~~r-~~lP 883 (931)
......|+..|++||.+.+ .......|+|++|++++++++|..||..... ......+...... ...+
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 2356789999999999988 5778899999999999999999999877653 3444444333322 1111
Q ss_pred --CCC----hHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 884 --QNT----SPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 884 --~~~----s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
... ...+.+++.+|+..+|..|.+..+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111 2578999999999999999999887765
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-25 Score=216.96 Aligned_cols=165 Identities=22% Similarity=0.352 Sum_probs=131.6
Q ss_pred CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCC
Q 002355 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820 (931)
Q Consensus 741 gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~ 820 (931)
|+|.+++... +..+++..++.++.||+.||.|||+.+ ||+|||++.++.+|+ ||++...... .
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~ 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE-----Q 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-----c
Confidence 6899999752 346999999999999999999999987 999999999999999 9998765443 2
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhccccc-----CCCCCChH--HHHH
Q 002355 821 VAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPA-QVVGAVAFQNRRL-----AIPQNTSP--VLAS 892 (931)
Q Consensus 821 ~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~-eii~~i~~~~~r~-----~lP~~~s~--eL~d 892 (931)
..||+.|+|||++.+..++.++|||||||++|||++|..||...... ..+..+....... ..+...+. .+.+
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFAD 143 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHH
Confidence 26899999999999999999999999999999999999999765432 2222222111111 11222333 6999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 893 LMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
||.+||..+|.+||++.++++++..+....
T Consensus 144 ~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 144 FMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred HHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 999999999999999999999998876554
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=273.96 Aligned_cols=196 Identities=19% Similarity=0.212 Sum_probs=144.0
Q ss_pred hcCC-CCeeeEEeeee-------eCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEE
Q 002355 712 RVRH-PNVVLFMGAVT-------KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783 (931)
Q Consensus 712 ~L~H-pNIV~Lid~f~-------~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~II 783 (931)
.++| +||++++++|. ....++++||++ +++|.+++... ...+++.+++.++.||+.||+|||++| |+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g--Iv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG--IV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence 4455 58888888872 334577889988 77999999752 345899999999999999999999999 99
Q ss_pred EeccCCCCeEECCC-------------------CcEEEEecCccccccccc----------------cccCCCCCCCccc
Q 002355 784 HWDLKSPNLLVDKN-------------------WTVKVCDFGLSRFKANTF----------------ISSKSVAGTPEWM 828 (931)
Q Consensus 784 HrDLKPeNILLd~d-------------------g~IKL~DFGlAr~~~~~~----------------~~~~~~~GT~~Y~ 828 (931)
||||||+||||+.. +.+||+|||+++...... .......||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999654 445666666665321100 0011235788999
Q ss_pred CcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCH
Q 002355 829 APEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSF 908 (931)
Q Consensus 829 APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa 908 (931)
|||++.+..++.++|||||||+||||++|..|+.... .....+.....+. ......+...+++.+||..+|.+||++
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~L~~~P~~Rps~ 259 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPP-QILLNWPKEASFCLWLLHPEPSCRPSM 259 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcCh-hhhhcCHHHHHHHHHhCCCChhhCcCh
Confidence 9999999999999999999999999999988875422 1222221111111 111224566789999999999999999
Q ss_pred HHHHHHH
Q 002355 909 ANIVESL 915 (931)
Q Consensus 909 ~ELLq~L 915 (931)
.|++++-
T Consensus 260 ~eil~h~ 266 (793)
T PLN00181 260 SELLQSE 266 (793)
T ss_pred HHHhhch
Confidence 9999863
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-24 Score=230.29 Aligned_cols=255 Identities=18% Similarity=0.283 Sum_probs=216.7
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCeEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~l~LV 734 (931)
.-.|+|+++||+|.||..++|+. +++.||||....... .-++..|.+.++.|. .++|...|.+...+.+..||
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 35799999999999999999974 899999998765432 234667888888884 78999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC-----CcEEEEecCccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN-----WTVKVCDFGLSR 809 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d-----g~IKL~DFGlAr 809 (931)
||++ |.+|.++... .++.++.+++..++.|++.-++|+|++. +|+|||||+|+||... ..|.|+|||+|+
T Consensus 103 idLL-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhh-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 9999 9999999986 4568999999999999999999999999 9999999999999753 358999999998
Q ss_pred ccccc-------ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcccc
Q 002355 810 FKANT-------FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLG---PAQVVGAVAFQNRR 879 (931)
Q Consensus 810 ~~~~~-------~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~---~~eii~~i~~~~~r 879 (931)
...++ ....+...||.+||+-....+.+.+.+.|+-|||-++..++-|..||.+.. ..+.+.+|......
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 65543 223456789999999999999999999999999999999999999998864 56667666544433
Q ss_pred cC---CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 880 LA---IPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 880 ~~---lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
.+ +..++|.++..-++-.-..+..+-|+++-+...+.+++..
T Consensus 258 T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 258 TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 32 4467899999999999999999999999999988888764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-25 Score=242.99 Aligned_cols=244 Identities=24% Similarity=0.376 Sum_probs=191.8
Q ss_pred CceEEEEEecccCceEEEEEEE-----cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCeEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~-----~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~l~ 732 (931)
+.|.++++||.|.|++||+|.+ ..+.||+|.+..... ..++.+|+++|..+. +.||+++.+++..++..+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 6789999999999999999954 456799999876543 356889999999995 889999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC-CCcEEEEecCccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGLSRFK 811 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~-dg~IKL~DFGlAr~~ 811 (931)
+|+||++.....+++.. ++...++.+++.++.||.++|..| ||||||||.|+|.+. .+.-.|+|||+|...
T Consensus 112 ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred EEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHHH
Confidence 99999999999888865 678889999999999999999999 999999999999975 456789999998610
Q ss_pred c-----------------c----------------c--c---------cccCCCCCCCcccCcccccCCC-CCchhHHHH
Q 002355 812 A-----------------N----------------T--F---------ISSKSVAGTPEWMAPEFLRGEP-SNEKSDVYS 846 (931)
Q Consensus 812 ~-----------------~----------------~--~---------~~~~~~~GT~~Y~APEvL~~~~-~t~ksDIWS 846 (931)
. . . . .......||++|+|||++...+ .++++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 0 0 0 0 0011346899999999998765 588999999
Q ss_pred HHHHHHHHHhCCCCCCCCCh-----HH---------HHHHHHhccc--------------------cc------------
Q 002355 847 FGVILWELVTMQQPWNGLGP-----AQ---------VVGAVAFQNR--------------------RL------------ 880 (931)
Q Consensus 847 LG~ILyELLTG~~PF~~~~~-----~e---------ii~~i~~~~~--------------------r~------------ 880 (931)
.|+|+..+++++.||..... .+ +.+.....+. ..
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n 343 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN 343 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence 99999999999999854211 11 1110000000 00
Q ss_pred ----CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 ----AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 ----~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
......+..+.+|+.+||..||.+|.|+++.|+|
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0012234578999999999999999999999986
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-24 Score=226.52 Aligned_cols=246 Identities=22% Similarity=0.358 Sum_probs=186.3
Q ss_pred cCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEe-eeeeCCeEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMG-AVTKRPHLSI 733 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid-~f~~~~~l~L 733 (931)
.+.|.|.+.||+|.||.+-+|++. ++.+++|.+..... ....|.+|...--.| .|.||+.-|+ +|+..+.+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 378999999999999999999885 45699998876542 235677887654445 4889998776 5778889999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC--CCcEEEEecCccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK--NWTVKVCDFGLSRFK 811 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~--dg~IKL~DFGlAr~~ 811 (931)
++||++.|+|..-+.. ..+-+....+++.|++.||.|||+.+ +||||||.+||||-. .-.|||||||+++..
T Consensus 100 ~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 9999999999988754 34778889999999999999999999 999999999999843 337999999999876
Q ss_pred cccccccCCCCCCCcccCcccccCCC-----CCchhHHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhcccccCCC
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRGEP-----SNEKSDVYSFGVILWELVTMQQPWNGL---GPAQVVGAVAFQNRRLAIP 883 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~~~-----~t~ksDIWSLG~ILyELLTG~~PF~~~---~~~eii~~i~~~~~r~~lP 883 (931)
+..-.. .--+..|.+||++.... ..+.+|+|.||+++|.++||..||... +..-+-...+.+......|
T Consensus 174 g~tV~~---~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 174 GTTVKY---LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP 250 (378)
T ss_pred Cceehh---hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc
Confidence 654321 22355799999865432 356789999999999999999999642 1221212222222333344
Q ss_pred ---CCChHHHHHHHHHhcccCCCCC---CCHHHHHHHH
Q 002355 884 ---QNTSPVLASLMESCWADDPAQR---PSFANIVESL 915 (931)
Q Consensus 884 ---~~~s~eL~dLI~rcL~~DPeeR---PSa~ELLq~L 915 (931)
...++.+..+.++-|+.+++.| .+++.....+
T Consensus 251 ~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 251 KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 4567888999999999999999 5555554443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=212.89 Aligned_cols=257 Identities=19% Similarity=0.305 Sum_probs=210.2
Q ss_pred cccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCeEE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~l~ 732 (931)
+..++|+++++||.|+||.+|+|.. .|..||||+.+...-. -++..|.++++.|+ ...|..+..++.+..+..
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 4558999999999999999999975 7899999998765422 24678999999997 468888888889999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC---CcEEEEecCccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN---WTVKVCDFGLSR 809 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d---g~IKL~DFGlAr 809 (931)
+||+++ |.+|.++..- ....++..+++-++-|++.-++|+|.++ +|||||||+|+|+.-+ ..+.|+|||+|+
T Consensus 88 lVMdLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eeeecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchh
Confidence 999999 9999999864 3456889999999999999999999999 9999999999999754 358899999998
Q ss_pred ccccc-------ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcccc
Q 002355 810 FKANT-------FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGP---AQVVGAVAFQNRR 879 (931)
Q Consensus 810 ~~~~~-------~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~---~eii~~i~~~~~r 879 (931)
..-+. ........||.+|.+-....+...+.+.|+-|+|.+|..+--|..||.+... .+.++.+......
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s 242 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS 242 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence 54332 2234567899999998888888888999999999999999999999998753 3444444432222
Q ss_pred c---CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 880 L---AIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 880 ~---~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
. .+..+.|.++...+.-|-..-.++-|++.-+.+...-++.+
T Consensus 243 ~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 243 TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 2 24578899999999999999999999998877776665543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-22 Score=223.29 Aligned_cols=165 Identities=19% Similarity=0.140 Sum_probs=127.6
Q ss_pred cccCceEEEEEecccCceEEEEEEE---cCCceEEEEEeeccc---chHHHHHHHHHHHHHHhcCCCCeee-EEeeeeeC
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW---HGSDVAVKVLTVQDF---LDDQLKEFLREVAIMKRVRHPNVVL-FMGAVTKR 728 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~---~g~~VAVKVlk~~~~---~~~~~~~~l~EIkILk~L~HpNIV~-Lid~f~~~ 728 (931)
...++|++.+.||+|+||+||+|++ .++.||||++..... .......+.+|+++|+.++|+||+. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 3458899999999999999999976 456689998753311 1223456899999999999999985 5432
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEecc-CCCCeEECCCCcEEEEecCc
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDL-KSPNLLVDKNWTVKVCDFGL 807 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDL-KPeNILLd~dg~IKL~DFGl 807 (931)
+..||||||++|++|... .. .. ...++.|++.+|.|||++| |+|||| ||+|||++.++.+||+|||+
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 468999999999999732 11 11 1357889999999999999 999999 99999999999999999999
Q ss_pred ccccccccc--------ccCCCCCCCcccCcccccCC
Q 002355 808 SRFKANTFI--------SSKSVAGTPEWMAPEFLRGE 836 (931)
Q Consensus 808 Ar~~~~~~~--------~~~~~~GT~~Y~APEvL~~~ 836 (931)
|+....... .-....++..|+|||.+...
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 985433210 11345678889999988643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-22 Score=213.10 Aligned_cols=256 Identities=32% Similarity=0.656 Sum_probs=217.4
Q ss_pred cccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
|....+.++-||.....|..|+|+|.|..++.|++............|..|.-.|+...||||+.+++++....++.++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 45567788899999999999999999999999999887666555567888888888889999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEE--EecCccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKV--CDFGLSRFKAN 813 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL--~DFGlAr~~~~ 813 (931)
.||+-|+|+.+++. ..+-..+..++.+++.+|++|++|||+..+-|-.--|+...+++|.+-+.+| +|--++...
T Consensus 267 q~mp~gslynvlhe-~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe-- 343 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHE-QTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE-- 343 (448)
T ss_pred eeccchHHHHHHhc-CccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec--
Confidence 99999999999987 3344578889999999999999999998754444568899999999877655 343333221
Q ss_pred cccccCCCCCCCcccCcccccCCCCC---chhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSN---EKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t---~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL 890 (931)
....-.+.||+||.+...+.+ .++|+|||++++||+.|...||....+.+.-.++...+.+..+|++++..+
T Consensus 344 -----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm 418 (448)
T KOG0195|consen 344 -----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHM 418 (448)
T ss_pred -----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHH
Confidence 122346789999999887653 478999999999999999999999999998888888899999999999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 002355 891 ASLMESCWADDPAQRPSFANIVESLKKLL 919 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~L~~Ll 919 (931)
..||.-|+.-||.+||.++.++-.|+++.
T Consensus 419 ~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 419 NKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99999999999999999999998887653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.5e-23 Score=236.70 Aligned_cols=225 Identities=27% Similarity=0.386 Sum_probs=192.6
Q ss_pred ecccCceEEEEEE-----EcCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCeEEEEEeecCC
Q 002355 667 VGAGSFGTVHRAE-----WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIVTEYLPR 740 (931)
Q Consensus 667 LG~G~fGtVylAr-----~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~l~LVmEy~~G 740 (931)
+|.|+||.|++++ +.+.-+|+|++++.............|..++...+ ||.+|+++.+|+.+...+++++++.|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999874 35677999999887654443345667889999997 99999999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCC
Q 002355 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820 (931)
Q Consensus 741 gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~ 820 (931)
+.|+..+.. ...+.+.....+...++.+++++|..+ |+|||+|++||+++.+|++++.|||+++..-....
T Consensus 82 g~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 82 GDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred chhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence 999888765 345777777788889999999999999 99999999999999999999999999987655432
Q ss_pred CCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhccc
Q 002355 821 VAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD 900 (931)
Q Consensus 821 ~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~ 900 (931)
.|||..|||||++. .+..+.|+||+|+++|||+||..||.. ++...+ ......+|...+.++.++++.++..
T Consensus 153 ~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I--l~~~~~~p~~l~~~a~~~~~~l~~r 224 (612)
T KOG0603|consen 153 ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI--LKAELEMPRELSAEARSLFRQLFKR 224 (612)
T ss_pred cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH--hhhccCCchhhhHHHHHHHHHHHhh
Confidence 28999999999999 578889999999999999999999988 333333 2446678899999999999999999
Q ss_pred CCCCCCCH
Q 002355 901 DPAQRPSF 908 (931)
Q Consensus 901 DPeeRPSa 908 (931)
+|.+|.-.
T Consensus 225 ~p~nrLg~ 232 (612)
T KOG0603|consen 225 NPENRLGA 232 (612)
T ss_pred CHHHHhcc
Confidence 99999654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5e-22 Score=235.68 Aligned_cols=246 Identities=22% Similarity=0.320 Sum_probs=185.5
Q ss_pred EEEEecccCceEEEEEEE--cCCceEEEEEee---cccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 663 VKERVGAGSFGTVHRAEW--HGSDVAVKVLTV---QDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 663 Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~---~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
-.+.+|.|++|.|+.+.. ..+.++.|..+. ..... .....+..|.-+-..+.|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 456799999998887754 233344444331 11112 222236667777788899999888877766665555599
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc-
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF- 815 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~- 815 (931)
||++ +|+.++.+. ..+....+..++.||+.|++|||+.| |.||||||+|+++..+|.+||+|||.+.......
T Consensus 402 ~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 999999762 45888889999999999999999999 9999999999999999999999999986433222
Q ss_pred ---cccCCCCCCCcccCcccccCCCCCc-hhHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHH-h-----cccccCCCC
Q 002355 816 ---ISSKSVAGTPEWMAPEFLRGEPSNE-KSDVYSFGVILWELVTMQQPWNGLGPAQVV-GAVA-F-----QNRRLAIPQ 884 (931)
Q Consensus 816 ---~~~~~~~GT~~Y~APEvL~~~~~t~-ksDIWSLG~ILyELLTG~~PF~~~~~~eii-~~i~-~-----~~~r~~lP~ 884 (931)
......+|...|+|||++.+..|.+ ..||||.|+++..|++|+.||......+.. .... . ......+..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS 555 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence 2345678999999999999998865 679999999999999999999764432211 1110 0 011112335
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 885 NTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 885 ~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.++...+.+|.+||+.+|.+|.|+++|++.
T Consensus 556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 556 LLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred hchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 677889999999999999999999999865
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.9e-20 Score=193.38 Aligned_cols=175 Identities=14% Similarity=0.127 Sum_probs=136.1
Q ss_pred ccccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHH-HHH------HHHHHHHHHhcCCCCeeeEEeeeee
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQ-LKE------FLREVAIMKRVRHPNVVLFMGAVTK 727 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~-~~~------~l~EIkILk~L~HpNIV~Lid~f~~ 727 (931)
.+..++|++++.||.|+||.||++..++..+|||++......... ... +.+|++.+.++.|++|..+.+++..
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 345689999999999999999998778889999999765433322 223 5789999999999999999888653
Q ss_pred C--------CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc
Q 002355 728 R--------PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT 799 (931)
Q Consensus 728 ~--------~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~ 799 (931)
. +..+|||||++|.+|.++.. +++ ....+++.+|..||..| ++|||+||.||+++.+|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCCC-
Confidence 3 35899999999999988742 222 24568999999999999 99999999999999988
Q ss_pred EEEEecCccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHH
Q 002355 800 VKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELV 855 (931)
Q Consensus 800 IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELL 855 (931)
++|+|||........... ..+.....+..+.|+|+||+++.-+.
T Consensus 173 i~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999987644222100 11333444667899999999886654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.1e-20 Score=187.58 Aligned_cols=141 Identities=16% Similarity=0.165 Sum_probs=107.4
Q ss_pred EEEecccCceEEEEEEE-cCCceEEEEEeecccchHH------------------------HHHHHHHHHHHHhcCCCCe
Q 002355 664 KERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQ------------------------LKEFLREVAIMKRVRHPNV 718 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~~~~------------------------~~~~l~EIkILk~L~HpNI 718 (931)
...||+|+||.||+|.+ +|+.||||+++........ .....+|++++..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999986 6889999999865321110 1123459999999987776
Q ss_pred eeEEeeeeeCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHH-HhCCCCEEEeccCCCCeEECCC
Q 002355 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL-HNLNPPILHWDLKSPNLLVDKN 797 (931)
Q Consensus 719 V~Lid~f~~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yL-Hs~G~~IIHrDLKPeNILLd~d 797 (931)
.....+.. .. .+|||||++|+++...... ...++...+..++.||+.+|.+| |+.| |+||||||+|||++ +
T Consensus 82 ~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL-KS-HVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe-cC-CEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-C
Confidence 43322222 22 3899999988777654322 23588899999999999999999 6989 99999999999998 5
Q ss_pred CcEEEEecCcccccc
Q 002355 798 WTVKVCDFGLSRFKA 812 (931)
Q Consensus 798 g~IKL~DFGlAr~~~ 812 (931)
+.++|+|||+|....
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 789999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.7e-19 Score=193.08 Aligned_cols=235 Identities=17% Similarity=0.246 Sum_probs=153.9
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCC----------CCeeeEEee-
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH----------PNVVLFMGA- 724 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~H----------pNIV~Lid~- 724 (931)
..+...+.||.|+++.||.+.+ +++.+|||++....... ...+.+.+|.-....+.+ -.++.-++.
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 3667889999999999999998 45889999997765322 345666666544443321 122222222
Q ss_pred --------eeeC---C-----eEEEEEeecCCCCHHHHhhc----CCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEE
Q 002355 725 --------VTKR---P-----HLSIVTEYLPRGSLYRLIHR----PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784 (931)
Q Consensus 725 --------f~~~---~-----~l~LVmEy~~GgSL~d~L~r----~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIH 784 (931)
+... . ..+++|+-+ .++|.+++.- ......+.......+..|+++.+++||.+| ++|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVH 168 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVH 168 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEe
Confidence 1111 1 247788888 6788887642 111223445566777799999999999999 999
Q ss_pred eccCCCCeEECCCCcEEEEecCccccccccccccCCCCCCCcccCcccccC--------CCCCchhHHHHHHHHHHHHHh
Q 002355 785 WDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRG--------EPSNEKSDVYSFGVILWELVT 856 (931)
Q Consensus 785 rDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~--------~~~t~ksDIWSLG~ILyELLT 856 (931)
+||+|+|++++.+|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|+||+++|.|++
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 999999999999999999999987766554321 234578999997643 245789999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCC
Q 002355 857 MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQR 905 (931)
Q Consensus 857 G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeR 905 (931)
+..||........... ......++|+.++.||+.+|+++|++|
T Consensus 246 ~~lPf~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999976543221110 222233889999999999999999987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.6e-20 Score=222.48 Aligned_cols=245 Identities=22% Similarity=0.279 Sum_probs=183.1
Q ss_pred ceEEEEEecccCceEEEEEEEcCCceEEEEEeecc--cchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQD--FLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~--~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
+|...+-||.+.|=.|.+|++....|+|||+.++. ..-....+-+.|++ ...+++||++.+.-+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 67888999999999999999877779999997765 22233344455666 5667899999998887778888999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc----cc
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK----AN 813 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~----~~ 813 (931)
+ ..+|++.+.. ...+..-+.+.|+.||+.||.-+|..| |+|||||.+||||+.-+-+.|+||..-+.. ++
T Consensus 103 v-khnLyDRlST---RPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 V-KHNLYDRLST---RPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred H-hhhhhhhhcc---chHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 9 6799999864 456888889999999999999999999 999999999999999888999999865531 11
Q ss_pred cccc---cCCCCCCCcccCcccccCC----------C-CCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc--
Q 002355 814 TFIS---SKSVAGTPEWMAPEFLRGE----------P-SNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQ-- 876 (931)
Q Consensus 814 ~~~~---~~~~~GT~~Y~APEvL~~~----------~-~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~-- 876 (931)
+... ..+......|+|||.+... . .++++||||+||+++||++ |++||.- .+.+......
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---SQL~aYr~~~~~ 253 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---SQLLAYRSGNAD 253 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---HHHHhHhccCcc
Confidence 1100 0111234479999976432 2 4678999999999999987 5777742 1111110000
Q ss_pred ccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 877 NRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 877 ~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.....+..-.+..++++|..|++.||++|.++++.|+.
T Consensus 254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 00000112334579999999999999999999999876
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.6e-19 Score=178.85 Aligned_cols=140 Identities=16% Similarity=0.149 Sum_probs=109.0
Q ss_pred EEEecccCceEEEEEEE-cCCceEEEEEeecccch----------------------HH--HHHHHHHHHHHHhcCCCCe
Q 002355 664 KERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLD----------------------DQ--LKEFLREVAIMKRVRHPNV 718 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~~----------------------~~--~~~~l~EIkILk~L~HpNI 718 (931)
.+.||+|+||.||+|++ +|+.||||+++...... .. ...+.+|.+.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999987 58999999998753210 00 1234578999999999887
Q ss_pred eeEEeeeeeCCeEEEEEeecCCCCHHHH-hhcCCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCCEEEeccCCCCeEECC
Q 002355 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRL-IHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDK 796 (931)
Q Consensus 719 V~Lid~f~~~~~l~LVmEy~~GgSL~d~-L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs-~G~~IIHrDLKPeNILLd~ 796 (931)
.....+... ..+|||||++|+++... +.. ..++...+..++.|++.+|.+||. .| |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-
Confidence 544333332 24899999988755433 322 347788899999999999999999 99 99999999999998
Q ss_pred CCcEEEEecCcccccc
Q 002355 797 NWTVKVCDFGLSRFKA 812 (931)
Q Consensus 797 dg~IKL~DFGlAr~~~ 812 (931)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-18 Score=182.24 Aligned_cols=188 Identities=18% Similarity=0.149 Sum_probs=142.5
Q ss_pred EEEEEecccCceEEEEEEEcCCceEEEEEeecccchHH--HHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCeEEEEEeec
Q 002355 662 HVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQ--LKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIVTEYL 738 (931)
Q Consensus 662 ~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~--~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~l~LVmEy~ 738 (931)
.+...|++|+||+||++...+.+++.+.+......... ...+.+|+++|++|. |++|++++++ +..+++|||+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 35678999999999999888888888887766543221 235789999999995 5789999886 4469999999
Q ss_pred CCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEecc-CCCCeEECCCCcEEEEecCcccccccccc-
Q 002355 739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDL-KSPNLLVDKNWTVKVCDFGLSRFKANTFI- 816 (931)
Q Consensus 739 ~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDL-KPeNILLd~dg~IKL~DFGlAr~~~~~~~- 816 (931)
.|.+|...+.. . ...++.|++.+|.++|++| |+|||| ||+|||++.++.++|+|||+|........
T Consensus 81 ~G~~L~~~~~~---------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 81 AGAAMYQRPPR---------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred cCccHHhhhhh---------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 99998754421 1 1346789999999999999 999999 79999999999999999999985433211
Q ss_pred ----c--------cCCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002355 817 ----S--------SKSVAGTPEWMAPEFLRG--EPSNEKSDVYSFGVILWELVTMQQPWNGLG 865 (931)
Q Consensus 817 ----~--------~~~~~GT~~Y~APEvL~~--~~~t~ksDIWSLG~ILyELLTG~~PF~~~~ 865 (931)
. ......++.|+.|+...- ...-.+.++++.|+.+|.++|+..++.+.+
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 011124677888875332 222356799999999999999998876543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.5e-19 Score=213.18 Aligned_cols=204 Identities=27% Similarity=0.449 Sum_probs=155.0
Q ss_pred CceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|..++.|-.|+||.||+++++ .+.+|+|+- ++... ++- |+....+|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~li-------lRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNLI-------LRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhccc-ccchh-------hhc--cccccCCccee-----------------
Confidence 78899999999999999999875 677998543 32211 110 33333444444
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc--
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT-- 814 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~-- 814 (931)
|+=...++. -+.++. +++.+++|||+.| |+|||+||+|++|+.-|++|++|||+++.....
T Consensus 136 ----gDc~tllk~---~g~lPv--------dmvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ----GDCATLLKN---IGPLPV--------DMVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ----chhhhhccc---CCCCcc--------hhhHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 222233322 122433 3378999999999 999999999999999999999999998742111
Q ss_pred -------------ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc-c
Q 002355 815 -------------FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR-L 880 (931)
Q Consensus 815 -------------~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r-~ 880 (931)
....+.++||+.|+|||++....|+..+|||++|+|+||++.|..||.+..+++++..+...... .
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp 278 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 278 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence 11235679999999999999999999999999999999999999999999999998877543322 2
Q ss_pred CCCCCChHHHHHHHHHhcccCCCCCC
Q 002355 881 AIPQNTSPVLASLMESCWADDPAQRP 906 (931)
Q Consensus 881 ~lP~~~s~eL~dLI~rcL~~DPeeRP 906 (931)
+-....+++++++|.++|..+|..|-
T Consensus 279 E~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 279 EEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 22456789999999999999999993
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.2e-18 Score=187.34 Aligned_cols=197 Identities=24% Similarity=0.360 Sum_probs=150.3
Q ss_pred CCCCeeeEEeeeee---------------------------CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHH
Q 002355 714 RHPNVVLFMGAVTK---------------------------RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766 (931)
Q Consensus 714 ~HpNIV~Lid~f~~---------------------------~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~ 766 (931)
+|||||++..+|.+ +..+|+||.-. ..+|..++.. ...+.+...-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc----CCCchHHHHHHHH
Confidence 59999999887742 23689999988 5699999864 2366778888999
Q ss_pred HHHHHHHHHHhCCCCEEEeccCCCCeEEC--CCC--cEEEEecCcccccccc-----ccc-cCCCCCCCcccCcccccCC
Q 002355 767 DVAKGINYLHNLNPPILHWDLKSPNLLVD--KNW--TVKVCDFGLSRFKANT-----FIS-SKSVAGTPEWMAPEFLRGE 836 (931)
Q Consensus 767 QIa~AL~yLHs~G~~IIHrDLKPeNILLd--~dg--~IKL~DFGlAr~~~~~-----~~~-~~~~~GT~~Y~APEvL~~~ 836 (931)
|+++|+.|||.+| |.|||+|..|||+. .++ .+.|+|||++--..+. +.. .-...|....||||+....
T Consensus 349 QlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 9999999999999 99999999999984 343 4789999987532221 000 1233567789999998754
Q ss_pred CC------CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHH
Q 002355 837 PS------NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFAN 910 (931)
Q Consensus 837 ~~------t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~E 910 (931)
+- ..++|.|+.|.+.||+++..-||........-.....+...+.+|..+++.+++++..+|+.||.+|++..-
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence 32 357899999999999999999998855433322223334456788999999999999999999999998766
Q ss_pred HHHHHHH
Q 002355 911 IVESLKK 917 (931)
Q Consensus 911 LLq~L~~ 917 (931)
....|+-
T Consensus 507 AANvl~L 513 (598)
T KOG4158|consen 507 AANVLNL 513 (598)
T ss_pred HHhHHHH
Confidence 5555543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=203.65 Aligned_cols=249 Identities=20% Similarity=0.286 Sum_probs=187.3
Q ss_pred cccccccCceEEEEEecccCceEEEEEEE-cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC---CCCeeeEEeeeee
Q 002355 652 DWLEISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR---HPNVVLFMGAVTK 727 (931)
Q Consensus 652 ~~lei~~drY~Ii~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~---HpNIV~Lid~f~~ 727 (931)
..+++..+.|.|.+.||+|+||+||+|.. +++.||||+-+.....+- .--.+++.+|+ -+.|..+..++.-
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf-----YI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF-----YICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee-----eehHHHHHhhchhhhcchHHHHHHHcc
Confidence 35677889999999999999999999965 688899999988765432 11233444454 2355556666666
Q ss_pred CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC-------CCcE
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-------NWTV 800 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~-------dg~I 800 (931)
.+.-+||+||.+.|+|.+++. ..+.+++..+..++.|++.-|+.||..+ |||+||||.|+||.. +.-+
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred CCcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccce
Confidence 677789999999999999997 3556899999999999999999999999 999999999999953 3458
Q ss_pred EEEecCcccc---ccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc
Q 002355 801 KVCDFGLSRF---KANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN 877 (931)
Q Consensus 801 KL~DFGlAr~---~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~ 877 (931)
+|+|||.+.- ..+. ......++|-.+-.+|...|.+|++.+|.|.|+.+++-|+.|+..= + ..+
T Consensus 841 ~lIDfG~siDm~lfp~~-~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------~-~~g 907 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------V-KNG 907 (974)
T ss_pred EEEecccceeeeEcCCC-cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------h-cCC
Confidence 9999998852 2222 1234567888999999999999999999999999999999986421 1 011
Q ss_pred cccC----CCCCCh-HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCch
Q 002355 878 RRLA----IPQNTS-PVLASLMESCWADDPAQRPSFANIVESLKKLLKSPA 923 (931)
Q Consensus 878 ~r~~----lP~~~s-~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~ 923 (931)
.... ++.... ....+|+..+|+.+-..=|...+|...++..+....
T Consensus 908 ~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~ 958 (974)
T KOG1166|consen 908 SSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHF 958 (974)
T ss_pred cceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHH
Confidence 1111 222222 234678888888555555888898888888776544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4e-17 Score=166.80 Aligned_cols=136 Identities=22% Similarity=0.356 Sum_probs=115.0
Q ss_pred EEecccCceEEEEEEEcCCceEEEEEeecccchH------HHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeec
Q 002355 665 ERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD------QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYL 738 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~------~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~ 738 (931)
+.||+|++|.||+|++.+..|++|+......... ....+.+|+.++..+.|++|.....++......++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5799999999999999999999998765433211 1245778999999999999877776776777889999999
Q ss_pred CCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 739 ~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
+|++|.+++... .. ....++.+++.+|.+||..+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999998641 11 77889999999999999999 99999999999999 78999999998864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.7e-17 Score=169.24 Aligned_cols=134 Identities=16% Similarity=0.231 Sum_probs=102.8
Q ss_pred EEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhc-----CCCCeeeEEeeeeeCC---e-EEEE
Q 002355 664 KERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-----RHPNVVLFMGAVTKRP---H-LSIV 734 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-----~HpNIV~Lid~f~~~~---~-l~LV 734 (931)
.+.||+|+||.||.-...+. .+||++...... ....+.+|+++++.+ .||||+++++++..+. . +.+|
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEECCCCcC-eEEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 45799999999996322333 478888764322 335789999999999 5799999999998663 4 4478
Q ss_pred Eee--cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHH-HHHHhCCCCEEEeccCCCCeEECC----CCcEEEEecCc
Q 002355 735 TEY--LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI-NYLHNLNPPILHWDLKSPNLLVDK----NWTVKVCDFGL 807 (931)
Q Consensus 735 mEy--~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL-~yLHs~G~~IIHrDLKPeNILLd~----dg~IKL~DFGl 807 (931)
||| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++ |+||||||+|||++. ++.++|+||+.
T Consensus 84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 999 5579999999652 25554 34577888777 9999999 999999999999974 34799999543
Q ss_pred c
Q 002355 808 S 808 (931)
Q Consensus 808 A 808 (931)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.4e-17 Score=164.05 Aligned_cols=132 Identities=19% Similarity=0.304 Sum_probs=108.5
Q ss_pred ecccCceEEEEEEEcCCceEEEEEeecccch------HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCC
Q 002355 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLD------DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPR 740 (931)
Q Consensus 667 LG~G~fGtVylAr~~g~~VAVKVlk~~~~~~------~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~G 740 (931)
||+|+||+||+|.+.+..|++|+........ ....++.+|++++..+.|+++....-++......++||||++|
T Consensus 2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g 81 (199)
T TIGR03724 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG 81 (199)
T ss_pred CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence 8999999999999999999999976543221 1235677899999999988765544455566677999999999
Q ss_pred CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 741 gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
++|.+++.... . .++.+++.+|.+||+.| ++|+|++|.||+++ ++.++++|||++...
T Consensus 82 ~~l~~~~~~~~---~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 82 KPLKDVIEEGN---D-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ccHHHHHhhcH---H-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99998875411 0 68899999999999999 99999999999999 889999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-16 Score=186.16 Aligned_cols=138 Identities=20% Similarity=0.307 Sum_probs=115.3
Q ss_pred CceEEEEEecccCceEEEEEEEcCCceEEEEEeecccch------HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLD------DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~------~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
..|...++||+|+||+||++++.+..+++|+........ ....++.+|+++++.++|++|+..+.++......+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 345678999999999999999988887777654332211 12356789999999999999988877777777789
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
+||||++|++|.+++. ....++.|++.+|.+||+.| ++||||||+|||+ .++.++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999998874 24568899999999999999 9999999999999 678999999999865
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.6e-16 Score=168.92 Aligned_cols=145 Identities=17% Similarity=0.116 Sum_probs=110.9
Q ss_pred ceEEEEEecccCceEEEEEE---EcCCceEEEEEeecccch---------------------H-HHHHHHHHHHHHHhcC
Q 002355 660 ELHVKERVGAGSFGTVHRAE---WHGSDVAVKVLTVQDFLD---------------------D-QLKEFLREVAIMKRVR 714 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr---~~g~~VAVKVlk~~~~~~---------------------~-~~~~~l~EIkILk~L~ 714 (931)
-|++.+.||.|+||.||+|. .+|+.||||+++...... . ....+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 368899999998643210 0 1123568999999997
Q ss_pred CC--CeeeEEeeeeeCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCe
Q 002355 715 HP--NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNL 792 (931)
Q Consensus 715 Hp--NIV~Lid~f~~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNI 792 (931)
+. .+.++++. . ..++||||+.|.+|..+... ...+....+..++.||+.+|.+||.+| .|+||||||+||
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhE
Confidence 53 33444432 2 34899999998888765422 223566677889999999999999975 499999999999
Q ss_pred EECCCCcEEEEecCccccccc
Q 002355 793 LVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 793 LLd~dg~IKL~DFGlAr~~~~ 813 (931)
+++ ++.++|+|||.+.....
T Consensus 181 li~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEE-CCCEEEEEChhhhccCC
Confidence 999 88999999999875443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.4e-16 Score=179.70 Aligned_cols=210 Identities=32% Similarity=0.558 Sum_probs=164.7
Q ss_pred HHhcCCCCeeeEEeeeeeCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCC
Q 002355 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS 789 (931)
Q Consensus 710 Lk~L~HpNIV~Lid~f~~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKP 789 (931)
|+.+.|.|+.++++.+.++...++|.+||..|+|.+.+.. ....+++.-...++++|++||+|||.-.. ..|+-++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSPI-GYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeecc
Confidence 4568899999999999999999999999999999999975 33457888888999999999999998651 39999999
Q ss_pred CCeEECCCCcEEEEecCcccccccc--ccccCCCCCCCcccCcccccCCC-------CCchhHHHHHHHHHHHHHhCCCC
Q 002355 790 PNLLVDKNWTVKVCDFGLSRFKANT--FISSKSVAGTPEWMAPEFLRGEP-------SNEKSDVYSFGVILWELVTMQQP 860 (931)
Q Consensus 790 eNILLd~dg~IKL~DFGlAr~~~~~--~~~~~~~~GT~~Y~APEvL~~~~-------~t~ksDIWSLG~ILyELLTG~~P 860 (931)
.|.+++..+.+||+|||+....... ........-...|.|||.+.+.. .+.+.||||+|++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998765321 00111112234699999987642 35678999999999999999999
Q ss_pred CCCCC----hHHHHHHHHhcccccCCC-----CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 861 WNGLG----PAQVVGAVAFQNRRLAIP-----QNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 861 F~~~~----~~eii~~i~~~~~r~~lP-----~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
|.... +.+++..+.........| ...++++..++..||..+|+.||+++++-..+..+.+..
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 97632 344555543312222222 144557999999999999999999999999998887754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=7.1e-16 Score=157.69 Aligned_cols=137 Identities=20% Similarity=0.157 Sum_probs=106.9
Q ss_pred ceEEEEEecccCceEEEEEEE-cCCceEEEEEeecccch--------------------HHHHHHHHHHHHHHhcCCCC-
Q 002355 660 ELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLD--------------------DQLKEFLREVAIMKRVRHPN- 717 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~~--------------------~~~~~~l~EIkILk~L~HpN- 717 (931)
.|.+.+.||.|+||.||+|.. +++.||||++....... .......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 377789999999999999977 68899999977543110 01123567899999997774
Q ss_pred -eeeEEeeeeeCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC
Q 002355 718 -VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK 796 (931)
Q Consensus 718 -IV~Lid~f~~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~ 796 (931)
+...++ ....++||||++|++|..+... .....++.+|+.++.++|..| |+||||||+||+++.
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~~ 160 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVDD 160 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEcC
Confidence 444443 2345899999999998765431 234568889999999999999 999999999999999
Q ss_pred CCcEEEEecCccccc
Q 002355 797 NWTVKVCDFGLSRFK 811 (931)
Q Consensus 797 dg~IKL~DFGlAr~~ 811 (931)
++.++|+|||++...
T Consensus 161 ~~~~~liDfg~~~~~ 175 (198)
T cd05144 161 DEKIYIIDWPQMVST 175 (198)
T ss_pred CCcEEEEECCccccC
Confidence 999999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.5e-15 Score=142.60 Aligned_cols=134 Identities=19% Similarity=0.210 Sum_probs=112.4
Q ss_pred EEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCC--CCeeeEEeeeeeCCeEEEEEeecCC
Q 002355 663 VKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH--PNVVLFMGAVTKRPHLSIVTEYLPR 740 (931)
Q Consensus 663 Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~H--pNIV~Lid~f~~~~~l~LVmEy~~G 740 (931)
+++.||.|.++.||+++..+..+++|+...... ...+.+|+.+++.++| .++++++.++...+..+++|||+.|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 457899999999999999888999999866542 3567889999999976 5899999988888899999999988
Q ss_pred CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCC-CCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN-PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 741 gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G-~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
..+..+ +......++.+++.+|++||... .+++|+|++|.||+++..+.++++|||.+..
T Consensus 78 ~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777543 34555668899999999999841 2399999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.9e-15 Score=149.34 Aligned_cols=137 Identities=19% Similarity=0.122 Sum_probs=97.9
Q ss_pred EEEecccCceEEEEEEEc-CCceEEEEEeecccchHHHHH----------------------HHHHHHHHHhcCCCC--e
Q 002355 664 KERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKE----------------------FLREVAIMKRVRHPN--V 718 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~~-g~~VAVKVlk~~~~~~~~~~~----------------------~l~EIkILk~L~HpN--I 718 (931)
.+.||+|+||+||+|++. ++.||||++............ ...|...+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999875 889999998764322211111 135666666664432 4
Q ss_pred eeEEeeeeeCCeEEEEEeecCCCCHHH-HhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCCEEEeccCCCCeEECC
Q 002355 719 VLFMGAVTKRPHLSIVTEYLPRGSLYR-LIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDK 796 (931)
Q Consensus 719 V~Lid~f~~~~~l~LVmEy~~GgSL~d-~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs-~G~~IIHrDLKPeNILLd~ 796 (931)
.+.++. ...++||||++|+.+.. .+... .....+..++.+++.++.++|. ++ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLLEDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hhcccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-
Confidence 444433 23589999998854321 11110 0015677899999999999999 99 99999999999999
Q ss_pred CCcEEEEecCcccccc
Q 002355 797 NWTVKVCDFGLSRFKA 812 (931)
Q Consensus 797 dg~IKL~DFGlAr~~~ 812 (931)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.2e-16 Score=177.24 Aligned_cols=174 Identities=25% Similarity=0.383 Sum_probs=134.0
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
.++||.|++|...+|.+++.+.......+......++.|++.|++| +| .+|+|+||.||++..+..+||+|||+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhhhhhhhe
Confidence 4689999999999999999876777788899999999999999999 67 999999999999999999999999997
Q ss_pred cccccc------ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccC
Q 002355 809 RFKANT------FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLA 881 (931)
Q Consensus 809 r~~~~~------~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~ 881 (931)
...... ........||..||+||.|.+..++.++|||+||++++|++. -...|.... ....+.....+..
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~---t~~d~r~g~ip~~ 480 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA---TLTDIRDGIIPPE 480 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH---hhhhhhcCCCChH
Confidence 643322 123345679999999999999999999999999999999997 233332211 1111211111211
Q ss_pred CCCCChHHHHHHHHHhcccCCCCCCCHHHH
Q 002355 882 IPQNTSPVLASLMESCWADDPAQRPSFANI 911 (931)
Q Consensus 882 lP~~~s~eL~dLI~rcL~~DPeeRPSa~EL 911 (931)
+..+ .+.-..|+.+++...|.+||++.+.
T Consensus 481 ~~~d-~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 481 FLQD-YPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred Hhhc-CcHHHHHHHHhcCCCcccCchHHHH
Confidence 2222 2344689999999999999955443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.4e-14 Score=151.23 Aligned_cols=136 Identities=17% Similarity=0.222 Sum_probs=106.4
Q ss_pred EEec-ccCceEEEEEEEcCCceEEEEEeecccc-----------hHHHHHHHHHHHHHHhcCCCCe--eeEEeeeeeC-C
Q 002355 665 ERVG-AGSFGTVHRAEWHGSDVAVKVLTVQDFL-----------DDQLKEFLREVAIMKRVRHPNV--VLFMGAVTKR-P 729 (931)
Q Consensus 665 ~kLG-~G~fGtVylAr~~g~~VAVKVlk~~~~~-----------~~~~~~~l~EIkILk~L~HpNI--V~Lid~f~~~-~ 729 (931)
..|| .||.|+||.++..+..++||.+...... ......+.+|+.++..|.|++| +..+++.... .
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4588 8999999999888999999988653321 1223567889999999998875 6677664332 2
Q ss_pred ---eEEEEEeecCC-CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEec
Q 002355 730 ---HLSIVTEYLPR-GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDF 805 (931)
Q Consensus 730 ---~l~LVmEy~~G-gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DF 805 (931)
..++|||+++| .+|.+++.. ..+++. .+.||+.+|.+||++| |+||||||.|||++.++.++|+||
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~~v~LIDf 186 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG--VYHADLNAHNILLDPDGKFWLIDF 186 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCCCEEEEEC
Confidence 23599999997 689888854 234443 3568999999999999 999999999999999999999999
Q ss_pred Ccccc
Q 002355 806 GLSRF 810 (931)
Q Consensus 806 GlAr~ 810 (931)
|.+..
T Consensus 187 g~~~~ 191 (239)
T PRK01723 187 DRGEL 191 (239)
T ss_pred CCccc
Confidence 98864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.4e-16 Score=187.56 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=195.9
Q ss_pred CceEEEEEecccCceEEEEEEE---cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCeEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW---HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~---~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~l~LV 734 (931)
..|.+.+-||+|+|+.|-++.. ....+|+|.+...........++..|..+-+.+. |+|++.+++........+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 5678888899999999988854 2334666665554433334455566888877786 99999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHH-hCCCCEEEeccCCCCeEECCCC-cEEEEecCcccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH-NLNPPILHWDLKSPNLLVDKNW-TVKVCDFGLSRFKA 812 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLH-s~G~~IIHrDLKPeNILLd~dg-~IKL~DFGlAr~~~ 812 (931)
+++..|+++++.+.. ......+...+..++.|+..++.|+| ..+ +.|+||||+|.+++..+ .+++.|||+|....
T Consensus 100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 999999999988832 12213555666778999999999999 888 99999999999999999 99999999997654
Q ss_pred c---cccccCCCCC-CCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhccc--ccCCCC
Q 002355 813 N---TFISSKSVAG-TPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVG-AVAFQNR--RLAIPQ 884 (931)
Q Consensus 813 ~---~~~~~~~~~G-T~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~-~i~~~~~--r~~lP~ 884 (931)
. ........+| ++.|+|||...+. ......|+||.|+++.-+++|..||.......... ....... ......
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN 256 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence 4 1222345577 9999999999885 45778999999999999999999997655433221 1111111 234557
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 885 NTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 885 ~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.++....+++.+++..+|..|.+..++...
T Consensus 257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 257 SISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred cCChhhhhcccccccCCchhcccccccccc
Confidence 788899999999999999999999887654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.7e-13 Score=155.26 Aligned_cols=250 Identities=24% Similarity=0.211 Sum_probs=188.8
Q ss_pred cCceEEEEEecc--cCceEEEEEEE----cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCe
Q 002355 658 WDELHVKERVGA--GSFGTVHRAEW----HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPH 730 (931)
Q Consensus 658 ~drY~Ii~kLG~--G~fGtVylAr~----~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~ 730 (931)
...+.+.+.+|. |.+|.||.++. .+..+|+|.-+..........+=++|....++++ |+|.++.+..|..+++
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 356778889999 99999999876 4567888874443322222223346666666664 9999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHH----HHHHHHhCCCCEEEeccCCCCeEECCC-CcEEEEec
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK----GINYLHNLNPPILHWDLKSPNLLVDKN-WTVKVCDF 805 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~----AL~yLHs~G~~IIHrDLKPeNILLd~d-g~IKL~DF 805 (931)
.++-+|++ +.+|..+... ....++...++..+.+... ||.++|+.+ ++|-|+||.||++..+ ..++++||
T Consensus 193 lfiqtE~~-~~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred ceeeeccc-cchhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCc
Confidence 99999999 7888888764 3445888899999999999 999999998 9999999999999999 78899999
Q ss_pred Cccccccccccc-----cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc
Q 002355 806 GLSRFKANTFIS-----SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL 880 (931)
Q Consensus 806 GlAr~~~~~~~~-----~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~ 880 (931)
|+....+..... .....|...|++||.+.+. ++...|||+||.++.+-.++..+........+.. +.....+.
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-~r~~~ip~ 345 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-LRQGYIPL 345 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCccc-cccccCch
Confidence 998765544321 1233678899999988776 6889999999999999998876665442211111 11111233
Q ss_pred CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 ~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
++....+..+...+..|+..+|..|++++.++.+
T Consensus 346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 4445566777779999999999999999887754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.2e-11 Score=121.78 Aligned_cols=130 Identities=17% Similarity=0.091 Sum_probs=96.6
Q ss_pred EEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCe-eeEEeeeeeCCeEEEEEeecCCCC
Q 002355 664 KERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV-VLFMGAVTKRPHLSIVTEYLPRGS 742 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNI-V~Lid~f~~~~~l~LVmEy~~GgS 742 (931)
++.|+.|.++.||+++..+..|++|+....... ...+.+|..+++.+.+.++ .+++.+.. ...++|||+++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL---LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCccc---ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 467899999999999999999999997554211 1235678999998865544 34554433 33579999999987
Q ss_pred HHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCC---CEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 743 LYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP---PILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 743 L~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~---~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
+.... . ....++.+++.+|+.||..+. .++|+|++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 75430 1 112356789999999999761 259999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.3e-11 Score=140.38 Aligned_cols=141 Identities=25% Similarity=0.285 Sum_probs=95.6
Q ss_pred EEecccCceEEEEEEE-cCCceEEEEEeecccch--HH--------------------------H----------HHHHH
Q 002355 665 ERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLD--DQ--------------------------L----------KEFLR 705 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~~--~~--------------------------~----------~~~l~ 705 (931)
+.||.|++|.||+|+. +|+.||||+.+...... .. . -.+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5699999999999987 68999999986532100 00 0 01344
Q ss_pred HHHHHHhcC----CCCeeeEEeee-eeCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHH-HHHHHHhCC
Q 002355 706 EVAIMKRVR----HPNVVLFMGAV-TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK-GINYLHNLN 779 (931)
Q Consensus 706 EIkILk~L~----HpNIV~Lid~f-~~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~-AL~yLHs~G 779 (931)
|.+.+.+++ |.+-+.+-..+ ......+|||||++|.+|.++......+ .. ...++.+++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--LD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--CC---HHHHHHHHHHHHHHHHHhCC
Confidence 555555552 22222222222 2234569999999999998876431111 11 2345555655 467889999
Q ss_pred CCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 780 ~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
++|+|+||.||+++.++.++|+|||++....
T Consensus 278 --~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 --FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred --ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999987554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.23 E-value=6.5e-11 Score=139.59 Aligned_cols=144 Identities=19% Similarity=0.240 Sum_probs=91.6
Q ss_pred cCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccc--------------------------------hHHHHHH
Q 002355 658 WDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL--------------------------------DDQLKEF 703 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~--------------------------------~~~~~~~ 703 (931)
+..|.. +.||.|++|.||+|+.. |+.||||+.+..-.. ++....+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345665 78999999999999873 899999999754200 0111222
Q ss_pred ------HHHHHHHHhcC----CCCeeeEEeee-eeCCeEEEEEeecCCCCHHHHh--hcCCC-CCCCcHHHHHHHHHHHH
Q 002355 704 ------LREVAIMKRVR----HPNVVLFMGAV-TKRPHLSIVTEYLPRGSLYRLI--HRPAA-GEMMDQRRRLRMALDVA 769 (931)
Q Consensus 704 ------l~EIkILk~L~----HpNIV~Lid~f-~~~~~l~LVmEy~~GgSL~d~L--~r~~~-~~~L~e~~~~~Ia~QIa 769 (931)
.+|...+.+++ +.+.+.+-..+ .-....+|||||+.|+.|.++. ...+. ...+.+..+..++.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 33333333332 33333322222 2244567999999999998753 22110 11234444444444443
Q ss_pred HHHHHHHhCCCCEEEeccCCCCeEECCCC----cEEEEecCccccc
Q 002355 770 KGINYLHNLNPPILHWDLKSPNLLVDKNW----TVKVCDFGLSRFK 811 (931)
Q Consensus 770 ~AL~yLHs~G~~IIHrDLKPeNILLd~dg----~IKL~DFGlAr~~ 811 (931)
..| ++|+|+||.||+++.+| .++++|||+....
T Consensus 278 -------~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 -------RDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred -------hCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 568 99999999999999888 9999999998644
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.7e-12 Score=155.68 Aligned_cols=249 Identities=24% Similarity=0.303 Sum_probs=192.8
Q ss_pred cccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchH-HHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD-QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~-~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
...+.+.+.+-+-.|+++.++.++- .+...+.|+......... +...+..+-.++-..++|.++.....|......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 4568889999999999999999864 344456666554432222 2344455555555556788887777777888999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
|+++|+.|++|...++... ..+...++..+..++.+++|||... ++|+|++|.|++...+|+.++.|||.....+
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCccccccccc
Confidence 9999999999999987633 4566667778888999999999987 9999999999999999999999998332110
Q ss_pred cc-------------------------------ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002355 813 NT-------------------------------FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPW 861 (931)
Q Consensus 813 ~~-------------------------------~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF 861 (931)
.. ........||+.|.+||.+.+..+...+|+|++|++++|.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 01123456899999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHhccccc-CCCCCChHHHHHHHHHhcccCCCCCCCHH
Q 002355 862 NGLGPAQVVGAVAFQNRRL-AIPQNTSPVLASLMESCWADDPAQRPSFA 909 (931)
Q Consensus 862 ~~~~~~eii~~i~~~~~r~-~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ 909 (931)
....+.+++..+....... .-+...+.+..+++.+.+..+|.+|..+.
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9998888887664333222 23456788999999999999999997765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.3e-10 Score=134.74 Aligned_cols=164 Identities=18% Similarity=0.251 Sum_probs=128.0
Q ss_pred EcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHH
Q 002355 680 WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQR 759 (931)
Q Consensus 680 ~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~ 759 (931)
..+.+|.|.+.+.... .....+.+-++-|+.|+||||+++++.+...+++|||+|-+ ..|..++++ +...
T Consensus 35 ~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~ 104 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKE 104 (690)
T ss_pred ccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHH
Confidence 4677788888776654 33445677888999999999999999999999999999988 477778875 4466
Q ss_pred HHHHHHHHHHHHHHHHHh-CCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCCCCCCCcccCcccccCCCC
Q 002355 760 RRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPS 838 (931)
Q Consensus 760 ~~~~Ia~QIa~AL~yLHs-~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~ 838 (931)
.....+.||+.||.|||. .+ ++|++|.-.-|+|+..|..||++|-++..............--..|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc-
Confidence 677788999999999985 55 99999999999999999999999988765433321112222233567777665544
Q ss_pred CchhHHHHHHHHHHHHHhC
Q 002355 839 NEKSDVYSFGVILWELVTM 857 (931)
Q Consensus 839 t~ksDIWSLG~ILyELLTG 857 (931)
-..|.|.|||+++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 346999999999999998
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2e-11 Score=133.49 Aligned_cols=201 Identities=21% Similarity=0.368 Sum_probs=141.8
Q ss_pred HHhcCCCCeeeEEeeeeeC-----CeEEEEEeecCCCCHHHHhhcCC-CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEE
Q 002355 710 MKRVRHPNVVLFMGAVTKR-----PHLSIVTEYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783 (931)
Q Consensus 710 Lk~L~HpNIV~Lid~f~~~-----~~l~LVmEy~~GgSL~d~L~r~~-~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~II 783 (931)
|-++-|.|||+++.||.+. ....++.|||..|+|..++++.. ....+......+|+-||+.||.|||+..++|+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 4445699999999999654 34788999999999999998633 23457788888999999999999999999999
Q ss_pred EeccCCCCeEECCCCcEEEEecCcccc--ccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCC
Q 002355 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF--KANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQ 859 (931)
Q Consensus 784 HrDLKPeNILLd~dg~IKL~DFGlAr~--~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~ 859 (931)
|+.+...-|++..+|-|||+---.... ..+.. .......+-++|.+||.=.....+.++|||++|....||.-+..
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 999999999999999888753221110 00110 01122345678999998776667789999999999999987754
Q ss_pred CCCCC-ChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002355 860 PWNGL-GPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 860 PF~~~-~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
--... .....-..+. . .+..-....-+++|++|+.-.|..||++.+++-|.
T Consensus 281 q~tnseS~~~~ee~ia--~---~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 281 QSTNSESKVEVEENIA--N---VIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred ccCCCcceeehhhhhh--h---heeeccCccccCcCcccccCCCCCCcchhhhhcCc
Confidence 32111 1110000010 0 01111122346789999999999999999988763
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.4e-10 Score=116.53 Aligned_cols=138 Identities=17% Similarity=0.134 Sum_probs=98.4
Q ss_pred EEecccCceEEEEEEEc--------CCceEEEEEeecccc----------h----------HHHHH----HHHHHHHHHh
Q 002355 665 ERVGAGSFGTVHRAEWH--------GSDVAVKVLTVQDFL----------D----------DQLKE----FLREVAIMKR 712 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~~--------g~~VAVKVlk~~~~~----------~----------~~~~~----~l~EIkILk~ 712 (931)
..||.|-=+.||.|... +..+|||+.+..... + ..... ..+|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999653 368999998653210 0 00112 2479999999
Q ss_pred cCC--CCeeeEEeeeeeCCeEEEEEeecCCCCHHH-HhhcCCCCCCCcHHHHHHHHHHHHHHHHHH-HhCCCCEEEeccC
Q 002355 713 VRH--PNVVLFMGAVTKRPHLSIVTEYLPRGSLYR-LIHRPAAGEMMDQRRRLRMALDVAKGINYL-HNLNPPILHWDLK 788 (931)
Q Consensus 713 L~H--pNIV~Lid~f~~~~~l~LVmEy~~GgSL~d-~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yL-Hs~G~~IIHrDLK 788 (931)
+.. -++...+++ ...+|||||+.+..+.. .++. ..++......+..+++.+|..| |..| |||+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCC
Confidence 853 355666654 45689999996543422 2221 1244556677889999999999 8999 9999999
Q ss_pred CCCeEECCCCcEEEEecCccccccc
Q 002355 789 SPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 789 PeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
+.|||++ ++.+.|+|||.+.....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCCC
Confidence 9999997 46899999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.3e-09 Score=112.49 Aligned_cols=132 Identities=22% Similarity=0.316 Sum_probs=104.2
Q ss_pred EecccCceEEEEEEEcCCceEEEEEeecccchHHH------HHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecC
Q 002355 666 RVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQL------KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLP 739 (931)
Q Consensus 666 kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~------~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~ 739 (931)
.+++|+-+.+|.+.+.|..+.+|.=..+.+....+ .+..+|.+++.+++--.|..-+=++.+...-.|+|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 57899999999998888888888766555543332 346789999999875555444445566677789999999
Q ss_pred CCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 740 RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 740 GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
|..|.+++... ...++..+-.-+.-||..| |||+||.++||++..++ +.++|||++..
T Consensus 83 G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA----------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999898752 1346777888888999999 99999999999998765 99999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.3e-09 Score=110.95 Aligned_cols=141 Identities=17% Similarity=0.213 Sum_probs=106.7
Q ss_pred EEecccCceEEEEEEEcC-CceEEEEEeecccchHHHHHHHHHHHHHHhcCCC--CeeeEEeeeeeC---CeEEEEEeec
Q 002355 665 ERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP--NVVLFMGAVTKR---PHLSIVTEYL 738 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~~g-~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~Hp--NIV~Lid~f~~~---~~l~LVmEy~ 738 (931)
+.||.|..+.||++...+ +.+++|+....... .....+.+|.++++.+.+. ++.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998765 88999997654321 1234578899999999753 456677766553 3678999999
Q ss_pred CCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 002355 739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL---------------------------------------- 778 (931)
Q Consensus 739 ~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~---------------------------------------- 778 (931)
+|.++...+.. ..++......++.+++.+|..||+.
T Consensus 83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99888765531 2366667777888888888888842
Q ss_pred --------------CCCEEEeccCCCCeEECC--CCcEEEEecCcccc
Q 002355 779 --------------NPPILHWDLKSPNLLVDK--NWTVKVCDFGLSRF 810 (931)
Q Consensus 779 --------------G~~IIHrDLKPeNILLd~--dg~IKL~DFGlAr~ 810 (931)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 124799999999999998 66789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.2e-10 Score=135.45 Aligned_cols=251 Identities=20% Similarity=0.187 Sum_probs=183.2
Q ss_pred ccccccCceEEEEEecccCceEEEEEEE---cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeC
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEW---HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKR 728 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~---~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~ 728 (931)
|......+|..+.+||.|.|+.|+.+.. .+..|++|-+.........-..-+.|+.+...+ .|.|++..+..|...
T Consensus 259 ~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 259 WTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred cceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc
Confidence 3445567899999999999999998853 355688887766544333222335666666666 489999999999888
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC-CcEEEEecCc
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN-WTVKVCDFGL 807 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d-g~IKL~DFGl 807 (931)
...|+=-|||.++++...+. ....+.+...+.+..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.
T Consensus 339 r~~~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred ccccCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcccccc
Confidence 88889999999998876552 2345778888999999999999999988 9999999999999886 7789999998
Q ss_pred cccccccccccCCCCCCCccc--CcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCC
Q 002355 808 SRFKANTFISSKSVAGTPEWM--APEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQN 885 (931)
Q Consensus 808 Ar~~~~~~~~~~~~~GT~~Y~--APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~ 885 (931)
.....-. ......+.+++ +++......+..+.|++|||..+.+.+++...-+....-. .......+....
T Consensus 414 ~t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~-----~i~~~~~p~~~~ 485 (524)
T KOG0601|consen 414 WTRLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL-----TIRSGDTPNLPG 485 (524)
T ss_pred cccccee---cccccccccccccchhhccccccccccccccccccccccccCcccCcccccce-----eeecccccCCCc
Confidence 7532111 12223344455 4444556677889999999999999999864333222111 112233344455
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 886 TSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
...++..+...++..++..||.+.++..+..
T Consensus 486 ~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 486 LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 5588899999999999999999988776543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=7e-09 Score=106.95 Aligned_cols=146 Identities=20% Similarity=0.242 Sum_probs=110.0
Q ss_pred EEEEecccCceEEEEEEEcCCceEEEEEeecccchHH------HHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 663 VKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQ------LKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 663 Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~------~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
.+..|-+|+-+.|+++.+.|+...||.-....+.... ..+..+|+++|.++.--.|..-.-+|.+...-+|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 4667899999999999999999888876554443222 2456789999999865555444445666667789999
Q ss_pred ecCC-CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC---cEEEEecCccccc
Q 002355 737 YLPR-GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW---TVKVCDFGLSRFK 811 (931)
Q Consensus 737 y~~G-gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg---~IKL~DFGlAr~~ 811 (931)
|++| .++.+++....... ........++..|-..|.-||..+ |||+||..+||++..++ .+.++|||++...
T Consensus 91 ~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9976 47888886543333 223333678889999999999999 99999999999997655 4689999998643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.9e-08 Score=112.18 Aligned_cols=251 Identities=17% Similarity=0.219 Sum_probs=164.6
Q ss_pred EEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEee------ee-eCCeEEEE
Q 002355 663 VKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGA------VT-KRPHLSIV 734 (931)
Q Consensus 663 Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~------f~-~~~~l~LV 734 (931)
..+.||+|+-+.+|-.-.-+..|| ||.......... .-+..|... .||-+-.=+.+ .- .+..+.++
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~~a-----qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAAQA-----QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchhhchhh-eeecCCCchHHH-----HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 346799999999996644444444 666544322211 112222222 35532221111 11 23347889
Q ss_pred EeecCCCCHHHHhh----cCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 735 TEYLPRGSLYRLIH----RPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 735 mEy~~GgSL~d~L~----r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
|..+.|..--..+. +........|..+++.+++|+.+.+.||.+| .+-+|++++|+|+++++.|.|+|=..-..
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEcccceee
Confidence 99987764333222 2344456789999999999999999999999 99999999999999999999998654333
Q ss_pred ccccccccCCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHhC-CCCCCCCC-------hHH-HHHHH---
Q 002355 811 KANTFISSKSVAGTPEWMAPEFLR-----GEPSNEKSDVYSFGVILWELVTM-QQPWNGLG-------PAQ-VVGAV--- 873 (931)
Q Consensus 811 ~~~~~~~~~~~~GT~~Y~APEvL~-----~~~~t~ksDIWSLG~ILyELLTG-~~PF~~~~-------~~e-ii~~i--- 873 (931)
..+.. ...-.+|..+|.+||.-. +...+...|.|.||+++|+++.| ++||.+.- +-+ .+..-
T Consensus 167 ~~ng~-~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 167 NANGT-LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred ccCCc-eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 33322 223457889999999744 44557788999999999999987 99998752 111 11000
Q ss_pred ---HhcccccC----CC-CCChHHHHHHHHHhcccC--CCCCCCHHHHHHHHHHHhhCc
Q 002355 874 ---AFQNRRLA----IP-QNTSPVLASLMESCWADD--PAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 874 ---~~~~~r~~----lP-~~~s~eL~dLI~rcL~~D--PeeRPSa~ELLq~L~~Llks~ 922 (931)
.......+ .| ..+++.+..|..+|++.- +.-|||++-++..|..+..+-
T Consensus 246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 00001111 11 356788999999999643 668999999999988876553
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.69 E-value=9.2e-08 Score=99.23 Aligned_cols=127 Identities=26% Similarity=0.213 Sum_probs=81.7
Q ss_pred EEEEEEE-cCCceEEEEEeecccc----------------------h--HHHHHHHHHHHHHHhcCCC--CeeeEEeeee
Q 002355 674 TVHRAEW-HGSDVAVKVLTVQDFL----------------------D--DQLKEFLREVAIMKRVRHP--NVVLFMGAVT 726 (931)
Q Consensus 674 tVylAr~-~g~~VAVKVlk~~~~~----------------------~--~~~~~~l~EIkILk~L~Hp--NIV~Lid~f~ 726 (931)
-||.|.. .+..+|||+.+..... . .......+|.+.|.++..- ++.+.+++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3889976 6778999998763210 0 0124567899999999765 456666442
Q ss_pred eCCeEEEEEeecC--CCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHH-HHhCCCCEEEeccCCCCeEECCCCcEEEE
Q 002355 727 KRPHLSIVTEYLP--RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY-LHNLNPPILHWDLKSPNLLVDKNWTVKVC 803 (931)
Q Consensus 727 ~~~~l~LVmEy~~--GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~y-LHs~G~~IIHrDLKPeNILLd~dg~IKL~ 803 (931)
..+|||||+. |..+..+.... +.......++.+++..+.. +|..| |+|+||.+.|||++.+ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc-eEEEE
Confidence 2379999998 66665544321 1123445567777775555 57989 9999999999999887 89999
Q ss_pred ecCcccccc
Q 002355 804 DFGLSRFKA 812 (931)
Q Consensus 804 DFGlAr~~~ 812 (931)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.1e-07 Score=101.47 Aligned_cols=132 Identities=20% Similarity=0.118 Sum_probs=94.0
Q ss_pred EEEEEEcCCceEEEEEeecccch--H-------HHHHHHHHHHHHHhcCCCCe--eeEEeeeee-----CCeEEEEEeec
Q 002355 675 VHRAEWHGSDVAVKVLTVQDFLD--D-------QLKEFLREVAIMKRVRHPNV--VLFMGAVTK-----RPHLSIVTEYL 738 (931)
Q Consensus 675 VylAr~~g~~VAVKVlk~~~~~~--~-------~~~~~l~EIkILk~L~HpNI--V~Lid~f~~-----~~~l~LVmEy~ 738 (931)
|+++...|+.|.||......... . ....+.+|...+..|..-+| +..++++.. ...-+||||++
T Consensus 38 vvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l 117 (268)
T PRK15123 38 TLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDL 117 (268)
T ss_pred EEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeC
Confidence 55677778888888664332111 0 01136788888888853333 344444432 23578999999
Q ss_pred CCC-CHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC-------CCcEEEEecCccc
Q 002355 739 PRG-SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-------NWTVKVCDFGLSR 809 (931)
Q Consensus 739 ~Gg-SL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~-------dg~IKL~DFGlAr 809 (931)
++. +|.+++.... ....+......++.+++..+.-||..| |+|+|+++.|||++. ++.+.|+||+.+.
T Consensus 118 ~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 118 APTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred CCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 876 7988875311 123556677889999999999999999 999999999999975 4679999999875
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.3e-06 Score=99.17 Aligned_cols=217 Identities=17% Similarity=0.173 Sum_probs=150.4
Q ss_pred CceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeee----eCCeEEEEEeecCCC-CH
Q 002355 671 SFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT----KRPHLSIVTEYLPRG-SL 743 (931)
Q Consensus 671 ~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~----~~~~l~LVmEy~~Gg-SL 743 (931)
--.+-|+|.. +|..|++|.+.-..... ......-+++|+++.|.|||.+.++|. .+..+++|++|.++. +|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 3456788854 78889999882221110 111234467899999999999999986 456799999998754 67
Q ss_pred HHHhhc------------CCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 744 YRLIHR------------PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 744 ~d~L~r------------~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
.++.-. ...+...+++.+|.++.||..||.++|+.| +.-+-|.|.+||++.+-.|+|.--|+....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeee
Confidence 665421 123345788999999999999999999999 999999999999998888888766665443
Q ss_pred cccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHhcccccCCCCCChHHH
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQP-WNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~P-F~~~~~~eii~~i~~~~~r~~lP~~~s~eL 890 (931)
.... . |.+.. ..+-|.=-||.+++.|.||..- +......+. ....+....+.++
T Consensus 444 ~~d~------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s--------~~~~I~~~yS~D~ 498 (655)
T KOG3741|consen 444 QEDP------------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSS--------HLTRITTTYSTDL 498 (655)
T ss_pred cCCC------------C--cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHH--------HHHHhhhhhhHHH
Confidence 3221 0 11221 2456999999999999998542 211111111 0112345678889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
+++|.-+...++++ -++.+++..+-.
T Consensus 499 rn~v~yl~s~~~~~-ksI~~llp~~~~ 524 (655)
T KOG3741|consen 499 RNVVEYLESLNFRE-KSIQDLLPMIGS 524 (655)
T ss_pred HHHHHHHHhcCccc-ccHHHHHHHHHH
Confidence 99999988888887 678888766543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.5e-06 Score=90.69 Aligned_cols=105 Identities=27% Similarity=0.324 Sum_probs=80.9
Q ss_pred HHHHHHHHHHHhcCCCC--eeeEEeeeeeC----CeEEEEEeecCCC-CHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHH
Q 002355 701 KEFLREVAIMKRVRHPN--VVLFMGAVTKR----PHLSIVTEYLPRG-SLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773 (931)
Q Consensus 701 ~~~l~EIkILk~L~HpN--IV~Lid~f~~~----~~l~LVmEy~~Gg-SL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~ 773 (931)
.+..+|...+..|..-+ +...+++.... ...+||+|++++. +|.+++.... ..+......++.+++..+.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHHH
Confidence 45678888888775333 33445554432 2458999999885 7988886522 1556677889999999999
Q ss_pred HHHhCCCCEEEeccCCCCeEECCCC---cEEEEecCcccc
Q 002355 774 YLHNLNPPILHWDLKSPNLLVDKNW---TVKVCDFGLSRF 810 (931)
Q Consensus 774 yLHs~G~~IIHrDLKPeNILLd~dg---~IKL~DFGlAr~ 810 (931)
-||..| |+|+|+++.|||++.++ .+.|+||+-++.
T Consensus 133 ~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999 99999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=9.1e-08 Score=113.59 Aligned_cols=147 Identities=19% Similarity=0.306 Sum_probs=108.2
Q ss_pred HHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc---------ccCCCCCCCcccCcccccCC
Q 002355 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI---------SSKSVAGTPEWMAPEFLRGE 836 (931)
Q Consensus 766 ~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~---------~~~~~~GT~~Y~APEvL~~~ 836 (931)
.+++.|+.|+|..- ++||+.|.|++|.++.++..||+.|+++........ ......-...|.|||++.+.
T Consensus 106 ~~v~dgl~flh~sA-k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA-KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hcccchhhhhccCc-ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 35558999999752 499999999999999999999999998764322110 01111234579999999998
Q ss_pred CCCchhHHHHHHHHHHHHH-hCCCCCCCCChHHHHHH--HHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002355 837 PSNEKSDVYSFGVILWELV-TMQQPWNGLGPAQVVGA--VAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVE 913 (931)
Q Consensus 837 ~~t~ksDIWSLG~ILyELL-TG~~PF~~~~~~eii~~--i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq 913 (931)
..+.++|+|||||++|.+. .|+..+...+....... ............+++.++++=|.+++..++..||++.+++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 8899999999999999999 56666655433222221 12222334456889999999999999999999998777653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.9e-06 Score=93.76 Aligned_cols=139 Identities=22% Similarity=0.170 Sum_probs=97.5
Q ss_pred ceEEEEEecccCceEEEEEEE-cCCceEEEEEeecccch--------------------HHHHHHHHHHHHHHhcCCC--
Q 002355 660 ELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLD--------------------DQLKEFLREVAIMKRVRHP-- 716 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~~--------------------~~~~~~l~EIkILk~L~Hp-- 716 (931)
=+.+..+||-|--|.||.|.+ +|.++|||.=+....+- -......+|.++|.+|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 346789999999999999987 58999999754432110 1123457899999999644
Q ss_pred CeeeEEeeeeeCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC
Q 002355 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK 796 (931)
Q Consensus 717 NIV~Lid~f~~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~ 796 (931)
.|.+-+++ +...+|||++.|-.|...-- .....-.++..|+.-+.-+-..| |||+|+++-||+++.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~~ 237 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEEec
Confidence 55555543 44579999999877764431 12223334444444444444678 999999999999999
Q ss_pred CCcEEEEecCcccccc
Q 002355 797 NWTVKVCDFGLSRFKA 812 (931)
Q Consensus 797 dg~IKL~DFGlAr~~~ 812 (931)
+|.+.++||-.+....
T Consensus 238 dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 238 DGDIVVIDWPQAVPIS 253 (304)
T ss_pred CCCEEEEeCcccccCC
Confidence 9999999998775433
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.1e-05 Score=82.31 Aligned_cols=143 Identities=18% Similarity=0.219 Sum_probs=85.2
Q ss_pred EEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCC--CeeeEEeeee---eCCeEEEEEeec
Q 002355 664 KERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP--NVVLFMGAVT---KRPHLSIVTEYL 738 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~Hp--NIV~Lid~f~---~~~~l~LVmEy~ 738 (931)
++.|+.|..+.||++...+..+++|+.... .....+.+|..+++.+... .+.+++.... .....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 578999999999999988889999996544 2345677888888888533 3456665442 334579999999
Q ss_pred CCCCHHH----------------Hhh---cC-CCCCCCcHHH---------HHHH------------HHHHHH-HHHHHH
Q 002355 739 PRGSLYR----------------LIH---RP-AAGEMMDQRR---------RLRM------------ALDVAK-GINYLH 776 (931)
Q Consensus 739 ~GgSL~d----------------~L~---r~-~~~~~L~e~~---------~~~I------------a~QIa~-AL~yLH 776 (931)
+|..+.. .+. .. .....+.... .... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988877 111 11 0111111000 0000 111222 333333
Q ss_pred h-----CCCCEEEeccCCCCeEEC-CCCcEEEEecCcccc
Q 002355 777 N-----LNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSRF 810 (931)
Q Consensus 777 s-----~G~~IIHrDLKPeNILLd-~dg~IKL~DFGlAr~ 810 (931)
. ....++|+|+.|.|||++ .++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 223499999999999999 667778999987643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.3e-05 Score=85.01 Aligned_cols=139 Identities=21% Similarity=0.130 Sum_probs=101.1
Q ss_pred cccCceEEEEEEEcCCceEEEEEeecccc----hHHHHHHHHHHHHHHhcCCC--CeeeEEeeee---eC--CeEEEEEe
Q 002355 668 GAGSFGTVHRAEWHGSDVAVKVLTVQDFL----DDQLKEFLREVAIMKRVRHP--NVVLFMGAVT---KR--PHLSIVTE 736 (931)
Q Consensus 668 G~G~fGtVylAr~~g~~VAVKVlk~~~~~----~~~~~~~l~EIkILk~L~Hp--NIV~Lid~f~---~~--~~l~LVmE 736 (931)
|+||-+-|++....|..+-||.-...... .--...|.+|...|..|..- .+.+.. ++. .+ -.-+||+|
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEE
Confidence 78999999999888887777765421100 11235788999999999533 244444 332 11 23679999
Q ss_pred ecCC-CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc--EEEEecCcccc
Q 002355 737 YLPR-GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT--VKVCDFGLSRF 810 (931)
Q Consensus 737 y~~G-gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~--IKL~DFGlAr~ 810 (931)
-+.| .+|.+++... .-...+......++.+++..|.-||..| +.|+|+.+.|||++.+|. ++++||--++.
T Consensus 106 ~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 106 DMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 8843 5888887542 2234577777889999999999999999 999999999999987777 99999976653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.2e-05 Score=85.64 Aligned_cols=140 Identities=18% Similarity=0.199 Sum_probs=97.6
Q ss_pred cccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchH-HHHH------HHHHHHHHHhcCCC---CeeeEEeee
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD-QLKE------FLREVAIMKRVRHP---NVVLFMGAV 725 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~-~~~~------~l~EIkILk~L~Hp---NIV~Lid~f 725 (931)
+...+|.+++.+-......|.+-..+++.+.+|..+....... .... ..+++..+..+... .+..++.+.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4558999999999999999999999999999999876542221 1121 23444444444322 222322222
Q ss_pred e-----eCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcE
Q 002355 726 T-----KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV 800 (931)
Q Consensus 726 ~-----~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~I 800 (931)
. -....+|||||++|..|.++.. +++ .+...|+.++.-||..| ++|+|.+|.|++++.++ +
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECCc-E
Confidence 2 2234568999999988876642 222 24456777899999999 99999999999998655 9
Q ss_pred EEEecCccc
Q 002355 801 KVCDFGLSR 809 (931)
Q Consensus 801 KL~DFGlAr 809 (931)
+++||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.3e-05 Score=83.35 Aligned_cols=137 Identities=15% Similarity=0.130 Sum_probs=84.3
Q ss_pred EEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCC--eeeEEeeeeeCCeEEEEEeecCCCC
Q 002355 665 ERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN--VVLFMGAVTKRPHLSIVTEYLPRGS 742 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpN--IV~Lid~f~~~~~l~LVmEy~~GgS 742 (931)
..||.|..+.||+. .+..+++|...... . ...+.+|.++++.+..-. +.+.+++...++...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-D---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC-C---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 46899999999984 35677888876432 1 234678999999886433 4667777777778899999998863
Q ss_pred -HHHHh---------------------hcCC-CCCCCcHHHHHHHHHH----------HHH-HHHHHH--hCCCCEEEec
Q 002355 743 -LYRLI---------------------HRPA-AGEMMDQRRRLRMALD----------VAK-GINYLH--NLNPPILHWD 786 (931)
Q Consensus 743 -L~d~L---------------------~r~~-~~~~L~e~~~~~Ia~Q----------Ia~-AL~yLH--s~G~~IIHrD 786 (931)
+...+ +... ....++... ..+..+ +.. ...+|. .....++|+|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 21111 1100 011111100 000000 011 122222 2223488999
Q ss_pred cCCCCeEECCCCcEEEEecCccc
Q 002355 787 LKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 787 LKPeNILLd~dg~IKL~DFGlAr 809 (931)
+.|.||+++.++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.10 E-value=5.1e-05 Score=89.92 Aligned_cols=140 Identities=24% Similarity=0.289 Sum_probs=86.7
Q ss_pred EEecccCceEEEEEEEc-CCceEEEEEeecccc--hHH--------------------------H----H------HHHH
Q 002355 665 ERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFL--DDQ--------------------------L----K------EFLR 705 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~~-g~~VAVKVlk~~~~~--~~~--------------------------~----~------~~l~ 705 (931)
+.|+.++-|.||+|+.. |+.|||||.+..-.. ... + + .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 56999999999999985 899999998763210 000 0 1 1233
Q ss_pred HHHHHHhcC-----CCCeeeEEeeeeeCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHH-HHHHHhCC
Q 002355 706 EVAIMKRVR-----HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG-INYLHNLN 779 (931)
Q Consensus 706 EIkILk~L~-----HpNIV~Lid~f~~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~A-L~yLHs~G 779 (931)
|..-+.+++ .++|.--.=++.-.+.-.|+|||+.|-.+.+....... .++.+. ++..++.+ +..+=..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~---ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRKE---LAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHHH---HHHHHHHHHHHHHHhcC
Confidence 444444442 23322212223334556899999999999888532111 233222 22222221 12222357
Q ss_pred CCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 780 ~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
++|.|.+|.||+++.+|.+.+.|||+....
T Consensus 286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred --ccccCCCccceEEecCCcEEEEcCcceecC
Confidence 999999999999999999999999987543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.05 E-value=4.1e-05 Score=80.91 Aligned_cols=138 Identities=22% Similarity=0.173 Sum_probs=83.5
Q ss_pred ecccCc-eEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCeEEEEEeecCCCCHH
Q 002355 667 VGAGSF-GTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIVTEYLPRGSLY 744 (931)
Q Consensus 667 LG~G~f-GtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~l~LVmEy~~GgSL~ 744 (931)
|-.|.+ +.||+....+..+.||+..... ...+.+|+++++.+. +--+.+++++...++..++|||+++|.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 344444 7899997777778888875432 234567888888884 334557777777667789999999998776
Q ss_pred HHh-------------------hcCC-CCCCCcHH--HHHHHHH--------------------HHHHHHHHHHh-----
Q 002355 745 RLI-------------------HRPA-AGEMMDQR--RRLRMAL--------------------DVAKGINYLHN----- 777 (931)
Q Consensus 745 d~L-------------------~r~~-~~~~L~e~--~~~~Ia~--------------------QIa~AL~yLHs----- 777 (931)
... +... ....+... ....... .+...+..|-.
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 1100 01011100 0000000 01111222211
Q ss_pred CCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 778 ~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
..+.++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12348999999999999998778899999774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00016 Score=76.44 Aligned_cols=127 Identities=27% Similarity=0.397 Sum_probs=92.4
Q ss_pred CceEEEEEecccCc-eEEEEEEEcCCceEEEEEeecc----------cch---------HHHHHHHHHHHHHHhcC---C
Q 002355 659 DELHVKERVGAGSF-GTVHRAEWHGSDVAVKVLTVQD----------FLD---------DQLKEFLREVAIMKRVR---H 715 (931)
Q Consensus 659 drY~Ii~kLG~G~f-GtVylAr~~g~~VAVKVlk~~~----------~~~---------~~~~~~l~EIkILk~L~---H 715 (931)
.+++.++.||.|.- |.||+++..|+.+|||+++.-. ... ....-|..|-+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 78999999999999 9999999999999999943311 000 12234677888777774 5
Q ss_pred CCe--eeEEeeeeeC------------------CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHH
Q 002355 716 PNV--VLFMGAVTKR------------------PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775 (931)
Q Consensus 716 pNI--V~Lid~f~~~------------------~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yL 775 (931)
.++ |+++++..-. ....||.||++... .+.. .-+.+|.+-|..+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKIL 180 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHHH
Confidence 566 8999987321 13467888875543 1222 2355777888899
Q ss_pred HhCCCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 776 Hs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
|..| |+-+|+++.|.. +| +|+|||.+
T Consensus 181 ~k~g--I~~~Dv~~~ny~---~G--~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLG--IVPRDVKPRNYR---GG--KLVDFSSS 206 (207)
T ss_pred HHCC--eeeccCcccccc---CC--EEEecccC
Confidence 9999 999999999986 22 89999864
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.98 E-value=1.8e-05 Score=85.61 Aligned_cols=139 Identities=19% Similarity=0.135 Sum_probs=92.0
Q ss_pred EEEecccCceEEEEEEE-cCCceEEEEEeecccchHHH----------------------HHHHHHHHHHHhcCCC--Ce
Q 002355 664 KERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQL----------------------KEFLREVAIMKRVRHP--NV 718 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~~~~~----------------------~~~l~EIkILk~L~Hp--NI 718 (931)
...|..|--+.||+|.. .+..+|+|+.+........+ .....|..-|+++... .+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 34678888889999965 68899999998754322111 1124566666666322 22
Q ss_pred eeEEeeeeeCCeEEEEEeecCCCCHHH-HhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCCEEEeccCCCCeEECC
Q 002355 719 VLFMGAVTKRPHLSIVTEYLPRGSLYR-LIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDK 796 (931)
Q Consensus 719 V~Lid~f~~~~~l~LVmEy~~GgSL~d-~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs-~G~~IIHrDLKPeNILLd~ 796 (931)
.+-+.+. +..|||||+....+-. .|+ .-.+....+..+..++++.+.-|-. .+ +||+||..-|||+.
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~- 201 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH- 201 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-
Confidence 3333332 3479999994431100 011 1123333677788889998888866 78 99999999999999
Q ss_pred CCcEEEEecCccccccc
Q 002355 797 NWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 797 dg~IKL~DFGlAr~~~~ 813 (931)
++.+.|+|||.|....+
T Consensus 202 ~~~p~iID~~QaV~~~h 218 (268)
T COG1718 202 DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred CCeEEEEECccccccCC
Confidence 88999999999865543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00038 Score=86.99 Aligned_cols=79 Identities=15% Similarity=0.169 Sum_probs=55.7
Q ss_pred EEEecccCceEEEEEEEcC----CceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCe--eeEEeeeeeC---CeEEE
Q 002355 664 KERVGAGSFGTVHRAEWHG----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNV--VLFMGAVTKR---PHLSI 733 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~~g----~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNI--V~Lid~f~~~---~~l~L 733 (931)
++.|+.|.+..+|+....+ ..+++|+........ ....+.+|.++|+.+. |.+| .+++.++.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 5778999999999987654 356777654332111 1235779999999995 6665 6777776654 46789
Q ss_pred EEeecCCCCH
Q 002355 734 VTEYLPRGSL 743 (931)
Q Consensus 734 VmEy~~GgSL 743 (931)
||||++|..+
T Consensus 122 VME~v~G~~~ 131 (822)
T PLN02876 122 IMEYLEGRIF 131 (822)
T ss_pred EEEecCCccc
Confidence 9999987643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00033 Score=74.01 Aligned_cols=73 Identities=19% Similarity=0.208 Sum_probs=45.7
Q ss_pred EEecccCceE-EEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCC---CeeeEEeeeeeC---CeEEEEEee
Q 002355 665 ERVGAGSFGT-VHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP---NVVLFMGAVTKR---PHLSIVTEY 737 (931)
Q Consensus 665 ~kLG~G~fGt-VylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~Hp---NIV~Lid~f~~~---~~l~LVmEy 737 (931)
+.|+.|+... ||+. +..+.+|+..... ....+.+|.++|..|... -+.++++..... ...+++|++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 4577777774 8876 3457777654321 224678899999888532 334444443322 245899999
Q ss_pred cCCCCHH
Q 002355 738 LPRGSLY 744 (931)
Q Consensus 738 ~~GgSL~ 744 (931)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.61 E-value=1.1e-05 Score=95.49 Aligned_cols=184 Identities=18% Similarity=0.198 Sum_probs=132.5
Q ss_pred EEEEEecccCceEEEEEEEcCCc-eEEEEEeecccchHHHHHHHHHHHHHHhcCCCC-eeeEEeeeeeCCeEEEEEeecC
Q 002355 662 HVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN-VVLFMGAVTKRPHLSIVTEYLP 739 (931)
Q Consensus 662 ~Ii~kLG~G~fGtVylAr~~g~~-VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpN-IV~Lid~f~~~~~l~LVmEy~~ 739 (931)
...+-+++|+++.+++.|...+. ...+.+... ....-++++|.+++||| .+..++-++...+.+++|+++.
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 34455799999999998775443 223443322 23456889999999999 7777777788889999999997
Q ss_pred CC-CHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccccc
Q 002355 740 RG-SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS 818 (931)
Q Consensus 740 Gg-SL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~ 818 (931)
++ +-...+. .....+.+-+...+.+.-+++++++|+.- =+|+| ||+... +..+..||+......... ..
T Consensus 318 ~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~ 387 (829)
T KOG0576|consen 318 TGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KP 387 (829)
T ss_pred CCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccCccc-cc
Confidence 76 2211111 11112334445566777788999999864 47888 777655 678999999987665543 44
Q ss_pred CCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002355 819 KSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWN 862 (931)
Q Consensus 819 ~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~ 862 (931)
.+..+|+.++|||++.+..+..+.|.|++|.--.+|.-|.+|-.
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 67789999999999999999999999999986667776666543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00051 Score=71.34 Aligned_cols=132 Identities=25% Similarity=0.281 Sum_probs=92.4
Q ss_pred ceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCee-eEEeeeeeCCeEEEEEeec
Q 002355 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV-LFMGAVTKRPHLSIVTEYL 738 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV-~Lid~f~~~~~l~LVmEy~ 738 (931)
..++.+.||+|++|.||++.+.+..+|+|+-+.... ...+..|.++|..+...++. +++.+.. .++.|||+
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i 94 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYI 94 (201)
T ss_pred hhhhhhhhhcccccEEEEeeccCceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhh
Confidence 345678899999999999999999999999766542 34677899999999876664 4444432 24559999
Q ss_pred CCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccC-CCCeEECCCCcEEEEecCccccc
Q 002355 739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLK-SPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 739 ~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLK-PeNILLd~dg~IKL~DFGlAr~~ 811 (931)
.|..|.+.-.. ...++. ..++..---|...| |-|+.|. |..++|..++.+.|+||.-|...
T Consensus 95 ~G~~L~~~~~~------~~rk~l----~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 95 DGRPLGKLEIG------GDRKHL----LRVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred cCcchhhhhhc------ccHHHH----HHHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 88888766542 122232 33444433455667 8888886 44455555558999999988643
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00087 Score=70.24 Aligned_cols=73 Identities=18% Similarity=0.245 Sum_probs=48.4
Q ss_pred EEEecccCceEEEEEEEc---CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCC-eeeEEeeeeeCCeEEEEEeecC
Q 002355 664 KERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN-VVLFMGAVTKRPHLSIVTEYLP 739 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~~---g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpN-IV~Lid~f~~~~~l~LVmEy~~ 739 (931)
++.|..|-...||++... ++.|++|+....... .....+|+.+++.+...+ ..+++..+.. .+||||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeC
Confidence 467888889999999765 467889977543211 112246888888885333 3455544332 38999998
Q ss_pred CCCH
Q 002355 740 RGSL 743 (931)
Q Consensus 740 GgSL 743 (931)
|.++
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 8765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0016 Score=82.04 Aligned_cols=232 Identities=16% Similarity=0.177 Sum_probs=152.7
Q ss_pred ecccCceEEEEEEEcCC------ceEEEEEeeccc-chHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe----EEEEE
Q 002355 667 VGAGSFGTVHRAEWHGS------DVAVKVLTVQDF-LDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH----LSIVT 735 (931)
Q Consensus 667 LG~G~fGtVylAr~~g~------~VAVKVlk~~~~-~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~----l~LVm 735 (931)
|..-.+|+|++.++.-+ .+-++.-.-... ...++....-|+..+..+.|+|++.++.+-..... ..+..
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~ 265 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ 265 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence 67778899998876321 111111100000 11223344557777888899999999887653322 33455
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCC---CeEECCCCcEEEE--ecCcccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSP---NLLVDKNWTVKVC--DFGLSRF 810 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPe---NILLd~dg~IKL~--DFGlAr~ 810 (931)
+++..-++...+.. -..++....+.+..+++.||+|+|+.. ..|.-+.-. +-..+..+.+.++ ||+....
T Consensus 266 ~~~s~~~~~~~~q~---v~~i~~~~~r~~~~~~~~GL~~~h~~~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~ 340 (1351)
T KOG1035|consen 266 EICSKVELRSLLQS---VGSIPLETLRILHQKLLEGLAYLHSLS--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKP 340 (1351)
T ss_pred hhcCccchHHHHhh---ccccCHHHHHHHHHHHhhhHHHHHHhc--cceeEEecccccccccCccceeecchhhhccccc
Confidence 78888888887764 346888999999999999999999976 555544444 4445666777777 9988876
Q ss_pred ccccccccCCCCCCCcccCcccccCCCCCc--hhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChH
Q 002355 811 KANTFISSKSVAGTPEWMAPEFLRGEPSNE--KSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888 (931)
Q Consensus 811 ~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~--ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~ 888 (931)
..+.... .....+..+.++|......... ..|+|.+|.....+..|..+-...... ..-++.....
T Consensus 341 l~d~~~~-~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~-----------~~~l~~~~~~ 408 (1351)
T KOG1035|consen 341 LPDNEKS-FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVP-----------VSLLDVLSTS 408 (1351)
T ss_pred CCCcccc-hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccch-----------hhhhccccch
Confidence 5554322 2334466778888877665544 469999999999988875433221100 0111222222
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002355 889 VLASLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
...+++.+|+.-++++|+++.+++.+.
T Consensus 409 ~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 409 ELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhhhhhcchhhhhccchhhhhhch
Confidence 678899999999999999999999873
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0026 Score=70.45 Aligned_cols=80 Identities=10% Similarity=-0.019 Sum_probs=58.0
Q ss_pred ceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCC---CCeeeEEeeeee---CCeEEE
Q 002355 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH---PNVVLFMGAVTK---RPHLSI 733 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~H---pNIV~Lid~f~~---~~~l~L 733 (931)
...-.+.||.|..+.||+....+..+.+|..+... . ...+.+|...|+.|.. -.+.++++++.. .+..+|
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~-~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQGNPMPLMARSFS-T---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCCCEEEEEecccc-c---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 34456789999999999997766677778754311 1 1467789999988853 256778877643 466899
Q ss_pred EEeecCCCCH
Q 002355 734 VTEYLPRGSL 743 (931)
Q Consensus 734 VmEy~~GgSL 743 (931)
|||+++|.++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999988754
|
|
| >smart00460 TGc Transglutaminase/protease-like homologues | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00033 Score=59.78 Aligned_cols=53 Identities=26% Similarity=0.328 Sum_probs=42.9
Q ss_pred ccccchhhhHHHHHHHhhhcCCCceeeecccc---------cCCCCceeEEEEecCcccccceeEee
Q 002355 404 LSMGLCRHRAILFKKLADYIGLPCRIARGCRY---------CEADHRSSCLVKIEDDRRSSREYVVD 461 (931)
Q Consensus 404 l~~G~~rhRAlLFKvLaD~i~l~c~lv~G~~y---------~~~~~~~~~~v~~~~~~~~~~~~ivD 461 (931)
-+.|.|.+.|.||..|+-.+|||||+|.|-.- -....|+|++|.++ + +=+.+|
T Consensus 4 ~~~G~C~~~a~l~~~llr~~GIpar~v~g~~~~~~~~~~~~~~~~~H~W~ev~~~-~----~W~~~D 65 (68)
T smart00460 4 TKYGTCGEFAALFVALLRSLGIPARVVSGYLKAPDTIGGLRSIWEAHAWAEVYLE-G----GWVPVD 65 (68)
T ss_pred ccceeeHHHHHHHHHHHHHCCCCeEEEeeeecCCCCCcccccCCCcEEEEEEEEC-C----CeEEEe
Confidence 36799999999999999999999999999321 13688999999987 3 245555
|
Transglutaminases are enzymes that establish covalent links between proteins. A subset of transglutaminase homologues appear to catalyse the reverse reaction, the hydrolysis of peptide bonds. Proteins with this domain are both extracellular and intracellular, and it is likely that the eukaryotic intracellular proteins are involved in signalling events. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0033 Score=66.19 Aligned_cols=133 Identities=17% Similarity=0.252 Sum_probs=92.7
Q ss_pred EEecccCceEEEEEEEcCCceEEEEEeecc--------------cchHHHHHHHHHHHHHHhcC------CCCeeeEEee
Q 002355 665 ERVGAGSFGTVHRAEWHGSDVAVKVLTVQD--------------FLDDQLKEFLREVAIMKRVR------HPNVVLFMGA 724 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~~g~~VAVKVlk~~~--------------~~~~~~~~~l~EIkILk~L~------HpNIV~Lid~ 724 (931)
..||+|+.=.||.-- .+....|||..... .......+..+|+..+..+. +.+|.+++++
T Consensus 7 ~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 358999999998653 33456788887765 11112356677887777776 7799999999
Q ss_pred eeeCCeEEEEEeecCC------CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC-
Q 002355 725 VTKRPHLSIVTEYLPR------GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN- 797 (931)
Q Consensus 725 f~~~~~l~LVmEy~~G------gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d- 797 (931)
...+--..+|+|.+.+ .+|.+++.+. .++. ..... +-.-..||-.++ |+.+||+|.||++...
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~~~~~---L~~f~~~l~~~~--Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-ELRQA---LDEFKRYLLDHH--IVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-HHHHH---HHHHHHHHHHcC--CeecCCCcccEEEEecC
Confidence 9998888999988543 3688888542 2444 33333 334456777888 9999999999999543
Q ss_pred -C--cEEEEe-cCcc
Q 002355 798 -W--TVKVCD-FGLS 808 (931)
Q Consensus 798 -g--~IKL~D-FGlA 808 (931)
+ .+.|+| ||..
T Consensus 156 ~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 156 SGEFRLVLIDGLGEK 170 (199)
T ss_pred CCceEEEEEeCCCCc
Confidence 2 577888 4543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0022 Score=70.62 Aligned_cols=142 Identities=11% Similarity=0.077 Sum_probs=78.5
Q ss_pred EEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCC--eeeEEe------eeeeCCeEEEEE
Q 002355 664 KERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN--VVLFMG------AVTKRPHLSIVT 735 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpN--IV~Lid------~f~~~~~l~LVm 735 (931)
++.|+.|...++|+....+..+++|+.. . ... ..+..|+.++..|...+ +.+.+. +....+..++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~-~-~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~ 101 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQGEYVLTLFE-R-LTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV 101 (319)
T ss_pred cchhccccccceEEEEeCCCcEEEEEec-c-CCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence 4567888888999998777789999875 2 122 23344566666663221 233332 123356689999
Q ss_pred eecCCCCHH-----------HHhh---cCCC--------CCCC-cHHHHHH------------HHHH-HHHHHHHHHh--
Q 002355 736 EYLPRGSLY-----------RLIH---RPAA--------GEMM-DQRRRLR------------MALD-VAKGINYLHN-- 777 (931)
Q Consensus 736 Ey~~GgSL~-----------d~L~---r~~~--------~~~L-~e~~~~~------------Ia~Q-Ia~AL~yLHs-- 777 (931)
++++|..+. +.+. .... ...+ .+..... .+.+ +...++.+..
T Consensus 102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 181 (319)
T PRK05231 102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA 181 (319)
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence 999887431 1111 1000 0001 1111100 1111 1112233321
Q ss_pred ---CCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 778 ---LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 778 ---~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
....+||+|++|.||+++.+...-|+||+.+..
T Consensus 182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 222499999999999999766568999998753
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00088 Score=71.63 Aligned_cols=137 Identities=16% Similarity=0.116 Sum_probs=77.4
Q ss_pred ecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCe-eeEEeeeeeCCeEEEEEeecCCCCHHH
Q 002355 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV-VLFMGAVTKRPHLSIVTEYLPRGSLYR 745 (931)
Q Consensus 667 LG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNI-V~Lid~f~~~~~l~LVmEy~~GgSL~d 745 (931)
+..|-...+|+....++.+++|+.......- .....+|..+++.+....+ .+++.... -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 5667788899988778788888754321110 0123578888888864333 33443332 268999998876532
Q ss_pred --------------Hh---hcCC-CCCCCcHH-HHHHHHHHH---------HHHHHHHHhC------CCCEEEeccCCCC
Q 002355 746 --------------LI---HRPA-AGEMMDQR-RRLRMALDV---------AKGINYLHNL------NPPILHWDLKSPN 791 (931)
Q Consensus 746 --------------~L---~r~~-~~~~L~e~-~~~~Ia~QI---------a~AL~yLHs~------G~~IIHrDLKPeN 791 (931)
.+ +... ....++.. ....+..++ ...+..+-.. ...++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 11 1111 11112211 111111111 1112222111 2248999999999
Q ss_pred eEECCCCcEEEEecCcccc
Q 002355 792 LLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 792 ILLd~dg~IKL~DFGlAr~ 810 (931)
|+++.++ +.|+||..|..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0017 Score=70.62 Aligned_cols=142 Identities=18% Similarity=0.150 Sum_probs=85.4
Q ss_pred EEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCC--eeeEEee------eeeCCeEEEEE
Q 002355 664 KERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN--VVLFMGA------VTKRPHLSIVT 735 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpN--IV~Lid~------f~~~~~l~LVm 735 (931)
++.|..|....+|+....+..+++|+.... . ...+..|+.++..|.+.+ +.+++.. ...++..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV--S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCC--C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 567888888999999877778999987641 1 234567888888874332 4444432 23345678999
Q ss_pred eecCCCCHHH--------H---h---hcC--C-CC-----CCCcHHHHH----------HHHHHHHHHHHHHHh-----C
Q 002355 736 EYLPRGSLYR--------L---I---HRP--A-AG-----EMMDQRRRL----------RMALDVAKGINYLHN-----L 778 (931)
Q Consensus 736 Ey~~GgSL~d--------~---L---~r~--~-~~-----~~L~e~~~~----------~Ia~QIa~AL~yLHs-----~ 778 (931)
++++|..+.. + + +.. . .. ....+.... .....+..++.++.. .
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9998876521 0 1 100 0 00 000111000 011112334444443 1
Q ss_pred CCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 779 G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
...++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 12399999999999999987788999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.21 E-value=4.2e-05 Score=97.15 Aligned_cols=202 Identities=14% Similarity=0.097 Sum_probs=137.3
Q ss_pred CceEEEEEecccCceEEEEEEEcCC---ceEEEEEeeccc---chHHHHHHHHHHHHHHhcCCCCeeeEEeeee--eCCe
Q 002355 659 DELHVKERVGAGSFGTVHRAEWHGS---DVAVKVLTVQDF---LDDQLKEFLREVAIMKRVRHPNVVLFMGAVT--KRPH 730 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~g~---~VAVKVlk~~~~---~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~--~~~~ 730 (931)
..+++.=-+|.|.+ +++++-+. .+.+|+.+...+ .+...+....|...++...|+++.....-.. ....
T Consensus 1229 e~~EV~l~i~~~~~---~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~e 1305 (2724)
T KOG1826|consen 1229 EHSEVNLGISNHFH---FRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTE 1305 (2724)
T ss_pred hhhheeeeccccee---eccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChH
Confidence 45555444554444 35555322 234455443221 1222334455666666678998877665443 3345
Q ss_pred EEEEEeecCCCCHHHHhhcCCC-CCCCcHHHHHHHHHHHHHHHHHHHhC---CCCEEEeccCCCCeEECCCCcEEEEecC
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAA-GEMMDQRRRLRMALDVAKGINYLHNL---NPPILHWDLKSPNLLVDKNWTVKVCDFG 806 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~-~~~L~e~~~~~Ia~QIa~AL~yLHs~---G~~IIHrDLKPeNILLd~dg~IKL~DFG 806 (931)
.+.+++++.+|.+++.+-+... ...+...-+.....+.+.+..-+|+. |...+|+++|+.|.+|..+.++|++++|
T Consensus 1306 e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~g 1385 (2724)
T KOG1826|consen 1306 EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGG 1385 (2724)
T ss_pred HHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccc
Confidence 7899999999999999865322 22334444444444547777776753 3457999999999999999999999999
Q ss_pred ccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002355 807 LSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNG 863 (931)
Q Consensus 807 lAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~ 863 (931)
+.+.............+++.|+.|++.....++.++|+|..|+.+|+..-|..+|..
T Consensus 1386 LdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~ 1442 (2724)
T KOG1826|consen 1386 LDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIF 1442 (2724)
T ss_pred cccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHH
Confidence 999555544444566788999999999988888889999999999999888777643
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0024 Score=70.27 Aligned_cols=144 Identities=17% Similarity=0.127 Sum_probs=83.9
Q ss_pred EEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCC--eeeEEeee------eeCCeEEE
Q 002355 662 HVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN--VVLFMGAV------TKRPHLSI 733 (931)
Q Consensus 662 ~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpN--IV~Lid~f------~~~~~l~L 733 (931)
..++.++.|....+|++...+..+.+|+...... ...+..|++++..|...+ +.+++... ..++..++
T Consensus 25 ~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~----~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~ 100 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTTDVGRYILTLYEKRVK----AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC 100 (307)
T ss_pred eeccccCCccccceEEEEeCCCcEEEEEecCCCC----HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence 4456788888889999987666788898754321 123456777777774322 33443321 23456789
Q ss_pred EEeecCCCCHH-----------HH---hhcCCCC--------CCCc-HHHHH------------HHHHHHHHHHHHHHh-
Q 002355 734 VTEYLPRGSLY-----------RL---IHRPAAG--------EMMD-QRRRL------------RMALDVAKGINYLHN- 777 (931)
Q Consensus 734 VmEy~~GgSL~-----------d~---L~r~~~~--------~~L~-e~~~~------------~Ia~QIa~AL~yLHs- 777 (931)
++++++|..+. .. ++....+ .... +.... .....+...++++..
T Consensus 101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~ 180 (307)
T TIGR00938 101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF 180 (307)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence 99999885432 11 1110000 0011 10000 001123334555532
Q ss_pred ----CCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 778 ----LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 778 ----~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 181 WPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 22349999999999999988877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0016 Score=67.69 Aligned_cols=102 Identities=18% Similarity=0.209 Sum_probs=78.2
Q ss_pred HHHHHHHhcCC-CCeeeEEeeeeeCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhC--CCC
Q 002355 705 REVAIMKRVRH-PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL--NPP 781 (931)
Q Consensus 705 ~EIkILk~L~H-pNIV~Lid~f~~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~--G~~ 781 (931)
.|.-+++.+.+ +++.++++++-. ++|.||...+++......-......+|..+.+|+.+++..+++|+.. | .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~-~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG-F 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC-c
Confidence 57888888876 699999999833 57889997666642210000112368999999999999999999862 3 3
Q ss_pred EEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 782 IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
+.-.|++|+|+-++.+|.+|++|.......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0014 Score=78.11 Aligned_cols=139 Identities=22% Similarity=0.227 Sum_probs=83.3
Q ss_pred EEecccCceEEEEEEE-cCCceEEEEEeecccc-----------------------------hHHHHH------HHHHHH
Q 002355 665 ERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFL-----------------------------DDQLKE------FLREVA 708 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~-----------------------------~~~~~~------~l~EIk 708 (931)
+.||.-+.|.||+|+. .|+.|||||-+..-.. ++-.+. |.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 4689999999999986 5778999997653210 000011 223333
Q ss_pred HHHh----cCCCC------eeeEEeeeeeCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHH-HHh
Q 002355 709 IMKR----VRHPN------VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY-LHN 777 (931)
Q Consensus 709 ILk~----L~HpN------IV~Lid~f~~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~y-LHs 777 (931)
-..+ +.|-+ |.++| +.-.....|+||||.|..+.++-.-. ...++... ++..+.++... |=.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~--~~gi~~~~---i~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAID--KRGISPHD---ILNKLVEAYLEQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHH--HcCCCHHH---HHHHHHHHHHHHHHh
Confidence 2222 23434 33333 22334578999999999877653211 11244333 33333333222 224
Q ss_pred CCCCEEEeccCCCCeEECC----CCcEEEEecCcccccc
Q 002355 778 LNPPILHWDLKSPNLLVDK----NWTVKVCDFGLSRFKA 812 (931)
Q Consensus 778 ~G~~IIHrDLKPeNILLd~----dg~IKL~DFGlAr~~~ 812 (931)
.| ++|+|=+|.||++.. ++.+.+.|||+.....
T Consensus 320 ~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cC--CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 57 999999999999984 6789999999976543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0036 Score=68.46 Aligned_cols=74 Identities=18% Similarity=0.275 Sum_probs=48.0
Q ss_pred EEEecccCceEEEEEEEc--------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCe-eeEEeeeeeCCeEEEE
Q 002355 664 KERVGAGSFGTVHRAEWH--------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV-VLFMGAVTKRPHLSIV 734 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~~--------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNI-V~Lid~f~~~~~l~LV 734 (931)
++.|..|-...||++... ++.+++|+...... ......+|.++++.+...++ .+++.++.. .+|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v 75 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYGIFPN----GRI 75 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence 456777777789988754 36789999655321 11234678888888853333 355555543 358
Q ss_pred EeecCCCCHH
Q 002355 735 TEYLPRGSLY 744 (931)
Q Consensus 735 mEy~~GgSL~ 744 (931)
+||++|..+.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 9999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.014 Score=67.66 Aligned_cols=77 Identities=18% Similarity=0.033 Sum_probs=52.9
Q ss_pred EEEecccCceEEEEEEEcCC--ceEEEEEeeccc-----chHHHHHHHHHHHHHHhcC---CCCeeeEEeeeeeCCeEEE
Q 002355 664 KERVGAGSFGTVHRAEWHGS--DVAVKVLTVQDF-----LDDQLKEFLREVAIMKRVR---HPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~~g~--~VAVKVlk~~~~-----~~~~~~~~l~EIkILk~L~---HpNIV~Lid~f~~~~~l~L 733 (931)
.+.||.|.+..||++...+. .|.||.-....- ..-...+...|.+.|+.+. ..++.+++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46799999999999988653 799998532110 0112356677888888763 2456777766 3356789
Q ss_pred EEeecCCCC
Q 002355 734 VTEYLPRGS 742 (931)
Q Consensus 734 VmEy~~GgS 742 (931)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999997644
|
|
| >COG5279 CYK3 Uncharacterized protein involved in cytokinesis, contains TGc (transglutaminase/protease-like) domain [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0012 Score=76.70 Aligned_cols=53 Identities=32% Similarity=0.622 Sum_probs=46.7
Q ss_pred cccchhhhHHHHHHHhhhcCCCceeeecccccC---------CCCceeEEEEecCcccccceeEeeccC
Q 002355 405 SMGLCRHRAILFKKLADYIGLPCRIARGCRYCE---------ADHRSSCLVKIEDDRRSSREYVVDLVG 464 (931)
Q Consensus 405 ~~G~~rhRAlLFKvLaD~i~l~c~lv~G~~y~~---------~~~~~~~~v~~~~~~~~~~~~ivDlm~ 464 (931)
--++|-..|.|||.||-..||||.+|+| |.. +.+||||+|++.+. =|.||.--
T Consensus 208 heavCtgYa~lfK~lcn~lgIp~~iIeg--f~k~~~~~~~~~~iNHaWN~VkiD~~-----yy~VDtTw 269 (521)
T COG5279 208 HEAVCTGYAELFKELCNALGIPCEIIEG--FLKSPIYYTRDININHAWNIVKIDNE-----YYLVDTTW 269 (521)
T ss_pred cccccchHHHHHHHHHHhcCCceEEEee--cccccccccCCccccceeeEEEECCe-----EEEEeeec
Confidence 4589999999999999999999999999 422 66999999999996 89999854
|
|
| >PF01841 Transglut_core: Transglutaminase-like superfamily; InterPro: IPR002931 This domain is found in many proteins known to have transglutaminase activity, i | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.0015 Score=60.68 Aligned_cols=47 Identities=26% Similarity=0.383 Sum_probs=37.2
Q ss_pred cccchhhhHHHHHHHhhhcCCCceeeeccccc----------CCCCceeEEEEecCc
Q 002355 405 SMGLCRHRAILFKKLADYIGLPCRIARGCRYC----------EADHRSSCLVKIEDD 451 (931)
Q Consensus 405 ~~G~~rhRAlLFKvLaD~i~l~c~lv~G~~y~----------~~~~~~~~~v~~~~~ 451 (931)
+.|.|...|.||..|+-.+|||||+|.|...- +...|+||+|.+++.
T Consensus 50 ~~G~C~~~a~l~~allr~~Gipar~v~g~~~~~~~~~~~~~~~~~~H~w~ev~~~~~ 106 (113)
T PF01841_consen 50 GRGDCEDYASLFVALLRALGIPARVVSGYVKGPDPDGDYSVDGNDNHAWVEVYLPGG 106 (113)
T ss_dssp EEESHHHHHHHHHHHHHHHT--EEEEEEEEEECSSTTCTSTSSEEEEEEEEEEETTT
T ss_pred CCCccHHHHHHHHHHHhhCCCceEEEEEEcCCccccccccCCCCCCEEEEEEEEcCC
Confidence 45999999999999999999999999993321 244589999999666
|
e. which cross-link proteins through an acyl-transfer reaction between the gamma-carboxamide group of peptide-bound glutamine and the epsilon-amino group of peptide-bound lysine, resulting in a epsilon-(gamma-glutamyl)lysine isopeptide bond. Tranglutaminases have been found in a diverse range of species, from bacteria through to mammals. The enzymes require calcium binding and their activity leads to post-translational modification of proteins through acyl-transfer reactions, involving peptidyl glutamine residues as acyl donors and a variety of primary amines as acyl acceptors, with the generation of proteinase resistant isopeptide bonds []. Sequence conservation in this superfamily primarily involves three motifs that centre around conserved cysteine, histidine, and aspartate residues that form the catalytic triad in the structurally characterised transglutaminase, the human blood clotting factor XIIIa' []. On the basis of the experimentally demonstrated activity of the Methanobacterium phage psiM2 pseudomurein endoisopeptidase [], it is proposed that many, if not all, microbial homologs of the transglutaminases are proteases and that the eukaryotic transglutaminases have evolved from an ancestral protease []. A subunit of plasma Factor XIII revealed that each Factor XIIIA subunit is composed of four domains (termed N-terminal beta-sandwich, core domain (containing the catalytic and the regulatory sites), and C-terminal beta-barrels 1 and 2) and that two monomers assemble into the native dimer through the surfaces in domains 1 and 2, in opposite orientation. This organisation in four domains is highly conserved during evolution among transglutaminase isoforms [].; PDB: 2F4M_A 2F4O_A 1GGY_B 1FIE_B 1GGU_B 1GGT_B 1F13_A 1QRK_B 1EVU_A 1EX0_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.038 Score=60.32 Aligned_cols=64 Identities=16% Similarity=0.234 Sum_probs=40.4
Q ss_pred EEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCC--CeeeEEee------eeeCCeEEEEEeecCCCCH
Q 002355 674 TVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP--NVVLFMGA------VTKRPHLSIVTEYLPRGSL 743 (931)
Q Consensus 674 tVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~Hp--NIV~Lid~------f~~~~~l~LVmEy~~GgSL 743 (931)
.||++...+..+++|+.... . ..+..|+.++..|... .++.++.. ...++..++|+++++|..+
T Consensus 11 ~v~~v~t~~g~~~LK~~~~~---~---~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~ 82 (313)
T TIGR02906 11 NVYKVETDSGNKCLKKINYP---P---ERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC 82 (313)
T ss_pred cEEEEEeCCCCeEEEEcCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence 38998876667899987532 1 2345567777766432 33444332 2345678999999988654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.02 Score=64.72 Aligned_cols=144 Identities=17% Similarity=0.260 Sum_probs=82.0
Q ss_pred CceEEEEEecccCceEEEEEEEc------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCe-eeEEeeeeeCCeE
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV-VLFMGAVTKRPHL 731 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNI-V~Lid~f~~~~~l 731 (931)
+...+ ..|-.|-.-.+|++... ++.|.+|+..... ...+. -.+|..+++.+..-++ .++++.+..+
T Consensus 37 ~~~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g--- 109 (344)
T PLN02236 37 EALQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG--- 109 (344)
T ss_pred CcEEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc---
Confidence 34444 45555888899998752 2568888875532 11111 2578888888864444 3556666443
Q ss_pred EEEEeecCCCCHHHH-----------------hhcCC-CCC--CCcHHHHHHHHHHH-----------------HHHHHH
Q 002355 732 SIVTEYLPRGSLYRL-----------------IHRPA-AGE--MMDQRRRLRMALDV-----------------AKGINY 774 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~-----------------L~r~~-~~~--~L~e~~~~~Ia~QI-----------------a~AL~y 774 (931)
.|.+|+++.+|..- ++... ... ......+..+..++ ...+..
T Consensus 110 -~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~ 188 (344)
T PLN02236 110 -RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL 188 (344)
T ss_pred -eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence 57899887776311 11101 111 11223333333221 111222
Q ss_pred H----Hh--CCCCEEEeccCCCCeEECC-CCcEEEEecCcccc
Q 002355 775 L----HN--LNPPILHWDLKSPNLLVDK-NWTVKVCDFGLSRF 810 (931)
Q Consensus 775 L----Hs--~G~~IIHrDLKPeNILLd~-dg~IKL~DFGlAr~ 810 (931)
| .. ....++|+|+++.||+++. ++.+.|+||..+..
T Consensus 189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2 11 1124899999999999986 46899999988753
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.03 Score=62.93 Aligned_cols=148 Identities=15% Similarity=0.212 Sum_probs=81.8
Q ss_pred ccccCceEEEEEecccCceEEEEEEEcC-----CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCe-eeEEeeeeeC
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV-VLFMGAVTKR 728 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~~g-----~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNI-V~Lid~f~~~ 728 (931)
.+..+.+++... -.|=...+|+....+ ..|.+|+...... ..-.-.+|..+++.+..-++ .++++++..+
T Consensus 11 ~~~~~~i~i~~l-~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G 86 (330)
T PLN02421 11 DLDDSDFSVERI-SGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVIDRERELQAIKYLSAAGFGAKLLGVFGNG 86 (330)
T ss_pred cCCcCceEEEEe-CCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEechHHHHHHHHHHHhcCCCCceeEEeCCc
Confidence 334455655544 448888899886543 2688888754321 11112468888888865444 4566666433
Q ss_pred CeEEEEEeecCCCCHHH--------------Hh---hcCC-CCC--CCcHHHHHHHHHHH--------------------
Q 002355 729 PHLSIVTEYLPRGSLYR--------------LI---HRPA-AGE--MMDQRRRLRMALDV-------------------- 768 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d--------------~L---~r~~-~~~--~L~e~~~~~Ia~QI-------------------- 768 (931)
+|.+|++|..|.. .+ +... ... ...+..+..+..++
T Consensus 87 ----~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~ 162 (330)
T PLN02421 87 ----MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFE 162 (330)
T ss_pred ----EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHH
Confidence 5888887776521 11 1101 111 11122222222111
Q ss_pred --HHHHHHHH----hCC--CCEEEeccCCCCeEECC-CCcEEEEecCcccc
Q 002355 769 --AKGINYLH----NLN--PPILHWDLKSPNLLVDK-NWTVKVCDFGLSRF 810 (931)
Q Consensus 769 --a~AL~yLH----s~G--~~IIHrDLKPeNILLd~-dg~IKL~DFGlAr~ 810 (931)
..-+..+. ..+ ...+|+|+.+.|||++. ++.++++||..|..
T Consensus 163 ~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 163 ELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11122221 112 23789999999999975 57899999998753
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.0043 Score=69.83 Aligned_cols=136 Identities=19% Similarity=0.159 Sum_probs=93.7
Q ss_pred CceEEEEEecccCceEEEEEEE-cCCceEEEEEeecccchHH--------------------HHHHHHHHHHHHhcC-CC
Q 002355 659 DELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQ--------------------LKEFLREVAIMKRVR-HP 716 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~~~~--------------------~~~~l~EIkILk~L~-Hp 716 (931)
.=+.+++.||-|--+-||.+-+ .|+..++|.-+....+-.. .-...+|...|+.|. |-
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 3567899999999999999977 4888888865443221110 122456777888774 22
Q ss_pred -CeeeEEeeeeeCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC
Q 002355 717 -NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD 795 (931)
Q Consensus 717 -NIV~Lid~f~~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd 795 (931)
-+.+.++ .+.-|+|||++.|-.|...-+- .+.. .+...++.-+--|-.+| +||+|.+--||+++
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v------~d~~---~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVRHV------EDPP---TLYDDLMGLIVRLANHG--LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeeeec------CChH---HHHHHHHHHHHHHHHcC--ceecccchheeEEe
Confidence 2223332 3456899999988888755432 1222 23444555556677889 99999999999999
Q ss_pred CCCcEEEEecCccc
Q 002355 796 KNWTVKVCDFGLSR 809 (931)
Q Consensus 796 ~dg~IKL~DFGlAr 809 (931)
.++.++++||-...
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 99999999997654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.066 Score=59.27 Aligned_cols=30 Identities=20% Similarity=0.283 Sum_probs=27.2
Q ss_pred CEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 781 ~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
.++|+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999999999999988754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.063 Score=60.61 Aligned_cols=141 Identities=17% Similarity=0.200 Sum_probs=81.9
Q ss_pred EEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCC--CeeeEEeeeeeCC--eEEEEEee
Q 002355 662 HVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP--NVVLFMGAVTKRP--HLSIVTEY 737 (931)
Q Consensus 662 ~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~Hp--NIV~Lid~f~~~~--~l~LVmEy 737 (931)
.+++.+-.|.--.+|.....++.+.|+ ...............+|..+++.+.-- -+...++.+.++. ..+.||++
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred ceeeeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 344445444444456666667778888 322122223345566788888887432 2233455555444 67999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHH-HHHHHHHHHH----------------------------------------
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMAL-DVAKGINYLH---------------------------------------- 776 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~-QIa~AL~yLH---------------------------------------- 776 (931)
+.|..+.+.+... ... ..++. .++..|.-||
T Consensus 107 veGe~~~~~~~~~----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 107 VEGEVVWSALPPE----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred ecceeccCcCCcc----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 9884332222110 000 11111 3333333333
Q ss_pred ----------hCC------CCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 777 ----------NLN------PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 777 ----------s~G------~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
.+- +.++|+|+.+.||+++.++-+-++||+++...
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 322 14999999999999999988999999998653
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.064 Score=58.99 Aligned_cols=30 Identities=20% Similarity=0.403 Sum_probs=25.2
Q ss_pred CEEEeccCCCCeEECCCCc-EEEEecCcccc
Q 002355 781 PILHWDLKSPNLLVDKNWT-VKVCDFGLSRF 810 (931)
Q Consensus 781 ~IIHrDLKPeNILLd~dg~-IKL~DFGlAr~ 810 (931)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 56999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.076 Score=59.05 Aligned_cols=76 Identities=20% Similarity=0.169 Sum_probs=49.5
Q ss_pred eEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcC---CCCeeeEEeeeeeCCeEEEEEee
Q 002355 661 LHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR---HPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~---HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
.+-.+.||-|....+|+....++.+.||+-.... ...+..|..-|+.|. .-.+.+.+.+....+..+|||||
T Consensus 19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~ 93 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF 93 (288)
T ss_dssp --EEEEE--SSSSEEEEEETTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred eeeeEecCCCChhheEEEECCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence 4556789999999999999888899999987322 235677888888883 33677888888777777999999
Q ss_pred cCCC
Q 002355 738 LPRG 741 (931)
Q Consensus 738 ~~Gg 741 (931)
++.+
T Consensus 94 l~~~ 97 (288)
T PF03881_consen 94 LEMG 97 (288)
T ss_dssp ----
T ss_pred ecCC
Confidence 8766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.073 Score=61.16 Aligned_cols=142 Identities=16% Similarity=0.169 Sum_probs=92.6
Q ss_pred EEEEecccCceEEEEEEE-cCCceEEEEEeecccc-----------------------hHHH-HHHHHHHHHHHhcCCCC
Q 002355 663 VKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFL-----------------------DDQL-KEFLREVAIMKRVRHPN 717 (931)
Q Consensus 663 Ii~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~-----------------------~~~~-~~~l~EIkILk~L~HpN 717 (931)
|-..|..|--+-||.|.. +|..+||||.+.+-.. ...+ .....|++-|++|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 445788899999999965 6788999998664221 0111 12345778888886444
Q ss_pred eeeEEeeeeeCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHH-hCCCCEEEeccCCCCeEECC
Q 002355 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH-NLNPPILHWDLKSPNLLVDK 796 (931)
Q Consensus 718 IV~Lid~f~~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLH-s~G~~IIHrDLKPeNILLd~ 796 (931)
|..---+.. ....|||+|+.+..-..-.- ....++...+..+..|++.-+.-|- .++ +||.||.--|+|+.
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH- 299 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE-
Confidence 321110000 12368999994322211111 1234666778888888888888774 566 99999999999995
Q ss_pred CCcEEEEecCcccccc
Q 002355 797 NWTVKVCDFGLSRFKA 812 (931)
Q Consensus 797 dg~IKL~DFGlAr~~~ 812 (931)
+|.+.|+|.+.+....
T Consensus 300 dG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEHD 315 (520)
T ss_pred CCEEEEEEccccccCC
Confidence 4689999999886443
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.061 Score=61.00 Aligned_cols=138 Identities=19% Similarity=0.239 Sum_probs=82.4
Q ss_pred ecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCC------eeeE----EeeeeeCCeEEEEEe
Q 002355 667 VGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN------VVLF----MGAVTKRPHLSIVTE 736 (931)
Q Consensus 667 LG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpN------IV~L----id~f~~~~~l~LVmE 736 (931)
|.+ .-..||+....+..++||+.... ... ..+..|+..|..|.-.. +..+ +..+..+...+-|++
T Consensus 34 l~s-~eN~~f~~~~~~g~~iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRYILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccc-ccCceEEEEecCCCeEEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 444 45568999887777799998776 333 34567888888884222 2222 222222247888999
Q ss_pred ecCCCCHHH-H-----------h---hc---------CCCCCCCcHHH-------------HHHHHHHHHHHHHHHHhCC
Q 002355 737 YLPRGSLYR-L-----------I---HR---------PAAGEMMDQRR-------------RLRMALDVAKGINYLHNLN 779 (931)
Q Consensus 737 y~~GgSL~d-~-----------L---~r---------~~~~~~L~e~~-------------~~~Ia~QIa~AL~yLHs~G 779 (931)
|++|..+.. . + +. +.......+.. -.....++...++.+.+.-
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 998887772 1 1 00 00111122220 0112334444555554321
Q ss_pred ------CC--EEEeccCCCCeEECCCCc-EEEEecCccc
Q 002355 780 ------PP--ILHWDLKSPNLLVDKNWT-VKVCDFGLSR 809 (931)
Q Consensus 780 ------~~--IIHrDLKPeNILLd~dg~-IKL~DFGlAr 809 (931)
.+ +||+|+.|.||+++.+.. +.++|||.++
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 12 899999999999998875 8899999875
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.066 Score=62.37 Aligned_cols=76 Identities=13% Similarity=-0.033 Sum_probs=51.9
Q ss_pred EEEEecccCceEEEEEEEcCCceEEEEEeeccc--c---hHHHHHHHHHHHHHHhcC---CCCeeeEEeeeeeCCeEEEE
Q 002355 663 VKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDF--L---DDQLKEFLREVAIMKRVR---HPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 663 Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~--~---~~~~~~~l~EIkILk~L~---HpNIV~Lid~f~~~~~l~LV 734 (931)
..+.||-|....||+....+..++||.-..... . .....+...|...|+.+. ..++.+++.+.. +..+++
T Consensus 36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 367899999999999988777799987652111 0 012344556677776664 247777887766 446788
Q ss_pred EeecCC
Q 002355 735 TEYLPR 740 (931)
Q Consensus 735 mEy~~G 740 (931)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.87 E-value=0.064 Score=63.67 Aligned_cols=156 Identities=19% Similarity=0.227 Sum_probs=93.5
Q ss_pred HHHHHHHHHHHhcCCCCeeeEEeeeee-CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCC
Q 002355 701 KEFLREVAIMKRVRHPNVVLFMGAVTK-RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779 (931)
Q Consensus 701 ~~~l~EIkILk~L~HpNIV~Lid~f~~-~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G 779 (931)
.+++-...+++.+.|+|....+++-.. .....+|||++ +.+|++++.... .. ..++. .++
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~----------~~s~~-------~~~ 87 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LK----------DESLL-------AHG 87 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cc----------hhhhc-------ccc
Confidence 345666788999999999999887643 34478899999 889999986522 11 01111 222
Q ss_pred CCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCC
Q 002355 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQ 859 (931)
Q Consensus 780 ~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~ 859 (931)
+.|- || ++++| -++ .. ...+.| +++|||++|.++.++.-|..
T Consensus 88 --~~~~-----~~-------~~~td-~~~---t~----~~~~~~----------------pKsdVwsl~~i~~el~L~~~ 129 (725)
T KOG1093|consen 88 --VLHL-----NI-------IYITD-HFL---TK----YPSPIG----------------PKSDVWSLGFIILELYLGIS 129 (725)
T ss_pred --ccee-----hh-------hhccc-ccc---cc----CCCCCC----------------cchhhhhHHHHHHHHHHhhH
Confidence 3222 22 22333 000 00 011111 38999999999999999877
Q ss_pred CCCCCChHHHHHHHHhccc-cc---------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002355 860 PWNGLGPAQVVGAVAFQNR-RL---------AIPQNTSPVLASLMESCWADDPAQRPSFANIVE 913 (931)
Q Consensus 860 PF~~~~~~eii~~i~~~~~-r~---------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq 913 (931)
.|.....-+....+..-.. .. .+-..++..+.++..+|+-..|..||...++.+
T Consensus 130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 130 LEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 7765443333222210000 00 112345667788899999999999987666554
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.13 E-value=0.43 Score=55.25 Aligned_cols=84 Identities=13% Similarity=0.156 Sum_probs=47.7
Q ss_pred cccCceEEEEEecccCceEEEEEEEcC---CceEEE-EEeec-ccchHHHHHHHHHHHHHHhcCCCCe-eeEEeeeeeCC
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWHG---SDVAVK-VLTVQ-DFLDDQLKEFLREVAIMKRVRHPNV-VLFMGAVTKRP 729 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~g---~~VAVK-Vlk~~-~~~~~~~~~~l~EIkILk~L~HpNI-V~Lid~f~~~~ 729 (931)
+..+.+++. .|..|-...+|++...+ ..+.+| ++... .......-.-.+|+++++.|...++ .++++.|..
T Consensus 48 ~~~~~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~-- 124 (383)
T PTZ00384 48 VNPEFIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD-- 124 (383)
T ss_pred CCcccEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC--
Confidence 333455554 55558889999996532 223233 12111 0011111112468999999965554 566777654
Q ss_pred eEEEEEeecCCCCHH
Q 002355 730 HLSIVTEYLPRGSLY 744 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~ 744 (931)
++|.||++|.+|.
T Consensus 125 --g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 --FTIQEWVEGNTMG 137 (383)
T ss_pred --EEEEEEeccccCC
Confidence 5899999887763
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.96 E-value=0.3 Score=53.24 Aligned_cols=78 Identities=26% Similarity=0.291 Sum_probs=58.9
Q ss_pred EEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCC---CCeeeEEeeeeeCCeEEEEEeec
Q 002355 662 HVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH---PNVVLFMGAVTKRPHLSIVTEYL 738 (931)
Q Consensus 662 ~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~H---pNIV~Lid~f~~~~~l~LVmEy~ 738 (931)
+..+++.-|.--..|...+....+-||+-.. .....|..|+.-|+.|.. -.+.+.+.+....++.|+||||+
T Consensus 19 ~er~~v~gG~inea~~v~dg~~~~FvK~n~~-----~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 19 KEREEVSGGDINEAWRLRDGTDPFFVKCNQR-----EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred hcccccCCccccceeEeecCCcceEEEecch-----hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence 4455677777777888888888899998543 334677888877777743 45778898999999999999999
Q ss_pred CCCCHH
Q 002355 739 PRGSLY 744 (931)
Q Consensus 739 ~GgSL~ 744 (931)
+-+.+.
T Consensus 94 ~~~~~d 99 (286)
T COG3001 94 PTGPLD 99 (286)
T ss_pred cCCCCC
Confidence 876554
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=93.85 E-value=0.3 Score=56.23 Aligned_cols=74 Identities=19% Similarity=0.046 Sum_probs=46.7
Q ss_pred EecccCceEEEEEEEcC--CceEEEEEeecc-----cchHHHHHHHHHHHHHHhcC--CC-CeeeEEeeeeeCCeEEEEE
Q 002355 666 RVGAGSFGTVHRAEWHG--SDVAVKVLTVQD-----FLDDQLKEFLREVAIMKRVR--HP-NVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 666 kLG~G~fGtVylAr~~g--~~VAVKVlk~~~-----~~~~~~~~~l~EIkILk~L~--Hp-NIV~Lid~f~~~~~l~LVm 735 (931)
.||-|....||++...+ +.|+||.-.... ...-...+...|...|+... .| ++.+++. .+.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 47999999999998754 478888643211 11122345667888887763 34 4445543 3445556899
Q ss_pred eecCCC
Q 002355 736 EYLPRG 741 (931)
Q Consensus 736 Ey~~Gg 741 (931)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998554
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.85 E-value=0.23 Score=53.86 Aligned_cols=118 Identities=13% Similarity=0.057 Sum_probs=76.7
Q ss_pred ccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeecCCCCHHHHhh
Q 002355 669 AGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH 748 (931)
Q Consensus 669 ~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~~GgSL~d~L~ 748 (931)
-|+.++.-.++.+-.+..+|+++.-..-- ...-+.++.+++.++. .|+++..- ++-.+.++.|.|-....
T Consensus 72 ~~gNsTl~~~kt~iG~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----- 141 (308)
T PF07387_consen 72 FNGNSTLLIGKTKIGPLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----- 141 (308)
T ss_pred cCCceEEEEeccccchhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----
Confidence 35666666665544455666665433220 1234577888888886 78888732 44457799999832211
Q ss_pred cCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCc
Q 002355 749 RPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807 (931)
Q Consensus 749 r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGl 807 (931)
.. ..++.-=+++|.-.|+.....+|+|..|+||+=|+.|.+||.|-+.
T Consensus 142 -------~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 -------NF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred -------ch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 10 1122222467788896545699999999999999999999999874
|
The function of this family is unknown. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.72 E-value=0.49 Score=55.77 Aligned_cols=83 Identities=12% Similarity=0.221 Sum_probs=51.4
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEc----------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCee-eE
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWH----------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV-LF 721 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~----------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV-~L 721 (931)
|..+..++. -++.|..|-.-.+|++... ++.|.+++.-.... . +-.-.+|..+++.+...+|- ++
T Consensus 100 W~~~~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te--~-lIdR~~E~~v~~~ls~~gi~P~l 175 (442)
T PTZ00296 100 WRRFTEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD--E-LYNPISEFEVYKTMSKYRIAPQL 175 (442)
T ss_pred cccCCcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc--c-eeCHHHHHHHHHHHHHCCCCCce
Confidence 444555666 5677878888889998653 35688888644321 1 11224578888777644443 56
Q ss_pred EeeeeeCCeEEEEEeecCCCCH
Q 002355 722 MGAVTKRPHLSIVTEYLPRGSL 743 (931)
Q Consensus 722 id~f~~~~~l~LVmEy~~GgSL 743 (931)
++.|.. +.|.+|++|.+|
T Consensus 176 ~~~f~g----g~I~efi~g~~l 193 (442)
T PTZ00296 176 LNTFSG----GRIEEWLYGDPL 193 (442)
T ss_pred EEEeCC----CEEEEeeCCccC
Confidence 666543 357899987744
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=92.46 E-value=0.32 Score=56.65 Aligned_cols=76 Identities=18% Similarity=0.067 Sum_probs=50.1
Q ss_pred EEEecccCceEEEEEEEc--CCceEEEEEeec----ccchHHHHHHHHHHHHHHhcC--CC-CeeeEEeeeeeCCeEEEE
Q 002355 664 KERVGAGSFGTVHRAEWH--GSDVAVKVLTVQ----DFLDDQLKEFLREVAIMKRVR--HP-NVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~~--g~~VAVKVlk~~----~~~~~~~~~~l~EIkILk~L~--Hp-NIV~Lid~f~~~~~l~LV 734 (931)
.+.||-|.-..||++.+. ++.|+||.-... ....-...+...|..+|+.+. .| ++.+++. .+.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 577899999999999874 567898864321 111122456777888888773 34 4555553 344556788
Q ss_pred EeecCCC
Q 002355 735 TEYLPRG 741 (931)
Q Consensus 735 mEy~~Gg 741 (931)
||+++..
T Consensus 112 MEdL~~~ 118 (409)
T PRK12396 112 MEDLSDH 118 (409)
T ss_pred HHhCccc
Confidence 9888543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 931 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-114 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-112 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-42 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-42 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-42 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-41 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-41 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-41 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-40 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-40 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-40 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-40 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-40 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-39 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-39 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-39 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-39 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-39 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-39 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-39 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-39 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-38 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-38 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-38 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-38 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-37 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-37 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-36 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-36 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-36 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-36 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-36 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-36 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-36 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-36 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-36 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-36 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-36 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-36 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-36 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-36 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-36 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-36 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-36 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-36 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-36 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-36 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-36 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-36 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-34 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-33 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-33 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-33 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-33 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-32 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-32 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-32 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-31 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-31 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-31 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-31 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-31 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-31 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-31 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-31 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-31 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-31 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-31 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-31 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-31 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-31 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-31 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-31 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-31 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-31 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-31 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-31 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-31 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-31 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-31 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-31 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-31 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-31 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-31 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-31 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-31 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-30 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-30 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-30 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-30 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-30 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-30 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-30 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-30 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-30 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-30 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-30 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-30 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-30 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-30 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-30 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-30 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-30 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-30 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-30 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-30 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-30 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-30 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-30 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-30 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-30 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-30 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-30 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-30 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-30 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-30 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-30 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-30 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-30 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-30 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-30 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-30 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-30 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-30 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-30 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-30 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-30 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-30 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-30 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-30 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-30 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-30 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-30 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-30 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-30 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-30 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-30 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-30 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-30 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-30 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-29 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-29 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-29 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-29 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-29 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-29 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-29 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-29 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-29 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-29 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-29 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-29 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-29 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-29 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-29 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-29 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-29 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-29 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-29 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-29 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-29 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-29 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-29 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-29 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-29 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-29 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-29 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-29 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-29 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-29 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-29 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-29 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-29 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-29 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-29 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-29 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-29 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-29 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-29 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-29 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-29 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-29 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-28 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-28 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-28 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-28 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-28 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-28 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-28 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-28 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-28 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-28 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-28 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-28 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-27 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-27 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-27 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-27 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-27 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-27 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-27 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-27 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-27 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-27 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-27 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-27 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-27 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-27 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-27 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-27 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-27 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-27 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-27 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-27 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-26 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-26 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-26 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-26 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-26 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-26 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-26 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-26 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-26 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-26 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-26 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-26 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-26 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-26 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-26 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-26 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-26 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-26 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-26 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-26 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-26 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-25 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-25 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-25 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-25 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-25 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-25 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-25 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-25 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-25 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-25 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-25 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-25 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-25 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-25 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-25 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-25 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-25 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-25 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-25 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-24 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-24 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-24 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-24 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-24 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-24 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-24 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-24 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-24 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-24 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-24 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-24 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-24 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-24 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-24 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-24 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-24 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-24 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-24 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-24 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-24 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-24 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-24 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-24 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-24 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-23 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-23 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-23 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-23 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-23 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-23 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-23 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-23 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-23 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-23 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-23 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-23 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-23 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-23 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-23 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-23 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-23 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-23 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-23 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-23 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-23 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-23 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-23 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-23 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-23 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-23 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-23 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-23 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-23 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-23 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-23 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-23 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 6e-23 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-23 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-23 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-23 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-23 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-23 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-23 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-23 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-23 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-23 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-23 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-23 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-23 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-23 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-22 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-22 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-22 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-22 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-22 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-22 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-22 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-22 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-22 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-22 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-22 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-22 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-22 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-22 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-22 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-22 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-22 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-22 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-22 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-22 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-22 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-22 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-22 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-22 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-21 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-21 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-21 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-21 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-21 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-21 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-21 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-21 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-21 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-21 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-21 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-21 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-21 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-21 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-21 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-20 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-20 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-20 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-20 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-20 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-20 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-20 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-20 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-20 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-20 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-20 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-20 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-20 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-20 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-20 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-20 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-20 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-20 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-20 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-20 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-20 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-19 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-19 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-19 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-19 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-19 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-19 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-19 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-19 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-19 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-19 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-19 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-19 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-19 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-19 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-19 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-19 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-19 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-19 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-19 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-19 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-19 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-19 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-19 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-19 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-19 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-19 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-19 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-19 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-19 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-19 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-19 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-19 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-19 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-19 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-19 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-19 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-19 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-19 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-19 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-19 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-19 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-19 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-19 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-18 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-18 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-18 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-18 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-18 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-18 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-18 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-18 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-18 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-18 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-18 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-18 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-18 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-18 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-18 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-18 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-18 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-18 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-18 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-18 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-18 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-18 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-18 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-18 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-18 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-18 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-18 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-18 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-18 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-18 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-18 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-18 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-18 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-18 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-18 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-18 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-18 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-18 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-18 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-18 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-18 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-18 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-18 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-18 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-18 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-18 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-18 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-18 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-18 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-18 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-18 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-18 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-18 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-18 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-18 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-18 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-18 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-18 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-18 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-18 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-18 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-18 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-18 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-18 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-18 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-18 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-17 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-17 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-17 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-17 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-17 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-17 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-17 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-17 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-17 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-17 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-17 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-17 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-17 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-17 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-17 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-17 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-17 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-17 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-17 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-17 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-17 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-17 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-16 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-16 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-16 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-16 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-16 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-16 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-16 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-16 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-16 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-16 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-16 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-16 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-16 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-16 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-16 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-16 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-15 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-14 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-14 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-14 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-14 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-13 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-13 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-13 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-12 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-12 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-10 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 9e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 4e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 6e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-06 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 475 bits (1225), Expect = e-162
Identities = 192/290 (66%), Positives = 236/290 (81%)
Query: 638 PGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLD 697
P L + ++ D ++I W +L++KE++GAGSFGTVHRAEWHGSDVAVK+L QDF
Sbjct: 16 PTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHA 75
Query: 698 DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMD 757
+++ EFLREVAIMKR+RHPN+VLFMGAVT+ P+LSIVTEYL RGSLYRL+H+ A E +D
Sbjct: 76 ERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLD 135
Query: 758 QRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817
+RRRL MA DVAKG+NYLHN NPPI+H +LKSPNLLVDK +TVKVCDFGLSR KA+TF+S
Sbjct: 136 ERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS 195
Query: 818 SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN 877
SKS AGTPEWMAPE LR EPSNEKSDVYSFGVILWEL T+QQPW L PAQVV AV F+
Sbjct: 196 SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC 255
Query: 878 RRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQ 927
+RL IP+N +P +A+++E CW ++P +RPSFA I++ L+ L+KS
Sbjct: 256 KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 424 bits (1092), Expect = e-143
Identities = 85/271 (31%), Positives = 148/271 (54%), Gaps = 11/271 (4%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
I + +L+ ++ G + + W G+D+ VKVL V+D+ + ++F E ++
Sbjct: 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 715 HPNVVLFMGAVTKRP--HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
HPNV+ +GA P H +++T ++P GSLY ++H ++DQ + ++ ALD+A+G+
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGM 124
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEF 832
+LH L P I L S ++++D++ T ++ + S P W+APE
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-----QSPGRMYAPAWVAPEA 179
Query: 833 LRGEPSN---EKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPV 889
L+ +P + +D++SF V+LWELVT + P+ L ++ VA + R IP SP
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239
Query: 890 LASLMESCWADDPAQRPSFANIVESLKKLLK 920
++ LM+ C +DPA+RP F IV L+K+
Sbjct: 240 VSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 418 bits (1077), Expect = e-140
Identities = 101/276 (36%), Positives = 149/276 (53%), Gaps = 17/276 (6%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLD--DQLKEFLREVAIMK 711
LEI + EL ++E +G G FG V+RA W G +VAVK D ++ +E +
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
++HPN++ G K P+L +V E+ G L R++ G+ + + A+ +A+G
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARG 117
Query: 772 INYLHNLNP-PILHWDLKSPNLLVDK--------NWTVKVCDFGLSRFKANTFISSKSVA 822
+NYLH+ PI+H DLKS N+L+ + N +K+ DFGL+R T + S A
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAA 175
Query: 823 GTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAI 882
G WMAPE +R ++ SDV+S+GV+LWEL+T + P+ G+ V VA L I
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235
Query: 883 PQNTSPVLASLMESCWADDPAQRPSFANIVESLKKL 918
P A LME CW DP RPSF NI++ L +
Sbjct: 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 410 bits (1056), Expect = e-137
Identities = 89/304 (29%), Positives = 149/304 (49%), Gaps = 21/304 (6%)
Query: 640 PRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQ 699
PR + +W +I +++L + E +G G FG V+ WHG +VA++++ ++ +DQ
Sbjct: 15 PRKASQTSIFLQEW-DIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQ 72
Query: 700 LKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQR 759
LK F REV ++ RH NVVLFMGA PHL+I+T +LY ++ ++D
Sbjct: 73 LKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVN 130
Query: 760 RRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK 819
+ ++A ++ KG+ YLH ILH DLKS N+ D N V + DFGL +
Sbjct: 131 KTRQIAQEIVKGMGYLHA--KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187
Query: 820 S-----VAGTPEWMAPEFLRG---------EPSNEKSDVYSFGVILWELVTMQQPWNGLG 865
G +APE +R P ++ SDV++ G I +EL + P+
Sbjct: 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247
Query: 866 PAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQL 925
++ + + ++ ++ CWA + +RP+F +++ L+KL K +L
Sbjct: 248 AEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307
Query: 926 IQMG 929
G
Sbjct: 308 SHPG 311
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 403 bits (1038), Expect = e-134
Identities = 100/278 (35%), Positives = 163/278 (58%), Gaps = 16/278 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
DW EI ++ V +R+G+GSFGTV++ +WHG DVAVK+L V QL+ F EV +++
Sbjct: 18 DW-EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 75
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
+ RH N++LFMG T P L+IVT++ SLY +H + ++ + +A A+G
Sbjct: 76 KTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARG 132
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK--SVAGTPEWMA 829
++YLH + I+H DLKS N+ + ++ TVK+ DFGL+ K+ S + ++G+ WMA
Sbjct: 133 MDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 830 PEFLRGEPSN---EKSDVYSFGVILWELVTMQQPWNGLGPA-QVVGAVAFQNRR---LAI 882
PE +R + SN +SDVY+FG++L+EL+T Q P++ + Q++ V + +
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV 250
Query: 883 PQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920
N + LM C +RPSF I+ +++L +
Sbjct: 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 401 bits (1032), Expect = e-133
Identities = 85/290 (29%), Positives = 132/290 (45%), Gaps = 19/290 (6%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
+L E +G G FG + + + + + F ++ + FL+EV +M+ +
Sbjct: 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE 65
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
HPNV+ F+G + K L+ +TEY+ G+L +I +R+ A D+A G+ Y
Sbjct: 66 HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAY 123
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF--------------KANTFISSKS 820
LH++N I+H DL S N LV +N V V DFGL+R K +
Sbjct: 124 LHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 821 VAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAF-QNRR 879
V G P WMAPE + G +EK DV+SFG++L E++ P + +
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241
Query: 880 LAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQMG 929
P N P + C DP +RPSF + L+ L A + +G
Sbjct: 242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 399 bits (1027), Expect = e-133
Identities = 92/283 (32%), Positives = 151/283 (53%), Gaps = 23/283 (8%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD-----QLKEFL 704
++ +E+ ++++G G FG VH+ S VA+K L + D + + +EF
Sbjct: 12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRM 764
REV IM + HPN+V G + P +V E++P G LY + + +LR+
Sbjct: 72 REVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK--AHPIKWSVKLRL 127
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-----NWTVKVCDFGLSRFKANTFISSK 819
LD+A GI Y+ N NPPI+H DL+SPN+ + KV DFGLS+ ++
Sbjct: 128 MLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---VS 184
Query: 820 SVAGTPEWMAPEFLRGE--PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQV--VGAVAF 875
+ G +WMAPE + E EK+D YSF +IL+ ++T + P++ ++ + +
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244
Query: 876 QNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKL 918
+ R IP++ P L +++E CW+ DP +RP F+ IV+ L +L
Sbjct: 245 EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 399 bits (1028), Expect = e-133
Identities = 95/270 (35%), Positives = 148/270 (54%), Gaps = 12/270 (4%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
I + E+ V+E VG G+FG V +A+W DVA+K + + + K F+ E+ + RV
Sbjct: 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES----ERKAFIVELRQLSRVN 59
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
HPN+V GA + +V EY GSLY ++H + L ++G+ Y
Sbjct: 60 HPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 775 LHNLNP-PILHWDLKSPNLLVDKNWTV-KVCDFGLSRFKANTFISSKSVAGTPEWMAPEF 832
LH++ P ++H DLK PNLL+ TV K+CDFG + ++K G+ WMAPE
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAPEV 174
Query: 833 LRGEPSNEKSDVYSFGVILWELVTMQQPWNGL-GPAQVVGAVAFQNRRLAIPQNTSPVLA 891
G +EK DV+S+G+ILWE++T ++P++ + GPA + R + +N +
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE 234
Query: 892 SLMESCWADDPAQRPSFANIVESLKKLLKS 921
SLM CW+ DP+QRPS IV+ + L++
Sbjct: 235 SLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 349 bits (898), Expect = e-113
Identities = 85/309 (27%), Positives = 133/309 (43%), Gaps = 51/309 (16%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAI--MKR 712
++ + +++G G +G V +W G VAVKV + + RE I
Sbjct: 33 RTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEE-----ASWFRETEIYQTVL 87
Query: 713 VRHPNVVLFMGAVTK----RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDV 768
+RH N++ F+ A K L ++T+Y GSLY + +D + L++A
Sbjct: 88 MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSS 143
Query: 769 AKGINYLHNL------NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT----FISS 818
G+ +LH P I H DLKS N+LV KN T + D GL+ + I
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 819 KSVAGTPEWMAPEFLRG------EPSNEKSDVYSFGVILWELVT----------MQQPWN 862
+ GT +M PE L S +D+YSFG+ILWE+ Q P++
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263
Query: 863 GLGPAQ-----VVGAVAFQNRRLAIPQNTS-----PVLASLMESCWADDPAQRPSFANIV 912
L P+ + V + R + P S + LM CWA +PA R + +
Sbjct: 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
Query: 913 ESLKKLLKS 921
++L K+ +S
Sbjct: 324 KTLAKMSES 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 343 bits (881), Expect = e-111
Identities = 83/301 (27%), Positives = 134/301 (44%), Gaps = 51/301 (16%)
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAI--MKRVRHPN 717
++ + E VG G +G V R W G +VAVK+ + +D K + RE + +RH N
Sbjct: 9 DITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHEN 63
Query: 718 VVLFMGAVTK----RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
++ F+ + L ++T Y GSLY + +D LR+ L +A G+
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLA 119
Query: 774 YLHNL------NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF----ISSKSVAG 823
+LH P I H DLKS N+LV KN + D GL+ + + + + G
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179
Query: 824 TPEWMAPEFLRGEP------SNEKSDVYSFGVILWELVT----------MQQPWNGLGP- 866
T +MAPE L S ++ D+++FG++LWE+ + P+ + P
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239
Query: 867 ----AQVVGAVAFQNRRLAIPQN-----TSPVLASLMESCWADDPAQRPSFANIVESLKK 917
+ V +R IP T LA LM+ CW +P+ R + I ++L K
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
Query: 918 L 918
+
Sbjct: 300 I 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 332 bits (852), Expect = e-106
Identities = 84/309 (27%), Positives = 138/309 (44%), Gaps = 51/309 (16%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAI--MKR 712
+ ++E +G G FG V R +W G +VAVK+ + ++ + + RE I
Sbjct: 38 RTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVM 92
Query: 713 VRHPNVVLFMGAVTK----RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDV 768
+RH N++ F+ A K L +V++Y GSL+ ++R + +++AL
Sbjct: 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALST 148
Query: 769 AKGINYLH------NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT----FISS 818
A G+ +LH P I H DLKS N+LV KN T + D GL+ + I+
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208
Query: 819 KSVAGTPEWMAPEFLRGE------PSNEKSDVYSFGVILWELVT----------MQQPWN 862
GT +MAPE L S +++D+Y+ G++ WE+ Q P+
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268
Query: 863 GLGPA-----QVVGAVAFQNRRLAIPQNTS-----PVLASLMESCWADDPAQRPSFANIV 912
L P+ ++ V Q R IP V+A +M CW + A R + I
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328
Query: 913 ESLKKLLKS 921
++L +L +
Sbjct: 329 KTLSQLSQQ 337
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 326 bits (837), Expect = e-104
Identities = 75/326 (23%), Positives = 129/326 (39%), Gaps = 47/326 (14%)
Query: 636 VGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDF 695
+G + + L + L L + E G FG V +A+ VAVK+ +QD
Sbjct: 1 MGHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD- 59
Query: 696 LDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH----LSIVTEYLPRGSLYRLIHRPA 751
Q + EV + ++H N++ F+GA + L ++T + +GSL +
Sbjct: 60 --KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV 117
Query: 752 AGEMMDQRRRLRMALDVAKGINYLHN--------LNPPILHWDLKSPNLLVDKNWTVKVC 803
+ +A +A+G+ YLH P I H D+KS N+L+ N T +
Sbjct: 118 ----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 804 DFGLSRFK--ANTFISSKSVAGTPEWMAPEFLRGEP-----SNEKSDVYSFGVILWELVT 856
DFGL+ + + GT +MAPE L G + + D+Y+ G++LWEL +
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 857 MQQPWNGLGPA----------------QVVGAVAFQNRRLAIPQNTSP-----VLASLME 895
+G + V + +R + +L +E
Sbjct: 234 RCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE 293
Query: 896 SCWADDPAQRPSFANIVESLKKLLKS 921
CW D R S + E + ++ +
Sbjct: 294 ECWDHDAEARLSAGCVGERITQMQRL 319
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 316 bits (810), Expect = e-100
Identities = 78/325 (24%), Positives = 124/325 (38%), Gaps = 63/325 (19%)
Query: 650 AMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAI 709
A + + D L + E +G G +G V++ VAVKV + + + F+ E I
Sbjct: 5 ASEP-SLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR-----QNFINEKNI 58
Query: 710 MK--RVRHPNVVLFMGAVTK-----RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL 762
+ + H N+ F+ + R +V EY P GSL + + D
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114
Query: 763 RMALDVAKGINYLHN-------LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815
R+A V +G+ YLH P I H DL S N+LV + T + DFGLS
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 816 --------ISSKSVAGTPEWMAPEFLRG-------EPSNEKSDVYSFGVILWELVT---- 856
++ S GT +MAPE L G E + ++ D+Y+ G+I WE+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 857 ---------MQQPWNGLGP-----AQVVGAVAFQNRRLAIPQNTSP------VLASLMES 896
Q + + V+ + +R P+ L +E
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 897 CWADDPAQRPSFANIVESLKKLLKS 921
CW D R + E + +L+
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMI 319
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 3e-71
Identities = 91/301 (30%), Positives = 142/301 (47%), Gaps = 20/301 (6%)
Query: 637 GPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLT 691
G PR + D I + L + + +G G FG+V D VAVK +
Sbjct: 13 GLVPRGSEELQNKLEDV-VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMK 71
Query: 692 VQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR-----PHLSIVTEYLPRGSL--Y 744
+ + +++EFL E A MK HPNV+ +G + P ++ ++ G L Y
Sbjct: 72 LDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTY 131
Query: 745 RLIHRPAAGEM-MDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVC 803
L R G + + L+ +D+A G+ YL N N LH DL + N ++ + TV V
Sbjct: 132 LLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDMTVCVA 189
Query: 804 DFGLSRFKANTFISSKSVAGT-P-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQP 860
DFGLS+ + + P +W+A E L KSDV++FGV +WE+ T P
Sbjct: 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
Query: 861 WNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920
+ G+ ++ + RL P++ L +M SCW DP RP+F+ + L+KLL+
Sbjct: 250 YPGVQNHEMYDYLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308
Query: 921 S 921
S
Sbjct: 309 S 309
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 1e-70
Identities = 87/300 (29%), Positives = 141/300 (47%), Gaps = 20/300 (6%)
Query: 643 LNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFLD 697
++ E ++ + I + + +G G FG+V A+ D VAVK+L
Sbjct: 7 ISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS 66
Query: 698 DQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------PHLSIVTEYLPRGSL--YRLIHR 749
++EFLRE A MK HP+V +G + P ++ ++ G L + L R
Sbjct: 67 SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR 126
Query: 750 PAA-GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
+ + +R +D+A G+ YL + N +H DL + N ++ ++ TV V DFGLS
Sbjct: 127 IGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLS 184
Query: 809 RFKANTFISSKSVAGT-P-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLG 865
R + + A P +W+A E L SDV++FGV +WE++T Q P+ G+
Sbjct: 185 RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244
Query: 866 PAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQL 925
A++ + RL P + LM CW+ DP QRPSF + L+ +L + L
Sbjct: 245 NAEIYNYLI-GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL 303
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 1e-69
Identities = 87/277 (31%), Positives = 139/277 (50%), Gaps = 14/277 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGS--DVAVKVLTVQDFLDDQLKEFLREVAI 709
W ++ ++L + E++G G+FG V VAVK + D +FL+E I
Sbjct: 108 KW-VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARI 165
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
+K+ HPN+V +G T++ + IV E + G + G + + L+M D A
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAA 223
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT-P-EW 827
G+ YL + +H DL + N LV + +K+ DFG+SR +A+ ++ P +W
Sbjct: 224 AGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW 281
Query: 828 MAPE-FLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQN 885
APE G S+ +SDV+SFG++LWE ++ P+ L Q V + RL P+
Sbjct: 282 TAPEALNYGRYSS-ESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPEL 339
Query: 886 TSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
+ LME CWA +P QRPSF+ I + L+ + K
Sbjct: 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 1e-69
Identities = 93/304 (30%), Positives = 150/304 (49%), Gaps = 21/304 (6%)
Query: 640 PRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTV 692
P Y + D E++ +++ + +G GSFG V+ G VA+K +
Sbjct: 6 PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN- 64
Query: 693 QDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRP 750
+ + EFL E ++MK +VV +G V++ ++ E + RG L Y RP
Sbjct: 65 EAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRP 124
Query: 751 AAGEM-----MDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDF 805
A + ++MA ++A G+ YL+ +H DL + N +V +++TVK+ DF
Sbjct: 125 AMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDF 182
Query: 806 GLSRFKANTFISSKSVAGT-P-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWN 862
G++R T K G P WM+PE L+ SDV+SFGV+LWE+ T+ +QP+
Sbjct: 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242
Query: 863 GLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
GL QV+ V + L P N +L LM CW +P RPSF I+ S+K+ ++
Sbjct: 243 GLSNEQVLRFVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301
Query: 923 AQLI 926
+ +
Sbjct: 302 FREV 305
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 2e-69
Identities = 88/286 (30%), Positives = 149/286 (52%), Gaps = 15/286 (5%)
Query: 643 LNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKE 702
+ + ++ EL + + +G G FG V ++ G+ VAVK + D +
Sbjct: 5 VAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----DATAQA 60
Query: 703 FLREVAIMKRVRHPNVVLFMGAVTK-RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRR 761
FL E ++M ++RH N+V +G + + + L IVTEY+ +GSL + R ++
Sbjct: 61 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCL 119
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSV 821
L+ +LDV + + YL N +H DL + N+LV ++ KV DFGL++ ++T + K
Sbjct: 120 LKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-- 175
Query: 822 AGTP-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRR 879
P +W APE LR + + KSDV+SFG++LWE+ + + P+ + VV V + +
Sbjct: 176 --LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYK 232
Query: 880 LAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQL 925
+ P P + +M++CW D A RPSF + E L+ + L
Sbjct: 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHELHL 278
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 3e-69
Identities = 93/322 (28%), Positives = 148/322 (45%), Gaps = 27/322 (8%)
Query: 631 QGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD------ 684
+GK G N + I ++ +K +G G+FG V AE H
Sbjct: 13 EGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKM 72
Query: 685 -VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL 743
VAVK +++ + ++F RE ++ ++H ++V F G T+ L +V EY+ G L
Sbjct: 73 LVAVK--ALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL 130
Query: 744 --YRLIHRPAAGEMMDQRRR----------LRMALDVAKGINYLHNLNPPILHWDLKSPN 791
+ H P A + L +A VA G+ YL L+ +H DL + N
Sbjct: 131 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRN 188
Query: 792 LLVDKNWTVKVCDFGLSRFKANT-FISSKSVAGTP-EWMAPEFLRGEPSNEKSDVYSFGV 849
LV + VK+ DFG+SR +T + P WM PE + +SDV+SFGV
Sbjct: 189 CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGV 248
Query: 850 ILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSF 908
+LWE+ T +QPW L + + + Q R L P+ P + ++M CW +P QR S
Sbjct: 249 VLWEIFTYGKQPWYQLSNTEAIDCIT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSI 307
Query: 909 ANIVESLKKLLKSPAQLIQMGG 930
++ L+ L ++P + + G
Sbjct: 308 KDVHARLQALAQAPPVYLDVLG 329
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 7e-69
Identities = 100/366 (27%), Positives = 152/366 (41%), Gaps = 23/366 (6%)
Query: 574 AAGAPIQEYSRLVEENVAIEAAYKEEIVVSESSVIIKQPNATLPSQLDKEDESKLEKQGK 633
+ P+ + A AA S I S K L QG
Sbjct: 2 SPIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGA 61
Query: 634 FPVGPGPRYLNIEPSLAMD--WLEISWDELHVKERVGAGSFGTVHRAEWHGSD-----VA 686
V LN E A+ + S +H E +G G FG V+ +D A
Sbjct: 62 NTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 121
Query: 687 VKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK-RPHLSIVTEYLPRGSL-- 743
VK L + ++ +FL E IMK HPNV+ +G + +V Y+ G L
Sbjct: 122 VKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 180
Query: 744 YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVC 803
+ + + L VAKG+ +L + +H DL + N ++D+ +TVKV
Sbjct: 181 FIRNETHN----PTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVA 234
Query: 804 DFGLSRFKANT---FISSKSVAGTP-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-Q 858
DFGL+R + + +K+ A P +WMA E L+ + KSDV+SFGV+LWEL+T
Sbjct: 235 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 294
Query: 859 QPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKL 918
P+ + + + Q RRL P+ L +M CW RPSF+ +V + +
Sbjct: 295 PPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353
Query: 919 LKSPAQ 924
+
Sbjct: 354 FSTFIG 359
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 8e-69
Identities = 84/287 (29%), Positives = 137/287 (47%), Gaps = 14/287 (4%)
Query: 648 SLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFLDDQLKE 702
S+ I+ +++ + +G G FG V+ + VAVK +D D ++
Sbjct: 1 SMGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEK 59
Query: 703 FLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL 762
F+ E IMK + HP++V +G + + P I+ E P G L + R + +
Sbjct: 60 FMSEAVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERN--KNSLKVLTLV 116
Query: 763 RMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
+L + K + YL ++N +H D+ N+LV VK+ DFGLSR+ + SV
Sbjct: 117 LYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT 174
Query: 823 GTP-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRL 880
P +WM+PE + SDV+ F V +WE+++ +QP+ L V+G + + RL
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRL 233
Query: 881 AIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQ 927
P PVL +LM CW DP+ RP F +V SL + + +
Sbjct: 234 PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAM 280
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 8e-69
Identities = 77/293 (26%), Positives = 138/293 (47%), Gaps = 17/293 (5%)
Query: 647 PSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD------VAVKVLTVQDFLDDQL 700
P+ A+ + E + +G+G+FGTV++ W VA+K L +
Sbjct: 4 PNQAL-LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKAN 61
Query: 701 KEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRR 760
KE L E +M V +P+V +G + ++T+ +P G L + + + +
Sbjct: 62 KEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH--KDNIGSQY 118
Query: 761 RLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSK 819
L + +AKG+NYL + ++H DL + N+LV VK+ DFGL++ A
Sbjct: 119 LLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 820 SVAGTP-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQN 877
P +WMA E + +SDV+S+GV +WEL+T +P++G+ +++ + +
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KG 235
Query: 878 RRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQMGG 930
RL P + + +M CW D RP F ++ K+ + P + + + G
Sbjct: 236 ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 288
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 2e-68
Identities = 85/285 (29%), Positives = 132/285 (46%), Gaps = 21/285 (7%)
Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFLDDQLKEFLREV 707
+ S +H E +G G FG V+ +D AVK L + ++ +FL E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEG 77
Query: 708 AIMKRVRHPNVVLFMGAVTK-RPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRM 764
IMK HPNV+ +G + +V Y+ G L + + +
Sbjct: 78 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGF 133
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT---FISSKSV 821
L VAKG+ YL + +H DL + N ++D+ +TVKV DFGL+R + + +K+
Sbjct: 134 GLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 191
Query: 822 AGTP-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRR 879
A P +WMA E L+ + KSDV+SFGV+LWEL+T P+ + + + Q RR
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRR 250
Query: 880 LAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQ 924
L P+ L +M CW RPSF+ +V + + +
Sbjct: 251 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 3e-68
Identities = 90/291 (30%), Positives = 136/291 (46%), Gaps = 28/291 (9%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQLKEFLREV 707
I ++ +K +G G+FG V AE + VAVK ++D K+F RE
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK--ALKDPTLAARKDFQREA 68
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRR---- 761
++ ++H ++V F G L +V EY+ G L + H P A ++D + R
Sbjct: 69 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 762 -------LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814
L +A +A G+ YL + + +H DL + N LV N VK+ DFG+SR +T
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 186
Query: 815 FISSKSVAGT-P-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVG 871
P WM PE + +SDV+SFGVILWE+ T +QPW L +V+
Sbjct: 187 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 246
Query: 872 AVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
+ Q R L P+ + +M CW +P QR + I + L L K+
Sbjct: 247 CIT-QGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKAT 296
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 4e-68
Identities = 86/306 (28%), Positives = 144/306 (47%), Gaps = 31/306 (10%)
Query: 645 IEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD----VAVKVLTVQDFLDDQL 700
P + + W+++ ++ +G G+FG V +A A+K + + D
Sbjct: 12 NNPDPTIYP-VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDH 69
Query: 701 KEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMD 757
++F E+ ++ ++ HPN++ +GA R +L + EY P G+L + R +
Sbjct: 70 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 129
Query: 758 QRRR-----------LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806
L A DVA+G++YL +H DL + N+LV +N+ K+ DFG
Sbjct: 130 AIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFG 187
Query: 807 LSRFKANTFISSKS---VAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWN 862
LSR + + V WMA E L SDV+S+GV+LWE+V++ P+
Sbjct: 188 LSRGQEVYVKKTMGRLPV----RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243
Query: 863 GLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
G+ A++ + Q RL P N + LM CW + P +RPSFA I+ SL ++L+
Sbjct: 244 GMTCAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302
Query: 923 AQLIQM 928
+
Sbjct: 303 KTYVNT 308
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 2e-67
Identities = 87/284 (30%), Positives = 148/284 (52%), Gaps = 15/284 (5%)
Query: 645 IEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFL 704
+ ++ EL + + +G G FG V ++ G+ VAVK + D + FL
Sbjct: 179 AQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN----DATAQAFL 234
Query: 705 REVAIMKRVRHPNVVLFMGAVTK-RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLR 763
E ++M ++RH N+V +G + + + L IVTEY+ +GSL + R ++ L+
Sbjct: 235 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLK 293
Query: 764 MALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAG 823
+LDV + + YL N +H DL + N+LV ++ KV DFGL++ ++T + K
Sbjct: 294 FSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK---- 347
Query: 824 TP-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLA 881
P +W APE LR + + KSDV+SFG++LWE+ + + P+ + VV V + ++
Sbjct: 348 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMD 406
Query: 882 IPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQL 925
P P + +M++CW D A RP+F + E L+ + L
Sbjct: 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHELHL 450
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 2e-67
Identities = 79/273 (28%), Positives = 139/273 (50%), Gaps = 12/273 (4%)
Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMK 711
W I EL + +G+G FG VH W VA+K + + + ++ +F+ E +M
Sbjct: 3 W-VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEE--DFIEEAEVMM 58
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
++ HP +V G ++ + +VTE++ G L + + L M LDV +G
Sbjct: 59 KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEG 116
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP-EWMAP 830
+ YL ++H DL + N LV +N +KV DFG++RF + +S + P +W +P
Sbjct: 117 MAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 174
Query: 831 EFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPV 889
E + KSDV+SFGV++WE+ + + P+ ++VV ++ RL P+ S
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTH 233
Query: 890 LASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
+ +M CW + P RP+F+ ++ L ++ +S
Sbjct: 234 VYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 4e-67
Identities = 83/283 (29%), Positives = 136/283 (48%), Gaps = 17/283 (6%)
Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFLDDQLKEFLREV 707
+ H +G G FG V+ E+ A+K L+ + Q++ FLRE
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS-RITEMQQVEAFLREG 73
Query: 708 AIMKRVRHPNVVLFMGAVTKR-PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
+M+ + HPNV+ +G + ++ Y+ G L + I P + + L
Sbjct: 74 LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGL 131
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR--FKANTFISSKSVAGT 824
VA+G+ YL +H DL + N ++D+++TVKV DFGL+R + +
Sbjct: 132 QVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189
Query: 825 -P-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLA 881
P +W A E L+ KSDV+SFGV+LWEL+T P+ + P + +A Q RRL
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLP 248
Query: 882 IPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQ 924
P+ L +M+ CW DPA RP+F +V +++++ +
Sbjct: 249 QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 4e-67
Identities = 87/274 (31%), Positives = 143/274 (52%), Gaps = 12/274 (4%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIM 710
+W E+ + L + ER+GAG FG V ++G VAVK L Q + FL E +M
Sbjct: 7 EW-EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPD--AFLAEANLM 62
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
K+++H +V VT+ P I+TEY+ GSL + + +G + + L MA +A+
Sbjct: 63 KQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAE 120
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP-EWMA 829
G+ ++ N +H DL++ N+LV + K+ DFGL+R + +++ A P +W A
Sbjct: 121 GMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178
Query: 830 PEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888
PE + KSDV+SFG++L E+VT + P+ G+ +V+ + + R+ P N
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPE 237
Query: 889 VLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
L LM CW + P RP+F + L+ +
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 6e-67
Identities = 82/291 (28%), Positives = 139/291 (47%), Gaps = 12/291 (4%)
Query: 637 GPGPRYLN-IEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQD 694
GP L EI +L + +G G FG V +W G DVA+K++ +
Sbjct: 1 GPLGSKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EG 59
Query: 695 FLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGE 754
+ + EF+ E +M + H +V G TK+ + I+TEY+ G L +
Sbjct: 60 SMSED--EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RH 115
Query: 755 MMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814
++ L M DV + + YL + LH DL + N LV+ VKV DFGLSR+ +
Sbjct: 116 RFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173
Query: 815 FISSKSVAGTP-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGA 872
+S + P W PE L + KSD+++FGV++WE+ ++ + P+ ++
Sbjct: 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233
Query: 873 VAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPA 923
+A Q RL P S + ++M SCW + +RP+F ++ ++ ++ +
Sbjct: 234 IA-QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 283
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 1e-66
Identities = 76/305 (24%), Positives = 130/305 (42%), Gaps = 22/305 (7%)
Query: 638 PGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVL 690
P + S++ E+ + + +G G+FG V+ + G VAVK L
Sbjct: 10 PNYCFAGKTSSISDLK-EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL 68
Query: 691 TVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIH 748
+ + +FL E I+ + H N+V +G + I+ E + G L +
Sbjct: 69 P-EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET 127
Query: 749 RPAAGEM--MDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---NWTVKVC 803
RP + + L +A D+A G YL + +H D+ + N L+ K+
Sbjct: 128 RPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIG 185
Query: 804 DFGLSRFKANT-FISSKSVAGTP-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQP 860
DFG++R + A P +WM PE K+D +SFGV+LWE+ ++ P
Sbjct: 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
Query: 861 WNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920
+ +V+ V R+ P+N + +M CW P RP+FA I+E ++ +
Sbjct: 246 YPSKSNQEVLEFVT-SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304
Query: 921 SPAQL 925
P +
Sbjct: 305 DPDVI 309
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 1e-66
Identities = 90/332 (27%), Positives = 140/332 (42%), Gaps = 53/332 (15%)
Query: 638 PGPRYLNIEPSL---AMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAV 687
P P Y + L + E + + +G G+FG V +A G VAV
Sbjct: 24 PNPMYQRMPLLLNPKLLSL-EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAV 82
Query: 688 KVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YR 745
K+L ++ D +F RE A+M +PN+V +G + ++ EY+ G L +
Sbjct: 83 KMLK-EEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL 141
Query: 746 LIHRPAAGEMMDQRRR-------------------LRMALDVAKGINYLHNLNPPILHWD 786
P + L +A VA G+ YL +H D
Sbjct: 142 RSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRD 199
Query: 787 LKSPNLLVDKNWTVKVCDFGLSR---------FKANTFISSKSVAGTPEWMAPEFLRGEP 837
L + N LV +N VK+ DFGLSR N I + WM PE +
Sbjct: 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR-------WMPPESIFYNR 252
Query: 838 SNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMES 896
+SDV+++GV+LWE+ + QP+ G+ +V+ V LA P+N L +LM
Sbjct: 253 YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRL 311
Query: 897 CWADDPAQRPSFANIVESLKKLLKSPAQLIQM 928
CW+ PA RPSF +I L+++ + + +
Sbjct: 312 CWSKLPADRPSFCSIHRILQRMCERAEGTVGV 343
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 1e-66
Identities = 91/281 (32%), Positives = 152/281 (54%), Gaps = 12/281 (4%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGS--DVAVKVLTVQDFLDDQLKEFLREVAI 709
W E+ ++ +K ++G G +G V+ W VAVK L +D ++ + EFL+E A+
Sbjct: 7 KW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVE--EFLKEAAV 62
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
MK ++HPN+V +G T+ P I+TE++ G+L + R + + L MA ++
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQIS 121
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP-EWM 828
+ YL N +H DL + N LV +N VKV DFGLSR ++ + A P +W
Sbjct: 122 SAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 179
Query: 829 APEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTS 887
APE L + KSDV++FGV+LWE+ T P+ G+ +QV + ++ R+ P+
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 238
Query: 888 PVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQM 928
+ LM +CW +P+ RPSFA I ++ + + + + ++
Sbjct: 239 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 279
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 1e-66
Identities = 85/271 (31%), Positives = 148/271 (54%), Gaps = 12/271 (4%)
Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMK 711
E+ +E+ + + +G+G FG V +W G DVAVK++ + + + EF +E M
Sbjct: 3 M-ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSED--EFFQEAQTMM 58
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
++ HP +V F G +K + IVTEY+ G L + G+ ++ + L M DV +G
Sbjct: 59 KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEG 116
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP-EWMAP 830
+ +L + +H DL + N LVD++ VKV DFG++R+ + S P +W AP
Sbjct: 117 MAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAP 174
Query: 831 EFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPV 889
E + KSDV++FG+++WE+ ++ + P++ ++VV V+ Q RL P S
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDT 233
Query: 890 LASLMESCWADDPAQRPSFANIVESLKKLLK 920
+ +M SCW + P +RP+F ++ S++ L +
Sbjct: 234 IYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 3e-66
Identities = 90/314 (28%), Positives = 147/314 (46%), Gaps = 37/314 (11%)
Query: 639 GPRYLNIEPS--LAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKV 689
GP L+++ L E L + + +G G FG V +A VAVK+
Sbjct: 1 GPLSLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM 60
Query: 690 LTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLI 747
L ++ +L++ L E ++K+V HP+V+ GA ++ L ++ EY GSL +
Sbjct: 61 LK-ENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRE 119
Query: 748 HRPAAGEMMDQRRR-------------------LRMALDVAKGINYLHNLNPPILHWDLK 788
R + + A +++G+ YL + ++H DL
Sbjct: 120 SRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLA 177
Query: 789 SPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT-P-EWMAPEFLRGEPSNEKSDVYS 846
+ N+LV + +K+ DFGLSR K G P +WMA E L +SDV+S
Sbjct: 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWS 237
Query: 847 FGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQR 905
FGV+LWE+VT+ P+ G+ P ++ + R+ P N S + LM CW +P +R
Sbjct: 238 FGVLLWEIVTLGGNPYPGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296
Query: 906 PSFANIVESLKKLL 919
P FA+I + L+K++
Sbjct: 297 PVFADISKDLEKMM 310
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 3e-66
Identities = 76/343 (22%), Positives = 138/343 (40%), Gaps = 22/343 (6%)
Query: 600 IVVSESSVIIKQPNATLPSQLDKEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWD 659
+ + ++ + + + + P + S++ E+
Sbjct: 13 DIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLK-EVPRK 71
Query: 660 ELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQLKEFLREVAIMKR 712
+ + +G G+FG V+ + G VAVK L + + +FL E I+ +
Sbjct: 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP-EVCSEQDELDFLMEALIISK 130
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGE--MMDQRRRLRMALDV 768
H N+V +G + I+ E + G L + RP + + L +A D+
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDK---NWTVKVCDFGLSRFKANT-FISSKSVAGT 824
A G YL + +H D+ + N L+ K+ DFG++R + A
Sbjct: 191 ACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML 248
Query: 825 P-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAI 882
P +WM PE K+D +SFGV+LWE+ ++ P+ +V+ V R+
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SGGRMDP 307
Query: 883 PQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQL 925
P+N + +M CW P RP+FA I+E ++ + P +
Sbjct: 308 PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 350
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 4e-66
Identities = 92/303 (30%), Positives = 156/303 (51%), Gaps = 11/303 (3%)
Query: 633 KFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGS--DVAVKVL 690
+P + S D E+ ++ +K ++G G +G V+ W VAVK L
Sbjct: 194 HYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL 253
Query: 691 TVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRP 750
+D ++ + EFL+E A+MK ++HPN+V +G T+ P I+TE++ G+L + R
Sbjct: 254 K-EDTMEVE--EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RE 309
Query: 751 AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810
+ + L MA ++ + YL N +H +L + N LV +N VKV DFGLSR
Sbjct: 310 CNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRL 367
Query: 811 -KANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQ 868
+T+ + +W APE L + KSDV++FGV+LWE+ T P+ G+ +Q
Sbjct: 368 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 427
Query: 869 VVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQM 928
V + ++ R+ P+ + LM +CW +P+ RPSFA I ++ + + + + ++
Sbjct: 428 VYELLE-KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 486
Query: 929 GGE 931
E
Sbjct: 487 EKE 489
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 5e-66
Identities = 80/288 (27%), Positives = 134/288 (46%), Gaps = 20/288 (6%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD------VAVKVLTVQDFLDDQLKEFLREVA 708
EL + +G+G FGTVH+ W V +KV+ + +
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE-DKSGRQSFQAVTDHML 67
Query: 709 IMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRMAL 766
+ + H ++V +G L +VT+YLP GSL + HR A + + L +
Sbjct: 68 AIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGA----LGPQLLLNWGV 122
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTP 825
+AKG+ YL ++H +L + N+L+ V+V DFG++ + S A TP
Sbjct: 123 QIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 826 -EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIP 883
+WMA E + +SDV+S+GV +WEL+T +P+ GL A+V + + RLA P
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQP 239
Query: 884 QNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQMGGE 931
Q + + +M CW D RP+F + ++ + P + + + E
Sbjct: 240 QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRE 287
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 5e-66
Identities = 83/280 (29%), Positives = 138/280 (49%), Gaps = 19/280 (6%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFLDDQLKEFLRE 706
D+ EI + + + +G G FG VH+ + + VA+K D ++FL+E
Sbjct: 9 DY-EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQE 66
Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRM 764
M++ HP++V +G +T+ P I+ E G L + + + + +D +
Sbjct: 67 ALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYS----LDLASLILY 121
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
A ++ + YL + +H D+ + N+LV N VK+ DFGLSR+ ++ S
Sbjct: 122 AYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 179
Query: 825 P-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAI 882
P +WMAPE + SDV+ FGV +WE++ +P+ G+ V+G + RL +
Sbjct: 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPM 238
Query: 883 PQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
P N P L SLM CWA DP++RP F + L +L+
Sbjct: 239 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 6e-66
Identities = 94/329 (28%), Positives = 154/329 (46%), Gaps = 31/329 (9%)
Query: 622 KEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWH 681
D + + G E W E+ D L + + +G G+FG V AE
Sbjct: 33 HHDYDIPTTENLYFQGMLAGVSEYELPEDPRW-ELPRDRLVLGKPLGEGAFGQVVLAEAI 91
Query: 682 G---------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHL 731
G + VAVK+L D + L + + E+ +MK + +H N++ +GA T+ L
Sbjct: 92 GLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 150
Query: 732 SIVTEYLPRGSL--YRLIHRPAAGEMMDQRRR-----------LRMALDVAKGINYLHNL 778
++ EY +G+L Y RP E + A VA+G+ YL +
Sbjct: 151 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK 210
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT-P-EWMAPEFLRGE 836
+H DL + N+LV ++ +K+ DFGL+R + K+ G P +WMAPE L
Sbjct: 211 K--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 268
Query: 837 PSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895
+SDV+SFGV+LWE+ T+ P+ G+ ++ + + R+ P N + L +M
Sbjct: 269 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK-EGHRMDKPSNCTNELYMMMR 327
Query: 896 SCWADDPAQRPSFANIVESLKKLLKSPAQ 924
CW P+QRP+F +VE L +++ +
Sbjct: 328 DCWHAVPSQRPTFKQLVEDLDRIVALTSN 356
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 7e-66
Identities = 93/297 (31%), Positives = 148/297 (49%), Gaps = 11/297 (3%)
Query: 638 PGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFL 696
P LA D EI + L ++ ++G G FG V W+G+ VA+K L +
Sbjct: 163 VCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTM 221
Query: 697 DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMM 756
+ FL+E +MK++RH +V V++ P IVTEY+ +GSL + + G+ +
Sbjct: 222 SPE--AFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFL-KGETGKYL 277
Query: 757 DQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816
+ + MA +A G+ Y+ +N +H DL++ N+LV +N KV DFGL+R +
Sbjct: 278 RLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335
Query: 817 SSKSVAGTP-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVA 874
+++ A P +W APE KSDV+SFG++L EL T + P+ G+ +V+ V
Sbjct: 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
Query: 875 FQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQMGGE 931
+ R+ P L LM CW +P +RP+F + L+ S Q G
Sbjct: 396 -RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 451
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 9e-66
Identities = 75/267 (28%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 664 KERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF 721
+G GSF TV++ +VA L + + + F E ++K ++HPN+V F
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 722 MGA----VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
+ V + + +VTE + G+L + R M + + KG+ +LH
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHT 147
Query: 778 LNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGE 836
PPI+H DLK N+ + +VK+ D GL+ K +F +K+V GTPE+MAPE E
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMYE-E 204
Query: 837 PSNEKSDVYSFGVILWELVTMQQPWNGL-GPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895
+E DVY+FG+ + E+ T + P++ AQ+ V + + + P + ++E
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 264
Query: 896 SCWADDPAQRPSFANIVESLKKLLKSP 922
C + +R S K LL
Sbjct: 265 GCIRQNKDERYSI-------KDLLNHA 284
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-65
Identities = 93/299 (31%), Positives = 148/299 (49%), Gaps = 31/299 (10%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKE 702
W E D+L + + +G G+FG V AE G D VAVK+L D + L +
Sbjct: 29 KW-EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSD 86
Query: 703 FLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQR 759
+ E+ +MK + +H N++ +GA T+ L ++ EY +G+L Y RP E
Sbjct: 87 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 760 RR-----------LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
R + +A+G+ YL + +H DL + N+LV +N +K+ DFGL+
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 809 RFKANTFISSKSVAGT-P-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLG 865
R N K+ G P +WMAPE L +SDV+SFGV++WE+ T+ P+ G+
Sbjct: 205 RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264
Query: 866 PAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQ 924
++ + + R+ P N + L +M CW P+QRP+F +VE L ++L
Sbjct: 265 VEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 2e-65
Identities = 77/295 (26%), Positives = 139/295 (47%), Gaps = 17/295 (5%)
Query: 646 EPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD------VAVKVLTVQDFLDDQ 699
P+ A+ + E + +G+G+FGTV++ W VA+K L +
Sbjct: 3 APNQAL-LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKA 60
Query: 700 LKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQR 759
KE L E +M V +P+V +G + ++T+ +P G L + + + +
Sbjct: 61 NKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREH--KDNIGSQ 117
Query: 760 RRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISS 818
L + +AKG+NYL + ++H DL + N+LV VK+ DFGL++ A
Sbjct: 118 YLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 819 KSVAGTP-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQ 876
P +WMA E + +SDV+S+GV +WEL+T +P++G+ +++ + +
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-K 234
Query: 877 NRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQMGGE 931
RL P + + +M CW D RP F ++ K+ + P + + + G+
Sbjct: 235 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGD 289
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 4e-65
Identities = 88/283 (31%), Positives = 135/283 (47%), Gaps = 16/283 (5%)
Query: 646 EPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFL-DDQ 699
P ++ I +L + E++G GSFG V R EW VAVK L +
Sbjct: 6 GPLQSLTC-LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA 64
Query: 700 LKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQR 759
+ +F+REV M + H N++ G V P + +VTE P GSL + +
Sbjct: 65 MDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKH--QGHFLLG 121
Query: 760 RRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF--KANTFIS 817
R A+ VA+G+ YL + +H DL + NLL+ VK+ DFGL R + +
Sbjct: 122 TLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 179
Query: 818 SKSVAGTP-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAF 875
+ P W APE L+ + SD + FGV LWE+ T Q+PW GL +Q++ +
Sbjct: 180 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
Query: 876 QNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKL 918
+ RL P++ + ++M CWA P RP+F + + L +
Sbjct: 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 7e-65
Identities = 95/303 (31%), Positives = 142/303 (46%), Gaps = 18/303 (5%)
Query: 633 KFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGS-----DVAV 687
+F P + EI +H+++ +G+G G V VA+
Sbjct: 24 QFYAEPHTYEEPGRAGRSFTR-EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAI 82
Query: 688 KVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI 747
K L + + Q ++FL E +IM + HPN++ G VT+ IVTEY+ GSL +
Sbjct: 83 KALK-AGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL 141
Query: 748 HRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807
+ + M V G+ YL +L +H DL + N+LVD N KV DFGL
Sbjct: 142 RTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGL 197
Query: 808 SRFKANTFISSKSVAGT--P-EWMAPE-FLRGEPSNEKSDVYSFGVILWELVTM-QQPWN 862
SR + ++ + G P W APE S+ SDV+SFGV++WE++ ++P+
Sbjct: 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSS-ASDVWSFGVVMWEVLAYGERPYW 256
Query: 863 GLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
+ V+ +V + RL P L LM CW D AQRP F+ IV L L++SP
Sbjct: 257 NMTNRDVISSVE-EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315
Query: 923 AQL 925
L
Sbjct: 316 ESL 318
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 7e-65
Identities = 80/286 (27%), Positives = 126/286 (44%), Gaps = 27/286 (9%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQLKEFLREV 707
EIS + E +G FG V++ G VA+K L +EF E
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEA 63
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRR---- 761
+ R++HPNVV +G VTK LS++ Y G L + ++ P + R
Sbjct: 64 MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 762 -------LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814
+ + +A G+ YL + + ++H DL + N+LV VK+ D GL R
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 815 FISSKSVAGT-P-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVG 871
P WMAPE + + SD++S+GV+LWE+ + QP+ G VV
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 241
Query: 872 AVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKK 917
+ + L P + + +LM CW + P++RP F +I L+
Sbjct: 242 MIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 286
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 3e-64
Identities = 82/315 (26%), Positives = 140/315 (44%), Gaps = 31/315 (9%)
Query: 637 GPGPRYLN-IEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVK 688
G Y++ + W E + L + +GAG+FG V A +G VAVK
Sbjct: 1 GNNYVYIDPTQLPYDHKW-EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK 59
Query: 689 VLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YR 745
+L + + + E+ ++ + H N+V +GA T ++TEY G L +
Sbjct: 60 MLK-PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 118
Query: 746 LIHRPAA-------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNL 792
R + +D L + VAKG+ +L + N +H DL + N+
Sbjct: 119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNI 176
Query: 793 LVDKNWTVKVCDFGLSRFKANTFISSKSVAGT-P-EWMAPEFLRGEPSNEKSDVYSFGVI 850
L+ K+CDFGL+R N P +WMAPE + +SDV+S+G+
Sbjct: 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236
Query: 851 LWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFA 909
LWEL ++ P+ G+ + + R+ P++ + +M++CW DP +RP+F
Sbjct: 237 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK 296
Query: 910 NIVESLKKLLKSPAQ 924
IV+ ++K +
Sbjct: 297 QIVQLIEKQISESTN 311
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 225 bits (574), Expect = 3e-64
Identities = 93/297 (31%), Positives = 148/297 (49%), Gaps = 11/297 (3%)
Query: 638 PGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFL 696
P LA D EI + L ++ ++G G FG V W+G+ VA+K L +
Sbjct: 246 VCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTM 304
Query: 697 DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMM 756
+ FL+E +MK++RH +V V++ P IVTEY+ +GSL + + G+ +
Sbjct: 305 SPE--AFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFL-KGETGKYL 360
Query: 757 DQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816
+ + MA +A G+ Y+ +N +H DL++ N+LV +N KV DFGL+R +
Sbjct: 361 RLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418
Query: 817 SSKSVAGTP-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVA 874
+++ A P +W APE KSDV+SFG++L EL T + P+ G+ +V+ V
Sbjct: 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
Query: 875 FQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQMGGE 931
+ R+ P L LM CW +P +RP+F + L+ S Q G
Sbjct: 479 -RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 534
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 4e-64
Identities = 90/319 (28%), Positives = 151/319 (47%), Gaps = 34/319 (10%)
Query: 632 GKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD------- 684
+ P+ L + S W E D L + + +G G+FG V A+ G D
Sbjct: 4 DELPLDEHCERLPYDAS---KW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRT 59
Query: 685 VAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKR-PHLSIVTEYLPRGS 742
VAVK+L + + + + E+ I+ + H NVV +GA TK L ++ E+ G+
Sbjct: 60 VAVKMLK-EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 118
Query: 743 L-------------YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS 789
L Y++ + + + + VAKG+ +L + +H DL +
Sbjct: 119 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 176
Query: 790 PNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT-P-EWMAPEFLRGEPSNEKSDVYSF 847
N+L+ + VK+CDFGL+R + P +WMAPE + +SDV+SF
Sbjct: 177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 848 GVILWELVTM-QQPWNGL-GPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQR 905
GV+LWE+ ++ P+ G+ + + + R+ P T+P + M CW +P+QR
Sbjct: 237 GVLLWEIFSLGASPYPGVKIDEEFCRRLK-EGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 295
Query: 906 PSFANIVESLKKLLKSPAQ 924
P+F+ +VE L LL++ AQ
Sbjct: 296 PTFSELVEHLGNLLQANAQ 314
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 4e-64
Identities = 93/294 (31%), Positives = 147/294 (50%), Gaps = 31/294 (10%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKE 702
W E D+L + + +G G FG V AE G D VAVK+L D + L +
Sbjct: 75 KW-EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-DDATEKDLSD 132
Query: 703 FLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQR 759
+ E+ +MK + +H N++ +GA T+ L ++ EY +G+L Y RP E
Sbjct: 133 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 760 RR-----------LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
R + +A+G+ YL + +H DL + N+LV +N +K+ DFGL+
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLA 250
Query: 809 RFKANTFISSKSVAGT-P-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLG 865
R N K+ G P +WMAPE L +SDV+SFGV++WE+ T+ P+ G+
Sbjct: 251 RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310
Query: 866 PAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLL 919
++ + + R+ P N + L +M CW P+QRP+F +VE L ++L
Sbjct: 311 VEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 5e-64
Identities = 90/297 (30%), Positives = 150/297 (50%), Gaps = 19/297 (6%)
Query: 646 EPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGS------DVAVKVLTVQDFLDDQ 699
+ L EI + ++ +GAG FG V++ S VA+K L + + Q
Sbjct: 32 QAVLKFTT-EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQ 89
Query: 700 LKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQR 759
+FL E IM + H N++ G ++K + I+TEY+ G+L + +
Sbjct: 90 RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSVL 147
Query: 760 RRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK 819
+ + M +A G+ YL N+N +H DL + N+LV+ N KV DFGLSR + ++
Sbjct: 148 QLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 205
Query: 820 SVAGT--P-EWMAPE-FLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVA 874
+ +G P W APE + ++ SDV+SFG+++WE++T ++P+ L +V+ A+
Sbjct: 206 TTSGGKIPIRWTAPEAISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264
Query: 875 FQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQMGGE 931
RL P + + LM CW + A+RP FA+IV L KL+++P L +
Sbjct: 265 -DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADF 320
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 7e-64
Identities = 81/312 (25%), Positives = 135/312 (43%), Gaps = 34/312 (10%)
Query: 637 GPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD------VAVKVL 690
+ D + L +++G G+FG+V + VAVK L
Sbjct: 19 NLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL 78
Query: 691 TVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--RPHLSIVTEYLPRGSLYRLIH 748
Q ++ L++F RE+ I+K ++H N+V + G R +L ++ EYLP GSL +
Sbjct: 79 --QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 136
Query: 749 RPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
+ E +D + L+ + KG+ YL +H DL + N+LV+ VK+ DFGL+
Sbjct: 137 KH--KERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLT 192
Query: 809 RF-KANTFISSKSVAG-TP-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-------- 857
+ + G +P W APE L + SDV+SFGV+L+EL T
Sbjct: 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP 252
Query: 858 --------QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFA 909
+ ++ + N RL P + +M CW ++ QRPSF
Sbjct: 253 AEFMRMIGNDKQGQMIVFHLIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFR 311
Query: 910 NIVESLKKLLKS 921
++ + ++
Sbjct: 312 DLALRVDQIRDQ 323
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 8e-64
Identities = 96/320 (30%), Positives = 150/320 (46%), Gaps = 24/320 (7%)
Query: 623 EDESKLEKQGKFPVGPGPRYLNIEPSLAMD----WLEISW----DELHVKERVGAGSFGT 674
DE +L PG R ++P D E + + + + VGAG FG
Sbjct: 2 SDEKRLHFGNGHLKLPGLRTF-VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGE 60
Query: 675 VHRAEWHGSD-----VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729
V VA+K L V + + Q ++FL E +IM + HPN++ G VTK
Sbjct: 61 VCSGRLKLPSKKEISVAIKTLKV-GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119
Query: 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS 789
+ IVTEY+ GSL + + + + M +A G+ YL ++ +H DL +
Sbjct: 120 PVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAA 175
Query: 790 PNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT--P-EWMAPEFLRGEPSNEKSDVYS 846
N+L++ N KV DFGL R + ++ + G P W +PE + SDV+S
Sbjct: 176 RNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWS 235
Query: 847 FGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQR 905
+G++LWE+++ ++P+ + V+ AV + RL P + L LM CW D R
Sbjct: 236 YGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294
Query: 906 PSFANIVESLKKLLKSPAQL 925
P F IV L KL+++P L
Sbjct: 295 PKFEQIVSILDKLIRNPGSL 314
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 1e-63
Identities = 82/274 (29%), Positives = 144/274 (52%), Gaps = 11/274 (4%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIM 710
D EI + L +++++GAG FG V A ++ VAVK + + + FL E +M
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVE--AFLAEANVM 237
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
K ++H +V VTK P + I+TE++ +GSL + + G + + + +A+
Sbjct: 238 KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAE 295
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP-EWMA 829
G+ ++ N +H DL++ N+LV + K+ DFGL+R + +++ A P +W A
Sbjct: 296 GMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA 353
Query: 830 PEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888
PE + KSDV+SFG++L E+VT + P+ G+ +V+ A+ + R+ P+N
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPE 412
Query: 889 VLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
L ++M CW + P +RP+F I L +
Sbjct: 413 ELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 1e-63
Identities = 82/298 (27%), Positives = 135/298 (45%), Gaps = 38/298 (12%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD------VAVKVLTVQDFLDDQLKEFLREVA 708
+ L +++G G+FG+V + VAVK L Q ++ L++F RE+
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIE 63
Query: 709 IMKRVRHPNVVLFMGAVTK--RPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRM 764
I+K ++H N+V + G R +L ++ EYLP GSL Y H+ +D + L+
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQY 119
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAG 823
+ KG+ YL +H DL + N+LV+ VK+ DFGL++ + G
Sbjct: 120 TSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG 177
Query: 824 -TP-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM----------------QQPWNGLG 865
+P W APE L + SDV+SFGV+L+EL T +
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237
Query: 866 PAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPA 923
++ + N RL P + +M CW ++ QRPSF ++ + ++ + A
Sbjct: 238 VFHLIELLK-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 2e-63
Identities = 70/285 (24%), Positives = 128/285 (44%), Gaps = 17/285 (5%)
Query: 652 DWLEISWDELHVKERV-GAGSFGTVHRAEWHGS----DVAVKVLTVQDFLDDQLKEFLRE 706
+ + L ++++ G+G+FGTV + + VAVK+L + E L E
Sbjct: 10 EV-YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 68
Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
+M+++ +P +V +G + +V E G L + + + + + + +
Sbjct: 69 ANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVH 124
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF--KANTFISSKSVAGT 824
V+ G+ YL N +H DL + N+L+ K+ DFGLS+ + +++
Sbjct: 125 QVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
Query: 825 P-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAI 882
P +W APE + + KSDV+SFGV++WE + Q+P+ G+ ++V + + R+
Sbjct: 183 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGC 241
Query: 883 PQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQ 927
P + LM CW D RP FA + L+
Sbjct: 242 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 286
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 3e-63
Identities = 87/337 (25%), Positives = 143/337 (42%), Gaps = 39/337 (11%)
Query: 622 KEDESKLEKQGKFPVGPGPRYLNIEPS---LAMDWLEISWDELHVKERVGAGSFGTVHRA 678
ES+L + + Y ++ + W E + L + +G+G+FG V A
Sbjct: 7 FRYESQL-QMVQVTGSSDNEYFYVDFREYEYDLKW-EFPRENLEFGKVLGSGAFGKVMNA 64
Query: 679 EWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH 730
+G VAVK+L + + + + E+ +M ++ H N+V +GA T
Sbjct: 65 TAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123
Query: 731 LSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRR------------------LRMALDVAK 770
+ ++ EY G L Y R E + L A VAK
Sbjct: 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT-P-EWM 828
G+ +L + +H DL + N+LV VK+CDFGL+R + P +WM
Sbjct: 184 GMEFLEFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWM 241
Query: 829 APEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTS 887
APE L KSDV+S+G++LWE+ ++ P+ G+ + ++ P +
Sbjct: 242 APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYAT 301
Query: 888 PVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQ 924
+ +M+SCWA D +RPSF N+ L L +
Sbjct: 302 EEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 6e-63
Identities = 74/285 (25%), Positives = 133/285 (46%), Gaps = 17/285 (5%)
Query: 652 DWLEISWDELH-VKERVGAGSFGTVHRAEWHGS----DVAVKVLTVQDFLDDQLKEFLRE 706
+ D L +G G+FG+V + + DVA+KVL Q +E +RE
Sbjct: 3 KL-FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMRE 60
Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
IM ++ +P +V +G + +V E G L++ + E + +
Sbjct: 61 AQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGK--REEIPVSNVAELLH 117
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF--KANTFISSKSVAGT 824
V+ G+ YL N +H DL + N+L+ K+ DFGLS+ +++ +++S
Sbjct: 118 QVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175
Query: 825 P-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAI 882
P +W APE + + +SDV+S+GV +WE ++ Q+P+ + +V+ + Q +R+
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMEC 234
Query: 883 PQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQ 927
P P L +LM CW RP F + + ++ S A ++
Sbjct: 235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 1e-62
Identities = 81/303 (26%), Positives = 139/303 (45%), Gaps = 36/303 (11%)
Query: 646 EPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD------VAVKVLTVQDFLDDQ 699
+P+ +D L +G G FG V + VAVK L + +
Sbjct: 8 KPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-PESGGNH 66
Query: 700 LKEFLREVAIMKRVRHPNVVLFMGAVTK--RPHLSIVTEYLPRGSL--YRLIHRPAAGEM 755
+ + +E+ I++ + H N+V + G T+ + ++ E+LP GSL Y ++
Sbjct: 67 IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---- 122
Query: 756 MDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF--KAN 813
++ +++L+ A+ + KG++YL + +H DL + N+LV+ VK+ DFGL++
Sbjct: 123 INLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
Query: 814 TFISSKSVAGTP-EWMAPEFLRGEPSNEKSDVYSFGVILWELVT---------------M 857
+ + K +P W APE L SDV+SFGV L EL+T +
Sbjct: 181 EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI 240
Query: 858 QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKK 917
+ ++V + + +RL P N + LM CW P+ R SF N++E +
Sbjct: 241 GPTHGQMTVTRLVNTLK-EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299
Query: 918 LLK 920
LLK
Sbjct: 300 LLK 302
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 3e-62
Identities = 87/328 (26%), Positives = 146/328 (44%), Gaps = 24/328 (7%)
Query: 610 KQPNATLPSQLDKEDESKLEKQGKFPVGPGPRYLNIEP------SLAMDWLEISWDELHV 663
+ A +E + + V Y I + EI + + +
Sbjct: 335 EGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIEL 394
Query: 664 KERVGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
+G G FG VH+ + + VA+K D ++FL+E M++ HP++
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN-CTSDSVREKFLQEALTMRQFDHPHI 453
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
V +G +T+ P I+ E G L + + + + +D + A ++ + YL
Sbjct: 454 VKLIGVITENPVW-IIMELCTLGELRSFLQVRKFS----LDLASLILYAYQLSTALAYLE 508
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP-EWMAPEFLRG 835
+ +H D+ + N+LV N VK+ DFGLSR+ ++ S P +WMAPE +
Sbjct: 509 SKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 836 EPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894
SDV+ FGV +WE++ +P+ G+ V+G + RL +P N P L SLM
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPTLYSLM 625
Query: 895 ESCWADDPAQRPSFANIVESLKKLLKSP 922
CWA DP++RP F + L +L+
Sbjct: 626 TKCWAYDPSRRPRFTELKAQLSTILEEE 653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 3e-62
Identities = 83/311 (26%), Positives = 139/311 (44%), Gaps = 29/311 (9%)
Query: 639 GPRYLNIEPS---LAMDWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVK 688
G Y I+P+ W E + L + +GAG+FG V A G VAVK
Sbjct: 24 GNSYTFIDPTQLPYNEKW-EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK 82
Query: 689 VLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSL--YR 745
+L D+ + + E+ IM + +H N+V +GA T + ++TEY G L +
Sbjct: 83 MLK-STAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL 141
Query: 746 LIHRP---------AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK 796
A R L + VA+G+ +L + N +H D+ + N+L+
Sbjct: 142 RRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTN 199
Query: 797 NWTVKVCDFGLSRFKANTFISSKSVAGT-P-EWMAPEFLRGEPSNEKSDVYSFGVILWEL 854
K+ DFGL+R N P +WMAPE + +SDV+S+G++LWE+
Sbjct: 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259
Query: 855 VTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVE 913
++ P+ G+ + ++A P + S+M++CWA +P RP+F I
Sbjct: 260 FSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319
Query: 914 SLKKLLKSPAQ 924
L++ + +
Sbjct: 320 FLQEQAQEDRR 330
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 8e-61
Identities = 83/295 (28%), Positives = 126/295 (42%), Gaps = 35/295 (11%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD------VAVKVLTVQDFLDDQLKEFLREVA 708
L ++G G+FG+V + VAVK L Q DQ ++F RE+
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDFQREIQ 76
Query: 709 IMKRVRHPNVVLFMGAV--TKRPHLSIVTEYLPRGSL--YRLIHRPAAGEMMDQRRRLRM 764
I+K + +V + G R L +V EYLP G L + HR +D R L
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LDASRLLLY 132
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF--KANTFISSKSVA 822
+ + KG+ YL + +H DL + N+LV+ VK+ DFGL++ + +
Sbjct: 133 SSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 190
Query: 823 GTP-EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAF----- 875
+P W APE L + +SDV+SFGV+L+EL T + + +
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250
Query: 876 --------QNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
+ +RL P + LM+ CWA P RPSF+ + L L
Sbjct: 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 1e-60
Identities = 74/304 (24%), Positives = 130/304 (42%), Gaps = 38/304 (12%)
Query: 646 EPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD------VAVKVLTVQDFLDDQ 699
D L +G G FG V + ++ VAVK L D
Sbjct: 18 LFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQH 76
Query: 700 LKEFLREVAIMKRVRHPNVVLFMGAVTK--RPHLSIVTEYLPRGSL--YRLIHRPAAGEM 755
+ +E+ I++ + H +++ + G L +V EY+P GSL Y H ++
Sbjct: 77 RSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL 136
Query: 756 MDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF--KAN 813
+ A + +G+ YLH + +H DL + N+L+D + VK+ DFGL++ + +
Sbjct: 137 LL------FAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
Query: 814 TFISSKSVAGTP-EWMAPEFLRGEPSNEKSDVYSFGVILWELVT---------------M 857
+ + +P W APE L+ SDV+SFGV L+EL+T +
Sbjct: 189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI 248
Query: 858 QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKK 917
+ ++ + + RL P + LM++CW + + RP+F N++ LK
Sbjct: 249 GIAQGQMTVLRLTELLE-RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307
Query: 918 LLKS 921
+ +
Sbjct: 308 VHEK 311
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 3e-60
Identities = 60/287 (20%), Positives = 119/287 (41%), Gaps = 34/287 (11%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
+I ++L E +G G+F + + V +KVL + + F
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL--DKAHRNYSESFFE 61
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA 765
++M ++ H ++VL G +V E++ GSL + + ++ +L +A
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVA 119
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDK--------NWTVKVCDFGLSRFKANTFIS 817
+A +++L ++H ++ + N+L+ + +K+ D G+S +
Sbjct: 120 KQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI-----TVL 172
Query: 818 SKSVAGTP-EWMAPE-FLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVA 874
K + W+ PE + N +D +SFG LWE+ + +P + L + +
Sbjct: 173 PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232
Query: 875 FQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921
+L P+ LA+L+ +C +P RPSF I+ L L
Sbjct: 233 -DRHQLPAPKAAE--LANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 2e-58
Identities = 73/286 (25%), Positives = 133/286 (46%), Gaps = 15/286 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGS----DVAVKVLTVQDFLDDQLKEFLREV 707
+ L +G G+FG+V + + DVA+KVL Q +E +RE
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREA 387
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
IM ++ +P +V +G + +V E G L++ + E + +
Sbjct: 388 QIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQ 444
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF--KANTFISSKSVAGTP 825
V+ G+ YL N +H +L + N+L+ K+ DFGLS+ +++ +++S P
Sbjct: 445 VSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502
Query: 826 -EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIP 883
+W APE + + +SDV+S+GV +WE ++ Q+P+ + +V+ + Q +R+ P
Sbjct: 503 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECP 561
Query: 884 QNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQMG 929
P L +LM CW RP F + + ++ S A ++ G
Sbjct: 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGG 607
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-57
Identities = 66/263 (25%), Positives = 130/263 (49%), Gaps = 13/263 (4%)
Query: 662 HVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
+++G GSFG + G +K + + + +E REVA++ ++HPN+V
Sbjct: 27 VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIV 86
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
+ + + L IV +Y G L++ I+ G + + + L + + + ++H+
Sbjct: 87 QYRESFEENGSLYIVMDYCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRK 145
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSN 839
ILH D+KS N+ + K+ TV++ DFG++R +T +++ GTP +++PE +P N
Sbjct: 146 --ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYN 203
Query: 840 EKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWA 899
KSD+++ G +L+EL T++ + +V + + + S L SL+ +
Sbjct: 204 NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII-SGSFPPVSLHYSYDLRSLVSQLFK 262
Query: 900 DDPAQRPSFANIVESLKKLLKSP 922
+P RP S+ +L+
Sbjct: 263 RNPRDRP-------SVNSILEKG 278
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 1e-54
Identities = 69/260 (26%), Positives = 118/260 (45%), Gaps = 9/260 (3%)
Query: 662 HVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
V +G GS+G + G + K L + + + + EV +++ ++HPN+V
Sbjct: 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 68
Query: 720 LFMGAVTKRP--HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKGINYLH 776
+ + R L IV EY G L +I + +D+ LR+ + + H
Sbjct: 69 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 777 NLNPP---ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFL 833
+ +LH DLK N+ +D VK+ DFGL+R + +K+ GTP +M+PE +
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 834 RGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893
NEKSD++S G +L+EL + P+ ++ G + + + IP S L +
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDELNEI 247
Query: 894 MESCWADDPAQRPSFANIVE 913
+ RPS I+E
Sbjct: 248 ITRMLNLKDYHRPSVEEILE 267
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-54
Identities = 70/273 (25%), Positives = 138/273 (50%), Gaps = 10/273 (3%)
Query: 662 HVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNV 718
+++++G G F V+RA G VA+K + + D +D + + +E+ ++K++ HPNV
Sbjct: 35 RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV 94
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
+ + + + L+IV E G L R+I H ++ +R + + + + ++H+
Sbjct: 95 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEP 837
++H D+K N+ + VK+ D GL RF ++ ++ S+ GTP +M+PE +
Sbjct: 155 RR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 212
Query: 838 SNEKSDVYSFGVILWELVTMQQPWNG--LGPAQVVGAVAFQNRRLAIPQNT-SPVLASLM 894
N KSD++S G +L+E+ +Q P+ G + + + Q +P + S L L+
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-QCDYPPLPSDHYSEELRQLV 271
Query: 895 ESCWADDPAQRPSFANIVESLKKLLKSPAQLIQ 927
C DP +RP + + K++ A ++
Sbjct: 272 NMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 6e-51
Identities = 77/275 (28%), Positives = 133/275 (48%), Gaps = 27/275 (9%)
Query: 667 VGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQ-LKEFLREVAIMKRVRHPNVVLFMGA 724
+G G FG V++ G+ VA+K T + Q ++EF E+ + RHP++V +G
Sbjct: 47 IGHGVFGKVYKGVLRDGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGF 103
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIH-RPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
+R + ++ +Y+ G+L R ++ M +RL + + A+G++YLH I+
Sbjct: 104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT--RAII 161
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF---KANTFISSKSVAGTPEWMAPEFLRGEPSNE 840
H D+KS N+L+D+N+ K+ DFG+S+ T +S+ V GT ++ PE+ E
Sbjct: 162 HRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV-VKGTLGYIDPEYFIKGRLTE 220
Query: 841 KSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVA-----FQNRRLA----------IPQN 885
KSDVYSFGV+L+E++ + P ++V N +L I
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPE 280
Query: 886 TSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920
+ C A RPS +++ L+ L+
Sbjct: 281 SLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-50
Identities = 64/280 (22%), Positives = 120/280 (42%), Gaps = 43/280 (15%)
Query: 662 HVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
E +G+G FG V +A+ H G +K + + ++ REV + ++ H N+
Sbjct: 14 KEIELIGSGGFGQVFKAK-HRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNI 66
Query: 719 VLFMGA----------------VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL 762
V + G +K L I E+ +G+L + I + GE +D+ L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKVLAL 125
Query: 763 RMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
+ + KG++Y+H+ +++ DLK N+ + VK+ DFGL N ++S
Sbjct: 126 ELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK- 182
Query: 823 GTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAI 882
GT +M+PE + + ++ D+Y+ G+IL EL+ + A R I
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD------TAFETSKFFTDLRDGII 236
Query: 883 PQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
+L++ + P RP + ++L++
Sbjct: 237 SDIFDKKEKTLLQKLLSKKPEDRP-------NTSEILRTL 269
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 2e-50
Identities = 78/274 (28%), Positives = 133/274 (48%), Gaps = 22/274 (8%)
Query: 666 RVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQ--LKEFLREVAIMKRVRHPNVVLFMG 723
++G G FG V++ + + VAVK L + + ++F +E+ +M + +H N+V +G
Sbjct: 38 KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
+ L +V Y+P GSL + + R ++A A GIN+LH +
Sbjct: 98 FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHI 155
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF---KANTFISSKSVAGTPEWMAPEFLRGEPSNE 840
H D+KS N+L+D+ +T K+ DFGL+R A T ++S+ + GT +MAPE LRGE
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR-IVGTTAYMAPEALRGE-ITP 213
Query: 841 KSDVYSFGVILWELVTMQQPWNGLGPAQ--VVGAVAFQNRRLAIPQNTSPVL-------- 890
KSD+YSFGV+L E++T + Q + ++ I +
Sbjct: 214 KSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSV 273
Query: 891 ---ASLMESCWADDPAQRPSFANIVESLKKLLKS 921
S+ C + +RP + + L+++ S
Sbjct: 274 EAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 3e-50
Identities = 61/287 (21%), Positives = 113/287 (39%), Gaps = 28/287 (9%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIM 710
+ I +++G G F V E G A+K + + +E RE +
Sbjct: 24 VIIDNKHYLFIQKLGEGGFSYVDLVE-GLHDGHFYALKRILCHE--QQDREEAQREADMH 80
Query: 711 KRVRHPNVVLFMGAVTKRP----HLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMA 765
+ HPN++ + + ++ + RG+L+ I G + + + L +
Sbjct: 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA--- 822
L + +G+ +H H DLK N+L+ + D G S+
Sbjct: 141 LGICRGLEAIHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 823 ------GTPEWMAPEFL---RGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAV 873
T + APE +E++DV+S G +L+ ++ + P++ + A+
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258
Query: 874 AFQNRRLAIPQNT--SPVLASLMESCWADDPAQRPSFANIVESLKKL 918
A +L+IPQ+ S L L+ S DP QRP ++ L+ L
Sbjct: 259 A-VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-49
Identities = 72/296 (24%), Positives = 131/296 (44%), Gaps = 35/296 (11%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
+E+ L V+ + G F V+ A+ G + A+K L + +++ + ++EV MK
Sbjct: 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMK 80
Query: 712 RVR-HPNVVLFMGAVTKRPHLS-------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLR 763
++ HPN+V F A + S ++ L +G L + + + + L+
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 764 MALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA- 822
+ + + ++H PPI+H DLK NLL+ T+K+CDFG + ++ S S
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 823 -----------GTPEWMAPE---FLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQ 868
TP + PE P EK D+++ G IL+ L Q P+ +
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260
Query: 869 VVGAVAFQNRRLAIPQNT--SPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
+V N + +IP + V SL+ + +P +R S A +V L+++ +
Sbjct: 261 IV------NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-47
Identities = 65/302 (21%), Positives = 109/302 (36%), Gaps = 27/302 (8%)
Query: 618 SQLDKEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTV-- 675
QL S + + PG E + + R+G GS+G V
Sbjct: 24 HQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRL--------SRLGHGSYGEVFK 75
Query: 676 --HRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLS 732
+ + G AVK L EV ++V +HP V A + L
Sbjct: 76 VRSKED--GRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133
Query: 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNL 792
+ TE SL + G + + + D + +LH+ ++H D+K N+
Sbjct: 134 LQTELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANI 188
Query: 793 LVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILW 852
+ K+ DFGL + T + + G P +MAPE L+G +DV+S G+ +
Sbjct: 189 FLGPRGRCKLGDFGLLV-ELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTIL 246
Query: 853 ELVTMQQPWNGLGPAQVVGAVAFQNR-RLAIPQNTSPVLASLMESCWADDPAQRPSFANI 911
E+ + +G Q + Q S L S++ DP R + +
Sbjct: 247 EVACNMELPHGGEGWQQL----RQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEAL 302
Query: 912 VE 913
+
Sbjct: 303 LA 304
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-47
Identities = 70/268 (26%), Positives = 119/268 (44%), Gaps = 28/268 (10%)
Query: 664 KERVGAGSFGTVHRA-EWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF 721
+ RVG GSFG VHR + G AVK + ++ F + E+ + P +V
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPL 115
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
GAV + P ++I E L GSL +LI + + + R L +G+ YLH
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR-- 170
Query: 782 ILHWDLKSPNLLVDKN-WTVKVCDFGLSR-----FKANTFISSKSVAGTPEWMAPEFLRG 835
ILH D+K+ N+L+ + +CDFG + + ++ + GT MAPE + G
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 836 EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-RLAIPQNTSPVLASLM 894
+P + K D++S ++ ++ PW + +A + IP + +P+ A +
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAI 290
Query: 895 ESCWADDPAQRPSFANIVESLKKLLKSP 922
+ +P R S A +L +
Sbjct: 291 QEGLRKEPVHRAS-A------MELRRKV 311
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 6e-47
Identities = 71/228 (31%), Positives = 120/228 (52%), Gaps = 15/228 (6%)
Query: 646 EPSLAMDWLEI-SWDELHV-------KERVGAGSFGTVHRAE-WHGSDVAVKVLTVQDFL 696
+P + + L+ S EL V K +G G FG V++ G+ VAVK L +
Sbjct: 9 DPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ 68
Query: 697 DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEM- 755
+ +F EV ++ H N++ G +V Y+ GS+ + +
Sbjct: 69 GGE-LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP 127
Query: 756 MDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF--KA 812
+D +R R+AL A+G+ YLH+ +P I+H D+K+ N+L+D+ + V DFGL++
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187
Query: 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQP 860
+T +++ V GT +APE+L S+EK+DV+ +GV+L EL+T Q+
Sbjct: 188 DTHVTTA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 234
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 8e-47
Identities = 68/264 (25%), Positives = 128/264 (48%), Gaps = 21/264 (7%)
Query: 667 VGAGSFGTVHRA-EWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
+G G++G V+ + +A+K + +D + E+A+ K ++H N+V ++G+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRM-ALDVAKGINYLHNLNPPIL 783
++ + I E +P GSL L+ R G + D + + + +G+ YLH+ I+
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IV 144
Query: 784 HWDLKSPNLLVD-KNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPS--NE 840
H D+K N+L++ + +K+ DFG S+ A +++ GT ++MAPE + P +
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGK 204
Query: 841 KSDVYSFG-VILWELVTMQQPWNGLG-PAQVVGAVAFQNRRLAIPQNTSPVLASLMESCW 898
+D++S G I+ E+ T + P+ LG P + V IP++ S + + C+
Sbjct: 205 AADIWSLGCTII-EMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCF 263
Query: 899 ADDPAQRPSFANIVESLKKLLKSP 922
DP +R A LL
Sbjct: 264 EPDPDKRAC-A------NDLLVDE 280
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 9e-47
Identities = 58/286 (20%), Positives = 104/286 (36%), Gaps = 43/286 (15%)
Query: 662 HVKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPN 717
H E++G+G FG+V + D A+K + LREV + +H +
Sbjct: 14 HELEKIGSGEFGSVFKCV-KRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKGINYLH 776
VV + A + H+ I EY GSL I + + L V +G+ Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 777 NLNPPILHWDLKSPNLLVDKN-------------------WTVKVCDFGLSRFKANTFIS 817
+++ ++H D+K N+ + + K+ D G ++
Sbjct: 133 SMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP--- 187
Query: 818 SKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ 876
+ G ++A E L+ K+D+++ + + + + Q
Sbjct: 188 -QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI----RQ 242
Query: 877 NRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
R IPQ S L++ DP +RP S L+K
Sbjct: 243 GRLPRIPQVLSQEFTELLKVMIHPDPERRP-------SAMALVKHS 281
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-46
Identities = 62/298 (20%), Positives = 126/298 (42%), Gaps = 39/298 (13%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
+ + +G G FG V A+ + D A+K + + + + ++ +REV + ++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAK-NKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEH 62
Query: 716 PNVVLFMGA------------VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLR 763
P +V + A + + +L I + + +L ++ E ++ L
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 764 MALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA- 822
+ L +A+ + +LH+ ++H DLK N+ + VKV DFGL +
Sbjct: 123 IFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 823 -----------GTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVG 871
GT +M+PE + G + K D++S G+IL+EL + + + +
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL--LYPFSTQMERVRTLT 238
Query: 872 AVAFQNRRL-AIPQNTSPVLASLMESCWADDPAQRPSFANIVES--LKKLLKSPAQLI 926
V +N + + P +++ + P +RP NI+E+ + L P + +
Sbjct: 239 DV--RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED-LDFPGKTV 293
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 1e-45
Identities = 56/318 (17%), Positives = 123/318 (38%), Gaps = 36/318 (11%)
Query: 617 PSQLDKEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVH 676
S + + +K E+Q G + S A + + + + +++G+G V
Sbjct: 14 GSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVF 73
Query: 677 RAE-WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN--VVLFMGAVTKRPHLSI 733
+ A+K + +++ + L + E+A + +++ + ++ ++ +
Sbjct: 74 QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133
Query: 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL------DVAKGINYLHNLNPPILHWDL 787
V E L + +++ + ++ + ++ +H I+H DL
Sbjct: 134 VMEC-GNIDLNSWLK---------KKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDL 181
Query: 788 KSPNLLVDKNWTVKVCDFGLSRFKAN--TFISSKSVAGTPEWMAPEFLRGEPSN------ 839
K N L+ +K+ DFG++ T + S G +M PE ++ S+
Sbjct: 182 KPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKS 240
Query: 840 -----EKSDVYSFGVILWELVTMQQPWNGL-GPAQVVGAVAFQNRRLAIPQNTSPVLASL 893
KSDV+S G IL+ + + P+ + + A+ N + P L +
Sbjct: 241 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDV 300
Query: 894 MESCWADDPAQRPSFANI 911
++ C DP QR S +
Sbjct: 301 LKCCLKRDPKQRISIPEL 318
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 5e-45
Identities = 52/267 (19%), Positives = 110/267 (41%), Gaps = 24/267 (8%)
Query: 662 HVKERVGAGSFGTVHRAE-WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN--V 718
+ +++G+G V + A+K + +++ + L + E+A + +++ + +
Sbjct: 12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
+ ++ +V E L + + + +D R ++ + ++ +H
Sbjct: 72 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN--TFISSKSVAGTPEWMAPEFLRGE 836
I+H DLK N L+ +K+ DFG++ T + S GT +M PE ++
Sbjct: 128 G--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 837 PS-----------NEKSDVYSFGVILWELVTMQQPWNGL-GPAQVVGAVAFQNRRLAIPQ 884
S + KSDV+S G IL+ + + P+ + + A+ N + P
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244
Query: 885 NTSPVLASLMESCWADDPAQRPSFANI 911
L +++ C DP QR S +
Sbjct: 245 IPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 8e-45
Identities = 52/267 (19%), Positives = 110/267 (41%), Gaps = 24/267 (8%)
Query: 662 HVKERVGAGSFGTVHRA-EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN--V 718
+ +++G+G V + A+K + +++ + L + E+A + +++ + +
Sbjct: 31 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
+ ++ +V E L + + + +D R ++ + ++ +H
Sbjct: 91 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN--TFISSKSVAGTPEWMAPEFLRGE 836
I+H DLK N L+ +K+ DFG++ T + S GT +M PE ++
Sbjct: 147 G--IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 837 PS-----------NEKSDVYSFGVILWELVTMQQPWNGL-GPAQVVGAVAFQNRRLAIPQ 884
S + KSDV+S G IL+ + + P+ + + A+ N + P
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 263
Query: 885 NTSPVLASLMESCWADDPAQRPSFANI 911
L +++ C DP QR S +
Sbjct: 264 IPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 70/293 (23%), Positives = 118/293 (40%), Gaps = 50/293 (17%)
Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
+G G+FG V +A + A+K + +++L L EV ++ + H VV
Sbjct: 10 EIAVLGQGAFGQVVKAR-NALDSRYYAIKKI---RHTEEKLSTILSEVMLLASLNHQYVV 65
Query: 720 LFMGA-------------VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
+ A V K+ L I EY G+LY LIH + R+
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFR 123
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS-------- 818
+ + ++Y+H+ I+H DLK N+ +D++ VK+ DFGL++ +
Sbjct: 124 QILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 819 ------KSVAGTPEWMAPEFLRGEPS-NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVG 871
S GT ++A E L G NEK D+YS G+I +E++ G+ ++
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILK 239
Query: 872 AVAFQNRRL--AIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
+ + N V ++ DP +RP + LL S
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP-------GARTLLNSG 285
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-44
Identities = 76/274 (27%), Positives = 138/274 (50%), Gaps = 45/274 (16%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
E++G GSFG V + VA+K++ +++ +D++++ +E+ ++ + P V +
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
G+ K L I+ EYL GS L+ +D+ + + ++ KG++YLH+
Sbjct: 87 GSYLKDTKLWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK--K 140
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLS------RFKANTFISSKSVAGTPEWMAPEFLRGE 836
+H D+K+ N+L+ ++ VK+ DFG++ + K NTF+ GTP WMAPE ++
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEVIKQS 194
Query: 837 PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS---- 892
+ K+D++S G+ EL + P + L P +V+ IP+N P L
Sbjct: 195 AYDSKADIWSLGITAIELARGEPPHSELHPMKVL---------FLIPKNNPPTLEGNYSK 245
Query: 893 ----LMESCWADDPAQRPSFANIVESLKKLLKSP 922
+E+C +P+ RP + K+LLK
Sbjct: 246 PLKEFVEACLNKEPSFRP-------TAKELLKHK 272
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 64/252 (25%), Positives = 124/252 (49%), Gaps = 23/252 (9%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
E++G G+ GTV+ A G +VA++ + +Q + + + E+ +M+ ++PN+V ++
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYL 83
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
+ L +V EYL GSL ++ MD+ + + + + + +LH+ +
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ--V 137
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLS------RFKANTFISSKSVAGTPEWMAPEFLRGE 836
+H D+KS N+L+ + +VK+ DFG + K +T + GTP WMAPE + +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV------GTPYWMAPEVVTRK 191
Query: 837 PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-RLAIPQNTSPVLASLME 895
K D++S G++ E++ + P+ P + + +A L P+ S + +
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251
Query: 896 SCWADDPAQRPS 907
C D +R S
Sbjct: 252 RCLEMDVEKRGS 263
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 4e-42
Identities = 63/285 (22%), Positives = 112/285 (39%), Gaps = 31/285 (10%)
Query: 662 HVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
+ + +G G+ V R H G A+KV + +RE ++K++ H N+
Sbjct: 12 LLSDILGQGATANVFRGR-HKKTGDLFAIKVFN-NISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 719 V-LF--MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
V LF T R H ++ E+ P GSLY ++ P+ + + L + DV G+N+L
Sbjct: 70 VKLFAIEEETTTR-HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 776 HNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMAP 830
I+H ++K N++ D K+ DFG +R + + S+ GT E++ P
Sbjct: 129 RENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHP 184
Query: 831 EFLRGEPS--------NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAI 882
+ D++S GV + T P+ + V ++
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 883 PQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQ 927
S V E+ D P ++ L+ LL ++
Sbjct: 245 SGAISGV--QKAENGPIDWSGDMPVSCSLSRGLQVLLT---PVLA 284
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-42
Identities = 64/252 (25%), Positives = 115/252 (45%), Gaps = 23/252 (9%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
++G GS G V A G VAVK++ ++ + + EV IM+ +H NVV
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMY 108
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
+ L ++ E+L G+L ++ + +++ + + V + + YLH +
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG--V 162
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLS------RFKANTFISSKSVAGTPEWMAPEFLRGE 836
+H D+KS ++L+ + VK+ DFG K + + GTP WMAPE +
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVISRS 216
Query: 837 PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-RLAIPQNTSPVLASLME 895
+ D++S G+++ E+V + P+ P Q + + +L SPVL +E
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE 276
Query: 896 SCWADDPAQRPS 907
DP +R +
Sbjct: 277 RMLVRDPQERAT 288
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 71/267 (26%), Positives = 127/267 (47%), Gaps = 30/267 (11%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
E++G GS+G+V++A G VA+K + ++ L+E ++E++IM++ P+VV +
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
G+ K L IV EY GS+ +I + + + + KG+ YLH +
Sbjct: 91 GSYFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEYLHFMR--K 146
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLS------RFKANTFISSKSVAGTPEWMAPEFLRGE 836
+H D+K+ N+L++ K+ DFG++ K NT I GTP WMAPE ++
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI------GTPFWMAPEVIQEI 200
Query: 837 PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-RLAIPQNTSPVLASLME 895
N +D++S G+ E+ + P+ + P + + + P+ S ++
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVK 260
Query: 896 SCWADDPAQRPSFANIVESLKKLLKSP 922
C P QR + +LL+ P
Sbjct: 261 QCLVKSPEQRA-------TATQLLQHP 280
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-41
Identities = 73/301 (24%), Positives = 132/301 (43%), Gaps = 63/301 (20%)
Query: 659 DELHVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
D+ ++E +G+G+ V A VA+K + + + + E L+E+ M + HP
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL-EKCQTSMDELLKEIQAMSQCHHP 73
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLR------MALDVAK 770
N+V + + + L +V + L GS+ +I + + + L + +V +
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDII-KHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-----------KANTFISSK 819
G+ YLH +H D+K+ N+L+ ++ +V++ DFG+S F TF+
Sbjct: 133 GLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV--- 187
Query: 820 SVAGTPEWMAPE-FLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR 878
GTP WMAPE + + K+D++SFG+ EL T P++ P +V+
Sbjct: 188 ---GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL-------- 236
Query: 879 RLAIPQNTSPVLAS-----------------LMESCWADDPAQRPSFANIVESLKKLLKS 921
+ QN P L + ++ C DP +RP+ A +LL+
Sbjct: 237 -MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT-A------AELLRH 288
Query: 922 P 922
Sbjct: 289 K 289
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 2e-41
Identities = 62/260 (23%), Positives = 117/260 (45%), Gaps = 17/260 (6%)
Query: 655 EISWDELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
E+ D+ +GAG+ G V + + G +A K++ + + + +RE+ ++
Sbjct: 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHE 87
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
P +V F GA +SI E++ GSL +++ + + ++ ++++ V KG+
Sbjct: 88 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 144
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG----LSRFKANTFISSKSVAGTPEWM 828
YL I+H D+K N+LV+ +K+CDFG L AN+F+ GT +M
Sbjct: 145 TYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYM 197
Query: 829 APEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888
+PE L+G + +SD++S G+ L E+ + P ++ Q A P
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257
Query: 889 VLASLMESCWADDPAQRPSF 908
+ + D +
Sbjct: 258 RTPGRPLNKFGMDSRPPMAI 277
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 9e-41
Identities = 73/278 (26%), Positives = 135/278 (48%), Gaps = 45/278 (16%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFM 722
+G G+FG V++A+ G+ A KV+ + +++L++++ E+ I+ HP +V +
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLL 82
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLR------MALDVAKGINYLH 776
GA L I+ E+ P G++ + M++ R L + + + +N+LH
Sbjct: 83 GAYYHDGKLWIMIEFCPGGAVDAI--------MLELDRGLTEPQIQVVCRQMLEALNFLH 134
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS------RFKANTFISSKSVAGTPEWMAP 830
+ I+H DLK+ N+L+ +++ DFG+S K ++FI GTP WMAP
Sbjct: 135 SKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAP 186
Query: 831 E-----FLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-RLAIPQ 884
E ++ P + K+D++S G+ L E+ ++ P + L P +V+ +A + L P
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPS 246
Query: 885 NTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
S ++ +P RP S +LL+ P
Sbjct: 247 KWSVEFRDFLKIALDKNPETRP-------SAAQLLEHP 277
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 67/283 (23%), Positives = 131/283 (46%), Gaps = 30/283 (10%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAI-M 710
+E+ D+L +G G++G V + G +AVK + + K L ++ I M
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA-TVNSQEQKRLLMDLDISM 60
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL------RM 764
+ V P V F GA+ + + I E + SL + + ++D+ + + ++
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQ-----VIDKGQTIPEDILGKI 114
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
A+ + K + +LH+ ++H D+K N+L++ VK+CDFG+S + + ++ AG
Sbjct: 115 AVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD-VAKDIDAGC 172
Query: 825 PEWMAPEFLRGEPS----NEKSDVYSFGVILWELVTMQQPWNGLG-PAQVVGAVAFQNRR 879
+MAPE + E + + KSD++S G+ + EL ++ P++ G P Q + V +
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP 232
Query: 880 LAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
S C + +RP++ +L++ P
Sbjct: 233 QLPADKFSAEFVDFTSQCLKKNSKERPTY-------PELMQHP 268
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-40
Identities = 73/316 (23%), Positives = 139/316 (43%), Gaps = 52/316 (16%)
Query: 628 LEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRA--EWHGSDV 685
+E GK + P + + + ++L +G G++G+V++ + G +
Sbjct: 3 IESSGKLKISPEQHW------------DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIM 50
Query: 686 AVKVLTVQDFLDDQLKEFLREVAI-MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY 744
AVK + + + K+ L ++ + M+ P +V F GA+ + I E + S
Sbjct: 51 AVKRIRS-TVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFD 108
Query: 745 RLIHR--PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKV 802
+ +++ + ++ L K +N+L N I+H D+K N+L+D++ +K+
Sbjct: 109 KFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKL 167
Query: 803 CDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNE----KSDVYSFGVILWELVTMQ 858
CDFG+S ++ I+ AG +MAPE + S + +SDV+S G+ L+EL T +
Sbjct: 168 CDFGISGQLVDS-IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
Query: 859 QPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD------------DPAQRP 906
P+ V Q + + P L++ E ++ D ++RP
Sbjct: 227 FPYPKWNS---VFDQLTQ-----VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP 278
Query: 907 SFANIVESLKKLLKSP 922
K+LLK P
Sbjct: 279 -------KYKELLKHP 287
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-40
Identities = 63/279 (22%), Positives = 110/279 (39%), Gaps = 28/279 (10%)
Query: 662 HVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
+ + +G G+ V R H G A+KV + +RE ++K++ H N+
Sbjct: 12 LLSDILGQGATANVFRGR-HKKTGDLFAIKVFN-NISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 719 V-LF--MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
V LF T R H ++ E+ P GSLY ++ P+ + + L + DV G+N+L
Sbjct: 70 VKLFAIEEETTTR-HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 776 HNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMAP 830
I+H ++K N++ D K+ DFG +R + + S+ GT E++ P
Sbjct: 129 RENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--VSLYGTEEYLHP 184
Query: 831 EFLRGEPS--------NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAI 882
+ D++S GV + T P+ + V ++
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 883 PQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921
S V E+ D P ++ L+ LL
Sbjct: 245 SGAISGV--QKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-39
Identities = 64/273 (23%), Positives = 128/273 (46%), Gaps = 23/273 (8%)
Query: 663 VKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQ--LKEFLREVAIMKRVRHPNV 718
+ +++G G TV+ AE VA+K + + + LK F REV ++ H N+
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIF-IPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
V + + +V EY+ +L I + + + GI + H++
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM 130
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMAPEFLRGEP 837
I+H D+K N+L+D N T+K+ DFG+++ + + V GT ++ +PE +GE
Sbjct: 131 R--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 838 SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQ-------NTSPVL 890
++E +D+YS G++L+E++ + P+NG ++A ++ + ++P + L
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFNGETAV----SIAIKHIQDSVPNVTTDVRKDIPQSL 244
Query: 891 ASLMESCWADDPAQRPSFAN-IVESLKKLLKSP 922
++++ D A R + + L +L
Sbjct: 245 SNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 62/281 (22%), Positives = 115/281 (40%), Gaps = 27/281 (9%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAI-M 710
+ ++L +G+G+ G V + G +AVK + ++ K L ++ + +
Sbjct: 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR-SGNKEENKRILMDLDVVL 78
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGS--LYRLIHRPAAGEMMDQRRRLRMALDV 768
K P +V G + I E + + L + + P + +R +M + +
Sbjct: 79 KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP-----IPERILGKMTVAI 133
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWM 828
K + YL + ++H D+K N+L+D+ +K+CDFG+S + + AG +M
Sbjct: 134 VKALYYLKEKHG-VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD-KAKDRSAGCAAYM 191
Query: 829 APE-----FLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGP--AQVVGAVAFQNRRLA 881
APE + ++DV+S G+ L EL T Q P+ + + + L
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP 251
Query: 882 IPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
S S ++ C D +RP KLL+
Sbjct: 252 GHMGFSGDFQSFVKDCLTKDHRKRP-------KYNKLLEHS 285
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-38
Identities = 66/286 (23%), Positives = 109/286 (38%), Gaps = 43/286 (15%)
Query: 662 HVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
+KER+G G FG V R H G VA+K Q+ + + E+ IMK++ HPNV
Sbjct: 17 EMKERLGTGGFGYVLRWI-HQDTGEQVAIKQCR-QELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 719 V-LF-----MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
V + + + EY G L + +++ + + + D++ +
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKN---WTVKVCDFGLSR-FKANTFISSKSVAGTPEWM 828
YLH I+H DLK N+++ K+ D G ++ GT +++
Sbjct: 135 RYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFVGTLQYL 190
Query: 829 APEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQV------------------- 869
APE L + D +SFG + +E +T +P+
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250
Query: 870 VGAVAFQNRRLAIPQNTSPVLASLMESCWAD----DPAQRPSFANI 911
GAV F L P + S +LA +E QR +
Sbjct: 251 TGAVKFS-SVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-38
Identities = 64/261 (24%), Positives = 108/261 (41%), Gaps = 29/261 (11%)
Query: 664 KERVGAGSFGTVHRAE-WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLF 721
K+ +G G+ GT+ + DVAVK + L + REV +++ HPNV+ +
Sbjct: 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRI-----LPECFSFADREVQLLRESDEHPNVIRY 83
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
R I E +L + + + + L G+ +LH+LN
Sbjct: 84 FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITL--LQQTTSGLAHLHSLN-- 138
Query: 782 ILHWDLKSPNLLV-----DKNWTVKVCDFGLSRF---KANTFISSKSVAGTPEWMAPEFL 833
I+H DLK N+L+ + DFGL + ++F V GT W+APE L
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 834 RGEPS---NEKSDVYSFGVILWELVTM-QQPWNGLGPAQV---VGAVAFQNRRLAIPQNT 886
+ D++S G + + +++ P+ Q +GA + L ++
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLD--CLHPEKHE 256
Query: 887 SPVLASLMESCWADDPAQRPS 907
+ L+E A DP +RPS
Sbjct: 257 DVIARELIEKMIAMDPQKRPS 277
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 63/253 (24%), Positives = 116/253 (45%), Gaps = 20/253 (7%)
Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLT----VQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
G G FG V+ A +A+KVL + ++ QL+ REV I +RHPN++
Sbjct: 18 GKGKFGNVYLAR-EKQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILR 73
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
G + ++ EY P G++YR + + + +QR ++A ++Y H+
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTA-TYITELANALSYCHSKR- 129
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNE 840
++H D+K NLL+ +K+ DFG S ++ + GT +++ PE + G +E
Sbjct: 130 -VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--RTDLCGTLDYLPPEMIEGRMHDE 186
Query: 841 KSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD 900
K D++S GV+ +E + + P+ + + P + L+
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLISRLLKH 244
Query: 901 DPAQRPSFANIVE 913
+P+QRP ++E
Sbjct: 245 NPSQRPMLREVLE 257
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 5e-38
Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 61/289 (21%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLF 721
E VG G++G V++ G A+KV+ D D+ +E +E+ ++K+ H N+ +
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATY 86
Query: 722 MGAVTKRP------HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRR--LRMALDVAKGIN 773
GA K+ L +V E+ GS+ LI + ++ R L +G++
Sbjct: 87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL---RGLS 143
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS------RFKANTFISSKSVAGTPEW 827
+LH ++H D+K N+L+ +N VK+ DFG+S + NTFI GTP W
Sbjct: 144 HLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYW 195
Query: 828 MAPEFLRGEPS-----NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAI 882
MAPE + + + + KSD++S G+ E+ P + P + + I
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---------FLI 246
Query: 883 PQNTSPVLASL---------MESCWADDPAQRPSFANIVESLKKLLKSP 922
P+N +P L S +ESC + +QRP + ++L+K P
Sbjct: 247 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRP-------ATEQLMKHP 288
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 71/275 (25%), Positives = 123/275 (44%), Gaps = 44/275 (16%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDF-LDDQLKEFLREVAIMKRVRHPNVVLF 721
+G GSFG V+ A + VA+K ++ +++ ++ ++EV ++++RHPN + +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
G + +V EY GS L+ + + + + +G+ YLH+ N
Sbjct: 120 RGCYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHN-- 174
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLS--RFKANTFISSKSVAGTPEWMAPE---FLRGE 836
++H D+K+ N+L+ + VK+ DFG + AN+F+ GTP WMAPE +
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAMDEG 228
Query: 837 PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA----- 891
+ K DV+S G+ EL + P + + I QN SP L
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---------YHIAQNESPALQSGHWS 279
Query: 892 ----SLMESCWADDPAQRPSFANIVESLKKLLKSP 922
+ ++SC P RP + + LLK
Sbjct: 280 EYFRNFVDSCLQKIPQDRP-------TSEVLLKHR 307
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-37
Identities = 48/234 (20%), Positives = 92/234 (39%), Gaps = 23/234 (9%)
Query: 668 GAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAV 725
G TV+ A G V V+ + ++ ++ + E+ + K HPN+V +
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 726 TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHW 785
L +VT ++ GS LI + M++ + V K ++Y+H++ +H
Sbjct: 96 IADNELWVVTSFMAYGSAKDLI-CTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHR 152
Query: 786 DLKSPNLLVDKNWTVKVCDFGLS------RFKANT-FISSKSVAGTPEWMAPEFLRGEPS 838
+K+ ++L+ + V + + + K W++PE L+
Sbjct: 153 SVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQ 212
Query: 839 --NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890
+ KSD+YS G+ EL P+ + Q++ L T P L
Sbjct: 213 GYDAKSDIYSVGITACELANGHVPFKDMPATQML---------LEKLNGTVPCL 257
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 64/253 (25%), Positives = 116/253 (45%), Gaps = 20/253 (7%)
Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLT----VQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
G G FG V+ A +A+KVL ++ ++ QL+ RE+ I +RHPN++
Sbjct: 23 GKGKFGNVYLAR-EKQNKFIMALKVLFKSQLEKEGVEHQLR---REIEIQSHLRHPNILR 78
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
R + ++ E+ PRG LY+ + + G +QR ++A ++Y H
Sbjct: 79 MYNYFHDRKRIYLMLEFAPRGELYKELQK--HGRFDEQRSA-TFMEELADALHYCHERK- 134
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNE 840
++H D+K NLL+ +K+ DFG S + +++ GT +++ PE + G+ +E
Sbjct: 135 -VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RTMCGTLDYLPPEMIEGKTHDE 191
Query: 841 KSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWAD 900
K D++ GV+ +E + P++ + + N L P S L+
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDLKFPPFLSDGSKDLISKLLRY 249
Query: 901 DPAQRPSFANIVE 913
P QR ++E
Sbjct: 250 HPPQRLPLKGVME 262
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 55/166 (33%), Positives = 92/166 (55%), Gaps = 5/166 (3%)
Query: 762 LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR--FKANTFISSK 819
+ + VAKG+ +L + +H DL + N+L+ + VK+CDFGL+R +K ++
Sbjct: 196 ICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 820 SVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNR 878
+WMAPE + +SDV+SFGV+LWE+ ++ P+ G+ + +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 313
Query: 879 RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQ 924
R+ P T+P + M CW +P+QRP+F+ +VE L LL++ AQ
Sbjct: 314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 359
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 6e-16
Identities = 36/167 (21%), Positives = 62/167 (37%), Gaps = 20/167 (11%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQLKEFL 704
W E D L + + +G G+FG V A+ G D VAVK+L + + + +
Sbjct: 16 KW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALM 73
Query: 705 REVAIMKRV-RHPNVVLFMGAVTKRPH-LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL 762
E+ I+ + H NVV +GA TK L ++ E+ G+L + +R
Sbjct: 74 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS---------KRNE 124
Query: 763 RMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
+ + DLK + + + F +
Sbjct: 125 FVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 77/265 (29%), Positives = 123/265 (46%), Gaps = 35/265 (13%)
Query: 663 VKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQ--LKEFLREVAIMKRVRHPNV 718
+ E +G G VH A DVAVKVL D D F RE + HP +
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 719 VLFMGAV--------TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
V AV P IV EY+ +L ++H M +R + + D +
Sbjct: 75 V----AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS---SKSVAGTPEW 827
+N+ H I+H D+K N+++ VKV DFG++R A++ S + +V GT ++
Sbjct: 128 ALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 828 MAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP---- 883
++PE RG+ + +SDVYS G +L+E++T + P+ G P +VA+Q+ R
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV----SVAYQHVREDPIPPSA 241
Query: 884 --QNTSPVLASLMESCWADDPAQRP 906
+ S L +++ A +P R
Sbjct: 242 RHEGLSADLDAVVLKALAKNPENRY 266
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 50/214 (23%), Positives = 88/214 (41%), Gaps = 31/214 (14%)
Query: 668 GAGSFGTVHRAEWHGSDVAVKVL---------------TVQDFLDDQLKEFLREVAIMKR 712
G F + E A+K + + + +F E+ I+
Sbjct: 40 NQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD 99
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK-- 770
+++ + G +T + I+ EY+ S+ + ++D+ + + V K
Sbjct: 100 IKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY---FFVLDKNYTCFIPIQVIKCI 156
Query: 771 ------GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
+Y+HN I H D+K N+L+DKN VK+ DFG S + + I K GT
Sbjct: 157 IKSVLNSFSYIHNEKN-ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI--KGSRGT 213
Query: 825 PEWMAPEFLRGEP--SNEKSDVYSFGVILWELVT 856
E+M PEF E + K D++S G+ L+ +
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-36
Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 27/202 (13%)
Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
VKE +G G+F V R H G + A K++ + ++ RE I ++++HPN+V
Sbjct: 10 VKEELGKGAFSVVRRCV-HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVAKGIN 773
++ + +V + + G L+ ++ R A + Q + + I
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ---------ILESIA 119
Query: 774 YLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMA 829
Y H+ I+H +LK NLL+ K VK+ DFGL+ + AGTP +++
Sbjct: 120 YCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLS 175
Query: 830 PEFLRGEPSNEKSDVYSFGVIL 851
PE L+ +P ++ D+++ GVIL
Sbjct: 176 PEVLKKDPYSKPVDIWACGVIL 197
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-36
Identities = 66/262 (25%), Positives = 107/262 (40%), Gaps = 36/262 (13%)
Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKE-FLREVAIMKRVRHPNVVLFMG 723
G G F A K++ L +E E++I + + H +VV F G
Sbjct: 24 GKGGFAKCFEIS-DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
+ +V E R SL L R + + R + G YLH ++
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKR--RKALTEPEAR-YYLRQIVLGCQYLHRNR--VI 137
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSD 843
H DLK NL ++++ VK+ DFGL+ K + GTP ++APE L + + + D
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVD 197
Query: 844 VYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ------------NRRLAIPQNTSPVLA 891
V+S G I++ L +VG F+ +IP++ +PV A
Sbjct: 198 VWSIGCIMYTL--------------LVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA 243
Query: 892 SLMESCWADDPAQRPSFANIVE 913
SL++ DP RP+ ++
Sbjct: 244 SLIQKMLQTDPTARPTINELLN 265
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-35
Identities = 36/293 (12%), Positives = 84/293 (28%), Gaps = 47/293 (16%)
Query: 661 LHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKR----- 712
L +G A G V V + + +K+ EV ++
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 713 -----------------VRHPNVVLFMGAVTKRPHLSIVTEYL----PRGSLYRLI---- 747
V+ P + + +++ + + +L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 748 HRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807
+ + + RL++ L V + + LH+ ++H L+ ++++D+ V + F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 808 SR-FKANTFISSKSVAGTPEWMAPEFLRGEPSNEK-----SDVYSFGVILWELVTMQQPW 861
A+ PE A L + D ++ G+ ++ + P
Sbjct: 258 LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317
Query: 862 NGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914
+ +N + +L+E R +E+
Sbjct: 318 TDDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 74/252 (29%), Positives = 123/252 (48%), Gaps = 17/252 (6%)
Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV-LFMG 723
G G+F V A H G +VA+K++ L++ REV IMK + HPN+V LF
Sbjct: 24 GKGNFAKVKLAR-HILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
T++ L ++ EY G ++ + A G M ++ R + + Y H I+
Sbjct: 83 IETEK-TLYLIMEYASGGEVFDYLV--AHGRMKEKEAR-SKFRQIVSAVQYCHQKR--IV 136
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSVAGTPEWMAPEFLRGEPSN-EK 841
H DLK+ NLL+D + +K+ DFG S F + + G P + APE +G+ + +
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGAPPYAAPELFQGKKYDGPE 194
Query: 842 SDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADD 901
DV+S GVIL+ LV+ P++G ++ V + IP S +L++ +
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQNLKELRERV--LRGKYRIPFYMSTDCENLLKRFLVLN 252
Query: 902 PAQRPSFANIVE 913
P +R + I++
Sbjct: 253 PIKRGTLEQIMK 264
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 54/264 (20%), Positives = 98/264 (37%), Gaps = 38/264 (14%)
Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQ--LKEFLREVAIMKRVRHPN 717
++ VG G G V+ AE VA+K+++ + D RE R++ P+
Sbjct: 37 RLRRLVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 718 VVLFMGAV----TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
VV + L + + L ++ R + R + + + ++
Sbjct: 96 VV----PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALD 148
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI-SSKSVAGTPEWMAPEF 832
H H D+K N+LV + + DFG++ + + + GT +MAPE
Sbjct: 149 AAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206
Query: 833 LRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ----------NRRLAI 882
+ ++D+Y+ +L+E +T P+ G +V R I
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPPYQGDQL-----SVMGAHINQAIPRPSTVRPGI 261
Query: 883 PQNTSPVLASLMESCWADDPAQRP 906
P V+A M A +P R
Sbjct: 262 PVAFDAVIARGM----AKNPEDRY 281
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 61/265 (23%), Positives = 110/265 (41%), Gaps = 41/265 (15%)
Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLT----VQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
G GSF V+RAE G +VA+K++ + + +++ EV I +++HP+++
Sbjct: 20 GKGSFAGVYRAE-SIHTGLEVAIKMIDKKAMYKAGMVQRVQ---NEVKIHCQLKHPSILE 75
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
++ +V E G + R + + R M + G+ YLH+
Sbjct: 76 LYNYFEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMH-QIITGMLYLHSHG- 132
Query: 781 PILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNE 840
ILH DL NLL+ +N +K+ DFGL+ ++ GTP +++PE
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGL 191
Query: 841 KSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ------------NRRLAIPQNTSP 888
+SDV+S G + + L ++G F +P S
Sbjct: 192 ESDVWSLGCMFYTL--------------LIGRPPFDTDTVKNTLNKVVLADYEMPSFLSI 237
Query: 889 VLASLMESCWADDPAQRPSFANIVE 913
L+ +PA R S +++++
Sbjct: 238 EAKDLIHQLLRRNPADRLSLSSVLD 262
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 67/262 (25%), Positives = 107/262 (40%), Gaps = 36/262 (13%)
Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKE-FLREVAIMKRVRHPNVVLFMG 723
G G F A K++ L +E E++I + + H +VV F G
Sbjct: 50 GKGGFAKCFEIS-DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
+ +V E R SL L R + + R + G YLH ++
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKR--RKALTEPEAR-YYLRQIVLGCQYLHRNR--VI 163
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSD 843
H DLK NL ++++ VK+ DFGL+ K + GTP ++APE L + + + D
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVD 223
Query: 844 VYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLA------------IPQNTSPVLA 891
V+S G I++ L +VG F+ L IP++ +PV A
Sbjct: 224 VWSIGCIMYTL--------------LVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA 269
Query: 892 SLMESCWADDPAQRPSFANIVE 913
SL++ DP RP+ ++
Sbjct: 270 SLIQKMLQTDPTARPTINELLN 291
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 26/200 (13%)
Query: 663 VKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
E +G+G+F V + G A+K + D E+A++K+++H N+V
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS--SLENEIAVLKKIKHENIVT 70
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVAKGINY 774
H +V + + G L+ R++ R A ++ Q V + Y
Sbjct: 71 LEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ---------VLSAVKY 121
Query: 775 LHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPE 831
LH I+H DLK NLL ++N + + DFGLS+ + N + + GTP ++APE
Sbjct: 122 LHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--STACGTPGYVAPE 177
Query: 832 FLRGEPSNEKSDVYSFGVIL 851
L +P ++ D +S GVI
Sbjct: 178 VLAQKPYSKAVDCWSIGVIT 197
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 68/201 (33%), Positives = 100/201 (49%), Gaps = 26/201 (12%)
Query: 663 VKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
+ +G GSFG V + + + AVKV+ + LREV ++K++ HPN++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVAKGINY 774
+ IV E G L+ +I R A ++ Q V GI Y
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ---------VFSGITY 136
Query: 775 LHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMAP 830
+H N I+H DLK N+L+ +K+ +K+ DFGLS F+ NT + K GT ++AP
Sbjct: 137 MHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAP 192
Query: 831 EFLRGEPSNEKSDVYSFGVIL 851
E LRG +EK DV+S GVIL
Sbjct: 193 EVLRG-TYDEKCDVWSAGVIL 212
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 48/230 (20%), Positives = 91/230 (39%), Gaps = 25/230 (10%)
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA 765
++ M N V + + + +L I + + +L ++R + E + L +
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA--- 822
+ +A+ + +LH+ ++H DLK N+ + VKV DFGL +
Sbjct: 171 IQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 823 ---------GTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAV 873
GT +M+PE + G + K D++S G+IL+EL +
Sbjct: 229 AYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL------LYSFSTQMERVRI 282
Query: 874 AFQNRRLAIP---QNTSPVLASLMESCWADDPAQRPSFANIVES--LKKL 918
R L P P +++ + P +RP +I+E+ + L
Sbjct: 283 ITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 14/63 (22%), Positives = 31/63 (49%), Gaps = 3/63 (4%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
+ + +G G FG V A+ + A+K + + + + ++ +REV + ++ HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHP 64
Query: 717 NVV 719
+V
Sbjct: 65 GIV 67
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-34
Identities = 49/200 (24%), Positives = 94/200 (47%), Gaps = 22/200 (11%)
Query: 663 VKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
+ E +G G+F V R G + A ++ + ++ RE I + ++HPN+V
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVAKGINY 774
++++ H ++ + + G L+ ++ R A + Q + + + +
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ---------ILEAVLH 125
Query: 775 LHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPE 831
H + ++H +LK NLL+ K VK+ DFGL+ + AGTP +++PE
Sbjct: 126 CHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE 183
Query: 832 FLRGEPSNEKSDVYSFGVIL 851
LR +P + D+++ GVIL
Sbjct: 184 VLRKDPYGKPVDLWACGVIL 203
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-34
Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 25/201 (12%)
Query: 663 VKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
VKE +G G+F V R G + A K++ + ++ RE I ++++HPN+V
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVAKGINY 774
++ + +V + + G L+ ++ R A + Q + + I Y
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ---------ILESIAY 143
Query: 775 LHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMAP 830
H+ I+H +LK NLL+ K VK+ DFGL+ + AGTP +++P
Sbjct: 144 CHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSP 199
Query: 831 EFLRGEPSNEKSDVYSFGVIL 851
E L+ +P ++ D+++ GVIL
Sbjct: 200 EVLKKDPYSKPVDIWACGVIL 220
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 7e-34
Identities = 51/291 (17%), Positives = 97/291 (33%), Gaps = 46/291 (15%)
Query: 604 ESSVIIKQPNATLPSQLDKEDESKLEKQGKFPVGPGPRYL-------NIEPSLAMDWLEI 656
S + PN + + D + KL PV P I+P ++
Sbjct: 6 SSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTE---FQL 62
Query: 657 SWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQLKEF---LRE 706
++V +G G+F V+ A + +KV EF +
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-----PANPWEFYIGTQL 117
Query: 707 VAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI--HRPAAGEMMDQRRRLRM 764
+ +K + F A + +V E G+L I ++ ++M Q +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLV-----------DKNWTVKVCDFGLSR---- 809
A+ + I +H+ I+H D+K N ++ D + + + D G S
Sbjct: 178 AMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 810 FKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQP 860
F T + T + E L +P N + D + ++ ++
Sbjct: 236 FPKGTIF--TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-34
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 32/207 (15%)
Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVL----TVQDFLDDQLKEFLREVAIMKRVRH 715
+ E +G+G F V + G + A K + +E REV I++ +RH
Sbjct: 9 MGEELGSGQFAIVRKCR-QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVA 769
PN++ + + ++ E + G L+ L + A + + Q +
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ---------IL 118
Query: 770 KGINYLHNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGLSR-FKANTFISSKSVAGT 824
G++YLH+ I H+DLK N+++ N +K+ DFG++ +A K++ GT
Sbjct: 119 DGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGT 174
Query: 825 PEWMAPEFLRGEPSNEKSDVYSFGVIL 851
PE++APE + EP ++D++S GVI
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-34
Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 17/199 (8%)
Query: 660 ELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
+ E +G G FG VH+ E G +A K++ + + D+ +E E+++M ++ H
Sbjct: 90 TVSKTEILGGGRFGQVHKCE-ETATGLKLAAKIIKTRG-MKDK-EEVKNEISVMNQLDHA 146
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
N++ A + + +V EY+ G L+ R+I + + + + +GI ++
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE---SYNLTELDTILFMKQICEGIRHM 203
Query: 776 HNLNPPILHWDLKSPNLLV--DKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMAPEF 832
H + ILH DLK N+L +K+ DFGL+R +K + K GTPE++APE
Sbjct: 204 HQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEFLAPEV 259
Query: 833 LRGEPSNEKSDVYSFGVIL 851
+ + + +D++S GVI
Sbjct: 260 VNYDFVSFPTDMWSVGVIA 278
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-34
Identities = 76/291 (26%), Positives = 123/291 (42%), Gaps = 55/291 (18%)
Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVL------------------------TVQDF 695
+K+ +G GS+G V A + + A+KVL
Sbjct: 17 LKDEIGKGSYGVVKLAY-NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 696 LDDQLKEFLREVAIMKRVRHPNVV-LF--MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAA 752
+++ +E+AI+K++ HPNVV L + + HL +V E + +G + +
Sbjct: 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVPTLKPL 134
Query: 753 GEMMDQ-RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811
E DQ R + D+ KGI YLH I+H D+K NLLV ++ +K+ DFG+S
Sbjct: 135 SE--DQARFYFQ---DLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVS--- 184
Query: 812 ANTFISS----KSVAGTPEWMAPEFLRGEPSN---EKSDVYSFGVILWELVTMQQPWNGL 864
N F S + GTP +MAPE L + DV++ GV L+ V Q P+
Sbjct: 185 -NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243
Query: 865 GPAQVVGAVAFQNRRLAIPQ--NTSPVLASLMESCWADDPAQRPSFANIVE 913
+ + +++ L P + + L L+ +P R I
Sbjct: 244 RIMCLHSKI--KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-33
Identities = 58/256 (22%), Positives = 100/256 (39%), Gaps = 32/256 (12%)
Query: 663 VKERVGAGSFGTVHRAE---WHGSDVAVKVLTVQDFLDDQLKE-FLREVAIMKRVRHPNV 718
VK + G G ++ A +G V +K L D + + + E + V HP++
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSI 141
Query: 719 VL-----FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
V P IV EY+ SL R + + + L++ ++
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALS 196
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFL 833
YLH++ +++ DLK N+++ + +K+ D G S + GTP + APE +
Sbjct: 197 YLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVS----RINSFGYLYGTPGFQAPEIV 249
Query: 834 RGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893
R P+ +D+Y+ G L L NG + V + + L L
Sbjct: 250 RTGPT-VATDIYTVGRTLAALTLDLPTRNG----RYVDGLPEDDPVLKTY----DSYGRL 300
Query: 894 MESCWADDPAQRPSFA 909
+ DP QR + A
Sbjct: 301 LRRAIDPDPRQRFTTA 316
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVL----TVQDFLDDQLKEFLREVAIMKRVRH 715
+ E +G+G F V + G + A K + + +E REV+I+++V H
Sbjct: 16 IGEELGSGQFAIVKKCR-EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVA 769
NV+ R + ++ E + G L+ L + A + Q +
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ---------IL 125
Query: 770 KGINYLHNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGLSR-FKANTFISSKSVAGT 824
G+NYLH I H+DLK N+++ +K+ DFGL+ + K++ GT
Sbjct: 126 DGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGT 181
Query: 825 PEWMAPEFLRGEPSNEKSDVYSFGVIL 851
PE++APE + EP ++D++S GVI
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVL----TVQDFLDDQLKEFLREVAIMKRVRH 715
E +G+G F V + G A K + T ++ REV+I+K ++H
Sbjct: 15 TGEELGSGQFAVVKKCR-EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVA 769
PNV+ + + ++ E + G L+ L + A E + Q +
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ---------IL 124
Query: 770 KGINYLHNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGLSR-FKANTFISSKSVAGT 824
G+ YLH+L I H+DLK N+++ +K+ DFGL+ K++ GT
Sbjct: 125 NGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGT 180
Query: 825 PEWMAPEFLRGEPSNEKSDVYSFGVIL 851
PE++APE + EP ++D++S GVI
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 38/214 (17%)
Query: 662 HVKERVGAGSFGTVHRAEWH---GSDVAVKV-------LTVQDFLDDQLKEFLREVAIMK 711
KE +G G V R H + AVK+ + + + + L+EV I++
Sbjct: 20 EPKEILGRGVSSVVRRCI-HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 712 RV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRM 764
+V HPN++ +V + + +G L+ L + ++M
Sbjct: 79 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA------ 132
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAG 823
+ + I LH LN I+H DLK N+L+D + +K+ DFG S + + V G
Sbjct: 133 ---LLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCG 185
Query: 824 TPEWMAPEFLRGEPS------NEKSDVYSFGVIL 851
TP ++APE + + ++ D++S GVI+
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 51/197 (25%), Positives = 97/197 (49%), Gaps = 13/197 (6%)
Query: 662 HVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
K ++G+G+FG VH E G + +K + +D +++ E+ ++K + HPN++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTIN-KDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
++ IV E G L R++ A G+ + + + + + Y H+
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 779 NPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMAPEFLR 834
+ ++H DLK N+L + +K+ DFGL+ FK++ + AGT +MAPE +
Sbjct: 144 H--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPEVFK 199
Query: 835 GEPSNEKSDVYSFGVIL 851
+ K D++S GV++
Sbjct: 200 RD-VTFKCDIWSAGVVM 215
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-33
Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKV-----LTVQDFLDDQLKEFLREVAIMKRVR 714
+ E +G G F V R + G AVK+ T L + + RE +I ++
Sbjct: 28 LCEVIGKGPFSVVRRCI-NRETGQQFAVKIVDVAKFTSSPGLSTE--DLKREASICHMLK 84
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
HP++V + + L +V E++ L ++ R AG + + + + +
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 774 YLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAP 830
Y H+ N I+H D+K +L+ + + VK+ FG++ + + + GTP +MAP
Sbjct: 145 YCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 831 EFLRGEPSNEKSDVYSFGVIL 851
E ++ EP + DV+ GVIL
Sbjct: 203 EVVKREPYGKPVDVWGCGVIL 223
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-32
Identities = 71/258 (27%), Positives = 114/258 (44%), Gaps = 36/258 (13%)
Query: 619 QLDKEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRA 678
L QG PG + + L+ + +++G+G++G V
Sbjct: 5 HHHSSGRENLYFQGDLQATPGMFITSKKGHLS--------EMYQRVKKLGSGAYGEVLLC 56
Query: 679 EWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735
+ A+K++ + L EVA++K + HPN++ + + +V
Sbjct: 57 R-DKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115
Query: 736 EYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS 789
E G L+ +IHR A ++ Q V G+ YLH N I+H DLK
Sbjct: 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQ---------VLSGVTYLHKHN--IVHRDLKP 164
Query: 790 PNLLV---DKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVY 845
NLL+ +K+ +K+ DFGLS F+ + K GT ++APE LR +EK DV+
Sbjct: 165 ENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPEVLRK-KYDEKCDVW 221
Query: 846 SFGVILWELVTMQQPWNG 863
S GVIL+ L+ P+ G
Sbjct: 222 SIGVILFILLAGYPPFGG 239
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 28/202 (13%)
Query: 662 HVKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
++ +G GS+G V A A K + + F++D F +E+ IMK + HPN++
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIP-KYFVEDV-DRFKQEIEIMKSLDHPNII 69
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVAKGIN 773
+ +V E G L+ R++H+ A +M V +
Sbjct: 70 RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKD---------VLSAVA 120
Query: 774 YLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMA 829
Y H LN + H DLK N L + +K+ DFGL+ FK + ++ GTP +++
Sbjct: 121 YCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVS 176
Query: 830 PEFLRGEPSNEKSDVYSFGVIL 851
P+ L G + D +S GV++
Sbjct: 177 PQVLEG-LYGPECDEWSAGVMM 197
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 30/204 (14%)
Query: 664 KERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH-PNVV 719
+ +G G F V + G + A K L + D E L E+A+++ + P V+
Sbjct: 34 SKELGRGKFAVVRQCI-SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRP-------AAGEMMDQRRRLRMALDVAKG 771
+ ++ EY G ++ + ++ Q + +G
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ---------ILEG 143
Query: 772 INYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEW 827
+ YLH N I+H DLK N+L+ +K+ DFG+SR + + + GTPE+
Sbjct: 144 VYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGTPEY 199
Query: 828 MAPEFLRGEPSNEKSDVYSFGVIL 851
+APE L +P +D+++ G+I
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIA 223
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 32/207 (15%)
Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVL----TVQDFLDDQLKEFLREVAIMKRVRH 715
+ E +G+G F V + G + A K + + +E REV+I+++V H
Sbjct: 16 IGEELGSGQFAIVKKCR-EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVA 769
PN++ R + ++ E + G L+ L + A + Q +
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ---------IL 125
Query: 770 KGINYLHNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGLSR-FKANTFISSKSVAGT 824
G+NYLH I H+DLK N+++ +K+ DFGL+ + K++ GT
Sbjct: 126 DGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGT 181
Query: 825 PEWMAPEFLRGEPSNEKSDVYSFGVIL 851
PE++APE + EP ++D++S GVI
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-32
Identities = 59/278 (21%), Positives = 110/278 (39%), Gaps = 42/278 (15%)
Query: 664 KERVGAGSFGTVHRA-EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLF 721
++ +G GS GTV + G VAVK + L D L E+ ++ HPNV+ +
Sbjct: 20 EKILGYGSSGTVVFQGSFQGRPVAVKRM-----LIDFCDIALMEIKLLTESDDHPNVIRY 74
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL----DVAKGINYLHN 777
+ T L I E +L L+ + + ++ + +A G+ +LH+
Sbjct: 75 YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 778 LNPPILHWDLKSPNLLVD-------------KNWTVKVCDFGLSRF----KANTFISSKS 820
L I+H DLK N+LV +N + + DFGL + +++ + +
Sbjct: 134 LK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 821 VAGTPEWMAPEFLRG-------EPSNEKSDVYSFGVILWELVTMQQP--WNGLGPAQVV- 870
+GT W APE L D++S G + + +++ + + +
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251
Query: 871 -GAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPS 907
G + + ++ L+ DP +RP+
Sbjct: 252 RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT 289
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-32
Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 17/197 (8%)
Query: 662 HVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
+ E +G+G+FG VHR G K + LD E++IM ++ HP +
Sbjct: 54 DILEELGSGAFGVVHRCV-EKATGRVFVAKFINTPYPLDKY--TVKNEISIMNQLHHPKL 110
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
+ A + + ++ E+L G L+ R+ M + + +G+ ++H
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHE 167
Query: 778 LNPPILHWDLKSPNLLV--DKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMAPEFLR 834
+ I+H D+K N++ K +VK+ DFGL+ + + K T E+ APE +
Sbjct: 168 HS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEIVD 223
Query: 835 GEPSNEKSDVYSFGVIL 851
EP +D+++ GV+
Sbjct: 224 REPVGFYTDMWAIGVLG 240
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-32
Identities = 69/209 (33%), Positives = 104/209 (49%), Gaps = 28/209 (13%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
+ ++ +G GSFG V + + + AVKV+ + LREV ++K++ H
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCK-DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVA 769
PN++ + IV E G L+ +I R A ++ Q V
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ---------VF 131
Query: 770 KGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR-FKANTFISSKSVAGTP 825
GI Y+H N I+H DLK N+L+ +K+ +K+ DFGLS F+ NT + K GT
Sbjct: 132 SGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTA 187
Query: 826 EWMAPEFLRGEPSNEKSDVYSFGVILWEL 854
++APE LRG +EK DV+S GVIL+ L
Sbjct: 188 YYIAPEVLRG-TYDEKCDVWSAGVILYIL 215
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-32
Identities = 50/212 (23%), Positives = 98/212 (46%), Gaps = 37/212 (17%)
Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVL------TVQDFLDDQLKEFLREVAIMKRV 713
K+ +G G V R H G + AVK++ + L++ + RE I+++V
Sbjct: 98 PKDVIGRGVSSVVRRCV-HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQV 156
Query: 714 R-HPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMAL 766
HP+++ + + + +V + + +G L+ L + +M
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRS-------- 208
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAGTP 825
+ + +++LH N I+H DLK N+L+D N +++ DFG S + + + + GTP
Sbjct: 209 -LLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELCGTP 263
Query: 826 EWMAPEFLRGEPS------NEKSDVYSFGVIL 851
++APE L+ ++ D+++ GVIL
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 31/206 (15%)
Query: 660 ELHVKERV-GAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR- 714
+L +K++ G GSF + H AVK+++ +E+ +K
Sbjct: 11 DLDLKDKPLGEGSFSICRKCV-HKKSNQAFAVKIIS-----KRMEANTQKEITALKLCEG 64
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDV 768
HPN+V + H +V E L G L+ R+ + A +M + +
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRK---------L 115
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKANTFISSKSVAGTP 825
++++H++ ++H DLK NLL + N +K+ DFG +R K K+ T
Sbjct: 116 VSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTL 173
Query: 826 EWMAPEFLRGEPSNEKSDVYSFGVIL 851
+ APE L +E D++S GVIL
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 69/268 (25%), Positives = 114/268 (42%), Gaps = 40/268 (14%)
Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEF--LREVAIMKRVRHPNVV-LF 721
G GS+G V AVK+L + E +E+ +++R+RH NV+ L
Sbjct: 14 GEGSYGKVKEVL-DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 722 --MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------G 771
+ K+ + +V EY G EM+D R + A G
Sbjct: 73 DVLYNEEKQ-KMYMVMEYCVCGM----------QEMLDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS----RFKANTFISSKSVAGTPEW 827
+ YLH+ I+H D+K NLL+ T+K+ G++ F A+ ++ G+P +
Sbjct: 122 LEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC--RTSQGSPAF 177
Query: 828 MAPEFLRGEP--SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQN 885
PE G S K D++S GV L+ + T P+ G ++ + AIP +
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI--GKGSYAIPGD 235
Query: 886 TSPVLASLMESCWADDPAQRPSFANIVE 913
P L+ L++ +PA+R S I +
Sbjct: 236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 29/205 (14%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
D V+ +G G+ V+R + G+ A+KVL E+ ++ R+ HP
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI----VRTEIGVLLRLSHP 108
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVAK 770
N++ +S+V E + G L+ R++ + A + + Q + +
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ---------ILE 159
Query: 771 GINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRF-KANTFISSKSVAGTPE 826
+ YLH I+H DLK NLL + +K+ DFGLS+ + + K+V GTP
Sbjct: 160 AVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPG 215
Query: 827 WMAPEFLRGEPSNEKSDVYSFGVIL 851
+ APE LRG + D++S G+I
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 63/266 (23%), Positives = 109/266 (40%), Gaps = 44/266 (16%)
Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLT------VQDFLDDQLKEFLREVAIMKRVRHPNV 718
G+G+FG V A +V VK + D +L + E+AI+ RV H N+
Sbjct: 33 GSGAFGFVWTAV-DKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQ-RRRLRMALDVAK------- 770
+ + + +V E G ++ R R+ +A
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG-----------LDLFAFIDRHPRLDEPLASYIFRQLV 140
Query: 771 -GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWM 828
+ YL + I+H D+K N+++ +++T+K+ DFG + + + GT E+
Sbjct: 141 SAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTFCGTIEYC 196
Query: 829 APEFLRGEP-SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTS 887
APE L G P + +++S GV L+ LV + P+ L + V A + P S
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL--EETVEA------AIHPPYLVS 248
Query: 888 PVLASLMESCWADDPAQRPSFANIVE 913
L SL+ P +R + +V
Sbjct: 249 KELMSLVSGLLQPVPERRTTLEKLVT 274
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 42/203 (20%), Positives = 88/203 (43%), Gaps = 30/203 (14%)
Query: 662 HVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
+ E +G G FG VHR K + V+ +K +E++I+ RH N+
Sbjct: 8 MIAEDLGRGEFGIVHRCV-ETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNI 63
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR------PAAGEMMDQRRRLRMALDVAKG 771
+ + L ++ E++ ++ R+ + Q V +
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ---------VCEA 114
Query: 772 INYLHNLNPPILHWDLKSPNLLV--DKNWTVKVCDFGLSRF-KANTFISSKSVAGTPEWM 828
+ +LH+ N I H+D++ N++ ++ T+K+ +FG +R K + + PE+
Sbjct: 115 LQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYY 170
Query: 829 APEFLRGEPSNEKSDVYSFGVIL 851
APE + + + +D++S G ++
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLV 193
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 33/211 (15%)
Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLTVQDFLD--DQLKEFLREVAIMKRVRHPNVVLFM 722
G G++G V A + VAVK++ ++ +D + +K +E+ I K + H NVV F
Sbjct: 16 GEGAYGEVQLAV-NRVTEEAVAVKIVDMKRAVDCPENIK---KEICINKMLNHENVVKFY 71
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
G + + EY G L+ I + M A+ G+ Y
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRI-----------EPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS--KSVAGTPEWMAPEF 832
LH + I H D+K NLL+D+ +K+ DFGL+ + GT ++APE
Sbjct: 121 LHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 833 LRGEP-SNEKSDVYSFGVILWELVTMQQPWN 862
L+ E DV+S G++L ++ + PW+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-31
Identities = 77/265 (29%), Positives = 122/265 (46%), Gaps = 31/265 (11%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVR 714
D + +G GSFG V + G + AVKV++ + + LREV ++K++
Sbjct: 26 DRYKGQRVLGKGSFGEVILCK-DKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDV 768
HPN++ + + +V E G L+ +I R A ++ Q V
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ---------V 135
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR-FKANTFISSKSVAGT 824
GI Y+H I+H DLK NLL+ K+ +++ DFGLS F+A+ + K GT
Sbjct: 136 LSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGT 191
Query: 825 PEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP- 883
++APE L G +EK DV+S GVIL+ L++ P+NG ++ V +P
Sbjct: 192 AYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ 250
Query: 884 -QNTSPVLASLMESCWADDPAQRPS 907
+ S L+ P+ R S
Sbjct: 251 WKKVSESAKDLIRKMLTYVPSMRIS 275
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-31
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 34/204 (16%)
Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724
G+G+FG VAVK + +D+ ++ RE+ + +RHPN+V F
Sbjct: 29 GSGNFGVARLMR-DKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNIVRFKEV 84
Query: 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINYLH 776
+ HL+I+ EY G LY I R + D A+ G++Y H
Sbjct: 85 ILTPTHLAIIMEYASGGELYERI-----------CNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 777 NLNPPILHWDLKSPNLLVDKNWT--VKVCDFGLSR-FKANTFISSKSVAGTPEWMAPEFL 833
++ I H DLK N L+D + +K+CDFG S+ ++ KS GTP ++APE L
Sbjct: 134 SMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVL 189
Query: 834 RGEPSN-EKSDVYSFGVILWELVT 856
+ + + +DV+S GV L+ ++
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLV 213
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-31
Identities = 30/294 (10%), Positives = 70/294 (23%), Gaps = 46/294 (15%)
Query: 661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPN 717
L + E + G V D A+KV T+ +L+ R+ +
Sbjct: 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123
Query: 718 VV---------------------LFMGAVTKRPHLSIVTEYL----PRGSLYRLIHR--- 749
F + ++ L L L
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183
Query: 750 -PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808
+ + + L + ++H NL + + + + D
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 809 RFKANTFISSKSVAGTPEWMAPEFLRGE--PSNEKSDVYSFGVILWELVTMQQPWNGLGP 866
+ + + EFL + + G+ ++ + + P+ + P
Sbjct: 242 WKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 867 AQ-------VVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVE 913
+ + + +L+ D +R +E
Sbjct: 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 36/272 (13%)
Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNVV-LFM 722
G G+FG V E H G VAVK+L Q + + RE+ +K RHP+++ L+
Sbjct: 20 GVGTFGKVKIGE-HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
T +V EY+ G L+ I + R+ A+ ++Y
Sbjct: 79 VISTPT-DFFMVMEYVSGGELFDYI-----------CKHGRVEEMEARRLFQQILSAVDY 126
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMAPEFL 833
H ++H DLK N+L+D + K+ DFGLS F+ ++ G+P + APE +
Sbjct: 127 CHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAAPEVI 182
Query: 834 RGEP-SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892
G + + D++S GVIL+ L+ P++ + + + IP+ + +A+
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI--RGGVFYIPEYLNRSVAT 240
Query: 893 LMESCWADDPAQRPSFANIVES--LKKLLKSP 922
L+ DP +R + +I E K+ L S
Sbjct: 241 LLMHMLQVDPLKRATIKDIREHEWFKQDLPSY 272
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-30
Identities = 59/222 (26%), Positives = 107/222 (48%), Gaps = 39/222 (17%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH---GSDVAVKVL-----------TVQDFLDDQLKEFL 704
+ ++G+G++G V + S+ A+KV+ ++ +E
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCK-EKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 705 REVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQ 758
E++++K + HPN++ + + +VTE+ G L+ ++I+R A +M Q
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154
Query: 759 RRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR-FKANT 814
+ GI YLH N I+H D+K N+L+ + +K+ DFGLS F +
Sbjct: 155 ---------ILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203
Query: 815 FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT 856
+ + GT ++APE L+ + NEK DV+S GVI++ L+
Sbjct: 204 KL--RDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLC 242
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-30
Identities = 66/292 (22%), Positives = 116/292 (39%), Gaps = 37/292 (12%)
Query: 578 PIQEYS-RLVEENVAIEAAYKEEIVVSESSVIIKQPNATLPSQLDKEDESKLEKQGKFPV 636
++Y R++ EN ++ E + +I E + +G
Sbjct: 74 AGKQYEFRIIAENKHGQSKPCEP---TAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSS 130
Query: 637 GPGPRYLNIEPSLAMDWLEISWDELH----VKERVGAGSFGTVHRAEWH---GSDVAVKV 689
+I +EI D + + E +G G+FG VHR G++ A K
Sbjct: 131 NYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVT-ERATGNNFAAKF 189
Query: 690 LTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIH 748
+ D + +E+ M +RHP +V A + ++ E++ G L+ ++
Sbjct: 190 VMTPHESDKE--TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD 247
Query: 749 R------PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV--DKNWTV 800
A E M Q V KG+ ++H N +H DLK N++ ++ +
Sbjct: 248 EHNKMSEDEAVEYMRQ---------VCKGLCHMHENN--YVHLDLKPENIMFTTKRSNEL 296
Query: 801 KVCDFGLSR-FKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVIL 851
K+ DFGL+ + K GT E+ APE G+P +D++S GV+
Sbjct: 297 KLIDFGLTAHLDPKQSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 37/299 (12%), Positives = 85/299 (28%), Gaps = 56/299 (18%)
Query: 660 ELHVKERVGAGSFGTVHRAEWH--GSDVAVKVL-TVQDFLDDQLKEFLREVAIMKRVR-- 714
L +G A G V V + + +K+ EV ++ +R
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 715 -----------------------HPNVVLFMGAVTKRPHLSIVTEY-LPRGSLYR----L 746
++ LS Y + +L L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 747 IHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806
+ + + + RL++ L V + + LH+ ++H L+ ++++D+ V + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFE 251
Query: 807 LSRFKANTFISSKSVAGTPEWMAPEFL-----------RGEPSNEKSDVYSFGVILWELV 855
+ + + + PE R D ++ G++++ +
Sbjct: 252 HLV-RDGAR---VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 856 TMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914
P + +N + +L+E R +E+
Sbjct: 308 CADLPITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 49/211 (23%), Positives = 88/211 (41%), Gaps = 37/211 (17%)
Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVL------TVQDFLDDQLKEFLREVAIMKRV 713
+ + +G+G+ G V A VA+K++ D E+ I+K++
Sbjct: 14 MSKTLGSGACGEVKLAF-ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALD 767
HP ++ IV E + G L+ +++ Q
Sbjct: 73 NHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ--------- 122
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRF-KANTFISSKSVAG 823
+ + YLH I+H DLK N+L+ +++ +K+ DFG S+ + + +++ G
Sbjct: 123 MLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLCG 178
Query: 824 TPEWMAPEFLRGEPS---NEKSDVYSFGVIL 851
TP ++APE L + N D +S GVIL
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-30
Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 37/212 (17%)
Query: 662 HVKERVGAGSFGTVHRAEWH---GSDVAVKVL------TVQDFLDDQLKEFLREVAIMKR 712
+ + +G+G+ G V A VA++++ D E+ I+K+
Sbjct: 138 IMSKTLGSGACGEVKLAF-ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMAL 766
+ HP ++ IV E + G L+ +++ Q
Sbjct: 197 LNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ-------- 247
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRF-KANTFISSKSVA 822
+ + YLH I+H DLK N+L+ +++ +K+ DFG S+ + + +++
Sbjct: 248 -MLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLC 302
Query: 823 GTPEWMAPEFLRGEPS---NEKSDVYSFGVIL 851
GTP ++APE L + N D +S GVIL
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 33/211 (15%)
Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLTVQDFLD--DQLKEFLREVAIMKRVRHPNVVLFM 722
G G++G V A + VAVK++ ++ +D + +K +E+ I K + H NVV F
Sbjct: 16 GEGAYGEVQLAV-NRVTEEAVAVKIVDMKRAVDCPENIK---KEICINKMLNHENVVKFY 71
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
G + + EY G L+ I + M A+ G+ Y
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRI-----------EPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISS--KSVAGTPEWMAPEF 832
LH + I H D+K NLL+D+ +K+ DFGL+ + GT ++APE
Sbjct: 121 LHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 833 LRGEP-SNEKSDVYSFGVILWELVTMQQPWN 862
L+ E DV+S G++L ++ + PW+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 49/207 (23%), Positives = 90/207 (43%), Gaps = 32/207 (15%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKR-VR 714
D VKE +G GS+ R H + AVK++ D ++ E+ I+ R +
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCI-HKATNMEFAVKII------DKSKRDPTEEIEILLRYGQ 74
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDV 768
HPN++ ++ +VTE + G L +++ + A ++ +
Sbjct: 75 HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT---------I 125
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
K + YLH ++H DLK N+L ++++CDFG ++ + T
Sbjct: 126 TKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYT 183
Query: 825 PEWMAPEFLRGEPSNEKSDVYSFGVIL 851
++APE L + + D++S GV+L
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 61/253 (24%), Positives = 111/253 (43%), Gaps = 30/253 (11%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
+G GSF TV A + A+K+L + + ++++ RE +M R+ HP V
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
L Y G L + I + G + R A ++ + YLH I+
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTA-EIVSALEYLHGKG--II 152
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSR--------FKANTFISSKSVAGTPEWMAPEFLRG 835
H DLK N+L++++ +++ DFG ++ +AN+F+ GT ++++PE L
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV------GTAQYVSPELLTE 206
Query: 836 EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN---RRLAIPQNTSPVLAS 892
+ + + SD+++ G I+++LV P+ + FQ P+ P
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-----FQKIIKLEYDFPEKFFPKARD 261
Query: 893 LMESCWADDPAQR 905
L+E D +R
Sbjct: 262 LVEKLLVLDATKR 274
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 75/262 (28%), Positives = 118/262 (45%), Gaps = 37/262 (14%)
Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNVV-LFM 722
G GSFG V A H VA+K ++ Q + + RE++ +K +RHP+++ L+
Sbjct: 18 GEGSFGKVKLAT-HYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQ-RRRLRMALDVAK--------GIN 773
T + +V EY A GE+ D + RM D + I
Sbjct: 77 VITTPT-DIVMVIEY-------------AGGELFDYIVEKKRMTEDEGRRFFQQIICAIE 122
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMAPEF 832
Y H I+H DLK NLL+D N VK+ DFGLS F+ K+ G+P + APE
Sbjct: 123 YCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL--KTSCGSPNYAAPEV 178
Query: 833 LRGEP-SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891
+ G+ + + DV+S G++L+ ++ + P++ + V + +P SP
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQ 236
Query: 892 SLMESCWADDPAQRPSFANIVE 913
SL+ DP QR + I
Sbjct: 237 SLIRRMIVADPMQRITIQEIRR 258
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 55/274 (20%), Positives = 99/274 (36%), Gaps = 58/274 (21%)
Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLT----VQDFLDDQLKEFLREVAIMKRVR----HP 716
G G FGTV VA+KV+ + EVA++ +V HP
Sbjct: 40 GKGGFGTVFAGH-RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQ-RRRLRMALDVAK----- 770
V+ + + +V E ++ D + + ++
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPA-----------QDLFDYITEKGPLGEGPSRCFFGQ 147
Query: 771 ---GINYLHNLNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSRFKANTFISSKSVAGTPE 826
I + H+ ++H D+K N+L+D + K+ DFG + GT
Sbjct: 148 VVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY--TDFDGTRV 203
Query: 827 WMAPEFLRGEP-SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR------ 879
+ PE++ + V+S G++L+++V G + F+ +
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVC--------------GDIPFERDQEILEAE 249
Query: 880 LAIPQNTSPVLASLMESCWADDPAQRPSFANIVE 913
L P + SP +L+ C A P+ RPS I+
Sbjct: 250 LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-30
Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 40/207 (19%)
Query: 664 KERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVV 719
K+ +G G G V H G A+K+L + +EV + P++V
Sbjct: 34 KQVLGLGVNGKVLECF-HRRTGQKCALKLL-------YDSPKARQEVDHHWQASGGPHIV 85
Query: 720 LFMGA----VTKRPHLSIVTEYLPRGSLY-RLIHRP-------AAGEMMDQRRRLRMALD 767
+ + L I+ E + G L+ R+ R A E+M
Sbjct: 86 CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRD--------- 136
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
+ I +LH+ N I H D+K NLL +K+ +K+ DFG ++ + ++ T
Sbjct: 137 IGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL--QTPCYT 192
Query: 825 PEWMAPEFLRGEPSNEKSDVYSFGVIL 851
P ++APE L E ++ D++S GVI+
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 55/249 (22%), Positives = 95/249 (38%), Gaps = 54/249 (21%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLT---VQDFLDDQLKEFLREVAIMKR 712
+ H+K +G GS+G V A + A+K++ ++ ++ EV +MK+
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAI-ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLY-RLIHRPAAGEMMDQRRRLRMAL----- 766
+ HPN+ ++ +V E G L +L ++ +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 767 -------------------------------DVAKGINYLHNLNPPILHWDLKSPNLLV- 794
+ ++YLHN I H D+K N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFS 202
Query: 795 -DKNWTVKVCDFGLSRF----KANTFISSKSVAGTPEWMAPEFLRG--EPSNEKSDVYSF 847
+K++ +K+ DFGLS+ + + AGTP ++APE L E K D +S
Sbjct: 203 TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262
Query: 848 GVILWELVT 856
GV+L L+
Sbjct: 263 GVLLHLLLM 271
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 56/266 (21%), Positives = 105/266 (39%), Gaps = 44/266 (16%)
Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLT---VQDFLDDQLKEFL-REVAIMKRVRH--PNV 718
G+G FG+V+ VA+K + + D+ + + EV ++K+V V
Sbjct: 52 GSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMD---QRRRL------RMALDVA 769
+ + + ++ E P ++ D +R L V
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPV----------QDLFDFITERGALQEELARSFFWQVL 159
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKN-WTVKVCDFGLSRFKANTFISSKSVAGTPEWM 828
+ + + HN +LH D+K N+L+D N +K+ DFG +T GT +
Sbjct: 160 EAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY--TDFDGTRVYS 215
Query: 829 APEFLRGEP-SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTS 887
PE++R + V+S G++L+++V P+ +++ ++ Q S
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE--HDEEIIRG------QVFFRQRVS 267
Query: 888 PVLASLMESCWADDPAQRPSFANIVE 913
L+ C A P+ RP+F I
Sbjct: 268 SECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 39/213 (18%)
Query: 664 KERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVV 719
++ +G G+ V + + AVK++ Q REV ++ + + H NV+
Sbjct: 18 EDVLGEGAHARVQTCI-NLITSQEYAVKIIEKQPGHIRS--RVFREVEMLYQCQGHRNVL 74
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLY-RLIHR-----PAAGEMMDQRRRLRMALDVAKGIN 773
+ + +V E + GS+ + R A ++ VA ++
Sbjct: 75 ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQD---------VASALD 125
Query: 774 YLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSR-FKANTFISS------KSVAG 823
+LHN I H DLK N+L ++ VK+CDF L K N S + G
Sbjct: 126 FLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 824 TPEWMAPEFLRGEPSNEKS-----DVYSFGVIL 851
+ E+MAPE + D++S GVIL
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 64/263 (24%), Positives = 104/263 (39%), Gaps = 49/263 (18%)
Query: 610 KQPNATLPSQLDKEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGA 669
P P+ + +FP L I+ + +D +++ L G
Sbjct: 19 PPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVL------GL 72
Query: 670 GSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGA- 724
G G V + + A+K+L + REV + R + P++V +
Sbjct: 73 GINGKVLQIF-NKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVDVY 124
Query: 725 ---VTKRPHLSIVTEYLPRGSLY-RLIHRP-------AAGEMMDQRRRLRMALDVAKGIN 773
R L IV E L G L+ R+ R A E+M + + I
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS---------IGEAIQ 175
Query: 774 YLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRF--KANTFISSKSVAGTPEWM 828
YLH++N I H D+K NLL N +K+ DFG ++ N+ + TP ++
Sbjct: 176 YLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYV 230
Query: 829 APEFLRGEPSNEKSDVYSFGVIL 851
APE L E ++ D++S GVI+
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVIM 253
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 69/261 (26%), Positives = 120/261 (45%), Gaps = 34/261 (13%)
Query: 668 GAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFL-REVAIMKRVRHPNVV-LFM 722
G G+FG V + H G VAVK+L Q + + RE+ +K RHP+++ L+
Sbjct: 25 GVGTFGKVKVGK-HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINY 774
T + +V EY+ G L+ I + R+ ++ G++Y
Sbjct: 84 VISTPS-DIFMVMEYVSGGELFDYI-----------CKNGRLDEKESRRLFQQILSGVDY 131
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-FKANTFISSKSVAGTPEWMAPEFL 833
H ++H DLK N+L+D + K+ DFGLS F+ ++ G+P + APE +
Sbjct: 132 CHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL--RTSCGSPNYAAPEVI 187
Query: 834 RGEP-SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892
G + + D++S GVIL+ L+ P++ + + + PQ +P + S
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI--CDGIFYTPQYLNPSVIS 245
Query: 893 LMESCWADDPAQRPSFANIVE 913
L++ DP +R + +I E
Sbjct: 246 LLKHMLQVDPMKRATIKDIRE 266
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-26
Identities = 51/242 (21%), Positives = 99/242 (40%), Gaps = 31/242 (12%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
+G G+F V + + A+K++ D L ++ F E ++ +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINYL 775
A +L +V EY G L L+ + R+ ++A+ I+ +
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLL----------SKFGERIPAEMARFYLAEIVMAIDSV 178
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSVAGTPEWMAPEFLR 834
H L +H D+K N+L+D+ +++ DFG + +A+ + S GTP++++PE L+
Sbjct: 179 HRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236
Query: 835 GEPSNEKSDVY-------SFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTS 887
+ Y + GV +E+ Q P+ A+ G + L++P
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE 296
Query: 888 PV 889
V
Sbjct: 297 GV 298
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 63/251 (25%), Positives = 112/251 (44%), Gaps = 28/251 (11%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
+G G+FG V + A+K+L + + D++ + E +++ RHP +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
A L V EY G L+ + R ++R R A ++ + YLH+ + ++
Sbjct: 73 AFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGA-EIVSALEYLHSRD--VV 127
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSR------FKANTFISSKSVAGTPEWMAPEFLRGEP 837
+ D+K NL++DK+ +K+ DFGL + TF GTPE++APE L
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF------CGTPEYLAPEVLEDND 181
Query: 838 SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ---NRRLAIPQNTSPVLASLM 894
D + GV+++E++ + P+ ++ F+ + P+ SP SL+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-----FELILMEEIRFPRTLSPEAKSLL 236
Query: 895 ESCWADDPAQR 905
DP QR
Sbjct: 237 AGLLKKDPKQR 247
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-26
Identities = 51/240 (21%), Positives = 100/240 (41%), Gaps = 29/240 (12%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
+G G+FG V + +D A+K+L + L + F E ++ +
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK--------GINYL 775
A +L +V +Y G L L+ + R+ ++A+ I+ +
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLL----------SKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSVAGTPEWMAPEFLR 834
H L+ +H D+K N+L+D N +++ DFG + + + S GTP++++PE L+
Sbjct: 192 HQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 835 GEPSNEKS-----DVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPV 889
+ D +S GV ++E++ + P+ + G + R P + V
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 34/256 (13%), Positives = 70/256 (27%), Gaps = 44/256 (17%)
Query: 663 VKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKE-FLREVAIMKRVRHPNVV 719
+ G +A VA+ + Q L D + + L + R+ P V
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
+ V R +V E++ GSL + +R +A + H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG 149
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSN 839
+ + V + V + +N
Sbjct: 150 --VALSIDHPSRVRVSIDGDVVLAYPAT---------------------------MPDAN 180
Query: 840 EKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQ------NTSPVLASL 893
+ D+ G L+ L+ + P G + A A ++ + + ++++
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGL-APAERDTAGQPIEPADIDRDIPFQISAV 239
Query: 894 MESCWADDPAQRPSFA 909
D R +
Sbjct: 240 AARSVQGDGGIRSAST 255
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 65/260 (25%), Positives = 118/260 (45%), Gaps = 25/260 (9%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLD-DQLKEFLREVAIMK 711
D+ + +G GSFG V + S A+K+L Q + Q++ L E I++
Sbjct: 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
V P +V + +L +V EY+ G ++ + R G + R A +
Sbjct: 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAA-QIVLT 153
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF---KANTFISSKSVAGTPEWM 828
YLH+L+ +++ DLK NLL+D+ ++V DFG ++ + T GTPE +
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL------CGTPEAL 205
Query: 829 APEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN---RRLAIPQN 885
APE + + N+ D ++ GV+++E+ P+ P Q+ ++ ++ P +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-----YEKIVSGKVRFPSH 260
Query: 886 TSPVLASLMESCWADDPAQR 905
S L L+ + D +R
Sbjct: 261 FSSDLKDLLRNLLQVDLTKR 280
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-26
Identities = 62/245 (25%), Positives = 112/245 (45%), Gaps = 15/245 (6%)
Query: 667 VGAGSFGTVHRAEWHGSDV--AVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
+G G+FG V + + A+K+L + + D++ L E +++ RHP +
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
+ L V EY G L+ + R + R R A ++ ++YLH+ ++
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGA-EIVSALDYLHSEKN-VV 271
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSD 843
+ DLK NL++DK+ +K+ DFGL + + K+ GTPE++APE L D
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 331
Query: 844 VYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ---NRRLAIPQNTSPVLASLMESCWAD 900
+ GV+++E++ + P+ ++ F+ + P+ P SL+
Sbjct: 332 WWGLGVVMYEMMCGRLPFYNQDHEKL-----FELILMEEIRFPRTLGPEAKSLLSGLLKK 386
Query: 901 DPAQR 905
DP QR
Sbjct: 387 DPKQR 391
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-25
Identities = 60/263 (22%), Positives = 116/263 (44%), Gaps = 25/263 (9%)
Query: 667 VGAGSFGTVHRAEWHGSDV--AVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
+G GSFG V + + + A+K + Q + ++++ +E+ IM+ + HP +V
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
+ + +V + L G L + + ++ +L + ++ ++YL N I+
Sbjct: 83 SFQDEEDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFIC-ELVMALDYLQNQR--II 137
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKS 842
H D+K N+L+D++ V + DF ++ T ++AGT +MAPE S
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRET--QITTMAGTKPYMAPEMFSSRKGAGYS 195
Query: 843 ---DVYSFGVILWELVTMQQPWNGLGPAQVVGAV-AFQNRRLAIPQNTSPVLASLMESCW 898
D +S GV +EL+ ++P++ V F+ + P S + SL++
Sbjct: 196 FAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLL 255
Query: 899 ADDPAQR----------PSFANI 911
+P QR P +I
Sbjct: 256 EPNPDQRFSQLSDVQNFPYMNDI 278
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 60/264 (22%), Positives = 113/264 (42%), Gaps = 21/264 (7%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIM 710
L + ++ V + +G G+FG V + A+K+L+ + + F E IM
Sbjct: 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 123
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
P VV A +L +V EY+P G L L+ ++ ++ R A +V
Sbjct: 124 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTA-EVVL 179
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSVAGTPEWMA 829
++ +H++ +H D+K N+L+DK+ +K+ DFG + + + GTP++++
Sbjct: 180 ALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237
Query: 830 PEFLRGEPSNEK----SDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQN 885
PE L+ + + D +S GV L+E++ P+ + L P +
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 297
Query: 886 T--SPVLASLMES--CWADDPAQR 905
S +L+ + D R
Sbjct: 298 NDISKEAKNLICAFLT---DREVR 318
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 73/268 (27%), Positives = 119/268 (44%), Gaps = 39/268 (14%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFM 722
+G GSFG V AE+ ++ A+K L L DD ++ + E ++ HP +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
+ +L V EYL G L I + R A ++ G+ +LH+ I
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAA-EIILGLQFLHSKG--I 139
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR------FKANTFISSKSVAGTPEWMAPEFLRGE 836
++ DLK N+L+DK+ +K+ DFG+ + K NTF GTP+++APE L G+
Sbjct: 140 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF------CGTPDYIAPEILLGQ 193
Query: 837 PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ---NRRLAIPQNTSPVLASL 893
N D +SFGV+L+E++ Q P++G ++ F P+ L
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-----FHSIRMDNPFYPRWLEKEAKDL 248
Query: 894 MESCWADDPAQR----------PSFANI 911
+ + +P +R P F I
Sbjct: 249 LVKLFVREPEKRLGVRGDIRQHPLFREI 276
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-24
Identities = 71/250 (28%), Positives = 120/250 (48%), Gaps = 24/250 (9%)
Query: 667 VGAGSFGTVHRAE-WHGSDV----AVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF 721
+G GSFG V + GSD A+KVL E I+ V HP +V
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
A L ++ ++L G L+ + + ++ + +A ++A +++LH+L
Sbjct: 92 HYAFQTEGKLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLA-ELALALDHLHSLG-- 146
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSR------FKANTFISSKSVAGTPEWMAPEFLRG 835
I++ DLK N+L+D+ +K+ DFGLS+ KA +F GT E+MAPE +
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF------CGTVEYMAPEVVNR 200
Query: 836 EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895
+ +D +SFGV+++E++T P+ G + + + L +PQ SP SL+
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--LGMPQFLSPEAQSLLR 258
Query: 896 SCWADDPAQR 905
+ +PA R
Sbjct: 259 MLFKRNPANR 268
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 60/248 (24%), Positives = 116/248 (46%), Gaps = 25/248 (10%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
+G GSFG VH + A+KVL + + Q++ E ++ V HP ++ G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
+ ++ +Y+ G L+ L+ + + + + A +V + YLH+ + I+
Sbjct: 74 TFQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAA-EVCLALEYLHSKD--II 128
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSRF---KANTFISSKSVAGTPEWMAPEFLRGEPSNE 840
+ DLK N+L+DKN +K+ DFG +++ T GTP+++APE + +P N+
Sbjct: 129 YRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL------CGTPDYIAPEVVSTKPYNK 182
Query: 841 KSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN---RRLAIPQNTSPVLASLMESC 897
D +SFG++++E++ P+ + ++ L P + + L+
Sbjct: 183 SIDWWSFGILIYEMLAGYTPFYDSNTMKT-----YEKILNAELRFPPFFNEDVKDLLSRL 237
Query: 898 WADDPAQR 905
D +QR
Sbjct: 238 ITRDLSQR 245
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 30/210 (14%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKE-----FLREVAIMKRVRHPN 717
E++G G++GTV +A+ VA+K + + D E LRE+ ++K ++H N
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRL-----DDDDEGVPSSALREICLLKELKHKN 62
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRR-LRMALDVAKGINYLH 776
+V + L++V E+ + L + + + L L KG+ + H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGFCH 118
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPE----WM-APE 831
+ N +LH DLK NLL+++N +K+ +FGL+R + E W P+
Sbjct: 119 SRN--VLHRDLKPQNLLINRNGELKLANFGLARAF-----GIPVRCYSAEVVTLWYRPPD 171
Query: 832 FLRGEPS-NEKSDVYSFGVILWELVTMQQP 860
L G + D++S G I EL +P
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 70/315 (22%), Positives = 120/315 (38%), Gaps = 72/315 (22%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEF-----LREVAIMKRVRHPN 717
++G GS+G V + G VA+K FL+ + LRE+ ++K+++HPN
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKGINYLH 776
+V + ++ L +V EY ++ + + L + +N+ H
Sbjct: 64 LVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL---QAVNFCH 119
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPE----WM-APE 831
N +H D+K N+L+ K+ +K+CDFG +R ++ S E W +PE
Sbjct: 120 KHN--CIHRDVKPENILITKHSVIKLCDFGFAR-----LLTGPSDYYDDEVATRWYRSPE 172
Query: 832 FLRGEPSNEKS-DVYSFGVILWELVTMQ------------------------QPWNGLGP 866
L G+ DV++ G + EL++ +
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232
Query: 867 AQVVGAVAF------QNRRLAIPQNTSPVLASLMESCWADDPAQRPS---------FANI 911
Q V + L P N S L++ C DP +R + F NI
Sbjct: 233 NQYFSGVKIPDPEDMEPLELKFP-NISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291
Query: 912 --VESLKKLLKSPAQ 924
+E L K PA+
Sbjct: 292 REIEDLAKEHDKPAE 306
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 7e-24
Identities = 57/249 (22%), Positives = 93/249 (37%), Gaps = 19/249 (7%)
Query: 667 VGAGSFGTVHRAEWHGSDV--AVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
+G G FG V + + A K L + L E I+++V VV
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPIL 783
A + L +V + G L I+ + R A ++ G+ LH I+
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA-EICCGLEDLHRER--IV 308
Query: 784 HWDLKSPNLLVDKNWTVKVCDFGLSR-----FKANTFISSKSVAGTPEWMAPEFLRGEPS 838
+ DLK N+L+D + +++ D GL+ GT +MAPE ++ E
Sbjct: 309 YRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR------VGTVGYMAPEVVKNERY 362
Query: 839 NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ--NRRLAIPQNTSPVLASLMES 896
D ++ G +L+E++ Q P+ V + SP SL
Sbjct: 363 TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQ 422
Query: 897 CWADDPAQR 905
DPA+R
Sbjct: 423 LLCKDPAER 431
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 65/256 (25%), Positives = 120/256 (46%), Gaps = 28/256 (10%)
Query: 667 VGAGSFGTVHRAEWHGSDV--AVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFM 722
+G GS+ V +D A+KV+ + D+ + E + ++ HP +V
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
L V EY+ G L + R ++ ++ R A +++ +NYLH I
Sbjct: 77 SCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSA-EISLALNYLHERG--I 131
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRF------KANTFISSKSVAGTPEWMAPEFLRGE 836
++ DLK N+L+D +K+ D+G+ + +TF GTP ++APE LRGE
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF------CGTPNYIAPEILRGE 185
Query: 837 PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGA----VAFQ---NRRLAIPQNTSPV 889
D ++ GV+++E++ + P++ +G + FQ +++ IP++ S
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 245
Query: 890 LASLMESCWADDPAQR 905
AS+++S DP +R
Sbjct: 246 AASVLKSFLNKDPKER 261
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-23
Identities = 62/249 (24%), Positives = 115/249 (46%), Gaps = 23/249 (9%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFM 722
+G GSFG V +E G+D AVK+L + DD ++ + E ++ + P +
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
L V EY+ G L I + G + A ++A G+ +L + I
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAA-EIAIGLFFLQSKG--I 463
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRF------KANTFISSKSVAGTPEWMAPEFLRGE 836
++ DLK N+++D +K+ DFG+ + TF GTP+++APE + +
Sbjct: 464 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF------CGTPDYIAPEIIAYQ 517
Query: 837 PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMES 896
P + D ++FGV+L+E++ Q P+ G ++ ++ +A P++ S ++ +
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVAYPKSMSKEAVAICKG 575
Query: 897 CWADDPAQR 905
P +R
Sbjct: 576 LMTKHPGKR 584
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 29/207 (14%)
Query: 665 ERVGAGSFGTVHRA-EWHGSDVAVKVLTVQDFLDDQLKE-----FLREVAIMKRVRHPNV 718
E++G G++G V++A +G A+K + + ++ E +RE++I+K ++H N+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRL-----EKEDEGIPSTTIREISILKELKHSNI 62
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAG-EMMDQRRRLRMALDVAKGINYLHN 777
V + + L +V E+L + L +L+ G E + + L L GI Y H+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYCHD 118
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPE----WM-APEF 832
+LH DLK NLL+++ +K+ DFGL+R I + T E W AP+
Sbjct: 119 RR--VLHRDLKPQNLLINREGELKIADFGLARAFG---IPVRKY--THEIVTLWYRAPDV 171
Query: 833 LRGEPS-NEKSDVYSFGVILWELVTMQ 858
L G + D++S G I E+V
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 35/210 (16%)
Query: 665 ERVGAGSFGTVHRA-EWHGSDVAVKVLTVQDFLDDQLKE-----FLREVAIMKRVRHPNV 718
E+VG G++G V++A + G VA+K + + D E +RE++++K + HPN+
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRL-----DAEDEGIPSTAIREISLLKELHHPNI 81
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAG-EMMDQRRRLRMALDVAKGINYLHN 777
V + + L++V E++ + L +++ G + + L L +G+ + H
Sbjct: 82 VSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQ 137
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA---NTFISSKSVAGTPE----WM-A 829
ILH DLK NLL++ + +K+ DFGL+R ++ T E W A
Sbjct: 138 HR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--------THEVVTLWYRA 187
Query: 830 PEFLRGEPS-NEKSDVYSFGVILWELVTMQ 858
P+ L G + D++S G I E++T +
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 61/246 (24%), Positives = 101/246 (41%), Gaps = 10/246 (4%)
Query: 667 VGAGSFGTVHRAEWHGSDV--AVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMG 723
+G G FG V + + A K L + + + E I+ +V +V
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRM-ALDVAKGINYLHNLNPPI 782
A + L +V + G + I+ Q R + G+ +LH N I
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--I 310
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKS 842
++ DLK N+L+D + V++ D GL+ +K AGTP +MAPE L GE +
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSV 370
Query: 843 DVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ---NRRLAIPQNTSPVLASLMESCWA 899
D ++ GV L+E++ + P+ G + Q + + P SP E+
Sbjct: 371 DYFALGVTLYEMIAARGPFRARGEKVENKEL-KQRVLEQAVTYPDKFSPASKDFCEALLQ 429
Query: 900 DDPAQR 905
DP +R
Sbjct: 430 KDPEKR 435
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 65/287 (22%), Positives = 114/287 (39%), Gaps = 61/287 (21%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEF-----LREVAIMKRVRHPN 717
VG GS+G V + G VA+K FL+ + +RE+ ++K++RH N
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKGINYLH 776
+V + K+ +V E++ ++ + P + ++ L + GI + H
Sbjct: 86 LVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII---NGIGFCH 141
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPE----WM-APE 831
+ N I+H D+K N+LV ++ VK+CDFG +R +++ E W APE
Sbjct: 142 SHN--IIHRDIKPENILVSQSGVVKLCDFGFAR-----TLAAPGEVYDDEVATRWYRAPE 194
Query: 832 FLRGEPSNEKS-DVYSFGVILWELVTMQ------------------------QPWNGLGP 866
L G+ K+ DV++ G ++ E+ + +
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254
Query: 867 AQVVGAVAF------QNRRLAIPQNTSPVLASLMESCWADDPAQRPS 907
V V + P S V+ L + C DP +RP
Sbjct: 255 NPVFAGVRLPEIKEREPLERRYP-KLSEVVIDLAKKCLHIDPDKRPF 300
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 62/254 (24%), Positives = 112/254 (44%), Gaps = 30/254 (11%)
Query: 667 VGAGSFGTVHRAE-WHGSDV----AVKVLT----VQDFLDDQLKEFLREVAIMKRVRHPN 717
+G G +G V + G++ A+KVL V++ E I++ V+HP
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN--AKDTAHTKAERNILEEVKHPF 82
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
+V + A L ++ EYL G L+ + R G M+ +A +++ + +LH
Sbjct: 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLER--EGIFMEDTACFYLA-EISMALGHLHQ 139
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF------KANTFISSKSVAGTPEWMAPE 831
I++ DLK N++++ VK+ DFGL + +TF GT E+MAPE
Sbjct: 140 KG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF------CGTIEYMAPE 191
Query: 832 FLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891
L N D +S G ++++++T P+ G + + + L +P +
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK--LNLPPYLTQEAR 249
Query: 892 SLMESCWADDPAQR 905
L++ + A R
Sbjct: 250 DLLKKLLKRNAASR 263
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 71/252 (28%), Positives = 117/252 (46%), Gaps = 29/252 (11%)
Query: 667 VGAGSFGTVHRAEWHGSDV--AVKVLTVQDFL-DDQLKEFLREVAIM-KRVRHPNVVLFM 722
+G GSFG V A +V AVKVL + L + K + E ++ K V+HP +V
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
+ L V +Y+ G L+ + R ++ R R A ++A + YLH+LN I
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQR--ERCFLEPRARFYAA-EIASALGYLHSLN--I 160
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR------FKANTFISSKSVAGTPEWMAPEFLRGE 836
++ DLK N+L+D + + DFGL + +TF GTPE++APE L +
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF------CGTPEYLAPEVLHKQ 214
Query: 837 PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN---RRLAIPQNTSPVLASL 893
P + D + G +L+E++ P+ A++ + N + L + N + L
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-----YDNILNKPLQLKPNITNSARHL 269
Query: 894 MESCWADDPAQR 905
+E D +R
Sbjct: 270 LEGLLQKDRTKR 281
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-23
Identities = 64/256 (25%), Positives = 120/256 (46%), Gaps = 28/256 (10%)
Query: 667 VGAGSFGTVHRAEWHGSDV--AVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFM 722
+G GS+ V +D A++V+ + D+ + E + ++ HP +V
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
L V EY+ G L + R ++ ++ R A +++ +NYLH I
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSA-EISLALNYLHERG--I 174
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR------FKANTFISSKSVAGTPEWMAPEFLRGE 836
++ DLK N+L+D +K+ D+G+ + +TF GTP ++APE LRGE
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF------CGTPNYIAPEILRGE 228
Query: 837 PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGA----VAFQ---NRRLAIPQNTSPV 889
D ++ GV+++E++ + P++ +G + FQ +++ IP++ S
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 288
Query: 890 LASLMESCWADDPAQR 905
AS+++S DP +R
Sbjct: 289 AASVLKSFLNKDPKER 304
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-23
Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 34/211 (16%)
Query: 665 ERVGAGSFGTVHRA-EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV---- 719
+ +G GSFG V +A +VA+K + D + K RE+ IM+ V+HPNVV
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIK----KVLQDKRFK--NRELQIMRIVKHPNVVDLKA 99
Query: 720 LFMGAVTKR--PHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRR-RLRMALDVAKGINYL 775
F K+ L++V EY+P ++YR H + M +L M + + + Y+
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYM-YQLLRSLAYI 157
Query: 776 HNLNPPILHWDLKSPNLLVDKN-WTVKVCDFGLSRF----KANT-FISSKSVAGTPEWM- 828
H++ I H D+K NLL+D +K+ DFG ++ + N +I S+ +
Sbjct: 158 HSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR-------YYR 208
Query: 829 APEFLRGEPS-NEKSDVYSFGVILWELVTMQ 858
APE + G + D++S G ++ EL+ Q
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-23
Identities = 64/252 (25%), Positives = 115/252 (45%), Gaps = 29/252 (11%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFM 722
+G GSFG V +E G+D AVK+L + DD ++ + E ++ + P +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
L V EY+ G L I + G + A ++A G+ +L + I
Sbjct: 88 SCFQTMDRLYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAA-EIAIGLFFLQSKG--I 142
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR------FKANTFISSKSVAGTPEWMAPEFLRGE 836
++ DLK N+++D +K+ DFG+ + TF GTP+++APE + +
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF------CGTPDYIAPEIIAYQ 196
Query: 837 PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ---NRRLAIPQNTSPVLASL 893
P + D ++FGV+L+E++ Q P+ G ++ FQ +A P++ S ++
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-----FQSIMEHNVAYPKSMSKEAVAI 251
Query: 894 MESCWADDPAQR 905
+ P +R
Sbjct: 252 CKGLMTKHPGKR 263
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 62/252 (24%), Positives = 104/252 (41%), Gaps = 29/252 (11%)
Query: 667 VGAGSFGTVHRAEWHGSD--VAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFM 722
+G GSFG V A + AVKVL L DD ++ + E I+ HP +
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782
L V E++ G L I + + + R R A ++ + +LH+ I
Sbjct: 91 CCFQTPDRLFFVMEFVNGGDLMFHIQK--SRRFDEARARFYAA-EIISALMFLHDKG--I 145
Query: 783 LHWDLKSPNLLVDKNWTVKVCDFGLSR------FKANTFISSKSVAGTPEWMAPEFLRGE 836
++ DLK N+L+D K+ DFG+ + TF GTP+++APE L+
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF------CGTPDYIAPEILQEM 199
Query: 837 PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ---NRRLAIPQNTSPVLASL 893
D ++ GV+L+E++ P+ + F+ N + P +
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL-----FEAILNDEVVYPTWLHEDATGI 254
Query: 894 MESCWADDPAQR 905
++S +P R
Sbjct: 255 LKSFMTKNPTMR 266
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 51/220 (23%)
Query: 665 ERVGAGSFGTVHRAEWH--GSDVAVK-VLTVQDFLDDQLKEF-LREVAIMKRVRHPNVV- 719
+ +G GSFG V++A+ G VA+K VL QD K F RE+ IM+++ H N+V
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVL--QD------KRFKNRELQIMRKLDHCNIVR 111
Query: 720 ---LFMGAVTKR--PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK---- 770
F + K+ +L++V +Y+P ++YR+ + R + + + K
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYS-------RAKQTLPVIYVKLYMY 163
Query: 771 ----GINYLHNLNPPILHWDLKSPNLLVDKN-WTVKVCDFGLSRF----KANT-FISSKS 820
+ Y+H+ I H D+K NLL+D + +K+CDFG ++ + N +I S+
Sbjct: 164 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR- 220
Query: 821 VAGTPEWM-APEFLRGEPS-NEKSDVYSFGVILWELVTMQ 858
+ APE + G DV+S G +L EL+ Q
Sbjct: 221 ------YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-22
Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 33/211 (15%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKE-----FLREVAIMKRVRHPN 717
+ +G G F TV++A VA+K + + + K+ LRE+ +++ + HPN
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGH--RSEAKDGINRTALREIKLLQELSHPN 73
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAG-EMMDQRRRLRMALDVAKGINYLH 776
++ + A + ++S+V +++ L +I + + + M L +G+ YLH
Sbjct: 74 IIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL---QGLEYLH 129
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA---NTFISSKSVAGTPE----WM- 828
ILH DLK NLL+D+N +K+ DFGL++ + T + W
Sbjct: 130 QHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--------THQVVTRWYR 179
Query: 829 APEFLRGEPS-NEKSDVYSFGVILWELVTMQ 858
APE L G D+++ G IL EL+
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 51/208 (24%), Positives = 78/208 (37%), Gaps = 60/208 (28%)
Query: 663 VKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNV 718
+ +G G G V + + A+K+L + REV + R + P++
Sbjct: 22 TSQVLGLGINGKVLQIF-NKRTQEKFALKML-------QDCPKARREVELHWRASQCPHI 73
Query: 719 VLFMGA----VTKRPHLSIVTEYLPRGSLY-RLIHRP-------AAGEMMDQRRRLRMAL 766
V + R L IV E L G L+ R+ R A E+M
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS-------- 125
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKANTFISSKSVAG 823
+ + I YLH++N I H D+K NLL N +K+ DFG
Sbjct: 126 -IGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF---------------- 166
Query: 824 TPEWMAPEFLRGEPSNEKSDVYSFGVIL 851
A E E ++ D++S GVI+
Sbjct: 167 -----AKETTG-EKYDKSCDMWSLGVIM 188
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 5e-22
Identities = 53/208 (25%), Positives = 100/208 (48%), Gaps = 31/208 (14%)
Query: 665 ERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKE-----FLREVAIMKRVRHPN 717
+++G G++ TV++ + + VA+K + ++ +E +REV+++K ++H N
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEH------EEGAPCTAIREVSLLKDLKHAN 61
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAG-EMMDQRRRLRMALDVAKGINYLH 776
+V + L++V EYL + L + + M + + L L +G+ Y H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL---RGLAYCH 117
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPE----WM-APE 831
+LH DLK NLL+++ +K+ DFGL+R K S + E W P+
Sbjct: 118 RQK--VLHRDLKPQNLLINERGELKLADFGLARAK-----SIPTKTYDNEVVTLWYRPPD 170
Query: 832 FLRGEPS-NEKSDVYSFGVILWELVTMQ 858
L G + + D++ G I +E+ T +
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 21/202 (10%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPNVVL 720
+ +G+G+ G V A +VA+K L+ +Q K RE+ +MK V H N++
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHKNIIG 88
Query: 721 FMGAVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
+ T + L IV E + +L ++I + +R + + GI +
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQME----LDHERMSYLL-YQMLCGIKH 142
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLR 834
LH+ I+H DLK N++V + T+K+ DFGL+R +F+ + V T + APE +
Sbjct: 143 LHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVIL 199
Query: 835 GEPSNEKSDVYSFGVILWELVT 856
G E D++S G I+ E++
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIK 221
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-21
Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 34/216 (15%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKE-F----LREVAIMKRVRHPN 717
++G G+FG V +A G VA+K + + + KE F LRE+ I++ ++H N
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLM-----ENEKEGFPITALREIKILQLLKHEN 77
Query: 718 VVLFMGAVTKRPH--------LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRL-RMALDV 768
VV + + + +V ++ L L+ + + +R+ +M L
Sbjct: 78 VVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLL-- 134
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPE-- 826
G+ Y+H ILH D+K+ N+L+ ++ +K+ DFGL+R + +S+ T
Sbjct: 135 -NGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAF-SLAKNSQPNRYTNRVV 190
Query: 827 --WM-APEFLRGEPS-NEKSDVYSFGVILWELVTMQ 858
W PE L GE D++ G I+ E+ T
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-21
Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 49/224 (21%)
Query: 663 VKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMK---RVRHPN 717
V+ G G+FGTV + G VA+K + D + + RE+ IM+ + HPN
Sbjct: 27 VERMAGQGTFGTVQLGKEKSTGMSVAIKKV----IQDPRFR--NRELQIMQDLAVLHHPN 80
Query: 718 VV----LFMGAVTKRPH---LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
+V F + L++V EY+P +L+R RR++ + K
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYY-------RRQVAPPPILIK 132
Query: 771 --------GINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGLSRF----KANT-FI 816
I LH + + H D+K N+LV++ + T+K+CDFG ++ + N +I
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 817 SSKSVAGTPEWM-APEFLRGEPSNEKS-DVYSFGVILWELVTMQ 858
S+ + APE + G + D++S G I E++ +
Sbjct: 193 CSR-------YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 5e-21
Identities = 49/212 (23%), Positives = 89/212 (41%), Gaps = 34/212 (16%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKE-----FLREVAIMKRVRHPN 717
++G G++G V++A VA+K + + + +E +REV+++K ++H N
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRL-----EHEEEGVPGTAIREVSLLKELQHRN 94
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
++ + L ++ EY L + + + M + L + G+N+ H+
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLI---NGVNFCHS 150
Query: 778 LNPPILHWDLKSPNLLVDKNWT-----VKVCDFGLSRFKANTFISSKSVAGTPE----WM 828
LH DLK NLL+ + +K+ DFGL+R T E W
Sbjct: 151 RR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-----GIPIRQFTHEIITLWY 203
Query: 829 -APEFLRGEPS-NEKSDVYSFGVILWELVTMQ 858
PE L G + D++S I E++
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 6e-21
Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 42/216 (19%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKE-----FLREVAIMKRVRHPN 717
E++G G++ TV++ G VA+K + + +E +RE+++MK ++H N
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDS------EEGTPSTAIREISLMKELKHEN 64
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEM------MDQRRRLRMALDVAKG 771
+V + L++V E++ L + + G + L +G
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL---QG 120
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA---NTFISSKSVAGTPE-- 826
+ + H ILH DLK NLL++K +K+ DFGL+R NTF + E
Sbjct: 121 LAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--------SSEVV 170
Query: 827 --WM-APEFLRGEPS-NEKSDVYSFGVILWELVTMQ 858
W AP+ L G + + D++S G IL E++T +
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 8e-21
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 662 HVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPN 717
+ +G+G+ G V A +VA+K L+ +Q K RE+ +MK V H N
Sbjct: 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHKN 122
Query: 718 VVLFMGAVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
++ + T + L +V E + +L ++I + +R + + G
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME----LDHERMSYLL-YQMLCG 176
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPE 831
I +LH+ I+H DLK N++V + T+K+ DFGL+R +F+ + V T + APE
Sbjct: 177 IKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPE 233
Query: 832 FLRGEPSNEKSDVYSFGVILWELVT 856
+ G E D++S G I+ E+V
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVR 258
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 2e-20
Identities = 66/325 (20%), Positives = 126/325 (38%), Gaps = 26/325 (8%)
Query: 591 AIEAAYKEEIVVSESSVIIKQPNATLPSQLDKEDESKLEKQGKFPVGPGPRYLNIEPSLA 650
AIE + + + + L + K + KF + + + L
Sbjct: 128 AIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLT 187
Query: 651 MDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDV--AVKVLTVQDFL-DDQLKEFLREV 707
M+ + + +G G FG V+ + A+K L + L E
Sbjct: 188 MNDFSV----HRI---IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240
Query: 708 AIMKRV---RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRM 764
++ V P +V A LS + + + G L+ + + G + R
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYA 298
Query: 765 ALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGT 824
A ++ G+ ++HN +++ DLK N+L+D++ V++ D GL+ + + GT
Sbjct: 299 A-EIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVGT 353
Query: 825 PEWMAPEFLRGEPSNEKS-DVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN---RRL 880
+MAPE L+ + + S D +S G +L++L+ P+ + +
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMAV 411
Query: 881 AIPQNTSPVLASLMESCWADDPAQR 905
+P + SP L SL+E D +R
Sbjct: 412 ELPDSFSPELRSLLEGLLQRDVNRR 436
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 5e-20
Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 46/221 (20%)
Query: 665 ERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEF----LREVAIMKRVR---H 715
+G G++GTV++A G VA+K + V +REVA+++R+ H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRV-PNGGGGGGGLPISTVREVALLRRLEAFEH 73
Query: 716 PNVV-----LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
PNVV + +++V E++ + L +D+ + + K
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTY---------LDKAPPPGLPAETIK 123
Query: 771 --------GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA 822
G+++LH I+H DLK N+LV TVK+ DFGL+R S +A
Sbjct: 124 DLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIY------SYQMA 175
Query: 823 GTPE----WM-APEFLRGEPSNEKSDVYSFGVILWELVTMQ 858
TP W APE L D++S G I E+ +
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-20
Identities = 46/217 (21%), Positives = 83/217 (38%), Gaps = 34/217 (15%)
Query: 662 HVKERVGAGSFGTVHRA-EWHGSDVAVKVLTVQDFLDDQLKEF---------LREVAIMK 711
V+ + +GS+G V + G VA+K + + LRE+ ++
Sbjct: 25 TVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLN 84
Query: 712 RVRHPNVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAAGEMMDQRRR----- 761
HPN++ + +VTE + L ++IH + Q +
Sbjct: 85 HFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRI-VISPQHIQYFMYH 142
Query: 762 -LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820
L G++ LH ++H DL N+L+ N + +CDF L+R +
Sbjct: 143 ILL-------GLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHY 193
Query: 821 VAGTPEWMAPEFLRGEPSNEKS-DVYSFGVILWELVT 856
V + APE + K D++S G ++ E+
Sbjct: 194 VT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 7e-20
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 52/223 (23%)
Query: 665 ERVGAGSFGTVHRA---EWHGSDVAVKVLTVQDFLDDQLKE-----FLREVAIMKRVR-- 714
+G G++G V +A + G VA+K + V +E +REVA+++ +
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRV-----QTGEEGMPLSTIREVAVLRHLETF 71
Query: 715 -HPNVV----LFMGAVTKRPH-LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDV 768
HPNVV + + T R L++V E++ + L +D+ + +
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTY---------LDKVPEPGVPTET 121
Query: 769 AK--------GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS 820
K G+++LH+ ++H DLK N+LV + +K+ DFGL+R S
Sbjct: 122 IKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIY------SFQ 173
Query: 821 VAGTPE----WM-APEFLRGEPSNEKSDVYSFGVILWELVTMQ 858
+A T W APE L D++S G I E+ +
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 62/259 (23%), Positives = 111/259 (42%), Gaps = 32/259 (12%)
Query: 667 VGAGSFGTVHRAE-WHGSDV----AVKVLTVQDFL--DDQLKEFLREVAIMKRVRH-PNV 718
+G G++G V G D A+KVL + + E +++ +R P +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
V A L ++ +Y+ G L+ + + + ++ + ++ + +LH L
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYVG-EIVLALEHLHKL 178
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-------FKANTFISSKSVAGTPEWMAPE 831
I++ D+K N+L+D N V + DFGLS+ +A F GT E+MAP+
Sbjct: 179 G--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF------CGTIEYMAPD 230
Query: 832 FLRGEPSNEKSDV--YSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN---RRLAIPQNT 886
+RG S V +S GV+++EL+T P+ G + + PQ
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-SRRILKSEPPYPQEM 289
Query: 887 SPVLASLMESCWADDPAQR 905
S + L++ DP +R
Sbjct: 290 SALAKDLIQRLLMKDPKKR 308
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-19
Identities = 58/221 (26%), Positives = 90/221 (40%), Gaps = 42/221 (19%)
Query: 662 HVKERVGAGSFGTVHRA--EWHGSDVAVKVLTV-QDFLDDQLKEFLREVAIMKRVRHPNV 718
+K +G G++G V A + G VA+K + L LRE+ I+K +H N+
Sbjct: 14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF--ALRTLREIKILKHFKHENI 71
Query: 719 VLFMGAVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRR------LRMAL 766
+ + + I+ E + L+R+I + D + LR
Sbjct: 72 ITIF-NIQRPDSFENFNEVYIIQELMQT-DLHRVIS---TQMLSDDHIQYFIYQTLR--- 123
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPE 826
+ LH N ++H DLK NLL++ N +KVCDFGL+R + + G
Sbjct: 124 ----AVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 827 WM----------APEFLRGEPS-NEKSDVYSFGVILWELVT 856
M APE + + DV+S G IL EL
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 48/206 (23%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 665 ERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVV- 719
++G G + V A + V VK+L + K+ RE+ I++ +R PN++
Sbjct: 42 RKLGRGKYSEVFEA-INITNNEKVVVKILK-----PVKKKKIKREIKILENLRGGPNIIT 95
Query: 720 ---LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
+ V++ P L V E++ +L D R + L K ++Y H
Sbjct: 96 LADIVKDPVSRTPAL--VFEHVNNTDFKQLYQTL---TDYDIRFYMYEIL---KALDYCH 147
Query: 777 NLNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRG 835
++ I+H D+K N+++D ++ +++ D+GL+ F + VA + + PE L
Sbjct: 148 SMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA-SRYFKGPELLVD 204
Query: 836 EPSNEKS-DVYSFGVILWELVTMQQP 860
+ S D++S G +L ++ ++P
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 54/250 (21%), Positives = 100/250 (40%), Gaps = 79/250 (31%)
Query: 665 ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV--- 719
+ +G GSFG V G A+K + D + K RE+ IMK + H N++
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALK----KVLQDPRYK--NRELDIMKVLDHVNIIKLV 66
Query: 720 -LFMGAVTKRPH----------------------------------LSIVTEYLPRGSLY 744
F + P L+++ EY+P +L+
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLH 125
Query: 745 RLIHRPAAGEMMDQRRRLRMALD--------VAKGINYLHNLNPPILHWDLKSPNLLVD- 795
+++ R + ++ + + + ++H+L I H D+K NLLV+
Sbjct: 126 KVLKSFI-------RSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNS 176
Query: 796 KNWTVKVCDFGLSRF----KANT-FISSKSVAGTPEWM-APEFLRGEPS-NEKSDVYSFG 848
K+ T+K+CDFG ++ + + +I S+ + APE + G D++S G
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSR-------FYRAPELMLGATEYTPSIDLWSIG 229
Query: 849 VILWELVTMQ 858
+ EL+ +
Sbjct: 230 CVFGELILGK 239
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 6e-18
Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH---- 715
V + +G GSFG V +A H VA+K++ + Q E+ I++ +R
Sbjct: 100 EVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA---AEEIRILEHLRKQDKD 156
Query: 716 --PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKGI 772
NV+ + T R H+ + E L +LY LI G + R+ A + + +
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRK--FAHSILQCL 213
Query: 773 NYLHNLNPPILHWDLKSPN-LLVDKNWT-VKVCDFGLSRFKAN---TFISSKSVAGTPEW 827
+ LH I+H DLK N LL + + +KV DFG S ++ T+I S+ +
Sbjct: 214 DALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF------Y 265
Query: 828 MAPEFLRGEPSNEKSDVYSFGVILWELVT 856
APE + G D++S G IL EL+T
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 8e-18
Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 33/219 (15%)
Query: 663 VKERVGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
+VG G++G V++A+ D A+K + RE+A+++ ++HPNV
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM----SACREIALLRELKHPNV 80
Query: 719 VLFMGAVTKRPHLSI--VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA------LDVAK 770
+ + + +Y L+ +I A + + +L +
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 771 GINYLHNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGLSRFKANTFISSKSVA-GTP 825
GI+YLH +LH DLK N+LV + VK+ D G +R K +A P
Sbjct: 140 GIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN---SPLKPLADLDP 194
Query: 826 E----WM-APEFLRGEPSNEKS-DVYSFGVILWELVTMQ 858
W APE L G K+ D+++ G I EL+T +
Sbjct: 195 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 8e-18
Identities = 53/219 (24%), Positives = 98/219 (44%), Gaps = 36/219 (16%)
Query: 662 HVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
+ +G G G V A VA+K + + D +K LRE+ I++R+ H N+V
Sbjct: 14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS--VKHALREIKIIRRLDHDNIV 71
Query: 720 ----LFMGAVTKRPHLS----------IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRM- 764
+ + ++ IV EY+ L ++ G ++++ RL M
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMY 127
Query: 765 -ALDVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSRFKANTFISSKS-- 820
L +G+ Y+H+ N +LH DLK NL ++ ++ +K+ DFGL+R +
Sbjct: 128 QLL---RGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 821 --VAGTPEWMAPEFLRGEPS-NEKSDVYSFGVILWELVT 856
+ T + +P L + + D+++ G I E++T
Sbjct: 183 EGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 50/258 (19%), Positives = 103/258 (39%), Gaps = 48/258 (18%)
Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR----- 714
+ ++G G F TV A+ + VA+K++ + E+ +++RV
Sbjct: 22 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA---AEDEIKLLQRVNDADNT 78
Query: 715 ------HPNVV----LFMGAVTKRPHLSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLR 763
+++ F H+ +V E L +L LI + G + ++
Sbjct: 79 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ-- 135
Query: 764 MALDVAKGINYLHNLNPPILHWDLKSPNLLVD------KNWTVKVCDFGLSRFKANTFIS 817
++ + G++Y+H I+H D+K N+L++ +K+ D G + + + +
Sbjct: 136 ISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 194
Query: 818 SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN 877
S T E+ +PE L G P +D++S +++EL+T G F+
Sbjct: 195 SIQ---TREYRSPEVLLGAPWGCGADIWSTACLIFELIT--------------GDFLFEP 237
Query: 878 RRLAIPQNTSPVLASLME 895
+A ++E
Sbjct: 238 DEGHSYTKDDDHIAQIIE 255
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 50/212 (23%), Positives = 98/212 (46%), Gaps = 36/212 (16%)
Query: 662 HVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPN 717
VG+G++G+V A + G VA+K L+ ++ K RE+ ++K ++H N
Sbjct: 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS--RPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 718 VVLFMGAVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRR------LRMA 765
V+ + T L +V ++ L +++ +++ + L+
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK----FSEEKIQYLVYQMLK-- 137
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP 825
G+ Y+H+ ++H DLK NL V+++ +K+ DFGL+R + V T
Sbjct: 138 -----GLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--TGYVV-TR 187
Query: 826 EWMAPEFLRGEPSNEKS-DVYSFGVILWELVT 856
+ APE + ++ D++S G I+ E++T
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 219
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 56/238 (23%), Positives = 95/238 (39%), Gaps = 54/238 (22%)
Query: 663 VKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPNV 718
+K +G GS+G V+ A + +VA+K V +D + K LRE+ I+ R++ +
Sbjct: 30 IKHLIGRGSYGYVYLAYDKNTEKNVAIK--KVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 719 VLFMGAVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRR------LRMAL 766
+ + L IV E L +L P + ++ + L
Sbjct: 88 IRLY-DLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPI--FLTEEHIKTILYNLLL--- 140
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR------------FKANT 814
G N++H I+H DLK N L++++ +VKVCDFGL+R
Sbjct: 141 ----GENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 815 FISSKSVAGTPEWM----------APEFLRGEPS-NEKSDVYSFGVILWELVTMQQPW 861
+ + APE + + + + D++S G I EL+ M Q
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVL-TVQDFLDDQLKEFLREVAIMKRVRHP-- 716
+ +G GSFG V +A VA+K++ + FL+ E V +++ +
Sbjct: 57 EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE----VRLLELMNKHDT 112
Query: 717 ----NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKG 771
+V R HL +V E L +LY L+ + G ++ R+ A +
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRK--FAQQMCTA 169
Query: 772 INYLHNLNPPILHWDLKSPNLLV--DKNWTVKVCDFGLSRFKAN---TFISSKSVAGTPE 826
+ +L I+H DLK N+L+ K +K+ DFG S +I S+
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF------ 223
Query: 827 WMAPEFLRGEPSNEKSDVYSFGVILWELVT 856
+ +PE L G P + D++S G IL E+ T
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 6e-17
Identities = 56/209 (26%), Positives = 102/209 (48%), Gaps = 35/209 (16%)
Query: 665 ERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPNVVL 720
+ VG+G++G V A G+ VA+K L +L K RE+ ++K +RH NV+
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLY--RPFQSELFAKRAYRELRLLKHMRHENVIG 88
Query: 721 FMGAVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRR------LRMALDV 768
+ T L +V ++ L +L+ ++ + R + L+
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMK---HEKLGEDRIQFLVYQMLK----- 139
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWM 828
G+ Y+H I+H DLK NL V+++ +K+ DFGL+R +A++ ++ V T +
Sbjct: 140 --GLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR-QADSEMTG-YVV-TRWYR 192
Query: 829 APEFLRGEPSNEKS-DVYSFGVILWELVT 856
APE + ++ D++S G I+ E++T
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMIT 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 6e-17
Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 35/212 (16%)
Query: 662 HVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPN 717
VG+G++G+V A G VAVK L+ + K RE+ ++K ++H N
Sbjct: 32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 718 VVLFMGAVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRR------LRMA 765
V+ + T L +VT + L ++ ++ D + LR
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVK---CQKLTDDHVQFLIYQILR-- 143
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP 825
G+ Y+H+ + I+H DLK NL V+++ +K+ DFGL+R A+ + VA T
Sbjct: 144 -----GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM--TGYVA-TR 193
Query: 826 EWMAPEFLRGEPS-NEKSDVYSFGVILWELVT 856
+ APE + N+ D++S G I+ EL+T
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 52/221 (23%), Positives = 93/221 (42%), Gaps = 49/221 (22%)
Query: 662 HVKERVGAGSFGTVHRA--EWHGSDVAVKVLTV-QDFLDDQLKEFLREVAIMKRVRHPNV 718
+G G++G V A + VA+K ++ + + LRE+ I+ R RH N+
Sbjct: 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY--CQRTLREIKILLRFRHENI 87
Query: 719 VLFMGAVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRR------LRMAL 766
+ + + P + IV + + LY+L+ + + LR
Sbjct: 88 IGIN-DIIRAPTIEQMKDVYIVQDLME-TDLYKLLK---TQHLSNDHICYFLYQILR--- 139
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPE 826
G+ Y+H+ N +LH DLK NLL++ +K+CDFGL+R +
Sbjct: 140 ----GLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-------VADPDHDHTG 186
Query: 827 WM----------APEFLRGEPS-NEKSDVYSFGVILWELVT 856
++ APE + + D++S G IL E+++
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 3e-16
Identities = 58/243 (23%), Positives = 98/243 (40%), Gaps = 59/243 (24%)
Query: 662 HVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVRHPN 717
++ +G GS+G V A + VA+K + +D + K LRE+AI+ R+ H +
Sbjct: 56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIK--KILRVFEDLIDCKRILREIAILNRLNHDH 113
Query: 718 VVLFMGAVTKRPHLS------IVTEYLPRGSLYRLIHRPAAGEMMDQRRR------LRMA 765
VV + + + +V E +L P + + + L
Sbjct: 114 VVKVL-DIVIPKDVEKFDELYVVLEIADS-DFKKLFRTP--VYLTELHIKTLLYNLLV-- 167
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP 825
G+ Y+H+ ILH DLK N LV+++ +VKVCDFGL+R + + +P
Sbjct: 168 -----GVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 826 EWM---------------------------APEFLRGEPSNEKS-DVYSFGVILWELVTM 857
APE + + + ++ DV+S G I EL+ M
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280
Query: 858 QQP 860
+
Sbjct: 281 IKE 283
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 52/232 (22%), Positives = 97/232 (41%), Gaps = 54/232 (23%)
Query: 662 HVKERVGAGSFGTVHRA--EWHGSDVAVKVLTVQDFLDDQL--KEFLREVAIMKRVR-HP 716
+ +++G G++G V ++ G VAVK + D + + RE+ I+ + H
Sbjct: 12 ELVKKLGKGAYGIVWKSIDRRTGEVVAVK--KIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 717 NVVLFMGAVTKRP----HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRR------LRMAL 766
N+V + + R + +V +Y+ L+ +I A + ++ ++
Sbjct: 70 NIVNLLNVL--RADNDRDVYLVFDYME-TDLHAVIR---ANILEPVHKQYVVYQLIK--- 120
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR-----------FKANTF 815
I YLH+ +LH D+K N+L++ VKV DFGLSR +
Sbjct: 121 ----VIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 816 ISSKSVAGTPEWM----------APEFLRGEPS-NEKSDVYSFGVILWELVT 856
++++ + APE L G + D++S G IL E++
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 56/232 (24%), Positives = 101/232 (43%), Gaps = 52/232 (22%)
Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVL-TVQDFLDDQLKEFLREVAIMKRVRH--- 715
V ++G G+FG V + AVKV+ ++ + E I+K++++
Sbjct: 38 LVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDI 93
Query: 716 --PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAKGI 772
N+V + G H+ ++ E L SLY +I G ++ + +++ K +
Sbjct: 94 NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKL--YCIEILKAL 150
Query: 773 NYLHNLNPPILHWDLKSPN-LLVD------------------------KNWTVKVCDFGL 807
NYL ++ + H DLK N LL D K+ +K+ DFG
Sbjct: 151 NYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 808 SRFKAN---TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT 856
+ FK++ + I+++ + APE + + SD++SFG +L EL T
Sbjct: 209 ATFKSDYHGSIINTRQ------YRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-13
Identities = 48/228 (21%), Positives = 85/228 (37%), Gaps = 48/228 (21%)
Query: 662 HVKERVGAGSFGTVHRAEWH---GSDVAVKVL-TVQDFLDDQLKEFLREVAIMKRVRHP- 716
+ +G G+FG V H S VA+K++ V + + E + ++K+++
Sbjct: 22 EIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKD 77
Query: 717 -----NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAK 770
VL H+ I E L + + + + R MA +
Sbjct: 78 KENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRH--MAYQLCH 134
Query: 771 GINYLHNLNPPILHWDLKSPN-LLVD------------------KNWTVKVCDFGLSRFK 811
+ +LH + H DLK N L V+ KN +++V DFG + F
Sbjct: 135 ALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD 192
Query: 812 AN---TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT 856
T ++++ + PE + + DV+S G IL+E
Sbjct: 193 HEHHTTIVATRH------YRPPEVILELGWAQPCDVWSIGCILFEYYR 234
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 54/228 (23%), Positives = 88/228 (38%), Gaps = 48/228 (21%)
Query: 662 HVKERVGAGSFGTVHRA---EWHGSDVAVKVL-TVQDFLDDQLKEFLREVAIMKRVRHP- 716
+ + +G G+FG V + G VAVK++ V + + E + +++ +
Sbjct: 17 EIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE----IQVLEHLNTTD 72
Query: 717 -----NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI-HRPAAGEMMDQRRRLRMALDVAK 770
V + H+ IV E L S Y I +D R+ MA + K
Sbjct: 73 PNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRK--MAYQICK 129
Query: 771 GINYLHNLNPPILHWDLKSPN-LLVD------------------KNWTVKVCDFGLSRFK 811
+N+LH+ + H DLK N L V N +KV DFG + +
Sbjct: 130 SVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187
Query: 812 AN---TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT 856
T +S++ + APE + ++ DV+S G IL E
Sbjct: 188 DEHHSTLVSTRH------YRAPEVILALGWSQPCDVWSIGCILIEYYL 229
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 62/319 (19%), Positives = 105/319 (32%), Gaps = 100/319 (31%)
Query: 618 SQLDKEDESKLEKQGKFPVGPG----PRYLNIEPSLAMDWLEISWDELHVKERVGAGSFG 673
++ED + K G V G RY HV ++G G F
Sbjct: 11 DDDEQEDPNDYCKGGYHLVKIGDLFNGRY-------------------HVIRKLGWGHFS 51
Query: 674 TVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-----HPN---VVLFMG 723
TV + VA+KV+ + + E+ ++K VR PN VV +
Sbjct: 52 TVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRNSDPNDPNREMVVQLLD 108
Query: 724 AVT-KRP---HLSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLRMALDVAKGINYLHNL 778
H+ +V E L L + I + G + ++ + V +G++YLH
Sbjct: 109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKK--IIQQVLQGLDYLHTK 165
Query: 779 NPPILHWDLKSPNLLV-------------------------------------------- 794
I+H D+K N+L+
Sbjct: 166 CR-IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNP 224
Query: 795 -----DKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGV 849
+ VK+ D G + + F T ++ + E L G N +D++S
Sbjct: 225 LEPKNAEKLKVKIADLGNACWVHKHF---TEDIQTRQYRSLEVLIGSGYNTPADIWSTAC 281
Query: 850 ILWELVTMQ---QPWNGLG 865
+ +EL T +P +G
Sbjct: 282 MAFELATGDYLFEPHSGEE 300
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 59.9 bits (144), Expect = 1e-09
Identities = 28/195 (14%), Positives = 59/195 (30%), Gaps = 42/195 (21%)
Query: 656 ISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLK------EFLREVAI 709
+ ++L E++G G FG V + + VA+K++ ++ E L E+ I
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 710 MKRV---------RHPNVVLFMGA--VTKRPHLSIVTEY----------------LPRGS 742
K + R + V ++ +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 743 LYRLIHRPAAGEMMDQRRR--------LRMALDVAKGINYLHNLNPPILHWDLKSPNLLV 794
L+ ++ G ++Q R + + + + H DL N+L+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA-SLRFEHRDLHWGNVLL 195
Query: 795 DKNWTVKVCDFGLSR 809
K K+ +
Sbjct: 196 KKTSLKKLHYTLNGK 210
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-08
Identities = 56/281 (19%), Positives = 100/281 (35%), Gaps = 39/281 (13%)
Query: 663 VKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
+ +++G+G FG ++ A A V+ V+ + L E+ +RV + +
Sbjct: 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF---SELKFYQRVAKKDCIK 97
Query: 721 FMGAVTKRPHLSIVTEY-----LPRGSLYRLIHRPAAG----EMMDQRRR------LRMA 765
+ +L I Y +G YR + G ++ Q L++
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLG 157
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKV--CDFGLS-RFKANT------FI 816
+ + + Y+H +H D+K+ NLL+ +V D+GLS R+ N
Sbjct: 158 IRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215
Query: 817 SSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAF 875
K GT E+ + + +G S +SDV G + + + PW V A
Sbjct: 216 PRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK 274
Query: 876 QNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916
N +PQ+ + F SL
Sbjct: 275 TNLLDELPQSVLK-----WAPSG-SSCCEIAQFLVCAHSLA 309
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.2 bits (132), Expect = 1e-07
Identities = 74/457 (16%), Positives = 135/457 (29%), Gaps = 150/457 (32%)
Query: 534 LKDIGLPKSSKDALVNQPRAEKESSLVPLKLQGNPKNSDAAAGAPIQEYSRLVEENVAIE 593
K I L K D ++ A + + L + + VEE +
Sbjct: 42 PKSI-LSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEM----------VQKFVEE--VLR 88
Query: 594 AAYKEEIVVSESSVIIKQPNATLPSQLDKEDESKLEKQG-KFPVGPGPRYLNIEPSLAM- 651
Y + ++S +QP ++ +++ E +L F R ++P L +
Sbjct: 89 INY--KFLMSPIKTEQRQP--SMMTRMYIEQRDRLYNDNQVFAKYNVSR---LQPYLKLR 141
Query: 652 DWLEISWDELHVKERV---GAGSFG-TVHRAEWHGSDVAVKVL---TVQDFLDDQ---LK 701
L EL + V G G T VA+ V VQ +D + L
Sbjct: 142 QALL----ELRPAKNVLIDGVLGSGKTW---------VALDVCLSYKVQCKMDFKIFWLN 188
Query: 702 EFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR--PAAGEMMDQR 759
+K P VL M L +L+++ P D
Sbjct: 189 --------LKNCNSPETVLEM--------------------LQKLLYQIDPNWTSRSDHS 220
Query: 760 RRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV-----DKNWTVKVCDFG-----LSR 809
+++ + + L L + ++ LLV + + +R
Sbjct: 221 SNIKLRIHSIQ--AELRRL---LKSKPYEN-CLLVLLNVQNA-KAWNAFNLSCKILLTTR 273
Query: 810 FKANTFISSKSVAG-----------TPE--------W---------------------MA 829
FK T S + TP+ + +
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII 333
Query: 830 PEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNR--RLAI-PQN 885
E +R + D + V +L T ++ N L PA+ ++ RL++ P +
Sbjct: 334 AESIRDGLA--TWDNWKH-VNCDKLTTIIESSLNVLEPAE------YRKMFDRLSVFPPS 384
Query: 886 TSPVLASLMESCWADDPAQRPSFANIVESL--KKLLK 920
+ L+ W D +V L L++
Sbjct: 385 A-HIPTILLSLIWFDVIKSDVM--VVVNKLHKYSLVE 418
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 8e-05
Identities = 85/643 (13%), Positives = 173/643 (26%), Gaps = 184/643 (28%)
Query: 64 TTTTTKNLKNSAAPLSVSD-LFTSGDEKFKVKKQQFAAFC--------DWLTE--KKEDR 112
+ ++ S +S + LF + K +++ F +L K E R
Sbjct: 47 SKEEIDHIIMSKDAVSGTLRLFWTLLSK---QEEMVQKFVEEVLRINYKFLMSPIKTEQR 103
Query: 113 SASRHVKSFQSRLSSGADEDREPLLPPPEP-EPVPVPVPDTVTNIDNDRNFDRQVSLPRL 171
S + + + R+ L + V + + +L L
Sbjct: 104 QPSMMTRMYIEQ--------RDRLYNDNQVFAKYNVSRLQPYLKL--------RQALLEL 147
Query: 172 SSTGSSYAASSLFSGTTLDGNFSSDVKDTSTRVSTSRQEVEEEESKDTAAQRTKESYMLQ 231
+DG S K A SY +Q
Sbjct: 148 RPAK----------NVLIDGVLGS--------------------GKTWVALDVCLSYKVQ 177
Query: 232 LTLARR---LTLQACIFSGPLLLQESALEVSDTETVSYRLWVSGCLSYNDKISDGFYNIL 288
+ + L L+ C +L L Y++ + S +D S+ I
Sbjct: 178 CKMDFKIFWLNLKNCNSPETVLEMLQKL--------LYQIDPNWT-SRSDHSSNIKLRIH 228
Query: 289 GMNPYLWVMCNDLEEGKRLP-SLMSLKDIDSTE-------------TSMEVVLIDRHGDS 334
+ L L + K L+ L ++ + + T+ + D +
Sbjct: 229 SIQAEL----RRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAA 284
Query: 335 RLKEL----------EDKAQELY--CASENTLVLVEE--LGKLVAICMGGTFPIEQGDLH 380
+ D+ + L L E + + +
Sbjct: 285 TTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW 344
Query: 381 KRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLA---DYIGLP----CRI-ARG 432
WK + K I + L R +F +L+ +P I
Sbjct: 345 DNWKHVNCD--KLTTIIESSLNVLEPAEYRK---MFDRLSVFPPSAHIPTILLSLIWFDV 399
Query: 433 CRYCEAD-----HRSSCLVKIEDDRRSSREYVVDL-------VGEPGNIHGP---NFSIN 477
+ H+ S + K + S + + + +H +++I
Sbjct: 400 IKSDVMVVVNKLHKYSLVEK---QPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIP 456
Query: 478 GGFLSSMPSPFQLSDLKEFQKPYMDNTSYCQLPDSRSNSAFPESPPYSGIIRK------- 530
F D + PY+D Y + N PE + R
Sbjct: 457 KTF-----------DSDDLIPPYLDQYFYSHIGHHLKNIEHPER---MTLFRMVFLDFRF 502
Query: 531 -GQKLKDIGLPKSSKDALVNQPRAEKESSLVPLKLQGN--PKNSDAAAGAPIQEYSRLVE 587
QK++ ++ +++N +L LK N +Y RLV
Sbjct: 503 LEQKIRHDSTAWNASGSILN--------TLQQLKFYKPYICDNDP--------KYERLVN 546
Query: 588 ENVAIEAAYKEEIVVSESSVIIK----QPNATL----PSQLDK 622
+ +E ++ S+ + +++ + + Q+ +
Sbjct: 547 AILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQVQR 589
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 45/236 (19%), Positives = 83/236 (35%), Gaps = 44/236 (18%)
Query: 663 VKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLF 721
V +G G FG ++ A+ + V V E+ +R P +
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQK 98
Query: 722 MGAVTKRPHLSIVTEY-----LPRGSLYRLIHRPAAGEMMD------------QRRR--- 761
K +L + + G YR + +MD +R
Sbjct: 99 WIRTRKLKYLGVPKYWGSGLHDKNGKSYRFM-------IMDRFGSDLQKIYEANAKRFSR 151
Query: 762 ---LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKV--CDFGLS-RFKAN-- 813
L+++L + + Y+H +H D+K+ NLL++ +V D+GL+ R+
Sbjct: 152 KTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209
Query: 814 ----TFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGL 864
+ GT E+ + + G PS + D+ G + + +T PW
Sbjct: 210 HKAYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDN 264
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 9e-05
Identities = 43/221 (19%), Positives = 90/221 (40%), Gaps = 32/221 (14%)
Query: 663 VKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH-PNVV 719
V +++G G+FG + + + VA+K+ + + + E K++ +
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM----KSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK----GINYL 775
+ ++V E L SL L ++ D+ L+ L +A + Y+
Sbjct: 69 QVYYFGPCGKYNAMVLELLGP-SLEDLF------DLCDRTFSLKTVLMIAIQLISRMEYV 121
Query: 776 HNLNPPILHWDLKSPNLLVDKNWT-----VKVCDFGLSRF--KANT-----FISSKSVAG 823
H+ N +++ D+K N L+ + + + DF L++ T + KS+ G
Sbjct: 122 HSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179
Query: 824 TPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGL 864
T +M+ G+ + + D+ + G + + PW GL
Sbjct: 180 TARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 30/219 (13%)
Query: 663 VKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH-PNVV 719
+ ++G+GSFG ++ G +VA+K+ V+ QL E I K ++ +
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLH---IESKIYKMMQGGVGIP 68
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA----KGINYL 775
+ + +V E L SL L ++ L+ L +A I Y+
Sbjct: 69 TIRWCGAEGDYNVMVMELLGP-SLEDLF------NFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 776 HNLNPPILHWDLKSPNLLVDKNWT---VKVCDFGLSRF--KANT-----FISSKSVAGTP 825
H+ N +H D+K N L+ V + DFGL++ A T + +K++ GT
Sbjct: 122 HSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 826 EWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGL 864
+ + G + + D+ S G +L PW GL
Sbjct: 180 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 46/219 (21%), Positives = 90/219 (41%), Gaps = 30/219 (13%)
Query: 663 VKERVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVV 719
+ ++G+GSFG ++ +VA+K+ V+ QL E I + ++ +
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLL---YESKIYRILQGGTGIP 66
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK----GINYL 775
+ + +V + L SL L ++ L+ L +A + ++
Sbjct: 67 NVRWFGVEGDYNVLVMDLLGP-SLEDLF------NFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 776 HNLNPPILHWDLKSPNLLVDKNWT---VKVCDFGLSRF--KANT-----FISSKSVAGTP 825
H+ + LH D+K N L+ V + DFGL++ +T + +K++ GT
Sbjct: 120 HSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 826 EWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGL 864
+ + G + + D+ S G +L + PW GL
Sbjct: 178 RYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 38/236 (16%), Positives = 76/236 (32%), Gaps = 44/236 (18%)
Query: 663 VKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDF---LDDQLKEFLREVAIMKRVRHPNVV 719
+K + G ++ A + Q F LD + E +R P V
Sbjct: 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 720 LFMGAVTKRPHLSI--VTEYLPRGSLYRLIHRPAAGEMMD-------------QRRR--- 761
+ P L+I + YR + ++ +
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFL-------VLPSLGRSLQSALDVSPKHVLSE 158
Query: 762 ---LRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKV--CDFGLSRFKANT-- 814
L++A + + +LH +H ++ + N+ VD +V +G + +
Sbjct: 159 RSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
Query: 815 -----FISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGL 864
S G E+++ + +G PS +SD+ S G + + + PW
Sbjct: 217 HVAYVEGSRSPHEGDLEFISMDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTNC 271
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 931 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.02 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.81 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.66 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.36 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.26 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.24 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.02 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.01 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.92 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.85 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.56 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.4 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.39 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.07 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.0 | |
| 3isr_A | 293 | Transglutaminase-like enzymes, putative cysteine; | 96.9 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.83 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.76 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.54 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.51 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.47 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.43 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.35 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.91 | |
| 2f4m_A | 295 | Peptide N-glycanase; glycoproteins, ubiquitin-depe | 95.61 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.56 | |
| 3kd4_A | 506 | Putative protease; structural genomics, joint cent | 95.37 | |
| 1x3z_A | 335 | Peptide: N-glycanase; hydrolase-hydrolase inhibito | 93.43 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.93 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.66 | |
| 2q3z_A | 687 | Transglutaminase 2; transglutaminase 2, tissue tra | 90.97 | |
| 1g0d_A | 695 | Protein-glutamine gamma-glutamyltransferase; tissu | 84.42 | |
| 1vjj_A | 692 | Protein-glutamine glutamyltransferase E; transglut | 81.63 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-54 Score=475.37 Aligned_cols=253 Identities=26% Similarity=0.483 Sum_probs=222.9
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|+++++||+|+||+||+|++ +++.||||++............+.+|+++|++|+|||||+++++|.+++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 47999999999999999999987 4889999999988777777788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
|||+||+|.+++... .+..+++..++.|+.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+......
T Consensus 103 Ey~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 999999999999753 2445799999999999999999999999 9999999999999999999999999998765443
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~ 895 (931)
......+||+.|||||++.+..++.++|||||||++|||+||+.||.+.+..+++..+.... ....+..+++++++||.
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~~~~~~s~~~~~li~ 258 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-FPPVSLHYSYDLRSLVS 258 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCCTTSCHHHHHHHH
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCCccCCHHHHHHHH
Confidence 33355689999999999999999999999999999999999999999988888887775433 34567789999999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 002355 896 SCWADDPAQRPSFANIVES 914 (931)
Q Consensus 896 rcL~~DPeeRPSa~ELLq~ 914 (931)
+||++||.+|||+.|+++|
T Consensus 259 ~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 259 QLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHTCSSGGGSCCHHHHHTS
T ss_pred HHccCChhHCcCHHHHhcC
Confidence 9999999999999999986
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=459.83 Aligned_cols=271 Identities=32% Similarity=0.557 Sum_probs=228.0
Q ss_pred ccccCceEEEEEecccCceEEEEEEEc-------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK 727 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~~-------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~ 727 (931)
.+..++|.+.++||+|+||+||+|++. ++.||||+++.. .....+.|.+|+++|++++|||||++++++.+
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 456689999999999999999999864 567999999754 34455789999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhhcCCC------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRPAA------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD 795 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~~~------------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd 795 (931)
++.+|||||||++|+|.+++++... ...+++.+++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVG 192 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEEC
Confidence 9999999999999999999975321 245899999999999999999999999 99999999999999
Q ss_pred CCCcEEEEecCcccccccc--ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 002355 796 KNWTVKVCDFGLSRFKANT--FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGA 872 (931)
Q Consensus 796 ~dg~IKL~DFGlAr~~~~~--~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~ 872 (931)
.++++||+|||+|+..... .......+||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..+++..
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 272 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC 272 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 9999999999999864332 122345679999999999999999999999999999999999 8999999998888777
Q ss_pred HHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhhhcCCC
Q 002355 873 VAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQMGG 930 (931)
Q Consensus 873 i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l~~~~~ 930 (931)
+. ...+.+.|..+++++.+||.+||+.||++|||+.||+++|+.+.+.|..++.+-|
T Consensus 273 i~-~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp~~ld~lG 329 (329)
T 4aoj_A 273 IT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 329 (329)
T ss_dssp HH-HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC-------
T ss_pred HH-cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCcccccCCC
Confidence 65 4556778899999999999999999999999999999999999999877766544
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=457.15 Aligned_cols=264 Identities=36% Similarity=0.610 Sum_probs=223.7
Q ss_pred cccccccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 652 ~~lei~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
..|+|..++|++.++||+|+||+||+|++.+ .||||+++.........+.|.+|+++|++++|||||++++++.. +.+
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 3578999999999999999999999998765 59999998766666677889999999999999999999998765 568
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
|||||||+||+|.+++... ...+++..+..|+.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+..
T Consensus 107 ~iVmEy~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEEEECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEEEcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 9999999999999999752 346999999999999999999999999 999999999999999999999999999865
Q ss_pred ccc--ccccCCCCCCCcccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-c---cCC
Q 002355 812 ANT--FISSKSVAGTPEWMAPEFLRG---EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-R---LAI 882 (931)
Q Consensus 812 ~~~--~~~~~~~~GT~~Y~APEvL~~---~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~-r---~~l 882 (931)
... .......+||+.|||||++.+ ..++.++|||||||++|||+||+.||.+.+....+........ . ...
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 262 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKL 262 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTS
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence 432 223356789999999999964 3588999999999999999999999998776555544433332 2 235
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 883 PQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 883 P~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
+..+++++.+||.+||+.||++|||+.|++++|+.+.++
T Consensus 263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 263 YKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 678899999999999999999999999999999877654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-53 Score=463.22 Aligned_cols=256 Identities=22% Similarity=0.399 Sum_probs=226.6
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|++++.||+|+||+||+|++ +++.||||++.+..... .....+.+|+++|+.|+|||||+++++|.+++++||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6899999999999999999987 57889999998754322 33567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc-
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT- 814 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~- 814 (931)
|||+||+|.+++.+. +.+++..++.++.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+.....
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999999999763 46999999999999999999999999 999999999999999999999999999865422
Q ss_pred -ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 815 -FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 815 -~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
.....+.+||+.|||||++.+..++.++|||||||++|+|++|++||.+.+..+++..+.. ....+|..+++++++|
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~dl 264 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK--LEYDFPEKFFPKARDL 264 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCTTCCHHHHHH
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCcccCHHHHHH
Confidence 2234567999999999999999999999999999999999999999999888888877754 3456788999999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 894 MESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 894 I~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
|.+||..||++|||++|++.+ ..++++|
T Consensus 265 i~~lL~~dp~~R~t~~e~~~~-~~i~~Hp 292 (311)
T 4aw0_A 265 VEKLLVLDATKRLGCEEMEGY-GPLKAHP 292 (311)
T ss_dssp HHHHSCSSGGGSTTSGGGTCH-HHHHTSG
T ss_pred HHHHccCCHhHCcChHHHcCC-HHHHCCC
Confidence 999999999999999998765 3344443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=455.74 Aligned_cols=269 Identities=31% Similarity=0.515 Sum_probs=233.5
Q ss_pred ccccCceEEEEEecccCceEEEEEEEc-------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK 727 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~~-------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~ 727 (931)
.|..++|.+.++||+|+||+||+|++. +..||||+++.. .....+.|.+|+++|++++|||||++++++.+
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 567789999999999999999999863 567999999754 34455789999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhhcCC----------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRPA----------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN 797 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~~----------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d 797 (931)
++.+|||||||++|+|.+++++.. ....+++..++.|+.||+.||+|||+++ ||||||||+||||+.+
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCC
Confidence 999999999999999999997532 2346999999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 002355 798 WTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVA 874 (931)
Q Consensus 798 g~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~ 874 (931)
+++||+|||+|+...... .......||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..+++..+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999998543321 12234568999999999999999999999999999999998 899999999888887765
Q ss_pred hcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhhhcC
Q 002355 875 FQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQM 928 (931)
Q Consensus 875 ~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l~~~ 928 (931)
...+...|..+++++.+||.+||+.||++|||+.++++.|+.+.+....++.+
T Consensus 245 -~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~~ldi 297 (299)
T 4asz_A 245 -QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPVYLDI 297 (299)
T ss_dssp -HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCCCSCC
T ss_pred -cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCccccC
Confidence 44566788999999999999999999999999999999999988765544443
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=462.52 Aligned_cols=248 Identities=28% Similarity=0.447 Sum_probs=221.7
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
+.|+++++||+|+||+||+|++ +|+.||||++....... .+.+.+|+++|+.++|||||+++++|.+++++|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5799999999999999999988 57889999997654332 3467899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
||+||+|.+++.+ ..+++..++.++.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+.......
T Consensus 152 y~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 152 FLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp CCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 9999999999975 24899999999999999999999999 99999999999999999999999999987665544
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-ccCCCCCChHHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-RLAIPQNTSPVLASLME 895 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~-r~~lP~~~s~eL~dLI~ 895 (931)
...+.+||+.|||||++.+..++.++|||||||++|||++|++||.+.+..+.+..+..... ....+..+++++++||.
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~ 305 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 305 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHH
Confidence 55678999999999999999999999999999999999999999999888877776653322 23344678999999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 002355 896 SCWADDPAQRPSFANIVES 914 (931)
Q Consensus 896 rcL~~DPeeRPSa~ELLq~ 914 (931)
+||++||++|||+.|+++|
T Consensus 306 ~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 306 RLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HHSCSSTTTSCCHHHHTTC
T ss_pred HHcCCChhHCcCHHHHhcC
Confidence 9999999999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-52 Score=447.69 Aligned_cols=248 Identities=28% Similarity=0.486 Sum_probs=215.3
Q ss_pred eEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee----CCeEEEE
Q 002355 661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK----RPHLSIV 734 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~----~~~l~LV 734 (931)
|++.++||+|+||+||+|++ ++..||+|++..........+.+.+|+++|++|+|||||+++++|.. +..+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 47888999999999999987 46789999998877666677889999999999999999999999864 3568999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC-CCcEEEEecCccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~-dg~IKL~DFGlAr~~~~ 813 (931)
||||+||+|.+++.+. ..+++..++.|+.||+.||+|||++|++||||||||+||||+. +|.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999999763 4699999999999999999999998878999999999999984 79999999999986544
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcccccCCCCCChHHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGP-AQVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~-~eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
. ...+.+||+.|||||++.+ .++.++|||||||++|||+||+.||.+... ..+...+.....+..++...++++++
T Consensus 185 ~--~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (290)
T 3fpq_A 185 S--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261 (290)
T ss_dssp T--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred C--ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHH
Confidence 3 3356789999999999876 589999999999999999999999987654 44445554444445566778899999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 002355 893 LMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~ 914 (931)
||.+||+.||.+|||+.|+++|
T Consensus 262 li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 262 IIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999876
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=457.07 Aligned_cols=253 Identities=28% Similarity=0.446 Sum_probs=221.3
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
..+.|++.++||+|+||+||+|++ +++.||||+++..... .+|+.+|+.|+|||||+++++|.+++.+|||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 346899999999999999999987 4788999999875432 4699999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC-cEEEEecCccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-TVKVCDFGLSRFKAN 813 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg-~IKL~DFGlAr~~~~ 813 (931)
||||+||+|.+++++. ..+++..++.++.||+.||+|||++| ||||||||+||||+.+| ++||+|||+|+....
T Consensus 129 mEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp ECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred EeccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 9999999999999763 36999999999999999999999999 99999999999999988 699999999986543
Q ss_pred cc-----cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc-cCCCCCCh
Q 002355 814 TF-----ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR-LAIPQNTS 887 (931)
Q Consensus 814 ~~-----~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r-~~lP~~~s 887 (931)
.. ......+||+.|||||++.+..++.++|||||||++|||+||++||.+.+..++...+.....+ ..++..++
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s 283 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA 283 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSC
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCC
Confidence 21 1223468999999999999999999999999999999999999999988777666666544433 35788999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 888 PVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 888 ~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
+++.+||.+||++||.+|||+.|++++|...+..
T Consensus 284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 9999999999999999999999999999988764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=457.20 Aligned_cols=249 Identities=27% Similarity=0.410 Sum_probs=214.6
Q ss_pred CceEEEEEecccCceEEEEEEE-----cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~-----~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
++|+++++||+|+||+||+|++ +++.||||++...........++.+|+++|++++|||||+++++|.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 6899999999999999999986 35679999997655433333467889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
|||||+||+|.+++.+. ..+++..++.++.||+.||+|||++| ||||||||+|||++.+|++||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999763 36999999999999999999999999 99999999999999999999999999986554
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
......+.+||+.|||||++.+..++.++|||||||++|||+||+.||.+.+..++...+.. ....+|..+++++++|
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~l 256 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK--AKLGMPQFLSPEAQSL 256 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHH
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc--CCCCCCCcCCHHHHHH
Confidence 44445678999999999999999999999999999999999999999999988888877753 3456788999999999
Q ss_pred HHHhcccCCCCCCC-----HHHHHHH
Q 002355 894 MESCWADDPAQRPS-----FANIVES 914 (931)
Q Consensus 894 I~rcL~~DPeeRPS-----a~ELLq~ 914 (931)
|.+||+.||++||| ++|+++|
T Consensus 257 i~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 257 LRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 99999999999998 4677765
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=447.99 Aligned_cols=261 Identities=29% Similarity=0.501 Sum_probs=227.2
Q ss_pred cccccCceEEEEEecccCceEEEEEEE-------cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEW-------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT 726 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~-------~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~ 726 (931)
.++..++++++++||+|+||+||+|++ +++.||||+++... .....+.|.+|+.+|++++|||||++++++.
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 356778999999999999999999986 34679999987543 2233467999999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhhcCCC-------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeE
Q 002355 727 KRPHLSIVTEYLPRGSLYRLIHRPAA-------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLL 793 (931)
Q Consensus 727 ~~~~l~LVmEy~~GgSL~d~L~r~~~-------------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNIL 793 (931)
.++.++||||||++|+|.+++..... ...+++..++.|+.||+.||+|||+++ ||||||||+|||
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NIL 177 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVL 177 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceE
Confidence 99999999999999999999964321 235899999999999999999999999 999999999999
Q ss_pred ECCCCcEEEEecCcccccccc--ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 002355 794 VDKNWTVKVCDFGLSRFKANT--FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVV 870 (931)
Q Consensus 794 Ld~dg~IKL~DFGlAr~~~~~--~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii 870 (931)
|+.++++||+|||+|+..... .......+||+.|||||++.+..++.++|||||||++|||+| |..||.+.+..++.
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~ 257 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999999864332 223345679999999999999999999999999999999998 89999999988887
Q ss_pred HHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 002355 871 GAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKL 918 (931)
Q Consensus 871 ~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~L 918 (931)
..+. ...+.+.|..+++++.+||.+||+.||++|||+.||+++|+..
T Consensus 258 ~~i~-~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 258 EMIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHH-cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 7765 4556678899999999999999999999999999999998753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=465.24 Aligned_cols=249 Identities=28% Similarity=0.443 Sum_probs=222.9
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.+.|+++++||+|+||+||+|++ +|+.||||++....... .+.+.+|+.+|+.++|||||+++++|..++.+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 36799999999999999999987 57889999998654332 346789999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
|||+||+|.+++.. ..+++..++.++.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+......
T Consensus 228 Ey~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 228 EFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp ECCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred eCCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 99999999999975 24899999999999999999999999 9999999999999999999999999998765554
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-ccCCCCCChHHHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-RLAIPQNTSPVLASLM 894 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~-r~~lP~~~s~eL~dLI 894 (931)
....+.+||+.|||||++.+..++.++|||||||++|||++|++||.+.+..+.+..+..... ....+..+++++++||
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli 381 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL 381 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHH
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHH
Confidence 455678999999999999999999999999999999999999999999888887776654322 3345568899999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 002355 895 ESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 895 ~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+||..||++|||+.|+|+|
T Consensus 382 ~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 382 DRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHHSCSSTTTSCCHHHHTTC
T ss_pred HHHcCCChhHCcCHHHHhcC
Confidence 99999999999999999987
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=440.68 Aligned_cols=249 Identities=27% Similarity=0.473 Sum_probs=206.5
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|+++++||+|+||+||+|++ +++.||||++.+..... .....+.+|+++|+.++|||||+++++|.+.+.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999987 57899999998765443 33467899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+ +|+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++++||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 78999998763 46999999999999999999999999 9999999999999999999999999998654432
Q ss_pred cccCCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPS-NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~-t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI 894 (931)
...+.+||+.|||||++.+..+ +.++|||||||++|+|+||+.||.+.+..++...+.. ....+|..+++++++||
T Consensus 167 -~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li 243 (275)
T 3hyh_A 167 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN--GVYTLPKFLSPGAAGLI 243 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCTTSCHHHHHHH
T ss_pred -ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHH
Confidence 3346789999999999998876 5799999999999999999999999887777776653 34567888999999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHH
Q 002355 895 ESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 895 ~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
.+||+.||++|||+.|+++|=+
T Consensus 244 ~~~L~~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 244 KRMLIVNPLNRISIHEIMQDDW 265 (275)
T ss_dssp HHHSCSSGGGSCCHHHHHHCHH
T ss_pred HHHccCChhHCcCHHHHHcCcc
Confidence 9999999999999999998743
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=457.90 Aligned_cols=269 Identities=30% Similarity=0.545 Sum_probs=232.9
Q ss_pred cccccccCceEEEEEecccCceEEEEEEEcC-------CceEEEEEeecccchHHHHHHHHHHHHHHhcCC-CCeeeEEe
Q 002355 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH-PNVVLFMG 723 (931)
Q Consensus 652 ~~lei~~drY~Ii~kLG~G~fGtVylAr~~g-------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~H-pNIV~Lid 723 (931)
+.|+|..++|+++++||+|+||+||+|++.+ +.||||++.... .....+.+.+|+++|.++.| ||||++++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 4578999999999999999999999998743 459999987654 33445789999999999965 89999999
Q ss_pred eeee-CCeEEEEEeecCCCCHHHHhhcCC-------------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCC
Q 002355 724 AVTK-RPHLSIVTEYLPRGSLYRLIHRPA-------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS 789 (931)
Q Consensus 724 ~f~~-~~~l~LVmEy~~GgSL~d~L~r~~-------------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKP 789 (931)
+|.. ++.+|||||||++|+|.++++... ....+++..++.++.||+.||+|||+++ ||||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~ 213 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 213 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCc
Confidence 9865 567999999999999999997532 1345899999999999999999999999 99999999
Q ss_pred CCeEECCCCcEEEEecCcccccccc--ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 002355 790 PNLLVDKNWTVKVCDFGLSRFKANT--FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGP 866 (931)
Q Consensus 790 eNILLd~dg~IKL~DFGlAr~~~~~--~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~ 866 (931)
+|||++.++++||+|||+|+..... .......+||+.|||||++.+..++.++|||||||++|||+| |..||.+...
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999865332 223345678999999999999999999999999999999998 8999998876
Q ss_pred HHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCch
Q 002355 867 AQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPA 923 (931)
Q Consensus 867 ~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~ 923 (931)
.+.+........+...|..+++++.+||.+||+.||++|||+.||+++|+.++++.+
T Consensus 294 ~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 294 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 665555555677788899999999999999999999999999999999999987543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=429.00 Aligned_cols=249 Identities=24% Similarity=0.397 Sum_probs=194.7
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC-------
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP------- 729 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~------- 729 (931)
++|++++.||+|+||+||+|++ +++.||||++.... .....+.+.+|+++|++|+|||||+++++|...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 5799999999999999999987 47889999998654 2334567899999999999999999999986543
Q ss_pred -----eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEe
Q 002355 730 -----HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCD 804 (931)
Q Consensus 730 -----~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~D 804 (931)
++|||||||.||+|.+++..........+..++.++.||+.||+|||++| ||||||||+||||+.+|++||+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCcEEEcc
Confidence 47999999999999999986444444667778999999999999999999 99999999999999999999999
Q ss_pred cCcccccccccc------------ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHH
Q 002355 805 FGLSRFKANTFI------------SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPA-QVVG 871 (931)
Q Consensus 805 FGlAr~~~~~~~------------~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~-eii~ 871 (931)
||+|+....... .....+||+.|||||++.+..++.++|||||||++|||++ ||.+.... ..+.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 999986543211 1234579999999999999999999999999999999996 77653221 1222
Q ss_pred HHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 872 AVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 872 ~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+.. ....+.+...++.+.+||.+||+.||.+|||+.|+++|
T Consensus 239 ~~~~-~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 239 DVRN-LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHT-TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHhc-CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2211 11111223345678899999999999999999999885
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=437.15 Aligned_cols=250 Identities=23% Similarity=0.363 Sum_probs=213.2
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeee------eCCe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT------KRPH 730 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~------~~~~ 730 (931)
++|+++++||+|+||+||+|++ +|+.||||+++.........+.+.+|+++|+.|+|||||++++++. +.++
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 6899999999999999999987 5889999999876655666678899999999999999999999875 3468
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
+||||||| +|+|.+++.+ ...+++..++.++.||+.||+|||++| ||||||||+|||++.+|.+||+|||+|+.
T Consensus 134 ~~ivmE~~-~g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLM-ESDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECC-SEEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCC-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEeecceeee
Confidence 99999999 5689999975 346999999999999999999999999 99999999999999999999999999986
Q ss_pred cccc----ccccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccC----
Q 002355 811 KANT----FISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLA---- 881 (931)
Q Consensus 811 ~~~~----~~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~---- 881 (931)
.... .....+.+||+.|||||++.+. .++.++||||+||++|||++|++||.+.+..+.+..+........
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 4322 1233567899999999998875 468999999999999999999999999887776655532211110
Q ss_pred -------------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 882 -------------------------IPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 882 -------------------------lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+...+++++.+||.+||.+||.+|||+.|+|+|
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 113568899999999999999999999999987
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=421.74 Aligned_cols=256 Identities=30% Similarity=0.502 Sum_probs=203.3
Q ss_pred CceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC----eEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP----HLSIV 734 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~----~l~LV 734 (931)
.+|.+.++||+|+||+||+|+++|+.||||++.... ........|+.++..++|||||++++++..++ .+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 478999999999999999999999999999987543 21122345666677889999999999997553 68999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhC------CCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL------NPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~------G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
||||+||+|.+++++. .+++..+.+++.|++.||+|||++ .++||||||||+||||+.++++||+|||+|
T Consensus 80 ~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999999752 489999999999999999999986 123999999999999999999999999999
Q ss_pred cccccccc----ccCCCCCCCcccCcccccCC------CCCchhHHHHHHHHHHHHHhCCCCCCC----------C----
Q 002355 809 RFKANTFI----SSKSVAGTPEWMAPEFLRGE------PSNEKSDVYSFGVILWELVTMQQPWNG----------L---- 864 (931)
Q Consensus 809 r~~~~~~~----~~~~~~GT~~Y~APEvL~~~------~~t~ksDIWSLG~ILyELLTG~~PF~~----------~---- 864 (931)
+....... .....+||+.|||||++.+. .++.++|||||||++|||+||.+||.. .
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 86543221 22345799999999999765 246789999999999999999766532 1
Q ss_pred -ChHHHHHHHHhcccccCCCCC-----ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 865 -GPAQVVGAVAFQNRRLAIPQN-----TSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 865 -~~~eii~~i~~~~~r~~lP~~-----~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
...++...+.....++.+|.. .+..+.+||.+||..||++|||+.|+++.|+++.+.
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 122333334334444455532 345789999999999999999999999999998765
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=410.52 Aligned_cols=272 Identities=70% Similarity=1.181 Sum_probs=233.7
Q ss_pred cccccccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 652 ~~lei~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
+.+++.+++|++.++||+|+||+||+|+++++.||||++............+.+|++++++++||||+++++++...+.+
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 44567889999999999999999999999999999999988776667778899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
++||||+.+++|.+++.+......+++..++.++.||+.||+|||++|++|+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999999998643333489999999999999999999998877999999999999999999999999999865
Q ss_pred cccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHH
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~ 891 (931)
...........||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+........++..+++.+.
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 269 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 269 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred cccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence 55444445678999999999999999999999999999999999999999999988888777767777888999999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHhhCch
Q 002355 892 SLMESCWADDPAQRPSFANIVESLKKLLKSPA 923 (931)
Q Consensus 892 dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~ 923 (931)
+||.+||..+|.+|||+.++++.|+.++++..
T Consensus 270 ~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 270 AIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999988743
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=417.95 Aligned_cols=244 Identities=21% Similarity=0.307 Sum_probs=199.7
Q ss_pred CceEEEEEecccCceEEEEEEEc-----CCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~-----g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~ 732 (931)
++|+++++||+|+||+||+|+++ ++.||||++..... ..++.+|+++|+.+ +||||++++++|...+++|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 78999999999999999999763 56799999865432 24678999999998 6999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC-CcEEEEecCccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN-WTVKVCDFGLSRFK 811 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d-g~IKL~DFGlAr~~ 811 (931)
||||||+|++|.+++.. +++.+++.++.||+.||+|||++| ||||||||+|||++.+ +.+||+|||+|+..
T Consensus 97 lvmE~~~g~~L~~~~~~------l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 97 IAMPYLEHESFLDILNS------LSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEECCCCCCHHHHHTT------CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEeCCCcccHHHHHcC------CCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 99999999999999853 899999999999999999999999 9999999999999876 89999999999754
Q ss_pred cccc----------------------------cccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCC
Q 002355 812 ANTF----------------------------ISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWN 862 (931)
Q Consensus 812 ~~~~----------------------------~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~ 862 (931)
.... ......+||+.|||||++.+. .++.++||||+||++|||++|+.||.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 3221 112345799999999999876 47999999999999999999999996
Q ss_pred CCC-hHHHHHHHHhc----------------------------------------------------ccccCCCCCChHH
Q 002355 863 GLG-PAQVVGAVAFQ----------------------------------------------------NRRLAIPQNTSPV 889 (931)
Q Consensus 863 ~~~-~~eii~~i~~~----------------------------------------------------~~r~~lP~~~s~e 889 (931)
... ..+.+..+... .........++++
T Consensus 249 ~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~ 328 (361)
T 4f9c_A 249 KASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE 328 (361)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred CCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence 543 22222221100 0001122457889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 890 LASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 890 L~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+++||.+||.+||.+|+|++|+|+|
T Consensus 329 a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 329 AYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHCcCChhHCcCHHHHhcC
Confidence 9999999999999999999999876
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=439.59 Aligned_cols=250 Identities=24% Similarity=0.416 Sum_probs=221.0
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|+++++||+|+||+||+|++ +|+.||||++..... .....+.+|+++|+.|+|||||+++++|.+..++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch--hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 37899999999999999999987 578899999977542 33467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC--CcEEEEecCccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN--WTVKVCDFGLSRFKAN 813 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d--g~IKL~DFGlAr~~~~ 813 (931)
|||.||+|.+++.+ ....+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+|+....
T Consensus 234 E~~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 234 EFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp ECCCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred eecCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99999999999864 2346999999999999999999999999 9999999999999854 8999999999987654
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc--CCCCCChHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL--AIPQNTSPVLA 891 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~--~lP~~~s~eL~ 891 (931)
.. .....+||+.|||||++.+..++.++|||||||++|||++|..||.+.+..+.+..+....... ..+..++++++
T Consensus 310 ~~-~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 388 (573)
T 3uto_A 310 KQ-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388 (573)
T ss_dssp TS-EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred CC-ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 32 2345689999999999999999999999999999999999999999999888887776443332 23467899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 002355 892 SLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 892 dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+||.+||.+||.+|||+.|+++|
T Consensus 389 dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 389 DFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=444.78 Aligned_cols=250 Identities=22% Similarity=0.337 Sum_probs=212.7
Q ss_pred cccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchH-HHHHHH---HHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD-QLKEFL---REVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~-~~~~~l---~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
+..++|++++.||+|+||+||+|++ +|+.||||++.+...... ....+. .++.+++.++|||||+++++|.+.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 4568999999999999999999987 578899999987543221 122233 4456667778999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
++|||||||+||+|.+++.+. ..+++..++.++.||+.||+|||++| ||||||||+||||+.+|++||+|||+|+
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999999763 46999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcccccCCCCC
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGP---AQVVGAVAFQNRRLAIPQN 885 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~---~eii~~i~~~~~r~~lP~~ 885 (931)
..... ...+.+||+.|||||++.+ ..++.++|||||||++|||++|.+||.+.+. .++...+ ......+|..
T Consensus 341 ~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i--~~~~~~~p~~ 416 (689)
T 3v5w_A 341 DFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTMAVELPDS 416 (689)
T ss_dssp ECSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH--HHCCCCCCTT
T ss_pred ecCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh--cCCCCCCCcc
Confidence 76543 3456799999999999974 6799999999999999999999999976432 2333333 2345567889
Q ss_pred ChHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 002355 886 TSPVLASLMESCWADDPAQRPS-----FANIVES 914 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPS-----a~ELLq~ 914 (931)
+++++++||.+||+.||.+|++ +.|+++|
T Consensus 417 ~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 417 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 9999999999999999999998 7888877
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=374.81 Aligned_cols=261 Identities=32% Similarity=0.627 Sum_probs=232.7
Q ss_pred cccccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC--CeE
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR--PHL 731 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~--~~l 731 (931)
.++..++|++.++||+|+||+||+|+++++.||||++............+.+|+.++++++||||+++++++... ...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 356778999999999999999999999999999999988776666677899999999999999999999999876 789
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
++||||+++++|.+++.... ...+++..++.++.||+.||+|||++|++|+||||||+||+++.++.++|+|||++...
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred EeeecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 99999999999999997632 33589999999999999999999998878999999999999999999999999887543
Q ss_pred cccccccCCCCCCCcccCcccccCCCCCc---hhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChH
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRGEPSNE---KSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~~~~t~---ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~ 888 (931)
.. ....||+.|+|||++.+...+. ++|||||||++|+|++|..||......+....+.........+..+++
T Consensus 164 ~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (271)
T 3kmu_A 164 QS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238 (271)
T ss_dssp SC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred cc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence 22 3456899999999998765544 799999999999999999999998888877777767777788899999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 002355 889 VLASLMESCWADDPAQRPSFANIVESLKKLLK 920 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llk 920 (931)
.+.+||.+||..||.+|||+.++++.|+.+.+
T Consensus 239 ~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 239 HVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 99999999999999999999999999998864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=392.04 Aligned_cols=250 Identities=26% Similarity=0.477 Sum_probs=223.9
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
..++|+++++||+|+||+||+|++ +++.||||++............+.+|+++|+.++||||+++++++...+.+|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 457999999999999999999987 688899999988766666677889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||++|++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp ECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 9999999999999753 35899999999999999999999999 999999999999999999999999999765433
Q ss_pred ccccCCCCCCCcccCcccccCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 815 FISSKSVAGTPEWMAPEFLRGEPSN-EKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~~~~~t-~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
. .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+..+....+.. ....+|..+++.+.+|
T Consensus 168 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~l 244 (328)
T 3fe3_A 168 G-KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR--GKYRIPFYMSTDCENL 244 (328)
T ss_dssp C-GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHH
T ss_pred C-ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHH
Confidence 2 33556899999999999988764 799999999999999999999999888777766653 3445677899999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 002355 894 MESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 894 I~rcL~~DPeeRPSa~ELLq~ 914 (931)
|.+||..||.+|||+.|+++|
T Consensus 245 i~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHCCCChhHCcCHHHHhcC
Confidence 999999999999999999987
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=390.29 Aligned_cols=270 Identities=30% Similarity=0.529 Sum_probs=229.9
Q ss_pred cccccccCceEEEEEecccCceEEEEEEEc-------CCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEe
Q 002355 652 DWLEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMG 723 (931)
Q Consensus 652 ~~lei~~drY~Ii~kLG~G~fGtVylAr~~-------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid 723 (931)
..|++..++|+++++||+|+||+||+|++. ++.||||++.... .......+.+|+++++++ +||||+++++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 356788899999999999999999999853 3679999997643 334457789999999999 7899999999
Q ss_pred eeeeCC-eEEEEEeecCCCCHHHHhhcCCC--------------------------------------------------
Q 002355 724 AVTKRP-HLSIVTEYLPRGSLYRLIHRPAA-------------------------------------------------- 752 (931)
Q Consensus 724 ~f~~~~-~l~LVmEy~~GgSL~d~L~r~~~-------------------------------------------------- 752 (931)
++...+ .+++||||+.+++|.+++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 987654 59999999999999999975321
Q ss_pred -------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc--cc
Q 002355 753 -------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF--IS 817 (931)
Q Consensus 753 -------------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~--~~ 817 (931)
...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++....... ..
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeecccccchh
Confidence 122889999999999999999999999 9999999999999999999999999997543321 12
Q ss_pred cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHH
Q 002355 818 SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMES 896 (931)
Q Consensus 818 ~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~r 896 (931)
.....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+..............+..+++++.+||.+
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 331 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD 331 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHH
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 334567889999999999889999999999999999998 9999988776665555555666777888899999999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHHhhCchh
Q 002355 897 CWADDPAQRPSFANIVESLKKLLKSPAQ 924 (931)
Q Consensus 897 cL~~DPeeRPSa~ELLq~L~~Llks~~~ 924 (931)
||+.||.+|||+.+++++|+.+++..+|
T Consensus 332 ~l~~dP~~Rps~~ell~~L~~~~~~~~~ 359 (359)
T 3vhe_A 332 CWHGEPSQRPTFSELVEHLGNLLQANAQ 359 (359)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHHHTC
T ss_pred HccCChhhCCCHHHHHHHHHHHHHHhcC
Confidence 9999999999999999999999876543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=381.76 Aligned_cols=250 Identities=25% Similarity=0.450 Sum_probs=219.8
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|+++++||+|+||+||+|++ +++.||||++....... ...+.+|+.+++.++||||++++++|..++.+|+||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 47899999999999999999976 57889999997665433 356789999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+.|++|.+++.+. .+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 97 e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp ECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999999752 4899999999999999999999999 9999999999999999999999999998765544
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-cccCCCCCChHHHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN-RRLAIPQNTSPVLASLM 894 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~-~r~~lP~~~s~eL~dLI 894 (931)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.... .....+..+++.+.+||
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 250 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHH
T ss_pred cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHH
Confidence 44456789999999999999999999999999999999999999999887766555443322 23445678899999999
Q ss_pred HHhcccCCCCCCCHHHHHHHH
Q 002355 895 ESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 895 ~rcL~~DPeeRPSa~ELLq~L 915 (931)
.+||..||.+|||+.|+++|-
T Consensus 251 ~~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 251 NRCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp HHHSCSSTTTSCCHHHHTTCG
T ss_pred HHHccCChhHCcCHHHHhhCh
Confidence 999999999999999999863
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=392.26 Aligned_cols=251 Identities=24% Similarity=0.451 Sum_probs=222.4
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
..++|++++.||+|+||+||+|++ +++.||||++...... ......+.+|+.+|+.++||||++++++|...+++|+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 458999999999999999999987 4788999999865322 2334678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
||||++|++|..++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+++....
T Consensus 83 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999999752 35899999999999999999999999 99999999999999999999999999986443
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.. ....+|..+++++.+|
T Consensus 158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~l 235 (337)
T 1o6l_A 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRTLSPEAKSL 235 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHH
T ss_pred CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHH
Confidence 33344567899999999999999999999999999999999999999998887777766653 3455778899999999
Q ss_pred HHHhcccCCCCCC-----CHHHHHHH
Q 002355 894 MESCWADDPAQRP-----SFANIVES 914 (931)
Q Consensus 894 I~rcL~~DPeeRP-----Sa~ELLq~ 914 (931)
|.+||+.||.+|| ++.++++|
T Consensus 236 i~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 236 LAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 9999999999999 89999987
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=371.86 Aligned_cols=259 Identities=39% Similarity=0.678 Sum_probs=216.3
Q ss_pred cccccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccch--HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLD--DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~--~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
+++..++|++.++||+|+||+||+|++.++.||||++....... .....+.+|+++++.++||||+++++++..++..
T Consensus 2 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CBCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred CccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 35677999999999999999999999999999999987653322 2346788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCC-CEEEeccCCCCeEECC--------CCcEEE
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP-PILHWDLKSPNLLVDK--------NWTVKV 802 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~-~IIHrDLKPeNILLd~--------dg~IKL 802 (931)
++||||+.+++|.+++.. ..+++..++.++.||+.||+|||++|. +|+||||||+|||++. ++.+||
T Consensus 82 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp EEEEECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred EEEEEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 999999999999999853 358999999999999999999999873 3889999999999986 778999
Q ss_pred EecCccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCC
Q 002355 803 CDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAI 882 (931)
Q Consensus 803 ~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~l 882 (931)
+|||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.........
T Consensus 158 ~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (271)
T 3dtc_A 158 TDFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235 (271)
T ss_dssp CCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC
T ss_pred ccCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC
Confidence 9999998654432 23457899999999999988999999999999999999999999998887777777666667778
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 002355 883 PQNTSPVLASLMESCWADDPAQRPSFANIVESLKKL 918 (931)
Q Consensus 883 P~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~L 918 (931)
+..+++.+.+||.+||+.||.+|||+.+++++|+.+
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 889999999999999999999999999999999754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=370.28 Aligned_cols=260 Identities=30% Similarity=0.587 Sum_probs=228.4
Q ss_pred cccccCceEEEEEecccCceEEEEEEE-cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
|.+..++|+++++||+|+||+||+|++ +++.||+|++....... ..+.+|++++++++||||+++++++..++..+
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 81 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred EEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence 456779999999999999999999988 56779999998765433 45789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+++++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++....
T Consensus 82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp EEEECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred EEEEeCCCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEecccccccccc
Confidence 999999999999999652 346899999999999999999999999 9999999999999999999999999998654
Q ss_pred ccc-cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHH
Q 002355 813 NTF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 813 ~~~-~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL 890 (931)
... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+. .......+...++.+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 236 (269)
T 4hcu_A 158 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHV 236 (269)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSCHHH
T ss_pred ccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-cCccCCCCCcCCHHH
Confidence 321 12234456788999999998889999999999999999999 999999988877776664 334556677889999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 891 ASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
.+||.+||..+|++|||+.+++++|+++.++
T Consensus 237 ~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 237 YQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 9999999999999999999999999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=391.13 Aligned_cols=264 Identities=31% Similarity=0.560 Sum_probs=228.1
Q ss_pred cccccCceEEEEEecccCceEEEEEEEc---------CCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEe
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWH---------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMG 723 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~---------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid 723 (931)
+++..++|++++.||+|+||+||+|++. +..||||+++... .......+.+|+.+|+.+ +||||+++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 4566789999999999999999999863 2359999987653 345567899999999999 8999999999
Q ss_pred eeeeCCeEEEEEeecCCCCHHHHhhcCCC-------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCC
Q 002355 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAA-------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSP 790 (931)
Q Consensus 724 ~f~~~~~l~LVmEy~~GgSL~d~L~r~~~-------------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPe 790 (931)
++...+.+|+||||+.+++|.+++..... ...+++..++.++.||+.||+|||++| |+||||||+
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~ 232 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAAR 232 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGG
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchh
Confidence 99999999999999999999999976321 235789999999999999999999999 999999999
Q ss_pred CeEECCCCcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 002355 791 NLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPA 867 (931)
Q Consensus 791 NILLd~dg~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~ 867 (931)
|||++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999999998654322 12234456789999999999999999999999999999999 99999998877
Q ss_pred HHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 868 QVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 868 eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
+....+. ...+...+..++.++.+||.+||..+|.+|||+.|+++.|+.++..
T Consensus 313 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 313 ELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp GHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 7766553 3445667888999999999999999999999999999999998753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=383.07 Aligned_cols=265 Identities=34% Similarity=0.568 Sum_probs=227.4
Q ss_pred ccccCceEEEEEecccCceEEEEEEEc-----CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~~-----g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
++..++|++.++||+|+||+||+|++. +..||||++.... .......+.+|+.+++.++||||+++++++..++
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 456789999999999999999999873 3349999997543 3444577899999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
..|+||||+.|++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred ccEEEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCccc
Confidence 999999999999999999652 346899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccc---ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCC
Q 002355 810 FKANTFI---SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQN 885 (931)
Q Consensus 810 ~~~~~~~---~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~ 885 (931)
....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+. .......+..
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 278 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMG 278 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTT
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCCCCCCCC
Confidence 6543211 1223345778999999998889999999999999999999 999999988877776664 3455667788
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhh
Q 002355 886 TSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQL 925 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l 925 (931)
+++.+.+||.+||..||.+|||+.++++.|+.+++++..+
T Consensus 279 ~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 279 CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 9999999999999999999999999999999999887654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=374.77 Aligned_cols=252 Identities=27% Similarity=0.411 Sum_probs=211.4
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch------------------------HHHHHHHHHHHHH
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD------------------------DQLKEFLREVAIM 710 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~------------------------~~~~~~l~EIkIL 710 (931)
..++|++.++||+|+||+||+|++ +++.||||++....... .....+.+|++++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 458999999999999999999987 57789999997654321 1235688999999
Q ss_pred HhcCCCCeeeEEeeeee--CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccC
Q 002355 711 KRVRHPNVVLFMGAVTK--RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLK 788 (931)
Q Consensus 711 k~L~HpNIV~Lid~f~~--~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLK 788 (931)
+.++||||+++++++.. ..++|+||||+++++|.+++.. ..+++..++.++.||+.||+|||++| |+|||||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlk 164 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIK 164 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCC
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCC
Confidence 99999999999999986 6789999999999999876543 46899999999999999999999999 9999999
Q ss_pred CCCeEECCCCcEEEEecCccccccccccccCCCCCCCcccCcccccCCCC---CchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002355 789 SPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPS---NEKSDVYSFGVILWELVTMQQPWNGLG 865 (931)
Q Consensus 789 PeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~---t~ksDIWSLG~ILyELLTG~~PF~~~~ 865 (931)
|+|||++.++.+||+|||+++.............||+.|+|||++.+... +.++|||||||++|+|++|..||....
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 99999999999999999999865544333345679999999999987653 778999999999999999999999887
Q ss_pred hHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 866 PAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 866 ~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.......+............+++.+.+||.+||..||.+|||+.|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 7666665554444444456789999999999999999999999999876
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=394.98 Aligned_cols=251 Identities=24% Similarity=0.389 Sum_probs=216.1
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~ 732 (931)
..++|+++++||+|+||+||+|++ +++.||||+++...... .....+.+|+.+++.+ +||||++++++|...+.+|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 458999999999999999999987 47789999998754322 2346678999999998 6999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+.|++|..++.+. ..+++..++.++.||+.||+|||++| |+||||||+||||+.+|++||+|||+++...
T Consensus 101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 999999999999999763 35999999999999999999999999 9999999999999999999999999998644
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHH
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
.........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+.. ....+|..+++.+.+
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~ 253 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--DEVVYPTWLHEDATG 253 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHH
Confidence 443445667899999999999998899999999999999999999999999888888777653 345567889999999
Q ss_pred HHHHhcccCCCCCCCH------HHHHHH
Q 002355 893 LMESCWADDPAQRPSF------ANIVES 914 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa------~ELLq~ 914 (931)
||.+||+.||.+||++ .++++|
T Consensus 254 li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 254 ILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 9999999999999998 788875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=380.71 Aligned_cols=269 Identities=32% Similarity=0.517 Sum_probs=228.4
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEcC-------CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAV 725 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~g-------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f 725 (931)
.+++..++|++++.||+|+||.||+|++.+ +.||||++.... .......+.+|+.+++.++||||+++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 456778999999999999999999998754 679999987553 334457789999999999999999999999
Q ss_pred eeCCeEEEEEeecCCCCHHHHhhcCCC---------------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEE
Q 002355 726 TKRPHLSIVTEYLPRGSLYRLIHRPAA---------------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784 (931)
Q Consensus 726 ~~~~~l~LVmEy~~GgSL~d~L~r~~~---------------------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIH 784 (931)
..++..++||||+.+++|.+++..... ...+++..++.++.||+.||+|||++| |+|
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH 197 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVH 197 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eec
Confidence 999999999999999999999976321 146899999999999999999999999 999
Q ss_pred eccCCCCeEECCCCcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 002355 785 WDLKSPNLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPW 861 (931)
Q Consensus 785 rDLKPeNILLd~dg~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF 861 (931)
|||||+|||++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 9999999999999999999999997543221 12234567889999999998889999999999999999999 99999
Q ss_pred CCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhh
Q 002355 862 NGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQL 925 (931)
Q Consensus 862 ~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l 925 (931)
.+....+....+. .......+..+++.+.+||.+||..||.+|||+.+++++|+++.....+.
T Consensus 278 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~~ 340 (343)
T 1luf_A 278 YGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGT 340 (343)
T ss_dssp TTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-----
T ss_pred CCCChHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhhh
Confidence 9988777766654 34445677889999999999999999999999999999999998776543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=366.24 Aligned_cols=260 Identities=33% Similarity=0.636 Sum_probs=225.7
Q ss_pred cccccCceEEEEEecccCceEEEEEEEcCC-ceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWHGS-DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~g~-~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
+++..++|+++++||+|+||+||+|++.+. .||+|++....... ..+.+|+++++.++||||+++++++..+...+
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 456779999999999999999999988654 69999998765443 45789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+++++|.+++... ...+++..++.++.||+.||+|||+.| |+||||||+||+++.++.+||+|||++....
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVL 155 (268)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred EEEEccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecc
Confidence 999999999999999753 335899999999999999999999999 9999999999999999999999999998654
Q ss_pred ccc-cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHH
Q 002355 813 NTF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 813 ~~~-~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL 890 (931)
... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+. .......+...++.+
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 234 (268)
T 3sxs_A 156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTI 234 (268)
T ss_dssp TTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTSCHHH
T ss_pred hhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCCCCCCcChHHH
Confidence 332 12234456778999999998888999999999999999999 999999888777666554 344555677789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 891 ASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
.+||.+||..+|.+|||+.+++++|+.+...
T Consensus 235 ~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 235 YQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 9999999999999999999999999988654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=368.72 Aligned_cols=261 Identities=30% Similarity=0.559 Sum_probs=224.8
Q ss_pred cccccccCceEEEEEecccCceEEEEEEEcC-CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe
Q 002355 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH 730 (931)
Q Consensus 652 ~~lei~~drY~Ii~kLG~G~fGtVylAr~~g-~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~ 730 (931)
..+++..++|+++++||+|+||+||+|++.+ ..||||++....... ..+.+|+++++.++||||+++++++..++.
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRP 93 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence 3456778999999999999999999998864 479999998665443 457899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
.++||||+.+++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRY 169 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred eEEEEeccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEcccccccc
Confidence 99999999999999999752 235899999999999999999999999 99999999999999999999999999986
Q ss_pred ccccc-cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChH
Q 002355 811 KANTF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888 (931)
Q Consensus 811 ~~~~~-~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~ 888 (931)
..... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+. .......+...++
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 248 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASE 248 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCH
T ss_pred ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-cccCCCCCCcCCH
Confidence 54321 12234456788999999998889999999999999999998 999999988777766654 3445556778899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 002355 889 VLASLMESCWADDPAQRPSFANIVESLKKLLK 920 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llk 920 (931)
.+.+||.+||..+|.+|||+.+++++|++++.
T Consensus 249 ~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 249 KVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 99999999999999999999999999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=370.54 Aligned_cols=251 Identities=23% Similarity=0.347 Sum_probs=210.6
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|+++++||+|+||+||+|++ +++.||||++............+.+|+.++++++||||+++++++..++++++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 6899999999999999999988 57789999998776555556778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+.+ +|.+++.. ....+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 9965 66665544 2346999999999999999999999999 99999999999999999999999999987654444
Q ss_pred ccCCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHhcccc---------------
Q 002355 817 SSKSVAGTPEWMAPEFLRGEP-SNEKSDVYSFGVILWELVTMQQPW-NGLGPAQVVGAVAFQNRR--------------- 879 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~-~t~ksDIWSLG~ILyELLTG~~PF-~~~~~~eii~~i~~~~~r--------------- 879 (931)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..|| .+.+..+....+......
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 445667899999999998766 799999999999999999887774 555544444443221110
Q ss_pred ------------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 ------------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 ------------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
......+++.+++||.+||+.||++|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 11223578899999999999999999999999876
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=375.84 Aligned_cols=261 Identities=33% Similarity=0.530 Sum_probs=218.4
Q ss_pred ccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
.+..++|++.++||+|+||+||+|++ +++.||+|++... .......+.+|+++++.++||||+++++++..++..+
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 35668999999999999999999987 4778999988543 3455678899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+.+++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMV 159 (310)
T ss_dssp EEEECCTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence 999999999999999762 346899999999999999999999999 9999999999999999999999999998654
Q ss_pred ccccc--------------cCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHhcc
Q 002355 813 NTFIS--------------SKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVV-GAVAFQN 877 (931)
Q Consensus 813 ~~~~~--------------~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii-~~i~~~~ 877 (931)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~ 239 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF 239 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc
Confidence 32211 12567999999999999999999999999999999999999998764321110 0000011
Q ss_pred cccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 878 RRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 878 ~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
.....+..+++.+.+||.+||..||++|||+.++++.|+.+...
T Consensus 240 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 240 LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp HHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 12235677889999999999999999999999999999988765
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=376.45 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=209.6
Q ss_pred ccCceEEEEEecccCceEEEEEEE-cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
..++|+++++||+|+||+||+|++ +++.||||++............+.+|+++++.++||||+++++++..+.++++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 458999999999999999999988 5788999999766544444567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+. ++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 99 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 99 EFME-KDLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp ECCS-EEHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred cCCC-CCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9996 5888887652 345899999999999999999999999 9999999999999999999999999998765443
Q ss_pred cccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc--------------
Q 002355 816 ISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL-------------- 880 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~-------------- 880 (931)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+.......
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 34455678999999999876 557999999999999999999999998877655554442211100
Q ss_pred --------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 --------------AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 --------------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.....+++++.+||.+||++||.+|||+.|+++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0123567899999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=381.04 Aligned_cols=268 Identities=29% Similarity=0.461 Sum_probs=224.6
Q ss_pred ccccccCceEEEEEecccCceEEEEEEE-------cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEee
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEW-------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGA 724 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~-------~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~ 724 (931)
.+++..++|++.+.||+|+||+||+|++ .+..||||++.... .......+.+|+.+++++ +||||++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3577889999999999999999999986 23469999997543 223346788999999999 89999999999
Q ss_pred eeeCCeEEEEEeecCCCCHHHHhhcCCCC--------------------CCCcHHHHHHHHHHHHHHHHHHHhCCCCEEE
Q 002355 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAG--------------------EMMDQRRRLRMALDVAKGINYLHNLNPPILH 784 (931)
Q Consensus 725 f~~~~~l~LVmEy~~GgSL~d~L~r~~~~--------------------~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIH 784 (931)
+..++..++||||+++++|.+++...... ..+++..++.++.||+.||+|||++| |+|
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH 195 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVH 195 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccc
Confidence 99999999999999999999999763221 34789999999999999999999999 999
Q ss_pred eccCCCCeEECCCCcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 002355 785 WDLKSPNLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPW 861 (931)
Q Consensus 785 rDLKPeNILLd~dg~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF 861 (931)
|||||+|||++.++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 9999999999999999999999997544321 11234456889999999998889999999999999999998 99999
Q ss_pred CCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCch
Q 002355 862 NGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPA 923 (931)
Q Consensus 862 ~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~ 923 (931)
.+...................+..+++.+.+||.+||..||.+|||+.+++++|+.++....
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 276 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp TTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred ccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 88876655555555556667788899999999999999999999999999999999987643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=378.35 Aligned_cols=269 Identities=30% Similarity=0.495 Sum_probs=213.1
Q ss_pred cccccCceEEEEEecccCceEEEEEEEcCC-----ceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWHGS-----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~g~-----~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~ 728 (931)
+.+..++|++++.||+|+||+||+|++... .||||++............+.+|+++++.++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 456678999999999999999999986432 699999987665556678899999999999999999999999876
Q ss_pred CeE------EEEEeecCCCCHHHHhhcCCC---CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc
Q 002355 729 PHL------SIVTEYLPRGSLYRLIHRPAA---GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT 799 (931)
Q Consensus 729 ~~l------~LVmEy~~GgSL~d~L~r~~~---~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~ 799 (931)
... ++||||+.+++|.+++..... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSC
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCCCC
Confidence 654 999999999999999864221 225899999999999999999999999 999999999999999999
Q ss_pred EEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 002355 800 VKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQ 876 (931)
Q Consensus 800 IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~ 876 (931)
+||+|||+++...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+. .
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~ 254 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI-G 254 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-T
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh-c
Confidence 9999999997643321 12233456789999999999999999999999999999999 999999988877776654 3
Q ss_pred ccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhh
Q 002355 877 NRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQL 925 (931)
Q Consensus 877 ~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l 925 (931)
......+..+++.+.+||.+||..||.+|||+.++++.|++++..+.-.
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~ 303 (323)
T 3qup_A 255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL 303 (323)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence 4455677889999999999999999999999999999999999987643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=372.40 Aligned_cols=265 Identities=31% Similarity=0.556 Sum_probs=228.7
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEc-------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAV 725 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~-------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f 725 (931)
.+++..++|++.+.||+|+||.||+|++. ++.||||++.... .......+.+|+++++.++||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 45667899999999999999999999762 3679999987543 345567889999999999999999999999
Q ss_pred eeCCeEEEEEeecCCCCHHHHhhcCCC---------------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEE
Q 002355 726 TKRPHLSIVTEYLPRGSLYRLIHRPAA---------------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784 (931)
Q Consensus 726 ~~~~~l~LVmEy~~GgSL~d~L~r~~~---------------------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIH 784 (931)
..++..++||||+.+++|.+++..... ...+++..++.++.||+.||+|||++| |+|
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH 173 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVH 173 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccc
Confidence 999999999999999999999976332 134889999999999999999999999 999
Q ss_pred eccCCCCeEECCCCcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCC
Q 002355 785 WDLKSPNLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPW 861 (931)
Q Consensus 785 rDLKPeNILLd~dg~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF 861 (931)
|||||+|||++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999997653321 12234457889999999998889999999999999999999 99999
Q ss_pred CCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 862 NGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 862 ~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
.+.........+. .......+..+++.+.+||.+||..||.+|||+.+++++|+.++..
T Consensus 254 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 254 PGIPPERLFNLLK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp TTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCHHHHHHHhh-cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 9888777665554 3445567788999999999999999999999999999999998864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=371.31 Aligned_cols=267 Identities=29% Similarity=0.492 Sum_probs=229.2
Q ss_pred ccccccCceEEEEEecccCceEEEEEEE-------cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEee
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEW-------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGA 724 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~-------~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~ 724 (931)
.+++..++|++.+.||+|+||+||+|++ .++.||||++..... ......+.+|+++++++ +||||++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh-HHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 4677889999999999999999999985 346799999976542 33457789999999999 89999999999
Q ss_pred eeeCCeEEEEEeecCCCCHHHHhhcCCC---------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCC
Q 002355 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAA---------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS 789 (931)
Q Consensus 725 f~~~~~l~LVmEy~~GgSL~d~L~r~~~---------------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKP 789 (931)
+..++..++||||+++++|.+++..... ...+++..++.++.||+.||+|||++| |+||||||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp 173 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAA 173 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCcc
Confidence 9999999999999999999999976321 124899999999999999999999999 99999999
Q ss_pred CCeEECCCCcEEEEecCcccccccccc--ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 002355 790 PNLLVDKNWTVKVCDFGLSRFKANTFI--SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGP 866 (931)
Q Consensus 790 eNILLd~dg~IKL~DFGlAr~~~~~~~--~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~ 866 (931)
+||+++.++.+||+|||++........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 999999999999999999986544321 1233456788999999998889999999999999999999 9999988776
Q ss_pred HHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 867 AQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 867 ~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
................+..+++.+.+||.+||..||.+|||+.+++++|++++...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred hhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 55555554455556667889999999999999999999999999999999988653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=381.19 Aligned_cols=248 Identities=25% Similarity=0.468 Sum_probs=220.7
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
..++|++++.||+|+||+||+|++ +++.||||++....... .....+.+|+.+++.++||||++++++|.+...+|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 458999999999999999999987 57889999998653222 234667899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
||||++|++|.+++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+++....
T Consensus 84 v~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 84 IMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp EECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EEeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 9999999999999976 235899999999999999999999999 99999999999999999999999999986544
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
. ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.. ....+|..+++++.+|
T Consensus 159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~l 233 (318)
T 1fot_A 159 V---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AELRFPPFFNEDVKDL 233 (318)
T ss_dssp C---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHH
T ss_pred c---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHH
Confidence 3 3456899999999999999999999999999999999999999999887777766653 3455778899999999
Q ss_pred HHHhcccCCCCCC-----CHHHHHHH
Q 002355 894 MESCWADDPAQRP-----SFANIVES 914 (931)
Q Consensus 894 I~rcL~~DPeeRP-----Sa~ELLq~ 914 (931)
|.+||..||.+|| ++.++++|
T Consensus 234 i~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 234 LSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 9999999999999 89999876
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=379.94 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=210.5
Q ss_pred cccCceEEEEEecccCceEEEEEEE-----cCCceEEEEEeecccch--HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLD--DQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~-----~g~~VAVKVlk~~~~~~--~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~ 728 (931)
+..++|+++++||+|+||+||+|++ +++.||||++....... .....+.+|+.+|+.++||||++++++|..+
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 4558999999999999999999986 57789999998754322 2345678899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
+++|+||||+.|++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999999752 35889999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChH
Q 002355 809 RFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888 (931)
Q Consensus 809 r~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~ 888 (931)
+............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.. ....+|..+++
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~ 246 (327)
T 3a62_A 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK--CKLNLPPYLTQ 246 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--TCCCCCTTSCH
T ss_pred cccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCH
Confidence 7644333334556899999999999999999999999999999999999999999887777666543 34557788999
Q ss_pred HHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 002355 889 VLASLMESCWADDPAQRP-----SFANIVES 914 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRP-----Sa~ELLq~ 914 (931)
++.+||.+||..||.+|| ++.++++|
T Consensus 247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 999999999999999999 88899886
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=396.98 Aligned_cols=252 Identities=23% Similarity=0.395 Sum_probs=222.6
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|+++++||+|+||+||+|.+ +++.||+|++............+.+|+++++.++||||+++++++..++..|+||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 37899999999999999999987 5788999999887766666778899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC---CCCcEEEEecCcccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD---KNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd---~dg~IKL~DFGlAr~~~ 812 (931)
||+.|++|.+++.. ...+++..+..++.||+.||+|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 90 E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 90 DLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp CCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 99999999999876 345999999999999999999999999 99999999999998 56789999999998765
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC--CCChHHH
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP--QNTSPVL 890 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP--~~~s~eL 890 (931)
..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.........+ ..+++++
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 54434456789999999999999999999999999999999999999999988888877776544433322 5789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+||.+||..||.+|||+.|+++|
T Consensus 245 ~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 245 KDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHcCCChhHCCCHHHHhcC
Confidence 999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=384.72 Aligned_cols=265 Identities=31% Similarity=0.567 Sum_probs=230.2
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEcC---------CceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEE
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWHG---------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFM 722 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~g---------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Li 722 (931)
.+++..++|+++++||+|+||+||+|++.+ ..||||++.... .......+.+|+++++.+ +||||++++
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 356788999999999999999999998632 459999997653 344567889999999999 899999999
Q ss_pred eeeeeCCeEEEEEeecCCCCHHHHhhcCCC-------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCC
Q 002355 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPAA-------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS 789 (931)
Q Consensus 723 d~f~~~~~l~LVmEy~~GgSL~d~L~r~~~-------------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKP 789 (931)
+++..++..++||||+.+++|.+++..... ...+++..++.++.||+.||+|||++| |+||||||
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp 219 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAA 219 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCc
Confidence 999999999999999999999999975321 245899999999999999999999999 99999999
Q ss_pred CCeEECCCCcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 002355 790 PNLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGP 866 (931)
Q Consensus 790 eNILLd~dg~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~ 866 (931)
+|||++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998654322 12334457889999999999999999999999999999999 9999999887
Q ss_pred HHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 867 AQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 867 ~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
.+....+. .......+..+++++.+||.+||+.||.+|||+.+++++|+.++..
T Consensus 300 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 300 EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp HHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 77666554 4455667788999999999999999999999999999999998754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=385.44 Aligned_cols=252 Identities=25% Similarity=0.434 Sum_probs=221.3
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|+++++||+|+||+||+|++ +++.||+|++............+.+|+.+++.++||||+++++++...+..|+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 47899999999999999999987 4788999999887766666778999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC---CcEEEEecCcccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN---WTVKVCDFGLSRFKA 812 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d---g~IKL~DFGlAr~~~ 812 (931)
||+.|++|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++....
T Consensus 108 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 108 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp CCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 99999999999875 346899999999999999999999999 9999999999999865 459999999998655
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC--CCChHHH
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP--QNTSPVL 890 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP--~~~s~eL 890 (931)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.........+ ..+++++
T Consensus 183 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (362)
T 2bdw_A 183 DSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 261 (362)
T ss_dssp TCC-SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred CCc-ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 432 2345689999999999999999999999999999999999999999988777777665443332222 4678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
.+||.+||..||.+|||+.++++|-
T Consensus 262 ~~li~~~L~~dP~~R~t~~e~l~hp 286 (362)
T 2bdw_A 262 KSLIDSMLTVNPKKRITADQALKVP 286 (362)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCc
Confidence 9999999999999999999999873
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=382.73 Aligned_cols=251 Identities=24% Similarity=0.406 Sum_probs=216.7
Q ss_pred ccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccc-hHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~ 732 (931)
..++|++++.||+|+||.||+|++. ++.||||++...... ......+.+|+.+++.+ +||||++++++|.....+|
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 4589999999999999999999874 678999999876543 34556788999999998 8999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||++|++|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+++...
T Consensus 87 lv~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999999752 35899999999999999999999999 9999999999999999999999999998644
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC---------ChHHHHHHHHhcccccCCC
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGL---------GPAQVVGAVAFQNRRLAIP 883 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~---------~~~eii~~i~~~~~r~~lP 883 (931)
.........+||+.|+|||++.+..++.++|||||||++|||++|..||... ....+...+. .....+|
T Consensus 162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~--~~~~~~p 239 (345)
T 3a8x_A 162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--EKQIRIP 239 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH--HCCCCCC
T ss_pred CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH--cCCCCCC
Confidence 3333445678999999999999999999999999999999999999999753 2222333332 3445678
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 002355 884 QNTSPVLASLMESCWADDPAQRPSF------ANIVES 914 (931)
Q Consensus 884 ~~~s~eL~dLI~rcL~~DPeeRPSa------~ELLq~ 914 (931)
..+++.+.+||.+||..||.+||++ .++++|
T Consensus 240 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 8899999999999999999999995 677765
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=369.07 Aligned_cols=263 Identities=36% Similarity=0.638 Sum_probs=212.6
Q ss_pred cccccccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 652 ~~lei~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
+..++..++|++.++||+|+||+||+|++.+ .||+|+++...........+.+|+.+++.++||||++++++. .....
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 3457788999999999999999999998765 599999987776667778899999999999999999999954 56678
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
++||||+.+++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 95 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEEEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceecccc
Confidence 9999999999999999652 346899999999999999999999999 999999999999999999999999999754
Q ss_pred ccc--ccccCCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-c---cCC
Q 002355 812 ANT--FISSKSVAGTPEWMAPEFLR---GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-R---LAI 882 (931)
Q Consensus 812 ~~~--~~~~~~~~GT~~Y~APEvL~---~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~-r---~~l 882 (931)
... ........||+.|+|||++. +..++.++|||||||++|+|++|..||................. . ...
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV 250 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSS
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhc
Confidence 321 11223457899999999987 56678899999999999999999999988765544433322222 1 223
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 002355 883 PQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920 (931)
Q Consensus 883 P~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llk 920 (931)
+..+++.+.+||.+||..+|.+|||+.++++.|+++.+
T Consensus 251 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 45788999999999999999999999999999998865
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=361.39 Aligned_cols=253 Identities=24% Similarity=0.411 Sum_probs=222.3
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|++.++||+|+||+||+|.+ +++.||+|++............+.+|+.+++.++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 37999999999999999999987 4778999999887766666788899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc---EEEEecCcccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT---VKVCDFGLSRFKA 812 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~---IKL~DFGlAr~~~ 812 (931)
||+.+++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+||+++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999999888752 35899999999999999999999999 999999999999986655 9999999997655
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCC--CCCChHHH
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAI--PQNTSPVL 890 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~l--P~~~s~eL 890 (931)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+......... ...+++++
T Consensus 160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T 3kk8_A 160 DSE-AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238 (284)
T ss_dssp SSC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred cCc-cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence 432 224467899999999999999999999999999999999999999998887777766544433332 35789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
.+||.+||+.||.+|||+.|++++-.
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 239 KSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred HHHHHHHcccChhhCCCHHHHhcCcc
Confidence 99999999999999999999998743
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=394.69 Aligned_cols=262 Identities=31% Similarity=0.585 Sum_probs=228.6
Q ss_pred cccccccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC-e
Q 002355 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP-H 730 (931)
Q Consensus 652 ~~lei~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~-~ 730 (931)
..|++..++|+++++||+|+||.||+|+++++.||||+++... ..+.+.+|+++|++++||||+++++++.... .
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 3467788999999999999999999999999999999997654 2356889999999999999999999987654 7
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
+|+||||+.+++|.+++.... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 999999999999999997632 334789999999999999999999999 99999999999999999999999999985
Q ss_pred ccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHH
Q 002355 811 KANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPV 889 (931)
Q Consensus 811 ~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~e 889 (931)
..... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. ...+...|..+++.
T Consensus 339 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~p~~~~~~ 414 (450)
T 1k9a_A 339 ASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPA 414 (450)
T ss_dssp CC---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCHH
T ss_pred ccccc---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHH
Confidence 44321 23367889999999999999999999999999999998 999999988777766654 44566788899999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchh
Q 002355 890 LASLMESCWADDPAQRPSFANIVESLKKLLKSPAQ 924 (931)
Q Consensus 890 L~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~ 924 (931)
+.+||.+||..||.+|||+.++++.|+.+..+...
T Consensus 415 l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~l~ 449 (450)
T 1k9a_A 415 VYDVMKNCWHLDAATRPTFLQLREQLEHIRTHELH 449 (450)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTTTT
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhhcc
Confidence 99999999999999999999999999999876543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=370.29 Aligned_cols=263 Identities=30% Similarity=0.518 Sum_probs=216.3
Q ss_pred ccccCceEEEEEecccCceEEEEEEE------cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee-
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEW------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK- 727 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~------~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~- 727 (931)
++..++|+++++||+|+||+||+|++ +++.||||++.... ......+.+|+++++.++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 45668999999999999999999985 46789999987543 4455778999999999999999999999854
Q ss_pred -CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecC
Q 002355 728 -RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806 (931)
Q Consensus 728 -~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFG 806 (931)
..++++||||+++++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCc
Confidence 46799999999999999999763 235899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccc---cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---------------
Q 002355 807 LSRFKANTF---ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQ--------------- 868 (931)
Q Consensus 807 lAr~~~~~~---~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~e--------------- 868 (931)
++....... .......++..|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 998654321 11233456778999999999999999999999999999999999986532110
Q ss_pred HHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCch
Q 002355 869 VVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPA 923 (931)
Q Consensus 869 ii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~ 923 (931)
..........+...+..+++++.+||.+||..||++|||+.++++.|+.+.++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 1112223344566788899999999999999999999999999999999987653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=370.68 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=207.9
Q ss_pred CceEEEEEecccCceEEEEEEEc-CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~-g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
++|+++++||+|+||+||+|++. ++.||+|++............+.+|+.+++.++||||+++++++...++.++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 68999999999999999999874 78899999976654433345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccc
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~ 817 (931)
+.+ +|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.........
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence 964 999988752 345899999999999999999999999 999999999999999999999999999865443333
Q ss_pred cCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc-----------------
Q 002355 818 SKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR----------------- 879 (931)
Q Consensus 818 ~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r----------------- 879 (931)
.....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+....+......
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence 3455789999999999764 5799999999999999999999999988766655444321100
Q ss_pred ----------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 ----------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 ----------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
......+++++.+||.+||..||.+|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 01224578999999999999999999999999876
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=388.70 Aligned_cols=253 Identities=26% Similarity=0.455 Sum_probs=219.7
Q ss_pred ccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCe
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH 730 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~ 730 (931)
.+..++|++++.||+|+||+||+|++ +++.||||+++..... ......+.+|..++..+ +||||++++++|...++
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 34568999999999999999999987 4778999999875322 22345678899999887 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
+|+||||++||+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+++.
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999999752 35899999999999999999999999 99999999999999999999999999986
Q ss_pred ccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHH
Q 002355 811 KANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 811 ~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL 890 (931)
...........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+.. ....+|..+++++
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~ 245 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRWLEKEA 245 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHH
T ss_pred cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh--CCCCCCcccCHHH
Confidence 44333344667899999999999999999999999999999999999999999888877776653 3345678899999
Q ss_pred HHHHHHhcccCCCCCCCHH-HHHHH
Q 002355 891 ASLMESCWADDPAQRPSFA-NIVES 914 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~-ELLq~ 914 (931)
.+||.+||..||.+||++. ++++|
T Consensus 246 ~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 246 KDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred HHHHHHHhcCCHhHcCCChHHHHcC
Confidence 9999999999999999997 77654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=370.84 Aligned_cols=261 Identities=24% Similarity=0.416 Sum_probs=219.8
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
..++|+++++||+|+||+||+|++ .++.||+|++...... ......+.+|+.+++.++||||+++++++..++.+|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 458999999999999999999987 5778999998765433 3455788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
||||++|++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 89 v~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999999763 35899999999999999999999999 99999999999999999999999999986543
Q ss_pred cc-cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc---cCCCCCChHH
Q 002355 814 TF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR---LAIPQNTSPV 889 (931)
Q Consensus 814 ~~-~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r---~~lP~~~s~e 889 (931)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+................ ...+..+++.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHH
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHH
Confidence 32 1233457999999999999999999999999999999999999999988776655444322221 2245778999
Q ss_pred HHHHHHHhcccCCCCCC-CHHHHHHHHHHHhhCc
Q 002355 890 LASLMESCWADDPAQRP-SFANIVESLKKLLKSP 922 (931)
Q Consensus 890 L~dLI~rcL~~DPeeRP-Sa~ELLq~L~~Llks~ 922 (931)
+.++|.+||..||.+|| +++++.+.|..++...
T Consensus 244 l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 244 LSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp HHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred HHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 99999999999999998 9999999999887654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=385.07 Aligned_cols=251 Identities=24% Similarity=0.434 Sum_probs=218.7
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchH----HHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD----QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~----~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
.++|++++.||+|+||+||+|++ +++.||+|++........ ....+.+|+.+|+.++||||++++++|.....+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 37899999999999999999987 478899999987653321 235788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC----cEEEEecCc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW----TVKVCDFGL 807 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg----~IKL~DFGl 807 (931)
|+||||++|++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 999999999999999975 346999999999999999999999999 99999999999998877 799999999
Q ss_pred cccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc--CCCCC
Q 002355 808 SRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL--AIPQN 885 (931)
Q Consensus 808 Ar~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~--~lP~~ 885 (931)
+....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....... ..+..
T Consensus 166 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (361)
T 2yab_A 166 AHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244 (361)
T ss_dssp CEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred ceEcCCCC-ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccC
Confidence 98655432 2345679999999999999999999999999999999999999999988877777665333221 12357
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 886 TSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+++.+++||.+||..||.+|||+.|+++|
T Consensus 245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 245 TSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 88999999999999999999999999976
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=388.69 Aligned_cols=264 Identities=32% Similarity=0.536 Sum_probs=228.4
Q ss_pred cccccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 652 DWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 652 ~~lei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
+.|++..++|++.++||+|+||.||+|++ +++.||||+++... .......+.+|+++|+.++||||+++++++..++
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 45677889999999999999999999998 47889999987542 3344567889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
.+|+||||+++++|.+++... +..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSR 261 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred CcEEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCce
Confidence 999999999999999999752 345899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccccc--CCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCC
Q 002355 810 FKANTFISS--KSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNT 886 (931)
Q Consensus 810 ~~~~~~~~~--~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~ 886 (931)
......... ....+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. ...+...|..+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 340 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELC 340 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-TTCCCCCCTTC
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCC
Confidence 644332111 12234678999999998889999999999999999998 999999988777665543 45566778889
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 887 SPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
++.+.+||.+||+.||++|||+.++++.|+.+.+.
T Consensus 341 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 341 PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 99999999999999999999999999999998753
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=365.39 Aligned_cols=256 Identities=36% Similarity=0.684 Sum_probs=217.3
Q ss_pred cccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHH-----HHHHHHHHHHHHhcCCCCeeeEEeeeeeC
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQ-----LKEFLREVAIMKRVRHPNVVLFMGAVTKR 728 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~-----~~~~l~EIkILk~L~HpNIV~Lid~f~~~ 728 (931)
+..++|++.++||+|+||+||+|++ +++.||||++......... ...+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 4558999999999999999999988 5788999998765433211 16788999999999999999999999766
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc-----EEEE
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT-----VKVC 803 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~-----IKL~ 803 (931)
. ++||||+.+++|.+++... ...+++..++.++.||+.||+|||++|++|+||||||+|||++.++. +||+
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred C--eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 5 6999999999999988652 34689999999999999999999998877999999999999988776 9999
Q ss_pred ecCccccccccccccCCCCCCCcccCccccc--CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhcccc
Q 002355 804 DFGLSRFKANTFISSKSVAGTPEWMAPEFLR--GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQV--VGAVAFQNRR 879 (931)
Q Consensus 804 DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~--~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~ei--i~~i~~~~~r 879 (931)
|||+++..... .....||+.|+|||++. ...++.++|||||||++|+|++|..||........ ...+......
T Consensus 172 Dfg~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 248 (287)
T 4f0f_A 172 DFGLSQQSVHS---VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248 (287)
T ss_dssp CCTTCBCCSSC---EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC
T ss_pred CCCcccccccc---ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC
Confidence 99999855443 24567899999999984 44568899999999999999999999987654333 4444445556
Q ss_pred cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 002355 880 LAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKL 918 (931)
Q Consensus 880 ~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~L 918 (931)
...+..+++.+.+||.+||+.||.+|||+.++++.|+++
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 678889999999999999999999999999999998753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=359.59 Aligned_cols=260 Identities=30% Similarity=0.590 Sum_probs=226.9
Q ss_pred cccccCceEEEEEecccCceEEEEEEE-cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
|.+..++|++++.||+|+||+||+|++ +++.||+|++....... +.+.+|+.+++.++||||+++++++...+..+
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred eEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 456779999999999999999999988 56679999998765433 46789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+++++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++....
T Consensus 80 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp EEECCCTTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred EEEeCCCCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEcccccccccc
Confidence 999999999999999752 346899999999999999999999999 9999999999999999999999999998653
Q ss_pred ccc-cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHH
Q 002355 813 NTF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 813 ~~~-~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL 890 (931)
... .......++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+.. ......+...++.+
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l 234 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHV 234 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTTSCHHH
T ss_pred cccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc-CCcCCCCccCcHHH
Confidence 321 12234467889999999998889999999999999999999 8999998887777666543 34455677889999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 891 ASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
.+||.+||..+|.+|||+.+++++|+.+.+.
T Consensus 235 ~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 235 YQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999865
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=386.70 Aligned_cols=251 Identities=24% Similarity=0.411 Sum_probs=220.2
Q ss_pred ccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccc-hHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~ 732 (931)
..++|++++.||+|+||+||+|++. ++.||||++...... ......+.+|..++..+ +||||++++++|...+++|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4589999999999999999999884 567999999875432 12345678899999988 7999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||++|++|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+++...
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 999999999999999752 35899999999999999999999999 9999999999999999999999999998644
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHH
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
.........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+.. ....+|..+++++.+
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~ 250 (353)
T 2i0e_A 173 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEAVA 250 (353)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHH
Confidence 333344667899999999999999999999999999999999999999999888887777653 345577889999999
Q ss_pred HHHHhcccCCCCCCC-----HHHHHHH
Q 002355 893 LMESCWADDPAQRPS-----FANIVES 914 (931)
Q Consensus 893 LI~rcL~~DPeeRPS-----a~ELLq~ 914 (931)
||.+||..||.+||+ +.++++|
T Consensus 251 li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 251 ICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 999999999999995 5888776
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=392.11 Aligned_cols=252 Identities=23% Similarity=0.417 Sum_probs=215.6
Q ss_pred cccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccch-HHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l 731 (931)
+..++|+++++||+|+||+||+|++. ++.||||++++..... .....+.+|+.++.++ +||||++++++|...+.+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 34589999999999999999999874 6679999998765443 3345678899999887 899999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
|+||||+.|++|..++.+. ..+++..++.++.||+.||+|||++| |+||||||+||||+.+|++||+|||+|+..
T Consensus 129 ~lV~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999999763 35999999999999999999999999 999999999999999999999999999864
Q ss_pred cccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHhcccccCC
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLG---------PAQVVGAVAFQNRRLAI 882 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~---------~~eii~~i~~~~~r~~l 882 (931)
..........+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...+ ......+
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~ 281 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRI 281 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH--HHCCCCC
T ss_pred ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH--hccccCC
Confidence 443344567789999999999999999999999999999999999999996432 12223333 2445667
Q ss_pred CCCChHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 002355 883 PQNTSPVLASLMESCWADDPAQRPSF------ANIVES 914 (931)
Q Consensus 883 P~~~s~eL~dLI~rcL~~DPeeRPSa------~ELLq~ 914 (931)
|..+++++.+||.+||+.||.+||++ .++++|
T Consensus 282 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 282 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 88999999999999999999999985 677765
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=383.02 Aligned_cols=255 Identities=24% Similarity=0.371 Sum_probs=213.4
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch---HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD---DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~---~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
.++|++++.||+|+||+||+|++ +++.||||++....... .....+.+|+.+++.++||||+++++++..++.+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 37899999999999999999987 57889999997643211 12457889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcC-CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc---EEEEecCcc
Q 002355 733 IVTEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT---VKVCDFGLS 808 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~-~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~---IKL~DFGlA 808 (931)
+||||+.|++|.+++.+. ..+..+++..++.++.||+.||+|||++| |+||||||+|||++.++. +||+|||++
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999998877542 22345899999999999999999999999 999999999999986654 999999999
Q ss_pred ccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccC--CCCCC
Q 002355 809 RFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLA--IPQNT 886 (931)
Q Consensus 809 r~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~--lP~~~ 886 (931)
.............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. .+....+........ ....+
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~ 259 (351)
T 3c0i_A 181 IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHI 259 (351)
T ss_dssp EECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTS
T ss_pred eEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccC
Confidence 876554333455689999999999999989999999999999999999999998743 344444432222111 12567
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002355 887 SPVLASLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
++++.+||.+||..||.+|||+.++++|-
T Consensus 260 s~~~~~li~~~L~~dP~~R~s~~e~l~hp 288 (351)
T 3c0i_A 260 SESAKDLVRRMLMLDPAERITVYEALNHP 288 (351)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence 89999999999999999999999999863
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=366.23 Aligned_cols=262 Identities=30% Similarity=0.550 Sum_probs=214.4
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEc-----CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK 727 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~-----g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~ 727 (931)
.+++..++|++.++||+|+||+||+|++. +..||+|++.... .......+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 86 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence 35677799999999999999999999873 2358888876542 3344567899999999999999999999985
Q ss_pred CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCc
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGl 807 (931)
++..++||||+.+++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC---
T ss_pred cCccEEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECcccc
Confidence 46789999999999999999752 345899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccc-ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCC
Q 002355 808 SRFKANTFI-SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQN 885 (931)
Q Consensus 808 Ar~~~~~~~-~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~ 885 (931)
++....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+. .......+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~ 241 (281)
T 1mp8_A 163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPN 241 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTT
T ss_pred ccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-cCCCCCCCCC
Confidence 986543221 1233456789999999998889999999999999999996 999999888777766654 3345567788
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 886 TSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
+++.+.+||.+||..||.+|||+.++++.|+++++.
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 242 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999998764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=384.03 Aligned_cols=248 Identities=25% Similarity=0.430 Sum_probs=221.0
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
..++|++++.||+|+||.||+|++ +++.||||++....... .....+.+|+++|+.++||||++++++|.+..++|+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 347999999999999999999987 47889999997654322 334678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
||||++|++|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+++....
T Consensus 119 v~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999999763 35899999999999999999999999 99999999999999999999999999986544
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
. ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+... ...+|..+++.+.+|
T Consensus 194 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~l 268 (350)
T 1rdq_E 194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDL 268 (350)
T ss_dssp C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTCCHHHHHH
T ss_pred C---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHH
Confidence 3 24568999999999999999999999999999999999999999998887777776533 456778899999999
Q ss_pred HHHhcccCCCCCCC-----HHHHHHH
Q 002355 894 MESCWADDPAQRPS-----FANIVES 914 (931)
Q Consensus 894 I~rcL~~DPeeRPS-----a~ELLq~ 914 (931)
|.+||+.||.+||+ +.++++|
T Consensus 269 i~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 269 LRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHHhhcCHHhccCCccCCHHHHHhC
Confidence 99999999999998 8888876
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=366.24 Aligned_cols=261 Identities=29% Similarity=0.499 Sum_probs=216.4
Q ss_pred ccccCceEEEEEecccCceEEEEEEE------cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEW------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~------~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~ 728 (931)
.+..++|+++++||+|+||.||+|++ +++.||||++..... ......+.+|+++++.++||||+++++++...
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 34567899999999999999999984 567899999976532 22346788999999999999999999999766
Q ss_pred --CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecC
Q 002355 729 --PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806 (931)
Q Consensus 729 --~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFG 806 (931)
..+++||||+.+++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCT
T ss_pred CCceEEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECccc
Confidence 6799999999999999999652 345899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccc---cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC--------------ChHHH
Q 002355 807 LSRFKANTF---ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGL--------------GPAQV 869 (931)
Q Consensus 807 lAr~~~~~~---~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~--------------~~~ei 869 (931)
++....... .......||..|+|||++.+..++.++|||||||++|+|++|..|+... .....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 998654332 1234456888999999999988999999999999999999999886432 11122
Q ss_pred HHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 002355 870 VGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920 (931)
Q Consensus 870 i~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llk 920 (931)
.............+..+++.+.+||.+||..||.+|||+.++++.|+.+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 222233445566788899999999999999999999999999999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=365.48 Aligned_cols=264 Identities=33% Similarity=0.607 Sum_probs=230.2
Q ss_pred cccccccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 652 DWLEISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 652 ~~lei~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
+.+++..++|++.++||+|+||+||+|++. +..||+|++.... .....+.+|+++++.++||||+++++++...+
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 456788899999999999999999999885 6789999997543 23467889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
..++||||+.|++|.+++.... ...+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++.
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred CEEEEEEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCccce
Confidence 9999999999999999997632 345899999999999999999999999 9999999999999999999999999998
Q ss_pred cccccc-cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCCh
Q 002355 810 FKANTF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTS 887 (931)
Q Consensus 810 ~~~~~~-~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s 887 (931)
...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+. .......+..++
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 238 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-ccCCCCCCCCCC
Confidence 654332 12233456788999999998889999999999999999999 999999888776665553 344566778899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 888 PVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 888 ~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
+.+.+||.+||..||.+|||+.++++.|+.++...
T Consensus 239 ~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 239 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 99999999999999999999999999999988753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=381.96 Aligned_cols=255 Identities=21% Similarity=0.334 Sum_probs=213.1
Q ss_pred ccCceEEEEEeccc--CceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 657 SWDELHVKERVGAG--SFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 657 ~~drY~Ii~kLG~G--~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
..++|+++++||+| +||+||+|++. ++.||||++............+.+|+.+++.++||||++++++|..++.+|
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 55899999999999 99999999984 788999999887766666788899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+.+++|.+++.... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||.+....
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 9999999999999997632 345899999999999999999999999 9999999999999999999999999886432
Q ss_pred cc-------ccccCCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-----
Q 002355 813 NT-------FISSKSVAGTPEWMAPEFLRG--EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR----- 878 (931)
Q Consensus 813 ~~-------~~~~~~~~GT~~Y~APEvL~~--~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~----- 878 (931)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+.....
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 11 112233478999999999987 5789999999999999999999999987665443322211000
Q ss_pred ---------------------------------------ccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 ---------------------------------------RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 ---------------------------------------r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
....+..+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 112345678899999999999999999999999976
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=370.24 Aligned_cols=268 Identities=30% Similarity=0.528 Sum_probs=226.8
Q ss_pred ccccccCceEEEEEecccCceEEEEEEE-------cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEee
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEW-------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGA 724 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~-------~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~ 724 (931)
.+++..++|++++.||+|+||+||+|++ +++.||||++.... .......+.+|+++++.+ +||||++++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 3567789999999999999999999985 24679999997653 334456789999999999 69999999999
Q ss_pred eeeC-CeEEEEEeecCCCCHHHHhhcCCC-------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCC
Q 002355 725 VTKR-PHLSIVTEYLPRGSLYRLIHRPAA-------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSP 790 (931)
Q Consensus 725 f~~~-~~l~LVmEy~~GgSL~d~L~r~~~-------------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPe 790 (931)
+... ..+++||||+.+++|.+++..... ...+++..++.++.||+.||.|||++| |+||||||+
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~ 177 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAAR 177 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCccc
Confidence 8765 459999999999999999976332 123889999999999999999999999 999999999
Q ss_pred CeEECCCCcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 002355 791 NLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPA 867 (931)
Q Consensus 791 NILLd~dg~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~ 867 (931)
||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 9999999999999999997543321 12234457889999999999889999999999999999998 99999887755
Q ss_pred HHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCch
Q 002355 868 QVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPA 923 (931)
Q Consensus 868 eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~ 923 (931)
...............+...++.+.+||.+||..||.+|||+.+++++|+.+++...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 55544444555666778899999999999999999999999999999999987643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=371.69 Aligned_cols=269 Identities=31% Similarity=0.499 Sum_probs=229.1
Q ss_pred ccccccccCceEEEEEecccCceEEEEEEEc-------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 002355 651 MDWLEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMG 723 (931)
Q Consensus 651 ~~~lei~~drY~Ii~kLG~G~fGtVylAr~~-------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid 723 (931)
.+.+++..++|++.+.||+|+||+||+|++. ++.||||++.... .......+.+|+++++.++||||+++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 3456778899999999999999999999764 5679999987543 3344567889999999999999999999
Q ss_pred eeeeCCeEEEEEeecCCCCHHHHhhcCC-------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC
Q 002355 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPA-------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK 796 (931)
Q Consensus 724 ~f~~~~~l~LVmEy~~GgSL~d~L~r~~-------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~ 796 (931)
++..++..++||||+.+++|.+++.... ....+++..++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAE 173 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECT
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcC
Confidence 9999999999999999999999986421 1235789999999999999999999999 999999999999999
Q ss_pred CCcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 002355 797 NWTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAV 873 (931)
Q Consensus 797 dg~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i 873 (931)
++.+||+|||++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 253 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence 9999999999997543321 12233456889999999998889999999999999999999 89999998877766655
Q ss_pred HhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCch
Q 002355 874 AFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPA 923 (931)
Q Consensus 874 ~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~ 923 (931)
. .......+..+++.+.+||.+||..||.+|||+.+++++|+.++....
T Consensus 254 ~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~ 302 (322)
T 1p4o_A 254 M-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 302 (322)
T ss_dssp H-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred H-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCC
Confidence 4 334455678899999999999999999999999999999998876543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=377.77 Aligned_cols=258 Identities=28% Similarity=0.450 Sum_probs=211.0
Q ss_pred cccccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC----
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP---- 729 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~---- 729 (931)
+.+..++|+++++||+|+||+||+|++.++.||||++.... .......+|+.+++.++||||+++++++....
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence 45677899999999999999999999999999999997543 33345567999999999999999999997643
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhC----------CCCEEEeccCCCCeEECCCCc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL----------NPPILHWDLKSPNLLVDKNWT 799 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~----------G~~IIHrDLKPeNILLd~dg~ 799 (931)
++++||||+++++|.+++.. ..+++..++.++.||+.||+|||+. | |+||||||+|||++.++.
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTTCC
T ss_pred eEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCCCe
Confidence 47999999999999999975 2489999999999999999999998 8 999999999999999999
Q ss_pred EEEEecCcccccccccc--ccCCCCCCCcccCcccccCC-----CCCchhHHHHHHHHHHHHHhCCCCCCCCCh------
Q 002355 800 VKVCDFGLSRFKANTFI--SSKSVAGTPEWMAPEFLRGE-----PSNEKSDVYSFGVILWELVTMQQPWNGLGP------ 866 (931)
Q Consensus 800 IKL~DFGlAr~~~~~~~--~~~~~~GT~~Y~APEvL~~~-----~~t~ksDIWSLG~ILyELLTG~~PF~~~~~------ 866 (931)
+||+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+...
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 99999999976543221 23346799999999999873 345688999999999999999999975421
Q ss_pred ----------HHHHHHHHhcccccCCCC-----CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 002355 867 ----------AQVVGAVAFQNRRLAIPQ-----NTSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920 (931)
Q Consensus 867 ----------~eii~~i~~~~~r~~lP~-----~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llk 920 (931)
......+.....+..++. ..++++.+||.+||+.||++|||+.++++.|+++.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 122222222222222222 234569999999999999999999999999999865
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=384.33 Aligned_cols=268 Identities=26% Similarity=0.437 Sum_probs=228.6
Q ss_pred cccccCceEEEEEecccCceEEEEEEEc-------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT 726 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~-------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~ 726 (931)
.++..++|+++++||+|+||+||+|++. ++.||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 4567799999999999999999999853 4579999986543 3344567889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhhcCC----CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC---c
Q 002355 727 KRPHLSIVTEYLPRGSLYRLIHRPA----AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW---T 799 (931)
Q Consensus 727 ~~~~l~LVmEy~~GgSL~d~L~r~~----~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg---~ 799 (931)
.....++||||+.|++|.+++.... ....+++..++.++.||+.||+|||++| |+||||||+|||++.++ .
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCC
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCce
Confidence 9999999999999999999997532 2245899999999999999999999999 99999999999999655 5
Q ss_pred EEEEecCcccccccc--ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 002355 800 VKVCDFGLSRFKANT--FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQ 876 (931)
Q Consensus 800 IKL~DFGlAr~~~~~--~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~ 876 (931)
+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++ |..||......+....+. .
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~-~ 301 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 301 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-T
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-c
Confidence 999999999753221 112234567899999999999899999999999999999998 999999988877776654 3
Q ss_pred ccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhh
Q 002355 877 NRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQL 925 (931)
Q Consensus 877 ~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l 925 (931)
......+..++..+.+||.+||+.+|.+|||+.+++++|+.+.+.+...
T Consensus 302 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~ 350 (367)
T 3l9p_A 302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 350 (367)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhc
Confidence 4455677889999999999999999999999999999999998876543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=375.38 Aligned_cols=251 Identities=18% Similarity=0.335 Sum_probs=217.9
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|+++++||+|+||+||+|++ +++.||+|++.... .....+.+|+.+++.++||||+++++++...+.+++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 37999999999999999999987 46789999987543 33456789999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC--CCcEEEEecCccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK--NWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~--dg~IKL~DFGlAr~~~~ 813 (931)
||++|++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++. ++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 81 EFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EeCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999999752 346899999999999999999999999 999999999999987 78999999999986543
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccC--CCCCChHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLA--IPQNTSPVLA 891 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~--lP~~~s~eL~ 891 (931)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+........ ....+++++.
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T 1tki_A 157 GD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CC-ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence 32 22345789999999999998889999999999999999999999999888777776654333221 2257899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 892 SLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 892 dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
+||.+||..||.+|||+.|+++|-+
T Consensus 236 ~li~~~L~~dp~~Rpt~~e~l~hp~ 260 (321)
T 1tki_A 236 DFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred HHHHHHcCCChhHCcCHHHHhcChh
Confidence 9999999999999999999999754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=395.30 Aligned_cols=253 Identities=25% Similarity=0.454 Sum_probs=213.0
Q ss_pred ccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
.+..++|+++++||+|+||.||+|++ +++.||||++...... ......+.+|+.+++.++||||++++++|...+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 34568999999999999999999987 5778999999865332 23446678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs-~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
|+||||++|++|.+++.+. ..+++..++.++.||+.||+|||+ +| |+||||||+||||+.++.+||+|||+++.
T Consensus 224 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EEEECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEEEeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 9999999999999999762 358999999999999999999998 89 99999999999999999999999999986
Q ss_pred ccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHH
Q 002355 811 KANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 811 ~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL 890 (931)
...........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.. ....+|..+++++
T Consensus 299 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~ 376 (446)
T 4ejn_A 299 GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLGPEA 376 (446)
T ss_dssp TCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHH
T ss_pred ccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHH
Confidence 44433344567899999999999999999999999999999999999999999888777766643 3445778899999
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHHHH
Q 002355 891 ASLMESCWADDPAQRP-----SFANIVES 914 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRP-----Sa~ELLq~ 914 (931)
.+||.+||..||.+|| ++.|+++|
T Consensus 377 ~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 9999999999999999 99999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=366.20 Aligned_cols=251 Identities=23% Similarity=0.372 Sum_probs=208.0
Q ss_pred CceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|+++++||+|+||+||+|++. ++.||||++............+.+|+++++.++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 78999999999999999999884 7889999997766555556778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+.+++|..++.. ...+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 9999999988865 345899999999999999999999999 99999999999999999999999999987654433
Q ss_pred ccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-----------------
Q 002355 817 SSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR----------------- 878 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~----------------- 878 (931)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 3445678999999999976 5679999999999999999999999998876655443321100
Q ss_pred --ccCC----------CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 --RLAI----------PQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 --r~~l----------P~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.... ...+++.+.+||.+||..||.+|||+.|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 13578889999999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=372.89 Aligned_cols=251 Identities=25% Similarity=0.444 Sum_probs=217.2
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchH----HHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD----QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~----~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
.++|++.+.||+|+||+||+|++ +++.||+|++........ ....+.+|+.+|+.++||||++++++|.....+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 36899999999999999999987 478899999987543211 245788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC----cEEEEecCc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW----TVKVCDFGL 807 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg----~IKL~DFGl 807 (931)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 999999999999999975 346999999999999999999999999 99999999999999887 899999999
Q ss_pred cccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc--CCCCC
Q 002355 808 SRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL--AIPQN 885 (931)
Q Consensus 808 Ar~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~--~lP~~ 885 (931)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+....... ..+..
T Consensus 165 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (326)
T 2y0a_A 165 AHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243 (326)
T ss_dssp CEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred CeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence 98654332 2345679999999999999999999999999999999999999999888777666554332221 12357
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 886 TSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.++.+.+||.+||..||.+|||+.++++|
T Consensus 244 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 88999999999999999999999999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=370.86 Aligned_cols=261 Identities=22% Similarity=0.366 Sum_probs=214.7
Q ss_pred cccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC--eE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP--HL 731 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~--~l 731 (931)
+..++|++.++||+|+||+||+|++. ++.||||++....... ....+.+|+++++.++||||+++++++.... +.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 34589999999999999999999885 7889999997654322 2456789999999999999999999997654 88
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEE----CCCCcEEEEecCc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGL 807 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILL----d~dg~IKL~DFGl 807 (931)
++||||+++++|.+++........+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||+
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 999999999999999987554445999999999999999999999999 9999999999999 7888899999999
Q ss_pred cccccccccccCCCCCCCcccCccccc--------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHh
Q 002355 808 SRFKANTFISSKSVAGTPEWMAPEFLR--------GEPSNEKSDVYSFGVILWELVTMQQPWNGLGP----AQVVGAVAF 875 (931)
Q Consensus 808 Ar~~~~~~~~~~~~~GT~~Y~APEvL~--------~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~----~eii~~i~~ 875 (931)
++...... ......||+.|+|||++. +..++.++|||||||++|||++|..||..... .+....+..
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 98655432 224567999999999986 56788999999999999999999999975432 233333322
Q ss_pred cccc-----------------------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 002355 876 QNRR-----------------------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920 (931)
Q Consensus 876 ~~~r-----------------------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llk 920 (931)
.... ..++..++..+.+||++||+.||++|||+.|++++..+...
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 1110 01223456789999999999999999999999999987654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=360.84 Aligned_cols=265 Identities=28% Similarity=0.492 Sum_probs=227.3
Q ss_pred cccccCceEEEE-EecccCceEEEEEEE----cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC
Q 002355 654 LEISWDELHVKE-RVGAGSFGTVHRAEW----HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728 (931)
Q Consensus 654 lei~~drY~Ii~-kLG~G~fGtVylAr~----~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~ 728 (931)
+.+..++|.+.+ .||+|+||+||+|.+ .+..||||++.... .......+.+|+++++.++||||+++++++ ..
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence 445678999988 999999999999975 46679999997653 334567889999999999999999999999 55
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
+..++||||+.+++|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLS 157 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCcEEEEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccce
Confidence 679999999999999999964 2346899999999999999999999999 999999999999999999999999999
Q ss_pred ccccccc---cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCC
Q 002355 809 RFKANTF---ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQ 884 (931)
Q Consensus 809 r~~~~~~---~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~ 884 (931)
....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+. ...+...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-~~~~~~~~~ 236 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPP 236 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCT
T ss_pred eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-cCCcCCCCC
Confidence 8654321 11233456889999999988889999999999999999998 999999888777665554 344566788
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhh
Q 002355 885 NTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQL 925 (931)
Q Consensus 885 ~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l 925 (931)
.+++.+.+||.+||..+|.+||++.+++++|+.++.+...-
T Consensus 237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 99999999999999999999999999999999998875543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=370.82 Aligned_cols=264 Identities=31% Similarity=0.561 Sum_probs=227.0
Q ss_pred cccccCceEEEEEecccCceEEEEEEEc---------CCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEe
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWH---------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMG 723 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~---------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid 723 (931)
+++..++|++++.||+|+||+||+|++. +..||||++.... .......+.+|+++++.+ +||||+++++
T Consensus 30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 4667799999999999999999999863 4569999987543 344567789999999999 8999999999
Q ss_pred eeeeCCeEEEEEeecCCCCHHHHhhcCCC-------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCC
Q 002355 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAA-------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSP 790 (931)
Q Consensus 724 ~f~~~~~l~LVmEy~~GgSL~d~L~r~~~-------------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPe 790 (931)
++...+..++||||+.+++|.+++..... ...+++..++.++.||+.||+|||++| |+||||||+
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~ 186 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAAR 186 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccc
Confidence 99999999999999999999999976331 234889999999999999999999999 999999999
Q ss_pred CeEECCCCcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChH
Q 002355 791 NLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPA 867 (931)
Q Consensus 791 NILLd~dg~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~ 867 (931)
|||++.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 9999999999999999998654322 12234456889999999988889999999999999999999 99999988877
Q ss_pred HHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 868 QVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 868 eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
+....+. .......+..++..+.+||.+||..+|.+|||+.+++++|+.++..
T Consensus 267 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 267 ELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp HHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHh-cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 7665553 3445567788999999999999999999999999999999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=371.43 Aligned_cols=246 Identities=23% Similarity=0.255 Sum_probs=204.1
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|+++++||+|+||+||+|++ +++.||||++...............|+..+..+ +||||++++++|..++.+|+||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 7899999999999999999988 478899999876655545455566666666655 8999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+ +++|.+++... +..+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||++.......
T Consensus 137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 999 77999888753 346999999999999999999999999 9999999999999999999999999987654432
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~ 895 (931)
......||+.|+|||++.+ .++.++|||||||++|||++|..||.... ....+.........+..+++++.+||.
T Consensus 212 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~ 286 (311)
T 3p1a_A 212 -AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYLPPEFTAGLSSELRSVLV 286 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCCCHHHHTTSCHHHHHHHH
T ss_pred -CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCCCcccccCCCHHHHHHHH
Confidence 2345579999999999887 68999999999999999999977765532 222332222333445678999999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 002355 896 SCWADDPAQRPSFANIVES 914 (931)
Q Consensus 896 rcL~~DPeeRPSa~ELLq~ 914 (931)
+||+.||++|||+.|++++
T Consensus 287 ~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 287 MMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHSCSSTTTSCCHHHHHTS
T ss_pred HHcCCChhhCcCHHHHHhC
Confidence 9999999999999999976
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=371.97 Aligned_cols=266 Identities=30% Similarity=0.506 Sum_probs=227.1
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEcC-------CceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEee
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGA 724 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~g-------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~ 724 (931)
.+++..++|++.+.||+|+||+||+|++.+ ..||+|++.... .......+.+|+.+++.+ +||||++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 457788999999999999999999998742 369999987654 234457789999999999 89999999999
Q ss_pred eeeCCeEEEEEeecCCCCHHHHhhcCC-----------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeE
Q 002355 725 VTKRPHLSIVTEYLPRGSLYRLIHRPA-----------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLL 793 (931)
Q Consensus 725 f~~~~~l~LVmEy~~GgSL~d~L~r~~-----------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNIL 793 (931)
+..++..++||||+++++|.+++.... ....+++..++.++.||+.||+|||++| |+||||||+|||
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl 196 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVL 196 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEE
Confidence 999999999999999999999987521 1345799999999999999999999999 999999999999
Q ss_pred ECCCCcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 002355 794 VDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVV 870 (931)
Q Consensus 794 Ld~dg~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii 870 (931)
++.++.+||+|||++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 9999999999999998543321 11233456789999999998889999999999999999998 99999887765555
Q ss_pred HHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 871 GAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 871 ~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
............+...++.+.+||.+||..||.+|||+.+++++|+++...
T Consensus 277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 555555556667788899999999999999999999999999999988754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=361.53 Aligned_cols=252 Identities=24% Similarity=0.465 Sum_probs=216.8
Q ss_pred cccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchH-HHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDD-QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~-~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
+..++|++++.||+|+||+||+|++. +..||||++........ ....+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 45689999999999999999999874 56799999976543222 2356789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+++++|.+++... ..+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||++....
T Consensus 86 lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999998753 35899999999999999999999999 9999999999999999999999999986544
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHH
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+. ......+..+++.+.+
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 236 (279)
T 3fdn_A 161 SS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARD 236 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSCHHHHH
T ss_pred cc--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH--hCCCCCCCcCCHHHHH
Confidence 33 2245678999999999999989999999999999999999999999888777666554 3344567889999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHH
Q 002355 893 LMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
||.+||..||.+|||+.|+++|-+
T Consensus 237 li~~~l~~~p~~Rps~~e~l~h~~ 260 (279)
T 3fdn_A 237 LISRLLKHNPSQRPMLREVLEHPW 260 (279)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred HHHHHhccChhhCCCHHHHhhCcc
Confidence 999999999999999999998844
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=383.34 Aligned_cols=265 Identities=32% Similarity=0.585 Sum_probs=218.5
Q ss_pred ccccCceEEEEEecccCceEEEEEEEc-----CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~~-----g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
++..++|++.+.||+|+||+||+|++. +..||||+++... .......+.+|+.++++++||||+++++++..++
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 456689999999999999999999864 5679999987643 3445578999999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
..++||||+++++|.+++.+. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred ceEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 999999999999999999752 346899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccc---ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCC
Q 002355 810 FKANTFI---SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQN 885 (931)
Q Consensus 810 ~~~~~~~---~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~ 885 (931)
....... ......++..|+|||++.+..++.++|||||||++|||++ |..||......+....+. ...+...+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~ 274 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMD 274 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-TTEECCCCTT
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcc
Confidence 6543221 1122235678999999999899999999999999999998 999999988777766654 3445566778
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhh
Q 002355 886 TSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQL 925 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l 925 (931)
++..+.+||.+||..||.+||++.++++.|+.+++++..+
T Consensus 275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~~ 314 (373)
T 2qol_A 275 CPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSL 314 (373)
T ss_dssp CBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGGGG
T ss_pred ccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcccc
Confidence 8999999999999999999999999999999999887544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=393.03 Aligned_cols=256 Identities=23% Similarity=0.391 Sum_probs=220.3
Q ss_pred cccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH 730 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~ 730 (931)
+.+..++|+++++||+|+||+||+|++ +++.||+|++.+..... .....+.+|+.+++.++||||++++++|.++.+
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 345668999999999999999999988 46789999997643211 122347789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
+|+||||++||+|.+++.+ ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+|+.
T Consensus 144 ~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 9999999999999999975 24899999999999999999999999 99999999999999999999999999976
Q ss_pred ccccc-cccCCCCCCCcccCcccccCCC----CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC--
Q 002355 811 KANTF-ISSKSVAGTPEWMAPEFLRGEP----SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP-- 883 (931)
Q Consensus 811 ~~~~~-~~~~~~~GT~~Y~APEvL~~~~----~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP-- 883 (931)
..... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+....+........+|
T Consensus 218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 297 (410)
T 3v8s_A 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 297 (410)
T ss_dssp CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTT
T ss_pred eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCc
Confidence 54332 2234678999999999998765 6789999999999999999999999988888887776544334444
Q ss_pred CCChHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 002355 884 QNTSPVLASLMESCWADDPAQ--RPSFANIVESL 915 (931)
Q Consensus 884 ~~~s~eL~dLI~rcL~~DPee--RPSa~ELLq~L 915 (931)
..+++++++||.+||+.+|.+ ||++.|+++|-
T Consensus 298 ~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 298 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred ccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 478999999999999988988 99999999873
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=373.84 Aligned_cols=252 Identities=25% Similarity=0.387 Sum_probs=210.1
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|+++++||+|+||+||+|++ +++.||||++....... ....+.+|+.+++.++||||+++++++..++..|+||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc-hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 37999999999999999999987 47889999997654322 2356789999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc-
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT- 814 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~- 814 (931)
||++|++|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 85 EYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp ECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999999999865 345899999999999999999999999 999999999999999999999999999754322
Q ss_pred -ccccCCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcccccCCCCCChHHHH
Q 002355 815 -FISSKSVAGTPEWMAPEFLRGEPS-NEKSDVYSFGVILWELVTMQQPWNGLGPA-QVVGAVAFQNRRLAIPQNTSPVLA 891 (931)
Q Consensus 815 -~~~~~~~~GT~~Y~APEvL~~~~~-t~ksDIWSLG~ILyELLTG~~PF~~~~~~-eii~~i~~~~~r~~lP~~~s~eL~ 891 (931)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ..................+++.+.
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHH
Confidence 122345689999999999988765 77899999999999999999999876543 222232222223333467889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHH
Q 002355 892 SLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 892 dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
+||.+||..||.+|||+.|++++-
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~h~ 263 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKKDR 263 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred HHHHHHccCChhhCcCHHHHhhCh
Confidence 999999999999999999998873
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=365.78 Aligned_cols=268 Identities=30% Similarity=0.500 Sum_probs=219.0
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEc-----CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK 727 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~-----g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~ 727 (931)
.+.+..++|++.+.||+|+||+||+|++. +..||+|++............+.+|+.+++.++||||+++++++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 34566789999999999999999999763 2369999998776666667889999999999999999999999876
Q ss_pred CC-----eEEEEEeecCCCCHHHHhhcC---CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc
Q 002355 728 RP-----HLSIVTEYLPRGSLYRLIHRP---AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT 799 (931)
Q Consensus 728 ~~-----~l~LVmEy~~GgSL~d~L~r~---~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~ 799 (931)
.. ..++||||+.+++|.+++... .....+++..++.++.||+.||.|||++| |+||||||+|||++.++.
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECTTSC
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCc
Confidence 54 469999999999999998432 23356899999999999999999999999 999999999999999999
Q ss_pred EEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhc
Q 002355 800 VKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQ 876 (931)
Q Consensus 800 IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~ 876 (931)
+||+|||++....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+. .
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~ 264 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL-H 264 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-T
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH-c
Confidence 9999999997643321 12234457889999999999999999999999999999999 899999888777666554 3
Q ss_pred ccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCch
Q 002355 877 NRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPA 923 (931)
Q Consensus 877 ~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~ 923 (931)
......+..+++.+.+||.+||..+|.+|||+.+++++|+.+++...
T Consensus 265 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 265 GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 44556778899999999999999999999999999999999987543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=371.39 Aligned_cols=264 Identities=28% Similarity=0.527 Sum_probs=217.0
Q ss_pred cccCceEEEEEecccCceEEEEEEE--cCCc----eEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW--HGSD----VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~--~g~~----VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
+..++|+++++||+|+||+||+|++ +++. ||+|.+.... .......+.+|+.++++++||||+++++++..+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 3558999999999999999999987 3444 4666654332 2233467889999999999999999999998765
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
.++|+|++.+++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred -eEEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCccee
Confidence 78899999999999999763 346899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccc--ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCC
Q 002355 810 FKANTFI--SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNT 886 (931)
Q Consensus 810 ~~~~~~~--~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~ 886 (931)
....... ......+|..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. .......+..+
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 244 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC 244 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTB
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-cCCCCCCCccC
Confidence 6543221 1233456789999999999999999999999999999999 999999887766655543 44556677889
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhhh
Q 002355 887 SPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLI 926 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l~ 926 (931)
+..+.+||.+||+.+|.+||++.+++++|+.+...+....
T Consensus 245 ~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~~ 284 (327)
T 3poz_A 245 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 284 (327)
T ss_dssp CHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHHHHB
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhhhhh
Confidence 9999999999999999999999999999999988765443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=385.90 Aligned_cols=246 Identities=27% Similarity=0.438 Sum_probs=208.9
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHH-HHhcCCCCeeeEEeeeeeCCeEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAI-MKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkI-Lk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
..++|++++.||+|+||+||+|++ +++.||||++.+..... .....+.+|..+ ++.++||||++++++|...+++|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 458999999999999999999988 46779999998765443 334566777776 56789999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+.|++|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+++...
T Consensus 116 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999999762 35889999999999999999999999 9999999999999999999999999998644
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHH
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
.........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+.. ....++..++..+.+
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~ 268 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--KPLQLKPNITNSARH 268 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH--SCCCCCSSSCHHHHH
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh--cccCCCCCCCHHHHH
Confidence 433345677899999999999999999999999999999999999999999888877777653 345567889999999
Q ss_pred HHHHhcccCCCCCCCHH
Q 002355 893 LMESCWADDPAQRPSFA 909 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ 909 (931)
||.+||+.||.+||++.
T Consensus 269 li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 269 LLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHHHTCSSGGGSTTTT
T ss_pred HHHHHcccCHHhCCCCC
Confidence 99999999999999974
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=357.69 Aligned_cols=263 Identities=32% Similarity=0.578 Sum_probs=225.0
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEcC-CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~g-~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
.|++..++|++++.||+|+||+||+|++.+ ..||||++...... ...+.+|+++++.++||||+++++++. .+..
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 82 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPI 82 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCc
Confidence 467788999999999999999999998864 47999999765433 356889999999999999999999886 4568
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
++||||+.+++|.+++.... ...+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++...
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 99999999999999997521 225899999999999999999999999 999999999999999999999999999865
Q ss_pred cccc-cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHH
Q 002355 812 ANTF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPV 889 (931)
Q Consensus 812 ~~~~-~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~e 889 (931)
.... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+. .......+..+++.
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 238 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEE 238 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHH
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-cccCCCCcccccHH
Confidence 4332 12234456789999999998888999999999999999999 999999888777666554 33445567788999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCch
Q 002355 890 LASLMESCWADDPAQRPSFANIVESLKKLLKSPA 923 (931)
Q Consensus 890 L~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~ 923 (931)
+.+||.+||..+|++|||+.++++.|++++....
T Consensus 239 l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 9999999999999999999999999999887643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=365.55 Aligned_cols=255 Identities=24% Similarity=0.448 Sum_probs=214.1
Q ss_pred ccccCceEEEEEecccCceEEEEEEEc--C-------CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEWH--G-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAV 725 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~~--g-------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f 725 (931)
++..++|++.++||+|+||+||+|++. + ..||+|++..... ...+.+.+|+.+++.++||||+++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR--NYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG--GGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 456789999999999999999999763 3 4599999865432 2346788999999999999999999999
Q ss_pred eeCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc------
Q 002355 726 TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT------ 799 (931)
Q Consensus 726 ~~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~------ 799 (931)
..++..++||||+.+++|.+++.+. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBC
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCccccccc
Confidence 9999999999999999999999763 234899999999999999999999999 999999999999998887
Q ss_pred --EEEEecCccccccccccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHh
Q 002355 800 --VKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAF 875 (931)
Q Consensus 800 --IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG-~~PF~~~~~~eii~~i~~ 875 (931)
+||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++| .+||............
T Consensus 158 ~~~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-- 231 (289)
T 4fvq_A 158 PFIKLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-- 231 (289)
T ss_dssp CEEEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--
T ss_pred ceeeeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh--
Confidence 999999998755432 23457889999999987 6789999999999999999995 5566555544433322
Q ss_pred cccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 876 QNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 876 ~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
......+...++++.+||.+||+.||.+|||+.+++++|++++...
T Consensus 232 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 232 -EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp -HTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred -hccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 2345566777889999999999999999999999999999988753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=360.23 Aligned_cols=264 Identities=30% Similarity=0.519 Sum_probs=221.8
Q ss_pred cccccCceEEEEEecccCceEEEEEEEcC-----CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~g-----~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~ 728 (931)
+.+..++|++.+.||+|+||+||+|++.+ ..||+|++.... .......+.+|+.+++.++||||+++++++..+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 45667999999999999999999998643 249999987653 334457789999999999999999999998754
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
..++||||+.+++|.+++.+. ...+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 160 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLS 160 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred -CCEEEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCC
Confidence 568999999999999999752 345899999999999999999999999 999999999999999999999999999
Q ss_pred ccccccc-cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCC
Q 002355 809 RFKANTF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNT 886 (931)
Q Consensus 809 r~~~~~~-~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~ 886 (931)
....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+. .......+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 239 (281)
T 3cc6_A 161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLC 239 (281)
T ss_dssp GCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-HTCCCCCCTTC
T ss_pred cccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-cCCCCCCCCCC
Confidence 8654322 12234456889999999998889999999999999999998 999998877766665543 34455667788
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchh
Q 002355 887 SPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQ 924 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~ 924 (931)
++.+.+||.+||..||.+|||+.+++++|+++++...+
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 277 (281)
T 3cc6_A 240 PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277 (281)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence 99999999999999999999999999999998875433
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=362.51 Aligned_cols=251 Identities=33% Similarity=0.603 Sum_probs=204.8
Q ss_pred ccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHh--cCCCCeeeEEeeeee----CCe
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR--VRHPNVVLFMGAVTK----RPH 730 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~--L~HpNIV~Lid~f~~----~~~ 730 (931)
..++|+++++||+|+||+||+|+++++.||||++.... ...+.+|.+++.. ++||||+++++++.. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 44799999999999999999999999999999986542 2445667777777 789999999998653 356
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHH--------hCCCCEEEeccCCCCeEECCCCcEEE
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH--------NLNPPILHWDLKSPNLLVDKNWTVKV 802 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLH--------s~G~~IIHrDLKPeNILLd~dg~IKL 802 (931)
+++||||+++++|.++++. ..+++..++.++.||+.||+||| +++ |+||||||+|||++.++.+||
T Consensus 81 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTTSCEEE
T ss_pred eEEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCCCCEEE
Confidence 8999999999999999964 35899999999999999999999 888 999999999999999999999
Q ss_pred EecCcccccccccc----ccCCCCCCCcccCcccccCC------CCCchhHHHHHHHHHHHHHhC----------CCCCC
Q 002355 803 CDFGLSRFKANTFI----SSKSVAGTPEWMAPEFLRGE------PSNEKSDVYSFGVILWELVTM----------QQPWN 862 (931)
Q Consensus 803 ~DFGlAr~~~~~~~----~~~~~~GT~~Y~APEvL~~~------~~t~ksDIWSLG~ILyELLTG----------~~PF~ 862 (931)
+|||+++....... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 99999975443221 12345799999999999876 345789999999999999999 88886
Q ss_pred CCCh-----HHHHHHHHhcccccCCC-----CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 002355 863 GLGP-----AQVVGAVAFQNRRLAIP-----QNTSPVLASLMESCWADDPAQRPSFANIVESLKKL 918 (931)
Q Consensus 863 ~~~~-----~eii~~i~~~~~r~~lP-----~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~L 918 (931)
.... ......+........++ ...++.+.+||.+||+.||.+|||+.++++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 5432 22222222223333333 23567899999999999999999999999999876
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=364.11 Aligned_cols=259 Identities=32% Similarity=0.596 Sum_probs=217.4
Q ss_pred cccccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee-CCeEE
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK-RPHLS 732 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~-~~~l~ 732 (931)
+.+..++|++++.||+|+||+||+|+++++.||||++.... ..+.+.+|+++++.++||||+++++++.. .+..+
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 91 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceE
Confidence 45677999999999999999999999999999999987543 34578899999999999999999998754 45799
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+.+++|.+++.+.. ...+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp EEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEEecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 9999999999999997522 223788999999999999999999999 9999999999999999999999999987654
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHH
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~ 891 (931)
... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||......+....+. .......+..+++.+.
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 244 (278)
T 1byg_A 169 STQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVY 244 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHH
T ss_pred ccc---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCcccCCHHHH
Confidence 432 23467889999999998889999999999999999998 999999887776665553 3445567788999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHhhCch
Q 002355 892 SLMESCWADDPAQRPSFANIVESLKKLLKSPA 923 (931)
Q Consensus 892 dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~ 923 (931)
+||.+||..||.+|||+.++++.|+.+.....
T Consensus 245 ~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~~ 276 (278)
T 1byg_A 245 EVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 276 (278)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred HHHHHHhcCChhhCCCHHHHHHHHHHHHhhhc
Confidence 99999999999999999999999999876543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=369.49 Aligned_cols=250 Identities=23% Similarity=0.398 Sum_probs=202.7
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC-------
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP------- 729 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~------- 729 (931)
++|+++++||+|+||+||+|++ +++.||||++..... ....+.+.+|+++|+.++||||++++++|....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST-TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 6899999999999999999988 578899999986542 234467899999999999999999999985543
Q ss_pred --------------------------------------------------eEEEEEeecCCCCHHHHhhcCCCCCCCcHH
Q 002355 730 --------------------------------------------------HLSIVTEYLPRGSLYRLIHRPAAGEMMDQR 759 (931)
Q Consensus 730 --------------------------------------------------~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~ 759 (931)
++++||||+.|++|.+++.+........+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 389999999999999999875555566777
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc------------cccCCCCCCCcc
Q 002355 760 RRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF------------ISSKSVAGTPEW 827 (931)
Q Consensus 760 ~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~------------~~~~~~~GT~~Y 827 (931)
.++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...... .......||+.|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 89999999999999999999 9999999999999999999999999998654431 122345799999
Q ss_pred cCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCC
Q 002355 828 MAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPS 907 (931)
Q Consensus 828 ~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPS 907 (931)
+|||++.+..++.++|||||||++|+|++|..|+.. ......... .......+...++.+.+||.+||+.||.+|||
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 319 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPE 319 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHH-TTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCC
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhh-ccCCCcccccCChhHHHHHHHHccCCCCcCCC
Confidence 999999999999999999999999999998766522 111222211 11111112345678899999999999999999
Q ss_pred HHHHHHH
Q 002355 908 FANIVES 914 (931)
Q Consensus 908 a~ELLq~ 914 (931)
+.|++++
T Consensus 320 ~~~~l~~ 326 (332)
T 3qd2_B 320 ATDIIEN 326 (332)
T ss_dssp HHHHHHS
T ss_pred HHHHhhc
Confidence 9999976
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=358.83 Aligned_cols=257 Identities=18% Similarity=0.260 Sum_probs=217.2
Q ss_pred cccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~ 732 (931)
+..++|++++.||+|+||+||+|++ +++.||||++...... ..+.+|+.+++.+ +|+||+++++++..+...+
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 3458999999999999999999985 6788999998754322 3467899999999 7999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc-----EEEEecCc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT-----VKVCDFGL 807 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~-----IKL~DFGl 807 (931)
+||||+ +++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++. +||+|||+
T Consensus 83 lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 999999 99999999763 345899999999999999999999999 999999999999987776 99999999
Q ss_pred ccccccccc-------ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhcc
Q 002355 808 SRFKANTFI-------SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLG---PAQVVGAVAFQN 877 (931)
Q Consensus 808 Ar~~~~~~~-------~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~---~~eii~~i~~~~ 877 (931)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. ..+.+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence 986544321 2345679999999999999999999999999999999999999998753 333333332222
Q ss_pred c---ccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 878 R---RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 878 ~---r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
. .......+++++.+||.+||..||.+|||+.++++.|+++++.
T Consensus 238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 1 1223457899999999999999999999999999999998864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=360.87 Aligned_cols=263 Identities=26% Similarity=0.475 Sum_probs=222.5
Q ss_pred cccccCceEEEE-EecccCceEEEEEEE----cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC
Q 002355 654 LEISWDELHVKE-RVGAGSFGTVHRAEW----HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728 (931)
Q Consensus 654 lei~~drY~Ii~-kLG~G~fGtVylAr~----~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~ 728 (931)
+.+..++|++.+ .||+|+||+||+|.+ .++.||||++............+.+|+++++.++||||+++++++ ..
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 89 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA 89 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence 345668999999 999999999999965 246799999987654445567899999999999999999999999 66
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
+..++||||+.+++|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCcEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 788999999999999999976 235899999999999999999999999 999999999999999999999999999
Q ss_pred cccccccc---ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCC
Q 002355 809 RFKANTFI---SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQ 884 (931)
Q Consensus 809 r~~~~~~~---~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~ 884 (931)
........ ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+. .......+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 243 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPA 243 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCT
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCC
Confidence 76543211 1123346788999999988888999999999999999999 999999988777665554 344566778
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCch
Q 002355 885 NTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPA 923 (931)
Q Consensus 885 ~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~ 923 (931)
.+++.+.+||.+||..||.+||++.++++.|+.++.+..
T Consensus 244 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 244 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 899999999999999999999999999999999987644
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=368.33 Aligned_cols=267 Identities=32% Similarity=0.553 Sum_probs=224.4
Q ss_pred ccccCceEEEEEecccCceEEEEEEEcC------CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEWHG------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~~g------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~ 728 (931)
++..++|++.+.||+|+||+||+|++.. ..||||++.... .......+.+|+++++.++||||+++++++...
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 5677899999999999999999998642 249999987543 344456789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
+..++||||+.+++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred CCcEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcc
Confidence 9999999999999999999752 346899999999999999999999999 999999999999999999999999999
Q ss_pred cccccccc---ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCC
Q 002355 809 RFKANTFI---SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQ 884 (931)
Q Consensus 809 r~~~~~~~---~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~ 884 (931)
+....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+. ...+...+.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~~~~~~~~~ 273 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPM 273 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCT
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-CCCcCCCcc
Confidence 86543211 1122345788999999999999999999999999999999 999999888777766654 334556677
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhhhc
Q 002355 885 NTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQ 927 (931)
Q Consensus 885 ~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l~~ 927 (931)
.+++.+.+||.+||..+|.+||++.++++.|++++..+..+..
T Consensus 274 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~~ 316 (333)
T 1mqb_A 274 DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKT 316 (333)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGGS
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhhh
Confidence 8999999999999999999999999999999999988765543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=372.14 Aligned_cols=257 Identities=19% Similarity=0.323 Sum_probs=214.9
Q ss_pred cccccCceEEEEEecccCceEEEEEEE-cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCC--CCeeeEEeeeeeCCe
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH--PNVVLFMGAVTKRPH 730 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~H--pNIV~Lid~f~~~~~ 730 (931)
+.+..++|+++++||+|+||+||+|.+ +++.||||++............+.+|+.+|+.++| +||+++++++..+..
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 345678999999999999999999987 46679999998877666667889999999999976 999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
+|+|||+. +++|.+++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++ ++.+||+|||+++.
T Consensus 84 ~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 84 IYMVMECG-NIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEEEECCC-SEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEEEEeCC-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccccc
Confidence 99999954 8899999976 345899999999999999999999999 99999999999997 67899999999986
Q ss_pred cccccc--ccCCCCCCCcccCcccccC-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhc
Q 002355 811 KANTFI--SSKSVAGTPEWMAPEFLRG-----------EPSNEKSDVYSFGVILWELVTMQQPWNGLGP-AQVVGAVAFQ 876 (931)
Q Consensus 811 ~~~~~~--~~~~~~GT~~Y~APEvL~~-----------~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~-~eii~~i~~~ 876 (931)
...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+...
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 236 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence 543221 2235679999999999864 6678999999999999999999999987543 3334444444
Q ss_pred ccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002355 877 NRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 877 ~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
......+...+..+.+||.+||..||.+|||+.++++|.+-
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 55666788889999999999999999999999999988553
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=372.66 Aligned_cols=263 Identities=28% Similarity=0.512 Sum_probs=218.8
Q ss_pred cccCceEEEEEecccCceEEEEEEEc--CCc----eEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH--GSD----VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~--g~~----VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
+..++|+++++||+|+||+||+|++. ++. ||+|++..... ......+.+|+.+++.++||||+++++++. +.
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 35689999999999999999999873 444 66666643321 112245678999999999999999999886 56
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
..++||||+.+++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCccc
Confidence 789999999999999999753 346889999999999999999999999 9999999999999999999999999998
Q ss_pred cccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCC
Q 002355 810 FKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNT 886 (931)
Q Consensus 810 ~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~ 886 (931)
...... .......||..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+. .......+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 242 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQIC 242 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-TTCBCCCCTTB
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCCCcC
Confidence 654322 12234567889999999998889999999999999999999 999999887766655543 44566677788
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhh
Q 002355 887 SPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQL 925 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l 925 (931)
+..+.+||.+||..||.+|||+.+++++|+.+.+.+...
T Consensus 243 ~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~~~ 281 (325)
T 3kex_A 243 TIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRY 281 (325)
T ss_dssp CTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHHHH
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence 999999999999999999999999999999998876544
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=367.62 Aligned_cols=268 Identities=31% Similarity=0.607 Sum_probs=224.3
Q ss_pred ccccCceEEEEEecccCceEEEEEEE--cCCc--eEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCC
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRP 729 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~--~g~~--VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~ 729 (931)
.+.+++|++.+.||+|+||.||+|++ ++.. ||+|++.... .......+.+|+.+++++ +||||+++++++...+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 34668999999999999999999986 4444 4888886532 223346788999999999 8999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhhcCC-------------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPA-------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK 796 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~-------------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~ 796 (931)
..++||||+++++|.+++.... ....+++..++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGE 177 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcC
Confidence 9999999999999999997532 2346899999999999999999999999 999999999999999
Q ss_pred CCcEEEEecCccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHh
Q 002355 797 NWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAF 875 (931)
Q Consensus 797 dg~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~ 875 (931)
++.+||+|||+++...... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 178 ~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~- 255 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 255 (327)
T ss_dssp GGCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-
T ss_pred CCeEEEcccCcCccccccc-cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh-
Confidence 9999999999987543321 2234457889999999998888999999999999999998 999999988777665543
Q ss_pred cccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhhhc
Q 002355 876 QNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQ 927 (931)
Q Consensus 876 ~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l~~ 927 (931)
.......+..+++.+.+||.+||..+|.+|||+.+++++|+.++.......+
T Consensus 256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 307 (327)
T 1fvr_A 256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN 307 (327)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCccc
Confidence 3445566778899999999999999999999999999999999988765543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=394.03 Aligned_cols=257 Identities=19% Similarity=0.348 Sum_probs=220.2
Q ss_pred cccccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH 730 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~ 730 (931)
+.+..++|+++++||+|+||+||+|++. ++.||||++.+..... .....+.+|+.++..++||||++++++|.++++
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 3456689999999999999999999884 5779999997643221 122347889999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
+||||||++||+|.+++.+. ...+++..++.++.||+.||+|||++| ||||||||+||||+.++++||+|||+|+.
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 99999999999999999762 346999999999999999999999999 99999999999999999999999999976
Q ss_pred ccccc-cccCCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC-
Q 002355 811 KANTF-ISSKSVAGTPEWMAPEFLR-----GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP- 883 (931)
Q Consensus 811 ~~~~~-~~~~~~~GT~~Y~APEvL~-----~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP- 883 (931)
..... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+..+.+..+........+|
T Consensus 225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 304 (437)
T 4aw2_A 225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304 (437)
T ss_dssp CCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS
T ss_pred cccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc
Confidence 54322 2234568999999999987 5568999999999999999999999999988888887776544444444
Q ss_pred --CCChHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 002355 884 --QNTSPVLASLMESCWADDPAQ--RPSFANIVES 914 (931)
Q Consensus 884 --~~~s~eL~dLI~rcL~~DPee--RPSa~ELLq~ 914 (931)
..+++++++||++||..+|.+ ||+++|+++|
T Consensus 305 ~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 358999999999999988888 9999999987
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=384.25 Aligned_cols=252 Identities=22% Similarity=0.407 Sum_probs=215.3
Q ss_pred ccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
.+..++|++++.||+|+||+||+|++ +++.||+|++....... .....+.+|+++|+.++||||++++++|.....+
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 45668999999999999999999987 46779999997654222 3346788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
|+||||+.|++|..++.+ ...+++..++.++.||+.||.|||++| |+||||||+|||++.+|++||+|||++...
T Consensus 91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp EEEECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 999999999999999976 345999999999999999999999999 999999999999999999999999999865
Q ss_pred cccccccCCCCCCCcccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcccccCCCCC
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRG---EPSNEKSDVYSFGVILWELVTMQQPWNGLGP---AQVVGAVAFQNRRLAIPQN 885 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~---~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~---~eii~~i~~~~~r~~lP~~ 885 (931)
.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... .+....+ .......|..
T Consensus 166 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~~~~~~~p~~ 242 (384)
T 4fr4_A 166 PRET-QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--ETTVVTYPSA 242 (384)
T ss_dssp CTTC-CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH--HHCCCCCCTT
T ss_pred cCCC-ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH--hhcccCCCCc
Confidence 4332 3356789999999999974 4578999999999999999999999975432 3333332 2345567888
Q ss_pred ChHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 002355 886 TSPVLASLMESCWADDPAQRPS-FANIVES 914 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPS-a~ELLq~ 914 (931)
+++.+.+||.+||..||.+||+ +.++++|
T Consensus 243 ~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred CCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 9999999999999999999998 7777654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=358.88 Aligned_cols=252 Identities=28% Similarity=0.484 Sum_probs=215.3
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee----CCe
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK----RPH 730 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~----~~~ 730 (931)
....|++.++||+|+||+||+|++ ++..||+|++............+.+|+.+++.++||||++++++|.. +..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 346799999999999999999987 45679999998877666777889999999999999999999999864 467
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC-CCCcEEEEecCccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSR 809 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd-~dg~IKL~DFGlAr 809 (931)
+++||||+++++|.+++.+. ..+++..++.++.||+.||.|||+.|.+|+||||||+|||++ .++.+||+|||++.
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 99999999999999999752 358999999999999999999999876799999999999997 78999999999997
Q ss_pred cccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcccccCCCCCChH
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGP-AQVVGAVAFQNRRLAIPQNTSP 888 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~-~eii~~i~~~~~r~~lP~~~s~ 888 (931)
...... .....||+.|+|||++.+. ++.++|||||||++|+|++|..||..... ......+.........+...++
T Consensus 181 ~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (290)
T 1t4h_A 181 LKRASF--AKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp GCCTTS--BEESCSSCCCCCGGGGGTC-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred cccccc--cccccCCcCcCCHHHHhcc-CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence 654432 2345789999999988754 89999999999999999999999988554 4444444433344455667789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 889 VLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
++.+||.+||..||.+|||+.++++|
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhC
Confidence 99999999999999999999999876
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=366.64 Aligned_cols=256 Identities=35% Similarity=0.680 Sum_probs=212.0
Q ss_pred cccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
+..++|++.+.||+|+||+||+|++.++.||||++... .....+.+|++++++++||||+++++++.+ ..++||
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence 45689999999999999999999999999999998643 234678899999999999999999998874 479999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHh---CCCCEEEeccCCCCeEECCCCc-EEEEecCccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN---LNPPILHWDLKSPNLLVDKNWT-VKVCDFGLSRFK 811 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs---~G~~IIHrDLKPeNILLd~dg~-IKL~DFGlAr~~ 811 (931)
||+++++|.+++........++...++.++.||+.||+|||+ +| |+||||||+|||++.++. +||+|||++...
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 999999999999864443457889999999999999999999 67 999999999999998886 799999999755
Q ss_pred cccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcccccCCCCCChHHH
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQ-VVGAVAFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~e-ii~~i~~~~~r~~lP~~~s~eL 890 (931)
.... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ..............+..+++.+
T Consensus 157 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (307)
T 2eva_A 157 QTHM---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHH
T ss_pred cccc---ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHH
Confidence 4321 34468999999999999999999999999999999999999998654322 1222223344556677899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 891 ASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
.+||.+||..||.+|||+.++++.|+.+.+..
T Consensus 234 ~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 234 ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred HHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 99999999999999999999999999987643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=376.21 Aligned_cols=252 Identities=28% Similarity=0.425 Sum_probs=202.8
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
..++|+++++||+|+||+||+|++ +++.||||++....... ..+.+|+.+++.++||||+++++++...+++|+|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence 458999999999999999999988 57889999998654333 3577999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc--EEEEecCcccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT--VKVCDFGLSRFKA 812 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~--IKL~DFGlAr~~~ 812 (931)
|||+.|++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++. +||+|||+++...
T Consensus 95 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 95 MEYASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred EEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 9999999999998652 35899999999999999999999999 999999999999987765 9999999997433
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcccccCCCCCCh
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEK-SDVYSFGVILWELVTMQQPWNGLGP----AQVVGAVAFQNRRLAIPQNTS 887 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~k-sDIWSLG~ILyELLTG~~PF~~~~~----~eii~~i~~~~~r~~lP~~~s 887 (931)
... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+... ......+.......+....++
T Consensus 170 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 248 (361)
T 3uc3_A 170 LHS-QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS 248 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred ccC-CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence 222 2345679999999999988877655 8999999999999999999987543 233333333333333344689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002355 888 PVLASLMESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 888 ~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
+.+.+||.+||..||.+|||+.|+++|-+-
T Consensus 249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f 278 (361)
T 3uc3_A 249 PECCHLISRIFVADPATRISIPEIKTHSWF 278 (361)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence 999999999999999999999999998553
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=390.19 Aligned_cols=255 Identities=21% Similarity=0.361 Sum_probs=218.0
Q ss_pred ccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
.+..++|+++++||+|+||+||+|++ +++.||||++.+..... .....+.+|+.++..++||||++++++|.+.+++
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 45568999999999999999999987 57889999997643222 2234578899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
||||||++|++|.+++.+. +..+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+++..
T Consensus 137 ~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKL 212 (412)
T ss_dssp EEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechhheec
Confidence 9999999999999999753 236899999999999999999999999 999999999999999999999999999765
Q ss_pred cccc-cccCCCCCCCcccCccccc-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC
Q 002355 812 ANTF-ISSKSVAGTPEWMAPEFLR-------GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP 883 (931)
Q Consensus 812 ~~~~-~~~~~~~GT~~Y~APEvL~-------~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP 883 (931)
.... ......+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+..+.+..+........+|
T Consensus 213 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 292 (412)
T 2vd5_A 213 RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP 292 (412)
T ss_dssp CTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred cCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCC
Confidence 4332 1234568999999999987 3567899999999999999999999999988888777775443333333
Q ss_pred ---CCChHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 002355 884 ---QNTSPVLASLMESCWADDPAQR---PSFANIVES 914 (931)
Q Consensus 884 ---~~~s~eL~dLI~rcL~~DPeeR---PSa~ELLq~ 914 (931)
..+++++++||.+||. +|.+| |+++|+++|
T Consensus 293 ~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 293 LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 6789999999999999 99998 589999876
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=370.40 Aligned_cols=253 Identities=22% Similarity=0.315 Sum_probs=198.0
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|+++++||+|+||+||+|++ +++.||||++...... .....+.+|+.+++.++||||+++++++..++.+++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE-GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT-CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc-ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 37899999999999999999976 4788999999765422 22356789999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCC---CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 736 EYLPRGSLYRLIHRPA---AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~---~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
||+. ++|.+++.... ....+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 9996 69999886421 2235899999999999999999999999 9999999999999999999999999998765
Q ss_pred ccccccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-------------
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR------------- 878 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~------------- 878 (931)
..........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 433333456789999999999864 579999999999999999999999998887666554432110
Q ss_pred -------------------ccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 -------------------RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 -------------------r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
....+..++.++.+||.+||+.||.+|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 001223578899999999999999999999999876
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=360.81 Aligned_cols=258 Identities=26% Similarity=0.455 Sum_probs=219.3
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeee--eCCeEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT--KRPHLSI 733 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~--~~~~l~L 733 (931)
.++|++++.||+|+||+||+|++ +++.||+|++..........+.+.+|+.+++.++||||+++++++. .+..+++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 47999999999999999999987 5788999999887666666778999999999999999999999884 4678999
Q ss_pred EEeecCCCCHHHHhhcCC-CCCCCcHHHHHHHHHHHHHHHHHHHhCC---CCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 734 VTEYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLN---PPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~-~~~~L~e~~~~~Ia~QIa~AL~yLHs~G---~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999987522 2345899999999999999999999976 349999999999999999999999999997
Q ss_pred cccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHH
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPV 889 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~e 889 (931)
.............||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+.. .....++..++.+
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~ 243 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSDE 243 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-TCCCCCCTTSCHH
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh-cccccCCcccCHH
Confidence 654432222345689999999999998899999999999999999999999998887766655543 3344677789999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 890 LASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 890 L~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
+.+||.+||..||.+|||+.+++++++
T Consensus 244 l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 244 LNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 999999999999999999999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=366.34 Aligned_cols=250 Identities=26% Similarity=0.426 Sum_probs=216.8
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
..|+..++||+|+||+||+|++ +++.||||++....... ...+.+|+.+++.++||||+++++++..++..++|||
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS--HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 3578889999999999999987 57889999997654322 3567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|++|++|.+++.+ ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++........
T Consensus 123 ~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 123 FLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp CCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred cCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc
Confidence 9999999999864 35899999999999999999999999 99999999999999999999999999986654433
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-ccCCCCCChHHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-RLAIPQNTSPVLASLME 895 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~-r~~lP~~~s~eL~dLI~ 895 (931)
......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+..... ....+..+++.+.+||.
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 276 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE 276 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHH
T ss_pred ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHH
Confidence 44566899999999999999899999999999999999999999998887766655543222 12233467899999999
Q ss_pred HhcccCCCCCCCHHHHHHHHH
Q 002355 896 SCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 896 rcL~~DPeeRPSa~ELLq~L~ 916 (931)
+||..||.+|||+.+++++-.
T Consensus 277 ~~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 277 RMLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp HHSCSSTTTSCCHHHHHTSGG
T ss_pred HHccCChhhCcCHHHHhcChh
Confidence 999999999999999998744
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=378.17 Aligned_cols=250 Identities=23% Similarity=0.333 Sum_probs=200.6
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeC--CeEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKR--PHLS 732 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~--~~l~ 732 (931)
.++|+++++||+|+||+||+|++ +++.||||++............+.+|+.+++.+. ||||++++++|... ..+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 47999999999999999999987 5788999999766555566678889999999997 99999999999754 4799
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+. ++|..++.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+...
T Consensus 88 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 9999995 689998875 25899999999999999999999999 9999999999999999999999999997543
Q ss_pred cc---------------------ccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 002355 813 NT---------------------FISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVV 870 (931)
Q Consensus 813 ~~---------------------~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii 870 (931)
.. .......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 21 111234579999999999987 66899999999999999999999999988766555
Q ss_pred HHHHhcccc---------------------------------------------cCCCCCChHHHHHHHHHhcccCCCCC
Q 002355 871 GAVAFQNRR---------------------------------------------LAIPQNTSPVLASLMESCWADDPAQR 905 (931)
Q Consensus 871 ~~i~~~~~r---------------------------------------------~~lP~~~s~eL~dLI~rcL~~DPeeR 905 (931)
..+...... ...+..+++++.+||.+||..||.+|
T Consensus 241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 444211100 01123678899999999999999999
Q ss_pred CCHHHHHHH
Q 002355 906 PSFANIVES 914 (931)
Q Consensus 906 PSa~ELLq~ 914 (931)
||+.|+++|
T Consensus 321 ~t~~e~l~H 329 (388)
T 3oz6_A 321 ISANDALKH 329 (388)
T ss_dssp CCHHHHTTS
T ss_pred CCHHHHhCC
Confidence 999999987
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=368.93 Aligned_cols=256 Identities=25% Similarity=0.358 Sum_probs=212.0
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeeccc---chHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDF---LDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~---~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
.++|+++++||+|+||+||+|++ +++.||+|++..... .......+.+|+++++.++||||+++++++...+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 37899999999999999999987 466799999976532 2234567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCC-------------------------------------CCCCCcHHHHHHHHHHHHHHHHHH
Q 002355 733 IVTEYLPRGSLYRLIHRPA-------------------------------------AGEMMDQRRRLRMALDVAKGINYL 775 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~-------------------------------------~~~~L~e~~~~~Ia~QIa~AL~yL 775 (931)
+||||++|++|.+++.... ....+++..++.++.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 9999999999999985210 012346788999999999999999
Q ss_pred HhCCCCEEEeccCCCCeEECCCC--cEEEEecCccccccccc----cccCCCCCCCcccCcccccC--CCCCchhHHHHH
Q 002355 776 HNLNPPILHWDLKSPNLLVDKNW--TVKVCDFGLSRFKANTF----ISSKSVAGTPEWMAPEFLRG--EPSNEKSDVYSF 847 (931)
Q Consensus 776 Hs~G~~IIHrDLKPeNILLd~dg--~IKL~DFGlAr~~~~~~----~~~~~~~GT~~Y~APEvL~~--~~~t~ksDIWSL 847 (931)
|++| |+||||||+|||++.++ .+||+|||++....... .......||+.|+|||++.+ ..++.++|||||
T Consensus 185 H~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 185 HNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 9999 99999999999998776 89999999997543211 12245679999999999975 667899999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC--CCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002355 848 GVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP--QNTSPVLASLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 848 G~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP--~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
||++|+|++|..||.+....+....+.........+ ..+++.+.+||.+||..||.+||++.+++++-
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp 332 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSH
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCh
Confidence 999999999999999988877777665444433322 34789999999999999999999999999873
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=375.33 Aligned_cols=270 Identities=22% Similarity=0.279 Sum_probs=210.2
Q ss_pred cchhhhhhhhhcCCCcCCCCCCCCCCCccccccccccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch
Q 002355 620 LDKEDESKLEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD 697 (931)
Q Consensus 620 ~~~E~es~~~~~g~~Pv~~G~ry~~~epsl~~~~lei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~ 697 (931)
.+.|+...+.+++++++..|..+. ++|+++++||+|+||+||+|++ +++.||||++... .
T Consensus 13 ~~~e~~~~~~~~~~~~~~~g~~~~---------------~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~ 74 (397)
T 1wak_A 13 DEQEDPNDYCKGGYHLVKIGDLFN---------------GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---E 74 (397)
T ss_dssp ---------CC--CCSSCTTCEET---------------TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---H
T ss_pred ccccccccCCCCCceEEehhhhcC---------------CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---C
Confidence 344556678888889888876543 7999999999999999999987 4678999999754 2
Q ss_pred HHHHHHHHHHHHHHhcC--------CCCeeeEEeeee----eCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHH
Q 002355 698 DQLKEFLREVAIMKRVR--------HPNVVLFMGAVT----KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA 765 (931)
Q Consensus 698 ~~~~~~l~EIkILk~L~--------HpNIV~Lid~f~----~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia 765 (931)
.....+.+|+++++.++ |+||++++++|. .+.++|+||||+ +++|.+++.+. ....+++..++.++
T Consensus 75 ~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~ 152 (397)
T 1wak_A 75 HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKII 152 (397)
T ss_dssp HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHH
T ss_pred cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHH
Confidence 34467889999999995 788999999997 567899999999 66777766542 23468999999999
Q ss_pred HHHHHHHHHHHhC-CCCEEEeccCCCCeEECCCC----------------------------------------------
Q 002355 766 LDVAKGINYLHNL-NPPILHWDLKSPNLLVDKNW---------------------------------------------- 798 (931)
Q Consensus 766 ~QIa~AL~yLHs~-G~~IIHrDLKPeNILLd~dg---------------------------------------------- 798 (931)
.||+.||+|||++ | |+||||||+|||++.++
T Consensus 153 ~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (397)
T 1wak_A 153 QQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNA 230 (397)
T ss_dssp HHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGG
T ss_pred HHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccc
Confidence 9999999999998 8 99999999999999775
Q ss_pred ---cEEEEecCccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh------HHH
Q 002355 799 ---TVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGP------AQV 869 (931)
Q Consensus 799 ---~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~------~ei 869 (931)
.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...
T Consensus 231 ~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~ 307 (397)
T 1wak_A 231 EKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH 307 (397)
T ss_dssp GGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHH
T ss_pred cccceEecccccccccccc---CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHH
Confidence 7999999999876543 2455789999999999999999999999999999999999999976542 111
Q ss_pred HHHHHhccc----------------------------------------ccCCCCCChHHHHHHHHHhcccCCCCCCCHH
Q 002355 870 VGAVAFQNR----------------------------------------RLAIPQNTSPVLASLMESCWADDPAQRPSFA 909 (931)
Q Consensus 870 i~~i~~~~~----------------------------------------r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ 909 (931)
...+..... ....+...++.+.+||.+||+.||.+|||+.
T Consensus 308 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 387 (397)
T 1wak_A 308 IALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA 387 (397)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHH
T ss_pred HHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHH
Confidence 111110000 0112233457789999999999999999999
Q ss_pred HHHHH
Q 002355 910 NIVES 914 (931)
Q Consensus 910 ELLq~ 914 (931)
|+++|
T Consensus 388 e~l~h 392 (397)
T 1wak_A 388 ECLRH 392 (397)
T ss_dssp HHHTS
T ss_pred HHhhC
Confidence 99976
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=367.48 Aligned_cols=255 Identities=18% Similarity=0.284 Sum_probs=214.0
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~L 733 (931)
..++|+++++||+|+||+||+|++ +++.||||++...... ..+.+|+.+++.+ +||||+++++++..+...++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 347899999999999999999986 6788999998765322 3477899999999 89999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc-----EEEEecCcc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT-----VKVCDFGLS 808 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~-----IKL~DFGlA 808 (931)
||||+ +++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++. +||+|||++
T Consensus 83 v~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EEEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 99999 99999999763 346999999999999999999999999 999999999999999887 999999999
Q ss_pred cccccccc-------ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhccc
Q 002355 809 RFKANTFI-------SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPA---QVVGAVAFQNR 878 (931)
Q Consensus 809 r~~~~~~~-------~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~---eii~~i~~~~~ 878 (931)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.... +.+..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 86543221 124568999999999999999999999999999999999999999885433 23333321111
Q ss_pred ccC---CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 879 RLA---IPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 879 r~~---lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
... .....+ ++.+||.+||..+|.+||++.+|++.|+++++.
T Consensus 238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 111 223455 999999999999999999999999999988764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=390.39 Aligned_cols=263 Identities=30% Similarity=0.566 Sum_probs=228.4
Q ss_pred cccccccCceEEEEEecccCceEEEEEEEc-CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe
Q 002355 652 DWLEISWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH 730 (931)
Q Consensus 652 ~~lei~~drY~Ii~kLG~G~fGtVylAr~~-g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~ 730 (931)
+.|++..++|++.++||+|+||+||+|++. +..||||+++..... .+.+.+|+++|+.++||||+++++++. .+.
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 457888899999999999999999999985 667999999865432 357889999999999999999999986 667
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
+++||||+.+++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred cEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 899999999999999997522 235788999999999999999999999 99999999999999999999999999986
Q ss_pred ccccc-cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChH
Q 002355 811 KANTF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888 (931)
Q Consensus 811 ~~~~~-~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~ 888 (931)
..... .......+|..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. ...+...|..+++
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~ 412 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPE 412 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTSCH
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence 54321 12233456789999999998889999999999999999999 999999988887776664 3455667888999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 889 VLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
++.+||.+||..||++|||+.+|++.|++++...
T Consensus 413 ~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 413 ELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 9999999999999999999999999999987653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=364.07 Aligned_cols=253 Identities=25% Similarity=0.321 Sum_probs=207.0
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch---HHHHHHHHHHHHHHhc---CCCCeeeEEeeeeeC
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD---DQLKEFLREVAIMKRV---RHPNVVLFMGAVTKR 728 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~---~~~~~~l~EIkILk~L---~HpNIV~Lid~f~~~ 728 (931)
..++|+++++||+|+||+||+|++ +++.||||++....... .....+.+|+.+++.+ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357999999999999999999985 67889999997654211 1113455677777666 499999999999765
Q ss_pred C-----eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEE
Q 002355 729 P-----HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVC 803 (931)
Q Consensus 729 ~-----~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~ 803 (931)
. .+++||||+. ++|.+++.... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEEe
Confidence 4 5899999995 69999997633 334899999999999999999999999 9999999999999999999999
Q ss_pred ecCccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc---
Q 002355 804 DFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL--- 880 (931)
Q Consensus 804 DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~--- 880 (931)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+.......
T Consensus 163 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 163 DFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp SCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 999998654432 2345678999999999999999999999999999999999999999988776665553221110
Q ss_pred ----------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 ----------------------AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 ----------------------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.....+++.+.+||.+||++||.+|||+.|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0123578899999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=370.65 Aligned_cols=268 Identities=28% Similarity=0.530 Sum_probs=219.6
Q ss_pred cccCceEEEEEecccCceEEEEEEE--cCCce----EEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDV----AVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~--~g~~V----AVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
+..++|+++++||+|+||+||+|++ +++.| |+|.+.... .......+.+|+.+++.++||||+++++++..+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 3558999999999999999999987 45555 555554332 2223467889999999999999999999998765
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
.++|++++.+++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred -ceEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 78999999999999999763 346899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccc--ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCC
Q 002355 810 FKANTFI--SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNT 886 (931)
Q Consensus 810 ~~~~~~~--~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~ 886 (931)
....... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+. .......+..+
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 244 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC 244 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTB
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccC
Confidence 6543221 1233456788999999999999999999999999999999 999999888777665543 44556677889
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhhhcCCC
Q 002355 887 SPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQMGG 930 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l~~~~~ 930 (931)
+..+.+||.+||..||.+|||+.++++.|+.+...+.......|
T Consensus 245 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~g 288 (327)
T 3lzb_A 245 TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 288 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHHHBCCCC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCceEEecc
Confidence 99999999999999999999999999999999988776655443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=358.22 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=222.4
Q ss_pred ccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
..++|++.+.||+|+||+||+|++. ++.||+|++...... ......+.+|+.+++.++||||+++++++..++..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 4579999999999999999999884 678999999876433 3445678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
||||+.+++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++.....
T Consensus 93 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EEECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999999998752 35899999999999999999999999 99999999999999999999999999986554
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+. .....++..+++.+.+|
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l 245 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASL 245 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHH
T ss_pred CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hccCCCccccCHHHHHH
Confidence 3333455678999999999999889999999999999999999999999887766665543 33455678899999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHH
Q 002355 894 MESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 894 I~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
|.+||..||.+|||+.+++++-.
T Consensus 246 i~~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 246 IQKMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp HHHHTCSSGGGSCCGGGGGGSHH
T ss_pred HHHHcccChhhCcCHHHHhhChh
Confidence 99999999999999999998743
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=359.74 Aligned_cols=252 Identities=24% Similarity=0.417 Sum_probs=193.4
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
..++|++.+.||+|+||+||+|++ +++.||||++....... .....+.+|+.+++.++||||+++++++...+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 347899999999999999999987 67889999997643222 123678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
||||+++++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++.....
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999999752 346899999999999999999999999 99999999999999999999999999986554
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. ......+..++.++.+|
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l 242 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV--LADYEMPSFLSIEAKDL 242 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC--SSCCCCCTTSCHHHHHH
T ss_pred CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh--hcccCCccccCHHHHHH
Confidence 3333345678999999999999889999999999999999999999998766544443322 22345677889999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 002355 894 MESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 894 I~rcL~~DPeeRPSa~ELLq~ 914 (931)
|.+||..||.+|||+.+++++
T Consensus 243 i~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 243 IHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp HHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHcccCHhhCCCHHHHhcC
Confidence 999999999999999999876
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=369.65 Aligned_cols=249 Identities=25% Similarity=0.373 Sum_probs=209.4
Q ss_pred cccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-----CCCeeeEEeeeeeC
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-----HPNVVLFMGAVTKR 728 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-----HpNIV~Lid~f~~~ 728 (931)
+..++|+++++||+|+||+||+|++ +++.||||++... ......+..|+.+++.+. ||||+++++++...
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~ 108 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY 108 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence 3458999999999999999999998 6778999999743 233456778999999996 99999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC------------
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK------------ 796 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~------------ 796 (931)
++.|+||||+ +++|.+++.+.. ...+++..++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 109 ~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 109 DHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp TEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred CeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchhc
Confidence 9999999999 999999997633 335899999999999999999999999 999999999999975
Q ss_pred -------------CCcEEEEecCccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002355 797 -------------NWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNG 863 (931)
Q Consensus 797 -------------dg~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~ 863 (931)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 789999999999865443 2456789999999999999999999999999999999999999998
Q ss_pred CChHHHHHHHHhcccccC------------------------CC--------------------CCChHHHHHHHHHhcc
Q 002355 864 LGPAQVVGAVAFQNRRLA------------------------IP--------------------QNTSPVLASLMESCWA 899 (931)
Q Consensus 864 ~~~~eii~~i~~~~~r~~------------------------lP--------------------~~~s~eL~dLI~rcL~ 899 (931)
....+....+.......+ .| ...++.+.+||.+||+
T Consensus 262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 776655544322111100 11 1123778899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 002355 900 DDPAQRPSFANIVES 914 (931)
Q Consensus 900 ~DPeeRPSa~ELLq~ 914 (931)
.||.+|||+.|+++|
T Consensus 342 ~dP~~Rpta~elL~h 356 (360)
T 3llt_A 342 IDPTLRPSPAELLKH 356 (360)
T ss_dssp SSGGGSCCHHHHTTS
T ss_pred CChhhCCCHHHHhcC
Confidence 999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=357.53 Aligned_cols=253 Identities=25% Similarity=0.452 Sum_probs=219.9
Q ss_pred ccccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
.+..++|++.+.||+|+||+||+|++. ++.||||++....... .....+.+|+.+++.++||||+++++++..++..
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 345689999999999999999999884 5679999997643222 1235688999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++...
T Consensus 90 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp EEEECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 9999999999999999763 35899999999999999999999999 999999999999999999999999998765
Q ss_pred cccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHH
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~ 891 (931)
... ......|++.|+|||++.+..++.++|||||||++|+|++|..||......+....+. .....++..++..+.
T Consensus 165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 240 (284)
T 2vgo_A 165 PSL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDLKFPPFLSDGSK 240 (284)
T ss_dssp SSS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHH
T ss_pred ccc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh--ccccCCCCcCCHHHH
Confidence 433 2345678999999999999889999999999999999999999999887766665554 334457788999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 892 SLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 892 dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
+||.+||..||.+|||+.++++|-.
T Consensus 241 ~li~~~l~~~p~~Rps~~~ll~h~~ 265 (284)
T 2vgo_A 241 DLISKLLRYHPPQRLPLKGVMEHPW 265 (284)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTCHH
T ss_pred HHHHHHhhcCHhhCCCHHHHhhCHH
Confidence 9999999999999999999998743
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=371.67 Aligned_cols=252 Identities=22% Similarity=0.284 Sum_probs=201.5
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
..++|+++++||+|+||+||+|++ +++.||||++............+.+|+++++.++||||+++++++..+..+|+|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 458999999999999999999986 577899999977655444556778999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC-----CCCcEEEEecCccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD-----KNWTVKVCDFGLSR 809 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd-----~dg~IKL~DFGlAr 809 (931)
|||+. ++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+++
T Consensus 112 ~e~~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EECCS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EecCC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99996 5999999763 35899999999999999999999999 99999999999994 45569999999998
Q ss_pred cccccccccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccC-------
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLA------- 881 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~------- 881 (931)
.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+....+........
T Consensus 186 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
T 3gbz_A 186 AFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265 (329)
T ss_dssp HHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhh
Confidence 655443334556789999999999875 479999999999999999999999998877666555432211100
Q ss_pred ---------------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 882 ---------------------IPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 882 ---------------------lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
++..+++++.+||.+||+.||.+|||+.|+++|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 011267899999999999999999999999876
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=355.85 Aligned_cols=258 Identities=31% Similarity=0.557 Sum_probs=217.2
Q ss_pred CceEEEEEecccCceEEEEEEEc--CC---ceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE-E
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH--GS---DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL-S 732 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~--g~---~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l-~ 732 (931)
-.|++.++||+|+||+||+|++. +. .||+|++.... .......+.+|+.+++.++||||+++++++...+.. +
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 46778899999999999999862 22 58999986533 334567889999999999999999999999766554 9
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+.+++|.+++.. ....+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 100 ~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EEECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 99999999999999975 2346899999999999999999999999 9999999999999999999999999997543
Q ss_pred cc----ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcccccCCCCCCh
Q 002355 813 NT----FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTS 887 (931)
Q Consensus 813 ~~----~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG-~~PF~~~~~~eii~~i~~~~~r~~lP~~~s 887 (931)
.. ........+|+.|+|||.+.+..++.++|||||||++|+|++| .+||...........+ ........+..++
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 254 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-AQGRRLPQPEYCP 254 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH-HTTCCCCCCTTCC
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh-hcCCCCCCCccch
Confidence 32 1223445678899999999999999999999999999999995 5556666655555444 3445566778899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 888 PVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 888 ~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
+.+.+||.+||..||.+|||+.++++.|+++++..
T Consensus 255 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 255 DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999988753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=358.24 Aligned_cols=257 Identities=24% Similarity=0.432 Sum_probs=201.2
Q ss_pred cccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
+++..++|+++++||+|+||+||+|++ +++.||||++............+.++..+++.++||||+++++++..++..
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 356779999999999999999999998 678899999977654444444455566668888999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcC-CCCCCCcHHHHHHHHHHHHHHHHHHHhC-CCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 732 SIVTEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNL-NPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~-~~~~~L~e~~~~~Ia~QIa~AL~yLHs~-G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
++||||+. ++|.+++... .....+++..++.++.||+.||+|||++ | |+||||||+||+++.++.+||+|||++.
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 99999996 5887776531 2345699999999999999999999997 9 9999999999999999999999999997
Q ss_pred cccccccccCCCCCCCcccCcccc----cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcccccCCCC
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFL----RGEPSNEKSDVYSFGVILWELVTMQQPWNGLG-PAQVVGAVAFQNRRLAIPQ 884 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL----~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~-~~eii~~i~~~~~r~~lP~ 884 (931)
...... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.... .................+.
T Consensus 159 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T 3fme_A 159 YLVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred cccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence 654432 22344789999999996 55678899999999999999999999998643 3444444443444444456
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 885 NTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 885 ~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+++++.+||.+||+.||.+|||+.|+++|
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 789999999999999999999999999985
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=379.33 Aligned_cols=252 Identities=29% Similarity=0.451 Sum_probs=214.8
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
..++|++++.||+|+||+||+|++ +++.||||++....... .....+.+|+.+++.++||||+++++++...+.+++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 458999999999999999999987 67889999997643221 112467899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
||||+ +|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 87 v~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp EECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EEECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 99999 78999988652 35899999999999999999999999 99999999999999999999999999986544
Q ss_pred cccccCCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPS-NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~-t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
.. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+ ......+|..+++.+.+
T Consensus 161 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~ 237 (336)
T 3h4j_B 161 GN-FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQS 237 (336)
T ss_dssp SB-TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHH
T ss_pred Cc-ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHH
Confidence 32 2345689999999999998776 78999999999999999999999876543332221 12334567789999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHH
Q 002355 893 LMESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
||++||..||.+|||+.|++++-+-
T Consensus 238 li~~~L~~dP~~Rpt~~eil~hp~~ 262 (336)
T 3h4j_B 238 LIRRMIVADPMQRITIQEIRRDPWF 262 (336)
T ss_dssp HHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred HHHHHcCCChhHCcCHHHHHhChhh
Confidence 9999999999999999999988553
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=353.62 Aligned_cols=247 Identities=23% Similarity=0.339 Sum_probs=210.8
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~LV 734 (931)
.++|+++++||+|+||+||+|++ +++.||||++............+.+|+.++..+ +||||+++++++...+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 37899999999999999999988 488899999987655555667888999999999 899999999999999999999
Q ss_pred EeecCCCCHHHHhhcCC-CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC----------------
Q 002355 735 TEYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN---------------- 797 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~-~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d---------------- 797 (931)
|||+++++|.+++.... ....+++..++.++.||+.||+|||++| |+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999999999997531 1245899999999999999999999999 9999999999999844
Q ss_pred ---CcEEEEecCccccccccccccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 002355 798 ---WTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAV 873 (931)
Q Consensus 798 ---g~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i 873 (931)
..+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+++..... ...+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~ 240 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEI 240 (289)
T ss_dssp --CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHH
T ss_pred CCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHH
Confidence 47999999999876543 344689999999999876 556899999999999999999887755432 2222
Q ss_pred HhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 874 AFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 874 ~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.......++..+++.+.+||.+||..||.+|||+.++++|
T Consensus 241 -~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 241 -RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 2344456778899999999999999999999999999876
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=363.17 Aligned_cols=251 Identities=24% Similarity=0.426 Sum_probs=217.2
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchH----HHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD----QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~----~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
.++|++++.||+|+||+||+|++ +++.||+|++........ ....+.+|+.+++.++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 47899999999999999999987 478899999987543221 246788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC----cEEEEecCc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW----TVKVCDFGL 807 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg----~IKL~DFGl 807 (931)
++||||+++++|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 999999999999999975 346899999999999999999999999 99999999999999888 799999999
Q ss_pred cccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc--CCCCC
Q 002355 808 SRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL--AIPQN 885 (931)
Q Consensus 808 Ar~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~--~lP~~ 885 (931)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+....... ..+..
T Consensus 166 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (321)
T 2a2a_A 166 AHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244 (321)
T ss_dssp CEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred ceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcc
Confidence 98655432 2345578999999999999999999999999999999999999999888777666654322211 12357
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 886 TSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.++.+.+||.+||..||.+|||+.++++|
T Consensus 245 ~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 245 TSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 88999999999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=393.06 Aligned_cols=263 Identities=33% Similarity=0.606 Sum_probs=229.9
Q ss_pred cccccccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 652 DWLEISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 652 ~~lei~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
+.|++..++|++.++||+|+||.||+|++. +..||||+++..... ...+.+|+.+|++++||||+++++++....
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 456788899999999999999999999885 678999998765432 357889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
.+||||||+.+++|.+++.... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred cEEEEEEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeecccce
Confidence 9999999999999999997632 345899999999999999999999999 9999999999999999999999999998
Q ss_pred cccccc-cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCCh
Q 002355 810 FKANTF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTS 887 (931)
Q Consensus 810 ~~~~~~-~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s 887 (931)
...... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+. ...+...+..++
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 445 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCP 445 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCC
T ss_pred eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 654322 12233456789999999998889999999999999999999 999999988777665553 455667788999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 888 PVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 888 ~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
+.+.+||.+||..||.+|||+.+|++.|+.++..
T Consensus 446 ~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 446 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999987654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=358.36 Aligned_cols=261 Identities=33% Similarity=0.577 Sum_probs=214.3
Q ss_pred cccCceEEEEEecccCceEEEEEEEc---CC--ceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH---GS--DVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~---g~--~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
+..++|+++++||+|+||+||+|++. ++ .||||++...... ....+.+.+|+++++.++||||+++++++....
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 45689999999999999999999863 22 4899998765432 245678899999999999999999999998765
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
.++||||+.+++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++.
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred -ceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEccccccc
Confidence 89999999999999999752 245899999999999999999999999 9999999999999999999999999997
Q ss_pred ccccccc---ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCC
Q 002355 810 FKANTFI---SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQN 885 (931)
Q Consensus 810 ~~~~~~~---~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~ 885 (931)
....... ......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+.........+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 249 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcC
Confidence 6543221 2234467889999999998888999999999999999999 99999999888887777666666677788
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 886 TSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
++..+.+||.+||..||.+|||+.++++.|+++...
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 999999999999999999999999999999987654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=357.89 Aligned_cols=260 Identities=32% Similarity=0.497 Sum_probs=217.1
Q ss_pred ccCceEEEEEecccCceEEEEEEEcC---C--ceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeee-eeCCe
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWHG---S--DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAV-TKRPH 730 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~g---~--~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f-~~~~~ 730 (931)
...+|++.++||+|+||+||+|++.. + .||+|++.... .......+.+|+.++++++||||+++++++ ..++.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 34689999999999999999998632 2 47888876533 334457789999999999999999999985 56678
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
.++||||+.+++|.+++.. ....+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||+++.
T Consensus 102 ~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp CEEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred eEEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECccccccc
Confidence 9999999999999999975 2346889999999999999999999999 99999999999999999999999999975
Q ss_pred ccccc----cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCC
Q 002355 811 KANTF----ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQN 885 (931)
Q Consensus 811 ~~~~~----~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~ 885 (931)
..... .......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||......+....+. .......+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 256 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEY 256 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTCCCCCCTT
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCCCCCCCcc
Confidence 43321 12234457789999999999899999999999999999999 677787776665555443 3445556778
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 886 TSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
+++.+.+||.+||..+|.+|||+.++++.|+.++...
T Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 257 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 8999999999999999999999999999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=357.84 Aligned_cols=264 Identities=25% Similarity=0.474 Sum_probs=209.5
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
..++|++.++||+|+||.||+|++ +++.||||++...... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 347899999999999999999986 5788999999864433 3455778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcC-CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 734 VTEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~-~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
||||+.+++|.+++... .....+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++....
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999998642 12346899999999999999999999999 9999999999999999999999999998655
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcccccCCCCCChHHH
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLG--PAQVVGAVAFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~--~~eii~~i~~~~~r~~lP~~~s~eL 890 (931)
..........|++.|+|||++.+..++.++|||||||++|+|++|..||.+.. .......+.....+...+..+++++
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence 44333345578999999999999999999999999999999999999997643 2333333333233333346789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 891 ASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
.+||.+||..||.+|||+.++++.|+++....
T Consensus 268 ~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 268 RQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 99999999999999999999999999987653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=353.69 Aligned_cols=254 Identities=25% Similarity=0.380 Sum_probs=215.8
Q ss_pred CceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|++.++||+|+||+||+|++. +..||+|++....... ...+.+|+++++.++||||+++++++..+...++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 68999999999999999999884 5579999987654332 3578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEE---CCCCcEEEEecCccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILL---d~dg~IKL~DFGlAr~~~~ 813 (931)
|+.+++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+||++ +.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 87 LCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred ccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999999988752 35899999999999999999999999 9999999999999 7889999999999976544
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCC--CCCChHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAI--PQNTSPVLA 891 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~l--P~~~s~eL~ 891 (931)
.. ......||+.|+|||++.+. ++.++|||||||++|+|++|..||......+....+......... ...+++.+.
T Consensus 162 ~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T 3f3z_A 162 GK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE 239 (277)
T ss_dssp TS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred cc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence 32 23456789999999998765 889999999999999999999999998877776665433222211 136889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH--HHHHhhC
Q 002355 892 SLMESCWADDPAQRPSFANIVES--LKKLLKS 921 (931)
Q Consensus 892 dLI~rcL~~DPeeRPSa~ELLq~--L~~Llks 921 (931)
+||.+||+.||.+|||+.++++| +++.+..
T Consensus 240 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~ 271 (277)
T 3f3z_A 240 SLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCC
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhccccc
Confidence 99999999999999999999976 4444433
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=371.51 Aligned_cols=253 Identities=25% Similarity=0.405 Sum_probs=218.4
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
.++|++++.||+|+||+||+|++ +++.||||++...... ......+.+|+++++.++||||+++++++..++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 36799999999999999999986 5778999999865433 34456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||+. |+|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 99996 6888877542 346899999999999999999999999 999999999999999999999999999765433
Q ss_pred ccccCCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHH
Q 002355 815 FISSKSVAGTPEWMAPEFLR---GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~---~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~ 891 (931)
....||+.|+|||++. +..++.++|||||||++|||++|..||.+.+.......+.....+...+..+++.+.
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 283 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 283 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 4567999999999985 466789999999999999999999999988876666665544444445678899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 002355 892 SLMESCWADDPAQRPSFANIVESLKKLL 919 (931)
Q Consensus 892 dLI~rcL~~DPeeRPSa~ELLq~L~~Ll 919 (931)
+||.+||..||.+|||+.+++++..-..
T Consensus 284 ~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 284 NFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 9999999999999999999998865433
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=362.06 Aligned_cols=263 Identities=25% Similarity=0.448 Sum_probs=200.7
Q ss_pred cccccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeee--
Q 002355 652 DWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVT-- 726 (931)
Q Consensus 652 ~~lei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~-- 726 (931)
..+++...+|++.++||+|+||+||+|++ +++.||||++.... ......+.+|+.+++++. ||||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 34566778999999999999999999998 67889999986653 334467889999999996 999999999984
Q ss_pred ------eCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcE
Q 002355 727 ------KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV 800 (931)
Q Consensus 727 ------~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~I 800 (931)
....+++||||+ +|+|.+++........+++..++.++.||+.||+|||++|++|+||||||+|||++.++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred ccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 345689999999 5799998865444456999999999999999999999987779999999999999999999
Q ss_pred EEEecCcccccccccc------------ccCCCCCCCcccCcccc---cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Q 002355 801 KVCDFGLSRFKANTFI------------SSKSVAGTPEWMAPEFL---RGEPSNEKSDVYSFGVILWELVTMQQPWNGLG 865 (931)
Q Consensus 801 KL~DFGlAr~~~~~~~------------~~~~~~GT~~Y~APEvL---~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~ 865 (931)
||+|||+++....... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 9999999986543211 11244689999999998 56678899999999999999999999997755
Q ss_pred hHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 866 PAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 866 ~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
...... .......+...+..+.+||.+||+.||.+|||+.+++++|+.+...
T Consensus 258 ~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 258 KLRIVN----GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp ------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhhc----CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 433322 2233444567778899999999999999999999999999998764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=371.92 Aligned_cols=261 Identities=18% Similarity=0.244 Sum_probs=208.4
Q ss_pred cccCceEEEEEecccCceEEEEEEEc-------CCceEEEEEeecccchHH-H--------HHHHHHHHHHHhcCCCCee
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQ-L--------KEFLREVAIMKRVRHPNVV 719 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~-------g~~VAVKVlk~~~~~~~~-~--------~~~l~EIkILk~L~HpNIV 719 (931)
+..++|+++++||+|+||+||+|++. ++.||||++......... . ..+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 45679999999999999999999873 467999998765421110 0 1234566667778899999
Q ss_pred eEEeeeeeC----CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC
Q 002355 720 LFMGAVTKR----PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD 795 (931)
Q Consensus 720 ~Lid~f~~~----~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd 795 (931)
++++++... .+.||||||+ |++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~ 186 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLN 186 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEE
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEe
Confidence 999998754 5689999999 99999999762 356999999999999999999999999 99999999999999
Q ss_pred --CCCcEEEEecCcccccccccc-------ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Q 002355 796 --KNWTVKVCDFGLSRFKANTFI-------SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGP 866 (931)
Q Consensus 796 --~dg~IKL~DFGlAr~~~~~~~-------~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~ 866 (931)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+...
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 889999999999976433211 11344599999999999999999999999999999999999999986432
Q ss_pred HHHHHHHHhccc---------ccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 867 AQVVGAVAFQNR---------RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 867 ~eii~~i~~~~~---------r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
............ ....+..+++++.+||..||..+|.+||++.+|++.|.++++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp CHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 222211111110 0112367799999999999999999999999999999998874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=386.61 Aligned_cols=266 Identities=32% Similarity=0.580 Sum_probs=225.6
Q ss_pred ccccccccCceEEEEEecccCceEEEEEEEcC-CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 651 MDWLEISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 651 ~~~lei~~drY~Ii~kLG~G~fGtVylAr~~g-~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
.+.|++..++|++.++||+|+||+||+|++.+ ..||||+++..... .+.+.+|+++|++++||||+++++++.. +
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 45678889999999999999999999999865 56999999765433 2468899999999999999999999876 6
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
.+++||||+.+++|.+++... .+..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLAR 328 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred ceEEEehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccce
Confidence 789999999999999999742 2245899999999999999999999999 9999999999999999999999999998
Q ss_pred cccccc-cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCCh
Q 002355 810 FKANTF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTS 887 (931)
Q Consensus 810 ~~~~~~-~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s 887 (931)
...... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. ...+...+..++
T Consensus 329 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~ 407 (452)
T 1fmk_A 329 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 407 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSC
T ss_pred ecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 654321 11233456789999999998889999999999999999999 999999988877776664 445666788999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchh
Q 002355 888 PVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQ 924 (931)
Q Consensus 888 ~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~ 924 (931)
+.+.+||.+||..||++|||+.++++.|++++....+
T Consensus 408 ~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 408 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 9999999999999999999999999999998876543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=360.92 Aligned_cols=253 Identities=26% Similarity=0.437 Sum_probs=209.6
Q ss_pred cccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeee-----
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTK----- 727 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~----- 727 (931)
...++|++++.||+|+||+||+|++ +++.||||++...... ...+.+|+.+++.+ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 3568999999999999999999998 6788999999765432 24678999999999 79999999999976
Q ss_pred -CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecC
Q 002355 728 -RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806 (931)
Q Consensus 728 -~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFG 806 (931)
...+++||||+.+++|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCT
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEEEeeCc
Confidence 568999999999999999997632 346899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccCCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccC
Q 002355 807 LSRFKANTFISSKSVAGTPEWMAPEFLR-----GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLA 881 (931)
Q Consensus 807 lAr~~~~~~~~~~~~~GT~~Y~APEvL~-----~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~ 881 (931)
++..............||+.|+|||++. +..++.++|||||||++|+|++|..||...........+........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 254 (326)
T 2x7f_A 175 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 254 (326)
T ss_dssp TTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred CceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccC
Confidence 9986554333334567899999999987 55678899999999999999999999998887666655544444444
Q ss_pred CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 882 IPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 882 lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+..++..+.+||.+||..||.+||++.+++++
T Consensus 255 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 255 KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 567789999999999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=366.36 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=221.8
Q ss_pred ccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
..++|++++.||+|+||.||+|++. ++.||+|++...... ......+.+|+.+++.++||||+++++++...+.+|+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 4579999999999999999999874 678999999876433 3455678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
||||+.+++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 119 v~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp EECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999999998752 35899999999999999999999999 99999999999999999999999999986554
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+. .....++..+++.+.+|
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l 271 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASL 271 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCCTTSCHHHHHH
T ss_pred CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh--cCCCCCCccCCHHHHHH
Confidence 3333455679999999999999889999999999999999999999999887766665543 23445678899999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHH
Q 002355 894 MESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 894 I~rcL~~DPeeRPSa~ELLq~L 915 (931)
|.+||..||.+|||+.+++++-
T Consensus 272 i~~~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 272 IQKMLQTDPTARPTINELLNDE 293 (335)
T ss_dssp HHHHTCSSGGGSCCGGGGGGSH
T ss_pred HHHHccCChhHCcCHHHHhcCc
Confidence 9999999999999999999873
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=360.86 Aligned_cols=255 Identities=32% Similarity=0.571 Sum_probs=206.7
Q ss_pred ccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhc--CCCCeeeEEeeeeeC----Ce
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV--RHPNVVLFMGAVTKR----PH 730 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L--~HpNIV~Lid~f~~~----~~ 730 (931)
..++|+++++||+|+||+||+|+++++.||||++.... .....+|.+++..+ +||||+++++++... ..
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34799999999999999999999999999999986543 13344556665554 899999999999877 78
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhC--------CCCEEEeccCCCCeEECCCCcEEE
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL--------NPPILHWDLKSPNLLVDKNWTVKV 802 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~--------G~~IIHrDLKPeNILLd~dg~IKL 802 (931)
+++||||+.+++|.+++... .+++..++.++.||+.||+|||++ | |+||||||+|||++.++.+||
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTTSCEEE
T ss_pred eEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCCCCEEE
Confidence 99999999999999999652 489999999999999999999998 7 999999999999999999999
Q ss_pred EecCcccccccccc----ccCCCCCCCcccCcccccCCCCCch------hHHHHHHHHHHHHHhC----------CCCCC
Q 002355 803 CDFGLSRFKANTFI----SSKSVAGTPEWMAPEFLRGEPSNEK------SDVYSFGVILWELVTM----------QQPWN 862 (931)
Q Consensus 803 ~DFGlAr~~~~~~~----~~~~~~GT~~Y~APEvL~~~~~t~k------sDIWSLG~ILyELLTG----------~~PF~ 862 (931)
+|||+++....... ......||+.|+|||++.+...+.. +|||||||++|||++| ..||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 99999975433221 1234579999999999988766554 9999999999999999 77776
Q ss_pred CCCh-----HHHHHHHHhcccccCCCC-----CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 863 GLGP-----AQVVGAVAFQNRRLAIPQ-----NTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 863 ~~~~-----~eii~~i~~~~~r~~lP~-----~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
.... ......+.........+. .+++++.+||.+||+.||.+|||+.+++++|+.+..+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 5421 222222222233333332 56778999999999999999999999999999998875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=370.22 Aligned_cols=266 Identities=28% Similarity=0.443 Sum_probs=217.7
Q ss_pred ccccCceEEEEEecccCceEEEEEEEc-CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~~-g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
+...++|++.+.||+|+||+||+|++. ++.||||++..... .....+.+|+.+++.++||||+++++++..++..++
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 335589999999999999999999874 78899998766532 334678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCC-CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 734 VTEYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~-~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
||||+.+++|.+++.... ....+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999999986532 2235899999999999999999999999 9999999999999999999999999997643
Q ss_pred ccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhcc-------
Q 002355 813 NTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVV------GAVAFQN------- 877 (931)
Q Consensus 813 ~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii------~~i~~~~------- 877 (931)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....+.+.. .......
T Consensus 191 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred cccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 221 1223445899999999998888999999999999999999999999765432211 0110000
Q ss_pred --cccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchh
Q 002355 878 --RRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQ 924 (931)
Q Consensus 878 --~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~ 924 (931)
.....+...+..+.+||.+||+.||++|||+.+++++|+.+++....
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~~ 319 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSCC
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcccC
Confidence 01112234567899999999999999999999999999999876544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=355.61 Aligned_cols=251 Identities=27% Similarity=0.506 Sum_probs=221.5
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.+.|+++++||+|+||+||+|++ +++.||||++...... .....+.+|+.+++.++||||+++++++.....+++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 46899999999999999999987 4778999999765432 23467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+.+++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++.......
T Consensus 100 e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 100 EYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp ECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred EeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 99999999999864 35899999999999999999999999 9999999999999999999999999998765544
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~ 895 (931)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+. ......++..++..+.+||.
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~ 252 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVE 252 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSCCCCCCSSCCHHHHHHHH
T ss_pred cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh-cCCCCCCccccCHHHHHHHH
Confidence 34456678999999999999989999999999999999999999999887766655543 33445567788999999999
Q ss_pred HhcccCCCCCCCHHHHHHHHH
Q 002355 896 SCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 896 rcL~~DPeeRPSa~ELLq~L~ 916 (931)
+||..||.+|||+.+++++..
T Consensus 253 ~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 253 ACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp HHCCSSGGGSCCHHHHTTCHH
T ss_pred HHcCCChhhCcCHHHHhhChh
Confidence 999999999999999998754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=387.33 Aligned_cols=252 Identities=29% Similarity=0.461 Sum_probs=217.1
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|+++++||+|+||+||+|++ +++.||||++............+.+|+++|++++||||+++++++.....+|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 37999999999999999999987 4788999999765433333467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC---CCCcEEEEecCcccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD---KNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd---~dg~IKL~DFGlAr~~~ 812 (931)
||+.|++|.+++.+. ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 101 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999988653 35899999999999999999999999 99999999999995 45679999999998654
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC--CCChHHH
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP--QNTSPVL 890 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP--~~~s~eL 890 (931)
... .....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+.+..+.........+ ..+++++
T Consensus 176 ~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 253 (486)
T 3mwu_A 176 QNT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253 (486)
T ss_dssp CC-----CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHH
T ss_pred CCC-ccCCCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHH
Confidence 432 23456799999999999874 8999999999999999999999999988888877776544443333 4678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
++||.+||..||.+|||+.++++|-+
T Consensus 254 ~~li~~~L~~dp~~R~t~~~~l~hp~ 279 (486)
T 3mwu_A 254 KDLIRKMLTFHPSLRITATQCLEHPW 279 (486)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCHh
Confidence 99999999999999999999998743
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=368.45 Aligned_cols=253 Identities=24% Similarity=0.390 Sum_probs=212.9
Q ss_pred cccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
+..++|+++++||+|+||+||+|++. ++.||+|++.... .......+.+|+.+++.++||||+++++++..++.+++
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 45589999999999999999999985 7889999998653 34445778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhC-CCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL-NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~-G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
||||++|++|.+++.+. ..+++..++.++.||+.||+|||+. | |+||||||+|||++.++.+||+|||++....
T Consensus 109 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp EECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEECCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 99999999999999763 3589999999999999999999985 8 9999999999999999999999999987543
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------------------
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAV------------------- 873 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i------------------- 873 (931)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+.....
T Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 184 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp HH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred cc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 32 224557899999999999999999999999999999999999999876654432211
Q ss_pred -----------------------HhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 874 -----------------------AFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 874 -----------------------~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
............++.++.+||.+||+.||.+|||+.++++|-.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 1111111223457889999999999999999999999998743
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=364.02 Aligned_cols=266 Identities=26% Similarity=0.436 Sum_probs=222.8
Q ss_pred ccccCceEEEEEecccCceEEEEEEE-------cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEW-------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK 727 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~-------~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~ 727 (931)
++..++|++++.||+|+||+||+|++ .++.||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 56678999999999999999999984 35679999986443 33445678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhhcCCC----CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC---CCcE
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRPAA----GEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---NWTV 800 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~~~----~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~---dg~I 800 (931)
....|+||||+++++|.+++..... ...+++..++.++.||+.||.|||++| |+||||||+|||++. +..+
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceE
Confidence 9999999999999999999976321 145889999999999999999999999 999999999999984 4469
Q ss_pred EEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcc
Q 002355 801 KVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQN 877 (931)
Q Consensus 801 KL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~ 877 (931)
||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+. ..
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~ 261 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SG 261 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TT
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh-cC
Confidence 999999987533221 12234467889999999998889999999999999999998 999999887776665554 34
Q ss_pred cccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchh
Q 002355 878 RRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQ 924 (931)
Q Consensus 878 ~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~ 924 (931)
.....+..+++.+.+||.+||..||.+||++.+++++|+.+...+..
T Consensus 262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 308 (327)
T 2yfx_A 262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308 (327)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence 45566788999999999999999999999999999999999887643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=364.52 Aligned_cols=261 Identities=31% Similarity=0.507 Sum_probs=217.7
Q ss_pred cccCceEEEEEecccCceEEEEEEE------cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeee--e
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT--K 727 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~------~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~--~ 727 (931)
+..++|+++++||+|+||+||+|++ .++.||||++.... ......+.+|+++++.++||||+++++++. .
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 3558999999999999999999984 46679999987653 344567899999999999999999999886 5
Q ss_pred CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCc
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGl 807 (931)
....++||||+++++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGG
T ss_pred CceEEEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEccccc
Confidence 67799999999999999999752 235899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccc---cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--------------HHH
Q 002355 808 SRFKANTF---ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPA--------------QVV 870 (931)
Q Consensus 808 Ar~~~~~~---~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~--------------eii 870 (931)
+....... .......||..|+|||++.+..++.++|||||||++|+|++|..||...... ...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 98654322 1223456788899999999888899999999999999999999998653321 112
Q ss_pred HHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 871 GAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 871 ~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
............+..+++.+.+||.+||..||.+|||+.+++++|+.+....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 2223344556677889999999999999999999999999999999887653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=368.90 Aligned_cols=250 Identities=21% Similarity=0.324 Sum_probs=202.1
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|+++++||+|+||+||+|++ +++.||||++...... .....+.+|+++++.++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 6899999999999999999987 4778999999754321 111234579999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+. ++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 81 YLD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CCS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred ccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 995 5899888753 346899999999999999999999999 99999999999999999999999999986554433
Q ss_pred ccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc---------------
Q 002355 817 SSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL--------------- 880 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~--------------- 880 (931)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 3445678999999999877 567999999999999999999999999988766655443211110
Q ss_pred -------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 -------------AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 -------------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.....+++++.+||.+||+.||.+|||+.|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0123568899999999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=371.73 Aligned_cols=248 Identities=24% Similarity=0.388 Sum_probs=210.3
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~LV 734 (931)
.++|++++.||+|+||+||+|++ +++.||||++...... ..+|++++.++ +||||++++++|.++..+|+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 37899999999999999999987 4778999999765422 34688888888 799999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC----CcEEEEecCcccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN----WTVKVCDFGLSRF 810 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d----g~IKL~DFGlAr~ 810 (931)
|||+.|++|.+++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||+..+ +.+||+|||++..
T Consensus 95 ~E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 95 TELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp ECCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999999975 345899999999999999999999999 9999999999998443 3599999999986
Q ss_pred ccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHhccccc--CCCCC
Q 002355 811 KANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGL---GPAQVVGAVAFQNRRL--AIPQN 885 (931)
Q Consensus 811 ~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~---~~~eii~~i~~~~~r~--~lP~~ 885 (931)
...........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ...++...+....... ..+..
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 249 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS 249 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence 654433445678999999999998888889999999999999999999999863 3445555554333222 23367
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 886 TSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
+++++.+||.+||..||.+|||+.++++|-+
T Consensus 250 ~s~~~~~li~~~L~~dP~~R~t~~~il~hp~ 280 (342)
T 2qr7_A 250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280 (342)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence 8999999999999999999999999998754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=373.76 Aligned_cols=254 Identities=19% Similarity=0.329 Sum_probs=213.5
Q ss_pred cccCceEEEEEecccCceEEEEEEEc-CCceEEEEEeecccchHHHHHHHHHHHHHHhcC--CCCeeeEEeeeeeCCeEE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR--HPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~-g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~--HpNIV~Lid~f~~~~~l~ 732 (931)
+...+|+++++||+|+||+||+|.+. ++.||||++............+.+|+.+|+.++ ||||+++++++...+.+|
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 34568999999999999999999874 677999999887666666788999999999996 599999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
||||+ .+++|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++ ++.+||+|||+++...
T Consensus 133 lv~E~-~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 133 MVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEEEC-CSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred EEEec-CCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99995 588999999763 36888999999999999999999999 99999999999995 5899999999998654
Q ss_pred ccc--cccCCCCCCCcccCcccccC-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhccc
Q 002355 813 NTF--ISSKSVAGTPEWMAPEFLRG-----------EPSNEKSDVYSFGVILWELVTMQQPWNGLGP-AQVVGAVAFQNR 878 (931)
Q Consensus 813 ~~~--~~~~~~~GT~~Y~APEvL~~-----------~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~-~eii~~i~~~~~ 878 (931)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ...+..+.....
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~ 285 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 285 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTS
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccc
Confidence 321 12345679999999999875 3578899999999999999999999987643 344445544455
Q ss_pred ccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 879 RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 879 r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
....+...+..+.+||.+||..||.+|||+.|++++-+
T Consensus 286 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 323 (390)
T 2zmd_A 286 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323 (390)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence 55677788899999999999999999999999998744
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=386.03 Aligned_cols=249 Identities=28% Similarity=0.423 Sum_probs=211.3
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|+++++||+|+||+||+|++ ++..||||++............+.+|+.+++.++||||++++++|.....+|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 6899999999999999999988 46789999998765443334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC---CCcEEEEecCccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---NWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~---dg~IKL~DFGlAr~~~~ 813 (931)
|+.|++|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++. ++.+||+|||++.....
T Consensus 117 ~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 117 CYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999999988653 35899999999999999999999999 999999999999976 45599999999986654
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC--CCChHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP--QNTSPVLA 891 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP--~~~s~eL~ 891 (931)
.. .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+....+.........+ ..+++.+.
T Consensus 192 ~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 269 (494)
T 3lij_A 192 QK-KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269 (494)
T ss_dssp TB-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred Cc-cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence 32 2345679999999999874 58999999999999999999999999998888877776544433322 57899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 002355 892 SLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 892 dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+||.+||..||.+|||+.++++|
T Consensus 270 ~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 270 DLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHHHCCCChhhCccHHHHhcC
Confidence 99999999999999999999977
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=369.14 Aligned_cols=248 Identities=25% Similarity=0.365 Sum_probs=197.7
Q ss_pred ccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
..++|++.++||+|+||+||+|++. ++.||||++.... ..+.+.+|+.+|+.++||||++++++|.....+++|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 3478999999999999999999984 5679999997643 234677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC---CCcEEEEecCccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---NWTVKVCDFGLSRFK 811 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~---dg~IKL~DFGlAr~~ 811 (931)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+++..
T Consensus 127 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 127 LELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp ECCCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 999999999999975 345899999999999999999999999 999999999999975 889999999999865
Q ss_pred cccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhccccc--CCCCCChH
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQ-VVGAVAFQNRRL--AIPQNTSP 888 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~e-ii~~i~~~~~r~--~lP~~~s~ 888 (931)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+ ....+....... .....++.
T Consensus 202 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 202 EHQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred Cccc-ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 4432 2245678999999999999999999999999999999999999998766544 444443222221 23357899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 889 VLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+.+||.+||..||++|||+.+++++
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=365.63 Aligned_cols=258 Identities=28% Similarity=0.415 Sum_probs=208.5
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC----
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP---- 729 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~---- 729 (931)
..++|+++++||+|+||+||+|++ +++.||||++....... .....+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 458999999999999999999986 57789999998764433 44567889999999999999999999987543
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
..|+||||++|++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred ccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 459999999999999999752 35899999999999999999999999 9999999999999999999999999997
Q ss_pred cccccc---cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc--CCCC
Q 002355 810 FKANTF---ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL--AIPQ 884 (931)
Q Consensus 810 ~~~~~~---~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~--~lP~ 884 (931)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+................. ....
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 244 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHST
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccC
Confidence 644321 12234568999999999999999999999999999999999999999888766655543322211 1235
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHH-HHHHHh
Q 002355 885 NTSPVLASLMESCWADDPAQRPSFANIVE-SLKKLL 919 (931)
Q Consensus 885 ~~s~eL~dLI~rcL~~DPeeRPSa~ELLq-~L~~Ll 919 (931)
.+++++.+||.+||+.||.+||++.+++. .|..+.
T Consensus 245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 68999999999999999999997766664 454443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=366.73 Aligned_cols=254 Identities=26% Similarity=0.356 Sum_probs=210.4
Q ss_pred ccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
..++|+++++||+|+||+||+|++. ++.||||++............+.+|+++++.++||||+++++++...+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 4589999999999999999999884 78899999987765555567788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||+.+++|..++.. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++......
T Consensus 103 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 103 FEFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 999999999888764 235899999999999999999999999 999999999999999999999999999865544
Q ss_pred ccccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc--------------
Q 002355 815 FISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR-------------- 879 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r-------------- 879 (931)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+....+......
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 3334556789999999999875 6789999999999999999999999988765554433211000
Q ss_pred ---cC------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002355 880 ---LA------------IPQNTSPVLASLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 880 ---~~------------lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
.. ....+++.+.+||.+||..||.+|||+.|+++|-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 308 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00 1135789999999999999999999999999873
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=375.71 Aligned_cols=250 Identities=22% Similarity=0.386 Sum_probs=216.2
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|+++++||+|+||+||+|++ +++.||+|++..... .....+.+|+.+|+.++||||++++++|.....+++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch--hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 37899999999999999999987 477899999976542 23357889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC--CCcEEEEecCccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK--NWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~--dg~IKL~DFGlAr~~~~ 813 (931)
||+.|++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++. ++.+||+|||+++....
T Consensus 128 E~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 128 EFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp ECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EcCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999999752 346899999999999999999999999 999999999999974 57899999999986544
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc--cCCCCCChHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR--LAIPQNTSPVLA 891 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r--~~lP~~~s~eL~ 891 (931)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...... ......+++++.
T Consensus 204 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 204 DE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp TS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred Cc-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 32 223457899999999999999999999999999999999999999998877776665433322 233457899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 002355 892 SLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 892 dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+||.+||..||.+|||+.+++++
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHcCCChhHCcCHHHHhhC
Confidence 99999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=382.04 Aligned_cols=250 Identities=26% Similarity=0.319 Sum_probs=191.3
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee-----CCeE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK-----RPHL 731 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~-----~~~l 731 (931)
++|+++++||+|+||+||+|++ +++.||||++..........+++.+|+++|+.++||||++++++|.. ...+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 7899999999999999999976 57889999997765555566789999999999999999999999943 3579
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||++| ||||||||+||||+.++.+||+|||+|+..
T Consensus 133 ~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecccccchhc
Confidence 9999998 6799999875 346999999999999999999999999 999999999999999999999999999865
Q ss_pred cccc---------------------------cccCCCCCCCcccCcccc-cCCCCCchhHHHHHHHHHHHHHh-------
Q 002355 812 ANTF---------------------------ISSKSVAGTPEWMAPEFL-RGEPSNEKSDVYSFGVILWELVT------- 856 (931)
Q Consensus 812 ~~~~---------------------------~~~~~~~GT~~Y~APEvL-~~~~~t~ksDIWSLG~ILyELLT------- 856 (931)
.... ......+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 4221 112345789999999986 45678999999999999999999
Q ss_pred ----CCCCCCCCCh--------------------HHHHHHHHhc-c----------------------------cccCCC
Q 002355 857 ----MQQPWNGLGP--------------------AQVVGAVAFQ-N----------------------------RRLAIP 883 (931)
Q Consensus 857 ----G~~PF~~~~~--------------------~eii~~i~~~-~----------------------------~r~~lP 883 (931)
|.++|.+... ...+..+... + ......
T Consensus 287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (458)
T 3rp9_A 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF 366 (458)
T ss_dssp SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence 6777765431 0111111000 0 000112
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 884 QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 884 ~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
...++++.+||.+||.+||.+|||+.|+++|
T Consensus 367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 367 PASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 4568999999999999999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=364.54 Aligned_cols=259 Identities=29% Similarity=0.454 Sum_probs=203.0
Q ss_pred ccccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHH--HHhcCCCCeeeEEeeee-----e
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAI--MKRVRHPNVVLFMGAVT-----K 727 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkI--Lk~L~HpNIV~Lid~f~-----~ 727 (931)
.+..++|+++++||+|+||+||+|+++++.||||++..... ..+..|..+ +..++||||+++++.+. .
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR-----QNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred CcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccch-----hhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 45668999999999999999999999999999999975431 233334444 45589999999997553 3
Q ss_pred CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhC---------CCCEEEeccCCCCeEECCCC
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL---------NPPILHWDLKSPNLLVDKNW 798 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~---------G~~IIHrDLKPeNILLd~dg 798 (931)
...+++||||+++++|.+++... ..++..++.++.||+.||+|||+. | |+||||||+|||++.++
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTTS
T ss_pred CceEEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCCC
Confidence 34689999999999999999752 358889999999999999999998 8 99999999999999999
Q ss_pred cEEEEecCcccccccc--------ccccCCCCCCCcccCcccccC-------CCCCchhHHHHHHHHHHHHHhCCCCCCC
Q 002355 799 TVKVCDFGLSRFKANT--------FISSKSVAGTPEWMAPEFLRG-------EPSNEKSDVYSFGVILWELVTMQQPWNG 863 (931)
Q Consensus 799 ~IKL~DFGlAr~~~~~--------~~~~~~~~GT~~Y~APEvL~~-------~~~t~ksDIWSLG~ILyELLTG~~PF~~ 863 (931)
.+||+|||+++..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||..
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 9999999999764322 112234579999999999987 3456789999999999999999766533
Q ss_pred CCh------------------HHHHHHHHhcccccCCCCC------ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHh
Q 002355 864 LGP------------------AQVVGAVAFQNRRLAIPQN------TSPVLASLMESCWADDPAQRPSFANIVESLKKLL 919 (931)
Q Consensus 864 ~~~------------------~eii~~i~~~~~r~~lP~~------~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Ll 919 (931)
... ......+.....+..++.. .++.+.+||.+||..||.+|||+.|+++.|+.++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 211 1111222222333344433 4558999999999999999999999999999999
Q ss_pred hCchh
Q 002355 920 KSPAQ 924 (931)
Q Consensus 920 ks~~~ 924 (931)
.....
T Consensus 318 ~~~~~ 322 (336)
T 3g2f_A 318 MIWER 322 (336)
T ss_dssp HCCCC
T ss_pred HHHHh
Confidence 76543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=387.45 Aligned_cols=252 Identities=27% Similarity=0.481 Sum_probs=220.8
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
..++|++++.||+|+||+||+|++ +++.||||++....... .....+.+|+.+++.++||||+++++++...+.+|+
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 458999999999999999999987 58889999997654322 234578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
||||++|++|.+++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 94 v~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 94 VMEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EEECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999999975 346999999999999999999999999 99999999999999999999999999986544
Q ss_pred cccccCCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPS-NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~-t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
.. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+.. .....|..+++++.+
T Consensus 169 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~ 245 (476)
T 2y94_A 169 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD--GIFYTPQYLNPSVIS 245 (476)
T ss_dssp TC-CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHT--TCCCCCTTCCHHHHH
T ss_pred cc-cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc--CCcCCCccCCHHHHH
Confidence 32 2345689999999999998765 6899999999999999999999998877777666543 344567788999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHH
Q 002355 893 LMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
||.+||..||.+|||+.++++|-+
T Consensus 246 Li~~~L~~dP~~Rpt~~eil~hp~ 269 (476)
T 2y94_A 246 LLKHMLQVDPMKRATIKDIREHEW 269 (476)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred HHHHHcCCCchhCcCHHHHHhCHH
Confidence 999999999999999999998743
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=360.43 Aligned_cols=257 Identities=28% Similarity=0.463 Sum_probs=216.1
Q ss_pred CceEEEEEecccCceEEEEEEE------cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee--CCe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--RPH 730 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~------~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~--~~~ 730 (931)
..|+++++||+|+||+||++.+ +++.||||++.... .......+.+|+++++.++||||+++++++.. ...
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 4459999999999999999865 56779999997653 33445778999999999999999999999987 468
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
+++||||+++++|.+++.+. .+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||++..
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCcccccc
Confidence 99999999999999999752 3899999999999999999999999 99999999999999999999999999986
Q ss_pred ccccc---cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--------------HHHHH
Q 002355 811 KANTF---ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQ--------------VVGAV 873 (931)
Q Consensus 811 ~~~~~---~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~e--------------ii~~i 873 (931)
..... .......+|..|+|||++.+..++.++|||||||++|+|++|..||....... .....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 54332 12234567889999999999889999999999999999999999997532210 11222
Q ss_pred HhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 874 AFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 874 ~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
.........+..+++.+.+||.+||..||.+|||+.++++.|+.+....
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 2334456677889999999999999999999999999999999987654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=350.89 Aligned_cols=252 Identities=26% Similarity=0.473 Sum_probs=210.4
Q ss_pred cccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
+..++|+++++||+|+||.||+|++ +++.||||++....... .....+.+|+.+++.++||||+++++++...+..+
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF 87 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence 3558999999999999999999987 47889999997653221 22457889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+.+++|.+++... ..+++..++.++.||+.||.|||++| |+|+||||+||+++.++.+||+|||++....
T Consensus 88 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999999753 35899999999999999999999999 9999999999999999999999999998654
Q ss_pred ccccccCCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHH
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPS-NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~-t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~ 891 (931)
... ......|++.|+|||++.+..+ +.++|||||||++|+|++|..||...........+. ......+..++..+.
T Consensus 163 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~ 239 (276)
T 2h6d_A 163 DGE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR--GGVFYIPEYLNRSVA 239 (276)
T ss_dssp C--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HCCCCCCTTSCHHHH
T ss_pred CCc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh--cCcccCchhcCHHHH
Confidence 432 2234578999999999988765 689999999999999999999998887766665554 233456778899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHH
Q 002355 892 SLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 892 dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
+||.+||..||.+|||+.+++++-
T Consensus 240 ~li~~~l~~~p~~Rps~~~~l~h~ 263 (276)
T 2h6d_A 240 TLLMHMLQVDPLKRATIKDIREHE 263 (276)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHccCChhhCCCHHHHHhCh
Confidence 999999999999999999999973
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=356.57 Aligned_cols=250 Identities=23% Similarity=0.368 Sum_probs=214.9
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|++++.||+|+||+||+|++ +++.||||++...... ....+.+|+.+++.++||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 37899999999999999999987 4788999999865322 2356789999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEE---CCCCcEEEEecCcccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILL---d~dg~IKL~DFGlAr~~~ 812 (931)
||+.+++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||++ +.++.+||+|||++....
T Consensus 86 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 86 QLVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EcCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999998652 35899999999999999999999999 9999999999999 788999999999997654
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc--cCCCCCChHHH
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR--LAIPQNTSPVL 890 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r--~~lP~~~s~eL 890 (931)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...... ...+..+++.+
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (304)
T 2jam_A 161 NG--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA 238 (304)
T ss_dssp CB--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred CC--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHH
Confidence 33 123346899999999999999999999999999999999999999988877776666543332 23446789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
.+||.+||..||.+|||+.+++++-.
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 239 KDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp HHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 99999999999999999999998743
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=348.21 Aligned_cols=250 Identities=25% Similarity=0.398 Sum_probs=211.1
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|++++.||+|+||.||+|++ +++.||||++...... .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 6899999999999999999987 4788999999765433 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc-
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF- 815 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~- 815 (931)
|+.+++|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 9999999999865 345899999999999999999999999 9999999999999999999999999997543221
Q ss_pred -cccCCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcccccCCCCCChHHHHH
Q 002355 816 -ISSKSVAGTPEWMAPEFLRGEPS-NEKSDVYSFGVILWELVTMQQPWNGLGPA-QVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 816 -~~~~~~~GT~~Y~APEvL~~~~~-t~ksDIWSLG~ILyELLTG~~PF~~~~~~-eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ..................+++.+.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHH
Confidence 12345678999999999988765 67899999999999999999999876543 2222322222222333568899999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 002355 893 LMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~ 914 (931)
||.+||..||.+|||+.+++++
T Consensus 241 li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 241 LLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHCCCCchhCCCHHHHhcC
Confidence 9999999999999999999876
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=350.94 Aligned_cols=250 Identities=25% Similarity=0.475 Sum_probs=212.7
Q ss_pred CceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchH----HHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDD----QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~----~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
++|+++++||+|+||+||+|++. ++.||+|++........ ....+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 68999999999999999999884 78899999987643321 2467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC----cEEEEecCcc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW----TVKVCDFGLS 808 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg----~IKL~DFGlA 808 (931)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+||+++.++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 99999999999999975 235899999999999999999999999 99999999999998877 8999999999
Q ss_pred ccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc--CCCCCC
Q 002355 809 RFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL--AIPQNT 886 (931)
Q Consensus 809 r~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~--~lP~~~ 886 (931)
....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+....... ..+...
T Consensus 160 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T 3bhy_A 160 HKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 238 (283)
T ss_dssp EECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred eeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccC
Confidence 8654332 2234568999999999999889999999999999999999999999888776666554322211 123567
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 887 SPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
++.+.+||.+||..||.+|||+.+++++
T Consensus 239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 239 SELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 8999999999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=354.76 Aligned_cols=251 Identities=25% Similarity=0.441 Sum_probs=208.1
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|++.++||+|+||+||+|++ .+..||+|++...... .....+.+|+++++.++||||+++++++......++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 7899999999999999999987 4778999999876432 224678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcC-CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEE---CCCCcEEEEecCcccccc
Q 002355 737 YLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 737 y~~GgSL~d~L~r~-~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILL---d~dg~IKL~DFGlAr~~~ 812 (931)
|+.+++|.+++... ..+..+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||++....
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999999988542 12356899999999999999999999999 9999999999999 456789999999997654
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccC-CCCCChHHHH
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLA-IPQNTSPVLA 891 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~-lP~~~s~eL~ 891 (931)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+............. ....+++.+.
T Consensus 179 ~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (285)
T 3is5_A 179 SDE-HSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAV 256 (285)
T ss_dssp ---------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHH
T ss_pred Ccc-cCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHH
Confidence 432 2345678999999998864 578999999999999999999999999887766655543333222 2245789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 002355 892 SLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 892 dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+||.+||..||.+|||+.|++++
T Consensus 257 ~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 257 DLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=385.05 Aligned_cols=248 Identities=26% Similarity=0.362 Sum_probs=203.4
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC------C
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------P 729 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~------~ 729 (931)
.++|+++++||+|+||+||+|++ +++.||||++............+.+|+.+|+.++||||++++++|... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47999999999999999999987 577899999987655556677889999999999999999999999644 4
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
++||||||+.+ +|.+.+.. .+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 68999999955 57777643 3889999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc---------
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL--------- 880 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~--------- 880 (931)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+.......
T Consensus 213 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 213 TAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CC-CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred ecCCCc-ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 765432 2345689999999999999999999999999999999999999999887655554443211100
Q ss_pred -----------C---------CCCC-----------ChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 -----------A---------IPQN-----------TSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 -----------~---------lP~~-----------~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
. ++.. .++++.+||.+||.+||.+|||+.|+++|
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000 15679999999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=359.87 Aligned_cols=257 Identities=28% Similarity=0.472 Sum_probs=211.5
Q ss_pred eEEEEEecccCceEEEEEEEcCCceEEEEEeeccc--chHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeec
Q 002355 661 LHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDF--LDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYL 738 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~--~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~ 738 (931)
|...++||+|+||+||+|+++++.||||++..... .......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 33457899999999999999999999999976432 2234567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc--c
Q 002355 739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF--I 816 (931)
Q Consensus 739 ~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~--~ 816 (931)
++++|.+++........+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++....... .
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 99999999976444556999999999999999999999999 9999999999999999999999999997654321 1
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHhc---------ccccCCC
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQV----VGAVAFQ---------NRRLAIP 883 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~ei----i~~i~~~---------~~r~~lP 883 (931)
......||+.|+|||++.+. ++.++|||||||++|+|++|..||......+. ...+... ......+
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD 269 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCC
T ss_pred cccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccc
Confidence 22345789999999988764 78899999999999999999999987543221 1111110 0111223
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 002355 884 QNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920 (931)
Q Consensus 884 ~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llk 920 (931)
...+..+.+||.+||..+|.+|||+.+++++|+++..
T Consensus 270 ~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 270 STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 3456789999999999999999999999999998764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=370.89 Aligned_cols=247 Identities=26% Similarity=0.365 Sum_probs=205.8
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC------C
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------P 729 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~------~ 729 (931)
.++|++++.||+|+||+||+|++ +++.||||++............+.+|+++|+.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 37899999999999999999987 578899999876555555567889999999999999999999999765 3
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 569999999 8999999875 25899999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc----------
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR---------- 878 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~---------- 878 (931)
..... ....++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 177 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 177 QADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp ECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred ccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 75443 245678999999999887 6789999999999999999999999998776555444321110
Q ss_pred -------------------ccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 -------------------RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 -------------------r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
...+....++.+.+||.+||..||.+|||+.++++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 011235678999999999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=350.18 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=211.9
Q ss_pred cCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee--------
Q 002355 658 WDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK-------- 727 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~-------- 727 (931)
.++|++++.||+|+||.||+|++. ++.||+|++.... ..+.+|+++++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 368999999999999999999884 8889999997654 245689999999999999999998854
Q ss_pred --------CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc
Q 002355 728 --------RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT 799 (931)
Q Consensus 728 --------~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~ 799 (931)
...+++||||+++++|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCCCC
Confidence 456899999999999999997532 346899999999999999999999999 999999999999999999
Q ss_pred EEEEecCccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc
Q 002355 800 VKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR 879 (931)
Q Consensus 800 IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r 879 (931)
+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||... ......+ ..
T Consensus 161 ~kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~----~~ 233 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDL----RD 233 (284)
T ss_dssp EEECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHH----HT
T ss_pred EEECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHh----hc
Confidence 9999999998655432 234457899999999999998999999999999999999999887431 1222222 22
Q ss_pred cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhhh
Q 002355 880 LAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLI 926 (931)
Q Consensus 880 ~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l~ 926 (931)
..++..++..+.+||.+||..||.+|||+.+++++|+.+.+++....
T Consensus 234 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~ 280 (284)
T 2a19_B 234 GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE 280 (284)
T ss_dssp TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC------
T ss_pred ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCccc
Confidence 34567789999999999999999999999999999999988876543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=402.83 Aligned_cols=252 Identities=24% Similarity=0.415 Sum_probs=221.6
Q ss_pred cccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l 731 (931)
+..++|+++++||+|+||+||+|++ +++.||||+++..... ......+..|..+|..+ +||||++++++|...+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 4568999999999999999999987 4667999999865322 22345678899999988 699999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
||||||++|++|..++.+. ..+++..++.++.||+.||+|||++| ||||||||+||||+.+|++||+|||+++..
T Consensus 418 ~lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999999763 35999999999999999999999999 999999999999999999999999999864
Q ss_pred cccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHH
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~ 891 (931)
..........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+++..+.. ....+|..+++++.
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~ 570 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEAV 570 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS--SCCCCCTTSCHHHH
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHH
Confidence 4433445677899999999999999999999999999999999999999999888888877753 44567889999999
Q ss_pred HHHHHhcccCCCCCCCH-----HHHHHH
Q 002355 892 SLMESCWADDPAQRPSF-----ANIVES 914 (931)
Q Consensus 892 dLI~rcL~~DPeeRPSa-----~ELLq~ 914 (931)
+||.+||+.||.+||++ .+|++|
T Consensus 571 ~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 571 AICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 99999999999999997 777765
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=363.60 Aligned_cols=256 Identities=25% Similarity=0.428 Sum_probs=215.8
Q ss_pred ccccCceEEE-EEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCe
Q 002355 655 EISWDELHVK-ERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPH 730 (931)
Q Consensus 655 ei~~drY~Ii-~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~ 730 (931)
+...++|.+. ++||+|+||+||+|++. ++.||||++............+.+|+.+++.+. ||||++++++|.....
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3345788888 89999999999999874 788999999876544434467889999999995 6999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC---CCcEEEEecCc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---NWTVKVCDFGL 807 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~---dg~IKL~DFGl 807 (931)
.++||||+.+++|.+++... ....+++..++.++.||+.||+|||++| |+||||||+|||++. ++.+||+|||+
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred EEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 99999999999999998652 2456899999999999999999999999 999999999999988 78999999999
Q ss_pred cccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc--ccCCCCC
Q 002355 808 SRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR--RLAIPQN 885 (931)
Q Consensus 808 Ar~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~--r~~lP~~ 885 (931)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+..... .......
T Consensus 181 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 259 (327)
T 3lm5_A 181 SRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSS 259 (327)
T ss_dssp CEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred ccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcc
Confidence 98665432 22446799999999999999999999999999999999999999999887776665543332 2234467
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 886 TSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+++.+.+||.+||..||.+|||+.+++++
T Consensus 260 ~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 260 VSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 89999999999999999999999999876
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=386.07 Aligned_cols=253 Identities=29% Similarity=0.442 Sum_probs=219.5
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
..++|++.++||+|+||+||+|++ +++.||||++...... ......+.+|+.++++++||||++++++|...+.+|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 347999999999999999999987 5788999999765433 2234678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEE---CCCCcEEEEecCcccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRF 810 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILL---d~dg~IKL~DFGlAr~ 810 (931)
||||+.|++|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||++..
T Consensus 104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 9999999999999875 346999999999999999999999999 9999999999999 5678999999999976
Q ss_pred ccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC--CCChH
Q 002355 811 KANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP--QNTSP 888 (931)
Q Consensus 811 ~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP--~~~s~ 888 (931)
..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+.........+ ..+++
T Consensus 179 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 256 (484)
T 3nyv_A 179 FEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256 (484)
T ss_dssp BCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred ccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCH
Confidence 54432 2234579999999999987 58999999999999999999999999998888877776544443333 56889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 889 VLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
.+++||.+||+.+|.+|||+.++++|-+
T Consensus 257 ~~~~li~~~L~~dp~~R~s~~e~l~h~~ 284 (484)
T 3nyv_A 257 SAKDLIRKMLTYVPSMRISARDALDHEW 284 (484)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence 9999999999999999999999998744
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=383.79 Aligned_cols=252 Identities=26% Similarity=0.434 Sum_probs=213.6
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-----------HHHHHHHHHHHHHHhcCCCCeeeEEee
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-----------DQLKEFLREVAIMKRVRHPNVVLFMGA 724 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-----------~~~~~~l~EIkILk~L~HpNIV~Lid~ 724 (931)
.++|+++++||+|+||+||+|++ +++.||||++....... .....+.+|+.+|+.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 47899999999999999999987 46789999998754332 123578899999999999999999999
Q ss_pred eeeCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC---cEE
Q 002355 725 VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW---TVK 801 (931)
Q Consensus 725 f~~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg---~IK 801 (931)
|..+..+|+||||+.|++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEE
Confidence 99999999999999999999998652 35899999999999999999999999 99999999999998776 699
Q ss_pred EEecCccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccC
Q 002355 802 VCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLA 881 (931)
Q Consensus 802 L~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~ 881 (931)
|+|||++....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+++..+........
T Consensus 190 l~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 267 (504)
T 3q5i_A 190 IVDFGLSSFFSKDY-KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267 (504)
T ss_dssp ECCCTTCEECCTTS-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred EEECCCCEEcCCCC-ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99999998655432 2345679999999999875 589999999999999999999999999888888777654433222
Q ss_pred C--CCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 882 I--PQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 882 l--P~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
. ...+++++.+||.+||..||.+|||+.|+++|-+
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 304 (504)
T 3q5i_A 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW 304 (504)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence 1 2578999999999999999999999999998743
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=367.11 Aligned_cols=244 Identities=23% Similarity=0.401 Sum_probs=187.1
Q ss_pred CceEEE---EEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCeEE
Q 002355 659 DELHVK---ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 659 drY~Ii---~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~l~ 732 (931)
++|++. ++||+|+||+||+|++ +++.||||++.... ...+.+|+.+++.+. ||||+++++++.++.+.|
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-----EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh-----hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 567765 7899999999999988 47889999997542 245678999999997 999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC---cEEEEecCccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW---TVKVCDFGLSR 809 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg---~IKL~DFGlAr 809 (931)
+||||+.|++|.+++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+++
T Consensus 83 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 83 LVMELLNGGELFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp EEECCCCSCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred EEEEccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 99999999999999976 346999999999999999999999999 99999999999997765 89999999998
Q ss_pred cccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcccccCC
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGP-------AQVVGAVAFQNRRLAI 882 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~-------~eii~~i~~~~~r~~l 882 (931)
............+||+.|+|||++.+..++.++|||||||++|+|++|..||..... .+....+... ....
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~--~~~~ 235 (325)
T 3kn6_A 158 LKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG--DFSF 235 (325)
T ss_dssp ECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT--CCCC
T ss_pred ecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC--CCCC
Confidence 655444344566789999999999999999999999999999999999999976543 2333333222 1222
Q ss_pred C----CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 883 P----QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 883 P----~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+ ..+++++.+||.+||..||.+|||+.++++|
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 2 3578999999999999999999999999876
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=377.46 Aligned_cols=263 Identities=22% Similarity=0.360 Sum_probs=216.0
Q ss_pred cccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC--eE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP--HL 731 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~--~l 731 (931)
...++|++.++||+|+||+||+|++. ++.||||++....... ....+.+|+++++.++||||+++++++.... +.
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 34589999999999999999999884 7889999997654322 2456789999999999999999999997654 78
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEE----CCCCcEEEEecCc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV----DKNWTVKVCDFGL 807 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILL----d~dg~IKL~DFGl 807 (931)
++||||+.+++|.+++.+......+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 999999999999999987544445999999999999999999999999 9999999999999 7788899999999
Q ss_pred cccccccccccCCCCCCCcccCcccccC--------CCCCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHh
Q 002355 808 SRFKANTFISSKSVAGTPEWMAPEFLRG--------EPSNEKSDVYSFGVILWELVTMQQPWNGLG----PAQVVGAVAF 875 (931)
Q Consensus 808 Ar~~~~~~~~~~~~~GT~~Y~APEvL~~--------~~~t~ksDIWSLG~ILyELLTG~~PF~~~~----~~eii~~i~~ 875 (931)
++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.... ..+....+..
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp CEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred ceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 98654432 2345679999999999865 456789999999999999999999996532 2333333332
Q ss_pred cccc-----------------------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 876 QNRR-----------------------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 876 ~~~r-----------------------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
.... ..++..++..+.+||.+||..||++||++.++++.+.+++...
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 2110 0112345678999999999999999999999999999998763
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=363.30 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=207.3
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee--------
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK-------- 727 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~-------- 727 (931)
.++|+++++||+|+||+||+|++ +++.||||++............+.+|+++++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 47999999999999999999987 57889999987665444334567899999999999999999999876
Q ss_pred CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCc
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGl 807 (931)
++.+|+||||+. ++|.+.+... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccC-CCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 457999999996 4777777642 345899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccc----ccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccC-
Q 002355 808 SRFKANT----FISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLA- 881 (931)
Q Consensus 808 Ar~~~~~----~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~- 881 (931)
++..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+........
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 9764321 122245578999999999876 4579999999999999999999999999877666555432211111
Q ss_pred -CCCC----------------------------ChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 882 -IPQN----------------------------TSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 882 -lP~~----------------------------~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.... .++.+.+||.+||+.||.+|||+.|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1011 26779999999999999999999999987
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=370.24 Aligned_cols=247 Identities=25% Similarity=0.405 Sum_probs=207.7
Q ss_pred eEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEeec
Q 002355 661 LHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYL 738 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy~ 738 (931)
|...+.||+|+||.||+|++ +++.||+|++..... .....+.+|+++|++++||||+++++++...+.++|||||+
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 34477899999999999987 578899999987543 33467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEE--CCCCcEEEEecCcccccccccc
Q 002355 739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV--DKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 739 ~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILL--d~dg~IKL~DFGlAr~~~~~~~ 816 (931)
++++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||+++......
T Consensus 169 ~~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~- 243 (373)
T 2x4f_A 169 DGGELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE- 243 (373)
T ss_dssp TTCEEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence 999999988652 235899999999999999999999999 9999999999999 667899999999998654432
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc--CCCCCChHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL--AIPQNTSPVLASLM 894 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~--~lP~~~s~eL~dLI 894 (931)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+....... .....+++++.+||
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 323 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI 323 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence 2344579999999999999889999999999999999999999999988777766665433222 12356899999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 002355 895 ESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 895 ~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+||..||.+|||+.|+++|
T Consensus 324 ~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 324 SKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp HTTSCSSGGGSCCHHHHHHS
T ss_pred HHHcCCChhhCCCHHHHhcC
Confidence 99999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=374.28 Aligned_cols=251 Identities=25% Similarity=0.319 Sum_probs=200.5
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC-----Ce
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR-----PH 730 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~-----~~ 730 (931)
.++|+++++||+|+||+||+|++ +++.||||++..........+++.+|+++|+.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 37999999999999999999987 467799999987655555667899999999999999999999999765 67
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
+|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIA-DSDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecC-CcCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 99999999 5699999975 345999999999999999999999999 99999999999999999999999999986
Q ss_pred cccccc----------------------ccCCCCCCCcccCcccc-cCCCCCchhHHHHHHHHHHHHHhC----------
Q 002355 811 KANTFI----------------------SSKSVAGTPEWMAPEFL-RGEPSNEKSDVYSFGVILWELVTM---------- 857 (931)
Q Consensus 811 ~~~~~~----------------------~~~~~~GT~~Y~APEvL-~~~~~t~ksDIWSLG~ILyELLTG---------- 857 (931)
...... .....+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 543211 12556899999999986 556689999999999999999984
Q ss_pred -CCCCCCCCh-----------------HHHHHHH------------------------HhcccccC-----CCCCChHHH
Q 002355 858 -QQPWNGLGP-----------------AQVVGAV------------------------AFQNRRLA-----IPQNTSPVL 890 (931)
Q Consensus 858 -~~PF~~~~~-----------------~eii~~i------------------------~~~~~r~~-----lP~~~s~eL 890 (931)
.++|.+.+. ...+..+ ........ ....+++++
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 338 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG 338 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence 444433220 0001000 00000000 114578999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+||.+||..||.+|||+.|+++|
T Consensus 339 ~dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 339 INLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHHHHhcCCcccCCCHHHHhcC
Confidence 999999999999999999999987
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=359.07 Aligned_cols=262 Identities=19% Similarity=0.270 Sum_probs=210.6
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
..++|++.++||+|+||+||+|++ +++.||||++....... .....+.+|+.+++.++||||+++++++..++..|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 347999999999999999999987 47789999987654433 334778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
||||+.+++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.....
T Consensus 112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999999763 35899999999999999999999999 99999999999999999999999999876543
Q ss_pred cc-cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-cccCCCCCChHHHH
Q 002355 814 TF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN-RRLAIPQNTSPVLA 891 (931)
Q Consensus 814 ~~-~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~-~r~~lP~~~s~eL~ 891 (931)
.. .......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+.... .....+..+++.+.
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 266 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFD 266 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHH
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHH
Confidence 22 12234578999999999999889999999999999999999999998866553333332211 12345678899999
Q ss_pred HHHHHhcccCCCCCC-CHHHHHHHHHHHhhCch
Q 002355 892 SLMESCWADDPAQRP-SFANIVESLKKLLKSPA 923 (931)
Q Consensus 892 dLI~rcL~~DPeeRP-Sa~ELLq~L~~Llks~~ 923 (931)
+||.+||..||++|| +++++++.|+.++....
T Consensus 267 ~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 267 AVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred HHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 999999999999999 99999999998877654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=353.41 Aligned_cols=251 Identities=27% Similarity=0.486 Sum_probs=211.5
Q ss_pred ccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
..++|+++++||+|+||+||+|++. ++.||||++..... ...+.+|+.+++.++||||+++++++...+.+++|
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 4478999999999999999999884 78899999976532 24678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||+.+++|.+++.. ....+++..++.++.||+.||.|||++| |+|+||||+||+++.++.+||+|||++......
T Consensus 103 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 103 MEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp EECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred eecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 999999999999863 2346899999999999999999999999 999999999999999999999999999866554
Q ss_pred ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-cccCCCCCChHHHHHH
Q 002355 815 FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN-RRLAIPQNTSPVLASL 893 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~-~r~~lP~~~s~eL~dL 893 (931)
........||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.... .....+..++..+.+|
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 258 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDF 258 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHH
Confidence 434455678999999999999889999999999999999999999999877665544433222 1223455678999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHH
Q 002355 894 MESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 894 I~rcL~~DPeeRPSa~ELLq~L 915 (931)
|.+||..||.+|||+.+++++-
T Consensus 259 i~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 259 VKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp HHHHTCSCTTTSCCHHHHTTSH
T ss_pred HHHHccCChhhCcCHHHHHhCH
Confidence 9999999999999999999863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=372.26 Aligned_cols=249 Identities=25% Similarity=0.353 Sum_probs=199.2
Q ss_pred cCceEEE-EEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHh-cCCCCeeeEEeeeee----CC
Q 002355 658 WDELHVK-ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR-VRHPNVVLFMGAVTK----RP 729 (931)
Q Consensus 658 ~drY~Ii-~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~-L~HpNIV~Lid~f~~----~~ 729 (931)
.++|.+. ++||+|+||+||+|++ +++.||||++... ..+.+|+.++.+ ++||||++++++|.. ..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 3678877 7899999999999987 4778999999643 345678888744 589999999999875 66
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC---CCcEEEEecC
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---NWTVKVCDFG 806 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~---dg~IKL~DFG 806 (931)
++||||||+.|++|.+++.... ...+++..++.++.||+.||+|||++| |+||||||+|||++. ++.+||+|||
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecc
Confidence 8999999999999999997632 346999999999999999999999999 999999999999997 7899999999
Q ss_pred ccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHhcccccC-
Q 002355 807 LSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQ----VVGAVAFQNRRLA- 881 (931)
Q Consensus 807 lAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~e----ii~~i~~~~~r~~- 881 (931)
+++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... ....+........
T Consensus 210 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 210 FAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp TCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred cccccCCCC-ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 998654332 2345678999999999999999999999999999999999999997654321 2233322222222
Q ss_pred -CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002355 882 -IPQNTSPVLASLMESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 882 -lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
....+++++.+||++||..||.+|||+.++++|-+-
T Consensus 289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 225689999999999999999999999999998553
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=366.82 Aligned_cols=267 Identities=31% Similarity=0.551 Sum_probs=220.0
Q ss_pred ccccccccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe
Q 002355 651 MDWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH 730 (931)
Q Consensus 651 ~~~lei~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~ 730 (931)
...+++..++|++.+.||+|+||+||+|++.+ .||+|++............+.+|+.+++.++||||+++++++...+.
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 34567888999999999999999999998866 59999987654433334557789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
.++||||+.|++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++ ++.+||+|||++..
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred eEEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 99999999999999999752 346889999999999999999999999 99999999999998 67999999999875
Q ss_pred cccc-----ccccCCCCCCCcccCcccccC---------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 002355 811 KANT-----FISSKSVAGTPEWMAPEFLRG---------EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ 876 (931)
Q Consensus 811 ~~~~-----~~~~~~~~GT~~Y~APEvL~~---------~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~ 876 (931)
.... ........|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 258 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence 4211 112234468899999999874 34688999999999999999999999998877777666544
Q ss_pred ccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCch
Q 002355 877 NRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPA 923 (931)
Q Consensus 877 ~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~ 923 (931)
......+..++.++.+||.+||..||.+|||+.++++.|+.+.+...
T Consensus 259 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 259 MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp CCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred CCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 44444445788899999999999999999999999999998877643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=348.97 Aligned_cols=256 Identities=21% Similarity=0.303 Sum_probs=207.4
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEe-eeeeCCeEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMG-AVTKRPHLSIV 734 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid-~f~~~~~l~LV 734 (931)
.++|++++.||+|+||+||+|++ +++.||||++...... ..+.+|+.+++.++|++++..+. ++..+...++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 37899999999999999999986 5778999987654322 34678999999998877665554 45788899999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEE---CCCCcEEEEecCccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILL---d~dg~IKL~DFGlAr~~ 811 (931)
|||+ +++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||+++..
T Consensus 84 ~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 9999 99999999752 345899999999999999999999999 9999999999999 78899999999999865
Q ss_pred ccccc-------ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhccc---
Q 002355 812 ANTFI-------SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPA---QVVGAVAFQNR--- 878 (931)
Q Consensus 812 ~~~~~-------~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~---eii~~i~~~~~--- 878 (931)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.... +....+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 43321 223567899999999999999999999999999999999999999875432 22222211111
Q ss_pred ccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 879 RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 879 r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
.......+++.+.+||.+||+.+|++|||+.++++.|+++++..
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 11233678999999999999999999999999999999998753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=371.62 Aligned_cols=265 Identities=28% Similarity=0.436 Sum_probs=212.7
Q ss_pred cccccccccCceEEEEEecccCceEEEEEEE-cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC
Q 002355 650 AMDWLEISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728 (931)
Q Consensus 650 ~~~~lei~~drY~Ii~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~ 728 (931)
....+.+..++|++.++||+|+||+||+|++ +++.||||++....... ....+.+|+++++.++||||+++++++...
T Consensus 21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp CTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred cHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 3445667779999999999999999999986 57889999987653221 123578999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhhcCC-CCCCCcHHHHHHHHHHHHHHHHHHHhC---CCCEEEeccCCCCeEECCCCcEEEEe
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNL---NPPILHWDLKSPNLLVDKNWTVKVCD 804 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~-~~~~L~e~~~~~Ia~QIa~AL~yLHs~---G~~IIHrDLKPeNILLd~dg~IKL~D 804 (931)
+..++||||+.+++|.+++.... ....+++..++.++.||+.||+|||++ | |+||||||+|||++.++.+||+|
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTTCCEEECC
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCCCCEEecc
Confidence 99999999999999999997643 234589999999999999999999998 8 99999999999999999999999
Q ss_pred cCccccccccc-cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHh---
Q 002355 805 FGLSRFKANTF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGL-----GPAQVVGAVAF--- 875 (931)
Q Consensus 805 FGlAr~~~~~~-~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~-----~~~eii~~i~~--- 875 (931)
||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||... ........+..
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 99998654322 2234456999999999998888999999999999999999999999521 11111111100
Q ss_pred cc---------cccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002355 876 QN---------RRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 876 ~~---------~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
.. .....+...+..+.+||.+||+.||.+|||+.+++++|+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 00 0111223345789999999999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=347.83 Aligned_cols=256 Identities=21% Similarity=0.300 Sum_probs=211.3
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEe-eeeeCCeEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMG-AVTKRPHLSIV 734 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid-~f~~~~~l~LV 734 (931)
.++|++++.||+|+||+||+|++ +++.||||++...... ..+.+|+.+++.++|++++..+. ++..+...++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 37999999999999999999986 6788999998765432 34778999999999877655444 44678889999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEE---CCCCcEEEEecCccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILL---d~dg~IKL~DFGlAr~~ 811 (931)
|||+ +++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||++...
T Consensus 84 ~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 9999 99999999742 346999999999999999999999999 9999999999999 47889999999999865
Q ss_pred ccccc-------ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcc---c
Q 002355 812 ANTFI-------SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGP---AQVVGAVAFQN---R 878 (931)
Q Consensus 812 ~~~~~-------~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~---~eii~~i~~~~---~ 878 (931)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... .+.+..+.... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 44321 12456799999999999999999999999999999999999999987432 22222222111 1
Q ss_pred ccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 879 RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 879 r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
....+..+++.+.+||.+||+.||.+|||+.++++.|++++...
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 11234678999999999999999999999999999999987653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=364.94 Aligned_cols=254 Identities=23% Similarity=0.304 Sum_probs=206.0
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch---HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD---DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~---~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
..++|++++.||+|+||+||+|++ +++.||||++....... .....+.+|+++++.++||||++++++|...+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 347999999999999999999987 47889999987643222 1124678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
++||||+.+ +|..++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 999999965 888888652 346888999999999999999999999 999999999999999999999999999876
Q ss_pred cccccccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccC---------
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLA--------- 881 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~--------- 881 (931)
...........||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+....+.+..+........
T Consensus 163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 5444344566889999999999764 478999999999999999999999998887666655432211100
Q ss_pred -----------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002355 882 -----------------IPQNTSPVLASLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 882 -----------------lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
+....++.+.+||.+||..||.+|||+.|++++-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0145678999999999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=355.18 Aligned_cols=248 Identities=23% Similarity=0.305 Sum_probs=207.1
Q ss_pred ccCceEEEEEecccCceEEEEEEE---cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCC------CeeeEEeeeee
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW---HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP------NVVLFMGAVTK 727 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~---~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~Hp------NIV~Lid~f~~ 727 (931)
..++|+++++||+|+||+||+|.+ .++.||||++... ......+.+|+.+++.++|+ +|+++++++..
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 347999999999999999999986 4678999998753 23446778899999998655 59999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC-----------
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK----------- 796 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~----------- 796 (931)
.++.|+||||+ +++|.+++.... ...+++..++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC---
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCcc
Confidence 99999999999 899999997632 345889999999999999999999999 999999999999987
Q ss_pred --------CCcEEEEecCccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH
Q 002355 797 --------NWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQ 868 (931)
Q Consensus 797 --------dg~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~e 868 (931)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 668999999999865433 245678999999999999999999999999999999999999999877655
Q ss_pred HHHHHHhcccc------------------------------------------cCCCCCChHHHHHHHHHhcccCCCCCC
Q 002355 869 VVGAVAFQNRR------------------------------------------LAIPQNTSPVLASLMESCWADDPAQRP 906 (931)
Q Consensus 869 ii~~i~~~~~r------------------------------------------~~lP~~~s~eL~dLI~rcL~~DPeeRP 906 (931)
....+...... ...+...++.+.+||.+||..||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 44333211100 011223467899999999999999999
Q ss_pred CHHHHHHH
Q 002355 907 SFANIVES 914 (931)
Q Consensus 907 Sa~ELLq~ 914 (931)
|+.|+++|
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999876
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=391.63 Aligned_cols=265 Identities=32% Similarity=0.582 Sum_probs=229.4
Q ss_pred ccccccccCceEEEEEecccCceEEEEEEEcC-CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 651 MDWLEISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 651 ~~~lei~~drY~Ii~kLG~G~fGtVylAr~~g-~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
.+.|++..++|++.++||+|+||+||+|++.+ ..||||+++..... .+.+.+|+++|++++|+||+++++++.. +
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 34578889999999999999999999999865 56999999865433 2468899999999999999999999876 6
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
.+||||||+.+++|.+++... .+..+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+++
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~ 411 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLAR 411 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred cceEeeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccce
Confidence 789999999999999999742 1235889999999999999999999999 9999999999999999999999999998
Q ss_pred cccccc-cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCCh
Q 002355 810 FKANTF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTS 887 (931)
Q Consensus 810 ~~~~~~-~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s 887 (931)
...... .......++..|+|||++.+..++.++|||||||+||||++ |..||.+....++...+. ...+...+..++
T Consensus 412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~ 490 (535)
T 2h8h_A 412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECP 490 (535)
T ss_dssp TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCC
T ss_pred ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence 654321 11233456789999999998889999999999999999999 999999988877776664 445566788899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCch
Q 002355 888 PVLASLMESCWADDPAQRPSFANIVESLKKLLKSPA 923 (931)
Q Consensus 888 ~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~ 923 (931)
..+.+||.+||..||++|||+.+|++.|+.++....
T Consensus 491 ~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 491 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 999999999999999999999999999999877543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=366.79 Aligned_cols=258 Identities=19% Similarity=0.227 Sum_probs=203.9
Q ss_pred cccCceEEEEEecccCceEEEEEEE-----cCCceEEEEEeecccchHH---------HHHHHHHHHHHHhcCCCCeeeE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLDDQ---------LKEFLREVAIMKRVRHPNVVLF 721 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~-----~g~~VAVKVlk~~~~~~~~---------~~~~l~EIkILk~L~HpNIV~L 721 (931)
+..++|+++++||+|+||+||+|++ .+..||||++......... ...+.+|+.+++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 4568999999999999999999988 4567999999765422110 1235678899999999999999
Q ss_pred Eeeeee----CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC
Q 002355 722 MGAVTK----RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN 797 (931)
Q Consensus 722 id~f~~----~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d 797 (931)
++++.. ....|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++| |+||||||+|||++.+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESS
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccC
Confidence 999987 78899999999 999999997632 6899999999999999999999999 9999999999999887
Q ss_pred C--cEEEEecCccccccccc-------cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-H
Q 002355 798 W--TVKVCDFGLSRFKANTF-------ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGP-A 867 (931)
Q Consensus 798 g--~IKL~DFGlAr~~~~~~-------~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~-~ 867 (931)
+ .+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 99999999997643221 111445799999999999999999999999999999999999999965322 1
Q ss_pred HHHHHHHhcccccCCC---------CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 002355 868 QVVGAVAFQNRRLAIP---------QNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920 (931)
Q Consensus 868 eii~~i~~~~~r~~lP---------~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llk 920 (931)
...... .......++ ..+++++.+||.+||..||.+|||+.++++.|+++..
T Consensus 268 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 268 VAVQTA-KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHH-HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHH-HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 111111 111111222 2788999999999999999999999999999987543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=351.69 Aligned_cols=254 Identities=25% Similarity=0.443 Sum_probs=210.2
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
..++|.....||+|+||+||+|++ +++.||||++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 20 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 97 (295)
T 2clq_A 20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 97 (295)
T ss_dssp CBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence 345555566899999999999987 56789999987653 23346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC-CCcEEEEecCccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~-dg~IKL~DFGlAr~~~~ 813 (931)
|||+++++|.+++........+++..++.++.||+.||+|||++| |+|+||||+||+++. ++.+||+|||++.....
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 999999999999976443445778999999999999999999999 999999999999987 89999999999986554
Q ss_pred cccccCCCCCCCcccCcccccCCC--CCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcccccCCCCCChHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEP--SNEKSDVYSFGVILWELVTMQQPWNGLGPAQ-VVGAVAFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~--~t~ksDIWSLG~ILyELLTG~~PF~~~~~~e-ii~~i~~~~~r~~lP~~~s~eL 890 (931)
.........||+.|+|||++.+.. ++.++|||||||++|+|++|..||....... .............++..+++++
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (295)
T 2clq_A 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA 255 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHH
T ss_pred CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHH
Confidence 333334567899999999987643 7889999999999999999999997654332 2222223344556778899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+||.+||..||++||++.+++++
T Consensus 256 ~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 256 KAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHccCChhhCCCHHHHhcC
Confidence 999999999999999999999876
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=389.76 Aligned_cols=255 Identities=25% Similarity=0.383 Sum_probs=218.9
Q ss_pred cccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
+..++|++++.||+|+||+||+|++ +++.||||++....... .....+.+|+++|+.++||||++++++|.....+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 4568999999999999999999987 57889999997654322 23467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCC-CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPA-AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~-~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
+||||++|++|..++.... ....+++..++.++.||+.||+|||++| |+||||||+|||++.+|++||+|||+++..
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999999999987532 2346899999999999999999999999 999999999999999999999999999876
Q ss_pred cccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcccccCCCCCCh
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLG----PAQVVGAVAFQNRRLAIPQNTS 887 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~----~~eii~~i~~~~~r~~lP~~~s 887 (931)
..........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..++...+. .....+|..++
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~--~~~~~~p~~~s 417 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL--EQAVTYPDKFS 417 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH--HCCCCCCTTSC
T ss_pred cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh--hcccCCCcccC
Confidence 544333455689999999999999999999999999999999999999998753 334444443 33455778899
Q ss_pred HHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 002355 888 PVLASLMESCWADDPAQRPSF-----ANIVES 914 (931)
Q Consensus 888 ~eL~dLI~rcL~~DPeeRPSa-----~ELLq~ 914 (931)
+.+.+||.+||+.||.+||++ .++++|
T Consensus 418 ~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred HHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 999999999999999999964 777765
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=354.56 Aligned_cols=252 Identities=27% Similarity=0.500 Sum_probs=209.3
Q ss_pred ccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
..++|++++.||+|+||+||+|++. ++.||+|++..... .....+.+|+++++.++||||+++++++..++..++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 3479999999999999999999984 77899999875432 2246788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||+++++|.+++.+. ...+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++......
T Consensus 95 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp EECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999988652 345899999999999999999999999 999999999999999999999999998643332
Q ss_pred ccccCCCCCCCcccCcccc-----cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-ccCCCCCChH
Q 002355 815 FISSKSVAGTPEWMAPEFL-----RGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-RLAIPQNTSP 888 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL-----~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~-r~~lP~~~s~ 888 (931)
........||+.|+|||++ .+..++.++|||||||++|+|++|..||...+.......+..... ....+..++.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV 250 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCH
Confidence 2223456789999999998 466788999999999999999999999998887666555443322 2234567889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 889 VLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+.+||.+||..||.+|||+.++++|
T Consensus 251 ~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 251 EFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcC
Confidence 99999999999999999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=348.55 Aligned_cols=251 Identities=24% Similarity=0.406 Sum_probs=214.6
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeeccc---c----hHHHHHHHHHHHHHHhcC-CCCeeeEEeeeee
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDF---L----DDQLKEFLREVAIMKRVR-HPNVVLFMGAVTK 727 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~---~----~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~ 727 (931)
.++|++.++||+|+||.||+|++ +++.||||++..... . ......+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 48999999999999999999988 467899999976531 1 123456789999999996 9999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCc
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGl 807 (931)
+...++||||+.+++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcEEEecccc
Confidence 99999999999999999999752 35899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccCCCCCCCcccCccccc------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccC
Q 002355 808 SRFKANTFISSKSVAGTPEWMAPEFLR------GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLA 881 (931)
Q Consensus 808 Ar~~~~~~~~~~~~~GT~~Y~APEvL~------~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~ 881 (931)
+....... ......|++.|+|||++. ...++.++|||||||++|+|++|..||...........+........
T Consensus 171 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (298)
T 1phk_A 171 SCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 249 (298)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred hhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccC
Confidence 97654332 234567899999999985 45678899999999999999999999998887776666554433332
Q ss_pred CC--CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 882 IP--QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 882 lP--~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+ ..++..+.+||.+||..||.+|||+.+++++
T Consensus 250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 22 4678999999999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=357.89 Aligned_cols=255 Identities=32% Similarity=0.556 Sum_probs=211.7
Q ss_pred ccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHh--cCCCCeeeEEeeeeeCC----e
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR--VRHPNVVLFMGAVTKRP----H 730 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~--L~HpNIV~Lid~f~~~~----~ 730 (931)
..++|++.+.||+|+||+||+|+++++.||||++.... ...+.+|++++.. ++||||+++++++.... .
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 34789999999999999999999999999999986542 2457789999988 68999999999998765 8
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHH--------hCCCCEEEeccCCCCeEECCCCcEEE
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH--------NLNPPILHWDLKSPNLLVDKNWTVKV 802 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLH--------s~G~~IIHrDLKPeNILLd~dg~IKL 802 (931)
+++||||+.+++|.+++.+. .+++..++.++.||+.||+||| +.| |+||||||+|||++.++.+||
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTTSCEEE
T ss_pred eEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCCCCEEE
Confidence 99999999999999999752 4899999999999999999999 778 999999999999999999999
Q ss_pred EecCcccccccccc----ccCCCCCCCcccCcccccCCC------CCchhHHHHHHHHHHHHHhC----------CCCCC
Q 002355 803 CDFGLSRFKANTFI----SSKSVAGTPEWMAPEFLRGEP------SNEKSDVYSFGVILWELVTM----------QQPWN 862 (931)
Q Consensus 803 ~DFGlAr~~~~~~~----~~~~~~GT~~Y~APEvL~~~~------~t~ksDIWSLG~ILyELLTG----------~~PF~ 862 (931)
+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++| ..||.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 99999976543321 224557999999999998763 23689999999999999999 78987
Q ss_pred CCC-----hHHHHHHHHhcccccCCCC-----CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 863 GLG-----PAQVVGAVAFQNRRLAIPQ-----NTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 863 ~~~-----~~eii~~i~~~~~r~~lP~-----~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
... .......+.....+..++. ..+..+.+||.+||..||.+|||+.+++++|+++.++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 653 2333333333333333442 34568999999999999999999999999999998763
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=356.84 Aligned_cols=263 Identities=22% Similarity=0.344 Sum_probs=212.3
Q ss_pred cccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeee----e
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT----K 727 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~----~ 727 (931)
+.+..++|+++++||+|+||.||+|++ +++.||||++.... ......+.+|+.+++.++||||+++++++. .
T Consensus 24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 445678999999999999999999986 67889999987643 344567889999999999999999999986 3
Q ss_pred CCeEEEEEeecCCCCHHHHhhcC-CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecC
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~-~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFG 806 (931)
....++||||+.+++|.+++.+. .....+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCS
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEecC
Confidence 45789999999999999998652 12456899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccc---------ccCCCCCCCcccCcccccCCC---CCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHH
Q 002355 807 LSRFKANTFI---------SSKSVAGTPEWMAPEFLRGEP---SNEKSDVYSFGVILWELVTMQQPWNGLGP--AQVVGA 872 (931)
Q Consensus 807 lAr~~~~~~~---------~~~~~~GT~~Y~APEvL~~~~---~t~ksDIWSLG~ILyELLTG~~PF~~~~~--~eii~~ 872 (931)
++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ......
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 9875432110 012235799999999998654 58899999999999999999999954211 111111
Q ss_pred HHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 873 VAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 873 i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
.........+..+++.+.+||.+||..||.+|||+.+++++|+.+...
T Consensus 260 -~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 260 -VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp -HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred -hhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 122333444567899999999999999999999999999999987654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=362.66 Aligned_cols=252 Identities=22% Similarity=0.356 Sum_probs=215.0
Q ss_pred cccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchH---------------HHHHHHHHHHHHHhcCCCCeee
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD---------------QLKEFLREVAIMKRVRHPNVVL 720 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~---------------~~~~~l~EIkILk~L~HpNIV~ 720 (931)
+..++|++++.||+|+||.||+|+++++.||||++........ ....+.+|+.+++.++||||++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 3458999999999999999999999999999999976532211 1167889999999999999999
Q ss_pred EEeeeeeCCeEEEEEeecCCCCHHHH------hhcCCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCCEEEeccCCCCeE
Q 002355 721 FMGAVTKRPHLSIVTEYLPRGSLYRL------IHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLL 793 (931)
Q Consensus 721 Lid~f~~~~~l~LVmEy~~GgSL~d~------L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs-~G~~IIHrDLKPeNIL 793 (931)
+++++...+..++||||+++++|.++ +.. .....+++..++.++.||+.||+|||+ +| |+||||||+||+
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil 184 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNIL 184 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEE
Confidence 99999999999999999999999998 543 224579999999999999999999999 99 999999999999
Q ss_pred ECCCCcEEEEecCccccccccccccCCCCCCCcccCcccccCC-CCCc-hhHHHHHHHHHHHHHhCCCCCCCCCh-HHHH
Q 002355 794 VDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGE-PSNE-KSDVYSFGVILWELVTMQQPWNGLGP-AQVV 870 (931)
Q Consensus 794 Ld~dg~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~-~~t~-ksDIWSLG~ILyELLTG~~PF~~~~~-~eii 870 (931)
++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||..... .+..
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 999999999999999865443 23456789999999999887 5555 99999999999999999999988766 5555
Q ss_pred HHHHhcccccCCC-------------------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 871 GAVAFQNRRLAIP-------------------QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 871 ~~i~~~~~r~~lP-------------------~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
..+... ....+ ..+++.+.+||.+||..||.+|||+.++++|
T Consensus 263 ~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 263 NNIRTK--NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHTSC--CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhcc--CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 554322 22233 5688999999999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=367.12 Aligned_cols=243 Identities=26% Similarity=0.438 Sum_probs=209.7
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchH------HHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD------QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH 730 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~------~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~ 730 (931)
++|+++++||+|+||+||+|++ +++.||||++........ ....+.+|+.+++.++||||++++++|...+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 7899999999999999999976 577899999987643221 23456789999999999999999999999999
Q ss_pred EEEEEeecCCC-CHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 731 LSIVTEYLPRG-SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 731 l~LVmEy~~Gg-SL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
+++||||+.++ +|.+++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEEeecccce
Confidence 99999998666 99999976 335999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccCCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChH
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLRGEPS-NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~~~~~-t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~ 888 (931)
...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ........+..+++
T Consensus 179 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~~~ 249 (335)
T 3dls_A 179 YLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------TVEAAIHPPYLVSK 249 (335)
T ss_dssp ECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------GTTTCCCCSSCCCH
T ss_pred ECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------HHhhccCCCcccCH
Confidence 654432 2345679999999999998876 7899999999999999999999976332 12233445677899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002355 889 VLASLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
++.+||.+||..||.+|||+.+++++-
T Consensus 250 ~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 250 ELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 999999999999999999999999873
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=363.33 Aligned_cols=250 Identities=25% Similarity=0.330 Sum_probs=201.2
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC------
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP------ 729 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~------ 729 (931)
.++|++++.||+|+||+||+|++ +++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 47999999999999999999987 4778999999876555566678899999999999999999999997654
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
.+|+||||+. ++|.+++.. .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 7899999995 578888853 4889999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc----------
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR---------- 879 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r---------- 879 (931)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 176 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 176 TAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred cccccc-ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 654432 224467899999999999999999999999999999999999999988766555444321110
Q ss_pred ----------cC--------------CCC------CChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 880 ----------LA--------------IPQ------NTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 880 ----------~~--------------lP~------~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
.. .|. ..++.+.+||.+||..||.+|||+.|+++|-.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 00 011 11578999999999999999999999998743
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=357.98 Aligned_cols=261 Identities=30% Similarity=0.520 Sum_probs=217.2
Q ss_pred ccccCceEEEEEecccCceEEEEEEE------cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEW------HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~------~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~ 728 (931)
.+..++|+++++||+|+||.||+|++ +++.||||++.... ......+.+|+++++.++||||+++++++...
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 45678999999999999999999985 46789999987643 34457789999999999999999999998654
Q ss_pred --CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecC
Q 002355 729 --PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806 (931)
Q Consensus 729 --~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFG 806 (931)
..+++||||+++++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCT
T ss_pred CCCceEEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCc
Confidence 4789999999999999999763 345899999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccc---ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-----------H----
Q 002355 807 LSRFKANTFI---SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPA-----------Q---- 868 (931)
Q Consensus 807 lAr~~~~~~~---~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~-----------e---- 868 (931)
++........ ......++..|+|||++.+..++.++|||||||++|+|++|..||...... .
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 9986543321 123345678899999999888899999999999999999999998642110 0
Q ss_pred HHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 869 VVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 869 ii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
.+........+...+..+++++.+||.+||..||.+|||+.++++.|+++...
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11122223344566788999999999999999999999999999999998764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=363.48 Aligned_cols=263 Identities=19% Similarity=0.319 Sum_probs=207.6
Q ss_pred hhhcCCCcCCCCCCCCCCCccccccccccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHH
Q 002355 628 LEKQGKFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLR 705 (931)
Q Consensus 628 ~~~~g~~Pv~~G~ry~~~epsl~~~~lei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~ 705 (931)
|.++|++|+..|..+ ..++|+++++||+|+||+||+|++ +++.||||++.... .....+.+
T Consensus 2 y~~~~~~p~~~~~~~--------------~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ 64 (373)
T 1q8y_A 2 YRPGGYHPAFKGEPY--------------KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAED 64 (373)
T ss_dssp -----CCCCCTTCEE--------------TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHH
T ss_pred CCCCCceeeecCCcc--------------cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc---cchhhhhH
Confidence 567788888776654 337999999999999999999986 57789999997532 23456788
Q ss_pred HHHHHHhcC-----------CCCeeeEEeeeeeCC----eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHH
Q 002355 706 EVAIMKRVR-----------HPNVVLFMGAVTKRP----HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770 (931)
Q Consensus 706 EIkILk~L~-----------HpNIV~Lid~f~~~~----~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~ 770 (931)
|+++++++. |+||+++++++...+ ++++|||++ +++|.+++.... ...+++..++.++.||+.
T Consensus 65 e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~ 142 (373)
T 1q8y_A 65 EIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLL 142 (373)
T ss_dssp HHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHH
Confidence 999998886 889999999997544 799999999 999999997633 345899999999999999
Q ss_pred HHHHHHhC-CCCEEEeccCCCCeEEC------CCCcEEEEecCccccccccccccCCCCCCCcccCcccccCCCCCchhH
Q 002355 771 GINYLHNL-NPPILHWDLKSPNLLVD------KNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSD 843 (931)
Q Consensus 771 AL~yLHs~-G~~IIHrDLKPeNILLd------~dg~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksD 843 (931)
||+|||++ | |+||||||+|||++ ..+.+||+|||++...... .....||+.|+|||++.+..++.++|
T Consensus 143 aL~~lH~~~~--ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~D 217 (373)
T 1q8y_A 143 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGAD 217 (373)
T ss_dssp HHHHHHHTTC--EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHH
T ss_pred HHHHHHhcCC--EEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHh
Confidence 99999998 9 99999999999994 4458999999999866543 24457899999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhc----------------------------------------c
Q 002355 844 VYSFGVILWELVTMQQPWNGLGP------AQVVGAVAFQ----------------------------------------N 877 (931)
Q Consensus 844 IWSLG~ILyELLTG~~PF~~~~~------~eii~~i~~~----------------------------------------~ 877 (931)
||||||++|+|++|..||..... ...+..+... .
T Consensus 218 i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (373)
T 1q8y_A 218 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT 297 (373)
T ss_dssp HHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh
Confidence 99999999999999999986542 1112111110 0
Q ss_pred cccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 878 RRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 878 ~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
....++...++++.+||.+||+.||.+|||+.|+++|
T Consensus 298 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 298 EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred hcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 1112344567889999999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=355.70 Aligned_cols=247 Identities=25% Similarity=0.384 Sum_probs=201.3
Q ss_pred CceEEE-EEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEEEE
Q 002355 659 DELHVK-ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 659 drY~Ii-~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~LV 734 (931)
++|++. +.||+|+||+||+|++ +++.||||++...... ....+.+|++++.++ +||||+++++++..++.+|+|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH--IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC--CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch--hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 688985 7899999999999986 5788999999765422 235788999999995 799999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc---EEEEecCccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT---VKVCDFGLSRFK 811 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~---IKL~DFGlAr~~ 811 (931)
|||+.|++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++. +||+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999999763 35899999999999999999999999 999999999999998776 999999998754
Q ss_pred ccc-------ccccCCCCCCCcccCcccccC-----CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-------------
Q 002355 812 ANT-------FISSKSVAGTPEWMAPEFLRG-----EPSNEKSDVYSFGVILWELVTMQQPWNGLGP------------- 866 (931)
Q Consensus 812 ~~~-------~~~~~~~~GT~~Y~APEvL~~-----~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~------------- 866 (931)
... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 321 111234568999999999875 4468899999999999999999999977542
Q ss_pred --HHHHHHHHhcccccCCC----CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 867 --AQVVGAVAFQNRRLAIP----QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 867 --~eii~~i~~~~~r~~lP----~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
......+.. ....++ ..+++.+.+||.+||..||.+|||+.|+++|
T Consensus 245 ~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQE--GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHH--CCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhc--cCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 222333322 222233 4678999999999999999999999999987
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=350.08 Aligned_cols=253 Identities=23% Similarity=0.383 Sum_probs=211.1
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc--hHHHHHHHHHHHHHHhcCCCCeeeEEeee--eeCCeE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL--DDQLKEFLREVAIMKRVRHPNVVLFMGAV--TKRPHL 731 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~--~~~~~~~l~EIkILk~L~HpNIV~Lid~f--~~~~~l 731 (931)
.++|++++.||+|+||.||+|++ +++.||+|++...... ......+.+|+++++.++||||+++++++ ......
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 37899999999999999999987 5678999999765422 12346788999999999999999999998 455689
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
++||||+.++ |.+++... ....+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999766 77777653 2456899999999999999999999999 999999999999999999999999999764
Q ss_pred ccc--ccccCCCCCCCcccCcccccCCCC--CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCCh
Q 002355 812 ANT--FISSKSVAGTPEWMAPEFLRGEPS--NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTS 887 (931)
Q Consensus 812 ~~~--~~~~~~~~GT~~Y~APEvL~~~~~--t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s 887 (931)
... ........||+.|+|||++.+... +.++|||||||++|+|++|..||.+....+....+. .....++..++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~--~~~~~~~~~~~ 237 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG--KGSYAIPGDCG 237 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HCCCCCCSSSC
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHh--cCCCCCCCccC
Confidence 321 112235568999999999987544 779999999999999999999999887776666554 23445678899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 888 PVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 888 ~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
+.+.+||.+||..||.+|||+.+++++-.
T Consensus 238 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 238 PPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 99999999999999999999999998744
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=371.00 Aligned_cols=248 Identities=24% Similarity=0.320 Sum_probs=208.3
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhc------CCCCeeeEEeeeeeC
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV------RHPNVVLFMGAVTKR 728 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L------~HpNIV~Lid~f~~~ 728 (931)
...+|+++++||+|+||+||+|++ +++.||||++.... .....+.+|+++++.+ .|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK---RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc---chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 347899999999999999999987 46789999997542 3335677888888887 477999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc--EEEEecC
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT--VKVCDFG 806 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~--IKL~DFG 806 (931)
.++|+||||+ +++|.+++.... ...+++..++.++.||+.||+|||++| |+||||||+||||+.++. +||+|||
T Consensus 172 ~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 172 NHICMTFELL-SMNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp TEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred CeEEEEEecc-CCCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEEeecc
Confidence 9999999999 569999987633 345899999999999999999999999 999999999999999887 9999999
Q ss_pred ccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc------
Q 002355 807 LSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL------ 880 (931)
Q Consensus 807 lAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~------ 880 (931)
+++..... ....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+..+.......
T Consensus 248 ~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~ 324 (429)
T 3kvw_A 248 SSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324 (429)
T ss_dssp TCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 99765443 245689999999999999999999999999999999999999999887666554432110000
Q ss_pred ---------------------------------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHH
Q 002355 881 ---------------------------------------------------AIPQNTSPVLASLMESCWADDPAQRPSFA 909 (931)
Q Consensus 881 ---------------------------------------------------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ 909 (931)
.++...++.+.+||.+||++||++|||+.
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~ 404 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence 01223478899999999999999999999
Q ss_pred HHHHH
Q 002355 910 NIVES 914 (931)
Q Consensus 910 ELLq~ 914 (931)
|+++|
T Consensus 405 e~L~H 409 (429)
T 3kvw_A 405 QALRH 409 (429)
T ss_dssp HHHTS
T ss_pred HHhCC
Confidence 99987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=370.90 Aligned_cols=259 Identities=31% Similarity=0.489 Sum_probs=210.4
Q ss_pred cCceEEEEEecccCceEEEEEEEc--C---CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeee-eCCeE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEWH--G---SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT-KRPHL 731 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~~--g---~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~-~~~~l 731 (931)
...|++.++||+|+||+||+|++. + ..||+|++.... .......+.+|+.++++++||||+++++++. .++..
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 356899999999999999999863 2 248888876532 3345678999999999999999999999864 55688
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
++||||+.+++|.+++.. ....+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 167 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEEEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeeccccccc
Confidence 999999999999999975 2345889999999999999999999999 999999999999999999999999999754
Q ss_pred cccc----cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCC
Q 002355 812 ANTF----ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNT 886 (931)
Q Consensus 812 ~~~~----~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~ 886 (931)
.... .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||...+..+....+. ...+...|..+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-~~~~~~~p~~~ 321 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYC 321 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-TTCCCCCCTTC
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-cCCCCCCCCCC
Confidence 3221 11233457789999999999999999999999999999999 788888777666555443 34455667889
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 887 SPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
+..+.+||.+||..+|.+|||+.++++.|+.++...
T Consensus 322 ~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 322 PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 999999999999999999999999999999998764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=366.32 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=203.6
Q ss_pred ccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee-----
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK----- 727 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~----- 727 (931)
+...++|+++++||+|+||+||+|++ +++.||||++..... ...+|+++++.++||||++++++|..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 34568999999999999999999987 678899999876532 22379999999999999999999843
Q ss_pred ---------------------------------CCeEEEEEeecCCCCHHHHhhcC-CCCCCCcHHHHHHHHHHHHHHHH
Q 002355 728 ---------------------------------RPHLSIVTEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGIN 773 (931)
Q Consensus 728 ---------------------------------~~~l~LVmEy~~GgSL~d~L~r~-~~~~~L~e~~~~~Ia~QIa~AL~ 773 (931)
..++++||||++ ++|.+.+... ..+..+++..++.++.||+.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 345899999996 5877776531 23456999999999999999999
Q ss_pred HHHhCCCCEEEeccCCCCeEEC-CCCcEEEEecCccccccccccccCCCCCCCcccCcccccCCC-CCchhHHHHHHHHH
Q 002355 774 YLHNLNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEP-SNEKSDVYSFGVIL 851 (931)
Q Consensus 774 yLHs~G~~IIHrDLKPeNILLd-~dg~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~-~t~ksDIWSLG~IL 851 (931)
|||++| |+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++
T Consensus 156 ~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 156 FIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 999999 99999999999997 68899999999998654332 234567899999999988754 89999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHhccc---------------------------ccCCCCCChHHHHHHHHHhcccCCCC
Q 002355 852 WELVTMQQPWNGLGPAQVVGAVAFQNR---------------------------RLAIPQNTSPVLASLMESCWADDPAQ 904 (931)
Q Consensus 852 yELLTG~~PF~~~~~~eii~~i~~~~~---------------------------r~~lP~~~s~eL~dLI~rcL~~DPee 904 (931)
|+|++|+.||.+....+.+..+..... ...++...++++.+||.+||.+||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 999999999998876665544432110 01145568899999999999999999
Q ss_pred CCCHHHHHHH
Q 002355 905 RPSFANIVES 914 (931)
Q Consensus 905 RPSa~ELLq~ 914 (931)
|||+.|+++|
T Consensus 313 R~t~~e~l~h 322 (383)
T 3eb0_A 313 RINPYEAMAH 322 (383)
T ss_dssp SCCHHHHHTS
T ss_pred CCCHHHHhcC
Confidence 9999999976
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=351.67 Aligned_cols=243 Identities=19% Similarity=0.316 Sum_probs=201.8
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeeee--CCeEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTK--RPHLS 732 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~--~~~l~ 732 (931)
.++|+++++||+|+||+||+|++ +++.||||++.... ...+.+|+++++.++ ||||+++++++.. ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 47999999999999999999986 57889999987543 256789999999997 9999999999987 67899
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC-cEEEEecCccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-TVKVCDFGLSRFK 811 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg-~IKL~DFGlAr~~ 811 (931)
+||||+.+++|.+++.. +++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+++..
T Consensus 110 lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EEEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999999999854 889999999999999999999999 99999999999999777 8999999999865
Q ss_pred cccccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhc-----------cc
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLG-PAQVVGAVAFQ-----------NR 878 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~-~~eii~~i~~~-----------~~ 878 (931)
.... ......||..|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+.+..+... ..
T Consensus 182 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 182 HPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp CTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence 4332 2345578999999999887 668999999999999999999999995443 22221111000 00
Q ss_pred ------------------------ccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 ------------------------RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 ------------------------r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
....+..+++++.+||.+||+.||.+|||+.|+++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 001122378999999999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=389.92 Aligned_cols=253 Identities=25% Similarity=0.324 Sum_probs=217.8
Q ss_pred cccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
+..++|++++.||+|+||.||+|++ +++.||||++....... .....+.+|+++|+.++||||++++++|...+++|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 4558999999999999999999987 57889999997654322 23456789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||++||+|.+++.... ...+++..++.++.||+.||+|||++| |+||||||+||||+.+|++||+|||+++...
T Consensus 261 lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 9999999999999997633 335899999999999999999999999 9999999999999999999999999998654
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHhcccccCCCCCChH
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLG----PAQVVGAVAFQNRRLAIPQNTSP 888 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~----~~eii~~i~~~~~r~~lP~~~s~ 888 (931)
... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.... ..++...+. .....++..+++
T Consensus 338 ~~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~--~~~~~~p~~~s~ 414 (576)
T 2acx_A 338 EGQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK--EVPEEYSERFSP 414 (576)
T ss_dssp TTC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH--HCCCCCCTTSCH
T ss_pred cCc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh--cccccCCccCCH
Confidence 332 2234589999999999999889999999999999999999999998754 233333332 334556788999
Q ss_pred HHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 002355 889 VLASLMESCWADDPAQRP-----SFANIVES 914 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRP-----Sa~ELLq~ 914 (931)
++.+||.+||+.||.+|| ++.|+++|
T Consensus 415 ~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 999999999999999999 78999876
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=352.39 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=209.2
Q ss_pred cCceEEEEEecccCceEEEEEEE---cCCceEEEEEeecccchHHHHHHHHHHHHHHhc---CCCCeeeEEeeee-----
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW---HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV---RHPNVVLFMGAVT----- 726 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~---~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L---~HpNIV~Lid~f~----- 726 (931)
.++|+++++||+|+||+||+|++ .++.||||++............+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 37899999999999999999987 366799999976543322223455777777666 8999999999987
Q ss_pred eCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecC
Q 002355 727 KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806 (931)
Q Consensus 727 ~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFG 806 (931)
.....++||||+. ++|.+++.... ...+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCEEEecCc
Confidence 5678999999996 69999987633 335899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc--------
Q 002355 807 LSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-------- 878 (931)
Q Consensus 807 lAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~-------- 878 (931)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+......+..+.....
T Consensus 166 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (326)
T 1blx_A 166 LARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244 (326)
T ss_dssp SCCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred ccccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence 998654332 23456789999999999999899999999999999999999999998877666555432110
Q ss_pred -----------------ccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 -----------------RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 -----------------r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
...+...++..+.+||.+||..||.+|||+.++++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 011335688999999999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=359.60 Aligned_cols=248 Identities=22% Similarity=0.356 Sum_probs=206.8
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC-----CeE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR-----PHL 731 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~-----~~l 731 (931)
++|+++++||+|+||+||+|++ +++.||||++.... .......+.+|+++++.++||||+++++++... ...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 6899999999999999999987 46779999997543 334457789999999999999999999998654 478
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
|+||||+. ++|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999995 699999865 24899999999999999999999999 999999999999999999999999999865
Q ss_pred ccccc---ccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc--------
Q 002355 812 ANTFI---SSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR-------- 879 (931)
Q Consensus 812 ~~~~~---~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r-------- 879 (931)
..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+.+..+......
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 43321 1244579999999998765 45799999999999999999999999887765555443211000
Q ss_pred ----------------c-----CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 ----------------L-----AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 ----------------~-----~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
. .....+++++.+||.+||..||.+|||+.|+++|
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0124678899999999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=349.53 Aligned_cols=259 Identities=19% Similarity=0.322 Sum_probs=214.5
Q ss_pred ccccccccCceEEEEEecccCceEEEEEEE-cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC--CCCeeeEEeeeee
Q 002355 651 MDWLEISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR--HPNVVLFMGAVTK 727 (931)
Q Consensus 651 ~~~lei~~drY~Ii~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~--HpNIV~Lid~f~~ 727 (931)
...+.+..++|+++++||+|+||.||+|++ +++.||||++............+.+|+.+++.++ |+||+++++++..
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 345667778999999999999999999987 4677999999877666666788999999999997 5999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCc
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGl 807 (931)
++..++|||+ .+++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++. +.+||+|||+
T Consensus 100 ~~~~~lv~e~-~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 100 DQYIYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp SSEEEEEECC-CSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred CCEEEEEEec-CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeeccc
Confidence 9999999995 488999999763 36899999999999999999999999 999999999999964 8999999999
Q ss_pred ccccccccc--ccCCCCCCCcccCcccccC-----------CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHH
Q 002355 808 SRFKANTFI--SSKSVAGTPEWMAPEFLRG-----------EPSNEKSDVYSFGVILWELVTMQQPWNGLGP-AQVVGAV 873 (931)
Q Consensus 808 Ar~~~~~~~--~~~~~~GT~~Y~APEvL~~-----------~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~-~eii~~i 873 (931)
+........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 252 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH
Confidence 986543211 1234578999999999876 4678899999999999999999999987643 3334444
Q ss_pred HhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 874 AFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 874 ~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
.........+...+..+.+||.+||..||.+||++.+++++-.
T Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 253 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 4444555677788999999999999999999999999998854
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=360.43 Aligned_cols=251 Identities=22% Similarity=0.407 Sum_probs=213.9
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeeccc--ch----HHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeC
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDF--LD----DQLKEFLREVAIMKRV-RHPNVVLFMGAVTKR 728 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~--~~----~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~ 728 (931)
.++|++.+.||+|+||.||+|++ +|+.||||++..... .. .....+.+|+.+++.+ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 36899999999999999999987 478999999976542 11 2245678999999999 799999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
...|+||||+.|++|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEEecCcc
Confidence 9999999999999999999752 35899999999999999999999999 999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCcccCcccccC------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCC
Q 002355 809 RFKANTFISSKSVAGTPEWMAPEFLRG------EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAI 882 (931)
Q Consensus 809 r~~~~~~~~~~~~~GT~~Y~APEvL~~------~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~l 882 (931)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.........
T Consensus 248 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 326 (365)
T 2y7j_A 248 CHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS 326 (365)
T ss_dssp EECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred cccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 7654332 2345679999999999863 35788999999999999999999999988777666655433332221
Q ss_pred --CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 883 --PQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 883 --P~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
....+..+.+||.+||..||.+|||+.+++++
T Consensus 327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 25678899999999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=353.66 Aligned_cols=258 Identities=26% Similarity=0.488 Sum_probs=196.0
Q ss_pred cccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
+.+..++|++.+.||+|+||+||+|++ +++.||||++..... ......+.+|+.+++.++||||+++++++...+..
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 356678999999999999999999976 678899999865432 22346678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcC-----CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecC
Q 002355 732 SIVTEYLPRGSLYRLIHRP-----AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~-----~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFG 806 (931)
++||||+++++|.+++... .....+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEecc
Confidence 9999999999999998631 12345899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccc-----cccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc-
Q 002355 807 LSRFKANTF-----ISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR- 879 (931)
Q Consensus 807 lAr~~~~~~-----~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r- 879 (931)
++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..................
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence 987543221 11234578999999999876 56789999999999999999999999887766555443322111
Q ss_pred -------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 -------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 -------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
......+++.+.+||.+||..||.+|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 12335678999999999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=389.35 Aligned_cols=263 Identities=27% Similarity=0.490 Sum_probs=221.6
Q ss_pred cccccCceEEEE-EecccCceEEEEEEEc----CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC
Q 002355 654 LEISWDELHVKE-RVGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728 (931)
Q Consensus 654 lei~~drY~Ii~-kLG~G~fGtVylAr~~----g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~ 728 (931)
+.+..+++.+.+ +||+|+||+||+|.+. +..||||+++.... ......+.+|+++|+.++||||+++++++..
T Consensus 330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 455667888877 8999999999999763 34699999976532 2335678999999999999999999999976
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
+.+++||||+.+++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||++
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred CCeEEEEEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 5699999999999999999652 346899999999999999999999999 999999999999999999999999999
Q ss_pred cccccccc---ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCC
Q 002355 809 RFKANTFI---SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQ 884 (931)
Q Consensus 809 r~~~~~~~---~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~ 884 (931)
+....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....++...+. ...+...|.
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~ 562 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPP 562 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-TTCCCCCCT
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCC
Confidence 86543211 1122345689999999998899999999999999999998 999999988877776654 455667888
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCch
Q 002355 885 NTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPA 923 (931)
Q Consensus 885 ~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~ 923 (931)
.+++++.+||.+||..+|++||++.++++.|+.++.+..
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 999999999999999999999999999999999876543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=390.98 Aligned_cols=261 Identities=26% Similarity=0.480 Sum_probs=220.5
Q ss_pred cccccCceEEEE-EecccCceEEEEEEE----cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC
Q 002355 654 LEISWDELHVKE-RVGAGSFGTVHRAEW----HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728 (931)
Q Consensus 654 lei~~drY~Ii~-kLG~G~fGtVylAr~----~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~ 728 (931)
+.+....+.+.. +||+|+||+||+|.+ .++.||||+++...........+.+|+++|++++||||+++++++..
T Consensus 363 ~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~- 441 (635)
T 4fl3_A 363 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA- 441 (635)
T ss_dssp SBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred ccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 344556666654 899999999999965 34679999998765444455789999999999999999999999864
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
+..++||||+.+++|.+++.. ...+++..++.++.||+.||+|||++| ||||||||+||||+.++.+||+|||++
T Consensus 442 ~~~~lv~E~~~~g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla 516 (635)
T 4fl3_A 442 ESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLS 516 (635)
T ss_dssp SSEEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHH
T ss_pred CCEEEEEEccCCCCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCc
Confidence 568999999999999999975 346899999999999999999999999 999999999999999999999999999
Q ss_pred ccccccc---cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCC
Q 002355 809 RFKANTF---ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQ 884 (931)
Q Consensus 809 r~~~~~~---~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~ 884 (931)
+...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....++...+. ...+...+.
T Consensus 517 ~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~ 595 (635)
T 4fl3_A 517 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPA 595 (635)
T ss_dssp HHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCT
T ss_pred cccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCC
Confidence 8653321 11233456788999999999999999999999999999998 999999988877766654 455667888
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 885 NTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 885 ~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
.+++++.+||.+||..||++||++.+|++.|++++.+
T Consensus 596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 596 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999998764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=348.46 Aligned_cols=250 Identities=29% Similarity=0.466 Sum_probs=214.8
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|+++++||+|+||+||+|++ +++.||||++............+.+|++++++++||||+++++++...+..++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 47999999999999999999988 5788999999876544444567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC---CcEEEEecCcccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN---WTVKVCDFGLSRFKA 812 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d---g~IKL~DFGlAr~~~ 812 (931)
||+.+++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++.+ +.+||+|||++....
T Consensus 101 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999999988652 35899999999999999999999999 9999999999999754 479999999987654
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC--CCChHHH
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP--QNTSPVL 890 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP--~~~s~eL 890 (931)
... ......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+....+.........+ ..+++++
T Consensus 176 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (287)
T 2wei_A 176 QNT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA 253 (287)
T ss_dssp CCS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHH
T ss_pred CCC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHH
Confidence 332 22334578899999998765 8899999999999999999999999988777766665443333332 5789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+||.+||..||.+|||+.+++++
T Consensus 254 ~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 254 KDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHcccChhhCcCHHHHhcC
Confidence 999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=367.27 Aligned_cols=254 Identities=24% Similarity=0.404 Sum_probs=210.7
Q ss_pred cccCceEEEEEecccCceEEEEEEE-----cCCceEEEEEeecccc--hHHHHHHHHHHHHHHhc-CCCCeeeEEeeeee
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFL--DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTK 727 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~-----~g~~VAVKVlk~~~~~--~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~ 727 (931)
+..++|+++++||+|+||+||+|++ +++.||||+++..... ......+.+|+++|+.+ .||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 3458999999999999999999987 5788999998754321 11224566899999999 69999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCc
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGl 807 (931)
...+++||||+.+++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred CceEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999999753 35899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccc-ccccCCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhccccc
Q 002355 808 SRFKANT-FISSKSVAGTPEWMAPEFLRG--EPSNEKSDVYSFGVILWELVTMQQPWNGLGP----AQVVGAVAFQNRRL 880 (931)
Q Consensus 808 Ar~~~~~-~~~~~~~~GT~~Y~APEvL~~--~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~----~eii~~i~~~~~r~ 880 (931)
++..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ..+...+. ....
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~~ 283 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL--KSEP 283 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH--HCCC
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh--ccCC
Confidence 9754322 122345679999999999986 3468899999999999999999999975432 22222222 3345
Q ss_pred CCCCCChHHHHHHHHHhcccCCCCCC-----CHHHHHHHHH
Q 002355 881 AIPQNTSPVLASLMESCWADDPAQRP-----SFANIVESLK 916 (931)
Q Consensus 881 ~lP~~~s~eL~dLI~rcL~~DPeeRP-----Sa~ELLq~L~ 916 (931)
..+..++..+.+||.+||..||.+|| ++.+++++..
T Consensus 284 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 284 PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 57788999999999999999999999 9999998753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=351.67 Aligned_cols=247 Identities=22% Similarity=0.309 Sum_probs=203.5
Q ss_pred cCceEEEEEecccCceEEEEEEEc--C-CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCC------eeeEEeeeeeC
Q 002355 658 WDELHVKERVGAGSFGTVHRAEWH--G-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN------VVLFMGAVTKR 728 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~~--g-~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpN------IV~Lid~f~~~ 728 (931)
.++|+++++||+|+||+||+|++. + +.||||++... ......+.+|+.+++.++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 379999999999999999999873 3 57999999753 233456788999999997655 89999999999
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEE--------------
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV-------------- 794 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILL-------------- 794 (931)
++.|+||||+ +++|.+++.... ...+++..++.++.||+.||+|||++| |+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeccccccccccccc
Confidence 9999999999 677777776522 346899999999999999999999999 9999999999999
Q ss_pred -----CCCCcEEEEecCccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH
Q 002355 795 -----DKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQV 869 (931)
Q Consensus 795 -----d~dg~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~ei 869 (931)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......+.
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56789999999999865433 2456799999999999999999999999999999999999999998776554
Q ss_pred HHHHHhccccc------------------------------------------CCCCCChHHHHHHHHHhcccCCCCCCC
Q 002355 870 VGAVAFQNRRL------------------------------------------AIPQNTSPVLASLMESCWADDPAQRPS 907 (931)
Q Consensus 870 i~~i~~~~~r~------------------------------------------~lP~~~s~eL~dLI~rcL~~DPeeRPS 907 (931)
...+....... ......++++.+||.+||..||.+|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 43332111000 011223568999999999999999999
Q ss_pred HHHHHHH
Q 002355 908 FANIVES 914 (931)
Q Consensus 908 a~ELLq~ 914 (931)
+.|+++|
T Consensus 328 ~~e~l~h 334 (355)
T 2eu9_A 328 LAEALLH 334 (355)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999876
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=362.92 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=206.3
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE-----
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL----- 731 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l----- 731 (931)
++|++.++||+|+||+||+|++ +++.||||++............+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 7999999999999999999987 478899999987665566667889999999999999999999999876654
Q ss_pred -EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 732 -SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 732 -~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
|+||||+. ++|.+++.. .+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 122 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred EEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999995 688888743 4899999999999999999999999 99999999999999999999999999986
Q ss_pred ccccccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc---------
Q 002355 811 KANTFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL--------- 880 (931)
Q Consensus 811 ~~~~~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~--------- 880 (931)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus 194 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 194 ADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred cccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 5443 245678999999999987 678999999999999999999999999887665554442211100
Q ss_pred --------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 --------------------AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 --------------------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
..+..+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 1124578999999999999999999999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=360.74 Aligned_cols=255 Identities=17% Similarity=0.226 Sum_probs=209.5
Q ss_pred ccCceEEEEEecccCceEEEEEEEc----------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeee------
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWH----------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL------ 720 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~----------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~------ 720 (931)
..++|++.++||+|+||+||+|++. ++.||||++... ..+.+|++++++++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 4589999999999999999999874 678999998754 35778999999999999887
Q ss_pred ---------EEeeeee-CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCC
Q 002355 721 ---------FMGAVTK-RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSP 790 (931)
Q Consensus 721 ---------Lid~f~~-~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPe 790 (931)
+++++.. +...|+||||+ +++|.+++.... ...+++..++.++.||+.||+|||++| |+||||||+
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~ 188 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAE 188 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGG
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHH
Confidence 5666665 78899999999 999999997631 346999999999999999999999999 999999999
Q ss_pred CeEECCCC--cEEEEecCcccccccccc-------ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002355 791 NLLVDKNW--TVKVCDFGLSRFKANTFI-------SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPW 861 (931)
Q Consensus 791 NILLd~dg--~IKL~DFGlAr~~~~~~~-------~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF 861 (931)
|||++.++ .+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 899999999976443211 123457899999999999999999999999999999999999999
Q ss_pred CCCC--hHHHHHHHHh-cccccCCC------CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 862 NGLG--PAQVVGAVAF-QNRRLAIP------QNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 862 ~~~~--~~eii~~i~~-~~~r~~lP------~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
.... ...+...... ......++ ..+++++.+||.+||..||.+|||+.++++.|+.+++..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp GGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 8764 2222222111 11111111 256899999999999999999999999999999988653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=358.85 Aligned_cols=256 Identities=17% Similarity=0.186 Sum_probs=211.6
Q ss_pred ccccccCceEEEEEecccCceEEEEEE-------EcCCceEEEEEeecccchHHHHHHHHHHHHHHhcC---CCCeeeEE
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAE-------WHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR---HPNVVLFM 722 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr-------~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~---HpNIV~Li 722 (931)
.+++..++|++.++||+|+||+||+|. ..++.||||++.... ...+.+|+++++.++ |+||++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 456677999999999999999999993 257889999997543 245678888888887 89999999
Q ss_pred eeeeeCCeEEEEEeecCCCCHHHHhhcCC--CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC----
Q 002355 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPA--AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---- 796 (931)
Q Consensus 723 d~f~~~~~l~LVmEy~~GgSL~d~L~r~~--~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~---- 796 (931)
+++..++..||||||++|++|.+++.... ....+++..++.++.||+.||+|||++| ||||||||+||||+.
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTC
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccC
Confidence 99999999999999999999999997421 2456999999999999999999999999 999999999999998
Q ss_pred -------CCcEEEEecCcccccc--ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Q 002355 797 -------NWTVKVCDFGLSRFKA--NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPA 867 (931)
Q Consensus 797 -------dg~IKL~DFGlAr~~~--~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~ 867 (931)
++.+||+|||+|+... .........+||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 8999999999997532 1112334567999999999999999999999999999999999999999653321
Q ss_pred HHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHHhhC
Q 002355 868 QVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQR-PSFANIVESLKKLLKS 921 (931)
Q Consensus 868 eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeR-PSa~ELLq~L~~Llks 921 (931)
.. ...........++.+.+++..||+.+|.+| |++.++.+.|..++..
T Consensus 292 ~~------~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 292 EC------KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp EE------EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ce------eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 10 001111112357889999999999999999 6888888888887765
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=368.31 Aligned_cols=246 Identities=24% Similarity=0.362 Sum_probs=192.2
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC------Ce
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------PH 730 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~------~~ 730 (931)
++|++++.||+|+||+||+|++ +++.||||++............+.+|+++|+.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 7999999999999999999986 577899999976554555567889999999999999999999998654 56
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
+|+|||++ +++|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC------
T ss_pred EEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 89999999 8899998864 35899999999999999999999999 99999999999999999999999999986
Q ss_pred ccccccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc----------
Q 002355 811 KANTFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR---------- 879 (931)
Q Consensus 811 ~~~~~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r---------- 879 (931)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+......
T Consensus 182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 182 TADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred cccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 5433 245678999999999887 67899999999999999999999999988765554443221100
Q ss_pred -----------cC--------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 -----------LA--------IPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 -----------~~--------lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.. .....++.+.+||.+||..||.+|||+.++++|
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00 113567889999999999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=370.24 Aligned_cols=250 Identities=23% Similarity=0.349 Sum_probs=198.0
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch------HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD------DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~------~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
.++|++.++||+|+||+||+|++ +++.||||++....... .....+.+|+.+|++++||||+++++++. .+
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 47899999999999999999987 46789999998754321 12235789999999999999999999975 45
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC---cEEEEecC
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW---TVKVCDFG 806 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg---~IKL~DFG 806 (931)
..|+||||+.+++|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecc
Confidence 68999999999999998865 346899999999999999999999999 99999999999997544 59999999
Q ss_pred ccccccccccccCCCCCCCcccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhcccc--c
Q 002355 807 LSRFKANTFISSKSVAGTPEWMAPEFLRG---EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQV-VGAVAFQNRR--L 880 (931)
Q Consensus 807 lAr~~~~~~~~~~~~~GT~~Y~APEvL~~---~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~ei-i~~i~~~~~r--~ 880 (931)
+++...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ...+...... .
T Consensus 288 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~ 366 (419)
T 3i6u_A 288 HSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366 (419)
T ss_dssp TTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred cceecCCCc-cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence 998765432 2345679999999999864 5678899999999999999999999987543322 2222211111 1
Q ss_pred CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 ~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.....+++.+.+||.+||..||.+|||+.|+++|
T Consensus 367 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1225688999999999999999999999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=354.21 Aligned_cols=250 Identities=23% Similarity=0.360 Sum_probs=201.2
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc------hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL------DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~------~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
.++|+++++||+|+||.||+|++ +++.||||++...... ......+.+|+.+|+.++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 37899999999999999999987 4678999999765421 122345789999999999999999999987655
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc---EEEEecC
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT---VKVCDFG 806 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~---IKL~DFG 806 (931)
.|+||||+.+++|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++. +||+|||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp -EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred -eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 8999999999999999865 346899999999999999999999999 999999999999987654 9999999
Q ss_pred ccccccccccccCCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcccc--c
Q 002355 807 LSRFKANTFISSKSVAGTPEWMAPEFLR---GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPA-QVVGAVAFQNRR--L 880 (931)
Q Consensus 807 lAr~~~~~~~~~~~~~GT~~Y~APEvL~---~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~-eii~~i~~~~~r--~ 880 (931)
++....... ......||+.|+|||++. ...++.++|||||||++|+|++|..||...... .....+...... .
T Consensus 163 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T 2ycf_A 163 HSKILGETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241 (322)
T ss_dssp TCEECCCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCH
T ss_pred cceeccccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCc
Confidence 998654432 123446899999999974 566789999999999999999999999775433 222222211111 1
Q ss_pred CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 ~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
..+..+++.+.+||.+||..||.+|||+.++++|
T Consensus 242 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 1235678999999999999999999999999865
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=350.97 Aligned_cols=249 Identities=25% Similarity=0.358 Sum_probs=205.2
Q ss_pred cCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC-----Ce
Q 002355 658 WDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR-----PH 730 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~-----~~ 730 (931)
.++|++.+.||+|+||+||+|++. ++.||||++.... .......+.+|+++++.++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 479999999999999999999884 7789999996543 233456788999999999999999999987654 68
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
.++||||+. ++|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++..
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 999999995 689998875 35899999999999999999999999 99999999999999999999999999986
Q ss_pred cccccc----------ccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc
Q 002355 811 KANTFI----------SSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR 879 (931)
Q Consensus 811 ~~~~~~----------~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r 879 (931)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 543211 1223578999999998765 67899999999999999999999999987755444333211000
Q ss_pred c------------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 L------------------------------AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 ~------------------------------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
. .....+++.+.+||.+||..||.+|||+.++++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0124678999999999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=365.10 Aligned_cols=248 Identities=23% Similarity=0.298 Sum_probs=200.0
Q ss_pred cCceEEEEEecccCceEEEEEEE-cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC------e
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP------H 730 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~------~ 730 (931)
..+|+++++||+|+||+||+|++ .+..||+|++...... ..+|+++++.++||||++++++|...+ .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 46899999999999999999988 3455899988654321 236999999999999999999995433 3
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC-CCCcEEEEecCccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSR 809 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd-~dg~IKL~DFGlAr 809 (931)
+++||||+.++.+..+.........+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+++
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 8899999976544333322223456899999999999999999999999 99999999999999 79999999999998
Q ss_pred cccccccccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc----------
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR---------- 878 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~---------- 878 (931)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+.....
T Consensus 191 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 191 ILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp ECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 654332 23456789999999999775 489999999999999999999999998876555444322100
Q ss_pred -----c------------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 -----R------------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 -----r------------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
. ..++...++++.+||.+||.+||.+|||+.|+++|
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0 01234578999999999999999999999999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=371.73 Aligned_cols=245 Identities=13% Similarity=0.124 Sum_probs=196.8
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeeccc-chHHHHHHHHHHH---HHHhcCCCCeeeEE-------e
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDF-LDDQLKEFLREVA---IMKRVRHPNVVLFM-------G 723 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~-~~~~~~~~l~EIk---ILk~L~HpNIV~Li-------d 723 (931)
..++|++.++||+|+||+||+|++ +++.||||++..... .....+.+.+|+. +++.++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 457999999999999999999985 588999999986533 2334577889995 45555799999988 5
Q ss_pred eeeeCC-----------------eEEEEEeecCCCCHHHHhhcCCC----CCCCcHHHHHHHHHHHHHHHHHHHhCCCCE
Q 002355 724 AVTKRP-----------------HLSIVTEYLPRGSLYRLIHRPAA----GEMMDQRRRLRMALDVAKGINYLHNLNPPI 782 (931)
Q Consensus 724 ~f~~~~-----------------~l~LVmEy~~GgSL~d~L~r~~~----~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~I 782 (931)
++...+ ..||||||+ +|+|.+++.+... ...+++..++.++.||+.||+|||++| |
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i 227 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--L 227 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--e
Confidence 555443 389999999 7899999975221 122445888899999999999999999 9
Q ss_pred EEeccCCCCeEECCCCcEEEEecCccccccccccccCCCCCCCcccCcccccCC-----------CCCchhHHHHHHHHH
Q 002355 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGE-----------PSNEKSDVYSFGVIL 851 (931)
Q Consensus 783 IHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~-----------~~t~ksDIWSLG~IL 851 (931)
+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++.+. .++.++|||||||++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR---VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTCE---EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCCc---ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 99999999999999999999999999864432 245567 999999999887 789999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 852 WELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 852 yELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
|||++|+.||.+........ .....+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 304 ~elltg~~Pf~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSE------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHSSCCC------CCSG------GGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHCCCCCcccccccchh------hhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99999999997755332221 1122346789999999999999999999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=355.28 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=205.0
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe------
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH------ 730 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~------ 730 (931)
++|.+.+.||+|+||+||+|++ +++.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 7899999999999999999987 47889999998765555556788999999999999999999999976654
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
.|+||||+. ++|.+++.. .+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEeecccccC
Confidence 599999995 688877743 4899999999999999999999999 99999999999999999999999999986
Q ss_pred ccccccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-----------
Q 002355 811 KANTFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR----------- 878 (931)
Q Consensus 811 ~~~~~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~----------- 878 (931)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 176 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 176 ADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred CCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 5433 234578999999999887 6788999999999999999999999998776554443321100
Q ss_pred ------------------ccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 ------------------RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 ------------------r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
........++.+.+||.+||..||.+|||+.++++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 012234678999999999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=369.65 Aligned_cols=246 Identities=24% Similarity=0.319 Sum_probs=199.6
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC------Ce
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR------PH 730 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~------~~ 730 (931)
.+|++++.||+|+||+||+|++ +++.||||++..... ...+|+++|+.++||||++++++|... ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 5899999999999999999988 578899999875431 234799999999999999999988532 24
Q ss_pred EEEEEeecCCCCHHHHhhcC-CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC-CcEEEEecCcc
Q 002355 731 LSIVTEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN-WTVKVCDFGLS 808 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~-~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d-g~IKL~DFGlA 808 (931)
+++||||+.+ +|.+++... .....+++..++.++.||+.||+|||++| |+||||||+||||+.+ +.+||+|||++
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 7899999965 676665421 23456899999999999999999999999 9999999999999965 67899999999
Q ss_pred ccccccccccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc----------
Q 002355 809 RFKANTFISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN---------- 877 (931)
Q Consensus 809 r~~~~~~~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~---------- 877 (931)
+...... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+....
T Consensus 205 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 205 KQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp EECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 8654332 23456789999999999765 68999999999999999999999999877655444332210
Q ss_pred -----cccC------------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 878 -----RRLA------------IPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 878 -----~r~~------------lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.... ++...++++.+||.+||.+||.+|||+.|+++|
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0011 234678999999999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=357.21 Aligned_cols=252 Identities=21% Similarity=0.277 Sum_probs=193.0
Q ss_pred cccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC----
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP---- 729 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~---- 729 (931)
...++|++.++||+|+||+||+|++. ++.||||++....... ....+|++.+..++||||++++++|....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---HHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 35589999999999999999999874 7889999986653222 24567788889999999999999996533
Q ss_pred ---eEEEEEeecCCCCHHHHhh-cCCCCCCCcHHHHHHHHHHHHHHHHHHH--hCCCCEEEeccCCCCeEECC-CCcEEE
Q 002355 730 ---HLSIVTEYLPRGSLYRLIH-RPAAGEMMDQRRRLRMALDVAKGINYLH--NLNPPILHWDLKSPNLLVDK-NWTVKV 802 (931)
Q Consensus 730 ---~l~LVmEy~~GgSL~d~L~-r~~~~~~L~e~~~~~Ia~QIa~AL~yLH--s~G~~IIHrDLKPeNILLd~-dg~IKL 802 (931)
.+++||||+.+ +|...+. .......+++..++.++.||+.||.||| ++| |+||||||+|||++. ++.+||
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEE
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEE
Confidence 28999999966 5544432 2223456899999999999999999999 888 999999999999996 899999
Q ss_pred EecCccccccccccccCCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc---
Q 002355 803 CDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEP-SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR--- 878 (931)
Q Consensus 803 ~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~-~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~--- 878 (931)
+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 174 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3e3p_A 174 CDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252 (360)
T ss_dssp CCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence 9999998655432 234557899999999987654 79999999999999999999999999877666554432110
Q ss_pred ---------------------------ccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 ---------------------------RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 ---------------------------r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
....+...++++.+||.+||+.||.+|||+.|+++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 011223367899999999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=356.98 Aligned_cols=254 Identities=20% Similarity=0.292 Sum_probs=202.1
Q ss_pred ccccCceEEEEEecccCceEEEEEEE-cCCceEEEEEeecccc---------hHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFL---------DDQLKEFLREVAIMKRVRHPNVVLFMGA 724 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~---------~~~~~~~l~EIkILk~L~HpNIV~Lid~ 724 (931)
....++|+++++||+|+||+||+|++ .++.||||++...... ......+.+|++++++++||||++++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 34558999999999999999999976 5778999999664321 2234678999999999999999999999
Q ss_pred eee-----CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc
Q 002355 725 VTK-----RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT 799 (931)
Q Consensus 725 f~~-----~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~ 799 (931)
+.. ...+|+||||+. ++|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~ 172 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNND 172 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCC
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCCCC
Confidence 843 347899999996 688888865 2346899999999999999999999999 999999999999999999
Q ss_pred EEEEecCccccccccccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc
Q 002355 800 VKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR 878 (931)
Q Consensus 800 IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~ 878 (931)
+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+.....
T Consensus 173 ~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 251 (362)
T 3pg1_A 173 ITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251 (362)
T ss_dssp EEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEEEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 9999999997544332 2345578999999999887 6789999999999999999999999998876655544432111
Q ss_pred cc------------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 RL------------------------------AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 r~------------------------------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.. ..+...++.+.+||.+||..||.+|||+.|+++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 00 1234568889999999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.49 Aligned_cols=249 Identities=21% Similarity=0.323 Sum_probs=200.4
Q ss_pred cCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeee---------
Q 002355 658 WDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT--------- 726 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~--------- 726 (931)
.++|+++++||+|+||+||+|++. ++.||||++.... ......+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 479999999999999999999885 7789999987543 344577899999999999999999999873
Q ss_pred -----eCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC-CCCcE
Q 002355 727 -----KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTV 800 (931)
Q Consensus 727 -----~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd-~dg~I 800 (931)
.....++||||+. ++|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeE
Confidence 4468999999996 699999864 35889999999999999999999999 99999999999997 56799
Q ss_pred EEEecCccccccccc---cccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Q 002355 801 KVCDFGLSRFKANTF---ISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ 876 (931)
Q Consensus 801 KL~DFGlAr~~~~~~---~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~ 876 (931)
||+|||+++...... .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999998653221 12234467899999998875 67899999999999999999999999988765554443221
Q ss_pred ccc----------------------------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002355 877 NRR----------------------------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVESL 915 (931)
Q Consensus 877 ~~r----------------------------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L 915 (931)
... ...+..++.++.+||.+||+.||.+|||+.++++|-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP 307 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSH
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCc
Confidence 100 012346789999999999999999999999999873
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.31 Aligned_cols=254 Identities=24% Similarity=0.411 Sum_probs=193.8
Q ss_pred cccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
+.+..++|+++++||+|+||+||+|++ +++.||||++............+..+..+++.++||||+++++++..++.+
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 345668999999999999999999988 478899999987654444444445556678888999999999999999999
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhC-CCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL-NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~-G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
++||||+ ++.+..+..+. ...+++..++.++.||+.||.|||+. | |+||||||+||+++.++.+||+|||++..
T Consensus 100 ~lv~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred EEEEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 9999999 66676666532 34689999999999999999999995 9 99999999999999999999999999975
Q ss_pred ccccccccCCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcccccCCC-
Q 002355 811 KANTFISSKSVAGTPEWMAPEFLR-----GEPSNEKSDVYSFGVILWELVTMQQPWNGLG-PAQVVGAVAFQNRRLAIP- 883 (931)
Q Consensus 811 ~~~~~~~~~~~~GT~~Y~APEvL~-----~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~-~~eii~~i~~~~~r~~lP- 883 (931)
..... ......||+.|+|||++. +..++.++|||||||++|+|++|..||.... ..+....+. .......+
T Consensus 175 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~ 252 (318)
T 2dyl_A 175 LVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL-QEEPPLLPG 252 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH-HSCCCCCCS
T ss_pred ccCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh-ccCCCCCCc
Confidence 54332 223457899999999984 4567889999999999999999999998754 333443333 22222233
Q ss_pred -CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 884 -QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 884 -~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
..+++.+.+||.+||..||.+||++.+++++
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 253 HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 4689999999999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=365.80 Aligned_cols=249 Identities=13% Similarity=0.088 Sum_probs=187.8
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhc--CCCCeeeEE-------eee
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRV--RHPNVVLFM-------GAV 725 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L--~HpNIV~Li-------d~f 725 (931)
..+|+++++||+|+||+||+|++ +++.||||++....... .....+.+|+.+++.| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 35799999999999999999987 57789999999876533 4456777886555555 699988865 444
Q ss_pred eeC-----------------CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHH------HHHHHHHHHHHHHHHhCCCCE
Q 002355 726 TKR-----------------PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRR------LRMALDVAKGINYLHNLNPPI 782 (931)
Q Consensus 726 ~~~-----------------~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~------~~Ia~QIa~AL~yLHs~G~~I 782 (931)
... .++||||||+. ++|.+++.... ..+.+..+ +.++.||+.||+|||++| |
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--i 215 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG--L 215 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--C
Confidence 322 34899999997 89999997532 22444445 677799999999999999 9
Q ss_pred EEeccCCCCeEECCCCcEEEEecCccccccccccccCCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCC
Q 002355 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRG--EPSNEKSDVYSFGVILWELVTMQQP 860 (931)
Q Consensus 783 IHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~--~~~t~ksDIWSLG~ILyELLTG~~P 860 (931)
+||||||+||||+.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCEE---EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCCc---cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999998765432 14456799999999987 6789999999999999999999999
Q ss_pred CCCCChHHHH--HH---HHhc--ccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 861 WNGLGPAQVV--GA---VAFQ--NRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 861 F~~~~~~eii--~~---i~~~--~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
|.+....... .. .... ......+..+++.+.+||.+||..||++|||+.++++|
T Consensus 293 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp TTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 9876432110 00 0000 11122235789999999999999999999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.83 Aligned_cols=246 Identities=27% Similarity=0.443 Sum_probs=197.9
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee---------
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--------- 727 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~--------- 727 (931)
++|++++.||+|+||+||+|++ +++.||||++... ......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 6899999999999999999987 5788999999653 3445678899999999999999999998854
Q ss_pred ----CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEE
Q 002355 728 ----RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVC 803 (931)
Q Consensus 728 ----~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~ 803 (931)
....|+||||+++++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEEC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCCCEEEe
Confidence 45789999999999999999752 345788999999999999999999999 9999999999999999999999
Q ss_pred ecCcccccccc--------------ccccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC-hH
Q 002355 804 DFGLSRFKANT--------------FISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLG-PA 867 (931)
Q Consensus 804 DFGlAr~~~~~--------------~~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~-~~ 867 (931)
|||++...... ........||+.|+|||++.+. .++.++|||||||++|+|++ ||.... ..
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 99999764321 1122345689999999999865 68899999999999999998 564332 22
Q ss_pred HHHHHHHhcc--cccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 868 QVVGAVAFQN--RRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 868 eii~~i~~~~--~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.....+.... .+...+...++.+.+||.+||..||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 3333332211 1233456677889999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=348.73 Aligned_cols=256 Identities=23% Similarity=0.445 Sum_probs=186.7
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHH-HHHhcCCCCeeeEEeeeeeCC
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVA-IMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIk-ILk~L~HpNIV~Lid~f~~~~ 729 (931)
.+++..++|++++.||+|+||.||+|++. ++.||||++...... .....+.+|+. +++.++||||+++++++...+
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE-KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG 94 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH-HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc-hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence 34667799999999999999999999885 788999999865432 33345566665 677789999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhhc--CCCCCCCcHHHHHHHHHHHHHHHHHHHhC-CCCEEEeccCCCCeEECCCCcEEEEecC
Q 002355 730 HLSIVTEYLPRGSLYRLIHR--PAAGEMMDQRRRLRMALDVAKGINYLHNL-NPPILHWDLKSPNLLVDKNWTVKVCDFG 806 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r--~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~-G~~IIHrDLKPeNILLd~dg~IKL~DFG 806 (931)
..++||||+.+ +|.+++.. ......+++..++.++.|++.||.|||+. | |+||||||+|||++.++.+||+|||
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECCCS
T ss_pred ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEccCC
Confidence 99999999964 88777752 11235689999999999999999999998 9 9999999999999999999999999
Q ss_pred ccccccccccccCCCCCCCcccCcccc----cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcccccC
Q 002355 807 LSRFKANTFISSKSVAGTPEWMAPEFL----RGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPA-QVVGAVAFQNRRLA 881 (931)
Q Consensus 807 lAr~~~~~~~~~~~~~GT~~Y~APEvL----~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~-eii~~i~~~~~r~~ 881 (931)
+++...... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||...... +....+ .......
T Consensus 172 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~ 249 (327)
T 3aln_A 172 ISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDPPQ 249 (327)
T ss_dssp SSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC-CCSCCCC
T ss_pred Cceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH-hcCCCCC
Confidence 997654432 22334789999999998 4566889999999999999999999999875432 111111 1111111
Q ss_pred C----CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 882 I----PQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 882 l----P~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+ ...+++.+.+||.+||..||.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 2 24678999999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=354.06 Aligned_cols=249 Identities=23% Similarity=0.297 Sum_probs=203.5
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CC-----CeeeEEeeeeeCC
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HP-----NVVLFMGAVTKRP 729 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-Hp-----NIV~Lid~f~~~~ 729 (931)
.++|+++++||+|+||+||+|++ +++.||||++.... .....+.+|+++++.++ |+ +|+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK---AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH---HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH---HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 47999999999999999999987 46789999997532 33456778899988885 44 4999999999999
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC--CCCcEEEEecCc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD--KNWTVKVCDFGL 807 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd--~dg~IKL~DFGl 807 (931)
++|+||||+. ++|.+++.... ...+++..++.++.||+.||.|||++..+|+||||||+|||++ .++.+||+|||+
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred ceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 9999999995 59999997632 2458999999999999999999995323399999999999995 478899999999
Q ss_pred cccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccC------
Q 002355 808 SRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLA------ 881 (931)
Q Consensus 808 Ar~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~------ 881 (931)
++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+........
T Consensus 208 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (382)
T 2vx3_A 208 SCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ 284 (382)
T ss_dssp CEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred ceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 9876543 2456789999999999999999999999999999999999999998877666554432111000
Q ss_pred ----------CCC----------------------------------------------CChHHHHHHHHHhcccCCCCC
Q 002355 882 ----------IPQ----------------------------------------------NTSPVLASLMESCWADDPAQR 905 (931)
Q Consensus 882 ----------lP~----------------------------------------------~~s~eL~dLI~rcL~~DPeeR 905 (931)
++. ...+.+.+||.+||++||.+|
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 364 (382)
T 2vx3_A 285 APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTR 364 (382)
T ss_dssp CTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTS
T ss_pred hHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhC
Confidence 000 011478999999999999999
Q ss_pred CCHHHHHHH
Q 002355 906 PSFANIVES 914 (931)
Q Consensus 906 PSa~ELLq~ 914 (931)
||+.|+|+|
T Consensus 365 pta~e~L~h 373 (382)
T 2vx3_A 365 IQPYYALQH 373 (382)
T ss_dssp CCHHHHTTS
T ss_pred CCHHHHhcC
Confidence 999999876
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=381.42 Aligned_cols=262 Identities=30% Similarity=0.550 Sum_probs=221.5
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEc-----CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWH-----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK 727 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~-----g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~ 727 (931)
.+++..++|++.+.||+|+||+||+|++. +..||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 45667799999999999999999999873 2348888876532 3344577899999999999999999999985
Q ss_pred CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCc
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGl 807 (931)
++..|+||||+.+++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred cCceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecCC
Confidence 45689999999999999999752 335899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccc-cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCC
Q 002355 808 SRFKANTF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQN 885 (931)
Q Consensus 808 Ar~~~~~~-~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~ 885 (931)
++...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. ...+...+..
T Consensus 538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~ 616 (656)
T 2j0j_A 538 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPN 616 (656)
T ss_dssp CCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-HTCCCCCCTT
T ss_pred CeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCCCCCCcc
Confidence 98654332 12223456789999999998889999999999999999997 999999988877776654 3445667889
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 886 TSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
+++.+.+||.+||..||.+|||+.++++.|+.++..
T Consensus 617 ~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 617 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999998753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=347.18 Aligned_cols=247 Identities=22% Similarity=0.343 Sum_probs=178.0
Q ss_pred cCceEEEE-EecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHH-HHHHhcCCCCeeeEEeeeee----CC
Q 002355 658 WDELHVKE-RVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREV-AIMKRVRHPNVVLFMGAVTK----RP 729 (931)
Q Consensus 658 ~drY~Ii~-kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EI-kILk~L~HpNIV~Lid~f~~----~~ 729 (931)
.++|++++ .||+|+||+||+|++. ++.||||++.... ...+|+ ..++.+.||||+++++++.. +.
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 47899965 5999999999999885 7899999987542 122233 34667799999999999975 55
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC---CCcEEEEecC
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---NWTVKVCDFG 806 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~---dg~IKL~DFG 806 (931)
.+++||||+.|++|.+++.+.. ...+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred eEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccc
Confidence 6899999999999999997632 346999999999999999999999999 999999999999976 4559999999
Q ss_pred ccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHhcc--ccc
Q 002355 807 LSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGA----VAFQN--RRL 880 (931)
Q Consensus 807 lAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~----i~~~~--~r~ 880 (931)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........... +.... ...
T Consensus 177 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (336)
T 3fhr_A 177 FAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN 254 (336)
T ss_dssp TCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCT
T ss_pred cceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCc
Confidence 99865433 22456789999999999888889999999999999999999999977654433211 11111 111
Q ss_pred CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 881 AIPQNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 881 ~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
.....+++.+.+||.+||..||.+|||+.+++++-+
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 290 (336)
T 3fhr_A 255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW 290 (336)
T ss_dssp TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 223578999999999999999999999999998744
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=343.16 Aligned_cols=243 Identities=25% Similarity=0.414 Sum_probs=199.4
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch----HHHHHHHHHHHHHHhc----CCCCeeeEEeeee
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD----DQLKEFLREVAIMKRV----RHPNVVLFMGAVT 726 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~----~~~~~~l~EIkILk~L----~HpNIV~Lid~f~ 726 (931)
..++|+++++||+|+||+||+|++ +++.||||++....... .....+.+|+.+++++ +|+||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 447899999999999999999987 57789999997654332 1223456799999999 8999999999999
Q ss_pred eCCeEEEEEee-cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC-CCCcEEEEe
Q 002355 727 KRPHLSIVTEY-LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTVKVCD 804 (931)
Q Consensus 727 ~~~~l~LVmEy-~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd-~dg~IKL~D 804 (931)
..+..++|||+ +.+++|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+||+++ .++.+||+|
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECC
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEE
Confidence 99999999999 7899999999762 35899999999999999999999999 99999999999999 889999999
Q ss_pred cCccccccccccccCCCCCCCcccCcccccCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCC
Q 002355 805 FGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSN-EKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP 883 (931)
Q Consensus 805 FGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t-~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP 883 (931)
||++...... ......|+..|+|||++.+..+. .++|||||||++|+|++|+.||.... +. ......++
T Consensus 184 fg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~------~~~~~~~~ 253 (312)
T 2iwi_A 184 FGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--EI------LEAELHFP 253 (312)
T ss_dssp CSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HH------HHTCCCCC
T ss_pred cchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--HH------hhhccCCc
Confidence 9999866543 23456789999999998876654 58999999999999999999997532 11 12344567
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 884 QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 884 ~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
..++..+.+||.+||..||++|||+.+++++
T Consensus 254 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 8899999999999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=361.36 Aligned_cols=251 Identities=22% Similarity=0.322 Sum_probs=185.5
Q ss_pred CceEE-EEEecccCceEEEEEEEc----CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeee--eCCeE
Q 002355 659 DELHV-KERVGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT--KRPHL 731 (931)
Q Consensus 659 drY~I-i~kLG~G~fGtVylAr~~----g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~--~~~~l 731 (931)
+.|++ .++||+|+||+||+|++. ++.||||++...... ..+.+|+.+|+.++||||++++++|. .+..+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 56776 458999999999999864 678999999765433 35678999999999999999999995 47789
Q ss_pred EEEEeecCCCCHHHHhhcC------CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEE----CCCCcEE
Q 002355 732 SIVTEYLPRGSLYRLIHRP------AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV----DKNWTVK 801 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~------~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILL----d~dg~IK 801 (931)
|+||||+. ++|.+++... .....+++..++.++.||+.||+|||++| |+||||||+|||| +.++.+|
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999995 6888877531 11224899999999999999999999999 9999999999999 6778999
Q ss_pred EEecCccccccccc---cccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChH---------H
Q 002355 802 VCDFGLSRFKANTF---ISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPA---------Q 868 (931)
Q Consensus 802 L~DFGlAr~~~~~~---~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~---------e 868 (931)
|+|||+++...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.... +
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 99999998654321 123456789999999999874 4899999999999999999999999765431 1
Q ss_pred HHHHHHhc-cccc-----------------------------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHH
Q 002355 869 VVGAVAFQ-NRRL-----------------------------------AIPQNTSPVLASLMESCWADDPAQRPSFANIV 912 (931)
Q Consensus 869 ii~~i~~~-~~r~-----------------------------------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELL 912 (931)
.+..+... ..+. ......++.+.+||.+||.+||.+|||+.|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 11111100 0000 01112367889999999999999999999999
Q ss_pred HHHH
Q 002355 913 ESLK 916 (931)
Q Consensus 913 q~L~ 916 (931)
+|-+
T Consensus 333 ~hp~ 336 (405)
T 3rgf_A 333 QDPY 336 (405)
T ss_dssp TSGG
T ss_pred cChh
Confidence 8743
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=366.19 Aligned_cols=254 Identities=20% Similarity=0.309 Sum_probs=212.5
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCC-CCeeeEEeeeeeCCeEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH-PNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~H-pNIV~Lid~f~~~~~l~LV 734 (931)
.++|+++++||+|+||.||+|++ +++.||||++...... ..+.+|+++++.|+| ++|..+..++..+...+||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 47999999999999999999987 4788999998765432 246789999999986 5666777777888999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEE---CCCCcEEEEecCccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLV---DKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILL---d~dg~IKL~DFGlAr~~ 811 (931)
|||+ +++|.+++... ...+++..++.|+.||+.||+|||++| ||||||||+|||| +.++.+||+|||+++..
T Consensus 82 me~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EECC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 9999 99999999752 346999999999999999999999999 9999999999999 58899999999999865
Q ss_pred ccccc-------ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcc---c
Q 002355 812 ANTFI-------SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGP---AQVVGAVAFQN---R 878 (931)
Q Consensus 812 ~~~~~-------~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~---~eii~~i~~~~---~ 878 (931)
..... ......||+.|+|||++.+..++.++|||||||+||||++|..||.+... .+.+..+.... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS 236 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence 44321 12356799999999999999999999999999999999999999987653 22333222111 1
Q ss_pred ccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 002355 879 RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920 (931)
Q Consensus 879 r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llk 920 (931)
...++..+++++.+||.+||..+|++||++.+|++.|++++.
T Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 122346789999999999999999999999999999999876
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=347.06 Aligned_cols=244 Identities=22% Similarity=0.367 Sum_probs=206.9
Q ss_pred cccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch----HHHHHHHHHHHHHHhcC--CCCeeeEEeeeee
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD----DQLKEFLREVAIMKRVR--HPNVVLFMGAVTK 727 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~----~~~~~~l~EIkILk~L~--HpNIV~Lid~f~~ 727 (931)
...++|+++++||+|+||+||+|++ +++.||||++....... .....+.+|+.+++.++ |+||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3458999999999999999999987 57789999998764322 11234567999999996 5999999999999
Q ss_pred CCeEEEEEeecCC-CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC-CCCcEEEEec
Q 002355 728 RPHLSIVTEYLPR-GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTVKVCDF 805 (931)
Q Consensus 728 ~~~l~LVmEy~~G-gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd-~dg~IKL~DF 805 (931)
.+..++|||++.+ ++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+||
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCC
T ss_pred CCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 9999999999976 8999999752 35899999999999999999999999 99999999999999 7899999999
Q ss_pred CccccccccccccCCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCC
Q 002355 806 GLSRFKANTFISSKSVAGTPEWMAPEFLRGEPS-NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQ 884 (931)
Q Consensus 806 GlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~-t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~ 884 (931)
|++....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... .. .......+.
T Consensus 195 g~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~------~~~~~~~~~ 264 (320)
T 3a99_A 195 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EI------IRGQVFFRQ 264 (320)
T ss_dssp TTCEECCSSC--BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HH------HHCCCCCSS
T ss_pred cccccccccc--ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--hh------hcccccccc
Confidence 9998665432 244578999999999987665 678999999999999999999997632 11 122344667
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 885 NTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 885 ~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+++++.+||.+||..||.+|||+.+++++
T Consensus 265 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 265 RVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 889999999999999999999999999886
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=353.23 Aligned_cols=250 Identities=25% Similarity=0.363 Sum_probs=192.8
Q ss_pred ccccCceEEEEEecccCceEE-EEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEE
Q 002355 655 EISWDELHVKERVGAGSFGTV-HRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtV-ylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~ 732 (931)
.+...+|++.+.||+|+||+| |++..+++.||||++...... .+.+|+++|+.+ +||||+++++++.+....|
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 94 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQFQY 94 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence 445578999999999999985 555678999999999764432 245799999999 7999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC-----CCcEEEEecCc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-----NWTVKVCDFGL 807 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~-----dg~IKL~DFGl 807 (931)
|||||+ +++|.+++.... ..+.+..++.++.||+.||+|||++| |+||||||+|||++. ...+||+|||+
T Consensus 95 lv~E~~-~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 95 IAIELC-AATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp EEEECC-SEEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred EEEECC-CCCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 999999 469999997632 23444556789999999999999999 999999999999953 23588999999
Q ss_pred cccccccc---cccCCCCCCCcccCccccc---CCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccc-
Q 002355 808 SRFKANTF---ISSKSVAGTPEWMAPEFLR---GEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRR- 879 (931)
Q Consensus 808 Ar~~~~~~---~~~~~~~GT~~Y~APEvL~---~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r- 879 (931)
++...... .......||+.|+|||++. ...++.++|||||||++|||++ |..||..................
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~ 249 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC 249 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTT
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccc
Confidence 98654321 2234567999999999997 4556789999999999999999 89999765544332221111111
Q ss_pred cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 LAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 ~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
...+...+..+.+||.+||+.||.+|||+.++++|
T Consensus 250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 11223446678999999999999999999999965
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=348.45 Aligned_cols=247 Identities=23% Similarity=0.379 Sum_probs=188.6
Q ss_pred cCceEEEEEecccCceEEEEE-EEcCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRA-EWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylA-r~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.+.|.+.+.||+|+||+||.+ ..+++.||||++.... ...+.+|+++|+.+ +||||+++++++..+..+|+||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 356677899999999999765 5578999999987543 24567899999887 8999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCC----CCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC-------------C
Q 002355 736 EYLPRGSLYRLIHRPAAGE----MMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN-------------W 798 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~----~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d-------------g 798 (931)
||+ +++|.+++....... ...+..++.++.||+.||+|||++| |+||||||+|||++.+ +
T Consensus 89 E~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 89 ELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred ecC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCce
Confidence 999 469999997632211 1123345779999999999999999 9999999999999754 4
Q ss_pred cEEEEecCcccccccccc----ccCCCCCCCcccCcccccC-------CCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 002355 799 TVKVCDFGLSRFKANTFI----SSKSVAGTPEWMAPEFLRG-------EPSNEKSDVYSFGVILWELVT-MQQPWNGLGP 866 (931)
Q Consensus 799 ~IKL~DFGlAr~~~~~~~----~~~~~~GT~~Y~APEvL~~-------~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~ 866 (931)
.+||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 899999999986544221 1234579999999999976 567899999999999999999 9999976554
Q ss_pred HHHHHHHHhcccccC-C----CCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 867 AQVVGAVAFQNRRLA-I----PQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 867 ~eii~~i~~~~~r~~-l----P~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+. .+........ . +..+++++.+||.+||..||.+|||+.++++|
T Consensus 246 ~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 246 RES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hHH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 331 1211111111 1 12346889999999999999999999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=327.23 Aligned_cols=230 Identities=17% Similarity=0.154 Sum_probs=190.9
Q ss_pred cCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
.++|+++++||+|+||+||+|++. ++.||||++...... ......+.+|+.++..++||||+++++++..++..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 378999999999999999999985 788999999876543 34557889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||++|++|.+++.+ . .....+..++.||+.||+|||++| |+||||||+|||++.+|.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 999999999999954 1 345567889999999999999999 9999999999999999999997443
Q ss_pred ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHhccc--ccCCCCCChHH
Q 002355 815 FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVG---AVAFQNR--RLAIPQNTSPV 889 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~---~i~~~~~--r~~lP~~~s~e 889 (931)
|++ .++.++|||||||++|+|++|+.||.+.+....+. ....... ....+..++++
T Consensus 175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T 3uqc_A 175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ 235 (286)
T ss_dssp ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHH
T ss_pred ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHH
Confidence 333 26889999999999999999999998765432110 0000000 01234678999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 890 LASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 890 L~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
+.+||.+||..||.+| |+.++++.|.++....
T Consensus 236 l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 236 ISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred HHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 9999999999999999 9999999999987654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.89 Aligned_cols=227 Identities=25% Similarity=0.388 Sum_probs=183.5
Q ss_pred cCceEEE-EEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHH-HhcCCCCeeeEEeeeee----CC
Q 002355 658 WDELHVK-ERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIM-KRVRHPNVVLFMGAVTK----RP 729 (931)
Q Consensus 658 ~drY~Ii-~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkIL-k~L~HpNIV~Lid~f~~----~~ 729 (931)
.++|.++ +.||+|+||+||+|++ +++.||||++... ..+.+|+.++ +.++||||+++++++.. +.
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 3678887 7899999999999987 5778999999753 3456888887 55689999999999976 67
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC---CCcEEEEecC
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---NWTVKVCDFG 806 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~---dg~IKL~DFG 806 (931)
.+++||||++|++|.+++.... ...+++..++.++.||+.||+|||++| |+||||||+|||++. ++.+||+|||
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred eEEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 8999999999999999997632 346999999999999999999999999 999999999999998 7889999999
Q ss_pred ccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--ccccCCC-
Q 002355 807 LSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ--NRRLAIP- 883 (931)
Q Consensus 807 lAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~--~~r~~lP- 883 (931)
++.... +..++.++|||||||++|+|++|..||............... ......+
T Consensus 166 ~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (299)
T 3m2w_A 166 FAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223 (299)
T ss_dssp TCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred cccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence 986432 133677999999999999999999999775543322111100 1111222
Q ss_pred ---CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002355 884 ---QNTSPVLASLMESCWADDPAQRPSFANIVESLK 916 (931)
Q Consensus 884 ---~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~ 916 (931)
..+++++.+||.+||..||.+|||+.|+++|-.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~ 259 (299)
T 3m2w_A 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 259 (299)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence 567899999999999999999999999998743
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=340.42 Aligned_cols=241 Identities=17% Similarity=0.207 Sum_probs=189.5
Q ss_pred ccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccc------hHHHHHHHHHHHHHHhcC---------CCCeeeE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFL------DDQLKEFLREVAIMKRVR---------HPNVVLF 721 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~------~~~~~~~l~EIkILk~L~---------HpNIV~L 721 (931)
..++|+++++||+|+||+||+|+++++.||||++...... ......+.+|+.+++.++ ||||+++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 4578999999999999999999999999999999876421 122356788999998886 6777666
Q ss_pred Eeee-----------------ee-------------CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHH
Q 002355 722 MGAV-----------------TK-------------RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771 (931)
Q Consensus 722 id~f-----------------~~-------------~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~A 771 (931)
++.+ .. .+.+||||||+.+|++.+.+.+ ..+++..++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 6653 22 7889999999999977666643 358999999999999999
Q ss_pred HHHHH-hCCCCEEEeccCCCCeEECCCC--------------------cEEEEecCccccccccccccCCCCCCCcccCc
Q 002355 772 INYLH-NLNPPILHWDLKSPNLLVDKNW--------------------TVKVCDFGLSRFKANTFISSKSVAGTPEWMAP 830 (931)
Q Consensus 772 L~yLH-s~G~~IIHrDLKPeNILLd~dg--------------------~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~AP 830 (931)
|+||| ++| |+||||||+||||+.++ .+||+|||+|+..... ..+||+.|+||
T Consensus 174 L~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aP 246 (336)
T 2vuw_A 174 LAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCS
T ss_pred HHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccCh
Confidence 99999 899 99999999999999887 8999999999865543 34799999999
Q ss_pred ccccCCCCCchhHHHHHHHH-HHHHHhCCCCCCCCCh-HHHHHHHHhc-ccccC----CCCCChHHHHHHHHHhcccCCC
Q 002355 831 EFLRGEPSNEKSDVYSFGVI-LWELVTMQQPWNGLGP-AQVVGAVAFQ-NRRLA----IPQNTSPVLASLMESCWADDPA 903 (931)
Q Consensus 831 EvL~~~~~t~ksDIWSLG~I-LyELLTG~~PF~~~~~-~eii~~i~~~-~~r~~----lP~~~s~eL~dLI~rcL~~DPe 903 (931)
|++.+.. +.++||||||++ .+++++|..||..... ......+... ..... .+..+++++.+||.+||++|
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-- 323 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-- 323 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence 9999876 899999998777 7788899999854211 1111122111 11111 12356889999999999976
Q ss_pred CCCCHHHHH-HH
Q 002355 904 QRPSFANIV-ES 914 (931)
Q Consensus 904 eRPSa~ELL-q~ 914 (931)
|+.|++ +|
T Consensus 324 ---sa~e~l~~H 332 (336)
T 2vuw_A 324 ---SATDLLCQH 332 (336)
T ss_dssp ---SHHHHHHHC
T ss_pred ---CHHHHHhcC
Confidence 898888 65
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=367.29 Aligned_cols=260 Identities=22% Similarity=0.289 Sum_probs=207.3
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee------CCe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK------RPH 730 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~------~~~ 730 (931)
++|++.++||+|+||+||+|++ +++.||||++.... .......+.+|+++++.++||||+++++++.. ++.
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 7899999999999999999976 57889999987643 34455778999999999999999999998755 678
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCc---EEEEecCc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWT---VKVCDFGL 807 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~---IKL~DFGl 807 (931)
.++||||++|++|.+++........+++..++.++.||+.||+|||+.| |+||||||+||+++.++. +||+|||+
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 8999999999999999987555556899999999999999999999999 999999999999997664 99999999
Q ss_pred cccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH---------HHHHh-c-
Q 002355 808 SRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVV---------GAVAF-Q- 876 (931)
Q Consensus 808 Ar~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii---------~~i~~-~- 876 (931)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....... ..... .
T Consensus 171 a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (676)
T 3qa8_A 171 AKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249 (676)
T ss_dssp CCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred cccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence 98765432 234567899999999999999999999999999999999999999764322110 00000 0
Q ss_pred -c------c----ccCCCCCChHHHHHHHHHhcccCCCCCCCHHH-----HHHHHHHHhhCc
Q 002355 877 -N------R----RLAIPQNTSPVLASLMESCWADDPAQRPSFAN-----IVESLKKLLKSP 922 (931)
Q Consensus 877 -~------~----r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~E-----LLq~L~~Llks~ 922 (931)
. . +..+...+++.+.+||.+||.+||.+|||+.+ +++.+++++...
T Consensus 250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 0 0 01122346789999999999999999999988 556677777653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=340.81 Aligned_cols=245 Identities=14% Similarity=0.122 Sum_probs=190.2
Q ss_pred ccCceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccch-HHHHHHHHHHHHHHhcCC-CCee-------------
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH-PNVV------------- 719 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~H-pNIV------------- 719 (931)
....|.+.+.||+|+||+||+|++. ++.||||++....... ...+.+.+|+.+++.++| +|+.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 4467999999999999999999975 8899999987443222 234678899999999976 2211
Q ss_pred --------eEEeeeee-----CCeEEEEEeecCCCCHHHHhhc----CCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCE
Q 002355 720 --------LFMGAVTK-----RPHLSIVTEYLPRGSLYRLIHR----PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPI 782 (931)
Q Consensus 720 --------~Lid~f~~-----~~~l~LVmEy~~GgSL~d~L~r----~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~I 782 (931)
.++.++.. ...++++|+++ +++|.+++.. ......+++..++.++.||+.||+|||++| |
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i 232 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--L 232 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--c
Confidence 11111221 23467888877 7899998852 122445888899999999999999999999 9
Q ss_pred EEeccCCCCeEECCCCcEEEEecCccccccccccccCCCCCCCcccCcccc----------cCCCCCchhHHHHHHHHHH
Q 002355 783 LHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFL----------RGEPSNEKSDVYSFGVILW 852 (931)
Q Consensus 783 IHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL----------~~~~~t~ksDIWSLG~ILy 852 (931)
+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++|
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 99999999999999999999999999875544 345577 999999999 5556788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 853 ELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 853 ELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
||++|+.||......+....+ ......+++.+.+||.+||..||++||++.+++++
T Consensus 309 elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHCCCCCCCcchhhhHHHH------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999999876544322211 22234678999999999999999999998888654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=355.52 Aligned_cols=242 Identities=23% Similarity=0.297 Sum_probs=196.3
Q ss_pred ccCceEEEEEecccCceEEEEEEE---cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe---
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW---HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH--- 730 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~---~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~--- 730 (931)
..++|+++++||+|+||+||+|++ +++.||||++.... .......+.+|++++++++||||++++++|...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 458999999999999999999987 36789999886543 23445678899999999999999999999986655
Q ss_pred --EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 731 --LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 731 --l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
.||||||++|++|.+++.. .+++..++.++.||+.||.|||++| ||||||||+|||++.+ .+||+|||++
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999987753 5899999999999999999999999 9999999999999885 8999999999
Q ss_pred ccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChH
Q 002355 809 RFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888 (931)
Q Consensus 809 r~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~ 888 (931)
+..... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+...... .........++
T Consensus 229 ~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------~~~~~~~~~~~ 295 (681)
T 2pzi_A 229 SRINSF----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------PEDDPVLKTYD 295 (681)
T ss_dssp EETTCC----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------CTTCHHHHHCH
T ss_pred hhcccC----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc--------cccccccccCH
Confidence 865543 4567999999999987764 8899999999999999999998865321100 00000012346
Q ss_pred HHHHHHHHhcccCCCCCC-CHHHHHHHHHHHhh
Q 002355 889 VLASLMESCWADDPAQRP-SFANIVESLKKLLK 920 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRP-Sa~ELLq~L~~Llk 920 (931)
.+.+||.+||..||.+|| +++++.+.|..++.
T Consensus 296 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 296 SYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred HHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 899999999999999999 46666677776653
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-29 Score=296.73 Aligned_cols=184 Identities=15% Similarity=0.112 Sum_probs=132.4
Q ss_pred EecccCceEEEEEE--EcCCceEEEEEeecccc--------hHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCeEEEE
Q 002355 666 RVGAGSFGTVHRAE--WHGSDVAVKVLTVQDFL--------DDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 666 kLG~G~fGtVylAr--~~g~~VAVKVlk~~~~~--------~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~l~LV 734 (931)
.++.|++|.+..++ +.|+.||+|++...... ....+++.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 56788888887765 47999999999875321 12346789999999999 699999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||++|++|.+++.+. ..++.. .|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 9999999999999863 346654 47899999999999999 999999999999999999999999999876554
Q ss_pred ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCC
Q 002355 815 FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQ 858 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~ 858 (931)
.....+.+||+.|||||++.+. ...++|+|++|+++++|.++.
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred CccccCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence 4444567899999999999875 567899999999988776553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-26 Score=267.20 Aligned_cols=185 Identities=19% Similarity=0.224 Sum_probs=146.9
Q ss_pred EEEEEecccCceEEEEEEEcCCceEEEEEeecccchH------HHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 662 HVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDD------QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 662 ~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~------~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
...++||+|+||+||+|++.++.+++|+......... ..+++.+|+++|++++||||+++..++...+..||||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 3467899999999999998999999999866543322 2356899999999999999996555555777789999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||++|++|.+++.. +..++.||+.||+|||++| |+||||||+|||++. .+||+|||+++......
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 99999999999864 4578999999999999999 999999999999998 99999999998765432
Q ss_pred cc-------cCCCCCCCcccCcccccC--CCCCchhHHHHHHHHHHHHHhCCCCC
Q 002355 816 IS-------SKSVAGTPEWMAPEFLRG--EPSNEKSDVYSFGVILWELVTMQQPW 861 (931)
Q Consensus 816 ~~-------~~~~~GT~~Y~APEvL~~--~~~t~ksDIWSLG~ILyELLTG~~PF 861 (931)
.. ....+||+.|||||++.. ..|+..+|+|+..+-..+.+.++.+|
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 135679999999999987 55677889999988888887776665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.7e-22 Score=214.68 Aligned_cols=147 Identities=16% Similarity=0.103 Sum_probs=116.7
Q ss_pred cCceEEEEEecccCceEEEEEEE-cCCceEEEEEeecccch----------------HHHHHHHHHHHHHHhcCCCCeee
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLD----------------DQLKEFLREVAIMKRVRHPNVVL 720 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~~----------------~~~~~~l~EIkILk~L~HpNIV~ 720 (931)
...|.+++.||+|+||.||+|++ +++.||||+++...... .....+.+|+.+|+.++ | ++
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 34567779999999999999998 47789999996543211 13467889999999999 4 56
Q ss_pred EEeeeeeCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcE
Q 002355 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTV 800 (931)
Q Consensus 721 Lid~f~~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~I 800 (931)
+.+++.. +..|+||||++|++|.+ +.. .....++.||+.||.|||++| |+||||||+|||++ ++.+
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~~~v 231 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-EEGI 231 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-TTEE
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-CCcE
Confidence 6665544 45699999999999988 432 123468999999999999999 99999999999999 9999
Q ss_pred EEEecCccccccccccccCCCCCCCcccCccccc
Q 002355 801 KVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLR 834 (931)
Q Consensus 801 KL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~ 834 (931)
||+|||+|+. +..++|||++.
T Consensus 232 kl~DFG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 232 WIIDFPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp EECCCTTCEE-------------TTSTTHHHHHH
T ss_pred EEEECCCCeE-------------CCCCCHHHHHH
Confidence 9999999863 34568888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=4.5e-19 Score=186.58 Aligned_cols=138 Identities=17% Similarity=0.151 Sum_probs=107.3
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCc--eEEEEEeecccch----------------------HHHHHHHHHHHHHHhc
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSD--VAVKVLTVQDFLD----------------------DQLKEFLREVAIMKRV 713 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~--VAVKVlk~~~~~~----------------------~~~~~~l~EIkILk~L 713 (931)
-|++.+.||+|+||.||+|++ +|+. ||||+++...... .....+.+|+.+|+.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999987 7888 9999976542110 1123578899999999
Q ss_pred CCCCe--eeEEeeeeeCCeEEEEEeecCC-C----CHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHH-hCCCCEEEe
Q 002355 714 RHPNV--VLFMGAVTKRPHLSIVTEYLPR-G----SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH-NLNPPILHW 785 (931)
Q Consensus 714 ~HpNI--V~Lid~f~~~~~l~LVmEy~~G-g----SL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLH-s~G~~IIHr 785 (931)
.|++| ..+++. ...+|||||+.+ | +|.++... .++..+..++.||+.+|.||| ++| |+||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g--ivHr 195 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE--LVHA 195 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC--EECS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC--EEeC
Confidence 87754 344432 356899999932 3 77766532 234567789999999999999 999 9999
Q ss_pred ccCCCCeEECCCCcEEEEecCccccc
Q 002355 786 DLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 786 DLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
||||+|||++. .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.2e-16 Score=179.99 Aligned_cols=138 Identities=17% Similarity=0.156 Sum_probs=100.4
Q ss_pred CceEEEEEecccCceEEEEEEE-cCCceEEEEEeecccc---------------h-HH--H--HHHHHHHHHHHhcCCCC
Q 002355 659 DELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFL---------------D-DQ--L--KEFLREVAIMKRVRHPN 717 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~---------------~-~~--~--~~~l~EIkILk~L~HpN 717 (931)
--|++.++||.|+||.||+|.+ +|+.||||+++..... . .. . ....+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3499999999999999999986 6889999998643210 0 00 0 11235677777775444
Q ss_pred ee--eEEeeeeeCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC
Q 002355 718 VV--LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD 795 (931)
Q Consensus 718 IV--~Lid~f~~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd 795 (931)
+. ..++. . ..+|||||+.|.+|.++... .....++.||+.+|.+||++| ||||||||.|||++
T Consensus 175 v~vp~p~~~---~-~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQ---S-RHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG--LIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEE---E-TTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE
T ss_pred CCCCeeeec---c-CceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEe
Confidence 32 22221 1 23799999999888765432 123467899999999999999 99999999999998
Q ss_pred CCC----------cEEEEecCccccc
Q 002355 796 KNW----------TVKVCDFGLSRFK 811 (931)
Q Consensus 796 ~dg----------~IKL~DFGlAr~~ 811 (931)
.+| .+.|+||+.+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 776 3899999987643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=8.9e-12 Score=129.30 Aligned_cols=141 Identities=13% Similarity=0.049 Sum_probs=112.2
Q ss_pred CceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCeEEEEEee
Q 002355 659 DELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
+.|++...+|.|+.+.||++...++.+++|+........ ...+.+|+.+++.+. +..+.++++++...+..|+|||+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 578999999999999999998888899999987532111 135778999999995 66788899999989999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN-------------------------------------- 779 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G-------------------------------------- 779 (931)
++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 92 i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 92 ADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred cCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999999876421 1122357889999999999810
Q ss_pred -------------------CCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 780 -------------------PPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 780 -------------------~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
..++|+|++|.||+++.++.+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 239999999999999876566799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.04 E-value=4.1e-10 Score=114.94 Aligned_cols=136 Identities=18% Similarity=0.126 Sum_probs=99.1
Q ss_pred CceEEEEEecccCceEEEEEEEc-CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCC--eeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN--VVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~-g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpN--IV~Lid~f~~~~~l~LVm 735 (931)
..|.+....+.|..+.||++... ++.+++|+..... ...+.+|+.+++.+.+.+ +.++++++..++..++||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 45565444446667999999764 5679999976541 134678999999886444 566888888888899999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN------------------------------------ 779 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G------------------------------------ 779 (931)
|+++|.+|. ... .. ...++.+++..|..||+..
T Consensus 95 e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 95 GEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp ECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999998884 221 11 1246677778888888643
Q ss_pred --------------------CCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 780 --------------------PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 780 --------------------~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
..++|+|++|.||+++.++.+.|+|||.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 1299999999999998776677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.02 E-value=5.7e-10 Score=121.69 Aligned_cols=142 Identities=16% Similarity=0.192 Sum_probs=107.0
Q ss_pred EEEEecccCceEEEEEEEcCCceEEEEEe--ecccchHHHHHHHHHHHHHHhcCC--CCeeeEEeeeeeC---CeEEEEE
Q 002355 663 VKERVGAGSFGTVHRAEWHGSDVAVKVLT--VQDFLDDQLKEFLREVAIMKRVRH--PNVVLFMGAVTKR---PHLSIVT 735 (931)
Q Consensus 663 Ii~kLG~G~fGtVylAr~~g~~VAVKVlk--~~~~~~~~~~~~l~EIkILk~L~H--pNIV~Lid~f~~~---~~l~LVm 735 (931)
.++.|+.|.++.||++...+..+++|+.. ..... .....+.+|..+++.|.+ ..+.+++.++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 46789999999999998888888998875 32211 112467789999999974 4578888888766 4589999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhC-------------------------------------
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL------------------------------------- 778 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~------------------------------------- 778 (931)
|+++|..+.+.. ...++......++.+++..|..||..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999988775321 12367788888999999999999973
Q ss_pred -------------------CCCEEEeccCCCCeEECCCCc--EEEEecCcccc
Q 002355 779 -------------------NPPILHWDLKSPNLLVDKNWT--VKVCDFGLSRF 810 (931)
Q Consensus 779 -------------------G~~IIHrDLKPeNILLd~dg~--IKL~DFGlAr~ 810 (931)
...++|+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134999999999999997753 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.81 E-value=2.8e-09 Score=113.72 Aligned_cols=184 Identities=20% Similarity=0.201 Sum_probs=121.0
Q ss_pred EEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCC--eeeEEeeeeeCC---eEEEEEeec
Q 002355 665 ERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPN--VVLFMGAVTKRP---HLSIVTEYL 738 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpN--IV~Lid~f~~~~---~l~LVmEy~ 738 (931)
+.++.|....||++. ..+++|+.... .....+.+|..+|+.+. +.. +.+++.....+. ..|+||+++
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 348999999999873 67889986432 23456789999999884 332 345555443333 358999999
Q ss_pred CCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 002355 739 PRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN--------------------------------------- 779 (931)
Q Consensus 739 ~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G--------------------------------------- 779 (931)
+|.+|...... .++......++.+++..|..||+..
T Consensus 99 ~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99888754321 3667777788888888888888621
Q ss_pred -----------------CCEEEeccCCCCeEECC--CCcEEEEecCccccccccccccCCCCCCCcccCccccc------
Q 002355 780 -----------------PPILHWDLKSPNLLVDK--NWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLR------ 834 (931)
Q Consensus 780 -----------------~~IIHrDLKPeNILLd~--dg~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~------ 834 (931)
..++|+|++|.||+++. .+.+.|+||+.+................ .-..|+...
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~-~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD-EEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT-TSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc-cccCHHHHHHHHHHc
Confidence 23899999999999998 4567899999986532211100000000 002222111
Q ss_pred CCCC--------CchhHHHHHHHHHHHHHhCCCCC
Q 002355 835 GEPS--------NEKSDVYSFGVILWELVTMQQPW 861 (931)
Q Consensus 835 ~~~~--------t~ksDIWSLG~ILyELLTG~~PF 861 (931)
+... ....+.|+++.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1100 12358999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=4.5e-06 Score=89.75 Aligned_cols=135 Identities=16% Similarity=0.170 Sum_probs=94.6
Q ss_pred EEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCC---CeeeEEeeee-eCCeEEEEEeecC
Q 002355 664 KERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP---NVVLFMGAVT-KRPHLSIVTEYLP 739 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~Hp---NIV~Lid~f~-~~~~l~LVmEy~~ 739 (931)
++.++.|....||+. +..+++|+-.. ......+.+|.++|+.|.+. .+.+.+.+.. ..+..++|||+++
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 355899999999988 67889998432 23345788999999999752 3556666663 4566789999999
Q ss_pred CCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 002355 740 RGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN---------------------------------------- 779 (931)
Q Consensus 740 GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G---------------------------------------- 779 (931)
|..|....-. .++......++.++...|..||+..
T Consensus 97 G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 97 GQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp SEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred CeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 9888763211 1344444555555555555555421
Q ss_pred ------------------CCEEEeccCCCCeEECC---CCc-EEEEecCcccc
Q 002355 780 ------------------PPILHWDLKSPNLLVDK---NWT-VKVCDFGLSRF 810 (931)
Q Consensus 780 ------------------~~IIHrDLKPeNILLd~---dg~-IKL~DFGlAr~ 810 (931)
..++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 23799999999999987 455 48999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=7.2e-06 Score=85.03 Aligned_cols=132 Identities=14% Similarity=0.149 Sum_probs=95.5
Q ss_pred ecccCce-EEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCeEEEEEeecCCCC
Q 002355 667 VGAGSFG-TVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIVTEYLPRGS 742 (931)
Q Consensus 667 LG~G~fG-tVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~l~LVmEy~~GgS 742 (931)
+..|..+ .||+... .+..+.||+-... ....+.+|..+|+.|. +--+.+++.++.+++..++|||+++|.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 4445444 6898765 3567899986543 2356778999999885 2236678888888899999999999998
Q ss_pred HHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 002355 743 LYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN------------------------------------------- 779 (931)
Q Consensus 743 L~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G------------------------------------------- 779 (931)
+.+..... ......+..++...|.-||...
T Consensus 107 ~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 87765431 1122346667777777777532
Q ss_pred -------------CCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 780 -------------PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 780 -------------~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
..++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 0279999999999999877778999998753
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.02 E-value=2.5e-05 Score=83.04 Aligned_cols=141 Identities=15% Similarity=0.124 Sum_probs=80.4
Q ss_pred EEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcC--CCCeeeEEe------eeeeCCeEEEEE
Q 002355 664 KERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR--HPNVVLFMG------AVTKRPHLSIVT 735 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~--HpNIV~Lid------~f~~~~~l~LVm 735 (931)
++.|+.|..+.||++...+..+++|+.... . ..+..|..+++.|. .-.+.+++. +...++..++||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EEECC----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeeccccccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 356777788999999877767999998752 1 22334555555553 112333332 123467789999
Q ss_pred eecCCCCHH-----------H---HhhcC---C--CCC------CCcHHH------------------------------
Q 002355 736 EYLPRGSLY-----------R---LIHRP---A--AGE------MMDQRR------------------------------ 760 (931)
Q Consensus 736 Ey~~GgSL~-----------d---~L~r~---~--~~~------~L~e~~------------------------------ 760 (931)
++++|..+. . .++.. . ... ...+..
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986542 1 11110 0 000 011111
Q ss_pred -HHHHHHHHHHHHHHHHh-----------CCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 761 -RLRMALDVAKGINYLHN-----------LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 761 -~~~Ia~QIa~AL~yLHs-----------~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
...+..++..++++|+. ....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 01111223345666653 233499999999999998888899999997743
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=9.3e-06 Score=88.04 Aligned_cols=82 Identities=10% Similarity=0.021 Sum_probs=56.6
Q ss_pred eEEEEEe-cccCceEEEEEEEc--------CCceEEEEEeecc---cchHHHHHHHHHHHHHHhcC-C--CCeeeEEeee
Q 002355 661 LHVKERV-GAGSFGTVHRAEWH--------GSDVAVKVLTVQD---FLDDQLKEFLREVAIMKRVR-H--PNVVLFMGAV 725 (931)
Q Consensus 661 Y~Ii~kL-G~G~fGtVylAr~~--------g~~VAVKVlk~~~---~~~~~~~~~l~EIkILk~L~-H--pNIV~Lid~f 725 (931)
...++.| +.|....+|+.... ++.+++|+..... ... ...+.+|..+++.|. + -.+.+++.+.
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~--~~~~~~E~~~l~~L~~~~~vpvP~v~~~~ 99 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP--TYRLDHQFEVIRLVGELTDVPVPRVRWIE 99 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS--CCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc--hhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence 3456788 89999999998765 6778888865432 100 124567888888874 2 2466777776
Q ss_pred eeC---CeEEEEEeecCCCCHH
Q 002355 726 TKR---PHLSIVTEYLPRGSLY 744 (931)
Q Consensus 726 ~~~---~~l~LVmEy~~GgSL~ 744 (931)
.++ +..++|||+++|..+.
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBCCC
T ss_pred cCCCccCCceEEEEecCCCChh
Confidence 654 3578999999887654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=4.6e-05 Score=84.18 Aligned_cols=76 Identities=16% Similarity=0.084 Sum_probs=49.1
Q ss_pred EEEecccCceEEEEEEE--cCCceEEEEEeeccc-ch----HHHHHHHHHHHHHHhcCC--C-CeeeEEeeeeeCCeEEE
Q 002355 664 KERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDF-LD----DQLKEFLREVAIMKRVRH--P-NVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~-~~----~~~~~~l~EIkILk~L~H--p-NIV~Lid~f~~~~~l~L 733 (931)
++.||.|..+.||+++. .++.++||....... .. ....++..|.++|+.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 56799999999999954 567899998653211 00 012356778888888742 3 34456543 3445689
Q ss_pred EEeecCCC
Q 002355 734 VTEYLPRG 741 (931)
Q Consensus 734 VmEy~~Gg 741 (931)
|||++.|.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00042 Score=75.56 Aligned_cols=76 Identities=20% Similarity=0.143 Sum_probs=61.4
Q ss_pred EEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcC---CCCeeeEEeeeeeCCeEEEEEeecC
Q 002355 663 VKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR---HPNVVLFMGAVTKRPHLSIVTEYLP 739 (931)
Q Consensus 663 Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~---HpNIV~Lid~f~~~~~l~LVmEy~~ 739 (931)
-++.|+.|....+|+....+..++||+..... ...+..|...|+.|. ...+.+++.+....+..++|||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~-----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDEVQTVFVKINERSY-----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEEECCSSSSEEEEEESSSCEEEEEEEEGGG-----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeEEeCCccceeeeEEEECCCeEEEEeCCccc-----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 45789999999999998888889999876431 356778988888884 3567788888887888999999999
Q ss_pred CCCH
Q 002355 740 RGSL 743 (931)
Q Consensus 740 GgSL 743 (931)
|..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00038 Score=77.86 Aligned_cols=77 Identities=16% Similarity=0.154 Sum_probs=46.4
Q ss_pred CCEEEeccCCCCeEECCCCcEEEEecCccccccccccccCCCC-CCCcccCcccccCCC---CCchhHHHHHHHHHHHHH
Q 002355 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVA-GTPEWMAPEFLRGEP---SNEKSDVYSFGVILWELV 855 (931)
Q Consensus 780 ~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~~~~-GT~~Y~APEvL~~~~---~t~ksDIWSLG~ILyELL 855 (931)
..++|+|++|.|||++.++ ++|+||+.+.............. -...|++|+...... .....++..+...+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 3499999999999998877 99999998875432211000000 012456665543211 122345557777777776
Q ss_pred hC
Q 002355 856 TM 857 (931)
Q Consensus 856 TG 857 (931)
++
T Consensus 311 ~~ 312 (420)
T 2pyw_A 311 NK 312 (420)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00032 Score=74.68 Aligned_cols=146 Identities=11% Similarity=0.072 Sum_probs=82.3
Q ss_pred eEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCC--eeeEEee------eeeCCeEE
Q 002355 661 LHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN--VVLFMGA------VTKRPHLS 732 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpN--IV~Lid~------f~~~~~l~ 732 (931)
..-++.|+.|....||+....+..+++|+...... ...+..|+.+++.|...+ +.+++.. ....+..+
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred ceEeeccCCCcccceEEEEeCCccEEEEEeCCCCC----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 34467788999999999987777899999865311 123456777777774212 2333321 12346679
Q ss_pred EEEeecCCCCHHH-----------H---hhcC--C-CCC---CC---cHHHHHH------------HHHHHHHHHHHHHh
Q 002355 733 IVTEYLPRGSLYR-----------L---IHRP--A-AGE---MM---DQRRRLR------------MALDVAKGINYLHN 777 (931)
Q Consensus 733 LVmEy~~GgSL~d-----------~---L~r~--~-~~~---~L---~e~~~~~------------Ia~QIa~AL~yLHs 777 (931)
++|++++|..+.. . ++.. . ... .. .+..... +...+...+++++.
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 9999998865311 0 1110 0 000 00 1111000 00113445556653
Q ss_pred C-----CCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 778 L-----NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 778 ~-----G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
. ...++|+|+++.|||++.++.+.|+||+.+..
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 2 12399999999999998876668999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0014 Score=69.13 Aligned_cols=81 Identities=16% Similarity=0.068 Sum_probs=55.8
Q ss_pred ccCceEEEEEecccCceEEEEEEE-cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCC---CeeeEEeeeeeCCeEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP---NVVLFMGAVTKRPHLS 732 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~Hp---NIV~Lid~f~~~~~l~ 732 (931)
...+..-++.+|.|..+.||+.+. +|+.|.+|+-....... ...+..|...|+.|... -+.+++.+. .-+
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~ 86 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRT 86 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTE
T ss_pred cCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc----Cce
Confidence 345677789999999999999987 57889999864332111 13467899999988421 344555432 237
Q ss_pred EEEeecCCCCH
Q 002355 733 IVTEYLPRGSL 743 (931)
Q Consensus 733 LVmEy~~GgSL 743 (931)
+|||++.++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999877643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0014 Score=70.47 Aligned_cols=31 Identities=29% Similarity=0.338 Sum_probs=27.0
Q ss_pred CEEEeccCCCCeEECCC----CcEEEEecCccccc
Q 002355 781 PILHWDLKSPNLLVDKN----WTVKVCDFGLSRFK 811 (931)
Q Consensus 781 ~IIHrDLKPeNILLd~d----g~IKL~DFGlAr~~ 811 (931)
.++|+|+.+.||+++.+ +.+.|+||+.+...
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 49999999999999874 68999999988653
|
| >3isr_A Transglutaminase-like enzymes, putative cysteine; protease, hutchinsoni MCSG, structural genomics; 1.90A {Cytophaga hutchinsonii} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0015 Score=70.90 Aligned_cols=95 Identities=18% Similarity=0.162 Sum_probs=68.5
Q ss_pred HHHHHHHHHHhhccChHHHHHHHHHHHHHhhCCCcCCCcchhhhhHHHHHHHHHhhhcCceEEeecccccchhhhHHHHH
Q 002355 338 ELEDKAQELYCASENTLVLVEELGKLVAICMGGTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFK 417 (931)
Q Consensus 338 ~l~~~a~~~~~~~~~~~~~~~~la~~V~~~mgg~~~~~~~~~~~~~~~~~~~l~~~~~~~v~plG~l~~G~~rhRAlLFK 417 (931)
++.+.|.++..+..++.+.+..|...|.+.+.=...... ..... ...| .-+.|+|++.|.||-
T Consensus 127 ~i~~~A~~~~~~~~~~~~~~~ai~~~v~~~~~Y~~~~~~--~~~~a---~~~l------------~~~~G~C~d~A~l~v 189 (293)
T 3isr_A 127 KLQKLAYKEFGKIENVYSKVLAITDWIYNNVEYISGSTN--SQTSA---FDTI------------TERAGVCRDFAHLGI 189 (293)
T ss_dssp GSHHHHHHHHTTCCSHHHHHHHHHHHHHHHSEECTTSCC--TTCCH---HHHH------------HHCEECHHHHHHHHH
T ss_pred HHHHHHHHHhccCCCHHHHHHHHHHHHHhhcEEeccCCC--CCCCH---HHhh------------cCCcEehHHHHHHHH
Confidence 466677777777777888999999999998651110000 00011 1111 236899999999999
Q ss_pred HHhhhcCCCceeeecccccC----CCCceeEEEEecCc
Q 002355 418 KLADYIGLPCRIARGCRYCE----ADHRSSCLVKIEDD 451 (931)
Q Consensus 418 vLaD~i~l~c~lv~G~~y~~----~~~~~~~~v~~~~~ 451 (931)
.||-.+|||||+|.| |.. .+.|||++|.++.+
T Consensus 190 al~Ra~GIPAR~VsG--y~~~~~~~~~HAW~Evyl~gg 225 (293)
T 3isr_A 190 ALCRALSIPARYFTG--YAFKLNPPDFHACFEAYIGGN 225 (293)
T ss_dssp HHHHHTTCCEEEEEE--EETTCSSCCEEEEEEEEETTE
T ss_pred HHHHHCCCCEEEEEE--ECCCCCCCCeEEEEEEEECCc
Confidence 999999999999999 553 46799999999863
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0014 Score=69.68 Aligned_cols=71 Identities=14% Similarity=0.106 Sum_probs=44.7
Q ss_pred EEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCe-eeEEeeeeeCCeEEEEEeec-CCC
Q 002355 664 KERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV-VLFMGAVTKRPHLSIVTEYL-PRG 741 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNI-V~Lid~f~~~~~l~LVmEy~-~Gg 741 (931)
++.|+.|....+|++ ..+++|+...... ......+|..+++.+...++ .+++.++ .+.-++|+||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTE---EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCcc---ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 577999999999999 6788998764311 00112457777777742222 4555443 33347899999 665
Q ss_pred CH
Q 002355 742 SL 743 (931)
Q Consensus 742 SL 743 (931)
+|
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 54
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0024 Score=72.21 Aligned_cols=73 Identities=15% Similarity=0.238 Sum_probs=49.6
Q ss_pred EEEEecccCceEEEEEEEc---------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCe-eeEEeeeeeCCeEE
Q 002355 663 VKERVGAGSFGTVHRAEWH---------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV-VLFMGAVTKRPHLS 732 (931)
Q Consensus 663 Ii~kLG~G~fGtVylAr~~---------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNI-V~Lid~f~~~~~l~ 732 (931)
-++.|+.|....||++... ++.+.+|+..... . ...+.+|..+++.|...++ .++++.+.+ .
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 3567899999999999864 4678999874321 1 1234578888888853333 567766553 2
Q ss_pred EEEeecCCCCH
Q 002355 733 IVTEYLPRGSL 743 (931)
Q Consensus 733 LVmEy~~GgSL 743 (931)
+|+||++|.+|
T Consensus 149 ~v~e~l~G~~l 159 (429)
T 1nw1_A 149 RLEEYIPSRPL 159 (429)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEeCCccc
Confidence 89999987444
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.54 E-value=0.013 Score=61.57 Aligned_cols=146 Identities=13% Similarity=0.146 Sum_probs=96.9
Q ss_pred CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHH-hCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccccC
Q 002355 741 GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH-NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSK 819 (931)
Q Consensus 741 gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLH-s~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~~~ 819 (931)
.+|.+++.. .+.+++++++|.++.|.+.+|.-+- ... -..+=+.|..|+|..+|+|.+.+ +.+.
T Consensus 33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc----------
Confidence 478998875 3568999999999999999887662 111 11233457899999999987653 2111
Q ss_pred CCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcc
Q 002355 820 SVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWA 899 (931)
Q Consensus 820 ~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~ 899 (931)
.....+.+||... ...+.+.=|||||+++|.-+--..| ..-+..+++.+..||..|..
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHMAN 155 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHHTT
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHHHh
Confidence 1123456787663 3456889999999999998752221 12234678889999988875
Q ss_pred c-------------------------CCCCCCCHHHHHHHHHHHhhCch
Q 002355 900 D-------------------------DPAQRPSFANIVESLKKLLKSPA 923 (931)
Q Consensus 900 ~-------------------------DPeeRPSa~ELLq~L~~Llks~~ 923 (931)
- .+..|+++++|++....=++.+.
T Consensus 156 ~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~~ps 204 (229)
T 2yle_A 156 TVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLPTES 204 (229)
T ss_dssp CCC--------------------CCSCCCCCCSHHHHHHHHHTTSSSGG
T ss_pred cccccccccccccccccccccccccccccCcCCHHHHHHHHHhhccCcc
Confidence 5 24688999999988877666653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0043 Score=71.08 Aligned_cols=74 Identities=11% Similarity=0.046 Sum_probs=48.8
Q ss_pred EEEEecccCceEEEEEEEcC--CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCe-eeEEeeeeeCCeEEEEEeecC
Q 002355 663 VKERVGAGSFGTVHRAEWHG--SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV-VLFMGAVTKRPHLSIVTEYLP 739 (931)
Q Consensus 663 Ii~kLG~G~fGtVylAr~~g--~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNI-V~Lid~f~~~~~l~LVmEy~~ 739 (931)
-++.|+.|-...+|++...+ ..+.+|+....... .-.-.+|..+++.|...++ .++++.+.+ .+||||++
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~ 184 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMD 184 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeC
Confidence 35678999999999998876 77899987432100 0011478999999865444 567777642 35999998
Q ss_pred CCCH
Q 002355 740 RGSL 743 (931)
Q Consensus 740 GgSL 743 (931)
|.+|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0023 Score=69.97 Aligned_cols=73 Identities=11% Similarity=0.140 Sum_probs=43.8
Q ss_pred EEEecccCceEEEEEEEcC----------CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCC-eeeEEeeeeeCCeEE
Q 002355 664 KERVGAGSFGTVHRAEWHG----------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN-VVLFMGAVTKRPHLS 732 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~~g----------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpN-IV~Lid~f~~~~~l~ 732 (931)
++.|+.|....+|++...+ +.+++|+...... .......|..+++.|...+ +.++++.+. -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---ceecHHHHHHHHHHHHhcCCCCceEEecC----Cc
Confidence 4678888889999998654 6788888654211 1111346888888775333 346665542 26
Q ss_pred EEEeecCCCCH
Q 002355 733 IVTEYLPRGSL 743 (931)
Q Consensus 733 LVmEy~~GgSL 743 (931)
+||||++|..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999987543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.43 E-value=0.022 Score=60.57 Aligned_cols=140 Identities=12% Similarity=0.069 Sum_probs=78.5
Q ss_pred EEecccCceEEEEEEEc-CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCC--CeeeEEee-----eeeCCeEEEEEe
Q 002355 665 ERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP--NVVLFMGA-----VTKRPHLSIVTE 736 (931)
Q Consensus 665 ~kLG~G~fGtVylAr~~-g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~Hp--NIV~Lid~-----f~~~~~l~LVmE 736 (931)
..|+ |....||++... |+.+++|+........ ..+..|..+++.|... .+.+++.. ...++..++||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 3466 888899998764 5579999986433222 3455688887777422 23444432 223556789999
Q ss_pred ecCCCCHH-----------HH---hhc---CCC---CCCCcHHHH----HHH---------------HHHHHHHHHHHHh
Q 002355 737 YLPRGSLY-----------RL---IHR---PAA---GEMMDQRRR----LRM---------------ALDVAKGINYLHN 777 (931)
Q Consensus 737 y~~GgSL~-----------d~---L~r---~~~---~~~L~e~~~----~~I---------------a~QIa~AL~yLHs 777 (931)
+++|..+. .. ++. ... ......... ..+ ...+-..++.+..
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 99875432 01 111 000 011111110 001 0011112333322
Q ss_pred -----CCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 778 -----LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 778 -----~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 223489999999999999 4 899999998764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=0.01 Score=64.74 Aligned_cols=68 Identities=9% Similarity=0.046 Sum_probs=44.3
Q ss_pred cccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcC---CCCeeeEEee------eeeCCeEEEEEeec
Q 002355 668 GAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR---HPNVVLFMGA------VTKRPHLSIVTEYL 738 (931)
Q Consensus 668 G~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~---HpNIV~Lid~------f~~~~~l~LVmEy~ 738 (931)
|.|....||+....+..+++|+...... ..|+.+++.|. -+++.+.+.. ...++..++||+|+
T Consensus 32 G~g~~N~vy~v~~~~g~~vLK~~~~~~~--------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i 103 (339)
T 3i1a_A 32 GADTNAFAYQADSESKSYFIKLKYGYHD--------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFI 103 (339)
T ss_dssp TSCSSCEEEEEECSSCEEEEEEEECSSC--------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECC
T ss_pred cCccccceEEEEeCCCCEEEEEecCccc--------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEecc
Confidence 4444789999987655899998776542 24566666553 2224444432 23457789999999
Q ss_pred CCCCH
Q 002355 739 PRGSL 743 (931)
Q Consensus 739 ~GgSL 743 (931)
+|..+
T Consensus 104 ~G~~~ 108 (339)
T 3i1a_A 104 HAPNG 108 (339)
T ss_dssp CCCBT
T ss_pred CCCcC
Confidence 98765
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.91 E-value=0.016 Score=64.81 Aligned_cols=148 Identities=15% Similarity=0.177 Sum_probs=84.2
Q ss_pred ccccCceEEEEEecccCceEEEEEEEc---------CCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEee
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEWH---------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGA 724 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~~---------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~ 724 (931)
.+..+.+++ +.|..|-...+|++... ++.+.+|+-.... .....+.+|.++++.|. +.-..+++++
T Consensus 47 ~~~~~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~ 122 (379)
T 3feg_A 47 RVQPEELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGV 122 (379)
T ss_dssp GCCGGGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEE
T ss_pred CCCcCceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 333345553 56777888889999763 3678888853211 11234558999988884 2223566766
Q ss_pred eeeCCeEEEEEeecCCCCHHH--------------Hh---hcC--CCCCCC--cHHHHHHHHHHHHH-------------
Q 002355 725 VTKRPHLSIVTEYLPRGSLYR--------------LI---HRP--AAGEMM--DQRRRLRMALDVAK------------- 770 (931)
Q Consensus 725 f~~~~~l~LVmEy~~GgSL~d--------------~L---~r~--~~~~~L--~e~~~~~Ia~QIa~------------- 770 (931)
+.++ +||||++|.+|.. .+ +.. ..+... -++++.++..++-.
T Consensus 123 ~~~g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~ 198 (379)
T 3feg_A 123 FPEG----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLE 198 (379)
T ss_dssp ETTE----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHH
T ss_pred cCCc----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhh
Confidence 6542 9999998866531 11 111 011111 23455555544322
Q ss_pred ------HHHHHH----hC--CCCEEEeccCCCCeEECCC----CcEEEEecCcccc
Q 002355 771 ------GINYLH----NL--NPPILHWDLKSPNLLVDKN----WTVKVCDFGLSRF 810 (931)
Q Consensus 771 ------AL~yLH----s~--G~~IIHrDLKPeNILLd~d----g~IKL~DFGlAr~ 810 (931)
.+..|. .. ...++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 199 ~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 199 MYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 233332 22 1248999999999999876 7899999998753
|
| >2f4m_A Peptide N-glycanase; glycoproteins, ubiquitin-dependent protein degradation, NUCL excision repair, peptide:N-glycanase; 1.85A {Mus musculus} SCOP: d.3.1.4 PDB: 2f4o_A* | Back alignment and structure |
|---|
Probab=95.61 E-value=0.011 Score=64.33 Aligned_cols=42 Identities=19% Similarity=0.205 Sum_probs=39.7
Q ss_pred ccccchhhhHHHHHHHhhhcCCCceeeecccccCCCCceeEEEEecC
Q 002355 404 LSMGLCRHRAILFKKLADYIGLPCRIARGCRYCEADHRSSCLVKIED 450 (931)
Q Consensus 404 l~~G~~rhRAlLFKvLaD~i~l~c~lv~G~~y~~~~~~~~~~v~~~~ 450 (931)
-+.|+|++-|.||-.|+-.+|||||+|-| | +.|+|++|.++.
T Consensus 138 ~r~G~C~d~A~lf~al~Ra~GIpAR~V~G--y---~~HaW~Evy~~g 179 (295)
T 2f4m_A 138 TRCGRCGEWANCFTLCCRALGFEARYVWD--Y---TDHVWTEVYSPS 179 (295)
T ss_dssp HCEESHHHHHHHHHHHHHHTTCCEEEEEE--T---TTEEEEEEEETT
T ss_pred cCCEeeHHHHHHHHHHHHHCCCCEEEEcC--C---CCEEEEEEEECC
Confidence 47899999999999999999999999999 4 899999999987
|
| >3kd4_A Putative protease; structural genomics, joint center for STR genomics, JCSG, protein structure initiative, PSI-2, hydrol; HET: MSE; 2.00A {Parabacteroides distasonis atcc 8503} | Back alignment and structure |
|---|
Probab=95.37 E-value=0.04 Score=63.97 Aligned_cols=106 Identities=15% Similarity=0.094 Sum_probs=73.9
Q ss_pred HHHHHHHHHHHhhccChHHHHHHHHHHHHHhhCCC-cCCCcchh-hhhHHHHHHHHHhhhcCceEEeecccccchhhhHH
Q 002355 337 KELEDKAQELYCASENTLVLVEELGKLVAICMGGT-FPIEQGDL-HKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAI 414 (931)
Q Consensus 337 ~~l~~~a~~~~~~~~~~~~~~~~la~~V~~~mgg~-~~~~~~~~-~~~~~~~~~~l~~~~~~~v~plG~l~~G~~rhRAl 414 (931)
..++++|.++..+..++.+.++.|-.+|.+.+.=. ...+.... ..... .-|+. +.|.|+-.|+
T Consensus 228 ~~i~~~a~~l~~~~~~~~ek~~~iy~~V~~~i~y~~~~~~~~g~~~~~a~---~vl~~------------~~G~C~d~a~ 292 (506)
T 3kd4_A 228 YESKTFAQFLTDKSGNEQEKVNIIRDHILNNLSTCPIPMAMTGYTVRDID---TVLRS------------AYGTPLEIAQ 292 (506)
T ss_dssp HHHHHHHHHHHSSCSSHHHHHHHHHHHHHHHCEECCCCGGGGTTCCCCHH---HHHHH------------TEECHHHHHH
T ss_pred HHHHHHHHHHHhcCCCHHHHHHHHHHHHHhccEecceecccCCCCCCCHH---HHHHh------------CCcchHHHHH
Confidence 34666777888888999999999999999988411 00000000 00011 11221 2699999999
Q ss_pred HHHHHhhhcCCCceeeecc--------cccCCCCceeEEEEecCcccccceeEeec
Q 002355 415 LFKKLADYIGLPCRIARGC--------RYCEADHRSSCLVKIEDDRRSSREYVVDL 462 (931)
Q Consensus 415 LFKvLaD~i~l~c~lv~G~--------~y~~~~~~~~~~v~~~~~~~~~~~~ivDl 462 (931)
||..|+-.+||||++|-+. +..+.-+|+|+.|.+++. .|++|-
T Consensus 293 Ll~AllRa~GIpA~~v~~~t~~~~~~~~~lp~~nh~i~~v~~~g~-----~y~lDa 343 (506)
T 3kd4_A 293 LLNVMLNAAGIPSEVLAVYPGHLDTDACGLAAIQTLAVKATVDGK-----DQYLSA 343 (506)
T ss_dssp HHHHHHHHTTCCEEEEEEEETTSCGGGCCSTTCCEEEEEEEETTE-----EEEESS
T ss_pred HHHHHHHHCCCCcEEEEEEcCCCCCccCCCCCCCEEEEEEEECCE-----EEEEec
Confidence 9999999999999999984 223334899999988654 899997
|
| >1x3z_A Peptide: N-glycanase; hydrolase-hydrolase inhibitor complex; HET: SUC; 2.80A {Saccharomyces cerevisiae} SCOP: d.3.1.4 PDB: 1x3w_A* 3esw_A* | Back alignment and structure |
|---|
Probab=93.43 E-value=0.057 Score=59.54 Aligned_cols=43 Identities=19% Similarity=0.197 Sum_probs=39.8
Q ss_pred ccccchhhhHHHHHHHhhhcCCCceeeecccccCCCCceeEEEEecCc
Q 002355 404 LSMGLCRHRAILFKKLADYIGLPCRIARGCRYCEADHRSSCLVKIEDD 451 (931)
Q Consensus 404 l~~G~~rhRAlLFKvLaD~i~l~c~lv~G~~y~~~~~~~~~~v~~~~~ 451 (931)
.+.|.|.|-|-||=.|+=.+|||+|+|.| .++|+|++|-+...
T Consensus 179 tr~G~C~e~A~lF~~llRalGi~aR~V~~-----~~~H~W~EV~~~~~ 221 (335)
T 1x3z_A 179 TRKGRCGEWCNLFTLILKSFGLDVRYVWN-----REDHVWCEYFSNFL 221 (335)
T ss_dssp HCEECHHHHHHHHHHHHHTTTCCEEEEEE-----TTTEEEEEEEETTT
T ss_pred hCCcChHHHHHHHHHHHHHCCCCeEEEec-----CCCcEEEEEEECCC
Confidence 35799999999999999999999999998 78999999999875
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.93 E-value=0.34 Score=53.89 Aligned_cols=29 Identities=24% Similarity=0.422 Sum_probs=24.7
Q ss_pred EEEeccCCCCeEE------CCCCcEEEEecCcccc
Q 002355 782 ILHWDLKSPNLLV------DKNWTVKVCDFGLSRF 810 (931)
Q Consensus 782 IIHrDLKPeNILL------d~dg~IKL~DFGlAr~ 810 (931)
++|+|+.+.|||+ +.++.++++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4467799999998754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.66 E-value=0.3 Score=55.50 Aligned_cols=74 Identities=7% Similarity=0.100 Sum_probs=47.6
Q ss_pred EEEEecccCceEEEEEEEc---------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCC-eeeEEeeeeeCCeEE
Q 002355 663 VKERVGAGSFGTVHRAEWH---------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN-VVLFMGAVTKRPHLS 732 (931)
Q Consensus 663 Ii~kLG~G~fGtVylAr~~---------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpN-IV~Lid~f~~~~~l~ 732 (931)
-++.|..|-...+|++... ++.+.+|+..... .......+|.++++.|...+ ..++++.+. -+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~ 146 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----EG 146 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence 3466788888999999875 5778998864321 10111246888888874222 345565443 27
Q ss_pred EEEeecCCCCH
Q 002355 733 IVTEYLPRGSL 743 (931)
Q Consensus 733 LVmEy~~GgSL 743 (931)
+||||++|..|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999988764
|
| >2q3z_A Transglutaminase 2; transglutaminase 2, tissue transglutaminase, TG2, transferas; 2.00A {Homo sapiens} SCOP: b.1.18.9 b.1.5.1 b.1.5.1 d.3.1.4 PDB: 1kv3_A 3ly6_A* | Back alignment and structure |
|---|
Probab=90.97 E-value=0.11 Score=62.25 Aligned_cols=74 Identities=15% Similarity=0.211 Sum_probs=51.7
Q ss_pred hccChHHHHHHHHHHHHHh--------------hCCCcCCCcchhhhhHHHHHHHHHhhhcCceEEeecccccchhhhHH
Q 002355 349 ASENTLVLVEELGKLVAIC--------------MGGTFPIEQGDLHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAI 414 (931)
Q Consensus 349 ~~~~~~~~~~~la~~V~~~--------------mgg~~~~~~~~~~~~~~~~~~~l~~~~~~~v~plG~l~~G~~rhRAl 414 (931)
...++..++..|.+.|... .+|.. ...|.....-+..++.+.+.| .+.|.|++-|-
T Consensus 213 ~r~dPv~v~r~lsa~vn~~~d~gvl~g~w~~~y~~g~~-------p~~~~gs~~il~~~~~~~~~~---~k~G~C~dfA~ 282 (687)
T 2q3z_A 213 RRSSPVYVGRVGSGMVNCNDDQGVLLGRWDNNYGDGVS-------PMSWIGSVDILRRWKNHGCQR---VKYGQCWVFAA 282 (687)
T ss_dssp HTTCHHHHHHHHHHTTTCTTTTSSEEECCSSCCTTSCC-------TTTCCBSHHHHHHHHHTTTCC---EEEECHHHHHH
T ss_pred cCCCHHHHHHHHHHHhhcccccceEeeccccCcCCCCC-------CccccCchHHHHHHHhcCCCc---cceeehHHHHH
Confidence 4578998998888888653 11222 123433333334444433333 78999999999
Q ss_pred HHHHHhhhcCCCceeeec
Q 002355 415 LFKKLADYIGLPCRIARG 432 (931)
Q Consensus 415 LFKvLaD~i~l~c~lv~G 432 (931)
+|=+|+=.+|||||.|.|
T Consensus 283 ~~~~llRalGIPAR~VsG 300 (687)
T 2q3z_A 283 VACTVLRCLGIPTRVVTN 300 (687)
T ss_dssp HHHHHHHHHTCCEEEEEE
T ss_pred HHHHHHHhCCCCcEEEee
Confidence 999999999999999999
|
| >1g0d_A Protein-glutamine gamma-glutamyltransferase; tissue transglutaminase,acyltransferase; 2.50A {Pagrus major} SCOP: b.1.18.9 b.1.5.1 b.1.5.1 d.3.1.4 | Back alignment and structure |
|---|
Probab=84.42 E-value=0.76 Score=55.11 Aligned_cols=82 Identities=17% Similarity=0.228 Sum_probs=55.6
Q ss_pred hhccChHHHHHHHHHHHHHhhC-CCcCC-----Ccch-hhhhHHHHHHHHHhhhcCceEEeecccccchhhhHHHHHHHh
Q 002355 348 CASENTLVLVEELGKLVAICMG-GTFPI-----EQGD-LHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLA 420 (931)
Q Consensus 348 ~~~~~~~~~~~~la~~V~~~mg-g~~~~-----~~~~-~~~~~~~~~~~l~~~~~~~v~plG~l~~G~~rhRAlLFKvLa 420 (931)
....++..++..|.+.|-..-. |.+.. -... -...|-....-|++.+.+.+.| ++.|.|.|-|-+|-+|+
T Consensus 207 ~~r~dpv~v~r~lsa~vn~~dD~gvl~g~W~~~y~~g~~P~~w~gs~~il~~~~~~~~~P---V~~G~C~~fA~v~~t~l 283 (695)
T 1g0d_A 207 EHRSDPVYVGRTITAMVNSNGDRGVLTGRWEEPYTDGVAPYRWTGSVPILQQWSKAGVRP---VKYGQCWVFAAVACTVL 283 (695)
T ss_dssp HHTTCHHHHHHHHHHHHTTCTTTCSEEECCSSCCTTSCCGGGCSBSHHHHHHHHHTTSCC---EEEECHHHHHHHHHHHH
T ss_pred ccCCCHHHHHHHHHHHhhccCcCceeecccccccCCCcCCcccCChHHHHHHHHHcCCCc---ccceeeHHHHHHHHHHH
Confidence 3457899999999999866521 11100 0000 1234554444555555555444 58899999999999999
Q ss_pred hhcCCCceeeec
Q 002355 421 DYIGLPCRIARG 432 (931)
Q Consensus 421 D~i~l~c~lv~G 432 (931)
=.+|||||+|.|
T Consensus 284 R~lGIPaR~Vtg 295 (695)
T 1g0d_A 284 RCLGIPTRPITN 295 (695)
T ss_dssp HHHTCCEEEEEE
T ss_pred HhCCCCeeEEcc
Confidence 999999999999
|
| >1vjj_A Protein-glutamine glutamyltransferase E; transglutaminase 3, X-RAY crystallography, metalloenzyme, calcium ION; HET: GDP; 1.90A {Homo sapiens} SCOP: b.1.18.9 b.1.5.1 b.1.5.1 d.3.1.4 PDB: 1sgx_A* 1l9m_A 1l9n_A* 1nud_A 1nuf_A 1nug_A 1rle_A* | Back alignment and structure |
|---|
Probab=81.63 E-value=0.65 Score=55.72 Aligned_cols=81 Identities=16% Similarity=0.294 Sum_probs=54.3
Q ss_pred hccChHHHHHHHHHHHHHhh-CCCcCC-----Ccchh-hhhHHHHHHHHHhhhcCceEEeecccccchhhhHHHHHHHhh
Q 002355 349 ASENTLVLVEELGKLVAICM-GGTFPI-----EQGDL-HKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKLAD 421 (931)
Q Consensus 349 ~~~~~~~~~~~la~~V~~~m-gg~~~~-----~~~~~-~~~~~~~~~~l~~~~~~~v~plG~l~~G~~rhRAlLFKvLaD 421 (931)
...++..++..|++.|...- .|.+.. -.... ...|.....-|++.+.+.+.| ++.|.|+|-|-+|=+|+=
T Consensus 208 ~r~dpv~v~r~lsa~vn~~~d~gvl~g~w~~~y~~g~~P~~~~gs~~il~~~~~~~~~P---V~~G~C~~fA~~~~~~lR 284 (692)
T 1vjj_A 208 SRNDPKYVGRVLSAMINSNDDNGVLAGNWSGTYTGGRDPRSWNGSVEILKNWKKSGLSP---VRYGQCWVFAGTLNTALR 284 (692)
T ss_dssp GGGCHHHHHHHHHHHTBCTTTTCSEEECCSSCCTTSCCGGGCCBSHHHHHHHHHTTSCC---EEEECHHHHHHHHHHHHH
T ss_pred cCCCHHHHHHHHHHHhhccCccceeecccccccCCCcCCcccCChHHHHHHHHHcCCCc---ccceeeHHHHHHHHHHHH
Confidence 45788999999998886541 111100 00011 234544444455555555554 578999999999999999
Q ss_pred hcCCCceeeec
Q 002355 422 YIGLPCRIARG 432 (931)
Q Consensus 422 ~i~l~c~lv~G 432 (931)
.+|||||+|.|
T Consensus 285 ~lGIPaR~Vtg 295 (692)
T 1vjj_A 285 SLGIPSRVITN 295 (692)
T ss_dssp HHTCCEEEEEE
T ss_pred hCCCCeeEEcc
Confidence 99999999999
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 931 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-82 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-75 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-71 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-71 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-71 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-70 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-69 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-69 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-69 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-69 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-68 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-68 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-68 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-68 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-67 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-67 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-67 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-67 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-66 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-66 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-66 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-65 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-65 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-63 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-63 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-63 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-62 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-62 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-59 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-58 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-56 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-56 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-56 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-56 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-56 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-56 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-53 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-52 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-51 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-50 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-49 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-49 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-47 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-44 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-44 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-37 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-17 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 265 bits (679), Expect = 1e-82
Identities = 96/279 (34%), Positives = 158/279 (56%), Gaps = 16/279 (5%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMK 711
DW EI ++ V +R+G+GSFGTV++ +WHG DVAVK+L V QL+ F EV +++
Sbjct: 2 DW-EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
+ RH N++LFMG T P L+IVT++ SLY +H + + + +A A+G
Sbjct: 60 KTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQG 116
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF--KANTFISSKSVAGTPEWMA 829
++YLH I+H DLKS N+ + ++ TVK+ DFGL+ + + + ++G+ WMA
Sbjct: 117 MDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 830 PEFLRGE---PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL----AI 882
PE +R + P + +SDVY+FG++L+EL+T Q P++ + + + + +
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234
Query: 883 PQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921
N + LM C +RP F I+ S++ L +S
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (628), Expect = 1e-75
Identities = 84/268 (31%), Positives = 143/268 (53%), Gaps = 14/268 (5%)
Query: 653 WLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
W ++ EL + + +G G FG V ++ G+ VAVK + D + FL E ++M +
Sbjct: 2 W-ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQ 56
Query: 713 VRHPNVVLFMGAVTK-RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
+RH N+V +G + + + L IVTEY+ +GSL + ++ L+ +LDV +
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEA 115
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPE 831
+ YL +H DL + N+LV ++ KV DFGL++ ++T + +W APE
Sbjct: 116 MEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPE 170
Query: 832 FLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890
LR + + KSDV+SFG++LWE+ + + P+ + VV V + ++ P P +
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAV 229
Query: 891 ASLMESCWADDPAQRPSFANIVESLKKL 918
+M++CW D A RPSF + E L+ +
Sbjct: 230 YEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 236 bits (603), Expect = 1e-71
Identities = 88/282 (31%), Positives = 142/282 (50%), Gaps = 17/282 (6%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFLDDQLKEFLREVAI 709
EI + +++ +GAG FG V VA+K L + + Q ++FL E +I
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASI 80
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
M + HPNV+ G VTK + I+TE++ GSL + + + + M +A
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIA 138
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN-----TFISSKSVAGT 824
G+ YL + +H DL + N+LV+ N KV DFGLSRF + T+ S+
Sbjct: 139 AGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196
Query: 825 PEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIP 883
W APE ++ SDV+S+G+++WE+++ ++P+ + V+ A+ Q+ RL P
Sbjct: 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPP 255
Query: 884 QNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQL 925
+ L LM CW D RP F IV +L K++++P L
Sbjct: 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSL 297
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (600), Expect = 2e-71
Identities = 69/263 (26%), Positives = 121/263 (46%), Gaps = 9/263 (3%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
++ V +G GS+G + G + K L + + + + EV +++ ++HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 717 NVVLFMGAVTKRP--HLSIVTEYLPRGSLYRLIHR-PAAGEMMDQRRRLRMALDVAKGIN 773
N+V + + R L IV EY G L +I + + +D+ LR+ + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 774 YLHNLN---PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAP 830
H + +LH DLK N+ +D VK+ DFGL+R + +K+ GTP +M+P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 831 EFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890
E + NEKSD++S G +L+EL + P+ ++ G + + + IP S L
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDEL 242
Query: 891 ASLMESCWADDPAQRPSFANIVE 913
++ RPS I+E
Sbjct: 243 NEIITRMLNLKDYHRPSVEEILE 265
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (599), Expect = 3e-71
Identities = 83/272 (30%), Positives = 133/272 (48%), Gaps = 10/272 (3%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIM 710
+W E+ + L + ER+GAG FG V ++ + VAVK L FL E +M
Sbjct: 7 EW-EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLM 62
Query: 711 KRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAK 770
K+++H +V VT+ P I+TEY+ GSL + P+ G + + L MA +A+
Sbjct: 63 KQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAE 120
Query: 771 GINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTPEWMA 829
G+ ++ N +H DL++ N+LV + K+ DFGL+R + N + + + +W A
Sbjct: 121 GMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178
Query: 830 PEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPV 889
PE + KSDV+SFG++L E+VT + V + R+ P N
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238
Query: 890 LASLMESCWADDPAQRPSFANIVESLKKLLKS 921
L LM CW + P RP+F + L+ +
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 7e-70
Identities = 89/279 (31%), Positives = 142/279 (50%), Gaps = 11/279 (3%)
Query: 647 PSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-VAVKVLTVQDFLDDQLKEFLR 705
LA D EI + L ++ ++G G FG V W+G+ VA+K L + FL+
Sbjct: 5 QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQ 61
Query: 706 EVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA 765
E +MK++RH +V V++ P IVTEY+ +GSL + G+ + + + MA
Sbjct: 62 EAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMA 119
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGT 824
+A G+ Y+ +N +H DL++ N+LV +N KV DFGL+R + N + + +
Sbjct: 120 AQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 177
Query: 825 PEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQ-PWNGLGPAQVVGAVAFQNRRLAIP 883
+W APE KSDV+SFG++L EL T + P+ G+ +V+ V + R+ P
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCP 236
Query: 884 QNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
L LM CW +P +RP+F + L+ S
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 2e-69
Identities = 76/269 (28%), Positives = 134/269 (49%), Gaps = 11/269 (4%)
Query: 656 ISWDELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
I EL + +G+G FG VH W + VA+K + + ++F+ E +M ++
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLS 58
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
HP +V G ++ + +V E++ G L + + L M LDV +G+ Y
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAY 116
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS-SKSVAGTPEWMAPEFL 833
L ++H DL + N LV +N +KV DFG++RF + + S +W +PE
Sbjct: 117 LEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 834 RGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892
+ KSDV+SFGV++WE+ + + P+ ++VV ++ RL P+ S +
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQ 233
Query: 893 LMESCWADDPAQRPSFANIVESLKKLLKS 921
+M CW + P RP+F+ ++ L ++ +S
Sbjct: 234 IMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 2e-69
Identities = 75/283 (26%), Positives = 133/283 (46%), Gaps = 16/283 (5%)
Query: 654 LEISWDELHVKERV-GAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVA 708
L + D L + + G G+FG+V + + DVA+KVL Q +E +RE
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQ 61
Query: 709 IMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDV 768
IM ++ +P +V +G V + L +V E G L++ + E + + V
Sbjct: 62 IMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQV 118
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF---KANTFISSKSVAGTP 825
+ G+ YL N +H DL + N+L+ K+ DFGLS+ + + + +
Sbjct: 119 SMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 826 EWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQ 884
+W APE + + +SDV+S+GV +WE ++ Q+P+ + +V+ + Q +R+ P
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPP 235
Query: 885 NTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQ 927
P L +LM CW RP F + + ++ S A ++
Sbjct: 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (588), Expect = 2e-69
Identities = 84/293 (28%), Positives = 146/293 (49%), Gaps = 24/293 (8%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGS----DVAVKVLTVQDFLDDQLKEFLREVAIM 710
+ W+++ ++ +G G+FG V +A D A+K + + D ++F E+ ++
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVL 64
Query: 711 KRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR-------------PAAGEMM 756
++ HPN++ +GA R +L + EY P G+L + + + +
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 757 DQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816
++ L A DVA+G++YL +H DL + N+LV +N+ K+ DFGLSR + ++
Sbjct: 125 SSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQ-EVYV 181
Query: 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQ-PWNGLGPAQVVGAVAF 875
WMA E L SDV+S+GV+LWE+V++ P+ G+ A++ +
Sbjct: 182 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP- 240
Query: 876 QNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQM 928
Q RL P N + LM CW + P +RPSFA I+ SL ++L+ +
Sbjct: 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT 293
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 9e-69
Identities = 78/266 (29%), Positives = 130/266 (48%), Gaps = 11/266 (4%)
Query: 656 ISWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
I +L + +G G FG V +W DVA+K++ +D EF+ E +M +
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLS 57
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
H +V G TK+ + I+TEY+ G L + ++ L M DV + + Y
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEY 115
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTPEWMAPEFL 833
L + LH DL + N LV+ VKV DFGLSR+ + + SS W PE L
Sbjct: 116 LE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 834 RGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892
+ KSD+++FGV++WE+ ++ + P+ ++ +A Q RL P S + +
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYT 232
Query: 893 LMESCWADDPAQRPSFANIVESLKKL 918
+M SCW + +RP+F ++ ++ +
Sbjct: 233 IMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 1e-68
Identities = 86/273 (31%), Positives = 132/273 (48%), Gaps = 15/273 (5%)
Query: 656 ISWDELHVKERVGAGSFGTVHRAEWHGSD-----VAVKVLTVQDFLDDQ-LKEFLREVAI 709
I +L + E++G GSFG V R EW VAVK L + + +F+REV
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
M + H N++ G V P + +VTE P GSL + + R A+ VA
Sbjct: 65 MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVA 121
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF---KANTFISSKSVAGTPE 826
+G+ YL + +H DL + NLL+ VK+ DFGL R + ++ +
Sbjct: 122 EGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 827 WMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQN 885
W APE L+ + SD + FGV LWE+ T Q+PW GL +Q++ + + RL P++
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239
Query: 886 TSPVLASLMESCWADDPAQRPSFANIVESLKKL 918
+ ++M CWA P RP+F + + L +
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (578), Expect = 2e-68
Identities = 72/261 (27%), Positives = 126/261 (48%), Gaps = 14/261 (5%)
Query: 661 LHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
L +G GSF TV++ +VA L + + + F E ++K ++HPN+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 719 VLFMGA----VTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
V F + V + + +VTE + G+L + R ++M + + KG+ +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQF 127
Query: 775 LHNLNPPILHWDLKSPN-LLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFL 833
LH PPI+H DLK N + +VK+ D GL+ K +F +K+V GTPE+MAPE
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAVIGTPEFMAPEMY 185
Query: 834 RGEPSNEKSDVYSFGVILWELVTMQQPWNGLG-PAQVVGAVAFQNRRLAIPQNTSPVLAS 892
+ E DVY+FG+ + E+ T + P++ AQ+ V + + + P +
Sbjct: 186 EEKYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244
Query: 893 LMESCWADDPAQRPSFANIVE 913
++E C + +R S +++
Sbjct: 245 IIEGCIRQNKDERYSIKDLLN 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 2e-68
Identities = 80/315 (25%), Positives = 136/315 (43%), Gaps = 38/315 (12%)
Query: 639 GPRYLNIEP---SLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVK 688
Y ++ + W E + L + +G+G+FG V A +G VAVK
Sbjct: 15 DNEYFYVDFREYEYDLKW-EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK 73
Query: 689 VLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI 747
+L + + + + E+ +M ++ H N+V +GA T + ++ EY G L +
Sbjct: 74 MLK-EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL 132
Query: 748 HR--------------------PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDL 787
++ L A VAKG+ +L +H DL
Sbjct: 133 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDL 190
Query: 788 KSPNLLVDKNWTVKVCDFGLSRF--KANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVY 845
+ N+LV VK+CDFGL+R + ++ + +WMAPE L KSDV+
Sbjct: 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 250
Query: 846 SFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQ 904
S+G++LWE+ ++ P+ G+ + ++ P + + +M+SCWA D +
Sbjct: 251 SYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRK 310
Query: 905 RPSFANIVESLKKLL 919
RPSF N+ L L
Sbjct: 311 RPSFPNLTSFLGCQL 325
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 226 bits (576), Expect = 9e-68
Identities = 87/307 (28%), Positives = 138/307 (44%), Gaps = 37/307 (12%)
Query: 645 IEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLD 697
+ P L LE + + +G G+FG V +A G VAVK+L ++
Sbjct: 1 LNPKLLS--LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-EEASA 57
Query: 698 DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR-------- 749
D +F RE A+M +PN+V +G + ++ EY+ G L +
Sbjct: 58 DMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCS 117
Query: 750 -------------PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK 796
+ +L +A VA G+ YL +H DL + N LV +
Sbjct: 118 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGE 175
Query: 797 NWTVKVCDFGLSRF--KANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWEL 854
N VK+ DFGLSR A+ + + + A WM PE + +SDV+++GV+LWE+
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 235
Query: 855 VTMQQ-PWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVE 913
+ P+ G+ +V+ V LA P+N L +LM CW+ PA RPSF +I
Sbjct: 236 FSYGLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
Query: 914 SLKKLLK 920
L+++ +
Sbjct: 295 ILQRMCE 301
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 225 bits (575), Expect = 1e-67
Identities = 85/274 (31%), Positives = 138/274 (50%), Gaps = 10/274 (3%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAI 709
W E+ ++ +K ++G G +G V+ W VAVK L +++EFL+E A+
Sbjct: 11 KW-EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAV 66
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
MK ++HPN+V +G T+ P I+TE++ G+L + E+ L MA ++
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQIS 125
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTPEWM 828
+ YL +H DL + N LV +N VKV DFGLSR +T+ + +W
Sbjct: 126 SAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 183
Query: 829 APEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888
APE L + KSDV++FGV+LWE+ T V + ++ R+ P+
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 243
Query: 889 VLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
+ LM +CW +P+ RPSFA I ++ + + +
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 2e-67
Identities = 83/280 (29%), Positives = 132/280 (47%), Gaps = 14/280 (5%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD------VAVKVLTVQDFLDDQLKEFLREVA 708
EI + ++ +GAG FG V++ S VA+K L + + Q +FL E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAG 61
Query: 709 IMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDV 768
IM + H N++ G ++K + I+TEY+ G+L + + + + M +
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGI 119
Query: 769 AKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKS---VAGTP 825
A G+ YL N +H DL + N+LV+ N KV DFGLSR + ++ +
Sbjct: 120 AAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 826 EWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQN 885
W APE + SDV+SFG+++WE++T + V RL P +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 237
Query: 886 TSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQL 925
+ LM CW + A+RP FA+IV L KL+++P L
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 8e-67
Identities = 67/263 (25%), Positives = 128/263 (48%), Gaps = 14/263 (5%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
D + +G G+FG V++A+ + A KV+ + +++L++++ E+ I+ HP
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHP 69
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
N+V + A +L I+ E+ G++ ++ + + + + +NYLH
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLH 127
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFL--- 833
+ I+H DLK+ N+L + +K+ DFG+S T S GTP WMAPE +
Sbjct: 128 DNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 185
Query: 834 --RGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-RLAIPQNTSPVL 890
+ P + K+DV+S G+ L E+ ++ P + L P +V+ +A LA P S
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245
Query: 891 ASLMESCWADDPAQRPSFANIVE 913
++ C + R + + +++
Sbjct: 246 KDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 9e-67
Identities = 82/275 (29%), Positives = 140/275 (50%), Gaps = 13/275 (4%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSD---VAVKVLTVQDFLDDQLKE-FLREV 707
D+ EI + + + +G G FG VH+ + + +AV + T ++ D ++E FL+E
Sbjct: 1 DY-EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 59
Query: 708 AIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
M++ HP++V +G +T+ + I+ E G L + +D + A
Sbjct: 60 LTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQ 116
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF-KANTFISSKSVAGTPE 826
++ + YL + +H D+ + N+LV N VK+ DFGLSR+ + +T+ + +
Sbjct: 117 LSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 827 WMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQN 885
WMAPE + SDV+ FGV +WE++ +P+ G+ V+G + RL +P N
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPN 233
Query: 886 TSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920
P L SLM CWA DP++RP F + L +L+
Sbjct: 234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 1e-66
Identities = 70/266 (26%), Positives = 125/266 (46%), Gaps = 16/266 (6%)
Query: 660 ELHVKERV-GAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR 714
L ++++ G+G+FGTV + + VAVK+L + E L E +M+++
Sbjct: 7 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 66
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
+P +V +G + + +V E G L + + + + + + + V+ G+ Y
Sbjct: 67 NPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKY 122
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF---KANTFISSKSVAGTPEWMAPE 831
L N +H DL + N+L+ K+ DFGLS+ N + + +W APE
Sbjct: 123 LEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 832 FLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890
+ + KSDV+SFGV++WE + Q+P+ G+ ++V + + R+ P +
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREM 239
Query: 891 ASLMESCWADDPAQRPSFANIVESLK 916
LM CW D RP FA + L+
Sbjct: 240 YDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 2e-66
Identities = 87/294 (29%), Positives = 131/294 (44%), Gaps = 17/294 (5%)
Query: 640 PRYLNIEPSLAMDWLEISWDEL--HVKERVGAGSFGTVHRAEWHGSD-----VAVKVLTV 692
LN E A+ + I L H E +G G FG V+ +D AVK L
Sbjct: 6 LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN- 64
Query: 693 QDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP-HLSIVTEYLPRGSLYRLIHRPA 751
+ ++ +FL E IMK HPNV+ +G + +V Y+ G L I
Sbjct: 65 RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE- 123
Query: 752 AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF- 810
+ + L VAKG+ +L + +H DL + N ++D+ +TVKV DFGL+R
Sbjct: 124 -THNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180
Query: 811 ---KANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPA 867
+ ++ + +WMA E L+ + KSDV+SFGV+LWEL+T P
Sbjct: 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 240
Query: 868 QVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921
+ Q RRL P+ L +M CW RPSF+ +V + + +
Sbjct: 241 FDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 7e-66
Identities = 62/258 (24%), Positives = 118/258 (45%), Gaps = 12/258 (4%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQL-KEFLREVAIMKRVRH 715
++ + +G G FG V+ A S +A+KVL + + REV I +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
PN++ G + ++ EY P G++YR + + D++R ++A ++Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYC 122
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRG 835
H+ ++H D+K NLL+ +K+ DFG S ++ ++ GT +++ PE + G
Sbjct: 123 HSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEG 178
Query: 836 EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895
+EK D++S GV+ +E + + P+ + + P + L+
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFPDFVTEGARDLIS 236
Query: 896 SCWADDPAQRPSFANIVE 913
+P+QRP ++E
Sbjct: 237 RLLKHNPSQRPMLREVLE 254
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (560), Expect = 2e-65
Identities = 82/311 (26%), Positives = 143/311 (45%), Gaps = 33/311 (10%)
Query: 639 GPRYLNIEPS---LAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVK 688
G Y+ I+P+ W E + L + +GAG+FG V A +G VAVK
Sbjct: 1 GNNYVYIDPTQLPYDHKW-EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK 59
Query: 689 VLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLI 747
+L L ++ + + E+ ++ + H N+V +GA T ++TEY G L +
Sbjct: 60 MLKPSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 118
Query: 748 HR---------------PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNL 792
R +D L + VAKG+ +L + N +H DL + N+
Sbjct: 119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNI 176
Query: 793 LVDKNWTVKVCDFGLSRF--KANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVI 850
L+ K+CDFGL+R + ++ + +WMAPE + +SDV+S+G+
Sbjct: 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236
Query: 851 LWELVTMQQPWN-GLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFA 909
LWEL ++ G+ + + R+ P++ + +M++CW DP +RP+F
Sbjct: 237 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK 296
Query: 910 NIVESLKKLLK 920
IV+ ++K +
Sbjct: 297 QIVQLIEKQIS 307
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 219 bits (558), Expect = 4e-65
Identities = 61/255 (23%), Positives = 113/255 (44%), Gaps = 15/255 (5%)
Query: 665 ERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQ-LKEFLREVAIMKRVRHPNVVLF 721
+G GSFG V+ A VA+K ++ ++ ++ ++EV ++++RHPN + +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 722 MGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPP 781
G + +V EY + L + + + + +G+ YLH+ N
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN-- 135
Query: 782 ILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGE---PS 838
++H D+K+ N+L+ + VK+ DFG + A S GTP WMAPE +
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQY 191
Query: 839 NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCW 898
+ K DV+S G+ EL + P + + +A + S + ++SC
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251
Query: 899 ADDPAQRPSFANIVE 913
P RP+ +++
Sbjct: 252 QKIPQDRPTSEVLLK 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 1e-63
Identities = 62/255 (24%), Positives = 124/255 (48%), Gaps = 11/255 (4%)
Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
E++G G+ GTV+ A G +VA++ + +Q + + + E+ +M+ ++PN+V
Sbjct: 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIV 80
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
++ + L +V EYL GSL ++ MD+ + + + + + +LH+
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSN 839
++H D+KS N+L+ + +VK+ DFG ++ GTP WMAPE + +
Sbjct: 137 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 840 EKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-RLAIPQNTSPVLASLMESCW 898
K D++S G++ E++ + P+ P + + +A L P+ S + + C
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254
Query: 899 ADDPAQRPSFANIVE 913
D +R S +++
Sbjct: 255 DMDVEKRGSAKELLQ 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 3e-63
Identities = 73/285 (25%), Positives = 135/285 (47%), Gaps = 16/285 (5%)
Query: 656 ISWDELHVKERVGAGSFGTVHRAEWHGSD------VAVKVLTVQDFLDDQLKEFLREVAI 709
+ E + +G+G+FGTV++ W VA+K L + KE L E +
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYV 64
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
M V +P+V +G + ++T+ +P G L + + + + L + +A
Sbjct: 65 MASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIA 121
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF--KANTFISSKSVAGTPEW 827
KG+NYL + ++H DL + N+LV VK+ DFGL++ ++ +W
Sbjct: 122 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 828 MAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNT 886
MA E + +SDV+S+GV +WEL+T +P++G+ +++ + + RL P
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPIC 238
Query: 887 SPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQMGGE 931
+ + +M CW D RP F ++ K+ + P + + + G+
Sbjct: 239 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGD 283
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 4e-63
Identities = 82/303 (27%), Positives = 137/303 (45%), Gaps = 47/303 (15%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV 718
+ ++E +G G FG V R +W G +VAVK+ + ++ ++ E+ +RH N+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENI 59
Query: 719 VLFMGAVTKR----PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
+ F+ A K L +V++Y GSL+ ++R + +++AL A G+ +
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAH 115
Query: 775 LHNL------NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN----TFISSKSVAGT 824
LH P I H DLKS N+LV KN T + D GL+ + I+ GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 825 PEWMAPEFLRGE------PSNEKSDVYSFGVILWELVT----------MQQPWNGLGPA- 867
+MAPE L S +++D+Y+ G++ WE+ Q P+ L P+
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 868 ----QVVGAVAFQNRRLAIPQNTSP-----VLASLMESCWADDPAQRPSFANIVESLKKL 918
++ V Q R IP V+A +M CW + A R + I ++L +L
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
Query: 919 LKS 921
+
Sbjct: 296 SQQ 298
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 5e-63
Identities = 85/298 (28%), Positives = 143/298 (47%), Gaps = 21/298 (7%)
Query: 640 PRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTV 692
P Y + D E++ +++ + +G GSFG V+ G VA+K +
Sbjct: 1 PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN- 59
Query: 693 QDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIH---- 748
+ + EFL E ++MK +VV +G V++ ++ E + RG L +
Sbjct: 60 EAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRP 119
Query: 749 ---RPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDF 805
+ ++MA ++A G+ YL+ +H DL + N +V +++TVK+ DF
Sbjct: 120 AMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDF 177
Query: 806 GLSRF--KANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWN 862
G++R + + + WM+PE L+ SDV+SFGV+LWE+ T +QP+
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 237
Query: 863 GLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920
GL QV+ V + L P N +L LM CW +P RPSF I+ S+K+ ++
Sbjct: 238 GLSNEQVLRFV-MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (539), Expect = 1e-62
Identities = 85/297 (28%), Positives = 140/297 (47%), Gaps = 29/297 (9%)
Query: 652 DWLEISWDELHVKERVGAGSFGTVHRAEWHGSD-------VAVKVLTVQDFLDDQLKEFL 704
W E D L + + +G G+FG V A+ G D VAVK+L + + + +
Sbjct: 7 KW-EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALM 64
Query: 705 REVAIMKR-VRHPNVVLFMGAVTKRP-HLSIVTEYLPRGSLYRLIHR------------- 749
E+ I+ H NVV +GA TK L ++ E+ G+L +
Sbjct: 65 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124
Query: 750 PAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809
+ + + + VAKG+ +L + +H DL + N+L+ + VK+CDFGL+R
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLAR 182
Query: 810 F--KANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGP 866
K ++ +WMAPE + +SDV+SFGV+LWE+ + P+ G+
Sbjct: 183 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242
Query: 867 AQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPA 923
+ + R+ P T+P + M CW +P+QRP+F+ +VE L LL++ A
Sbjct: 243 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 299
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 2e-62
Identities = 85/291 (29%), Positives = 146/291 (50%), Gaps = 30/291 (10%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWHGSD---------VAVKVLTVQDFLDDQLKEFLR 705
E+ D L + + +G G+FG V AE G D VAVK+L D + L + +
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLIS 67
Query: 706 EVAIMKRV-RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHR-------------PA 751
E+ +MK + +H N++ +GA T+ L ++ EY +G+L +
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 752 AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF- 810
E + + + A VA+G+ YL + +H DL + N+LV ++ +K+ DFGL+R
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 811 -KANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQ 868
+ + + + +WMAPE L +SDV+SFGV+LWE+ T+ P+ G+ +
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
Query: 869 VVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLL 919
+ + + R+ P N + L +M CW P+QRP+F +VE L +++
Sbjct: 246 LFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 6e-62
Identities = 61/304 (20%), Positives = 124/304 (40%), Gaps = 51/304 (16%)
Query: 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMK 711
+E+ D+ +GAG+ G V + S +A K++ + + +RE+ ++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLH 59
Query: 712 RVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
P +V F GA +SI E++ GSL +++ + + ++ ++++ V KG
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKG 116
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPE 831
+ YL + I+H D+K N+LV+ +K+CDFG+S ++ + S GT +M+PE
Sbjct: 117 LTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPE 173
Query: 832 FLRGEPSNEKSDVYSFGVILWELVTMQQPWNG---------------------------- 863
L+G + +SD++S G+ L E+ + P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 864 --------------LGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFA 909
+ +++ + + S + C +PA+R
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 910 NIVE 913
++
Sbjct: 294 QLMV 297
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 1e-59
Identities = 67/270 (24%), Positives = 118/270 (43%), Gaps = 14/270 (5%)
Query: 659 DELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
++ + + +G G++G V A ++ VAVK++ ++ D + +E+ I K + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHE 63
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
NVV F G + + EY G L+ I M + R + G+ YLH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF--KANTFISSKSVAGTPEWMAPEFLR 834
+ I H D+K NLL+D+ +K+ DFGL+ N + GT ++APE L+
Sbjct: 121 GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 835 GEP-SNEKSDVYSFGVILWELVTMQQPWNGLGP-AQVVGAVAFQNRRLAIPQNTSPVLAS 892
E DV+S G++L ++ + PW+ Q + L + +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238
Query: 893 LMESCWADDPAQRPSFANIVES--LKKLLK 920
L+ ++P+ R + +I + K LK
Sbjct: 239 LLHKILVENPSARITIPDIKKDRWYNKPLK 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 6e-58
Identities = 58/269 (21%), Positives = 112/269 (41%), Gaps = 13/269 (4%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQ-LKEFLREVAIMKRVRH 715
++ + +G GSF TV A + A+K+L + + + + RE +M R+ H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
P V L Y G L + I + + D+ ++ + YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYL 124
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA--NTFISSKSVAGTPEWMAPEFL 833
H I+H DLK N+L++++ +++ DFG ++ + + + S GT ++++PE L
Sbjct: 125 HG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 834 RGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893
+ + + SD+++ G I+++LV P+ + + P+ P L
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI--IKLEYDFPEKFFPKARDL 240
Query: 894 MESCWADDPAQRPSFANIVESLKKLLKSP 922
+E D +R + E L P
Sbjct: 241 VEKLLVLDATKRLGCEEM-EGYGPLKAHP 268
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 196 bits (500), Expect = 1e-56
Identities = 61/261 (23%), Positives = 112/261 (42%), Gaps = 13/261 (4%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
D + E +G G+FG VHR G++ A K + + + +E+ M +RHP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHP 83
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
+V A + ++ E++ G L+ + M + + V KG+ ++H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 777 NLNPPILHWDLKSPNLLV--DKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLR 834
N +H DLK N++ ++ +K+ DFGL+ + S K GT E+ APE
Sbjct: 142 ENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAH-LDPKQSVKVTTGTAEFAAPEVAE 198
Query: 835 GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL--AIPQNTSPVLAS 892
G+P +D++S GV+ + L++ P+ G + + V + + + S
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258
Query: 893 LMESCWADDPAQRPSFANIVE 913
+ DP R + +E
Sbjct: 259 FIRKLLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 196 bits (499), Expect = 2e-56
Identities = 59/261 (22%), Positives = 115/261 (44%), Gaps = 13/261 (4%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
D + E +G+G+FG VHR G K + LD E++IM ++ HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQLHHP 86
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
++ A + + ++ E+L G L+ I M + + +G+ ++H
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMH 144
Query: 777 NLNPPILHWDLKSPNLLVD--KNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLR 834
+ I+H D+K N++ + K +VK+ DFGL+ I + T E+ APE +
Sbjct: 145 EHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIVD 201
Query: 835 GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL--AIPQNTSPVLAS 892
EP +D+++ GV+ + L++ P+ G + + V + + SP
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261
Query: 893 LMESCWADDPAQRPSFANIVE 913
+++ +P +R + + +E
Sbjct: 262 FIKNLLQKEPRKRLTVHDALE 282
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 192 bits (489), Expect = 6e-56
Identities = 60/274 (21%), Positives = 117/274 (42%), Gaps = 24/274 (8%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKE-------FLREVA 708
++ KE +G G V R + AVK++ V +E L+EV
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 709 IMKRVR-HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
I+++V HPN++ +V + + +G L+ + + ++ ++
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRA 118
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEW 827
+ + I LH LN I+H DLK N+L+D + +K+ DFG S + + V GTP +
Sbjct: 119 LLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQ-LDPGEKLREVCGTPSY 175
Query: 828 MAPEFLRGEPS------NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLA 881
+APE + + ++ D++S GVI++ L+ P+ ++ + N +
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235
Query: 882 IPQ--NTSPVLASLMESCWADDPAQRPSFANIVE 913
P+ + S + L+ P +R + +
Sbjct: 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 193 bits (492), Expect = 6e-56
Identities = 57/260 (21%), Positives = 109/260 (41%), Gaps = 10/260 (3%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
D ++ +G G+F V AE VA+K + + L+ + E+A++ +++HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA-KKALEGKEGSMENEIAVLHKIKHP 67
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
N+V HL ++ + + G L+ I +R R+ V + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLH 124
Query: 777 NLN-PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRG 835
+L +D++ + + DFGLS+ + + S + GTP ++APE L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-TACGTPGYVAPEVLAQ 183
Query: 836 EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIP--QNTSPVLASL 893
+P ++ D +S GVI + L+ P+ A++ + P + S
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243
Query: 894 MESCWADDPAQRPSFANIVE 913
+ DP +R + ++
Sbjct: 244 IRHLMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 6e-56
Identities = 48/279 (17%), Positives = 121/279 (43%), Gaps = 17/279 (6%)
Query: 658 WDELHVKERVGAGSFGTVHRAEWHGSD--VAVKVLTVQDFLDDQLKEFLREVAIMKRVRH 715
+++ + E +G G FG VHR S K + V+ +E++I+ RH
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARH 60
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
N++ + L ++ E++ ++ I+ +++R + V + + +L
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFL 118
Query: 776 HNLNPPILHWDLKSPNLLVD--KNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFL 833
H+ N I H+D++ N++ ++ T+K+ +FG +R + + + PE+ APE
Sbjct: 119 HSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAPEVH 175
Query: 834 RGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL--AIPQNTSPVLA 891
+ + + +D++S G +++ L++ P+ Q++ + + S
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235
Query: 892 SLMESCWADDPAQRPSFANIVES---LKKLLKSPAQLIQ 927
++ + R + + ++ +K+ + ++I+
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIR 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 8e-56
Identities = 66/258 (25%), Positives = 119/258 (46%), Gaps = 11/258 (4%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRV-R 714
++ + + +G GSFG V AE+ A+K L L DD ++ + E ++
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 715 HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINY 774
HP + + +L V EYL G L I D R A ++ G+ +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQF 118
Query: 775 LHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLR 834
LH+ I++ DLK N+L+DK+ +K+ DFG+ + + + GTP+++APE L
Sbjct: 119 LHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL 176
Query: 835 GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894
G+ N D +SFGV+L+E++ Q P++G ++ ++ + P+ L+
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRWLEKEAKDLL 234
Query: 895 ESCWADDPAQRPSFANIV 912
+ +P +R +
Sbjct: 235 VKLFVREPEKRLGVRGDI 252
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 186 bits (473), Expect = 3e-53
Identities = 64/269 (23%), Positives = 123/269 (45%), Gaps = 15/269 (5%)
Query: 657 SWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRV 713
S + + +G GSFG VH G A+KVL + + Q++ E ++ V
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
HP ++ G + ++ +Y+ G L+ L+ + + A +V +
Sbjct: 62 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALE 118
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFL 833
YLH+ I++ DLK N+L+DKN +K+ DFG +++ + ++ GTP+++APE +
Sbjct: 119 YLHS--KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVV 173
Query: 834 RGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893
+P N+ D +SFG++++E++ P+ + + N L P + + L
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--LNAELRFPPFFNEDVKDL 231
Query: 894 MESCWADDPAQRPSFANIVESLKKLLKSP 922
+ D +QR N+ + + P
Sbjct: 232 LSRLITRDLSQRLG--NLQNGTEDVKNHP 258
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 183 bits (466), Expect = 9e-53
Identities = 74/274 (27%), Positives = 121/274 (44%), Gaps = 18/274 (6%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQ-LKEFLREVAIMKRVRH 715
D + E +G G VH A DVAVKVL D F RE + H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 716 PNVVLFMGAV----TKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
P +V P IV EY+ +L ++H M +R + + D +
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQA 123
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF---KANTFISSKSVAGTPEWM 828
+N+ H I+H D+K N+++ VKV DFG++R N+ + +V GT +++
Sbjct: 124 LNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 829 APEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR--LAIPQNT 886
+PE RG+ + +SDVYS G +L+E++T + P+ G P V ++ A +
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241
Query: 887 SPVLASLMESCWADDPAQRPSFAN-IVESLKKLL 919
S L +++ A +P R A + L ++
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 1e-52
Identities = 61/270 (22%), Positives = 120/270 (44%), Gaps = 12/270 (4%)
Query: 656 ISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKR 712
++ ++ + +G G+FG V G A+K+L + + D++ + E +++
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
RHP + A L V EY G L+ + R + + R ++ +
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSAL 118
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEF 832
YLH+ +++ D+K NL++DK+ +K+ DFGL + + + K+ GTPE++APE
Sbjct: 119 EYLHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176
Query: 833 LRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892
L D + GV+++E++ + P+ ++ + + P+ SP S
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRTLSPEAKS 234
Query: 893 LMESCWADDPAQRPSFANIVESLKKLLKSP 922
L+ DP QR K++++
Sbjct: 235 LLAGLLKKDPKQRLGGGP--SDAKEVMEHR 262
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 8e-51
Identities = 63/267 (23%), Positives = 118/267 (44%), Gaps = 18/267 (6%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQ----LKEFLREVAIMKR 712
D E +G+G F V + G A K + + + ++ REV+I+K
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 713 VRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
++HPNV+ + + ++ E + G L+ + E + + + G+
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGV 126
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWT----VKVCDFGLSRFKANTFISSKSVAGTPEWM 828
YLH+ I H+DLK N+++ +K+ DFGL+ K++ GTPE++
Sbjct: 127 YYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPEFV 183
Query: 829 APEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL--AIPQNT 886
APE + EP ++D++S GVI + L++ P+ G + + V+ N NT
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243
Query: 887 SPVLASLMESCWADDPAQRPSFANIVE 913
S + + DP +R + + ++
Sbjct: 244 SALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (451), Expect = 2e-50
Identities = 52/277 (18%), Positives = 107/277 (38%), Gaps = 26/277 (9%)
Query: 663 VKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVL 720
+ ++G+GSFG ++ G +VA+K+ V + + E I K ++ +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV----KTKHPQLHIESKIYKMMQGGVGIP 66
Query: 721 FMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNP 780
+ +++ L SL L + + L +A + I Y+H+ N
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN- 123
Query: 781 PILHWDLKSPNLLV---DKNWTVKVCDFGLSRF-------KANTFISSKSVAGTPEWMAP 830
+H D+K N L+ K V + DFGL++ + + +K++ GT + +
Sbjct: 124 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 831 EFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAV-AFQNRRLAIP-----Q 884
G + + D+ S G +L PW GL A ++++ P +
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 885 NTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921
A+ + C + +P ++ + + + L
Sbjct: 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 179 bits (454), Expect = 3e-50
Identities = 57/275 (20%), Positives = 115/275 (41%), Gaps = 17/275 (6%)
Query: 656 ISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQ----LKEFLREVAI 709
++ ++ V +G G FG V+ G A+K L + Q +++
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 710 MKRVRHPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVA 769
+ P +V A LS + + + G L+ + + + + A ++
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEII 117
Query: 770 KGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMA 829
G+ ++HN +++ DLK N+L+D++ V++ D GL+ + + GT +MA
Sbjct: 118 LGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMA 173
Query: 830 PEFL-RGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPA-QVVGAVAFQNRRLAIPQNTS 887
PE L +G + +D +S G +L++L+ P+ + + +P + S
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233
Query: 888 PVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
P L SL+E D +R +++ +SP
Sbjct: 234 PELRSLLEGLLQRDVNRRLGCLG--RGAQEVKESP 266
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 175 bits (444), Expect = 1e-49
Identities = 45/281 (16%), Positives = 87/281 (30%), Gaps = 30/281 (10%)
Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH-PNV 718
V R+G GSFG + VA+K + E K + +
Sbjct: 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLAGCTGI 63
Query: 719 VLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
+ H +V + L L G + A + + +H
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 779 NPPILHWDLKSPNLLVDK-----NWTVKVCDFGLSRFKANT-------FISSKSVAGTPE 826
+ +++ D+K N L+ + + V DFG+ +F + + K+++GT
Sbjct: 121 S--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 827 WMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQV------VGAVAFQNRRL 880
+M+ G + + D+ + G + + PW GL A +G
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 881 AIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921
+ M P + + K+L+
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 2e-49
Identities = 63/278 (22%), Positives = 111/278 (39%), Gaps = 29/278 (10%)
Query: 663 VKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVV 719
+ +G G G V + A+K+L + REV + R + P++V
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIV 68
Query: 720 ----LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
++ R L IV E L G L+ I + +R + + + I YL
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYL 127
Query: 776 HNLNPPILHWDLKSPNLLVDK---NWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEF 832
H++N I H D+K NLL N +K+ DFG ++ + S + TP ++APE
Sbjct: 128 HSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYVAPEV 184
Query: 833 LRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAI------PQNT 886
L E ++ D++S GVI++ L+ P+ + + + R
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244
Query: 887 SPVLASLMESCWADDPAQRPSFANIVES--LKKLLKSP 922
S + L+ + +P QR + + + + K P
Sbjct: 245 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 282
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 3e-47
Identities = 53/262 (20%), Positives = 95/262 (36%), Gaps = 24/262 (9%)
Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDD----QLKEFLREVAIMKRVR- 714
V +G+G FG+V+ VA+K + D EV ++K+V
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 715 -HPNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
V+ + + ++ E + + V + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVR 124
Query: 774 YLHNLNPPILHWDLKSPNLLVDKN-WTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEF 832
+ HN +LH D+K N+L+D N +K+ DFG +T GT + PE+
Sbjct: 125 HCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEW 180
Query: 833 LRGEP-SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891
+R + V+S G++L+++V P+ ++ Q S
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------IIRGQVFFRQRVSSECQ 232
Query: 892 SLMESCWADDPAQRPSFANIVE 913
L+ C A P+ RP+F I
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQN 254
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 167 bits (424), Expect = 3e-46
Identities = 64/267 (23%), Positives = 122/267 (45%), Gaps = 15/267 (5%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRH 715
D+ + +G GSFG V + G+ A+K+L Q + Q++ L E I++ V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 716 PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
P +V + +L +V EY+ G ++ + R + A + YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYL 157
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRG 835
H+L+ +++ DLK NLL+D+ ++V DFG ++ ++ GTPE +APE +
Sbjct: 158 HSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEALAPEIILS 212
Query: 836 EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895
+ N+ D ++ GV+++E+ P+ P Q+ + + ++ P + S L L+
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--VSGKVRFPSHFSSDLKDLLR 270
Query: 896 SCWADDPAQRPSFANIVESLKKLLKSP 922
+ D +R F N+ + +
Sbjct: 271 NLLQVDLTKR--FGNLKNGVNDIKNHK 295
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-45
Identities = 60/285 (21%), Positives = 114/285 (40%), Gaps = 34/285 (11%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
+ E++G G++G V++A G VA+K + + + +RE++++K + HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 717 NVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLH 776
N+V + + L +V E+L + + G + + + +G+ + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 119
Query: 777 NLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGE 836
+ +LH DLK NLL++ +K+ DFGL+R + T + APE L G
Sbjct: 120 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 837 P-SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVV----------------GAVAFQNRR 879
+ D++S G I E+VT + + G + G + + +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 880 LAIPQ-----------NTSPVLASLMESCWADDPAQRPSFANIVE 913
+ P+ SL+ DP +R S +
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 162 bits (410), Expect = 4e-45
Identities = 60/284 (21%), Positives = 113/284 (39%), Gaps = 34/284 (11%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN 717
++ H E++G G++G V++A+ + G A+K + ++ + +RE++I+K ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 718 VVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777
+V + + L +V E+L + L ++ L + GI Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 778 LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEP 837
+LH DLK NLL+++ +K+ DFGL+R T + AP+ L G
Sbjct: 119 RR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 838 S-NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAV----------------------- 873
+ D++S G I E+V + G+ A + +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 874 ----AFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVE 913
+ + L+ DP QR + +E
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-44
Identities = 64/291 (21%), Positives = 114/291 (39%), Gaps = 41/291 (14%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKR--- 712
+ +G G++G V +A G VA+K + VQ + +REVA+++
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 713 VRHPNVVLFMGAVT-----KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
HPNVV T + L++V E++ + L P G + M
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQ 124
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEW 827
+ +G+++LH+ ++H DLK N+LV + +K+ DFGL+R + ++ SV T +
Sbjct: 125 LLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALTSVVVTLWY 181
Query: 828 MAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAV-------------- 873
APE L D++S G I E+ + + G +G +
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 874 -----------AFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVE 913
+ + L+ C +PA+R S + +
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 3e-44
Identities = 60/281 (21%), Positives = 113/281 (40%), Gaps = 37/281 (13%)
Query: 665 ERVGAGSFGTVHRAEWHGSD--VAVKVL---TVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
+ +G G F TV++A ++ VA+K + + D + LRE+ +++ + HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
+ A + ++S+V +++ + ++ L +G+ YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLH--Q 118
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPS- 838
ILH DLK NLL+D+N +K+ DFGL++ + + T + APE L G
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 839 NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAV------------------------- 873
D+++ G IL EL+ G + +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 874 AFQNRRLA-IPQNTSPVLASLMESCWADDPAQRPSFANIVE 913
+F L I L L++ + +P R + ++
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 4e-44
Identities = 62/280 (22%), Positives = 118/280 (42%), Gaps = 20/280 (7%)
Query: 656 ISWDELHVKERVGAGSFGTVHRAE-----WHGSDVAVKVLTVQDFLDDQ--LKEFLREVA 708
+ + + + +G G++G V G A+KVL + + E
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 709 IMKRVRH-PNVVLFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALD 767
+++ +R P +V A L ++ +Y+ G L+ + + E + +
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGE 137
Query: 768 VAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS-RFKANTFISSKSVAGTPE 826
+ + +LH L I++ D+K N+L+D N V + DFGLS F A+ + GT E
Sbjct: 138 IVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195
Query: 827 WMAPEFLRGEPS--NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQ--NRRLAI 882
+MAP+ +RG S ++ D +S GV+++EL+T P+ G ++ +
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 255
Query: 883 PQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922
PQ S + L++ DP +R ++ +
Sbjct: 256 PQEMSALAKDLIQRLLMKDPKKRLGCGP--RDADEIKEHL 293
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-41
Identities = 59/297 (19%), Positives = 114/297 (38%), Gaps = 50/297 (16%)
Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
++G G+FG V +A G VA+K + +++ + LRE+ I++ ++H NVV
Sbjct: 13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72
Query: 720 LFMGAVTKRP--------HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
+ + + +V ++ L + + + +R ++M L+ G
Sbjct: 73 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN---G 129
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF----KANTFISSKSVAGTPEW 827
+ Y+H ILH D+K+ N+L+ ++ +K+ DFGL+R K + + T +
Sbjct: 130 LYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 828 MAPEFLRGEPS-NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVA------------ 874
PE L GE D++ G I+ E+ T G + ++
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 875 ------------------FQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVE 913
+ + P L++ DPAQR + +
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-40
Identities = 57/283 (20%), Positives = 110/283 (38%), Gaps = 36/283 (12%)
Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
E++G G++GTV +A+ VA+K + + D + LRE+ ++K ++H N+V
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 720 LFMGAVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN 779
+ L++V E+ + + + +D + KG+ + H+ N
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQ---DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 780 PPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPS- 838
+LH DLK NLL+++N +K+ +FGL+R + T + P+ L G
Sbjct: 122 --VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 839 NEKSDVYSFGVILWELVTMQQPW----------------------------NGLGPAQVV 870
+ D++S G I EL +P L +
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 871 GAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVE 913
+ + + L+++ +P QR S ++
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 4e-40
Identities = 57/291 (19%), Positives = 110/291 (37%), Gaps = 46/291 (15%)
Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
+G G++G V A + VA+K ++ + + LRE+ I+ R RH N++
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENII 69
Query: 720 LFMGAVTKRPHLS----IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYL 775
+ + +L LY+L+ + + + +G+ Y+
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYI 125
Query: 776 HNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF---KANTFISSKSVAGTPEWMAPEF 832
H+ N +LH DLK NLL++ +K+CDFGL+R + T + APE
Sbjct: 126 HSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 833 L-RGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQV------------------VGAV 873
+ + + D++S G IL E+++ + + G + +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 874 AFQNRRLAIPQ-----------NTSPVLASLMESCWADDPAQRPSFANIVE 913
+N L++P N L++ +P +R +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 8e-40
Identities = 58/295 (19%), Positives = 101/295 (34%), Gaps = 47/295 (15%)
Query: 655 EISWDELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKR 712
E+S+ + V +G GSFG V++A+ G VA+K + + RE+ IM++
Sbjct: 19 EVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRK 69
Query: 713 VRHPNVVLFMGAVT------KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
+ H N+V +L++V +Y+P H A + +
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 767 DVAKGINYLHNLNPPILHWDLK-SPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTP 825
+ + + Y+H+ I H D+K LL +K+CDFG ++ + +
Sbjct: 130 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 826 EWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPA-------QVVGAVAFQNR 878
DV+S G +L EL+ Q + G +V+G +
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 879 RLAIPQ--------------------NTSPVLASLMESCWADDPAQRPSFANIVE 913
R P T P +L P R +
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-37
Identities = 63/285 (22%), Positives = 111/285 (38%), Gaps = 38/285 (13%)
Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
+ VG+G++G V A G+ VA+K L + K RE+ ++K +RH NV+
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 80
Query: 720 LFMGAVTKRPHLSIVTE-YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL 778
+ T L T+ YL + + + E + + R + + KG+ Y+H
Sbjct: 81 GLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA 140
Query: 779 NPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRG-EP 837
H DLK NL V+++ +K+ DFGL+R + T + APE +
Sbjct: 141 GII--HRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVILNWMR 195
Query: 838 SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL----------------- 880
+ D++S G I+ E++T + + G + +
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255
Query: 881 ------------AIPQNTSPVLASLMESCWADDPAQRPSFANIVE 913
+I N SP+ +L+E D QR + +
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-34
Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 17/216 (7%)
Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
+ +G+G+ G V A +VA+K L+ K RE+ +MK V H N++
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 720 LFMGAVTKRP------HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGIN 773
+ T + + +V E + + +D R + + GI
Sbjct: 80 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIK 133
Query: 774 YLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFL 833
+LH + I+H DLK N++V + T+K+ DFGL+R +F+ + V T + APE +
Sbjct: 134 HLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV-VTRYYRAPEVI 190
Query: 834 RGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQV 869
G E D++S G I+ E+V + + G
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 130 bits (327), Expect = 1e-33
Identities = 52/306 (16%), Positives = 109/306 (35%), Gaps = 60/306 (19%)
Query: 654 LEISW---DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVA 708
+ W D+ + ++G G + V A V VK+L + K+ RE+
Sbjct: 27 HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIK 81
Query: 709 IMKRVR-HPNVVLFMGAVTKRPH--LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMA 765
I++ +R PN++ V ++V E++ +L +
Sbjct: 82 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYM 135
Query: 766 LDVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSRFKANTFISSKSVAGT 824
++ K ++Y H++ I+H D+K N+++D ++ +++ D+GL+ F + V +
Sbjct: 136 YEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-AS 192
Query: 825 PEWMAPEFLRGEPS-NEKSDVYSFGVILWELVTMQQPW--------------NGLGPAQV 869
+ PE L + D++S G +L ++ ++P+ LG +
Sbjct: 193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252
Query: 870 VGAVAFQNRRLA----------------------IPQNTSPVLASLMESCWADDPAQRPS 907
+ N L SP ++ D R +
Sbjct: 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 312
Query: 908 FANIVE 913
+E
Sbjct: 313 AREAME 318
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 5e-33
Identities = 62/290 (21%), Positives = 115/290 (39%), Gaps = 46/290 (15%)
Query: 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP 716
+ VG+G++G+V A G VAVK L+ K RE+ ++K ++H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 717 NVVLFMGAVTKRPHLS-----IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKG 771
NV+ + T L + +L L ++ + + + + +G
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRG 133
Query: 772 INYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPE 831
+ Y+H+ + I+H DLK NL V+++ +K+ DFGL+R + T + APE
Sbjct: 134 LKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPE 188
Query: 832 -FLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAV----------------- 873
L N+ D++S G I+ EL+T + + G + +
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 874 -AFQNRRLAIPQ-----------NTSPVLASLMESCWADDPAQRPSFANI 911
+ +N ++ Q +P+ L+E D +R + A
Sbjct: 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (262), Expect = 5e-25
Identities = 35/220 (15%), Positives = 81/220 (36%), Gaps = 22/220 (10%)
Query: 662 HVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVV 719
+ ++G G F TV A+ + VA+K++ + E+ +++RV +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA---AEDEIKLLQRVNDADNT 72
Query: 720 LFMGAVTKRP-------------HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMAL 766
+ +V + G + + + +++
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 767 DVAKGINYLHNLNPPILHWDLKSPNLLVDKN-WTVKVCDFGLSRFKANTFISSKS--VAG 823
+ G++Y+H I+H D+K N+L++ + ++ +
Sbjct: 133 QLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 824 TPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNG 863
T E+ +PE L G P +D++S +++EL+T +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.8 bits (196), Expect = 1e-17
Identities = 26/206 (12%), Positives = 53/206 (25%), Gaps = 36/206 (17%)
Query: 663 VKERVGAGSFGTVHRAEWH-GSDVAVKVL--------TVQDFLDDQLKEFLREVAIMKRV 713
+ + +G G V + VK V++ D F R
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 714 RHPNVVLFMGAVTKRPHLSIVTEY-LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGI 772
+ L++ Y ++ + + + + + +
Sbjct: 64 EFRALQKLQ-------GLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEV 116
Query: 773 NYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEF 832
+ + I+H DL N+LV + + DF S E E
Sbjct: 117 AKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV-------------EVGEEGWREI 160
Query: 833 LRGEPSNEKSD---VYSFGVILWELV 855
L + N + Y + +
Sbjct: 161 LERDVRNIITYFSRTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 931 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.42 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.79 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.0 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.26 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.19 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.78 | |
| d2f4ma1 | 287 | Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) | 93.79 | |
| d2q3za4 | 316 | Transglutaminase catalytic domain {Human (Homo sap | 85.84 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=435.99 Aligned_cols=249 Identities=24% Similarity=0.481 Sum_probs=222.1
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~L 733 (931)
..++|++++.||+|+||+||+|++ +++.||+|++....... .....+.+|+++++.++||||+++++++.+++.+||
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 357999999999999999999987 47789999997654322 224578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~ 813 (931)
||||++||+|.+++.+. ..+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+|+....
T Consensus 84 vmEy~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EEeecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999999763 35999999999999999999999999 99999999999999999999999999986554
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....+|..+++++++|
T Consensus 159 ~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~l 234 (263)
T d2j4za1 159 S--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDL 234 (263)
T ss_dssp C--CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHH
T ss_pred C--cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHHH
Confidence 3 2345689999999999999999999999999999999999999999988877777664 34456788899999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 002355 894 MESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 894 I~rcL~~DPeeRPSa~ELLq~ 914 (931)
|.+||..||.+|||+.|+++|
T Consensus 235 i~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 235 ISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHccCCHhHCcCHHHHHcC
Confidence 999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-52 Score=438.28 Aligned_cols=255 Identities=27% Similarity=0.470 Sum_probs=212.5
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee--CCeEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK--RPHLSIV 734 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~--~~~l~LV 734 (931)
++|++++.||+|+||+||+|++ +|+.||||++..........+.+.+|+++|++++|||||++++++.+ ++.+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 7899999999999999999987 47889999998887777777889999999999999999999999864 5678999
Q ss_pred EeecCCCCHHHHhhcC-CCCCCCcHHHHHHHHHHHHHHHHHHHhCC---CCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 735 TEYLPRGSLYRLIHRP-AAGEMMDQRRRLRMALDVAKGINYLHNLN---PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~-~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G---~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
||||+||+|.+++.+. .....+++..++.++.||+.||+|||+.| .+||||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998642 12456999999999999999999999864 2499999999999999999999999999987
Q ss_pred ccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHH
Q 002355 811 KANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 811 ~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL 890 (931)
...........+||+.|||||++.+..++.++|||||||++|||+||+.||.+.+..++...+.. .....+|..+++++
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~s~~l 242 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRYSDEL 242 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-TCCCCCCTTSCHHH
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHH
Confidence 65544444567899999999999999999999999999999999999999999888887777654 33446778899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+||.+||+.||.+|||+.|+++|
T Consensus 243 ~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 243 NEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCChhHCcCHHHHHhC
Confidence 999999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=439.17 Aligned_cols=263 Identities=36% Similarity=0.618 Sum_probs=222.7
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
.|+|..++|+++++||+|+||+||+|++++ .||||+++.........+.+.+|+.+|++++|||||++++++.. +.++
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~ 79 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA 79 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence 468899999999999999999999998765 59999998776666667889999999999999999999998754 5689
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
|||||++||+|.+++... ...+++..++.++.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+...
T Consensus 80 lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEEECCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEEecCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 999999999999999752 346999999999999999999999999 9999999999999999999999999998654
Q ss_pred ccc--cccCCCCCCCcccCcccccCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc----cCCC
Q 002355 813 NTF--ISSKSVAGTPEWMAPEFLRGE---PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR----LAIP 883 (931)
Q Consensus 813 ~~~--~~~~~~~GT~~Y~APEvL~~~---~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r----~~lP 883 (931)
... .......||+.|||||++.+. .++.++|||||||++|||+||+.||.+......+......... ...+
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 235 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSC
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcc
Confidence 321 223456899999999998753 4788999999999999999999999987765554444333322 2356
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 884 QNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 884 ~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
..+++++.+||.+||..||.+|||+.+++++|+.+.++
T Consensus 236 ~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 78899999999999999999999999999999998876
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-51 Score=437.47 Aligned_cols=248 Identities=25% Similarity=0.460 Sum_probs=220.5
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|+++++||+|+||+||+|++ +|+.||||++....... .+.+.+|+.+|++++|||||+++++|..++++|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 5799999999999999999986 58899999998765433 3568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
||+||+|.+++.+ ..+++..++.++.||+.||+|||++| ||||||||+|||++.+|++||+|||+|+.......
T Consensus 98 y~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred ecCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 9999999998865 24899999999999999999999999 99999999999999999999999999987654444
Q ss_pred ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc-cccCCCCCChHHHHHHHH
Q 002355 817 SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN-RRLAIPQNTSPVLASLME 895 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~-~r~~lP~~~s~eL~dLI~ 895 (931)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.... .....+..+++++++||.
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 251 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHH
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHH
Confidence 4566789999999999999999999999999999999999999999888766665554333 234566788999999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 002355 896 SCWADDPAQRPSFANIVES 914 (931)
Q Consensus 896 rcL~~DPeeRPSa~ELLq~ 914 (931)
+||..||.+|||+.|+++|
T Consensus 252 ~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 252 RCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHTCSSTTTSCCHHHHTTC
T ss_pred HHccCChhHCcCHHHHhcC
Confidence 9999999999999999876
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-50 Score=433.31 Aligned_cols=265 Identities=34% Similarity=0.607 Sum_probs=220.5
Q ss_pred ccccCceEEEEEecccCceEEEEEEEc--CC---ceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEWH--GS---DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~~--g~---~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
++..++|++.++||+|+||+||+|++. ++ .||||++.... .....+.+.+|+++|++++|||||++++++..++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 355689999999999999999999873 32 37777765433 3445678999999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
.+++|||||++|+|.+++.+. ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccce
Confidence 999999999999999988752 346899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccccc-----ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCC
Q 002355 810 FKANTFI-----SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIP 883 (931)
Q Consensus 810 ~~~~~~~-----~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP 883 (931)
....... ......||+.|||||++.+..++.++|||||||++|||+| |..||.+....++...+. ...+.+.|
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~~ 255 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPP 255 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCC
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCC
Confidence 6543211 1123457899999999999999999999999999999998 899999998888777664 45566678
Q ss_pred CCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhh
Q 002355 884 QNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQL 925 (931)
Q Consensus 884 ~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l 925 (931)
..+++++.+||.+||..||.+|||+.|+++.|++++++|..+
T Consensus 256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~sl 297 (299)
T d1jpaa_ 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSL 297 (299)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChhhC
Confidence 889999999999999999999999999999999999998654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.5e-51 Score=433.91 Aligned_cols=263 Identities=33% Similarity=0.583 Sum_probs=227.7
Q ss_pred cccccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 652 DWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 652 ~~lei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
+.|++..++|++.++||+|+||+||+|++ +++.||||+++..... .+++.+|+++|++++|||||+++++|.+++
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 45788999999999999999999999988 4778999998765432 356889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
.++|||||+++|+|.+++.+. ....+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+|+
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred eeEEEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEcccccee
Confidence 999999999999999999753 3456899999999999999999999999 9999999999999999999999999998
Q ss_pred cccccc-cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHhcccccCCCCCCh
Q 002355 810 FKANTF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPW-NGLGPAQVVGAVAFQNRRLAIPQNTS 887 (931)
Q Consensus 810 ~~~~~~-~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF-~~~~~~eii~~i~~~~~r~~lP~~~s 887 (931)
...... .......|++.|+|||++.+..++.++|||||||++|||++|..|| .+.+..++.. ......+...|..++
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~-~i~~~~~~~~~~~~~ 242 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGCP 242 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-HHHTTCCCCCCTTCC
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHH-HHhcCCCCCCCccch
Confidence 754432 2223445789999999999999999999999999999999976655 4555555444 334556777888999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 888 PVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 888 ~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
+++.+||.+||..||++|||+.++++.|+.+++.
T Consensus 243 ~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 243 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999988765
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=429.72 Aligned_cols=250 Identities=25% Similarity=0.397 Sum_probs=210.7
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|+++++||+|+||+||+|++ +++.||||++...... ...+.+.+|+++|++++||||+++++++.+++.+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 7899999999999999999987 4788999999765432 233578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc--
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT-- 814 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~-- 814 (931)
|++||+|.+++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 84 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 9999999999965 346999999999999999999999999 999999999999999999999999999865322
Q ss_pred ccccCCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcccccCCCCCChHHHHH
Q 002355 815 FISSKSVAGTPEWMAPEFLRGEPS-NEKSDVYSFGVILWELVTMQQPWNGLGPA-QVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~~~~~-t~ksDIWSLG~ILyELLTG~~PF~~~~~~-eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
.......+||+.|||||++.+..+ +.++|||||||++|||++|+.||...... ..................+++++.+
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHH
Confidence 222356789999999999988776 57899999999999999999999776543 2333333222333334678999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 002355 893 LMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~ 914 (931)
||.+||..||++|||+.|+++|
T Consensus 239 li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 239 LLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHcCCChhHCcCHHHHhcC
Confidence 9999999999999999998775
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=433.99 Aligned_cols=250 Identities=27% Similarity=0.470 Sum_probs=219.0
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
+.|+++++||+|+||+||+|++ +++.||||++..... ...+.+.+|+++|++++|||||+++++|.+.+.+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 5799999999999999999987 577899999976532 334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
||+||+|.+++.+. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+.......
T Consensus 90 y~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 90 FCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred cCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence 99999999997652 346999999999999999999999999 99999999999999999999999999986554433
Q ss_pred ccCCCCCCCcccCccccc-----CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc-ccCCCCCChHHH
Q 002355 817 SSKSVAGTPEWMAPEFLR-----GEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR-RLAIPQNTSPVL 890 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~-----~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~-r~~lP~~~s~eL 890 (931)
.....+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+..+.+..+..... ....+..+++++
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~ 245 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNF 245 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHH
Confidence 445678999999999984 45578999999999999999999999999888887776654332 334567889999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+||.+||+.||.+|||+.|+++|
T Consensus 246 ~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 246 KDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHccCChhHCcCHHHHhcC
Confidence 999999999999999999999876
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=434.14 Aligned_cols=255 Identities=22% Similarity=0.384 Sum_probs=221.4
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|++++.||+|+||+||+|++ +++.||||++...... ......+.+|+++|++++||||++++++|.+++.+||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 7899999999999999999987 4788999999865432 233467899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||++||+|.+++... ..+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999999998753 46999999999999999999999999 9999999999999999999999999998654321
Q ss_pred --cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 816 --ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 816 --~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+.. ....+|..+++++++|
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~l 240 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDL 240 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT--TCCCCCTTCCHHHHHH
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc--CCCCCCccCCHHHHHH
Confidence 223456899999999999999999999999999999999999999999888887777653 3456788899999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 894 MESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 894 I~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
|.+||+.||.+|||++|++++-+ ++++
T Consensus 241 i~~~L~~dP~~R~t~~e~~~~~~-i~~H 267 (288)
T d1uu3a_ 241 VEKLLVLDATKRLGCEEMEGYGP-LKAH 267 (288)
T ss_dssp HHTTSCSSGGGSTTSGGGTCHHH-HHTS
T ss_pred HHHHccCCHhHCcCHHHHcCCHH-HHcC
Confidence 99999999999999999877633 4444
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=439.02 Aligned_cols=252 Identities=25% Similarity=0.422 Sum_probs=211.7
Q ss_pred ccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
++..++|+++++||+|+||+||+|++ +++.||+|+++.... ......+.+|+.+|++++|||||+++++|.+.+++|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 56679999999999999999999987 477899999976532 333467899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHh-CCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN-LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs-~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
|||||++||+|.+++.+. ..+++..++.++.||+.||.|||+ +| |+||||||+||||+.+|++||+|||+|+..
T Consensus 81 iVmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 999999999999999763 359999999999999999999997 58 999999999999999999999999999865
Q ss_pred cccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH------------------
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAV------------------ 873 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i------------------ 873 (931)
... ...+.+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.....
T Consensus 156 ~~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 156 IDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HHH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred CCC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 443 234678999999999999999999999999999999999999999775432211000
Q ss_pred -----------------------HhcccccCCC-CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 874 -----------------------AFQNRRLAIP-QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 874 -----------------------~~~~~r~~lP-~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.........+ ...+.++.+||.+||.+||.+|||+.|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000111122 3467899999999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=424.57 Aligned_cols=262 Identities=32% Similarity=0.581 Sum_probs=225.5
Q ss_pred cccccccCceEEEEEecccCceEEEEEEEc-CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe
Q 002355 652 DWLEISWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH 730 (931)
Q Consensus 652 ~~lei~~drY~Ii~kLG~G~fGtVylAr~~-g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~ 730 (931)
+.|+|..++|+++++||+|+||+||+|+++ ++.||||+++...... +.+.+|+++|++++|||||++++++.+ +.
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~ 81 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCH---HHHHHHHHHHHhCCCCCEeEEEeeecc-CC
Confidence 457889999999999999999999999986 4679999997654332 468999999999999999999998754 56
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
+++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARL 158 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceEE
Confidence 799999999999999886522 335899999999999999999999999 99999999999999999999999999987
Q ss_pred ccccc-cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcccccCCCCCChH
Q 002355 811 KANTF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888 (931)
Q Consensus 811 ~~~~~-~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG-~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~ 888 (931)
..... .......||+.|+|||++.+..++.++|||||||++|||+|| .+||......+....+. ...+...|..+++
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~ 237 (272)
T d1qpca_ 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPE 237 (272)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCH
T ss_pred ccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCcccChH
Confidence 54432 233456789999999999988899999999999999999996 55566666666665553 4566678889999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 889 VLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
++.+||.+||+.||++|||+.++++.|++++.+
T Consensus 238 ~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 999999999999999999999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=422.19 Aligned_cols=257 Identities=30% Similarity=0.588 Sum_probs=215.9
Q ss_pred ccCceEEEEEecccCceEEEEEEEc-CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~~-g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
..++|+++++||+|+||+||+|++. ++.||||++....... +.+.+|++++++++|||||++++++..++.+++||
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 3478999999999999999999984 5679999987654433 46889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+++|+|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++......
T Consensus 80 E~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp ECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred EecCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccCCC
Confidence 999999999998752 346889999999999999999999999 9999999999999999999999999998654332
Q ss_pred -cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHH
Q 002355 816 -ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASL 893 (931)
Q Consensus 816 -~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dL 893 (931)
.......||+.|+|||++.+..++.++|||||||++|||+| |.+||......++...+. ...+...|..+++++.+|
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~l 234 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQI 234 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH-HTCCCCCCTTSCHHHHHH
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHH
Confidence 22234578999999999999999999999999999999999 567777777777766654 355666788899999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 894 MESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 894 I~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
|.+||+.||++|||+.+++++|++++++
T Consensus 235 i~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 235 MNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 9999999999999999999999998764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-50 Score=424.30 Aligned_cols=248 Identities=28% Similarity=0.487 Sum_probs=213.9
Q ss_pred eEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee----CCeEEEE
Q 002355 661 LHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK----RPHLSIV 734 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~----~~~l~LV 734 (931)
|++.++||+|+||+||+|++. ++.||+|++..........+.+.+|+++|++++|||||+++++|.. +..+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 478889999999999999884 6689999998877666667789999999999999999999999864 4568999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC-CCCcEEEEecCccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD-KNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd-~dg~IKL~DFGlAr~~~~ 813 (931)
|||++||+|.+++.+. ..+++..++.++.||+.||+|||+++++|+||||||+|||++ .++.+||+|||+|+....
T Consensus 91 mE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999999763 358999999999999999999999887899999999999996 578999999999986544
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHhcccccCCCCCChHHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGP-AQVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~-~eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
. .....+||+.|||||++.+ .++.++|||||||++|||++|+.||.+... .++...+.....+..++...++++.+
T Consensus 168 ~--~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 244 (270)
T d1t4ha_ 168 S--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 244 (270)
T ss_dssp T--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred C--ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHH
Confidence 3 2345689999999999876 489999999999999999999999987654 44445554444445566778999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 002355 893 LMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~ 914 (931)
||.+||..||++|||+.|+++|
T Consensus 245 li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 245 IIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHccCCHhHCcCHHHHhCC
Confidence 9999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-50 Score=435.08 Aligned_cols=261 Identities=30% Similarity=0.472 Sum_probs=223.6
Q ss_pred cccccCceEEEEEecccCceEEEEEEEcC--C-----ceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeee
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWHG--S-----DVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAV 725 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~g--~-----~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f 725 (931)
|++..++|+++++||+|+||+||+|++.+ + .||+|++.... .......+.+|+.+|.++ +|||||+++++|
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 57888999999999999999999998743 2 48888886543 223346788999999998 899999999999
Q ss_pred eeCCeEEEEEeecCCCCHHHHhhcCCC--------------------CCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEe
Q 002355 726 TKRPHLSIVTEYLPRGSLYRLIHRPAA--------------------GEMMDQRRRLRMALDVAKGINYLHNLNPPILHW 785 (931)
Q Consensus 726 ~~~~~l~LVmEy~~GgSL~d~L~r~~~--------------------~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHr 785 (931)
...+.+|||||||++|+|.++++.... ...+++..++.++.||+.||+|||+++ ||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHR 188 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHR 188 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEET
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeec
Confidence 999999999999999999999975321 235889999999999999999999999 9999
Q ss_pred ccCCCCeEECCCCcEEEEecCcccccccccc--ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCC
Q 002355 786 DLKSPNLLVDKNWTVKVCDFGLSRFKANTFI--SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWN 862 (931)
Q Consensus 786 DLKPeNILLd~dg~IKL~DFGlAr~~~~~~~--~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~ 862 (931)
||||+|||++.++++||+|||+|+....... ......||+.|||||++.+..++.++|||||||++|||+| |..||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986443321 2234567999999999999999999999999999999998 899999
Q ss_pred CCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 002355 863 GLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKK 917 (931)
Q Consensus 863 ~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~ 917 (931)
+....+.+..+.....+...|..+++++.+||.+||+.||++|||++||+++|.-
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 8877776666666777788889999999999999999999999999999999863
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-50 Score=437.62 Aligned_cols=252 Identities=24% Similarity=0.452 Sum_probs=225.8
Q ss_pred cccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
+..++|++++.||+|+||+||+|++ +++.||||++.+..... .....+.+|+.+|+.++||||++++++|.+.+++|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 3558999999999999999999987 57889999998754322 34567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+|||||+||+|.+++.+ ...+++..++.++.||+.||+|||++| ||||||||+|||++.+|++||+|||+|+...
T Consensus 82 iv~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred cceeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999999999976 346899999999999999999999999 9999999999999999999999999998755
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHH
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
.........+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..++...+.. ....+|..+++++++
T Consensus 157 ~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~d 234 (337)
T d1o6la_ 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRTLSPEAKS 234 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHH
T ss_pred cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc--CCCCCCccCCHHHHH
Confidence 544445667899999999999999999999999999999999999999999988887776653 446678899999999
Q ss_pred HHHHhcccCCCCCCC-----HHHHHHH
Q 002355 893 LMESCWADDPAQRPS-----FANIVES 914 (931)
Q Consensus 893 LI~rcL~~DPeeRPS-----a~ELLq~ 914 (931)
||.+||++||.+|++ +.|+++|
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 235 LLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHhhccCCchhhcccccccHHHHHcC
Confidence 999999999999994 8899886
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.6e-50 Score=431.26 Aligned_cols=247 Identities=25% Similarity=0.405 Sum_probs=218.6
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
+.|+++++||+|+||+||+|++ +++.||||++....... ...+.+.+|+++|++++|||||+++++|.+++++||||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3699999999999999999987 46789999998765443 45577899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
|||.+|+|..++.. ...+++..++.++.||+.||.|||++| ||||||||+||||+.++++||+|||+|+.....
T Consensus 95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 99999999877654 346999999999999999999999999 999999999999999999999999999865443
Q ss_pred cccCCCCCCCcccCcccccC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRG---EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLAS 892 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~---~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~d 892 (931)
...+||+.|||||++.+ ..++.++|||||||++|||++|..||.+.+..+.+..+.....+...+..+++++.+
T Consensus 169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~ 245 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (309)
T ss_dssp ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHH
T ss_pred ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence 45689999999999864 357889999999999999999999999988877777766555555556778999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 002355 893 LMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~ 914 (931)
||.+||+.||.+|||+.|+++|
T Consensus 246 li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 246 FVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHCcCChhHCcCHHHHHhC
Confidence 9999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=418.80 Aligned_cols=268 Identities=32% Similarity=0.555 Sum_probs=224.0
Q ss_pred ccccCceEEEEEecccCceEEEEEEEcC------CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC
Q 002355 655 EISWDELHVKERVGAGSFGTVHRAEWHG------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728 (931)
Q Consensus 655 ei~~drY~Ii~kLG~G~fGtVylAr~~g------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~ 728 (931)
||..+.|++.+.||+|+||+||+|++.+ ..||||++.... .......+.+|+++|++++|||||++++++...
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 4566899999999999999999998743 259999986543 344456789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
+..++||||+.+++|.+++... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla 157 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLS 157 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred CceEEEEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchh
Confidence 9999999999999999988652 346899999999999999999999999 999999999999999999999999999
Q ss_pred cccccccc---ccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHhcccccCCCC
Q 002355 809 RFKANTFI---SSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVAFQNRRLAIPQ 884 (931)
Q Consensus 809 r~~~~~~~---~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG-~~PF~~~~~~eii~~i~~~~~r~~lP~ 884 (931)
+....... ......||+.|+|||++.+..++.++|||||||++|||++| .+||......++...+ ....+.+.|.
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i-~~~~~~~~~~ 236 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-NDGFRLPTPM 236 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCCCCT
T ss_pred hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH-hccCCCCCch
Confidence 86543211 22345689999999999999999999999999999999996 5555666666666555 3556677888
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhhhcC
Q 002355 885 NTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQM 928 (931)
Q Consensus 885 ~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l~~~ 928 (931)
.++..+.+||.+||..||++|||+.||++.|+++++.|..+-++
T Consensus 237 ~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~l~~l 280 (283)
T d1mqba_ 237 DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTL 280 (283)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGGSB
T ss_pred hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCccccccc
Confidence 99999999999999999999999999999999999998776543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-49 Score=429.43 Aligned_cols=250 Identities=24% Similarity=0.416 Sum_probs=203.8
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|++++.||+|+||+||+|++ +++.||||++....... ....+.+|+++|++++|||||+++++|.+++.+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 47799999999999999999987 47889999998765433 2356789999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC---CCCcEEEEecCcccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD---KNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd---~dg~IKL~DFGlAr~~~ 812 (931)
|||+||+|.+++.+ ...+++..++.++.||+.||+|||++| ||||||||+|||+. .++.+||+|||+|+...
T Consensus 87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999999975 346999999999999999999999999 99999999999995 57899999999998654
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc--CCCCCChHHH
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL--AIPQNTSPVL 890 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~--~lP~~~s~eL 890 (931)
... .....+||+.|||||++.+..++.++|||||||++|||++|..||.+....+....+....... ..+..+++++
T Consensus 162 ~~~-~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 240 (307)
T d1a06a_ 162 PGS-VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred CCC-eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence 432 2345689999999999999999999999999999999999999999988877777765544433 3446789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 002355 891 ASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.+||.+||..||.+|||+.|+++|
T Consensus 241 ~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 241 KDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCHhHCcCHHHHhcC
Confidence 999999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-49 Score=419.35 Aligned_cols=250 Identities=26% Similarity=0.449 Sum_probs=219.5
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch----HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD----DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLS 732 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~----~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~ 732 (931)
++|+++++||+|+||+||+|++ +|+.||||++.+..... ...+.+.+|+++|++++|||||+++++|.+.+++|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 6899999999999999999987 47889999998754332 12467899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC----cEEEEecCcc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW----TVKVCDFGLS 808 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg----~IKL~DFGlA 808 (931)
||||||+||+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+|
T Consensus 90 iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhh
Confidence 999999999999999763 36999999999999999999999999 99999999999998776 5999999999
Q ss_pred ccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc--CCCCCC
Q 002355 809 RFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL--AIPQNT 886 (931)
Q Consensus 809 r~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~--~lP~~~ 886 (931)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+....... ..+..+
T Consensus 165 ~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (293)
T d1jksa_ 165 HKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243 (293)
T ss_dssp EECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred hhcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCC
Confidence 8764432 3345679999999999999999999999999999999999999999988888777765443322 234678
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 887 SPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
++.+++||.+||..||.+|||+.|+++|
T Consensus 244 s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 244 SALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=415.59 Aligned_cols=261 Identities=30% Similarity=0.559 Sum_probs=215.7
Q ss_pred cccccCceEEEEEecccCceEEEEEEEcC-----CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR 728 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~g-----~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~ 728 (931)
|+|..++|++++.||+|+||+||+|++.. ..||||+++... .......+.+|+.+|++++||||+++++++. .
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 67888999999999999999999998742 236677664332 3444577999999999999999999999986 4
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
+.+|+||||+++|+|.+++... ...+++..++.++.||+.||+|||+++ ||||||||+||+++.++.+||+|||+|
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC----
T ss_pred CeEEEEEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhh
Confidence 6789999999999999987652 346899999999999999999999999 999999999999999999999999999
Q ss_pred ccccccc-cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCC
Q 002355 809 RFKANTF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNT 886 (931)
Q Consensus 809 r~~~~~~-~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~ 886 (931)
+...... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..++...+. ...+.+.|..+
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~ 234 (273)
T d1mp8a_ 156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNC 234 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTC
T ss_pred eeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCC
Confidence 8654322 23345578999999999999999999999999999999998 899999998888877765 44556788899
Q ss_pred hHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 887 SPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 887 s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
++++.+||.+||..||++|||+.||+++|+.+++.
T Consensus 235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999998753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.6e-49 Score=425.12 Aligned_cols=247 Identities=24% Similarity=0.467 Sum_probs=221.5
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
.++|+++++||+|+||+||+|++ +|+.||||++....... ...+.+.+|+.+|+.++|||||+++++|.+++.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 47899999999999999999987 47889999998654322 3356788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||+.|++|..++.. ...+++..++.++.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eeecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 999999999999876 345888999999999999999999999 999999999999999999999999999876544
Q ss_pred ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHH
Q 002355 815 FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI 894 (931)
....+||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.. ....+|..+++++.++|
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li 232 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--AELRFPPFFNEDVKDLL 232 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHH
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc--CCCCCCCCCCHHHHHHH
Confidence 2467899999999999999999999999999999999999999999888887777653 34567788999999999
Q ss_pred HHhcccCCCCCC-----CHHHHHHH
Q 002355 895 ESCWADDPAQRP-----SFANIVES 914 (931)
Q Consensus 895 ~rcL~~DPeeRP-----Sa~ELLq~ 914 (931)
.+||..||.+|+ |++++++|
T Consensus 233 ~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 233 SRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHHhhhCHHhccccchhhHHHHHcC
Confidence 999999999996 89999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=417.58 Aligned_cols=260 Identities=27% Similarity=0.497 Sum_probs=224.2
Q ss_pred ccccCceEEEE-EecccCceEEEEEEEc----CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 655 EISWDELHVKE-RVGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 655 ei~~drY~Ii~-kLG~G~fGtVylAr~~----g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
-+..++|.+.+ +||+|+||+||+|.+. +..||||+++... .....+.+.+|+++|++++|||||++++++.. +
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence 35668899998 5999999999999763 3369999997653 34456789999999999999999999999865 5
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
.+||||||+++|+|.+++.. ....+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|||+|+
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~ 157 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSK 157 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhh
Confidence 68999999999999999864 2346999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccc---cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCC
Q 002355 810 FKANTF---ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQN 885 (931)
Q Consensus 810 ~~~~~~---~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~ 885 (931)
...... .......||+.|+|||++.+..++.++|||||||++|||+| |..||.+....++...+. ...+.+.|..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~ 236 (285)
T d1u59a_ 158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPE 236 (285)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTT
T ss_pred cccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCc
Confidence 654321 12234568999999999998899999999999999999998 899999988777766654 4566778899
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 886 TSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
+++++.+||.+||..||++|||+.++++.|+.+..+
T Consensus 237 ~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 999999999999999999999999999998876643
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.8e-49 Score=430.40 Aligned_cols=250 Identities=24% Similarity=0.426 Sum_probs=219.4
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|++++.||+|+||+||+|++ +|+.||||++.... ....+.+.+|+++|++++|||||+++++|.+++++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 36899999999999999999987 47889999997654 233467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC--CCCcEEEEecCccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD--KNWTVKVCDFGLSRFKAN 813 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd--~dg~IKL~DFGlAr~~~~ 813 (931)
|||+||+|.+++.+. ...+++..++.++.||+.||+|||++| ||||||||+|||++ .++.+||+|||+|+....
T Consensus 103 E~~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 103 EFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCCCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EcCCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999998642 346999999999999999999999999 99999999999995 467899999999987554
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccC--CCCCChHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLA--IPQNTSPVLA 891 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~--lP~~~s~eL~ 891 (931)
.. ......||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+........ ....++++++
T Consensus 179 ~~-~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 257 (350)
T d1koaa2 179 KQ-SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257 (350)
T ss_dssp TS-CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred cc-ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 32 23456899999999999999999999999999999999999999999888888777754443322 2356889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 002355 892 SLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 892 dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+||.+||..||.+|||+.|+++|
T Consensus 258 ~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 258 DFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-48 Score=430.44 Aligned_cols=249 Identities=23% Similarity=0.387 Sum_probs=219.8
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|+++++||+|+||+||+|++ +++.||||++..... .....+.+|+.+|++++|||||+++++|.+++++|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 6899999999999999999987 578899999986542 233578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEEC--CCCcEEEEecCcccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVD--KNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd--~dg~IKL~DFGlAr~~~~~ 814 (931)
||+||+|.+++.+ .+..+++..++.++.||+.||+|||++| ||||||||+||||+ .++.+||+|||+|......
T Consensus 107 ~~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 107 FLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred cCCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999999988765 2346999999999999999999999999 99999999999998 5789999999999876543
Q ss_pred ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc--cCCCCCChHHHHH
Q 002355 815 FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR--LAIPQNTSPVLAS 892 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r--~~lP~~~s~eL~d 892 (931)
. ......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+..+.+..+...... ...+..+++++.+
T Consensus 183 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 183 E-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp S-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred C-ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 2 234567999999999999999999999999999999999999999998888877776544433 2344678999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 002355 893 LMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 893 LI~rcL~~DPeeRPSa~ELLq~ 914 (931)
||.+||+.||.+|||+.|+++|
T Consensus 262 li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999886
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=415.50 Aligned_cols=255 Identities=27% Similarity=0.492 Sum_probs=215.2
Q ss_pred ceEEE-EEecccCceEEEEEEEc----CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEE
Q 002355 660 ELHVK-ERVGAGSFGTVHRAEWH----GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 660 rY~Ii-~kLG~G~fGtVylAr~~----g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
.+.+. ++||+|+||+||+|.+. ++.||||+++.........+.+.+|+++|++++|||||++++++.. +..+||
T Consensus 7 ~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lv 85 (277)
T d1xbba_ 7 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV 85 (277)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEE
T ss_pred hCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEE
Confidence 34444 47999999999999763 3469999997665555556789999999999999999999999865 467899
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||+++|+|.+++.+ ...+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 86 mE~~~~g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 86 MEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp EECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhcccc
Confidence 999999999999976 345999999999999999999999999 999999999999999999999999999864322
Q ss_pred c---cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHH
Q 002355 815 F---ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 815 ~---~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL 890 (931)
. .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....++...+. ...+...|..+++++
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~ 239 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREM 239 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHH
T ss_pred ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHH
Confidence 1 12234578999999999999989999999999999999998 899999988877776654 456677889999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 891 ASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
.+||.+||+.||++|||+.+|++.|+..+.+
T Consensus 240 ~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 240 YDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 9999999999999999999999988876543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-49 Score=413.47 Aligned_cols=253 Identities=30% Similarity=0.556 Sum_probs=224.2
Q ss_pred cCceEEEEEecccCceEEEEEEEc-CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 658 WDELHVKERVGAGSFGTVHRAEWH-GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~~-g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
.++|+++++||+|+||+||+|++. ++.||||+++...... +.+.+|++++++++||||+++++++.+.+.+++|||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 378999999999999999999985 4579999998765543 468899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc-
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF- 815 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~- 815 (931)
|+.+|+|..++... ...+++..+++++.||++||+|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 80 y~~~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 80 YMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp CCTTEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred ccCCCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999999997652 345889999999999999999999999 9999999999999999999999999997544332
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI 894 (931)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++...+. ...+...|...++++.+||
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li 234 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIM 234 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHH
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-hCCCCCCcccccHHHHHHH
Confidence 22334678999999999999999999999999999999998 899999999888877765 4556778899999999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHH
Q 002355 895 ESCWADDPAQRPSFANIVESLKKL 918 (931)
Q Consensus 895 ~rcL~~DPeeRPSa~ELLq~L~~L 918 (931)
.+||+.||++|||+++++++|.+|
T Consensus 235 ~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 235 YSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHccCCHhHCcCHHHHHHHhhCC
Confidence 999999999999999999998653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=417.05 Aligned_cols=268 Identities=30% Similarity=0.542 Sum_probs=219.4
Q ss_pred cccccccCceEEEEEecccCceEEEEEEEc-------CCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEe
Q 002355 652 DWLEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMG 723 (931)
Q Consensus 652 ~~lei~~drY~Ii~kLG~G~fGtVylAr~~-------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid 723 (931)
+.|++..++|+++++||+|+||+||+|++. ++.||||+++.... ......+.+|..++.++ +|+||+.+++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-cHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 457889999999999999999999999863 24699999875433 33446778888888777 6889999999
Q ss_pred eeee-CCeEEEEEeecCCCCHHHHhhcCC-------------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCC
Q 002355 724 AVTK-RPHLSIVTEYLPRGSLYRLIHRPA-------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS 789 (931)
Q Consensus 724 ~f~~-~~~l~LVmEy~~GgSL~d~L~r~~-------------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKP 789 (931)
++.. +..+++|||||++|+|.+++.... ....+++..++.++.||+.||+|||+++ ||||||||
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp 162 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 162 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCG
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCc
Confidence 8764 457899999999999999996432 1235889999999999999999999999 99999999
Q ss_pred CCeEECCCCcEEEEecCcccccccc--ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCh
Q 002355 790 PNLLVDKNWTVKVCDFGLSRFKANT--FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGP 866 (931)
Q Consensus 790 eNILLd~dg~IKL~DFGlAr~~~~~--~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG-~~PF~~~~~ 866 (931)
+||||+.++++||+|||+|+..... ........||+.|+|||++.+..++.++|||||||++|||+|| .+||.+...
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999854332 2233456799999999999999999999999999999999987 568888776
Q ss_pred HHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCc
Q 002355 867 AQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSP 922 (931)
Q Consensus 867 ~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~ 922 (931)
.+.+........+...|..+++++.+||.+||..||++|||+.|++++|+.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 243 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 66665555666777888999999999999999999999999999999999998753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=417.54 Aligned_cols=272 Identities=32% Similarity=0.577 Sum_probs=226.5
Q ss_pred cccccccccccCceEEEEEecccCceEEEEEEEcC-CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeee
Q 002355 648 SLAMDWLEISWDELHVKERVGAGSFGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT 726 (931)
Q Consensus 648 sl~~~~lei~~drY~Ii~kLG~G~fGtVylAr~~g-~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~ 726 (931)
.+..+.|+|..++|+++++||+|+||+||+|++.+ +.||||++....... +.+.+|+.+|++++|||||++++++.
T Consensus 6 ~~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~ 82 (285)
T d1fmka3 6 GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVS 82 (285)
T ss_dssp SSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEe
Confidence 45567789999999999999999999999998854 579999997654432 56889999999999999999999986
Q ss_pred eCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecC
Q 002355 727 KRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFG 806 (931)
Q Consensus 727 ~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFG 806 (931)
+ +.+++||||+++|+|..++.... ...+++..++.++.||+.||+|||+.| |+||||||+||||+.++++||+|||
T Consensus 83 ~-~~~~lv~Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfG 158 (285)
T d1fmka3 83 E-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFG 158 (285)
T ss_dssp S-SSCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred c-CCeEEEEEecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccc
Confidence 5 55789999999999998886522 345899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccc-cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHhcccccCCCC
Q 002355 807 LSRFKANTF-ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQ-QPWNGLGPAQVVGAVAFQNRRLAIPQ 884 (931)
Q Consensus 807 lAr~~~~~~-~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~-~PF~~~~~~eii~~i~~~~~r~~lP~ 884 (931)
+|+...... .......||+.|+|||++.+..++.++|||||||++|||++|. +||.+....+++..+. ...+.+.+.
T Consensus 159 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~~~~~ 237 (285)
T d1fmka3 159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPP 237 (285)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCT
T ss_pred hhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCCc
Confidence 998654332 2223467899999999999999999999999999999999965 5556666666665554 455667889
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhhhc
Q 002355 885 NTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLIQ 927 (931)
Q Consensus 885 ~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l~~ 927 (931)
.+++++.+||.+||..||++|||+++|++.|+..+.+..+..+
T Consensus 238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~ 280 (285)
T d1fmka3 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280 (285)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCC
T ss_pred ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCC
Confidence 9999999999999999999999999999999998887765444
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-48 Score=426.85 Aligned_cols=246 Identities=26% Similarity=0.434 Sum_probs=220.6
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
++|+++++||+|+||+||+|++ +|+.||||++.+..... .....+.+|+++|+.++|||||+++++|.....+++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 7999999999999999999987 48899999997654322 33567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
||+.||+|..++.+. ..+++..++.++.||+.||.|||++| ||||||||+||||+.+|++||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 999999999999763 35999999999999999999999999 999999999999999999999999999876543
Q ss_pred cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHHH
Q 002355 816 ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLME 895 (931)
Q Consensus 816 ~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~ 895 (931)
.....||+.|||||++.+..++.++|||||||++|||+||+.||.+.+.......+.. .....|..+++++.+||+
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--GKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTCCHHHHHHHH
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc--CCCCCCccCCHHHHHHHH
Confidence 2456899999999999999999999999999999999999999999888777777653 345567889999999999
Q ss_pred HhcccCCCCCC-----CHHHHHHH
Q 002355 896 SCWADDPAQRP-----SFANIVES 914 (931)
Q Consensus 896 rcL~~DPeeRP-----Sa~ELLq~ 914 (931)
+||..||.+|+ |++++++|
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHhhhCHHhccccccccHHHHHcC
Confidence 99999999994 89999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=413.49 Aligned_cols=257 Identities=32% Similarity=0.603 Sum_probs=220.2
Q ss_pred cccccCceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee-CCeEE
Q 002355 654 LEISWDELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK-RPHLS 732 (931)
Q Consensus 654 lei~~drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~-~~~l~ 732 (931)
|++..++|+++++||+|+||.||+|+++++.||||+++... ..+.+.+|++++++++||||+++++++.+ .+.+|
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 67888999999999999999999999999999999997543 23568899999999999999999999854 56789
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKA 812 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~ 812 (931)
+||||+++|+|.+++.+.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 78 lv~ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp EEECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred EEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceecC
Confidence 9999999999999996522 235899999999999999999999999 9999999999999999999999999998654
Q ss_pred ccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChHHHH
Q 002355 813 NTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLA 891 (931)
Q Consensus 813 ~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~ 891 (931)
... ....+|..|+|||++.+..++.++|||||||++|||+| |++||......++...+. ...+.++|..+++++.
T Consensus 155 ~~~---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~ 230 (262)
T d1byga_ 155 STQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVY 230 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHH
T ss_pred CCC---ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHH
Confidence 432 44568999999999999899999999999999999998 789998888888777764 4567778889999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 892 SLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 892 dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
+||.+||..||.+|||+.+++++|+.+..+
T Consensus 231 ~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 231 EVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 999999999999999999999999988653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.5e-48 Score=406.88 Aligned_cols=257 Identities=28% Similarity=0.428 Sum_probs=215.5
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC----e
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP----H 730 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~----~ 730 (931)
.++|++++.||+|+||+||+|++ +++.||||+++.....+ .....+.+|+++|+.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 37899999999999999999987 57889999998765443 44567899999999999999999999997543 4
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
+||||||++|++|.+++... ..+++..++.++.||+.||+|||++| ||||||||+|||++.++.++|+|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeehhhhhhh
Confidence 89999999999999988753 35999999999999999999999999 99999999999999999999999999875
Q ss_pred cccc---ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc--cCCCCC
Q 002355 811 KANT---FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR--LAIPQN 885 (931)
Q Consensus 811 ~~~~---~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r--~~lP~~ 885 (931)
.... .......+||+.|+|||++.+..++.++|||||||++|+|+||++||.+.+..+....+...... ......
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSS
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccC
Confidence 4322 12335568999999999999999999999999999999999999999998887777666544332 234567
Q ss_pred ChHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHh
Q 002355 886 TSPVLASLMESCWADDPAQRP-SFANIVESLKKLL 919 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRP-Sa~ELLq~L~~Ll 919 (931)
+|+++.+||.+||..||.+|| |++++++.|..+.
T Consensus 241 ~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 899999999999999999998 8999999988775
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-48 Score=415.03 Aligned_cols=264 Identities=32% Similarity=0.540 Sum_probs=227.8
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEcC-------CceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeee
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWHG-------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAV 725 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~g-------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f 725 (931)
.+|++.++|+++++||+|+||+||+|++.+ +.||||++.... .....+++.+|+.+|++++||||+++++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 467788999999999999999999998753 569999987543 344557899999999999999999999999
Q ss_pred eeCCeEEEEEeecCCCCHHHHhhcCC---------------------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEE
Q 002355 726 TKRPHLSIVTEYLPRGSLYRLIHRPA---------------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILH 784 (931)
Q Consensus 726 ~~~~~l~LVmEy~~GgSL~d~L~r~~---------------------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIH 784 (931)
...+..++||||+.+|+|.+++.... ....+++..++.++.||+.||+|||+++ |||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivH 163 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVH 163 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEe
Confidence 99999999999999999999986421 1234788999999999999999999999 999
Q ss_pred eccCCCCeEECCCCcEEEEecCcccccccc--ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCC-CCC
Q 002355 785 WDLKSPNLLVDKNWTVKVCDFGLSRFKANT--FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQ-QPW 861 (931)
Q Consensus 785 rDLKPeNILLd~dg~IKL~DFGlAr~~~~~--~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~-~PF 861 (931)
|||||+||||+.++++||+|||+|+..... ........||+.|+|||++.+..++.++|||||||++|||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 999999999999999999999999754322 22234567889999999999999999999999999999999995 789
Q ss_pred CCCChHHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 002355 862 NGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920 (931)
Q Consensus 862 ~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llk 920 (931)
.+.+..++...+.. ..+...|..+++++.+||.+||+.+|++|||+.||++.|+++.+
T Consensus 244 ~~~~~~e~~~~v~~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 244 YGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCHHHHHHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 99888888777653 44667888999999999999999999999999999999998753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=420.61 Aligned_cols=249 Identities=27% Similarity=0.458 Sum_probs=219.5
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccc-hHHHHHHHHHHHHHH-hcCCCCeeeEEeeeeeCCeEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFL-DDQLKEFLREVAIMK-RVRHPNVVLFMGAVTKRPHLSIV 734 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~-~~~~~~~l~EIkILk-~L~HpNIV~Lid~f~~~~~l~LV 734 (931)
++|+++++||+|+||+||+|++ +++.||||++.+.... ......+.+|..++. .++|||||+++++|.+++++|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 6899999999999999999988 5788999999865422 223456677777765 68999999999999999999999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANT 814 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~ 814 (931)
|||++||+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++++||+|||+|+.....
T Consensus 82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhhhcccc
Confidence 9999999999999763 35899999999999999999999999 999999999999999999999999999866554
Q ss_pred ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCChHHHHHHH
Q 002355 815 FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSPVLASLM 894 (931)
Q Consensus 815 ~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~eL~dLI 894 (931)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++...+.. ....+|..+++++.+||
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~dli 234 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRWLEKEAKDLL 234 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHH
T ss_pred cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCccCCHHHHHHH
Confidence 4455667899999999999999999999999999999999999999999888887777653 34567888999999999
Q ss_pred HHhcccCCCCCCCHH-HHHHH
Q 002355 895 ESCWADDPAQRPSFA-NIVES 914 (931)
Q Consensus 895 ~rcL~~DPeeRPSa~-ELLq~ 914 (931)
.+||..||.+||++. ++++|
T Consensus 235 ~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 235 VKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp HHHSCSSGGGSBTTBSCGGGS
T ss_pred HHhcccCCCCCcCHHHHHHhC
Confidence 999999999999995 77654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.3e-47 Score=406.37 Aligned_cols=250 Identities=23% Similarity=0.380 Sum_probs=218.0
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch-------HHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeC
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD-------DQLKEFLREVAIMKRVR-HPNVVLFMGAVTKR 728 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~-------~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~ 728 (931)
++|+++++||+|+||+||+|++ +++.||||++.+..... ...+.+.+|+.+|++++ ||||++++++|.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 7999999999999999999987 57889999998764321 22356889999999997 99999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
+++||||||++||+|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEEccchhe
Confidence 9999999999999999999753 35999999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCcccCcccccC------CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccC-
Q 002355 809 RFKANTFISSKSVAGTPEWMAPEFLRG------EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLA- 881 (931)
Q Consensus 809 r~~~~~~~~~~~~~GT~~Y~APEvL~~------~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~- 881 (931)
+...... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+.......+........
T Consensus 158 ~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 236 (277)
T d1phka_ 158 CQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236 (277)
T ss_dssp EECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred eEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 8765432 3355689999999999853 3468899999999999999999999999888777776665444332
Q ss_pred -CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 882 -IPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 882 -lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
....+|+++++||.+||+.||.+|||+.|+++|
T Consensus 237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 334789999999999999999999999999876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=412.13 Aligned_cols=262 Identities=28% Similarity=0.524 Sum_probs=218.8
Q ss_pred cCceEEEEEecccCceEEEEEEEc--CC----ceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEWH--GS----DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHL 731 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~~--g~----~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l 731 (931)
.++|+++++||+|+||+||+|++. ++ .||+|+++... .....+.+.+|+++|++++|||||++++++.++ ..
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 367999999999999999999873 33 47788775432 222346789999999999999999999999865 56
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
+++||++.+++|.+++... ...+++..++.++.||+.||+|||++| ||||||||+||||+.++++||+|||+|+..
T Consensus 86 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred eEEEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceec
Confidence 7788889899999988762 456899999999999999999999999 999999999999999999999999999865
Q ss_pred cccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCCChH
Q 002355 812 ANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQNTSP 888 (931)
Q Consensus 812 ~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~~s~ 888 (931)
.... .......||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..++...+. ...+...|..+++
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~~ 240 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTI 240 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-HTCCCCCCTTBCH
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCH
Confidence 4322 12234568999999999999999999999999999999998 799999888777665553 4566778889999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhhh
Q 002355 889 VLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLI 926 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l~ 926 (931)
.+.+||.+||..||.+|||+.|++++|..+.+.+....
T Consensus 241 ~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~~~~ 278 (317)
T d1xkka_ 241 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 278 (317)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHHHHB
T ss_pred HHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhChHhhc
Confidence 99999999999999999999999999999988765443
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=414.85 Aligned_cols=249 Identities=18% Similarity=0.344 Sum_probs=217.6
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVm 735 (931)
.++|++++.||+|+||+||+|++ +++.||||+++... .....+.+|+++|+.++|||||+++++|.+++++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 48999999999999999999987 47789999997654 22346789999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC--CcEEEEecCccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN--WTVKVCDFGLSRFKAN 813 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d--g~IKL~DFGlAr~~~~ 813 (931)
|||+|++|.+++... +..+++.+++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++....
T Consensus 81 E~~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 81 EFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999999752 336899999999999999999999999 9999999999999854 5899999999986544
Q ss_pred cccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccC--CCCCChHHHH
Q 002355 814 TFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLA--IPQNTSPVLA 891 (931)
Q Consensus 814 ~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~--lP~~~s~eL~ 891 (931)
.. ......+|+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+.+..+........ .+..++++++
T Consensus 157 ~~-~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 157 GD-NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TC-EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CC-cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence 32 23456789999999999999999999999999999999999999999888888777754333221 2247899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 002355 892 SLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 892 dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+||.+||..||.+|||+.|+++|
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 99999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.1e-47 Score=421.57 Aligned_cols=251 Identities=22% Similarity=0.311 Sum_probs=211.4
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchH----HHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCe
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD----QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPH 730 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~----~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~ 730 (931)
+.++|+++++||+|+||+||+|++ +|+.||||++........ ......+|+++++.++|||||+++++|...+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 457999999999999999999987 578899999976543222 12223345667777789999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
+||||||++||+|.+++.+. ..+++..++.++.||+.||+|||++| ||||||||+|||++.+|.+||+|||+|+.
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999999763 35889999999999999999999999 99999999999999999999999999986
Q ss_pred ccccccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HhcccccCCCCCChH
Q 002355 811 KANTFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAV-AFQNRRLAIPQNTSP 888 (931)
Q Consensus 811 ~~~~~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i-~~~~~r~~lP~~~s~ 888 (931)
.... .....+||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+.......... .........|..+++
T Consensus 157 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 234 (364)
T d1omwa3 157 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234 (364)
T ss_dssp CSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCH
T ss_pred cCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCH
Confidence 6543 3356689999999999874 56899999999999999999999999876543332221 223445567788999
Q ss_pred HHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 002355 889 VLASLMESCWADDPAQRPS-----FANIVES 914 (931)
Q Consensus 889 eL~dLI~rcL~~DPeeRPS-----a~ELLq~ 914 (931)
++++||.+||..||.+||| ++|+++|
T Consensus 235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred HHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 9999999999999999999 7999876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=409.80 Aligned_cols=266 Identities=32% Similarity=0.629 Sum_probs=224.3
Q ss_pred cccCceEEEEEecccCceEEEEEEEc--CC--ceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeeeCCe
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWH--GS--DVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTKRPH 730 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~--g~--~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~~~~ 730 (931)
|.+++|++.++||+|+||+||+|++. +. .||||.+.... .....+.+.+|+++|+++ +|||||++++++..++.
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence 46699999999999999999999874 33 36666664332 233456789999999999 79999999999999999
Q ss_pred EEEEEeecCCCCHHHHhhcC-------------CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC
Q 002355 731 LSIVTEYLPRGSLYRLIHRP-------------AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN 797 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~-------------~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d 797 (931)
+++||||++||+|.+++.+. .....+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN 163 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcCC
Confidence 99999999999999999753 23457999999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHhc
Q 002355 798 WTVKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQ-QPWNGLGPAQVVGAVAFQ 876 (931)
Q Consensus 798 g~IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~-~PF~~~~~~eii~~i~~~ 876 (931)
+.+||+|||+|+...... ......||..|+|||.+.+..++.++|||||||++|||++|. +||.+.+..++...+. .
T Consensus 164 ~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~-~ 241 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-Q 241 (309)
T ss_dssp GCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-G
T ss_pred CceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH-h
Confidence 999999999998654432 234557899999999999999999999999999999999975 6788888877776654 4
Q ss_pred ccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchhhh
Q 002355 877 NRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQLI 926 (931)
Q Consensus 877 ~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~l~ 926 (931)
..++..|..+++++.+||.+||..||++|||+.|++++|+++++.....+
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~~ 291 (309)
T d1fvra_ 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 291 (309)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcCCC
Confidence 56677888999999999999999999999999999999999997765443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=406.17 Aligned_cols=258 Identities=33% Similarity=0.586 Sum_probs=214.4
Q ss_pred cccCceEEEEEecccCceEEEEEEEcC-----CceEEEEEeecccch-HHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC
Q 002355 656 ISWDELHVKERVGAGSFGTVHRAEWHG-----SDVAVKVLTVQDFLD-DQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP 729 (931)
Q Consensus 656 i~~drY~Ii~kLG~G~fGtVylAr~~g-----~~VAVKVlk~~~~~~-~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~ 729 (931)
|..++|++++.||+|+||+||+|++.+ ..||||++....... ...+.+.+|+++|++++||||+++++++.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 345789999999999999999998632 258999987654433 445789999999999999999999999975 4
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
..++||||+++++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+++
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred chheeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhh
Confidence 678999999999999887652 345999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccc---cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcccccCCCCC
Q 002355 810 FKANTF---ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGPAQVVGAVAFQNRRLAIPQN 885 (931)
Q Consensus 810 ~~~~~~---~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~~eii~~i~~~~~r~~lP~~ 885 (931)
...... .......||..|+|||++.+..++.++|||||||++|||+| |.+||.+.+..+....+.....+.+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCccc
Confidence 654332 12234567889999999999999999999999999999998 89999999999888888777777788899
Q ss_pred ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 002355 886 TSPVLASLMESCWADDPAQRPSFANIVESLKKL 918 (931)
Q Consensus 886 ~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~L 918 (931)
+++.+.+||.+||..||++|||+.+|++.|++.
T Consensus 240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 999999999999999999999999999988864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=407.78 Aligned_cols=247 Identities=23% Similarity=0.299 Sum_probs=204.9
Q ss_pred EEEEecccCceEEEEEEE--cCCceEEEEEeecccchH---HHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 663 VKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDD---QLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 663 Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~---~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
.+++||+|+||+||+|++ +++.||||+++....... ....+.+|+.+|++++|||||+++++|..++++||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 568999999999999987 578899999876543321 134688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccc
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~ 817 (931)
+.++++..+... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+........
T Consensus 82 ~~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 82 METDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp CSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred hcchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 988877766643 446889999999999999999999999 999999999999999999999999999876655445
Q ss_pred cCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc----------------
Q 002355 818 SKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL---------------- 880 (931)
Q Consensus 818 ~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~---------------- 880 (931)
....+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+..+.......
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 5567899999999998754 57999999999999999999999999888777665553211100
Q ss_pred ----------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 ----------AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 ----------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
......++++.+||.+||++||++|||+.|+|+|
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0113568899999999999999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=406.20 Aligned_cols=265 Identities=31% Similarity=0.567 Sum_probs=226.1
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEcC---------CceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEE
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWHG---------SDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFM 722 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~g---------~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Li 722 (931)
.|+|..++|+++++||+|+||.||+|++.+ ..||||++.... .......+.+|..++.++ +|||||+++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 367888999999999999999999998632 359999987654 344557788999999888 799999999
Q ss_pred eeeeeCCeEEEEEeecCCCCHHHHhhcCC-------------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCC
Q 002355 723 GAVTKRPHLSIVTEYLPRGSLYRLIHRPA-------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS 789 (931)
Q Consensus 723 d~f~~~~~l~LVmEy~~GgSL~d~L~r~~-------------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKP 789 (931)
++|.+++.+++||||+.+|+|.+++.... ....+++.+++.++.||+.||+|||+++ ||||||||
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp 163 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAA 163 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecc
Confidence 99999999999999999999999997532 1245899999999999999999999999 99999999
Q ss_pred CCeEECCCCcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 002355 790 PNLLVDKNWTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGP 866 (931)
Q Consensus 790 eNILLd~dg~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~ 866 (931)
+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+.
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 99999999999999999998654432 22345678999999999999999999999999999999998 7999998888
Q ss_pred HHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 867 AQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 867 ~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
.++...+. ...+...|..+++++.+||.+||+.||.+|||+.|+++.|+.++..
T Consensus 244 ~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 244 EELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp HHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHH-cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 77766554 4667788899999999999999999999999999999999998753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=405.76 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=208.2
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|+++++||+|+||+||+|++ +++.||||++............+.+|+++|++++|||||+++++|..++++|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999987 47889999997655443445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
|+.+ .+..++... ....+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~-~~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CCSE-EHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred ecCC-chhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 9955 555555432 2456999999999999999999999999 99999999999999999999999999987655544
Q ss_pred ccCCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc-c--------------
Q 002355 817 SSKSVAGTPEWMAPEFLRGEP-SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR-L-------------- 880 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~-~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r-~-------------- 880 (931)
......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+..+....+...... .
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 555668999999999887765 478999999999999999999999988766555443211100 0
Q ss_pred -C-----------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 -A-----------IPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 -~-----------lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
. ....+++++.+||.+||..||.+|||+.|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 013567889999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-47 Score=406.90 Aligned_cols=269 Identities=31% Similarity=0.509 Sum_probs=233.2
Q ss_pred cccccccCceEEEEEecccCceEEEEEEEc-------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEee
Q 002355 652 DWLEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGA 724 (931)
Q Consensus 652 ~~lei~~drY~Ii~kLG~G~fGtVylAr~~-------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~ 724 (931)
+.|+|..++|+++++||+|+||+||+|.+. ++.||||+++... .......+.+|++++++++||||++++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 457899999999999999999999999764 3579999987543 34455678999999999999999999999
Q ss_pred eeeCCeEEEEEeecCCCCHHHHhhcC-------CCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCC
Q 002355 725 VTKRPHLSIVTEYLPRGSLYRLIHRP-------AAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKN 797 (931)
Q Consensus 725 f~~~~~l~LVmEy~~GgSL~d~L~r~-------~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~d 797 (931)
+...+..++||||+.+|+|.+++... .....+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED 169 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCC
Confidence 99999999999999999999988642 12234688999999999999999999999 9999999999999999
Q ss_pred CcEEEEecCccccccccc--cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHH
Q 002355 798 WTVKVCDFGLSRFKANTF--ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTM-QQPWNGLGPAQVVGAVA 874 (931)
Q Consensus 798 g~IKL~DFGlAr~~~~~~--~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG-~~PF~~~~~~eii~~i~ 874 (931)
+++||+|||+|+...... .......||+.|+|||.+.+..++.++|||||||++|||+|| .+||.+.+..+++..+.
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~ 249 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999998654322 123344689999999999999999999999999999999998 58899988888887665
Q ss_pred hcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhCchh
Q 002355 875 FQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKSPAQ 924 (931)
Q Consensus 875 ~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks~~~ 924 (931)
...+...|..+++.+.+||.+||+.+|.+|||+.+|+++|++.++....
T Consensus 250 -~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 250 -EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred -hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence 4556778889999999999999999999999999999999988776533
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.9e-47 Score=401.38 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=209.5
Q ss_pred CceEEEEEecccCceEEEEEEE-cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEee
Q 002355 659 DELHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
++|+++++||+|+||+||+|++ +++.||||++..........+.+.+|+.+|++++||||++++++|...++.+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 7999999999999999999987 468899999977655444457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccccc
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFIS 817 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~~ 817 (931)
+.++.+..+... ...+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||.|.........
T Consensus 82 ~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 82 LDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp CSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence 977766666543 356999999999999999999999999 999999999999999999999999999876555444
Q ss_pred cCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc-----------------
Q 002355 818 SKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR----------------- 879 (931)
Q Consensus 818 ~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r----------------- 879 (931)
.....|++.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+......
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 4566789999999998764 5689999999999999999999999988776665544221100
Q ss_pred ----------cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 ----------LAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 ----------~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.......++.+.+||++||..||++|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11235678899999999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=404.64 Aligned_cols=266 Identities=29% Similarity=0.509 Sum_probs=230.8
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEc-------CCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEee
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWH-------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGA 724 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~-------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~ 724 (931)
.|++..++|+++++||+|+||.||+|++. ++.||||+++.... ......+.+|+.+++.+ +|||||+++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC-HHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 36889999999999999999999999863 34699999976543 34456789999999999 69999999999
Q ss_pred eeeCCeEEEEEeecCCCCHHHHhhcCC---------------CCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCC
Q 002355 725 VTKRPHLSIVTEYLPRGSLYRLIHRPA---------------AGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKS 789 (931)
Q Consensus 725 f~~~~~l~LVmEy~~GgSL~d~L~r~~---------------~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKP 789 (931)
+..+..+++|||||++|+|.+++.+.. ....+++..++.++.||+.||+|||+++ ||||||||
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp 173 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAA 173 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccccc
Confidence 999999999999999999999997532 1235889999999999999999999999 99999999
Q ss_pred CCeEECCCCcEEEEecCcccccccc--ccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCh
Q 002355 790 PNLLVDKNWTVKVCDFGLSRFKANT--FISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVT-MQQPWNGLGP 866 (931)
Q Consensus 790 eNILLd~dg~IKL~DFGlAr~~~~~--~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLT-G~~PF~~~~~ 866 (931)
+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||+| |.+||.....
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999865432 223345678999999999999999999999999999999998 6677777776
Q ss_pred HHHHHHHHhcccccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 867 AQVVGAVAFQNRRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 867 ~eii~~i~~~~~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
...+..+.....+...+..+++.+.+||.+||+.||++|||+.+|++.|++++..
T Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 6666666667777888889999999999999999999999999999999987654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=401.30 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=207.6
Q ss_pred CceEEEEEecccCceEEEEEEEc---CCceEEEEEeecccchHHHHHHHHHHHHHHhc---CCCCeeeEEeeee-----e
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH---GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV---RHPNVVLFMGAVT-----K 727 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~---g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L---~HpNIV~Lid~f~-----~ 727 (931)
++|+++++||+|+||+||+|++. ++.||||+++...........+.+|+.+|+.| +||||++++++|. .
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 79999999999999999999873 45699999987654333233456777777666 7999999999985 2
Q ss_pred CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCc
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGl 807 (931)
..+++++||++.++.+...... ....+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeeecchhh
Confidence 3578999999987766544433 3456899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc---------
Q 002355 808 SRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR--------- 878 (931)
Q Consensus 808 Ar~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~--------- 878 (931)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..+.....
T Consensus 163 ~~~~~~~~-~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 163 ARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp CCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred hhhhcccc-cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence 88654432 34567899999999999999999999999999999999999999999887766655432110
Q ss_pred ----------------ccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 ----------------RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 ----------------r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
....+..+++.+.+||.+||++||++|||+.|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 011345678999999999999999999999999886
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=410.05 Aligned_cols=246 Identities=26% Similarity=0.385 Sum_probs=203.2
Q ss_pred cCceEEEE-EecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhc-CCCCeeeEEeeeee----CC
Q 002355 658 WDELHVKE-RVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRV-RHPNVVLFMGAVTK----RP 729 (931)
Q Consensus 658 ~drY~Ii~-kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L-~HpNIV~Lid~f~~----~~ 729 (931)
.++|+++. .||+|+||+||+|++ +++.||||+++.. ..+.+|+.++.++ +|||||+++++|.+ +.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 37899886 599999999999987 5788999998753 3567899987655 89999999999865 56
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC---CCcEEEEecC
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---NWTVKVCDFG 806 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~---dg~IKL~DFG 806 (931)
++|||||||+||+|.+++.+.. ...+++.+++.++.||+.||+|||++| |+||||||+|||++. .+.+||+|||
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccc
Confidence 7999999999999999997632 346999999999999999999999999 999999999999985 5679999999
Q ss_pred ccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc--cccCCC-
Q 002355 807 LSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN--RRLAIP- 883 (931)
Q Consensus 807 lAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~--~r~~lP- 883 (931)
+|+...... .....+||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+.......+.... ....+|
T Consensus 160 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~ 238 (335)
T d2ozaa1 160 FAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 238 (335)
T ss_dssp TCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred eeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 998655432 3356689999999999999999999999999999999999999998766544433332211 122233
Q ss_pred ---CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 884 ---QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 884 ---~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
..+++++.+||.+||+.||++|||+.|+++|
T Consensus 239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2578899999999999999999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=404.12 Aligned_cols=247 Identities=26% Similarity=0.361 Sum_probs=205.6
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC------
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP------ 729 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~------ 729 (931)
.++|+++++||+|+||+||+|++ +++.||||+++.........+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 47999999999999999999987 4888999999876666666778999999999999999999999997554
Q ss_pred eEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 730 HLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 730 ~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
++|+||||+ +.+|..+++. ..+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhccccccccccccccee
Confidence 579999999 7788888764 35999999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc----------
Q 002355 810 FKANTFISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR---------- 878 (931)
Q Consensus 810 ~~~~~~~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~---------- 878 (931)
..... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.............
T Consensus 170 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 170 QADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp ECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred ccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 76554 2456799999999998764 568999999999999999999999988776554433221110
Q ss_pred -------------------ccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 -------------------RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 -------------------r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
........++++.+||.+||.+||.+|||+.|+|+|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 011335678999999999999999999999999987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=397.73 Aligned_cols=241 Identities=22% Similarity=0.378 Sum_probs=205.4
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccch----HHHHHHHHHHHHHHhcC--CCCeeeEEeeeeeCCe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLD----DQLKEFLREVAIMKRVR--HPNVVLFMGAVTKRPH 730 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~----~~~~~~l~EIkILk~L~--HpNIV~Lid~f~~~~~ 730 (931)
++|++.++||+|+||+||+|++ +++.||||++....... ....++.+|+.+|++++ |||||+++++|...+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 6899999999999999999987 47889999998654322 11234668999999996 8999999999999999
Q ss_pred EEEEEeecCC-CCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC-CCcEEEEecCcc
Q 002355 731 LSIVTEYLPR-GSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-NWTVKVCDFGLS 808 (931)
Q Consensus 731 l~LVmEy~~G-gSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~-dg~IKL~DFGlA 808 (931)
.++||||+.+ +++.+++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++. ++.+||+|||+|
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccc
Confidence 9999999976 578888865 236999999999999999999999999 999999999999985 479999999999
Q ss_pred ccccccccccCCCCCCCcccCcccccCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccCCCCCCh
Q 002355 809 RFKANTFISSKSVAGTPEWMAPEFLRGEPS-NEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLAIPQNTS 887 (931)
Q Consensus 809 r~~~~~~~~~~~~~GT~~Y~APEvL~~~~~-t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~lP~~~s 887 (931)
+..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.. + + ......++..+|
T Consensus 159 ~~~~~~--~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~----i--~~~~~~~~~~~s 228 (273)
T d1xwsa_ 159 ALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----I--IRGQVFFRQRVS 228 (273)
T ss_dssp EECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----H--HHCCCCCSSCCC
T ss_pred eecccc--cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--H----H--hhcccCCCCCCC
Confidence 865544 2345789999999999987665 567899999999999999999997632 1 1 123445778899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 888 PVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 888 ~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
+++++||.+||..||++|||++|+++|
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 999999999999999999999999886
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-45 Score=394.40 Aligned_cols=254 Identities=31% Similarity=0.495 Sum_probs=212.4
Q ss_pred EEEEEecccCceEEEEEEEcC---C--ceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee-CCeEEEEE
Q 002355 662 HVKERVGAGSFGTVHRAEWHG---S--DVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK-RPHLSIVT 735 (931)
Q Consensus 662 ~Ii~kLG~G~fGtVylAr~~g---~--~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~-~~~l~LVm 735 (931)
+..++||+|+||+||+|++.. + .||||+++.. .......++.+|+++|++++||||+++++++.. ++.+++||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 346889999999999998732 2 4889988643 244556889999999999999999999999765 56899999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTF 815 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~ 815 (931)
|||++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 109 E~~~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp ECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEeecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999999875 2345788889999999999999999999 9999999999999999999999999998643321
Q ss_pred ----cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhcccccCCCCCChHHH
Q 002355 816 ----ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLG-PAQVVGAVAFQNRRLAIPQNTSPVL 890 (931)
Q Consensus 816 ----~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~-~~eii~~i~~~~~r~~lP~~~s~eL 890 (931)
.......||+.|+|||++.+..++.++|||||||++|||+||..||.... ..++...+ ....+...|..+++++
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i-~~g~~~~~p~~~~~~l 263 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQPEYCPDPL 263 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH-HTTCCCCCCTTCCHHH
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCcccCcHHH
Confidence 12234568999999999999999999999999999999999877775543 33344443 3456677888999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 891 ASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 891 ~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
.+||.+||..||++||++.|++++|+.+++.
T Consensus 264 ~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 264 YEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999876
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=384.12 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=213.7
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCCeEEEEEe
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRPHLSIVTE 736 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~~l~LVmE 736 (931)
++|+++++||+|+||+||+|++ +++.||||+++..........++.+|+.+|+.++||||++++++|....+.++||+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 6899999999999999999987 57789999998776656667889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccccccccc
Q 002355 737 YLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFKANTFI 816 (931)
Q Consensus 737 y~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~~~~~~ 816 (931)
++.+++|..++.. ...+++..++.++.|++.||+|||++| |+||||||+|||++.++.+||+|||.|+.......
T Consensus 82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 9999998888765 346899999999999999999999999 99999999999999999999999999987665544
Q ss_pred ccCCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhccc----------------
Q 002355 817 SSKSVAGTPEWMAPEFLRGEP-SNEKSDVYSFGVILWELVTMQQPWNG-LGPAQVVGAVAFQNR---------------- 878 (931)
Q Consensus 817 ~~~~~~GT~~Y~APEvL~~~~-~t~ksDIWSLG~ILyELLTG~~PF~~-~~~~eii~~i~~~~~---------------- 878 (931)
......+++.|+|||++.+.. ++.++|||||||++|||++|+.||.. .+..+....+.....
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 445567889999999987665 68999999999999999999988644 344444433321111
Q ss_pred -----------ccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 -----------RLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 -----------r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
....+..+++.+.+||++||..||.+|||++|+|+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111334668899999999999999999999999876
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=387.62 Aligned_cols=252 Identities=22% Similarity=0.307 Sum_probs=202.3
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee--------
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK-------- 727 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~-------- 727 (931)
.++|+++++||+|+||+||+|++ +++.||||++...........++.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 48999999999999999999987 57889999987765544445678899999999999999999998854
Q ss_pred CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCc
Q 002355 728 RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGL 807 (931)
Q Consensus 728 ~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGl 807 (931)
..++|+||||+.++.+..+.. ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEeeecce
Confidence 457899999997766554443 2456899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccc----ccccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccccC-
Q 002355 808 SRFKANT----FISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRLA- 881 (931)
Q Consensus 808 Ar~~~~~----~~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~~- 881 (931)
++..... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9754322 1223445799999999998765 688999999999999999999999998777665544432111110
Q ss_pred -C-------------------C---------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 882 -I-------------------P---------QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 882 -l-------------------P---------~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
. + ...++++.+||.+||.+||++|||+.|+++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0 0 0125678899999999999999999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=394.71 Aligned_cols=246 Identities=24% Similarity=0.298 Sum_probs=200.6
Q ss_pred ceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeee------CCeE
Q 002355 660 ELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTK------RPHL 731 (931)
Q Consensus 660 rY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~------~~~l 731 (931)
+|+.+++||+|+||+||+|++ +++.||||++..... ...+|+++|++++||||++++++|.. ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 799999999999999999998 578899999976542 23479999999999999999999853 3468
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC-cEEEEecCcccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-TVKVCDFGLSRF 810 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg-~IKL~DFGlAr~ 810 (931)
|||||||.++.+..+.........+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+++.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhh
Confidence 999999976544443332234557999999999999999999999999 99999999999999775 899999999986
Q ss_pred ccccccccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcc------------
Q 002355 811 KANTFISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQN------------ 877 (931)
Q Consensus 811 ~~~~~~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~------------ 877 (931)
..... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+..+....
T Consensus 173 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 173 LVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred ccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 54432 2345689999999998875 468999999999999999999999998877655544432110
Q ss_pred ---ccc------------CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 878 ---RRL------------AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 878 ---~r~------------~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
... ......++++.+||.+||.+||++|||+.|+++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 1124578899999999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-44 Score=388.17 Aligned_cols=248 Identities=23% Similarity=0.358 Sum_probs=200.4
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC-----eE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP-----HL 731 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~-----~l 731 (931)
++|+++++||+|+||+||+|++ +++.||||++.... .....+.+.+|+.+|++++||||+++++++.... ++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 5799999999999999999987 58889999997644 3344567899999999999999999999986543 35
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
|++|+ +.|++|.+++.. ..+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+|...
T Consensus 87 ~l~~~-~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTH-LMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEE-CCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEe-ecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 55555 559999999964 25899999999999999999999999 999999999999999999999999999754
Q ss_pred cccc---cccCCCCCCCcccCcccccC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccc---------
Q 002355 812 ANTF---ISSKSVAGTPEWMAPEFLRG-EPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNR--------- 878 (931)
Q Consensus 812 ~~~~---~~~~~~~GT~~Y~APEvL~~-~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~--------- 878 (931)
.... ......+||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+...............
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 3321 12345679999999999854 5568899999999999999999999988765444332211100
Q ss_pred ---------------cc-----CCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 879 ---------------RL-----AIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 879 ---------------r~-----~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.. .....+++++.+||.+||.+||.+|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0124677899999999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=384.05 Aligned_cols=255 Identities=31% Similarity=0.502 Sum_probs=200.0
Q ss_pred CceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeCC----eEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKRP----HLSIV 734 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~~----~l~LV 734 (931)
++|.+.++||+|+||+||+|+++|+.||||++.... ........|+..+..++||||+++++++...+ .+|+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 578999999999999999999999999999986543 21122234555566789999999999997543 68999
Q ss_pred EeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhC------CCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 735 TEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNL------NPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 735 mEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~------G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
|||+++|+|.+++++. .+++..++.++.|++.||+|||+. .++||||||||+||||+.++++||+|||++
T Consensus 80 ~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999999762 488999999999999999999973 123999999999999999999999999999
Q ss_pred ccccccc----cccCCCCCCCcccCcccccCCC------CCchhHHHHHHHHHHHHHhCCCCCCCCC-------------
Q 002355 809 RFKANTF----ISSKSVAGTPEWMAPEFLRGEP------SNEKSDVYSFGVILWELVTMQQPWNGLG------------- 865 (931)
Q Consensus 809 r~~~~~~----~~~~~~~GT~~Y~APEvL~~~~------~t~ksDIWSLG~ILyELLTG~~PF~~~~------------- 865 (931)
+...... .......||+.|+|||++.+.. ++.++|||||||+||||+||..||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 8654321 1234567999999999987653 4668999999999999999988774321
Q ss_pred --hHHHHHHHHhcccccCCCCC-----ChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 002355 866 --PAQVVGAVAFQNRRLAIPQN-----TSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920 (931)
Q Consensus 866 --~~eii~~i~~~~~r~~lP~~-----~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llk 920 (931)
.......+.....++.++.. ....+.+||.+||+.||++|||+.||++.|+++..
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 12222233223333334332 23568999999999999999999999999998864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-43 Score=382.08 Aligned_cols=243 Identities=20% Similarity=0.312 Sum_probs=198.9
Q ss_pred cCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeeee--CCeEE
Q 002355 658 WDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTK--RPHLS 732 (931)
Q Consensus 658 ~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~--~~~l~ 732 (931)
.++|+++++||+|+||+||+|++ +++.||||+++... .+++.+|+.+|+.++ ||||++++++|.. ..+++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 37899999999999999999987 47889999987543 356789999999995 9999999999974 46799
Q ss_pred EEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCC-cEEEEecCccccc
Q 002355 733 IVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNW-TVKVCDFGLSRFK 811 (931)
Q Consensus 733 LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg-~IKL~DFGlAr~~ 811 (931)
+||||+.+++|..+.+ .+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+|+..
T Consensus 109 ~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceec
Confidence 9999999999977643 4899999999999999999999999 99999999999998655 6999999999865
Q ss_pred cccccccCCCCCCCcccCcccccCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHh-c------------
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRGE-PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQ-VVGAVAF-Q------------ 876 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~~-~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~e-ii~~i~~-~------------ 876 (931)
.... .....++|+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ....+.. .
T Consensus 181 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 181 HPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp CTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred cCCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 4432 33566789999999998775 47999999999999999999999997654321 1111100 0
Q ss_pred c----------------------cccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 877 N----------------------RRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 877 ~----------------------~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
. ........+++++.+||++||.+||.+|||++|+|+|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000113467899999999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-43 Score=374.74 Aligned_cols=253 Identities=21% Similarity=0.292 Sum_probs=204.6
Q ss_pred CceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCC-eeeEEeeeeeCCeEEEEE
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN-VVLFMGAVTKRPHLSIVT 735 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpN-IV~Lid~f~~~~~l~LVm 735 (931)
++|+++++||+|+||+||+|++. ++.||||++...... .++.+|+++++.++|+| |+.+..++..++..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 68999999999999999999874 778999998765422 34678999999998665 556667778889999999
Q ss_pred eecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC---CCcEEEEecCcccccc
Q 002355 736 EYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK---NWTVKVCDFGLSRFKA 812 (931)
Q Consensus 736 Ey~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~---dg~IKL~DFGlAr~~~ 812 (931)
||+ +++|...+.. ....+++..++.++.||+.||+|||++| ||||||||+|||++. +..+||+|||+|+...
T Consensus 83 e~~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 83 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp ECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEc-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 999 6677776654 2346999999999999999999999999 999999999999864 4579999999998654
Q ss_pred ccc-------cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hc---ccc
Q 002355 813 NTF-------ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVA---FQ---NRR 879 (931)
Q Consensus 813 ~~~-------~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~---~~---~~r 879 (931)
... .......||+.|+|||++.+..++.++|||||||++|||++|..||...........+. .. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 321 12345689999999999999999999999999999999999999998765443322211 11 111
Q ss_pred cCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhh
Q 002355 880 LAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLK 920 (931)
Q Consensus 880 ~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llk 920 (931)
...+..+|+++.+||.+||+.+|++||++.++.+.|+.++.
T Consensus 238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 22456889999999999999999999999999888887754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=388.81 Aligned_cols=247 Identities=23% Similarity=0.326 Sum_probs=204.5
Q ss_pred CceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeeeeC-----CeE
Q 002355 659 DELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVTKR-----PHL 731 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~~~-----~~l 731 (931)
++|+++++||+|+||+||+|++ +++.||||++..........+++.+|+++|++++|||||+++++|... ...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 7899999999999999999987 578899999987766666667889999999999999999999998633 234
Q ss_pred EEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCccccc
Q 002355 732 SIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRFK 811 (931)
Q Consensus 732 ~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~~ 811 (931)
+++|+++.|++|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+|++|||++...
T Consensus 98 ~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred EEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccccchhccc
Confidence 555666779999999964 35999999999999999999999999 999999999999999999999999999765
Q ss_pred cccccccCCCCCCCcccCcccccCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhccccc----------
Q 002355 812 ANTFISSKSVAGTPEWMAPEFLRGEP-SNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRRL---------- 880 (931)
Q Consensus 812 ~~~~~~~~~~~GT~~Y~APEvL~~~~-~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r~---------- 880 (931)
... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+.......
T Consensus 172 ~~~---~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 172 DDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp TGG---GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred Ccc---cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence 543 25567899999999877654 5889999999999999999999999877655544442211110
Q ss_pred -----------C--------CCCCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 881 -----------A--------IPQNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 881 -----------~--------lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
. .....++++++||++||..||.+|||+.|+++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0 123578899999999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.9e-43 Score=373.97 Aligned_cols=256 Identities=18% Similarity=0.252 Sum_probs=213.3
Q ss_pred ccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCC-CCeeeEEeeeeeCCeEEE
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRH-PNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~H-pNIV~Lid~f~~~~~l~L 733 (931)
..++|+++++||+|+||+||+|++ +++.||||++...... ..+.+|+++++.|.| +||+.+++++..+.+.++
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 357999999999999999999987 4778999998665322 246688999999975 899999999999999999
Q ss_pred EEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECC-----CCcEEEEecCcc
Q 002355 734 VTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDK-----NWTVKVCDFGLS 808 (931)
Q Consensus 734 VmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~-----dg~IKL~DFGlA 808 (931)
||||+ +++|.+++... +..++...+..++.|++.||+|||++| ||||||||+|||++. ++.+||+|||+|
T Consensus 79 vme~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEEec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEccccee
Confidence 99999 88999998752 346899999999999999999999999 999999999999974 578999999999
Q ss_pred ccccccc-------cccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcc-
Q 002355 809 RFKANTF-------ISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGP---AQVVGAVAFQN- 877 (931)
Q Consensus 809 r~~~~~~-------~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~---~eii~~i~~~~- 877 (931)
+...... ......+||+.|||||++.+..++.++|||||||++|||++|..||.+... ......+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 8654321 123456799999999999999999999999999999999999999986543 22222222111
Q ss_pred --cccCCCCCChHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHhhC
Q 002355 878 --RRLAIPQNTSPVLASLMESCWADDPAQRPSFANIVESLKKLLKS 921 (931)
Q Consensus 878 --~r~~lP~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~L~~Llks 921 (931)
....++..+|+++.+||..|++.+|++||+++.+.+.|+++++.
T Consensus 234 ~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 234 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 12224467899999999999999999999999999999988753
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-44 Score=390.60 Aligned_cols=247 Identities=26% Similarity=0.357 Sum_probs=197.1
Q ss_pred CceEEEEEecccCceEEEEEEEc--CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCeeeEEeeee------eCCe
Q 002355 659 DELHVKERVGAGSFGTVHRAEWH--GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNVVLFMGAVT------KRPH 730 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~--g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNIV~Lid~f~------~~~~ 730 (931)
++|+++++||+|+||+||+|++. |+.||||++...........++.+|+.+|++++||||++++++|. ...+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999984 788999999887766666778999999999999999999999995 3478
Q ss_pred EEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 731 LSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
+|+||||+.++ +.+.+.. .+++..++.++.||+.||+|||++| |+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchH-HHHhhhc-----CCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeechhhhhc
Confidence 99999999655 4444432 4899999999999999999999999 99999999999999999999999999886
Q ss_pred ccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcccc-----------
Q 002355 811 KANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAFQNRR----------- 879 (931)
Q Consensus 811 ~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~~~~r----------- 879 (931)
..... .....+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+......
T Consensus 169 ~~~~~-~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 169 AGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred ccccc-ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 55443 334567899999999999999999999999999999999999999887765544333211100
Q ss_pred ---------cC--------------CC------CCChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 880 ---------LA--------------IP------QNTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 880 ---------~~--------------lP------~~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
.. .+ ...++++.+||++||.+||++|||++|+|+|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 00 1236678999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-44 Score=388.03 Aligned_cols=253 Identities=24% Similarity=0.396 Sum_probs=211.1
Q ss_pred ccCceEEEEEecccCceEEEEEEE-----cCCceEEEEEeecccch--HHHHHHHHHHHHHHhcCC-CCeeeEEeeeeeC
Q 002355 657 SWDELHVKERVGAGSFGTVHRAEW-----HGSDVAVKVLTVQDFLD--DQLKEFLREVAIMKRVRH-PNVVLFMGAVTKR 728 (931)
Q Consensus 657 ~~drY~Ii~kLG~G~fGtVylAr~-----~g~~VAVKVlk~~~~~~--~~~~~~l~EIkILk~L~H-pNIV~Lid~f~~~ 728 (931)
..++|+++++||+|+||+||+|++ +|+.||||+++...... ...+.+.+|+++|++++| |||+++++++.+.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 348899999999999999999976 36789999987654321 223567899999999976 8999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEEecCcc
Q 002355 729 PHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVCDFGLS 808 (931)
Q Consensus 729 ~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~DFGlA 808 (931)
..+++||||+.+++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred CceeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999999763 35788999999999999999999999 999999999999999999999999999
Q ss_pred ccccc-cccccCCCCCCCcccCcccccCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--cccccCCC
Q 002355 809 RFKAN-TFISSKSVAGTPEWMAPEFLRGE--PSNEKSDVYSFGVILWELVTMQQPWNGLGPAQVVGAVAF--QNRRLAIP 883 (931)
Q Consensus 809 r~~~~-~~~~~~~~~GT~~Y~APEvL~~~--~~t~ksDIWSLG~ILyELLTG~~PF~~~~~~eii~~i~~--~~~r~~lP 883 (931)
+.... .........|++.|++||.+.+. .++.++|||||||+||+|++|..||.+.+.......+.. ......+|
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~ 256 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc
Confidence 76433 22234556799999999999764 357899999999999999999999987654443333322 23345677
Q ss_pred CCChHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 002355 884 QNTSPVLASLMESCWADDPAQRP-----SFANIVES 914 (931)
Q Consensus 884 ~~~s~eL~dLI~rcL~~DPeeRP-----Sa~ELLq~ 914 (931)
..+++++.+||.+||.+||.+|| |++|+++|
T Consensus 257 ~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 88999999999999999999999 58999875
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-40 Score=356.99 Aligned_cols=260 Identities=17% Similarity=0.291 Sum_probs=198.4
Q ss_pred CCcCCCCCCCCCCCccccccccccccCceEEEEEecccCceEEEEEEE--cCCceEEEEEeecccchHHHHHHHHHHHHH
Q 002355 633 KFPVGPGPRYLNIEPSLAMDWLEISWDELHVKERVGAGSFGTVHRAEW--HGSDVAVKVLTVQDFLDDQLKEFLREVAIM 710 (931)
Q Consensus 633 ~~Pv~~G~ry~~~epsl~~~~lei~~drY~Ii~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~~~~~~~~~~l~EIkIL 710 (931)
+||+..|+.+.+ ++|+++++||+|+||+||+|++ +|+.||||+++... ...+.+.+|++++
T Consensus 1 ~~p~~~g~~~~~--------------~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l 63 (362)
T d1q8ya_ 1 YHPAFKGEPYKD--------------ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLL 63 (362)
T ss_dssp CCCCCTTCEETT--------------TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHH
T ss_pred CCCCCCCCCccC--------------CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHH
Confidence 578888877643 6799999999999999999987 57889999997653 2234667899988
Q ss_pred HhcC-----------CCCeeeEEeeeee--CCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHh
Q 002355 711 KRVR-----------HPNVVLFMGAVTK--RPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHN 777 (931)
Q Consensus 711 k~L~-----------HpNIV~Lid~f~~--~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs 777 (931)
+.+. |+||+++++++.. ....+++|+++..+..............+++..++.++.||+.||+|||+
T Consensus 64 ~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~ 143 (362)
T d1q8ya_ 64 QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR 143 (362)
T ss_dssp HHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh
Confidence 8875 5789999988853 45666777666555443333333345678999999999999999999997
Q ss_pred -CCCCEEEeccCCCCeEECCCCc------EEEEecCccccccccccccCCCCCCCcccCcccccCCCCCchhHHHHHHHH
Q 002355 778 -LNPPILHWDLKSPNLLVDKNWT------VKVCDFGLSRFKANTFISSKSVAGTPEWMAPEFLRGEPSNEKSDVYSFGVI 850 (931)
Q Consensus 778 -~G~~IIHrDLKPeNILLd~dg~------IKL~DFGlAr~~~~~~~~~~~~~GT~~Y~APEvL~~~~~t~ksDIWSLG~I 850 (931)
+| |+||||||+||||+.++. ++|+|||.+...... ....+||+.|+|||++.+..++.++|||||||+
T Consensus 144 ~~~--IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 218 (362)
T d1q8ya_ 144 RCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACL 218 (362)
T ss_dssp TTC--EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHH
T ss_pred hcC--cccccCChhHeeeeccCcccccceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHH
Confidence 88 999999999999987653 999999999865443 255679999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChH------HHHHHH-Hhcc---------------------------------------cccCCCC
Q 002355 851 LWELVTMQQPWNGLGPA------QVVGAV-AFQN---------------------------------------RRLAIPQ 884 (931)
Q Consensus 851 LyELLTG~~PF~~~~~~------eii~~i-~~~~---------------------------------------~r~~lP~ 884 (931)
+++|++|+.||...... ...... .... .....+.
T Consensus 219 l~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (362)
T d1q8ya_ 219 IFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 298 (362)
T ss_dssp HHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCH
T ss_pred HHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCc
Confidence 99999999999754321 111100 0000 0011123
Q ss_pred CChHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002355 885 NTSPVLASLMESCWADDPAQRPSFANIVES 914 (931)
Q Consensus 885 ~~s~eL~dLI~rcL~~DPeeRPSa~ELLq~ 914 (931)
..++++.+||.+||.+||.+|||++|+|+|
T Consensus 299 ~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 299 DEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred ccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 346789999999999999999999999876
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.3e-22 Score=201.65 Aligned_cols=164 Identities=15% Similarity=0.096 Sum_probs=118.4
Q ss_pred eEEEEEecccCceEEEEEEE-cCCceEEEEEeecccc----------------hHHHHHHHHHHHHHHhcCCCCeeeEEe
Q 002355 661 LHVKERVGAGSFGTVHRAEW-HGSDVAVKVLTVQDFL----------------DDQLKEFLREVAIMKRVRHPNVVLFMG 723 (931)
Q Consensus 661 Y~Ii~kLG~G~fGtVylAr~-~g~~VAVKVlk~~~~~----------------~~~~~~~l~EIkILk~L~HpNIV~Lid 723 (931)
+.+.++||+|+||+||+|++ +|+.||||+++..... ......+.+|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 36889999999999999986 6788999997642211 011234567889999999999998876
Q ss_pred eeeeCCeEEEEEeecCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCCCCEEEeccCCCCeEECCCCcEEEE
Q 002355 724 AVTKRPHLSIVTEYLPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLNPPILHWDLKSPNLLVDKNWTVKVC 803 (931)
Q Consensus 724 ~f~~~~~l~LVmEy~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G~~IIHrDLKPeNILLd~dg~IKL~ 803 (931)
+.. .+++|||+.+..+.+ ++...+..++.||+.+|+|||++| |+||||||+|||++.+ .++|+
T Consensus 82 ~~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-EEEEC
T ss_pred ecC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-CEEEE
Confidence 532 279999998765533 233445678999999999999999 9999999999999865 58999
Q ss_pred ecCccccccccccccCCCCCCCcccCcc-----cccCCCCCchhHHHHHHH
Q 002355 804 DFGLSRFKANTFISSKSVAGTPEWMAPE-----FLRGEPSNEKSDVYSFGV 849 (931)
Q Consensus 804 DFGlAr~~~~~~~~~~~~~GT~~Y~APE-----vL~~~~~t~ksDIWSLG~ 849 (931)
|||+|........ ..|.... .+....++.++|+||+.-
T Consensus 145 DFG~a~~~~~~~~--------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 145 DFPQSVEVGEEGW--------REILERDVRNIITYFSRTYRTEKDINSAID 187 (191)
T ss_dssp CCTTCEETTSTTH--------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred ECCCcccCCCCCc--------HHHHHHHHHHHHHHHcCCCCCcccHHHHHH
Confidence 9999976543311 1111110 012345677889999653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.42 E-value=4.5e-07 Score=91.21 Aligned_cols=142 Identities=13% Similarity=0.031 Sum_probs=101.1
Q ss_pred CceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcC-CCCeeeEEeeeeeCCeEEEEEee
Q 002355 659 DELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVR-HPNVVLFMGAVTKRPHLSIVTEY 737 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~-HpNIV~Lid~f~~~~~l~LVmEy 737 (931)
+.|+.++..+-++.+.||+....++.+.||+........ ...+.+|..++..|. +--+.+++.+...++..++||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 577777776666668999998888888899876543211 224567888888774 32356788888888999999999
Q ss_pred cCCCCHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 002355 738 LPRGSLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN-------------------------------------- 779 (931)
Q Consensus 738 ~~GgSL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G-------------------------------------- 779 (931)
++|.++.+..... .. ...++.++...+..||+..
T Consensus 92 l~G~~~~~~~~~~-----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 92 ADGVLCSEEYEDE-----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHTTTC-----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred ccccccccccccc-----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 9998886654220 11 2234556666677777532
Q ss_pred -------------------CCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 780 -------------------PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 780 -------------------~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
..++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 0279999999999999876677999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.79 E-value=3.4e-05 Score=76.73 Aligned_cols=129 Identities=19% Similarity=0.173 Sum_probs=83.1
Q ss_pred EecccC-ceEEEEEEEcC-CceEEEEEeecccchHHHHHHHHHHHHHHhcCCC--CeeeEEeeeeeCCeEEEEEeecCCC
Q 002355 666 RVGAGS-FGTVHRAEWHG-SDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHP--NVVLFMGAVTKRPHLSIVTEYLPRG 741 (931)
Q Consensus 666 kLG~G~-fGtVylAr~~g-~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~Hp--NIV~Lid~f~~~~~l~LVmEy~~Gg 741 (931)
.+..|. -+.||+....+ ..+.+|....... ..+..|...|+.|... .+.+++.+..+++..++||++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 344554 46899998754 4578887654432 2356788888777432 3567788888888999999999887
Q ss_pred CHHHHhhcCCCCCCCcHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 002355 742 SLYRLIHRPAAGEMMDQRRRLRMALDVAKGINYLHNLN------------------------------------------ 779 (931)
Q Consensus 742 SL~d~L~r~~~~~~L~e~~~~~Ia~QIa~AL~yLHs~G------------------------------------------ 779 (931)
++.... .... .++.++...|.-||+..
T Consensus 92 ~~~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
T d1nd4a_ 92 DLLSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 160 (255)
T ss_dssp ETTTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred cccccc--------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence 663211 1110 11223333334444211
Q ss_pred --------------CCEEEeccCCCCeEECCCCcEEEEecCcccc
Q 002355 780 --------------PPILHWDLKSPNLLVDKNWTVKVCDFGLSRF 810 (931)
Q Consensus 780 --------------~~IIHrDLKPeNILLd~dg~IKL~DFGlAr~ 810 (931)
..++|+|+.|.|||++.+..+.|+||+.+..
T Consensus 161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1279999999999999876678999997743
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.00 E-value=0.00074 Score=72.74 Aligned_cols=78 Identities=15% Similarity=0.081 Sum_probs=48.3
Q ss_pred EEEecccCceEEEEEEE--cCCceEEEEEeecc-c----chHHHHHHHHHHHHHHhcC-C--CCeeeEEeeeeeCCeEEE
Q 002355 664 KERVGAGSFGTVHRAEW--HGSDVAVKVLTVQD-F----LDDQLKEFLREVAIMKRVR-H--PNVVLFMGAVTKRPHLSI 733 (931)
Q Consensus 664 i~kLG~G~fGtVylAr~--~g~~VAVKVlk~~~-~----~~~~~~~~l~EIkILk~L~-H--pNIV~Lid~f~~~~~l~L 733 (931)
.+.||.|....||++.. .++.++||.-.... . ......+...|...|+.+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45689999999999975 35678888654311 0 0011234556888887763 2 345566644 4445678
Q ss_pred EEeecCCCCH
Q 002355 734 VTEYLPRGSL 743 (931)
Q Consensus 734 VmEy~~GgSL 743 (931)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.26 E-value=0.0028 Score=66.05 Aligned_cols=68 Identities=12% Similarity=0.045 Sum_probs=44.2
Q ss_pred ceEEEEEEE-cCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCe--eeEE-----eeeeeCCeEEEEEeecCCCC
Q 002355 672 FGTVHRAEW-HGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV--VLFM-----GAVTKRPHLSIVTEYLPRGS 742 (931)
Q Consensus 672 fGtVylAr~-~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNI--V~Li-----d~f~~~~~l~LVmEy~~GgS 742 (931)
--.||+++. +|+.|++|+.+....+.. ++..|+..+..|...+| +..+ ..+..++..+.+++++.|..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~---~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTAD---QILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHH---HHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHH---HHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 357999986 677899999876544443 45678888887742222 1111 12345677889999987644
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.19 E-value=0.0082 Score=61.38 Aligned_cols=147 Identities=9% Similarity=-0.009 Sum_probs=78.0
Q ss_pred CceEEEEEecccCceEEEEEEEcCCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCC-----eeeEE---eeeeeCCe
Q 002355 659 DELHVKERVGAGSFGTVHRAEWHGSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPN-----VVLFM---GAVTKRPH 730 (931)
Q Consensus 659 drY~Ii~kLG~G~fGtVylAr~~g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpN-----IV~Li---d~f~~~~~ 730 (931)
+++.-.+.|..|---+.|+.+.++..+++|+...... ...+..|++++..|...+ .+... .+......
T Consensus 18 g~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~----~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~ 93 (316)
T d2ppqa1 18 GSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 93 (316)
T ss_dssp CCEEEEEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred CCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCCC----HHHHHHHHHHHHhhhhccccccccceecCCCcceeeecc
Confidence 3455567788888899999998888899999865321 134456777777774222 22110 01223455
Q ss_pred EEEEEeecCCCCHHHH-----------h---hc-------CCCCCCCc-----------------HHHHHHHHHHHHHHH
Q 002355 731 LSIVTEYLPRGSLYRL-----------I---HR-------PAAGEMMD-----------------QRRRLRMALDVAKGI 772 (931)
Q Consensus 731 l~LVmEy~~GgSL~d~-----------L---~r-------~~~~~~L~-----------------e~~~~~Ia~QIa~AL 772 (931)
...++.++.|...... + +. ........ .......+..+...+
T Consensus 94 ~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 173 (316)
T d2ppqa1 94 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 173 (316)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred cceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhh
Confidence 6666776655433110 0 00 00000000 001111222222223
Q ss_pred HHHHh--CCCCEEEeccCCCCeEECCCCcEEEEecCccc
Q 002355 773 NYLHN--LNPPILHWDLKSPNLLVDKNWTVKVCDFGLSR 809 (931)
Q Consensus 773 ~yLHs--~G~~IIHrDLKPeNILLd~dg~IKL~DFGlAr 809 (931)
.-.+. ...++||+|+.+.||+++.+...-|+||+.+.
T Consensus 174 ~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 174 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 32221 11239999999999999988777899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.78 E-value=0.0095 Score=63.47 Aligned_cols=82 Identities=16% Similarity=0.351 Sum_probs=54.0
Q ss_pred ccccccCceEEEEEecccCceEEEEEEEc---------CCceEEEEEeecccchHHHHHHHHHHHHHHhcCCCCe-eeEE
Q 002355 653 WLEISWDELHVKERVGAGSFGTVHRAEWH---------GSDVAVKVLTVQDFLDDQLKEFLREVAIMKRVRHPNV-VLFM 722 (931)
Q Consensus 653 ~lei~~drY~Ii~kLG~G~fGtVylAr~~---------g~~VAVKVlk~~~~~~~~~~~~l~EIkILk~L~HpNI-V~Li 722 (931)
|-.+..+.+++ +.|+-|-.-.+|++... .+.|.+++.-... . . ....+|..+++.+.-.++ .+++
T Consensus 37 W~~~~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~--~-idr~~E~~i~~~ls~~gl~Pkll 111 (395)
T d1nw1a_ 37 WKTVPLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T--E-SHLVAESVIFTLLSERHLGPKLY 111 (395)
T ss_dssp HHHCCGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C--H-HHHHHHHHHHHHHHHTTSSSCEE
T ss_pred ccCCCccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-h--h-hHHHHHHHHHHHHHhCCCCCeEE
Confidence 43445566665 67899999999999763 2457777765321 1 1 234578888888853344 5777
Q ss_pred eeeeeCCeEEEEEeecCCCCH
Q 002355 723 GAVTKRPHLSIVTEYLPRGSL 743 (931)
Q Consensus 723 d~f~~~~~l~LVmEy~~GgSL 743 (931)
++|.+ .+||||++|..|
T Consensus 112 ~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 112 GIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp EEETT----EEEECCCCEEEC
T ss_pred EEcCC----ceEEEEeccccC
Confidence 77754 589999987654
|
| >d2f4ma1 d.3.1.4 (A:164-450) Peptide:N-glycanase 1, PNG1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Cysteine proteinases superfamily: Cysteine proteinases family: Transglutaminase core domain: Peptide:N-glycanase 1, PNG1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=93.79 E-value=0.022 Score=59.27 Aligned_cols=54 Identities=17% Similarity=0.116 Sum_probs=45.4
Q ss_pred eecccccchhhhHHHHHHHhhhcCCCceeeecccccCCCCceeEEEEecCcccccceeEeec
Q 002355 401 IGSLSMGLCRHRAILFKKLADYIGLPCRIARGCRYCEADHRSSCLVKIEDDRRSSREYVVDL 462 (931)
Q Consensus 401 lG~l~~G~~rhRAlLFKvLaD~i~l~c~lv~G~~y~~~~~~~~~~v~~~~~~~~~~~~ivDl 462 (931)
|=.-+.|.|.|-|.||-.++=.+|+|||.|.| -.+|+|++|......+ =.-||-
T Consensus 135 ll~tr~G~C~e~a~~~~~~~Ra~g~~aR~v~~-----~~~H~W~Ev~~~~~~r---Wv~vDp 188 (287)
T d2f4ma1 135 LLETRCGRCGEWANCFTLCCRALGFEARYVWD-----YTDHVWTEVYSPSQQR---WLHCDA 188 (287)
T ss_dssp HHHHCEESHHHHHHHHHHHHHHTTCCEEEEEE-----TTTEEEEEEEETTTTE---EEEEET
T ss_pred HHHhcCccHHHHHHHHHHHHHHcCCCeEEEec-----CCcceeEEEEecCCCc---EEEecC
Confidence 33567899999999999999999999999999 6799999999988732 334564
|
| >d2q3za4 d.3.1.4 (A:146-461) Transglutaminase catalytic domain {Human (Homo sapiens), tissue isozyme [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Cysteine proteinases superfamily: Cysteine proteinases family: Transglutaminase core domain: Transglutaminase catalytic domain species: Human (Homo sapiens), tissue isozyme [TaxId: 9606]
Probab=85.84 E-value=0.17 Score=52.63 Aligned_cols=83 Identities=14% Similarity=0.164 Sum_probs=60.2
Q ss_pred HhhccChHHHHHHHHHHHHHhh------CCCc-CCCcchhhhhHHHHHHHHHhhhcCceEEeecccccchhhhHHHHHHH
Q 002355 347 YCASENTLVLVEELGKLVAICM------GGTF-PIEQGDLHKRWKMHSKRLRKFRKCIVLPIGSLSMGLCRHRAILFKKL 419 (931)
Q Consensus 347 ~~~~~~~~~~~~~la~~V~~~m------gg~~-~~~~~~~~~~~~~~~~~l~~~~~~~v~plG~l~~G~~rhRAlLFKvL 419 (931)
++...+|-.++..|.+.|-..= |.-. .-.+......|.-+..-|++..++...| ++.|-|-|-|-.+-++
T Consensus 66 ~~~R~dPv~V~Rv~samvns~dd~GVL~G~Ws~~y~~G~~P~~W~GSv~IL~q~~~~~~~p---VkyGqCwvFA~v~~tv 142 (316)
T d2q3za4 66 CSRRSSPVYVGRVGSGMVNCNDDQGVLLGRWDNNYGDGVSPMSWIGSVDILRRWKNHGCQR---VKYGQCWVFAAVACTV 142 (316)
T ss_dssp HHHTTCHHHHHHHHHHTTTCTTTTSSEEECCSSCCTTSCCTTTCCBSHHHHHHHHHTTTCC---EEEECHHHHHHHHHHH
T ss_pred hhhcCCchhhhhhhhhhhccCCCCceeecccccccCCCcCCCCCCCcHHHHHHHHHcCCcc---cccchhHHHHHHHHHH
Confidence 3445788888888888875221 1000 0111122346887777888888877766 7899999999999999
Q ss_pred hhhcCCCceeeec
Q 002355 420 ADYIGLPCRIARG 432 (931)
Q Consensus 420 aD~i~l~c~lv~G 432 (931)
+=.+|||||+|.|
T Consensus 143 lR~lGIPaRvVT~ 155 (316)
T d2q3za4 143 LRCLGIPTRVVTN 155 (316)
T ss_dssp HHHHTCCEEEEEE
T ss_pred HHhcCCCceEecc
Confidence 9999999999999
|